Citrus Sinensis ID: 001561

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050--
Protein Sequence
MWESMVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA
Secondary Structure (PSIPRED)
cccccHHccccHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccccccccEEEccccccccccccEEEEEccccccEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEEcccccccccccEEEcccccccccccHHHHHccccccEEEccccccccccccccccccccEEccccccccccccHHHcccccccEEEccccccEEcccHHccccccccEEEcccccccccccccccccccccccccccccccccccHHHHccccccEEEcccccccccccccccccccccEEccccccccccccccccccccccEEEccccEEEEEccccccccccccEEEcccccccccccccccccccccccEEEcccccccccccccccccccccEEEccccEEEEcccHHHHcccccccEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccHHHHHccccccEEEcccccccccccHHHHcccccccccccccccccccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccEEEEEccccccccHHHHHHHHcccccccEEEEccccEEEEEEEccccEEEEEEEEcccccccHHHHHHHHHHccccccccccEEEEEEEcccEEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHcccccccccccEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHccccccEEEccccccccHHHHHHHHHHHHHccccccccccccHHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHccccccccccccccccccEEEEEccccccccccccEEEEEEccccccccccHHHcccccccEEEcccccccccccHHHHcccccEEEEcccccccccccHHHccccccEEEEEccccccccccccccccccEEEEEccccccccccHHHHHccccccEEEEccccccccccccccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEEccccccccccccccHccccccEEEEEEcccccccccccccccccEEEEEEccccccccccHHHHccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHHccccccEEEcccccccccccccEEEcccccccccccccccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccccccccccccHHccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEccccccccccHHHHHHHHccccHHHEEEccccEEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHcHHHHHEEEcccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEEHHHEEEEccccHHHHcccHHHHccccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccEEccHHHcccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
MWESMVVLGFVPMTCLKWLFLAFFVCSclglqtpfqscdpsdLLALKEFAgnltngsiitswsnesmccqwdgvvcghgstgsnagrvTMLILprkglkgiiprslghlnqlkLLDLScnhlegvvpvelsnlkqlevldlshnmlsgpvsgMLAGLNLIQSLnvssnsfngslfelgefsnlavfnisnnsftgkLNSRIWSASKEIQILDLSMnhfmgslqgldhspslkqlhvdnnllggdlpdslysmsSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFgnqfsgklpnvlgnlTQLEFFVAhsnsfsgplplslslcsklhvldlrnnsltgpidlnfsglsslctldlatnhfsgplpnslsdchdlKILSLAKNelsgqvpesfgKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTtliltknfvgeeipenvggFESLMVLALGncglkghipVWLLRCKKLQVLdlswnhfdgnippwigqmENLFyldfsnntltgeipKSLTELKSLIssnctssnptasagiplyvkhnrstnglpynqassfppsvflsnnringtippeigqlkhlhvldlsrnnitgtipssiseirnlevldlssndlhgsipgsfeklTFLSKFSvannhlqgtiptggqfysfpnssfegnpglcgeidspcdsmhaklkpvipsgsnskfgpgsiIAITFSIGVGIALLLAVTLLKMsrrdsgcpiddldedmgrpqrLSEALASSKLVlfqnsdckdltvsDLLKStnnfnqaniigcgGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGycrhgndrLLIYSYMENGSLDYWLhesvdkdsvlKWDVRLKIAQGAARGLAYLHKvcephivhrdvkssnilldEKFEAHLAdfglsrllrpydthvttdlvgtlgyippeysqtltatcrgdvYSFGVVLLELLtgrrpvevckgkncrDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKcidqdprrrpfIEEVVTWLdgigidaa
Flexible Loop (DISEMBL)
MWESMVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLtgrrpvevckgkncrDLVSWVfqmksekreveiidasiwHKDREKQLLEMLEIACKcidqdprrrpFIEEVVtwldgigidaa
Low Complexity Region (SEG)
MWESMVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHsnsfsgplplslslcsklHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEsfgkltsllflslsnnsfnhlsGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA
Disordered region (IsUnstruct)
***SMVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLD****LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLT*L******************IPLYVK******************SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFE**PGLCGEI**********************FGPGSIIAITFSIGVGIALLLAVTLLKMS****************************KLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM**EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI***
Disordered Region (DISOPRED)
*******LGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFA************SNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDS*************************IIAITFSIGVGIALLLAVTLLKMSRRD*************************KLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG*MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE*********L*SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI***
Disordered Region (DISEMBL)
MWESMVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA
Disordered Region (DISPRO)
*W*SMVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCD***************SKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDS*********************ASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MWESMVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1052	2.2.26 [Sep-21-2011]
Q9FN37	1036	Phytosulfokine receptor 2	yes	no	0.971	0.986	0.664	0.0
Q8LPB4	1021	Phytosulfokine receptor 1	N/A	no	0.944	0.973	0.492	0.0
Q9ZVR7	1008	Phytosulfokine receptor 1	no	no	0.943	0.985	0.490	0.0
Q9C7S5	1095	Tyrosine-sulfated glycope	no	no	0.971	0.933	0.450	0.0
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.947	0.855	0.337	1e-148
Q9LJF3	1164	Receptor-like protein kin	no	no	0.902	0.815	0.342	1e-147
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.884	0.778	0.371	1e-143
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.921	0.773	0.341	1e-143
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.885	0.746	0.347	1e-141
Q9ZPS9	1143	Serine/threonine-protein	no	no	0.923	0.850	0.333	1e-141

>sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1

 Score = 1338 bits (3463), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 692/1041 (66%), Positives = 834/1041 (80%), Gaps = 19/1041 (1%)

Query: 19   LFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGH 78
            L L FFV S +      Q C P+DL AL+E AG L N S+  SW N S CC+WDGV C  
Sbjct: 5    LLLVFFVGSSVS-----QPCHPNDLSALRELAGALKNKSVTESWLNGSRCCEWDGVFC-E 58

Query: 79   GSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEV 138
            GS  S  GRVT L+LP KGL+G+I +SLG L +L++LDLS N L+G VP E+S L+QL+V
Sbjct: 59   GSDVS--GRVTKLVLPEKGLEGVISKSLGELTELRVLDLSRNQLKGEVPAEISKLEQLQV 116

Query: 139  LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLN 198
            LDLSHN+LSG V G+++GL LIQSLN+SSNS +G L ++G F  L + N+SNN F G+++
Sbjct: 117  LDLSHNLLSGSVLGVVSGLKLIQSLNISSNSLSGKLSDVGVFPGLVMLNVSNNLFEGEIH 176

Query: 199  SRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 257
              + S+S  IQ+LDLSMN  +G+L GL + S S++QLH+D+N L G LPD LYS+  L+ 
Sbjct: 177  PELCSSSGGIQVLDLSMNRLVGNLDGLYNCSKSIQQLHIDSNRLTGQLPDYLYSIRELEQ 236

Query: 258  VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 317
            +SLS N  SG+LS+ +SNL+ L+ L+I  N+FS  +P+V GNLTQLE     SN FSG  
Sbjct: 237  LSLSGNYLSGELSKNLSNLSGLKSLLISENRFSDVIPDVFGNLTQLEHLDVSSNKFSGRF 296

Query: 318  PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 377
            P SLS CSKL VLDLRNNSL+G I+LNF+G + LC LDLA+NHFSGPLP+SL  C  +KI
Sbjct: 297  PPSLSQCSKLRVLDLRNNSLSGSINLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPKMKI 356

Query: 378  LSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE 437
            LSLAKNE  G++P++F  L SLLFLSLSNNSF   S T++VLQ C+NL+TLIL+KNF+GE
Sbjct: 357  LSLAKNEFRGKIPDTFKNLQSLLFLSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGE 416

Query: 438  EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 497
            EIP NV GF++L +LALGNCGL+G IP WLL CKKL+VLDLSWNHF G IP WIG+ME+L
Sbjct: 417  EIPNNVTGFDNLAILALGNCGLRGQIPSWLLNCKKLEVLDLSWNHFYGTIPHWIGKMESL 476

Query: 498  FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASS 557
            FY+DFSNNTLTG IP ++TELK+LI  N T+S  T S+GIPLYVK N+S+NGLPYNQ S 
Sbjct: 477  FYIDFSNNTLTGAIPVAITELKNLIRLNGTASQMTDSSGIPLYVKRNKSSNGLPYNQVSR 536

Query: 558  FPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 617
            FPPS++L+NNR+NGTI PEIG+LK LH+LDLSRNN TGTIP SIS + NLEVLDLS N L
Sbjct: 537  FPPSIYLNNNRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHL 596

Query: 618  HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMH 677
            +GSIP SF+ LTFLS+FSVA N L G IP+GGQFYSFP+SSFEGN GLC  IDSPCD + 
Sbjct: 597  YGSIPLSFQSLTFLSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLM 656

Query: 678  AKLKPVIPSGSN------SKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDL 731
            + +  + P GS+       KFG  SI+ +T S+ +GI LLL+V LL++SR+D    I+D+
Sbjct: 657  SNM--LNPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDV 714

Query: 732  DEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT 791
            DE+      +S+AL  SK+VLF +  CKDL+V +LLKSTNNF+QANIIGCGGFGLVYKA 
Sbjct: 715  DEET--ISGVSKALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKAN 772

Query: 792  LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN 851
              +G+KAAVKRLSGDCGQMEREFQAEVEALSRA+HKNLVSLQGYC+HGNDRLLIYS+MEN
Sbjct: 773  FPDGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMEN 832

Query: 852  GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF 911
            GSLDYWLHE VD +  L WDVRLKIAQGAARGLAYLHKVCEP+++HRDVKSSNILLDEKF
Sbjct: 833  GSLDYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKF 892

Query: 912  EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 971
            EAHLADFGL+RLLRPYDTHVTTDLVGTLGYIPPEYSQ+L ATCRGDVYSFGVVLLEL+TG
Sbjct: 893  EAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTG 952

Query: 972  RRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDP 1031
            RRPVEVCKGK+CRDLVS VFQMK+EKRE E+ID +I     E+ +LEMLEIACKCID +P
Sbjct: 953  RRPVEVCKGKSCRDLVSRVFQMKAEKREAELIDTTIRENVNERTVLEMLEIACKCIDHEP 1012

Query: 1032 RRRPFIEEVVTWLDGIGIDAA 1052
            RRRP IEEVVTWL+ + +++ 
Sbjct: 1013 RRRPLIEEVVTWLEDLPMESV 1033

Phytosulfokine receptor with a serine/threonine-protein kinase activity.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1

 Score =  918 bits (2373), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 518/1051 (49%), Positives = 683/1051 (64%), Gaps = 57/1051 (5%)

Query: 19   LFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWS-NESM-----CCQWD 72
            L L  F    + + +   +C+ +DL AL+ F   L   S I  W  NES      CC W 
Sbjct: 10   LILVGFCVQIVVVNSQNLTCNSNDLKALEGFMRGLE--SSIDGWKWNESSSFSSNCCDWV 67

Query: 73   GVVCGHG-STG----SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVP 127
            G+ C    S G    + +GRV  L L R+ L G +  S+  L+QLK              
Sbjct: 68   GISCKSSVSLGLDDVNESGRVVELELGRRKLSGKLSESVAKLDQLK-------------- 113

Query: 128  VELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFN 187
                      VL+L+HN LSG ++  L  L+ ++ L++SSN F+G    L    +L V N
Sbjct: 114  ----------VLNLTHNSLSGSIAASLLNLSNLEVLDLSSNDFSGLFPSLINLPSLRVLN 163

Query: 188  ISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQ-GLDHSPSLKQLHVDNNLLGGDLP 246
            +  NSF G + + + +    I+ +DL+MN+F GS+  G+ +  S++ L + +N L G +P
Sbjct: 164  VYENSFHGLIPASLCNNLPRIREIDLAMNYFDGSIPVGIGNCSSVEYLGLASNNLSGSIP 223

Query: 247  DSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFF 306
              L+ +S+L  ++L  N  SG LS K+  L++L  L I  N+FSGK+P+V   L +L +F
Sbjct: 224  QELFQLSNLSVLALQNNRLSGALSSKLGKLSNLGRLDISSNKFSGKIPDVFLELNKLWYF 283

Query: 307  VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLP 366
             A SN F+G +P SLS    + +L LRNN+L+G I LN S +++L +LDLA+N FSG +P
Sbjct: 284  SAQSNLFNGEMPRSLSNSRSISLLSLRNNTLSGQIYLNCSAMTNLTSLDLASNSFSGSIP 343

Query: 367  NSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLT 426
            ++L +C  LK ++ AK +   Q+PESF    SL  LS SN+S  ++S  L +LQ C+NL 
Sbjct: 344  SNLPNCLRLKTINFAKIKFIAQIPESFKNFQSLTSLSFSNSSIQNISSALEILQHCQNLK 403

Query: 427  TLILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG 485
            TL+LT NF  EE+P      F++L VL + +C L+G +P WL     LQ+LDLSWN   G
Sbjct: 404  TLVLTLNFQKEELPSVPSLQFKNLKVLIIASCQLRGTVPQWLSNSPSLQLLDLSWNQLSG 463

Query: 486  NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNR 545
             IPPW+G + +LFYLD SNNT  GEIP SLT L+SL+S       P  S   P + K N 
Sbjct: 464  TIPPWLGSLNSLFYLDLSNNTFIGEIPHSLTSLQSLVSKENAVEEP--SPDFPFFKKKNT 521

Query: 546  STNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIR 605
            +  GL YNQ SSFPP + LS N +NG+I PE G L+ LHVL+L  NN++G IP+++S + 
Sbjct: 522  NAGGLQYNQPSSFPPMIDLSYNSLNGSIWPEFGDLRQLHVLNLKNNNLSGNIPANLSGMT 581

Query: 606  NLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 665
            +LEVLDLS N+L G+IP S  KL+FLS FSVA N L G IPTG QF +FPNSSFEGN GL
Sbjct: 582  SLEVLDLSHNNLSGNIPPSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGL 641

Query: 666  CGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSG 725
            CGE  SPC   H   +    S   SK     I+A+    G+G   LL VTLL + R  S 
Sbjct: 642  CGEHASPC---HITDQSPHGSAVKSKKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTSR 698

Query: 726  CPIDDLDEDMGRPQRLSEA----LASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANIIG 780
              +D        P++ ++A    L S  +VLF N D   +L++ D+LKST++FNQANIIG
Sbjct: 699  GEVD--------PEKKADADEIELGSRSVVLFHNKDSNNELSLDDILKSTSSFNQANIIG 750

Query: 781  CGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN 840
            CGGFGLVYKATL +GTK A+KRLSGD GQM+REFQAEVE LSRAQH NLV L GYC + N
Sbjct: 751  CGGFGLVYKATLPDGTKVAIKRLSGDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKN 810

Query: 841  DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV 900
            D+LLIYSYM+NGSLDYWLHE VD    L W  RL+IA+GAA GLAYLH+ CEPHI+HRD+
Sbjct: 811  DKLLIYSYMDNGSLDYWLHEKVDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDI 870

Query: 901  KSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
            KSSNILL + F AHLADFGL+RL+ PYDTHVTTDLVGTLGYIPPEY Q   AT +GDVYS
Sbjct: 871  KSSNILLSDTFVAHLADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYS 930

Query: 961  FGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML 1020
            FGVVLLELLTGRRP++VCK +  RDL+SWV QMK+EKRE EI D  I+ KD  +++L +L
Sbjct: 931  FGVVLLELLTGRRPMDVCKPRGSRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVL 990

Query: 1021 EIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1051
            EIAC+C+ ++P+ RP  +++V+WL+ I + +
Sbjct: 991  EIACRCLGENPKTRPTTQQLVSWLENIDVSS 1021

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score =  909 bits (2348), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 511/1042 (49%), Positives = 686/1042 (65%), Gaps = 49/1042 (4%)

Query: 15   CLKWLFLAFFVCSCLGLQTPFQS-CDPSDLLALKEFAGNLT---NGSIITSWSNESMCCQ 70
            C+  +FL   +C     ++   S C P DL AL++F  +L    +G I +S S +  CC 
Sbjct: 7    CVIVIFLTELLCFFYSSESQTTSRCHPHDLEALRDFIAHLEPKPDGWINSSSSTD--CCN 64

Query: 71   WDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL 130
            W G+ C      +N GRV  L L  K L G +  SLG L+++++L+LS N ++  +P+ +
Sbjct: 65   WTGITC----NSNNTGRVIRLELGNKKLSGKLSESLGKLDEIRVLNLSRNFIKDSIPLSI 120

Query: 131  SNLKQLEVLDLSHNMLSGPVSGMLAGLNL--IQSLNVSSNSFNGSLFELGEFSNLAVFNI 188
             NLK L+ LDLS N LSG   G+   +NL  +QS ++SSN FNGS               
Sbjct: 121  FNLKNLQTLDLSSNDLSG---GIPTSINLPALQSFDLSSNKFNGS--------------- 162

Query: 189  SNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHVDNNLLGGDLPD 247
                    L S I   S +I+++ L++N+F G+   G      L+ L +  N L G++P+
Sbjct: 163  --------LPSHICHNSTQIRVVKLAVNYFAGNFTSGFGKCVLLEHLCLGMNDLTGNIPE 214

Query: 248  SLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFV 307
             L+ +  L  + +  N  SG LS +I NL+SL  L +  N FSG++P+V   L QL+FF+
Sbjct: 215  DLFHLKRLNLLGIQENRLSGSLSREIRNLSSLVRLDVSWNLFSGEIPDVFDELPQLKFFL 274

Query: 308  AHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN 367
              +N F G +P SL+    L++L+LRNNSL+G + LN + + +L +LDL TN F+G LP 
Sbjct: 275  GQTNGFIGGIPKSLANSPSLNLLNLRNNSLSGRLMLNCTAMIALNSLDLGTNRFNGRLPE 334

Query: 368  SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 427
            +L DC  LK ++LA+N   GQVPESF    SL + SLSN+S  ++S  L +LQ CKNLTT
Sbjct: 335  NLPDCKRLKNVNLARNTFHGQVPESFKNFESLSYFSLSNSSLANISSALGILQHCKNLTT 394

Query: 428  LILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGN 486
            L+LT NF GE +P++    FE L VL + NC L G +P WL    +LQ+LDLSWN   G 
Sbjct: 395  LVLTLNFHGEALPDDSSLHFEKLKVLVVANCRLTGSMPRWLSSSNELQLLDLSWNRLTGA 454

Query: 487  IPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 546
            IP WIG  + LFYLD SNN+ TGEIPKSLT+L+SL S N + + P  S   P ++K N S
Sbjct: 455  IPSWIGDFKALFYLDLSNNSFTGEIPKSLTKLESLTSRNISVNEP--SPDFPFFMKRNES 512

Query: 547  TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 606
               L YNQ   FPP++ L +N ++G I  E G LK LHV DL  N ++G+IPSS+S + +
Sbjct: 513  ARALQYNQIFGFPPTIELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTS 572

Query: 607  LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 666
            LE LDLS+N L GSIP S ++L+FLSKFSVA N+L G IP+GGQF +FPNSSFE N  LC
Sbjct: 573  LEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESN-HLC 631

Query: 667  GEIDSPCDSMHAKLKPVIPSGSNSKFGP-GSIIAITFSIGVGIALLLAVTLLKMSRRDSG 725
            GE   PC         +I     S+ G  G  I I F  G    L L   ++  +RR SG
Sbjct: 632  GEHRFPCS--EGTESALIKRSRRSRGGDIGMAIGIAF--GSVFLLTLLSLIVLRARRRSG 687

Query: 726  CPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFG 785
                +++E     ++    + S  +VLFQ++D K+L+  DLL STN+F+QANIIGCGGFG
Sbjct: 688  EVDPEIEESESMNRKELGEIGSKLVVLFQSND-KELSYDDLLDSTNSFDQANIIGCGGFG 746

Query: 786  LVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI 845
            +VYKATL +G K A+K+LSGDCGQ+EREF+AEVE LSRAQH NLV L+G+C + NDRLLI
Sbjct: 747  MVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLI 806

Query: 846  YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNI 905
            YSYMENGSLDYWLHE  D  ++LKW  RL+IAQGAA+GL YLH+ C+PHI+HRD+KSSNI
Sbjct: 807  YSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNI 866

Query: 906  LLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVL 965
            LLDE F +HLADFGL+RL+ PY+THV+TDLVGTLGYIPPEY Q   AT +GDVYSFGVVL
Sbjct: 867  LLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVL 926

Query: 966  LELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACK 1025
            LELLT +RPV++CK K CRDL+SWV +MK E R  E+ D  I+ K+ +K++  +LEIAC 
Sbjct: 927  LELLTDKRPVDMCKPKGCRDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACL 986

Query: 1026 CIDQDPRRRPFIEEVVTWLDGI 1047
            C+ ++P++RP  +++V+WLD +
Sbjct: 987  CLSENPKQRPTTQQLVSWLDDV 1008

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C7S5|PSYR1_ARATH Tyrosine-sulfated glycopeptide receptor 1 OS=Arabidopsis thaliana GN=PSYR1 PE=2 SV=1

 Score =  855 bits (2210), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 483/1072 (45%), Positives = 668/1072 (62%), Gaps = 50/1072 (4%)

Query: 12   PMTCLKWLFLAFFV--CSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCC 69
            P++    LF+  +V   S   L      C+  D  +L  F+GN+++      W++   CC
Sbjct: 20   PLSPHMVLFVLLYVLSISVFFLTVSEAVCNLQDRDSLLWFSGNVSSPVSPLHWNSSIDCC 79

Query: 70   QWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVE 129
             W+G+ C      S   RVT +IL  +GL G +P S+  L +L  LDLS N L G +P  
Sbjct: 80   SWEGISCDK----SPENRVTSIILSSRGLSGNLPSSVLDLQRLSRLDLSHNRLSGPLPPG 135

Query: 130  -LSNLKQLEVLDLSHNMLSG--PVSGMLA----GLNLIQSLNVSSNSFNG-----SLFEL 177
             LS L QL VLDLS+N   G  P+         G+  IQ++++SSN   G     S+F  
Sbjct: 136  FLSALDQLLVLDLSYNSFKGELPLQQSFGNGSNGIFPIQTVDLSSNLLEGEILSSSVFLQ 195

Query: 178  GEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHV 236
            G F NL  FN+SNNSFTG + S + +AS ++  LD S N F G L Q L     L  L  
Sbjct: 196  GAF-NLTSFNVSNNSFTGSIPSFMCTASPQLTKLDFSYNDFSGDLSQELSRCSRLSVLRA 254

Query: 237  DNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV 296
              N L G++P  +Y++  L+ + L VN  SG++   I+ LT L  L ++ N   G++P  
Sbjct: 255  GFNNLSGEIPKEIYNLPELEQLFLPVNRLSGKIDNGITRLTKLTLLELYSNHIEGEIPKD 314

Query: 297  LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID-LNFSGLSSLCTLD 355
            +G L++L     H N+  G +P+SL+ C+KL  L+LR N L G +  ++FS   SL  LD
Sbjct: 315  IGKLSKLSSLQLHVNNLMGSIPVSLANCTKLVKLNLRVNQLGGTLSAIDFSRFQSLSILD 374

Query: 356  LATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGT 415
            L  N F+G  P+++  C  +  +  A N+L+GQ+     +L SL F + S+N   +L+G 
Sbjct: 375  LGNNSFTGEFPSTVYSCKMMTAMRFAGNKLTGQISPQVLELESLSFFTFSDNKMTNLTGA 434

Query: 416  LSVLQQCKNLTTLILTKNFVGEEIPEN-----VGGFESLMVLALGNCGLKGHIPVWLLRC 470
            LS+LQ CK L+TLI+ KNF  E +P N       GF SL +  +G C L G IP WL++ 
Sbjct: 435  LSILQGCKKLSTLIMAKNFYDETVPSNKDFLRSDGFPSLQIFGIGACRLTGEIPAWLIKL 494

Query: 471  KKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSN 530
            ++++V+DLS N F G IP W+G + +LFYLD S+N LTGE+PK L +L++L+S     + 
Sbjct: 495  QRVEVMDLSMNRFVGTIPGWLGTLPDLFYLDLSDNFLTGELPKELFQLRALMSQKAYDAT 554

Query: 531  PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR 590
                  +P++V  N  T    YNQ SS PP++++  N + GTIP E+GQLK LH+L+L  
Sbjct: 555  ERNYLELPVFVNPNNVTTNQQYNQLSSLPPTIYIKRNNLTGTIPVEVGQLKVLHILELLG 614

Query: 591  NNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQ 650
            NN +G+IP  +S + NLE LDLS+N+L G IP S   L FLS F+VANN L G IPTG Q
Sbjct: 615  NNFSGSIPDELSNLTNLERLDLSNNNLSGRIPWSLTGLHFLSYFNVANNTLSGPIPTGTQ 674

Query: 651  FYSFPNSSFEGNPGLCGEID-SPCDSMHAKLKPVIPSGSNSKFGPGSI-------IAITF 702
            F +FP ++FEGNP LCG +  + CD             S +K G G +       + +  
Sbjct: 675  FDTFPKANFEGNPLLCGGVLLTSCDPTQH---------STTKMGKGKVNRTLVLGLVLGL 725

Query: 703  SIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSK-----LVLFQNS- 756
              GV + L+L   L+   RR +    ++ + ++      SE    S      ++LF NS 
Sbjct: 726  FFGVSLILVLLALLVLSKRRVNPGDSENAELEINSNGSYSEVPPGSDKDISLVLLFGNSR 785

Query: 757  -DCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQ 815
             + KDLT+ +LLK+T+NF+QANIIGCGGFGLVYKATL NGTK AVK+L+GD G ME+EF+
Sbjct: 786  YEVKDLTIFELLKATDNFSQANIIGCGGFGLVYKATLDNGTKLAVKKLTGDYGMMEKEFK 845

Query: 816  AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
            AEVE LSRA+H+NLV+LQGYC H + R+LIYS+MENGSLDYWLHE+ +  + L W  RL 
Sbjct: 846  AEVEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSLDYWLHENPEGPAQLDWPKRLN 905

Query: 876  IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
            I +GA+ GLAY+H++CEPHIVHRD+KSSNILLD  F+A++ADFGLSRL+ PY THVTT+L
Sbjct: 906  IMRGASSGLAYMHQICEPHIVHRDIKSSNILLDGNFKAYVADFGLSRLILPYRTHVTTEL 965

Query: 936  VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS 995
            VGTLGYIPPEY Q   AT RGDVYSFGVV+LELLTG+RP+EV + K  R+LV+WV  MK 
Sbjct: 966  VGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKRPMEVFRPKMSRELVAWVHTMKR 1025

Query: 996  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            + +  E+ D  +     E+ +L +L+IAC C++Q+P +RP I++VV WL  I
Sbjct: 1026 DGKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQNPMKRPNIQQVVDWLKNI 1077

Tyrosine-sulfated glycopeptide receptor with a serine/threonine-protein kinase activity. Regulates, in response to tyrosine-sulfated glycopeptide binding, a signaling cascade involved in cellular proliferation and plant growth. Not involved in PSK perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  526 bits (1355), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 377/1116 (33%), Positives = 572/1116 (51%), Gaps = 119/1116 (10%)

Query: 43   LLALKEFAGNLTNGSIITSWSNESM--CCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKG 100
            LLA K+ +      +++ +W  ES    C W GV C      S+ GR+  L L   GL G
Sbjct: 38   LLAFKQNSVKSDPNNVLGNWKYESGRGSCSWRGVSC------SDDGRIVGLDLRNSGLTG 91

Query: 101  IIP----RSLGHLNQL--------------------KLLDLSCNHLE------------- 123
             +      +L +L  L                    ++LDLS N +              
Sbjct: 92   TLNLVNLTALPNLQNLYLQGNYFSSGGDSSGSDCYLQVLDLSSNSISDYSMVDYVFSKCS 151

Query: 124  GVVPVELSN-------------LKQLEVLDLSHNMLSG--PVSGMLAGLNLIQSLNVSSN 168
             +V V +SN             L+ L  +DLS+N+LS   P S +      ++ L+++ N
Sbjct: 152  NLVSVNISNNKLVGKLGFAPSSLQSLTTVDLSYNILSDKIPESFISDFPASLKYLDLTHN 211

Query: 169  SFNGSLFEL--GEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLD 226
            + +G   +L  G   NL  F++S N+ +G          K ++ L++S N+  G +   +
Sbjct: 212  NLSGDFSDLSFGICGNLTFFSLSQNNLSGDKFPITLPNCKFLETLNISRNNLAGKIPNGE 271

Query: 227  HSPS---LKQLHVDNNLLGGDLPDSLYSM-SSLQHVSLSVNNFSGQLSEKISNLTSLRHL 282
            +  S   LKQL + +N L G++P  L  +  +L  + LS N FSG+L  + +    L++L
Sbjct: 272  YWGSFQNLKQLSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNL 331

Query: 283  IIFGNQFSGKLPN-VLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPI 341
             +  N  SG   N V+  +T + +     N+ SG +P+SL+ CS L VLDL +N  TG +
Sbjct: 332  NLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNV 391

Query: 342  DLNFSGLSSLCTLD---LATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTS 398
               F  L S   L+   +A N+ SG +P  L  C  LK + L+ NEL+G +P+    L +
Sbjct: 392  PSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPN 451

Query: 399  LLFLSLSNNSFNHLSGTL--SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGN 456
            L  L +  N   +L+GT+   V  +  NL TLIL  N +   IPE++    +++ ++L +
Sbjct: 452  LSDLVMWAN---NLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSS 508

Query: 457  CGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLT 516
              L G IP  +    KL +L L  N   GN+P  +G  ++L +LD ++N LTG++P  L 
Sbjct: 509  NRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELA 568

Query: 517  ELKSLISSNCTSSNPTA-----------SAG---------------IPLY--VKHNRSTN 548
                L+     S    A            AG               +P+       R  +
Sbjct: 569  SQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYS 628

Query: 549  GLPYNQASSFPPSVF--LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 606
            G+     S+    ++  +S N ++G IPP  G + +L VL+L  N ITGTIP S   ++ 
Sbjct: 629  GMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKA 688

Query: 607  LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 666
            + VLDLS N+L G +PGS   L+FLS   V+NN+L G IP GGQ  +FP S +  N GLC
Sbjct: 689  IGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLC 748

Query: 667  GEIDSPCDSMHAKLKPVIPS--GSNSKFGPGSIIAITFSIGVGIALLLA---VTLLKMSR 721
            G    PC S  A  +P+               I  I FS    + L++A   V  ++   
Sbjct: 749  GVPLRPCGS--APRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKE 806

Query: 722  RDSGCPIDDLDEDMGRPQRLSEALA--SSKLVLFQNSDCKDLTVSDLLKSTNNFNQANII 779
            +     I+ L        +LS      S  +  F+    + LT + LL++TN F+   ++
Sbjct: 807  QKREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKP-LRKLTFAHLLEATNGFSAETMV 865

Query: 780  GCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG 839
            G GGFG VYKA L +G+  A+K+L    GQ +REF AE+E + + +H+NLV L GYC+ G
Sbjct: 866  GSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVG 925

Query: 840  NDRLLIYSYMENGSLDYWLHESVDKDS--VLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
             +RLL+Y YM+ GSL+  LHE   K     L W  R KIA GAARGLA+LH  C PHI+H
Sbjct: 926  EERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIH 985

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRG 956
            RD+KSSN+LLDE FEA ++DFG++RL+   DTH++ + L GT GY+PPEY Q+   T +G
Sbjct: 986  RDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKG 1045

Query: 957  DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS-IWHKDREKQ 1015
            DVYS+GV+LLELL+G++P++  +     +LV W  Q+  EKR  EI+D   +  K  + +
Sbjct: 1046 DVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVE 1105

Query: 1016 LLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1051
            L   L+IA +C+D  P +RP + +++     +  D 
Sbjct: 1106 LFHYLKIASQCLDDRPFKRPTMIQLMAMFKEMKADT 1141

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  522 bits (1345), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 374/1091 (34%), Positives = 568/1091 (52%), Gaps = 142/1091 (13%)

Query: 69   CQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIP----------RSL------------ 106
            C W GV C      S+ GRV  L L   GL G +           RSL            
Sbjct: 65   CTWRGVSC------SSDGRVIGLDLRNGGLTGTLNLNNLTALSNLRSLYLQGNNFSSGDS 118

Query: 107  --GHLNQLKLLDLSCNHL--EGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLN-LIQ 161
                   L++LDLS N L    +V    S    L  ++ SHN L+G +    +  N  I 
Sbjct: 119  SSSSGCSLEVLDLSSNSLTDSSIVDYVFSTCLNLVSVNFSHNKLAGKLKSSPSASNKRIT 178

Query: 162  SLNVSSNSFNGSLFEL--------------------GEFS--------NLAVFNISNNSF 193
            ++++S+N F+  + E                     G+FS        NL VF++S NS 
Sbjct: 179  TVDLSNNRFSDEIPETFIADFPNSLKHLDLSGNNVTGDFSRLSFGLCENLTVFSLSQNSI 238

Query: 194  TGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH---SPSLKQLHVDNNLLGGDLPDSLY 250
            +G       S  K ++ L+LS N  +G + G D+     +L+QL + +NL  G++P  L 
Sbjct: 239  SGDRFPVSLSNCKLLETLNLSRNSLIGKIPGDDYWGNFQNLRQLSLAHNLYSGEIPPELS 298

Query: 251  SM-SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGK-LPNVLGNLTQLEFFVA 308
             +  +L+ + LS N+ +GQL +  ++  SL+ L +  N+ SG  L  V+  L+++     
Sbjct: 299  LLCRTLEVLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYL 358

Query: 309  HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLD---LATNHFSGPL 365
              N+ SG +P+SL+ CS L VLDL +N  TG +   F  L S   L+   +A N+ SG +
Sbjct: 359  PFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTV 418

Query: 366  PNSLSDCHDLKILSLAKNELSGQVPE---SFGKLTSLLFLSLSNNSFNHLSGTL--SVLQ 420
            P  L  C  LK + L+ N L+G +P+   +  KL+ L+  +      N+L+G +  S+  
Sbjct: 419  PVELGKCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWA------NNLTGGIPESICV 472

Query: 421  QCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSW 480
               NL TLIL  N +   +PE++    +++ ++L +  L G IPV + + +KL +L L  
Sbjct: 473  DGGNLETLILNNNLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLGN 532

Query: 481  NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTA------- 533
            N   GNIP  +G  +NL +LD ++N LTG +P  L     L+     S    A       
Sbjct: 533  NSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEGG 592

Query: 534  -----SAGIPLY-------VKH---------NRSTNGLPYNQASSFPPSVF--LSNNRIN 570
                 + G+  +       ++H          R  +G+     SS    ++  LS N ++
Sbjct: 593  TDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVS 652

Query: 571  GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTF 630
            G+IP   G + +L VL+L  N +TGTIP S   ++ + VLDLS NDL G +PGS   L+F
Sbjct: 653  GSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSF 712

Query: 631  LSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNS 690
            LS   V+NN+L G IP GGQ  +FP + +  N GLCG    PC S         P+ S++
Sbjct: 713  LSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSGSR------PTRSHA 766

Query: 691  KFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALA---- 746
                 S IA   S G+  + +  V L+    R        + +   + ++  E+L     
Sbjct: 767  HPKKQS-IATGMSAGIVFSFMCIVMLIMALYR-----ARKVQKKEKQREKYIESLPTSGS 820

Query: 747  ------------SSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTN 794
                        S  +  F+    + LT + LL++TN F+  ++IG GGFG VYKA L +
Sbjct: 821  SSWKLSSVHEPLSINVATFEKP-LRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLAD 879

Query: 795  GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            G+  A+K+L    GQ +REF AE+E + + +H+NLV L GYC+ G +RLL+Y YM+ GSL
Sbjct: 880  GSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSL 939

Query: 855  DYWLHESVDKDSV-LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA 913
            +  LHE   K  + L W  R KIA GAARGLA+LH  C PHI+HRD+KSSN+LLD+ F A
Sbjct: 940  ETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVA 999

Query: 914  HLADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR 972
             ++DFG++RL+   DTH++ + L GT GY+PPEY Q+   T +GDVYS+GV+LLELL+G+
Sbjct: 1000 RVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGK 1059

Query: 973  RPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS-IWHKDREKQLLEMLEIACKCIDQDP 1031
            +P++  +     +LV W  Q+  EKR  EI+D   +  K  + +LL  L+IA +C+D  P
Sbjct: 1060 KPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRP 1119

Query: 1032 RRRPFIEEVVT 1042
             +RP + +V+T
Sbjct: 1120 FKRPTMIQVMT 1130

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  510 bits (1314), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 374/1007 (37%), Positives = 547/1007 (54%), Gaps = 76/1007 (7%)

Query: 109  LNQLKLLDLSCNHLEG--VVPVELSN-LKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 165
            LN L++LDLS N + G  VV   LS+   +L+ L +S N +SG V  +   +NL + L+V
Sbjct: 172  LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNL-EFLDV 229

Query: 166  SSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL 225
            SSN+F+  +  LG+ S L   +IS N  +G   SR  S   E+++L++S N F+G +  L
Sbjct: 230  SSNNFSTGIPFLGDCSALQHLDISGNKLSGDF-SRAISTCTELKLLNISSNQFVGPIPPL 288

Query: 226  DHSPSLKQLHVDNNLLGGDLPDSLY-SMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLII 284
                SL+ L +  N   G++PD L  +  +L  + LS N+F G +     + + L  L +
Sbjct: 289  PLK-SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 347

Query: 285  FGNQFSGKLP-NVLGNLTQLEFFVAHSNSFSGPLPLSLS-LCSKLHVLDLRNNSLTGPID 342
              N FSG+LP + L  +  L+      N FSG LP SL+ L + L  LDL +N+ +GPI 
Sbjct: 348  SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 407

Query: 343  LNF--SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLL 400
             N   +  ++L  L L  N F+G +P +LS+C +L  L L+ N LSG +P S G L+ L 
Sbjct: 408  PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 467

Query: 401  FLSLSNNSFNHLSGTL-SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 459
             L L     N L G +   L   K L TLIL  N +  EIP  +    +L  ++L N  L
Sbjct: 468  DLKLW---LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 524

Query: 460  KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELK 519
             G IP W+ R + L +L LS N F GNIP  +G   +L +LD + N   G IP ++ +  
Sbjct: 525  TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 584

Query: 520  SLISSNCTSSNPTA------------SAGIPLYVKHNRST--NGLPYNQASSFPPSVF-- 563
              I++N  +                  AG  L  +  RS   N L      +    V+  
Sbjct: 585  GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 644

Query: 564  ----------------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNL 607
                            +S N ++G IP EIG + +L +L+L  N+I+G+IP  + ++R L
Sbjct: 645  HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 704

Query: 608  EVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCG 667
             +LDLSSN L G IP +   LT L++  ++NN+L G IP  GQF +FP + F  NPGLCG
Sbjct: 705  NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 764

Query: 668  EIDSPCDSMHAK----------LKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTL- 716
                 CD  +A            +P   +GS +     S + I   I VG  +       
Sbjct: 765  YPLPRCDPSNADGYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKK 824

Query: 717  ---LKMSRRDSGCPIDDLDEDMG-RPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNN 772
               L+M     G   D    +   +   + EAL S  L  F+    + LT +DLL++TN 
Sbjct: 825  EAELEMYAEGHGNSGDRTANNTNWKLTGVKEAL-SINLAAFEKP-LRKLTFADLLQATNG 882

Query: 773  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            F+  ++IG GGFG VYKA L +G+  A+K+L    GQ +REF AE+E + + +H+NLV L
Sbjct: 883  FHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPL 942

Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
             GYC+ G++RLL+Y +M+ GSL+  LH+       L W  R KIA G+ARGLA+LH  C 
Sbjct: 943  LGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCS 1002

Query: 893  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLT 951
            PHI+HRD+KSSN+LLDE  EA ++DFG++RL+   DTH++ + L GT GY+PPEY Q+  
Sbjct: 1003 PHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1062

Query: 952  ATCRGDVYSFGVVLLELLTGRRPVEVCK-GKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
             + +GDVYS+GVVLLELLTG+RP +    G N  +LV WV Q  ++ R  ++ D  +  +
Sbjct: 1063 CSTKGDVYSYGVVLLELLTGKRPTDSPDFGDN--NLVGWVKQ-HAKLRISDVFDPELMKE 1119

Query: 1011 DR--EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD----GIGIDA 1051
            D   E +LL+ L++A  C+D    RRP + +V+        G GID+
Sbjct: 1120 DPALEIELLQHLKVAVACLDDRAWRRPTMVQVMAMFKEIQAGSGIDS 1166

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  509 bits (1311), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 377/1105 (34%), Positives = 545/1105 (49%), Gaps = 136/1105 (12%)

Query: 45   ALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTML---ILPRKGLKGI 101
             + E  GNL N  ++   S     C+  G++       S  GR+  L   IL    L+G 
Sbjct: 159  TIPETFGNLVNLQMLALAS-----CRLTGLIP------SRFGRLVQLQTLILQDNELEGP 207

Query: 102  IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
            IP  +G+   L L   + N L G +P EL+ LK L+ L+L  N  SG +   L  L  IQ
Sbjct: 208  IPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQ 267

Query: 162  SLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 220
             LN+  N   G +   L E +NL   ++S+N+ TG ++   W  + +++ L L+ N   G
Sbjct: 268  YLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMN-QLEFLVLAKNRLSG 326

Query: 221  SL--------------------------QGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSS 254
            SL                            + +  SLK L + NN L G +PDSL+ +  
Sbjct: 327  SLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVE 386

Query: 255  LQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS 314
            L ++ L+ N+  G LS  ISNLT+L+   ++ N   GK+P  +G L +LE    + N FS
Sbjct: 387  LTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFS 446

Query: 315  GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHD 374
            G +P+ +  C++L  +D   N L+G I  +   L  L  L L  N   G +P SL +CH 
Sbjct: 447  GEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQ 506

Query: 375  LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF---------------------NHLS 413
            + ++ LA N+LSG +P SFG LT+L    + NNS                      N  +
Sbjct: 507  MTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFN 566

Query: 414  GTLS------------------------VLQQCKNLTTLILTKNFVGEEIPENVGGFESL 449
            G++S                         L +  NL  L L KN     IP   G    L
Sbjct: 567  GSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISEL 626

Query: 450  MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG 509
             +L +    L G IPV L  CKKL  +DL+ N+  G IP W+G++  L  L  S+N   G
Sbjct: 627  SLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVG 686

Query: 510  EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNG--LPYNQASSFPPSVF---- 563
             +P  +  L ++++     ++   S  IP  + + ++ N   L  NQ S   PS      
Sbjct: 687  SLPTEIFSLTNILTLFLDGNSLNGS--IPQEIGNLQALNALNLEENQLSGPLPSTIGKLS 744

Query: 564  ------LSNNRINGTIPPEIGQLKHLH-VLDLSRNNITGTIPSSISEIRNLEVLDLSSND 616
                  LS N + G IP EIGQL+ L   LDLS NN TG IPS+IS +  LE LDLS N 
Sbjct: 745  KLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQ 804

Query: 617  LHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSM 676
            L G +PG    +  L   +++ N+L+G +    QF  +   +F GN GLCG   S C+  
Sbjct: 805  LVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRA 862

Query: 677  HAKLKPVIPSGSNSKFGPGSIIAIT-FSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDM 735
             +K        +     P +++ I+  S    IAL++ V +L   +       D   +  
Sbjct: 863  GSK--------NQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNH-----DLFKKVR 909

Query: 736  GRPQRLSEALASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTN 794
            G     S   +SS+  LF N   K D+   D++++T+  N+  +IG GG G VYKA L N
Sbjct: 910  GGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKN 969

Query: 795  GTKAAVKR-LSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND--RLLIYSYMEN 851
            G   AVK+ L  D     + F  EV+ L   +H++LV L GYC    D   LLIY YM N
Sbjct: 970  GETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMAN 1029

Query: 852  GSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE 909
            GS+  WLH  E+  K  VL W+ RLKIA G A+G+ YLH  C P IVHRD+KSSN+LLD 
Sbjct: 1030 GSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDS 1089

Query: 910  KFEAHLADFGLSRLLRP-YDTHVTTD--LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLL 966
              EAHL DFGL+++L   YDT+  ++    G+ GYI PEY+ +L AT + DVYS G+VL+
Sbjct: 1090 NIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLM 1149

Query: 967  ELLTGRRPVEVCKGKNCRDLVSWVFQM-----KSEKREVEIIDASIWH--KDREKQLLEM 1019
            E++TG+ P E    +   D+V WV  +      SE RE ++ID+ +       E+   ++
Sbjct: 1150 EIVTGKMPTEAMFDEET-DMVRWVETVLDTPPGSEARE-KLIDSELKSLLPCEEEAAYQV 1207

Query: 1020 LEIACKCIDQDPRRRPFIEEVVTWL 1044
            LEIA +C    P+ RP   +   +L
Sbjct: 1208 LEIALQCTKSYPQERPSSRQASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  503 bits (1294), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 366/1052 (34%), Positives = 522/1052 (49%), Gaps = 120/1052 (11%)

Query: 87   RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 146
            RV  LIL    L+G IP  LG+ + L +   + N L G +P EL  L+ LE+L+L++N L
Sbjct: 192  RVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSL 251

Query: 147  SGPVSGMLAGLNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSAS 205
            +G +   L  ++ +Q L++ +N   G + + L +  NL   ++S N+ TG++    W+ S
Sbjct: 252  TGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMS 311

Query: 206  KEIQILDLSM--NHFMGSLQG--------------------------LDHSPSLKQLHVD 237
               Q+LDL +  NH  GSL                            L    SLKQL + 
Sbjct: 312  ---QLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLS 368

Query: 238  NNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVL 297
            NN L G +P++L+ +  L  + L  N   G LS  ISNLT+L+ L+++ N   GKLP  +
Sbjct: 369  NNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEI 428

Query: 298  GNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLA 357
              L +LE    + N FSG +P  +  C+ L ++D+  N   G I  +   L  L  L L 
Sbjct: 429  SALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLR 488

Query: 358  TNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF-------- 409
             N   G LP SL +CH L IL LA N+LSG +P SFG L  L  L L NNS         
Sbjct: 489  QNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSL 548

Query: 410  -------------NHLSGTLS------------------------VLQQCKNLTTLILTK 432
                         N L+GT+                          L   +NL  L L K
Sbjct: 549  ISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGK 608

Query: 433  NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 492
            N +  +IP  +G    L +L + +  L G IP+ L+ CKKL  +DL+ N   G IPPW+G
Sbjct: 609  NQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLG 668

Query: 493  QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTN--GL 550
            ++  L  L  S+N     +P  L     L+  +   ++   S  IP  + +  + N   L
Sbjct: 669  KLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGS--IPQEIGNLGALNVLNL 726

Query: 551  PYNQASSFPPSVF----------LSNNRINGTIPPEIGQLKHLH-VLDLSRNNITGTIPS 599
              NQ S   P             LS N + G IP EIGQL+ L   LDLS NN TG IPS
Sbjct: 727  DKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPS 786

Query: 600  SISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSF 659
            +I  +  LE LDLS N L G +PGS   +  L   +V+ N+L G +    QF  +P  SF
Sbjct: 787  TIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSF 844

Query: 660  EGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKM 719
             GN GLCG   S C+ + +  K    S  +       I AI+    +G+ ++L + L   
Sbjct: 845  LGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVI----ISAISALTAIGL-MILVIALFFK 899

Query: 720  SRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANI 778
             R D    +             S+A   +   LF+N   K D+   D++++T+N ++  +
Sbjct: 900  QRHDFFKKVGHGSTAYTSSSSSSQA---THKPLFRNGASKSDIRWEDIMEATHNLSEEFM 956

Query: 779  IGCGGFGLVYKATLTNGTKAAVKR-LSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            IG GG G VYKA L NG   AVK+ L  D     + F  EV+ L R +H++LV L GYC 
Sbjct: 957  IGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCS 1016

Query: 838  HGND--RLLIYSYMENGSLDYWLHESV----DKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
              ++   LLIY YM+NGS+  WLHE       K  +L W+ RL+IA G A+G+ YLH  C
Sbjct: 1017 SKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDC 1076

Query: 892  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP---YDTHVTTDLVGTLGYIPPEYSQ 948
             P IVHRD+KSSN+LLD   EAHL DFGL+++L      +T   T    + GYI PEY+ 
Sbjct: 1077 VPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAY 1136

Query: 949  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV---FQMKSEKREVEIIDA 1005
            +L AT + DVYS G+VL+E++TG+ P +   G    D+V WV    ++    R+ ++ID 
Sbjct: 1137 SLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEM-DMVRWVETHLEVAGSARD-KLIDP 1194

Query: 1006 SI--WHKDREKQLLEMLEIACKCIDQDPRRRP 1035
             +       E    ++LEIA +C    P+ RP
Sbjct: 1195 KLKPLLPFEEDAACQVLEIALQCTKTSPQERP 1226

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1

 Score =  503 bits (1294), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 374/1122 (33%), Positives = 555/1122 (49%), Gaps = 150/1122 (13%)

Query: 39   DPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGL 98
            D   LL+ K    +  N +I+++WS     CQ+ GV C         GRVT + L   GL
Sbjct: 39   DSLSLLSFKTMIQDDPN-NILSNWSPRKSPCQFSGVTC-------LGGRVTEINLSGSGL 90

Query: 99   KGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLN 158
             GI+       N    LD                   L VL LS N      + +L    
Sbjct: 91   SGIV-----SFNAFTSLD------------------SLSVLKLSENFFVLNSTSLLLLPL 127

Query: 159  LIQSLNVSSNSFNGSLFE--LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 216
             +  L +SS+   G+L E    ++SNL    +S N+FTGKL + ++ +SK++Q LDLS N
Sbjct: 128  TLTHLELSSSGLIGTLPENFFSKYSNLISITLSYNNFTGKLPNDLFLSSKKLQTLDLSYN 187

Query: 217  HFMGSLQGL----DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEK 272
            +  G + GL        S+  L    N + G + DSL + ++L+ ++LS NNF GQ+ + 
Sbjct: 188  NITGPISGLTIPLSSCVSMTYLDFSGNSISGYISDSLINCTNLKSLNLSYNNFDGQIPKS 247

Query: 273  ISNLTSLRHLIIFGNQFSGKLPNVLGNLTQ-LEFFVAHSNSFSGPLPLSLSLCSKLHVLD 331
               L  L+ L +  N+ +G +P  +G+  + L+      N+F+G +P SLS CS L  LD
Sbjct: 248  FGELKLLQSLDLSHNRLTGWIPPEIGDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSLD 307

Query: 332  LRNNSLTGPI-DLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVP 390
            L NN+++GP  +       SL  L L+ N  SG  P S+S C  L+I   + N  SG +P
Sbjct: 308  LSNNNISGPFPNTILRSFGSLQILLLSNNLISGDFPTSISACKSLRIADFSSNRFSGVIP 367

Query: 391  ESF-GKLTSLLFLSLSNN---------------------SFNHLSGTLSV-LQQCKNLTT 427
                    SL  L L +N                     S N+L+GT+   +   + L  
Sbjct: 368  PDLCPGAASLEELRLPDNLVTGEIPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKLEQ 427

Query: 428  LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCK---------------- 471
             I   N +  EIP  +G  ++L  L L N  L G IP     C                 
Sbjct: 428  FIAWYNNIAGEIPPEIGKLQNLKDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTGEV 487

Query: 472  --------KLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSL------TE 517
                    +L VL L  N+F G IPP +G+   L +LD + N LTGEIP  L        
Sbjct: 488  PKDFGILSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPGSKA 547

Query: 518  LKSLISSNCTS-----SNPTASAG--------IPLYVKHNRSTNGLPYNQASSFPP-SVF 563
            L  L+S N  +      N     G         P  +    S     + +  S P  S+F
Sbjct: 548  LSGLLSGNTMAFVRNVGNSCKGVGGLVEFSGIRPERLLQIPSLKSCDFTRMYSGPILSLF 607

Query: 564  ----------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLS 613
                      LS N++ G IP EIG++  L VL+LS N ++G IP +I +++NL V D S
Sbjct: 608  TRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSHNQLSGEIPFTIGQLKNLGVFDAS 667

Query: 614  SNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPC 673
             N L G IP SF  L+FL +  ++NN L G IP  GQ  + P + +  NPGLCG     C
Sbjct: 668  DNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGVPLPEC 727

Query: 674  DSMHAKLKPVIPSGSNSKFGPGSI-----IAITFSIGVGIALLLAVTLLKMSRRDSGCPI 728
             + + +L      G  +K G  +      I +   I      +L V  + +  R      
Sbjct: 728  KNGNNQLPAGTEEGKRAKHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARRRDADD 787

Query: 729  DDLDEDMG--------RPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIG 780
              +   +         + ++  E L S  +  FQ    + L  S L+++TN F+ A++IG
Sbjct: 788  AKMLHSLQAVNSATTWKIEKEKEPL-SINVATFQR-QLRKLKFSQLIEATNGFSAASMIG 845

Query: 781  CGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN 840
             GGFG V+KATL +G+  A+K+L     Q +REF AE+E L + +H+NLV L GYC+ G 
Sbjct: 846  HGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE 905

Query: 841  DRLLIYSYMENGSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
            +RLL+Y +M+ GSL+  LH   + +K  +L W+ R KIA+GAA+GL +LH  C PHI+HR
Sbjct: 906  ERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHR 965

Query: 899  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGD 957
            D+KSSN+LLD+  EA ++DFG++RL+   DTH++ + L GT GY+PPEY Q+   T +GD
Sbjct: 966  DMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGD 1025

Query: 958  VYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK------- 1010
            VYS GVV+LE+L+G+RP +  +  +  +LV W      E + +E+ID  +  +       
Sbjct: 1026 VYSIGVVMLEILSGKRPTDKEEFGDT-NLVGWSKMKAREGKHMEVIDEDLLKEGSSESLN 1084

Query: 1011 DRE--------KQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            ++E        K++L  LEIA +C+D  P +RP + +VV  L
Sbjct: 1085 EKEGFEGGVIVKEMLRYLEIALRCVDDFPSKRPNMLQVVASL 1126

Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1052
224117138	1052	predicted protein [Populus trichocarpa]	0.988	0.988	0.772	0.0
255574664	1050	Phytosulfokine receptor precursor, putat	0.995	0.997	0.772	0.0
224128288	1050	predicted protein [Populus trichocarpa]	0.994	0.996	0.757	0.0
225461500	1053	PREDICTED: phytosulfokine receptor 2-lik	0.996	0.995	0.736	0.0
147805140	1021	hypothetical protein VITISV_006966 [Viti	0.965	0.995	0.717	0.0
356546862	1133	PREDICTED: phytosulfokine receptor 2-lik	0.963	0.894	0.710	0.0
356544058	1058	PREDICTED: phytosulfokine receptor 2-lik	0.990	0.984	0.698	0.0
356543354	1052	PREDICTED: phytosulfokine receptor 2-lik	0.993	0.993	0.682	0.0
358248168	1043	phytosulfokine receptor 2-like precursor	0.984	0.993	0.683	0.0
297792807	1036	hypothetical protein ARALYDRAFT_495467 [	0.971	0.986	0.673	0.0

>gi|224117138|ref|XP_002317487.1| predicted protein [Populus trichocarpa] gi|222860552|gb|EEE98099.1| predicted protein [Populus trichocarpa]

 Score = 1606 bits (4159), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 804/1041 (77%), Positives = 908/1041 (87%), Gaps = 1/1041 (0%)

Query: 5    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSN 64
            MVV+   PM  L+  F A F+CS  GL+T  QSCDP+D LALKEFAGNLTNGSIITSWSN
Sbjct: 1    MVVVESAPMIFLRCAFFACFLCSSWGLKTIAQSCDPNDSLALKEFAGNLTNGSIITSWSN 60

Query: 65   ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 124
            ++ CCQWDGVVCG    GS   RVTMLIL RKGL+G+IPRS+GHL+QLK LDLSCNHL+G
Sbjct: 61   KADCCQWDGVVCGSNINGSIHRRVTMLILSRKGLQGLIPRSIGHLDQLKSLDLSCNHLQG 120

Query: 125  VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 184
             +P+ELS+LKQ+EVLDLSHN+LSG VSG+L+GL  IQSLN+SSN F   LFELG + NL 
Sbjct: 121  GLPLELSSLKQMEVLDLSHNLLSGQVSGVLSGLISIQSLNISSNLFREDLFELGGYPNLV 180

Query: 185  VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGG 243
            VFNISNNSFTG + S+I S+SK IQI+DLSMNH +G+L GL + S SL+QLH+D+N L G
Sbjct: 181  VFNISNNSFTGPVTSQICSSSKGIQIVDLSMNHLVGNLAGLYNCSKSLQQLHLDSNSLSG 240

Query: 244  DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 303
             LPD +YS  +L+H S+S NNFSGQLS+++S L+SL+ L+I+GN+FSG +PN  GNLT L
Sbjct: 241  SLPDFIYSTLALEHFSISNNNFSGQLSKEVSKLSSLKTLVIYGNRFSGHIPNAFGNLTHL 300

Query: 304  EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG 363
            E FVAHSN  SGPLP +LS CSKLH+LDLRNNSLTGP+DLNF+G+ SLCTLDLA NHFSG
Sbjct: 301  EHFVAHSNMLSGPLPSTLSFCSKLHILDLRNNSLTGPVDLNFAGMPSLCTLDLAANHFSG 360

Query: 364  PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCK 423
            PLPNSLSDC +L+ILSLAKNEL+G++P SF KL+SLLFLSLSNNS   LSG L+VLQ C+
Sbjct: 361  PLPNSLSDCRELEILSLAKNELTGKIPVSFAKLSSLLFLSLSNNSLVDLSGALTVLQHCQ 420

Query: 424  NLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 483
            NL+TLILTKNFVGEEIP NV GF++LMVLA GNC LKGHIPVWLL C+KL+VLDLSWNH 
Sbjct: 421  NLSTLILTKNFVGEEIPRNVSGFQNLMVLAFGNCALKGHIPVWLLSCRKLEVLDLSWNHL 480

Query: 484  DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 543
            DGNIP WIGQMENLFYLD SNN+LTGEIPKSLT+LKSLIS+N +S + TASAGIPLYVK 
Sbjct: 481  DGNIPSWIGQMENLFYLDLSNNSLTGEIPKSLTDLKSLISANSSSPHLTASAGIPLYVKR 540

Query: 544  NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 603
            N+S +GLPY QASSFPPS+ LSNNRINGTIPPE+G+LK LHVLDLSRNNITGTIP+S S+
Sbjct: 541  NQSASGLPYKQASSFPPSILLSNNRINGTIPPEVGRLKDLHVLDLSRNNITGTIPNSFSQ 600

Query: 604  IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNP 663
            + NLE+LD SSN+LHGSIP S EKLTFLSKFSVANNHL+G IPTGGQFYSFP SSFEGNP
Sbjct: 601  MENLEILDFSSNNLHGSIPPSLEKLTFLSKFSVANNHLRGQIPTGGQFYSFPCSSFEGNP 660

Query: 664  GLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRD 723
            GLCG I SPC++++  LKP IPSGS  +FG  +I++IT +IGVG+AL+LA+ L KMSRR+
Sbjct: 661  GLCGVIISPCNAINNTLKPGIPSGSERRFGRSNILSITITIGVGLALVLAIVLHKMSRRN 720

Query: 724  SGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGG 783
             G PI DL+E+   P RLSEAL SSKLVLFQNSDCK+L+V+DLLKSTNNFNQANIIGCGG
Sbjct: 721  VGDPIGDLEEEGSLPHRLSEALRSSKLVLFQNSDCKELSVADLLKSTNNFNQANIIGCGG 780

Query: 784  FGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL 843
            FGLVYKA   N TKAA+KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN RL
Sbjct: 781  FGLVYKANFPNDTKAAIKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNYRL 840

Query: 844  LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSS 903
            LIYSYMENGSLDYWLHESVD  SVLKW+VRLKIAQGAA GLAYLHKVCEPHIVHRDVKSS
Sbjct: 841  LIYSYMENGSLDYWLHESVDGTSVLKWEVRLKIAQGAACGLAYLHKVCEPHIVHRDVKSS 900

Query: 904  NILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGV 963
            NILLDE FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL ATCRGDVYSFGV
Sbjct: 901  NILLDENFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLMATCRGDVYSFGV 960

Query: 964  VLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIA 1023
            VLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE EIID +IW KD +KQL EMLEIA
Sbjct: 961  VLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREAEIIDPAIWDKDHQKQLFEMLEIA 1020

Query: 1024 CKCIDQDPRRRPFIEEVVTWL 1044
            C+C+D DPR+RP IEEVV+WL
Sbjct: 1021 CRCLDPDPRKRPLIEEVVSWL 1041

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255574664|ref|XP_002528241.1| Phytosulfokine receptor precursor, putative [Ricinus communis] gi|223532327|gb|EEF34126.1| Phytosulfokine receptor precursor, putative [Ricinus communis]

 Score = 1598 bits (4137), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 811/1050 (77%), Positives = 906/1050 (86%), Gaps = 3/1050 (0%)

Query: 5    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSN 64
            M+VLG  PM+ LKW+FLA F+ S LGL T  + CDPSD LALKEFAGNLTNGSIIT+WS+
Sbjct: 1    MMVLGIAPMSFLKWVFLACFIYSSLGLNTLTKFCDPSDFLALKEFAGNLTNGSIITAWSD 60

Query: 65   ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 124
            +S CC WDGVVCG+   GS   RVTML+LPRKGLKGII RSLG L+QLK LDLSCNHL+G
Sbjct: 61   KSNCCHWDGVVCGNNGNGSTVSRVTMLMLPRKGLKGIISRSLGRLDQLKSLDLSCNHLQG 120

Query: 125  VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 184
             +P++ S LKQLEVLDLSHNMLSG VSG+L+GL+ +QS N+SSN F   + ELG F N+ 
Sbjct: 121  EMPMDFSRLKQLEVLDLSHNMLSGQVSGVLSGLSSLQSFNISSNLFKEDVSELGGFPNVV 180

Query: 185  VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGG 243
            VFN+SNNSFTG++ S   S+S  IQ+LDLSMNH +GSL+GL + S SL+QL +D+N L G
Sbjct: 181  VFNMSNNSFTGQIPSHFCSSSSGIQVLDLSMNHLVGSLEGLYNCSKSLQQLQLDSNSLSG 240

Query: 244  DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 303
             LPD LYSMSSLQ  S+S NNFSGQLS+++S L+SL+ L+I+GN+FSG +P+V  NLTQL
Sbjct: 241  SLPDYLYSMSSLQQFSISNNNFSGQLSKELSKLSSLKTLVIYGNRFSGHIPDVFDNLTQL 300

Query: 304  EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG 363
            E FVAHSN  SGPLP +L+LCS+L +LDLRNNSLTGPI+LNF+ +  L TLDLATNH SG
Sbjct: 301  EQFVAHSNLLSGPLPSTLALCSELCILDLRNNSLTGPINLNFTAMPRLSTLDLATNHLSG 360

Query: 364  PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCK 423
             LPNSLSDC +LKILSLAKNELSG +P+SF  LTSLL L+LSNNSF  LSG LSV+Q+CK
Sbjct: 361  QLPNSLSDCRELKILSLAKNELSGHIPKSFANLTSLLVLTLSNNSFTDLSGALSVMQECK 420

Query: 424  NLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 483
            NLTTLILTKNFVGEEIP NV GF+SLMVLALGNC L+G IP WLL C+KL+VLDLSWNH 
Sbjct: 421  NLTTLILTKNFVGEEIPRNVSGFQSLMVLALGNCALRGQIPDWLLNCRKLEVLDLSWNHL 480

Query: 484  DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 543
            DGN+PPWIGQMENLFYLDFSNN+LTG IPKSLTELKSLI  NC+S N T SA IPLYVK 
Sbjct: 481  DGNVPPWIGQMENLFYLDFSNNSLTGGIPKSLTELKSLIYMNCSSYNLT-SAIIPLYVKR 539

Query: 544  NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 603
            NRS NGL YNQASSFPPS+ LSNNRI+G I PEIGQLK LHVLDLSRN +TG IPSSISE
Sbjct: 540  NRSANGLQYNQASSFPPSILLSNNRISGKIWPEIGQLKELHVLDLSRNELTGIIPSSISE 599

Query: 604  IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNP 663
            + NLEVLDLSSN L+GSIP SFEKLTFLS+FSVANNHL+G IPTGGQF SFP SSFEGN 
Sbjct: 600  MENLEVLDLSSNGLYGSIPPSFEKLTFLSRFSVANNHLKGQIPTGGQFSSFPTSSFEGNL 659

Query: 664  GLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRD 723
            GLCG I SPC+ +   LKP I SGSNS FG  +I+ IT +IGVG+AL+LA+ LLK+SRRD
Sbjct: 660  GLCGGIVSPCNVITNMLKPGIQSGSNSAFGRANILGITITIGVGLALILAIVLLKISRRD 719

Query: 724  S-GCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCG 782
              G P DDLDE++ RP RLSEAL SSKLVLFQNSDCKDLTV+DLLK+TNNFNQANIIGCG
Sbjct: 720  YVGDPFDDLDEEVSRPHRLSEALGSSKLVLFQNSDCKDLTVADLLKATNNFNQANIIGCG 779

Query: 783  GFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 842
            GFGLVYKA+L NG KAA+KRLSGDCGQMEREF+AEVEALSRAQHKNLVSLQGYCRHGNDR
Sbjct: 780  GFGLVYKASLPNGAKAAIKRLSGDCGQMEREFRAEVEALSRAQHKNLVSLQGYCRHGNDR 839

Query: 843  LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 902
            LLIYSYMENGSLDYWLHE  D  S LKW+VRLKIAQGAA GLAYLHKVCEPHIVHRDVKS
Sbjct: 840  LLIYSYMENGSLDYWLHECADGASFLKWEVRLKIAQGAASGLAYLHKVCEPHIVHRDVKS 899

Query: 903  SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 962
            SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG
Sbjct: 900  SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 959

Query: 963  VVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1022
            VVLLELLTGRRPVEVCKGKNCRDLVSW+FQMK EKRE EIID+SIW+KD EKQL EMLEI
Sbjct: 960  VVLLELLTGRRPVEVCKGKNCRDLVSWMFQMKYEKRETEIIDSSIWNKDLEKQLSEMLEI 1019

Query: 1023 ACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1052
            AC+C+DQDPRRRP I+EVV+WLDGIGI  A
Sbjct: 1020 ACRCLDQDPRRRPLIDEVVSWLDGIGIQGA 1049

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224128288|ref|XP_002329127.1| predicted protein [Populus trichocarpa] gi|222869796|gb|EEF06927.1| predicted protein [Populus trichocarpa]

 Score = 1570 bits (4066), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 795/1050 (75%), Positives = 907/1050 (86%), Gaps = 4/1050 (0%)

Query: 5    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSN 64
            M ++   PMT L+ +F A F+CS  GL+T  QSCDP+D+ ALKEFAG LTNGSIITSWS+
Sbjct: 1    MAMVETAPMTFLRSVFFACFLCSSWGLKTTTQSCDPNDMRALKEFAGKLTNGSIITSWSS 60

Query: 65   ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 124
            ++ CCQW+GVVC     GS   RVTMLIL + GL+G+IP SLG L+QLK ++LS N L G
Sbjct: 61   KTDCCQWEGVVCRSNINGSIHSRVTMLILSKMGLQGLIPPSLGRLDQLKSVNLSFNQLSG 120

Query: 125  VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 184
             +P ELS+LKQLE LDLSHN+LSG VSG+L+ L  I++LN+SSN F   L ELG + NL 
Sbjct: 121  GLPSELSSLKQLEDLDLSHNLLSGQVSGVLSRLLSIRTLNISSNLFKEDLLELGGYPNLV 180

Query: 185  VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGG 243
             FN+SNNSFTG+++S+I S+S+ IQILDLS NH +G L+GL + S SL+QLH+D+N L G
Sbjct: 181  AFNMSNNSFTGRISSQICSSSEGIQILDLSANHLVGDLEGLFNCSRSLQQLHLDSNSLSG 240

Query: 244  DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 303
             LPD LYSMS+LQH S+  NNFSGQLS+++S L +L++L+I+GNQFSG +PN   NLT L
Sbjct: 241  SLPDFLYSMSALQHFSIPNNNFSGQLSKEVSKLFNLKNLVIYGNQFSGHIPNAFVNLTYL 300

Query: 304  EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG 363
            E FVAHSN  SGPLP +LS CSKLH+LDLRNNSLTGPIDLNFSG+ SLCTLDLA+NH SG
Sbjct: 301  EQFVAHSNMLSGPLPSTLSFCSKLHILDLRNNSLTGPIDLNFSGMPSLCTLDLASNHLSG 360

Query: 364  PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCK 423
            PLPNSLS C +LKILSL KNEL+G++PESF  L+SLLFLSLSNNSF  LSG L+VLQQC+
Sbjct: 361  PLPNSLSVCRELKILSLVKNELTGKIPESFANLSSLLFLSLSNNSFVDLSGALTVLQQCQ 420

Query: 424  NLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 483
            NL+TLILTKNFVGEEIP NV GF +LMVLA GNC LKG IPVWLLRC+KL+VLDLSWNH 
Sbjct: 421  NLSTLILTKNFVGEEIPRNVSGFRNLMVLAFGNCALKGQIPVWLLRCRKLEVLDLSWNHL 480

Query: 484  DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 543
            DG+IP WIGQMENLFYLDFSNN+LTGEIP SLT+LKSL  +N +S + TAS+GIPLYVK 
Sbjct: 481  DGSIPSWIGQMENLFYLDFSNNSLTGEIPLSLTQLKSL--ANSSSPHLTASSGIPLYVKR 538

Query: 544  NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 603
            N+S +GL YNQASSFPPS+ LSNNRI GTIPPE+G+L+ LHV DLSRNNITGTIPSS S+
Sbjct: 539  NQSASGLQYNQASSFPPSILLSNNRITGTIPPEVGRLQDLHVFDLSRNNITGTIPSSFSQ 598

Query: 604  IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNP 663
            + NLEVLDLSSN+L+GSIP S EKLTFLSKFSVANNHL+G IP+GGQFYSFP+SSFEGNP
Sbjct: 599  MENLEVLDLSSNNLYGSIPPSLEKLTFLSKFSVANNHLRGQIPSGGQFYSFPSSSFEGNP 658

Query: 664  GLCGEIDSPCDSMHAKLKPVIPSGSNS-KFGPGSIIAITFSIGVGIALLLAVTLLKMSRR 722
            GLCG I SPC+ ++  +KP IPSGS+S +FG G+I++IT +I VG+AL+LAV L KMSRR
Sbjct: 659  GLCGVIVSPCNVINNMMKPGIPSGSDSSRFGRGNILSITITIVVGLALVLAVVLHKMSRR 718

Query: 723  DSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCG 782
            + G PI DL+E++  P RLSEAL SSKLVLFQNSDCKDLTV DLLKSTNNFNQANIIGCG
Sbjct: 719  NVGDPIGDLEEEVSLPHRLSEALRSSKLVLFQNSDCKDLTVPDLLKSTNNFNQANIIGCG 778

Query: 783  GFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 842
            GFGLVYKA L NGTKAA+KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR
Sbjct: 779  GFGLVYKANLPNGTKAAIKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 838

Query: 843  LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 902
            LLIYSYMENGSLDYWLHESVD  SVLKW+VRLKIAQGAA GLAYLHKVCEPHIVHRDVKS
Sbjct: 839  LLIYSYMENGSLDYWLHESVDGGSVLKWEVRLKIAQGAACGLAYLHKVCEPHIVHRDVKS 898

Query: 903  SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 962
            SNILLDEKFEAHLADFGLSRLL PYDTHVTTDLVGTLGYIPPEYSQTL ATCRGDVYSFG
Sbjct: 899  SNILLDEKFEAHLADFGLSRLLCPYDTHVTTDLVGTLGYIPPEYSQTLMATCRGDVYSFG 958

Query: 963  VVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1022
            VVLLELLTGRRPVEVCKGKNCR+LVSW+FQMKSEKRE EIID++IW KDR+KQL EMLEI
Sbjct: 959  VVLLELLTGRRPVEVCKGKNCRNLVSWLFQMKSEKREAEIIDSAIWGKDRQKQLFEMLEI 1018

Query: 1023 ACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1052
            AC+C+DQDPRRRP IEEVV+WLDGIG  AA
Sbjct: 1019 ACRCLDQDPRRRPLIEEVVSWLDGIGFQAA 1048

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225461500|ref|XP_002282588.1| PREDICTED: phytosulfokine receptor 2-like [Vitis vinifera]

 Score = 1534 bits (3971), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 776/1053 (73%), Positives = 866/1053 (82%), Gaps = 5/1053 (0%)

Query: 5    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTP--FQSCDPSDLLALKEFAGNLTNGSIITSW 62
            MV+L F PMT LKW  LA  VCS L LQ P   QSCDP+DL ALKEFAGNLTNGSI   W
Sbjct: 1    MVMLEFTPMTFLKWALLACLVCSSLSLQIPNLTQSCDPNDLRALKEFAGNLTNGSIFFLW 60

Query: 63   SNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHL 122
            SN+S CC+WDGV C   + GS A RVT LILP KGLKG+   +LG L+ LK LDLS N L
Sbjct: 61   SNDSHCCRWDGVGCEDSNNGSVASRVTSLILPHKGLKGVNLTALGRLDHLKFLDLSSNQL 120

Query: 123  EGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSN 182
            +G +P+ELSNL QLEVLDLS+N L GPVS  L GL  I+SLN+SSN F+G    +G F N
Sbjct: 121  DGELPMELSNLHQLEVLDLSYNKLLGPVSRSLLGLKSIKSLNISSNLFSGDFLGVGGFLN 180

Query: 183  LAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS--PSLKQLHVDNNL 240
            L VFNISNN F G ++S+  S+S  IQ++DLSMNHF G L+GL +    SL+ LHVD N 
Sbjct: 181  LVVFNISNNFFNGSISSQFCSSSNAIQMIDLSMNHFTGGLEGLGNCSFTSLQNLHVDYNS 240

Query: 241  LGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNL 300
            L G LP+ L+S+ SL+ +S+  NNFSG LS K+S L SL+ L+IFGN+F G +PNV GNL
Sbjct: 241  LSGQLPEFLFSLPSLEQLSIPGNNFSGHLSRKLSKLHSLKALVIFGNRFRGPIPNVFGNL 300

Query: 301  TQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNH 360
            TQLE  +AHSNSF G LP +L+LCSKL VLDLRNNSLTG IDLNF+GL  LC LDLATNH
Sbjct: 301  TQLEILIAHSNSFYGVLPSTLALCSKLRVLDLRNNSLTGRIDLNFTGLPHLCALDLATNH 360

Query: 361  FSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQ 420
            FSG LPN+LS C +LK+LSLAKN+L G VPESF  L  L  L+LSNNSF +L+  LSVLQ
Sbjct: 361  FSGFLPNTLSSCRELKLLSLAKNDLRGPVPESFANLKYLSVLTLSNNSFVNLTEALSVLQ 420

Query: 421  QCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSW 480
            QCKNLTTLILTKNF GEEIP+NV GFESLM+ ALG C L+G IP WLL CKKLQVLDLSW
Sbjct: 421  QCKNLTTLILTKNFHGEEIPKNVKGFESLMIFALGYCALRGQIPYWLLNCKKLQVLDLSW 480

Query: 481  NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLY 540
            NH DG+IPPWIG+MENLFYLDFSNN+LTG IPKSLTELKSLI + C SSN T SAGIPLY
Sbjct: 481  NHLDGSIPPWIGEMENLFYLDFSNNSLTGRIPKSLTELKSLIFTKCNSSNITTSAGIPLY 540

Query: 541  VKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSS 600
            VK N+S NGL YNQ SSFPPS+FLSNNRINGTI PEIG+LK LHVLDLSRNNITGTIP S
Sbjct: 541  VKRNQSANGLQYNQVSSFPPSIFLSNNRINGTIWPEIGKLKQLHVLDLSRNNITGTIPDS 600

Query: 601  ISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFE 660
            IS + NLEVLDLS NDLHG IP S  KLTFLSKFSVA+N L+G IPTGGQF SFPNSSFE
Sbjct: 601  ISNMGNLEVLDLSCNDLHGEIPSSLNKLTFLSKFSVADNQLRGMIPTGGQFLSFPNSSFE 660

Query: 661  GNPGLCGEIDSPCDSMHA-KLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKM 719
            GNPGLCGE+  PCD+      KP I + SN KFG GSI  IT S+GVGIALLLAV  L+M
Sbjct: 661  GNPGLCGEVYIPCDTDDTMDPKPEIRASSNGKFGQGSIFGITISVGVGIALLLAVVWLRM 720

Query: 720  SRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANII 779
            SRRD G PI DLDE++ RP RLSE L SSKLVLFQNS CKDL+V+DLLKSTNNFNQANII
Sbjct: 721  SRRDVGDPIVDLDEEISRPHRLSEVLGSSKLVLFQNSGCKDLSVADLLKSTNNFNQANII 780

Query: 780  GCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG 839
            GCGGFGLVYKA L +GT+AA+KRLSGDCGQMEREF+AEVEALSRAQHKNLVSLQGYCRHG
Sbjct: 781  GCGGFGLVYKANLPDGTRAAIKRLSGDCGQMEREFRAEVEALSRAQHKNLVSLQGYCRHG 840

Query: 840  NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRD 899
            NDRLLIYSYMENGSLDYWLHE VD  S L WD R+KIAQGA RGLAYLHKVCEP +VHRD
Sbjct: 841  NDRLLIYSYMENGSLDYWLHERVDGGSFLTWDTRVKIAQGAGRGLAYLHKVCEPSVVHRD 900

Query: 900  VKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVY 959
            +KSSNILLDE FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT +GDVY
Sbjct: 901  IKSSNILLDETFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATFKGDVY 960

Query: 960  SFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEM 1019
            SFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK+E +I+D+S+W KDREKQ LE+
Sbjct: 961  SFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKKEEQIMDSSVWDKDREKQFLEV 1020

Query: 1020 LEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1052
            L IAC+CIDQDPR+RP I++VV+WLD +G +  
Sbjct: 1021 LGIACRCIDQDPRQRPSIDQVVSWLDAVGKEGV 1053

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147805140|emb|CAN68931.1| hypothetical protein VITISV_006966 [Vitis vinifera]

 Score = 1470 bits (3805), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 750/1045 (71%), Positives = 838/1045 (80%), Gaps = 29/1045 (2%)

Query: 13   MTCLKWLFLAFFVCSCLGLQTP--FQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQ 70
            MT LKW  LA  VCS L LQ P   QSCDP+DL ALKEFAGNLTNGSI   WSN+S CC+
Sbjct: 1    MTFLKWALLACLVCSSLSLQIPNLTQSCDPNDLRALKEFAGNLTNGSIFFLWSNDSHCCR 60

Query: 71   WDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL 130
            WDGV C   + GS A RVT LILP KGLKG+   +LG L+ LK LDLS N L+G +P+EL
Sbjct: 61   WDGVGCEDSNNGSVASRVTSLILPHKGLKGVNLTALGRLDHLKFLDLSSNQLDGELPMEL 120

Query: 131  SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISN 190
            S L QLEVLDLS+N L GPVS  L GL  I+SLN+S N F+G    +G F NL VFNISN
Sbjct: 121  SXLHQLEVLDLSYNKLLGPVSRSLLGLKSIKSLNISXNLFSGDFLGVGGFLNLVVFNISN 180

Query: 191  NSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS--PSLKQLHVDNNLLGGDLPDS 248
            N F G ++S+  S+S  IQ++DLSMNHF G L+GL +    SL+ LHVD N L G LP+ 
Sbjct: 181  NFFNGSISSQFCSSSNAIQMIDLSMNHFTGGLEGLGNCSFTSLQNLHVDYNSLSGQLPEF 240

Query: 249  LYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 308
            L+S+ SL+ +S+  NNFSG LS K+S L SL+ L+IFGN+F G +PNV GNLTQLE  +A
Sbjct: 241  LFSLPSLEQLSIPGNNFSGHLSRKLSKLHSLKALVIFGNRFRGPIPNVFGNLTQLEILIA 300

Query: 309  HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS 368
            HSNSF G LP +L+LCSKL VLDLRNNSLTG IDLNF+GL  LC LDLATNHFSG LPN+
Sbjct: 301  HSNSFYGVLPSTLALCSKLRVLDLRNNSLTGRIDLNFTGLPHLCALDLATNHFSGFLPNT 360

Query: 369  LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 428
            LS C +LK+LSLAKN+L G VPESF  L  L  L+LSNNSF +L+  LSVLQQCKNLTTL
Sbjct: 361  LSSCRELKLLSLAKNDLRGPVPESFANLKYLSVLTLSNNSFVNLTEALSVLQQCKNLTTL 420

Query: 429  ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 488
            ILTKNF GEEIP+NV GFESLM+ ALGNC L+G IP WLL CKKLQVLDLSWNH DG+IP
Sbjct: 421  ILTKNFHGEEIPKNVKGFESLMIFALGNCALRGQIPYWLLNCKKLQVLDLSWNHLDGSIP 480

Query: 489  PWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTN 548
            PWIG+MENLFYLDFSNN+LTG IPKSLTELKSLI + C SSN T SAGIPLYVK N+S N
Sbjct: 481  PWIGEMENLFYLDFSNNSLTGRIPKSLTELKSLIFTKCNSSNITTSAGIPLYVKRNQSAN 540

Query: 549  GLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLE 608
             L YNQ SSFPPS+ LSNNRINGTI PEIG+LK LHVLDLSRNNITGTIP SIS + NLE
Sbjct: 541  ALQYNQVSSFPPSIXLSNNRINGTIWPEIGKLKQLHVLDLSRNNITGTIPDSISNMGNLE 600

Query: 609  VLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGE 668
            VLDLS NDLHG IP S  KLTFLSKFSVA+N L+G IPTGGQF SFPNSSFEGNPGLCGE
Sbjct: 601  VLDLSCNDLHGXIPSSLNKLTFLSKFSVADNQLRGMIPTGGQFLSFPNSSFEGNPGLCGE 660

Query: 669  IDSPCDSMHA-KLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCP 727
            +  PCD+      KP I + SN                        V  L+MSRRD G P
Sbjct: 661  VYIPCDTDDTMDPKPEIRASSN------------------------VVWLRMSRRDVGDP 696

Query: 728  IDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLV 787
            I DLDE++ RP RLSE L SSKLVLFQNS CKDL+V+DLLKSTNNFNQANIIGCGGFGLV
Sbjct: 697  IVDLDEEISRPHRLSEVLGSSKLVLFQNSGCKDLSVADLLKSTNNFNQANIIGCGGFGLV 756

Query: 788  YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS 847
            YKA L +GT+AA+KRLSGDCGQMEREF+AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS
Sbjct: 757  YKANLPDGTRAAIKRLSGDCGQMEREFRAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS 816

Query: 848  YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL 907
            YMENGSLDYWLHE VD  S L WD R+KIAQGA RGLAYLHKVCEP +VHRD+KSSNILL
Sbjct: 817  YMENGSLDYWLHERVDGGSFLTWDTRVKIAQGAGRGLAYLHKVCEPSVVHRDIKSSNILL 876

Query: 908  DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLE 967
            DE FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT +GDVYSFGVVLLE
Sbjct: 877  DETFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATFKGDVYSFGVVLLE 936

Query: 968  LLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCI 1027
            LLTGRRPVEVCKGKNCRDLVSWVFQMKSEK+E +I+D+S+W KDREKQ LE+L IAC+CI
Sbjct: 937  LLTGRRPVEVCKGKNCRDLVSWVFQMKSEKKEEQIMDSSVWDKDREKQFLEVLGIACRCI 996

Query: 1028 DQDPRRRPFIEEVVTWLDGIGIDAA 1052
            DQDPR+RP I++VV+WLD +G +  
Sbjct: 997  DQDPRQRPSIDQVVSWLDAVGKEGV 1021

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356546862|ref|XP_003541841.1| PREDICTED: phytosulfokine receptor 2-like [Glycine max]

 Score = 1425 bits (3689), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 725/1020 (71%), Positives = 842/1020 (82%), Gaps = 6/1020 (0%)

Query: 38   CDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGH---GSTGSNAGRVTMLILP 94
            CDP DL ALKEFAGNLT+GSIIT+W N++ CC W GVVC +    + G+ A RVT LILP
Sbjct: 113  CDPHDLSALKEFAGNLTSGSIITAWPNDTFCCNWLGVVCANVTGDAGGTVASRVTKLILP 172

Query: 95   RKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGML 154
            +  L G I  SL  L+QL +L+LS NHL+G +PVE S LKQL+ LD+SHNMLSGPV+G L
Sbjct: 173  KMSLNGTISPSLAQLDQLNVLNLSFNHLKGALPVEFSKLKQLKFLDVSHNMLSGPVAGAL 232

Query: 155  AGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLS 214
            +GL  I+ LN+SSN   G+LF  GEF +L   N+SNNSFTG  +S+I SASK++  LDLS
Sbjct: 233  SGLQSIEVLNISSNLLTGALFPFGEFPHLLALNVSNNSFTGGFSSQICSASKDLHTLDLS 292

Query: 215  MNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS 274
            +NHF G L+GLD+  SL++LH+D+N   G LPDSLYSMS+L+ +++  NN SGQLSE++S
Sbjct: 293  VNHFDGGLEGLDNCTSLQRLHLDSNAFTGHLPDSLYSMSALEELTVCANNLSGQLSEQLS 352

Query: 275  NLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRN 334
             L++L+ L++ GN+FSG+ PNV GNL QLE   AH+NSF GPLP +L+LCSKL VL+LRN
Sbjct: 353  KLSNLKTLVVSGNRFSGEFPNVFGNLLQLEELEAHANSFFGPLPSTLALCSKLRVLNLRN 412

Query: 335  NSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFG 394
            NSL+G I LNF+GLS+L TLDLATNHF GPLP SLS+C  LK+LSLA+N L+G VPES+ 
Sbjct: 413  NSLSGQIGLNFTGLSNLQTLDLATNHFFGPLPTSLSNCRKLKVLSLARNGLNGSVPESYA 472

Query: 395  KLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG-GFESLMVLA 453
             LTSLLF+S SNNS  +LS  +SVLQQCKNLTTL+LTKNF GE I E+V   FESLM+LA
Sbjct: 473  NLTSLLFVSFSNNSIQNLSVAVSVLQQCKNLTTLVLTKNFRGEVISESVTVEFESLMILA 532

Query: 454  LGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPK 513
            LGNCGLKGHIP WL  C+KL VLDLSWNH +G++P WIGQM++LFYLDFSNN+LTGEIPK
Sbjct: 533  LGNCGLKGHIPSWLSNCRKLAVLDLSWNHLNGSVPSWIGQMDSLFYLDFSNNSLTGEIPK 592

Query: 514  SLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTI 573
             L ELK L+ +NC   N  A A IPL+VK N S +GL YNQASSFPPS+ LSNN ++G I
Sbjct: 593  GLAELKGLMCANCNRENLAAFAFIPLFVKRNTSVSGLQYNQASSFPPSILLSNNILSGNI 652

Query: 574  PPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSK 633
             PEIGQLK LHVLDLSRNNI GTIPS+ISE+ NLE LDLS NDL G IP SF  LTFLSK
Sbjct: 653  WPEIGQLKALHVLDLSRNNIAGTIPSTISEMENLESLDLSYNDLSGEIPPSFNNLTFLSK 712

Query: 634  FSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFG 693
            FSVA+N L+G IPTGGQF SFP+SSFEGN GLC EIDSPC  ++    P   SGS+ K G
Sbjct: 713  FSVAHNRLEGPIPTGGQFLSFPSSSFEGNLGLCREIDSPCKIVN-NTSPNNSSGSSKKRG 771

Query: 694  PGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDM-GRPQRLSEALASSKLVL 752
              +++ IT SIG+G+ALLLA+ LLKMS+RD   P+D+ DE++ GRP+RLSEALASSKLVL
Sbjct: 772  RSNVLGITISIGIGLALLLAIILLKMSKRDDDKPMDNFDEELNGRPRRLSEALASSKLVL 831

Query: 753  FQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER 812
            FQNSDCKDLTV+DLLKSTNNFNQANIIGCGGFGLVYKA L NG KAAVKRLSGDCGQMER
Sbjct: 832  FQNSDCKDLTVADLLKSTNNFNQANIIGCGGFGLVYKAYLPNGAKAAVKRLSGDCGQMER 891

Query: 813  EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV 872
            EFQAEVEALSRAQHKNLVSL+GYCRHGNDRLLIYSY+ENGSLDYWLHE VD++S LKWD 
Sbjct: 892  EFQAEVEALSRAQHKNLVSLKGYCRHGNDRLLIYSYLENGSLDYWLHECVDENSALKWDS 951

Query: 873  RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 932
            RLK+AQGAARGLAYLHK CEP IVHRDVKSSNILLD+ FEAHLADFGLSRLL+PYDTHVT
Sbjct: 952  RLKVAQGAARGLAYLHKGCEPFIVHRDVKSSNILLDDNFEAHLADFGLSRLLQPYDTHVT 1011

Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 992
            TDLVGTLGYIPPEYSQTLTAT RGDVYSFGVVLLELLTGRRPVEV KGKNCR+LVSWV+Q
Sbjct: 1012 TDLVGTLGYIPPEYSQTLTATFRGDVYSFGVVLLELLTGRRPVEVIKGKNCRNLVSWVYQ 1071

Query: 993  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1052
            MKSE +E EI D  IWHKD EKQLLE+L IACKC++QDPR+RP IE VV+WLD +  D +
Sbjct: 1072 MKSENKEQEIFDPVIWHKDHEKQLLEVLAIACKCLNQDPRQRPSIEIVVSWLDSVRFDGS 1131

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356544058|ref|XP_003540472.1| PREDICTED: phytosulfokine receptor 2-like [Glycine max]

 Score = 1409 bits (3647), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 735/1052 (69%), Positives = 860/1052 (81%), Gaps = 10/1052 (0%)

Query: 5    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQS---CDPSDLLALKEFAGNLTNGSIITS 61
            MV+L    +T L+W FLA  +C  LGL         CDP DL ALKEFAGNLT+GSIIT+
Sbjct: 1    MVLLRCFSVTLLQWCFLACLLCLSLGLNNNNNQALSCDPHDLSALKEFAGNLTSGSIITA 60

Query: 62   WSNESMCCQWDGVVCGH---GSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLS 118
            WSN+++CC W GVVC +    + G+ A RVT LILP  GL G I  SL  L+QL LL+LS
Sbjct: 61   WSNDTVCCNWLGVVCANVTGAAGGTVASRVTKLILPEMGLNGTISPSLAQLDQLNLLNLS 120

Query: 119  CNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELG 178
             NHL+GV+PVE S LK L+ LD+SHNMLSGP +G L+GL  I+ LN+SSN   G+LF  G
Sbjct: 121  FNHLKGVLPVEFSKLKLLKYLDVSHNMLSGPAAGALSGLQSIEVLNISSNLLTGALFPFG 180

Query: 179  EFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH-SPSLKQLHVD 237
            EF +L   N+SNNSFTG+ +S+I  A K++  LDLS+NHF G L+GLD+ + SL++LH+D
Sbjct: 181  EFPHLLALNVSNNSFTGRFSSQICRAPKDLHTLDLSVNHFDGGLEGLDNCATSLQRLHLD 240

Query: 238  NNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVL 297
            +N   G LPDSLYSMS+L+ +++  NN SGQL++ +S L++L+ L++ GN+FSG+ PNV 
Sbjct: 241  SNAFAGSLPDSLYSMSALEELTVCANNLSGQLTKHLSKLSNLKTLVVSGNRFSGEFPNVF 300

Query: 298  GNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLA 357
            GNL QLE   AH+NSFSGPLP +L+LCSKL VLDLRNNSL+GPI LNF+GLS+L TLDLA
Sbjct: 301  GNLLQLEELQAHANSFSGPLPSTLALCSKLRVLDLRNNSLSGPIGLNFTGLSNLQTLDLA 360

Query: 358  TNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLS 417
            TNHF GPLP SLS C +LK+LSLA+N L+G VPE++G LTSLLF+S SNNS  +LSG +S
Sbjct: 361  TNHFIGPLPTSLSYCRELKVLSLARNGLTGSVPENYGNLTSLLFVSFSNNSIENLSGAVS 420

Query: 418  VLQQCKNLTTLILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLLRCKKLQVL 476
            VLQQCKNLTTLIL+KNF GEEI E+V  GFESLM+LALGNCGLKGHIP WL  C+KL VL
Sbjct: 421  VLQQCKNLTTLILSKNFHGEEISESVTVGFESLMILALGNCGLKGHIPSWLFNCRKLAVL 480

Query: 477  DLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAG 536
            DLSWNH +G++P WIGQM++LFYLDFSNN+LTGEIP  LTELK L+ +NC   N  A A 
Sbjct: 481  DLSWNHLNGSVPSWIGQMDSLFYLDFSNNSLTGEIPIGLTELKGLMCANCNRENLAAFAF 540

Query: 537  IPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGT 596
            IPL+VK N S +GL YNQASSFPPS+ LSNN ++G I PEIGQLK LH LDLSRNNITGT
Sbjct: 541  IPLFVKRNTSVSGLQYNQASSFPPSILLSNNILSGNIWPEIGQLKALHALDLSRNNITGT 600

Query: 597  IPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 656
            IPS+ISE+ NLE LDLS NDL G IP SF  LTFLSKFSVA+NHL G IPTGGQF SFP+
Sbjct: 601  IPSTISEMENLESLDLSYNDLSGEIPPSFNNLTFLSKFSVAHNHLDGPIPTGGQFLSFPS 660

Query: 657  SSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTL 716
            SSFEGN GLC EIDSPC  ++    P   SGS+ K G  +++ IT SIG+G+ALLLA+ L
Sbjct: 661  SSFEGNQGLCREIDSPCKIVN-NTSPNNSSGSSKKRGRSNVLGITISIGIGLALLLAIIL 719

Query: 717  LKMSRRDSGCPIDDLDEDM-GRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQ 775
            L++S+R+    +D+ DE++  RP R SEAL SSKLVLFQNSDCKDLTV+DLLKSTNNFNQ
Sbjct: 720  LRLSKRNDDKSMDNFDEELNSRPHRSSEALVSSKLVLFQNSDCKDLTVADLLKSTNNFNQ 779

Query: 776  ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
            ANIIGCGGFGLVYKA L NGTKAA+KRLSGDCGQMEREFQAEVEALSRAQHKNLVSL+GY
Sbjct: 780  ANIIGCGGFGLVYKAYLPNGTKAAIKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLKGY 839

Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
            CRHGN+RLLIYSY+ENGSLDYWLHE VD+ S LKWD RLKIAQGAARGLAYLHK CEP I
Sbjct: 840  CRHGNERLLIYSYLENGSLDYWLHECVDESSALKWDSRLKIAQGAARGLAYLHKGCEPFI 899

Query: 896  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
            VHRDVKSSNILLD+KFEAHLADFGLSRLL+PYDTHVTTDLVGTLGYIPPEYSQTLTAT R
Sbjct: 900  VHRDVKSSNILLDDKFEAHLADFGLSRLLQPYDTHVTTDLVGTLGYIPPEYSQTLTATFR 959

Query: 956  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1015
            GDVYSFGVVLLELLTGRRPVEV KGKNCR+L+SWV+QMKSE +E EI D +IWHKD EKQ
Sbjct: 960  GDVYSFGVVLLELLTGRRPVEVIKGKNCRNLMSWVYQMKSENKEQEIFDPAIWHKDHEKQ 1019

Query: 1016 LLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            LLE+L IACKC++QDPR+RP IE VV+WLD +
Sbjct: 1020 LLEVLAIACKCLNQDPRQRPSIEVVVSWLDSV 1051

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356543354|ref|XP_003540126.1| PREDICTED: phytosulfokine receptor 2-like [Glycine max]

 Score = 1353 bits (3501), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 717/1050 (68%), Positives = 842/1050 (80%), Gaps = 5/1050 (0%)

Query: 5    MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSN 64
            MV+    PM  ++W FLA  +C  +GL+TP +SCD  DLLALKEFAGNLT GSIIT WS+
Sbjct: 1    MVLQRCYPMAFVQWGFLACLLCFSVGLETPARSCDKHDLLALKEFAGNLTKGSIITEWSD 60

Query: 65   ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 124
            + +CC+W GV C     G++A RV+ LILP  GL G+I  SL +L++LK L+LS N L+G
Sbjct: 61   DVVCCKWIGVYCDDVVDGADASRVSKLILPGMGLNGMISSSLAYLDKLKELNLSFNRLQG 120

Query: 125  VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 184
             +  E SNLKQLEVLDLSHNMLSGPV G L+GL  IQ LN+SSN F G LF      +L+
Sbjct: 121  ELSSEFSNLKQLEVLDLSHNMLSGPVGGALSGLQSIQILNISSNLFVGDLFRFRGLQHLS 180

Query: 185  VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH-SPSLKQLHVDNNLLGG 243
              NISNNSFT + NS+I S+SK I ILD+S NHF G L+ L + S SL++L +D+NL  G
Sbjct: 181  ALNISNNSFTDQFNSQICSSSKGIHILDISKNHFAGGLEWLGNCSMSLQELLLDSNLFSG 240

Query: 244  DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 303
             LPDSLYSMS+L+ +S+S+NN SGQLS+ +SNL+SL+ LII GN FSG+LPNV GNL  L
Sbjct: 241  TLPDSLYSMSALKQLSVSLNNLSGQLSKDLSNLSSLKSLIISGNHFSGELPNVFGNLLNL 300

Query: 304  EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG 363
            E  + +SNSFSG LP +L+LCSKL VLDLRNNSLTG + LNF+ LS+L TLDL +NHF+G
Sbjct: 301  EQLIGNSNSFSGSLPSTLALCSKLRVLDLRNNSLTGSVGLNFARLSNLFTLDLGSNHFNG 360

Query: 364  PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCK 423
             LPNSLS CH+L +LSLAKNEL+GQ+PES+  L+SLL LSLSNNSF +LS    VLQQCK
Sbjct: 361  SLPNSLSYCHELTMLSLAKNELTGQIPESYANLSSLLTLSLSNNSFENLSEAFYVLQQCK 420

Query: 424  NLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH 482
            NLTTL+LTKNF GEEIPEN+   FESL+VLALGNCGLKG IP WLL C KL+VLDLSWNH
Sbjct: 421  NLTTLVLTKNFHGEEIPENLTASFESLVVLALGNCGLKGRIPSWLLNCPKLEVLDLSWNH 480

Query: 483  FDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK 542
             +G++P WIGQM +LFYLD SNN+LTGEIPK LTEL+ LIS N   S+  ASA IPLYVK
Sbjct: 481  LEGSVPSWIGQMHHLFYLDLSNNSLTGEIPKGLTELRGLISPNYHISSLFASAAIPLYVK 540

Query: 543  HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSIS 602
             N+S +GL YN ASSFPPS++LSNNR++GTI PEIG+LK LH+LDLSRNNITGTIPSSIS
Sbjct: 541  RNKSASGLQYNHASSFPPSIYLSNNRLSGTIWPEIGRLKELHILDLSRNNITGTIPSSIS 600

Query: 603  EIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGN 662
            E++NLE LDLS+N L G+IP SF  LTFLSKFSVA NHL G IP GGQF SFPNSSFEGN
Sbjct: 601  EMKNLETLDLSNNTLVGTIPRSFNSLTFLSKFSVAYNHLWGLIPIGGQFSSFPNSSFEGN 660

Query: 663  PGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRR 722
             GLCGE    C   + +    + +    KF   +I+ IT  +GVG+ALLLAV LL+MS+R
Sbjct: 661  WGLCGETFHRC---YNEKDVGLRANHVGKFSKSNILGITIGLGVGLALLLAVILLRMSKR 717

Query: 723  DSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCG 782
            D   P D+ DE++  P R+ EALASSKLVLFQNSDCKDLTV DLLKST+NFNQ NIIGCG
Sbjct: 718  DEDKPADNFDEELSWPNRMPEALASSKLVLFQNSDCKDLTVEDLLKSTSNFNQENIIGCG 777

Query: 783  GFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 842
            GFGLVYK  L NGTK A+K+LSG CGQ+EREFQAEVEALSRAQHKNLVSL+GYC+H NDR
Sbjct: 778  GFGLVYKGNLPNGTKVAIKKLSGYCGQVEREFQAEVEALSRAQHKNLVSLKGYCQHFNDR 837

Query: 843  LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 902
            LLIYSY+ENGSLDYWLHES D +S LKWDVRLKIAQGAA GLAYLHK CEPHIVHRD+KS
Sbjct: 838  LLIYSYLENGSLDYWLHESEDGNSALKWDVRLKIAQGAAHGLAYLHKECEPHIVHRDIKS 897

Query: 903  SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 962
            SNILLD+KFEA+LADFGLSRLL+PYDTHV+TDLVGTLGYIPPEYSQ L AT +GD+YSFG
Sbjct: 898  SNILLDDKFEAYLADFGLSRLLQPYDTHVSTDLVGTLGYIPPEYSQVLKATFKGDIYSFG 957

Query: 963  VVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1022
            VVL+ELLTGRRP+EV   +  R+LVSWV QMK E RE EI D+ IWHKD EKQLL++L I
Sbjct: 958  VVLVELLTGRRPIEVTVSQRSRNLVSWVLQMKYENREQEIFDSVIWHKDNEKQLLDVLVI 1017

Query: 1023 ACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1052
            ACKCID+DPR+RP IE VV+WLD +G D +
Sbjct: 1018 ACKCIDEDPRQRPHIELVVSWLDNVGFDGS 1047

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248168|ref|NP_001239830.1| phytosulfokine receptor 2-like precursor [Glycine max] gi|223452341|gb|ACM89498.1| leucine-rich repeat transmembrane protein kinase [Glycine max]

 Score = 1348 bits (3489), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 712/1042 (68%), Positives = 835/1042 (80%), Gaps = 6/1042 (0%)

Query: 13   MTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWD 72
            M  + W FLA  +C  +GL+T  +SCD  DL+ALKEFAGNLT GSIIT WS++ +CC+W 
Sbjct: 1    MAFVLWGFLACLLCFSVGLETLARSCDKHDLMALKEFAGNLTKGSIITEWSDDVVCCKWT 60

Query: 73   GVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSN 132
            GV C     G  A RV+ LILP   L G I  SL +L++LK L+LS N L+G +  E SN
Sbjct: 61   GVYCDDVVDGVAASRVSKLILPGMDLNGTISSSLAYLDKLKELNLSFNRLQGELSSEFSN 120

Query: 133  LKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNS 192
            LKQL+VLDLSHNMLSGPV G  +GL  IQ LN+SSNSF G LF  G   +L+  NISNNS
Sbjct: 121  LKQLQVLDLSHNMLSGPVGGAFSGLQSIQILNISSNSFVGDLFHFGGLQHLSALNISNNS 180

Query: 193  FTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH-SPSLKQLHVDNNLLGGDLPDSLYS 251
            FTG+ NS+I S SK I ILD+S NHF G L+ L + S SL++LH+D+NL  G LPDSLYS
Sbjct: 181  FTGQFNSQICSTSKGIHILDISKNHFAGGLEWLGNCSTSLQELHLDSNLFSGPLPDSLYS 240

Query: 252  MSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSN 311
            MS+L+ +S+SVNN SGQLS+++SNL+SL+ LII GN FS +LPNV GNL  LE  + ++N
Sbjct: 241  MSALEQLSVSVNNLSGQLSKELSNLSSLKSLIISGNHFSEELPNVFGNLLNLEQLIGNTN 300

Query: 312  SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 371
            SFSG LP +L+LCSKL VLDLRNNSLTG + LNFSGLS+L TLDL +NHF+G LPNSLS 
Sbjct: 301  SFSGSLPSTLALCSKLRVLDLRNNSLTGSVALNFSGLSNLFTLDLGSNHFNGSLPNSLSY 360

Query: 372  CHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 431
            CH+L +LSLAKNEL+GQ+PES+  LTSLL LSLSNNSF +LSG L VLQQCKNLTTL+LT
Sbjct: 361  CHELTMLSLAKNELTGQIPESYANLTSLLTLSLSNNSFENLSGALYVLQQCKNLTTLVLT 420

Query: 432  KNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPW 490
            KNF GEEIPE +   F+SL+VLALGNCGLKG IP WLL C KL+VLDLSWNH  G++P W
Sbjct: 421  KNFHGEEIPEKLTASFKSLVVLALGNCGLKGRIPAWLLNCPKLEVLDLSWNHLKGSVPSW 480

Query: 491  IGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGL 550
            IGQM+ LFYLD SNN+LTGEIPK LT+L+ LISSN   S+  ASA IPLYVK N+S +GL
Sbjct: 481  IGQMDRLFYLDLSNNSLTGEIPKGLTQLRGLISSNYHISSLFASAAIPLYVKRNKSASGL 540

Query: 551  PYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVL 610
             YN ASSFPPS++LSNNR++GTI PEIG+LK LH+LDLSRNNITGTIPSSISE++NLE L
Sbjct: 541  QYNHASSFPPSIYLSNNRLSGTIWPEIGRLKELHILDLSRNNITGTIPSSISEMKNLETL 600

Query: 611  DLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEID 670
            DLS N L G+IP SF  LTFLSKFSVA NHL G IP GGQF SFPNSSFEGN GLCGEI 
Sbjct: 601  DLSYNSLVGTIPPSFNSLTFLSKFSVAYNHLWGLIPIGGQFSSFPNSSFEGNWGLCGEIF 660

Query: 671  SPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDD 730
              C+     L+    +    KF   +I+ IT  +GVG+ALLLAV LL++S+RD   P+D+
Sbjct: 661  HHCNEKDVGLR----ANHVGKFSKSNILGITIGLGVGLALLLAVILLRVSKRDEDKPVDN 716

Query: 731  LDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKA 790
            +DE++  P R  EAL SSKLV F+NSDCKDLTV DLLKST NFNQ NIIGCGGFGLVYK 
Sbjct: 717  IDEELSCPNRRPEALTSSKLVFFKNSDCKDLTVEDLLKSTGNFNQENIIGCGGFGLVYKG 776

Query: 791  TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME 850
             L NGTK A+K+LSG CGQ+EREFQAEVEALSRAQHKNLVSL+GYC+H +DRLLIYSY+E
Sbjct: 777  NLPNGTKVAIKKLSGYCGQVEREFQAEVEALSRAQHKNLVSLKGYCQHFSDRLLIYSYLE 836

Query: 851  NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK 910
            NGSLDYWLHES D +S LKWD RLKIA+GAA GLAYLHK CEPHIVHRD+KSSNILLD+K
Sbjct: 837  NGSLDYWLHESEDGNSALKWDARLKIAKGAAHGLAYLHKECEPHIVHRDIKSSNILLDDK 896

Query: 911  FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
            F+A+LADFGLSRLL+PYDTHV+TDLVGTLGYIPPEYSQ L AT +GD+YSFGVVL+ELLT
Sbjct: 897  FKAYLADFGLSRLLQPYDTHVSTDLVGTLGYIPPEYSQVLKATFKGDIYSFGVVLVELLT 956

Query: 971  GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQD 1030
            GRRPVEV  G+  R+LVSWV Q+KSE RE EI D+ IWHKD EKQLLE+L IACKCID+D
Sbjct: 957  GRRPVEVIIGQRSRNLVSWVLQIKSENREQEIFDSVIWHKDNEKQLLEVLAIACKCIDED 1016

Query: 1031 PRRRPFIEEVVTWLDGIGIDAA 1052
            PR+RP IE VV+WLD +G D +
Sbjct: 1017 PRQRPHIELVVSWLDNVGFDGS 1038

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297792807|ref|XP_002864288.1| hypothetical protein ARALYDRAFT_495467 [Arabidopsis lyrata subsp. lyrata] gi|297310123|gb|EFH40547.1| hypothetical protein ARALYDRAFT_495467 [Arabidopsis lyrata subsp. lyrata]

 Score = 1346 bits (3484), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 701/1041 (67%), Positives = 839/1041 (80%), Gaps = 19/1041 (1%)

Query: 19   LFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGH 78
            L LAFFV S + L     +C P+DL AL+EFAG L N S+   W N S CC+WDGV C  
Sbjct: 5    LLLAFFVGSSVSL-----TCHPNDLSALREFAGALKNMSVTEPWLNGSRCCEWDGVFCEG 59

Query: 79   GSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEV 138
            G     +GRVT L+L  KGL+G+I  SLG L++L++LDLS N L+G +PVE+S L+QLEV
Sbjct: 60   GDV---SGRVTKLVLSDKGLEGVISGSLGELSELRVLDLSRNQLKGDLPVEISKLEQLEV 116

Query: 139  LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLN 198
            LDLSHN+LSG V G ++GL LIQSLN+SSNS +G+L ++G F  L +FN+SNN F G+++
Sbjct: 117  LDLSHNLLSGSVLGAVSGLKLIQSLNISSNSLSGNLSDVGVFPGLVMFNVSNNLFEGEIH 176

Query: 199  SRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 257
              + S+S EIQ+LDLSMN  +G+L GL + S S+++LHV++N L G LPD LY +  L+ 
Sbjct: 177  PELCSSSGEIQVLDLSMNRLVGNLDGLYNCSKSIQRLHVNSNGLTGQLPDYLYLIRDLEQ 236

Query: 258  VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 317
            +S+S N  SGQLS+ +SNL+ L+ L+I  N+FSG +P+V GNLTQLE     SN FSG  
Sbjct: 237  LSVSGNYLSGQLSQNLSNLSGLKSLLISENRFSGVIPDVFGNLTQLEHLDVSSNKFSGRF 296

Query: 318  PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 377
            P SLS CSKL VLDLRNNSL+G I+LNF+G + LC LDLA+NHFSGPLP+SL  C  +KI
Sbjct: 297  PPSLSQCSKLRVLDLRNNSLSGSINLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPKMKI 356

Query: 378  LSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE 437
            LSLAKNE SG++P++F  L SLLFLSLSNNSF   S T++VLQ C+NL+TLIL+KNF+GE
Sbjct: 357  LSLAKNEFSGKIPDTFKNLDSLLFLSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGE 416

Query: 438  EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 497
            EIP NV GF +L  LALGNCGL+G IP WLL CKKL+VLDLSWNH  G IP WIG+ME+L
Sbjct: 417  EIPSNVTGFNNLATLALGNCGLRGQIPSWLLNCKKLEVLDLSWNHIYGTIPHWIGKMESL 476

Query: 498  FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASS 557
            FY+DFSNNTLTGEIP ++TELK+LI  NCT+S  T S+GIPLYVK N+S++GLPYNQ S 
Sbjct: 477  FYIDFSNNTLTGEIPVAITELKNLIHLNCTASQMTTSSGIPLYVKRNKSSSGLPYNQVSR 536

Query: 558  FPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 617
            FPPS++L+NNR+NGTI PEIG+LK LH+LDLSRNN +G IP SIS + NLEVLDLS N L
Sbjct: 537  FPPSIYLNNNRLNGTILPEIGRLKELHMLDLSRNNFSGRIPDSISGLDNLEVLDLSYNHL 596

Query: 618  HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDS-M 676
            +GSIP SF+ LTFLSKFSVA N L G IP+GGQFYSFP+SSFEGN GLC  IDSPCD  M
Sbjct: 597  YGSIPLSFQSLTFLSKFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLM 656

Query: 677  HAKLKPVIPSGSNS---KFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDE 733
               L P  PS SN+   +FG  SI+ +T S+ +GI LLL+V LL++SR+DS   I+D+DE
Sbjct: 657  SNMLNPKGPSRSNNTGGRFGRSSIVVLTISLAIGITLLLSVILLRISRKDSDDRINDVDE 716

Query: 734  DM--GRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT 791
            +   G P+    AL  SK+VLF +  CKDL+V +LLKSTNNF+QANIIGCGGFGLVYKA 
Sbjct: 717  ETISGVPK----ALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKAN 772

Query: 792  LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN 851
              +G+KAAVKRLSGDCGQMEREFQAEVEALSRA+HKNLVSLQGYC+HGNDRLLIYS+MEN
Sbjct: 773  FPDGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMEN 832

Query: 852  GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF 911
            GSLDYWLHE VD +  LKWDVRLKIAQGAARGLAYLHKVCEP+++HRDVKSSNILLDEKF
Sbjct: 833  GSLDYWLHERVDGNMTLKWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKF 892

Query: 912  EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 971
            EAHLADFGL+RLLRPYDTHVTTDLVGTLGYIPPEYSQ+L ATCRGDVYSFGVVLLEL+TG
Sbjct: 893  EAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTG 952

Query: 972  RRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDP 1031
            RRPVEVCKGK+CRDLVSWVFQMKSEKRE E+ID +I     EK +LEMLEIACKCID +P
Sbjct: 953  RRPVEVCKGKSCRDLVSWVFQMKSEKREAELIDTTIRENVNEKTVLEMLEIACKCIDHEP 1012

Query: 1032 RRRPFIEEVVTWLDGIGIDAA 1052
            RRRP IEEVVTWL+ + +++ 
Sbjct: 1013 RRRPLIEEVVTWLEDLPMESV 1033

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1052
TAIR|locus:2154709	1036	PSKR2 "phytosylfokine-alpha re	0.972	0.987	0.640	0.0
TAIR|locus:2051628	1008	PSKR1 "phytosulfokin receptor	0.878	0.916	0.488	5.1e-232
TAIR|locus:2207056	1095	PSY1R "PSY1 receptor" [Arabido	0.890	0.855	0.443	1.1e-211
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.880	0.795	0.344	5.6e-132
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.844	0.761	0.343	1.7e-128
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.925	0.817	0.333	3.4e-125
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.894	0.753	0.342	5.5e-125
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.876	0.736	0.339	5.7e-123
TAIR|locus:2005498	1196	BRI1 "BRASSINOSTEROID INSENSIT	0.867	0.763	0.349	7.2e-123
TAIR|locus:2041150	1143	BRL2 "BRI1-like 2" [Arabidopsi	0.876	0.806	0.334	1.9e-122

TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 3390 (1198.4 bits), Expect = 0., P = 0.
 Identities = 665/1038 (64%), Positives = 804/1038 (77%)

Query:    19 LFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGH 78
             L L FFV S +      Q C P+DL AL+E AG L N S+  SW N S CC+WDGV C  
Sbjct:     5 LLLVFFVGSSVS-----QPCHPNDLSALRELAGALKNKSVTESWLNGSRCCEWDGVFC-E 58

Query:    79 GSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEV 138
             GS  S  GRVT L+LP KGL+G+I +SLG L +L++LDLS N L+G VP E+S L+QL+V
Sbjct:    59 GSDVS--GRVTKLVLPEKGLEGVISKSLGELTELRVLDLSRNQLKGEVPAEISKLEQLQV 116

Query:   139 LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLN 198
             LDLSHN+LSG V G+++GL LIQSLN+SSNS +G L ++G F  L + N+SNN F G+++
Sbjct:   117 LDLSHNLLSGSVLGVVSGLKLIQSLNISSNSLSGKLSDVGVFPGLVMLNVSNNLFEGEIH 176

Query:   199 SRIWSASKEIQILDLSMNHFMGSLQGLDH-SPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 257
               + S+S  IQ+LDLSMN  +G+L GL + S S++QLH+D+N L G LPD LYS+  L+ 
Sbjct:   177 PELCSSSGGIQVLDLSMNRLVGNLDGLYNCSKSIQQLHIDSNRLTGQLPDYLYSIRELEQ 236

Query:   258 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXXXXXXX 317
             +SLS N  SG+LS+ +SNL+ L+ L+I  N+FS  +P+V GNLTQLE             
Sbjct:   237 LSLSGNYLSGELSKNLSNLSGLKSLLISENRFSDVIPDVFGNLTQLEHLDVSSNKFSGRF 296

Query:   318 XXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 377
                        VLDLRNNSL+G I+LNF+G + LC LDLA+NHFSGPLP+SL  C  +KI
Sbjct:   297 PPSLSQCSKLRVLDLRNNSLSGSINLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPKMKI 356

Query:   378 LSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSVLQQCKNLTTLILTKNFVGE 437
             LSLAKNE  G++P+                       T++VLQ C+NL+TLIL+KNF+GE
Sbjct:   357 LSLAKNEFRGKIPDTFKNLQSLLFLSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGE 416

Query:   438 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 497
             EIP NV GF++L +LALGNCGL+G IP WLL CKKL+VLDLSWNHF G IP WIG+ME+L
Sbjct:   417 EIPNNVTGFDNLAILALGNCGLRGQIPSWLLNCKKLEVLDLSWNHFYGTIPHWIGKMESL 476

Query:   498 FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASS 557
             FY+DFSNNTLTG IP ++TELK+LI  N T+S  T S+GIPLYVK N+S+NGLPYNQ S 
Sbjct:   477 FYIDFSNNTLTGAIPVAITELKNLIRLNGTASQMTDSSGIPLYVKRNKSSNGLPYNQVSR 536

Query:   558 FPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 617
             FPPS++L+NNR+NGTI PEIG+LK LH+LDLSRNN TGTIP SIS + NLEVLDLS N L
Sbjct:   537 FPPSIYLNNNRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHL 596

Query:   618 HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMH 677
             +GSIP SF+ LTFLS+FSVA N L G IP+GGQFYSFP+SSFEGN GLC  IDSPCD + 
Sbjct:   597 YGSIPLSFQSLTFLSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLM 656

Query:   678 AK-LKPVIPSGSNS---KFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDE 733
             +  L P   S  N+   KFG  SI+ +T S+ +GI LLL+V LL++SR+D    I+D+DE
Sbjct:   657 SNMLNPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDVDE 716

Query:   734 DMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT 793
             +      +S+AL  SK+VLF +  CKDL+V +LLKSTNNF+QANIIGCGGFGLVYKA   
Sbjct:   717 ET--ISGVSKALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFP 774

Query:   794 NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS 853
             +G+KAAVKRLSGDCGQMEREFQAEVEALSRA+HKNLVSLQGYC+HGNDRLLIYS+MENGS
Sbjct:   775 DGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGS 834

Query:   854 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA 913
             LDYWLHE VD +  L WDVRLKIAQGAARGLAYLHKVCEP+++HRDVKSSNILLDEKFEA
Sbjct:   835 LDYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEA 894

Query:   914 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRR 973
             HLADFGL+RLLRPYDTHVTTDLVGTLGYIPPEYSQ+L ATCRGDVYSFGVVLLEL+TGRR
Sbjct:   895 HLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRR 954

Query:   974 PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1033
             PVEVCKGK+CRDLVS VFQMK+EKRE E+ID +I     E+ +LEMLEIACKCID +PRR
Sbjct:   955 PVEVCKGKSCRDLVSRVFQMKAEKREAELIDTTIRENVNERTVLEMLEIACKCIDHEPRR 1014

Query:  1034 RPFIEEVVTWLDGIGIDA 1051
             RP IEEVVTWL+ + +++
Sbjct:  1015 RPLIEEVVTWLEDLPMES 1032

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2238 (792.9 bits), Expect = 5.1e-232, P = 5.1e-232
 Identities = 458/937 (48%), Positives = 611/937 (65%)

Query:   115 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL 174
             L+L    L G +   L  L ++ VL+LS N +   +   +  L  +Q+L++SSN  +G +
Sbjct:    81 LELGNKKLSGKLSESLGKLDEIRVLNLSRNFIKDSIPLSIFNLKNLQTLDLSSNDLSGGI 140

Query:   175 FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQ 233
                     L  F++S+N F G L S I   S +I+++ L++N+F G+   G      L+ 
Sbjct:   141 PTSINLPALQSFDLSSNKFNGSLPSHICHNSTQIRVVKLAVNYFAGNFTSGFGKCVLLEH 200

Query:   234 LHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKL 293
             L +  N L G++P+ L+ +  L  + +  N  SG LS +I NL+SL  L +  N FSG++
Sbjct:   201 LCLGMNDLTGNIPEDLFHLKRLNLLGIQENRLSGSLSREIRNLSSLVRLDVSWNLFSGEI 260

Query:   294 PNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCT 353
             P+V   L QL+FF+                    ++L+LRNNSL+G + LN + + +L +
Sbjct:   261 PDVFDELPQLKFFLGQTNGFIGGIPKSLANSPSLNLLNLRNNSLSGRLMLNCTAMIALNS 320

Query:   354 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXX 413
             LDL TN F+G LP +L DC  LK ++LA+N   GQVPE                      
Sbjct:   321 LDLGTNRFNGRLPENLPDCKRLKNVNLARNTFHGQVPESFKNFESLSYFSLSNSSLANIS 380

Query:   414 GTLSVLQQCKNLTTLILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLLRCKK 472
               L +LQ CKNLTTL+LT NF GE +P++    FE L VL + NC L G +P WL    +
Sbjct:   381 SALGILQHCKNLTTLVLTLNFHGEALPDDSSLHFEKLKVLVVANCRLTGSMPRWLSSSNE 440

Query:   473 LQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPT 532
             LQ+LDLSWN   G IP WIG  + LFYLD SNN+ TGEIPKSLT+L+SL S N + + P 
Sbjct:   441 LQLLDLSWNRLTGAIPSWIGDFKALFYLDLSNNSFTGEIPKSLTKLESLTSRNISVNEP- 499

Query:   533 ASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNN 592
              S   P ++K N S   L YNQ   FPP++ L +N ++G I  E G LK LHV DL  N 
Sbjct:   500 -SPDFPFFMKRNESARALQYNQIFGFPPTIELGHNNLSGPIWEEFGNLKKLHVFDLKWNA 558

Query:   593 ITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFY 652
             ++G+IPSS+S + +LE LDLS+N L GSIP S ++L+FLSKFSVA N+L G IP+GGQF 
Sbjct:   559 LSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQ 618

Query:   653 SFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGP-GSIIAITFSIGVGIALL 711
             +FPNSSFE N  LCGE   PC         +I     S+ G  G  I I F   V +  L
Sbjct:   619 TFPNSSFESNH-LCGEHRFPCSE--GTESALIKRSRRSRGGDIGMAIGIAFG-SVFLLTL 674

Query:   712 LAVTLLKMSRRDSGC-PIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKST 770
             L++ +L+  RR     P  +  E M R + L E + S  +VLFQ++D K+L+  DLL ST
Sbjct:   675 LSLIVLRARRRSGEVDPEIEESESMNRKE-LGE-IGSKLVVLFQSND-KELSYDDLLDST 731

Query:   771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
             N+F+QANIIGCGGFG+VYKATL +G K A+K+LSGDCGQ+EREF+AEVE LSRAQH NLV
Sbjct:   732 NSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLV 791

Query:   831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
              L+G+C + NDRLLIYSYMENGSLDYWLHE  D  ++LKW  RL+IAQGAA+GL YLH+ 
Sbjct:   792 LLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEG 851

Query:   891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
             C+PHI+HRD+KSSNILLDE F +HLADFGL+RL+ PY+THV+TDLVGTLGYIPPEY Q  
Sbjct:   852 CDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEYGQAS 911

Query:   951 TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
              AT +GDVYSFGVVLLELLT +RPV++CK K CRDL+SWV +MK E R  E+ D  I+ K
Sbjct:   912 VATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRDLISWVVKMKHESRASEVFDPLIYSK 971

Query:  1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
             + +K++  +LEIAC C+ ++P++RP  +++V+WLD +
Sbjct:   972 ENDKEMFRVLEIACLCLSENPKQRPTTQQLVSWLDDV 1008

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP;IDA

GO:0009611 "response to wounding" evidence=IGI

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 2032 (720.4 bits), Expect = 1.1e-211, Sum P(2) = 1.1e-211
 Identities = 437/985 (44%), Positives = 605/985 (61%)

Query:    87 RVTMLILPRKGLKGIIPRS-LGHLNQLKLLDLSCNHLEGVVPVELS------NLKQLEVL 139
             R++ L L    L G +P   L  L+QL +LDLS N  +G +P++ S       +  ++ +
Sbjct:   117 RLSRLDLSHNRLSGPLPPGFLSALDQLLVLDLSYNSFKGELPLQQSFGNGSNGIFPIQTV 176

Query:   140 DLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNS 199
             DLS N+L G +              +SS     S+F  G F NL  FN+SNNSFTG + S
Sbjct:   177 DLSSNLLEGEI--------------LSS-----SVFLQGAF-NLTSFNVSNNSFTGSIPS 216

Query:   200 RIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHV 258
              + +AS ++  LD S N F G L Q L     L  L    N L G++P  +Y++  L+ +
Sbjct:   217 FMCTASPQLTKLDFSYNDFSGDLSQELSRCSRLSVLRAGFNNLSGEIPKEIYNLPELEQL 276

Query:   259 SLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXXXXXXXX 318
              L VN  SG++   I+ LT L  L ++ N   G++P  +G L++L     H         
Sbjct:   277 FLPVNRLSGKIDNGITRLTKLTLLELYSNHIEGEIPKDIGKLSKLSSLQLHVNNLMGSIP 336

Query:   319 XXXXXXXXXHVLDLRNNSLTGPID-LNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 377
                        L+LR N L G +  ++FS   SL  LDL  N F+G  P+++  C  +  
Sbjct:   337 VSLANCTKLVKLNLRVNQLGGTLSAIDFSRFQSLSILDLGNNSFTGEFPSTVYSCKMMTA 396

Query:   378 LSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSVLQQCKNLTTLILTKNFVGE 437
             +  A N+L+GQ+                        G LS+LQ CK L+TLI+ KNF  E
Sbjct:   397 MRFAGNKLTGQISPQVLELESLSFFTFSDNKMTNLTGALSILQGCKKLSTLIMAKNFYDE 456

Query:   438 EIPENVG-----GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 492
              +P N       GF SL +  +G C L G IP WL++ ++++V+DLS N F G IP W+G
Sbjct:   457 TVPSNKDFLRSDGFPSLQIFGIGACRLTGEIPAWLIKLQRVEVMDLSMNRFVGTIPGWLG 516

Query:   493 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 552
              + +LFYLD S+N LTGE+PK L +L++L+S     +       +P++V  N  T    Y
Sbjct:   517 TLPDLFYLDLSDNFLTGELPKELFQLRALMSQKAYDATERNYLELPVFVNPNNVTTNQQY 576

Query:   553 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 612
             NQ SS PP++++  N + GTIP E+GQLK LH+L+L  NN +G+IP  +S + NLE LDL
Sbjct:   577 NQLSSLPPTIYIKRNNLTGTIPVEVGQLKVLHILELLGNNFSGSIPDELSNLTNLERLDL 636

Query:   613 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEID-S 671
             S+N+L G IP S   L FLS F+VANN L G IPTG QF +FP ++FEGNP LCG +  +
Sbjct:   637 SNNNLSGRIPWSLTGLHFLSYFNVANNTLSGPIPTGTQFDTFPKANFEGNPLLCGGVLLT 696

Query:   672 PCD-SMHAKLKPVIPSGS-NSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPID 729
              CD + H+  K  +  G  N     G ++ + F + + I +LLA+ +L   R + G   +
Sbjct:   697 SCDPTQHSTTK--MGKGKVNRTLVLGLVLGLFFGVSL-ILVLLALLVLSKRRVNPG-DSE 752

Query:   730 DLDEDMGRPQRLSEALASSK-----LVLFQNS--DCKDLTVSDLLKSTNNFNQANIIGCG 782
             + + ++      SE    S      ++LF NS  + KDLT+ +LLK+T+NF+QANIIGCG
Sbjct:   753 NAELEINSNGSYSEVPPGSDKDISLVLLFGNSRYEVKDLTIFELLKATDNFSQANIIGCG 812

Query:   783 GFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR 842
             GFGLVYKATL NGTK AVK+L+GD G ME+EF+AEVE LSRA+H+NLV+LQGYC H + R
Sbjct:   813 GFGLVYKATLDNGTKLAVKKLTGDYGMMEKEFKAEVEVLSRAKHENLVALQGYCVHDSAR 872

Query:   843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 902
             +LIYS+MENGSLDYWLHE+ +  + L W  RL I +GA+ GLAY+H++CEPHIVHRD+KS
Sbjct:   873 ILIYSFMENGSLDYWLHENPEGPAQLDWPKRLNIMRGASSGLAYMHQICEPHIVHRDIKS 932

Query:   903 SNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFG 962
             SNILLD  F+A++ADFGLSRL+ PY THVTT+LVGTLGYIPPEY Q   AT RGDVYSFG
Sbjct:   933 SNILLDGNFKAYVADFGLSRLILPYRTHVTTELVGTLGYIPPEYGQAWVATLRGDVYSFG 992

Query:   963 VVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1022
             VV+LELLTG+RP+EV + K  R+LV+WV  MK + +  E+ D  +     E+ +L +L+I
Sbjct:   993 VVMLELLTGKRPMEVFRPKMSRELVAWVHTMKRDGKPEEVFDTLLRESGNEEAMLRVLDI 1052

Query:  1023 ACKCIDQDPRRRPFIEEVVTWLDGI 1047
             AC C++Q+P +RP I++VV WL  I
Sbjct:  1053 ACMCVNQNPMKRPNIQQVVDWLKNI 1077

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0004888 "transmembrane signaling receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1294 (460.6 bits), Expect = 5.6e-132, P = 5.6e-132
 Identities = 343/996 (34%), Positives = 522/996 (52%)

Query:    81 TGSNAGRVTMLILPRKGLKGIIPRSL--GHLNQLKLLDLSCNHLEGVVP-VELSNLKQLE 137
             + SN  R+T + L        IP +      N LK LDLS N++ G    +     + L 
Sbjct:   171 SASNK-RITTVDLSNNRFSDEIPETFIADFPNSLKHLDLSGNNVTGDFSRLSFGLCENLT 229

Query:   138 VLDLSHNMLSG---PVSGMLAGLNLIQSLNVSSNSFNGSL---FELGEFSNLAVFNISNN 191
             V  LS N +SG   PVS  L+   L+++LN+S NS  G +      G F NL   ++++N
Sbjct:   230 VFSLSQNSISGDRFPVS--LSNCKLLETLNLSRNSLIGKIPGDDYWGNFQNLRQLSLAHN 287

Query:   192 SFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHVDNNLLGGDLPDSLY 250
              ++G++   +    + +++LDLS N   G L Q      SL+ L++ NN L GD   ++ 
Sbjct:   288 LYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVV 347

Query:   251 S-MSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 309
             S +S + ++ L  NN SG +   ++N ++LR L +  N+F+G++P+   +L         
Sbjct:   348 SKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQS------- 400

Query:   310 XXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL 369
                                 L + NN L+G + +      SL T+DL+ N  +G +P  +
Sbjct:   401 --------------SSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKEI 446

Query:   370 SDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTL-SVLQQCKNLTTL 428
                  L  L +  N L+G +PE                      G+L   + +C N+  +
Sbjct:   447 WTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNNNLLT--GSLPESISKCTNMLWI 504

Query:   429 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 488
              L+ N +  EIP  +G  E L +L LGN  L G+IP  L  CK L  LDL+ N+  GN+P
Sbjct:   505 SLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLP 564

Query:   489 PWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTAS-AGIPLY-VKH--- 543
               +     L        +++G   K    +++   ++C  +       GI    ++H   
Sbjct:   565 GELASQAGLVM----PGSVSG---KQFAFVRNEGGTDCRGAGGLVEFEGIRAERLEHFPM 617

Query:   544 ------NRSTNGLPYNQASSFPPSVFL--SNNRINGTIPPEIGQLKHLHVLDLSRNNITG 595
                    R  +G+     SS    ++L  S N ++G+IP   G + +L VL+L  N +TG
Sbjct:   618 VHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTG 677

Query:   596 TIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFP 655
             TIP S   ++ + VLDLS NDL G +PGS   L+FLS   V+NN+L G IP GGQ  +FP
Sbjct:   678 TIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFP 737

Query:   656 NSSFEGNPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAV- 714
              + +  N GLCG    PC S     +        S    G    I FS    + L++A+ 
Sbjct:   738 LTRYANNSGLCGVPLPPCSSGSRPTRSHAHPKKQS-IATGMSAGIVFSFMCIVMLIMALY 796

Query:   715 TLLKMSRRDSGCP--IDDLDEDMGRPQRLS---EALASSKLVLFQNSDCKDLTVSDLLKS 769
                K+ +++      I+ L        +LS   E L S  +  F+    + LT + LL++
Sbjct:   797 RARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPL-SINVATFEKP-LRKLTFAHLLEA 854

Query:   770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 829
             TN F+  ++IG GGFG VYKA L +G+  A+K+L    GQ +REF AE+E + + +H+NL
Sbjct:   855 TNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNL 914

Query:   830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV-LKWDVRLKIAQGAARGLAYLH 888
             V L GYC+ G +RLL+Y YM+ GSL+  LHE   K  + L W  R KIA GAARGLA+LH
Sbjct:   915 VPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLH 974

Query:   889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 947
               C PHI+HRD+KSSN+LLD+ F A ++DFG++RL+   DTH++   L GT GY+PPEY 
Sbjct:   975 HSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYY 1034

Query:   948 QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS- 1006
             Q+   T +GDVYS+GV+LLELL+G++P++  +     +LV W  Q+  EKR  EI+D   
Sbjct:  1035 QSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPEL 1094

Query:  1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042
             +  K  + +LL  L+IA +C+D  P +RP + +V+T
Sbjct:  1095 VTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMT 1130

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
 Identities = 321/935 (34%), Positives = 484/935 (51%)

Query:   136 LEVLDLSHNMLSGPVSGMLAGL-NLIQSLNVSSNSFNGSLFE--LGEFSNLAVFNISNNS 192
             L+ LDL+HN LSG  S +  G+   +   ++S N+ +G  F   L     L   NIS N+
Sbjct:   203 LKYLDLTHNNLSGDFSDLSFGICGNLTFFSLSQNNLSGDKFPITLPNCKFLETLNISRNN 262

Query:   193 FTGKL-NSRIWSASKEIQILDLSMNHFMGSLQG-LDH-SPSLKQLHVDNNLLGGDLPDSL 249
               GK+ N   W + + ++ L L+ N   G +   L     +L  L +  N   G+LP   
Sbjct:   263 LAGKIPNGEYWGSFQNLKQLSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQF 322

Query:   250 YSMSSLQHVSLSVNNFSGQ-LSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 308
              +   LQ+++L  N  SG  L+  +S +T + +L +  N  SG +P  L N + L     
Sbjct:   323 TACVWLQNLNLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDL 382

Query:   309 HXXXXXXXXXXXXXXXXXXHVLD---LRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPL 365
                                 VL+   + NN L+G + +      SL T+DL+ N  +GP+
Sbjct:   383 SSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPI 442

Query:   366 PNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSVLQQCKNL 425
             P  +    +L  L +  N L+G +PE                         S+  +C N+
Sbjct:   443 PKEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESI-SRCTNM 501

Query:   426 TTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG 485
               + L+ N +  +IP  +G    L +L LGN  L G++P  L  CK L  LDL+ N+  G
Sbjct:   502 IWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTG 561

Query:   486 NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTAS-AGIP------ 538
             ++P  +     L        +++G   K    +++   ++C  +       GI       
Sbjct:   562 DLPGELASQAGLVM----PGSVSG---KQFAFVRNEGGTDCRGAGGLVEFEGIRAERLER 614

Query:   539 LYVKHN----RSTNGLPYNQASSFPPSVF--LSNNRINGTIPPEIGQLKHLHVLDLSRNN 592
             L + H+    R  +G+     S+    ++  +S N ++G IPP  G + +L VL+L  N 
Sbjct:   615 LPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNR 674

Query:   593 ITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFY 652
             ITGTIP S   ++ + VLDLS N+L G +PGS   L+FLS   V+NN+L G IP GGQ  
Sbjct:   675 ITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLT 734

Query:   653 SFPNSSFEGNPGLCGEIDSPCDSMHAKLKPVIPS--GSNSKFGPGSIIAITFSIGVGIAL 710
             +FP S +  N GLCG    PC S  A  +P+               I  I FS    + L
Sbjct:   735 TFPVSRYANNSGLCGVPLRPCGS--APRRPITSRIHAKKQTVATAVIAGIAFSFMCFVML 792

Query:   711 LLAV-TLLKMSRRDSGCP--IDDLDEDMGRPQRLS---EALASSKLVLFQNSDCKDLTVS 764
             ++A+  + K+ +++      I+ L        +LS   E L S  +  F+    + LT +
Sbjct:   793 VMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPL-SINVATFEKP-LRKLTFA 850

Query:   765 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA 824
              LL++TN F+   ++G GGFG VYKA L +G+  A+K+L    GQ +REF AE+E + + 
Sbjct:   851 HLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKI 910

Query:   825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS--VLKWDVRLKIAQGAAR 882
             +H+NLV L GYC+ G +RLL+Y YM+ GSL+  LHE   K     L W  R KIA GAAR
Sbjct:   911 KHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAAR 970

Query:   883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGY 941
             GLA+LH  C PHI+HRD+KSSN+LLDE FEA ++DFG++RL+   DTH++   L GT GY
Sbjct:   971 GLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGY 1030

Query:   942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
             +PPEY Q+   T +GDVYS+GV+LLELL+G++P++  +     +LV W  Q+  EKR  E
Sbjct:  1031 VPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAE 1090

Query:  1002 IIDAS-IWHKDREKQLLEMLEIACKCIDQDPRRRP 1035
             I+D   +  K  + +L   L+IA +C+D  P +RP
Sbjct:  1091 ILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRP 1125

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1230 (438.0 bits), Expect = 3.4e-125, P = 3.4e-125
 Identities = 344/1030 (33%), Positives = 517/1030 (50%)

Query:    44 LALKEFAGNLTN--GSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGI 101
             + L  F+G + +  G+I    +  +  C ++G +    S   +  ++ +   P   LK  
Sbjct:   193 MGLNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNP---LKCS 249

Query:   102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
             IP+S G L+ L +L+L    L G++P EL N K L+ L LS N LSGP+   L+ + L+ 
Sbjct:   250 IPKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLL- 308

Query:   162 SLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 220
             + +   N  +GSL   +G++  L    ++NN F+G++   I      ++ L L+ N   G
Sbjct:   309 TFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPM-LKHLSLASNLLSG 367

Query:   221 SL-QGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 279
             S+ + L  S SL+ + +  NLL G + +     SSL  + L+ N  +G + E +  L  L
Sbjct:   368 SIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-L 426

Query:   280 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTG 339
               L +  N F+G++P  L   T L  F A                     L L +N LTG
Sbjct:   427 MALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTG 486

Query:   340 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXX 399
              I      L+SL  L+L  N F G +P  L DC  L  L L  N L GQ+P+        
Sbjct:   487 EIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQL 546

Query:   400 XXXXXXXXXXXXXXGTL--SVLQQCK--NLTTLI------LTKNFVGEEIPENVGGFESL 449
                            +   +   Q +  +L+ L       L+ N +   IPE +G    L
Sbjct:   547 QCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVL 606

Query:   450 MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG 509
             + ++L N  L G IP  L R   L +LDLS N   G+IP  +G    L  L+ +NN L G
Sbjct:   607 VEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNG 666

Query:   510 EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRI 569
              IP+S   L SL+  N T +       +P  + + +    +             LS N +
Sbjct:   667 HIPESFGLLGSLVKLNLTKNK--LDGPVPASLGNLKELTHMD------------LSFNNL 712

Query:   570 NGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLT 629
             +G +  E+  ++ L  L + +N  TG IPS +  +  LE LD+S N L G IP     L 
Sbjct:   713 SGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLP 772

Query:   630 FLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEI-DSPCDSMHAKLKPVIPSGS 688
              L   ++A N+L+G +P+ G       +   GN  LCG +  S C     KL+       
Sbjct:   773 NLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLR------- 825

Query:   689 NSKFG-PGSIIAITFSIGVGIALLLAVTLLK-MSRRDSGCPIDD------LDEDMG--RP 738
              S +G  G ++  T  + V +  L    + K + +RD    +++      +D+++     
Sbjct:   826 -SAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSG 884

Query:   739 QRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA 798
              R  E L S  + +F+    K + + D++++T++F++ NIIG GGFG VYKA L      
Sbjct:   885 SRSREPL-SINIAMFEQPLLK-VRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTV 942

Query:   799 AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWL 858
             AVK+LS    Q  REF AE+E L + +H NLVSL GYC    ++LL+Y YM NGSLD+WL
Sbjct:   943 AVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWL 1002

Query:   859 HESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 918
                     VL W  RLKIA GAARGLA+LH    PHI+HRD+K+SNILLD  FE  +ADF
Sbjct:  1003 RNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADF 1062

Query:   919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV- 977
             GL+RL+   ++HV+T + GT GYIPPEY Q+  AT +GDVYSFGV+LLEL+TG+ P    
Sbjct:  1063 GLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPD 1122

Query:   978 CKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1037
              K     +LV W  Q  ++ + V++ID  +     +   L +L+IA  C+ + P +RP +
Sbjct:  1123 FKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNM 1182

Query:  1038 EEVVTWLDGI 1047
              +V+  L  I
Sbjct:  1183 LDVLKALKEI 1192

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1228 (437.3 bits), Expect = 5.5e-125, P = 5.5e-125
 Identities = 339/990 (34%), Positives = 504/990 (50%)

Query:    79 GSTGSNAGRVTML---ILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQ 135
             G   S  G ++ L    L    L+G+IP+SL  L  L+ LDLS N+L G +P E  N+ Q
Sbjct:   253 GEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQ 312

Query:   136 LEVLDLSHNMLSGPVSGMLAGLNL-IQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSF 193
             L  L L++N LSG +   +   N  ++ L +S    +G +  EL +  +L   ++SNNS 
Sbjct:   313 LLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSL 372

Query:   194 TGKLNSRIWSASKEIQILDLSMNHFMGSLQ-GLDHSPSLKQLHVDNNLLGGDLPDSLYSM 252
              G +   ++    E+  L L  N   G+L   + +  +L+ L + +N L G LP  + ++
Sbjct:   373 AGSIPEALFELV-ELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISAL 431

Query:   253 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXX 312
               L+ + L  N FSG++ ++I N TSL+ + +FGN F G++P  +G L +L         
Sbjct:   432 RKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNE 491

Query:   313 XXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC 372
                            ++LDL +N L+G I  +F  L  L  L L  N   G LP+SL   
Sbjct:   492 LVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISL 551

Query:   373 HDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSVLQQCKNLTTLILTK 432
              +L  ++L+ N L+G +                          L  L   +NL  L L K
Sbjct:   552 RNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEI--PLE-LGNSQNLDRLRLGK 608

Query:   433 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 492
             N +  +IP  +G    L +L + +  L G IP+ L+ CKKL  +DL+ N   G IPPW+G
Sbjct:   609 NQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLG 668

Query:   493 QMENLFYLDFSNNTLTGEIPKSL---TELK--SLISSNCTSSNPTASAGIP----LYVKH 543
             ++  L  L  S+N     +P  L   T+L   SL  ++   S P     +     L +  
Sbjct:   669 KLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDK 728

Query:   544 NRSTNGLPYNQAS-SFPPSVFLSNNRINGTIPPEIGQLKHLH-VLDLSRNNITGTIPSSI 601
             N+ +  LP      S    + LS N + G IP EIGQL+ L   LDLS NN TG IPS+I
Sbjct:   729 NQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTI 788

Query:   602 SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEG 661
               +  LE LDLS N L G +PGS   +  L   +V+ N+L G +    QF  +P  SF G
Sbjct:   789 GTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLG 846

Query:   662 NPGLCGEIDSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSR 721
             N GLCG   S C+ + +  K     G +++     I AI+    +G+ ++L + L    R
Sbjct:   847 NTGLCGSPLSRCNRVRSNNKQ---QGLSAR-SVVIISAISALTAIGL-MILVIALFFKQR 901

Query:   722 RDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANIIG 780
              D    +             S + A+ K  LF+N   K D+   D++++T+N ++  +IG
Sbjct:   902 HDFFKKVGH--GSTAYTSSSSSSQATHK-PLFRNGASKSDIRWEDIMEATHNLSEEFMIG 958

Query:   781 CGGFGLVYKATLTNGTKAAVKR-LSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG 839
              GG G VYKA L NG   AVK+ L  D     + F  EV+ L R +H++LV L GYC   
Sbjct:   959 SGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSK 1018

Query:   840 ND--RLLIYSYMENGSLDYWLHESVD----KDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
             ++   LLIY YM+NGS+  WLHE       K  +L W+ RL+IA G A+G+ YLH  C P
Sbjct:  1019 SEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVP 1078

Query:   894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY-DTHVTTD--LVGTLGYIPPEYSQTL 950
              IVHRD+KSSN+LLD   EAHL DFGL+++L    DT+  ++     + GYI PEY+ +L
Sbjct:  1079 PIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSL 1138

Query:   951 TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV---FQMKSEKREVEIIDASI 1007
              AT + DVYS G+VL+E++TG+ P +   G    D+V WV    ++    R+ ++ID  +
Sbjct:  1139 KATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEM-DMVRWVETHLEVAGSARD-KLIDPKL 1196

Query:  1008 WH--KDREKQLLEMLEIACKCIDQDPRRRP 1035
                    E    ++LEIA +C    P+ RP
Sbjct:  1197 KPLLPFEEDAACQVLEIALQCTKTSPQERP 1226

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1209 (430.6 bits), Expect = 5.7e-123, P = 5.7e-123
 Identities = 333/982 (33%), Positives = 500/982 (50%)

Query:    98 LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
             L+G+IP+ L  L  L+ LDLS N+L GV+  E   + QLE L L+ N LSG +   +   
Sbjct:   276 LQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSN 335

Query:   158 NL-IQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSM 215
             N  ++ L +S    +G +  E+    +L + ++SNN+ TG++   ++    E+  L L+ 
Sbjct:   336 NTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLV-ELTNLYLNN 394

Query:   216 NHFMGSLQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS 274
             N   G+L   + +  +L++  + +N L G +P  +  +  L+ + L  N FSG++  +I 
Sbjct:   395 NSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIG 454

Query:   275 NLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRN 334
             N T L+ +  +GN+ SG++P+ +G L  L                         V+DL +
Sbjct:   455 NCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLAD 514

Query:   335 NSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXX 394
             N L+G I  +F  L++L    +  N   G LP+SL +  +L  ++ + N+ +G +     
Sbjct:   515 NQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCG 574

Query:   395 XXXXXXXXXXXXXXXXXXXGTLSV-LQQCKNLTTLILTKN-FVGEEIPENVGGFESLMVL 452
                                G + + L +  NL  L L KN F G  IP   G    L +L
Sbjct:   575 SSSYLSFDVTENGFE----GDIPLELGKSTNLDRLRLGKNQFTGR-IPRTFGKISELSLL 629

Query:   453 ALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 512
              +    L G IPV L  CKKL  +DL+ N+  G IP W+G++  L  L  S+N   G +P
Sbjct:   630 DISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLP 689

Query:   513 KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY--NQASSFPPSVF------- 563
               +  L ++++     ++   S  IP  + + ++ N L    NQ S   PS         
Sbjct:   690 TEIFSLTNILTLFLDGNSLNGS--IPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLF 747

Query:   564 ---LSNNRINGTIPPEIGQLKHLH-VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG 619
                LS N + G IP EIGQL+ L   LDLS NN TG IPS+IS +  LE LDLS N L G
Sbjct:   748 ELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVG 807

Query:   620 SIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAK 679
              +PG    +  L   +++ N+L+G +    QF  +   +F GN GLCG   S C+   +K
Sbjct:   808 EVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSK 865

Query:   680 LKPVIPSGSNSKFGPGSIIAIT-FSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRP 738
                     +     P +++ I+  S    IAL++ V +L   +       D   +  G  
Sbjct:   866 --------NQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNH-----DLFKKVRGGN 912

Query:   739 QRLSEALASSKLVLFQNSDCK-DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTK 797
                S   +SS+  LF N   K D+   D++++T+  N+  +IG GG G VYKA L NG  
Sbjct:   913 SAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGET 972

Query:   798 AAVKR-LSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND--RLLIYSYMENGSL 854
              AVK+ L  D     + F  EV+ L   +H++LV L GYC    D   LLIY YM NGS+
Sbjct:   973 IAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSV 1032

Query:   855 DYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE 912
               WLH  E+  K  VL W+ RLKIA G A+G+ YLH  C P IVHRD+KSSN+LLD   E
Sbjct:  1033 WDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIE 1092

Query:   913 AHLADFGLSRLLRP-YDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL 969
             AHL DFGL+++L   YDT+    T   G+ GYI PEY+ +L AT + DVYS G+VL+E++
Sbjct:  1093 AHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIV 1152

Query:   970 TGRRPVEVCKGKNCRDLVSWVFQMK-----SEKREVEIIDASIWH--KDREKQLLEMLEI 1022
             TG+ P E    +   D+V WV  +      SE RE ++ID+ +       E+   ++LEI
Sbjct:  1153 TGKMPTEAMFDEET-DMVRWVETVLDTPPGSEARE-KLIDSELKSLLPCEEEAAYQVLEI 1210

Query:  1023 ACKCIDQDPRRRPFIEEVVTWL 1044
             A +C    P+ RP   +   +L
Sbjct:  1211 ALQCTKSYPQERPSSRQASEYL 1232

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1208 (430.3 bits), Expect = 7.2e-123, P = 7.2e-123
 Identities = 339/970 (34%), Positives = 500/970 (51%)

Query:   112 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 171
             L+ LD+S N+    +P  L +   L+ LD+S N LSG  S  ++    ++ LN+SSN F 
Sbjct:   224 LEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 282

Query:   172 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSL 231
             G +  L    +L   +++ N FTG++   +  A   +  LDLS NHF G++     S SL
Sbjct:   283 GPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 341

Query:   232 -KQLHVDNNLLGGDLP-DSLYSMSSLQHVSLSVNNFSGQLSEKISNLT-SLRHLIIFGNQ 288
              + L + +N   G+LP D+L  M  L+ + LS N FSG+L E ++NL+ SL  L +  N 
Sbjct:   342 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 401

Query:   289 FSGK-LPNVLGNL--TQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNF 345
             FSG  LPN+  N   T  E ++ +                    L L  N L+G I  + 
Sbjct:   402 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS-LHLSFNYLSGTIPSSL 460

Query:   346 SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXX 405
               LS L  L L  N   G +P  L     L+ L L  N+L+G++P               
Sbjct:   461 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 520

Query:   406 XXXXXXXXGTLSV-LQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 464
                     G +   + + +NL  L L+ N     IP  +G   SL+ L L      G IP
Sbjct:   521 NNRLT---GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 577

Query:   465 VWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISS 524
               + +    Q   ++ N   G    +I           + N L  +  +S  +L  L + 
Sbjct:   578 AAMFK----QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS-EQLNRLSTR 632

Query:   525 NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLH 584
             N    N T+     +Y  H   T     N +  F   + +S N ++G IP EIG + +L 
Sbjct:   633 N--PCNITSR----VYGGHTSPT--FDNNGSMMF---LDMSYNMLSGYIPKEIGSMPYLF 681

Query:   585 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGT 644
             +L+L  N+I+G+IP  + ++R L +LDLSSN L G IP +   LT L++  ++NN+L G 
Sbjct:   682 ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 741

Query:   645 IPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAK--LKPVIPSGSNSKFGPGSI-IAIT 701
             IP  GQF +FP + F  NPGLCG     CD  +A          G       GS+ + + 
Sbjct:   742 IPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHGRRPASLAGSVAMGLL 801

Query:   702 FSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRP-QR-----------LSEALASSK 749
             FS      L+L    ++  RR     ++   E  G    R           + EAL S  
Sbjct:   802 FSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTGVKEAL-SIN 860

Query:   750 LVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ 809
             L  F+    + LT +DLL++TN F+  ++IG GGFG VYKA L +G+  A+K+L    GQ
Sbjct:   861 LAAFEKP-LRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQ 919

Query:   810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK 869
              +REF AE+E + + +H+NLV L GYC+ G++RLL+Y +M+ GSL+  LH+       L 
Sbjct:   920 GDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLN 979

Query:   870 WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 929
             W  R KIA G+ARGLA+LH  C PHI+HRD+KSSN+LLDE  EA ++DFG++RL+   DT
Sbjct:   980 WSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDT 1039

Query:   930 HVTTD-LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK-GKNCRDLV 987
             H++   L GT GY+PPEY Q+   + +GDVYS+GVVLLELLTG+RP +    G N  +LV
Sbjct:  1040 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDN--NLV 1097

Query:   988 SWVFQMKSEKREVEIIDASIWHKDR--EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              WV Q  ++ R  ++ D  +  +D   E +LL+ L++A  C+D    RRP + +V+    
Sbjct:  1098 GWVKQ-HAKLRISDVFDPELMKEDPALEIELLQHLKVAVACLDDRAWRRPTMVQVMAMFK 1156

Query:  1046 ----GIGIDA 1051
                 G GID+
Sbjct:  1157 EIQAGSGIDS 1166

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

GO:0010224 "response to UV-B" evidence=IGI

GO:0005768 "endosome" evidence=IDA

GO:0046982 "protein heterodimerization activity" evidence=IPI

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0010268 "brassinosteroid homeostasis" evidence=IEP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0043234 "protein complex" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0009911 "positive regulation of flower development" evidence=IGI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IEP;IMP

GO:0010584 "pollen exine formation" evidence=IMP

GO:0048657 "tapetal cell differentiation" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0005496 "steroid binding" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1204 (428.9 bits), Expect = 1.9e-122, P = 1.9e-122
 Identities = 323/966 (33%), Positives = 490/966 (50%)

Query:    88 VTMLILPRKGLKGIIPRSL-GHLNQLKLLDLSCNHLEGVVPVELS-NLKQLEVLDLSHNM 145
             +T L L   GL G +P +     + L  + LS N+  G +P +L  + K+L+ LDLS+N 
Sbjct:   129 LTHLELSSSGLIGTLPENFFSKYSNLISITLSYNNFTGKLPNDLFLSSKKLQTLDLSYNN 188

Query:   146 LSGPVSGMLAGLNLIQS---LNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRI 201
             ++GP+SG+   L+   S   L+ S NS +G + + L   +NL   N+S N+F G++  + 
Sbjct:   189 ITGPISGLTIPLSSCVSMTYLDFSGNSISGYISDSLINCTNLKSLNLSYNNFDGQI-PKS 247

Query:   202 WSASKEIQILDLSMNHFMGSLQGL--DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVS 259
             +   K +Q LDLS N   G +     D   SL+ L +  N   G +P+SL S S LQ + 
Sbjct:   248 FGELKLLQSLDLSHNRLTGWIPPEIGDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSLD 307

Query:   260 LSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFF-VAHXXXXXXXX 317
             LS NN SG     I  +  SL+ L++  N  SG  P  +     L     +         
Sbjct:   308 LSNNNISGPFPNTILRSFGSLQILLLSNNLISGDFPTSISACKSLRIADFSSNRFSGVIP 367

Query:   318 XXXXXXXXXXHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 377
                         L L +N +TG I    S  S L T+DL+ N+ +G +P  + +   L+ 
Sbjct:   368 PDLCPGAASLEELRLPDNLVTGEIPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKLEQ 427

Query:   378 LSLAKNELSGQVPEXXXXXXXXXXXXXXXXXXXXXXGTLSV-LQQCKNLTTLILTKNFVG 436
                  N ++G++P                       G +      C N+  +  T N + 
Sbjct:   428 FIAWYNNIAGEIPPEIGKLQNLKDLILNNNQLT---GEIPPEFFNCSNIEWVSFTSNRLT 484

Query:   437 EEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMEN 496
              E+P++ G    L VL LGN    G IP  L +C  L  LDL+ NH  G IPP +G+   
Sbjct:   485 GEVPKDFGILSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPG 544

Query:   497 LFYLD--FSNNTLT--GEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK--HNRSTNGL 550
                L    S NT+     +  S   +  L+  +     P     IP        R  +G 
Sbjct:   545 SKALSGLLSGNTMAFVRNVGNSCKGVGGLVEFS--GIRPERLLQIPSLKSCDFTRMYSGP 602

Query:   551 PYNQASSFPPSVFL--SNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLE 608
               +  + +    +L  S N++ G IP EIG++  L VL+LS N ++G IP +I +++NL 
Sbjct:   603 ILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSHNQLSGEIPFTIGQLKNLG 662

Query:   609 VLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGE 668
             V D S N L G IP SF  L+FL +  ++NN L G IP  GQ  + P + +  NPGLCG 
Sbjct:   663 VFDASDNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGV 722

Query:   669 IDSPCDSMHAKLKPVIPSGSNSKFGP------GSIIAITFSIGVGIALLLAVTLLKMSRR 722
                 C + + +L      G  +K G        SI+         + +L+   +   +RR
Sbjct:   723 PLPECKNGNNQLPAGTEEGKRAKHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARR 782

Query:   723 ---DSGCPIDDLDE----DMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQ 775
                D    +  L         + ++  E L S  +  FQ    + L  S L+++TN F+ 
Sbjct:   783 RDADDAKMLHSLQAVNSATTWKIEKEKEPL-SINVATFQRQ-LRKLKFSQLIEATNGFSA 840

Query:   776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
             A++IG GGFG V+KATL +G+  A+K+L     Q +REF AE+E L + +H+NLV L GY
Sbjct:   841 ASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 900

Query:   836 CRHGNDRLLIYSYMENGSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
             C+ G +RLL+Y +M+ GSL+  LH   + +K  +L W+ R KIA+GAA+GL +LH  C P
Sbjct:   901 CKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIP 960

Query:   894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTA 952
             HI+HRD+KSSN+LLD+  EA ++DFG++RL+   DTH++   L GT GY+PPEY Q+   
Sbjct:   961 HIIHRDMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 1020

Query:   953 TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012
             T +GDVYS GVV+LE+L+G+RP +  +  +  +LV W      E + +E+ID  +  +  
Sbjct:  1021 TAKGDVYSIGVVMLEILSGKRPTDKEEFGDT-NLVGWSKMKAREGKHMEVIDEDLLKEGS 1079

Query:  1013 EKQLLE 1018
              + L E
Sbjct:  1080 SESLNE 1085

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0010233 "phloem transport" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009734 "auxin mediated signaling pathway" evidence=RCA;IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FN37	PSKR2_ARATH	2, ., 7, ., 1, 1, ., 1	0.6647	0.9714	0.9864	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1052
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-118
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-34
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-27
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-23
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-22
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-20
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-04
COG5238	388	COG5238, RNA1, Ran GTPase-activating protein (RanG	3e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	6e-04
PLN03210	1153	PLN03210, PLN03210, Resistant to P	6e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.002
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.003
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.004
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  386 bits (993), Expect = e-118
 Identities = 291/1001 (29%), Positives = 475/1001 (47%), Gaps = 113/1001 (11%)

Query: 59   ITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLS 118
            +++W++ +  C W G+ C      +N+ RV  + L  K + G I  ++  L  ++ ++LS
Sbjct: 48   LSNWNSSADVCLWQGITC------NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLS 101

Query: 119  CNHLEGVVPVELSNL-KQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLF-E 176
             N L G +P ++      L  L+LS+N  +G +      +  +++L++S+N  +G +  +
Sbjct: 102  NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPND 159

Query: 177  LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHV 236
            +G FS+L V ++  N   GK+ + + + +                        SL+ L +
Sbjct: 160  IGSFSSLKVLDLGGNVLVGKIPNSLTNLT------------------------SLEFLTL 195

Query: 237  DNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV 296
             +N L G +P  L  M SL+ + L  NN SG++  +I  LTSL HL +  N  +G +P+ 
Sbjct: 196  ASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255

Query: 297  LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDL 356
            LGNL  L++   + N  SGP+P S+    KL  LDL +NSL+G I      L +L  L L
Sbjct: 256  LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL 315

Query: 357  ATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL 416
             +N+F+G +P +L+    L++L L  N+ SG++P++ GK  +L  L LS N+   L+G +
Sbjct: 316  FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN---LTGEI 372

Query: 417  -SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 475
               L    NL  LIL  N +  EIP+++G   SL  + L +    G +P    +   +  
Sbjct: 373  PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432

Query: 476  LDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSL--TELKSLISSNCTSSNPTA 533
            LD+S N+  G I      M +L  L  + N   G +P S     L++L  S         
Sbjct: 433  LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLS--------- 483

Query: 534  SAGIPLYVKHNRSTNGLPYNQASSFPP--SVFLSNNRINGTIPPEIGQLKHLHVLDLSRN 591
                      N+ +  +P  +  S      + LS N+++G IP E+   K L  LDLS N
Sbjct: 484  ---------RNQFSGAVP-RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533

Query: 592  NITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQF 651
             ++G IP+S SE+  L  LDLS N L G IP +   +  L + ++++NHL G++P+ G F
Sbjct: 534  QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF 593

Query: 652  YSFPNSSFEGNPGLCGEIDS----PCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVG 707
             +   S+  GN  LCG   +    PC       K V  +       P     IT ++G  
Sbjct: 594  LAINASAVAGNIDLCGGDTTSGLPPC-------KRVRKT-------PSWWFYITCTLGAF 639

Query: 708  IALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLL 767
            + L L        R  +   +  ++ + G          + +L  F +   K +T++D+L
Sbjct: 640  LVLALVAFGFVFIRGRNNLELKRVENEDG----------TWELQFFDSKVSKSITINDIL 689

Query: 768  KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
             S     + N+I  G  G  YK  ++ NG +  VK ++ D   +     A++  L   QH
Sbjct: 690  SSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIADMGKL---QH 742

Query: 827  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
             N+V L G CR      LI+ Y+E  +L   L         L W+ R KIA G A+ L +
Sbjct: 743  PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRF 795

Query: 887  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
            LH  C P +V  ++    I++D K E HL      RL  P      T    +  Y+ PE 
Sbjct: 796  LHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPET 849

Query: 947  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006
             +T   T + D+Y FG++L+ELLTG+ P +   G +   +V W     S+      ID S
Sbjct: 850  RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWIDPS 908

Query: 1007 IWHKD--REKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
            I       + +++E++ +A  C   DP  RP   +V+  L+
Sbjct: 909  IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (420), Expect = 7e-46
 Identities = 87/270 (32%), Positives = 122/270 (45%), Gaps = 26/270 (9%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
             +G G FG VYKA     G   AVK L    +  + ++  + E+  L R  H N+V L  
Sbjct: 6    KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 835  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                 +   L+  Y E G L  +L         L  D   KIA    RGL YLH      
Sbjct: 66   AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE---YSQTLT 951
            I+HRD+K  NILLDE     +ADFGL++      +   T  VGT  Y+ PE         
Sbjct: 119  IIHRDLKPENILLDENGVVKIADFGLAK-KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 952  ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011
                 DV+S GV+L ELLTG+ P     G+N  D +  + ++     E +      W   
Sbjct: 178  PKV--DVWSLGVILYELLTGKPP---FSGENILDQLQLIRRILGPPLEFDE---PKWSSG 229

Query: 1012 REKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             E    E  ++  KC+++DP +RP  EE++
Sbjct: 230  SE----EAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  163 bits (415), Expect = 1e-45
 Identities = 79/224 (35%), Positives = 104/224 (46%), Gaps = 23/224 (10%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
           +G GGFG VY A     G K A+K +   D   +  E   E+E L +  H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 837 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
              N   L+  Y E GSL   L E    +  L  D  L+I      GL YLH      I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 897 HRDVKSSNILLDEK-FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQTLTATC 954
           HRD+K  NILLD    +  LADFGLS+LL   D  +   +VGT  Y+ PE        + 
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 955 RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 998
           + D++S GV+L EL               +DL+  + Q   EKR
Sbjct: 174 KSDIWSLGVILYEL------------PELKDLIRKMLQKDPEKR 205

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  161 bits (409), Expect = 2e-44
 Identities = 78/272 (28%), Positives = 112/272 (41%), Gaps = 36/272 (13%)

Query: 777  NIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
              +G G FG VY A     G   A+K +      +       E++ L + +H N+V L  
Sbjct: 5    EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 835  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                 +   L+  Y E G L   L +   +  + + + R  + Q     L YLH      
Sbjct: 65   VFEDEDKLYLVMEYCEGGDLFDLLKK---RGRLSEDEARFYLRQ-ILSALEYLHSK---G 117

Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE------YSQ 948
            IVHRD+K  NILLDE     LADFGL+R L P      T  VGT  Y+ PE      Y  
Sbjct: 118  IVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYG- 174

Query: 949  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008
                    D++S GV+L ELLTG+ P          D +  +F+   + +          
Sbjct: 175  -----KAVDIWSLGVILYELLTGKPPFP------GDDQLLELFKKIGKPKPPFPPPEWDI 223

Query: 1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
              +  K L+       K + +DP +R   EE 
Sbjct: 224  SPE-AKDLIR------KLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  154 bits (392), Expect = 5e-42
 Identities = 75/274 (27%), Positives = 113/274 (41%), Gaps = 29/274 (10%)

Query: 778  IIGCGGFGLVYKATLTNGTKA-----AVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 831
             +G G FG VYK  L           AVK L  D   Q   EF  E   + +  H N+V 
Sbjct: 6    KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
            L G C       ++  YME G L  +L         L     L  A   ARG+ YL    
Sbjct: 66   LLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 892  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 951
              + +HRD+ + N L+ E     ++DFGLSR L   D +        + ++ PE  +   
Sbjct: 122  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 952  ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
             T + DV+SFGV+L E+ T G +P     G +  +++ ++       +            
Sbjct: 180  FTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLEYLKNGYRLPQPPNCPP------ 230

Query: 1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                   E+ ++  +C  +DP  RP   E+V  L
Sbjct: 231  -------ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  153 bits (388), Expect = 2e-41
 Identities = 78/277 (28%), Positives = 119/277 (42%), Gaps = 34/277 (12%)

Query: 778  IIGCGGFGLVYKATLTNG-----TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 831
             +G G FG VYK TL         + AVK L  D   Q   EF  E   + +  H N+V 
Sbjct: 6    KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
            L G C      +++  YM  G L  +L ++  +   L     L  A   ARG+ YL    
Sbjct: 66   LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 892  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 951
              + +HRD+ + N L+ E     ++DFGLSR L   D +        + ++ PE  +   
Sbjct: 123  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 952  ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
             T + DV+SFGV+L E+ T G  P     G +  +++ ++   K   R            
Sbjct: 181  FTSKSDVWSFGVLLWEIFTLGEEPYP---GMSNAEVLEYL---KKGYR------------ 222

Query: 1011 DREKQLL---EMLEIACKCIDQDPRRRPFIEEVVTWL 1044
               K      E+ ++  +C  +DP  RP   E+V  L
Sbjct: 223  -LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  151 bits (384), Expect = 5e-41
 Identities = 79/285 (27%), Positives = 118/285 (41%), Gaps = 58/285 (20%)

Query: 779  IGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSL 832
            +G G FG VYK TL        TK AVK L     + ER EF  E   + +  H N+V L
Sbjct: 7    LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
             G C  G    ++  YM  G L  +L         L     L++A   A+G+ YL     
Sbjct: 67   LGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK-- 121

Query: 893  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE-- 945
             + VHRD+ + N L+ E     ++DFGLSR +   D +         G +P     PE  
Sbjct: 122  -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR----KRGGGKLPIKWMAPESL 176

Query: 946  -YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003
               +  + +   DV+SFGV+L E+ T G +P     G +  +++  +             
Sbjct: 177  KDGKFTSKS---DVWSFGVLLWEIFTLGEQP---YPGMSNEEVLELL------------- 217

Query: 1004 DASIWHKDREKQLL-------EMLEIACKCIDQDPRRRPFIEEVV 1041
                   +   +L        E+ E+  +C   DP  RP   E+V
Sbjct: 218  -------EDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  142 bits (361), Expect = 5e-38
 Identities = 83/281 (29%), Positives = 121/281 (43%), Gaps = 39/281 (13%)

Query: 777  NIIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
              +G G FG VYK  L       T+ AVK L  D  + ER +F  E   + +  H N+V 
Sbjct: 1    KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHES-----VDKDSVLKWDVRLKIAQGAARGLAY 886
            L G C       L+  YME G L  +L +S       + S L     L  A   A+G+ Y
Sbjct: 61   LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 887  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP--- 943
            L        VHRD+ + N L+ E     ++DFGLSR +   D +       T G +P   
Sbjct: 121  LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173

Query: 944  --PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
              PE  +    T + DV+SFGV+L E+ T G  P     G +  +++ ++       R+ 
Sbjct: 174  MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP---GLSNEEVLEYL-------RKG 223

Query: 1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
              +    +  D      E+ E+   C   DP  RP   E+V
Sbjct: 224  YRLPKPEYCPD------ELYELMLSCWQLDPEDRPTFSELV 258

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (331), Expect = 7e-34
 Identities = 69/211 (32%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 777 NIIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
            ++G G FG VY A     G   AVK   LSGD  +     + E+  LS  QH N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 834 GYCRH-GNDRLLIY-SYMENGSL-----DYW-LHESVDKDSVLKWDVRLKIAQGAARGLA 885
           G  R    + L I+  Y+  GSL      +  L E V         +R    Q    GLA
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---------IRKYTRQ-ILEGLA 115

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGYIPP 944
           YLH      IVHRD+K +NIL+D      LADFG ++ L        T  + GT  ++ P
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 945 E-YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E            D++S G  ++E+ TG+ P
Sbjct: 173 EVIRGEE-YGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  123 bits (312), Expect = 2e-31
 Identities = 83/294 (28%), Positives = 124/294 (42%), Gaps = 65/294 (22%)

Query: 777  NIIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVS 831
             +IG G FG V +  L    K     A+K L +G   +   +F  E   + +  H N++ 
Sbjct: 10   KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
            L+G        ++I  YMENGSLD +L E    D        + + +G A G+ YL ++ 
Sbjct: 70   LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 892  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEY 946
                VHRD+ + NIL++      ++DFGLSR L   +   TT   G  G IP     PE 
Sbjct: 127  ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--G--GKIPIRWTAPEA 179

Query: 947  SQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005
                  T   DV+SFG+V+ E+++ G RP                 Q        ++I A
Sbjct: 180  IAYRKFTSASDVWSFGIVMWEVMSYGERPYW-----------DMSNQ--------DVIKA 220

Query: 1006 --------------SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                          S  +     QL  ML+    C  +D   RP   ++V+ LD
Sbjct: 221  VEDGYRLPPPMDCPSALY-----QL--MLD----CWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (296), Expect = 2e-29
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG GGFG VYKA     G + A+K +  +  + + +   E++ L + +H N+V   G   
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SY 66

Query: 838 HGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLK------IAQGAARGLAYLHKV 890
              D L ++  +   GSL         KD +   +  L       + +   +GL YLH  
Sbjct: 67  LKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
               I+HRD+K++NILL    E  L DFGLS  L   DT     +VGT  ++ PE     
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGK 172

Query: 951 TATCRGDVYSFGVVLLELLTGRRP 974
               + D++S G+  +EL  G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (298), Expect = 8e-29
 Identities = 74/270 (27%), Positives = 112/270 (41%), Gaps = 23/270 (8%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGD---CGQMEREFQAEVEALSRAQH-KNLVSLQG 834
            +G G FG VY A        A+K L+       +    F  E++ L+   H  N+V L  
Sbjct: 8    LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 835  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
            + +      L+  Y++ GSL+  L +   K   L     L I       L YLH      
Sbjct: 66   FFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH---SKG 121

Query: 895  IVHRDVKSSNILLDEK-FEAHLADFGLSRLLRPYDTHV-----TTDLVGTLGYIPPEYSQ 948
            I+HRD+K  NILLD       L DFGL++LL    +        +  VGT GY+ PE   
Sbjct: 122  IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 949  TLT---ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005
             L+   A+   D++S G+ L ELLTG  P E  K  +              +     + +
Sbjct: 182  GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----KIILELPTPSLAS 237

Query: 1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035
             +   + E       ++  K + +DP+ R 
Sbjct: 238  PLSPSNPELISKAASDLLKKLLAKDPKNRL 267

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  111 bits (280), Expect = 4e-27
 Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 27/262 (10%)

Query: 779  IGCGGFGLVYKATL-TNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSLQG-Y 835
            +G G  G+VYK      G   A+K++      +  ++   E++ L   +   +V   G +
Sbjct: 9    LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
             + G   +++  YM+ GSL   L + V K  + VL       IA+   +GL YLH   + 
Sbjct: 69   YKEGEISIVL-EYMDGGSLAD-LLKKVGKIPEPVLA-----YIARQILKGLDYLHT--KR 119

Query: 894  HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            HI+HRD+K SN+L++ K E  +ADFG+S++L        T  VGT+ Y+ PE  Q  + +
Sbjct: 120  HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQGESYS 178

Query: 954  CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE 1013
               D++S G+ LLE   G+ P       +  +L+  +         +   + S       
Sbjct: 179  YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI--CDGPPPSLPAEEFSP------ 230

Query: 1014 KQLLEMLEIACKCIDQDPRRRP 1035
                E  +    C+ +DP++RP
Sbjct: 231  ----EFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  111 bits (280), Expect = 5e-27
 Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 36/222 (16%)

Query: 779 IGCGGFGLVYKATLTNG------TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 831
           +G G FG V+     +          AVK L         ++F+ E E L+  QH+N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR-----------LKIAQGA 880
             G C  G+  ++++ YME+G L+ +L  S   D+                  L+IA   
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFL-RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
           A G+ YL      H VHRD+ + N L+       + DFG+SR     D + TTD     G
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVY-TTDYYRVGG 182

Query: 941 -------YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                  ++PPE       T   DV+SFGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  110 bits (277), Expect = 8e-27
 Identities = 77/281 (27%), Positives = 119/281 (42%), Gaps = 55/281 (19%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKR--LSGDCGQMEREF-QAEVEALSRAQHKNLVSLQG 834
            IG G FG VY     ++G    +K   LS    + ERE    EV+ L +  H N++    
Sbjct: 8    IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIK--- 63

Query: 835  YCRH--GNDRLLI-YSYMENGSLDYWLHESVDK------DSVLKWDVRLKIAQGAARGLA 885
            Y        +L I   Y + G L   + +   +      + +L W V+L +A      L 
Sbjct: 64   YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LK 117

Query: 886  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
            YLH      I+HRD+K  NI L       L DFG+S++L      +   +VGT  Y+ PE
Sbjct: 118  YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYYLSPE 173

Query: 946  ------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
                  Y+       + D++S G VL EL T + P E   G+N  +L      +K  K +
Sbjct: 174  LCQNKPYNY------KSDIWSLGCVLYELCTLKHPFE---GENLLELA-----LKILKGQ 219

Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
               I +   +    + L+         + +DP  RP I ++
Sbjct: 220  YPPIPSQ--YSSELRNLVS------SLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-26
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)

Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLS--GDCGQMEREFQAEVEALSRAQHKN 828
           N+   ++IG G FG+VYK   L  G   A+K++S      +  +    E++ L   +H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAAR 882
           +V   G     +   +I  Y ENGSL   +       ES+         V + + Q   +
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---------VAVYVYQ-VLQ 110

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GLAYLH   E  ++HRD+K++NIL  +     LADFG++  L          +VGT  ++
Sbjct: 111 GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWM 166

Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            PE  +   A+   D++S G  ++ELLTG  P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  108 bits (271), Expect = 4e-26
 Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 7/205 (3%)

Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           F     +G G FG V++    N  + A+K L  D    +++FQ EV+AL R +HK+L+SL
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
              C  G    +I   ME GSL  +L     +  VL     + +A   A G+AYL    E
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ--VLPVASLIDMACQVAEGMAYLE---E 122

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA 952
            + +HRD+ + NIL+ E     +ADFGL+RL++  D ++++D      +  PE +   T 
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHGTF 181

Query: 953 TCRGDVYSFGVVLLELLT-GRRPVE 976
           + + DV+SFG++L E+ T G+ P  
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYP 206

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  108 bits (272), Expect = 5e-26
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)

Query: 777 NIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLV 830
             +G G FG V            G + AVK L+     Q   +F+ E+E L    H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 831 SLQGYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
             +G C    G    LI  Y+ +GSL  +L    D+ ++ +    L  +    +G+ YL 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR---LLLFSSQICKGMDYLG 126

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP----- 943
                  +HRD+ + NIL++ +    ++DFGL+++L     +     V   G  P     
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY---VKEPGESPIFWYA 180

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           PE  +T   +   DV+SFGV L EL T   P
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (270), Expect = 8e-26
 Identities = 77/268 (28%), Positives = 123/268 (45%), Gaps = 30/268 (11%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
            +G G  G+V K      G   AVK  RL  +   ++++   E++ L +     +V   G 
Sbjct: 9    LGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
              +  D  +   YM+ GSLD  L E   +  + +L      KIA    +GL YLH+    
Sbjct: 68   FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKH-- 120

Query: 894  HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
             I+HRDVK SNIL++ + +  L DFG+S  L   ++   T  VGT  Y+ PE  Q    +
Sbjct: 121  KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF-VGTSSYMAPERIQGNDYS 177

Query: 954  CRGDVYSFGVVLLELLTGRRPV--EVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011
             + D++S G+ L+EL TGR P   E        +L+ ++      +     + +  +  D
Sbjct: 178  VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR-----LPSGKFSPD 232

Query: 1012 REKQLLEMLEIACKCIDQDPRRRPFIEE 1039
                     +    C+ +DPR RP  +E
Sbjct: 233  -------FQDFVNLCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (265), Expect = 3e-25
 Identities = 70/209 (33%), Positives = 95/209 (45%), Gaps = 16/209 (7%)

Query: 775 QANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVS 831
           + N IG G FG VY A  L  G   AVK  R+  +  +  +E   E++ L   +H NLV 
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
             G   H     +   Y   G+L+  L      D  +   +R+   Q    GLAYLH   
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---IRVYTLQ-LLEGLAYLH--- 116

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT---DLVGTLGYIPPEYSQ 948
              IVHRD+K +NI LD      L DFG +  L+   T +      L GT  Y+ PE   
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 949 TLTATCRG---DVYSFGVVLLELLTGRRP 974
                  G   D++S G V+LE+ TG+RP
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  104 bits (260), Expect = 1e-24
 Identities = 65/214 (30%), Positives = 111/214 (51%), Gaps = 14/214 (6%)

Query: 769 STNNFNQANIIGCGGFGLVYKATL-TNGTK---AAVKRLSGDCGQMER-EFQAEVEALSR 823
             ++  +  +IG G FG V++  L   G K    A+K L     + +R +F +E   + +
Sbjct: 3   HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ 62

Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
             H N++ L+G        ++I  YMENG+LD +L +   + S  +    + + +G A G
Sbjct: 63  FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAG 119

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGY 941
           + YL    + + VHRD+ + NIL++   E  ++DFGLSR+L   P  T+ T+     + +
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
             PE       T   DV+SFG+V+ E+++ G RP
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 2e-24
 Identities = 76/264 (28%), Positives = 117/264 (44%), Gaps = 29/264 (10%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    TK AVK L    G M  E F  E + + + +H  LV L   C 
Sbjct: 14   LGAGQFGEVWMGTWNGTTKVAVKTLKP--GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L     +   L+    + +A   A G+AYL      + +H
Sbjct: 72   EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
            RD+ + NIL+ E     +ADFGL+RL+    Y           + +  PE +     T +
Sbjct: 127  RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184

Query: 956  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014
             DV+SFG++L E++T GR P     G   R+++  V +     R     +          
Sbjct: 185  SDVWSFGILLTEIVTYGRVPYP---GMTNREVLEQVERGYRMPRPPNCPE---------- 231

Query: 1015 QLLEMLEIACKCIDQDPRRRPFIE 1038
               E+ ++  +C D+DP  RP  E
Sbjct: 232  ---ELYDLMLQCWDKDPEERPTFE 252

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  103 bits (259), Expect = 3e-24
 Identities = 73/271 (26%), Positives = 117/271 (43%), Gaps = 19/271 (7%)

Query: 771  NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKN 828
                + + +G G  G V K  L   G   A+K ++ D     +++   E+E     +   
Sbjct: 1    EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 829  LVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
            +V   G     +   +     Y E GSLD    +   +   +   V  KIA+   +GL+Y
Sbjct: 61   IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 887  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
            LH      I+HRD+K SNILL  K +  L DFG+S  L      +     GT  Y+ PE 
Sbjct: 121  LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPER 174

Query: 947  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR--DLVSWVFQMKSEKREVEIID 1004
             Q    +   DV+S G+ LLE+   R P            +L+S++  M + + + E  +
Sbjct: 175  IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035
               W +       E  +   +C+++DP RRP
Sbjct: 235  GIKWSE-------EFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 8e-24
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 39/215 (18%)

Query: 777 NIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE---FQA--EVEALSRAQHKNLV 830
             IG G +G VYKA     G   A+K++  +    E+E     A  E++ L + +H N+V
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRME---NEKEGFPITAIREIKLLQKLRHPNIV 61

Query: 831 SLQGYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR------ 882
            L+     +      +++ YM++           D   +L     +K  +   +      
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDH-----------DLTGLLD-SPEVKFTESQIKCYMKQL 109

Query: 883 --GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
             GL YLH      I+HRD+K SNIL++      LADFGL+R     ++   T+ V TL 
Sbjct: 110 LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166

Query: 941 YIPPEYSQTLTATCRG---DVYSFGVVLLELLTGR 972
           Y PPE    L AT  G   D++S G +L EL  G+
Sbjct: 167 YRPPEL--LLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  101 bits (254), Expect = 1e-23
 Identities = 63/234 (26%), Positives = 95/234 (40%), Gaps = 21/234 (8%)

Query: 772 NFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLS-GDCGQME--REFQAEVEALSRAQHK 827
           +F    +IG G FG V            A+K ++   C +    R    E   L    H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAARGLA 885
            LV+L    +   +  L+   +  G L Y L + V   ++ V  W   + +A      L 
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA------LE 114

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           YLH      I+HRD+K  NILLDE+   H+ DF ++  + P    +TT   GT GY+ PE
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--DTLTTSTSGTPGYMAPE 169

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
                  +   D +S GV   E L G+RP       + R +   +   +     
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYR----GHSRTIRDQIRAKQETADV 219

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V++    N T  AVK L    G M+ ++F AE + + + +H  L+ L   C 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 ++   M+ GSL  +L         LK    + +A   A G+AYL      + +H
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLE---AQNYIH 126

Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N+L+ E     +ADFGL+R+++   Y+          + +  PE +     + +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184

Query: 956 GDVYSFGVVLLELLT-GRRP 974
            DV+SFG++L E++T GR P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 99.9 bits (249), Expect = 2e-22
 Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 31/216 (14%)

Query: 777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQG 834
           N IG G  G VYK      G   A+K + G+    + R+   E+E L    H N+V    
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 835 YCRHGNDRLLIYSYMENGSLD--YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
              H  +  ++  +M+ GSL+  +   E    D          +A+    G+AYLH+   
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD----------VARQILSGIAYLHR--- 186

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTLGYIPPEYSQ 948
            HIVHRD+K SN+L++      +ADFG+SR+L       T D     VGT+ Y+ PE   
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ-----TMDPCNSSVGTIAYMSPERIN 241

Query: 949 T-----LTATCRGDVYSFGVVLLELLTGRRPVEVCK 979
           T           GD++S GV +LE   GR P  V +
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG V       G K AVK L  D     + F AE   ++  +H NLV L G    
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
           GN   ++  YM  GSL  +L       +V+    +L  A     G+ YL    E + VHR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126

Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL--GYIPPEYSQTLTATCRG 956
           D+ + N+L+ E   A ++DFGL++     +     D  G L   +  PE  +    + + 
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQD-SGKLPVKWTAPEALREKKFSTKS 180

Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.0 bits (240), Expect = 6e-22
 Identities = 60/204 (29%), Positives = 85/204 (41%), Gaps = 20/204 (9%)

Query: 779 IGCGGFGLVY--KATLTNGT---KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V   +   T      K   K+      ++E     E   LSR  H  +V L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59

Query: 834 GYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            Y     ++L L+  Y   G L   L +        +   R   A+     L YLH +  
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAE-IVLALEYLHSL-- 112

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY--SQTL 950
             I++RD+K  NILLD      L DFGL++ L   +   T    GT  Y+ PE    +  
Sbjct: 113 -GIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGKGY 170

Query: 951 TATCRGDVYSFGVVLLELLTGRRP 974
                 D +S GV+L E+LTG+ P
Sbjct: 171 GKAV--DWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 96.5 bits (240), Expect = 6e-22
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 16/207 (7%)

Query: 778 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +IG G FG V +  L    K     A+K L SG   +  R+F +E   + +  H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           +G        ++I  +MENG+LD +L ++  + +V++    + + +G A G+ YL    E
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL---SE 124

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLG--YIPPEYSQ 948
            + VHRD+ + NIL++      ++DFGLSR L     D   T+ L G +   +  PE   
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 949 TLTATCRGDVYSFGVVLLELLT-GRRP 974
               T   DV+S+G+V+ E+++ G RP
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.0 bits (239), Expect = 7e-22
 Identities = 82/269 (30%), Positives = 123/269 (45%), Gaps = 33/269 (12%)

Query: 779  IGCGGFGLVYKA-TLTNGTKAAVKRLS-GDCGQMERE----FQAEVEALSRAQHKNLVSL 832
            +G G FG VY+   L +G   AVK +S  D GQ  +E     + E+  LS+ QH N+V  
Sbjct: 8    LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 833  QGYCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
             G  R   D L I+   +  GSL   L +       +   +RL   Q    GL YLH   
Sbjct: 68   LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQ-ILLGLEYLH--- 119

Query: 892  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY-SQTL 950
            + + VHRD+K +NIL+D      LADFG+++ +  +         G+  ++ PE  +Q  
Sbjct: 120  DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQG 177

Query: 951  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
                  D++S G  +LE+ TG+ P    +G      V+ VF++   K    I D    H 
Sbjct: 178  GYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPPIPD----HL 227

Query: 1011 DREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              E +   +     KC+ +DP  RP   E
Sbjct: 228  SDEAKDFIL-----KCLQRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 829
            N  +   IG G  G VYKAT    G + A+K++       E     E+  +   +H N+
Sbjct: 22  KNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNI 77

Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA------RG 883
           V        G++  ++  YM+ GSL          D + +  VR+   Q A       +G
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQIAYVCREVLQG 128

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L YLH     +++HRD+KS NILL +     LADFG +  L    +   + +VGT  ++ 
Sbjct: 129 LEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMA 184

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           PE  +      + D++S G++ +E+  G  P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 95.3 bits (237), Expect = 2e-21
 Identities = 69/227 (30%), Positives = 98/227 (43%), Gaps = 31/227 (13%)

Query: 771 NNFNQANIIGCGGFGLVYKAT---LTNG---TKAAVKRLSGDCG-QMEREFQAEVEALSR 823
           NN      IG G FG V++A    L      T  AVK L  +    M+ +FQ E   ++ 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD--------YWLHESVDKDSV-------- 867
             H N+V L G C  G    L++ YM  G L+                  S         
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 868 --LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 925
             L    +L IA+  A G+AYL    E   VHRD+ + N L+ E     +ADFGLSR + 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 926 PYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
             D +     D +  + ++PPE       T   DV+++GVVL E+ +
Sbjct: 182 SADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 46/282 (16%)

Query: 773  FNQANIIGCGGFGLVYKATLT-NGTKA----AVKRLSGDCG-QMEREFQAEVEALSRAQH 826
              +  ++G G FG VYK      G K     A+K L  +   +  +E   E   ++   H
Sbjct: 9    LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 827  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKIAQGAARG 883
             ++V L G C   +   LI   M  G L  ++    D      +L W V++      A+G
Sbjct: 69   PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121

Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
            ++YL    E  +VHRD+ + N+L+       + DFGL++LL   +     +     G +P
Sbjct: 122  MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE----GGKVP 174

Query: 944  -----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 997
                  E       T + DV+S+GV + EL+T G +P E        DL+      K E+
Sbjct: 175  IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-----KGER 229

Query: 998  REV-EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIE 1038
                 I    ++          M+ + C  ID + R   F E
Sbjct: 230  LPQPPICTIDVY----------MVLVKCWMIDAESRPT-FKE 260

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 93.4 bits (232), Expect = 6e-21
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 10/198 (5%)

Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK A+K L    G M  E F AE   + + QH  LV L     
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  YMENGSL  +L     +   L  +  + +A   A G+A++      + +H
Sbjct: 72  Q-EPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD++++NIL+ E     +ADFGL+RL+   +          + +  PE     T T + D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 958 VYSFGVVLLELLT-GRRP 974
           V+SFG++L E++T GR P
Sbjct: 186 VWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.0 bits (233), Expect = 7e-21
 Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 38/288 (13%)

Query: 779  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G G FG V+ A   N          AVK L        ++F  E E L+  QH+++V  
Sbjct: 13   LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD----------VRLKIAQGAAR 882
             G C  G+  ++++ YM++G L+ +L      D+VL  +            L IAQ  A 
Sbjct: 73   YGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 883  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGY 941
            G+ YL      H VHRD+ + N L+ E     + DFG+SR +   D + V    +  + +
Sbjct: 132  GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
            +PPE       T   DV+S GVVL E+ T G++P              W +Q+ + +   
Sbjct: 189  MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------W-YQLSNNEVIE 233

Query: 1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048
             I    +  + R     E+ ++   C  ++P  R  I+E+ + L  + 
Sbjct: 234  CITQGRVLQRPRTCP-KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.1 bits (231), Expect = 1e-20
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 45/293 (15%)

Query: 779  IGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G G FG V+ A   N +        AVK L        ++FQ E E L+  QH+++V  
Sbjct: 13   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLH------------ESVDKDSVLKWDVRLKIAQGA 880
             G C  G+  ++++ YM++G L+ +L             +       L     L IA   
Sbjct: 73   YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 881  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTL 939
            A G+ YL      H VHRD+ + N L+       + DFG+SR +   D + V    +  +
Sbjct: 133  ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 940  GYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKR 998
             ++PPE       T   DV+SFGV+L E+ T G++P              W FQ+ +   
Sbjct: 190  RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------W-FQLSNT-- 232

Query: 999  EVEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048
              E+I+     +  E+  +   E+ +I   C  ++P++R  I+E+   L  +G
Sbjct: 233  --EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 31/270 (11%)

Query: 772  NFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEV--EA--LSRAQH 826
            +F   N IG G FG+V+K     +    A+K++  D  +M R  + E   EA  L++   
Sbjct: 1    DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQI--DLSKMNRREREEAIDEARVLAKLDS 58

Query: 827  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
              ++             ++  Y ENG L   L     +   L  D   +       GLA+
Sbjct: 59   SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAH 116

Query: 887  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
            LH      I+HRD+KS N+ LD      + D G+++LL   +T+    +VGT  Y+ PE 
Sbjct: 117  LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPEL 172

Query: 947  SQTLTATCRGDVYSFGVVLLELLTGRRPVEV-CKGKNCRDLVSWVFQMKSEKREVEIIDA 1005
             +      + DV++ GVVL E  TG+ P +   +G     ++  VF   S+    ++   
Sbjct: 173  CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQ- 231

Query: 1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035
                            +  +C+ +D R+RP
Sbjct: 232  ----------------LIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.7 bits (230), Expect = 1e-20
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-----------WDVRLKIAQGAA 881
            G C  G   L+++ YM +G L+ +L        +L                L IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLG 940
            G+ YL  +   H VHRD+ + N L+ +     + DFG+SR +   D + V    +  + 
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
           ++PPE       T   D++SFGVVL E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 72/291 (24%), Positives = 115/291 (39%), Gaps = 66/291 (22%)

Query: 777  NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQM-EREFQ---AEVEALSRAQHKNLVS 831
              IG G FG V K    ++G     K +  D G M E+E Q   +EV  L   +H N+V 
Sbjct: 6    ETIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKHPNIV- 62

Query: 832  LQGYCRHGNDR--LLIYSYME---NGSLD------YWLHESVDKDSVLKWDVRLKIAQGA 880
               Y     DR    +Y  ME    G L           + ++++ + +   +L +A   
Sbjct: 63   --RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA--- 117

Query: 881  ARGLAYLH--KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               L   H        ++HRD+K +NI LD      L DFGL+++L  +D+      VGT
Sbjct: 118  ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYVGT 173

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP----------VEVCKGKNCRDLVS 988
              Y+ PE    ++   + D++S G ++ EL     P           ++ +GK  R +  
Sbjct: 174  PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-FRRIPY 232

Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
                  S                      E+ E+    ++ DP +RP  EE
Sbjct: 233  ----RYSS---------------------ELNEVIKSMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 30/207 (14%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLS------GDCGQMEREFQAEVEALSRAQHKNLVS 831
           IG G +G+VYKA     G   A+K++       G      RE    ++ L    H N++ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE----IKLLKELNHPNIIK 62

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L    RH  D  L++ +M+            D+   L   +         +GLA+ H   
Sbjct: 63  LLDVFRHKGDLYLVFEFMDTD----LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS-- 116

Query: 892 EPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
             H I+HRD+K  N+L++ +    LADFGL+R          T  V T  Y  PE    L
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPE----L 169

Query: 951 TATCRG-----DVYSFGVVLLELLTGR 972
               +G     D++S G +  ELL+ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 778 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +IG G FG V    L    K     A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           +G        +++  YMENGSLD +L +   + +V++    + + +G A G+ YL  +  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLSDM-- 125

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIP-----PE 945
              VHRD+ + NIL++      ++DFGLSR+L   P   + T       G IP     PE
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG-----GKIPIRWTAPE 179

Query: 946 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                  T   DV+S+G+V+ E+++ G RP
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 91.7 bits (228), Expect = 4e-20
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 24/217 (11%)

Query: 779 IGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 831
           +G G FG VYK  LT      + T  A+K L  +   ++++EF+ E E +S  QH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWL-----HESV-------DKDSVLKWDVRLKIAQG 879
           L G C       +++ Y+ +G L  +L     H  V          S L     L IA  
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGT 938
            A G+ YL      H VHRD+ + N L+ E     ++DFGLSR +   D + V +  +  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
           + ++PPE       T   D++SFGVVL E+ + G +P
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 95.7 bits (238), Expect = 4e-20
 Identities = 60/184 (32%), Positives = 87/184 (47%), Gaps = 30/184 (16%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
           L N  + G IP +I +L+HL  ++LS N+I G IP S+  I +LEVLDLS N  +GSIP 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 624 SFEKLTFLSKFSVANNHLQGTIPT--GGQFYSFPNSSFEGNPGLCGEIDS--PCDSMHAK 679
           S  +LT L   ++  N L G +P   GG+     + +F  N GLCG I     C      
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IPGLRACG----- 538

Query: 680 LKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLLKMSRRDSGCPIDDLDEDMGRPQ 739
             P +  G+         I I F + V    L+   +    RR          +++ R Q
Sbjct: 539 --PHLSVGAK--------IGIAFGVSVAFLFLVICAMCWWKRR----------QNILRAQ 578

Query: 740 RLSE 743
           R++ 
Sbjct: 579 RIAA 582

Length = 623

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 10/204 (4%)

Query: 777 NIIGCGGFGLVYKA-TLTNGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQG 834
            +IG G   +VY A  L N  K A+KR+  + C     E + EV+A+S+  H N+V    
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
               G++  L+  Y+  GSL   + +S      L   +   + +   +GL YLH      
Sbjct: 67  SFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQ 123

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYD--THVTTDLVGTLGYIPPE-YSQTL 950
           I HRD+K+ NILL E     +ADFG+S  L    D    V    VGT  ++ PE   Q  
Sbjct: 124 I-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 951 TATCRGDVYSFGVVLLELLTGRRP 974
               + D++SFG+  +EL TG  P
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.8 bits (226), Expect = 7e-20
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 39/212 (18%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSG----DCG--QMEREFQAEVEALSRAQHKNLVS 831
           IG G  G+V+KA     G   A+K+++          Q  RE    ++AL   QH  +V 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVK 63

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR--------G 883
           L     HG+  +L+  YM +      L E      VL+ D    + +   +        G
Sbjct: 64  LLDVFPHGSGFVLVMEYMPSD-----LSE------VLR-DEERPLPEAQVKSYMRMLLKG 111

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           +AY+H      I+HRD+K +N+L+       +ADFGL+RL    +  + +  V T  Y  
Sbjct: 112 VAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRA 168

Query: 944 PEY---SQTLTATCRGDVYSFGVVLLELLTGR 972
           PE    ++        D+++ G +  ELL G 
Sbjct: 169 PELLYGARKYDPGV--DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.0 bits (224), Expect = 9e-20
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 18/202 (8%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVKRLS--GDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
            +G G +G VYKA     G   A+K +    D  ++ +E       L +     +V   G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISI----LKQCDSPYIVKYYG 65

Query: 835 YCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
                 D  ++  Y   GS  D  + +  +K   L  +    I     +GL YLH     
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSD--IMKITNK--TLTEEEIAAILYQTLKGLEYLHSN--- 118

Query: 894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTA 952
             +HRD+K+ NILL+E+ +A LADFG+S  L   DT    + ++GT  ++ PE  Q +  
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 953 TCRGDVYSFGVVLLELLTGRRP 974
             + D++S G+  +E+  G+ P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G FGLV+        K A+K +    G M E +F  E + + +  H  LV L G C 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
             +   L++ +ME+G L  +L     +      +  L +      G+AYL       ++H
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 954
           RD+ + N L+ E     ++DFG++R +   D   T+   GT   + +  PE       + 
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSS-TGTKFPVKWSSPEVFSFSKYSS 180

Query: 955 RGDVYSFGVVLLELLT-GRRPVE 976
           + DV+SFGV++ E+ + G+ P E
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 19/245 (7%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG+V+          A+K +    G M E +F  E + + +  H NLV L G C 
Sbjct: 12   LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM NG L  +L E   +   L  +  L +       + YL        +H
Sbjct: 70   KQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 954
            RD+ + N L+ E     ++DFGL+R +   D   T+   GT   + + PPE       + 
Sbjct: 124  RDLAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSS-QGTKFPVKWAPPEVFDYSRFSS 180

Query: 955  RGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM---KSEKREVEIIDASIWHK 1010
            + DV+SFGV++ E+ + G+ P E        + VS  +++   K    EV  I  S WH+
Sbjct: 181  KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240

Query: 1011 DREKQ 1015
              E +
Sbjct: 241  KPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.6 bits (219), Expect = 3e-19
 Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 28/270 (10%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L  Y  
Sbjct: 14   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69

Query: 838  HGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
               + + I + YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + V
Sbjct: 70   VSEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 124

Query: 897  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
            HRD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + 
Sbjct: 125  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 957  DVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1015
            DV+SFG++L EL T GR P      +   D V   ++M       E              
Sbjct: 185  DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-------------- 230

Query: 1016 LLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
               + ++ C+C  ++P  RP  E +  +L+
Sbjct: 231  --SLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 32/272 (11%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    TK AVK L    G M  E F  E + + + +H  LV L     
Sbjct: 14   LGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L +   +   LK    + +A   A G+AY+ ++   + +H
Sbjct: 72   E-EPIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIERM---NYIH 125

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++S+NIL+ +     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 126  RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV---FQMKSEKREVEIIDASIWHKDRE 1013
            V+SFG++L EL+T GR P     G N R+++  V   ++M   +      D  I      
Sbjct: 186  VWSFGILLTELVTKGRVPY---PGMNNREVLEQVERGYRMPCPQ------DCPI------ 230

Query: 1014 KQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                 + E+  +C  +DP  RP  E + ++L+
Sbjct: 231  ----SLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 5e-19
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 21/211 (9%)

Query: 771 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHK 827
           N +    ++G G +G+V K      G   A+K+   S D   +++    EV+ L + +H+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGL 884
           N+V+L+   R      L++ Y+E   L+  L  S   +  D+V     R  I Q   + +
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAV-----RSYIWQ-LLQAI 113

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           AY H     +I+HRD+K  NIL+ E     L DFG +R LR       TD V T  Y  P
Sbjct: 114 AYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 945 EYSQTLTATCRG---DVYSFGVVLLELLTGR 972
           E    +  T  G   DV++ G ++ ELL G 
Sbjct: 171 EL--LVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 7e-19
 Identities = 67/220 (30%), Positives = 97/220 (44%), Gaps = 22/220 (10%)

Query: 770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHK 827
           T  F    +IG G +G VYKA     G   A+K +       E E + E   L + + H 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHP 63

Query: 828 NLVSLQGYCRHGN-----DRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           N+ +  G     N     D+L L+      GS+   +     K   LK +    I +   
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTL 939
           RGLAYLH   E  ++HRD+K  NILL +  E  L DFG+S  L   D+ +      +GT 
Sbjct: 124 RGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGTP 177

Query: 940 GYIPPE-----YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            ++ PE          +   R DV+S G+  +EL  G+ P
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 87.0 bits (216), Expect = 9e-19
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 16/210 (7%)

Query: 779 IGCGGFGLVYKAT--LTNGT--KAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V K    + +G   + AVK L        ++EF  E   +++  H  +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
           G C+ G   +L+      G L  +L     +  +   D++    Q  A G+AYL      
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQ-VAMGMAYLE---SK 114

Query: 894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLT 951
           H VHRD+ + N+LL  + +A ++DFG+SR L     +      G   L +  PE      
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 952 ATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
            + + DV+S+GV L E  + G +P    KG
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 75/270 (27%), Positives = 119/270 (44%), Gaps = 35/270 (12%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            IG G FG VYK  L   T+ AVK   S     ++R+F  E E L +  H N+V L G C 
Sbjct: 3    IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-KVCEPHIV 896
                  ++   +  GSL  +L +  ++ +V K    L+++  AA G+ YL  K C    +
Sbjct: 63   QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK---LLQMSLDAAAGMEYLESKNC----I 115

Query: 897  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTLT 951
            HRD+ + N L+ E     ++DFG+S   R  +  + T +   L  IP     PE      
Sbjct: 116  HRDLAARNCLVGENNVLKISDFGMS---REEEGGIYT-VSDGLKQIPIKWTAPEALNYGR 171

Query: 952  ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
             T   DV+S+G++L E  + G  P      +  R+ +   ++M + +   E         
Sbjct: 172  YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE--------- 222

Query: 1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                   E+  +  +C   DP  RP   E+
Sbjct: 223  -------EIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 1e-18
 Identities = 66/217 (30%), Positives = 96/217 (44%), Gaps = 48/217 (22%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA----EVEALSRAQHKNLVSL 832
            +G G +G+VYKA     G   A+K++  D    E    +    E+  L   +H N+V L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDK------DSVLKWDVRLKIAQGAARGLAY 886
                      L++ Y +    D  L + +DK       +++K      I     RGLAY
Sbjct: 64  LDVIHTERKLYLVFEYCDM---D--LKKYLDKRPGPLSPNLIK-----SIMYQLLRGLAY 113

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYI 942
            H      I+HRD+K  NIL++      LADFGL+R     LR Y TH     V TL Y 
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THE----VVTLWYR 165

Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       YS  +      D++S G +  E++TG+
Sbjct: 166 APEILLGSKHYSTAV------DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.4 bits (216), Expect = 1e-18
 Identities = 82/298 (27%), Positives = 137/298 (45%), Gaps = 49/298 (16%)

Query: 771  NNFNQANIIGCGGFGLVYKATL-TNGTK--AAVKRLSGDCGQME-REFQAEVEALSR-AQ 825
            N+    ++IG G FG V KA +  +G +  AA+KR+     + + R+F  E+E L +   
Sbjct: 7    NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVR 873
            H N+++L G C H     L   Y  +G+L  +L +S  ++ D          S L     
Sbjct: 67   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 874  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
            L  A   ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 127  LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------ 177

Query: 934  DLVGTLGYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 987
             +  T+G +P  +    +      T   DV+S+GV+L E+++ G  P   C G  C +L 
Sbjct: 178  -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC-GMTCAELY 233

Query: 988  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + Q    ++ +   D             E+ ++  +C  + P  RP   +++  L+
Sbjct: 234  EKLPQGYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 47/273 (17%)

Query: 779  IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG-YC 836
            IG G +G VYKA  +  G   A+K +  + G      Q E+  L   +H N+V+  G Y 
Sbjct: 11   IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 837  RHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
            R   D+L I   Y   GSL      +      L       + +   +GLAYLH   E   
Sbjct: 71   R--RDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLH---ETGK 122

Query: 896  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT---TDLVGTLGYIPPEYSQTLTA 952
            +HRD+K +NILL E  +  LADFG+S  L    T         +GT  ++ PE +     
Sbjct: 123  IHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAVE-- 176

Query: 953  TCRG------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006
              +G      D+++ G+  +EL   + P            +  +  M    R + +I  S
Sbjct: 177  -RKGGYDGKCDIWALGITAIELAELQPP------------MFDLHPM----RALFLISKS 219

Query: 1007 IWH----KDREKQLLEMLEIACKCIDQDPRRRP 1035
             +     KD+EK      +   KC+ +DP++RP
Sbjct: 220  NFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 11/197 (5%)

Query: 777 NIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           + +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
           C       +I  +M  G+L  +L E  ++   +   V L +A   +  + YL K    + 
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLREC-NRQE-VNAVVLLYMATQISSAMEYLEK---KNF 125

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
           +HRD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFS 183

Query: 954 CRGDVYSFGVVLLELLT 970
            + DV++FGV+L E+ T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 29/215 (13%)

Query: 778 IIGCGGFGLVYKA-TLTNGTKAAVK------RLSGDCGQMERE----FQAEVEALSRAQH 826
           +IG G +G VY A  +T G   AVK       ++G     +++     ++E+E L    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLD--YWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            N+V   G+        +   Y+  GS+      +   ++  V          +    GL
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF------FTEQVLEGL 121

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP-YDTHVTTDLVGTLGYIP 943
           AYLH      I+HRD+K+ N+L+D      ++DFG+S+     YD      + G++ ++ 
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 944 PE----YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           PE    YSQ  +A  + D++S G V+LE+  GRRP
Sbjct: 179 PEVIHSYSQGYSA--KVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 34/222 (15%)

Query: 767 LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA-------EV 818
            +S   F + N IG G +G+VY+A   T+G   A+K++     +M+ E          E+
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLREI 57

Query: 819 EALSRAQHKNLVSL----QGYCRHGNDRLLIYSYMEN--GSLDYWLHESVDKDSVLKWDV 872
             L   +H N+V L     G  +H +   L+  Y E    SL       +D       + 
Sbjct: 58  TLLLNLRHPNIVELKEVVVG--KHLDSIFLVMEYCEQDLASL-------LDNMPTPFSES 108

Query: 873 RLK-IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 931
           ++K +     RGL YLH+     I+HRD+K SN+LL +K    +ADFGL+R        +
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165

Query: 932 TTDLVGTLGYIPPEYS-QTLTATCRGDVYSFGVVLLELLTGR 972
           T  +V TL Y  PE      T T   D+++ G +L ELL  +
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 70/269 (26%), Positives = 117/269 (43%), Gaps = 25/269 (9%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+     N TK AVK L    G M  + F  E   +   QH  LV L     
Sbjct: 14   LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  +I  YM  GSL  +L    D+   +     +  +   A G+AY+ +    + +H
Sbjct: 72   KEEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++N+L+ E     +ADFGL+R++   +          + +  PE     + T + D
Sbjct: 127  RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L E++T G+ P     G +  D++S + +     R              E   
Sbjct: 187  VWSFGILLYEIVTYGKIPY---PGMSNSDVMSALQRGYRMPR-------------MENCP 230

Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
             E+ +I   C  +    RP  + + + LD
Sbjct: 231  DELYDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 17/213 (7%)

Query: 771 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLS--GDCGQMEREFQA---EVEALSRA 824
            N+ +  ++G G FG VY    +  G + AVK++    D  + ++E  A   E++ L   
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 825 QHKNLVSLQGYCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
           QH+ +V   G C   ++ L I+  YM  GS+     + +     L   V  K  +    G
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEG 116

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGY 941
           + YLH      IVHRD+K +NIL D      L DFG S+ L+   +  T    + GT  +
Sbjct: 117 VEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           + PE         + DV+S G  ++E+LT + P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 28/270 (10%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    TK A+K L    G M  E F  E + + + +H  LV L  Y  
Sbjct: 14   LGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 838  HGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
               + + I + +M  GSL  +L E   K   LK    + +A   A G+AY+ ++   + +
Sbjct: 70   VSEEPIYIVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYIERM---NYI 124

Query: 897  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
            HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE +     T + 
Sbjct: 125  HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 957  DVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1015
            DV+SFG++L EL+T GR P      +   + V   ++M   +   E              
Sbjct: 185  DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE-------------S 231

Query: 1016 LLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
            L E++++   C  +DP  RP  E + ++L+
Sbjct: 232  LHELMKL---CWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 8e-18
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 9/165 (5%)

Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK 869
           + ++   E++ +   +   +VS  G   + N+  +   +M+ GSLD        K   + 
Sbjct: 46  VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK----KGGPIP 101

Query: 870 WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 929
            ++  KIA     GL YL+ V    I+HRD+K SNIL++ + +  L DFG+S  L     
Sbjct: 102 VEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---N 156

Query: 930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            +    VGT  Y+ PE  Q    T + DV+S G+ ++EL  G+ P
Sbjct: 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 9e-18
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 13/202 (6%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG VYKA     G  AA K +  +  +   +F  E++ LS  +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
           + N   ++  + + G+LD  + E    +  L       + +     L +LH      ++H
Sbjct: 73  YENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLH---SHKVIH 126

Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT---- 953
           RD+K+ NILL    +  LADFG+S   +       T  +GT  ++ PE     T      
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPY 185

Query: 954 -CRGDVYSFGVVLLELLTGRRP 974
             + D++S G+ L+EL     P
Sbjct: 186 DYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 79/285 (27%), Positives = 121/285 (42%), Gaps = 40/285 (14%)

Query: 777  NIIGCGGFGLVYKATLT----NGTKAAVKRLS--GDCGQMEREFQAEVEALSRAQHKNLV 830
             +IG G FG VY  TL          AVK L+   D  ++E +F  E   +    H N++
Sbjct: 1    RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVL 59

Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWL----HESVDKDSVLKWDVRLKIAQGAARGLA 885
            SL G C       L++  YM++G L  ++    H    KD +             A+G+ 
Sbjct: 60   SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI-------GFGLQVAKGME 112

Query: 886  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGYI 942
            YL        VHRD+ + N +LDE F   +ADFGL+R +     Y  H  T     + ++
Sbjct: 113  YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 943  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
              E  QT   T + DV+SFGV+L EL+T  R        +  D+  ++ Q +   +    
Sbjct: 170  ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVYLLQGRRLLQPEYC 227

Query: 1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
             D              + E+   C    P  RP   E+V+ ++ I
Sbjct: 228  PDP-------------LYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 22/216 (10%)

Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS------GDCGQMEREFQAEVEALSRA 824
            + +   +G G F   Y+A  +  GT  AVK+++       +  ++    + E+  ++R 
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H +++ + G     +   L   +M  GS+ + L     K    K  V +   +   RGL
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGL 116

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFE-AHLADFGLSRLLRPYDT---HVTTDLVGTLG 940
           +YLH   E  I+HRDVK +N+L+D   +   +ADFG +  L    T        L+GT+ 
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 941 YIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRP 974
           ++ PE    +    +C  DV+S G V++E+ T + P
Sbjct: 174 FMAPEVLRGEQYGRSC--DVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 43/234 (18%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSR-AQ 825
           ++F    IIG G F  V  A       + A+K L       E++ +    E E L+R   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 826 HKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAAR 882
           H  ++ L  Y     + L  +  Y  NG L  ++ +  S+D+        R   A+    
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-----CTRFYAAE-ILL 113

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL------- 935
            L YLH      I+HRD+K  NILLD+     + DFG +++L P  +  +          
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 936 ------------VGTLGYIPPEYSQTLT---ATCRGDVYSFGVVLLELLTGRRP 974
                       VGT  Y+ PE    L    A    D+++ G ++ ++LTG+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 80/296 (27%), Positives = 124/296 (41%), Gaps = 56/296 (18%)

Query: 778  IIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLV 830
             +G G FG V KAT          T  AVK L  +    E R+  +E   L +  H +++
Sbjct: 7    TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHES-------------VDKDSVLKWDVR---- 873
             L G C      LLI  Y + GSL  +L ES              +   +   D R    
Sbjct: 67   KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 874  ---LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 930
               +  A   +RG+ YL    E  +VHRD+ + N+L+ E  +  ++DFGLSR +   D++
Sbjct: 127  GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 931  VTTDLVGTLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCR 984
            V      + G IP      E       T + DV+SFGV+L E++T G  P      +   
Sbjct: 184  VKR----SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239

Query: 985  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            +L+   ++M+  +   E                EM  +   C  Q+P +RP   ++
Sbjct: 240  NLLKTGYRMERPENCSE----------------EMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+ AT    TK AVK +    G M  E F AE   +   QH  LV L     
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKW-DVRLKIAQGAARGLAYLHKVCEPHI 895
                 +I  +M  GSL D+   +   K  + K  D   +IA+G    +A++ +    + 
Sbjct: 72  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG----MAFIEQ---RNY 123

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           +HRD++++NIL+       +ADFGL+R++   +          + +  PE     + T +
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 956 GDVYSFGVVLLELLT-GRRP 974
            DV+SFG++L+E++T GR P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 24/231 (10%)

Query: 812  REFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKW 870
            R+   E+  LS  QH N+++   +    N  L+   Y   G+L D  + +   K  + + 
Sbjct: 44   RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ---KGQLFEE 100

Query: 871  DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 930
            ++ L         ++Y+HK     I+HRD+K+ NI L +     L DFG+S++L    + 
Sbjct: 101  EMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157

Query: 931  VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
              T +VGT  Y+ PE  Q +    + D+++ G VL ELLT +R  +     N  +LV  +
Sbjct: 158  AET-VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD---ATNPLNLVVKI 213

Query: 991  FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             Q               +         E++ +    + QDP +RP  +EV+
Sbjct: 214  VQ-------------GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 72/287 (25%), Positives = 108/287 (37%), Gaps = 55/287 (19%)

Query: 779  IGCGGFGLVYKATLTNGT----KAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQ 833
            +G G FG+V +   +         AVK L  D    +  +F  E   +    H+NL+ L 
Sbjct: 3    LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 834  GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVL---KWDVRLKIAQGAARGLAYLHKV 890
            G     +  +++      GSL   L +       L     D  ++IA G    + YL   
Sbjct: 63   GVVLT-HPLMMVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANG----MRYLE-- 114

Query: 891  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQ 948
                 +HRD+ + NILL    +  + DFGL R L   + H   +  L     +  PE  +
Sbjct: 115  -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 949  TLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
            T T +   DV+ FGV L E+ T G  P     G                        + I
Sbjct: 174  TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------------------------SQI 209

Query: 1008 WHK-DREKQLLEMLEIAC---------KCIDQDPRRRPFIEEVVTWL 1044
              K D+E + LE  E AC         +C   +P  RP    +  +L
Sbjct: 210  LKKIDKEGERLERPE-ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.9 bits (202), Expect = 7e-17
 Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 779 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
           +G G FG V  Y     N   G   AVK L  +CGQ     ++ E+  L    H+N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 833 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           +G C     +   LI  Y+  GSL DY     ++   +L +      AQ    G+AYLH 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF------AQQICEGMAYLH- 124

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 947
               H +HRD+ + N+LLD      + DFGL++ +     +  V  D    + +   E  
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 948 QTLTATCRGDVYSFGVVLLELLT 970
           +    +   DV+SFGV L ELLT
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.0 bits (200), Expect = 8e-17
 Identities = 68/250 (27%), Positives = 112/250 (44%), Gaps = 29/250 (11%)

Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQA-EVEALSRAQHKN 828
           +F     +G G +G VYK   L++    A+K +  G   Q ERE    E+  L+   H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           ++S +     GN   ++  Y   G L   + +   K  ++      +I     RGL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
              E  I+HRD+KS+NILL       + D G+S++L+    ++    +GT  Y+ PE  +
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEVWK 174

Query: 949 TLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK-------NCRDL---VS 988
               + + D++S G +L E+ T   P E          V +GK         +DL   + 
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234

Query: 989 WVFQMKSEKR 998
            + Q+K + R
Sbjct: 235 SMLQVKPKLR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 81.6 bits (202), Expect = 9e-17
 Identities = 67/205 (32%), Positives = 94/205 (45%), Gaps = 16/205 (7%)

Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQME-REFQAEVEALSRAQH-KNLVSLQGY 835
           IG G FG V K      GT  AVKR+     + E +    +++ + R+     +V   G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 836 CRHGNDRLLIYSYMENGSLD--Y-WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
                D  +    M+  SLD  Y +++E     SV+  ++  KIA    + L YL +  E
Sbjct: 72  LFREGDCWICMELMDI-SLDKFYKYVYEV--LKSVIPEEILGKIAVATVKALNYLKE--E 126

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA 952
             I+HRDVK SNILLD      L DFG+S  L   D+   T   G   Y+ PE       
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 953 T---CRGDVYSFGVVLLELLTGRRP 974
                R DV+S G+ L E+ TG+ P
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 78/268 (29%), Positives = 120/268 (44%), Gaps = 73/268 (27%)

Query: 768  KSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVKRLSGDCGQMERE-FQA----EVEA 820
            +  + F+    IG G +G VYKA    T G   A+K++  D    E+E F      E++ 
Sbjct: 4    RCVDKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRLD---NEKEGFPITAIREIKI 59

Query: 821  LSRAQHKNLVSLQGYCRHGNDRL----------LIYSYM--------ENGSLDYWLHESV 862
            L +  H+N+V+L+       D L          L++ YM        E+G + +      
Sbjct: 60   LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF------ 113

Query: 863  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 922
             +D +  +  +L        GL Y HK    + +HRD+K SNILL+ K +  LADFGL+R
Sbjct: 114  SEDHIKSFMKQL------LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Query: 923  LLRPYDTHVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
            L    ++   T+ V TL Y PPE       Y   +      DV+S G +L EL T ++P 
Sbjct: 165  LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAI------DVWSCGCILGELFT-KKP- 216

Query: 976  EVCKGKNCRDLVSWVFQMKSEKREVEII 1003
                          +FQ   E  ++E+I
Sbjct: 217  --------------IFQANQELAQLELI 230

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 77/274 (28%), Positives = 120/274 (43%), Gaps = 42/274 (15%)

Query: 778  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYC 836
            ++G G FG V+K TL + T  AVK    D  Q ++ +F +E   L +  H N+V L G C
Sbjct: 2    LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 837  RHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-KVCE 892
                 R  IY  ME    G    +L +  D+   LK    +K A  AA G+AYL  K C 
Sbjct: 62   ---TQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESKNC- 114

Query: 893  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 947
               +HRD+ + N L+ E     ++DFG+S   R  D  + +     L  IP     PE  
Sbjct: 115  ---IHRDLAARNCLVGENNVLKISDFGMS---RQEDDGIYSS--SGLKQIPIKWTAPEAL 166

Query: 948  QTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006
                 +   DV+S+G++L E  + G  P      +  R+ V   ++M   ++  +     
Sbjct: 167  NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPD----- 221

Query: 1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                       ++ ++  +C D  P  RP   E+
Sbjct: 222  -----------DVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 76/288 (26%), Positives = 124/288 (43%), Gaps = 38/288 (13%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
            NN +    +G G FG V +AT           K AVK L       ERE   +E++ +S 
Sbjct: 35   NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 824  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
               H+N+V+L G C  G   L+I  Y   G L  +L     ++S L  +  L  +   A+
Sbjct: 95   LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAK 152

Query: 883  GLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGT 938
            G+A+L  K C    +HRD+ + N+LL       + DFGL+R +     +V      L   
Sbjct: 153  GMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--P 206

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPV-EVCKGKNCRDLVSWVFQMKSE 996
            + ++ PE       T   DV+S+G++L E+ + G  P   +        L+   ++M   
Sbjct: 207  VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266

Query: 997  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            +                    E+ +I   C D DP +RP  +++V  +
Sbjct: 267  EHAPA----------------EIYDIMKTCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 77/299 (25%), Positives = 125/299 (41%), Gaps = 55/299 (18%)

Query: 778  IIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMEREFQ---AEVEALSR-AQHK 827
             +G G FG V KA           +  AVK L  D    E++     +E+E +    +HK
Sbjct: 19   PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHK 76

Query: 828  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWL--------HESVDKDSVLKWDVRLK---- 875
            N+++L G C       ++  Y  +G+L  +L        + S D     +  +  K    
Sbjct: 77   NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 876  IAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 934
             A   ARG+ +L  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  T 
Sbjct: 137  FAYQVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT- 191

Query: 935  LVGTLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 988
               T G +P     PE       T + DV+SFGV+L E+ T G  P      +    L  
Sbjct: 192  ---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-- 246

Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                +K   R  +  + +           E+  +   C  + P +RP  +++V  LD +
Sbjct: 247  ----LKEGYRMEKPQNCT----------QELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 65/255 (25%), Positives = 113/255 (44%), Gaps = 38/255 (14%)

Query: 772 NFNQANIIGCGGFGLVYKATLTNGTKAAVKR---LSGDCGQMEREFQAEVEALSRAQHKN 828
            +     IG G FG +Y A   + ++  V +   L+    + +   + EV  L++ +H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARGL 884
           +V+     +      ++  Y + G L   ++        +D +L W V++ +      GL
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
            ++H   +  I+HRD+KS NI L +    A L DFG++R L      +    VGT  Y+ 
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYLS 170

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKG----------KNC 983
           PE  Q      + D++S G VL EL T + P E          +C+G          ++ 
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDL 230

Query: 984 RDLVSWVFQMKSEKR 998
           R L+S +F++    R
Sbjct: 231 RSLISQLFKVSPRDR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.0 bits (201), Expect = 2e-16
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 57/226 (25%)

Query: 777 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQH 826
             IG G +G+V  A     G K A+K++S         F   ++A         L   +H
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRH 58

Query: 827 KNLVSLQGYCRHG-----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           +N++ L    R       ND  ++   ME            D   V+K    L       
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELME-----------TDLHKVIKSPQPLTDDHIQY 107

Query: 882 ------RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--T 933
                 RGL YLH     +++HRD+K SNIL++   +  + DFGL+R + P +      T
Sbjct: 108 FLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 934 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           + V T  Y  PE       Y++ +      D++S G +  ELLT +
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAI------DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 44/287 (15%)

Query: 779  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            +G G FG+VY+            T+ A+K ++ +    ER EF  E   +      ++V 
Sbjct: 14   LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
            L G    G   L++   M  G L  +L       E+            +++A   A G+A
Sbjct: 74   LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 886  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
            YL        VHRD+ + N ++ E     + DFG++R +   D +      G  G +P  
Sbjct: 134  YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 186

Query: 944  ---PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
               PE  +    T + DV+SFGVVL E+ T               L    +Q  S +  +
Sbjct: 187  WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQGLSNEEVL 231

Query: 1001 E-IIDASIWHKDREKQLLE-MLEIACKCIDQDPRRRPFIEEVVTWLD 1045
            + +ID    H D  +   + +LE+   C   +P+ RP   E+V+ L 
Sbjct: 232  KFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 68/238 (28%), Positives = 100/238 (42%), Gaps = 40/238 (16%)

Query: 777 NIIGCGGFGLVYKATLT--NGTKA----AVKRLSGDC-GQMEREFQAEVEALSRAQHKNL 829
             +G G FG VY+      +G       AVK L   C  Q E +F  E   +S+  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGLAY 886
           V L G       R ++   M  G L  +L E+    ++ S L     L  A+  A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY-- 941
           L    E H +HRD+ + N LL  K     A +ADFG++R           D+     Y  
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----------DIYRASYYRK 177

Query: 942 ----------IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 988
                     +PPE       T + DV+SFGV+L E+ + G  P      +   + V+
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 30/271 (11%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG+V+        K A+K ++   G M E +F  E + + +  H  LV L G C 
Sbjct: 12   LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  +MENG L  +L +   +   L  D+ L + Q    G+ YL +      +H
Sbjct: 70   QQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER---NSFIH 123

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD+ + N L+       ++DFG++R +   +   ++     + + PPE       + + D
Sbjct: 124  RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFGV++ E+ T G+ P                F+ KS    VE+I      +    +L
Sbjct: 184  VWSFGVLMWEVFTEGKMP----------------FEKKSNYEVVEMISRG--FRLYRPKL 225

Query: 1017 LEML--EIACKCIDQDPRRRPFIEEVVTWLD 1045
              M   E+   C  + P  RP   E++  + 
Sbjct: 226  ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 18/201 (8%)

Query: 777 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQG 834
            I+G G  G VYKA  L      AVK +  D   +++++  +E+E L +     ++   G
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 835 YCRHGNDRLLIYSYMENGSLD-YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
                N   +   +M+ GSLD Y           +   V  +IA    +GL YL  +   
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL--- 114

Query: 894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            I+HRDVK SN+L++ + +  L DFG+S  L      +    VGT  Y+ PE        
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYG 171

Query: 954 CRGDVYSFGVVLLELLTGRRP 974
              DV+S G+  +EL  GR P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 80.4 bits (199), Expect = 4e-16
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 43/214 (20%)

Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 828
           +G G +G V  A  T  G K A+K+LS       R FQ+ + A         L    H+N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 829 LVSLQGYCRHGNDRLLIYS--YMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLA 885
           ++ L          L  +   Y+    +   L+ ++ K   L  D ++  + Q   RGL 
Sbjct: 76  VIGLLD-VFTPASSLEDFQDVYLVTHLMGADLN-NIVKCQKLSDDHIQFLVYQ-ILRGLK 132

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y+H      I+HRD+K SNI ++E  E  + DFGL+R          T  V T  Y  PE
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPE 185

Query: 946 -------YSQTLTATCRGDVYSFGVVLLELLTGR 972
                  Y+QT+      D++S G ++ ELLTG+
Sbjct: 186 IMLNWMHYNQTV------DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 73/272 (26%), Positives = 114/272 (41%), Gaps = 30/272 (11%)

Query: 778  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
             IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G   
Sbjct: 13   TIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 838  HGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 L I + YM  GSL  +L       SVL  D  LK +      + YL      + V
Sbjct: 70   EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFV 124

Query: 897  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
            HRD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + 
Sbjct: 125  HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKS 180

Query: 957  DVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1015
            DV+SFG++L E+ + GR P      K+    V   ++M +      ++            
Sbjct: 181  DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV------------ 228

Query: 1016 LLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                 ++  +C   D   RP   ++   L+ I
Sbjct: 229  ----YDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.7 bits (194), Expect = 5e-16
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)

Query: 772 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKN 828
            + +  ++G G FG+V+        K  + +        + E  A   E + L    H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLH----ESVDKDSVLKWDVRLKIAQGAARGL 884
           ++            +++  Y   G+L  ++       +D+D++L + V++ +A       
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
             LH V    I+HRD+K+ NILLD+ K    + DFG+S++L       T  +VGT  YI 
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYIS 169

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           PE  +      + D+++ G VL EL + +R  E
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.0 bits (195), Expect = 7e-16
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 20/215 (9%)

Query: 773 FNQAN-----IIGCGGFGLVYKATLTNG------TKAAVKRLSG-DCGQMEREFQAEVEA 820
           F ++N      +G G FG V+ A           T   VK L       ++ EF+ E++ 
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-----VRLK 875
             +  HKN+V L G CR      +I  Y + G L  +L  +  KD  LK        ++ 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
           +    A G+ +L        VHRD+ + N L+  + E  ++   LS+ +   + +   + 
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           +  L ++ PE  Q    + + DV+SFGV++ E+ T
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.0 bits (195), Expect = 7e-16
 Identities = 83/292 (28%), Positives = 126/292 (43%), Gaps = 43/292 (14%)

Query: 779  IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
            +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 12   LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 834  GYCRHGNDRL---LIYSYMENGSLDYWL---HESVDKDSVLKWDVRLKIAQGAARGLAYL 887
            G C +   R    L+  Y+  GSL  +L    E +D   +L +      A    +G+ YL
Sbjct: 72   GVC-YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY------ASQICKGMEYL 124

Query: 888  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP---- 943
                    VHRD+ + NIL++ +    + DFGL+++L P D       V   G  P    
Sbjct: 125  G---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYK--VREPGESPIFWY 178

Query: 944  -PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
             PE       +   DV+SFGVVL EL T          K+C     ++  M ++K+   I
Sbjct: 179  APESLTESKFSVASDVWSFGVVLYELFT------YSD-KSCSPPAEFMRMMGNDKQGQMI 231

Query: 1003 IDASIWHKDREKQL-------LEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            +   I       +L        E+  I  +C + DP +RP   E+   ++ I
Sbjct: 232  VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 78.4 bits (194), Expect = 7e-16
 Identities = 78/259 (30%), Positives = 105/259 (40%), Gaps = 53/259 (20%)

Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQ-----AEVEALSRAQHKNLVSL 832
           I  G +G V+ A   + G   A+K +      M R+ Q      E + LS+AQ   +V L
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 833 QGYCRHGNDRL-LIYSYMENGSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
             Y   G   L L+  Y+  G L   L    S+D+D       R+ IA+     L YLH 
Sbjct: 59  Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-----RIYIAEIVL-ALEYLHS 111

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-------LLRPYDTHVTTDLVGTLGYI 942
                I+HRD+K  NIL+D      L DFGLS+       +    D      +VGT  YI
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 943 PPEY--SQTLTATCRGDVYSFGVVLLELLTGRRP-----VE-----VCKGK--------- 981
            PE    Q  + T   D +S G +L E L G  P      E     +  GK         
Sbjct: 169 APEVILGQGHSKTV--DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226

Query: 982 --NCRDLVSWVFQMKSEKR 998
                DL+S +     EKR
Sbjct: 227 SDEAIDLISKLLVPDPEKR 245

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 8e-16
 Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 46/215 (21%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA--------EVEALSRAQ-HKN 828
           +G G FG VY A     G   A+K+       M+++F +        EV++L +   H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKK-------MKKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 829 LVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           +V L+   R  ND L  ++ YME G+L Y L +        +  +R  I Q    GLA++
Sbjct: 60  IVKLKEVFRE-NDELYFVFEYME-GNL-YQLMKDRKGKPFSESVIRSIIYQILQ-GLAHI 115

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR---PYDTHVTTDLVGTLGYIPP 944
           HK       HRD+K  N+L+       +ADFGL+R +R   PY     TD V T  Y  P
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-----TDYVSTRWYRAP 167

Query: 945 E-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           E       YS  +      D+++ G ++ EL T R
Sbjct: 168 EILLRSTSYSSPV------DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.3 bits (195), Expect = 8e-16
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 779 IGCGGFGLVYKATLTNGTK-AAVKRLSGDCGQMEREFQ---AEVEALSRAQHKNLVSLQG 834
           IG G FG VY AT ++  +  AVK++S    Q   ++Q    EV+ L + +H N +  +G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                +   L+  Y    + D      V K  + + ++   I  GA +GLAYLH      
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIA-AITHGALQGLAYLHSHN--- 141

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC 954
           ++HRD+K+ NILL E  +  LADFG +    P ++      VGT  ++ PE    + A  
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTPYWMAPE---VILAMD 193

Query: 955 RG------DVYSFGVVLLELLTGRRPV 975
            G      DV+S G+  +EL   + P+
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.1 bits (195), Expect = 8e-16
 Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 30/208 (14%)

Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHKNLVSLQG 834
           IG G FG VY A         A+K++S    Q   ++Q    EV  L + +H N +  +G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 835 -YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR-LKIA---QGAARGLAYLHK 889
            Y R     L+    ME     Y L  + D   V K  ++ ++IA    GA +GLAYLH 
Sbjct: 83  CYLREHTAWLV----ME-----YCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
                 +HRD+K+ NILL E     LADFG + L+ P ++      VGT  ++ PE    
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILA 185

Query: 950 LTA---TCRGDVYSFGVVLLELLTGRRP 974
           +       + DV+S G+  +E L  R+P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 59/203 (29%), Positives = 82/203 (40%), Gaps = 19/203 (9%)

Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGD---CGQMEREFQAEVEALSRAQHKNLVSLQG 834
           +G GGFG V    + +     A+K +          +    +E E L    H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 835 YCRHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
             +   D+  IY  ME    G L   L    D+    ++  R  IA        YLH   
Sbjct: 61  TFK---DKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIAC-VVLAFEYLH--- 110

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 951
              I++RD+K  N+LLD      L DFG ++ L       T    GT  Y+ PE      
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILNKG 168

Query: 952 ATCRGDVYSFGVVLLELLTGRRP 974
                D +S G++L ELLTGR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 36/233 (15%)

Query: 777 NIIGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVS 831
           ++IG G FG V +A +        AA+K L     + + R+F  E+E L +   H N+++
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVRLKIAQG 879
           L G C +     +   Y   G+L  +L +S  ++ D          S L     L+ A  
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
            A G+ YL    E   +HRD+ + N+L+ E   + +ADFGLSR    Y       +  T+
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-------VKKTM 177

Query: 940 GYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 986
           G +P  +    +      T + DV+SFGV+L E+++ G  P   C G  C +L
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP--YC-GMTCAEL 227

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 52/135 (38%), Positives = 71/135 (52%), Gaps = 23/135 (17%)

Query: 848 YMENGSLDYWLHESVDKDSVLKWDVRL------KIAQGAARGLAYLHKVCEPH-IVHRDV 900
           +M+ GSLD           VLK   R+      KI+    RGL YL    E H I+HRDV
Sbjct: 80  HMDGGSLD----------QVLKKAGRIPENILGKISIAVLRGLTYLR---EKHKIMHRDV 126

Query: 901 KSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
           K SNIL++ + E  L DFG+S  L   D+   +  VGT  Y+ PE  Q    T + D++S
Sbjct: 127 KPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTHYTVQSDIWS 183

Query: 961 FGVVLLELLTGRRPV 975
            G+ L+E+  GR P+
Sbjct: 184 LGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 79/303 (26%), Positives = 129/303 (42%), Gaps = 58/303 (19%)

Query: 779  IGCGGFGLVY------------KATLTNGTK-----AAVKRLSGDCGQMER-EFQAEVEA 820
            +G G FG V+            KA   N         AVK L  D     R +F  EV+ 
Sbjct: 13   LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 821  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR------- 873
            LSR    N+  L G C       +I  YMENG L+ +L + V + S L  + +       
Sbjct: 73   LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 874  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VT 932
            L +A   A G+ YL      + VHRD+ + N L+ + +   +ADFG+SR L   D + V 
Sbjct: 133  LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGKNCRDLVSWV 990
                  + ++  E       T + DV++FGV L E+LT    +P                
Sbjct: 190  GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP---------------- 233

Query: 991  FQMKSEKREVEIIDASIWHKDREKQLL---------EMLEIACKCIDQDPRRRPFIEEVV 1041
            ++  ++++ +E  +A  + +D  +Q+          ++ E+  +C  +D   RP   E+ 
Sbjct: 234  YEHLTDQQVIE--NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291

Query: 1042 TWL 1044
             +L
Sbjct: 292  LFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 32/216 (14%)

Query: 777 NIIGCGGFGLVYKATLT-NGTK--AAVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVS 831
           ++IG G FG V KA +  +G +  AA+KR+     + + R+F  E+E L +   H N+++
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVRLKIAQG 879
           L G C H     L   Y  +G+L  +L +S  ++ D          S L     L  A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
            ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y       +  T+
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------VKKTM 170

Query: 940 GYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT 970
           G +P  +    +      T   DV+S+GV+L E+++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 70/247 (28%), Positives = 115/247 (46%), Gaps = 23/247 (9%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG+V           A+K +    G M E EF  E + + +  H+ LV L G C 
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM NG L  +L E   +    +    L++ +    G+AYL        +H
Sbjct: 70   KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLE---SKQFIH 123

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 954
            RD+ + N L+D++    ++DFGLSR +   D   T+  VG+   + + PPE       + 
Sbjct: 124  RDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLLYSKFSS 180

Query: 955  RGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIW 1008
            + DV++FGV++ E+ + G+ P E        + VS     +   + SEK  V  I  S W
Sbjct: 181  KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEK--VYAIMYSCW 238

Query: 1009 HKDREKQ 1015
            H+  E++
Sbjct: 239  HEKAEER 245

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM---EREF---QAEVEALSRAQH 826
           + +  ++G G +G VY      G   AVK++  D   +   E+E+   Q EV+ L   +H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
            N+V   G C   N   +   ++  GS+       +++   L   V  K  +    G+AY
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSIS----SILNRFGPLPEPVFCKYTKQILDGVAY 117

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLV----GTLGY 941
           LH  C   +VHRD+K +N++L       L DFG +R L     H T ++++    GT  +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           + PE         + D++S G  + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.0 bits (187), Expect = 6e-15
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)

Query: 778 IIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE---------FQAEVEALSRAQHK 827
           +IG G FG VY     ++G   AVK++         +            E+  L   QH+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 828 NLVSLQGYCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
           N+V   G      D L I+  Y+  GS+   L+     +  L   VR  + Q   +GL Y
Sbjct: 67  NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVRQ-ILKGLNY 121

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-----LVGTLGY 941
           LH      I+HRD+K +NIL+D K    ++DFG+S+ L        T+     L G++ +
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC 978
           + PE  +  + T + D++S G +++E+LTG+ P   C
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 779 IGCGGFGLVYKATL----TNGTKAAVKRLS-GDCGQMER-EFQAEVEALSRAQHKNLVSL 832
           IG G FG   KA L     +G +  +K ++       ER E + EV  LS  +H N+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARGLAYLH 888
           Q       +  ++  Y E G L   ++        +D +L W V++ +A         L 
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LK 115

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL----VGTLGYIPP 944
            V +  I+HRD+KS NI L +     L DFG++R+L     + T +L    +GT  Y+ P
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCIGTPYYLSP 170

Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
           E  +      + D+++ G VL E+ T +   E    KN
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.7 bits (186), Expect = 8e-15
 Identities = 66/280 (23%), Positives = 104/280 (37%), Gaps = 37/280 (13%)

Query: 779  IGCGGFGLVYKA---TLTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 834
            IG G FG V         +  +  VK L       E+  F  EV+      H N++   G
Sbjct: 3    IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 835  YCRHGNDRLLIYSYMENGSLDYWL-----HESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
             C      LL+  +   G L  +L       +         DV  ++A   A GL +LH+
Sbjct: 63   QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMACEVASGLLWLHQ 118

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE--- 945
                  +H D+   N  L       + D+GL+    P D ++T D     L ++ PE   
Sbjct: 119  A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 946  --YSQTLTA--TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
                  L    T + +++S GV + EL T   +P      +     V     +K  K ++
Sbjct: 176  IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235

Query: 1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            ++  +  W+           E+   C   DP  RP  EEV
Sbjct: 236  DLKYSDRWY-----------EVMQFCW-LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 75.4 bits (185), Expect = 8e-15
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 17/242 (7%)

Query: 778  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            IIG G FG V +   T G K AVK +   C    + F  E   +++  HKNLV L G   
Sbjct: 13   IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            H N   ++   M  G+L  +L       +++     L+ +   A G+ YL       +VH
Sbjct: 70   H-NGLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD+ + NIL+ E   A ++DFGL+R+       V    +  + +  PE  +    + + D
Sbjct: 124  RDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL-PVKWTAPEALKHKKFSSKSD 179

Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKR---EVEIIDASIWHKDRE 1013
            V+S+GV+L E+ + GR P      K  ++ V   ++M+  +    +V ++  S W  + +
Sbjct: 180  VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPK 239

Query: 1014 KQ 1015
            K+
Sbjct: 240  KR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.5 bits (189), Expect = 8e-15
 Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 58/298 (19%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLS---GDCGQMEREFQAEVEALSR-AQHKNLVSLQ 833
            +G G +G+V+KA         A+K++     +    +R F+ E+  L     H N+V L 
Sbjct: 15   LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73

Query: 834  GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAARGLAYLHKV 890
               +  ND+   L++ YME    D  LH +V + ++L+ DV  + I     + L Y+H  
Sbjct: 74   NVIKAENDKDIYLVFEYMET---D--LH-AVIRANILE-DVHKRYIMYQLLKALKYIH-- 124

Query: 891  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD----THVTTDLVGTLGYIPPE- 945
               +++HRD+K SNILL+      LADFGL+R L   +      V TD V T  Y  PE 
Sbjct: 125  -SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183

Query: 946  ------YSQTLTATCRGDVYSFGVVLLELLTGR-------------RPVEVCKGKNCRDL 986
                  Y++ +      D++S G +L E+L G+             + +EV    +  D+
Sbjct: 184  LLGSTRYTKGV------DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 987  VSWVFQMKSEKREVEIIDASIWHKDREKQLL-----EMLEIACKCIDQDPRRRPFIEE 1039
             S    +KS      +       +    +LL     + L++  K +  +P +R   EE
Sbjct: 238  ES----IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.2 bits (187), Expect = 9e-15
 Identities = 52/159 (32%), Positives = 82/159 (51%), Gaps = 9/159 (5%)

Query: 817 EVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           E++ L       +V   G      +  +   +M+ GSLD  L E+      +  ++  K+
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA----KRIPEEILGKV 108

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
           +    RGLAYL +  +  I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    V
Sbjct: 109 SIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFV 163

Query: 937 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
           GT  Y+ PE  Q    + + D++S G+ L+EL  GR P+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 20/229 (8%)

Query: 760 DLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEV 818
           D+ +S L      F    ++G G +G VYK   +  G  AA+K +     + E E + E+
Sbjct: 5   DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEI 63

Query: 819 EALSR-AQHKNLVSLQG-YCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD 871
             L + + H+N+ +  G + +     H +   L+  +   GS+   +  +  K + LK D
Sbjct: 64  NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKED 121

Query: 872 VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 931
               I +   RGLA+LH      ++HRD+K  N+LL E  E  L DFG+S  L       
Sbjct: 122 WIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178

Query: 932 TTDLVGTLGYIPPEY-----SQTLTATCRGDVYSFGVVLLELLTGRRPV 975
            T  +GT  ++ PE      +   T   R D++S G+  +E+  G  P+
Sbjct: 179 NT-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 40/275 (14%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA--LSRAQHKNLVSLQG 834
            ++G G +G V      T+G +  +K+L+           AE EA  LS+ +H N+V+ + 
Sbjct: 7    VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR- 65

Query: 835  YCRHGNDRLL--IYSYMENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLH 888
                G D LL  +  + E G L + L E   K    + V++W V++ +A      L YLH
Sbjct: 66   ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH 119

Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
               E HI+HRD+K+ N+ L       + D G++R+L       +T L+GT  Y+ PE   
Sbjct: 120  ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFS 175

Query: 949  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI- 1007
                  + DV++ G  + E+ T +         N +D+ S V++         II+  + 
Sbjct: 176  NKPYNYKSDVWALGCCVYEMATLKHAF------NAKDMNSLVYR---------IIEGKLP 220

Query: 1008 -WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
               KD   +L E++      + + P +RP ++ ++
Sbjct: 221  PMPKDYSPELGELIA---TMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.9 bits (186), Expect = 1e-14
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 773 FNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQ---AEVEALSRAQHKN 828
           F     IG G FG VY A      +  A+K++S    Q   ++Q    EV+ L R +H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
            +  +G     +   L+  Y    + D      V K  + + ++   I  GA +GLAYLH
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIA-AITHGALQGLAYLH 142

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
                +++HRD+K+ NILL E  +  LADFG + +  P ++      VGT  ++ PE   
Sbjct: 143 ---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPE--- 191

Query: 949 TLTATCRG------DVYSFGVVLLELLTGRRPV 975
            + A   G      DV+S G+  +EL   + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 76/274 (27%), Positives = 117/274 (42%), Gaps = 33/274 (12%)

Query: 773  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 829
            F +   IG G FG VYK  + N TK  V     D  + E E    Q E+  LS+     +
Sbjct: 6    FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 830  VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                G    G    +I  Y+  GS LD        K   L+      I +   +GL YLH
Sbjct: 65   TRYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLH 118

Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 947
                   +HRD+K++N+LL E+ +  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 119  ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
            +      + D++S G+  +EL  G  P          DL          K     ++   
Sbjct: 174  KQSAYDFKADIWSLGITAIELAKGEPPNS--------DLHPMRVLFLIPKNSPPTLEGQ- 224

Query: 1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             +    K+ +E       C+++DPR RP  +E++
Sbjct: 225  -YSKPFKEFVE------ACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 829
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 830 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
               G    G    +I  Y+  GS LD       D+  +        + +   +GL YLH
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLH 118

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 947
                  +HRD+K++N+LL E+ +  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 119 ---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           Q      + D++S G+  +EL  G  P
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 34/212 (16%)

Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRL------SGDCGQMEREFQAEVEALSRAQHKNLVS 831
           +G G + +VYKA     G   A+K++          G +      E++ L   +H N++ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDG-INFTALREIKLLQELKHPNIIG 66

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA------RGLA 885
           L     H ++  L++ +ME   L     E V KD      + L  A   +      RGL 
Sbjct: 67  LLDVFGHKSNINLVFEFME-TDL-----EKVIKDK----SIVLTPADIKSYMLMTLRGLE 116

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           YLH      I+HRD+K +N+L+       LADFGL+R     +  +T  +V T  Y  PE
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172

Query: 946 YSQTLTATCRG---DVYSFGVVLLELLTGRRP 974
                 A   G   D++S G +  ELL  R P
Sbjct: 173 L--LFGARHYGVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 13/201 (6%)

Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSLQG 834
           +G GGFG V    +   G   A K+L     +  +  Q    E + L +   + +VSL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 835 YCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
           Y     D L L+ + M  G L Y ++  V +    +       AQ    GL +LH   + 
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQ-IICGLEHLH---QR 114

Query: 894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            IV+RD+K  N+LLD+     ++D GL+  L+           GT GY+ PE  Q     
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 954 CRGDVYSFGVVLLELLTGRRP 974
              D ++ G  L E++ GR P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 48/223 (21%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G+V K   +  GT  AVKR+           +A V   S+ Q + L+ L    R
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI-----------RATVN--SQEQKRLLMDLDISMR 55

Query: 838 HGNDRLLIYSY------------ME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
             +    +  Y            ME  + SLD +  +  DK   +  D+  KIA    + 
Sbjct: 56  SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L YLH   +  ++HRDVK SN+L++   +  L DFG+S  L   D+   T   G   Y+ 
Sbjct: 116 LEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMA 171

Query: 944 PE----------YSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           PE          Y        + DV+S G+ ++EL TGR P +
Sbjct: 172 PERINPELNQKGYD------VKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 74.7 bits (183), Expect = 3e-14
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHKNLVSLQG 834
           IG G FG VY A  + N    A+K++S    Q   ++Q    EV  L + +H N +  +G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                +   L+  Y    + D      V K  + + ++   +  GA +GLAYLH     +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIA-AVTHGALQGLAYLHS---HN 135

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC 954
           ++HRDVK+ NILL E     L DFG + ++ P +       VGT  ++ PE    + A  
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPE---VILAMD 187

Query: 955 RG------DVYSFGVVLLELLTGRRPV 975
            G      DV+S G+  +EL   + P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 74.7 bits (183), Expect = 3e-14
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 22/233 (9%)

Query: 766 LLKSTNNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDCG-QMEREFQAEVE 819
           +LK T    +  ++G G FG VYK        T     A+K L+   G +   EF  E  
Sbjct: 3   ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61

Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   H +LV L G C     +L +   M +G L  ++HE  D      +L W V++  
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI-- 118

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
               A+G+ YL    E  +VHRD+ + N+L+       + DFGL+RLL   +     D  
Sbjct: 119 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Query: 937 GT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 987
              + ++  E       T + DV+S+GV + EL+T G +P +    +   DL+
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 46/226 (20%)

Query: 773 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS---GDCG---QMEREFQAEVEALSRAQ 825
           + +   IG G +G VYKA  L  G   A+K++     + G      RE  A ++ L   +
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59

Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD----------SVLKWDVRLK 875
           H N+V L   C HG          +       + E VD+D            L  +    
Sbjct: 60  HPNIVRLLDVC-HGPR-------TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD 111

Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TD 934
           + +   RG+ +LH      IVHRD+K  NIL+    +  +ADFGL+R+   Y   +  T 
Sbjct: 112 LMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTS 165

Query: 935 LVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           +V TL Y  PE      Y+  +      D++S G +  EL   RRP
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPV------DMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 21/216 (9%)

Query: 777 NIIGCGGFGLVYKATLTN----GT---KAAVKRL-SGDCGQMEREFQAEVEALSRAQHKN 828
           N +G G FG VY+ T T+    G+   + AVK L  G   Q ++EF  E   +S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGLA 885
           +V L G C     + +I   ME G L  +L ++        +L     L I    A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEA-----HLADFGLSRLLRPYDTH-VTTDLVGTL 939
           YL ++   H +HRD+ + N L+ EK         + DFGL+R +   D +    + +  +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
            ++ PE       T + DV+SFGV++ E+LT G++P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 76/295 (25%), Positives = 125/295 (42%), Gaps = 56/295 (18%)

Query: 779  IGCGGFGLVYKATL-----TNGTKAAVKRLSG-DCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G   FG +YK  L      +    A+K L   +  Q   EFQ E   ++   H N+V L
Sbjct: 13   LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWL-----HESV----DKDSVLKWDVR----LKIAQG 879
             G         +++ Y+  G L  +L     H  V    D+D  +K  +     L IA  
Sbjct: 73   LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 880  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGT 938
             A G+ YL        VH+D+ + NIL+ E+    ++D GLSR +   D + V    +  
Sbjct: 133  IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 997
            + ++PPE       +   D++SFGVVL E+ + G +P                +   S +
Sbjct: 190  IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP----------------YYGFSNQ 233

Query: 998  REVEIIDASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWL 1044
              +E++        R++QLL         M  +  +C  + P RRP  +++ T L
Sbjct: 234  EVIEMV--------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 20/219 (9%)

Query: 772 NFNQANIIGCGGFG--LVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHK 827
            +N   ++G G FG  L+ +   ++  K A+K  RL      +E   + E   L++ +H 
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHP 58

Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARG 883
           N+V+ +          ++  Y + G L   +     K    D++L+W V++ +      G
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------G 112

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           + ++H   E  ++HRD+KS NI L +  +  L DFG +RLL     +  T  VGT  Y+P
Sbjct: 113 VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVP 168

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
           PE  + +    + D++S G +L EL T + P +    KN
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 74.2 bits (182), Expect = 4e-14
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 47/273 (17%)

Query: 799  AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYW 857
            AVK L  D  +  R +F  EV+ LSR +  N++ L G C   +   +I  YMENG L+ +
Sbjct: 50   AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109

Query: 858  L--HESVDKDS-------------VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS 902
            L  H   DK+               + +   L +A   A G+ YL  +   + VHRD+ +
Sbjct: 110  LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLAT 166

Query: 903  SNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSF 961
             N L+ E     +ADFG+SR L   D + +    V  + ++  E       T   DV++F
Sbjct: 167  RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226

Query: 962  GVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID-ASIWHKDREKQLL--- 1017
            GV L E+L       +CK            Q   E  + ++I+ A  + +D+ +Q+    
Sbjct: 227  GVTLWEILM------LCKE-----------QPYGELTDEQVIENAGEFFRDQGRQVYLFR 269

Query: 1018 ------EMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                   + E+  +C  +D R RP   ++  +L
Sbjct: 270  PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 17/213 (7%)

Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-----FQAEVEALSRAQ 825
           N+ +  ++G G FG VY    +  G + A K++  D    E        + E++ L   Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 826 HKNLVSLQGYCR-HGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
           H+ +V   G  R      L I+  YM  GS+     + +     L   V  K  +    G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGY 941
           ++YLH      IVHRD+K +NIL D      L DFG S+ L+      T    + GT  +
Sbjct: 119 MSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           + PE         + DV+S G  ++E+LT + P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)

Query: 770 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN 828
            +   +  ++G G +G+VY A  L+   + A+K +     +  +    E+   S  +H+N
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARGL 884
           +V   G         +    +  GSL   L        D +  + +  + +I +G    L
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILEG----L 121

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
            YLH   +  IVHRD+K  N+L++       ++DFG S+ L   +   T    GTL Y+ 
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMA 177

Query: 944 PEYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 974
           PE    +    RG     D++S G  ++E+ TG+ P
Sbjct: 178 PE---VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.0 bits (180), Expect = 8e-14
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 58/233 (24%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVE 819
           +S + + + N I  G +G+VY+A     G   A+K+L     +ME+E +        E+ 
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREIN 56

Query: 820 ALSRAQHKNLVSLQ----GYCRHGNDRLLIYSYMENGSLDYWLHE-----SVDKDSVLKW 870
            L + QH N+V+++    G   + +   ++  Y+E        H+        K   L+ 
Sbjct: 57  ILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVE--------HDLKSLMETMKQPFLQS 106

Query: 871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRP 926
           +V+  + Q    G+A+LH   +  I+HRD+K+SN+LL+ +    + DFGL+R     L+P
Sbjct: 107 EVKCLMLQ-LLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162

Query: 927 YDTHVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           Y     T LV TL Y  PE       YS   TA    D++S G +  ELLT +
Sbjct: 163 Y-----TQLVVTLWYRAPELLLGAKEYS---TAI---DMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.9 bits (184), Expect = 1e-13
 Identities = 41/124 (33%), Positives = 65/124 (52%), Gaps = 3/124 (2%)

Query: 71  WDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL 130
           W G  C   ST      +  L L  +GL+G IP  +  L  L+ ++LS N + G +P  L
Sbjct: 404 WSGADCQFDST-KGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL 462

Query: 131 SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFEL--GEFSNLAVFNI 188
            ++  LEVLDLS+N  +G +   L  L  ++ LN++ NS +G +     G   + A FN 
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522

Query: 189 SNNS 192
           ++N+
Sbjct: 523 TDNA 526

Length = 623

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 76/262 (29%), Positives = 116/262 (44%), Gaps = 62/262 (23%)

Query: 769 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-F----QAEVEALS 822
              ++     +G G FG VYKA  +  G   A+K++       E++ F      E++ L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILK 62

Query: 823 RAQHKNLVSL--QGYCRHGN---DRLLIYS---YMENGSLDYWLHESVDKDSVLKWDVRL 874
           + +H N+V L      R       R  +Y    YM++  L   L             V+L
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP---------SVKL 112

Query: 875 KIAQGAA------RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
             +Q          G+ YLH   E HI+HRD+K++NIL+D +    +ADFGL+   RPYD
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA---RPYD 166

Query: 929 -------------THVTTDLVGTLGYIPPEY----SQTLTATCRGDVYSFGVVLLELLTG 971
                        T   T+LV T  Y PPE      +  TA    D++  G V  E+ T 
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV---DIWGIGCVFAEMFT- 222

Query: 972 RRPVEVCKGKNCRDLVSWVFQM 993
           RRP  + +GK+  D +  +F++
Sbjct: 223 RRP--ILQGKSDIDQLHLIFKL 242

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 1e-13
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 35/219 (15%)

Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKN 828
            +   + IG G +G+V  AT    G K A+K++S    Q   +R  + E++ L R +H+N
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHEN 64

Query: 829 LVSLQGYCRHG-----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAAR 882
           ++ +    R       ND  ++   ME       L++ + K   L  D ++  + Q   R
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETD-----LYK-LIKTQHLSNDHIQYFLYQ-ILR 117

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLG 940
           GL Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  
Sbjct: 118 GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 941 YIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           Y  PE       Y++ +      D++S G +L E+L+ R
Sbjct: 175 YRAPEIMLNSKGYTKAI------DIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 34/216 (15%)

Query: 778 IIGCGGFGLVYKATLT-NGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQHKNLVSLQG 834
            IG G +G+V  A  T +G K A+K++    D   + +    E++ L   +H N+++++ 
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71

Query: 835 YCR----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLAYLHK 889
             R       D  ++   ME+      LH  +  D  L  + +R  + Q   RGL Y+H 
Sbjct: 72  ILRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQ-LLRGLKYIHS 125

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYD-THVTTDLVGTLGYIPPE- 945
                ++HRD+K SN+L++E  E  + DFG++R L   P +  +  T+ V T  Y  PE 
Sbjct: 126 AN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182

Query: 946 ------YSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
                 Y+  +      D++S G +  E+L GRR +
Sbjct: 183 LLSLPEYTTAI------DMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)

Query: 778 IIGCGGFGLVYKATLT--NGT--KAAVKRLSGD-CGQME-REFQAEVEALSRAQHKNLVS 831
           I+G G FG V +  L+  +G+  K AVK +  D     E  EF +E   +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 832 LQGYCRHGNDR------LLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARG 883
           L G C   +        ++I  +M++G L  +L  S       K  ++  LK     A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT-LGYI 942
           + YL      + +HRD+ + N +L E     +ADFGLS+ +   D +    +    + +I
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
             E       T + DV++FGV + E+ T G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 40/153 (26%), Positives = 63/153 (41%), Gaps = 23/153 (15%)

Query: 883  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
            G+  LH+     I+HRD+K  N+L+D+     L DFGLSR             VGT  Y+
Sbjct: 109  GVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYL 160

Query: 943  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
             PE    +      D +S G V+ E L G  P          +    VF      R +  
Sbjct: 161  APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-------ETPDAVFD-NILSRRIN- 211

Query: 1003 IDASIWHKDREKQLL-EMLEIACKCIDQDPRRR 1034
                 W ++ ++    E +++  + +  DP +R
Sbjct: 212  -----WPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)

Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 829
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 830 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
               G         +I  Y+  GS LD      +D+  +        I +   +GL YLH
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLH 118

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 947
                  +HRD+K++N+LL E  E  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 119 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           +      + D++S G+  +EL  G  P
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 17/213 (7%)

Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQA---EVEALSRAQ 825
           N+    ++G G FG VY       G + AVK++    D  +  +E  A   E++ L   +
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 826 HKNLVSLQGYCR-HGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
           H  +V   G  R     +L I+  YM  GS+     + +     L  +V  +  +   +G
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGY 941
           ++YLH      IVHRD+K +NIL D      L DFG S+ ++      T    + GT  +
Sbjct: 119 VSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           + PE         + DV+S    ++E+LT + P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 64/212 (30%), Positives = 90/212 (42%), Gaps = 29/212 (13%)

Query: 778 IIGCGGFGLVYKATLTNGTKA--AVKRLSGD---------CGQMEREFQAEVEALSRAQH 826
           ++G G FG V  A L  GT    AVK L  D         C   E+     V AL+  +H
Sbjct: 2   VLGKGSFGKVLLAEL-KGTDELYAVKVLKKDVILQDDDVECTMTEKR----VLALAG-KH 55

Query: 827 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             L  L   C    DRL  +  Y+  G L + +     +            A     GL 
Sbjct: 56  PFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQ 110

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPP 944
           +LH   E  I++RD+K  N+LLD +    +ADFG+ +  +    T  T+   GT  YI P
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAP 165

Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           E           D ++ GV+L E+L G+ P E
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 16/205 (7%)

Query: 779 IGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           +G G +G VYK     T  T A  + RL  D  +   +   E++ L +A    +V   G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF-NQIIMELDILHKAVSPYIVDFYGA 67

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                   +   YM+ GSLD      V  + + + DV  +I     +GL +L +  E +I
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLKE--EHNI 124

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY------SQT 949
           +HRDVK +N+L++   +  L DFG+S  L      +    +G   Y+ PE       +Q 
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 950 LTATCRGDVYSFGVVLLELLTGRRP 974
            T T + DV+S G+ +LE+  GR P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE--FQAEVEALSRAQHKN 828
           NF +   IG G  G+V  AT  + G + AVK++     Q  RE  F  EV  +   QH N
Sbjct: 23  NFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFN-EVVIMRDYQHPN 77

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           +V +      G++  ++  ++E G+L D   H  ++++ +        +     + L++L
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFL 131

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
           H      ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE  
Sbjct: 132 HA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPEVI 187

Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
             L      D++S G++++E++ G  P
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 30/206 (14%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           IG G +G+V+K      G   A+K+   S D   +++    E+  L + +H NLV+L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHE------SVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
            R      L++ Y ++ ++   L+E       V +  + K      I     + + + HK
Sbjct: 69  FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKK------IIWQTLQAVNFCHK 118

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY--- 946
               + +HRDVK  NIL+ ++ +  L DFG +R+L        TD V T  Y  PE    
Sbjct: 119 ---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRWYRAPELLVG 174

Query: 947 -SQTLTATCRGDVYSFGVVLLELLTG 971
            +Q        DV++ G V  ELLTG
Sbjct: 175 DTQYGPPV---DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 18/215 (8%)

Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVS 831
           F    ++G G +G VYK       + A  ++    G  E E + E+  L + + H+N+ +
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 832 LQGYCRHGN-----DRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             G     N     D+L L+  +   GS+   +  +  K + LK +    I +   RGL+
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLS 125

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           +LH   +  ++HRD+K  N+LL E  E  L DFG+S  L        T  +GT  ++ PE
Sbjct: 126 HLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPE 181

Query: 946 Y-----SQTLTATCRGDVYSFGVVLLELLTGRRPV 975
                 +   T   + D++S G+  +E+  G  P+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 5e-13
 Identities = 67/239 (28%), Positives = 93/239 (38%), Gaps = 45/239 (18%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMERE----FQAEVEALSRA 824
           ++F    +IG G FG V+       T    A+K L      ++R      +AE + L+ A
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVR-DKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILADA 58

Query: 825 QHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
               +V L  Y     + L L+  YM  G L   L   + KD   +   R  IA+     
Sbjct: 59  DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELVL-A 113

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS--------RLLRPYDTHVTTDL 935
           L  +HK+     +HRD+K  NIL+D      LADFGL         R     D+H     
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 936 --------------------VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                               VGT  YI PE  +        D +S GV+L E+L G  P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 70.8 bits (173), Expect = 5e-13
 Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 15/183 (8%)

Query: 799 AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYW 857
           AVK L  D  +  R +F  E++ +SR ++ N++ L G C   +   +I  YMENG L+ +
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107

Query: 858 LHE---------SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD 908
           L +         + +  SV   ++ L +A   A G+ YL  +   + VHRD+ + N L+ 
Sbjct: 108 LSQREIESTFTHANNIPSVSIANL-LYMAVQIASGMKYLASL---NFVHRDLATRNCLVG 163

Query: 909 EKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLE 967
             +   +ADFG+SR L   D + +    V  + ++  E       T   DV++FGV L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 968 LLT 970
           + T
Sbjct: 224 MFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 48/218 (22%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLV 830
           IG G +G+VYKA     G   A+K++     ++E E +        E+  L    H N+V
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI-----RLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL--KIAQGAARGLAYLH 888
            L       N   L++ +     LD  L + +D   +   D  L         +G+AY  
Sbjct: 62  RLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY-- 114

Query: 889 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 943
             C  H ++HRD+K  N+L+D +    LADFGL+R     +R Y TH     V TL Y  
Sbjct: 115 --CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THE----VVTLWYRA 167

Query: 944 PE-------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           PE       YS   T     D++S G +  E++  RRP
Sbjct: 168 PEILLGSRQYS---TPV---DIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 43/112 (38%), Positives = 56/112 (50%), Gaps = 12/112 (10%)

Query: 875 KIAQGAARGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLS-RLLRPYDTHVT 932
           K+     + L YL    E H ++HRDVK SNILLD      L DFG+S RL+   D+   
Sbjct: 118 KMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAK 171

Query: 933 TDLVGTLGYIPPEYSQTLTAT----CRGDVYSFGVVLLELLTGRRPVEVCKG 980
           T   G   Y+ PE             R DV+S G+ L+EL TG+ P + CK 
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 7e-13
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRA 824
           ++F + + +G G  G+V+K +         ++L           Q+ RE Q     L   
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQV----LHEC 60

Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
               +V   G      +  +   +M+ GSLD    + + K   +   +  K++    +GL
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGL 116

Query: 885 AYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
            YL    E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ 
Sbjct: 117 TYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMS 170

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
           PE  Q    + + D++S G+ L+E+  GR P+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 71.8 bits (176), Expect = 8e-13
 Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 23/156 (14%)

Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL----VGTL 939
            L  +H V   H++HRD+KS+NILL       L DFG S++   Y   V+ D+     GT 
Sbjct: 153  LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM---YAATVSDDVGRTFCGTP 209

Query: 940  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
             Y+ PE  +    + + D++S GV+L ELLT +RP +   G+N  +++      + +   
Sbjct: 210  YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVMHKTLAGRYDPLP 266

Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035
              I               EM EI    +  DP+RRP
Sbjct: 267  PSISP-------------EMQEIVTALLSSDPKRRP 289

Length = 496

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 70/230 (30%), Positives = 100/230 (43%), Gaps = 24/230 (10%)

Query: 778 IIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL---- 832
           IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     +LVS     
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSLVSTGDCP 57

Query: 833 ----QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
                 Y  H  D+L  I   M  G L Y L +        + ++R    +    GL ++
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ---HGVFSEKEMRFYATE-IILGLEHM 113

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
           H      +V+RD+K +NILLDE     ++D GL+        H +   VGT GY+ PE  
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 167

Query: 948 QTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 996
           Q  TA     D +S G +L +LL G  P    K K+  ++      +  E
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 70.0 bits (171), Expect = 8e-13
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 16/202 (7%)

Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +G G FG V    Y     N G + AVK L     G    + + E+E L    H+N+V  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 833 QGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           +G C         LI  ++ +GSL  +L  + +K   +    +LK A    +G+ YL   
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG-- 126

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT--DLVGTLGYIPPEYSQ 948
                VHRD+ + N+L++ + +  + DFGL++ +     + T   DL   + +  PE   
Sbjct: 127 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 949 TLTATCRGDVYSFGVVLLELLT 970
                   DV+SFGV L ELLT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 69.6 bits (170), Expect = 9e-13
 Identities = 71/229 (31%), Positives = 98/229 (42%), Gaps = 21/229 (9%)

Query: 761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           L +  L   T+ +     IG G +G VYK T   +G+ AAVK L      ++ E +AE  
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYN 70

Query: 820 AL-SRAQHKNLVSLQGYCRH-----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR 873
            L S   H N+V   G         G    L+      GS+   +   +     L   + 
Sbjct: 71  ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130

Query: 874 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
             I  GA  GL +LH      I+HRDVK +NILL  +    L DFG+S  L        T
Sbjct: 131 SYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187

Query: 934 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
             VGT  ++ PE       Y  +  A C  DV+S G+  +EL  G  P+
Sbjct: 188 S-VGTPFWMAPEVIACEQQYDYSYDARC--DVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 69.7 bits (170), Expect = 9e-13
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 779 IGCGGFGLVYKATLTNG-------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 830
           +G G FG+VY+  +  G       T+ A+K ++      ER EF  E   +      ++V
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGL 884
            L G    G   L+I   M  G L  +L      ++ + V       K+ Q A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP- 943
           AYL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P 
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPV 185

Query: 944 ----PEYSQTLTATCRGDVYSFGVVLLELLT 970
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 70.2 bits (172), Expect = 1e-12
 Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 34/225 (15%)

Query: 771 NNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMERE---FQAEVEALSR 823
            +F+  +++G G FG V     KAT   G   A+K +       +     F+ E + LS 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 824 AQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQG 879
           +    +  LQ Y     D L L+  Y   G L   L+   +  D+D    +   L +A  
Sbjct: 58  SNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA-- 114

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS-RLLRPYDTHVTTDL-VG 937
                  +H V +   VHRD+K  N+L+D      LADFG + RL    +  V + L VG
Sbjct: 115 -------IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA--NKMVNSKLPVG 165

Query: 938 TLGYIPPEYSQTLTATCRG------DVYSFGVVLLELLTGRRPVE 976
           T  YI PE   T+    +G      D +S GV+  E++ GR P  
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 70.4 bits (172), Expect = 1e-12
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 19/228 (8%)

Query: 772 NFNQANIIGCGGFG---LVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA---- 824
           NF    ++G G +G   LV K T  +  K    ++      +++    E     R     
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 825 --QHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
             Q   LV+L  Y      +L LI  Y+  G +   L++   +D+  + +VR    +   
Sbjct: 61  VRQSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGE-II 115

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
             L +LHK+    IV+RD+K  NILLD +    L DFGLS+     +   T    GT+ Y
Sbjct: 116 LALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 942 IPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
           + PE  +      +  D +S G+++ ELLTG  P  +   +N +  VS
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 20/191 (10%)

Query: 796 TKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGS 853
           TK AVK L  D  + +  +  +E+E +    +HKN+++L G C       +I  Y   G+
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110

Query: 854 L------------DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDV 900
           L            +Y  + +   +  L +   +  A   ARG+ YL  K C    +HRD+
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC----IHRDL 166

Query: 901 KSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVY 959
            + N+L+ E     +ADFGL+R +   D +  TT+    + ++ PE       T + DV+
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226

Query: 960 SFGVVLLELLT 970
           SFGV+L E+ T
Sbjct: 227 SFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 1e-12
 Identities = 67/227 (29%), Positives = 100/227 (44%), Gaps = 51/227 (22%)

Query: 777 NIIGC---GGFGLVYKATLTN---GTKAAVKRLSGDCGQME-------REFQAEVEALSR 823
            I GC   G +G VYKA   N   G + A+K+  GD  Q         RE      AL R
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREI-----ALLR 57

Query: 824 A-QHKNLVSLQGYCRHGNDRL--LIYSYMENGSLDYW----LHESVDKDSVLKWDVRLKI 876
             +H+N+VSL        D+   L++ Y E+   D W     H    + S+    V+  +
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLL 114

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLSRLLR-PYDTHV 931
            Q    G+ YLH      ++HRD+K +NIL+     E+    + D GL+RL   P     
Sbjct: 115 WQ-ILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 932 TTD-LVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLT 970
             D +V T+ Y  PE       Y++ +      D+++ G +  ELLT
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAI------DIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)

Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGD--CGQMEREFQA---EVEALSRAQ 825
           N+    ++G G FG VY       G + AVK++  D    +  +E  A   E++ L    
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 826 HKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
           H+ +V   G  R   +R L     +M  GS+     + +     L  +V  K  +    G
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGY 941
           ++YLH      IVHRD+K +NIL D      L DFG S+ L+      T    + GT  +
Sbjct: 119 VSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           + PE         + D++S G  ++E+LT + P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 34/277 (12%)

Query: 779  IGCGGFGLVYKATLTNGT---KAAVKRLS-GDCGQMERE-FQAEVEALSRAQHKNLVSLQ 833
            +G G FG V +  L       K AVK +    C + E E F +E   +    H N++ L 
Sbjct: 7    LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 834  GYCRHGNDR------LLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAARGLA 885
            G C    +       ++I  +M++G L  +L  S   D    L   + +K     A G+ 
Sbjct: 67   GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 886  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT-LGYIPP 944
            YL        +HRD+ + N +L+E     +ADFGLS+ +   D +    +    + +I  
Sbjct: 127  YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 945  EYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003
            E       T + DV+SFGV + E+ T G+ P     G    ++  ++ Q    K+  + +
Sbjct: 184  ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY---PGVENSEIYDYLRQGNRLKQPPDCL 240

Query: 1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            D              +  +   C   +P+ RP  E +
Sbjct: 241  DG-------------LYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 16/205 (7%)

Query: 778 IIGCGGFGLVYKATLTNGTK----AAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSL 832
           I+G G FG + +  L   +K     A+  L   C  +  R F AE   L +  H N+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           +G    GN  +++  YM NG+LD +L +   +    +    + +  G A G+ YL    E
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPGLASGMKYL---SE 125

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG--TLGYIPPEYSQTL 950
              VH+ + +  +L++      ++ F   RL       + T + G   + +  PE  Q  
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             +   DV+SFG+V+ E+++ G RP
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.5 bits (170), Expect = 2e-12
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 18/208 (8%)

Query: 770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQH 826
           TN +     +G G FGLV  A     G   A+K++        + +    E++ L   +H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 827 KNLVSLQG-YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           +N++SL   +     D   IY   E    D  LH  +    + K  ++  + Q   RGL 
Sbjct: 69  ENIISLSDIFISPLED---IYFVTELLGTD--LHRLLTSRPLEKQFIQYFLYQ-ILRGLK 122

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y+H      +VHRD+K SNIL++E  +  + DFGL+   R  D  + T  V T  Y  PE
Sbjct: 123 YVHSA---GVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQM-TGYVSTRYYRAPE 175

Query: 946 YSQTLTA-TCRGDVYSFGVVLLELLTGR 972
              T        D++S G +  E+L G+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 72/219 (32%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 778 IIGCGGFGLVY---KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ- 833
           IIG GGFG VY   KA    G   A+K L     +M+   Q E  AL+     +LVS   
Sbjct: 1   IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMK---QGETLALNERIMLSLVSTGD 55

Query: 834 -------GYCRHGNDRL-LIYSYMENGSLDYWLHE-SVDKDSVLKWDVRLKIAQGAARGL 884
                   Y  H  D+L  I   M  G L Y L +  V  ++    ++R   A+    GL
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----EMRFYAAE-IILGL 110

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT GY+ P
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 164

Query: 945 EYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
           E  Q   A     D +S G +L +LL G  P    K K+
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 12/181 (6%)

Query: 799 AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYW 857
           AVK L  D  +  R +F  E++ +SR +  N++ L   C   +   +I  YMENG L+ +
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109

Query: 858 LHESVDKDSVLKWDVR-------LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK 910
           L     +++  K DV        + +A   A G+ YL  +   + VHRD+ + N L+ + 
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKN 166

Query: 911 FEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL 969
           +   +ADFG+SR L   D + +    V  + ++  E       T   DV++FGV L E+L
Sbjct: 167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Query: 970 T 970
           T
Sbjct: 227 T 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 68/295 (23%), Positives = 127/295 (43%), Gaps = 43/295 (14%)

Query: 773  FNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQH 826
            F    ++G G FG V +A L     +  K AVK L  D        EF  E   +    H
Sbjct: 1    FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 827  KNLVSLQGYCRHGNDR------LLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQ 878
             N++ L G       +      ++I  +M++G L  +L  S   ++   L     ++   
Sbjct: 61   PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 879  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
              A G+ YL      + +HRD+ + N +L+E     +ADFGLS+ +   D +      G 
Sbjct: 121  DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ----GC 173

Query: 939  LGYIPPEYS--QTLTA---TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQ 992
               +P ++   ++L     T   DV++FGV + E++T G+ P     G    ++ +++ +
Sbjct: 174  ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY---AGVENSEIYNYLIK 230

Query: 993  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                K+  + ++             ++ E+ C+C   +P+ RP  + +   L+ I
Sbjct: 231  GNRLKQPPDCLE-------------DVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 39/211 (18%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE----FQA--EVEALSRAQHKNLVS 831
           +G G +  VYK  +   G   A+K +      +E E    F A  E   L   +H N+V+
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIR-----LEHEEGAPFTAIREASLLKDLKHANIVT 67

Query: 832 LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDK-DSVLKWD-VRLKIAQGAARGLAYLH 888
           L     H    L L++ Y++       L + +D     L    VRL + Q   RGLAY H
Sbjct: 68  LHDII-HTKKTLTLVFEYLDTD-----LKQYMDDCGGGLSMHNVRLFLFQ-LLRGLAYCH 120

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP---- 944
           +     ++HRD+K  N+L+ E+ E  LADFGL+R  +   +   ++ V TL Y PP    
Sbjct: 121 Q---RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLL 176

Query: 945 ---EYSQTLTATCRGDVYSFGVVLLELLTGR 972
              EYS +L      D++  G +  E+ TGR
Sbjct: 177 GSTEYSTSL------DMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG VYKA     G  AA K +     +   ++  E+E L+   H  +V L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 ++  +   G++D  + E    D  L       I +     L YLH +    I+H
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIH 133

Query: 898 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPE--YSQTLT 951
           RD+K+ N+LL    +  LADFG+S    + L+  D+      +GT  ++ PE    +T+ 
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-----FIGTPYWMAPEVVMCETMK 188

Query: 952 AT---CRGDVYSFGVVLLEL 968
            T    + D++S G+ L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 54/163 (33%), Positives = 84/163 (51%), Gaps = 21/163 (12%)

Query: 817 EVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           EV  L   +H N+V+L           L++ Y+++  L  +L    +  S+   +V++ +
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSM--HNVKIFM 109

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            Q   RGL+Y HK     I+HRD+K  N+L++EK E  LADFGL+R  +   T   ++ V
Sbjct: 110 FQ-LLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEV 164

Query: 937 GTLGYIPP-------EYSQTLTATCRGDVYSFGVVLLELLTGR 972
            TL Y PP       EYS  +      D++  G +L E+ TGR
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPI------DMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 12/123 (9%)

Query: 871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 930
           +VR+ IA+     L +LH++    I++RD+K  NILLD +    L DFGLS+     +  
Sbjct: 106 EVRVYIAE-IVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161

Query: 931 VTTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRD 985
                 GT+ Y+ PE  +  +    G     D +S GV+  ELLTG  P  V   +N + 
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGS---GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218

Query: 986 LVS 988
            +S
Sbjct: 219 EIS 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 30/224 (13%)

Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTK----AAVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
               A+G+ YL    E  +VHRD+ + N+L+       + DFGL++LL   +     +  
Sbjct: 119 ----AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE-- 169

Query: 937 GTLGYIPP-----EYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
              G +P      E       T + DV+S+GV + EL+T G +P
Sbjct: 170 --GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 12/198 (6%)

Query: 779 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
            G++  ++  ++E G+L D   H  ++++ +        +     + L+ LH      ++
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLKALSVLHA---QGVI 138

Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L      
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 957 DVYSFGVVLLELLTGRRP 974
           D++S G++++E++ G  P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 21/200 (10%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG VYKA     G  AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
           + N+  ++  +   G++D  + E   +  + +  +R+ + +     L YLH   E  I+H
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLEL--ERPLTEPQIRV-VCKQTLEALNYLH---ENKIIH 126

Query: 898 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
           RD+K+ NIL     +  LADFG+S    R ++  D+      +GT  ++ PE     T+ 
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYWMAPEVVMCETSK 181

Query: 954 CR-----GDVYSFGVVLLEL 968
            R      DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 17/208 (8%)

Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKN 828
           NF Q   +G G +  VYK    T G   A+K   L  + G      + E+  +   +H+N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V L       N  +L++ YM+     Y   ++      L  +          +G+A+ H
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYM--DTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDLVGTLGYIPPEY- 946
              E  ++HRD+K  N+L++++ E  LADFGL+R    P +T  + ++V TL Y  P+  
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TLWYRAPDVL 172

Query: 947 --SQTLTATCRGDVYSFGVVLLELLTGR 972
             S+T + +   D++S G ++ E++TGR
Sbjct: 173 LGSRTYSTSI--DIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 6e-12
 Identities = 72/231 (31%), Positives = 108/231 (46%), Gaps = 33/231 (14%)

Query: 778 IIGCGGFG---LVYKATLTN-GTKAAVKRLSGDC--------GQMEREFQAEVEALSRAQ 825
           ++G G FG   LV K T  + G   A+K L             +MER+  AEV       
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56

Query: 826 HKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           H  +V L  Y      +L LI  ++  G L   L + V      + DV+  +A+  A  L
Sbjct: 57  HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALAL 111

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGTLGYIP 943
            +LH +    I++RD+K  NILLDE+    L DFGLS+     D         GT+ Y+ 
Sbjct: 112 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMA 166

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           PE       T   D +SFGV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ---GKDRKETMTMILKAK 214

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.4 bits (164), Expect = 6e-12
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 12/198 (6%)

Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  AT  + G + AVK++     Q       EV  +    H+N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
            G++  ++  ++E G+L D   H  ++++ +        +     R L+YLH      ++
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHN---QGVI 140

Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L      
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 957 DVYSFGVVLLELLTGRRP 974
           D++S G++++E++ G  P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 57/237 (24%)

Query: 771 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALS 822
           + + +   IG G FG V+KA         A+K++      ME E +        E++ L 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPITALREIKILQ 66

Query: 823 RAQHKNLVSLQGYCR-----HGNDRLLIYSYME-----------NGSLDYWLHESVDKDS 866
             +H+N+V+L   CR     +   +   Y   E           N ++ + L E      
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE------ 120

Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---L 923
            +K     K+ +    GL Y+H+     I+HRD+K++NIL+ +     LADFGL+R   L
Sbjct: 121 -IK-----KVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSL 171

Query: 924 LRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRPV 975
            +    +  T+ V TL Y PPE    L    R      D++  G ++ E+ T R P+
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPE----LLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.5 bits (162), Expect = 8e-12
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)

Query: 779 IGCGGFGLVYKATLTNGTK---AAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 834
           +G G FG V K       K    A+K L  +  +  R E   E E + +  +  +V + G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
            C      +L+      G L+ +L  S  KD +   +V   + Q  + G+ YL      +
Sbjct: 63  VCE-AEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQ-VSMGMKYLE---GKN 115

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLTA 952
            VHRD+ + N+LL  +  A ++DFGLS+ L   D++      G   L +  PE       
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 953 TCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
           + R DV+S+G+ + E  + G++P +  KG
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKG 204

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 35/282 (12%)

Query: 770  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQAEVEALSRA 824
              NF     IG G F +VYKA  L +G   A+K++      D    +   + E++ L + 
Sbjct: 1    LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 825  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES------VDKDSVLKWDVRLKIAQ 878
             H N++         N+  ++    + G L   +         + + ++ K+ V+L    
Sbjct: 60   DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL---- 115

Query: 879  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
                 L ++H      I+HRD+K +N+ +       L D GL R      T     LVGT
Sbjct: 116  --CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGT 169

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 998
              Y+ PE         + D++S G +L E+   + P    K  N   L     + K EK 
Sbjct: 170  PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSL----CK-KIEKC 223

Query: 999  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            +   + A  +     ++L +++     CI+ DP +RP I  V
Sbjct: 224  DYPPLPADHY----SEELRDLVSR---CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.8 bits (163), Expect = 9e-12
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 45/222 (20%)

Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKN 828
           NF +   IG G +G+VYKA     G   A+K  RL  +   +      E+  L    H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA----R 882
           +V L       N   L++ +         LH+ + K  D+     + L + +       +
Sbjct: 61  IVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111

Query: 883 GLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVG 937
           GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R     +R Y TH     V 
Sbjct: 112 GLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THE----VV 162

Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS   TA    D++S G +  E++T R
Sbjct: 163 TLWYRAPEILLGCKYYS---TAV---DIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.1 bits (169), Expect = 9e-12
 Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 34/202 (16%)

Query: 795 GTKAAVKRLSGDCGQMERE---FQAEVEALSRAQHKNLVSL--QGYCRHGNDRLL-IYSY 848
           G + A+K L  D  + E +   F+ E    +R  H N+V+L   G        L  ++ Y
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA--PPGLLFAVFEY 60

Query: 849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH---IVHRDVKSSNI 905
           +   +L            VL  D  L   +     L  L  +   H   IVHRD+K  NI
Sbjct: 61  VPGRTLR----------EVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNI 110

Query: 906 LL---DEKFEAHLADFGLSRLLRPYDTH--------VTTDLVGTLGYIPPEYSQTLTATC 954
           ++     +  A + DFG+  LL               TT+++GT  Y  PE  +    T 
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLP--GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 955 RGDVYSFGVVLLELLTGRRPVE 976
             D+Y++G++ LE LTG+R V+
Sbjct: 169 NSDLYAWGLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 9e-12
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 39/211 (18%)

Query: 779 IGCGGFGLVYK--ATLTNGTKAAVKRLSGDCGQMEREFQA------EVEALSRAQHKNLV 830
           +G G +  VYK  + LT+    A+K +     ++E E  A      EV  L   +H N+V
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEI-----RLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLAYLH 888
           +L           L++ Y     LD  L + +D   +S+   +V+L + Q   RGL Y H
Sbjct: 68  TLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQ-LLRGLNYCH 121

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP---- 944
           +     ++HRD+K  N+L++E+ E  LADFGL+R  +   T   ++ V TL Y PP    
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 945 ---EYSQTLTATCRGDVYSFGVVLLELLTGR 972
              +YS  +      D++  G +  E+ TGR
Sbjct: 178 GSTDYSTQI------DMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)

Query: 773 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME-REFQAEVEALSR---AQHK 827
           + +  +IG G +G VY+   +  G   A+K ++ D    +  + Q EV  LS+   +Q  
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           N+    G    G    +I  Y E GS+      ++ K   +       I +     L Y+
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSV-----RTLMKAGPIAEKYISVIIREVLVALKYI 117

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
           HKV    ++HRD+K++NIL+       L DFG++ LL    +  +T  VGT  ++ PE  
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVI 173

Query: 948 QTLTA-TCRGDVYSFGVVLLELLTGRRP 974
                   + D++S G+ + E+ TG  P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 46/216 (21%)

Query: 779 IGCGGFGLVYKAT--LTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNL 829
           IG G +G+VYKA   +TN T  A+K++     ++E+E +        E+  L   QH N+
Sbjct: 10  IGEGTYGVVYKARDRVTNET-IALKKI-----RLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 830 VSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRL--KIAQGAARGLAY 886
           V LQ    H   RL L++ Y     LD  L + +D       + RL         RG+AY
Sbjct: 64  VRLQDVV-HSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 887 LHKVCEPH-IVHRDVKSSNILLDEKFEA-HLADFGLSRLLR-PYDTHVTTDLVGTLGYIP 943
               C  H ++HRD+K  N+L+D +  A  LADFGL+R    P  T   T  V TL Y  
Sbjct: 118 ----CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVTLWYRA 171

Query: 944 PE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           PE       YS  +      D++S G +  E++  +
Sbjct: 172 PEILLGSRHYSTPV------DIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 43/271 (15%)

Query: 779  IGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVS 831
            +G GGFG V     +AT   G   A K+L+    +  + ++    E   L++   + +VS
Sbjct: 1    LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57

Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHK 889
            L    +   D  L+ + M  G L Y ++ +VD+++    + R     AQ    GL +LH 
Sbjct: 58   LAYAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQ-IISGLEHLH- 114

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
              +  I++RD+K  N+LLD      ++D GL+  L+   +  T    GT G++ PE  Q 
Sbjct: 115  --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQG 171

Query: 950  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE--IIDASI 1007
                   D ++ GV L E++  R P    +G+            K E +E++  I++ S+
Sbjct: 172  EEYDFSVDYFALGVTLYEMIAARGPFR-ARGE------------KVENKELKQRILNDSV 218

Query: 1008 WHKDR----EKQLLEMLEIACKCIDQDPRRR 1034
             + D+     K   E L      + +DP +R
Sbjct: 219  TYPDKFSPASKSFCEAL------LAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 65/265 (24%), Positives = 107/265 (40%), Gaps = 34/265 (12%)

Query: 779  IGCGGFGLVYKATL-TNGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYC 836
            IG G FG V+   L  + T  AVK         ++ +F  E   L +  H N+V L G C
Sbjct: 3    IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 837  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                   ++   ++ G    +L     +   LK    +++ + AA G+ YL      H +
Sbjct: 63   TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLE---SKHCI 116

Query: 897  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTLT 951
            HRD+ + N L+ EK    ++DFG+SR     +        G +  IP     PE      
Sbjct: 117  HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 952  ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
             +   DV+SFG++L E  + G  P                +   S ++  E I+  +   
Sbjct: 173  YSSESDVWSFGILLWEAFSLGAVP----------------YANLSNQQTREAIEQGVRLP 216

Query: 1011 DREKQLLEMLEIACKCIDQDPRRRP 1035
              E     +  +  +C + DP +RP
Sbjct: 217  CPELCPDAVYRLMERCWEYDPGQRP 241

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.8 bits (163), Expect = 2e-11
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 61/242 (25%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 828
           +G G +G V  A     G K A+K+LS       R FQ+E+ A         L   QH+N
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLS-------RPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHE-SVDKDSVLKWDVRLKIAQGAA 881
           ++ L              D  L+  YM+        H  S DK   L + +         
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------L 127

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---T 938
            GL Y+H      I+HRD+K  N+ ++E  E  + DFGL+R       H   ++ G   T
Sbjct: 128 CGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVT 177

Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 991
             Y  PE       Y+QT+      D++S G ++ E+LTG+    + KGK+  D ++ + 
Sbjct: 178 RWYRAPEVILNWMHYNQTV------DIWSVGCIMAEMLTGK---TLFKGKDYLDQLTQIL 228

Query: 992 QM 993
           ++
Sbjct: 229 KV 230

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 50/287 (17%)

Query: 784  FGLVYKATLTNGTKA------AVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            FG VYK  L            A+K L     G +  EF+ E    SR QH N+V L G  
Sbjct: 18   FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77

Query: 837  RHGNDRLLIYSYMENGSLDYWL-----HE---SVDKDSVLKWDVR----LKIAQGAARGL 884
                   +I+SY  +  L  +L     H    S D D  +K  +     + I    A G+
Sbjct: 78   TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137

Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT----LG 940
             +L      H+VH+D+ + N+L+ +K    ++D GL R +   D +    L+G     + 
Sbjct: 138  EFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNSLLPIR 191

Query: 941  YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
            ++ PE       +   D++S+GVVL E+ + G +P   C G + +D++  +       R+
Sbjct: 192  WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YC-GYSNQDVIEMI-----RNRQ 243

Query: 1000 VEII--DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            V     D   W          +  +  +C ++ P RRP  +++ + L
Sbjct: 244  VLPCPDDCPAW----------VYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 31/227 (13%)

Query: 770 TNNFNQANIIGCGGFGLVYKAT-LTNGTK----AAVKRLSGDCGQMEREFQAEVE---AL 821
                +  ++G G FG V+K   +  G       A+K +    G+  + FQ   +   A+
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAM 63

Query: 822 SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQ 878
               H  +V L G C  G    L+      GSL   + +   S+D   +L W V++    
Sbjct: 64  GSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI---- 118

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
             A+G+ YL +     +VHR++ + NILL       +ADFG++ LL P D         T
Sbjct: 119 --AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173

Query: 939 -LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-------GRRPVEV 977
            + ++  E       T + DV+S+GV + E+++       G RP EV
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 23/210 (10%)

Query: 771 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEA--LSRAQ 825
           +++ +   +G G +  VYK  +  NG   A+K  RL  + G     F A  EA  L   +
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT---PFTAIREASLLKGLK 61

Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDVRLKIAQGAARG 883
           H N+V L           L++ Y+      Y     +DK    +   +V+L + Q   RG
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHTDLCQY-----MDKHPGGLHPENVKLFLFQ-LLRG 115

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y+H   + +I+HRD+K  N+L+ +  E  LADFGL+R  +   +H  ++ V TL Y P
Sbjct: 116 LSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRP 171

Query: 944 PE--YSQTLTATCRGDVYSFGVVLLELLTG 971
           P+     T  +TC  D++  G + +E++ G
Sbjct: 172 PDVLLGSTEYSTCL-DMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 26/211 (12%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQ---HKNLVSL 832
           IG G +G VYKA    +G   A+K +     +  +      EV  L R +   H N+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 833 QGYCRHG-NDR----LLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIAQGAARGLA 885
              C     DR     L++ +     +D  L   +DK     L  +    + +   RGL 
Sbjct: 68  MDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPP 944
           +LH  C   IVHRD+K  NIL+    +  LADFGL+R+   Y   +  T +V TL Y  P
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAP 176

Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
           E     T     D++S G +  E+   R+P+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 782 GGFGLVYKATLTNGT-----KAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 835
           G FG ++   L +       +  VK +     +++      E   L    H+N++ +   
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 836 CRHGNDR-LLIYSYMENGSLDYWL----HESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           C    +   ++Y YM  G+L  +L        +    L     + +A   A G++YLHK 
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG-TLGYIPPEYSQT 949
               ++H+D+ + N ++DE+ +  + D  LSR L P D H   D     + ++  E    
Sbjct: 137 ---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193

Query: 950 LTATCRGDVYSFGVVLLELLT 970
              +   DV+SFGV+L EL+T
Sbjct: 194 KEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 778 IIGCGGFGLVYKATLTN-GTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
           ++G G +G+V K      G   A+K+   S D   +++    E+  L + +H+NLV+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
             R      L++ ++++  LD         D      VR  + Q   RG+ + H     +
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR---VRKYLFQ-ILRGIEFCHS---HN 120

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
           I+HRD+K  NIL+ +     L DFG +R L  P +  V TD V T  Y  PE     T  
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKY 178

Query: 954 CRG-DVYSFGVVLLELLTG 971
            R  D+++ G ++ E+LTG
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 49/163 (30%), Positives = 83/163 (50%), Gaps = 21/163 (12%)

Query: 817 EVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           EV  L   +H N+V+L           L++ Y++   L  ++ +  +  S+   +V++ +
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSM--HNVKIFL 110

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            Q   RGLAY H+     ++HRD+K  N+L++E+ E  LADFGL+R  +   T   ++ V
Sbjct: 111 YQ-ILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEV 165

Query: 937 GTLGYIPP-------EYSQTLTATCRGDVYSFGVVLLELLTGR 972
            TL Y PP       EYS  +      D++  G +  E+ +GR
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQI------DMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.7 bits (160), Expect = 3e-11
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 49/217 (22%)

Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 828
           +G G +G V  A     G K A+K+L        R FQ+E+ A         L   +H+N
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMKHEN 75

Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             +D  L+  +M         HE + +D +     +  + Q   +
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRI-----QFLVYQ-MLK 129

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K  N+ ++E  E  + DFGL+   R  D+ +T  +V T  Y 
Sbjct: 130 GLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVV-TRWYR 182

Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ E+LTG+
Sbjct: 183 APEVILNWMHYTQTV------DIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 33/208 (15%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE----FQAEVEA--LSRAQHKNLVS 831
           +G G +  VYK  +  NG   A+K +S     M+ E    F A  EA  L   +H N+V 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVIS-----MKTEEGVPFTAIREASLLKGLKHANIVL 67

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L            ++ YM      Y +        +  ++VRL + Q   RGLAY+H   
Sbjct: 68  LHDIIHTKETLTFVFEYMHTDLAQYMIQHP---GGLHPYNVRLFMFQ-LLRGLAYIHG-- 121

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP------- 944
             HI+HRD+K  N+L+    E  LADFGL+R  +   +   +  V TL Y PP       
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGAT 179

Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGR 972
           +YS  L      D++  G + +E+L G+
Sbjct: 180 DYSSAL------DIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 46/294 (15%)

Query: 766  LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTK----AAVKRLSGDCG-QMEREFQAEVE 819
            +LK T    +  ++G G FG VYK   + +G       A+K L  +   +  +E   E  
Sbjct: 3    ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 820  ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
             ++      +  L G C     +L +   M  G L  ++ E+ D+     +L W V++  
Sbjct: 62   VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI-- 118

Query: 877  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
                A+G++YL +V    +VHRD+ + N+L+       + DFGL+RLL   +T    D  
Sbjct: 119  ----AKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-- 169

Query: 937  GTLGYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV 990
               G +P ++    +      T + DV+S+GV + EL+T G +P +    +   DL+   
Sbjct: 170  --GGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL--- 224

Query: 991  FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQD--PRRRPFIEEVVT 1042
                 EK E  +    I   D     + M+ + C  ID +  PR R  ++E   
Sbjct: 225  -----EKGE-RLPQPPICTID-----VYMIMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 46/197 (23%), Positives = 92/197 (46%), Gaps = 10/197 (5%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G V+ A  +  G + A+K+++      +     E+  +   ++ N+V+      
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G++  ++  Y+  GSL   + E+   ++ +       + +   + L +LH      ++H
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLHA---NQVIH 138

Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+KS N+LL       L DFG    + P  +  +T +VGT  ++ PE         + D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 958 VYSFGVVLLELLTGRRP 974
           ++S G++ +E++ G  P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 75/277 (27%), Positives = 111/277 (40%), Gaps = 31/277 (11%)

Query: 779  IGCGGFGLVYKATLTNG---TKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQG 834
            IG G FG V    + +G    +  VK L      Q + +F  E +     QH NL+   G
Sbjct: 3    IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 835  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL--KIAQGAARGLAYLHKVCE 892
             C      LL+  +   G L  +L  S  K  ++  D     ++A   A GL +LHK   
Sbjct: 63   QCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118

Query: 893  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE-----Y 946
             + +H D+   N LL       + D+GLS      D +VT D L   L +I PE     +
Sbjct: 119  NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 947  SQTLTA--TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003
               L    T   +V+S GV + EL   G +P      +          Q+K  K  +++ 
Sbjct: 179  GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238

Query: 1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
             +  W+           E+   C  Q P +RP  EEV
Sbjct: 239  LSDRWY-----------EVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.2 bits (159), Expect = 5e-11
 Identities = 61/239 (25%), Positives = 92/239 (38%), Gaps = 65/239 (27%)

Query: 777 NIIGCGGFGLVYKATLTN-GTKAAVKRLS---------------GDCGQMEREFQA--EV 818
             +G G +G V KA  T  G   A+K++                G CG     F    E+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI---HFTTLREL 71

Query: 819 EALSRAQHKNLVSLQG-YCRHG--NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
           + ++  +H+N++ L   Y      N   L+   M +           D   V+   +RL 
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFIN---LVMDIMAS-----------DLKKVVDRKIRLT 117

Query: 876 IAQGAA------RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR------L 923
            +Q          GL  LHK    + +HRD+  +NI ++ K    +ADFGL+R       
Sbjct: 118 ESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174

Query: 924 LRPYDTHVT-------TDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGR 972
                   T       T  V TL Y  PE    + A       D++S G +  ELLTG+
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYRAPEL--LMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 6e-11
 Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 452 LALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEI 511
           L L N GL+G IP  + + + LQ ++LS N   GNIPP +G + +L  LD S N+  G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 512 PKSLTELKSL----ISSNCTSSN-PTASAGIPLY 540
           P+SL +L SL    ++ N  S   P A  G  L+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH 516

Length = 623

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 6e-11
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)

Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 77

Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 78  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 131

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 132 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 184

Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 185 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 6e-11
 Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREF-QAEVEALSRAQHKNLVSLQGYC 836
           IG G FG VYKA         A+K +  +  + E E  Q E++ LS+ +   +    G  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68

Query: 837 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
             G+   +I  Y   GS    L     K   L       I +    GL YLH   E   +
Sbjct: 69  LKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLH---EEGKI 120

Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT---DLVGTLGYIPPEYSQTLTAT 953
           HRD+K++NILL E+ +  LADFG+S  L    T   +     VGT  ++ PE  +     
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQL----TSTMSKRNTFVGTPFWMAPEVIKQSGYD 176

Query: 954 CRGDVYSFGVVLLELLTGRRP 974
            + D++S G+  +EL  G  P
Sbjct: 177 EKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 64.3 bits (156), Expect = 6e-11
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 23/225 (10%)

Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD-CGQMEREFQA--EVEALSRAQHKN 828
           F Q  ++G GGFG V    +   G   A K+L      + + E  A  E + L +   + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 829 LVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           +VSL  Y     D L L+ + M  G L + ++     ++  +    +  A     GL  L
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDL 118

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGYI 942
           H+     IV+RD+K  NILLD+     ++D GL+        HV         VGT+GY+
Sbjct: 119 HQ---ERIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGYM 168

Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 987
            PE  +    T   D ++ G +L E++ G+ P +  K K  R+ V
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 64.2 bits (156), Expect = 7e-11
 Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 10/197 (5%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G VY A  +  G + A+K+++      +     E+  +   +H N+V+      
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G++  ++  Y+  GSL   + E+   +  +       + +   + L +LH      ++H
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLH---SNQVIH 138

Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+KS NILL       L DFG    + P  +  +T +VGT  ++ PE         + D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 958 VYSFGVVLLELLTGRRP 974
           ++S G++ +E++ G  P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 64.7 bits (157), Expect = 7e-11
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 21/215 (9%)

Query: 772 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQHK 827
           +F    +IG G FG V    L N  K    ++      ++R     F+ E + L    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAY 886
            + +L    +  N+  L+  Y   G L   L +  D+   L  D+ R  +A+     +  
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYLAEM----VIA 114

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
           +  V + H VHRD+K  NIL+D      LADFG    L    T  ++  VGT  YI PE 
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 947 SQTLT-------ATCRGDVYSFGVVLLELLTGRRP 974
            Q +          C  D +S GV + E+L G  P
Sbjct: 175 LQAMEDGKGKYGPEC--DWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.0 bits (155), Expect = 7e-11
 Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 13/215 (6%)

Query: 761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           ++V D  K    F +   IG G  G VY A  +  G + A+K+++      +     E+ 
Sbjct: 12  VSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEIL 68

Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
            +   ++ N+V+       G++  ++  Y+  GSL   + E+   +  +       + + 
Sbjct: 69  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRE 123

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
             + L +LH      ++HRD+KS NILL       L DFG    + P  +  +T +VGT 
Sbjct: 124 CLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTP 179

Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            ++ PE         + D++S G++ +E++ G  P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.7 bits (155), Expect = 8e-11
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)

Query: 779 IGCGGFGLVYKATLTNGTKA--AVKRLS---GDCGQMEREFQAEVEAL--------SRAQ 825
           +G G FG VYK    N  +   A+K ++      G+ +RE    +  +         + +
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 826 HKNLVSLQGYCRH--GNDRL-LIYSYMENGSLDYWL------HESVDKDSVLKWDVRLKI 876
           H N+V    Y +    NDRL ++   +E   L           +   ++ +    V++ +
Sbjct: 68  HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
           A      L YLHK  E  IVHRD+  +NI+L E  +  + DFGL++  +P      T +V
Sbjct: 125 A------LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVV 174

Query: 937 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           GT+ Y  PE  +      + DV++FG +L ++ T
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.1 bits (156), Expect = 9e-11
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 778 IIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA-QHKNLVSL 832
           ++G G FG V  A L  +G   AVK L  D    + + +    E   LS A  H  L  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 833 QGYCRHGNDRLL-IYSYMENGSLDYWLHES--VDKDSVLKWDVRLKIAQGAARGLAYLHK 889
              C    DRL  +  ++  G L + + +S   D+     +   +  A      L +LH 
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA------LMFLH- 113

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
             +  I++RD+K  N+LLD +    LADFG+ +    ++   T+   GT  YI PE  Q 
Sbjct: 114 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQE 170

Query: 950 LTATCRGDVYSFGVVLLELLTGRRPVE 976
           +      D ++ GV+L E+L G  P E
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 17/209 (8%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEAL-SRAQHKNLVSLQGY- 835
           IG G +G V+K     NG+KAAVK L      ++ E +AE   L + + H N+V   G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 836 ----CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
                ++G+   L+      GS+   +   + +   ++  +   I   A  GL +LH   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--- 141

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY---SQ 948
               +HRDVK +NILL  +    L DFG+S  L        T  VGT  ++ PE     Q
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVIACEQ 200

Query: 949 TLTAT--CRGDVYSFGVVLLELLTGRRPV 975
            L +T   R DV+S G+  +EL  G  P+
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.2 bits (159), Expect = 1e-10
 Identities = 31/80 (38%), Positives = 46/80 (57%)

Query: 315 GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHD 374
           G +P  +S    L  ++L  NS+ G I  +   ++SL  LDL+ N F+G +P SL     
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 375 LKILSLAKNELSGQVPESFG 394
           L+IL+L  N LSG+VP + G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 63.7 bits (156), Expect = 1e-10
 Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 29/215 (13%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGD----CGQMEREFQAEVEALSRAQ 825
           ++F     +G G FG V         K  A+K LS        Q+E     E   L   +
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL-NEKRILQSIR 59

Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGL 884
           H  LV+L G  +  ++  L+  Y+  G L   L     K       V R   AQ     L
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVL-AL 114

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            YLH +    IV+RD+K  N+LLD      + DFG ++ ++      T  L GT  Y+ P
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----RTYTLCGTPEYLAP 167

Query: 945 EYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 974
           E         +G     D ++ G+++ E+L G  P
Sbjct: 168 EIIL-----SKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 25/218 (11%)

Query: 779 IGCGGFGLVYKATLTNGTKAAV------KRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +G GGFG V    + N  K         KRL    G  E+    E E L +     +V+L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG--EKMALLEKEILEKVNSPFIVNL 58

Query: 833 QGYCRHGNDRL-LIYSYMENGSLDYWLHE----SVDKDSVLKWDVRLKIAQGAARGLAYL 887
             Y       L L+ S M  G L Y ++      ++ + V+ +  ++        G+ +L
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI------TCGILHL 111

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
           H +    IV+RD+K  N+LLD++    L+D GL+  L+  D    T   GT GY+ PE  
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEIL 166

Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD 985
           +    +   D ++ G  + E++ GR P +  K K  ++
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 64.2 bits (156), Expect = 1e-10
 Identities = 97/399 (24%), Positives = 154/399 (38%), Gaps = 62/399 (15%)

Query: 115 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL 174
           L+LS N L  ++P  LS L  L++L  S  + S   S  L  L  + SL+++ N    ++
Sbjct: 52  LNLSSNTLL-LLPSSLSRLLSLDLLSPS-GISSLDGSENLLNLLPLPSLDLNLNRLRSNI 109

Query: 175 FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQL 234
            EL E +NL   ++ NN+ T  +   I      ++ LDLS N                  
Sbjct: 110 SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI---------------- 152

Query: 235 HVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLP 294
                     LP  L ++ +L+++ LS N+ S  L + +SNL++L +L + GN+ S  LP
Sbjct: 153 --------ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLP 202

Query: 295 NVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTL 354
             +  L+ LE     +NS    L  SLS    L  L+L NN L                 
Sbjct: 203 PEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE---------------- 245

Query: 355 DLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF-NHLS 413
                     LP S+ +  +L+ L L+ N++S     S G LT+L  L LS NS  N L 
Sbjct: 246 ---------DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALP 294

Query: 414 GTLSVLQQCKNLTTLILTKN--FVGEEIPENVGGFESLMVLALGNC--GLKGHIPVWLLR 469
               +L   + L  L+LT     +            S    +       L+    +W L 
Sbjct: 295 LIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLD 354

Query: 470 CKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLT 508
               +     +   + N    +  +              
Sbjct: 355 NALDESNLNRYIVKNPNAIGSLLDLVKKHVNQLLEKVNY 393

Length = 394

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 18/187 (9%)

Query: 799 AVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY 856
           AVK L  D  + +  +  +E+E +    +HKN+++L G C       +I  Y   G+L  
Sbjct: 51  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110

Query: 857 WLHESVDKDSVLKWDVR------------LKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
           +L           +D+             +      ARG+ YL        +HRD+ + N
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARN 167

Query: 905 ILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGV 963
           +L+ E     +ADFGL+R +   D +  TT+    + ++ PE       T + DV+SFGV
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 227

Query: 964 VLLELLT 970
           ++ E+ T
Sbjct: 228 LMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 57/224 (25%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLV 830
           IG G +G+VYK      G   A+K++     ++E E +        E+  L   QH N+V
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIREISLLKELQHPNIV 62

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
            LQ      +   LI+ ++   S+D   + +S+ K   +           A    +YL++
Sbjct: 63  CLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMD----------AELVKSYLYQ 109

Query: 890 V------CEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGT 938
           +      C    ++HRD+K  N+L+D K    LADFGL+R     +R Y TH     V T
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY-THE----VVT 164

Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
           L Y  PE       YS         D++S G +  E+ T ++P+
Sbjct: 165 LWYRAPEVLLGSPRYS------TPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 778 IIGCGGFGLVYKATLTNGTK-AAVKRLSGD---------CGQMEREFQAEVEALSRAQHK 827
           ++G G FG V  A L    +  A+K L  D         C  +ER     V AL+  +H 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERR----VLALA-WEHP 56

Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA--RG 883
            L  L  +C       L +   Y+  G L + +  S       ++D        A    G
Sbjct: 57  FLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSS------GRFDEARARFYAAEIICG 108

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L +LHK     I++RD+K  N+LLD+     +ADFG+ +     +   +T   GT  YI 
Sbjct: 109 LQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           PE  +        D +SFGV+L E+L G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.2 bits (153), Expect = 2e-10
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 13/215 (6%)

Query: 761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 13  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69

Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
            +   ++ N+V+       G++  ++  Y+  GSL   + E+   +  +       + + 
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRE 124

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
             + L +LH      ++HRD+KS NILL       L DFG    + P  +   + +VGT 
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTP 180

Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            ++ PE         + D++S G++ +E++ G  P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 30/210 (14%)

Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRL---SGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
           IG G +G V+KA         A+KR+     D G      + E+  L   +HKN+V L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66

Query: 835 YCRHGNDRL-LIYSYMENGSLDYW--LHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
              H + +L L++ Y +     Y+   +  +D + V  +  +L       +GLA+ H   
Sbjct: 67  VL-HSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCH--- 116

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIPPE-- 945
             +++HRD+K  N+L+++  E  LADFGL+R     +R Y   V      TL Y PP+  
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVL 171

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
           +   L +T   D++S G +  EL    RP+
Sbjct: 172 FGAKLYSTSI-DMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 67/286 (23%), Positives = 113/286 (39%), Gaps = 47/286 (16%)

Query: 772  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----------GDCGQMEREFQAEVEA 820
            NF     IG G F  VY+AT L +G   A+K++            DC +       E++ 
Sbjct: 3    NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-------EIDL 55

Query: 821  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES------VDKDSVLKWDVRL 874
            L +  H N++         N+  ++    + G L   +         + + +V K+ V+L
Sbjct: 56   LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115

Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 934
                     L ++H      ++HRD+K +N+ +       L D GL R      T     
Sbjct: 116  ------CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHS 165

Query: 935  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
            LVGT  Y+ PE         + D++S G +L E+   + P    K             + 
Sbjct: 166  LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLY 214

Query: 995  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            S  +++E  D      D   +  E+ ++   CI+ DP +RP I  V
Sbjct: 215  SLCKKIEQCDYPPLPSDHYSE--ELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 61/228 (26%), Positives = 89/228 (39%), Gaps = 22/228 (9%)

Query: 754 QNSDCKDLTVSDLLKSTNNFNQANIIGC---GGFGLVYKATL---TNGTKAAVKRLSGDC 807
               C+  + SD         Q NI+     G  G V+  T        K  VK ++G  
Sbjct: 74  CQEPCETTSSSDPASVVRM--QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG- 130

Query: 808 GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV 867
               +    E++ L    H+ +++L    R  +    +   M     D  L   VD+   
Sbjct: 131 ----KTPGREIDILKTISHRAIINLIHAYRWKS---TVCMVMPKYKCD--LFTYVDRSGP 181

Query: 868 LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS-RLLRP 926
           L  +  + I +     LAYLH      I+HRDVK+ NI LDE   A L DFG + +L   
Sbjct: 182 LPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            DT       GTL    PE         + D++S G+VL E+      
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS---------VLKWDVRLKIAQGAAR 882
           L G    G   L++   M +G L  +L  S+  ++          L+    +++A   A 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQ--EMIQMAAEIAD 130

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           G+AYL+       VHRD+ + N ++   F   + DFG++R +   D +      G  G +
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLL 183

Query: 943 P-----PEYSQTLTATCRGDVYSFGVVLLELLT 970
           P     PE  +    T   D++SFGVVL E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 20/191 (10%)

Query: 796 TKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGS 853
              AVK L  D    +  +  +E+E +    +HKN+++L G C       ++  Y   G+
Sbjct: 45  VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104

Query: 854 L------------DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDV 900
           L            DY        +  L +   +  A   ARG+ YL  + C    +HRD+
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDL 160

Query: 901 KSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVY 959
            + N+L+ E     +ADFGL+R +   D +  TT+    + ++ PE       T + DV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220

Query: 960 SFGVVLLELLT 970
           SFGV+L E+ T
Sbjct: 221 SFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 62/214 (28%), Positives = 90/214 (42%), Gaps = 35/214 (16%)

Query: 778 IIGCGGFGLVYKATLTN--GTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
            IG G FG VY+    +    K   AVK          RE F  E   + +  H ++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 833 QGYCRHGNDRLLIYSYME---NGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAY 886
            G          ++  ME    G L  +L     S+D  S++ +  +L  A      LAY
Sbjct: 73  IGVITENP----VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA------LAY 122

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL--GYIPP 944
           L        VHRD+ + N+L+       L DFGLSR L   D        G L   ++ P
Sbjct: 123 LESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE--DESYYKASKGKLPIKWMAP 177

Query: 945 E---YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
           E   + +  +A+   DV+ FGV + E+L  G +P
Sbjct: 178 ESINFRRFTSAS---DVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 35/87 (40%), Positives = 50/87 (57%), Gaps = 3/87 (3%)

Query: 330 LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQV 389
           L L N  L G I  + S L  L +++L+ N   G +P SL     L++L L+ N  +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 390 PESFGKLTSLLFLSLSNNSFNHLSGTL 416
           PES G+LTSL  L+L+ NS   LSG +
Sbjct: 483 PESLGQLTSLRILNLNGNS---LSGRV 506

Length = 623

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 50/292 (17%)

Query: 773  FNQANIIGCGGFGLV----YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALS------ 822
            F    ++G GGFG V     +AT   G   A K+L     + +R  + + EA++      
Sbjct: 2    FRHYRVLGKGGFGEVCACQVRAT---GKMYACKKL-----EKKRIKKRKGEAMALNEKQI 53

Query: 823  --RAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE----SVDKDSVLKWDVRLK 875
              +   + +VSL  Y     D L L+ + M  G L + ++       D++  + +   + 
Sbjct: 54   LEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEIT 112

Query: 876  IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
                   GL  LH+     IV+RD+K  NILLD+     ++D GL+  +   +T      
Sbjct: 113  C------GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR 161

Query: 936  VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD----LVSWVF 991
            VGT+GY+ PE  +    T   D +  G ++ E++ G+ P    K K  R+     V    
Sbjct: 162  VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221

Query: 992  QMKSEK--REVEIIDASIWHKDREKQLLEMLEIACKCI-DQDPRRRPFIEEV 1040
            +  SEK       I   +  KD   +L       C+    ++ +  PF    
Sbjct: 222  EEYSEKFSEAARSICRQLLTKDPGFRL------GCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 19/191 (9%)

Query: 815 QAEVEALSRA-QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHES--VDKDSVLKW 870
           Q E     +A  H  LV L   C     RL  +  Y+  G L + +     + ++    +
Sbjct: 43  QTEKHVFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY 101

Query: 871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDT 929
              + +A      L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT
Sbjct: 102 SAEISLA------LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152

Query: 930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS- 988
             T+   GT  YI PE  +        D ++ GV++ E++ GR P ++    +  D  + 
Sbjct: 153 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 210

Query: 989 -WVFQMKSEKR 998
            ++FQ+  EK+
Sbjct: 211 DYLFQVILEKQ 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.5 bits (152), Expect = 4e-10
 Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 36/217 (16%)

Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
           +GCG  GLV+ A  ++   + AVK++   D   ++   + E++ + R  H N+V +    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEVL 71

Query: 837 RHGNDRL--LIYSYMENGSLDYWLHESVDKD--SVLKWD------VRLKIAQGAARGLAY 886
                 L   + S  E  S+ Y + E ++ D  +VL+         RL + Q   RGL Y
Sbjct: 72  GPSGSDLTEDVGSLTELNSV-YIVQEYMETDLANVLEQGPLSEEHARLFMYQ-LLRGLKY 129

Query: 887 LHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYI 942
           +H     +++HRD+K +N+ ++ E     + DFGL+R++ P+ +H   ++  LV T  Y 
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYR 185

Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            P        Y++ +      D+++ G +  E+LTG+
Sbjct: 186 SPRLLLSPNNYTKAI------DMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 16/210 (7%)

Query: 779 IGCGGFGLVYKA---TLTNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V K       +    AVK L  D     ++ E   E   + +  +  +V + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
           G C      +L+    E G L+ +L     K+  +      ++    + G+ YL    E 
Sbjct: 63  GICE-AESWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLE---ET 114

Query: 894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLT 951
           + VHRD+ + N+LL  +  A ++DFGLS+ L   + +      G   + +  PE      
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 952 ATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
            + + DV+SFGV++ E  + G++P +  KG
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 38/273 (13%)

Query: 773  FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD-CGQMEREFQA--EVEALSRAQHKN 828
            F Q  ++G GGFG V    +   G   A KRL      + + E  A  E + L +   + 
Sbjct: 2    FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 829  LVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE----SVDKDSVLKWDVRLKIAQGAARG 883
            +V+L  Y     D L L+ + M  G L + ++       +++  L +      A     G
Sbjct: 62   VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY------AAEILCG 114

Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
            L  LH+    + V+RD+K  NILLD+     ++D GL+  ++  +       VGT+GY+ 
Sbjct: 115  LEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMA 169

Query: 944  PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR--EVE 1001
            PE       T   D +  G ++ E++ G+ P    K K  R+ V        ++R  E E
Sbjct: 170  PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--------DRRVLETE 221

Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRR 1034
             + ++ + ++  K + +ML      + +DP++R
Sbjct: 222  EVYSAKFSEE-AKSICKML------LTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 44/241 (18%)

Query: 772 NFNQANIIGCGGFGLVYKATLTNG------------TKAAV--KRLSGDCGQMEREFQAE 817
           NF    ++G G +G V+     +G             KA +  K  + +  + ER+    
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 818 VEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           +      Q   LV+L  Y    + +L LI  Y+  G L   L     ++   + +V++  
Sbjct: 61  IR-----QSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYS 111

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            +     L +LHK+    I++RD+K  NILLD      L DFGLS+     +        
Sbjct: 112 GE-IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC 167

Query: 937 GTLGYIPPEYSQTLTATCRG---------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 987
           GT+ Y+ P+         RG         D +S GV++ ELLTG  P  V   KN +  +
Sbjct: 168 GTIEYMAPD-------IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI 220

Query: 988 S 988
           S
Sbjct: 221 S 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.1 bits (151), Expect = 5e-10
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 39/214 (18%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAEVEALSRAQHKNLVS--- 831
           IG G FG+V+  T   +G + A+K++     +    +R F+ E++ L   +H N++S   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66

Query: 832 -LQ----GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLA 885
            LQ               IY   E    D  LH+ +     L  D V++ + Q   RGL 
Sbjct: 67  ILQPPHIDPFEE------IYVVTELMQSD--LHKIIVSPQPLSSDHVKVFLYQ-ILRGLK 117

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           YLH      I+HRD+K  N+L++      + DFGL+R+  P ++   T  V T  Y  PE
Sbjct: 118 YLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174

Query: 946 -------YSQTLTATCRGDVYSFGVVLLELLTGR 972
                  Y+  +      D++S G +  ELL  R
Sbjct: 175 ILMGSRHYTSAV------DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.7 bits (147), Expect = 6e-10
 Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 31/206 (15%)

Query: 779 IGCGGFGLVYKATLTNGTKA-------AVKRLS-GDCGQMEREFQAEVEA--LSRAQHKN 828
           +G G FG VY   L    KA        +K +  G+    E   QA  EA  LS+  H  
Sbjct: 8   LGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNE-TVQANQEAQLLSKLDHPA 63

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE------SVDKDSVLKWDVRLKIAQGAAR 882
           +V         +   +I  Y E   LD  L E      ++ ++ V +W ++L +      
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           G+ Y+H   +  I+HRD+K+ NI L       + DFG+SRLL      + T   GT  Y+
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGTPYYM 172

Query: 943 PPEYSQTLTATCRGDVYSFGVVLLEL 968
            PE  +      + D++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.8 bits (147), Expect = 8e-10
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 21/224 (9%)

Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD-CGQMEREFQA--EVEALSRAQHKN 828
           F    ++G GGFG V    +   G   A K+L      + + E  A  E   L +   + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 829 LVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE----SVDKDSVLKWDVRLKIAQGAARG 883
           +VSL  Y     D L L+ + M  G L + ++       D+   + +   L        G
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL------CCG 114

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L  L +     IV+RD+K  NILLD++    ++D GL+  +   +T      VGT+GY+ 
Sbjct: 115 LEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMA 169

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 987
           PE       T   D +  G ++ E++ G+ P    K +  R+ V
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 41/124 (33%), Positives = 64/124 (51%), Gaps = 22/124 (17%)

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 942
           L +LH   E  I++RD+K  N+LLD +    L D+G+ +  +RP DT  T+   GT  YI
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYI 163

Query: 943 PPEYSQTLTATCRGDVYSF-------GVVLLELLTGRRPVEVCKGKNCRDLVS--WVFQM 993
            PE         RG+ Y F       GV++ E++ GR P ++    +  D  +  ++FQ+
Sbjct: 164 APE-------ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV 216

Query: 994 KSEK 997
             EK
Sbjct: 217 ILEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 10/197 (5%)

Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  A    +G + AVK +     Q       EV  +   QH+N+V +     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G +  ++  +++ G+L       +   + L  +    + +   + L YLH      ++H
Sbjct: 89  VGEELWVLMEFLQGGAL-----TDIVSQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140

Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+KS +ILL       L+DFG    +   D      LVGT  ++ PE           D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 958 VYSFGVVLLELLTGRRP 974
           ++S G++++E++ G  P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 65/206 (31%), Positives = 89/206 (43%), Gaps = 21/206 (10%)

Query: 778 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQ---AEVEALSRA-QHKNLVSL 832
           ++G G FG V+ A L       A+K L  D   M+ + +    E   LS A +H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 833 QGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA--RGLAYLH 888
             YC       L +   Y+  G L + +       S  K+D+       A    GL +LH
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQ------SCHKFDLPRATFYAAEIICGLQFLH 113

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
                 IV+RD+K  NILLD      +ADFG+ +     D   T    GT  YI PE   
Sbjct: 114 ---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILL 169

Query: 949 TLTATCRGDVYSFGVVLLELLTGRRP 974
                   D +SFGV+L E+L G+ P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 6/116 (5%)

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGY 941
            L +LH   E  I++RD+K  N+LLD      L D+G+ +  L P DT  T+   GT  Y
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162

Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 997
           I PE  +        D ++ GV++ E++ GR P ++       +   ++FQ+  EK
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 50/154 (32%), Positives = 69/154 (44%), Gaps = 25/154 (16%)

Query: 883  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
            GL +LH      I++RD+K  N++LD      +ADFG+ +     D   +T   GT  YI
Sbjct: 108  GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYI 163

Query: 943  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
             PE  Q L  T   D +SFGV+L E+L G+ P                F    E    E 
Sbjct: 164  APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----------------FHGDDEDELFES 207

Query: 1003 IDASIWHKDR--EKQLLEMLEIACKCIDQDPRRR 1034
            I     H  R   K+  ++LE   K  ++DP RR
Sbjct: 208  IRVDTPHYPRWITKESKDILE---KLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 41/224 (18%)

Query: 772 NFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGD---------CGQMEREFQAEVEA 820
           +FN   ++G G FG V  A    GT    A+K L  D         C  +E+     V A
Sbjct: 1   DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKR----VLA 55

Query: 821 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
           L       L  L   C    DRL  +  Y+  G L Y + + V K    K    +  A  
Sbjct: 56  LPGKPP-FLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQ-VGK---FKEPHAVFYAAE 109

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGT 938
            A GL +LH      I++RD+K  N++LD +    +ADFG+ +  +    T  T    GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGT 164

Query: 939 LGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             YI PE      Y +++      D ++FGV+L E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 33/214 (15%)

Query: 778 IIGCGGFGLVYKATLTNGTKA--AVKRLSGD---------CGQMEREFQAEVEALSRAQH 826
           ++G G FG V  A L  GT    A+K L  D         C   E+     + AL+ A+H
Sbjct: 2   VLGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKR----ILALA-AKH 55

Query: 827 KNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI-AQGAARGL 884
             L +L   C    DRL  +  Y+  G L + +  S   D     + R +  A      L
Sbjct: 56  PFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLAL 109

Query: 885 AYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 942
            +LH+    H +++RD+K  NILLD +    LADFG+ +  +    T  TT   GT  YI
Sbjct: 110 MFLHR----HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163

Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
            PE  Q L      D ++ GV++ E++ G+ P E
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 28/68 (41%), Positives = 46/68 (67%)

Query: 231 LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFS 290
           L+ +++  N + G++P SL S++SL+ + LS N+F+G + E +  LTSLR L + GN  S
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503

Query: 291 GKLPNVLG 298
           G++P  LG
Sbjct: 504 GRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 31/88 (35%), Positives = 49/88 (55%)

Query: 234 LHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKL 293
           L +DN  L G +P+ +  +  LQ ++LS N+  G +   + ++TSL  L +  N F+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 294 PNVLGNLTQLEFFVAHSNSFSGPLPLSL 321
           P  LG LT L     + NS SG +P +L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 4e-09
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 53/219 (24%)

Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T    K AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLS-------RPFQSLIHARRTYRELRLLKHMKHEN 75

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWD------VRLKIAQGA 880
           ++ L        D     + +EN +  Y +      D ++++K        V+  I Q  
Sbjct: 76  VIGLL-------DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ-L 127

Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
            RGL Y+H      I+HRD+K SN+ ++E  E  + DFGL+   R  D  + T  V T  
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEM-TGYVATRW 180

Query: 941 YIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           Y  PE       Y+QT+      D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.9 bits (142), Expect = 5e-09
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 21/216 (9%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQH 826
           ++F    +IG G FG V    + +  +    ++      ++R     F+ E   L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLA 885
           + + +L    +  N   L+  Y   G L   L +  D+   L  D+ R  IA+     LA
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYIAEMV---LA 114

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
            +H + + H VHRD+K  N+LLD      LADFG    +    T  ++  VGT  YI PE
Sbjct: 115 -IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 946 YSQTLT-------ATCRGDVYSFGVVLLELLTGRRP 974
             Q +          C  D +S GV + E+L G  P
Sbjct: 174 ILQAMEDGMGKYGPEC--DWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.9 bits (143), Expect = 5e-09
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 39/216 (18%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSG------DCGQMEREFQAEVEALSRAQHKNLVS 831
           IG G +G+V  A       K A+K+++       D  +  RE    ++ L    H+N+++
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE----IKLLRHLDHENVIA 68

Query: 832 LQGYC-----RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLA 885
           ++           ND  ++Y  M     D  LH+ +     L  D  +  + Q   RGL 
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQ-LLRGLK 122

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPP 944
           Y+H     +++HRD+K SN+LL+   +  + DFGL+R     +     T+ V T  Y  P
Sbjct: 123 YIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWYRAP 177

Query: 945 EYSQTLTATCRG-----DVYSFGVVLLELLTGRRPV 975
           E    L   C       DV+S G +  ELL GR+P+
Sbjct: 178 E----LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 5e-09
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 19/209 (9%)

Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMERE--FQAEVEALSRAQHK 827
           +  +   +G G FG V+      +    A+K ++  +  ++++E     E   L    H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 828 NLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            ++ L  +    + R L  +  Y+  G L  +L  S    +       L  A      L 
Sbjct: 62  FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG----LFYASEIVCALE 115

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           YLH      IV+RD+K  NILLD++    L DFG ++ LR      T  L GT  Y+ PE
Sbjct: 116 YLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPE 168

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             Q+       D ++ G+++ E+L G  P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 5e-09
 Identities = 63/230 (27%), Positives = 94/230 (40%), Gaps = 36/230 (15%)

Query: 763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMERE----FQAE 817
           ++ L     +F+   +IG G FG V      +  +  A+K LS     ++R     F  E
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF-EMIKRSDSAFFWEE 93

Query: 818 VEALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSL-----DYWLHESVDKDSVLKW 870
            + ++ A  + +V L       +D+ L  +  YM  G L     +Y + E        KW
Sbjct: 94  RDIMAHANSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--------KW 143

Query: 871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 930
             R   A+     L  +H +     +HRDVK  N+LLD+     LADFG    +      
Sbjct: 144 -ARFYTAE-VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198

Query: 931 VTTDLVGTLGYIPPEYSQTLTAT------CRGDVYSFGVVLLELLTGRRP 974
                VGT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 20/212 (9%)

Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           +F     IG G +G VYKA  +  G  AA+K +  + G+     Q E+  +   +H N+V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 831 SLQG-YCRHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +  G Y R   D+L I   +   GSL    H +      L       +++   +GL YLH
Sbjct: 70  AYFGSYLRR--DKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLH 123

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
              +   +HRD+K +NILL +     LADFG+S  +        +  +GT  ++ PE + 
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAA 179

Query: 949 T-----LTATCRGDVYSFGVVLLELLTGRRPV 975
                     C  D+++ G+  +EL   + P+
Sbjct: 180 VERKGGYNQLC--DIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.5 bits (141), Expect = 7e-09
 Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 27/217 (12%)

Query: 772 NFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGD---------CGQMEREFQAEVEA 820
           +FN   ++G G FG V  A    GT    A+K L  D         C  +E+     V A
Sbjct: 1   DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKR----VLA 55

Query: 821 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
           LS  +   L  L   C    DRL  +  Y+  G L Y + + V +    K    +  A  
Sbjct: 56  LS-GKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYQIQQ-VGR---FKEPHAVFYAAE 109

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
            A GL +LH      I++RD+K  N++LD +    +ADFG+ +    +D   T    GT 
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTP 165

Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
            YI PE           D ++FGV+L E+L G+ P E
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.1 bits (140), Expect = 7e-09
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 29/213 (13%)

Query: 779 IGCGGFGLVYKA-TLTNGTK-AAVKRLSGDCGQMEREFQ--------AEVEALSRAQHKN 828
           IG G +G V+KA  L NG +  A+KR+     Q   E          A +  L   +H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 829 LVSLQGYCR-HGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
           +V L   C     DR     L++ +++     Y   + V +  V    ++  + Q   RG
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQ-LLRG 122

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYI 942
           L +LH      +VHRD+K  NIL+    +  LADFGL+R+   Y      T +V TL Y 
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYR 176

Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
            PE     +     D++S G +  E+   R+P+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.1 bits (140), Expect = 8e-09
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 26/164 (15%)

Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDV 872
           +HKN+++L G C       +I  Y   G+L            DY    +   +  L +  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 873 RLKIAQGAARGLAYLH-KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 931
            +  A   ARG+ YL  + C    +HRD+ + N+L+ E     +ADFGL+R +   D + 
Sbjct: 136 LVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 932 TTDLVGTLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT 970
            T    + G +P     PE       T + DV+SFG+++ E+ T
Sbjct: 192 KT----SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.1 bits (140), Expect = 9e-09
 Identities = 66/206 (32%), Positives = 91/206 (44%), Gaps = 21/206 (10%)

Query: 778 IIGCGGFGLVYKATLTNGTK-AAVKRLSGDC---GQMEREFQAEVEALSR-AQHKNLVSL 832
           +IG G FG V  A      K  AVK L        + E+   +E   L +  +H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 833 QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
             +     D+L  +  Y+  G L Y L     +   L+   R   A+  A  L YLH + 
Sbjct: 62  H-FSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAE-IASALGYLHSL- 115

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPPE--YSQ 948
             +IV+RD+K  NILLD +    L DFGL +  +    T  T+   GT  Y+ PE  + Q
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171

Query: 949 TLTATCRGDVYSFGVVLLELLTGRRP 974
               T   D +  G VL E+L G  P
Sbjct: 172 PYDRTV--DWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.8 bits (140), Expect = 9e-09
 Identities = 65/219 (29%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 773 FNQANIIGCGGFGLVYKATLTNGTKA-AVKRLS-GDCGQMEREFQAEVEAL--------- 821
           F    ++G G FG V  A      +  A+K L  GD   + R+   EVE+L         
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARD---EVESLMCEKRIFET 55

Query: 822 -SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
            +  +H  LV+L   C    D +  +  Y   G L   +H  V  +    +      A  
Sbjct: 56  ANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-----YAAC 109

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGT 938
              GL YLH   E  IV+RD+K  N+LLD +    +ADFGL +  +   D   T+   GT
Sbjct: 110 VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGT 164

Query: 939 LGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRP 974
             ++ PE    LT T      D +  GV++ E+L G  P
Sbjct: 165 PEFLAPE---VLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 1e-08
 Identities = 28/77 (36%), Positives = 47/77 (61%)

Query: 439 IPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLF 498
           IP ++     L  + L    ++G+IP  L     L+VLDLS+N F+G+IP  +GQ+ +L 
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 499 YLDFSNNTLTGEIPKSL 515
            L+ + N+L+G +P +L
Sbjct: 494 ILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.1 bits (140), Expect = 1e-08
 Identities = 75/252 (29%), Positives = 112/252 (44%), Gaps = 12/252 (4%)

Query: 109 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 168
           L  L  LDL  N++  + P+       L+ LDLS N +   +   L  L  +++L++S N
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173

Query: 169 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 228
             +     L   SNL   ++S N  +  L   I   S  ++ LDLS N  +  L  L + 
Sbjct: 174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA-LEELDLSNNSIIELLSSLSNL 231

Query: 229 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 288
            +L  L + NN L  DLP+S+ ++S+L+ + LS NN    +S  + +LT+LR L + GN 
Sbjct: 232 KNLSGLELSNNKL-EDLPESIGNLSNLETLDLS-NNQISSIS-SLGSLTNLRELDLSGNS 288

Query: 289 FSGKLP-NVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG 347
            S  LP   L  L                  L L L S L   ++ +N  T       S 
Sbjct: 289 LSNALPLIALLLLLLELLLNLLLTL----KALELKLNSILLNNNILSNGETS-SPEALSI 343

Query: 348 LSSLCTLDLATN 359
           L SL  L    N
Sbjct: 344 LESLNNLWTLDN 355

Length = 394

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.4 bits (144), Expect = 1e-08
 Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 33/233 (14%)

Query: 778 IIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMER---EFQAEVEALSRAQHKNLVSLQ 833
           +IG GG G VY A       + A+K++  D  +       F  E +  +   H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
             C  G+       Y+E  +L   L     K+S+ K    L         L+  HK+C  
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK---ELAEKTSVGAFLSIFHKICAT 125

Query: 894 ----H---IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL----------- 935
               H   ++HRD+K  NILL    E  + D+G + + +  +     D+           
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNICYSS 184

Query: 936 -------VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGK 981
                  VGT  Y+ PE    + A+   D+Y+ GV+L ++LT   P    KG+
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Length = 932

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 1e-08
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 30/212 (14%)

Query: 778 IIGCGGFGLVYKATLTNGT------------KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
           ++G GG+G V++     G             KA + R   D        +AE   L   +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT----KAERNILEAVK 58

Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H  +V L    + G    LI  Y+  G L  ++H  ++++ +   D         +  L 
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMH--LEREGIFMEDTACFYLSEISLALE 114

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           +LH+     I++RD+K  NILLD +    L DFGL +    ++  VT    GT+ Y+ PE
Sbjct: 115 HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPE 170

Query: 946 YSQTLTATCRG---DVYSFGVVLLELLTGRRP 974
               L  +  G   D +S G ++ ++LTG  P
Sbjct: 171 ---ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 65/205 (31%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 778 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA-----LSRAQHKNLVS 831
           +IG G FG V  A    +G   AVK L      + R+ Q  + A     L   +H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI-VLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 832 LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           L  Y     ++L  +  ++  G L + L     + S  +   R   A+  A  L YLH +
Sbjct: 61  LH-YSFQTTEKLYFVLDFVNGGELFFHLQR---ERSFPEPRARFYAAE-IASALGYLHSI 115

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPPEYSQT 949
              +IV+RD+K  NILLD +    L DFGL +  +   DT  TT   GT  Y+ PE  + 
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRK 170

Query: 950 LTATCRGDVYSFGVVLLELLTGRRP 974
                  D +  G VL E+L G  P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 40/276 (14%)

Query: 779  IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG--Y 835
            +G G +G VYKA  L  G  AAVK +  + G      Q E+  +   +H N+V+  G   
Sbjct: 17   VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 836  CRHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIA---QGAARGLAYLHKVC 891
             R   ++L I   Y   GSL    H       V      L+IA   +   +GLAYLH   
Sbjct: 77   SR---EKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 892  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-- 949
            +   +HRD+K +NILL +  +  LADFG++  +        +  +GT  ++ PE +    
Sbjct: 127  K---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEVAAVEK 182

Query: 950  ---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006
                   C  D+++ G+  +EL   + P+      +   + +     KS  +  ++ D +
Sbjct: 183  NGGYNQLC--DIWAVGITAIELAELQPPM-----FDLHPMRALFLMSKSNFQPPKLKDKT 235

Query: 1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042
             W           ++I+   + ++P++RP  E ++T
Sbjct: 236  KW----SSTFHNFVKIS---LTKNPKKRPTAERLLT 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 61/253 (24%), Positives = 106/253 (41%), Gaps = 37/253 (14%)

Query: 801  KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE 860
            K+       +    + E++ L R    N++ + G+     D L   S +       +L E
Sbjct: 52   KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111

Query: 861  SVDKDSVLKWDVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILLDEKFEAHLADFG 919
             +DK+  L +  +L +A    +GL  L+K   +P   ++++ S + L+ E ++  +   G
Sbjct: 112  VLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHG 168

Query: 920  LSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTA--TCRGDVYSFGVVLLELLTGRRPV 975
            L ++L   P+        V  + Y   +    + +  T + D+YS GVVL E+ TG+ P 
Sbjct: 169  LEKILSSPPFKN------VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222

Query: 976  EVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEM-LEIAC---KCIDQDP 1031
            E    K                   EI D  I   +  K  L+  LEI C    C   D 
Sbjct: 223  ENLTTK-------------------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDS 263

Query: 1032 RRRPFIEEVVTWL 1044
             +RP I+E++  L
Sbjct: 264  IKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 66/211 (31%), Positives = 93/211 (44%), Gaps = 31/211 (14%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA-----LSRAQHKNLVS 831
           +IG G FG V  A    +G   AVK L       ++E Q  + A     L   +H  LV 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVG 60

Query: 832 LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           L  Y     D+L  +  Y+  G L + L     + S  +   R   A+  A  L YLH +
Sbjct: 61  LH-YSFQTADKLYFVLDYVNGGELFFHLQR---ERSFPEPRARFYAAE-IASALGYLHSL 115

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPPE---- 945
              +I++RD+K  NILLD +    L DFGL +  +    T  T+   GT  Y+ PE    
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRK 170

Query: 946 --YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             Y +T+      D +  G VL E+L G  P
Sbjct: 171 QPYDRTV------DWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 3e-08
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 31/211 (14%)

Query: 778 IIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEA-----LSRAQHKNLVS 831
           +IG G FG V  A   ++G+  AVK L       ++E Q  + A     L   +H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60

Query: 832 LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           L  Y     ++L  +  Y+  G L + L     +   L+   R   A+  A  + YLH +
Sbjct: 61  LH-YSFQTAEKLYFVLDYVNGGELFFHLQR---ERCFLEPRARFYAAE-VASAIGYLHSL 115

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYIPPE---- 945
              +I++RD+K  NILLD +    L DFGL +  + P +T  T+   GT  Y+ PE    
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRK 170

Query: 946 --YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             Y +T+      D +  G VL E+L G  P
Sbjct: 171 EPYDRTV------DWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 3e-08
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 15/182 (8%)

Query: 815 QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVR 873
           ++E+  L+   H  +V      +  +  LLI  Y   G L+  + + + +    + ++V 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 874 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
           L   Q     L  +H      ++HRD+KS+NI L       L DFG S+    Y   V+ 
Sbjct: 173 LLFYQ-IVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSL 225

Query: 934 DL----VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           D+     GT  Y+ PE  +    + + D++S GV+L ELLT  RP    KG + R+++  
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQ 282

Query: 990 VF 991
           V 
Sbjct: 283 VL 284

Length = 478

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 13/210 (6%)

Query: 772 NFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHK 827
           +FN   ++G G FG V  A         A+K L  D    + + +    E   L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 828 NLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
             ++    C    DRL  +  Y+  G L Y + + V K    K    +  A   + GL +
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGK---FKEPQAVFYAAEISVGLFF 116

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
           LH+     I++RD+K  N++LD +    +ADFG+ +     D   T    GT  YI PE 
Sbjct: 117 LHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEI 172

Query: 947 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
                     D +++GV+L E+L G+ P +
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 66/279 (23%), Positives = 107/279 (38%), Gaps = 52/279 (18%)

Query: 779  IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQME---------REFQAEVEALSRAQHKN 828
            +G G F  +YK  L        V         ++           F      +S+  HK+
Sbjct: 3    LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 829  LVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSV-LKWDVRLKIAQGAARGLAY 886
            LV L G C R  N  +++  Y++ G LD +LH    K++V L W  +L +A+  A  L Y
Sbjct: 63   LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHRE--KNNVSLHW--KLDVAKQLASALHY 116

Query: 887  LHKVCEPHIVHRDVKSSNILL--DEKFE-----AHLADFGLSRLLRPYDTHVTTDLVGTL 939
            L    +  +VH +V   NIL+      E       L+D G+   +   +     + V  +
Sbjct: 117  LE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-----ERVERI 168

Query: 940  GYIPPEYSQTLTATCR--GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 997
             +I PE  +   A+     D +SFG  LLE+           G+    L +     K   
Sbjct: 169  PWIAPECIRNGQASLTIAADKWSFGTTLLEIC--------SNGE--EPLSTLSSSEKERF 218

Query: 998  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1036
             +    D          +L  ++    +C   DP +RP 
Sbjct: 219  YQ----DQHRLPMPDCAELANLIN---QCWTYDPTKRPS 250

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 44/233 (18%)

Query: 779 IGCGGFGLVYKATLTNGTKA---AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG- 834
           +G G +G VYKA   +G      A+K++ G    M      E+  L   +H N++SLQ  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66

Query: 835 YCRHGNDRL-LIYSYMENGSLDYW----LHESVDKDSVLKWDVRLKIAQGAARGLAY--- 886
           +  H + ++ L++ Y E+   D W     H +   +        +++ +G  + L Y   
Sbjct: 67  FLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKK-----PVQLPRGMVKSLLYQIL 118

Query: 887 --LHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLSRLLR-PYDTHVTTD-LVGT 938
             +H +    ++HRD+K +NIL+     E+    +AD G +RL   P       D +V T
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR 984
             Y  PE       Y++ +      D+++ G +  ELLT   P+  C+ ++ +
Sbjct: 179 FWYRAPELLLGARHYTKAI------DIWAIGCIFAELLTS-EPIFHCRQEDIK 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.1 bits (135), Expect = 5e-08
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 20/211 (9%)

Query: 429 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 488
           +   +     +P ++    SL +L+             LL    L  LDL+ N    NI 
Sbjct: 52  LNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRLRSNIS 110

Query: 489 PWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTN 548
             + ++ NL  LD  NN +T +IP  +  LKS +                L +  N+  +
Sbjct: 111 E-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKE--------------LDLSDNKIES 154

Query: 549 GLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLE 608
                +      ++ LS N ++  +P  +  L +L+ LDLS N I+  +P  I  +  LE
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212

Query: 609 VLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 639
            LDLS+N +   +  S   L  LS   ++NN
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242

Length = 394

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 5e-08
 Identities = 34/95 (35%), Positives = 44/95 (46%), Gaps = 9/95 (9%)

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
           +  V +   VHRD+K  N+LLD+     LADFG    L    T  +   VGT  YI PE 
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174

Query: 947 SQTLT-------ATCRGDVYSFGVVLLELLTGRRP 974
            Q +          C  D +S GV + E+L G  P
Sbjct: 175 LQAMEDGKGRYGPEC--DWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 44/171 (25%), Positives = 85/171 (49%), Gaps = 21/171 (12%)

Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK 869
            E  F+A    +S+  HK+LV   G C  G++ +++  Y++ GSLD +L ++ +  ++  
Sbjct: 43  SESFFEA-ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS- 100

Query: 870 WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--------LADFGLS 921
           W  +L++A+  A  L +L    +  + H +V + N+LL  + +          L+D G+S
Sbjct: 101 W--KLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Query: 922 RLLRPYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTG 971
             + P +      L+  + ++PPE        +   D +SFG  L E+ +G
Sbjct: 156 ITVLPKEI-----LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 49.9 bits (120), Expect = 6e-08
 Identities = 23/60 (38%), Positives = 28/60 (46%)

Query: 87  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 146
            +  L L    L  I   +   L  LK+LDLS N+L  + P   S L  L  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.6 bits (134), Expect = 6e-08
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 38/216 (17%)

Query: 778 IIGCGGFGLVYKA--TLTNGTKAAVKRLS------GDCGQMEREFQAEVEALSRAQHKNL 829
           +IG G +G+V  A  T T G K A+K+++       D  ++ RE    ++ L   +H ++
Sbjct: 7   VIGKGSYGVVCSAIDTHT-GEKVAIKKINDVFEHVSDATRILRE----IKLLRLLRHPDI 61

Query: 830 VSLQGYC-----RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           V ++        R   D  +++  ME+      LH+ +  +  L  +          R L
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT---TDLVGTLGY 941
            Y+H     ++ HRD+K  NIL +   +  + DFGL+R+    DT      TD V T  Y
Sbjct: 117 KYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF-NDTPTAIFWTDYVATRWY 172

Query: 942 IPPE-----YSQTLTATCRGDVYSFGVVLLELLTGR 972
             PE     +S+   A    D++S G +  E+LTG+
Sbjct: 173 RAPELCGSFFSKYTPAI---DIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 26/171 (15%)

Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV-LKWDVRLKIAQG 879
           +S+  H +L  + G C  G++ +++  ++E+G LD  L +  +K  V + W  ++ +AQ 
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAW--KITVAQQ 125

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT------T 933
            A  L+YL    + ++VH +V + NILL       LA+ G S  ++  D  V+       
Sbjct: 126 LASALSYLE---DKNLVHGNVCAKNILLARL---GLAE-GTSPFIKLSDPGVSFTALSRE 178

Query: 934 DLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLEL-------LTGRRPVE 976
           + V  + +I PE      + +   D +SFG  LLE+       L  R P E
Sbjct: 179 ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 65/286 (22%), Positives = 110/286 (38%), Gaps = 47/286 (16%)

Query: 772  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----------GDCGQMEREFQAEVEA 820
            NF     IG G F  VY+AT L +    A+K++            DC +       E++ 
Sbjct: 3    NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-------EIDL 55

Query: 821  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWL------HESVDKDSVLKWDVRL 874
            L +  H N++         N+  ++    + G L   +         + + +V K+ V+L
Sbjct: 56   LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 934
                     + ++H      ++HRD+K +N+ +       L D GL R      T     
Sbjct: 116  ------CSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHS 165

Query: 935  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
            LVGT  Y+ PE         + D++S G +L E+   + P    K             + 
Sbjct: 166  LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLF 214

Query: 995  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            S  +++E  D      +   + L   E+   CI  DP +RP I  V
Sbjct: 215  SLCQKIEQCDYPPLPTEHYSEKLR--ELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.9 bits (134), Expect = 9e-08
 Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 31/185 (16%)

Query: 794 NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI-------- 845
            G++AA+        Q+E E    + AL R  H+N++ ++   R   +  +I        
Sbjct: 202 AGSRAAI--------QLENE----ILALGRLNHENILKIEEILRSEANTYMITQKYDFDL 249

Query: 846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNI 905
           YS+M + + D+       KD  L    R  I +     + Y+H   +  ++HRD+K  NI
Sbjct: 250 YSFMYDEAFDW-------KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENI 298

Query: 906 LLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVL 965
            L+   +  L DFG +              VGT+    PE           D++S G++L
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358

Query: 966 LELLT 970
           L++L+
Sbjct: 359 LDMLS 363

Length = 501

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.4 bits (133), Expect = 1e-07
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 22/220 (10%)

Query: 764 SDLLKSTN-NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEAL 821
           +D+ +S N ++   NIIG G FG+VY+A  +    K A+K++  D     RE       +
Sbjct: 58  NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IM 113

Query: 822 SRAQHKNLVSLQGY----CRHGNDRLL----IYSYMENGSLDYWLHESVDKDSVLKWDVR 873
               H N++ L+ Y    C   N++ +    +  ++      Y  H + +  ++  + V+
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK 173

Query: 874 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVT 932
           L   Q   R LAY+H      I HRD+K  N+L+D       L DFG ++ L      V+
Sbjct: 174 LYSYQ-LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229

Query: 933 TDLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTG 971
              + +  Y  PE     T  T   D++S G ++ E++ G
Sbjct: 230 --YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 45/206 (21%), Positives = 76/206 (36%), Gaps = 22/206 (10%)

Query: 782 GGFGLVYKATLTNGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNLVSLQGYCRHG 839
                + K      T  AVK+++ D    E     Q E+    + QH N++         
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 840 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRD 899
           ++  ++   M  GS +  L ++   + + +  +   I +     L Y+H       +HR 
Sbjct: 72  SELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAF-ILKDVLNALDYIHSK---GFIHRS 126

Query: 900 VKSSNILLDEKFEAHLADFGLSRLLRPYDTH---------VTTDLVGTLGYIPPE-YSQT 949
           VK+S+ILL    +  L+     R       H              V  L ++ PE   Q 
Sbjct: 127 VKASHILLSGDGKVVLSGL---RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183

Query: 950 LTA-TCRGDVYSFGVVLLELLTGRRP 974
           L     + D+YS G+   EL  G  P
Sbjct: 184 LQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)

Query: 772 NFNQANIIGCGGFGLVYKATLTNGT--KAAVKRLSG----DCGQMEREFQAEVEALSRAQ 825
           +FN    +G G FG V  AT  N      A+KR          Q++  F +E + L+   
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYIN 89

Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H   V+L G  +  +   L+  ++  G    +L     ++     DV    A        
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFE 145

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           YL  +   +IV+RD+K  N+LLD+     + DFG ++++   DT   T L GT  YI PE
Sbjct: 146 YLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPE 198

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
               +      D ++ G+ + E+L G  P
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 74/271 (27%), Positives = 117/271 (43%), Gaps = 25/271 (9%)

Query: 396 LTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF-ESLMVLAL 454
           L +LL L   + + N L   +S L +  NLT+L L  N +  +IP  +G    +L  L L
Sbjct: 89  LLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNI-TDIPPLIGLLKSNLKELDL 147

Query: 455 GNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKS 514
            +  ++  +P  L     L+ LDLS+N    ++P  +  + NL  LD S N ++ ++P  
Sbjct: 148 SDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPE 204

Query: 515 LTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIP 574
             EL S +     S+N      +   + + ++ +GL             LSNN++     
Sbjct: 205 -IELLSALEELDLSNNSIIE--LLSSLSNLKNLSGLE------------LSNNKLEDLPE 249

Query: 575 PEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKF 634
             IG L +L  LDLS N I+    SS+  + NL  LDLS N L  ++P     L  L   
Sbjct: 250 S-IGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALP--LIALLLLLLE 304

Query: 635 SVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 665
            + N  L              N++   N   
Sbjct: 305 LLLNLLLTLKALELKLNSILLNNNILSNGET 335

Length = 394

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 35/91 (38%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L  LHK    ++++RD+K  NILLD +    L DFGL + L   D   T    GT  Y+ 
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLA 161

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           PE       T   D ++ GV+L E+LTG  P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 5/88 (5%)

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            GL YLH      I+HRDVK+ NI +++  +  + D G ++   P        L GT+  
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVET 222

Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELL 969
             PE         + D++S G+VL E+L
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 17/204 (8%)

Query: 779 IGCGGFGLVYKATL---TNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 834
           IG G FG V  + +   T   +  VK L  +    E+ EF  + +     QH N++   G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
            C      LL++ Y E G L  +L +        +  +  ++A   A G+ ++HK    +
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPE-----YS 947
            +H D+   N  L       + D+G+    R  + ++ T+      L ++ PE     + 
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178

Query: 948 QTLTA--TCRGDVYSFGVVLLELL 969
             +TA  T   +V++ GV L EL 
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 3e-07
 Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 61/236 (25%)

Query: 779 IGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQMEREFQAEVEALSRA----------- 824
           +G G +G+V  A           A+K+++         F  ++ A  RA           
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKIT-------NVFSKKILA-KRALRELKLLRHFR 59

Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDVRLKIAQGAA- 881
            HKN+  L        D  +++    N    Y   E ++ D   +++    L  A   + 
Sbjct: 60  GHKNITCLY-------DMDIVFPGNFNEL--YLYEELMEADLHQIIRSGQPLTDAHFQSF 110

Query: 882 -----RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT---T 933
                 GL Y+H     +++HRD+K  N+L++   E  + DFGL+R             T
Sbjct: 111 IYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 934 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
           + V T  Y  PE       Y++ +      DV+S G +L ELL GR+P  V KGK+
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAI------DVWSVGCILAELL-GRKP--VFKGKD 214

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 44/233 (18%)

Query: 779 IGCGGFGLVYKATLTNGT---KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           +G G +G VYKA   +G    + A+K++ G    M      E+  L   +H N+++LQ  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66

Query: 836 CRHGNDR--LLIYSYMENGSLDYW----LHESVDKDSVLKWDVRLKIAQGAARGLAY--- 886
               +DR   L++ Y E+   D W     H +   +        +++ +   + L Y   
Sbjct: 67  FLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKK-----PMQLPRSMVKSLLYQIL 118

Query: 887 --LHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLSRLLR-PYDTHVTTD-LVGT 938
             +H +    ++HRD+K +NIL+     E+    +AD G +RL   P       D +V T
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR 984
             Y  PE       Y++ +      D+++ G +  ELLT   P+  C+ ++ +
Sbjct: 179 FWYRAPELLLGARHYTKAI------DIWAIGCIFAELLTS-EPIFHCRQEDIK 224

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 30/211 (14%)

Query: 779 IGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQ---AEVEALSRAQHKN---LVS 831
           IG G FG VY+    +  +  A+K LS      ++E      E   L R        +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLAYLHKV 890
           L+   +  +D  L+  YM  G L +W    + K+     D  +  IA+     L +LHK 
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGEL-FW---HLQKEGRFSEDRAKFYIAE-LVLALEHLHKY 115

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE----- 945
               IV+RD+K  NILLD      L DFGLS+     D   T    GT  Y+ PE     
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 946 --YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             Y++ +      D +S GV++ E+  G  P
Sbjct: 172 KGYTKHV------DFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 10/205 (4%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTK-AAVKRLSGDCGQMEREFQA--EVEALSRAQHK 827
           N F    ++G G +G+V K       +  A+K+        E +     E++ L   + +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           N+V L+   R      L++ Y+E   L+  L E    + V    VR  I Q   + + + 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLEL-LEEM--PNGVPPEKVRSYIYQ-LIKAIHWC 116

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
           HK     IVHRD+K  N+L+       L DFG +R L        T+ V T  Y  PE  
Sbjct: 117 HK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 948 QTLTATCRGDVYSFGVVLLELLTGR 972
                    D++S G +L EL  G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 4e-07
 Identities = 73/271 (26%), Positives = 107/271 (39%), Gaps = 73/271 (26%)

Query: 771 NNFNQANIIGCGGFG---LVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEA----LSR 823
           ++F    +IG G FG   LV K     G   A+K+L      +E+E  A V A    L+ 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKD--TGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAE 57

Query: 824 AQHKNLVSLQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           A +  +V L  Y    ++    LI  Y+  G +   L   + KD+  + + R  IA+   
Sbjct: 58  ADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAE-TI 111

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD------- 934
             +  +HK+     +HRD+K  N+LLD K    L+DFGL   L+   +H T         
Sbjct: 112 LAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTEFYRILSHA 166

Query: 935 --------------------------------LVGTLGYIPPE-YSQT-LTATCRGDVYS 960
                                            VGT  YI PE + QT     C  D +S
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC--DWWS 224

Query: 961 FGVVLLELLTG------RRPVEVC-KGKNCR 984
            GV++ E+L G        P E   K  N +
Sbjct: 225 LGVIMYEMLVGYPPFCSDNPQETYRKIINWK 255

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 44/233 (18%)

Query: 821  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
            + +  HK++V L G C    + +++  ++E G LD ++H    K  VL    + K+A+  
Sbjct: 58   MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQL 114

Query: 881  ARGLAYLHKVCEPHIVHRDVKSSNILL-DEKFEAHLADF-GLSRLLRPYDTHVTTDLVGT 938
            A  L+YL    +  +VH +V + NILL  E  +     F  LS    P       + V  
Sbjct: 115  ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER 171

Query: 939  LGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 997
            + +I PE    +   +   D +SFG  L E+              C +            
Sbjct: 172  IPWIAPECVEDSKNLSIAADKWSFGTTLWEI--------------CYN------------ 205

Query: 998  REVEIIDASIWHKDR--EKQLL-------EMLEIACKCIDQDPRRRPFIEEVV 1041
             E+ + D ++  K+R  E Q +       E+ ++   C++ DP +RPF   ++
Sbjct: 206  GEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 19/205 (9%)

Query: 778 IIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHKNLV 830
           ++G G FG V     KAT   G   A+K L  +    + E      E   L  ++H  L 
Sbjct: 2   LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 831 SLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           +L+ Y    +DRL  +  Y   G L + L     ++ V   D            L YLH 
Sbjct: 59  ALK-YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHS 113

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
             E ++V+RD+K  N++LD+     + DFGL +     D        GT  Y+ PE  + 
Sbjct: 114 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLED 170

Query: 950 LTATCRGDVYSFGVVLLELLTGRRP 974
                  D +  GVV+ E++ GR P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.2 bits (126), Expect = 4e-07
 Identities = 50/163 (30%), Positives = 70/163 (42%), Gaps = 35/163 (21%)

Query: 826 HKNLVSLQGYCRHG-NDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARG 883
           + N + L  Y        +LI  Y+++G L D    E   K S  +  V+  I Q     
Sbjct: 68  NPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAE--VKKIIRQ-LVEA 121

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDLV--GTLG 940
           L  LHK    +I+H D+K  N+L D  K   +L D+GL +        + T     GTL 
Sbjct: 122 LNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLD 171

Query: 941 YIPPEYSQTLTATCRGDVY--SF-----GVVLLELLTGRRPVE 976
           Y  PE         +G  Y  SF     GV+  ELLTG+ P +
Sbjct: 172 YFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.8 bits (126), Expect = 5e-07
 Identities = 46/159 (28%), Positives = 66/159 (41%), Gaps = 10/159 (6%)

Query: 817 EVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
           E   L   +H  L SL+ Y     DRL  +  Y+  G L + L     ++ V   D    
Sbjct: 45  ESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRF 99

Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
                   L YLH      IV+RD+K  N++LD+     + DFGL +     D       
Sbjct: 100 YGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTF 155

Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            GT  Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.1 bits (125), Expect = 7e-07
 Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 24/166 (14%)

Query: 817 EVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRL 874
           E   L   +H  L +L+ Y    +DRL  +  Y   G L  + H S  ++ V   D  R 
Sbjct: 45  ESRVLQNTRHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLS--RERVFSEDRARF 99

Query: 875 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 934
             A+     L YLH  C+  +V+RD+K  N++LD+     + DFGL +        + T 
Sbjct: 100 YGAE-IVSALGYLHS-CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 154

Query: 935 LVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             GT  Y+ PE      Y + +      D +  GVV+ E++ GR P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 63/241 (26%), Positives = 101/241 (41%), Gaps = 63/241 (26%)

Query: 771 NNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDC----GQMEREFQAEVEALS 822
            +F    +I  G +G VY    K T     + A+K+++        Q+++ F  E + L+
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQ---RFAMKKINKQNLILRNQIQQVF-VERDILT 56

Query: 823 RAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWD-------VR 873
            A++  +VS+  +C     R L  +  Y+E G          D  ++LK          R
Sbjct: 57  FAENPFVVSM--FCSFETKRHLCMVMEYVEGG----------DCATLLKNIGALPVDMAR 104

Query: 874 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL------LRPY 927
           +  A+     L YLH      IVHRD+K  N+L+       L DFGLS++         Y
Sbjct: 105 MYFAE-TVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160

Query: 928 DTHVTTD--------LVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRR 973
           + H+  D        + GT  YI PE      Y + +      D ++ G++L E L G  
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV------DWWAMGIILYEFLVGCV 214

Query: 974 P 974
           P
Sbjct: 215 P 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.5 bits (126), Expect = 1e-06
 Identities = 34/111 (30%), Positives = 47/111 (42%), Gaps = 26/111 (23%)

Query: 354 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLS 413
           L L      G +PN +S    L+ ++L+ N + G +P S G +TSL  L LS NSFN   
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS- 481

Query: 414 GTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 464
                                    IPE++G   SL +L L    L G +P
Sbjct: 482 -------------------------IPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.4 bits (111), Expect = 1e-06
 Identities = 23/60 (38%), Positives = 32/60 (53%)

Query: 111 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSF 170
            LK LDLS N L  +       L  L+VLDLS N L+       +GL  ++SL++S N+ 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 7/89 (7%)

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           YLH      I++RD+K  N+LLD K    + DFG ++ +       T  L GT  Y+ PE
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             Q+       D ++ GV+L E + G  P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)

Query: 763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 818
           + DL     ++    +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           + ++ A    +V L  +    +DR L  +  YM  G L   ++   + D   KW  R   
Sbjct: 95  DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYT 148

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL- 935
           A+     L  +H +     +HRDVK  N+LLD+     LADFG    +   +  V  D  
Sbjct: 149 AE-VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTA 203

Query: 936 VGTLGYIPPEYSQTLTA------TCRGDVYSFGVVLLELLTGRRP 974
           VGT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.2 bits (125), Expect = 1e-06
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 17/152 (11%)

Query: 779 IGCGGFGLVYKATLTNGTK----AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
           I  G FG VY     N +K      VK+       M  + QAE +AL+ ++   +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLH--ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
             +  N+  L+  Y+  G +   LH     D++  +K+     I++  A  L YLH+   
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-----ISE-VALALDYLHR--- 122

Query: 893 PH-IVHRDVKSSNILLDEKFEAHLADFGLSRL 923
            H I+HRD+K  N+L+  +    L DFGLS++
Sbjct: 123 -HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.4 bits (123), Expect = 2e-06
 Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 2/82 (2%)

Query: 260 LSVNN--FSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 317
           L ++N    G +   IS L  L+ + + GN   G +P  LG++T LE      NSF+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 318 PLSLSLCSKLHVLDLRNNSLTG 339
           P SL   + L +L+L  NSL+G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSG 504

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 2e-06
 Identities = 27/58 (46%), Positives = 35/58 (60%), Gaps = 2/58 (3%)

Query: 561 SVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 617
           S+ LSNNR+   IP      L +L VLDLS NN+T   P + S + +L  LDLS N+L
Sbjct: 4   SLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 24/224 (10%)

Query: 763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 818
           +  L     +++   +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           + ++ A    +V L  +C   +D+ L  +  YM  G L   ++   + D   KW  +   
Sbjct: 95  DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL---VNLMSNYDVPEKW-AKFYT 148

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
           A+     L  +H +    ++HRDVK  N+LLD+     LADFG    +           V
Sbjct: 149 AE-VVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204

Query: 937 GTLGYIPPEYSQTLTA------TCRGDVYSFGVVLLELLTGRRP 974
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.3 bits (121), Expect = 2e-06
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 42/211 (19%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQ-AEVEALSR-AQHKNLVSLQGY 835
           IG G F  V KA +   G   A+K +      +E+     E++AL R + H N++ L   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL--- 63

Query: 836 CRHGNDRL-----LIYSYMENGSLDYWL----HESVDKDSVLKWDVRLKIAQGAARGLAY 886
                DR      L++  M+  +L Y L       + +  V  +  +L       + L +
Sbjct: 64  IEVLFDRKTGRLALVFELMD-MNL-YELIKGRKRPLPEKRVKSYMYQL------LKSLDH 115

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE- 945
           +H+     I HRD+K  NIL+ +     LADFG  R +  Y     T+ + T  Y  PE 
Sbjct: 116 MHR---NGIFHRDIKPENILIKDD-ILKLADFGSCRGI--YSKPPYTEYISTRWYRAPEC 169

Query: 946 ------YSQTLTATCRGDVYSFGVVLLELLT 970
                 Y   +      D+++ G V  E+L+
Sbjct: 170 LLTDGYYGPKM------DIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 51/223 (22%)

Query: 773 FNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEA---------LS 822
           + Q   IG G  G+V  A  T  G   AVK+LS       R FQ +  A         L 
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYRELVLLK 75

Query: 823 RAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDVRL 874
              HKN++SL      Q       D  L+   M+  +L   +H  +D +  S L + +  
Sbjct: 76  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLLYQMLC 134

Query: 875 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR------LLRPYD 928
                   G+ +LH      I+HRD+K SNI++       + DFGL+R      ++ PY 
Sbjct: 135 --------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY- 182

Query: 929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 971
                  V T  Y  PE    +      D++S G ++ EL+ G
Sbjct: 183 -------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.8 bits (119), Expect = 4e-06
 Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 36/171 (21%)

Query: 881  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT- 938
            ARG+ +L  + C    +HRD+ + NILL E     + DFGL+R     D +   D V   
Sbjct: 183  ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLAR-----DIYKDPDYVRKG 233

Query: 939  -----LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN--CRDLVSWV 990
                 L ++ PE       T + DV+SFGV+L E+ + G  P    +     CR L    
Sbjct: 234  DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT 293

Query: 991  FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             +M++ +                    E+  I   C   +P  RP   E+V
Sbjct: 294  -RMRAPEYATP----------------EIYSIMLDCWHNNPEDRPTFSELV 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.5 bits (106), Expect = 5e-06
 Identities = 22/60 (36%), Positives = 32/60 (53%)

Query: 582 HLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 641
           +L  LDLS N +T     +   + NL+VLDLS N+L    P +F  L  L    ++ N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 5e-06
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 22/164 (13%)

Query: 881  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGT 938
            A+G+++L  K C    +HRD+ + NILL       + DFGL+R +R    +V   +    
Sbjct: 224  AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 997
            + ++ PE       T   DV+S+G++L E+ + G  P                  M  + 
Sbjct: 280  VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP---------------GMPVDS 324

Query: 998  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
            +  ++I         E    EM +I   C D DP +RP  +++V
Sbjct: 325  KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.5 bits (118), Expect = 6e-06
 Identities = 34/92 (36%), Positives = 44/92 (47%), Gaps = 8/92 (8%)

Query: 771 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
           +N      +G G FG V +AT        N  + AVK L       ERE   +E++ LS 
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 824 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
             QHKN+V+L G C HG   L+I  Y   G L
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.8 bits (116), Expect = 7e-06
 Identities = 43/159 (27%), Positives = 66/159 (41%), Gaps = 10/159 (6%)

Query: 817 EVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
           E   L   +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +    
Sbjct: 45  ESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARF 99

Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
                   L YLH      +V+RD+K  N++LD+     + DFGL +     D       
Sbjct: 100 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTF 155

Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            GT  Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 9e-06
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 26/169 (15%)

Query: 881  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGT 938
            A+G+ +L  + C    +HRD+ + NILL E     + DFGL+R + +  D     D    
Sbjct: 189  AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMKS 995
            L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR       ++K 
Sbjct: 245  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-------RLKE 297

Query: 996  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
              R           +  +    EM +    C   +P +RP   E+V  L
Sbjct: 298  GTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 1e-05
 Identities = 62/246 (25%), Positives = 86/246 (34%), Gaps = 48/246 (19%)

Query: 773 FNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMEREFQ---AEVEALSRAQHK 827
           F +  ++G G  G V+   L  GT    A+K L         + +    E E L+   H 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRL-KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGL 884
            L +L  Y     +  L     Y   G  + +          L  +V R   A+     L
Sbjct: 62  FLPTL--YASFQTETYLCLVMDYCPGG--ELFRLLQRQPGKCLSEEVARFYAAEVLL-AL 116

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV------------- 931
            YLH      IV+RD+K  NILL E     L+DF LS+        V             
Sbjct: 117 EYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 932 ---------------TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
                          +   VGT  YI PE           D ++ G++L E+L G  P  
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF- 232

Query: 977 VCKGKN 982
             KG N
Sbjct: 233 --KGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 65/248 (26%), Positives = 86/248 (34%), Gaps = 35/248 (14%)

Query: 225 LDHSPSLKQLHVDNNLLGGD------LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLT- 277
           L   PSLK+L +  N  G        L   L     LQ + LS N         + +L  
Sbjct: 47  LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLR 106

Query: 278 --SLRHLIIFGNQFS-GKLPNVLGNLTQ----LEFFVAHSNSFSG----PLPLSLSLCSK 326
             SL+ L +  N      L  +   L      LE  V   N   G     L  +L     
Sbjct: 107 SSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRD 166

Query: 327 LHVLDLRNNSLTGP-IDLNFSGLSSLC---TLDLATNHF----SGPLPNSLSDCHDLKIL 378
           L  L+L NN +    I     GL + C    LDL  N      +  L  +L+    L++L
Sbjct: 167 LKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVL 226

Query: 379 SLAKNELSGQ-----VPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN---LTTLIL 430
           +L  N L+                SLL LSLS N      G   + +       L  L L
Sbjct: 227 NLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT-DDGAKDLAEVLAEKESLLELDL 285

Query: 431 TKNFVGEE 438
             N  GEE
Sbjct: 286 RGNKFGEE 293

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 39/148 (26%), Positives = 61/148 (41%), Gaps = 17/148 (11%)

Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--YSQTLTA 952
             +HRD+K  N L+D      L DFGLS+ +  Y   V    VG+  Y+ PE    +    
Sbjct: 122  YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV----VGSPDYMAPEVLRGKGYDF 177

Query: 953  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012
            T   D +S G +L E L G  P     G    +        ++ K   E +   ++   R
Sbjct: 178  TV--DYWSLGCMLYEFLCGFPPFS---GSTPNET------WENLKYWKETLQRPVYDDPR 226

Query: 1013 EKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                 E  ++  K I+   RR   +E++
Sbjct: 227  FNLSDEAWDLITKLINDPSRRFGSLEDI 254

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 48/179 (26%), Positives = 70/179 (39%), Gaps = 46/179 (25%)

Query: 881  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT- 938
            ARG+ +L  + C    +HRD+ + NILL E     + DFGL+R     D +   D V   
Sbjct: 184  ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLAR-----DIYKDPDYVRKG 234

Query: 939  -----LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPV-------EVCKGKNCRD 985
                 L ++ PE       T + DV+SFGV+L E+ + G  P        E C+      
Sbjct: 235  SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR----- 289

Query: 986  LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                  +  +  R  E     I+             I   C   DP+ RP    +V  L
Sbjct: 290  -----LKDGTRMRAPENATPEIY------------RIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 47.7 bits (114), Expect = 2e-05
 Identities = 54/212 (25%), Positives = 79/212 (37%), Gaps = 36/212 (16%)

Query: 208 IQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGD--------LPDSLYSMSSL 255
           +Q LDLS N       G L+ L  S SL++L ++NN LG          L D   ++  L
Sbjct: 83  LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142

Query: 256 QHVSLSVNNFSGQLSEKISNL----TSLRHLIIFGNQFSG----KLPNVLGNLTQLEFFV 307
               L  N   G   E ++        L+ L +  N         L   L     LE   
Sbjct: 143 V---LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199

Query: 308 AHSNSF----SGPLPLSLSLCSKLHVLDLRNNSLTGPI-----DLNFSGLSSLCTLDLAT 358
            ++N      +  L  +L+    L VL+L +N+LT            S   SL TL L+ 
Sbjct: 200 LNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSC 259

Query: 359 NHF----SGPLPNSLSDCHDLKILSLAKNELS 386
           N      +  L   L++   L  L L  N+  
Sbjct: 260 NDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 41/225 (18%)

Query: 771 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHK 827
           + + +   IG G +G VYKA     G   A+K  RL  D   +      E+  L      
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 828 N----LVSLQGYCRHGNDRLLIYSYME--NGSLDYWL-------HESVDKDSVLKWDVRL 874
                L+ ++ +    N +  +Y   E  +  L  ++          +   ++  +  +L
Sbjct: 61  IYIVRLLDVE-HVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 875 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTT 933
                   G+A+ HK     ++HRD+K  N+L+D +K    +AD GL R         T 
Sbjct: 120 LK------GVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170

Query: 934 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTG 971
           ++V TL Y  PE       YS  +      D++S G +  E+   
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPV------DIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.9 bits (111), Expect = 4e-05
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 9/102 (8%)

Query: 874 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
           L I +   R + YLH   E  I+HRD+K+ NI ++   +  L DFG +    P D +   
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDIN-AN 238

Query: 934 DLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGR 972
              G  G I     + L     G   D++S G+VL E+ T  
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.7 bits (111), Expect = 5e-05
 Identities = 65/298 (21%), Positives = 100/298 (33%), Gaps = 110/298 (36%)

Query: 772 NFNQANIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           +F     +G G FG+VYKA+L N       K  +K+ + + G        E+    R + 
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT-EYGA------VEIWMNERVRR 185

Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLD----YWL---HESVD------KDSVLKWDVR 873
               +    C        +Y ++E  S      YWL   +E         +     ++V 
Sbjct: 186 ----ACPNSCAD-----FVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236

Query: 874 ---LKIAQGAARGLAYLHKVCEP------------H---IVHRDVKSSNILLDEKFEAHL 915
              L   Q   +GL   +K+ +             H   IVHRDVK  NI+  E      
Sbjct: 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG----- 291

Query: 916 ADFGLSRLLRPYDTHVTTDLVGTLGYIP------PEYS---------QTLTATC------ 954
                S   +  D     DL   + YIP      P Y+         QT +A        
Sbjct: 292 -----SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 346

Query: 955 ------------RGDVYSFGVVLLE-----------LLTGRRPVEVCKGKNCRDLVSW 989
                       R D+YS G++ L+           L+   R ++        DLV+W
Sbjct: 347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRND----YDLVAW 400

Length = 566

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.3 bits (110), Expect = 5e-05
 Identities = 36/131 (27%), Positives = 46/131 (35%), Gaps = 45/131 (34%)

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-------------------- 925
            +HK+     +HRD+K  NIL+D      L DFGL    R                    
Sbjct: 116 SVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172

Query: 926 PYDTHVTTD----------------------LVGTLGYIPPEYSQTLTATCRGDVYSFGV 963
           P +     D                      LVGT  YI PE       T   D +S GV
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232

Query: 964 VLLELLTGRRP 974
           +L E+L G+ P
Sbjct: 233 ILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 58/244 (23%), Positives = 96/244 (39%), Gaps = 49/244 (20%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQH 826
           ++F    +IG G FG V      +       ++      +E+E     +AE + L  A  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
             +V +    +   +  LI  ++  G +   L   + KD++ +   +  IA+     +  
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAE-TVLAIDA 116

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR---------------PYD--- 928
           +H++     +HRD+K  N+LLD K    L+DFGL   L+               P D   
Sbjct: 117 IHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 929 ----------------THVTTDLVGTLGYIPPE-YSQT-LTATCRGDVYSFGVVLLELLT 970
                             +    VGT  YI PE + QT     C  D +S GV++ E+L 
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLI 231

Query: 971 GRRP 974
           G  P
Sbjct: 232 GYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 44/153 (28%), Positives = 64/153 (41%), Gaps = 19/153 (12%)

Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARG 883
           N+V L  Y    +   L+  + E G L  W H S    + ++ V +W   + +A      
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFLNIPEECVKRWAAEMVVA------ 97

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L  LH      IV RD+  +NILLD++    L  F     +         + V  + Y  
Sbjct: 98  LDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---SCDGEAVENM-YCA 150

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           PE       T   D +S G +L ELLTG+  VE
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 8e-05
 Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 49/243 (20%)

Query: 772 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQHK 827
           +F    +IG G FG V      +       ++      +E+E     +AE + L  A   
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
            +V +    +   +  LI  ++  G +   L   + KD++ + + +  IA+     +  +
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAE-TVLAIDSI 117

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL---------SRLLRPYDTHVTTDL--- 935
           H++     +HRD+K  N+LLD K    L+DFGL         +   R  +  + +D    
Sbjct: 118 HQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 936 ----------------------VGTLGYIPPE-YSQT-LTATCRGDVYSFGVVLLELLTG 971
                                 VGT  YI PE + QT     C  D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Query: 972 RRP 974
             P
Sbjct: 233 YPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.8 bits (106), Expect = 2e-04
 Identities = 32/108 (29%), Positives = 59/108 (54%), Gaps = 8/108 (7%)

Query: 870 WDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPY 927
            D+ L+ +   A+G+ +L  K C    +HRDV + N+LL +   A + DFGL+R ++   
Sbjct: 212 DDL-LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266

Query: 928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
           +  V  +    + ++ PE       T + DV+S+G++L E+ + G+ P
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 31/152 (20%), Positives = 52/152 (34%), Gaps = 16/152 (10%)

Query: 778 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC- 836
           ++  G    VY     +     +K         +RE   EV  L     K L   +    
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61

Query: 837 -RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                   L+  ++E  +LD    E  +            IA+  A  LA LH++    +
Sbjct: 62  GESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVL 110

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPY 927
            H D+   NIL+D+     + D+  +    P 
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.4 bits (93), Expect = 3e-04
 Identities = 18/59 (30%), Positives = 27/59 (45%), Gaps = 2/59 (3%)

Query: 375 LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
           LK L L+ N L+     +F  L +L  L LS N+   +S          +L +L L+ N
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE--AFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 31/165 (18%)

Query: 771 NNFNQANIIGCGGFG---LVYKATLTNGTKAAVKRLSGDCGQMEREFQ-----AEVEALS 822
            +F+   +IG G FG   LV K     G   A+K L     +M ++ Q     AE + L+
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKS--EMFKKDQLAHVKAERDVLA 56

Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV------RLKI 876
            +    +VSL    +      LI  ++  G L   L         +K+D       R  +
Sbjct: 57  ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTRFYM 107

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS 921
           A+     +  +HK+     +HRD+K  NIL+D      L+DFGLS
Sbjct: 108 AE-CVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 56/237 (23%), Positives = 86/237 (36%), Gaps = 54/237 (22%)

Query: 413 SGTLSVLQQCKNLTTLILTKNFVGEE----IPENVGGFESLMVLALGNC----------- 457
            G +  L+    L  + L+ N +G E    +   +    +L V+   +            
Sbjct: 20  KGVVEELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYS 79

Query: 458 GLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTE 517
            L   +   LL+C +LQ +DLS N F    P                    G++  S T+
Sbjct: 80  NLVMLLKA-LLKCPRLQKVDLSDNAFGSEFPE-----------------ELGDLISSSTD 121

Query: 518 LKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYN-QASSFPP--SVFLSNNRI-NGTI 573
           L  L  +N     P A   I   + H      L YN +A+  P    V    NR+ NG+ 
Sbjct: 122 LVHLKLNNN-GLGPIAGGRIGKALFH------LAYNKKAADKPKLEVVICGRNRLENGSK 174

Query: 574 PPEIGQLK---HLHVLDLSRNNI-----TGTIPSSISEIRNLEVLDLSSN--DLHGS 620
                 L+   +L  + + +N I     T      +    +LEVLDL  N   L GS
Sbjct: 175 ELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGS 231

Length = 388

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.8 bits (103), Expect = 4e-04
 Identities = 36/129 (27%), Positives = 51/129 (39%), Gaps = 8/129 (6%)

Query: 513 KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGT 572
            S T L    S +   S    S      +  + +   L         PS+ L+ NR+   
Sbjct: 55  SSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNL------LPLPSLDLNLNRLRSN 108

Query: 573 IPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLS 632
           I   + +L +L  LDL  NNIT   P       NL+ LDLS N +  S+P     L  L 
Sbjct: 109 ISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLK 166

Query: 633 KFSVANNHL 641
              ++ N L
Sbjct: 167 NLDLSFNDL 175

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 20/60 (33%), Positives = 29/60 (48%)

Query: 230 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 289
           +LK L + NN L      +   + +L+ + LS NN +    E  S L SLR L + GN  
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 20/57 (35%), Positives = 30/57 (52%)

Query: 353 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF 409
           +LDL+ N  +     +     +LK+L L+ N L+   PE+F  L SL  L LS N+ 
Sbjct: 4   SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.5 bits (102), Expect = 5e-04
 Identities = 39/130 (30%), Positives = 63/130 (48%), Gaps = 14/130 (10%)

Query: 845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSS 903
           + S  E    D  ++ES      L +   +  +   A G+ +L  K C    VHRD+ + 
Sbjct: 217 LPSAPERTRRDTLINES----PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAAR 268

Query: 904 NILLDEKFEAHLADFGLSR-LLRP--YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
           N+L+ E     + DFGL+R ++R   Y +  +T L   L ++ PE       T   DV+S
Sbjct: 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWS 326

Query: 961 FGVVLLELLT 970
           FG++L E+ T
Sbjct: 327 FGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.6 bits (102), Expect = 6e-04
 Identities = 57/246 (23%), Positives = 95/246 (38%), Gaps = 32/246 (13%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE---FQAEVEALSRAQHK 827
           N +     IG G FG V+        +    +     G  ERE      EV  +   +HK
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 828 NLVS-LQGYCRHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           N+V  +  +    N +L I   + + G L   + +       ++    + I +     LA
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 886 YLHKVCE----PHIVHRDVKSSNILLDEKFE-----------------AHLADFGLSRLL 924
           Y H + +      ++HRD+K  NI L                      A + DFGLS+ +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 925 RPYDTHVTTDLVGTLGYIPPE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
                 +    VGT  Y  PE    +T +   + D+++ G ++ EL +G+ P    K  N
Sbjct: 193 GI--ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH--KANN 248

Query: 983 CRDLVS 988
              L+S
Sbjct: 249 FSQLIS 254

Length = 1021

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 6e-04
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 39/218 (17%)

Query: 778 IIGCGGFGLVYKAT------LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 831
           +IGCGGFG VY+        + N   A ++ L  +   ME          +     + ++
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVME------TLVYNNIYDIDKIA 72

Query: 832 LQGYCRHGN-DRLLIYSYMENGSLDY-----------WLHESVDK--DSVLKWDVRL--K 875
           L  +    N D L I  Y   GS               L E+  +    +   + +L   
Sbjct: 73  L--WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN 130

Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---- 931
           I +     L Y+H   E  I H D+K  NI++D     ++ D+G++     +  H+    
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187

Query: 932 -TTDL-VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLE 967
              DL  GTL Y   +       T RGD+ S G  +L+
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 43.7 bits (103), Expect = 6e-04
 Identities = 89/342 (26%), Positives = 146/342 (42%), Gaps = 51/342 (14%)

Query: 102 IPRSLGHLNQLKLLDLS-CNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 160
           +P S+ +LN+L+ LD+S C +LE ++P  + NLK L  L+LS        S + +  ++ 
Sbjct: 673 LPSSIQYLNKLEDLDMSRCENLE-ILPTGI-NLKSLYRLNLSG------CSRLKSFPDI- 723

Query: 161 QSLNVSSNSFNGSLFELGEF-SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM 219
            S N+S    + +  E  EF SNL + N+         + ++W   + +Q L   M    
Sbjct: 724 -STNISWLDLDETAIE--EFPSNLRLENLDELILCEMKSEKLW---ERVQPLTPLMTML- 776

Query: 220 GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 279
                   SPSL +L + +     +LP S+ ++  L+H+ +        L   I NL SL
Sbjct: 777 --------SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESL 827

Query: 280 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 339
             L + G       P++  N++ L      S +    +P  +   S L  LD+   +   
Sbjct: 828 ESLDLSGCSRLRTFPDISTNISDLNL----SRTGIEEVPWWIEKFSNLSFLDMNGCNNLQ 883

Query: 340 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 399
            + LN S L  L T+D              SDC  L   S   N    +V  +   + S 
Sbjct: 884 RVSLNISKLKHLETVD-------------FSDCGALTEASW--NGSPSEVAMATDNIHSK 928

Query: 400 LFLSLSNNSFNHLSGTL-SVLQQCKNLTTLILTKNFVGEEIP 440
           L  ++  N  N  +    ++LQQ      LIL+    GEE+P
Sbjct: 929 LPSTVCINFINCFNLDQEALLQQQSIFKQLILS----GEEVP 966

syringae 6; Provisional. Length = 1153

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 8e-04
 Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 61/223 (27%)

Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA----------QHK 827
           IG G  G+V  A     G   A+K+LS       R FQ    A  RA           HK
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLS-------RPFQNVTHA-KRAYRELVLMKLVNHK 75

Query: 828 NLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD------SVLKWDVRLK 875
           N++ L      Q       D   +Y  ME   +D  L + +  D      S L + +   
Sbjct: 76  NIIGLLNVFTPQKSLEEFQD---VYLVME--LMDANLCQVIQMDLDHERMSYLLYQMLC- 129

Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
                  G+ +LH      I+HRD+K SNI++       + DFGL+R      + + T  
Sbjct: 130 -------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 177

Query: 936 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           V T  Y  PE      Y + +      D++S G ++ E++ G 
Sbjct: 178 VVTRYYRAPEVILGMGYKENV------DIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.3 bits (99), Expect = 0.001
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 36/165 (21%)

Query: 881  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGT 938
            ARG+ +L  K C    VHRD+ + N+LL +     + DFGL+R +     +V+       
Sbjct: 247  ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 998
            + ++ PE       T   DV+S+G++L E                      +F +     
Sbjct: 303  VKWMAPESIFDNLYTTLSDVWSYGILLWE----------------------IFSLGGTPY 340

Query: 999  EVEIIDASIWHKDR--------EKQLLEMLEIACKCIDQDPRRRP 1035
               I+D++ ++K +        +    E+ +I  KC + +P +RP
Sbjct: 341  PGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 41.2 bits (97), Expect = 0.002
 Identities = 58/241 (24%), Positives = 81/241 (33%), Gaps = 51/241 (21%)

Query: 411 HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG----GFES---LMVLALGNCGLKGH- 462
                 S L+   +L  L L+ N  G  IP  +     G      L  L L +  L    
Sbjct: 39  AAKALASALRPQPSLKELCLSLNETGR-IPRGLQSLLQGLTKGCGLQELDLSDNALGPDG 97

Query: 463 IPVW--LLRCKKLQVLDLSWNHFDGNIPPWIGQ-----MENLFYLDFSNNTLTGEIPKSL 515
             V   LLR   LQ L L+ N         + +        L  L    N L G    S 
Sbjct: 98  CGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA---SC 154

Query: 516 TELKSLISSNCT------SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRI 569
             L   + +N        ++N    AGI    +      GL  N        + L+NN +
Sbjct: 155 EALAKALRANRDLKELNLANNGIGDAGIRALAE------GLKANCNLEV---LDLNNNGL 205

Query: 570 N--------GTIPPEIGQLKHLHVLDLSRNNITGTI-----PSSISEIRNLEVLDLSSND 616
                     T+      LK L VL+L  NN+T         + +S   +L  L LS ND
Sbjct: 206 TDEGASALAETLA----SLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261

Query: 617 L 617
           +
Sbjct: 262 I 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.8 bits (95), Expect = 0.003
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 43/211 (20%)

Query: 779 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQH 826
           IG G  G+V   Y A L      A+K+LS       R FQ +  A         +    H
Sbjct: 25  IGSGAQGIVCAAYDAVLDR--NVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 75

Query: 827 KNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDVRLKIAQ 878
           KN++SL      Q       D  L+   M+  +L   +   +D +  S L + +      
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLC---- 130

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               G+ +LH      I+HRD+K SNI++       + DFGL+R      + + T  V T
Sbjct: 131 ----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVT 181

Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELL 969
             Y  PE    +      D++S G ++ E++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 40.6 bits (95), Expect = 0.004
 Identities = 24/71 (33%), Positives = 40/71 (56%), Gaps = 2/71 (2%)

Query: 180 FSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL-QGLDHSPSLKQLHVDN 238
             +L   N+S NS  G +   + S +  +++LDLS N F GS+ + L    SL+ L+++ 
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITS-LEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499

Query: 239 NLLGGDLPDSL 249
           N L G +P +L
Sbjct: 500 NSLSGRVPAAL 510

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.004
 Identities = 18/58 (31%), Positives = 23/58 (39%)

Query: 448 SLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 505
           +L  L L N  L             L+VLDLS N+     P     + +L  LD S N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.004
 Identities = 36/125 (28%), Positives = 45/125 (36%), Gaps = 46/125 (36%)

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDT-------HVTTD------------- 934
           +HRD+K  NIL+D      L DFGL    R  +D+       HV  D             
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 935 -------------------------LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL 969
                                    LVGT  YI PE       T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 970 TGRRP 974
            G+ P
Sbjct: 243 VGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1052
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.73
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.72
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.72
PRK10345	210	hypothetical protein; Provisional	99.71
smart00090	237	RIO RIO-like kinase.	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
PLN03150	623	hypothetical protein; Provisional	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
PLN03150	623	hypothetical protein; Provisional	99.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.53
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.5
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.49
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.36
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.32
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.32
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.31
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.22
KOG1243	690	consensus Protein kinase [General function predict	99.18
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.16
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.15
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.14
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.11
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.1
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.09
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.06
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.04
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.04
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.04
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.03
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.99
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.99
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.95
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.9
COG4248	637	Uncharacterized protein with protein kinase and he	98.86
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.82
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.77
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.76
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.75
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.75
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.71
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.69
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.67
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.52
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.5
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.49
PRK09902	216	hypothetical protein; Provisional	98.45
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.45
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.4
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.8e-116  Score=1131.07  Aligned_cols=942  Identities=30%  Similarity=0.511  Sum_probs=785.4

Q ss_pred             chhcccchhHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhcCCC-CCCCCCcCCCCCCceeeeeeeCCCCCCC
Q 001561            5 MVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTN-GSIITSWSNESMCCQWDGVVCGHGSTGS   83 (1052)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aLl~~k~~~~~-~~~l~sw~~~~~~c~w~gv~C~~~~~~~   83 (1052)
                      |+.-|-.-++|..+.+++++++.+.        -.++|+.||++||+++.+ .+.+.+|+..++||.|.||+|++     
T Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~-----   67 (968)
T PLN00113          1 MAKKGPQHCPYLIFMLFFLFLNFSM--------LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN-----   67 (968)
T ss_pred             CCCCCCCCCChHHHHHHHHHHHccC--------CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCC-----
Confidence            5666766777744333433333321        156899999999999964 45789999888999999999963     


Q ss_pred             CCCcEEEEEecCCCCcccCCccccCCcCCCeEecCCCCCCCCCccccc-CCCCccEEeccCCcccCcccccccccCCccE
Q 001561           84 NAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELS-NLKQLEVLDLSHNMLSGPVSGMLAGLNLIQS  162 (1052)
Q Consensus        84 ~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~  162 (1052)
                       .++|+.|+|++++++|.+++++..+++|+.|+|++|++++.+|..+. .+++|++|+|++|.+++.+|.  +.+++|++
T Consensus        68 -~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~  144 (968)
T PLN00113         68 -SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLET  144 (968)
T ss_pred             -CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCE
Confidence             46899999999999999999999999999999999999998887754 999999999999999987774  56899999


Q ss_pred             EEccCcccCCc-ccccccCCcccEEEecCCccCCccchhhhhcccccceeeccCccccc-ccccCCCCCCCCEEEccccc
Q 001561          163 LNVSSNSFNGS-LFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG-SLQGLDHSPSLKQLHVDNNL  240 (1052)
Q Consensus       163 L~Ls~N~l~~~-~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~l~~~~~L~~L~L~~N~  240 (1052)
                      |+|++|.+++. +..++.+++|++|++++|.+.+.+|.. +..+++|++|+|++|++.+ .|..+..+++|++|+|++|.
T Consensus       145 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~  223 (968)
T PLN00113        145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS-LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN  223 (968)
T ss_pred             EECcCCcccccCChHHhcCCCCCEEECccCcccccCChh-hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCc
Confidence            99999999864 456999999999999999999888775 5678999999999999975 46778999999999999999


Q ss_pred             CCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCcc
Q 001561          241 LGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLS  320 (1052)
Q Consensus       241 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~  320 (1052)
                      +++.+|..++++++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..+.++++|+.|++++|.+.+.+|..
T Consensus       224 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~  303 (968)
T PLN00113        224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL  303 (968)
T ss_pred             cCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCc
Q 001561          321 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLL  400 (1052)
Q Consensus       321 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  400 (1052)
                      +..+++|+.|++++|.+++..|..+..+++|+.|+|++|.+++.+|..++.+++|+.|++++|++++.+|..+..+++|+
T Consensus       304 ~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~  383 (968)
T PLN00113        304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF  383 (968)
T ss_pred             HcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEeccCCcCCCCcccchhhccCcccceEeccccccCccCCccccCCCcccEEEccCCccccCcchhhhcCCCCcEEeCcC
Q 001561          401 FLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSW  480 (1052)
Q Consensus       401 ~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  480 (1052)
                      .|++++|++....  ...+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|+|++
T Consensus       384 ~L~l~~n~l~~~~--p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  461 (968)
T PLN00113        384 KLILFSNSLEGEI--PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR  461 (968)
T ss_pred             EEECcCCEecccC--CHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcC
Confidence            9999999987532  24577899999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCChhhccCCCCCeEeccCCcccccCCcchhhhhhhcccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCC
Q 001561          481 NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP  560 (1052)
Q Consensus       481 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  560 (1052)
                      |++.+.+|..+ .+++|+.||+++|++++.+|..+.++++|                                      .
T Consensus       462 n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L--------------------------------------~  502 (968)
T PLN00113        462 NKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSEL--------------------------------------M  502 (968)
T ss_pred             ceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhcc--------------------------------------C
Confidence            99999998866 46899999999999999999999888777                                      4


Q ss_pred             eeeeecCcccccCCcccccccccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeecccc
Q 001561          561 SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNH  640 (1052)
Q Consensus       561 ~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~N~  640 (1052)
                      .|+|++|++.+.+|..++++++|++|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+.|++++|+
T Consensus       503 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~  582 (968)
T PLN00113        503 QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH  582 (968)
T ss_pred             EEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc
Confidence            68999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCccCCCCCCcccCCCCCcCCC----CCCCCCcCCCCCCcCCCCCCCCCCCCcEEEEeeehhHHHHHHHHhhh
Q 001561          641 LQGTIPTGGQFYSFPNSSFEGNPGLCGEI----DSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTL  716 (1052)
Q Consensus       641 l~g~~p~~~~~~~~~~~~~~gn~~lcg~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~ii~~~~~~~v~i~~l~~~~~  716 (1052)
                      ++|.+|..++|.++...+|.||+++||+.    .++|...           .  +... ..+.+++++++++++++++++
T Consensus       583 l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----------~--~~~~-~~~~~~~~~~~~~~~~~~~~~  648 (968)
T PLN00113        583 LHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----------R--KTPS-WWFYITCTLGAFLVLALVAFG  648 (968)
T ss_pred             ceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----------c--ccce-eeeehhHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999962    1234210           0  1111 111122222222222222222


Q ss_pred             hhhcccCCCCCCCCCccccCCcchhhHHhhccceeeecCCCCccccHHHHHHhhcCCcccCeEcccCceEEEEEEE-CCC
Q 001561          717 LKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATL-TNG  795 (1052)
Q Consensus       717 ~~~~rr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g  795 (1052)
                      ++++||++...........+.          .+...+.......++++++.   +.|+..++||+|+||.||+|+. .++
T Consensus       649 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~  715 (968)
T PLN00113        649 FVFIRGRNNLELKRVENEDGT----------WELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNG  715 (968)
T ss_pred             HHHHHhhhccccccccccccc----------ccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCC
Confidence            222333222111111000000          00111111112234455544   4577788999999999999987 478


Q ss_pred             cEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHH
Q 001561          796 TKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK  875 (1052)
Q Consensus       796 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~  875 (1052)
                      ..||||++......    ..+|++.+++++|||||+++++|.+++..++||||+++|+|.++++.       ++|.++.+
T Consensus       716 ~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~  784 (968)
T PLN00113        716 MQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRK  784 (968)
T ss_pred             cEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHH
Confidence            99999998644322    23468899999999999999999999999999999999999999863       78999999


Q ss_pred             HHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeecccccccccCccccCCcCCCcc
Q 001561          876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR  955 (1052)
Q Consensus       876 i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  955 (1052)
                      ++.|+++|++|||..+.++|+||||||+||+++.++.+++. ||.+......     ....||+.|+|||++.+..++.+
T Consensus       785 i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~  858 (968)
T PLN00113        785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEK  858 (968)
T ss_pred             HHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcc
Confidence            99999999999997767899999999999999999988875 6655433211     22368899999999999999999


Q ss_pred             cchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc--hhhHHHHHHHHHHHHHcccCCCCC
Q 001561          956 GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH--KDREKQLLEMLEIACKCIDQDPRR 1033 (1052)
Q Consensus       956 ~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~ 1033 (1052)
                      +|||||||++|||+||+.||+...+ ......+|..............++....  .....+..++.+++.+|++.||++
T Consensus       859 sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~  937 (968)
T PLN00113        859 SDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTA  937 (968)
T ss_pred             cchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchh
Confidence            9999999999999999999964322 2345566665444333333444444422  223455668899999999999999


Q ss_pred             CCCHHHHHHHHhhcCc
Q 001561         1034 RPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1034 RPs~~evl~~L~~i~~ 1049 (1052)
                      ||+|+||+++|+++.+
T Consensus       938 RPt~~evl~~L~~~~~  953 (968)
T PLN00113        938 RPCANDVLKTLESASR  953 (968)
T ss_pred             CcCHHHHHHHHHHhhc
Confidence            9999999999998865

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.3e-59  Score=600.81  Aligned_cols=514  Identities=33%  Similarity=0.516  Sum_probs=472.6

Q ss_pred             cCCCeEecCCCCCCCCCcccccCCCCccEEeccCCcccCccccc-ccccCCccEEEccCcccCCcccccccCCcccEEEe
Q 001561          110 NQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGM-LAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNI  188 (1052)
Q Consensus       110 ~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L  188 (1052)
                      .+++.|||++|++++.+|..|..+++|++|+|++|.+++.+|.. +..+.+|++|+|++|.+++... .+.+++|++|+|
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p-~~~l~~L~~L~L  147 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP-RGSIPNLETLDL  147 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccC-ccccCCCCEEEC
Confidence            47999999999999999999999999999999999999876655 4599999999999999987543 367899999999


Q ss_pred             cCCccCCccchhhhhcccccceeeccCccccc-ccccCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCc
Q 001561          189 SNNSFTGKLNSRIWSASKEIQILDLSMNHFMG-SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG  267 (1052)
Q Consensus       189 s~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  267 (1052)
                      ++|.+++.+|.. +..+++|++|+|++|.+.+ .|..+.++++|++|+|++|.+.+.+|..++++++|++|+|++|++++
T Consensus       148 s~n~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  226 (968)
T PLN00113        148 SNNMLSGEIPND-IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG  226 (968)
T ss_pred             cCCcccccCChH-HhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence            999999888765 5678999999999999874 56678999999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCccccc
Q 001561          268 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG  347 (1052)
Q Consensus       268 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  347 (1052)
                      .+|..++++++|++|+|++|++++.+|..++++++|+.|++++|++.+.+|..+.++++|++|++++|.+.+.+|..+.+
T Consensus       227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~  306 (968)
T PLN00113        227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ  306 (968)
T ss_pred             cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcEEeccCCcCCCCcccchhhccCcccce
Q 001561          348 LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT  427 (1052)
Q Consensus       348 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~  427 (1052)
                      +++|+.|++++|.+++.+|..+..+++|+.|++++|.+++.+|..++.+++|+.|++++|++++..  ...+..+++|+.
T Consensus       307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~--p~~~~~~~~L~~  384 (968)
T PLN00113        307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI--PEGLCSSGNLFK  384 (968)
T ss_pred             CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeC--ChhHhCcCCCCE
Confidence            999999999999999999999999999999999999999999999999999999999999987532  134667889999


Q ss_pred             EeccccccCccCCccccCCCcccEEEccCCccccCcchhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeEeccCCcc
Q 001561          428 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTL  507 (1052)
Q Consensus       428 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  507 (1052)
                      |++++|.+.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|.+++.+|..+..+++|++|+|++|++
T Consensus       385 L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~  464 (968)
T PLN00113        385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF  464 (968)
T ss_pred             EECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCcee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCcchhhhhhhcccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCcccccCCcccccccccceec
Q 001561          508 TGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLD  587 (1052)
Q Consensus       508 ~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~ip~~~~~l~~L~~L~  587 (1052)
                      .+.+|..+. ..+|                                      +.|++++|++++.+|..++++++|+.|+
T Consensus       465 ~~~~p~~~~-~~~L--------------------------------------~~L~ls~n~l~~~~~~~~~~l~~L~~L~  505 (968)
T PLN00113        465 FGGLPDSFG-SKRL--------------------------------------ENLDLSRNQFSGAVPRKLGSLSELMQLK  505 (968)
T ss_pred             eeecCcccc-cccc--------------------------------------eEEECcCCccCCccChhhhhhhccCEEE
Confidence            998887542 1222                                      5789999999999999999999999999


Q ss_pred             ccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeecccccccCCCCCC-ccCCCCCCcccCCCCCc
Q 001561          588 LSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGG-QFYSFPNSSFEGNPGLC  666 (1052)
Q Consensus       588 Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~gn~~lc  666 (1052)
                      |++|+++|.+|..++++++|++|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|..- .+..+....+.+|+..+
T Consensus       506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence            99999999999999999999999999999999999999999999999999999999999752 34455556677887544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-50  Score=452.54  Aligned_cols=291  Identities=51%  Similarity=0.831  Sum_probs=255.1

Q ss_pred             CCccccHHHHHHhhcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceE
Q 001561          757 DCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC  836 (1052)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  836 (1052)
                      ....|+++++..++++|...++||+|+||.||+|...+|..||||++........++|..|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45678999999999999999999999999999999999999999988765432156699999999999999999999999


Q ss_pred             eeCC-eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEE
Q 001561          837 RHGN-DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  915 (1052)
Q Consensus       837 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl  915 (1052)
                      .+.+ +.++|||||++|+|+++++.....  +++|..|++||.++|+||+|||+.+.++|+||||||+|||+|+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 599999999999999999975432  8899999999999999999999998889999999999999999999999


Q ss_pred             eecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhh
Q 001561          916 ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS  995 (1052)
Q Consensus       916 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  995 (1052)
                      +|||+|+..............||.+|+|||+...+..+.|+|||||||++.|++||+.|.+.........++.|......
T Consensus       219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999976543122211111899999999999999999999999999999999999999876554455568999988888


Q ss_pred             ccccccccccccc-chhhH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          996 EKREVEIIDASIW-HKDRE-KQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       996 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      .....+++|+.+. ..+.. .+..++..++.+|++.+|++||+|.||+++|+.+..
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            8889999999987 55554 678889999999999999999999999999977653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=378.93  Aligned_cols=249  Identities=28%  Similarity=0.443  Sum_probs=208.6

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC-eEEEEEEec
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-DRLLIYSYM  849 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  849 (1052)
                      ++..+.||+|..|+|||++++ +++.+|+|++... .....+++.+|++++++.+||+||.++|.|.... ...++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344778999999999999877 7889999999644 3566789999999999999999999999999988 599999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++|+|++++..    .+.+++....+|+.++++||.|||+.  .+||||||||+|||++..|++||||||.++.+...  
T Consensus       161 DgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  161 DGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             CCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999998875    35689999999999999999999973  59999999999999999999999999999886432  


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccC--CCCchhHHHHHHHhhhcccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK--GKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                       ....++||..|||||.+.+..|+.++||||||++++|+.+|+.||....  .....++..++....    .....+.  
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p----pP~lP~~--  305 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP----PPRLPEG--  305 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC----CCCCCcc--
Confidence             4567899999999999999999999999999999999999999997531  112223333322211    1111111  


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            ..+.++..++..|+++||.+||++.|+++
T Consensus       306 ------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  306 ------EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ------cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  34558999999999999999999999987

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=392.77  Aligned_cols=254  Identities=36%  Similarity=0.508  Sum_probs=208.3

Q ss_pred             ccCeEcccCceEEEEEEECCCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeCC-eEEEEEEeccC
Q 001561          775 QANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-DRLLIYSYMEN  851 (1052)
Q Consensus       775 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  851 (1052)
                      ..+.||.|+||+||+|.|.....||||++.....  ...++|.+|+.++++++|||||+++|+|.++. ...+|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3455999999999999998444599999986532  22568999999999999999999999999887 79999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEcCCCCCceEECCCC-CeEEeecccccccCCCCC
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-IVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~  929 (1052)
                      |+|.++++..  ....+++..+.+||.|||+|+.|||+.   + ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            9999999874  466799999999999999999999997   6 99999999999999997 99999999998764321 


Q ss_pred             eeeecccccccccCccccC--CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQ--TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ...+...||+.|||||++.  ...++.|+||||||+++|||+||+.||.....   ......+.....   ...+     
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~---Rp~~-----  267 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGL---RPPI-----  267 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCC---CCCC-----
Confidence            2334478999999999999  66999999999999999999999999975432   122222111111   1111     


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                          +..+...+..++.+||+.||++||++.|++..|+.+..
T Consensus       268 ----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  268 ----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             ----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                11144578899999999999999999999999987643

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-43  Score=391.57  Aligned_cols=247  Identities=26%  Similarity=0.412  Sum_probs=210.7

Q ss_pred             cCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      .+|+..+.||+|||++||.++. .+|+.||+|++.+..   ....+.+.+|+++.+.++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999987 789999999998632   334556889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      |+|++++|.++++    ...++++.+++.++.||+.|+.|||+.   +|+|||||..|++++++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999887    356799999999999999999999997   999999999999999999999999999999875


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      + .+...+.+|||.|.|||++....++..+||||+|||+|.|+.|++||+...   -.+....+.    .   .+..   
T Consensus       171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~---vkety~~Ik----~---~~Y~---  236 (592)
T KOG0575|consen  171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT---VKETYNKIK----L---NEYS---  236 (592)
T ss_pred             c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---HHHHHHHHH----h---cCcc---
Confidence            4 334556899999999999999999999999999999999999999997421   111111111    1   1111   


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                          .+...+.++.+||.++++++|.+|||+++|+.
T Consensus       237 ----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 ----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                11133447899999999999999999999986

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-44  Score=377.55  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=207.9

Q ss_pred             hcCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCch-------hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCG-------QMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  841 (1052)
                      .+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+...       .....+++|+++|++++|||||+++++|..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            35688899999999999999974 5899999999975421       123346799999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC---CCeEEeec
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK---FEAHLADF  918 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~---~~~kl~Df  918 (1052)
                      .|+|||||+||+|.+++-.    ...+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999998874    45577788899999999999999997   99999999999999755   88999999


Q ss_pred             ccccccCCCCCeeeecccccccccCccccCCcCCC---cccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhh
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT---CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS  995 (1052)
Q Consensus       919 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  995 (1052)
                      |+|+..+  ....+.+.+|||.|.|||++.+..++   .++|+||+||++|-+++|.+||....+..  .+.+.+.    
T Consensus       324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~----  395 (475)
T KOG0615|consen  324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQIL----  395 (475)
T ss_pred             chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHh----
Confidence            9999876  45667789999999999998765433   37899999999999999999997543322  1111111    


Q ss_pred             cccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561          996 EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                      .+.  -.+.+    .......++..++|.+|+..||++||+++|+++  |++.
T Consensus       396 ~G~--y~f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  396 KGR--YAFGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             cCc--ccccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence            111  01111    223455678999999999999999999999997  6653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=368.50  Aligned_cols=199  Identities=28%  Similarity=0.506  Sum_probs=180.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      .++|...+.||.|+||+||+|+++ ++..||||.+.+.  ..+..+-...|+++++.++|||||++++++.+++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457888888999999999999876 6899999999876  4566677899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC------CCeEEeeccc
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK------FEAHLADFGL  920 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~------~~~kl~DfG~  920 (1052)
                      |||+||+|.+|++.    .+.+++..++.++.|+|.|+++||+.   +||||||||+|||++..      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999985    34689999999999999999999985   99999999999999864      4689999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcc
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV  977 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~  977 (1052)
                      |+.+.+  .......+|+|-|||||+++..+|+.|+|+||+|+|+|||++|++||+.
T Consensus       162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            999863  3344567999999999999999999999999999999999999999974

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=388.59  Aligned_cols=256  Identities=28%  Similarity=0.447  Sum_probs=215.3

Q ss_pred             CCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          772 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      .++..+.||+|.||.||.|.+....+||+|.++.. ....+.|.+|+++|++++|++||+++++|..++..|||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            34557789999999999999997789999999755 33456789999999999999999999999998899999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+||+.  ..+..+...+.+.++.|||+|++||+++   ++|||||.++|||++++..+||+|||+|+...++....
T Consensus       286 GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  286 GSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             CcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            999999987  3566788999999999999999999996   99999999999999999999999999999655443333


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccch
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      .....-...|.|||.+....++.|||||||||+||||+| |+.||..+...+   .++.             ++.....+
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~~-------------le~GyRlp  424 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLEL-------------LERGYRLP  424 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHHH-------------HhccCcCC
Confidence            333344558999999999999999999999999999999 999987654222   2221             12222233


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561         1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1011 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      .+..++.++.++|..||+.+|++|||++.+...|+++..
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            344566789999999999999999999999999998754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-43  Score=353.03  Aligned_cols=256  Identities=25%  Similarity=0.348  Sum_probs=209.3

Q ss_pred             cCCcccCeEcccCceEEEEEE-ECCCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeeec-eEeeCCe-EEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQG-YCRHGND-RLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  845 (1052)
                      .+|++.++||+|.||+|||+. ..+|..||.|.+.-+  ..+...+...|+.++++++|||||++++ .+.++.+ .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            357788899999999999997 458999999988732  2445567889999999999999999999 4444444 8999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH--IVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      |||+++|+|...++......+.+++..+|+++.|+++||.++|+. .+.  |+||||||.||+++.+|.||++|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999999998888888999999999999999999999984 234  89999999999999999999999999999


Q ss_pred             cCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          924 LRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      +... .......+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.   +-..+...+.+.    ...   
T Consensus       178 l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qg----d~~---  246 (375)
T KOG0591|consen  178 LSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQG----DYP---  246 (375)
T ss_pred             hcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcC----CCC---
Confidence            8653 33345679999999999999999999999999999999999999999742   222222222111    111   


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                           .-.....+..+..+|..|+.+||+.||+.-.+++.
T Consensus       247 -----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  247 -----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             -----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence                 11124567789999999999999999985444443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=361.01  Aligned_cols=242  Identities=28%  Similarity=0.365  Sum_probs=201.5

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      .++|++.++||+|+||+||.++.. +++.+|+|++++...   ...+...+|..++.+++||+||+++..|++++..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            456999999999999999999755 688999999986542   2345678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      +||+.||.|..+|++    .+.+++..++.++.+|+.||.|||+.   +|||||+||+|||+|++|+++|+|||+++..-
T Consensus       104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999984    56799999999999999999999986   99999999999999999999999999998643


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      . ....+..++||+.|||||++.+..|+.++|+||+|+++|||++|.+||....      ...+........    .   
T Consensus       177 ~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k----~---  242 (357)
T KOG0598|consen  177 K-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK----L---  242 (357)
T ss_pred             c-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc----C---
Confidence            3 2334455899999999999999999999999999999999999999997422      111211111111    0   


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCC
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1035 (1052)
                         ...+.....++.+++.+++..||++|-
T Consensus       243 ---~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 ---PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence               001111234788999999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.7e-42  Score=343.53  Aligned_cols=261  Identities=24%  Similarity=0.321  Sum_probs=207.2

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecC--CchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ++|+...++|+|+||+|||++.+ +|+.||||++..  +++...+-..+|++++++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888899999999999999976 799999999863  334555667899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |++.--|++ ++.   ....++.+.+.+++.|++.|+.|+|++   +++||||||+|||++..|.+|+||||+|+.+.. 
T Consensus        82 ~~dhTvL~e-Le~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   82 YCDHTVLHE-LER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             ecchHHHHH-HHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            998765544 333   234578899999999999999999997   999999999999999999999999999998864 


Q ss_pred             CCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc----------
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----------  996 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----------  996 (1052)
                      .....++++.|..|+|||.+.+ .+|..++||||+||++.||++|.+-|.+.   .+.|....+....+.          
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~---SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR---SDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc---chHHHHHHHHHHHcccCHHHHHHhc
Confidence            4556678899999999997665 78999999999999999999999998643   222322222211110          


Q ss_pred             -cc------ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          997 -KR------EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       997 -~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                       .+      ..+.-+++......+....-+.+++.+|++.||.+|++.+|++.
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence             00      11111111112222334457889999999999999999999986

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.2e-45  Score=380.96  Aligned_cols=480  Identities=28%  Similarity=0.342  Sum_probs=303.1

Q ss_pred             CCcCCCeEecCCCCCCCCCcccccCCCCccEEeccCCcccCcccccccccCCccEEEccCcccCCcccccccCCcccEEE
Q 001561          108 HLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFN  187 (1052)
Q Consensus       108 ~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~  187 (1052)
                      .-..|+.|++++|.++ .+-..+.++..|++|++++|+++.. |++++.+..++.|+.++|+++..+.+++.+.+|+.++
T Consensus        43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~l-p~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~  120 (565)
T KOG0472|consen   43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQL-PAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLD  120 (565)
T ss_pred             hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhhhC-CHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhh
Confidence            3345677777777777 3444677777888888888877744 4466777777888888888877777777777777777


Q ss_pred             ecCCccCCccchhhhhcccccceeeccCcccccccccCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCc
Q 001561          188 ISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG  267 (1052)
Q Consensus       188 Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  267 (1052)
                      +++|.+. .++.+++ .+-.|+.++..+|++.+.|.++..+.+|..|++.+|++....|..+. ++.|++||..+|-++ 
T Consensus       121 ~s~n~~~-el~~~i~-~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-  196 (565)
T KOG0472|consen  121 CSSNELK-ELPDSIG-RLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-  196 (565)
T ss_pred             cccccee-ecCchHH-HHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-
Confidence            7777776 4444443 34556777777777777777777777777778888877754444444 777788887777776 


Q ss_pred             hhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCccccc
Q 001561          268 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG  347 (1052)
Q Consensus       268 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  347 (1052)
                      .+|+.++.+.+|..|+|..|+|. ..| .|..++.|.+|+++.|+|+-.......++++|.+|||..|+++ ..|..+.-
T Consensus       197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl  273 (565)
T KOG0472|consen  197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL  273 (565)
T ss_pred             cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence            67777777777777788888777 555 6777777777777777777443344457777777777777777 44556666


Q ss_pred             CCccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCC---cCcEEe-------ccCCcC------CC
Q 001561          348 LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLT---SLLFLS-------LSNNSF------NH  411 (1052)
Q Consensus       348 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~---~L~~L~-------L~~N~l------~~  411 (1052)
                      +.+|.+||+|+|.|+ .+|.+++++ .|+.|-+.+|.+.. +-..+-+..   -|++|.       ++.-.=      +.
T Consensus       274 LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~  350 (565)
T KOG0472|consen  274 LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTL  350 (565)
T ss_pred             hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCC
Confidence            777777777777777 466777777 77777777777652 111111100   011110       000000      00


Q ss_pred             CcccchhhccCcccceEeccccccCccCCccccC--CCcccEEEccCCccccCcchhhhcCCCCcE-EeCcCccCCCCCC
Q 001561          412 LSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG--FESLMVLALGNCGLKGHIPVWLLRCKKLQV-LDLSWNHFDGNIP  488 (1052)
Q Consensus       412 l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~-L~Ls~N~l~~~~p  488 (1052)
                      .+..+.......+.+.|+++.-+++....+.|..  -.-...++++.|++. ++|..+..++.+.+ +++++|.+ +-+|
T Consensus       351 ~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~  428 (565)
T KOG0472|consen  351 PSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVP  428 (565)
T ss_pred             CCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccch
Confidence            0111122334445566666665554322222211  112556666666665 56666655555443 33333333 3566


Q ss_pred             hhhccCCCCCeEeccCCcccccCCcchhhhhhhcccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCc
Q 001561          489 PWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNR  568 (1052)
Q Consensus       489 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~  568 (1052)
                      ..++.+++|..|+|++|-+. .+|..++.+..|                                      +.+++|.|+
T Consensus       429 ~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~L--------------------------------------q~LnlS~Nr  469 (565)
T KOG0472|consen  429 LELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRL--------------------------------------QTLNLSFNR  469 (565)
T ss_pred             HHHHhhhcceeeecccchhh-hcchhhhhhhhh--------------------------------------heecccccc
Confidence            66666666666666666655 456555555444                                      345666666


Q ss_pred             ccccCCcccccccccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeecccccc
Q 001561          569 INGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ  642 (1052)
Q Consensus       569 l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  642 (1052)
                      |. .+|..+-.+..|+.+-.++|++....|+.+++|.+|.+|||.+|.+. .||+.++++++|++|++++|++.
T Consensus       470 Fr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  470 FR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             cc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            65 56666666666666666667776544555777777777777777776 67777777777777777777776

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=360.29  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=210.7

Q ss_pred             HHhhcCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCe
Q 001561          767 LKSTNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       767 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  841 (1052)
                      .+...+|...+.||+|+|++||+|+. .+++.||||++.+..   ....+.+.+|-++|.++ .||.|++++..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            45567899999999999999999974 478999999987653   23345678899999999 89999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a  921 (1052)
                      .|+|+||+++|+|.++|+.    -+.+++..++.+|.+|+.|++|||+.   |||||||||+|||+|+|+++||+|||.|
T Consensus       149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            9999999999999999985    46799999999999999999999997   9999999999999999999999999999


Q ss_pred             cccCCCCCe----------e--eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHH
Q 001561          922 RLLRPYDTH----------V--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW  989 (1052)
Q Consensus       922 ~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~  989 (1052)
                      +.+.+....          .  ...++||..|.+||++.....++++|+|+||||+|+|+.|++||..   .+..-..+.
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra---~NeyliFqk  298 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA---ANEYLIFQK  298 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc---ccHHHHHHH
Confidence            987653221          1  1347999999999999999999999999999999999999999963   232223322


Q ss_pred             HHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          990 VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +....              ..+++..++.+.+|+.+.+..||.+|++..|+.+
T Consensus       299 I~~l~--------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  299 IQALD--------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHhc--------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            22111              1111222247889999999999999999988876

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.4e-41  Score=383.46  Aligned_cols=262  Identities=29%  Similarity=0.477  Sum_probs=216.0

Q ss_pred             cCCcccCeEcccCceEEEEEEECC------CcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  843 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  843 (1052)
                      .+.+..+.||+|+||+||+|+...      ..-||||.++.+... ...+|++|++++..++|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            344557889999999999997542      356999999877655 7789999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcccC------C----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCe
Q 001561          844 LIYSYMENGSLDYWLHESVD------K----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  913 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~  913 (1052)
                      +|+|||..|+|.+||+....      .    ..+++..+.+.||.|||.|+.||-++   ++|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence            99999999999999985431      1    23488999999999999999999997   99999999999999999999


Q ss_pred             EEeecccccccCCCCCeeee-cccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHH
Q 001561          914 HLADFGLSRLLRPYDTHVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF  991 (1052)
Q Consensus       914 kl~DfG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~  991 (1052)
                      ||+|||+++.+-..+.+... ...-..+|||||.+..+++|+++|||||||+|||+++ |+.||.+....+.   +    
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV---I----  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV---I----  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH---H----
Confidence            99999999975433322221 2234569999999999999999999999999999999 9999976443322   2    


Q ss_pred             HhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCccc
Q 001561          992 QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1051 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1051 (1052)
                      .....+.        + -+.++.++.+++.||..||+..|++||+++||-..|+...+++
T Consensus       716 e~i~~g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  716 ECIRAGQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             HHHHcCC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            1122221        1 2335566778999999999999999999999999998876543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-40  Score=326.85  Aligned_cols=261  Identities=23%  Similarity=0.342  Sum_probs=213.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .+|...+++|+|.||.||+|+.. +|+.||||+++...  ........+|++.++.++|+||+.++++|.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35777889999999999999854 89999999997542  2234557899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      ||+. +|+..+++   ....++..++..++.++++|++|||+.   .|+|||+||.|+|++++|.+||+|||+|+.+.+.
T Consensus        82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9976 78888876   566799999999999999999999986   9999999999999999999999999999998765


Q ss_pred             CCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ...... .+-|..|+|||.+.+ +.|+..+|+||.|||+.||+-|.+-|.   +.++-+....+++..+......+.+-.
T Consensus       155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp---G~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP---GDSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC---CCchHHHHHHHHHHcCCCCcccCcccc
Confidence            443333 377999999997655 579999999999999999999988875   445556666677665543333322211


Q ss_pred             ccch--------------hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1007 IWHK--------------DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~--------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ...+              ....+...+.+++.+|+..+|.+|++++|+++
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            1111              12334557799999999999999999999987

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-40  Score=346.30  Aligned_cols=266  Identities=23%  Similarity=0.354  Sum_probs=213.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCchhh-HHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .++|++.++||.|..++||+|+. ..++.||||++.-+.... .+.+.+|+..|+.++||||++++..|..+...|+||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            45799999999999999999974 478999999998665433 4789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      ||.+|++.+.+......+  +.+..+..|.+++++||.|||++   |.||||||+.|||++.+|.|||+|||.+..+...
T Consensus       105 fMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            999999999998876444  89999999999999999999997   9999999999999999999999999998765443


Q ss_pred             CCeee---ecccccccccCccccC--CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          928 DTHVT---TDLVGTLGYIPPEYSQ--TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       928 ~~~~~---~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      .....   ..++||+.|||||+++  ...|+.|+||||||++..||.+|+.||....+-.      .........+ ...
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~p-p~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDP-PTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCC-CCc
Confidence            32211   4569999999999844  3478999999999999999999999997543211      1111111111 111


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .......+........+.+++..|++.||++|||++++++  +++..
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence            1112222233344558899999999999999999999987  55544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=364.57  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=211.7

Q ss_pred             cCCcccCeEcccCceEEEEEE-ECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ..|+....||+|+.|.||.|. ..+++.||||++........+-+..|+.+|+..+|+|||.+++.|...++.|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            467778889999999999997 4578999999998777777777899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      +||+|.+.+..     ..+++.++..|..++++||+|||..   +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            99999998864     3489999999999999999999986   999999999999999999999999999998875443


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       .....+|||.|||||++....|.+++||||||++++||+.|++||-..   +   -++.++.....+ ..+       .
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE---~---PlrAlyLIa~ng-~P~-------l  489 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE---N---PLRALYLIATNG-TPK-------L  489 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC---C---hHHHHHHHhhcC-CCC-------c
Confidence             345679999999999999999999999999999999999999999521   1   111122222211 111       2


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ..++..+..+.+++.+|++.||++||++.|+++
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            233445568999999999999999999999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-41  Score=356.59  Aligned_cols=261  Identities=22%  Similarity=0.306  Sum_probs=211.6

Q ss_pred             hcCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCchhhHHHH-HHHHHHHHhcC-CCceeeeeceEeeCC-eEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREF-QAEVEALSRAQ-HKNLVSLQGYCRHGN-DRLLI  845 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~-~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  845 (1052)
                      .++|.+.+.||.|+||.||+|+- .+|+.||||+++.....+++.. .||++.+++++ |||||++.+++.+.+ ..|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            45788899999999999999974 4799999999987655544433 78999999998 999999999999988 89999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      ||||+. +|.+.+++.   ++.+++..++.|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+|+.+.
T Consensus        89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            999965 899998873   77899999999999999999999997   99999999999999998899999999999876


Q ss_pred             CCCCeeeecccccccccCccc-cCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ..  ...+.++.|..|+|||+ +....|+.+.|+||+|||++|+.+=++-|.+   .+..|.+..+.+..+.........
T Consensus       162 Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG---~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  162 SK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG---ASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC---CcHHHHHHHHHHHhCCCccccchh
Confidence            43  34567899999999996 5677899999999999999999999998864   333344444444433322211111


Q ss_pred             ----------------ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ----------------ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                      +.-....-..+..++.+++.+|+.+||.+|||+.|+++
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                            00000111235668899999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-40  Score=351.58  Aligned_cols=252  Identities=30%  Similarity=0.457  Sum_probs=203.8

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC--eEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN--DRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  847 (1052)
                      .++...+.||+|+||+||++... +|+..|||.+........+.+.+|+.++++++|||||+++|.....+  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34667889999999999999866 48999999987654333566899999999999999999999855444  5889999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCCeEEeecccccccCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~~  926 (1052)
                      |+++|+|.+++....  + .+++..+..++.||++||+|||++   +|+||||||+|||++. ++.+||+|||.++....
T Consensus        97 y~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999998642  2 699999999999999999999986   9999999999999999 79999999999987763


Q ss_pred             --CCCeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          927 --YDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       927 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                        ..........||+.|||||++..+ ....++||||+||++.||+||++||...     .+..++++..........+ 
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~i-  244 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEI-  244 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCC-
Confidence              122233457899999999999853 3445999999999999999999999642     2223333433333222211 


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                              +...+.+..+++.+|+..+|++|||++++++
T Consensus       245 --------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~  275 (313)
T KOG0198|consen  245 --------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLE  275 (313)
T ss_pred             --------CcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                    2223447899999999999999999999987

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=329.86  Aligned_cols=236  Identities=23%  Similarity=0.315  Sum_probs=199.1

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhH---HHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQME---REFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      .+|+..+.||.|+||+|..++.+ +|..+|+|++.+......   +....|..+++.+.||+++++++.+.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            35788999999999999999865 688999999987653333   34577999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||++||.|.++++.    .+.+++..++.+|.||+.|++|||+.   +|++||+||+|||+|++|++||+|||+|+.+..
T Consensus       124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999985    55689999999999999999999996   999999999999999999999999999998743


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                          .+.+.+|||.|+|||++....+..++|+|||||++|||+.|++||....   .....+.+...       ++.   
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~---~~~iY~KI~~~-------~v~---  259 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN---PIQIYEKILEG-------KVK---  259 (355)
T ss_pred             ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC---hHHHHHHHHhC-------ccc---
Confidence                2566899999999999999999999999999999999999999997432   22222222211       111   


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCC
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRR 1034 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~R 1034 (1052)
                          ++.....++.+|+.+.++.|-.+|
T Consensus       260 ----fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 ----FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----CCcccCHHHHHHHHHHHhhhhHhh
Confidence                112223368899999999999988

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-40  Score=352.64  Aligned_cols=262  Identities=26%  Similarity=0.344  Sum_probs=209.5

Q ss_pred             cCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  845 (1052)
                      ..|+..+.||+|+||.||+|+. .+|+.||+|+++-+.  .....-..+|+.+|+++.||||+++.+...+.  ...|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            3477788899999999999975 489999999987554  34445578999999999999999999998876  689999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      +|||+. +|.-++..   .+..+++.++..++.|+++||+|+|+.   +|+|||||.+|||+|.+|.+||+|||+|+++.
T Consensus       197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999987 56666653   456799999999999999999999996   99999999999999999999999999999988


Q ss_pred             CCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccc-
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII- 1003 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1003 (1052)
                      .......+..+-|..|+|||++.+ ..|+.++|+||.|||+.||++|++.|.+   .+..+.+..++..........+. 
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G---~tEveQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG---RTEVEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC---ccHHHHHHHHHHHhCCCChhcccc
Confidence            777666777889999999997655 5799999999999999999999999974   33444444455443322211111 


Q ss_pred             ---------cccccchh-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1004 ---------DASIWHKD-----REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1004 ---------~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                               .+......     .........+|+..++..||.+|.|+.++++
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                     11000000     1112346789999999999999999999986

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.2e-43  Score=369.10  Aligned_cols=480  Identities=25%  Similarity=0.359  Sum_probs=397.6

Q ss_pred             EEEEEecCCCCcccCCccccCCcCCCeEecCCCCCCCCCcccccCCCCccEEeccCCcccCcccccccccCCccEEEccC
Q 001561           88 VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSS  167 (1052)
Q Consensus        88 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~  167 (1052)
                      ...+.+++|.+... .+.+.++..|..|++++|++. ..|.+++.+..++.|+.|+|+++ .+|.....+.+|+.|++++
T Consensus        47 l~~lils~N~l~~l-~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   47 LQKLILSHNDLEVL-REDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhhccCchhhc-cHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence            45678889988864 456899999999999999998 67889999999999999999998 5667889999999999999


Q ss_pred             cccCCcccccccCCcccEEEecCCccCCccchhhhhcccccceeeccCcccccccccCCCCCCCCEEEcccccCCCCCCc
Q 001561          168 NSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPD  247 (1052)
Q Consensus       168 N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~  247 (1052)
                      |.+...+.+++.+..|..++..+|+++ .+|..++ .+.+|..+++.+|+++..++..-.++.|++||+..|.++ .+|.
T Consensus       124 n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~-~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~  200 (565)
T KOG0472|consen  124 NELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMV-NLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPP  200 (565)
T ss_pred             cceeecCchHHHHhhhhhhhccccccc-cCchHHH-HHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCCh
Confidence            999999999999999999999999999 5555543 467899999999999999988777999999999999998 7899


Q ss_pred             cccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccc-cCccccccccccCCcccCCCCcccccCCC
Q 001561          248 SLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVL-GNLTQLEFFVAHSNSFSGPLPLSLSLCSK  326 (1052)
Q Consensus       248 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~~~l~~l~~  326 (1052)
                      .++.+.+|+-|+|.+|++. ..| .|.+++.|++|+++.|+|+ .+|... .+++++..||+.+|+++ ..|+.+..+.+
T Consensus       201 ~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrs  276 (565)
T KOG0472|consen  201 ELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRS  276 (565)
T ss_pred             hhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhh
Confidence            9999999999999999998 666 8999999999999999999 666665 49999999999999999 77999999999


Q ss_pred             CcEEEecCccccCcCCcccccCCccceeecccccccCCCCccccCCC---ccceeec-------cccc----cccc-Cch
Q 001561          327 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH---DLKILSL-------AKNE----LSGQ-VPE  391 (1052)
Q Consensus       327 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~---~L~~L~L-------~~N~----l~~~-~p~  391 (1052)
                      |+.||+++|.+++ .|..++++ .|+.|.+.+|.+.. +-..+-+..   -|++|.=       +.-.    -++. .+.
T Consensus       277 L~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~  353 (565)
T KOG0472|consen  277 LERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSE  353 (565)
T ss_pred             hhhhcccCCcccc-CCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCC
Confidence            9999999999995 56688999 99999999999873 222222211   1222211       1110    0011 111


Q ss_pred             ---hhccCCcCcEEeccCCcCCCCcccchhhccCcccceEeccccccCccCCccccCCCcccEEEccCCccccCcchhhh
Q 001561          392 ---SFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLL  468 (1052)
Q Consensus       392 ---~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~  468 (1052)
                         ....+.+.+.|++++-+++.+|..+....+-.-.+..+++.|++ .++|..+..+..+.+.-+.+|+..+.+|..++
T Consensus       354 ~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL-~elPk~L~~lkelvT~l~lsnn~isfv~~~l~  432 (565)
T KOG0472|consen  354 SFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQL-CELPKRLVELKELVTDLVLSNNKISFVPLELS  432 (565)
T ss_pred             cccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchH-hhhhhhhHHHHHHHHHHHhhcCccccchHHHH
Confidence               12345678899999999999988766555556688899999998 57888888877776554444444559999999


Q ss_pred             cCCCCcEEeCcCccCCCCCChhhccCCCCCeEeccCCcccccCCcchhhhhhhcccCCCCCCCCCCCCccceeeccccCC
Q 001561          469 RCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTN  548 (1052)
Q Consensus       469 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~  548 (1052)
                      .+++|..|+|++|.+. .+|..++.+..|+.||+|.|+|. .+|+.+..+..+.                          
T Consensus       433 ~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE--------------------------  484 (565)
T KOG0472|consen  433 QLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE--------------------------  484 (565)
T ss_pred             hhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH--------------------------
Confidence            9999999999999998 89999999999999999999997 6888777666552                          


Q ss_pred             CcCCCCCCCCCCeeeeecCcccccCCcccccccccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCcc
Q 001561          549 GLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGS  624 (1052)
Q Consensus       549 ~l~~~~~~~~~~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~~  624 (1052)
                                  .+..++|++...-|..+++|.+|..|||.+|.|. .||..+++|++|++|+|++|+|.  .|+.
T Consensus       485 ------------tllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr~  545 (565)
T KOG0472|consen  485 ------------TLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPRH  545 (565)
T ss_pred             ------------HHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCHH
Confidence                        2334668887655656999999999999999999 89999999999999999999998  5543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=360.41  Aligned_cols=366  Identities=25%  Similarity=0.200  Sum_probs=304.4

Q ss_pred             EEeccCCcccCcccccccccCCccEEEccCcccCCcccccccCCcccEEEecCCccCCccchhhhhcccccceeeccCcc
Q 001561          138 VLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH  217 (1052)
Q Consensus       138 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~  217 (1052)
                      .||+|+|.++...+..|.++++|+++++.+|.++.+|.-.....+|+.|+|.+|.|+ .+..+-...++.|+.||||.|.
T Consensus        82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~  160 (873)
T KOG4194|consen   82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNL  160 (873)
T ss_pred             eeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhch
Confidence            344444444444444444444444444444444444443444445666666666666 5566667777888888888888


Q ss_pred             cccccc-cCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCccc
Q 001561          218 FMGSLQ-GLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV  296 (1052)
Q Consensus       218 l~~~~~-~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  296 (1052)
                      |+.++. .+..-.++++|+|++|.|+....+.|.++.+|..|.|++|+++...+..|.+|++|+.|+|..|+|.-.---.
T Consensus       161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt  240 (873)
T KOG4194|consen  161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT  240 (873)
T ss_pred             hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence            888874 5666689999999999999988999999999999999999999888889999999999999999998544667


Q ss_pred             ccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCccccCCCccc
Q 001561          297 LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK  376 (1052)
Q Consensus       297 ~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  376 (1052)
                      |.++++|+.|.|..|.++......|..+.++++|+|..|++...-...+.+++.|+.|+||+|.|...-++....+++|+
T Consensus       241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~  320 (873)
T KOG4194|consen  241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK  320 (873)
T ss_pred             hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence            89999999999999999988888999999999999999999988888889999999999999999988899999999999


Q ss_pred             eeecccccccccCchhhccCCcCcEEeccCCcCCCCcccchhhccCcccceEeccccccCccCC---ccccCCCcccEEE
Q 001561          377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIP---ENVGGFESLMVLA  453 (1052)
Q Consensus       377 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~  453 (1052)
                      +|+|++|+|+...+..|..|+.|++|+|++|++..+..  ..|..+++|++|||++|.+...+-   ..|.++++|+.|+
T Consensus       321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e--~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~  398 (873)
T KOG4194|consen  321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAE--GAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR  398 (873)
T ss_pred             eEeccccccccCChhHHHHHHHhhhhcccccchHHHHh--hHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence            99999999998889999999999999999999998865  467889999999999999876544   4678899999999


Q ss_pred             ccCCccccCcchhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeEeccCCcc
Q 001561          454 LGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTL  507 (1052)
Q Consensus       454 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  507 (1052)
                      |.+|+|+...-.+|.+++.|+.|||.+|.|...-|.+|..| +|+.|-+..-.+
T Consensus       399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf  451 (873)
T KOG4194|consen  399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF  451 (873)
T ss_pred             ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence            99999997777889999999999999999988889999998 899888865443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-39  Score=351.01  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=208.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+..  .+..+.+.+|++++++++|||||.++++|+...+.|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56888899999999999999855 68899999987553  3344668999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+.| +|..++..    ++.++++.+..++.+++.||.|||+.   +|.|||+||+|||++..|.+|+||||+|+.+.. 
T Consensus        82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9987 99999874    66799999999999999999999997   999999999999999999999999999998765 


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ...+.+...|||-|||||++.++.|+..+|.||+||++||+++|++||..      ..+.+-+.....+.        . 
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~--------v-  217 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDP--------V-  217 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCC--------C-
Confidence            45556678899999999999999999999999999999999999999952      12222222222111        0 


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        .++......+..++...+.+||.+|.+..+++.
T Consensus       218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             --CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence              112244457889999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=372.27  Aligned_cols=257  Identities=28%  Similarity=0.480  Sum_probs=215.4

Q ss_pred             CCcccCeEcccCceEEEEEEEC-C---CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-N---GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ...+.++||.|.||.||+|+++ .   ...||||.++... .+...+|..|+.+|.++.||||+++.|+.......+||.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3466889999999999999876 2   3579999998554 445578999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      |||++|+|+.||+..   ++.+++.+...|..+||.|++||-++   ++|||||.++|||++.+..+||+|||+++.+.+
T Consensus       710 EyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999874   56699999999999999999999987   999999999999999999999999999998765


Q ss_pred             CCCeeeecccc--cccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          927 YDTHVTTDLVG--TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       927 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      +.....+..-|  ..+|.|||.+..++++.++||||||++|||.++ |++||-.+..   ++.+..             +
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdVIka-------------I  847 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVIKA-------------I  847 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHHHHH-------------H
Confidence            54333333323  358999999999999999999999999999887 9999865432   222221             2


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      ......+.+.+++..+.+||..||++|-.+||.+.|++..|..+-.+
T Consensus       848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            22233344566777999999999999999999999999999887544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=354.27  Aligned_cols=250  Identities=28%  Similarity=0.382  Sum_probs=205.5

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC----ch-hhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCe
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD----CG-QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGND  841 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  841 (1052)
                      ..++|.+.+.||+|+||+|+.|... ++..||+|++...    .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4568999999999999999999754 7899999977653    12 34556779999999998 9999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-CCeEEeeccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGL  920 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~  920 (1052)
                      .|+||||+.||+|.+++..    ..++.+.++.+++.|++.|++|+|+.   +|+||||||+||++|.+ +.+||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999975    45688899999999999999999996   99999999999999999 9999999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCCcC-CC-cccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT-AT-CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      +.... .......+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.   .+...+...+.  ...-.
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~ki~--~~~~~  241 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRKIR--KGEFK  241 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHHHh--cCCcc
Confidence            99874 2233445679999999999999877 76 689999999999999999999974   22222221110  00000


Q ss_pred             ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ....+.           +.++..++.+|+.++|.+|+++.|+++
T Consensus       242 ~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  242 IPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             CCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            111110           447899999999999999999999985

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.2e-39  Score=347.44  Aligned_cols=252  Identities=26%  Similarity=0.319  Sum_probs=204.9

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ..++|+..++||+|+||.||.|+.+ +|+.+|+|++++..-.   ..+.+..|-.+|....+|.||+++..|.+.+..||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999754 7999999999866422   23457789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      ||||++||++..+|..    .+.++++.++.++.+++-|+..+|+.   |+|||||||+|+|||..|++||+|||++.-+
T Consensus       219 iMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999998874    56799999999999999999999997   9999999999999999999999999998643


Q ss_pred             CCC----------------------C-C----ee-------------------eecccccccccCccccCCcCCCcccch
Q 001561          925 RPY----------------------D-T----HV-------------------TTDLVGTLGYIPPEYSQTLTATCRGDV  958 (1052)
Q Consensus       925 ~~~----------------------~-~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv  958 (1052)
                      ...                      + .    ..                   ....+|||.|||||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            210                      0 0    00                   012389999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCcccCCC-CchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCC-
Q 001561          959 YSFGVVLLELLTGRRPVEVCKGK-NCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF- 1036 (1052)
Q Consensus       959 wslGvil~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs- 1036 (1052)
                      ||+|||+|||+.|.+||...... ..+.++.|........              ......++.++|.+|+. ||++|-. 
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            99999999999999999754432 2345555543322111              11122478999999999 9999975 


Q ss_pred             --HHHHHH
Q 001561         1037 --IEEVVT 1042 (1052)
Q Consensus      1037 --~~evl~ 1042 (1052)
                        +.||.+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              555543

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=315.42  Aligned_cols=265  Identities=25%  Similarity=0.324  Sum_probs=217.1

Q ss_pred             hhcCCcccCeEcccCceEEEEEE-ECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----eE
Q 001561          769 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----DR  842 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  842 (1052)
                      ..++|++.+.+|+|||+.||.++ ..++..+|+|++.....+..+...+|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34689999999999999999997 5678999999998777777788999999999999999999999875443     48


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      |++++|...|+|.+.++....++..+++.+.++|+.++++||++||+. +++++||||||.||++.+++.+++.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999999998887888999999999999999999999986 5679999999999999999999999999998


Q ss_pred             ccCCCCCee--------eecccccccccCccccC---CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHH
Q 001561          923 LLRPYDTHV--------TTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF  991 (1052)
Q Consensus       923 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~  991 (1052)
                      ...-.....        .....-|..|+|||.+.   +...++++|||||||++|+|+.|..||+...            
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~------------  245 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY------------  245 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh------------
Confidence            754221110        11235688999999765   4466889999999999999999999997321            


Q ss_pred             HhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          992 QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      + .+......+..+.+..+.....++.+.+++.+|+++||.+||++.+++..++++
T Consensus       246 ~-~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  246 Q-QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             h-cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            1 111122233333333333333667899999999999999999999999988765

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-39  Score=353.96  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=211.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      +-|+..+.||+|+.|.|..|++. +|+.+|||++.+..   ......+.+|+-+|+.+.||||+++++++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45788999999999999999865 89999999997653   122345789999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|.|++++-.    .+++++.++.+++.||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|||+|..-. 
T Consensus        92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-  163 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-  163 (786)
T ss_pred             EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence            99999999999974    56789999999999999999999998   99999999999999999999999999997643 


Q ss_pred             CCCeeeecccccccccCccccCCcCCC-cccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTAT-CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                       ....-.+.||+|.|.|||++.+.+|. .++||||.|||+|.|+||+.||+   +++.+.+...+.+..-          
T Consensus       164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~f----------  229 (786)
T KOG0588|consen  164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGVF----------  229 (786)
T ss_pred             -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCcc----------
Confidence             23344567999999999999999885 68999999999999999999997   4555555544432211          


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                          ..+...+.++++|+++|+..||++|.|+.||++  +|..
T Consensus       230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence                111233447899999999999999999999987  5543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.1e-38  Score=355.06  Aligned_cols=263  Identities=26%  Similarity=0.420  Sum_probs=205.1

Q ss_pred             hcCCcccCeEcccCceEEEEEEE------CCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCC-
Q 001561          770 TNNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN-  840 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-  840 (1052)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|++.... ....+.+.+|++++.++ +||||++++++|.+.+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            45789999999999999999974      235689999987543 23345688999999999 8999999999887654 


Q ss_pred             eEEEEEEeccCCChhhhhhcccCC--------------------------------------------------------
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDK--------------------------------------------------------  864 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------  864 (1052)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            578999999999999998753210                                                        


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee-eecccccccc
Q 001561          865 --DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGY  941 (1052)
Q Consensus       865 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y  941 (1052)
                        ..++++.++..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++......... .....+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              13578899999999999999999986   99999999999999999999999999998654322211 1233566789


Q ss_pred             cCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHH
Q 001561          942 IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML 1020 (1052)
Q Consensus       942 ~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1020 (1052)
                      +|||++.+..++.++|||||||++|||++ |+.||......  ......+   . ......         .+......+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~---~-~~~~~~---------~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRL---K-DGTRMR---------APENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHH---h-cCCCCC---------CCCCCCHHHH
Confidence            99999988899999999999999999997 99999643211  1111111   1 111000         0112234688


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561         1021 EIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1021 ~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      +++.+|++.||++||++.|+++.|+++..+
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=343.16  Aligned_cols=247  Identities=27%  Similarity=0.395  Sum_probs=207.8

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .|+..+.||+|.||.||+|... +++.||+|++..+..+ ..+++++|+.++..++++||.++++.+..+...+++|||+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            4677789999999999999754 7899999999866543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      .||++.+.++.    +..+.+.....++.++..|+.|+|++   +.+|||||+.||++..+|.||++|||.+.++.....
T Consensus        94 ~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   94 GGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             cCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999988863    44457788888999999999999997   999999999999999999999999999988765433


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      . ..+++|||.|||||++....|+.|+||||||++.+||.+|.+|+....+                ....-.+.+....
T Consensus       167 r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~PP  229 (467)
T KOG0201|consen  167 R-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAPP  229 (467)
T ss_pred             c-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCCC
Confidence            3 3678999999999999988999999999999999999999999864321                1111222222222


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .........+.+++..|++++|+.||++.++++
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            223355568999999999999999999999987

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=350.97  Aligned_cols=388  Identities=23%  Similarity=0.220  Sum_probs=328.0

Q ss_pred             ceeeccCcccccccc-cCCC--CCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEcc
Q 001561          209 QILDLSMNHFMGSLQ-GLDH--SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIF  285 (1052)
Q Consensus       209 ~~L~Ls~n~l~~~~~-~l~~--~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  285 (1052)
                      ..||++++++..+.. .+..  ++.-+.|++++|+++.+.+..|.++++|++++|.+|.++ .+|.......+|+.|+|.
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~  133 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR  133 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence            445666666654321 1211  245667999999999888888999999999999999998 778777777789999999


Q ss_pred             CCcCCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCC
Q 001561          286 GNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPL  365 (1052)
Q Consensus       286 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  365 (1052)
                      +|.|+.+-.+.+.-++.|+.|||+.|.|+...-.+|..-.++++|+|++|+|+......|.++.+|.+|.|+.|+++...
T Consensus       134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp  213 (873)
T KOG4194|consen  134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP  213 (873)
T ss_pred             ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence            99999888888899999999999999999776677888788999999999999998999999999999999999999777


Q ss_pred             CccccCCCccceeecccccccccCchhhccCCcCcEEeccCCcCCCCcccchhhccCcccceEeccccccCccCCccccC
Q 001561          366 PNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG  445 (1052)
Q Consensus       366 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  445 (1052)
                      +..|.++++|+.|+|..|+|.-.---.|..|++|+.|.|..|.+..+.++  .|..|.++++|+|+.|++...-..++.+
T Consensus       214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG--~Fy~l~kme~l~L~~N~l~~vn~g~lfg  291 (873)
T KOG4194|consen  214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDG--AFYGLEKMEHLNLETNRLQAVNEGWLFG  291 (873)
T ss_pred             HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCc--ceeeecccceeecccchhhhhhcccccc
Confidence            78898899999999999999844356789999999999999999988764  5788999999999999998888888999


Q ss_pred             CCcccEEEccCCccccCcchhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeEeccCCcccccCCcchhhhhhhcccC
Q 001561          446 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSN  525 (1052)
Q Consensus       446 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~  525 (1052)
                      +.+|+.|+|++|.|...-++...-.++|++|+|++|+++..-+..|..|..|+.|+|++|.++..-...|..+++|    
T Consensus       292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL----  367 (873)
T KOG4194|consen  292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSL----  367 (873)
T ss_pred             cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhh----
Confidence            9999999999999998888888889999999999999997778889999999999999999887666677777777    


Q ss_pred             CCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCcccccCCc---ccccccccceecccCceeeecCCCCcc
Q 001561          526 CTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPP---EIGQLKHLHVLDLSRNNITGTIPSSIS  602 (1052)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~ip~---~~~~l~~L~~L~Ls~N~l~g~ip~~~~  602 (1052)
                                                        ++|||++|.+++.|-+   .|.+|++|+.|+|.+|+|....-..|.
T Consensus       368 ----------------------------------~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfs  413 (873)
T KOG4194|consen  368 ----------------------------------HKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFS  413 (873)
T ss_pred             ----------------------------------hhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhc
Confidence                                              4578889998877654   467899999999999999955557899


Q ss_pred             cccCcCeeeCCCCcCCCCCCccccCccccCeeeecc
Q 001561          603 EIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN  638 (1052)
Q Consensus       603 ~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~  638 (1052)
                      .+.+|+.|||.+|.|...-|..|..+ .|+.|-+..
T Consensus       414 gl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  414 GLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             cCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            99999999999999988888889888 888876643

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=344.55  Aligned_cols=240  Identities=26%  Similarity=0.445  Sum_probs=202.5

Q ss_pred             cCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCChh
Q 001561          776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD  855 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  855 (1052)
                      .+-||.|+.|.||.|+++ ++.||||+++.       .-+.+++-+++++||||+.+.|+|.+...++||||||..|.|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            567999999999999987 88999998752       2245788899999999999999999999999999999999999


Q ss_pred             hhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeecc
Q 001561          856 YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL  935 (1052)
Q Consensus       856 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  935 (1052)
                      ..|+    .+..++......|..+||.|+.|||.+   .|||||||.-||||..+..|||+|||-++.....  .....+
T Consensus       201 ~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF  271 (904)
T KOG4721|consen  201 EVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF  271 (904)
T ss_pred             HHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence            9997    467789999999999999999999998   9999999999999999999999999999887543  223457


Q ss_pred             cccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHH
Q 001561          936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1015 (1052)
Q Consensus       936 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1052)
                      +||..|||||++...+.+.|+||||||||||||+||..||....    ...+-|           -+-...+....+..+
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd----ssAIIw-----------GVGsNsL~LpvPstc  336 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD----SSAIIW-----------GVGSNSLHLPVPSTC  336 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc----hheeEE-----------eccCCcccccCcccC
Confidence            99999999999999999999999999999999999999985211    000101           111122233445567


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1016 LLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1016 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      +..+.-|+++||+-.|..||++++++.-|+-.
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            77899999999999999999999999877543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=380.87  Aligned_cols=262  Identities=30%  Similarity=0.450  Sum_probs=212.5

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC--CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT--NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  842 (1052)
                      ....+..+.||+|+||.||+|...  +|.    .||+|.+.+.. .+.+.+|.+|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345667889999999999999865  343    48999887654 55667899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcccC---CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          843 LLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                      ++++|||++|+|..||++.+.   ....++..+.+.++.|||+|+.||++.   ++|||||.++|+|+++...|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999997532   245689999999999999999999985   99999999999999999999999999


Q ss_pred             cccccCCCCCeeeecc-cccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcc
Q 001561          920 LSRLLRPYDTHVTTDL-VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      +|+.+-..+....... .-...|||||.+..+.++.|+|||||||++||++| |..||.....   .+...   ......
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---~~v~~---~~~~gg  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEVLL---DVLEGG  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---HHHHH---HHHhCC
Confidence            9996543332222222 23358999999999999999999999999999999 9999964321   11111   111111


Q ss_pred             cccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561          998 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                                ..+.+..++..++++|..||+.+|++||++..+++.++.|..+
T Consensus       922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                      1223345566899999999999999999999999998887554

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-38  Score=348.89  Aligned_cols=242  Identities=24%  Similarity=0.325  Sum_probs=202.0

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  844 (1052)
                      .++|...++||+|.||+|++|..+ +++.+|||+++++..   ...+..+.|.+++... +||.++.++..|...++.|.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            457999999999999999999866 688999999987752   3345677888888888 59999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      ||||+.||++..+.+     .+.+++..+..+|..|+.||+|||++   +|||||||.+|||+|.+|++||+|||+++..
T Consensus       447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999555443     45689999999999999999999986   9999999999999999999999999999874


Q ss_pred             CCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .- ....+.+++|||.|||||++.+..|+.++|+|||||+||||+.|..||.+   ++.+++.+.+....          
T Consensus       519 m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g---ddEee~FdsI~~d~----------  584 (694)
T KOG0694|consen  519 MG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG---DDEEEVFDSIVNDE----------  584 (694)
T ss_pred             CC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCC----------
Confidence            42 23356779999999999999999999999999999999999999999974   33333333222111          


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1037 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1037 (1052)
                          ..++...+.+...++++++.++|++|--+
T Consensus       585 ----~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 ----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                11222334578899999999999999866

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=345.59  Aligned_cols=260  Identities=29%  Similarity=0.480  Sum_probs=207.3

Q ss_pred             hhcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ..+.+.+.+.||+|.||+||+|+|.  -.||||++..+.  .+..+.|+.|+.++++-+|.||+-+.|||..+.. .||+
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            3445667889999999999999986  368999987654  4455789999999999999999999999998877 9999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      .+++|.+|+.++|..   +..++..+.+.||.|||+|+.|||.   ++|||||+|..||++.+++.|||+|||++..-..
T Consensus       467 qwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             hhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            999999999999973   4678999999999999999999998   5999999999999999999999999999976432


Q ss_pred             C-CCeeeecccccccccCccccCC---cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          927 Y-DTHVTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       927 ~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      - .........|...|||||++..   .+|++.+||||||+++|||+||..||..    +..+.+-|   +...+..  .
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi----~~~dqIif---mVGrG~l--~  611 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI----QNRDQIIF---MVGRGYL--M  611 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC----CChhheEE---Eeccccc--C
Confidence            2 1122223457789999998754   4789999999999999999999999962    22222211   1111100  0


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      .|.   ......+..++.+|+..||..++++||.+.+++..|+.+..
T Consensus       612 pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  612 PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            111   11123445689999999999999999999999998887754

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-38  Score=309.55  Aligned_cols=247  Identities=27%  Similarity=0.375  Sum_probs=208.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   ...++++.+|+++.+.++||||++++++|.+....|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            46899999999999999999865 67899999987543   345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||..+|++...|++.  ....+++.....++.|+|.|+.|+|.   ++|+||||||+|+|++.++..|++|||.+..-. 
T Consensus       102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999854  34568888899999999999999997   599999999999999999999999999997543 


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                        .......+||..|.|||...+..++..+|+|++|+..||++.|.+||+...   ..+..+.+..       .++.++ 
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k-------~~~~~p-  242 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRK-------VDLKFP-  242 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHH-------ccccCC-
Confidence              333456799999999999999999999999999999999999999997533   1122221111       112222 


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            .....++.++|.+|+..+|.+|.+..|+++
T Consensus       243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  243 ------STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence                  233447899999999999999999999987

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.4e-37  Score=341.20  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=199.4

Q ss_pred             cCeEcccCceEEEEEEECCCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeeeeceEee----CCeEEEEEEe
Q 001561          776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKNLVSLQGYCRH----GNDRLLIYSY  848 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  848 (1052)
                      ...||+|++|.||+|.+ +|+.||||+++.....   ..+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            46799999999999998 5899999998754322   24667899999999999999999999876    3467899999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++|+|.+++..    ...+++..+..++.+++.|++|||+.  .+++||||||+||++++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999874    34688999999999999999999973  378899999999999999999999999998654321


Q ss_pred             CeeeecccccccccCccccCC--cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                          ....|++.|+|||++.+  ..++.++|||||||++|||++|+.||...   +..+....+..   ......     
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~---~~~~~~~~i~~---~~~~~~-----  242 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL---TTKEIYDLIIN---KNNSLK-----  242 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHh---cCCCCC-----
Confidence                23468899999999876  67899999999999999999999999742   22222222111   111000     


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                          .+...+..+.+++.+||+.||++|||++|+++.|+.++
T Consensus       243 ----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        243 ----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                11123447899999999999999999999999998875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=333.48  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=198.2

Q ss_pred             HhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--------------hhHHHHHHHHHHHHhcCCCceeee
Q 001561          768 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--------------QMEREFQAEVEALSRAQHKNLVSL  832 (1052)
Q Consensus       768 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l  832 (1052)
                      +..++|++.+.||+|.||.|-+|+.. +++.||||++.+...              ...+.+.+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999865 789999999964320              112468899999999999999999


Q ss_pred             eceEeeC--CeEEEEEEeccCCChhhhhhcccCCccc-cCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC
Q 001561          833 QGYCRHG--NDRLLIYSYMENGSLDYWLHESVDKDSV-LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE  909 (1052)
Q Consensus       833 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~  909 (1052)
                      +++..++  +..|||+|||..|.+...=     ...+ +++.++++|+.+++.||+|||.+   +|+||||||+|+|+++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence            9999875  5789999999999865432     3344 89999999999999999999997   9999999999999999


Q ss_pred             CCCeEEeecccccccCCCCCe----eeecccccccccCccccCCcC----CCcccchHHHHHHHHHHHcCCCCCcccCCC
Q 001561          910 KFEAHLADFGLSRLLRPYDTH----VTTDLVGTLGYIPPEYSQTLT----ATCRGDVYSFGVVLLELLTGRRPVEVCKGK  981 (1052)
Q Consensus       910 ~~~~kl~DfG~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltG~~pf~~~~~~  981 (1052)
                      +|+|||+|||.+.........    .....+|||.|+|||...++.    .+.+.||||+||+||+|+.|+.||-.   +
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~  322 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---D  322 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---c
Confidence            999999999999866322111    112358999999999766522    34678999999999999999999953   2


Q ss_pred             CchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          982 NCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ...++...            ++...+..+..++..+.+.++|.+|+.+||++|.+..+|..
T Consensus       323 ~~~~l~~K------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  323 FELELFDK------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             hHHHHHHH------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            22222221            12222222333345567899999999999999999999865

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-39  Score=312.47  Aligned_cols=250  Identities=23%  Similarity=0.327  Sum_probs=203.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      +.|++.++||+|.|+.||++... +|+.+|+|++...  .....+++.+|+++-+.++|||||++.+.+.+....|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            46788889999999999999654 7999999877522  23456778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC---CCCCeEEeeccccccc
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLL  924 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~---~~~~~kl~DfG~a~~~  924 (1052)
                      +|+|++|..-+-.    ....++..+-.++.||++|++|+|..   +|||||+||+|+++-   ...-+|++|||+|..+
T Consensus        91 ~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   91 LVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             cccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999998654432    24578899999999999999999986   999999999999995   3445899999999988


Q ss_pred             CCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .  ........+|||+|||||++...+|+..+|||+.|||+|-++.|++||.+   ++..++.+.+....-      -++
T Consensus       164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~y------d~~  232 (355)
T KOG0033|consen  164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAY------DYP  232 (355)
T ss_pred             C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhcccc------CCC
Confidence            7  44555678999999999999999999999999999999999999999963   222233333222111      122


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +..|..    ..++..+++++|+..||.+|.|+.|++.
T Consensus       233 ~~~w~~----is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  233 SPEWDT----VTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CcccCc----CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            222332    3347889999999999999999999986

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-38  Score=349.25  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=205.1

Q ss_pred             CcccCeEcccCceEEEEEEECC--C--cE-EEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          773 FNQANIIGCGGFGLVYKATLTN--G--TK-AAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~~--g--~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ....++||+|+||.||+|.+..  +  .. ||||..+.+.   .....+|.+|+++|+.++|||||+++|++......|+
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3445889999999999998652  2  23 8999988632   5566789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      |||+|+||+|.++|+..   ...++..++..++.++|+||+|||+.   +++||||.++|+|++.++.+||+|||+++.-
T Consensus       239 vmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999874   33689999999999999999999985   9999999999999999999999999998764


Q ss_pred             CCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ..+..... ...-...|+|||.+....++.++|||||||++||+++ |..||.+...   .+...++....   .     
T Consensus       313 ~~~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~kI~~~~---~-----  380 (474)
T KOG0194|consen  313 SQYVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKAKIVKNG---Y-----  380 (474)
T ss_pred             cceeeccc-cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHHHHHhcC---c-----
Confidence            32211110 1123459999999999999999999999999999999 8999975432   23333331111   0     


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                          ....+...+..+..++.+|+..+|++||+|.++.++++.+..
T Consensus       381 ----r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  381 ----RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             ----cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                011111334468888999999999999999999999988754

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.2e-37  Score=339.01  Aligned_cols=262  Identities=21%  Similarity=0.266  Sum_probs=202.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36889999999999999999876 67899999987542  2334567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |++++.+..+..    ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            999987765443    234588999999999999999999986   9999999999999999999999999999876543


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhh------------
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS------------  995 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~------------  995 (1052)
                      .........|++.|+|||++.+..++.++||||+||++|||++|++||.....   .+....+.....            
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE---IDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhhCCCCHHHHHhhhc
Confidence            33333446789999999999888899999999999999999999999974321   111111111000            


Q ss_pred             ccccccccccccc------chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          996 EKREVEIIDASIW------HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       996 ~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .........+...      .......+..+.+++.+|+++||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000000      0011123457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-36  Score=335.83  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             CcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      |+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|++++++++|++|+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999986 478999999986443   22334578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++|+|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999998887643  234588999999999999999999986   99999999999999999999999999998754322


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..   ....... .         
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~-~---------  221 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKED-Q---------  221 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhcc-c---------
Confidence              223457999999999999999999999999999999999999999743221111111   1111000 0         


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH--HHhhc
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~--~L~~i 1047 (1052)
                      ..........+.+++.+|++.||++||+     ++|+++  +++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            0111123347889999999999999997     788887  55544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.8e-36  Score=337.05  Aligned_cols=264  Identities=26%  Similarity=0.374  Sum_probs=204.4

Q ss_pred             cCCcccCeEcccCceEEEEEEECC-----------------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeee
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN-----------------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSL  832 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  832 (1052)
                      ++|++.+.||+|+||.||+|.+.+                 +..||+|.+.... .....++.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                 3369999987643 3345678999999999999999999


Q ss_pred             eceEeeCCeEEEEEEeccCCChhhhhhcccC---------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 001561          833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVD---------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH  897 (1052)
Q Consensus       833 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  897 (1052)
                      ++++.+.+..++||||+++|+|.+++.....               ....+++..+++++.|++.|++|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999998865321               123478899999999999999999986   9999


Q ss_pred             cCCCCCceEECCCCCeEEeecccccccCCCCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc--CCCC
Q 001561          898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRP  974 (1052)
Q Consensus       898 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~p  974 (1052)
                      |||||+||++++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999875433222 1223456789999999888889999999999999999986  5677


Q ss_pred             CcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          975 VEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       975 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      |....   ..+....+.............      ..+..++..+.+++.+|++.||++||++.||.+.|++
T Consensus       242 ~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELT---DEQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCC---HHHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            75432   222222222211111000000      0011223478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=355.97  Aligned_cols=257  Identities=23%  Similarity=0.318  Sum_probs=214.8

Q ss_pred             cCCcccCeEcccCceEEEEEEECCC-cEEEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeeeece-Eee------CCe
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNG-TKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY-CRH------GND  841 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~  841 (1052)
                      .++++.++|.+|||+.||.|....+ .+||+|++-.......+.+.+|+++|++++ |+|||.+++. ...      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4577789999999999999987755 999999988777777888999999999996 9999999993 221      235


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a  921 (1052)
                      ++|.||||+||.|-+++......  .|++.++++|+.|+++|+++||.. .++|||||||-+|||+..++..||||||.|
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            78999999999999999876533  399999999999999999999986 788999999999999999999999999999


Q ss_pred             cccCCCC-Ceee-------ecccccccccCcccc---CCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001561          922 RLLRPYD-THVT-------TDLVGTLGYIPPEYS---QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  990 (1052)
Q Consensus       922 ~~~~~~~-~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~  990 (1052)
                      ...-... ....       -...-|+.|+|||++   .+...++|+|||++||+||-|+....||+..            
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s------------  261 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES------------  261 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC------------
Confidence            7643322 1100       012568999999964   5778999999999999999999999999732            


Q ss_pred             HHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          991 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                             ....+++.....+..+.+...+.+||+.||+++|.+||++.||++.+.+++.
T Consensus       262 -------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  262 -------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             -------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                   1234555555555556778899999999999999999999999999887754

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=324.36  Aligned_cols=262  Identities=25%  Similarity=0.361  Sum_probs=202.2

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeeeceEee-----CCe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRH-----GND  841 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  841 (1052)
                      .+.|...+.||+|+||.|+.|..+ +|+.||||++...  .....++..+|++.++.++|+||+.+.+.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            456666889999999999999865 7899999998733  34455778899999999999999999998865     357


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a  921 (1052)
                      .|+|+|+| +-+|...++    .+..++.+.+..+++|+++|++|+|+.   +|+|||+||+|++++.+..+||+|||+|
T Consensus       101 vYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence            89999999 557887776    355599999999999999999999997   9999999999999999999999999999


Q ss_pred             cccCCC-CCeeeecccccccccCcccc-CCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc
Q 001561          922 RLLRPY-DTHVTTDLVGTLGYIPPEYS-QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  999 (1052)
Q Consensus       922 ~~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      +..... ....++.++-|..|+|||++ ....|+.+.||||.|||+.||++|++-|.+..   ..+.++.+....+....
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d---~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD---YVHQLQLILELLGTPSE  249 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc---hHHHHHHHHHhcCCCCH
Confidence            987543 22344678899999999965 45689999999999999999999999996421   11111111111111000


Q ss_pred             ---------------c--ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1000 ---------------V--EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1000 ---------------~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                     .  ....+..+....+.....+.+++.+|+..||.+|+|++|+++
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                           0  000011111111233457889999999999999999999987

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.7e-37  Score=315.71  Aligned_cols=261  Identities=26%  Similarity=0.301  Sum_probs=206.8

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchh--hHHHHHHHHHHHHhcCCCceeeeeceEee--CCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  845 (1052)
                      ++|+..+.|++|+||.||+|+.+ +++.||+|+++.+...  ..-.-.+|+.++.+++|||||.+-++...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45788899999999999999865 7889999999754321  11234789999999999999999998764  3679999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      ||||+. +|...++..   .+++...++..++.|+++|++|||..   .|+|||+|++|+|+...|.+||+|||+|+.++
T Consensus       156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999987 788888753   46789999999999999999999996   99999999999999999999999999999987


Q ss_pred             CCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccc-
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII- 1003 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1003 (1052)
                      .. ....+..+-|..|+|||.+.+ ..|++++|+||+|||+.||+++++-|.+   ....+.+..++..........+. 
T Consensus       229 sp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G---~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  229 SP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG---KSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             CC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC---CchHHHHHHHHHHhCCCccccCCC
Confidence            64 334556788999999997654 6799999999999999999999999863   44455666666655433222111 


Q ss_pred             --ccccc--------------chhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1004 --DASIW--------------HKDREK-QLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1004 --~~~~~--------------~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        ....+              ..+... ..+.-.+++..++..||++|.|+.|.++
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence              11111              001111 2356789999999999999999999986

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.3e-37  Score=334.76  Aligned_cols=255  Identities=23%  Similarity=0.399  Sum_probs=204.1

Q ss_pred             cCCcccCeEcccCceEEEEEEEC----CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888999999999999999753    35689999988653 33346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++|+|.+++...   ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+....
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999998753   34689999999999999999999986   99999999999999999999999999876543


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ...........++..|+|||.+.+..++.++||||||+++||+++ |+.||....   ..+....+.    ....  .  
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~---~~~~~~~~~----~~~~--~--  227 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---GQDVIKAVE----DGFR--L--  227 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHHH----CCCC--C--
Confidence            221111122345678999999988899999999999999999775 999996432   222222211    1100  0  


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                           ..+...+..+.+++.+|++.+|++||+++|+.+.|+++
T Consensus       228 -----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 -----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 01112344688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-37  Score=322.03  Aligned_cols=245  Identities=24%  Similarity=0.376  Sum_probs=205.2

Q ss_pred             cCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCchhhHH---HHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMER---EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      .+|++.+.||+|.||+|-+|.. ..|+.||||.++++..+.+.   .+.+|+++|+.++||||++++++|+..+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4688888999999999999974 68999999999877654443   4689999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||..+|.|.+|+.+    .+.+++.++++++.||+.|+.|+|.+   +++|||+|.+|||+|+++.+||+|||++-.+..
T Consensus       133 EYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999985    55699999999999999999999997   999999999999999999999999999987753


Q ss_pred             CCCeeeecccccccccCccccCCcCCC-cccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTAT-CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                        .....+++|+|-|.+||++.+.+|. +.+|-||+||++|.++.|..||++.   ....++.   +.. .+..   ..+
T Consensus       206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvr---QIs-~GaY---rEP  273 (668)
T KOG0611|consen  206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVR---QIS-RGAY---REP  273 (668)
T ss_pred             --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHH---Hhh-cccc---cCC
Confidence              3345678999999999999998885 6899999999999999999999742   1112222   111 1111   111


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .        .+..+.-+|++|+..+|++|.|+.+|..
T Consensus       274 ~--------~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  274 E--------TPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             C--------CCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            1        1114567999999999999999999875

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=324.80  Aligned_cols=259  Identities=31%  Similarity=0.451  Sum_probs=197.6

Q ss_pred             CcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHh--cCCCceeeeeceEeeCC----eEEEEE
Q 001561          773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR--AQHKNLVSLQGYCRHGN----DRLLIY  846 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~  846 (1052)
                      .+..++||+|.||.||||.+. ++.||||++..   +....|+.|-++++.  ++|+||++++++-...+    +++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            445678999999999999987 69999999973   344567777777665  58999999999876655    789999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC------EPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ||.+.|+|.+||..     ..++|....+|+..+++||+|||+..      .++|+|||||++|||+..|+++.|+|||+
T Consensus       288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999964     45899999999999999999999753      56899999999999999999999999999


Q ss_pred             ccccCCCCCe-eeecccccccccCccccCCcCC------CcccchHHHHHHHHHHHcCCCCC------------ccc--C
Q 001561          921 SRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTA------TCRGDVYSFGVVLLELLTGRRPV------------EVC--K  979 (1052)
Q Consensus       921 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwslGvil~elltG~~pf------------~~~--~  979 (1052)
                      |..+.+.... .....+||.+|||||++.+...      -.+.||||+|.++|||++...-+            +..  .
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            9998754332 2234699999999999876422      23689999999999999854332            211  1


Q ss_pred             CCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          980 GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      .+..++....+.+.+...   .+.+.....    ..+.-+.+.+..||+.||+.|-|+.=|-+.+.++
T Consensus       443 hPt~e~mq~~VV~kK~RP---~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRP---KIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CCCHHHHHHHHHhhccCC---CChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            122223333333322221   222221111    2344678999999999999999999888877665

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7e-37  Score=351.03  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=204.2

Q ss_pred             hcCCcccCeEcccCceEEEEEEE------CCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  841 (1052)
                      .++|++.+.||+|+||.||+|.+      .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34688899999999999999964      235689999987543 33445688999999999 89999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccC----------------------------------------------------------
Q 001561          842 RLLIYSYMENGSLDYWLHESVD----------------------------------------------------------  863 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  863 (1052)
                      .++||||+++|+|.++++....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999865321                                                          


Q ss_pred             -------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          864 -------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       864 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                                   ....+++..+..++.|+++|++|||+.   +|+||||||+||++++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         122578899999999999999999986   9999999999999999999999999999876433221


Q ss_pred             e-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          931 V-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       931 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      . .....++..|+|||++.+..++.++|||||||++|||++ |..||.....  .......+.....    ..  .+   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~~~~~~~----~~--~~---  339 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMIKEGYR----ML--SP---  339 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHHHHhCcc----CC--CC---
Confidence            1 122345668999999999999999999999999999998 8999864321  1122222111100    00  00   


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                          .....++.+++.+|++.||++||+++|+++.|++.
T Consensus       340 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 ----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                11123688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.3e-37  Score=350.50  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=204.3

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  841 (1052)
                      .++|++.+.||+|+||.||+|++.      ++..||+|+++... ......+.+|+++++.+ +|+|||+++++|.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            346889999999999999999742      23579999997543 33345688999999999 89999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccC----------------------------------------------------------
Q 001561          842 RLLIYSYMENGSLDYWLHESVD----------------------------------------------------------  863 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  863 (1052)
                      .++||||+++|+|.++++....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999998864210                                                          


Q ss_pred             --------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee-eec
Q 001561          864 --------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TTD  934 (1052)
Q Consensus       864 --------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~  934 (1052)
                              ...++++.++++++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++......... ...
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    113478899999999999999999986   99999999999999999999999999998754332211 122


Q ss_pred             ccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhH
Q 001561          935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE 1013 (1052)
Q Consensus       935 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1052)
                      ..+++.|+|||++....++.++|||||||++|||++ |+.||......  .....    .........  .+       .
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~~~----~~~~~~~~~--~~-------~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYK----MVKRGYQMS--RP-------D  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHHHH----HHHcccCcc--CC-------C
Confidence            345668999999988899999999999999999997 99999643211  11111    111110000  00       0


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561         1014 KQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1014 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      ..+.++.+++.+|++.||++||++.+++++|+++-
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            11347899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-37  Score=324.13  Aligned_cols=258  Identities=25%  Similarity=0.367  Sum_probs=200.3

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC---e--EEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN---D--RLLI  845 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~--~~lv  845 (1052)
                      .|+..+++|.|+||.||+|... +++.||||+.-.+..    .-.+|+++|++++|||||++..+|....   +  ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4666889999999999999865 578999999865533    2357999999999999999999886532   2  2489


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-CCeEEeeccccccc
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGLSRLL  924 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~~  924 (1052)
                      ||||+. +|.+.++.....+..++.-.+.-++.|+++|++|||+.   +|+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 89998887666677788888999999999999999996   99999999999999965 99999999999998


Q ss_pred             CCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccc-
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI- 1002 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1002 (1052)
                      .+.+...  .+.-|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.   +..+....+....+.....++ 
T Consensus       177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~---s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD---SSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC---CHHHHHHHHHHHhCCCCHHHHh
Confidence            7665543  3567889999997655 57999999999999999999999999753   222322222222211111111 


Q ss_pred             -------------ccccccch-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1003 -------------IDASIWHK-DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1003 -------------~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                   +.+..+.. .......+..+++.++++.+|.+|.++.|++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                         11111111 23344557899999999999999999999986

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3e-36  Score=329.02  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=208.2

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            356889999999999999999988888999998875432 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++|+|.++++..  ....+++..++.++.|+++|++|||+.   +++||||||+||++++++.++++|||.++.......
T Consensus        84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999998753  344678899999999999999999986   999999999999999999999999999987653322


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .......++..|+|||+.....++.++||||||+++|||++ |+.||...   ...+...++....    ..        
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~~~~~~~----~~--------  223 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM---SNSDVMSALQRGY----RM--------  223 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC---CHHHHHHHHHcCC----CC--------
Confidence            22223346678999999988889999999999999999998 99999632   1222222221110    00        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                       +.....+.++.+++.+|++.+|++||+++++.++|+++
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             00111234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.3e-36  Score=341.58  Aligned_cols=198  Identities=30%  Similarity=0.462  Sum_probs=175.1

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ++|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            57999999999999999999876 68899999987543 33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++|+|.+++..    ...+++..+..++.|++.|++|||+.  .+|+||||||+||+++.++.+||+|||++...... 
T Consensus        85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999874    34588999999999999999999974  36999999999999999999999999999765332 


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV  977 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~  977 (1052)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence              22345799999999999988999999999999999999999999963

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.7e-36  Score=327.27  Aligned_cols=252  Identities=24%  Similarity=0.443  Sum_probs=204.0

Q ss_pred             cCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      ++|++.+.||+|+||.||+|.+.++..+|+|.+.... ...+++..|++++++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4588889999999999999998888899999876442 334678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +|+|.++++..   ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+|++|||.++........
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999988753   23588999999999999999999986   9999999999999999999999999999865432222


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.||...   ...+....+....   .   ...+.   
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~---~~~~~~~~i~~~~---~---~~~~~---  224 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK---SNYEVVEMISRGF---R---LYRPK---  224 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHCCC---C---CCCCC---
Confidence            2223345668999999988889999999999999999999 99998632   2222222221110   0   00111   


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                          ....++.+++.+|++.+|++||+++|+++.|.
T Consensus       225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                12246899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=344.15  Aligned_cols=252  Identities=24%  Similarity=0.323  Sum_probs=203.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999876 68899999987542   223456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999864    34688999999999999999999986   999999999999999999999999999986543


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+....+......      ....
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~------~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST---PNETWENLKYWKET------LQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC---HHHHHHHHHhcccc------ccCC
Confidence                2234579999999999998899999999999999999999999996422   22222211111100      0000


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ...........++.+++.+|+..+|.+||++.|+++
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            001001123457889999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-36  Score=336.45  Aligned_cols=261  Identities=22%  Similarity=0.329  Sum_probs=199.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ++|++.+.||+|+||+||+|... ++..||+|+++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46899999999999999999865 68899999987443 22344678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            975 888887642   34578899999999999999999986   99999999999999999999999999997643222


Q ss_pred             CeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc---ccc--
Q 001561          929 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE---VEI-- 1002 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 1002 (1052)
                       .......|++.|+|||++.+ ..++.++||||+||++|||++|++||...   +..+....+.........   ..+  
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS---TVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCChHHhhcccc
Confidence             12234578999999998764 56899999999999999999999999642   222222222221111000   000  


Q ss_pred             -------ccccccc----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1003 -------IDASIWH----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1003 -------~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                             ..+....    ........++.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                   0000000    001112346789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=336.56  Aligned_cols=244  Identities=25%  Similarity=0.296  Sum_probs=200.4

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999876 68999999986432   223456789999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999874    34688999999999999999999986   999999999999999999999999999987543


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...   ...+..+.+..   ..  ..     
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~---~~~~~~~~i~~---~~--~~-----  216 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD---NPFGIYEKILA---GK--LE-----  216 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CC--cC-----
Confidence            2    22357999999999999888999999999999999999999999642   22222221111   10  00     


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1042 (1052)
                          .+......+.+++.+|++.||.+||+     ++|+++
T Consensus       217 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         217 ----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                01112346889999999999999995     888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-37  Score=306.87  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=204.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--------hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCC
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--------GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  840 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  840 (1052)
                      .+|.-.+++|+|..++|.++.++ +|..+|+|++....        .+..++-.+|+++++++ .||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            45677788999999999998755 78899999886322        12223456799999998 6999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..++|+|.|+.|.|.+++..    ...+++.+.++|+.|+.+|++|||..   .|||||+||+|||+|++.++||+|||+
T Consensus        97 F~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999974    45689999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccC------CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQ------TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      |..+.+.  ......+|||+|+|||.+.      ...|+..+|+|+.|||+|.++.|.+||....     . . .+.++.
T Consensus       170 a~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Q-m-lMLR~I  240 (411)
T KOG0599|consen  170 ACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----Q-M-LMLRMI  240 (411)
T ss_pred             eeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----H-H-HHHHHH
Confidence            9988654  3345679999999999754      3567889999999999999999999995311     0 0 011111


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcCc
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                      ..+. .+ +    ..+...+.+....++|.+|++.||.+|.|++|+++  ++..+..
T Consensus       241 meGk-yq-F----~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  241 MEGK-YQ-F----RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             Hhcc-cc-c----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            1111 01 1    11222344557899999999999999999999987  5554443

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.9e-36  Score=353.65  Aligned_cols=252  Identities=21%  Similarity=0.258  Sum_probs=206.1

Q ss_pred             CCcccCeEcccCceEEEEEEEC-C-CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-N-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .|.+.+.||+|++|.||+|... + +..||+|.+..........+.+|++++++++|||||++++++.+++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999754 4 6788888876555555567888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++|+|.++++.......++++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999998876554556789999999999999999999986   999999999999999999999999999987653322


Q ss_pred             -eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 -HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...   ...+.......   ... .        
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~---~~~~~~~~~~~---~~~-~--------  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP---SQREIMQQVLY---GKY-D--------  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CCC-C--------
Confidence             1233457999999999999999999999999999999999999999632   22222222111   100 0        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                       ..+.....++.+++.+|++.+|++||++.++++
T Consensus       290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             001112346899999999999999999999875

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-36  Score=328.29  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=207.0

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688899999999999999998778889999987543 23567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++....  +..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++.......
T Consensus        84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            9999999987532  45689999999999999999999986   999999999999999999999999999987653222


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      ........+..|+|||+..+..++.++||||||+++|||++ |+.||....   .......+.   . ....        
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~---~-~~~~--------  223 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQVD---Q-GYRM--------  223 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH---c-CCCC--------
Confidence            11112223458999999998899999999999999999999 999986321   112221111   1 1000        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                       .........+.+++.+|++.+|++||++.++++.|++.
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence             01112234789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-36  Score=317.88  Aligned_cols=269  Identities=25%  Similarity=0.345  Sum_probs=208.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCc-eeeeeceEeeCC------
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKN-LVSLQGYCRHGN------  840 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  840 (1052)
                      ..|+..+.||+|+||+||+|+.. +|+.||+|++.-+..  .......+|+.++++++|+| ||++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34666778999999999999854 789999999875533  23345689999999999999 999999998877      


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..++||||++. +|..++.........++...+..++.|+++|++|||++   +|+||||||+||+++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            78999999965 89999887553334577789999999999999999997   999999999999999999999999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  999 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      |+.+.-. ....+..++|..|+|||++.+. .|+...||||+|||++||+++++-|.+.   ...+....++...+....
T Consensus       167 Ara~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~---se~~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  167 ARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD---SEIDQLFRIFRLLGTPNE  242 (323)
T ss_pred             HHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHHHcCCCCc
Confidence            9976532 2224556889999999987765 7899999999999999999999998643   334455555555443221


Q ss_pred             cccc------ccc-ccchh------hH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhhc
Q 001561         1000 VEII------DAS-IWHKD------RE---KQLLEMLEIACKCIDQDPRRRPFIEEVVTW--LDGI 1047 (1052)
Q Consensus      1000 ~~~~------~~~-~~~~~------~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 1047 (1052)
                      ....      +-. .....      ..   .......+++.+|++.+|++|.+++.+++.  +..+
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            1111      111 00000      11   111367899999999999999999999883  5444

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.7e-36  Score=328.75  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=205.9

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .+|++.+.||+|+||.||+|.+. +++.||+|++..+. ...+++.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35778899999999999999865 58899999987543 33467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++...  ....+++..++.++.|+++|++|||+.   +++||||||+||++++++.+||+|||.+........
T Consensus        85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            999999998653  234589999999999999999999986   999999999999999999999999999987653322


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .......+++.|+|||...+..++.++||||||+++|||++ |..||...   ...+......    .....        
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~---~~~~~~~~~~----~~~~~--------  224 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLE----KGYRM--------  224 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHH----CCCCC--------
Confidence            22222234668999999988899999999999999999998 99998632   2222221111    11000        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                       ..+...+.++.+++.+|++.+|++||++.|++++|+++
T Consensus       225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             11112234789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-36  Score=330.86  Aligned_cols=257  Identities=30%  Similarity=0.475  Sum_probs=211.8

Q ss_pred             hhcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ...+|++.+.||.|+||.||+|...++..+|+|.+.........++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568889999999999999999888999999999876665567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.++++..  ....+++..++.++.|++.|++|||+.   +|+||||||+||++++++.+|++|||.+.......
T Consensus        84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            9999999999764  245689999999999999999999986   99999999999999999999999999998764322


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      . ......++..|+|||......++.++||||||+++|+|++ |+.||....   ..+.........  .    .     
T Consensus       159 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~--~----~-----  223 (261)
T cd05148         159 Y-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGY--R----M-----  223 (261)
T ss_pred             c-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCC--c----C-----
Confidence            1 1223346778999999988889999999999999999998 899996432   222222221100  0    0     


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                        ......+..+.+++.+|++.+|.+||+++++++.|+++
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              01112234688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-36  Score=339.69  Aligned_cols=241  Identities=23%  Similarity=0.326  Sum_probs=195.8

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  852 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  852 (1052)
                      ++||+|+||.||+|... +|+.||+|+++...   ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 78999999987542   223345778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeee
Q 001561          853 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  932 (1052)
Q Consensus       853 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  932 (1052)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~  152 (323)
T cd05571          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence            99988864    34689999999999999999999986   9999999999999999999999999999764322 1223


Q ss_pred             ecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhh
Q 001561          933 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012 (1052)
Q Consensus       933 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1052)
                      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||...   +.......+..   ..  ..         .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~~~~---~~--~~---------~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILM---EE--IR---------FP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC---CHHHHHHHHHc---CC--CC---------CC
Confidence            3457999999999999999999999999999999999999999632   21122211111   00  00         11


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1013 EKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1013 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                      .....++.+++.+|++.||++||     ++.|+++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            12234688999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4e-36  Score=339.07  Aligned_cols=244  Identities=22%  Similarity=0.289  Sum_probs=199.3

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46888999999999999999876 68899999987432   123356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999998874    34578899999999999999999986   999999999999999999999999999987643


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...   ........+.   ...  ..+  + 
T Consensus       171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~---~~~--~~~--p-  235 (329)
T PTZ00263        171 R----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD---TPFRIYEKIL---AGR--LKF--P-  235 (329)
T ss_pred             C----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC---CHHHHHHHHh---cCC--cCC--C-
Confidence            2    12357999999999999989999999999999999999999999632   1111111111   110  000  0 


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1042 (1052)
                            .....++.+++.+|++.||++||+     +++++.
T Consensus       236 ------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        236 ------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                  112236789999999999999997     677764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=333.86  Aligned_cols=251  Identities=23%  Similarity=0.367  Sum_probs=213.3

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCe-EEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND-RLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  846 (1052)
                      ++|...+++|+|+||.++.++++ ++..+|+|.+....  ....+....|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999999866 67899999887543  3334467899999999999999999999999888 89999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      +|++||++.+.+.+..  +..++++.+..|+.|++.|+.|||+.   +|+|||||++||+++.++.||++|||+|+.+.+
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998753  67799999999999999999999975   999999999999999999999999999999876


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .. .....++|||.||.||++.+.+|..|+||||+||++|||++-+++|..   .+...++..+....            
T Consensus       159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a---~~m~~Li~ki~~~~------------  222 (426)
T KOG0589|consen  159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA---SNMSELILKINRGL------------  222 (426)
T ss_pred             ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc---cchHHHHHHHhhcc------------
Confidence            54 234557999999999999999999999999999999999999999963   23333333332222            


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                       ..+.+..++.++..++..|++.+|+.||++.+++..
T Consensus       223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             122334455689999999999999999999999874

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=317.69  Aligned_cols=266  Identities=27%  Similarity=0.370  Sum_probs=205.2

Q ss_pred             hhcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhc--CCCceeeeeceEeeC----CeE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNLVSLQGYCRHG----NDR  842 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~  842 (1052)
                      ..++..+.+.||+|.||.||+|+|+ |+.||||++..   ..++.+.+|.++++..  +|+||+.+++.-..+    .+.
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            3467888999999999999999998 99999999974   3456788888888765  999999999986544    367


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEcCCCCCceEECCCCCeEEee
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV-----CEPHIVHRDVKSSNILLDEKFEAHLAD  917 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~HrDlkp~Nill~~~~~~kl~D  917 (1052)
                      |+|++|.+.|+|.|||.+     ..++.+..++++..+|.||+|||-.     ..|.|+|||||+.|||+.+++.+.|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            999999999999999974     4688999999999999999999964     367899999999999999999999999


Q ss_pred             cccccccCCCCCee---eecccccccccCccccCCc------CCCcccchHHHHHHHHHHHcC----------CCCCccc
Q 001561          918 FGLSRLLRPYDTHV---TTDLVGTLGYIPPEYSQTL------TATCRGDVYSFGVVLLELLTG----------RRPVEVC  978 (1052)
Q Consensus       918 fG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltG----------~~pf~~~  978 (1052)
                      +|+|..........   ....+||.+|||||++...      ..-..+||||||.|+||+.-.          ++||...
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            99998876553322   2346999999999987543      223479999999999998862          4677654


Q ss_pred             CCCC-chhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          979 KGKN-CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       979 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      .+.. ..+....+.-..+.++   . -+..|  ...+.+..+.++|+.||..+|..|-|+-.+-+.|.++..
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP---~-ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRP---N-IPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCCHHHHhcceeecccCC---C-CCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            3221 1111111111111111   0 11111  233567789999999999999999999999998887763

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.6e-36  Score=332.43  Aligned_cols=262  Identities=28%  Similarity=0.470  Sum_probs=210.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ++|.+.+.||+|+||.||+|...      ++..+|+|.+........+.+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45888899999999999999743      345689999887666666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCC
Q 001561          845 IYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE  912 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~  912 (1052)
                      ||||+++++|.+++.....            ....+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            9999999999999975321            224589999999999999999999986   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHH
Q 001561          913 AHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV  990 (1052)
Q Consensus       913 ~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~  990 (1052)
                      ++|+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....   ..+..+.+
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~  238 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS---NTEVIECI  238 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH
Confidence            999999999765432211 1223456789999999998899999999999999999999 999986422   11222211


Q ss_pred             HHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCccc
Q 001561          991 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1051 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1051 (1052)
                      .    ......         .....+..+.+++.+|++.+|++||++.+|+++|+++....
T Consensus       239 ~----~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         239 T----QGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             h----CCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence            1    111110         01112346889999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.1e-35  Score=323.57  Aligned_cols=261  Identities=22%  Similarity=0.311  Sum_probs=210.2

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD---CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+...   .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999865 7899999987532   2334456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++.........+++..+..++.|+++|++|||+.   +++||||||+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998875544455688999999999999999999986   999999999999999999999999999987643


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ... ......|++.|+|||...+..++.++||||||+++|||++|+.||.... .+..+..   ....... ...     
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-~~~~~~~---~~~~~~~-~~~-----  227 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLFSLC---QKIEQCD-YPP-----  227 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc-ccHHHHH---HHHhcCC-CCC-----
Confidence            221 1223468889999999988889999999999999999999999985321 1111111   1111100 000     


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                         .........+.+++.+|++.+|++||++.+|++.|++++
T Consensus       228 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 ---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence               011223457899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.9e-36  Score=340.70  Aligned_cols=267  Identities=22%  Similarity=0.325  Sum_probs=199.2

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC-----CeEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-----NDRL  843 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  843 (1052)
                      +|++.+.||+|+||.||+|+.. ++..||+|++....  .....++.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4888999999999999999865 78999999987432  23345688999999999999999999988543     2479


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      +||||++ ++|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 688887764    34589999999999999999999996   999999999999999999999999999986


Q ss_pred             cCCCCC--eeeecccccccccCccccCC--cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc
Q 001561          924 LRPYDT--HVTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  999 (1052)
Q Consensus       924 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      ......  .......||+.|+|||++.+  ..++.++|||||||++|||++|++||....   .......+.........
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~---~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---VVHQLDLITDLLGTPSP  229 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHhCCCCH
Confidence            432211  12234579999999998765  678999999999999999999999996422   11111111111100000


Q ss_pred             -----------ccc---cccccc---chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcCc
Q 001561         1000 -----------VEI---IDASIW---HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus      1000 -----------~~~---~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                                 ...   ......   ..........+.+++.+|++.||++||+++|+++  +++++..
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                       000   000000   0000112346789999999999999999999997  6665543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.6e-36  Score=330.58  Aligned_cols=258  Identities=29%  Similarity=0.487  Sum_probs=206.9

Q ss_pred             cCCcccCeEcccCceEEEEEEECC-C-----cEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN-G-----TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  843 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  843 (1052)
                      ++|++.+.||+|+||.||+|.... +     ..||+|.+.... .....++.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            368889999999999999997642 2     579999887543 334567899999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhhhcccCC------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC
Q 001561          844 LIYSYMENGSLDYWLHESVDK------------DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF  911 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~  911 (1052)
                      ++|||+++|+|.+++......            ...+++.+++.++.|++.|++|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999998754211            14588999999999999999999986   999999999999999999


Q ss_pred             CeEEeecccccccCCCCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHH
Q 001561          912 EAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSW  989 (1052)
Q Consensus       912 ~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~  989 (1052)
                      .++|+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||....   ..+....
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~---~~~~~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS---NQEVIEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence            999999999986543222 12233467889999999888889999999999999999998 999986432   2222222


Q ss_pred             HHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          990 VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      +.    .....         ..+...+.++.+++.+|++.+|++||+++|+++.|+++
T Consensus       239 i~----~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         239 IR----SRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HH----cCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            11    11110         11223345799999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-37  Score=331.16  Aligned_cols=264  Identities=27%  Similarity=0.392  Sum_probs=214.4

Q ss_pred             cCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhH-HHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ....+.+.||+|.||.|..+....+.+||||.++.+..... ++|.+|+++|.+++|||||+++|+|..++..++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            34667889999999999999988789999999998765544 88999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++|+|..|+..+....  +.-+...+|+.|||.|++||.+.   ++||||+.++|+|+|.++++||+|||+++-+-..+.
T Consensus       618 EnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             hcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999998764322  34456678999999999999997   999999999999999999999999999996544433


Q ss_pred             e-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc--CCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          930 H-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       930 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      + .....+-..+|||||.+.-++++.++|||+|||++||+++  ...||+...++   +.++..-...+....      .
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~------~  763 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGR------Q  763 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCc------c
Confidence            3 3344566779999999988999999999999999999776  88898754332   222222222221111      1


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      .....+..++.++++++.+||+.+-++||+++++...|++.+
T Consensus       764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            122234455668999999999999999999999999887654

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-35  Score=331.12  Aligned_cols=269  Identities=22%  Similarity=0.328  Sum_probs=202.7

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999876 788999999875432 223457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |++ +++.+++..   ....++++.+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            996 577777754   234588899999999999999999996   9999999999999999999999999999754322


Q ss_pred             CCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccc-----
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE----- 1001 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1001 (1052)
                       ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....  ...+....+...........     
T Consensus       157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         157 -SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK--DIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             -CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHHhCCCChhhccchh
Confidence             122234578999999998764 467889999999999999999999997432  11222222222111100000     


Q ss_pred             ---ccccccc---ch--hhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561         1002 ---IIDASIW---HK--DRE-----KQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus      1002 ---~~~~~~~---~~--~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                         ..++...   ..  ...     .....+.+++.+|++.||++|||+.|+++  ++.++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence               0000000   00  000     11246789999999999999999999987  665554

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.2e-36  Score=331.50  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=209.1

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  843 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  843 (1052)
                      ..+|.+.+.||+|+||+||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            356888999999999999999742      34568999987666566678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccc---------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeE
Q 001561          844 LIYSYMENGSLDYWLHESV---------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH  914 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~k  914 (1052)
                      +||||+++++|.+++....         .....+++..++.++.|++.||+|||+.   +++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            9999999999999987532         1223589999999999999999999986   999999999999999999999


Q ss_pred             EeecccccccCCCCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHH
Q 001561          915 LADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQ  992 (1052)
Q Consensus       915 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~  992 (1052)
                      ++|||.++........ ......+++.|+|||++.+..++.++||||||+++|||++ |++||....   ..+....+..
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~---~~~~~~~i~~  237 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECITQ  237 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHc
Confidence            9999999865432221 1122345778999999998899999999999999999998 999986322   1222221111


Q ss_pred             hhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          993 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                          ......         ....+.++.+++.+|++.+|.+||++.|+.+.|+++..
T Consensus       238 ----~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         238 ----GRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             ----CCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                110000         01123468999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-35  Score=334.03  Aligned_cols=199  Identities=28%  Similarity=0.459  Sum_probs=174.6

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367999999999999999999876 68889999887543 3344678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++|+|.+++..    ...+++..+..++.+++.|++|||+.  .+|+||||||+||++++++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999999864    34578899999999999999999973  37999999999999999999999999999765322


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV  977 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~  977 (1052)
                         ......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence               22335789999999999888899999999999999999999999963

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=325.50  Aligned_cols=255  Identities=27%  Similarity=0.460  Sum_probs=205.8

Q ss_pred             cCCcccCeEcccCceEEEEEEECC----CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      ++|++.+.||+|+||+||+|.+..    ...||+|.++... .....++.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568899999999999999998752    3579999887543 33456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++++|.+++...   ...+++..++.++.|++.|++|||+.   +|+||||||+||++++++.++++|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999998753   33689999999999999999999986   99999999999999999999999999998875


Q ss_pred             CCCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          926 PYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       926 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ..... ......+++.|+|||...+..++.++||||||+++|||++ |..||....   ..+....+..    ....   
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~----~~~~---  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAVED----GYRL---  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHc----CCCC---
Confidence            22222 2222345678999999988899999999999999999998 999985322   1122221111    0000   


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                            +.....+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  00112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.7e-36  Score=343.03  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGND  841 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  841 (1052)
                      .++|++.+.||+|+||.||+|...      .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            567889999999999999999753      134799999975433 33457899999999996 9999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccC----------------------------------------------------------
Q 001561          842 RLLIYSYMENGSLDYWLHESVD----------------------------------------------------------  863 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  863 (1052)
                      .++||||+++|+|.++++....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998865311                                                          


Q ss_pred             ----------------------------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC
Q 001561          864 ----------------------------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE  909 (1052)
Q Consensus       864 ----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~  909 (1052)
                                                        ....+++..+..++.|+++|++|||+.   +|+||||||+||++++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                              013478889999999999999999986   9999999999999999


Q ss_pred             CCCeEEeecccccccCCCCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHH
Q 001561          910 KFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV  987 (1052)
Q Consensus       910 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~  987 (1052)
                      ++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......  ....
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STFY  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHHH
Confidence            999999999999875432221 1223457788999999988889999999999999999997 99998643211  1111


Q ss_pred             HHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          988 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      ..+    ......         ........++.+++.+|++.+|++||++.++.++|+++-+
T Consensus       351 ~~~----~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         351 NKI----KSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHH----hcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            111    111000         0111234578999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-36  Score=316.44  Aligned_cols=252  Identities=25%  Similarity=0.318  Sum_probs=205.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|+..+.||+|.-|+||+++.+ ++..+|+|++.+...   +...+.+.|-++|+.+.||.++.+++.++.+...++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            34677889999999999999977 458899999987653   33456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      |||+||+|....+..  .+..+++..++.+|.+++-||+|||-.   |||+|||||+|||+.++|++.++||.++.....
T Consensus       157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999988754  567799999999999999999999997   999999999999999999999999998754311


Q ss_pred             C----------------------------------C---------------------CeeeecccccccccCccccCCcC
Q 001561          927 Y----------------------------------D---------------------THVTTDLVGTLGYIPPEYSQTLT  951 (1052)
Q Consensus       927 ~----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~  951 (1052)
                      .                                  .                     ......++||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            0                                  0                     00112358999999999999999


Q ss_pred             CCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCC
Q 001561          952 ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDP 1031 (1052)
Q Consensus       952 ~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1031 (1052)
                      ++.++|+|+|||++|||+.|+.||-+....+   ...            .++......+..+..+..+.+||++.+.+||
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---Tl~------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---TLR------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchh---hHH------------HHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence            9999999999999999999999996533222   111            1122222222223455689999999999999


Q ss_pred             CCCCC----HHHHHH
Q 001561         1032 RRRPF----IEEVVT 1042 (1052)
Q Consensus      1032 ~~RPs----~~evl~ 1042 (1052)
                      .+|-.    +.||-+
T Consensus       377 ~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhhccccchHHhhc
Confidence            99987    777755

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-35  Score=328.84  Aligned_cols=261  Identities=24%  Similarity=0.316  Sum_probs=196.1

Q ss_pred             cCCcccCeEcccCceEEEEEEEC--CCcEEEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeeeeceEe-----e
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT--NGTKAAVKRLSGDCG--QMEREFQAEVEALSRA---QHKNLVSLQGYCR-----H  838 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  838 (1052)
                      ++|++.+.||+|+||+||+|+..  ++..||+|+++....  .....+.+|+.+++.+   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  467899998864332  2234456777777766   6999999999885     2


Q ss_pred             CCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       839 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                      ....++||||++ ++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            356899999996 5888888653  234588999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       919 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      |+++.....  .......||+.|+|||++.+..++.++|||||||++|||++|++||....   ..+....+........
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~---~~~~~~~i~~~~~~~~  229 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIGLPG  229 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC---HHHHHHHHHHHhCCCC
Confidence            999875432  22334578999999999988889999999999999999999999997432   2233333322211100


Q ss_pred             cccc----------cccccc---chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          999 EVEI----------IDASIW---HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       999 ~~~~----------~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ..+.          ......   ..........+.+++.+|++.||++||++.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000          000000   0011123346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.4e-36  Score=330.13  Aligned_cols=257  Identities=28%  Similarity=0.476  Sum_probs=206.5

Q ss_pred             cCCcccCeEcccCceEEEEEEECC------CcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  843 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  843 (1052)
                      ++|.+.+.||+|+||.||+|...+      +..||+|.+...... ..+.+.+|++++++++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468888999999999999998643      478999998765433 4578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccc----------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCe
Q 001561          844 LIYSYMENGSLDYWLHESV----------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  913 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~  913 (1052)
                      +||||+++++|.++++...          .....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999997542          1234578999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHH
Q 001561          914 HLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF  991 (1052)
Q Consensus       914 kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~  991 (1052)
                      |++|||.++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....   ..+....+.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~---~~~~~~~~~  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEVIECIT  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH
Confidence            9999999976533221 11223356789999999999999999999999999999998 999986422   222222221


Q ss_pred             HhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          992 QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                          ......         .....+..+.+++.+|++.+|++||++.|+++.|++
T Consensus       239 ----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         239 ----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                111000         011223478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-35  Score=339.86  Aligned_cols=264  Identities=19%  Similarity=0.253  Sum_probs=201.0

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ..+|++.+.||+|+||.||+|... +++.||+|...      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999865 78899999753      23467899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +. ++|..++..    ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+......
T Consensus       165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            95 678777754    34578999999999999999999986   99999999999999999999999999997643332


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCC----chhHHHHHHHhhhcccccc---
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN----CRDLVSWVFQMKSEKREVE--- 1001 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~--- 1001 (1052)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||....+..    .......+.......+...   
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            233345689999999999998899999999999999999999998874322110    1111111111110000000   


Q ss_pred             ----------------ccccccc--chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1002 ----------------IIDASIW--HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1002 ----------------~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                                      ...+...  .........++.+++.+|++.||++|||++|+++  ++.++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                            0000000  0011123457889999999999999999999986  66554

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-35  Score=337.86  Aligned_cols=246  Identities=28%  Similarity=0.468  Sum_probs=192.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      +|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4566788999999999999865 68999999986543 334567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++|+|.+..        ...+..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++...... 
T Consensus       155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            999986532        245677889999999999999986   99999999999999999999999999998764321 


Q ss_pred             eeeecccccccccCccccCC-----cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ......+||..|+|||++..     ...+.++|||||||++|||++|+.||......+........   . .....    
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~-~~~~~----  294 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---C-MSQPP----  294 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---h-ccCCC----
Confidence            12234579999999998643     23456899999999999999999999732222111111111   0 00000    


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                           ........++.+++.+|++.||++||++.|+++
T Consensus       295 -----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        295 -----EAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             -----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 011123347899999999999999999999987

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-38  Score=313.74  Aligned_cols=246  Identities=24%  Similarity=0.374  Sum_probs=208.2

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      |.+.++||+|+||.||||.++ +|..+|+|.+..+  ....++..|+.+|++++.|++|+++|.|......|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            566788999999999999865 7999999998654  3456789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+..+.++-   ...++++.++..+....++||+|||..   .-+|||||+.|||++.+|.+|++|||.|..+.+. -..
T Consensus       113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK  185 (502)
T KOG0574|consen  113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK  185 (502)
T ss_pred             CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence            999999875   456799999999999999999999997   7899999999999999999999999999876432 223


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccc-ccccccch
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI-IDASIWHK 1010 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1010 (1052)
                      ...+.|||.|||||++..-.|+.++||||+|++..||..|++||..-.+               -+...-+ ..+.....
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---------------MRAIFMIPT~PPPTF~  250 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---------------MRAIFMIPTKPPPTFK  250 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---------------cceeEeccCCCCCCCC
Confidence            3457999999999999999999999999999999999999999963110               0011111 11222234


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1011 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .++.++.++.+++++|+.+.|++|.|+.++++
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            46677889999999999999999999999876

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.3e-35  Score=336.00  Aligned_cols=251  Identities=27%  Similarity=0.340  Sum_probs=198.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC----CCcEEEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC----GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  842 (1052)
                      +|++.+.||+|+||+||+|+..    +++.||+|++.+..    ....+.+..|+.+++++ +||+|+++++++.+++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999999753    57899999986432    22335578899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            999999999999998864    34588999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccc
Q 001561          923 LLRPYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      .+............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.  ......     
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~~-----  226 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILKC-----  226 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhcC-----
Confidence            7644333334456899999999988765 47889999999999999999999996432222211111  111110     


Q ss_pred             cccccccchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                        ++..    +......+.+++.+|++.||++||     +++++++
T Consensus       227 --~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 --DPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             --CCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence              0111    111234678999999999999999     6778775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.7e-36  Score=324.69  Aligned_cols=252  Identities=24%  Similarity=0.406  Sum_probs=203.0

Q ss_pred             cCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      ++|++.+.||+|+||+||+|.+.++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4688889999999999999998777789999887543 334678999999999999999999999998889999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +|+|.+++...   ...+++..++.++.|++.|++|||+.   +++|+||||+||++++++.+||+|||.++........
T Consensus        83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999998753   23689999999999999999999986   9999999999999999999999999999865433222


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||....   ..+....+...   ... .  .+    
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~---~~~-~--~~----  223 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN---NSETVEKVSQG---LRL-Y--RP----  223 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHHhcC---CCC-C--CC----
Confidence            2222345678999999988889999999999999999999 999986322   11222221111   000 0  00    


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                         ......+.+++.+|++.+|.+||++.++++.|+
T Consensus       224 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 ---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               012347899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=335.29  Aligned_cols=239  Identities=24%  Similarity=0.291  Sum_probs=192.3

Q ss_pred             EcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      ||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999875 67899999986432   23345678899999999999999999999999999999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeec
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  934 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  934 (1052)
                      .+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~  152 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNT  152 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccc
Confidence            998874    34588999999999999999999986   9999999999999999999999999999764322 222334


Q ss_pred             ccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHH
Q 001561          935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014 (1052)
Q Consensus       935 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1052)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||...   +........   ....  .         ..+..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~---~~~~~~~~~---~~~~--~---------~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE---NVNEMYRKI---LQEP--L---------RFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC---CHHHHHHHH---HcCC--C---------CCCCc
Confidence            57999999999999999999999999999999999999999632   111211111   1110  0         01112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 001561         1015 QLLEMLEIACKCIDQDPRRRPF---IEEVVT 1042 (1052)
Q Consensus      1015 ~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1042 (1052)
                      ...++.+++.+|++.||++||+   +.|++.
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            2346889999999999999985   555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-35  Score=336.26  Aligned_cols=244  Identities=23%  Similarity=0.289  Sum_probs=198.3

Q ss_pred             cCCcccCeEcccCceEEEEEEECC--CcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN--GTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      ++|++.+.||+|+||.||+|.+..  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468889999999999999997543  3689999986432   22345678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999874    34588999999999999999999986   99999999999999999999999999998754


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+.   ...  ..    
T Consensus       183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~---~~~~~~~~i~---~~~--~~----  246 (340)
T PTZ00426        183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN---EPLLIYQKIL---EGI--IY----  246 (340)
T ss_pred             CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC---CHHHHHHHHh---cCC--CC----
Confidence            32    23457999999999998888999999999999999999999999632   1111111111   110  00    


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                           .+......+.+++.+|++.||++|+     +++|+++
T Consensus       247 -----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        247 -----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             -----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                 0111223678999999999999995     8888876

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=364.40  Aligned_cols=480  Identities=27%  Similarity=0.311  Sum_probs=296.0

Q ss_pred             ecCCCCcccCCccccCCcCCCeEecCCCCCCCCCcccccCCCCccEEeccCCcccCcccccccccCCccEEEccCcccCC
Q 001561           93 LPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNG  172 (1052)
Q Consensus        93 L~~~~l~g~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  172 (1052)
                      ++..+++- ||.-+..-..++.|+++.|.+-...-+.....-+|+.||||+|.++. .|-.+..+..|+.|+++.|.|..
T Consensus         5 ~s~~~l~~-ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~-fp~~it~l~~L~~ln~s~n~i~~   82 (1081)
T KOG0618|consen    5 ASDEQLEL-IPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISS-FPIQITLLSHLRQLNLSRNYIRS   82 (1081)
T ss_pred             cccccCcc-cchhhccHHHHHhhhccccccccCchHHhhheeeeEEeecccccccc-CCchhhhHHHHhhcccchhhHhh
Confidence            33444433 45555555557777777777653322333344448888888887764 44566777778888888888877


Q ss_pred             cccccccCCcccEEEecCCccCCccchhhhhcccccceeeccCcccccccccCCCCCCCCEEEcccccCCCCCCccccCC
Q 001561          173 SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSM  252 (1052)
Q Consensus       173 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l  252 (1052)
                      ++...+++.+|++|+|.+|++. .+|. -+..+++|++||+|.|++...|..+..++.++++..++|.-.    ..++..
T Consensus        83 vp~s~~~~~~l~~lnL~~n~l~-~lP~-~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~----~~lg~~  156 (1081)
T KOG0618|consen   83 VPSSCSNMRNLQYLNLKNNRLQ-SLPA-SISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKI----QRLGQT  156 (1081)
T ss_pred             Cchhhhhhhcchhheeccchhh-cCch-hHHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhh----hhhccc
Confidence            7777778888888888888776 3343 345677788888888888888777777777778888777222    122222


Q ss_pred             CCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEe
Q 001561          253 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDL  332 (1052)
Q Consensus       253 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L  332 (1052)
                      . .+.++|..|.+.+.++..+..++.  .|+|.+|.+.   -..+.++.+|+.+....|+++...    -..++|+.|+.
T Consensus       157 ~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a  226 (1081)
T KOG0618|consen  157 S-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYA  226 (1081)
T ss_pred             c-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeee
Confidence            2 777777777777777777776666  6778887776   234566777777777777776321    12356777777


Q ss_pred             cCccccCcCCcccccCCccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcEEeccCCcCCCC
Q 001561          333 RNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL  412 (1052)
Q Consensus       333 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l  412 (1052)
                      +.|.++...+ .+ --.+|+++++++|+++ .+|++++.+.+|+.|+..+|+++ .+|..+....+|+.|++.+|.+..+
T Consensus       227 ~~n~l~~~~~-~p-~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yi  302 (1081)
T KOG0618|consen  227 DHNPLTTLDV-HP-VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYI  302 (1081)
T ss_pred             ccCcceeecc-cc-ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhC
Confidence            7777773222 22 2356777777777777 45677777777777777777775 6677777777777777777777776


Q ss_pred             cccchhhccCcccceEeccccccCccCCccccCCCc-ccEEEccCCccccCcch-hhhcCCCCcEEeCcCccCCCCCChh
Q 001561          413 SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFES-LMVLALGNCGLKGHIPV-WLLRCKKLQVLDLSWNHFDGNIPPW  490 (1052)
Q Consensus       413 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~  490 (1052)
                      |..   +.+.+.|++|+|..|.+....+..+.-+.. |..|+.+.|++. ..|. .=..++.|+.|++.+|+++...-+.
T Consensus       303 p~~---le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~  378 (1081)
T KOG0618|consen  303 PPF---LEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPV  378 (1081)
T ss_pred             CCc---ccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhh
Confidence            643   345677777777777774333322322222 555555555554 2221 1112445566666666666555555


Q ss_pred             hccCCCCCeEeccCCcccccCCcchhhhhhhcccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCccc
Q 001561          491 IGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRIN  570 (1052)
Q Consensus       491 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~  570 (1052)
                      +.++++|+.|+|++|++.......+.++..|                                      ++|+||+|+++
T Consensus       379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~L--------------------------------------eeL~LSGNkL~  420 (1081)
T KOG0618|consen  379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEEL--------------------------------------EELNLSGNKLT  420 (1081)
T ss_pred             hccccceeeeeecccccccCCHHHHhchHHh--------------------------------------HHHhcccchhh
Confidence            5566666666666666553333334444444                                      23556666665


Q ss_pred             ccCCcccccccccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCC-CCccccCccccCeeeecccc
Q 001561          571 GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS-IPGSFEKLTFLSKFSVANNH  640 (1052)
Q Consensus       571 g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~-~p~~~~~l~~L~~l~l~~N~  640 (1052)
                       .+|.++.++..|++|...+|+|. ..| .+..+++|+.+|||.|+|+-. +|...- -++|++|||++|.
T Consensus       421 -~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  421 -TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNT  487 (1081)
T ss_pred             -hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence             45566666666666666666665 445 556666666666666665532 222221 1556666666654

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-36  Score=324.21  Aligned_cols=251  Identities=24%  Similarity=0.419  Sum_probs=201.4

Q ss_pred             cCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+..... ...++.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35778899999999999999988778899999864432 34568889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +++|.+++...   ...+++..++.++.|++.|++|||+.   +|+||||||+||++++++.+|++|||.++........
T Consensus        83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999998753   33689999999999999999999986   9999999999999999999999999999865432221


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||.....   .+....+.   .. .  ....     
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~---~~-~--~~~~-----  222 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVS---AG-Y--RLYR-----  222 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHH---cC-C--cCCC-----
Confidence            1122234457999999988899999999999999999999 8999864221   12211111   10 0  0000     


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1044 (1052)
                        +...+.++.+++.+|+..+|++||++.|+++.|
T Consensus       223 --~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 --PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              111344789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-35  Score=323.32  Aligned_cols=253  Identities=28%  Similarity=0.465  Sum_probs=204.1

Q ss_pred             cCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      ++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46888999999999999999988888999999875433 3456899999999999999999999875 456889999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +++|.++++..  ....+++..++.++.+++.|++|||+.   +|+||||||+||++++++.++++|||.+..+......
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            99999998753  234589999999999999999999986   9999999999999999999999999999876443222


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||...   ...+.......    ....         
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~---~~~~~~~~~~~----~~~~---------  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQVER----GYRM---------  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHc----CCCC---------
Confidence            2222345668999999888889999999999999999999 89999642   22222222111    1000         


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      +.+...+..+.+++.+|+..+|++|||++++.++|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0111223478999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-35  Score=323.31  Aligned_cols=249  Identities=33%  Similarity=0.538  Sum_probs=194.1

Q ss_pred             ccCeEcccCceEEEEEEEC-----CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          775 QANIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       775 ~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +.+.||.|.||.||+|.+.     .+..|+||.+.... ....+++.+|++.+++++||||++++|++.+.+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999876     25679999996543 33467899999999999999999999999988889999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++|+|.++++..  ....+++..+..|+.|+++||+|||+.   +++|+||+++||++++++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999874  345689999999999999999999996   99999999999999999999999999998763222


Q ss_pred             Ce-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          929 TH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       929 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .. ......+...|+|||.+....++.++||||||+++||+++ |+.||...   ...+....+   ..... ...    
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~---~~~~~-~~~----  226 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKL---KQGQR-LPI----  226 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHH---HTTEE-TTS----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc---ccccc-cee----
Confidence            22 2233456779999999988889999999999999999999 78998532   222222222   11111 111    


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1044 (1052)
                           +......+.+++.+||+.+|++||++.++++.|
T Consensus       227 -----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 -----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 111233688999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=330.22  Aligned_cols=255  Identities=24%  Similarity=0.362  Sum_probs=212.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  844 (1052)
                      ...|++.+.||+|.||.||+++.. +|+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+.++|++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456888899999999999999876 5999999999866543   3457899999999998 9999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC----CCeEEeeccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK----FEAHLADFGL  920 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~----~~~kl~DfG~  920 (1052)
                      |||+++||.|.+.+...     .+++.++..++.|++.|++|||+.   +|+|||+||+|+|+...    +.+|++|||+
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999998764     389999999999999999999996   99999999999999633    5799999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      |.....  .......+||+.|+|||++....|+.++||||+||++|.|++|.+||......   ....   .......  
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---~~~~---~i~~~~~--  255 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---EIFL---AILRGDF--  255 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---HHHH---HHHcCCC--
Confidence            998875  44566789999999999999999999999999999999999999999743211   1111   1111111  


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                       .++    .++.......+.++++.|+..||.+|+++.++++  |+.+.
T Consensus       256 -~f~----~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  256 -DFT----SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             -CCC----CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence             122    2223344558899999999999999999999998  55544

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.3e-35  Score=332.04  Aligned_cols=241  Identities=23%  Similarity=0.319  Sum_probs=194.5

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  852 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  852 (1052)
                      +.||+|+||.||+|... +|..||+|++....   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999865 78999999987542   223345678999999999999999999999999999999999999


Q ss_pred             ChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeee
Q 001561          853 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  932 (1052)
Q Consensus       853 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  932 (1052)
                      +|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~  152 (323)
T cd05595          81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence            99888864    34689999999999999999999986   99999999999999999999999999987542221 222


Q ss_pred             ecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhh
Q 001561          933 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012 (1052)
Q Consensus       933 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1052)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+.   ...  ..         .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~~~---~~~--~~---------~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELIL---MEE--IR---------FP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHh---cCC--CC---------CC
Confidence            34579999999999998899999999999999999999999996321   111111111   000  00         01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1013 EKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1013 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                      .....++.+++.+|++.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            12234688999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.2e-35  Score=322.08  Aligned_cols=262  Identities=23%  Similarity=0.351  Sum_probs=211.9

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|++++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999876 78999999886322   233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++.........+++..+..++.+++.|++|||+.   +|+||||||+||++++++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999876554566789999999999999999999986   999999999999999999999999999876543


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ... ......+++.|+|||...+..++.++|||||||++|+|++|+.||....    .+..+...... ......     
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~~~~-----  227 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIE-KCDYPP-----  227 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhh-cCCCCC-----
Confidence            221 1233468889999999988889999999999999999999999985321    11111111111 000000     


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                         .........+.+++.+|+..+|++||++.+++++|+++.+
T Consensus       228 ---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~  267 (267)
T cd08224         228 ---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA  267 (267)
T ss_pred             ---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence               0011334478899999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.7e-35  Score=323.09  Aligned_cols=255  Identities=26%  Similarity=0.433  Sum_probs=204.1

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|++.+.||+|+||.||+|.+.++..||+|++..... ..+++.+|++++++++||||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356899999999999999999887777899999875432 3457899999999999999999999875 45679999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++|+|.+++...  ....+++..+..++.|+++||+|+|+.   +++||||||+||++++++.++|+|||.++.......
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            999999999753  234578999999999999999999986   999999999999999999999999999987654332


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .......++..|+|||+..+..++.++||||||+++|||++ |+.||....   .......   ... ...         
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~~~~~~~---~~~-~~~---------  221 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ---VER-GYR---------  221 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---hHHHHHH---Hhc-CCC---------
Confidence            22223356678999999988889999999999999999999 888986322   1111111   110 000         


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      .......+..+.+++.+|++++|++||++.++++.|++.
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            011123345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-35  Score=333.61  Aligned_cols=257  Identities=24%  Similarity=0.401  Sum_probs=203.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      .+|+..+.||+|+||.||+|.+. +++    .||+|++.... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999864 343    48999987543 34556788999999999999999999999764 5679


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      |+||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999998753   34578899999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCeee-ecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          925 RPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       925 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ........ ....++..|+|||++.+..++.++||||||+++|||++ |+.||+...   ..+..+..    ....  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~~~~~----~~~~--~~  230 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSIL----EKGE--RL  230 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----hCCC--CC
Confidence            54333222 22234678999999999999999999999999999998 999986421   11211111    1110  00


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      ..       +..+...+.+++.+|++.+|.+||++.++++.+..+..+
T Consensus       231 ~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         231 PQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            00       111223688999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=329.16  Aligned_cols=258  Identities=26%  Similarity=0.384  Sum_probs=213.6

Q ss_pred             hhcCCcccCeEcccCceEEEEEEECC---Cc--EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLTN---GT--KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~~---g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  842 (1052)
                      .++.....+.||+|.||.||+|.+.+   |+  .||||..+.++ ....+.|..|..+|+.++|||||+++|+|.+. ..
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence            34455667889999999999998653   33  58999988754 45567799999999999999999999999864 68


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      |+|||.++.|.|.+|++..   ...++......++.||..||+|||+-   .+|||||.++|||+.....||++|||+++
T Consensus       466 WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence            9999999999999999873   45688899999999999999999995   99999999999999999999999999999


Q ss_pred             ccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccc
Q 001561          923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      .+........+...-...|||||.+.-++++.++|||.|||++||++. |..||.+....+                ..-
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~  603 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIG  603 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEE
Confidence            887655444443344568999999999999999999999999999988 999997533221                111


Q ss_pred             cccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561         1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      .+...-..+.++.++..++.++.+||..+|.+||.+.|+...|+++.+
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            122222334456677789999999999999999999999999988755

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.1e-36  Score=352.29  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=205.1

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----  840 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  840 (1052)
                      ..++|++.+.||+|+||+||+|+.. +|+.||||++....  ......+.+|+..+..++|+|++++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            3468999999999999999999754 78999999986542  334456789999999999999999988775432     


Q ss_pred             ---eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEee
Q 001561          841 ---DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLAD  917 (1052)
Q Consensus       841 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~D  917 (1052)
                         ..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               36799999999999999987655566799999999999999999999986   999999999999999999999999


Q ss_pred             cccccccCCCC-CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc
Q 001561          918 FGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE  996 (1052)
Q Consensus       918 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      ||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...   ...+.....   ...
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~---~~~~~~~~~---~~~  260 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---NMEEVMHKT---LAG  260 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHH---hcC
Confidence            99998764322 22233467999999999999999999999999999999999999999632   212222111   111


Q ss_pred             ccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          997 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      . ..         ..+.....++.+++.+|++.+|++||++.++++
T Consensus       261 ~-~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        261 R-YD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             C-CC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            0 00         011123347889999999999999999999976

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.2e-35  Score=323.39  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=209.9

Q ss_pred             cCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||.||+|.. .++..||||.+....   .....++.+|+++++.++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3678889999999999999985 478999999876432   233457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++++|.+++.........+++..++.++.|++.|++|||+.   +++|+||||+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999875444456789999999999999999999986   999999999999999999999999999887643


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ... ......|++.|+|||...+..++.++||||||+++|+|++|..||....    .+..+....... .     ..+.
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~-~-----~~~~  227 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEQ-C-----DYPP  227 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc----chHHHHhhhhhc-C-----CCCC
Confidence            322 2233568899999999988889999999999999999999999985321    111111111110 0     0000


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      .   .......++.+++.+|++.+|.+||||.+|++.++++.
T Consensus       228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0   11123457899999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.6e-35  Score=345.91  Aligned_cols=266  Identities=20%  Similarity=0.312  Sum_probs=198.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--------C
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--------N  840 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  840 (1052)
                      .++|++.+.||+|+||+||+|... +++.||||++....    ....+|+.++++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999865 68899999886432    2245799999999999999999876432        2


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-CeEEeecc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFG  919 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG  919 (1052)
                      ..++||||+++ ++.+++.........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence            35689999975 67777765544566789999999999999999999986   999999999999999664 69999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      +|+.+....  ......||+.|+|||++.+ ..++.++||||+||++|||++|++||....   ..+....+........
T Consensus       217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS---SVDQLVRIIQVLGTPT  291 (440)
T ss_pred             cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCC
Confidence            998764322  2234578999999998765 468999999999999999999999996432   1122211111111000


Q ss_pred             c----------cc-----cccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561          999 E----------VE-----IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus       999 ~----------~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                      .          ..     +....+....+...+.++.+++.+|++.||.+|||+.|+++  +++++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            0          00     00000001111123457899999999999999999999986  665543

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-35  Score=336.35  Aligned_cols=252  Identities=23%  Similarity=0.289  Sum_probs=201.9

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36889999999999999999865 78999999987543   234456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            999999999998753   34689999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCeeeecccccccccCccccC------CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQ------TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ..........||+.|+|||++.      ...++.++|||||||++|||++|+.||....   .......+.   ......
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~---~~~~~~  228 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT---SAKTYNNIM---NFQRFL  228 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC---HHHHHHHHH---cCCCcc
Confidence            4333334457999999999876      4567889999999999999999999996322   111111111   111111


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ...       ........+.+++.+|++ +|++||++.++++
T Consensus       229 ~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            111       011223468899999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-35  Score=333.95  Aligned_cols=241  Identities=23%  Similarity=0.314  Sum_probs=195.0

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  852 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  852 (1052)
                      ++||+|+||.||+|... +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999987542   223456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeee
Q 001561          853 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  932 (1052)
Q Consensus       853 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  932 (1052)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  152 (328)
T cd05593          81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM  152 (328)
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence            99888864    34689999999999999999999986   9999999999999999999999999998764322 1222


Q ss_pred             ecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhh
Q 001561          933 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012 (1052)
Q Consensus       933 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1052)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+   ....  ..         .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~~~~---~~~~--~~---------~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELI---LMED--IK---------FP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---HHHHHHHh---ccCC--cc---------CC
Confidence            34579999999999998899999999999999999999999996321   11111111   1000  00         01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1013 EKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1013 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                      .....++.+++.+|+++||++||     ++.|+++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            12234688999999999999997     8898875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-35  Score=326.03  Aligned_cols=267  Identities=25%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             CcccCeEcccCceEEEEEEE-----CCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeEEE
Q 001561          773 FNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLL  844 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  844 (1052)
                      |+..+.||+|+||+||++..     .++..||+|.+.... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48889999999999988653     357789999987553 23456788999999999999999999988654  35789


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      ||||+++++|.+++..     ..+++..++.++.|++.|++|||+.   +|+||||||+||++++++.++++|||+++..
T Consensus        86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            9999999999999864     2489999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCee--eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          925 RPYDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       925 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      .......  .....++..|+|||......++.++||||||+++|||++|+.||..... ...+...+...........+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK-KFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc-hhhhhhcccccccchhhhhhh
Confidence            5322211  1223456679999999888899999999999999999999999853211 101111000000000000001


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      .+.......+...+.++.+++.+|++.+|++||++++++++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111111111223457899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=327.09  Aligned_cols=257  Identities=27%  Similarity=0.404  Sum_probs=213.3

Q ss_pred             hhcCCcccCeEcccCceEEEEEEECC-CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .+.+..+.++||.|.||.||.|.|+. .-.||||.++.+.. ..++|..|..+|+.++|||+|+++|+|..+..+|||+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            34456678899999999999999874 56899999986644 45679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      ||.+|+|.+||++.  ....++.-..+.||.||+.|+.||...   ++||||+.++|.|+.++-.|||+|||+++.+..+
T Consensus       344 fM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  344 FMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             cccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            99999999999976  344567778899999999999999984   9999999999999999999999999999998654


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ...-....--...|.|||-+....++.|+|||+|||+|||+.| |-.||.+..-.+       ++.         ++...
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~---------LLEkg  482 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYG---------LLEKG  482 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHH---------HHhcc
Confidence            3322222333558999999988899999999999999999999 888886422111       111         12222


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      ...+.++.++..+++||+.||++.|.+||+++|+-+.+|.+
T Consensus       483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            33344556777899999999999999999999999999876

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=338.96  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=199.2

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36889999999999999999875 68999999987432   223355788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||+++.+..
T Consensus        81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999874    34589999999999999999999986   999999999999999999999999999876432


Q ss_pred             CCCe-------------------------------------eeecccccccccCccccCCcCCCcccchHHHHHHHHHHH
Q 001561          927 YDTH-------------------------------------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL  969 (1052)
Q Consensus       927 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  969 (1052)
                      ....                                     .....+||+.|+|||++....++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011246999999999999989999999999999999999


Q ss_pred             cCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 001561          970 TGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF---IEEVVT 1042 (1052)
Q Consensus       970 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1042 (1052)
                      +|+.||....   ..+....+.   ...........       ......+.+++.+|+. +|.+|++   +.|+++
T Consensus       234 ~G~~Pf~~~~---~~~~~~~i~---~~~~~~~~~~~-------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDN---PQETYRKII---NWKETLQFPDE-------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCC---HHHHHHHHH---cCCCccCCCCC-------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999996422   112111111   11111111110       0123467889999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.8e-35  Score=323.61  Aligned_cols=251  Identities=23%  Similarity=0.295  Sum_probs=198.1

Q ss_pred             EcccCceEEEEEEEC-CCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      ||+|+||+||+|... +++.||+|.+......   ..+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 7889999998654322   234567899999999999999999999999999999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeec
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  934 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  934 (1052)
                      .+++.........+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988865444456789999999999999999999986   999999999999999999999999999987643322 2234


Q ss_pred             ccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHH
Q 001561          935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014 (1052)
Q Consensus       935 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1052)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||........  ...........         .  ...+..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~---------~--~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILND---------S--VTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhccc---------C--CCCccc
Confidence            5789999999999999999999999999999999999999964221111  00000000000         0  011122


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH--HHhh
Q 001561         1015 QLLEMLEIACKCIDQDPRRRP-----FIEEVVT--WLDG 1046 (1052)
Q Consensus      1015 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~--~L~~ 1046 (1052)
                      .+..+.+++.+|++.||++||     +++++++  ++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            344788999999999999999     7788876  4443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-35  Score=321.82  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=205.8

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|++.++||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            356888999999999999999988899999999875543 3457889999999999999999999874 45689999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++...  .+..+++.++..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999988653  345689999999999999999999986   999999999999999999999999999987653322


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .......++..|+|||+.....++.++||||||+++||+++ |+.||....   ..+....+....   . ..       
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~---~-~~-------  223 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQNLERGY---R-MP-------  223 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHcCC---C-CC-------
Confidence            22223456678999999988889999999999999999999 999996432   222222211110   0 00       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                        .....+.++.+++.+|++.+|++||+++++..+|++
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 --RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              011123478999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-35  Score=335.38  Aligned_cols=262  Identities=26%  Similarity=0.397  Sum_probs=204.0

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeeeeceEeeC-C
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHG-N  840 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  840 (1052)
                      .++|++.++||+|+||.||+|...      +++.||+|+++.... ...+.+.+|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357899999999999999999642      347899999875432 2345678899999999 899999999988654 5


Q ss_pred             eEEEEEEeccCCChhhhhhcccCC--------------------------------------------------------
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDK--------------------------------------------------------  864 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------  864 (1052)
                      ..+++|||+++|+|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            678999999999999988642210                                                        


Q ss_pred             -ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee-eeccccccccc
Q 001561          865 -DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYI  942 (1052)
Q Consensus       865 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~  942 (1052)
                       ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||+++.+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             13689999999999999999999986   99999999999999999999999999998764332221 22345667899


Q ss_pred             CccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHH
Q 001561          943 PPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLE 1021 (1052)
Q Consensus       943 aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1021 (1052)
                      |||++.+..++.++|||||||++|||++ |+.||......  +.....+    .......         .+.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~~----~~~~~~~---------~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRRL----KEGTRMR---------APEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHHH----hccCCCC---------CCccCCHHHHH
Confidence            9999999999999999999999999998 99999642211  1111111    1110000         01122346899


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561         1022 IACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1022 li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      ++.+|++.+|++||++.|+++.|+++-+
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-35  Score=338.45  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=200.3

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567999999999999999999865 68899999986432   2233457789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      ||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++...
T Consensus       121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            9999999999998864     2478888999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCeeeecccccccccCccccCCc----CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQTL----TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ...........+||+.|+|||++.+.    .++.++|||||||++|||++|+.||....   .......+.   ......
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~---~~~~~~  266 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIM---DHKNSL  266 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC---HHHHHHHHH---cCCCcC
Confidence            43322223346799999999987643    47889999999999999999999996422   111111111   111111


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRR--RPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1042 (1052)
                      ...+       ....+.++.+++.+|++.+|++  ||++.|+++
T Consensus       267 ~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         267 TFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            1111       1122347889999999999988  999999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-35  Score=326.32  Aligned_cols=263  Identities=26%  Similarity=0.391  Sum_probs=202.8

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-----CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEee--CCeEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRL  843 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  843 (1052)
                      .+|++.+.||+|+||+||+|...     ++..||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888999999999999999742     578999999886665566788999999999999999999998754  34678


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence            999999999999998653   34589999999999999999999986   999999999999999999999999999987


Q ss_pred             cCCCCCeee--ecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCC-------Cc--hhHHHHHHH
Q 001561          924 LRPYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGK-------NC--RDLVSWVFQ  992 (1052)
Q Consensus       924 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~-------~~--~~~~~~~~~  992 (1052)
                      .........  ....++..|+|||+..+..++.++||||||+++|||++|..|+......       ..  .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            644322111  1223445699999998888999999999999999999988775321100       00  000000000


Q ss_pred             hhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561          993 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      ....         ............++.+++.+|++.+|++|||+.|+++.|+.++
T Consensus       238 ~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         238 LLKN---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHhc---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            0000         0000111223347899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=339.49  Aligned_cols=251  Identities=26%  Similarity=0.347  Sum_probs=202.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999876 78999999987542   133456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999998753    5689999999999999999999986   999999999999999999999999999987654


Q ss_pred             CC----------------------------CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCccc
Q 001561          927 YD----------------------------THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC  978 (1052)
Q Consensus       927 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~  978 (1052)
                      ..                            ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                            01223457999999999999999999999999999999999999999643


Q ss_pred             CCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 001561          979 KGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF-IEEVVT 1042 (1052)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1042 (1052)
                      .   .......+.   ..........       ......++.+++.+|+. +|.+||+ +.|+++
T Consensus       234 ~---~~~~~~~i~---~~~~~~~~p~-------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         234 T---LQETYNKII---NWKESLRFPP-------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             C---HHHHHHHHh---ccCCcccCCC-------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            2   111111111   1000000000       00133478899999997 9999999 999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.3e-35  Score=335.54  Aligned_cols=252  Identities=23%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ......+.+|++++.+++||+|+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999865 68899999987542   223346788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999999874    34689999999999999999999986   999999999999999999999999999976432


Q ss_pred             CCC----------------------------------eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCC
Q 001561          927 YDT----------------------------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR  972 (1052)
Q Consensus       927 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~  972 (1052)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012357999999999999889999999999999999999999


Q ss_pred             CCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHccc--CCCCCCCCHHHHHH
Q 001561          973 RPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCID--QDPRRRPFIEEVVT 1042 (1052)
Q Consensus       973 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~ 1042 (1052)
                      .||....   ..+....+...   .....+ .+..      ....++.+++.+|+.  .++..||+++|+++
T Consensus       234 ~Pf~~~~---~~~~~~~i~~~---~~~~~~-p~~~------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         234 PPFCSET---PQETYKKVMNW---KETLIF-PPEV------PISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCCCCCC---HHHHHHHHHcC---cCcccC-CCcC------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            9996422   12222211110   000011 1100      112356677777543  23345689999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.2e-35  Score=325.23  Aligned_cols=259  Identities=24%  Similarity=0.398  Sum_probs=203.7

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCe
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  841 (1052)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|++.... .....++.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999753      24679999886432 2344568899999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccCC------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEE
Q 001561          842 RLLIYSYMENGSLDYWLHESVDK------DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  915 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl  915 (1052)
                      .++||||+++|+|.+++......      ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999998753221      23467889999999999999999986   9999999999999999999999


Q ss_pred             eecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHh
Q 001561          916 ADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM  993 (1052)
Q Consensus       916 ~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~  993 (1052)
                      +|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||....   ..+....+.. 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~~~~~~~~-  236 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQVLRFVME-  236 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHc-
Confidence            9999997654322211 112345778999999988889999999999999999999 788986321   1222221111 


Q ss_pred             hhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          994 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                         ......         +......+.+++.+|++.+|++||++.|+++.|++
T Consensus       237 ---~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         237 ---GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ---CCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence               110000         11123468999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=317.20  Aligned_cols=252  Identities=25%  Similarity=0.381  Sum_probs=211.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      +-|...+.||+|.|+.|-.|++- +|++||||++.+..  ......+..|++.|+.++|||||++|++.......|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45777888999999999999744 89999999998653  3345578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-CCCCeEEeecccccccCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG~a~~~~~  926 (1052)
                      .-++|+|++|+-.+   +..+.++.+.+++.||+.|+.|+|+.   ++||||+||+||.+- +-|-||++|||++-.+.+
T Consensus        98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999763   55689999999999999999999998   999999999999765 668999999999988765


Q ss_pred             CCCeeeecccccccccCccccCCcCCC-cccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTAT-CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .  ......+|+..|-|||++.+..|+ +++||||+|||+|-+++|++||+...+.+.   +..            ++|.
T Consensus       172 G--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---LTm------------ImDC  234 (864)
T KOG4717|consen  172 G--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---LTM------------IMDC  234 (864)
T ss_pred             c--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---hhh------------hhcc
Confidence            4  334567999999999999888876 678999999999999999999986544332   111            2222


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .  ...+...+.+..++|..|+..||++|.+.+|++.  ||+.+
T Consensus       235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            1  1223455668899999999999999999999986  77665

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=323.85  Aligned_cols=251  Identities=26%  Similarity=0.330  Sum_probs=200.5

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .|++.++||+|+||+||+|... +++.||+|++.....   .....+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999865 689999999865332   223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++|+|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999888643  234689999999999999999999986   9999999999999999999999999999875432


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      .  ......|++.|+|||++.+..++.++||||+||++|||++|+.||......   .....+........         
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~---------  221 (285)
T cd05605         156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREEVERRVKEDQ---------  221 (285)
T ss_pred             C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHHHHHHhhhcc---------
Confidence            2  123347899999999998888999999999999999999999999742211   11111111110000         


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                       ...+......+.+++.+|++.||++||     +++++++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence             011122344788999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.4e-35  Score=337.57  Aligned_cols=251  Identities=24%  Similarity=0.301  Sum_probs=195.6

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .|+..+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999865 68899999987542   2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999874    34578899999999999999999986   9999999999999999999999999998643210


Q ss_pred             CC----------------------------------------------eeeecccccccccCccccCCcCCCcccchHHH
Q 001561          928 DT----------------------------------------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSF  961 (1052)
Q Consensus       928 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  961 (1052)
                      ..                                              ......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00123579999999999988889999999999


Q ss_pred             HHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHH--cccCCCCCCCCHHH
Q 001561          962 GVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACK--CIDQDPRRRPFIEE 1039 (1052)
Q Consensus       962 Gvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~e 1039 (1052)
                      ||++|||++|+.||.....   .+....+..   ......+       +.......++.+++.+  |...+|..||++.|
T Consensus       235 G~il~elltG~~Pf~~~~~---~~~~~~i~~---~~~~~~~-------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTP---TETQLKVIN---WENTLHI-------PPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCH---HHHHHHHHc---cccccCC-------CCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            9999999999999964221   111111110   0000000       0011123467788887  55666677999999


Q ss_pred             HHH
Q 001561         1040 VVT 1042 (1052)
Q Consensus      1040 vl~ 1042 (1052)
                      +++
T Consensus       302 ~l~  304 (381)
T cd05626         302 IKA  304 (381)
T ss_pred             Hhc
Confidence            987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.1e-35  Score=319.25  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=196.6

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      +.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999865 78999999876543 34456789999999999999999999999999999999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeee-e
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-T  933 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~  933 (1052)
                      .+++..   ....+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+|++|||.+........... .
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            999864   234588999999999999999999986   999999999999999999999999999976442211111 1


Q ss_pred             cccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhh
Q 001561          934 DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012 (1052)
Q Consensus       934 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1052)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ........    ....         ...+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~~~~~----~~~~---------~~~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTREAIE----QGVR---------LPCP  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHHHHHH----cCCC---------CCCc
Confidence            1123457999999988889999999999999999998 9999863221   11111110    0000         0111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561         1013 EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus      1013 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      ...+..+.+++.+|++.+|++||++.|+.++|+.
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            1224478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.3e-35  Score=336.00  Aligned_cols=255  Identities=23%  Similarity=0.268  Sum_probs=199.4

Q ss_pred             HHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeE
Q 001561          767 LKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       767 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  842 (1052)
                      ....++|++.+.||+|+||.||+|... +++.||+|++.+..   ......+.+|+++++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            334578999999999999999999876 67899999986422   22344578899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+|.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence            999999999999998864     2478889999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCeeeecccccccccCccccCCc----CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          923 LLRPYDTHVTTDLVGTLGYIPPEYSQTL----TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      .............+||+.|+|||++...    .++.++||||+||++|||++|+.||...   ........+.   ....
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~---~~~~~~~~i~---~~~~  264 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD---SLVGTYSKIM---DHKN  264 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC---CHHHHHHHHH---hCCc
Confidence            7654333233456799999999987653    3778999999999999999999999632   1111111111   1111


Q ss_pred             ccccccccccchhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR--RPFIEEVVT 1042 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1042 (1052)
                      ...+       +........+.+++.+|+..++.+  ||++.|+++
T Consensus       265 ~~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         265 SLNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             ccCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            1111       111122346788999999755543  889999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.9e-35  Score=320.13  Aligned_cols=245  Identities=25%  Similarity=0.338  Sum_probs=192.6

Q ss_pred             EcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      ||+|+||.||+++.. +|+.||+|++....   ...++.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 68999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeec
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  934 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  934 (1052)
                      .+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~  153 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ  153 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence            9888643  234588999999999999999999986   99999999999999999999999999998764322  2234


Q ss_pred             ccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHH
Q 001561          935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014 (1052)
Q Consensus       935 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1052)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||.........  ...........  ....        ...
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~--~~~~--------~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLEDE--VKFE--------HQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhccc--cccc--------ccc
Confidence            57899999999998888999999999999999999999999643211111  11111111000  0000        011


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1015 QLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1015 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ...++.+++.+|+++||++||++.|+++
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            2346899999999999999999977653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.3e-35  Score=328.59  Aligned_cols=241  Identities=25%  Similarity=0.351  Sum_probs=193.2

Q ss_pred             CeEcccCceEEEEEEEC----CCcEEEEEEecCCc----hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          777 NIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +.||+|+||.||+++..    +++.||+|+++...    ......+..|++++++++||||+++++++.+++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999753    57889999987532    12234567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++|+|.+++..    ...+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999998864    34578889999999999999999986   99999999999999999999999999987543222


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+   ....  ..+      
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~---~~~~--~~~------  219 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKI---LKGK--LNL------  219 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHH---HcCC--CCC------
Confidence             22234579999999999988889999999999999999999999996421   11111111   1111  000      


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                         +......+.+++.+|++++|++||     ++.++++
T Consensus       220 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 ---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               111234688999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.9e-35  Score=337.20  Aligned_cols=264  Identities=23%  Similarity=0.328  Sum_probs=200.0

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----eEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----DRL  843 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  843 (1052)
                      +|+..+.||+|+||.||+|... +|+.||+|++....  ....+++.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999864 78999999986432  234467889999999999999999999998776     789


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      +|+||+. ++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 567776643    45689999999999999999999986   999999999999999999999999999987


Q ss_pred             cCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccc-
Q 001561          924 LRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE- 1001 (1052)
Q Consensus       924 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 1001 (1052)
                      .............+++.|+|||++.+ ..++.++||||+||++|||++|+.||.....   .+....+........... 
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP---IQQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCCCHHHH
Confidence            54433333344578999999998776 4578999999999999999999999964321   111111111110000000 


Q ss_pred             ----------c----ccc-cc--cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561         1002 ----------I----IDA-SI--WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1002 ----------~----~~~-~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                                +    ..+ ..  ..........++.+++.+|++.||++|||+.|+++  ++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence                      0    000 00  00001112457889999999999999999999987  4544

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.4e-35  Score=318.33  Aligned_cols=253  Identities=27%  Similarity=0.441  Sum_probs=202.9

Q ss_pred             cCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      ++|++.+.||+|++|.||+|...++..+|+|++.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4588889999999999999998877789999876543 23456889999999999999999998875 456789999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +|+|.++++..  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.++........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            99999999753  234578999999999999999999986   9999999999999999999999999999876433222


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||....   ..+...+...    ....         
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~----~~~~---------  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NREVLEQVER----GYRM---------  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHc----CCCC---------
Confidence            2222346678999999988889999999999999999999 999986422   2222222111    1000         


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      ..+...+..+.+++.+|++++|++||+++++++.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0111233578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.6e-35  Score=316.81  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=198.4

Q ss_pred             CeEcccCceEEEEEEECCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCChh
Q 001561          777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD  855 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  855 (1052)
                      ++||+|+||.||+|...++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3699999999999998888999999987654 333456889999999999999999999999999999999999999999


Q ss_pred             hhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeecc
Q 001561          856 YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL  935 (1052)
Q Consensus       856 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  935 (1052)
                      +++...   ...+++..+..++.|++.|+.|+|+.   +++||||||+||++++++.+|++|||++..............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            988653   34578999999999999999999986   999999999999999999999999999976433222112223


Q ss_pred             cccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHH
Q 001561          936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014 (1052)
Q Consensus       936 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1052)
                      .+++.|+|||+..+..++.++||||||+++||+++ |..||....   .......+.    ......         ....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~---~~~~~~~~~----~~~~~~---------~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT---NQQAREQVE----KGYRMS---------CPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHH----cCCCCC---------CCCC
Confidence            44668999999988889999999999999999998 999996432   111111111    110000         0111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561         1015 QLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus      1015 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                      .+..+.+++.+|++.+|++||++.|++++|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2347899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-35  Score=327.92  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=206.6

Q ss_pred             hcCCcccCeEcccCceEEEEEEECC------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  841 (1052)
                      .++|+..+.||+|+||.||+|....      ...+|+|.+.... .....++.+|+++++++ +|+||+++++++.+++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            4568889999999999999998642      3679999987543 33445688999999999 89999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhccc------------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC
Q 001561          842 RLLIYSYMENGSLDYWLHESV------------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE  909 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~  909 (1052)
                      .++||||+++|+|.++++...            .....+++..++.++.|++.|++|||+.   +|+||||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence            999999999999999987532            2345689999999999999999999986   9999999999999999


Q ss_pred             CCCeEEeecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHH
Q 001561          910 KFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV  987 (1052)
Q Consensus       910 ~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~  987 (1052)
                      ++.+|++|||.++.+....... .....++..|+|||+..+..++.++|||||||++||+++ |..||....   ..+..
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~  244 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEELF  244 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC---HHHHH
Confidence            9999999999998765432211 122345678999999988899999999999999999998 999986322   11222


Q ss_pred             HHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561          988 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      ...    .......         .+......+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus       245 ~~~----~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLL----KEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHH----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            111    1111000         11122346889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.9e-35  Score=324.36  Aligned_cols=257  Identities=27%  Similarity=0.426  Sum_probs=203.1

Q ss_pred             cCCcccCeEcccCceEEEEEEE-----CCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      .+|++.+.||+|+||+||+|.+     .++..||+|.+.... .....++.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3577889999999999999974     245789999987533 3344678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccC-------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC
Q 001561          845 IYSYMENGSLDYWLHESVD-------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF  911 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~  911 (1052)
                      ||||+++++|.+++.....             ....+++.++..++.|++.|++|||+.   +|+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999853211             123578899999999999999999986   999999999999999999


Q ss_pred             CeEEeecccccccCCCCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHH
Q 001561          912 EAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSW  989 (1052)
Q Consensus       912 ~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~  989 (1052)
                      .+|++|||+++....... .......++..|+|||+..+..++.++||||||+++|||++ |..||....   ..+..+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence            999999999987543221 12233456778999999988889999999999999999998 999986321   1122221


Q ss_pred             HHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          990 VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      +.    ......         .+.....++.+++.+|++.+|++||++.++.+.|..
T Consensus       239 ~~----~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VR----KRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----cCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11    111100         111123468899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.5e-35  Score=330.40  Aligned_cols=243  Identities=22%  Similarity=0.354  Sum_probs=191.1

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ++||+|+||.||+|... +++.||+|++....   ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 67899999987542   23345577888888877 799999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|..++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~  152 (329)
T cd05618          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT  152 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence            999888764    34689999999999999999999986   99999999999999999999999999997543221 22


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCC--chhHHHHHHHhhhcccccccccccccc
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN--CRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+......... ..        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~--------  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IR--------  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-CC--------
Confidence            234579999999999999999999999999999999999999996322111  1111222222111111 01        


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFI 1037 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1037 (1052)
                       .+.....++.+++.+|++.||++||++
T Consensus       224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 -IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             111223467899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.2e-35  Score=330.78  Aligned_cols=248  Identities=21%  Similarity=0.341  Sum_probs=195.2

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ++||+|+||.||+|... +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999865 68899999997542   22334578899999998 799999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~  152 (329)
T cd05588          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT  152 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence            999888764    34689999999999999999999986   9999999999999999999999999999753221 122


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCC--chhHHHHHHHhhhcccccccccccccc
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN--CRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+  ......+.......... .+       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------  224 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-RI-------  224 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-CC-------
Confidence            334679999999999999999999999999999999999999996432111  11111222221111110 00       


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPF------IEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 1042 (1052)
                        +.....++.+++.+|++.||.+||+      +.|+++
T Consensus       225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence              1112346889999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.4e-35  Score=352.83  Aligned_cols=260  Identities=24%  Similarity=0.341  Sum_probs=203.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....   ....+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999865 68999999987542   234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccC-------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          847 SYMENGSLDYWLHESVD-------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                      ||++||+|.+++.....       .....++..++.++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998865321       123456788899999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCC-----------------eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCC
Q 001561          920 LSRLLRPYDT-----------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN  982 (1052)
Q Consensus       920 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~  982 (1052)
                      +++.......                 ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.....  
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~--  236 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG--  236 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence            9987621110                 011234799999999999999999999999999999999999999964221  


Q ss_pred             chhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhc
Q 001561          983 CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP-FIEEVVTWLDGI 1047 (1052)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i 1047 (1052)
                       ...... ...         .++... ......+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus       237 -~ki~~~-~~i---------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        237 -RKISYR-DVI---------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             -hhhhhh-hhc---------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             111100 000         000000 00112334688999999999999996 667777777665

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.5e-35  Score=330.08  Aligned_cols=244  Identities=25%  Similarity=0.349  Sum_probs=192.7

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHH---HhcCCCceeeeeceEeeCCeEEEE
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEAL---SRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      |++.+.||+|+||.||+|... +++.||||+++...   ....+.+.+|++++   ++++||||+++++++.+++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667889999999999999865 68999999987542   12234466666554   566899999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++|+|..+++.     ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999887753     3589999999999999999999986   99999999999999999999999999987543


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ... ......+|++.|+|||++.+..++.++|||||||++|||++|+.||...   +..+....+.   ....  .    
T Consensus       153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~---~~~~~~~~i~---~~~~--~----  219 (324)
T cd05589         153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD---DEEEVFDSIV---NDEV--R----  219 (324)
T ss_pred             CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC---CHHHHHHHHH---hCCC--C----
Confidence            222 2233467999999999999889999999999999999999999999632   2222221111   1100  0    


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                           .+......+.+++.+|++.||.+||     ++.++++
T Consensus       220 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 -----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 0111234678999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1e-34  Score=320.45  Aligned_cols=262  Identities=23%  Similarity=0.389  Sum_probs=209.3

Q ss_pred             hcCCcccCeEcccCceEEEEEEECC-----CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEee-CCeE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRH-GNDR  842 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  842 (1052)
                      .++|++.++||+|+||.||+|.+.+     +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678899999999999999998765     6789999887543 3345668899999999999999999998776 4678


Q ss_pred             EEEEEeccCCChhhhhhcccCC----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          843 LLIYSYMENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                      ++++||+++|+|.+++......    ...+++..++.++.|++.|++|||+.   +++||||||+||++++++.+|++||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998764322    25689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCeee-ecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhc
Q 001561          919 GLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE  996 (1052)
Q Consensus       919 G~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      |+++.+........ ....++..|+|||+..+..++.++||||||+++||+++ |+.||...   ...+...+...   .
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~~~~~~~---~  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI---DPFEMAAYLKD---G  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC---CHHHHHHHHHc---C
Confidence            99987644332222 22345678999999988889999999999999999999 99999632   22222222211   1


Q ss_pred             ccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561          997 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      ....          .....+.++.+++.+|++.+|++||++.|+++.|+++..+
T Consensus       236 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         236 YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            0000          0111234688999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.4e-35  Score=324.42  Aligned_cols=259  Identities=29%  Similarity=0.425  Sum_probs=204.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      +|++.+.||+|+||.||+|...      ....+|+|.+.... .....++.+|+.++++++||||+++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999753      23578888887544 2334678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccC--------------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCc
Q 001561          845 IYSYMENGSLDYWLHESVD--------------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN  904 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~N  904 (1052)
                      |+||+++|+|.+++.....                    ....+++..++.++.|++.|++|||+.   +|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999998865321                    224588999999999999999999986   99999999999


Q ss_pred             eEECCCCCeEEeecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCC
Q 001561          905 ILLDEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN  982 (1052)
Q Consensus       905 ill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~  982 (1052)
                      |++++++.+||+|||+++......... .....++..|+|||...+..++.++||||||+++|||++ |+.||...   .
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI---A  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC---C
Confidence            999999999999999998654332211 122345678999999888889999999999999999998 99998632   2


Q ss_pred             chhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          983 CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      .....+...    .....         ........++.+++.+|++.+|++||+++|+++.|+++-.
T Consensus       235 ~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         235 PERLFNLLK----TGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHHHHh----CCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            222222211    11000         0011223478899999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.1e-35  Score=329.50  Aligned_cols=236  Identities=26%  Similarity=0.349  Sum_probs=190.1

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ++||+|+||+||+|... +++.||+|++....   ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 68899999987542   22334567788888877 699999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~  152 (320)
T cd05590          81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT  152 (320)
T ss_pred             chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence            999988864    34588999999999999999999986   9999999999999999999999999998764322 222


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...   +..+....+.   ...    ...+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~---~~~~~~~~i~---~~~----~~~~------  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAIL---NDE----VVYP------  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC---CHHHHHHHHh---cCC----CCCC------
Confidence            33457999999999999889999999999999999999999999642   2222222221   110    0001      


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFI 1037 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~ 1037 (1052)
                       .....++.+++.+|++.||++||++
T Consensus       217 -~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 -TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHCCCC
Confidence             1123468899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=336.59  Aligned_cols=251  Identities=24%  Similarity=0.293  Sum_probs=196.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36889999999999999999865 78999999986432   223356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999998864    34588999999999999999999986   999999999999999999999999999964321


Q ss_pred             CCCe----------------------------------------------eeecccccccccCccccCCcCCCcccchHH
Q 001561          927 YDTH----------------------------------------------VTTDLVGTLGYIPPEYSQTLTATCRGDVYS  960 (1052)
Q Consensus       927 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  960 (1052)
                      ....                                              .....+||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            1000                                              001246999999999999889999999999


Q ss_pred             HHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCC---CCH
Q 001561          961 FGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRR---PFI 1037 (1052)
Q Consensus       961 lGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~ 1037 (1052)
                      |||++|||++|++||....   ..+....+..   ........+       ......++.+++.+|+. +|.+|   +++
T Consensus       234 lGvil~elltG~~Pf~~~~---~~~~~~~i~~---~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         234 LGAIMFECLIGWPPFCSEN---SHETYRKIIN---WRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             cchhhhhhhcCCCCCCCCC---HHHHHHHHHc---cCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            9999999999999996422   1121111111   000111111       01123468899999997 67765   599


Q ss_pred             HHHHH
Q 001561         1038 EEVVT 1042 (1052)
Q Consensus      1038 ~evl~ 1042 (1052)
                      .|+++
T Consensus       300 ~~~l~  304 (377)
T cd05629         300 HEIKS  304 (377)
T ss_pred             HHHhc
Confidence            99887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.7e-35  Score=327.72  Aligned_cols=240  Identities=25%  Similarity=0.338  Sum_probs=189.4

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ++||+|+||.||+|... +++.||+|+++...   ....+.+..|.+++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 67889999987542   12233455666776654 899999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            999988864    34588999999999999999999986   99999999999999999999999999997643222 22


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+....+   .....           ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~~i---~~~~~-----------~~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFDSI---LNDRP-----------HF  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHHHH---HcCCC-----------CC
Confidence            334579999999999998889999999999999999999999996422   12222111   11100           00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIE-EVV 1041 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 1041 (1052)
                      +.....++.+++.+|++.+|++||++. +++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111234678999999999999999876 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.1e-34  Score=317.68  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=197.8

Q ss_pred             cCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ++|+..++||+|+||.||+|.. .++..||+|++.... ....+++.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999985 478899999986543 34456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      ++++++..+.        .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999986542        367888999999999999999986   9999999999999999999999999999765432 


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                        ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..........................     . 
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-  220 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----L-  220 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----C-
Confidence              22335789999999999988899999999999999999999999964322211110000011110000000     0 


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        .......++.+++.+|++.+|++||+++|+++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              01112336889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-34  Score=318.04  Aligned_cols=257  Identities=23%  Similarity=0.374  Sum_probs=201.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ++|++.+.||+|+||+||+|.+. +++    +|++|.+.... .....++..|+.+++++.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46888899999999999999864 444    47788775433 2334567888889999999999999998764 45788


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      ++||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.++..
T Consensus        86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999999999999752   34689999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          925 RPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       925 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ....... .....++..|+|||...+..++.++||||||+++||+++ |+.||.....   ....+. ..   ...  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~-~~---~~~--~~  230 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDL-LE---KGE--RL  230 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH-HH---CCC--cC
Confidence            4332221 223456779999999988889999999999999999998 9999964321   111111 11   111  00


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      ..+..       +...+.+++.+|+..+|++||++.|+++.|+.+..+
T Consensus       231 ~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         231 AQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            11111       123578899999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6e-35  Score=329.09  Aligned_cols=241  Identities=25%  Similarity=0.319  Sum_probs=193.0

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCC-ceeeeeceEeeCCeEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK-NLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  846 (1052)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|.+++..++|+ +|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999866 57899999987542   22345677899999999764 6888999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            99999999988864    34578999999999999999999986   999999999999999999999999999875322


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      . ........||+.|+|||++.+..++.++||||+||++|||++|+.||...   ...+....+..   ..  ..     
T Consensus       154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---~~~~~~~~i~~---~~--~~-----  219 (324)
T cd05587         154 G-GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQSIME---HN--VS-----  219 (324)
T ss_pred             C-CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHc---CC--CC-----
Confidence            1 12233457999999999999989999999999999999999999999632   22222222111   10  00     


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1037 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1037 (1052)
                          .+.....++.+++.+|++++|.+|++.
T Consensus       220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 ----YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                011123468899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-35  Score=319.73  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=201.9

Q ss_pred             CcccCeEcccCceEEEEEEEC-C---CcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCe-----
Q 001561          773 FNQANIIGCGGFGLVYKATLT-N---GTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND-----  841 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  841 (1052)
                      |++.+.||+|+||.||+|... +   +..||+|+++.+.  .....++.+|++.++.++||||+++++++.+.+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999864 2   3679999987543  2334678999999999999999999998876554     


Q ss_pred             -EEEEEEeccCCChhhhhhcccC--CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          842 -RLLIYSYMENGSLDYWLHESVD--KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       842 -~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                       .++|+||+++|+|..++.....  ....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             7899999999999998865431  234689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCeee-ecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhc
Q 001561          919 GLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE  996 (1052)
Q Consensus       919 G~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      |.++.+........ ....++..|+|||+..+..++.++||||||+++|||++ |..||....   ..+...+...    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~~----  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLRH----  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHc----
Confidence            99987643322211 11235678999999988889999999999999999999 999986422   2222222211    


Q ss_pred             ccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          997 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      .....         .+.....++.+++.+|++.||++||++.|+++.|+++
T Consensus       231 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11000         1112344789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.8e-35  Score=327.22  Aligned_cols=267  Identities=22%  Similarity=0.367  Sum_probs=202.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56889999999999999999865 67889999987443 22334577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++ ++.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 777777542   34578899999999999999999986   99999999999999999999999999997643322


Q ss_pred             CeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc---ccc--
Q 001561          929 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE---VEI-- 1002 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 1002 (1052)
                       .......+|+.|+|||++.+ ..++.++||||+|+++|||++|++||.....   .+....+.........   ..+  
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV---EDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHhhhcc
Confidence             12233468899999997754 5688999999999999999999999964321   2222211111110000   000  


Q ss_pred             ----cc---ccc----cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561         1003 ----ID---ASI----WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus      1003 ----~~---~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                          .+   +..    ..........++.+++.+|++.||++|||+.|+++  +++.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                00   000    00001123446789999999999999999999998  666654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.6e-35  Score=330.14  Aligned_cols=242  Identities=23%  Similarity=0.317  Sum_probs=194.4

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  852 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  852 (1052)
                      +.||+|+||.||+|... +|..||+|++....   ......+..|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 78999999987542   223355678999999999999999999999999999999999999


Q ss_pred             ChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeee
Q 001561          853 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  932 (1052)
Q Consensus       853 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  932 (1052)
                      +|.+++..    ...+++..+..++.|++.||+|||+.  ++|+||||||+||++++++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (325)
T cd05594          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM  153 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccc
Confidence            99888864    34689999999999999999999972  499999999999999999999999999987543222 222


Q ss_pred             ecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhh
Q 001561          933 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012 (1052)
Q Consensus       933 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1052)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .......+.   ...  ..         .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~---~~~~~~~i~---~~~--~~---------~p  216 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELIL---MEE--IR---------FP  216 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC---HHHHHHHHh---cCC--CC---------CC
Confidence            34579999999999998899999999999999999999999996322   111111111   000  00         01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1013 EKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1013 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                      .....++.+++.+|++.||++|+     ++.++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            11234688999999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.9e-35  Score=317.03  Aligned_cols=246  Identities=24%  Similarity=0.396  Sum_probs=196.1

Q ss_pred             eEcccCceEEEEEEEC---CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCC
Q 001561          778 IIGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  852 (1052)
Q Consensus       778 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  852 (1052)
                      .||+|+||.||+|.++   ++..+|+|+++...  ....+++..|+.++++++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   57889999986443  334567899999999999999999999885 45678999999999


Q ss_pred             ChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeee
Q 001561          853 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT  932 (1052)
Q Consensus       853 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  932 (1052)
                      +|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||.++..........
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999864    34588999999999999999999986   999999999999999999999999999987654433221


Q ss_pred             --ecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          933 --TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       933 --~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                        ....+++.|+|||......++.++||||||+++|||++ |+.||....   ..+....+.    .......       
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~i~----~~~~~~~-------  219 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK---GNEVTQMIE----SGERMEC-------  219 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----CCCCCCC-------
Confidence              12234578999999888889999999999999999998 999996422   122222111    1111111       


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                        +...+.++.+++.+|++.||++||++++|++.|++.
T Consensus       220 --~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 --PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              112334788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.4e-35  Score=318.78  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=200.8

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            47899999999999999999864 78899999987655445566889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.++++.    ...+++..+..++.|++.|++|||+.   +|+|||+||+||+++.++.++|+|||++........
T Consensus        89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999998864    34678999999999999999999986   999999999999999999999999999987643221


Q ss_pred             eeeecccccccccCccccC---CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                       ......|++.|+|||.+.   ...++.++|||||||++|||++|+.||.......  ..    ......    ....+.
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~--~~----~~~~~~----~~~~~~  230 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--AL----FLMSKS----NFQPPK  230 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh--hh----eeeecC----CCCCCC
Confidence             123356889999999874   4457889999999999999999999985322110  00    000000    000000


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                      .  ......+..+.+++.+|++.+|++||+++++++.
T Consensus       231 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         231 L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            0  0011234578999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.3e-35  Score=336.55  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=203.6

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGND  841 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  841 (1052)
                      .++|.+.+.||+|+||.||+|++.      .+..||+|++..... ...+.+.+|++++.++. ||||++++++|...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            345778899999999999999864      245799999975532 22346889999999997 9999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccC----------------------------------------------------------
Q 001561          842 RLLIYSYMENGSLDYWLHESVD----------------------------------------------------------  863 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  863 (1052)
                      .++||||+++|+|.++++....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999975321                                                          


Q ss_pred             ------------------------------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEE
Q 001561          864 ------------------------------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL  907 (1052)
Q Consensus       864 ------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill  907 (1052)
                                                          ....+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence                                                112467888999999999999999985   99999999999999


Q ss_pred             CCCCCeEEeecccccccCCCCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchh
Q 001561          908 DEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD  985 (1052)
Q Consensus       908 ~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~  985 (1052)
                      ++++.+|++|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..||....   ..+
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~---~~~  349 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP---MNE  349 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC---chH
Confidence            9999999999999986533221 11223457789999999988889999999999999999998 899986322   111


Q ss_pred             HHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          986 LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      .....   .......  .       .+.....++.+++.+|++.+|.+||+++|+++.|+++
T Consensus       350 ~~~~~---~~~~~~~--~-------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 QFYNA---IKRGYRM--A-------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHH---HHcCCCC--C-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11111   1111000  0       0111234789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7e-35  Score=328.39  Aligned_cols=241  Identities=25%  Similarity=0.305  Sum_probs=193.3

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      +|++.+.||+|+||+||+|... +++.||+|++.+...   ...+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999866 578999999875432   2234466788888777 5899999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            99999999988864    34588999999999999999999986   999999999999999999999999999975432


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      . ........||+.|+|||++.+..++.++|||||||++|||++|+.||...   +..+....+..   ...  .     
T Consensus       154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~---~~~--~-----  219 (323)
T cd05616         154 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIME---HNV--A-----  219 (323)
T ss_pred             C-CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CCC--C-----
Confidence            2 12233457999999999999999999999999999999999999999642   22222222211   100  0     


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1037 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1037 (1052)
                          .+.....++.+++.+|++.+|.+|++.
T Consensus       220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 ----YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                011223468899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.4e-35  Score=320.57  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=204.8

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  843 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  843 (1052)
                      ..+|+..+.||+|+||+||+|.+. +|+    +||+|++.... ....+++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            356888999999999999999854 444    48999987543 34456788999999999999999999998754 578


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      +++||+++|+|.++++..   ...+++..++.++.|+++|++|||+.   +|+||||||+||++++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            999999999999998752   34689999999999999999999986   999999999999999999999999999987


Q ss_pred             cCCCCCeee-ecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccc
Q 001561          924 LRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001 (1052)
Q Consensus       924 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ......... ....+++.|+|||...+..++.++||||||+++|||++ |..||...   .......++....   . ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~~~~---~-~~  231 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI---PAREIPDLLEKGE---R-LP  231 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHCCC---c-CC
Confidence            654332211 12245678999999988889999999999999999998 99998632   1222222211100   0 00


Q ss_pred             cccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCccc
Q 001561         1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1051 (1052)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1051 (1052)
                               ........+.+++.+|++.||++||++.|+++.|+++..++
T Consensus       232 ---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         232 ---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                     01122346889999999999999999999999999886653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-34  Score=314.48  Aligned_cols=255  Identities=28%  Similarity=0.464  Sum_probs=207.1

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|++.+.||+|+||.||+|...++..||+|.+.... ...+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46789999999999999999998878899999987543 23467899999999999999999999999888999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++...  ....+++..+..++.+++.|++|||+.   +++|+||||+||++++++.+|++|||.++.......
T Consensus        84 ~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          84 SKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             CCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999763  234689999999999999999999986   999999999999999999999999999987653221


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .......++..|+|||...+..++.++||||+|+++||+++ |+.||...   +.......+.....      .      
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~---~~~~~~~~~~~~~~------~------  223 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM---TNREVLEQVERGYR------M------  223 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCC------C------
Confidence            11122234568999999988889999999999999999998 99999532   22222222211100      0      


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                       ..+...+.++.+++.+|++.+|++||+++++.+.|++
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             0001113468999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.1e-35  Score=336.93  Aligned_cols=250  Identities=24%  Similarity=0.291  Sum_probs=195.6

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6899999999999999999865 68899999986432   1223557889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|..+...
T Consensus        82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999874    34578899999999999999999986   9999999999999999999999999998533110


Q ss_pred             C------------------------------------------CeeeecccccccccCccccCCcCCCcccchHHHHHHH
Q 001561          928 D------------------------------------------THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVL  965 (1052)
Q Consensus       928 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil  965 (1052)
                      .                                          .......+||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                          0001234799999999999999999999999999999


Q ss_pred             HHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCC---CHHHHHH
Q 001561          966 LELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP---FIEEVVT 1042 (1052)
Q Consensus       966 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~ 1042 (1052)
                      |||++|+.||.....   .+...   .............       ......++.+++.+|+ .+|.+|+   ++.|+++
T Consensus       235 yell~G~~Pf~~~~~---~~~~~---~i~~~~~~~~~~~-------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         235 YEMLVGQPPFLADTP---AETQL---KVINWETTLHIPS-------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eehhhCCCCCCCCCH---HHHHH---HHhccCccccCCC-------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            999999999964321   11111   1111000011100       1112335678888876 5999999   8899876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.1e-35  Score=317.05  Aligned_cols=252  Identities=35%  Similarity=0.497  Sum_probs=201.4

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHH--HHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      |++.+.||+|+||+||+|+.. +++.||+|++.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677899999999999999876 5678999999876543332  3456999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++.    ....+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++|+|||.+.... ...
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN  152 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred             cccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence            9999999997    345689999999999999999999996   99999999999999999999999999997642 223


Q ss_pred             eeeecccccccccCccccC-CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .......+++.|+|||+.. +..++.++||||+|+++|+|++|+.||....   ..+..................     
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN---SDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS---HHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc---chhhhhhhhhccccccccccc-----
Confidence            3445568899999999988 8889999999999999999999999997431   111111111111110000000     


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .  ......++.+++.+|++.||++||++.++++
T Consensus       225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             c--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  0000157999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.9e-35  Score=332.49  Aligned_cols=259  Identities=24%  Similarity=0.268  Sum_probs=201.0

Q ss_pred             HHHHHHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEee
Q 001561          763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRH  838 (1052)
Q Consensus       763 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  838 (1052)
                      +.++....++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4445555688999999999999999999876 67899999986422   2233457889999999999999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       839 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                      ++..++||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            9999999999999999998864     2478888999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCeeeecccccccccCccccCCc----CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL----TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       919 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      |+++.............+||+.|+|||++...    .++.++|||||||++|||++|+.||...   +.......+   .
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i---~  260 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKI---M  260 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHH---H
Confidence            99987654332233456799999999987653    3788999999999999999999999632   111111111   1


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR--RPFIEEVVT 1042 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1042 (1052)
                      .......+.+       .......+.+++.+|+..++.+  ||++.|+++
T Consensus       261 ~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         261 NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence            1111111111       1123346789999999844433  779998887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=315.74  Aligned_cols=251  Identities=29%  Similarity=0.458  Sum_probs=205.6

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            356888999999999999999875 88999999986644 4567899999999999999999999999889999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++.......
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          83 AKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            999999998753  223689999999999999999999986   999999999999999999999999999987632211


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                          ...++..|+|||.+....++.++||||||+++||+++ |+.||...   ...+......    ......       
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~----~~~~~~-------  219 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPHVE----KGYRME-------  219 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHh----cCCCCC-------
Confidence                2344568999999988889999999999999999997 99998632   2222221111    110000       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                        .+...+.++.+++.+|+..+|++||++.|++++|+++
T Consensus       220 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 --APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              0112235788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=313.67  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=200.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ++|++.+.||+|++|.||+|... ++.+||+|.+....     ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999864 68999999886432     1123467889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      |+||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||.++..
T Consensus        82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999999998864    34578899999999999999999986   9999999999999999999999999999865


Q ss_pred             CCCCCeee--ecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          925 RPYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       925 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ........  ....|+..|+|||+..+..++.++||||+|+++|||++|+.||...   +......+   ........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~---~~~~~~~~---~~~~~~~~--  226 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF---EAMAAIFK---IATQPTNP--  226 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc---chHHHHHH---HhccCCCC--
Confidence            43221111  2346788999999999888999999999999999999999998532   11111111   11111100  


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                             ..+......+.+++.+|++.+|.+||++.|+++
T Consensus       227 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         227 -------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             -------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence                   111223346889999999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-34  Score=326.74  Aligned_cols=241  Identities=25%  Similarity=0.348  Sum_probs=193.1

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ++||+|+||.||+|+.. +++.||+|++....   ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 57899999987542   22334567788888876 799999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~  152 (321)
T cd05591          81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT  152 (321)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence            999988864    34588999999999999999999986   99999999999999999999999999997643222 22


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||...   +..+....+..   ..    ...+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~---~~~~~~~~i~~---~~----~~~p------  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD---NEDDLFESILH---DD----VLYP------  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC---CHHHHHHHHHc---CC----CCCC------
Confidence            33457999999999999889999999999999999999999999642   22222222211   10    0000      


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRP-------FIEEVVT 1042 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 1042 (1052)
                       .....++.+++.+|++.||++||       ++.++++
T Consensus       217 -~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         217 -VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence             11224688999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.1e-34  Score=320.64  Aligned_cols=264  Identities=23%  Similarity=0.354  Sum_probs=203.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-----------------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeee
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-----------------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSL  832 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  832 (1052)
                      ++|++.+.||+|+||.||+|...                 ++..||+|++.... .....++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998533                 23468999987543 3345678999999999999999999


Q ss_pred             eceEeeCCeEEEEEEeccCCChhhhhhcccCC-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCce
Q 001561          833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDK-------DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNI  905 (1052)
Q Consensus       833 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Ni  905 (1052)
                      ++++..++..++||||+++|+|.+++......       ...+++..++.++.|++.|++|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999998764321       23478889999999999999999986   999999999999


Q ss_pred             EECCCCCeEEeecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc--CCCCCcccCCCC
Q 001561          906 LLDEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGKN  982 (1052)
Q Consensus       906 ll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~pf~~~~~~~  982 (1052)
                      ++++++.++++|||+++.+....... .....+++.|+|||......++.++|||||||++|||++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence            99999999999999998654332211 122344678999998888889999999999999999998  7788853221  


Q ss_pred             chhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          983 CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                       .+..................      +.+..++..+.+++.+|++.||++||++.|+++.|++
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 -EQVIENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -HHHHHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             12221111111110000000      0011123478899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.9e-35  Score=326.26  Aligned_cols=260  Identities=28%  Similarity=0.404  Sum_probs=205.2

Q ss_pred             cCCcccCeEcccCceEEEEEEEC--------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCC
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  840 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  840 (1052)
                      ++|.+.+.||+|+||.||+|...        ++..+|+|.+.... .....++.+|+++++++ +||||+++++++.+.+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            46889999999999999999753        23469999987543 33445688899999999 7999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001561          841 DRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  908 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~  908 (1052)
                      ..++||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.   +++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            99999999999999999976432            124589999999999999999999986   999999999999999


Q ss_pred             CCCCeEEeecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhH
Q 001561          909 EKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL  986 (1052)
Q Consensus       909 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~  986 (1052)
                      +++.+||+|||.++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...   ...+.
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~---~~~~~  251 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PVEEL  251 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC---CHHHH
Confidence            99999999999997654322111 112234568999999988889999999999999999998 88998532   11122


Q ss_pred             HHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          987 VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      ...    .......         ..+.....++.+++.+|++.+|++||++.|+++.|+++.+
T Consensus       252 ~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         252 FKL----LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             HHH----HHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            211    1111110         1111223478899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=322.03  Aligned_cols=264  Identities=24%  Similarity=0.366  Sum_probs=202.2

Q ss_pred             cCCcccCeEcccCceEEEEEEECC---------------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN---------------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQG  834 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  834 (1052)
                      ++|++.+.||+|+||.||+|....               ...||+|.+.... ......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987532               2358999987553 334457899999999999999999999


Q ss_pred             eEeeCCeEEEEEEeccCCChhhhhhcccC--------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceE
Q 001561          835 YCRHGNDRLLIYSYMENGSLDYWLHESVD--------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNIL  906 (1052)
Q Consensus       835 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nil  906 (1052)
                      ++...+..++||||+++++|.+++.....        ....+++..++.++.|+++|++|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            99999999999999999999999864321        112468899999999999999999986   9999999999999


Q ss_pred             ECCCCCeEEeecccccccCCCCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc--CCCCCcccCCCCc
Q 001561          907 LDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGKNC  983 (1052)
Q Consensus       907 l~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~pf~~~~~~~~  983 (1052)
                      +++++.+|++|||++......... ......+++.|+|||+.....++.++||||||+++|||++  |..||....   .
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~---~  238 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS---D  238 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---h
Confidence            999999999999999765432221 1222345678999999888889999999999999999998  667875322   1


Q ss_pred             hhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          984 RDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      .+...................      .....+..+.+++.+|++.+|++||++++|++.|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            222222111111100000000      011123478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.7e-35  Score=321.81  Aligned_cols=257  Identities=29%  Similarity=0.474  Sum_probs=204.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ++|+..+.||+|+||.||+|...      ++..+|+|.+..........+.+|++++++++|+||+++++++.+++..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999642      356899999886666666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccC-----------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCe
Q 001561          845 IYSYMENGSLDYWLHESVD-----------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  913 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~  913 (1052)
                      ||||+++|+|.+++.....           ....+++..++.++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999999875421           113588999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHH
Q 001561          914 HLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF  991 (1052)
Q Consensus       914 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~  991 (1052)
                      ||+|||+++........ ......+++.|+|||...+..++.++|||||||++|||++ |++||....   ..+......
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~  238 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS---NTEAIECIT  238 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC---HHHHHHHHH
Confidence            99999999765432211 1122345778999999988899999999999999999998 999985322   112221111


Q ss_pred             HhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          992 QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                          .......         +...+..+.+++.+|++.||.+||++.|+.+.|++
T Consensus       239 ----~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         239 ----QGRELER---------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ----cCccCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                1100000         01123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-34  Score=315.57  Aligned_cols=246  Identities=23%  Similarity=0.403  Sum_probs=194.9

Q ss_pred             EcccCceEEEEEEEC---CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          779 IGCGGFGLVYKATLT---NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      ||+|+||.||+|.+.   ++..||+|++.... ....+++.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999764   35579999987553 334467899999999999999999999885 4578999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeee--
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--  932 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~--  932 (1052)
                      .+++...   ...+++..+++++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++...........  
T Consensus        82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998742   34689999999999999999999986   999999999999999999999999999986543322211  


Q ss_pred             ecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          933 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       933 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      ....+++.|+|||......++.++||||||+++||+++ |+.||.....   .+....+.    .....         ..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~----~~~~~---------~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMSFIE----QGKRL---------DC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHH----CCCCC---------CC
Confidence            11233578999999888889999999999999999996 9999964322   12211111    11100         01


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      +.....++.+++.+|++.+|++||++.+|.+.|+.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            112345788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=297.06  Aligned_cols=271  Identities=24%  Similarity=0.390  Sum_probs=217.9

Q ss_pred             cHHHHHHhhcCCcccCeEcccCceEEEEEE-ECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeeeeceEeeC
Q 001561          762 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHG  839 (1052)
Q Consensus       762 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  839 (1052)
                      +++|+.+-+     .++||+|+|+.|..+. ..+|..||||++.+..+....++.+|++++...+ |+||++++++|+++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            466776666     4579999999999986 6689999999999988888899999999999995 99999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC---CeEEe
Q 001561          840 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF---EAHLA  916 (1052)
Q Consensus       840 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~---~~kl~  916 (1052)
                      +..|+|||-|.||.|-.++++    ...+++.++.++..+|+.||.|||.   +||+|||+||+|||..+-.   -+|||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence            999999999999999999885    4568999999999999999999998   5999999999999997554   47999


Q ss_pred             ecccccccCCCC------CeeeecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcCCCCCccc-------
Q 001561          917 DFGLSRLLRPYD------THVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVC-------  978 (1052)
Q Consensus       917 DfG~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~-------  978 (1052)
                      ||.++..+.-..      +......+|+..|||||++.     ...|+.++|.||+|||+|-|++|.+||.+.       
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            999886543211      11223458999999999643     346889999999999999999999999753       


Q ss_pred             -CCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcCcc
Q 001561          979 -KGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1050 (1052)
Q Consensus       979 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~ 1050 (1052)
                       .++.++...+..+....++. .++.|+     .....+.+..+++...+..||.+|-++.+++.  +..++.++
T Consensus       302 drGe~Cr~CQ~~LFesIQEGk-YeFPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGK-YEFPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccC-CcCChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence             23445555666665554432 222222     22345567889999999999999999999987  55555443

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.2e-34  Score=315.16  Aligned_cols=256  Identities=25%  Similarity=0.386  Sum_probs=198.0

Q ss_pred             CcccCeEcccCceEEEEEEECC-Cc--EEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC------Ce
Q 001561          773 FNQANIIGCGGFGLVYKATLTN-GT--KAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------ND  841 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  841 (1052)
                      |.+.+.||+|+||.||+|.+.+ +.  .||+|.++...  ....+.+.+|++++++++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3457889999999999998763 33  68999886542  33456788999999999999999999987532      24


Q ss_pred             EEEEEEeccCCChhhhhhccc--CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          842 RLLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                      .++||||+++|+|.+++....  .....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998875322  2234589999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCeee-ecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcc
Q 001561          920 LSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       920 ~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      +++.+........ ....+++.|+|||...+..++.++||||||+++|||++ |+.||...   ...+....+.    ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~~~~~~----~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEIYDYLR----QG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHH----cC
Confidence            9987643322111 12245678999999998899999999999999999999 89998632   1122221111    11


Q ss_pred             cccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          998 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      ....         ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus       231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1100         0112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.9e-35  Score=324.97  Aligned_cols=260  Identities=27%  Similarity=0.408  Sum_probs=206.3

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC--------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeC
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHG  839 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  839 (1052)
                      ..+|++.+.||+|+||.||+|++.        ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456888999999999999999742        24579999887543 33456789999999999 899999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhcccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEE
Q 001561          840 NDRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL  907 (1052)
Q Consensus       840 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill  907 (1052)
                      ...++||||+++|+|.+++.....            ....+++.++..++.|+++|++|||+.   +|+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            999999999999999999976421            124578899999999999999999986   99999999999999


Q ss_pred             CCCCCeEEeecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchh
Q 001561          908 DEKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD  985 (1052)
Q Consensus       908 ~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~  985 (1052)
                      ++++.+||+|||.++......... .....+++.|+|||+..+..++.++||||||+++|||++ |..||...   +..+
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---PVEE  247 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC---CHHH
Confidence            999999999999998765432221 222345678999999988889999999999999999998 88888532   2222


Q ss_pred             HHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561          986 LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      ....+    .......         .+......+.+++.+|++.+|.+||++.|+++.|+++.
T Consensus       248 ~~~~~----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         248 LFKLL----KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHHHH----HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            22211    1111100         01123347889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-34  Score=317.97  Aligned_cols=255  Identities=28%  Similarity=0.479  Sum_probs=203.4

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CC---cEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NG---TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      .+|+..+.||+|+||.||+|... ++   ..+|+|.+.... ....+++..|++++++++|||++++++++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46788899999999999999865 33   379999887543 33456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++++|.+++..   ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||++....
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999875   235689999999999999999999986   99999999999999999999999999998764


Q ss_pred             CCCCeeee--cccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          926 PYDTHVTT--DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       926 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ........  ....++.|+|||++....++.++||||||+++|||++ |+.||....   ..+....+.   .....   
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~---~~~~~~~i~---~~~~~---  229 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHEVMKAIN---DGFRL---  229 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHHh---cCCCC---
Confidence            33222111  1223457999999988889999999999999999997 999986322   112221111   11000   


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                             +.......++.+++.+|++.+|++||++.+|++.|+++
T Consensus       230 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 -------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   00112234689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-34  Score=327.16  Aligned_cols=243  Identities=23%  Similarity=0.327  Sum_probs=192.4

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||+||+|... +++.||+|+++....   ...+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 678999999975432   2334578899999888 699999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|..++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  152 (327)
T cd05617          81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT  152 (327)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence            999888764    34689999999999999999999986   9999999999999999999999999999753221 122


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............+.......... .+         
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~---------  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-RI---------  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-CC---------
Confidence            33467999999999999999999999999999999999999999643322222222222222211110 00         


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFI 1037 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~ 1037 (1052)
                      +...+..+.+++.+|++.||++||++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            11122367899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.7e-35  Score=326.09  Aligned_cols=257  Identities=30%  Similarity=0.471  Sum_probs=201.1

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCc--EEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGT--KAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      ++|++.+.||+|+||.||+|.+. ++.  .+|+|.+.... .....++.+|++++.++ +||||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46888899999999999999865 454  45777776432 33456788999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhhcccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCe
Q 001561          846 YSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  913 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~  913 (1052)
                      |||+++|+|.++++....            ....+++.+++.++.|++.|++|||+.   +|+||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999999975421            123588999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHH
Q 001561          914 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQ  992 (1052)
Q Consensus       914 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~  992 (1052)
                      ||+|||++........  .....++..|+|||+.....++.++|||||||++|||+| |..||....   ..+.....  
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~--  236 (303)
T cd05088         164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKL--  236 (303)
T ss_pred             EeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC---hHHHHHHH--
Confidence            9999999864321111  111234668999999888889999999999999999998 999996322   12222111  


Q ss_pred             hhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561          993 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                       . ......         ........+.+++.+|++.+|++||++.++++.|+++.
T Consensus       237 -~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         237 -P-QGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             -h-cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             1 100000         01112336889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-34  Score=317.89  Aligned_cols=255  Identities=27%  Similarity=0.459  Sum_probs=204.4

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-C---CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-N---GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46888999999999999999764 2   3379999887543 33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++++|.+++...   ...+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+..+.
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999753   34589999999999999999999986   99999999999999999999999999998765


Q ss_pred             CCCCeeee--cccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          926 PYDTHVTT--DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       926 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ........  ...++..|+|||.+.+..++.++||||||+++||+++ |+.||....   ..+....+....   .   .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~---~~~~~~~~~~~~---~---~  228 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS---NQDVIKAIEEGY---R---L  228 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC---HHHHHHHHhCCC---c---C
Confidence            43322222  1233568999999998889999999999999999886 999986422   122222221110   0   0


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                             +.....+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus       229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 -------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   00112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.2e-35  Score=324.12  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=204.3

Q ss_pred             cCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  842 (1052)
                      ++|++.+.||+|+||.||+|...      ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            46888999999999999999742      34579999887543 33345788999999999 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+++|+|.++++...  ...+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.++++|||.++
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999987532  23489999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          923 LLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       923 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ........ ......+++.|+|||.+.+..++.++||||+||++|||++ |+.||......  ........    .....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~----~~~~~  263 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIK----EGYRM  263 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHH----cCCcC
Confidence            76433221 1222356778999999988889999999999999999998 99998643211  11111111    11000


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      .         .......++.+++.+|++++|++||++.|+++.|++.
T Consensus       264 ~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 A---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             C---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            0         0111234789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.9e-35  Score=335.13  Aligned_cols=250  Identities=24%  Similarity=0.304  Sum_probs=194.3

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      +|+..+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999865 68899999987532   2234567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999998864    24578899999999999999999986   9999999999999999999999999997543210


Q ss_pred             C----------------------------------------------CeeeecccccccccCccccCCcCCCcccchHHH
Q 001561          928 D----------------------------------------------THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSF  961 (1052)
Q Consensus       928 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  961 (1052)
                      .                                              .......+||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000123479999999999999899999999999


Q ss_pred             HHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 001561          962 GVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF---IE 1038 (1052)
Q Consensus       962 Gvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ 1038 (1052)
                      ||++|||++|++||.....   .+...   ...........       +.......++.+++.+|+ .+|++|++   +.
T Consensus       235 Gvil~elltG~~Pf~~~~~---~~~~~---~i~~~~~~~~~-------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTP---LETQM---KVINWQTSLHI-------PPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCH---HHHHH---HHHccCCCcCC-------CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            9999999999999964221   11111   11110000000       001112345778887776 59999997   88


Q ss_pred             HHHH
Q 001561         1039 EVVT 1042 (1052)
Q Consensus      1039 evl~ 1042 (1052)
                      |+++
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            8765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.4e-34  Score=314.92  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=203.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|+..+.||+|++|.||+|... +++.||+|.+...  .....+++.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777889999999999999865 6899999988643  234556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.++++..  ....+++..++.++.+++.|++|||+.   +++||||||+||++++++.++++|||.++......
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999999764  245688999999999999999999986   99999999999999999999999999998765432


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      . ......|++.|+|||+..+..++.++||||||+++|||++|+.||....   ..........    ....        
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~----~~~~--------  219 (256)
T cd08529         156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIR----GVFP--------  219 (256)
T ss_pred             c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHc----CCCC--------
Confidence            2 2233468899999999998889999999999999999999999996322   1122211111    1000        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                       .........+.+++.+|++.+|++||++.++++
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence             011123347899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.7e-35  Score=323.81  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=201.1

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCc--EEEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGT--KAAVKRLSGD-CGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      ++|++.++||+|+||.||+|... ++.  .+|+|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46888999999999999999865 343  4788887743 233456789999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhcccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCe
Q 001561          846 YSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  913 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~  913 (1052)
                      +||+++|+|.++++....            ....+++..++.++.|++.|++|||+.   +|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999875321            123588999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHH
Q 001561          914 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQ  992 (1052)
Q Consensus       914 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~  992 (1052)
                      ||+|||++.......  .......+..|+|||+.....++.++|||||||++|||++ |+.||....   ..+.....  
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~---~~~~~~~~--  231 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT---CAELYEKL--  231 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH--
Confidence            999999986432111  1111223457999999988889999999999999999997 999996422   22222111  


Q ss_pred             hhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561          993 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                        ......         ..+......+.+++.+|++.+|.+||+++++++.|+++.
T Consensus       232 --~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         232 --PQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             --hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              111000         011122346889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.5e-35  Score=320.14  Aligned_cols=257  Identities=27%  Similarity=0.424  Sum_probs=202.1

Q ss_pred             hcCCcccCeEcccCceEEEEEEECC------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  842 (1052)
                      .++|++.+.||+|++|.||+|.+.+      +..||+|.+.... ...+..+..|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678899999999999999998753      5678999886443 33456789999999999999999999999998899


Q ss_pred             EEEEEeccCCChhhhhhcccC---CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC---CeEEe
Q 001561          843 LLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF---EAHLA  916 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~---~~kl~  916 (1052)
                      ++||||+++++|.+++.....   ....+++..+.+++.|++.|++|||+.   +++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            999999999999999876432   123589999999999999999999986   999999999999998654   59999


Q ss_pred             ecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhh
Q 001561          917 DFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       917 DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      |||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....   .+....+.   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~~---  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFVT---  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH---
Confidence            999998763222111 112234568999999988889999999999999999997 9999964221   12221111   


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                      .... .         ..+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       236 ~~~~-~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGGR-L---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCc-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1100 0         011122347889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-34  Score=324.62  Aligned_cols=241  Identities=27%  Similarity=0.346  Sum_probs=191.3

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||+||+|... +++.||+|+++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 57899999987542   12234456777888764 899999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++..    ...+++.++..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++...... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05619          81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence            999998864    34578999999999999999999986   99999999999999999999999999987532221 12


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||...   +..+..+.+..   ...   ..        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~---~~~~~~~~i~~---~~~---~~--------  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH---DEEELFQSIRM---DNP---CY--------  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CCC---CC--------
Confidence            33457999999999999889999999999999999999999999642   22222222111   000   00        


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIE-EVVT 1042 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1042 (1052)
                      +.....++.+++.+|++.+|++||++. ++.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111234678999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-34  Score=322.57  Aligned_cols=249  Identities=22%  Similarity=0.383  Sum_probs=203.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999854 68899999987665555677889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++..     ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+........
T Consensus       100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            99999998853     3478899999999999999999986   999999999999999999999999999886543221


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ......|++.|+|||...+..++.++|||||||++|+|++|+.||.....   ..   +........ ....       
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~---~~---~~~~~~~~~-~~~~-------  236 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LR---ALYLIATNG-TPEL-------  236 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH---HH---hHHHHhcCC-CCCC-------
Confidence             12334788999999999888899999999999999999999999963221   11   111111100 0000       


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ..+......+.+++.+|+.++|++||++.|+++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            011223346889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.6e-34  Score=318.87  Aligned_cols=265  Identities=27%  Similarity=0.407  Sum_probs=206.5

Q ss_pred             hcCCcccCeEcccCceEEEEEEECC-----------------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceee
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN-----------------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS  831 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  831 (1052)
                      .++|++.+.||+|+||.||+|...+                 +..||+|.+.... ....+++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999997542                 2458999987554 334567899999999999999999


Q ss_pred             eeceEeeCCeEEEEEEeccCCChhhhhhcccC-------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCc
Q 001561          832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN  904 (1052)
Q Consensus       832 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~N  904 (1052)
                      +++++..++..++||||+++++|.+++.....       ....+++..++.++.|++.|++|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999876431       123689999999999999999999986   99999999999


Q ss_pred             eEECCCCCeEEeecccccccCCCCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc--CCCCCcccCCC
Q 001561          905 ILLDEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT--GRRPVEVCKGK  981 (1052)
Q Consensus       905 ill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~pf~~~~~~  981 (1052)
                      |+++.++.++++|||.++....... .......+++.|+|||+.....++.++||||||+++|||++  |..||....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence            9999999999999999986543221 12233456789999999888889999999999999999998  777875322  


Q ss_pred             CchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          982 NCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                       ..+..................      ......+.++.+++.+|++.+|++||++.|++++|++
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         239 -DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence             222222222211111100000      0111223478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-35  Score=321.12  Aligned_cols=258  Identities=24%  Similarity=0.416  Sum_probs=205.7

Q ss_pred             hcCCcccCeEcccCceEEEEEEECC------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  842 (1052)
                      .++|++.+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578889999999999999997642      3689999986543 33445788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcccCC------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEe
Q 001561          843 LLIYSYMENGSLDYWLHESVDK------DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLA  916 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~  916 (1052)
                      ++||||+++|+|.+++......      ...+++..++.++.|++.|++|||+.   +|+||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            9999999999999998754321      23478899999999999999999986   99999999999999999999999


Q ss_pred             ecccccccCCCCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhh
Q 001561          917 DFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       917 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      |||+++....... .......++..|+|||...+..++.++||||||+++||+++ |+.||...   ..........   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~---~~~~~~~~~~---  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL---SNEEVLKFVI---  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC---CHHHHHHHHh---
Confidence            9999986543321 12223456789999999888889999999999999999998 99998632   2222222221   


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                       ........         ...+.++.+++.+|++.+|++|||+.|+++.|++
T Consensus       236 -~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 -DGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -cCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence             11111111         1123478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-34  Score=315.58  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=205.2

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46789999999999999999998778889999887543 234578899999999999999999999887 7789999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          83 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            999999998753  244578899999999999999999986   999999999999999999999999999976543222


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .......++..|+|||++....++.++|+||||+++|++++ |+.||...   ...+...+...    .....       
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~~~~~----~~~~~-------  223 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRALER----GYRMP-------  223 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHhC----CCCCC-------
Confidence            22223345678999999988889999999999999999998 99998632   22222222111    10000       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                        .......++.+++.+|++++|++||++.++.+.|++
T Consensus       224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              011223478899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=325.42  Aligned_cols=245  Identities=26%  Similarity=0.379  Sum_probs=202.5

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCChh
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD  855 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  855 (1052)
                      -++|+|.||+||-|+.. +...+|||.+.....+....+.+|+..-++++|.|||+++|.|.+++..-+.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            37999999999999865 45679999998766666667899999999999999999999999999999999999999999


Q ss_pred             hhhhcccCCcccc--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-CCCCeEEeecccccccCCCCCeee
Q 001561          856 YWLHESVDKDSVL--KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVT  932 (1052)
Q Consensus       856 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~  932 (1052)
                      +.++...   +++  .+.+.-.+.+||++||.|||..   .|||||||-+|||++ -.|.+||+|||-++++.. -+..+
T Consensus       661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~T  733 (1226)
T KOG4279|consen  661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCT  733 (1226)
T ss_pred             HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccc
Confidence            9998754   334  6677888999999999999986   999999999999996 679999999999998754 34556


Q ss_pred             ecccccccccCccccCCc--CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccch
Q 001561          933 TDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010 (1052)
Q Consensus       933 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      .++.||..|||||++..+  .|..++|||||||++.||.||++||.......     ..++...-.+     .    ..+
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-----AAMFkVGmyK-----v----HP~  799 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-----AAMFKVGMYK-----V----HPP  799 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-----Hhhhhhccee-----c----CCC
Confidence            678999999999988654  58889999999999999999999996433221     1122111111     1    123


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1011 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .+++...+...+|.+|+.+||.+||++.++++
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            34556678899999999999999999999986

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.1e-35  Score=322.83  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=202.4

Q ss_pred             CCcccCeEcccCceEEEEEEECC------CcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      +|++.+.||+|+||.||+|...+      +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46678889999999999998642      46899999875542 334668899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccc------------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCC
Q 001561          845 IYSYMENGSLDYWLHESV------------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE  912 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~  912 (1052)
                      ++||+++++|.+++....            .....+++..+.+++.|++.|++|+|+.   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999985321            1123578899999999999999999986   9999999999999999999


Q ss_pred             eEEeecccccccCCCCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHH
Q 001561          913 AHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV  990 (1052)
Q Consensus       913 ~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~  990 (1052)
                      +||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..||...   ...+..+.+
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~---~~~~~~~~i  239 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY---SNQDVIEMI  239 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHH
Confidence            99999999887543322 12233456789999999888889999999999999999998 88888632   222222221


Q ss_pred             HHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          991 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      ..    ....         ..+......+.+++.+|++.+|++||+++|+++.|+.
T Consensus       240 ~~----~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 RN----RQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             Hc----CCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11    1110         0111233468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-34  Score=322.99  Aligned_cols=240  Identities=26%  Similarity=0.345  Sum_probs=190.9

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ++||+|+||.||+|+.. +|+.||+|.++...   ......+..|.+++... +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999876 68899999987542   12334566777787765 899999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  152 (316)
T cd05620          81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence            999988864    34588999999999999999999986   9999999999999999999999999998753221 222


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||...   +.....+.+..   ..  ..     .    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~---~~~~~~~~~~~---~~--~~-----~----  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELFESIRV---DT--PH-----Y----  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CC--CC-----C----
Confidence            34467999999999999989999999999999999999999999632   22222221111   00  00     0    


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIE-EVV 1041 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 1041 (1052)
                      +.....++.+++.+|++.||++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            011234688999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.9e-35  Score=330.82  Aligned_cols=238  Identities=25%  Similarity=0.321  Sum_probs=192.1

Q ss_pred             CeEcccCceEEEEEEE----CCCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          777 NIIGCGGFGLVYKATL----TNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999974    3578999999875432  223456789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +|+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++...... .
T Consensus        82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~  153 (318)
T cd05582          82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K  153 (318)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence            9999998864    34689999999999999999999986   99999999999999999999999999998654322 2


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccch
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||...   +..+....+.   ....  .         
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~---~~~~~~~~i~---~~~~--~---------  216 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMIL---KAKL--G---------  216 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC---CHHHHHHHHH---cCCC--C---------
Confidence            233467999999999998888999999999999999999999999632   2122221111   1100  0         


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 001561         1011 DREKQLLEMLEIACKCIDQDPRRRPFIEE 1039 (1052)
Q Consensus      1011 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1039 (1052)
                      .+......+.+++.+|++.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            01112346789999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=325.44  Aligned_cols=254  Identities=24%  Similarity=0.278  Sum_probs=195.9

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999865 68899999986421   223355788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999998652   34588999999999999999999986   999999999999999999999999999977654


Q ss_pred             CCCeeeecccccccccCccccCC-----cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ..........||+.|+|||++..     ..++.++||||+||++|||++|+.||...   ...+....+   ........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~---~~~~~~~~i---~~~~~~~~  228 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKI---MNHKEHFQ  228 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC---CHHHHHHHH---HcCCCccc
Confidence            33322333579999999998763     45788999999999999999999999632   111111111   11111111


Q ss_pred             cccccccchhhHHHHHHHHHHHHHcccCCC--CCCCCHHHHHH
Q 001561         1002 IIDASIWHKDREKQLLEMLEIACKCIDQDP--RRRPFIEEVVT 1042 (1052)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~ 1042 (1052)
                      +..      .....+..+.+++.+|+..++  ..||++.++++
T Consensus       229 ~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         229 FPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             CCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            100      011133467888888775533  34789999887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.8e-34  Score=311.44  Aligned_cols=252  Identities=24%  Similarity=0.440  Sum_probs=202.7

Q ss_pred             cCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+..... ...++.+|++++++++||+++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35788899999999999999887788999998875432 34568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +++|.+++...   ...++++.+..++.+++.|++|||+.   +++||||||+||+++.++.++|+|||.++........
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999988752   34578999999999999999999986   9999999999999999999999999999865432222


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++.+|+|||...+..++.++||||||+++|||++ |+.||...   ...+..+...    ..  .....+..  
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~---~~~~~~~~~~----~~--~~~~~~~~--  225 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR---SNSEVVETIN----AG--FRLYKPRL--  225 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC---CHHHHHHHHh----CC--CCCCCCCC--
Confidence            2222345678999999988889999999999999999998 99998632   1122222111    10  01111111  


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                           ...++.+++.+|++.+|++||++.|++++|.
T Consensus       226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 1247899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-34  Score=314.44  Aligned_cols=249  Identities=27%  Similarity=0.417  Sum_probs=200.6

Q ss_pred             cCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEe-eCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR-HGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||+|+||.||+|... |..||+|.++.+.  ..+.+.+|+.++++++|+|++++++++. +++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999775 8889999986543  2456889999999999999999999764 456789999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+++...... 
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999998753  234578999999999999999999986   99999999999999999999999999987653322 


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                         ....++..|+|||+..+..++.++||||||+++|||++ |+.||...   ...+...++..    .....       
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~~----~~~~~-------  219 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEK----GYKMD-------  219 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhc----CCCCC-------
Confidence               12344568999999988889999999999999999997 99998632   11222222111    11111       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                        .....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              1112234788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-34  Score=325.28  Aligned_cols=241  Identities=24%  Similarity=0.322  Sum_probs=193.5

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||+||+|... ++..||+|+++...   ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 57899999987542   22334567888888888 699999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  152 (318)
T cd05570          81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT  152 (318)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence            999988864    34689999999999999999999986   99999999999999999999999999987532221 22


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+.   ....  .         .
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~---~~~~~~~~i~---~~~~--~---------~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD---DEDELFQSIL---EDEV--R---------Y  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC---CHHHHHHHHH---cCCC--C---------C
Confidence            23457999999999999999999999999999999999999999632   2222221111   1100  0         0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFI-----EEVVT 1042 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1042 (1052)
                      +.....++.+++.+|++.||++||++     .++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            11123468899999999999999999     88765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-34  Score=348.40  Aligned_cols=263  Identities=21%  Similarity=0.326  Sum_probs=203.8

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEee--CCeEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRL  843 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  843 (1052)
                      ..++|++.+.||+|+||+||+|... ++..||+|.+....  ......+..|+.++++++|||||+++++|.+  ....|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3467999999999999999999865 57789999886432  3345678899999999999999999998854  35689


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC----CCCeEEcCCCCCceEECC----------
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC----EPHIVHRDVKSSNILLDE----------  909 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~i~HrDlkp~Nill~~----------  909 (1052)
                      +||||+++|+|.+++.........+++..++.|+.||+.||+|||+..    .++|+||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999999865545567999999999999999999999852    136999999999999964          


Q ss_pred             -------CCCeEEeecccccccCCCCCeeeecccccccccCccccCC--cCCCcccchHHHHHHHHHHHcCCCCCcccCC
Q 001561          910 -------KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKG  980 (1052)
Q Consensus       910 -------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~  980 (1052)
                             .+.+||+|||++..+....  ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.... 
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence                   3458999999998764321  2234579999999998753  458899999999999999999999996321 


Q ss_pred             CCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcCc
Q 001561          981 KNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                       ....+    ............          .....++.++|..||+.+|.+||++.|+++  ++..+.+
T Consensus       248 -~~~ql----i~~lk~~p~lpi----------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        248 -NFSQL----ISELKRGPDLPI----------KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             -cHHHH----HHHHhcCCCCCc----------CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence             11111    111111111000          012346889999999999999999999984  7765543

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-34  Score=315.72  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=205.2

Q ss_pred             cCCcccCeEcccCceEEEEEEECC----CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      ++|++.+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            458888999999999999998643    2468999887654 4455678999999999999999999998875 457899


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++|+|.+++...   ...+++..++.++.+++.|++|||+.   +++||||||+||+++.++.++++|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999999753   33589999999999999999999986   99999999999999999999999999998764


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ...........+++.|+|||.+....++.++||||||+++||+++ |+.||....   ..+...+...   .... .   
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~~~---~~~~-~---  228 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK---NNDVIGRIEN---GERL-P---  228 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHc---CCcC-C---
Confidence            432222223345568999999888889999999999999999986 999996432   1122222111   1000 0   


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCccc
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1051 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1051 (1052)
                            .+...+..+.+++.+|+..+|.+||++.++++.|+++..++
T Consensus       229 ------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         229 ------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                  01122347889999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.8e-34  Score=321.26  Aligned_cols=264  Identities=26%  Similarity=0.392  Sum_probs=202.9

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ++|++.+.||+|+||.||+|... ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999865 67889999887543 33445688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.++++..    ..+++..+..++.|+++|++|||+.  .+++||||||+||+++.++.+|++|||.+...... 
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999998742    4588999999999999999999973  38999999999999999999999999998765322 


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc--------
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV-------- 1000 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 1000 (1052)
                        ......|++.|+|||...+..++.++||||||+++|||++|+.||....   ......+...........        
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD---AKELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc---hhhHHHhhcCccccccccCCcccccC
Confidence              2234578999999999888889999999999999999999999985322   111111110000000000        


Q ss_pred             ----------------ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561         1001 ----------------EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1001 ----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                                      .................++.+++.+|++.+|++||++.|+++  ++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                            000000000000013346889999999999999999999988  4544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-34  Score=313.99  Aligned_cols=250  Identities=22%  Similarity=0.378  Sum_probs=202.3

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      +|++.+.||+|+||.||++... ++..||+|.++... ....+.+..|+.++++++||||+++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999865 68899999886432 334567888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++|++.+++...  ....+++..+..++.|++.|++|||+.   +|+|+||||+||++++++.++++|||.+....... 
T Consensus        81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  154 (255)
T cd08219          81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-  154 (255)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence            999999888643  344578999999999999999999986   99999999999999999999999999997654322 


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .......|++.|+|||+..+..++.++||||||+++|+|++|+.||...   +.....   ..... .....        
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~---~~~~~~---~~~~~-~~~~~--------  219 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN---SWKNLI---LKVCQ-GSYKP--------  219 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC---CHHHHH---HHHhc-CCCCC--------
Confidence            2223457889999999998888999999999999999999999999632   111111   11111 11000        


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                       .+......+.+++.+|++.||++||++.|++..
T Consensus       220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             111233468899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=353.33  Aligned_cols=486  Identities=27%  Similarity=0.340  Sum_probs=396.9

Q ss_pred             cEEEEEecCCCCcccCCccccCCcCCCeEecCCCCCCCCCcccccCCCCccEEeccCCcccCcccccccccCCccEEEcc
Q 001561           87 RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVS  166 (1052)
Q Consensus        87 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls  166 (1052)
                      +++.|++.+|-+-...-+.+..--+|+.||||+|++. ..|..+..+.+|+.|+++.|.|...+ .....+.+|++|+|.
T Consensus        22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp-~s~~~~~~l~~lnL~   99 (1081)
T KOG0618|consen   22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVP-SSCSNMRNLQYLNLK   99 (1081)
T ss_pred             HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCc-hhhhhhhcchhheec
Confidence            4778888887655432344444555999999999998 67888999999999999999998654 778899999999999


Q ss_pred             CcccCCcccccccCCcccEEEecCCccCCccchhhhhcccccceeeccCcccccccccCCCCCCCCEEEcccccCCCCCC
Q 001561          167 SNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLP  246 (1052)
Q Consensus       167 ~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p  246 (1052)
                      +|.+...|..+..+.+|++|++|+|++. .+|. ....++.++.++.++|.....   ++.. .++.+++..|.+.+.++
T Consensus       100 ~n~l~~lP~~~~~lknl~~LdlS~N~f~-~~Pl-~i~~lt~~~~~~~s~N~~~~~---lg~~-~ik~~~l~~n~l~~~~~  173 (1081)
T KOG0618|consen  100 NNRLQSLPASISELKNLQYLDLSFNHFG-PIPL-VIEVLTAEEELAASNNEKIQR---LGQT-SIKKLDLRLNVLGGSFL  173 (1081)
T ss_pred             cchhhcCchhHHhhhcccccccchhccC-CCch-hHHhhhHHHHHhhhcchhhhh---hccc-cchhhhhhhhhcccchh
Confidence            9999999999999999999999999998 4443 345677888999999932222   2222 28999999999999988


Q ss_pred             ccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCcccccCCC
Q 001561          247 DSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK  326 (1052)
Q Consensus       247 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~  326 (1052)
                      ..+..+..  .|+|++|.+.   --.+.++.+|+.|....|+++..    --..++|+.|+.++|.+....+.  ..-.+
T Consensus       174 ~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~--p~p~n  242 (1081)
T KOG0618|consen  174 IDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH--PVPLN  242 (1081)
T ss_pred             cchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccc--ccccc
Confidence            88887777  7999999987   23577889999999999998832    23457899999999999833322  22368


Q ss_pred             CcEEEecCccccCcCCcccccCCccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcEEeccC
Q 001561          327 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN  406 (1052)
Q Consensus       327 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  406 (1052)
                      |++++++.|++++.+ ..+..+.+|+.|+..+|+++ .+|..+...++|+.|++.+|.++ .+|.....++.|+.|+|..
T Consensus       243 l~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~  319 (1081)
T KOG0618|consen  243 LQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQS  319 (1081)
T ss_pred             ceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehh
Confidence            999999999999765 88899999999999999997 78999999999999999999999 7888888999999999999


Q ss_pred             CcCCCCcccchhhccCc-ccceEeccccccCccCCccccCCCcccEEEccCCccccCcchhhhcCCCCcEEeCcCccCCC
Q 001561          407 NSFNHLSGTLSVLQQCK-NLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG  485 (1052)
Q Consensus       407 N~l~~l~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  485 (1052)
                      |+|..+|..+  +.-.. +|+.|+.+.|++....-..=..++.|+.|++.+|.++...-..+.+.+.|++|+|++|++. 
T Consensus       320 N~L~~lp~~~--l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-  396 (1081)
T KOG0618|consen  320 NNLPSLPDNF--LAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-  396 (1081)
T ss_pred             ccccccchHH--HhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-
Confidence            9999998732  33333 3788888888885443223345678999999999999888888999999999999999998 


Q ss_pred             CCCh-hhccCCCCCeEeccCCcccccCCcchhhhhhhcccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeee
Q 001561          486 NIPP-WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFL  564 (1052)
Q Consensus       486 ~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~L  564 (1052)
                      .+|. .+.++..|+.|+||+|+++ .+|..+.++..|.                                      +|..
T Consensus       397 ~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~--------------------------------------tL~a  437 (1081)
T KOG0618|consen  397 SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH--------------------------------------TLRA  437 (1081)
T ss_pred             cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH--------------------------------------HHhh
Confidence            5554 6779999999999999999 6789988888883                                      4556


Q ss_pred             ecCcccccCCcccccccccceecccCceeeec-CCCCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeeccc
Q 001561          565 SNNRINGTIPPEIGQLKHLHVLDLSRNNITGT-IPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN  639 (1052)
Q Consensus       565 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~-ip~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~N  639 (1052)
                      .+|++. ..| ++.+++.|+.+|+|.|+|+-. +|..... ++|++|||++|.=.-..-+.|..++++..+++.-|
T Consensus       438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            778887 667 899999999999999999843 3443333 89999999999843345567788888888888877

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.7e-34  Score=319.95  Aligned_cols=260  Identities=23%  Similarity=0.385  Sum_probs=203.6

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCe
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  841 (1052)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.++++++||||+++++++.+++.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567999999999999999999653      24579999876443 2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccC------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEE
Q 001561          842 RLLIYSYMENGSLDYWLHESVD------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  915 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl  915 (1052)
                      .++||||+++|+|.+++.....      .....++..+..++.|++.|++|||+.   +|+||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999975321      123457788999999999999999986   9999999999999999999999


Q ss_pred             eecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHh
Q 001561          916 ADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM  993 (1052)
Q Consensus       916 ~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~  993 (1052)
                      +|||+++......... .....++..|+|||...+..++.++|||||||++|||++ |+.||...   ...+....+.. 
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~---~~~~~~~~~~~-  236 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL---SNEQVLKFVMD-  236 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHc-
Confidence            9999998654322111 112345678999999988889999999999999999998 78898532   22222221111 


Q ss_pred             hhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          994 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                        . ....         .+......+.+++.+|++.+|++||++.|+++.|++.
T Consensus       237 --~-~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         237 --G-GYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             --C-CCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence              0 0000         0111234789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.2e-34  Score=316.12  Aligned_cols=255  Identities=26%  Similarity=0.348  Sum_probs=201.4

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .|+..++||+|+||.||+|... +++.||+|.+....   ......+..|+.++++++|++++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999865 68899999886432   2223457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++++|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++......
T Consensus        81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999988643  234588999999999999999999986   9999999999999999999999999999765432


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      .  ......|+..|+|||++.+..++.++||||+|+++|||++|+.||.........+..........     .      
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----~------  222 (285)
T cd05630         156 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-----E------  222 (285)
T ss_pred             c--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-----h------
Confidence            2  12234789999999999988999999999999999999999999974322111111111110000     0      


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH--HHhh
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDG 1046 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~--~L~~ 1046 (1052)
                        ........++.+++.+|++.||++||+     +.|+++  ++++
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence              011112346889999999999999999     888887  5443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-34  Score=320.10  Aligned_cols=262  Identities=25%  Similarity=0.407  Sum_probs=202.8

Q ss_pred             cCCcccCeEcccCceEEEEEEE-----CCCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeE
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDR  842 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  842 (1052)
                      +.|++.+.||+|+||.||+|.+     .++..||+|.+.... ......+.+|++++++++|||++++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999974     257889999987553 34456789999999999999999999998775  568


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+++++|.+++...   ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999998653   23589999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCe--eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCC--------CCchhHHHHHHH
Q 001561          923 LLRPYDTH--VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKG--------KNCRDLVSWVFQ  992 (1052)
Q Consensus       923 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~--------~~~~~~~~~~~~  992 (1052)
                      ........  ......++..|+|||+..+..++.++||||||+++|||++++.|+.....        ............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76543221  12234567789999998888899999999999999999998776432100        000000111111


Q ss_pred             hhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          993 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      .......         .+.....+.++.+++.+|++.+|++||++.++++.|+++
T Consensus       238 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111000         001112345789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1e-34  Score=326.96  Aligned_cols=237  Identities=25%  Similarity=0.352  Sum_probs=187.6

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHH-HHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVE-ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||+||+|... +|+.||+|++.....   ....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999875 789999999875321   22234445544 56788999999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~  152 (323)
T cd05575          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT  152 (323)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence            999988864    34688999999999999999999986   9999999999999999999999999998754222 222


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...   +..+....+.   ...  ..     .    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~---~~~~~~~~i~---~~~--~~-----~----  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DTAEMYDNIL---NKP--LR-----L----  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC---CHHHHHHHHH---cCC--CC-----C----
Confidence            33457999999999999989999999999999999999999999632   1112211111   110  00     0    


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIE 1038 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 1038 (1052)
                      .......+.+++.+|++.||++||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            111234688999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-34  Score=326.78  Aligned_cols=241  Identities=25%  Similarity=0.314  Sum_probs=188.8

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHH-HHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEV-EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||+||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 67889999987532   12223344444 456778999999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~  152 (325)
T cd05602          81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT  152 (325)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence            999998864    34577888899999999999999986   99999999999999999999999999997643222 22


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...   +..+....+...    .. .         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~----~~-~---------~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNK----PL-Q---------L  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC---CHHHHHHHHHhC----Cc-C---------C
Confidence            33467999999999999999999999999999999999999999632   222222222111    00 0         0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .......+.+++.+|++.+|.+||++.+.+.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            1122346889999999999999998875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-34  Score=312.21  Aligned_cols=248  Identities=27%  Similarity=0.407  Sum_probs=197.8

Q ss_pred             CeEcccCceEEEEEEEC-C---CcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-N---GTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||.||+|.+. .   +..||+|.+..... ...+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999754 2   26899999875543 34567899999999999999999999876 4568999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++...    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999753    3689999999999999999999986   99999999999999999999999999998765433222


Q ss_pred             eec--ccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          932 TTD--LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       932 ~~~--~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      ...  ..++..|+|||...+..++.++||||||+++|||++ |+.||....   ..+...++....   . .        
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~~~~~~---~-~--------  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAMLESGE---R-L--------  217 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHcCC---c-C--------
Confidence            211  123467999999988899999999999999999998 999996432   222322221111   0 0        


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                       ..+...+..+.+++.+|+..+|++||++.++++.|+++.
T Consensus       218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             011122347889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.2e-34  Score=315.91  Aligned_cols=255  Identities=27%  Similarity=0.471  Sum_probs=202.8

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CC---cEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NG---TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      .+|++.+.||+|+||.||+|... ++   ..||+|.+.... .....+|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35788999999999999999865 33   369999987542 34456799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++|+|.+++...   ...+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999998753   34589999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCCee--eeccc--ccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          926 PYDTHV--TTDLV--GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       926 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ......  .....  .+..|+|||+..+..++.++||||||+++||+++ |..||....   ..+...++....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i~~~~------  228 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAIEQDY------  228 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCC------
Confidence            322211  11111  2457999999998899999999999999999886 999986322   222333221110      


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      ..       +.....+..+.+++.+|++.+|.+||++.+++..|+++
T Consensus       229 ~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 RL-------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cC-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00       00112234688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-34  Score=312.64  Aligned_cols=239  Identities=24%  Similarity=0.420  Sum_probs=189.0

Q ss_pred             CeEcccCceEEEEEEECC-------------CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEE
Q 001561          777 NIIGCGGFGLVYKATLTN-------------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  843 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  843 (1052)
                      +.||+|+||.||+|.+.+             ..+||+|.+..........+.+|+.+++.++||||+++++++.+....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998542             2358899887655555567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCC-------eEEe
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-------AHLA  916 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~-------~kl~  916 (1052)
                      +||||+++|+|..++..   ....+++..+.+++.|+++|++|||+.   +|+||||||+||+++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999988764   234689999999999999999999986   9999999999999987654       8999


Q ss_pred             ecccccccCCCCCeeeecccccccccCccccC-CcCCCcccchHHHHHHHHHHH-cCCCCCcccCCCCchhHHHHHHHhh
Q 001561          917 DFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELL-TGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       917 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      |||.+......     ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+    ...   ..
T Consensus       155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~---~~  222 (262)
T cd05077         155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KER---FY  222 (262)
T ss_pred             CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HHH---HH
Confidence            99998765322     2346788999999876 567889999999999999997 5888875321111    000   00


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1044 (1052)
                      ...  ....     .+    ....+.+++.+|++.||++||++.++++.+
T Consensus       223 ~~~--~~~~-----~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 EGQ--CMLV-----TP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hcC--ccCC-----CC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            000  0000     01    123688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-34  Score=319.61  Aligned_cols=258  Identities=29%  Similarity=0.465  Sum_probs=204.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  842 (1052)
                      .++|+..+.||+|+||.||+|...      ++..||+|++.... ....+++.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457889999999999999999853      46789999987543 34456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcccC------------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCc
Q 001561          843 LLIYSYMENGSLDYWLHESVD------------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN  904 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~N  904 (1052)
                      ++||||+++|+|.+++.....                  ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            999999999999999975321                  123478899999999999999999986   99999999999


Q ss_pred             eEECCCCCeEEeecccccccCCCCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCC
Q 001561          905 ILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN  982 (1052)
Q Consensus       905 ill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~  982 (1052)
                      |++++++.++++|||.+..+...... ......+++.|+|||...+..++.++|||||||++|||++ |..||...   .
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~---~  237 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM---A  237 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---C
Confidence            99999999999999998765432211 1122345668999999888899999999999999999997 88888532   1


Q ss_pred             chhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          983 CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      ..+....+   .. .....         .+...+.++.+++.+|++.+|++||++.|+++.|++
T Consensus       238 ~~~~~~~~---~~-~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 HEEVIYYV---RD-GNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHHHH---hc-CCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            12222211   11 11100         011223478999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-34  Score=323.59  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=201.9

Q ss_pred             cCCcccCeEcccCceEEEEEEE------CCCcEEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeeeeceEeeC-Ce
Q 001561          771 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHG-ND  841 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  841 (1052)
                      ++|++.+.||+|+||+||+|.+      .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5689999999999999999974      2467899999975432 3345688999999999 689999999988654 46


Q ss_pred             EEEEEEeccCCChhhhhhcccC----------------------------------------------------------
Q 001561          842 RLLIYSYMENGSLDYWLHESVD----------------------------------------------------------  863 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  863 (1052)
                      .++||||+++|+|.++++....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999864311                                                          


Q ss_pred             -----CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe-eeecccc
Q 001561          864 -----KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVG  937 (1052)
Q Consensus       864 -----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g  937 (1052)
                           ....+++..+..++.|+++|++|||+.   +|+||||||+||++++++.+|++|||++......... ......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                 012478889999999999999999986   9999999999999999999999999999865332211 1122345


Q ss_pred             cccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHH
Q 001561          938 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016 (1052)
Q Consensus       938 t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1052)
                      ++.|+|||...+..++.++||||||+++|||++ |..||......  ......   .. .......  +       ....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~---~~-~~~~~~~--~-------~~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRR---LK-EGTRMRA--P-------DYTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHH---Hh-ccCCCCC--C-------CCCC
Confidence            678999999988889999999999999999997 99998642211  111111   11 1110000  0       0112


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561         1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1017 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      .++.+++.+|++.+|++||++.|+++.|+.+.++
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            3688999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.7e-34  Score=323.38  Aligned_cols=241  Identities=24%  Similarity=0.317  Sum_probs=192.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      +|+..+.||+|+||+||+|... +|+.||+|++....   ....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4777899999999999999865 68899999987542   223345778888888885 577888999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++.++..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            99999999998864    34589999999999999999999986   999999999999999999999999999976432


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...   ........+..   ...  .     
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---~~~~~~~~i~~---~~~--~-----  219 (323)
T cd05615         154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE---DEDELFQSIME---HNV--S-----  219 (323)
T ss_pred             CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CCC--C-----
Confidence            21 1223457999999999999888999999999999999999999999642   22222222211   100  0     


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1037 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1037 (1052)
                          .+.....++.+++.+|++.+|.+|++.
T Consensus       220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 ----YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                011123467899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.5e-34  Score=311.14  Aligned_cols=254  Identities=26%  Similarity=0.361  Sum_probs=192.4

Q ss_pred             CeEcccCceEEEEEEECC---CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCC
Q 001561          777 NIIGCGGFGLVYKATLTN---GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  852 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  852 (1052)
                      +.||+|+||.||+|.+.+   +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998653   4579999887544 334457889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcccC-CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          853 SLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       853 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      +|.++++.... .....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999976432 223467788889999999999999986   99999999999999999999999999997543322211


Q ss_pred             e-ecccccccccCccccCCc-------CCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          932 T-TDLVGTLGYIPPEYSQTL-------TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       932 ~-~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      . ....+++.|+|||++...       .++.++||||||+++|||++ |+.||.....   .+......  .  ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~~~~~--~--~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD---EQVLTYTV--R--EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHh--h--cccCCC
Confidence            1 234577899999987542       35789999999999999996 9999964221   11111111  0  111111


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                      .++....    .....+.+++.+|+ .+|++||+++||++.|+
T Consensus       231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2222111    12235788999998 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.1e-34  Score=309.55  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=200.0

Q ss_pred             CeEcccCceEEEEEEECC--C--cEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLTN--G--TKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ++||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3689999987665 566789999999999999999999999988 889999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++.....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++.........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999876432  5689999999999999999999986   99999999999999999999999999998765432211


Q ss_pred             --eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          932 --TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       932 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                        .....++..|+|||++.+..++.++||||||+++|||++ |+.||...   ...+.......   .....  .     
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~~---~~~~~--~-----  221 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL---SGSQILKKIDK---EGERL--E-----  221 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHh---cCCcC--C-----
Confidence              122457789999999998899999999999999999998 99998632   22222222111   10000  0     


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                        .....+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       222 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 --RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              01122347889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-34  Score=314.71  Aligned_cols=251  Identities=30%  Similarity=0.472  Sum_probs=196.0

Q ss_pred             CeEcccCceEEEEEEEC-CCc--EEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGT--KAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ++||+|+||.||+|... ++.  .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999875 343  46888887433 34456788999999999 799999999999999999999999999


Q ss_pred             CChhhhhhcccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          852 GSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       852 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                      |+|.+++.....            ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999875321            123578999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ++........  ......++.|+|||++....++.++||||||+++|||++ |..||...   ...+..+.+.    ...
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~---~~~~~~~~~~----~~~  228 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEKLP----QGY  228 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc---CHHHHHHHHh----CCC
Confidence            9864321111  111234567999999988889999999999999999997 99999632   2222222111    110


Q ss_pred             ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      ..+         .......++.+++.+|++.+|.+||++.|+++.|+++.
T Consensus       229 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            000         01112346889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.6e-34  Score=314.62  Aligned_cols=250  Identities=26%  Similarity=0.338  Sum_probs=198.0

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      |+..+.||+|+||+||+|... +++.||+|.+....   ......+.+|++++++++|++|+++.+++.+++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677889999999999999865 78899999986542   22234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.+++...  ....+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999888653  234689999999999999999999986   99999999999999999999999999997653221


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                        ......|+..|+|||++.+..++.++|+||+|+++|||++|+.||............  ........   .       
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~--~~~~~~~~---~-------  222 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--DRRVLETE---E-------  222 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhhhccc---c-------
Confidence              123457899999999998888999999999999999999999999642211111111  01111000   0       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1042 (1052)
                       .........+.+++.+|++.+|++||+     ++++++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             011122346789999999999999999     667766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-34  Score=310.47  Aligned_cols=248  Identities=27%  Similarity=0.380  Sum_probs=199.1

Q ss_pred             CeEcccCceEEEEEEECCCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCChh
Q 001561          777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD  855 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  855 (1052)
                      ++||+|+||.||+|...+++.||+|++...... ....+..|++++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877999999998765443 4567899999999999999999999999999999999999999999


Q ss_pred             hhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeee-ec
Q 001561          856 YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TD  934 (1052)
Q Consensus       856 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~~  934 (1052)
                      +++...   ...+++..+..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||.+........... ..
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            998653   34578999999999999999999986   999999999999999999999999999986542221111 11


Q ss_pred             ccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhH
Q 001561          935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE 1013 (1052)
Q Consensus       935 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1052)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+.    ...  ..       ..+.
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~~~----~~~--~~-------~~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRERIE----SGY--RM-------PAPQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHHHh----cCC--CC-------CCCc
Confidence            234567999999888889999999999999999999 8999864321   11111111    000  00       0111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561         1014 KQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus      1014 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      ..+.++.+++.+|++.+|.+||++.|+++.|+.
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            223478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.2e-34  Score=316.27  Aligned_cols=260  Identities=24%  Similarity=0.304  Sum_probs=193.9

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeeeeceEee-----CC
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRA---QHKNLVSLQGYCRH-----GN  840 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  840 (1052)
                      +|++.+.||+|+||+||+|... +++.||+|.++....  .....+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999865 688999998875321  1223456677776665   79999999998864     24


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..++||||+++ +|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            57899999975 788887653  234589999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ++......  ......||+.|+|||++.+..++.++||||+||++|||++|++||....   ..+....+..........
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~---~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDLIGLPPED  229 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC---HHHHHHHHHHHhCCCChh
Confidence            98764321  2234578999999999988889999999999999999999999996422   122222222211100000


Q ss_pred             c----------cccccc---cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 E----------IIDASI---WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~----------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .          ...+..   ...........+.+++.+|+++||++||++.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0          000000   00111123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.9e-34  Score=316.11  Aligned_cols=262  Identities=27%  Similarity=0.398  Sum_probs=203.4

Q ss_pred             HHHHHHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEe---
Q 001561          763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCR---  837 (1052)
Q Consensus       763 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---  837 (1052)
                      ++++..+.++|++.+.||+|+||.||+|... +++.+|+|++.... ....++..|+.+++++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4455567789999999999999999999865 67899999876432 2345678899999999 6999999999874   


Q ss_pred             --eCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEE
Q 001561          838 --HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  915 (1052)
Q Consensus       838 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl  915 (1052)
                        .++..++||||+++++|.+++.........+++..+..++.|+++|+.|||+.   +|+||||||+||++++++.+++
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence              34568999999999999998875544456789999999999999999999986   9999999999999999999999


Q ss_pred             eecccccccCCCCCeeeecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001561          916 ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  990 (1052)
Q Consensus       916 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~  990 (1052)
                      +|||+++....... ......|++.|+|||++.     ...++.++||||+||++|||++|+.||.....  ....    
T Consensus       166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--~~~~----  238 (286)
T cd06638         166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--MRAL----  238 (286)
T ss_pred             ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--hHHH----
Confidence            99999987643221 222346899999999874     34578899999999999999999999864221  1111    


Q ss_pred             HHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001561          991 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                      ..... .......++.       ....++.+++.+|++.+|++||++.|+++-
T Consensus       239 ~~~~~-~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 FKIPR-NPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hhccc-cCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11100 0001111111       122368899999999999999999999873

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.9e-34  Score=325.87  Aligned_cols=258  Identities=25%  Similarity=0.311  Sum_probs=194.9

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC------
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  840 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  840 (1052)
                      .++|++.+.||+|+||.||+|... +|..||+|++....  ......+.+|+.+++.++||||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999865 68999999986432  334456789999999999999999999986443      


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..++||||+++ ++.+.++.      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence            47999999976 45554432      377888999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh------
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK------  994 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~------  994 (1052)
                      ++....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||....   ..+.........      
T Consensus       170 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         170 ARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD---HIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             cccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCcHH
Confidence            976432  222334578999999999999999999999999999999999999996432   111111111000      


Q ss_pred             -------------hccccc------ccccccccc---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          995 -------------SEKREV------EIIDASIWH---KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       995 -------------~~~~~~------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                   ......      +........   ........++.+++.+|++.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                         000000      000000000   001112346889999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-34  Score=327.10  Aligned_cols=239  Identities=27%  Similarity=0.366  Sum_probs=188.4

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHH-HHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVE-ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||+||+|+.. +|+.||+|++....   .....++..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 78999999987542   222344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|..++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  152 (325)
T cd05604          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT  152 (325)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence            999888763    44689999999999999999999986   99999999999999999999999999987543221 22


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...   +..+....+.   .. . . ...       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~---~~~~~~~~~~---~~-~-~-~~~-------  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR---DVAEMYDNIL---HK-P-L-VLR-------  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC---CHHHHHHHHH---cC-C-c-cCC-------
Confidence            33457999999999999999999999999999999999999999632   1112221111   11 0 0 001       


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIEEV 1040 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1040 (1052)
                       ......+.+++.+|++.+|.+||++.+.
T Consensus       217 -~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         217 -PGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             -CCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence             1123467899999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.5e-34  Score=321.52  Aligned_cols=260  Identities=25%  Similarity=0.399  Sum_probs=204.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC--------CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCC
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  840 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  840 (1052)
                      ++|.+.+.||+|+||.||+|...        ....||+|.+.... .....++..|+++++++ +||||+++++++.+..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46888999999999999999742        24568999887543 33445688999999999 6999999999999988


Q ss_pred             eEEEEEEeccCCChhhhhhcccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001561          841 DRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  908 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~  908 (1052)
                      ..++||||+++|+|.+++.....            ....+++.++..++.|++.|++|||+.   +|+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            99999999999999999976421            234589999999999999999999986   999999999999999


Q ss_pred             CCCCeEEeecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhH
Q 001561          909 EKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL  986 (1052)
Q Consensus       909 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~  986 (1052)
                      +++.+|++|||.++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....   ..+.
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~~~  245 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VEEL  245 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence            99999999999998764322111 111234567999999988889999999999999999999 899986322   2222


Q ss_pred             HHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          987 VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      .....    .......         ......++.+++.+|++.+|++||++.|+++.|+++..
T Consensus       246 ~~~~~----~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         246 FKLLR----EGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHHH----cCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            22111    1111110         11223468899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.4e-34  Score=316.34  Aligned_cols=262  Identities=23%  Similarity=0.316  Sum_probs=197.6

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|++.+.||+|++|.||+|... ++..||+|++....  ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999865 68999999986432  22345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      ++ ++|.+++.... ....+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 58888876533 245689999999999999999999986   99999999999999999999999999997654322


Q ss_pred             CeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc--------
Q 001561          929 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE--------  999 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  999 (1052)
                       .......+++.|+|||++.+ ..++.++||||||+++|||++|++||.....  ....... .........        
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE--IDQLFRI-FRILGTPTEDVWPGVTS  231 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH-HHHhCCCChhhhhcchh
Confidence             22233467889999997765 4578899999999999999999999964211  1111111 000000000        


Q ss_pred             ----cccccc---cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1000 ----VEIIDA---SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1000 ----~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                          ....+.   ............++.+++.+|++.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                000000   0000001113457789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-34  Score=316.53  Aligned_cols=252  Identities=25%  Similarity=0.415  Sum_probs=198.0

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEeeC------C
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHG------N  840 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~  840 (1052)
                      +.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888999999999999999865 67899999986543 3345688999999998 799999999998753      4


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..++||||+++++|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence            578999999999999998753  234688999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhh
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS  995 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  995 (1052)
                      +........ ......|++.|+|||++.     ...++.++|||||||++|||++|+.||.....   ..  .. .... 
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~---~~--~~-~~~~-  229 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MR--AL-FLIP-  229 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH---HH--HH-HHHh-
Confidence            986543222 223457899999999875     34678899999999999999999999953211   11  11 1111 


Q ss_pred             cccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          996 EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ........        .......+.+++.+|++.+|.+||++.|+++
T Consensus       230 ~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cCCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            01111111        1112346889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.6e-34  Score=320.70  Aligned_cols=267  Identities=22%  Similarity=0.351  Sum_probs=202.1

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56889999999999999999865 68899999986443 22334577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      ++ ++|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 5888887653   34578999999999999999999986   99999999999999999999999999997643222


Q ss_pred             CeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc---cccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR---EVEIID 1004 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 1004 (1052)
                       .......+++.|+|||++.+ ..++.++|||||||++|||++|++||....   ..+....+........   .....+
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST---VEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCChhhchhhhc
Confidence             12223467889999998754 457889999999999999999999996432   2222222221111100   000000


Q ss_pred             ---------ccccc----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561         1005 ---------ASIWH----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus      1005 ---------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                               +....    .........+.+++.+|++.||++|||++|+++  +++.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                     00000    001122346789999999999999999999998  665554

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.8e-34  Score=312.98  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=199.1

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      |++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|||++++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            667788999999999999876 5778899998766555566788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      ++|..++..   ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+|++|||++....... ..
T Consensus        87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~  159 (282)
T cd06643          87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  159 (282)
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence            999888764   234689999999999999999999986   99999999999999999999999999987653221 22


Q ss_pred             eecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          932 TTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .....+++.|+|||++.     +..++.++|||||||++|||++|++||....   ..+..   ......... ....  
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~---~~~~~~~~~-~~~~--  230 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN---PMRVL---LKIAKSEPP-TLAQ--  230 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC---HHHHH---HHHhhcCCC-CCCC--
Confidence            23457899999999873     4457789999999999999999999986321   11111   111111100 0101  


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                           +.....++.+++.+|++.+|.+||++.++++
T Consensus       231 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         231 -----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 1122347889999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.9e-34  Score=312.87  Aligned_cols=254  Identities=23%  Similarity=0.356  Sum_probs=199.4

Q ss_pred             HhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          768 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       768 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      .++..+.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34455666778999999999999855 67889999988766666678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCcccc--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCCeEEeecccccc
Q 001561          847 SYMENGSLDYWLHESVDKDSVL--KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRL  923 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~  923 (1052)
                      ||+++++|.+++....   ..+  ++..+..++.|+++|++|||+.   +|+||||||+||+++. ++.++|+|||.+..
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          85 EQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             ecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999987532   234  7888899999999999999986   9999999999999986 67999999999976


Q ss_pred             cCCCCCeeeecccccccccCccccCCc--CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccc
Q 001561          924 LRPYDTHVTTDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001 (1052)
Q Consensus       924 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ...... ......|++.|+|||+....  .++.++||||||+++|+|++|+.||.......   ...+.......  .  
T Consensus       159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~--~--  230 (268)
T cd06624         159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKI--H--  230 (268)
T ss_pred             cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhcc--C--
Confidence            543221 22234688999999987654  37889999999999999999999986321111   11110000000  0  


Q ss_pred             cccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         +    ..+.....++.+++.+|++.+|.+||++.|+++
T Consensus       231 ---~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 ---P----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---C----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence               0    011123346889999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.7e-34  Score=311.85  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=204.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC------CCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL  843 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  843 (1052)
                      ++|+..+.||+|+||.||+|+..      +...||+|.+...... ...++.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999864      2457999988654433 4567899999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhhhcccCCc-----cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          844 LIYSYMENGSLDYWLHESVDKD-----SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                      +||||+++|+|.+++.......     ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997643221     2689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcc
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       919 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      |++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||....   ....+.....    .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~~~~~~~----~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEVLNRLQA----G  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHHHHHHHc----C
Confidence            9987543322222333466778999999888888999999999999999998 888985321   1222222111    1


Q ss_pred             cccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561          998 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                      ... ..       .....+..+.+++.+|++.+|++||++.|+++.|+
T Consensus       235 ~~~-~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLE-LP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcC-CC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            100 00       01112347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.9e-34  Score=310.55  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=203.2

Q ss_pred             cCCcccCeEcccCceEEEEEEECC-CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|+..+.||+|+||.||+|...+ +..||+|.+.....  .+++.+|++++++++||||+++++++.++...++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            568889999999999999998764 78999999875533  578999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++..   ....+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            99999999864   245689999999999999999999986   999999999999999999999999999987653321


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......  ..    ...... ...     .  ..
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--~~----~~~~~~-~~~-----~--~~  219 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--RA----IFMIPN-KPP-----P--TL  219 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--hh----hhhhcc-CCC-----C--CC
Confidence             223346888999999998889999999999999999999999998632111  00    000000 000     0  01


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .........+.+++.+|++.+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            112223347899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-34  Score=328.97  Aligned_cols=260  Identities=21%  Similarity=0.259  Sum_probs=199.8

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC---CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ..+|++.+.||+|+||.||+|...   .+.+||+|.+...     +...+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999753   3578999987643     23568999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      |++. ++|.+++.    ....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++....
T Consensus       166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9996 57877774    345689999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccc---
Q 001561          927 YDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI--- 1002 (1052)
Q Consensus       927 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1002 (1052)
                      ... .......||+.|+|||++....++.++|||||||++|||++|+.||..............+............   
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            322 2223467999999999999989999999999999999999999999754433222222222221111000000   


Q ss_pred             --------------ccccccc-h--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1003 --------------IDASIWH-K--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1003 --------------~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                    ..+.... .  .......++.+++.+|+..||++||++.|++.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                          0000000 0  00012346788999999999999999999987

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4e-34  Score=313.83  Aligned_cols=256  Identities=23%  Similarity=0.354  Sum_probs=202.9

Q ss_pred             CCcccCeEcccCceEEEEEEECC--CcEEEEEEecCC----------chhhHHHHHHHHHHHHh-cCCCceeeeeceEee
Q 001561          772 NFNQANIIGCGGFGLVYKATLTN--GTKAAVKRLSGD----------CGQMEREFQAEVEALSR-AQHKNLVSLQGYCRH  838 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  838 (1052)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999998764  678999987532          12233456778888875 699999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       839 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                      ++..++||||+++++|.+++.........+++..++.++.|++.|+.|||+.  .+++||||+|+||+++.++.++++||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998865444556789999999999999999999963  48999999999999999999999999


Q ss_pred             ccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       919 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      |.+.......  ......|+..|+|||...+..++.++||||||+++|||++|+.||...   ......   ........
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~---~~~~~~---~~~~~~~~  230 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST---NMLSLA---TKIVEAVY  230 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc---CHHHHH---HHHhhccC
Confidence            9998754432  334457899999999998888999999999999999999999998531   111111   11111110


Q ss_pred             ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                       ...        ........+.+++.+|++.||++||++.|+.+++++
T Consensus       231 -~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         231 -EPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             -CcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence             000        001123468899999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=308.54  Aligned_cols=250  Identities=31%  Similarity=0.482  Sum_probs=203.7

Q ss_pred             CeEcccCceEEEEEEECC----CcEEEEEEecCCchhh-HHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLTN----GTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||.||+|....    +..||+|.+....... .+++.+|++.+++++|+|++++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998763    7889999988654333 57789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcccCC-----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          852 GSLDYWLHESVDK-----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       852 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ++|.+++......     ...+++..++.++.|++.|++|||+.   +++||||||+||++++++.++++|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999864222     46789999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          927 YDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       927 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ... .......+++.|+|||......++.++||||+|+++|||++ |+.||...   ...+..+.+..    ....    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~~----~~~~----  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---SNEEVLEYLRK----GYRL----  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHc----CCCC----
Confidence            321 12233467889999999888889999999999999999999 69999643   22222222211    1000    


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                           ..+...+.++.+++.+|++.+|++||++.|+++.|+
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 111122457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.1e-34  Score=328.14  Aligned_cols=251  Identities=23%  Similarity=0.299  Sum_probs=195.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|+..+.||+|+||+||+|... +++.||+|++....   ......+.+|++++..++||+|+++++++.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999865 68999999987432   223456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999999864    34588999999999999999999986   999999999999999999999999999875432


Q ss_pred             CCC----------------------------------eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCC
Q 001561          927 YDT----------------------------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR  972 (1052)
Q Consensus       927 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~  972 (1052)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                  0012357999999999999999999999999999999999999


Q ss_pred             CCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 001561          973 RPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF---IEEVVT 1042 (1052)
Q Consensus       973 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1042 (1052)
                      .||....   .......+.   .......+ .+.      .....++.+++.+|+. +|++|++   +.|+++
T Consensus       234 ~Pf~~~~---~~~~~~~i~---~~~~~~~~-p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSET---PQETYRKVM---NWKETLVF-PPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCC---HHHHHHHHH---cCCCceec-CCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            9996422   111111111   10000011 110      0122367788888764 9999985   566655

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.8e-34  Score=322.74  Aligned_cols=254  Identities=24%  Similarity=0.282  Sum_probs=196.2

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+++.. +++.||+|++.+..   ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36889999999999999999876 57789999986422   122345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999752   34588999999999999999999986   999999999999999999999999999976543


Q ss_pred             CCCeeeecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      .........+||+.|+|||++.     ...++.++|||||||++|||++|+.||...   +..+...   ..........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~---~~~~~~~---~i~~~~~~~~  228 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYG---KIMNHKERFQ  228 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC---CHHHHHH---HHhCCCcccc
Confidence            3333333457999999999875     346788999999999999999999999632   1111111   1111111000


Q ss_pred             cccccccchhhHHHHHHHHHHHHHcccCCCC--CCCCHHHHHH
Q 001561         1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPR--RRPFIEEVVT 1042 (1052)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~ 1042 (1052)
                      +  +    ........++.+++.+|+..++.  .|+++.|+++
T Consensus       229 ~--p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         229 F--P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             C--C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            0  0    00112344688899998865444  4789999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-33  Score=318.26  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=188.4

Q ss_pred             cCeEcccCceEEEEEEEC---CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEee--CCeEEEEEEecc
Q 001561          776 ANIIGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLLIYSYME  850 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  850 (1052)
                      .+.||+|+||+||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            467999999999999864   45789999987543  23457889999999999999999998854  456789999986


Q ss_pred             CCChhhhhhccc-----CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEE----CCCCCeEEeecccc
Q 001561          851 NGSLDYWLHESV-----DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLS  921 (1052)
Q Consensus       851 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill----~~~~~~kl~DfG~a  921 (1052)
                      + +|.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 7777765322     1233588999999999999999999986   99999999999999    46689999999999


Q ss_pred             cccCCCCC--eeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCC------chhHHHHHHH
Q 001561          922 RLLRPYDT--HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN------CRDLVSWVFQ  992 (1052)
Q Consensus       922 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~------~~~~~~~~~~  992 (1052)
                      +.......  .......||+.|+|||++.+ ..++.++||||+||++|||++|++||.......      ..+....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            87643221  12234678999999998866 458899999999999999999999996432110      1111222221


Q ss_pred             hhhccccccc---------------ccccccc-----hh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          993 MKSEKREVEI---------------IDASIWH-----KD----REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       993 ~~~~~~~~~~---------------~~~~~~~-----~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ..........               .......     ..    ......++.+++.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1110000000               0000000     00    0001235789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-34  Score=323.69  Aligned_cols=192  Identities=22%  Similarity=0.318  Sum_probs=164.3

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ...+|++.+.||+|+||.||+|... +++.||+|.....      ....|+.++++++||||+++++++.++...++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999876 5678999975432      23568999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+. ++|.+++..   ....+++..+..|+.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++.....
T Consensus       138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            995 578887764   345689999999999999999999986   9999999999999999999999999999753321


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCC
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV  975 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf  975 (1052)
                        .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1223457999999999999989999999999999999999855544

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-34  Score=317.14  Aligned_cols=263  Identities=25%  Similarity=0.414  Sum_probs=205.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-----CCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEee--CCeE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDR  842 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  842 (1052)
                      ++|+..+.||+|+||.||+|.+.     ++..||+|++...... ..+++.+|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46778899999999999999864     3678999998765443 46779999999999999999999999877  5578


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999999753   23589999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCee--eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCch--------hHHHHHHH
Q 001561          923 LLRPYDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR--------DLVSWVFQ  992 (1052)
Q Consensus       923 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~--------~~~~~~~~  992 (1052)
                      .........  .....++..|+|||...+..++.++||||||+++|||++|+.|+.........        ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            765332211  11234556799999988888999999999999999999999998542211100        00111111


Q ss_pred             hhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561          993 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      ......         ..........++.+++.+|++.+|++||++.|++++|+++.
T Consensus       238 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         238 LLKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            111100         00111122357899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.7e-34  Score=313.74  Aligned_cols=239  Identities=23%  Similarity=0.393  Sum_probs=187.7

Q ss_pred             eEcccCceEEEEEEECC-------------------------CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeee
Q 001561          778 IIGCGGFGLVYKATLTN-------------------------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL  832 (1052)
Q Consensus       778 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  832 (1052)
                      .||+|+||.||+|.+..                         ...||+|++.........++.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         13588998876555555678899999999999999999


Q ss_pred             eceEeeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-
Q 001561          833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-  911 (1052)
Q Consensus       833 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-  911 (1052)
                      ++++.++...++||||+++|+|..++..   ....+++..+..++.|+++||+|||+.   +|+||||||+||++++++ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999998864   244688999999999999999999985   999999999999998643 


Q ss_pred             ------CeEEeecccccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHH-HcCCCCCcccCCCCc
Q 001561          912 ------EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLEL-LTGRRPVEVCKGKNC  983 (1052)
Q Consensus       912 ------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el-ltG~~pf~~~~~~~~  983 (1052)
                            .+|++|||.+......     ....++..|+|||.+.+ ..++.++||||||+++||+ ++|+.||......+ 
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                  4899999998654321     12357789999997765 5689999999999999998 47999986432211 


Q ss_pred             hhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561          984 RDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                        .. ......  ..   ..     ..    ....+.+++.+|++.+|++||++.++++.|+
T Consensus       230 --~~-~~~~~~--~~---~~-----~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 --KE-RFYEKK--HR---LP-----EP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HH-HHHHhc--cC---CC-----CC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              11 111100  00   00     00    1136889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.7e-34  Score=322.51  Aligned_cols=254  Identities=24%  Similarity=0.282  Sum_probs=197.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ......+.+|..++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999866 67889999986422   223345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999752   34688999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCeeeecccccccccCccccCC-----cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ..........||+.|+|||++.+     ..++.++|||||||++|||++|+.||...   +..+....+.   .......
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~---~~~~~~~  228 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIM---NHEERFQ  228 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC---CHHHHHHHHH---cCCCccc
Confidence            33333334579999999998765     46788999999999999999999999632   1111111111   1100000


Q ss_pred             cccccccchhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 001561         1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRR--RPFIEEVVT 1042 (1052)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1042 (1052)
                      . ..     .....+.++.+++.+|+..++++  |++++++++
T Consensus       229 ~-p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         229 F-PS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             C-CC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            0 00     01122347889999998865544  468888865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.5e-34  Score=314.74  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=203.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      .+|++.+.||+|+||+||+|... +|..||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46788899999999999999865 68899999876443 34567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.+++..    .+.+++..+..++.+++.|+.|||+.  .+++||||||+||++++++.++|+|||++...... 
T Consensus        85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            999999988864    34689999999999999999999973  38999999999999999999999999998754321 


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCC-----CchhHHHHHHHhhhcccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGK-----NCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                        ......|+..|+|||++.+..++.++|||||||++|++++|+.||......     .......+........ .    
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----  230 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-P----  230 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-C----
Confidence              122357899999999988888999999999999999999999999754321     1111122221111110 0    


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                       +...   .......+.+++.+|++.||++||++.|+++.
T Consensus       231 -~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         231 -PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             -CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             0000   11133468899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.9e-34  Score=315.22  Aligned_cols=249  Identities=21%  Similarity=0.375  Sum_probs=203.2

Q ss_pred             cCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+++++.++|||++++++++.+++..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4689999999999999999985 478999999987655555677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++..     ..+++.++..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999998853     3478999999999999999999996   999999999999999999999999999886543322


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....   .....   ....... .....      
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~---~~~~~---~~~~~~~-~~~~~------  236 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLRAL---YLIATNG-TPELQ------  236 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH---HHHHhcC-CcccC------
Confidence             1233468899999999988889999999999999999999999996422   11111   1111110 00000      


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                       .+......+.+++.+|+..||++||++.++++
T Consensus       237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             11122346889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1e-33  Score=319.63  Aligned_cols=268  Identities=21%  Similarity=0.265  Sum_probs=198.0

Q ss_pred             ccCeEccc--CceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          775 QANIIGCG--GFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       775 ~~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      +.++||+|  +|++||++..+ +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  78899999765 78999999987543  334456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++|+|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999986532  33588999999999999999999986   999999999999999999999999987644321111


Q ss_pred             e------eeecccccccccCccccCC--cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc-----
Q 001561          930 H------VTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE-----  996 (1052)
Q Consensus       930 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-----  996 (1052)
                      .      ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  ............     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccccc
Confidence            0      0112356778999998865  468899999999999999999999996422111  011000000000     


Q ss_pred             ---------cc-----cccc------------ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561          997 ---------KR-----EVEI------------IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus       997 ---------~~-----~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                               ..     ....            ................+.+++.+|++.||++|||++|+++  +++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                     00     0000            0000000111233457889999999999999999999998  666654


Q ss_pred             c
Q 001561         1049 I 1049 (1052)
Q Consensus      1049 ~ 1049 (1052)
                      .
T Consensus       315 ~  315 (327)
T cd08227         315 R  315 (327)
T ss_pred             h
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.1e-34  Score=317.46  Aligned_cols=254  Identities=22%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             cCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5799999999999999999986 478999999987655555567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++..     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+........
T Consensus        99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999998853     3478899999999999999999986   999999999999999999999999999976543322


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ......+++.|+|||...+..++.++|||||||++|++++|+.||.......  .    ........ ...       .
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~----~~~~~~~~-~~~-------~  235 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--A----LYLIATNG-TPE-------L  235 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--h----eeeeccCC-CCC-------C
Confidence             2233468899999999988889999999999999999999999996322110  0    00000000 000       0


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      ..+......+.+++.+|++.+|++||++.++++  +++..
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence            011223346789999999999999999999998  65543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5e-34  Score=312.68  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=199.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46778889999999999999865 68899999987665455566889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++..    ...+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+....... 
T Consensus        89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            99999998864    34688999999999999999999986   99999999999999999999999999997654321 


Q ss_pred             eeeecccccccccCccccC---CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .......|++.|+|||++.   ...++.++||||+||++|||++|+.||.....  .....    .............  
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~--~~~~~----~~~~~~~~~~~~~--  232 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALF----LMTKSNFQPPKLK--  232 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc--hhhHH----hhhccCCCCCccc--
Confidence            1223457899999999864   45688899999999999999999999853221  11111    1110100000000  


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                          ........+.+++.+|++.+|++||+++++++
T Consensus       233 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 ----DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ----ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                00112346889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.2e-33  Score=311.81  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=200.9

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      +.|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999999875 58899999998766666677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      +++++..++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+....... 
T Consensus        92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            999998877642   34589999999999999999999986   99999999999999999999999999987543221 


Q ss_pred             eeeecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .......+++.|+|||++.     ...++.++|||||||++|||++|+.||.....   ...   ......... .... 
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~---~~~~~~~~~-~~~~-  236 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRV---LLKIAKSEP-PTLS-  236 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHH---HHHHhcCCC-ccCC-
Confidence            1123346888999999874     34567899999999999999999999863211   111   111111110 0000 


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            .+.....++.+++.+|++.+|++||++.|+++
T Consensus       237 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         237 ------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  11122346889999999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.7e-34  Score=323.51  Aligned_cols=237  Identities=25%  Similarity=0.357  Sum_probs=186.6

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHH-HHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVE-ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ++||+|+||.||+|+.. +++.||+|++.....   .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 688999999875321   22334555544 57888999999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|..++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (321)
T cd05603          81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET  152 (321)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence            999888764    34578889999999999999999986   99999999999999999999999999987532221 22


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+.   .. . ..+         
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~---~~-~-~~~---------  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DVSQMYDNIL---HK-P-LQL---------  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC---CHHHHHHHHh---cC-C-CCC---------
Confidence            33457999999999999889999999999999999999999999642   1112111111   11 0 000         


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIE 1038 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 1038 (1052)
                      +.....++.+++.+|++.||++||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            111234688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=5.6e-37  Score=333.72  Aligned_cols=363  Identities=25%  Similarity=0.323  Sum_probs=234.9

Q ss_pred             cEEEEEecCCCCc-ccCCccccCCcCCCeEecCCCCCCCCCcccccCCCCccEEeccCCcccCcccccccccCCccEEEc
Q 001561           87 RVTMLILPRKGLK-GIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV  165 (1052)
Q Consensus        87 ~v~~l~L~~~~l~-g~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  165 (1052)
                      -|..+|+++|.++ +..|.....+++++.|.|...++. .+|..++.+.+|++|.+++|++..                 
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-----------------   69 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-----------------   69 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-----------------
Confidence            4666666777666 446666666666666666666665 556666666666666666666653                 


Q ss_pred             cCcccCCcccccccCCcccEEEecCCccC-CccchhhhhcccccceeeccCcccccccccCCCCCCCCEEEcccccCCCC
Q 001561          166 SSNSFNGSLFELGEFSNLAVFNISNNSFT-GKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGD  244 (1052)
Q Consensus       166 s~N~l~~~~~~l~~l~~L~~L~Ls~n~l~-~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~  244 (1052)
                             +-.++..++.|+.+++..|++. ..+|.++|. +..|+.||||+|+++..|.++...+++-.|+|++|+|..+
T Consensus        70 -------vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~-l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetI  141 (1255)
T KOG0444|consen   70 -------VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFR-LKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETI  141 (1255)
T ss_pred             -------hhhhhccchhhHHHhhhccccccCCCCchhcc-cccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccC
Confidence                   3333444444555555555444 345666663 6778888888888888888888888888888888888855


Q ss_pred             CCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCccc-CCCCccccc
Q 001561          245 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS-GPLPLSLSL  323 (1052)
Q Consensus       245 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~~~~l~~  323 (1052)
                      .-.-|-++..|-.||||+|++. .+|..+..|..|++|.|++|.+...--..+..+++|+.|.+++.+=+ ..+|.++..
T Consensus       142 Pn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~  220 (1255)
T KOG0444|consen  142 PNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDD  220 (1255)
T ss_pred             CchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhh
Confidence            4445667888888888888887 66777888888888888888776443344455667777777775433 456777777


Q ss_pred             CCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcEEe
Q 001561          324 CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLS  403 (1052)
Q Consensus       324 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  403 (1052)
                      +.+|..+|+|.|.+. ..|.++-++.+|+.|+||+|+|+ .+....+.-.+|++|+||+|+++ .+|+.+++++.|+.|+
T Consensus       221 l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy  297 (1255)
T KOG0444|consen  221 LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLY  297 (1255)
T ss_pred             hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHH
Confidence            777777777777777 56667777777777777777777 44445555667777777777777 6777777777777777


Q ss_pred             ccCCcCCCCcccchhhccCcccceEeccccccCccCCccccCCCcccEEEccCCccccCcchhhhcCCCCcEEeCcCcc
Q 001561          404 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH  482 (1052)
Q Consensus       404 L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~  482 (1052)
                      +.+|+++. .+..+.++++.+|+.+..++|.+ +..|+.+..+.+|+.|.|++|++- .+|+.+.-++.|++|||..|.
T Consensus       298 ~n~NkL~F-eGiPSGIGKL~~Levf~aanN~L-ElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  298 ANNNKLTF-EGIPSGIGKLIQLEVFHAANNKL-ELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             hccCcccc-cCCccchhhhhhhHHHHhhcccc-ccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence            77777642 11112233444444444444444 334444444444444444444444 444444444444444444443

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-34  Score=313.34  Aligned_cols=257  Identities=23%  Similarity=0.403  Sum_probs=204.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      .+|++.+.||+|+||+||+|.+. +|.    .||+|...... .....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56888999999999999999864 333    58999887554 3345678899999999999999999999987 78899


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      ||||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.++..
T Consensus        86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999998753   34589999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCeeee-cccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          925 RPYDTHVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       925 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ......... ...++..|+|||......++.++||||||+++||+++ |+.||....   ..+..+.+.    ....  .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~----~~~~--~  230 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP---AVEIPDLLE----KGER--L  230 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHh----CCCC--C
Confidence            543322221 1223568999999888889999999999999999998 999996432   122222111    1100  0


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      ..       +......+.+++.+|+..+|.+||++.++++.|+++..+
T Consensus       231 ~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         231 PQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            00       111223678999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.3e-34  Score=322.96  Aligned_cols=260  Identities=27%  Similarity=0.402  Sum_probs=205.0

Q ss_pred             cCCcccCeEcccCceEEEEEEECC--------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCC
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN--------GTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  840 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  840 (1052)
                      .+|++.+.||+|+||.||+|....        +..||+|.+.... ....+++.+|+++++++ +||||+++++++.+++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468899999999999999997421        2368999887543 33456789999999999 7999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcccC------------CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001561          841 DRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  908 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~  908 (1052)
                      ..++++||+++|+|.+++.....            ....+++.++..++.|++.|++|||+.   +|+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            99999999999999999875321            234588999999999999999999986   999999999999999


Q ss_pred             CCCCeEEeecccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhH
Q 001561          909 EKFEAHLADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL  986 (1052)
Q Consensus       909 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~  986 (1052)
                      +++.+||+|||.++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...   +..+.
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~  245 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---PVEEL  245 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---CHHHH
Confidence            99999999999998764322111 122234568999999998899999999999999999998 88998632   21222


Q ss_pred             HHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          987 VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      ...+.    .......         +.....++.+++.+|++.+|++||++.|+++.|+++..
T Consensus       246 ~~~~~----~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         246 FKLLK----EGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHH----cCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            21111    1111111         11223478899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3e-34  Score=339.29  Aligned_cols=266  Identities=20%  Similarity=0.256  Sum_probs=194.8

Q ss_pred             HHHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCC------CceeeeeceEee
Q 001561          766 LLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH------KNLVSLQGYCRH  838 (1052)
Q Consensus       766 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~  838 (1052)
                      +....++|++.+.||+|+||+||+|... +++.||||+++... ...+++..|++++++++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345678999999999999999999865 67889999986432 233456677777777754      458889998876


Q ss_pred             C-CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC------
Q 001561          839 G-NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF------  911 (1052)
Q Consensus       839 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~------  911 (1052)
                      . ...++|||++ +++|.+++..    ...+++..+..|+.|++.||+|||+.  .+|+||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccc
Confidence            5 4678999988 7788887764    34689999999999999999999972  3999999999999998765      


Q ss_pred             ----------CeEEeecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCC
Q 001561          912 ----------EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGK  981 (1052)
Q Consensus       912 ----------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~  981 (1052)
                                .+||+|||.+....    ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... 
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN-  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-
Confidence                      49999999886432    223346899999999999999999999999999999999999999974321 


Q ss_pred             CchhHHHHHHHhhhccc-----------cccc----------cccccc-------chhhHHHHHHHHHHHHHcccCCCCC
Q 001561          982 NCRDLVSWVFQMKSEKR-----------EVEI----------IDASIW-------HKDREKQLLEMLEIACKCIDQDPRR 1033 (1052)
Q Consensus       982 ~~~~~~~~~~~~~~~~~-----------~~~~----------~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~ 1033 (1052)
                        .+....+.......+           ..++          .++...       ..........+.+|+.+|++.||++
T Consensus       351 --~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        351 --LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             --HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence              111111111100000           0000          000000       0000011346789999999999999


Q ss_pred             CCCHHHHHH--HHhh
Q 001561         1034 RPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1034 RPs~~evl~--~L~~ 1046 (1052)
                      |||++|+++  ++..
T Consensus       429 R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        429 RLNARQMTTHPYVLK  443 (467)
T ss_pred             CCCHHHHhcCccccc
Confidence            999999998  6654

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=308.10  Aligned_cols=253  Identities=27%  Similarity=0.410  Sum_probs=204.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999865 67889999988665556678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+||+|||.+....... 
T Consensus        83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            999999988752   24688999999999999999999986   99999999999999999999999999998654321 


Q ss_pred             eeeecccccccccCccccCCc---CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTL---TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .......++..|+|||.....   .++.++||||||+++|||++|+.||......  ...    .......    .....
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--~~~----~~~~~~~----~~~~~  225 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RAL----FLISKSN----FPPPK  225 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhcc----CCCcc
Confidence            122345788899999988776   7889999999999999999999998632211  111    1111110    00000


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        .......+.++.+++.+|+..+|.+||++.+++.
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              1112334567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-33  Score=307.75  Aligned_cols=251  Identities=29%  Similarity=0.429  Sum_probs=193.3

Q ss_pred             CeEcccCceEEEEEEEC----CCcEEEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeeeeceEe-eCCeEEEEEEecc
Q 001561          777 NIIGCGGFGLVYKATLT----NGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQGYCR-HGNDRLLIYSYME  850 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  850 (1052)
                      +.||+|+||.||+|.+.    +...||+|++... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    2357999988543 2344567889999999999999999999876 4556789999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +|+|.+++...   ....++..+..++.|+++|++|||+.   +++||||||+||++++++.+|++|||+++........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999998753   23467788899999999999999986   9999999999999999999999999999765432111


Q ss_pred             e---eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcC-CCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          931 V---TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG-RRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       931 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .   .....+++.|+|||...+..++.++||||||+++|||++| .+||...   +..+....+.   .... .      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~~~---~~~~-~------  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYLL---QGRR-L------  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHh---cCCC-C------
Confidence            1   1123467789999999888899999999999999999994 6666432   2222222211   1100 0      


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                         ..+...+..+.+++.+|++.+|++||++.|+++.|+++..
T Consensus       222 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         222 ---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence               0011123468899999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.6e-34  Score=324.14  Aligned_cols=259  Identities=21%  Similarity=0.275  Sum_probs=195.6

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC------
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------  839 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  839 (1052)
                      ..++|++.+.||+|+||.||+|... .++.||+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468999999999999999999864 68899999987542  33345678899999999999999999988643      


Q ss_pred             CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          840 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       840 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                      ...++||||+++ ++.+.+..      .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            356999999976 55555532      378889999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh-----
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK-----  994 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~-----  994 (1052)
                      +++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+.........     
T Consensus       165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCH
Confidence            99865432  22334578999999999998899999999999999999999999996422   111111110000     


Q ss_pred             --------------hcccc-cccc-----ccccc---chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          995 --------------SEKRE-VEII-----DASIW---HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       995 --------------~~~~~-~~~~-----~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                    ..... ....     .....   .........++.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                          00000 0000     00000   0001112346789999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-33  Score=312.40  Aligned_cols=261  Identities=25%  Similarity=0.329  Sum_probs=202.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788999999999999999865 78999999987543  33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      + +++|.+++...   ...+++.+++.++.|+++|++|||+.   +++|+||||+||+++.++.++++|||.+.......
T Consensus        81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 99999988753   35689999999999999999999986   99999999999999999999999999998765433


Q ss_pred             CeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc--------
Q 001561          929 THVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE--------  999 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  999 (1052)
                      ........|+..|+|||++.+. .++.++||||+|+++|||++|++||....   ......++.........        
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN---DIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC---HHHHHHHHHHHcCCCChHHHhhccC
Confidence            2223345789999999987654 46889999999999999999988885322   12222222221111000        


Q ss_pred             ----ccccccc----ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1000 ----VEIIDAS----IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1000 ----~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                          ..+....    ............+.+++.+|++.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                0000000    000111123468899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.4e-34  Score=319.03  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=202.4

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-CC-----ceeeeeceEeeCCeEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HK-----NLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~l  844 (1052)
                      +|++.++||+|+||.|.+|... +++.||||+++... .-..+...|+.++..++ |.     |+|+++++|...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7999999999999999999754 79999999998653 33456688999999996 43     89999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC--CCCeEEeeccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE--KFEAHLADFGLSR  922 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~--~~~~kl~DfG~a~  922 (1052)
                      |+|.++ -+|.++++..  ....++...++.|+.||+.||.+||+.   +|||+||||+|||+.+  ...+||+|||.|.
T Consensus       266 VfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence            999885 5899999875  455699999999999999999999987   9999999999999974  3479999999998


Q ss_pred             ccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc------
Q 001561          923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE------  996 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~------  996 (1052)
                      +....    ...++.+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+   ++..|.+..+.+..+.      
T Consensus       340 ~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG---~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  340 FESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG---DNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             ccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC---CCHHHHHHHHHHHhCCCCHHHH
Confidence            75432    2256788899999999999999999999999999999999888753   3333333332222110      


Q ss_pred             ---ccccccccc---------------------------------------cccchh-hHHHHHHHHHHHHHcccCCCCC
Q 001561          997 ---KREVEIIDA---------------------------------------SIWHKD-REKQLLEMLEIACKCIDQDPRR 1033 (1052)
Q Consensus       997 ---~~~~~~~~~---------------------------------------~~~~~~-~~~~~~~l~~li~~cl~~dP~~ 1033 (1052)
                         ......++.                                       ..+... .......+.+++.+|+..||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence               000001111                                       000011 1133457899999999999999


Q ss_pred             CCCHHHHHH
Q 001561         1034 RPFIEEVVT 1042 (1052)
Q Consensus      1034 RPs~~evl~ 1042 (1052)
                      |+|..|+++
T Consensus       493 R~tp~qal~  501 (586)
T KOG0667|consen  493 RITPAQALN  501 (586)
T ss_pred             cCCHHHHhc
Confidence            999999987

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-35  Score=327.44  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=210.8

Q ss_pred             cccCeEcccCceEEEEEEEC-CCc----EEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          774 NQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       774 ~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      +..++||+|+||+||+|.|- .|+    +||+|++.... .+...++.+|+-+|.+++|||+++++++|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            44679999999999999864 443    68999887554 455678999999999999999999999998776 789999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      ||+.|+|.+|++.+   ...+..+..+.|..|||+|+.|||.+   +++||||.++|||+.+-..+||+|||+|+...++
T Consensus       778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999874   55688899999999999999999986   9999999999999999999999999999988776


Q ss_pred             CCeeeecc-cccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          928 DTHVTTDL-VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       928 ~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ..+..... .-.+.|||-|.+....++.++|||||||++||++| |..|+++....+..++++.                
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----------------  915 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----------------  915 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----------------
Confidence            55444332 22458999999999999999999999999999999 9999986554443333211                


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      ...-..++.+...++.++.+||..|+..||+++++...+.++..+
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            111223344556789999999999999999999999999887654

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-34  Score=312.80  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=204.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++.++...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46888999999999999999875 68899999988666666677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++...   +..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+....... 
T Consensus        85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            999999988752   34689999999999999999999986   99999999999999999999999999987654322 


Q ss_pred             eeeecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .......|++.|+|||.+.     ...++.++||||||+++|||++|+.||....   .....   ........ ...  
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~---~~~~~---~~~~~~~~-~~~--  228 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN---PMRVL---LKILKSEP-PTL--  228 (280)
T ss_pred             cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC---HHHHH---HHHhcCCC-CCc--
Confidence            1223356899999999864     3456789999999999999999999996421   11111   11111100 000  


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                           ..+.....++.+++.+|++.+|.+||++.++++  ++.+
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         229 -----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             -----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence                 011122346889999999999999999999987  4443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-35  Score=321.39  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=207.4

Q ss_pred             CCcccCeEcccCceEEEEEEEC--CCc--EEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT--NGT--KAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      +....+.||+|.||.|++|.|+  +|+  .||||.++.+... ...+|.+|+.+|-+++|||++++||+..+ ....+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            4455788999999999999987  344  5899999876543 56789999999999999999999999987 6788999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      |.++.|+|.+.|++  .....+-......++.|||.|+.||.+.   +.||||+.++|+++-....+||+|||+.+.++.
T Consensus       190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            99999999999987  3566788899999999999999999985   999999999999999999999999999998876


Q ss_pred             CCCee-eec-ccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          927 YDTHV-TTD-LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       927 ~~~~~-~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      .+... +.. .--.+.|+|||.+....++.++|||+|||++|||+| |+.||.++.+.   +++             +.+
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL-------------~~i  328 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QIL-------------KNI  328 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHH-------------Hhc
Confidence            54432 221 233458999999999999999999999999999999 88999755432   111             112


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      |.......++.+++.+++++..||...|++||++..+.+
T Consensus       329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            222233445567789999999999999999999999985

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-33  Score=312.04  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=202.2

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      +|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5888999999999999999876 78999999887542 333467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++.... ....+++..+..++.+++.|+.|||+.  .+|+||||||+||+++.++.++|+|||.+..+...  
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999999887532 234689999999999999999999963  48999999999999999999999999999765322  


Q ss_pred             eeeecccccccccCccccCCc------CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTL------TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                       ......+++.|+|||.+.+.      .++.++|||||||++|||++|+.||.....   ............ ....   
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~-~~~~---  228 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAIVD-GDPP---  228 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHHhh-cCCC---
Confidence             12234688899999987544      347899999999999999999999964221   111111111111 1100   


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                            ..+.....++.+++.+|++.+|++||++.++++  ++...
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         229 ------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             ------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence                  111123457889999999999999999999988  54443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-33  Score=307.07  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=199.9

Q ss_pred             CCcccCeEcccCceEEEEEEECCCcEEEEEEecCCc------hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      +|+..+.||+|+||+||+|...+++.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999988889999999886432      12234688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      +||+++++|.+++...    ..+++..+..++.|++.|++|||+.   +|+|+||+|+||++++++.++++|||.+....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999998642    3578999999999999999999986   99999999999999999999999999997653


Q ss_pred             CCC-----CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          926 PYD-----THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       926 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ...     ........|+..|+|||+..+..++.++||||||+++|||++|+.||.....  ....    ......... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~----~~~~~~~~~-  226 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--LAAM----FYIGAHRGL-  226 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--HHHH----HHhhhccCC-
Confidence            211     1112335689999999999988899999999999999999999999963211  1111    111111000 


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         .+..    +.....++.+++.+|++.+|++||++.|+++
T Consensus       227 ---~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 ---MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               0111    1123346889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-33  Score=313.38  Aligned_cols=263  Identities=28%  Similarity=0.383  Sum_probs=205.1

Q ss_pred             ccHHHHHHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 001561          761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH  838 (1052)
Q Consensus       761 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  838 (1052)
                      +++.++..+.++|++.+.||+|+||.||+|... +++.+|+|++.... ....++.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344555667789999999999999999999864 68899999986432 2345678899999999 89999999999875


Q ss_pred             C-----CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCe
Q 001561          839 G-----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  913 (1052)
Q Consensus       839 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~  913 (1052)
                      .     +..++||||+++|+|.++++........+++..++.++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     357999999999999998876544556789999999999999999999986   99999999999999999999


Q ss_pred             EEeecccccccCCCCCeeeecccccccccCccccCCc-----CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHH
Q 001561          914 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL-----TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS  988 (1052)
Q Consensus       914 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~  988 (1052)
                      ||+|||.+........ ......|+..|+|||.+...     .++.++|||||||++|||++|+.||.....  ....  
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~--  242 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTL--  242 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHH--
Confidence            9999999987543221 12234688999999986543     368899999999999999999999864221  1111  


Q ss_pred             HHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          989 WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        ..... .......+       .......+.+++.+|++.+|++||++.|+++
T Consensus       243 --~~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         243 --FKIPR-NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             --HHHhc-CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              11111 11111111       1123346899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-33  Score=323.81  Aligned_cols=258  Identities=20%  Similarity=0.260  Sum_probs=195.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC------C
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------N  840 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  840 (1052)
                      .++|++.+.||+|+||.||+|... .++.||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999865 68899999987542  33345678899999999999999999987543      3


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..++||||+++ ++.+++..      .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            57999999975 56665542      377889999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhh-----
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS-----  995 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~-----  995 (1052)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+....+.....     
T Consensus       173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD---HIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCHH
Confidence            9865432  22234578999999999999999999999999999999999999996422   1111111111000     


Q ss_pred             --------------ccccc-cc----cccccc----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          996 --------------EKREV-EI----IDASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       996 --------------~~~~~-~~----~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                    ..... ..    ..+...    .........++.+++.+|++.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                          00000 00    000000    0001112346889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-33  Score=308.26  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=190.0

Q ss_pred             eEcccCceEEEEEEECCC---cEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCC
Q 001561          778 IIGCGGFGLVYKATLTNG---TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS  853 (1052)
Q Consensus       778 ~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  853 (1052)
                      .||+|+||+||+|...++   ..+++|.+.... ....+.+.+|+..++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433   346677766443 3445688999999999999999999999999999999999999999


Q ss_pred             hhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC-Ceee
Q 001561          854 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVT  932 (1052)
Q Consensus       854 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~  932 (1052)
                      |.++++.........++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||.+....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999986543344567778889999999999999986   99999999999999999999999999986432111 1112


Q ss_pred             ecccccccccCccccCC-------cCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          933 TDLVGTLGYIPPEYSQT-------LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       933 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ....++..|+|||+...       ..++.++||||||+++|||++ |..||....   ..+....+.   . .......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~---~-~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DREVLNHVI---K-DQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH---h-hcccccCC
Confidence            23467889999998743       345789999999999999997 577875322   122222111   1 11112222


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                      +.....    ....+.+++..|+ .+|++||+++|+++.|.
T Consensus       232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222222    2236778899999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=308.93  Aligned_cols=247  Identities=27%  Similarity=0.392  Sum_probs=202.0

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      +|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            6788899999999999999865 68899999987543 334466889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++...     .+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||.++...... 
T Consensus        82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999998642     689999999999999999999986   99999999999999999999999999998775432 


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .......+++.|+|||+..+..++.++||||||+++|+|++|+.||....   .....   .... .........     
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~---~~~~~---~~~~-~~~~~~~~~-----  220 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH---PMRVL---FLIP-KNNPPSLEG-----  220 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc---hHHHH---HHhh-hcCCCCCcc-----
Confidence            22233578889999999988889999999999999999999999996322   11111   1111 111111110     


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .   .....+.+++.+|+..+|++||+++++++
T Consensus       221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            0   03346889999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-33  Score=312.32  Aligned_cols=261  Identities=24%  Similarity=0.332  Sum_probs=199.8

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ++|+..+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++|||++++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888999999999999999876 68999999886432  2334567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |++++.+..++..    ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999988877653    33589999999999999999999986   9999999999999999999999999999876543


Q ss_pred             CCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc----------
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----------  996 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----------  996 (1052)
                      .. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......   +....+......          
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV---DQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChHHhhhcc
Confidence            21 2233467889999998765 56788999999999999999999999643221   111111110000          


Q ss_pred             -cc---ccccccccccc---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          997 -KR---EVEIIDASIWH---KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       997 -~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                       ..   .....++....   .........+.+++.+|++++|++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             00   00000000000   001122457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=320.68  Aligned_cols=245  Identities=24%  Similarity=0.378  Sum_probs=195.0

Q ss_pred             cccCeEcccCceEEEEEEEC-CCcEEEEEEec----CCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCe--EEEEE
Q 001561          774 NQANIIGCGGFGLVYKATLT-NGTKAAVKRLS----GDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND--RLLIY  846 (1052)
Q Consensus       774 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  846 (1052)
                      +...+||+|+|-+||||... +|..||--.++    ...+...+.|..|+++++.++|||||++++++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44678999999999999765 67777743222    1223444779999999999999999999999987655  67899


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCCeEEeecccccccC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLR  925 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~  925 (1052)
                      |.|..|+|..|..++    +.+.......|+.||++||.|||++ +|+|+|||||-+||+|+. .|.|||+|+|+|+...
T Consensus       123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999999864    3467889999999999999999998 899999999999999985 5999999999999876


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ....   ..++|||.|||||+.. ..|+..+||||||++++||+|+..||..|....  .+...+....+......+-  
T Consensus       198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGiKP~sl~kV~--  269 (632)
T KOG0584|consen  198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGIKPAALSKVK--  269 (632)
T ss_pred             cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCCCHHHhhccC--
Confidence            4332   2369999999999887 689999999999999999999999997554221  1111122111111111111  


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                ..++.++|.+|+.. .++||++.|+++
T Consensus       270 ----------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  270 ----------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                      23789999999999 999999999987

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-33  Score=306.64  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=203.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|+..++||+|+||.||.++.. ++..+|+|.+....  ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4888999999999999999754 68899999876442  34456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.+++....  ...+++.++..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999987542  45689999999999999999999986   99999999999999999999999999998764433


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      . ......|++.|+|||...+..++.++||||||+++|||++|+.||...   ...+....   .......         
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~---~~~~~~~---------  219 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLVVK---IVQGNYT---------  219 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---CHHHHHHH---HHcCCCC---------
Confidence            2 233457899999999998888899999999999999999999999632   11122211   1111100         


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                       ........++.+++.+|++.+|.+||++.|+++.
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence             0012233468899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-33  Score=325.90  Aligned_cols=259  Identities=20%  Similarity=0.240  Sum_probs=195.3

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ...|.+.+.||+|+||.||+|... +++.||||....      ..+.+|++++++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            347999999999999999999876 578899996432      2356899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +. ++|.+++...   ...+++..++.|+.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            95 6888877642   34689999999999999999999986   99999999999999999999999999998754322


Q ss_pred             C-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccC-CCC----chhHHHHHHHhhhcc-cccc
Q 001561          929 T-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK-GKN----CRDLVSWVFQMKSEK-REVE 1001 (1052)
Q Consensus       929 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~-~~~----~~~~~~~~~~~~~~~-~~~~ 1001 (1052)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ...    ...+.+.+....... ....
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            1 12234579999999999999999999999999999999999887653221 111    111111111100000 0000


Q ss_pred             cc--------------------cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1002 II--------------------DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1002 ~~--------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ..                    ....|..+ ......+.+++.+|++.||++|||+.|+++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            00                    00000000 012236789999999999999999999987

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-33  Score=309.63  Aligned_cols=264  Identities=28%  Similarity=0.394  Sum_probs=206.8

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  847 (1052)
                      +|+..+.||.|++|.||+|... +++.||+|.+.... .....++.+|++++++++||||+++++++.+.  ...++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5788899999999999999875 68899999987543 34456789999999999999999999988653  46899999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++++|.+++.........+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999998775444556689999999999999999999986   9999999999999999999999999998765322


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCC--CCchhHHHHHHHhhhcccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKG--KNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .   .....++..|+|||...+..++.++||||+|+++|+|++|+.||.....  ....+...+.....    .....+.
T Consensus       159 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  231 (287)
T cd06621         159 L---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPELKDE  231 (287)
T ss_pred             c---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chhhccC
Confidence            1   1234678899999999888999999999999999999999999975422  11122222222111    0011000


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                       .  .........+.+++.+|++.+|.+|||+.|+++  ++.+..
T Consensus       232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             -C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence             0  001123457899999999999999999999998  655443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-33  Score=308.35  Aligned_cols=238  Identities=25%  Similarity=0.432  Sum_probs=189.2

Q ss_pred             CeEcccCceEEEEEEECCCc-----------EEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          777 NIIGCGGFGLVYKATLTNGT-----------KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999876332           5778877644333 6778999999999999999999999988 778999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-------CeEEeec
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-------EAHLADF  918 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-------~~kl~Df  918 (1052)
                      |||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++       .+|++||
T Consensus        79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999998753   22688999999999999999999986   999999999999999887       7999999


Q ss_pred             ccccccCCCCCeeeecccccccccCccccCCc--CCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhh
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKS  995 (1052)
Q Consensus       919 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  995 (1052)
                      |++.....     .....++..|+|||++...  .++.++||||||+++|||++ |..||......   ....+..   .
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~~~---~  221 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERFYQ---D  221 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHHHh---c
Confidence            99987543     1223567789999998776  78999999999999999999 57777543211   1111111   0


Q ss_pred             cccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561          996 EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                      . ..  ...+         ....+.+++.+|+..+|.+||++.|+++.|+
T Consensus       222 ~-~~--~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 Q-HR--LPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C-CC--CCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0 00  0000         0147889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-33  Score=308.74  Aligned_cols=254  Identities=23%  Similarity=0.362  Sum_probs=203.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEee--CCeEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLLIY  846 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  846 (1052)
                      +|++.+.||.|+||.||+|... ++..||+|++....  ....+++..|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999754 68899999886432  3344568899999999999999999998754  45678999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC--EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      ||+++++|.+++.........+++..++.++.|++.|++|||..+  ..+++|+||||+||++++++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999876555677999999999999999999999322  249999999999999999999999999999876


Q ss_pred             CCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ..... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....   .....+.+    .....     
T Consensus       161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~----~~~~~-----  227 (265)
T cd08217         161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI----KEGKF-----  227 (265)
T ss_pred             cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHH----hcCCC-----
Confidence            54322 1234578999999999988889999999999999999999999996422   11222111    11110     


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                          ...+.....++.+++.+|++.+|++||++.+|++
T Consensus       228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                1112233457899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-34  Score=314.28  Aligned_cols=262  Identities=26%  Similarity=0.350  Sum_probs=202.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...  ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999876 68899999886432  2334678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |++++.+..+...    ...+++.++..++.|++.|++|||+.   +++|||++|+||++++++.+||+|||.+......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9998777665542    34589999999999999999999986   9999999999999999999999999999876654


Q ss_pred             CCeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc----------
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----------  996 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----------  996 (1052)
                      .........++..|+|||++.+. .++.++||||||+++|+|++|++||....   ..+...........          
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS---DIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHHHhhhcc
Confidence            43233446788999999998877 88999999999999999999999996422   11111111111000          


Q ss_pred             --cc--cccccccccc----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          997 --KR--EVEIIDASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       997 --~~--~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        ..  .....+....    ..++.....++.+++.+|++.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence              00  0000000000    0011122567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-33  Score=321.28  Aligned_cols=263  Identities=24%  Similarity=0.316  Sum_probs=197.5

Q ss_pred             HhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeC-----
Q 001561          768 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHG-----  839 (1052)
Q Consensus       768 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  839 (1052)
                      ...++|++.+.||+|+||+||+|... ++..||||++.....  ...+.+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34568999999999999999999864 688999999875432  2345677899999999999999999987543     


Q ss_pred             -CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          840 -NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       840 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                       ...++++|++ +++|.+++.     ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence             3568999988 778887764     23589999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcc
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       919 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      |+++.....    .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....   ..+....+.......
T Consensus       163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~  235 (343)
T cd07878         163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND---YIDQLKRIMEVVGTP  235 (343)
T ss_pred             ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHhCCC
Confidence            999865432    234578999999998766 568899999999999999999999996421   111111111111000


Q ss_pred             ccccccc--------------ccccc----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561          998 REVEIID--------------ASIWH----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus       998 ~~~~~~~--------------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      . .+...              +....    .........+.+++.+|++.||++|||+.|+++  ++...
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         236 S-PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             C-HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            0 00000              00000    000011235789999999999999999999996  55543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-33  Score=309.22  Aligned_cols=248  Identities=26%  Similarity=0.447  Sum_probs=198.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch---------hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---------QMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  841 (1052)
                      +|.+.+.||+|++|.||+|... +++.||+|.+.....         ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999864 688999998864422         122567899999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a  921 (1052)
                      .++||||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            9999999999999999864    34578899999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCC-----eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc
Q 001561          922 RLLRPYDT-----HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE  996 (1052)
Q Consensus       922 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      +.......     .......|++.|+|||...+..++.++||||+|+++|+|++|+.||.....   ..   .+......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~---~~~~~~~~  227 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQ---AIFKIGEN  227 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HH---HHHHHhcc
Confidence            87652211     111234688899999999888899999999999999999999999964211   11   11111110


Q ss_pred             ccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          997 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            ..+.    .+......+.+++.+|++.||.+||++.|+++
T Consensus       228 ------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ------ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  0011    11123347889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.5e-33  Score=306.29  Aligned_cols=253  Identities=24%  Similarity=0.367  Sum_probs=189.6

Q ss_pred             eEcccCceEEEEEEECC---CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCC
Q 001561          778 IIGCGGFGLVYKATLTN---GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS  853 (1052)
Q Consensus       778 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  853 (1052)
                      .||+|+||+||+|...+   ...+|+|.+.... ......+.+|++.++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   3468888776443 3345678899999999999999999999999999999999999999


Q ss_pred             hhhhhhcccCC-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee-
Q 001561          854 LDYWLHESVDK-DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-  931 (1052)
Q Consensus       854 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-  931 (1052)
                      |.+++...... ....++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999765322 23456788899999999999999986   99999999999999999999999999987543322111 


Q ss_pred             eecccccccccCccccC-------CcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          932 TTDLVGTLGYIPPEYSQ-------TLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      .....+++.|+|||+..       ...++.++||||||+++|||++ |..||....   ..+........    ......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~~~----~~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS---DEQVLKQVVRE----QDIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHHhhc----cCccCC
Confidence            12234567899999764       3456789999999999999999 788886321   11222111111    111111


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                      .+..    .......+.+++..|+ .||++||+++||++.|.
T Consensus       232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1211    1122345677888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1e-33  Score=313.16  Aligned_cols=261  Identities=23%  Similarity=0.300  Sum_probs=197.0

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|+..+.||+|+||.||+|+.. +|+.||+|++....  ......+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999875 78999999986432  22235578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++ +|.+++...   ...+++..++.++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||.++......
T Consensus        81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            974 777776542   34589999999999999999999986   99999999999999999999999999998654322


Q ss_pred             CeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc---------
Q 001561          929 THVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR---------  998 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  998 (1052)
                       .......+++.|+|||++.+. .++.++|||||||++|||++|+.|+....  +..+....+........         
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhh
Confidence             122334678899999987654 47899999999999999999999864321  22222222211111000         


Q ss_pred             ------ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          999 ------EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       999 ------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            .........+.........++.+++.+|++.||.+|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                  00000000001111223457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=317.35  Aligned_cols=243  Identities=28%  Similarity=0.419  Sum_probs=198.9

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD---CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      |.-.+.||.|+||.||-|+.. +.+.||||++.-.   ..+...++..|++.+++++|||+|.+-|+|..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            444567999999999999854 7889999998743   234456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      |- |+-.+.+.-.   ..++.+.++..|..+++.||+|||++   +.||||||+.|||+++.|.||++|||.|..+.+. 
T Consensus       108 Cl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  108 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             Hh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            95 5677777653   45688889999999999999999998   9999999999999999999999999999877553 


Q ss_pred             CeeeecccccccccCcccc---CCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYS---QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                          ..++|||.|||||++   ..+.|+-++||||+|++-.|+...++|+-.+.   .   ....+.+..... ..    
T Consensus       180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---A---MSALYHIAQNes-Pt----  244 (948)
T KOG0577|consen  180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---A---MSALYHIAQNES-PT----  244 (948)
T ss_pred             ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch---H---HHHHHHHHhcCC-CC----
Confidence                347999999999975   45789999999999999999999999975322   2   222222222211 11    


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                       +   ...+++..+..++..|+++-|.+|||..+++.
T Consensus       245 -L---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 -L---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -C---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             1   13456678999999999999999999999876

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.7e-33  Score=306.54  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=199.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEee-CCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH-GNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  847 (1052)
                      +|++.+.||+|++|.||+|... +++.||+|++....  ....+.+..|++++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999865 57899999986432  2344568899999999999999999998764 446789999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++++|.+++...  ....+++.++..++.+++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999998753  244589999999999999999999986   9999999999999999999999999999876432


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      . .......+++.|+|||+..+..++.++||||+|+++|+|++|+.||....   ..   ......... ...       
T Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~---~~~~~~~~~-~~~-------  220 (257)
T cd08223         156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MN---SLVYRIIEG-KLP-------  220 (257)
T ss_pred             C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HH---HHHHHHHhc-CCC-------
Confidence            2 22234578999999999999899999999999999999999999986321   11   111111111 100       


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        ..+......+.+++.+|++.+|++||++.++++
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              011223347889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-33  Score=312.16  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=202.1

Q ss_pred             ccHHHHHHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 001561          761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH  838 (1052)
Q Consensus       761 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  838 (1052)
                      .++.++....+.|++.+.||+|+||.||+|... +++.||+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            355566667788999999999999999999864 68899999886543 2345678899999998 69999999999853


Q ss_pred             ------CCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCC
Q 001561          839 ------GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE  912 (1052)
Q Consensus       839 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~  912 (1052)
                            ....+++|||+++|+|.+++....  ...+++..+..++.|+++|++|||+.   +|+||||||+||++++++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence                  457899999999999999887532  34578888999999999999999986   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCeeeecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHH
Q 001561          913 AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV  987 (1052)
Q Consensus       913 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~  987 (1052)
                      ++|+|||++........ ......|++.|+|||.+.     ...++.++|||||||++|||++|+.||.......  .  
T Consensus       160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~--  234 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--A--  234 (282)
T ss_pred             EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--h--
Confidence            99999999876542211 122357899999999865     3467889999999999999999999996322110  0  


Q ss_pred             HHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          988 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        ...... .....     .   .....+..+.+++.+|++.||.+||++.|+++
T Consensus       235 --~~~~~~-~~~~~-----~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 --LFLIPR-NPPPK-----L---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --hhhHhh-CCCCC-----C---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence              011110 00000     0   01123347899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-34  Score=308.60  Aligned_cols=240  Identities=23%  Similarity=0.451  Sum_probs=189.1

Q ss_pred             CeEcccCceEEEEEEECC--------CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          777 NIIGCGGFGLVYKATLTN--------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +.||+|+||.||+|....        ..+||+|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999997642        234888887665555566788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCC--------eEEeeccc
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE--------AHLADFGL  920 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~--------~kl~DfG~  920 (1052)
                      +++|+|.++++..   ...+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.        ++++|||.
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999998753   33688999999999999999999986   9999999999999987765        59999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCC-CCCcccCCCCchhHHHHHHHhhhccc
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGR-RPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      +......     ....+++.|+|||++.+ ..++.++||||||+++|||++|. .||....   ......    ..... 
T Consensus       155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~~~~~~----~~~~~-  221 (258)
T cd05078         155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---SQKKLQ----FYEDR-  221 (258)
T ss_pred             ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---HHHHHH----HHHcc-
Confidence            8754321     22467889999998876 45789999999999999999985 5654211   111110    01110 


Q ss_pred             ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                       ..+         +.....++.+++.+|++.+|++||+++++++.|+
T Consensus       222 -~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 -HQL---------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -ccC---------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             001         0111236889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=291.16  Aligned_cols=251  Identities=23%  Similarity=0.268  Sum_probs=196.3

Q ss_pred             cCCcc-cCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEee----CCeEE
Q 001561          771 NNFNQ-ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH----GNDRL  843 (1052)
Q Consensus       771 ~~~~~-~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~  843 (1052)
                      ++|++ .++||-|-.|.|-.+..+ +++++|+|++... +    ..++|++.--+. .|||||+++++|+.    .....
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL  135 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-P----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL  135 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-H----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence            34443 357999999999999755 7999999988633 2    246777775555 69999999998853    34567


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC---CCCCeEEeeccc
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGL  920 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~---~~~~~kl~DfG~  920 (1052)
                      +|||+|+||.|...+++.  ....+++.++..|+.||+.|++|||+.   +|+||||||+|+|.+   .+..+|++|||+
T Consensus       136 iVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence            999999999999999875  466799999999999999999999997   999999999999997   456799999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      |+.-..  .......+-||.|.|||++...+|+..+|+||+||++|-|++|.+||....+...   --.+....... ..
T Consensus       211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~g-qy  284 (400)
T KOG0604|consen  211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTG-QY  284 (400)
T ss_pred             ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhcc-Cc
Confidence            987543  2233445789999999999999999999999999999999999999976443211   10111111100 01


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +     +..+.....++...++|+.++..+|.+|.|+.|++.
T Consensus       285 ~-----FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  285 E-----FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             c-----CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1     112233456778899999999999999999999986

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-33  Score=307.13  Aligned_cols=249  Identities=27%  Similarity=0.403  Sum_probs=194.4

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDR  842 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  842 (1052)
                      .+|+..+.||+|+||.||+|... ++..||+|++....     .+....+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999864 68899999886432     22335688899999999999999999988753  567


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++++||+++++|.+++..    ...+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            899999999999998864    33578899999999999999999986   99999999999999999999999999997


Q ss_pred             ccCCCCC--eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          923 LLRPYDT--HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       923 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      .......  .......++..|+|||.+.+..++.++||||+|+++|||++|+.||....      ....+........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~------~~~~~~~~~~~~~--  226 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE------AMAAIFKIATQPT--  226 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc------hHHHHHHHhcCCC--
Confidence            6543211  11123468889999999988889999999999999999999999996321      1111111111110  


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         .+    ..+......+.+++ +|+..+|++||+++|+++
T Consensus       227 ---~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 ---NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               11    11122233566677 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-33  Score=305.91  Aligned_cols=252  Identities=26%  Similarity=0.435  Sum_probs=200.8

Q ss_pred             CCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCc------hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      +|+..+.||+|++|.||+|.. .+++.||+|++....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999985 478999999986433      1234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-CeEEeecccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRL  923 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~  923 (1052)
                      ||||+++++|.+++..    ..++++..+..++.|++.|++|||+.   +++||||||+||+++.++ .++|+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            9999999999999864    34688999999999999999999986   999999999999998776 599999999987


Q ss_pred             cCCCCCe---eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          924 LRPYDTH---VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       924 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      .......   ......|+..|+|||...+..++.++||||+|+++|+|++|+.||........   ............. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~-  229 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATTA-  229 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCCC-
Confidence            6543211   12234688999999998888899999999999999999999999963222111   1111111111100 


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                              ...+.....++.+++.+|++.+|.+||++.|+++
T Consensus       230 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         230 --------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    1112233457889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.9e-34  Score=312.46  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=200.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566778999999999999865 67899999887443 334467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++..     ..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++++|||++........
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999988853     3578999999999999999999985   999999999999999999999999999987643221


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ......|+..|+|||++.+..++.++||||||+++|||++|+.||......   ....   ......      .+    
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~---~~~~~~------~~----  219 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLF---LIPKNS------PP----  219 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHh---hhhcCC------CC----
Confidence             122346888999999999888999999999999999999999998632111   1111   110000      00    


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                      ........++.+++.+|++.+|++||++.++++  ++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence            111223457889999999999999999999998  5543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.9e-34  Score=310.65  Aligned_cols=251  Identities=29%  Similarity=0.487  Sum_probs=197.4

Q ss_pred             CeEcccCceEEEEEEECC-------CcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          777 NIIGCGGFGLVYKATLTN-------GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +.||+|+||.||+|...+       +..+|+|.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2578999876543 23456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccC---CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-----CeEEeeccc
Q 001561          849 MENGSLDYWLHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-----EAHLADFGL  920 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-----~~kl~DfG~  920 (1052)
                      +++++|.+++.....   ....+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999975432   224578999999999999999999985   999999999999999887     899999999


Q ss_pred             ccccCCCCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          921 SRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       921 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||....   ..+....+.    ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~~----~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHVT----AGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHHh----cCC
Confidence            976543221 11122355778999999998899999999999999999998 999986321   122222111    110


Q ss_pred             ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      ..         ......+..+.+++.+|++.+|.+||+++++++.|++
T Consensus       231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            00         0111234578899999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=291.86  Aligned_cols=241  Identities=25%  Similarity=0.344  Sum_probs=199.0

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHH---HHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      .++|+..++||+|.||+|..++-+ +|+-+|+|+++++.....+++   ..|-++++..+||.+..+-..|+..++.+.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            356888999999999999999854 789999999998765444443   5688999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+.||.|.-++.+    ...+++...+.+-.+|+.||.|||+.   +||.||+|.+|.|+|+||++||+|||+++.--
T Consensus       247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999988874    56789999999999999999999996   99999999999999999999999999998643


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      . ....+..++|||.|+|||++....|..++|+|.+||++|||++|+.||...   +...+.+-+..       .++   
T Consensus       320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~---dh~kLFeLIl~-------ed~---  385 (516)
T KOG0690|consen  320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK---DHEKLFELILM-------EDL---  385 (516)
T ss_pred             c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc---chhHHHHHHHh-------hhc---
Confidence            3 234466789999999999999999999999999999999999999999632   11222221111       011   


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCC
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1035 (1052)
                          .++.....++..++...+.+||++|-
T Consensus       386 ----kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 ----KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence                11122233678899999999999996

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.9e-34  Score=316.54  Aligned_cols=257  Identities=25%  Similarity=0.435  Sum_probs=201.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCc----EEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ++|+..+.||+|+||.||+|.+. +|.    .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46788899999999999999864 444    578898875432 3344688999999999999999999998754 4679


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      ++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence            99999999999988753   34578999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          925 RPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       925 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....   ..+...++.    ....  .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~----~~~~--~  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLE----KGER--L  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----CCCC--C
Confidence            5332221 122345678999999988899999999999999999997 999986322   222222211    1100  0


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCcc
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      ..+       ......+.+++.+|+..+|++||+++++++.|+++..+
T Consensus       231 ~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 PQP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            000       11223678999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=305.95  Aligned_cols=249  Identities=26%  Similarity=0.319  Sum_probs=202.1

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ..+.|+.-++||+||||.||-+..+ +|+.+|.|++.+..   .+.+.....|-.++.+++.+.||.+-..|+..+..++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            4467888899999999999999755 79999999886543   2334556789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      |+..|.||+|.-++...  ....+++..+..+|.+|+.||++||+.   +||.||+||+|||+|+.|+++|+|.|+|..+
T Consensus       263 VLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999888765  345799999999999999999999997   9999999999999999999999999999987


Q ss_pred             CCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ...  ......+||.+|||||++.+..|+..+|+||+||++|||+.|+.||.......-.+-+   .+...         
T Consensus       338 ~~g--~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv---drr~~---------  403 (591)
T KOG0986|consen  338 PEG--KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV---DRRTL---------  403 (591)
T ss_pred             CCC--CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH---HHHHh---------
Confidence            643  3344459999999999999999999999999999999999999999632211111000   00000         


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1037 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1037 (1052)
                       .....+++..++++.++-...+.+||++|-..
T Consensus       404 -~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  404 -EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             -cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence             00112334445578888889999999999743

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.2e-33  Score=308.00  Aligned_cols=246  Identities=25%  Similarity=0.367  Sum_probs=201.4

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4777889999999999999865 68899999987543 344567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++|+|.+++..     ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++........
T Consensus        85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999998863     3578899999999999999999986   999999999999999999999999999977643221


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ......++..|+|||+..+..++.++||||||+++|||++|+.||......   ...   ..... .         ...
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~---~~~~~-~---------~~~  219 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVL---FLIPK-N---------NPP  219 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHh---hhhhc-C---------CCC
Confidence             223346888999999998888999999999999999999999998643211   111   10000 0         001


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .........+.+++.+|++.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            122334567889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-34  Score=307.53  Aligned_cols=252  Identities=22%  Similarity=0.358  Sum_probs=196.9

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecC--CchhhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      .+.|++.+.||+||.+.||++...+...||+|++..  .+.+...-|..|+..|.+++ |.+||++++|-..++..|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            456889999999999999999988888888887653  33455677999999999995 999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||= .-+|..+|....  .....| .++.+..|++.|+.+.|.+   ||||.||||.|+|+-+ |.+||+|||.|..+..
T Consensus       440 E~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             ecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            975 458999998642  222234 7788999999999999998   9999999999999875 6999999999999877


Q ss_pred             CCCeee-ecccccccccCccccCCc-----------CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001561          927 YDTHVT-TDLVGTLGYIPPEYSQTL-----------TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       927 ~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      +.+... ...+||+.||+||.+...           ..+.++||||+|||+|+|+.|++||..     ....++.+....
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-----~~n~~aKl~aI~  586 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-----IINQIAKLHAIT  586 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-----HHHHHHHHHhhc
Confidence            655443 346999999999976432           245789999999999999999999962     122222222222


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ...  .++.-+.....      .++.++|+.|+..||++||++.|+++
T Consensus       587 ~P~--~~Iefp~~~~~------~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  587 DPN--HEIEFPDIPEN------DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCC--ccccccCCCCc------hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            211  11111111111      13899999999999999999999987

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.1e-36  Score=327.00  Aligned_cols=370  Identities=25%  Similarity=0.395  Sum_probs=319.9

Q ss_pred             CCCCCEEEcccccCC-CCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccc
Q 001561          228 SPSLKQLHVDNNLLG-GDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFF  306 (1052)
Q Consensus       228 ~~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  306 (1052)
                      +|-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..++.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            455667788888888 478889999999999999999887 78999999999999999999988 566678889999999


Q ss_pred             cccCCccc-CCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCccccCCCccceeecccccc
Q 001561          307 VAHSNSFS-GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL  385 (1052)
Q Consensus       307 ~l~~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  385 (1052)
                      .+..|++. .-+|..+..+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|..+.-..|.+++.|-.||||+|++
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence            99999986 356778889999999999999998 5677788888999999999999944445577899999999999999


Q ss_pred             cccCchhhccCCcCcEEeccCCcCCCCcccchhhccCcccceEecccccc-CccCCccccCCCcccEEEccCCccccCcc
Q 001561          386 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFV-GEEIPENVGGFESLMVLALGNCGLKGHIP  464 (1052)
Q Consensus       386 ~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  464 (1052)
                      . .+|..+..+..|+.|+|++|.+..+  .+.-+..+++|+.|.+++.+- ...+|.++.++.+|..+||+.|.+. .+|
T Consensus       163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hf--QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP  238 (1255)
T KOG0444|consen  163 E-MLPPQIRRLSMLQTLKLSNNPLNHF--QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP  238 (1255)
T ss_pred             h-hcCHHHHHHhhhhhhhcCCChhhHH--HHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence            8 6788899999999999999998764  344556677888889988654 3468999999999999999999998 899


Q ss_pred             hhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeEeccCCcccccCCcchhhhhhhcccCCCCCCCCCCCCccceeecc
Q 001561          465 VWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHN  544 (1052)
Q Consensus       465 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~  544 (1052)
                      +.+-++++|+.|+||+|+|+ .+.-..+...+|+.|+||+|+++ .+|..+..|+.|+.                     
T Consensus       239 ecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k---------------------  295 (1255)
T KOG0444|consen  239 ECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK---------------------  295 (1255)
T ss_pred             HHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH---------------------
Confidence            99999999999999999998 67667778889999999999998 78999999888843                     


Q ss_pred             ccCCCcCCCCCCCCCCeeeeecCcccc-cCCcccccccccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCc
Q 001561          545 RSTNGLPYNQASSFPPSVFLSNNRING-TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG  623 (1052)
Q Consensus       545 ~~~~~l~~~~~~~~~~~l~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~  623 (1052)
                                       |.+.+|+++- -||..||+|.+|+.+..++|.+. ..|+.++.+..|+.|.|++|+|- .+|.
T Consensus       296 -----------------Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPe  356 (1255)
T KOG0444|consen  296 -----------------LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPE  356 (1255)
T ss_pred             -----------------HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echh
Confidence                             5567777763 48999999999999999999999 89999999999999999999998 7999


Q ss_pred             cccCccccCeeeecccccccCCC
Q 001561          624 SFEKLTFLSKFSVANNHLQGTIP  646 (1052)
Q Consensus       624 ~~~~l~~L~~l~l~~N~l~g~~p  646 (1052)
                      .+--|+.|..|||.+|.----+|
T Consensus       357 aIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  357 AIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             hhhhcCCcceeeccCCcCccCCC
Confidence            99999999999999996544444

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-33  Score=312.01  Aligned_cols=261  Identities=24%  Similarity=0.343  Sum_probs=199.3

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888999999999999999876 58999999876432  2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |++++.+.++...    ...+++.++..++.|+++|++|||+.   +++|||++|+||++++++.++++|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999998877653    33489999999999999999999986   9999999999999999999999999999875433


Q ss_pred             CCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc----------
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----------  996 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----------  996 (1052)
                      . .......++..|+|||+..+ ..++.++||||||+++|||++|++||.....   .+...........          
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHHhc
Confidence            2 22334568899999998765 4578899999999999999999999863221   1111111110000          


Q ss_pred             -ccc-cccccccccc-----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          997 -KRE-VEIIDASIWH-----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       997 -~~~-~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                       ... .....+....     .........+.+++.+|++.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             000 0000000000     001123457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.9e-33  Score=303.00  Aligned_cols=247  Identities=27%  Similarity=0.426  Sum_probs=199.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      +|+..+.||+|++|.||+|... +++.||+|.+....     .+..+.+.+|++++++++|+||+++++++.++...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999876 78999999886432     23456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      +||+++++|.+++..    ...+++..+..++.|+++|++|||+.   +|+|+||+|+||+++.++.+||+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999999874    23578999999999999999999986   99999999999999999999999999988754


Q ss_pred             CCCCeeeecccccccccCccccCCcC-CCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLT-ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ...  ......|++.|+|||...... ++.++|+||||+++|+|++|+.||....   .   ...............   
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~---~---~~~~~~~~~~~~~~~---  222 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE---G---VAAVFKIGRSKELPP---  222 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc---H---HHHHHHHHhcccCCC---
Confidence            322  223456889999999887666 8999999999999999999999996422   1   111111111111111   


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            .+......+.+++.+|++.+|.+||++.++++
T Consensus       223 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 ------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                  11122346789999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.2e-33  Score=303.49  Aligned_cols=251  Identities=30%  Similarity=0.476  Sum_probs=201.6

Q ss_pred             CcccCeEcccCceEEEEEEECC-----CcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          773 FNQANIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      |++.+.||+|+||.||+|...+     +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999998763     378999998755433 5668899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++++|.+++....  ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+.....
T Consensus        81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            9999999999987532  12289999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ..........+++.|+|||...+..++.++||||+|+++|+|++ |++||..   ....+..+.+....    ....   
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~---~~~~~~~~~~~~~~----~~~~---  225 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG---MSNEEVLEYLKKGY----RLPK---  225 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcCC----CCCC---
Confidence            32222212346789999999988889999999999999999998 8888864   22222222221111    0000   


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1044 (1052)
                            ....+.++.+++.+|+..+|++|||+.|++++|
T Consensus       226 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  111344788999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.2e-33  Score=302.81  Aligned_cols=255  Identities=27%  Similarity=0.456  Sum_probs=208.9

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      +|++.+.||+|++|.||+|... +++.||+|++..... ....++.+|++++.+++|+|++++++++..+...++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6888999999999999999876 589999999876543 44577999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      ++++|.+++...    ..+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++++|||.+.......
T Consensus        82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999998753    568999999999999999999998 6   99999999999999999999999999998765432


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .. .....++..|+|||...+..++.++||||||+++|+|++|+.||......+..+...++..    .....       
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~-------  222 (264)
T cd06623         155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GPPPS-------  222 (264)
T ss_pred             Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CCCCC-------
Confidence            22 2234678899999999888899999999999999999999999965432222233322221    11100       


Q ss_pred             chhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1009 HKDREK-QLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                        .... .+..+.+++.+|++.+|++||++.|+++  +++.+
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence              0111 3347899999999999999999999998  45443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-33  Score=306.64  Aligned_cols=247  Identities=27%  Similarity=0.452  Sum_probs=197.7

Q ss_pred             cCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      ++|++.+.||+|+||.||+|.. +++.||+|.+..+.  ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999975 57889999987543  235688999999999999999999998654 4799999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +++|.+++...  ....+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+.......  
T Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            99999998753  234578999999999999999999986   99999999999999999999999999997643211  


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                        .....+..|+|||.+.+..++.++||||||+++|||++ |+.||....   ..+.....   . ......        
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~---~-~~~~~~--------  217 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS---LKEVKECV---E-KGYRME--------  217 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC---HHHHHHHH---h-CCCCCC--------
Confidence              12234568999999988889999999999999999997 999986422   11111111   1 111000        


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                       .....+..+.+++.+|++.+|++||+++++++.|++
T Consensus       218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             011223478899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.9e-33  Score=307.64  Aligned_cols=253  Identities=27%  Similarity=0.410  Sum_probs=196.4

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHH-HHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEA-LSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.... ...+.++..|+.. ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888999999999999999875 68999999987543 2334456666665 566689999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |++ |+|.+++.........+++..++.++.|++.|++|||+.  .+++||||||+||+++.++.+||+|||.+......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 688888876544556789999999999999999999973  38999999999999999999999999999865422


Q ss_pred             CCeeeecccccccccCccccCC----cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQT----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      .  ......|+..|+|||.+.+    ..++.++|+||||+++|||++|+.||....  +..+...   ..... ......
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~---~~~~~-~~~~~~  229 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK--TPFQQLK---QVVEE-PSPQLP  229 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc--cCHHHHH---HHHhc-CCCCCC
Confidence            1  1223468889999998754    456889999999999999999999986321  1111111   11111 001110


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                              ....+.++.+++.+|+..+|++||++.++++
T Consensus       230 --------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         230 --------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    0113347899999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=310.16  Aligned_cols=256  Identities=28%  Similarity=0.427  Sum_probs=202.5

Q ss_pred             HhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCC-----
Q 001561          768 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN-----  840 (1052)
Q Consensus       768 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  840 (1052)
                      ...++|++.+.||+|++|.||+|... +++.+|+|++..... ..+++.+|+++++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            34678999999999999999999875 678999999875543 346789999999999 6999999999997644     


Q ss_pred             -eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          841 -DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       841 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                       ..++||||+++++|.+++.........+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             48999999999999999876544456789999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccCC-----cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      .+....... .......|++.|+|||++..     ..++.++||||||+++|+|++|+.||....   .....   ....
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~---~~~~  231 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH---PMRAL---FKIP  231 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc---hHHHH---HHhh
Confidence            997654322 22233568999999997643     346788999999999999999999996321   11111   1111


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .. .....       ........++.+++.+|+..||++|||+.|+++
T Consensus       232 ~~-~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RN-PPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cc-CCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11 01011       111224457889999999999999999999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.7e-33  Score=310.70  Aligned_cols=247  Identities=22%  Similarity=0.343  Sum_probs=198.6

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      |.....||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            334567999999999999864 6889999998765555567789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      ++|.+++..     ..+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++........ .
T Consensus       104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~  174 (292)
T cd06658         104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K  174 (292)
T ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence            999998753     3478999999999999999999986   999999999999999999999999999976543222 2


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....|++.|+|||...+..++.++||||||+++|||++|+.||....   ......   .... .     .......  
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~---~~~~-~-----~~~~~~~--  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP---PLQAMR---RIRD-N-----LPPRVKD--  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHh-c-----CCCcccc--
Confidence            233578999999999988889999999999999999999999986321   111111   1110 0     0000000  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .......+.+++.+|+..||.+||++.|+++
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1112336889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.8e-33  Score=311.90  Aligned_cols=196  Identities=26%  Similarity=0.359  Sum_probs=159.5

Q ss_pred             cCeEcccCceEEEEEEEC---CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEee--CCeEEEEEEecc
Q 001561          776 ANIIGCGGFGLVYKATLT---NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLLIYSYME  850 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  850 (1052)
                      ...||+|+||+||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999865   35789999887543  23457889999999999999999998854  456789999987


Q ss_pred             CCChhhhhhccc-----CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEE----CCCCCeEEeecccc
Q 001561          851 NGSLDYWLHESV-----DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLS  921 (1052)
Q Consensus       851 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill----~~~~~~kl~DfG~a  921 (1052)
                      + +|.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+||++    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 6766664321     1233588999999999999999999986   99999999999999    56789999999999


Q ss_pred             cccCCCCCe--eeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcc
Q 001561          922 RLLRPYDTH--VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEV  977 (1052)
Q Consensus       922 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~  977 (1052)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876433221  2234578999999998766 4578999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.3e-33  Score=304.89  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=195.4

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDR  842 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  842 (1052)
                      .+|++.+.||+|+||.||+|... ++..||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999865 68999999875321     22335678899999999999999999988764  467


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||.++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            8999999999999988642    3478888999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCC--eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          923 LLRPYDT--HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       923 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      .......  .......|+..|+|||...+..++.++||||||+++|||++|+.||....   ...   ..........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~---~~~~~~~~~~--  226 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE---AMA---AIFKIATQPT--  226 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc---hHH---HHHHHhcCCC--
Confidence            6543211  11233468899999999888889999999999999999999999996321   111   1111111100  


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         .    ...+......+.+++.+|+. +|++||+++|+++
T Consensus       227 ---~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 ---N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               0    11122334567889999985 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.5e-33  Score=305.07  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=201.1

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|+..+.||+|+||.||++... +|+.||+|++...  .....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4888999999999999999865 6889999998643  233446789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.+++...  ....+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999988753  234578899999999999999999986   99999999999999999999999999998654322


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      . ......|++.|+|||+..+..++.++||||||+++|+|++|+.||...   +..+...   ...... ...       
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~---~~~~~~-~~~-------  220 (256)
T cd08218         156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVL---KIIRGS-YPP-------  220 (256)
T ss_pred             h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHH---HHhcCC-CCC-------
Confidence            1 122346888999999998888999999999999999999999998632   1112111   111110 000       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        .+.....++.+++.+|++.+|.+||++.||++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              11122346899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.6e-33  Score=302.39  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=204.1

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999865 67899999987543 33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.++++.... ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999875322 34689999999999999999999986   99999999999999999999999999998765433


Q ss_pred             Ce---eeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          929 TH---VTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       929 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ..   ......|+..|+|||++... .++.++||||||+++|||++|+.||......  .......    .... .. ..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~----~~~~-~~-~~  228 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTL----QNDP-PS-LE  228 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHh----cCCC-CC-cC
Confidence            22   22334789999999987766 7899999999999999999999999643211  1111111    1100 00 00


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ..   ......+.++.+++.+|++.+|++||++.|+++
T Consensus       229 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             Cc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00   001123457889999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.4e-33  Score=305.64  Aligned_cols=252  Identities=29%  Similarity=0.435  Sum_probs=203.2

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      +|+..+.||.|++|.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++..+...++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999876 68899999987653 345567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      ++++|.+++....   ..+++..+..++.|++.|++|||+ .   +++||||||+||++++++.++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999987532   568899999999999999999998 5   99999999999999999999999999987654322


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      ..   ...++..|+|||...+..++.++||||||+++|+|++|+.||..... ......+.+...... .....      
T Consensus       156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~------  224 (265)
T cd06605         156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIVNE-PPPRL------  224 (265)
T ss_pred             hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHhcC-CCCCC------
Confidence            11   25788899999999888999999999999999999999999964321 111122211111111 00000      


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        .......++.++|.+|+..+|++||++.|++.
T Consensus       225 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 --PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             --ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence              00113457889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=314.54  Aligned_cols=256  Identities=25%  Similarity=0.311  Sum_probs=203.3

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|+..+.||+|++|+||+|... +++.||+|.+.....   ...+.+..|++++++++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999876 589999999876532   24456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++++|.+++...  ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999988743  245689999999999999999999986   999999999999999999999999999876532


Q ss_pred             CCCe----------------------------eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCccc
Q 001561          927 YDTH----------------------------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC  978 (1052)
Q Consensus       927 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~  978 (1052)
                      ....                            ......||..|+|||+..+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            2110                            111246889999999998888999999999999999999999999643


Q ss_pred             CCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH--HHhh
Q 001561          979 KGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF----IEEVVT--WLDG 1046 (1052)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~--~L~~ 1046 (1052)
                      ..   ......+   .....  .       ..........+.+++.+|++.+|++||+    +.|+++  ++++
T Consensus       236 ~~---~~~~~~~---~~~~~--~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         236 NR---DETFSNI---LKKEV--T-------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             ch---HHHHHHH---hcCCc--c-------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            21   1111111   11000  0       0001113457899999999999999999    777766  4444

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=319.26  Aligned_cols=240  Identities=26%  Similarity=0.294  Sum_probs=185.1

Q ss_pred             EcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhc---CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRA---QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ||+|+||+||+|+.. +++.||+|++.....   .....+..|..++.+.   +||+|+++++++.+.+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 689999999864321   1223345566666655   699999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~  152 (330)
T cd05586          81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT  152 (330)
T ss_pred             ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence            999988864    44689999999999999999999986   99999999999999999999999999997643222 22


Q ss_pred             eecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccch
Q 001561          932 TTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      ....+||+.|+|||++.+. .++.++||||+||++|||++|+.||...   +..+....+.    ... ..+..      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~---~~~~~~~~i~----~~~-~~~~~------  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE---DTQQMYRNIA----FGK-VRFPK------  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC---CHHHHHHHHH----cCC-CCCCC------
Confidence            3346799999999987654 5789999999999999999999999632   1112111111    000 01100      


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 001561         1011 DREKQLLEMLEIACKCIDQDPRRRP----FIEEVVT 1042 (1052)
Q Consensus      1011 ~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 1042 (1052)
                        ......+.+++.+|++.||++||    ++.|+++
T Consensus       219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              01233678999999999999998    5666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.7e-33  Score=305.15  Aligned_cols=253  Identities=25%  Similarity=0.427  Sum_probs=197.8

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch----------hhHHHHHHHHHHHHhcCCCceeeeeceEeeCC
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG----------QMEREFQAEVEALSRAQHKNLVSLQGYCRHGN  840 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  840 (1052)
                      +|.+.+.||+|+||.||+|... +|+.||+|.++....          ...+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4777899999999999999754 689999998753211          12245788999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..++||||+++++|.++++..    ..+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999998753    4688999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCe-eeecccccccccCccccCCcC--CCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcc
Q 001561          921 SRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLT--ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       921 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      ++........ ......|+..|+|||......  ++.++||||||+++||+++|+.||....      ............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~  228 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE------AIAAMFKLGNKR  228 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc------hHHHHHHhhccc
Confidence            9765432111 123356889999999876644  7899999999999999999999985321      111111111111


Q ss_pred             cccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          998 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .... +...    ........+.+++.+|+.++|.+||++.||++
T Consensus       229 ~~~~-~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 SAPP-IPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCc-CCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111 1111    11123457899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.3e-33  Score=304.04  Aligned_cols=256  Identities=26%  Similarity=0.437  Sum_probs=199.0

Q ss_pred             CcccCeEcccCceEEEEEEEC----CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC------
Q 001561          773 FNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  840 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  840 (1052)
                      |++.++||+|+||.||+|.+.    ++..||+|++....  ....+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999754    36789999987542  334567889999999999999999999886532      


Q ss_pred             eEEEEEEeccCCChhhhhhccc--CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          841 DRLLIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                      ..++++||+++|+|.+++....  .....+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988875432  1223578899999999999999999985   9999999999999999999999999


Q ss_pred             ccccccCCCCCee-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhc
Q 001561          919 GLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE  996 (1052)
Q Consensus       919 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      |.++......... .....+++.|++||......++.++||||||+++|||++ |++||...   +..+...+...   .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~---~~~~~~~~~~~---~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNYLIK---G  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC---CHHHHHHHHHc---C
Confidence            9998764322211 122345678999999988889999999999999999999 89998632   11222222111   1


Q ss_pred             ccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          997 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      .. ..         ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus       232 ~~-~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NR-LK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             Cc-CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00 00         0011234789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.9e-33  Score=308.42  Aligned_cols=264  Identities=22%  Similarity=0.305  Sum_probs=201.6

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchh-----hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ-----MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      +|+..+.||+|++|.||+|... +++.||+|++......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999865 6899999998754322     345567899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+ +|+|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||+++...
T Consensus        81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 89999998753   23689999999999999999999986   99999999999999999999999999998765


Q ss_pred             CCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc----
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV---- 1000 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 1000 (1052)
                      .... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||....   ..+...............    
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS---DIDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc---cHHHHHHHHHHcCCCchhhhhh
Confidence            4322 2223456889999998754 467889999999999999999988886322   112222222111100000    


Q ss_pred             -----cccccccc-----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561         1001 -----EIIDASIW-----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1001 -----~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                           ........     ..........+.+++.+|++++|++||++.|+++  ++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence                 00000000     0011223457889999999999999999999998  4554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-32  Score=300.24  Aligned_cols=251  Identities=31%  Similarity=0.456  Sum_probs=201.3

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|+..+.||+|+||.||+|... ++..||+|.+.....  ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999865 788999999876544  3567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.+++..    ...+++..+..++.++++|++|||+.   +|+|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999874    34578899999999999999999986   99999999999999999999999999998765433


Q ss_pred             Ceee---ecccccccccCccccCCcC---CCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          929 THVT---TDLVGTLGYIPPEYSQTLT---ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       929 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ....   ....+++.|+|||++....   ++.++||||||+++||+++|+.||....  ..   ......... .....+
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~--~~---~~~~~~~~~-~~~~~~  227 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD--NE---FQIMFHVGA-GHKPPI  227 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc--ch---HHHHHHHhc-CCCCCC
Confidence            2221   1356788999999987766   8899999999999999999999996422  11   111111111 100011


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .       ........+.+++.+|++.+|.+||++.|++.
T Consensus       228 ~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 P-------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C-------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0       11112346789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.9e-33  Score=308.86  Aligned_cols=254  Identities=22%  Similarity=0.371  Sum_probs=204.2

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57889999999999999999754 68899999987555455567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++..     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            99999998864     2478889999999999999999986   999999999999999999999999999876544322


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ......|++.|+|||......++.++||||||+++|++++|+.||.......   ..   .......        ....
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~---~~~~~~~--------~~~~  235 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---AL---YLIATNG--------TPEL  235 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---he---eehhcCC--------CCCC
Confidence             2233468889999999888888999999999999999999999996422111   00   0000000        0001


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .........+.+++.+|++.+|++||++.+++.  +++..
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA  275 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence            111223346889999999999999999999987  44433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-33  Score=309.11  Aligned_cols=262  Identities=23%  Similarity=0.355  Sum_probs=196.4

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57889999999999999999866 689999999865432 2234567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++ +|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||.++......
T Consensus        85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            985 898888653   34688999999999999999999986   99999999999999999999999999987543211


Q ss_pred             CeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccc---c--
Q 001561          929 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE---I-- 1002 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 1002 (1052)
                       .......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.....  ..+....+...........   .  
T Consensus       158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence             11122356889999998765 5578899999999999999999999964321  1111111111110000000   0  


Q ss_pred             -----------ccccccchh--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1003 -----------IDASIWHKD--REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1003 -----------~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                 .........  .......+.+++.+|++.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                       000000000  0011146789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=316.54  Aligned_cols=270  Identities=26%  Similarity=0.326  Sum_probs=205.0

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC------eEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------DRL  843 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  843 (1052)
                      .+...+.||+|+||.||+|+.+ +|+.||||.+.... ....+.+.+|++++++++|+|||++++.-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3455778999999999999954 89999999998654 344567889999999999999999999865433      568


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC--CCCC--eEEeecc
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD--EKFE--AHLADFG  919 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~--~~~~--~kl~DfG  919 (1052)
                      +|||||.+|+|...+++.. ....+++.+.+.+..+++.|+.|||++   +|+||||||.||++-  ++|+  .||+|||
T Consensus        94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            9999999999999998765 355699999999999999999999986   999999999999984  4444  6999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccC-CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      .|+.++..  ......+||..|.+||+.. .+.|+..+|.|||||++|+.+||..||....++.....+.|..-......
T Consensus       170 ~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  170 AARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             ccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            99988643  3566789999999999988 48889999999999999999999999986544322222223222221111


Q ss_pred             cccccccccc------------chhhHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHhhc
Q 001561          999 EVEIIDASIW------------HKDREKQLLEMLEIACKCIDQDPRRRP--FIEEVVTWLDGI 1047 (1052)
Q Consensus       999 ~~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i 1047 (1052)
                      ..........            ..........+...+..++..+|++|-  ...+....+.+|
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            1111111111            111233445667788888999999998  666666555544

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-33  Score=305.20  Aligned_cols=252  Identities=25%  Similarity=0.434  Sum_probs=200.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcC---CCceeeeeceEeeCCeEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQ---HKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... .....++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777889999999999999864 78999999987543 334456889999999997   999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++++|.++++.     ..+++..++.++.|+++|++|||+.   +|+||||+|+||++++++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            99999999998864     2688999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ... ......|+..|+|||...+ ..++.++||||||+++|+|++|+.||.....      ..+...... ...     +
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~~~~~-~~~-----~  220 (277)
T cd06917         154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMMLIPK-SKP-----P  220 (277)
T ss_pred             Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhhcccc-CCC-----C
Confidence            332 2234578999999998764 4568899999999999999999999963211      111111000 000     1


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .....   ....++.+++.+|++.||++||++.|+++  ++++.
T Consensus       221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            11110   13347889999999999999999999987  55443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-33  Score=312.25  Aligned_cols=267  Identities=24%  Similarity=0.306  Sum_probs=197.4

Q ss_pred             CCcccCeEcccCceEEEEEEEC---CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT---NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRL  843 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  843 (1052)
                      +|++.+.||+|+||.||+|...   ++..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999865   47899999988633   33345678899999999999999999999888  7899


Q ss_pred             EEEEeccCCChhhhhhcccCC-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC----CCCeEEeec
Q 001561          844 LIYSYMENGSLDYWLHESVDK-DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADF  918 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~----~~~~kl~Df  918 (1052)
                      +||||+++ ++.+++...... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 566666543332 33789999999999999999999986   9999999999999999    999999999


Q ss_pred             ccccccCCCCC--eeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCc------hhHHHH
Q 001561          919 GLSRLLRPYDT--HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC------RDLVSW  989 (1052)
Q Consensus       919 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~------~~~~~~  989 (1052)
                      |+++.......  .......+++.|+|||++.+ ..++.++||||||+++|||++|++||........      .+....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322  11223468899999997765 4578999999999999999999999975432210      011111


Q ss_pred             HHHhhhccc------------ccc--------ccc-ccccchhhH--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          990 VFQMKSEKR------------EVE--------IID-ASIWHKDRE--KQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       990 ~~~~~~~~~------------~~~--------~~~-~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +........            ...        ... .........  ....++.+++.+|+++||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111100000            000        000 000000000  23347889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.8e-33  Score=306.51  Aligned_cols=264  Identities=22%  Similarity=0.277  Sum_probs=195.8

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++|+||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3567999999999999999999864 68999999986543 222345778999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||++ +++.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 6776666432   34577888999999999999999986   999999999999999999999999999976432


Q ss_pred             CCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcc--------
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK--------  997 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--------  997 (1052)
                      .. .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||+....  ..+............        
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         156 PS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence            21 11233467899999998765 4578899999999999999999999974321  111111111100000        


Q ss_pred             -----cccccccccccchh-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          998 -----REVEIIDASIWHKD-----REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       998 -----~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                           ..............     .......+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                 00000000000000     0011346789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-32  Score=299.03  Aligned_cols=248  Identities=23%  Similarity=0.406  Sum_probs=200.2

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|+..+.||+|+||.||+|... +++.+|+|++....  ....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788999999999999999864 68899999986542  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-CCeEEeecccccccCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~  927 (1052)
                      +++++|.+++...  ....+++..+..++.++++|++|||+.   +++||||||+||+++++ +.+|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999999753  244588999999999999999999986   99999999999999865 45899999999876432


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      .  ......|+..|+|||...+..++.++||||||+++|+|++|+.||....   ..........   .. ...+     
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~~~---~~-~~~~-----  221 (256)
T cd08220         156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVLKIMS---GT-FAPI-----  221 (256)
T ss_pred             c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc---hHHHHHHHHh---cC-CCCC-----
Confidence            2  1223568899999999988889999999999999999999999986421   1122211111   10 0011     


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                          ......++.+++.+|++.+|++|||+.|+++
T Consensus       222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                1112346889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-33  Score=331.72  Aligned_cols=267  Identities=20%  Similarity=0.236  Sum_probs=189.3

Q ss_pred             hcCCcccCeEcccCceEEEEEEECC--CcEEEEEEe--------------c---CCchhhHHHHHHHHHHHHhcCCCcee
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN--GTKAAVKRL--------------S---GDCGQMEREFQAEVEALSRAQHKNLV  830 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~niv  830 (1052)
                      .++|++.+.||+|+||+||+|..+.  +..+++|.+              .   .........+.+|++++++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999987542  222222211              0   01122345688999999999999999


Q ss_pred             eeeceEeeCCeEEEEEEeccCCChhhhhhccc-CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC
Q 001561          831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESV-DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE  909 (1052)
Q Consensus       831 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~  909 (1052)
                      ++++++.+.+..|+|+|++. +++.+++.... ..........+..++.|++.||+|||+.   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            99999999999999999985 46666654322 1122334567788999999999999986   9999999999999999


Q ss_pred             CCCeEEeecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCC-CcccCCCCchhHHH
Q 001561          910 KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS  988 (1052)
Q Consensus       910 ~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~p-f~~~~~~~~~~~~~  988 (1052)
                      ++.+||+|||+++.+...........+||+.|+|||++.+..++.++|||||||++|||++|..+ +..........+..
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            99999999999987754433333456899999999999999999999999999999999998754 43222222222221


Q ss_pred             HHHHhhhcccccccccc----------cc----cchhh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          989 WVFQMKSEKREVEIIDA----------SI----WHKDR-----EKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       989 ~~~~~~~~~~~~~~~~~----------~~----~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .+.. .... ..++.+.          ..    .....     ......+.+++.+|++.||++||++.|+++
T Consensus       383 ~~~~-~~~~-~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        383 IIDS-LSVC-DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHh-cccC-hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1111 0000 0000000          00    00000     011235678899999999999999999987

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=312.36  Aligned_cols=250  Identities=23%  Similarity=0.380  Sum_probs=202.5

Q ss_pred             CCcccCeEcccCceEEEEEEECC-CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      .|+++.-||-|+||.||+|..++ +--.|.|++.....+..+++.-|++++..+.||+||++++.|...+..|++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            35667779999999999998764 44457788877767777789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      ||-.+..+-+   -+..+++.++..+.+|++.||.|||+.   .|||||+|+.|||++-+|.++++|||.+..... ...
T Consensus       113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q  185 (1187)
T KOG0579|consen  113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ  185 (1187)
T ss_pred             CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence            9999888765   467899999999999999999999996   999999999999999999999999999865322 222


Q ss_pred             eeecccccccccCcccc-----CCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYS-----QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ....++|||+|||||++     ...+|++++||||||+++.||..+.+|-...      .....+.......+ ..+.. 
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllKiaKSeP-PTLlq-  257 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSEP-PTLLQ-  257 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHHHhhcCC-CcccC-
Confidence            33457999999999975     4578999999999999999999999996421      11111111111111 11122 


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            +..+...+.+++.+|+..+|..||+++++++
T Consensus       258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                  2345567899999999999999999999986

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.8e-33  Score=307.80  Aligned_cols=247  Identities=22%  Similarity=0.337  Sum_probs=198.0

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      |+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334557999999999999865 6899999998754444556788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      ++|.+++..     ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++....... ..
T Consensus       103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~  173 (297)
T cd06659         103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK  173 (297)
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence            999887743     3578999999999999999999986   99999999999999999999999999997654322 12


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....|++.|+|||++.+..++.++||||||+++|||++|+.||....   ..+....   .... .....       ..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~~~~~---~~~~-~~~~~-------~~  239 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKR---LRDS-PPPKL-------KN  239 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH---Hhcc-CCCCc-------cc
Confidence            233578999999999988889999999999999999999999996321   1111111   1111 00000       00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .......+.+++.+|++.+|++||++.|+++
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            1112346789999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-32  Score=307.98  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=197.9

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      +|+..+.||+|+||.||+|... +++.||+|.+....   ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888999999999999999865 67899999987543   2233567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++.....
T Consensus        82 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          82 YVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999864    34588999999999999999999986   9999999999999999999999999998642110


Q ss_pred             CC--------------eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHh
Q 001561          928 DT--------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM  993 (1052)
Q Consensus       928 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  993 (1052)
                      ..              .......|+..|+|||.+....++.++|+||||+++|||++|+.||...   ...+....   .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~---~~~~~~~~---~  228 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFGQ---V  228 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHH---H
Confidence            00              0111246788999999988888999999999999999999999999632   11121111   1


Q ss_pred             hhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561          994 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                      ....    ...+..    ....+.++.+++.+|++.+|++||++.++.+.|+
T Consensus       229 ~~~~----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         229 ISDD----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             Hhcc----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            1110    000000    0112346889999999999999999766655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.3e-33  Score=305.94  Aligned_cols=260  Identities=24%  Similarity=0.322  Sum_probs=196.6

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|+..+.||.|++|.||+|+.. ++..||+|++....  ......+..|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999865 68999999887443  22335688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +. ++|.+++...  ....+++..+..++.|+++|++|||+.   +++||||+|+||++++++.+|++|||.+.......
T Consensus        81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 5788887653  245689999999999999999999986   99999999999999999999999999997654322


Q ss_pred             CeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc--------
Q 001561          929 THVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE--------  999 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  999 (1052)
                      . ......+++.|+|||+..+. .++.++||||||+++|||+||+.||....  +.....+. .........        
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRI-FRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH-HHHhCCCChhhhhhhhH
Confidence            1 12234578899999977654 46889999999999999999999996321  11111111 111100000        


Q ss_pred             --------cccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1000 --------VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1000 --------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                              ....... ..........++.+++.+|++.||++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQD-FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccC-HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                    0000000 00001112346789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-32  Score=307.33  Aligned_cols=245  Identities=27%  Similarity=0.389  Sum_probs=194.8

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      +.|+..+.||+|+||+||+|... +++.||+|++....   ....+++.+|+++++.++||||+++++++.+++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999865 68999999886432   233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||++ |++.+++...   ...+++..+..++.|++.|+.|||+.   +|+||||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 5666666432   34589999999999999999999986   999999999999999999999999999876543


Q ss_pred             CCCeeeecccccccccCccccC---CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      .     ....+++.|+|||++.   ...++.++||||||+++|||++|+.||....   ....   ........ ...  
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~---~~~~---~~~~~~~~-~~~--  233 (307)
T cd06607         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSA---LYHIAQND-SPT--  233 (307)
T ss_pred             C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc---HHHH---HHHHhcCC-CCC--
Confidence            2     2346788999999864   4568889999999999999999999985321   1111   11111110 000  


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            .....+...+.+++.+|++.+|++||++.+++.
T Consensus       234 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         234 ------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             ------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  011224457899999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2e-32  Score=303.69  Aligned_cols=244  Identities=24%  Similarity=0.307  Sum_probs=199.3

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999999865 68999999986432   233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||+|+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999999875    35689999999999999999999986   999999999999999999999999999987643


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .    .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||....   .......+.   ...  ..     
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~---~~~--~~-----  216 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKIL---EGK--VR-----  216 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHh---cCC--cc-----
Confidence            3    234578999999999888888999999999999999999999996322   111111111   100  00     


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                          .+......+.+++.+|+..+|.+||     +++|+++
T Consensus       217 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 ----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                0111134788999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.2e-32  Score=294.27  Aligned_cols=249  Identities=28%  Similarity=0.472  Sum_probs=204.5

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      +|+..+.||+|++|.||+|... ++..+++|++........+.+.+|++++++++|++++++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999876 688999999987655556789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +++|.+++...   ...+++..+..++.|+++|++|||+.   +++||||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999988753   25689999999999999999999986   999999999999999999999999999987654332 


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccch
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       .....++..|+|||.+....++.++||||||+++|+|++|+.||....   .   .+....... .........     
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~---~~~~~~~~~-~~~~~~~~~-----  220 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP---P---MKALFKIAT-NGPPGLRNP-----  220 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc---h---HHHHHHHHh-cCCCCcCcc-----
Confidence             234568889999999988889999999999999999999999986321   1   111111111 111111111     


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1011 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        ......+.+++.+|++.||++||++.|+++
T Consensus       221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             --cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              112347899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-32  Score=302.39  Aligned_cols=246  Identities=24%  Similarity=0.364  Sum_probs=199.2

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      -|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3677889999999999999864 68899999876433 334467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++++|.+++..     ..+++..+..++.+++.|++|||+.   +++|+||||+||+++.++.++++|||++....... 
T Consensus        85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            99999998863     3578999999999999999999985   99999999999999999999999999987654322 


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .......++..|+|||...+..++.++|||||||++|+|++|..||....   ......   .......          .
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~~~~~~---~~~~~~~----------~  219 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH---PMKVLF---LIPKNNP----------P  219 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc---hHHHHH---HHhcCCC----------C
Confidence            11223468889999999988888999999999999999999999986321   111111   1111100          0


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ........++.+++.+|++.+|.+||++.++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            011123346889999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.2e-32  Score=302.51  Aligned_cols=248  Identities=22%  Similarity=0.333  Sum_probs=199.9

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      .|...+.||+|++|.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++..++..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555678999999999999864 788999999875555555678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +++|.+++..     ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+........ 
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            9999998864     3578999999999999999999986   999999999999999999999999999876543222 


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccch
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      ......|++.|+|||...+..++.++||||||+++|||++|+.||....   .....   ...... ......       
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~---~~~~~---~~~~~~-~~~~~~-------  236 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP---PLQAM---KRIRDN-LPPKLK-------  236 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC---HHHHH---HHHHhc-CCCCCc-------
Confidence            2233568999999999988889999999999999999999999985321   11111   111111 000000       


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1011 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ........+.+++.+|++.+|++||++.++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            01112347899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.1e-32  Score=306.86  Aligned_cols=264  Identities=21%  Similarity=0.256  Sum_probs=196.1

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCe-----
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGND-----  841 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  841 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999865 689999998765432  23356788999999995 6999999999887665     


Q ss_pred             EEEEEEeccCCChhhhhhcccCC-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCCeEEeecc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDK-DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFG  919 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG  919 (1052)
                      .|+||||+++ ++.+++...... ...+++..++.++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 788887654322 45689999999999999999999986   9999999999999998 8999999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      .++.+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||....   .......+........
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS---ELQQLLHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHHhCCCC
Confidence            9986543211 1222357889999997754 457899999999999999999999996422   1111111111110000


Q ss_pred             cc---cc---cc----cccc----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          999 EV---EI---ID----ASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       999 ~~---~~---~~----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ..   ..   .+    +...    ....+....++.+++.+|++++|.+||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00   00   00    0000    0001123457889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.9e-32  Score=303.06  Aligned_cols=262  Identities=23%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      +|+..+.||+|++|.||+|+.. +|..||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999875 688999999875432 23456778999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++ ++.+++.... ....+++..+..++.|+++|++|||+.   +++||||||+||++++++.++++|||.+........
T Consensus        81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 7888876533 234689999999999999999999986   999999999999999999999999999976543211


Q ss_pred             eeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc---------
Q 001561          930 HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE---------  999 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------  999 (1052)
                       ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....   ..+....+.........         
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN---NEDQLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCChhhHHHHhcC
Confidence             1223467889999998755 457889999999999999999999996432   12222211111100000         


Q ss_pred             ccccc--c----cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1000 VEIID--A----SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1000 ~~~~~--~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .....  +    .......+.....+.+++.+|++.||.+||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000  0    0001111223457889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.8e-33  Score=300.76  Aligned_cols=247  Identities=25%  Similarity=0.314  Sum_probs=200.9

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      +|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999876 68999999987543   2345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++++|.+++...    ..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++++|||.+......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999988642    4688999999999999999999986   9999999999999999999999999999875432


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      .  ......|+..|+|||...+..++.++|+||+|+++|+|++|+.||...........    ...... . ..      
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~-~-~~------  219 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET-A-DV------  219 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc-c-cc------
Confidence            2  22345688899999999888899999999999999999999999975432211111    111110 0 00      


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFI--EEVV 1041 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 1041 (1052)
                        ..+......+.+++.+|++.||.+||++  +|++
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              1111223578899999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-32  Score=304.39  Aligned_cols=261  Identities=23%  Similarity=0.291  Sum_probs=197.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  845 (1052)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++...  ......+.+|++++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999876 68899999987443  22234567899999999999999999998877  889999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++ +|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.+....
T Consensus        85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999974 888887653   23689999999999999999999986   99999999999999999999999999998765


Q ss_pred             CCCCeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc--------
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE--------  996 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--------  996 (1052)
                      .... ......+++.|+|||.+.+. .++.++|+||+|+++|||++|++||.....   .+....+......        
T Consensus       158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE---IDQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchHHHHH
Confidence            4321 22334678899999987654 468899999999999999999999974321   1111111111000        


Q ss_pred             ---------ccccccccccccchhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          997 ---------KREVEIIDASIWHKDREK-QLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       997 ---------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                               ...............+.. ....+.+++.+|++.+|++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                     000000000000111111 2456889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-32  Score=308.79  Aligned_cols=262  Identities=27%  Similarity=0.329  Sum_probs=197.2

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLL  844 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  844 (1052)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++....  .....+.+|++++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457999999999999999999865 689999999864332  2223466899999999999999999998755  56899


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      ||||+++ +|.+++...   ...+++.++..++.|+++|++|||+.   +++||||||+||++++++.+||+|||.+...
T Consensus        86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999975 788877643   25689999999999999999999996   9999999999999999999999999999876


Q ss_pred             CCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc---
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV--- 1000 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 1000 (1052)
                      .... .......+++.|+|||.+.+ ..++.++||||+|+++|||++|++||....   ..+....+..........   
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~---~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         159 GLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS---EIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCChhhch
Confidence            5432 12223356788999998765 567899999999999999999999996432   222222222211110000   


Q ss_pred             ---------cc-ccccccch---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 ---------EI-IDASIWHK---DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ---------~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                               .. ........   ........+.+++.+|++.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                     00 00000000   00112456789999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.4e-32  Score=301.37  Aligned_cols=256  Identities=26%  Similarity=0.406  Sum_probs=205.8

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ..+.|+..+.||+|++|.||+|... ++..||+|++..... ..+.+.+|++++++++|+|++++++++...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3456888889999999999999876 688999999976544 45678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++++|.+++....   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999998632   3689999999999999999999986   9999999999999999999999999998765432


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      .. ......+++.|+|||++.+..++.++|||||||++|+|++|+.||.....   ....   ...... ......    
T Consensus       170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~---~~~~~~-~~~~~~----  237 (286)
T cd06614         170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRAL---FLITTK-GIPPLK----  237 (286)
T ss_pred             hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhc-CCCCCc----
Confidence            21 22234578899999998888899999999999999999999999853211   1111   111111 111110    


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                         ........+.+++.+|++.+|.+||++.++++  ++++
T Consensus       238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         238 ---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             ---chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence               11113347889999999999999999999986  4444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-32  Score=298.27  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=206.7

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|++.+.||.|+||.||+|... ++.+||+|++.....  ...+++.+|++++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999876 688999999875532  4556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.+++.........+++..+..++.+++.|++|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999987554457799999999999999999999986   99999999999999999999999999998765432


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                       .......|++.|+|||......++.++||||+|+++|+|++|+.||....   ..+....   ... .....       
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~---~~~-~~~~~-------  222 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALK---ILK-GQYPP-------  222 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHH---Hhc-CCCCC-------
Confidence             23334578999999999888889999999999999999999999986321   1111111   111 11101       


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        .+.....++.+++.+|+..+|++||++.|+++
T Consensus       223 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 --IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              01122346889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3e-32  Score=301.14  Aligned_cols=257  Identities=22%  Similarity=0.215  Sum_probs=193.7

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCceeeeeceEeeC--CeEEEEEE
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHG--NDRLLIYS  847 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  847 (1052)
                      |++.+.||+|+||.||+|... ++..||+|+++... ........+|+.++.++. |+|++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999865 68899999987542 222334467888999885 99999999999887  88999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |++ |++.+++...   ...+++.+++.++.|++.||+|||+.   +++||||||+||+++. +.+||+|||.++.....
T Consensus        81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            997 4777777542   34689999999999999999999986   9999999999999999 99999999999876432


Q ss_pred             CCeeeecccccccccCccccC-CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc--------
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR--------  998 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~--------  998 (1052)
                      ..  .....+++.|+|||.+. +..++.++||||+||++|||++|++||....   ..+.+.+.........        
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN---ELDQIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC---HHHHHHHHHHHcCCCCHHHHHhhc
Confidence            22  22346788999999654 4567889999999999999999999996422   2222222222111100        


Q ss_pred             ---cccccccccc----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          999 ---EVEIIDASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       999 ---~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         ......+...    .......+..+.+++.+|++++|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence               0000000000    0011234568999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=302.97  Aligned_cols=260  Identities=23%  Similarity=0.303  Sum_probs=195.8

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      |++.+.||.|++|.||+|... +|..||+|++....  ....+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999865 79999999987543  223356788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      + ++|.+++....  ...+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++|||.+........
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 68988886532  24689999999999999999999986   999999999999999999999999999976543221


Q ss_pred             eeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc---------
Q 001561          930 HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE---------  999 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------  999 (1052)
                       ......+++.|+|||++.+ ..++.++||||||+++|+|++|++||....   ..+....+.........         
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS---EIDQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChHHhhhhhhc
Confidence             1222356889999997755 457889999999999999999999996421   11111111111000000         


Q ss_pred             cc----ccc--ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1000 VE----IID--ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1000 ~~----~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .+    ...  ..............+.+++.+|++++|++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00    000  00000111122357889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-32  Score=306.26  Aligned_cols=264  Identities=27%  Similarity=0.348  Sum_probs=197.9

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----  840 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  840 (1052)
                      ..++|++.+.||+|+||.||+|... +|+.||+|+++...  ......+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567999999999999999999876 68899999987543  223346778999999999999999999987654     


Q ss_pred             -----eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEE
Q 001561          841 -----DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  915 (1052)
Q Consensus       841 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl  915 (1052)
                           ..++|+||+++ ++...+...   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence                 78999999986 666666542   34689999999999999999999986   9999999999999999999999


Q ss_pred             eecccccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001561          916 ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       916 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      +|||.+...............+++.|+|||.+.+ ..++.++|||||||++|||++|++||....   ..+....+....
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~---~~~~~~~~~~~~  234 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ---ELAQLELISRLC  234 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHh
Confidence            9999998765433222233456788999997754 457889999999999999999999996322   222222222211


Q ss_pred             hccccc---ccc--------cccc-----cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          995 SEKREV---EII--------DASI-----WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       995 ~~~~~~---~~~--------~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ......   .+.        +...     ........+..+.+++.+|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111000   000        0000     00001112457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.5e-33  Score=300.61  Aligned_cols=249  Identities=25%  Similarity=0.382  Sum_probs=200.0

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|+..+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++|+||+++++.+.+++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999876 68899999986532  23345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCC-eEEeecccccccCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-AHLADFGLSRLLRPY  927 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~  927 (1052)
                      +++++|.+++...  ....+++..+..++.|+++|++|||+.   +++|+||||+||++++++. +|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998753  234578999999999999999999986   9999999999999998864 699999999876532


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      . .......|++.|+|||+..+..++.++||||||+++|||++|+.||....      ..++........ ....     
T Consensus       156 ~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~~-----  222 (257)
T cd08225         156 M-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGY-FAPI-----  222 (257)
T ss_pred             c-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhccc-CCCC-----
Confidence            2 22233468899999999888889999999999999999999999986321      111222211111 0000     


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                          ......++.+++.+|++.+|++||++.|+++
T Consensus       223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                1122346889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=303.08  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=198.8

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeEEEEEE
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLIYS  847 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  847 (1052)
                      |++.+.||.|++|.||+|... +++.+|+|++....  ......+.+|++++++++|||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999876 58899999998653  33345688999999999999999999999887  78999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+++ +|.+++...   ...+++..++.++.|+++|++|||+.   +++|+||||+||++++++.+|++|||.+......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 788777642   24689999999999999999999986   9999999999999999999999999999876554


Q ss_pred             CCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccc---
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII--- 1003 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1003 (1052)
                      .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....   ..+....+.............   
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST---ELEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCchhhccccc
Confidence            3222334467889999997654 467899999999999999999999996432   122222222211110000000   


Q ss_pred             --------------cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1004 --------------DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1004 --------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                    ..............++.+++.+|++.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                          000000000112557899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=328.63  Aligned_cols=259  Identities=26%  Similarity=0.274  Sum_probs=207.5

Q ss_pred             HHHHHHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEee
Q 001561          763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRH  838 (1052)
Q Consensus       763 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  838 (1052)
                      +.++.-..++|++.++||+|+||.|..++++ +++.||.|++.+..   .....-|..|-++|.....+-|++++..|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4455566789999999999999999999876 68899999987632   2334568889999998899999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       839 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                      ....|+|||||+||+|-..+..+   + .+++..++.++..|+-||.-+|+.   |+|||||||+|||+|..|++|++||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            99999999999999999998753   2 799999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCeeeecccccccccCccccC----C-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHh
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ----T-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM  993 (1052)
Q Consensus       919 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  993 (1052)
                      |.+..+..+..-.....+|||.|.+||++.    + +.|++.+|+||+||++|||+.|..||...      .++...-.+
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KI  293 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKI  293 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHH
Confidence            999988876665666779999999999764    2 57889999999999999999999999631      122111111


Q ss_pred             hhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 001561          994 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF---IEEVVT 1042 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1042 (1052)
                      ........+       +.....++++.++|.+.+. +|+.|-.   +.++-.
T Consensus       294 m~hk~~l~F-------P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  294 MNHKESLSF-------PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hchhhhcCC-------CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            111111111       1122356688899988776 6677776   666654

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-32  Score=299.04  Aligned_cols=249  Identities=24%  Similarity=0.357  Sum_probs=204.0

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|++.+.||+|+||.||+|... +++.+|+|++....  .....++.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999755 78899999987542  23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.+++.........+++..++.++.|+++|++|||+.   +++||||+|+||++++++.+|++|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999876544456789999999999999999999986   9999999999999999999999999999876543 


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                        ......+++.|+|||...+..++.++|+||+|+++|||++|+.||....   ........    .....         
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~~~~----~~~~~---------  218 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS---MQDLRYKV----QRGKY---------  218 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----hcCCC---------
Confidence              2223468889999999988889999999999999999999999996422   11111111    11111         


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .........++.+++.+|++.+|++||++.|+++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1111234457899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-33  Score=313.18  Aligned_cols=266  Identities=26%  Similarity=0.403  Sum_probs=197.5

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC-----CeE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-----NDR  842 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  842 (1052)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999864 78999999986432 23445678899999999999999999987654     357


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++|+||+++ ++.+++.     ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            999999975 7776664     34589999999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCe--eeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc
Q 001561          923 LLRPYDTH--VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  999 (1052)
Q Consensus       923 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      ........  ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||....   .......+.........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~---~~~~~~~~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YLHQLNLILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCH
Confidence            75432211  1223578999999997644 568899999999999999999999996321   11111111111111000


Q ss_pred             c---cccc-------------ccc-cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1000 V---EIID-------------ASI-WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1000 ~---~~~~-------------~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .   .+.+             ... .....+....++.+++.+|++.+|++||++.|+++  +++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            0   0000             000 00001123457889999999999999999999987  45443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-32  Score=304.37  Aligned_cols=255  Identities=27%  Similarity=0.376  Sum_probs=194.6

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999865 68999999987543 344567889999999996 99999999999999999999999


Q ss_pred             ccCCChhhhhhcc-cCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          849 MENGSLDYWLHES-VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       849 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      ++. ++.++.... ......+++..+..++.+++.|++|||+.  .+|+||||||+||+++.++.++|+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 554433211 11235689999999999999999999973  48999999999999999999999999999765432


Q ss_pred             CCeeeecccccccccCccccCCc---CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTL---TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ..  .....|++.|+|||++.+.   .++.++||||+|+++|||++|+.||....     .....+........      
T Consensus       162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~------  228 (288)
T cd06616         162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDP------  228 (288)
T ss_pred             Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCC------
Confidence            21  1233688999999988765   68899999999999999999999996422     11111111111100      


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +..........+.++.+++.+|++.+|++||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111111224457899999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-33  Score=276.35  Aligned_cols=249  Identities=25%  Similarity=0.412  Sum_probs=195.7

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEEEEec
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .+....||.|..|.||+++.+ +|...|||.+.... .+..+++.+.++++.+-+ .|.||+.+|||..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344667999999999999866 68999999987654 344467788888877765 899999999999999999999998


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      .. .++..+..   ...++++..+-++...++.||.||.+-  .+|+|||+||+|||+|+.|.+|+||||.+.++-+...
T Consensus       174 s~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  174 ST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            54 45666654   245688888999999999999999763  5899999999999999999999999999988754332


Q ss_pred             eeeecccccccccCccccCC---cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                        .+..+|-+.|||||.+..   ..|+.++||||||+.++|+.||+.||..+.  .+.+....+..   .++  ...+..
T Consensus       248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln---~eP--P~L~~~  318 (391)
T KOG0983|consen  248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLN---EEP--PLLPGH  318 (391)
T ss_pred             --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHh---cCC--CCCCcc
Confidence              344579999999997754   468889999999999999999999998643  23333433332   111  111111


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            ...+..+.+++..|+.+|+.+||...++++
T Consensus       319 ------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 ------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                  113447899999999999999999998875

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-33  Score=306.47  Aligned_cols=248  Identities=24%  Similarity=0.328  Sum_probs=204.2

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchh--hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      ..+.|.+.+.||+|.|++|..|++. ++..||+|.+++....  ....+.+|+++|..++|||||+++.+.......|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467889999999999999999865 7999999999876532  223488999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+.+|.+++++...    +...+..+..++.|+.+|++|||+.   .|+|||||++||+++++..+||+|||++.++.
T Consensus       134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999853    3455588899999999999999985   99999999999999999999999999999886


Q ss_pred             CCCCeeeecccccccccCccccCCcCC-CcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .  .......+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++..-.+-++               .++-
T Consensus       207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~  269 (596)
T KOG0586|consen  207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLR  269 (596)
T ss_pred             c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hhee
Confidence            3  344556899999999999998776 478999999999999999999998532111100               1111


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ....-++.  ...+..+++++++..+|.+|++++++.+
T Consensus       270 gk~rIp~~--ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  270 GKYRIPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eeecccce--eechhHHHHHHhhccCccccCCHHHhhh
Confidence            11111111  1225679999999999999999999986

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.5e-32  Score=308.87  Aligned_cols=259  Identities=21%  Similarity=0.282  Sum_probs=196.5

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC------
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------  839 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  839 (1052)
                      ..++|+..+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3568999999999999999999865 78999999986432  33345677899999999999999999988643      


Q ss_pred             CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          840 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       840 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                      ...++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            357999999964 77776643      178889999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhh----
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS----  995 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----  995 (1052)
                      .++......  ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.....   .+....+.....    
T Consensus       164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~  238 (353)
T cd07850         164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGTPSD  238 (353)
T ss_pred             cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence            998754321  22345688999999999988999999999999999999999999964221   111111110000    


Q ss_pred             ---------------ccc------cccccccccc----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          996 ---------------EKR------EVEIIDASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       996 ---------------~~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                     ...      ..........    .........++.+++.+|++.||++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                           000      0000000000    0001123456889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7e-33  Score=280.11  Aligned_cols=268  Identities=25%  Similarity=0.304  Sum_probs=201.5

Q ss_pred             cCCcccCeEcccCceEEEEEEECC-----CcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEee-CCeE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH-GNDR  842 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  842 (1052)
                      ..|+.+..||+|.||.||+|...+     ...+|+|+++.+.  ........+|+..++.++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            468999999999999999996432     2368999997552  1223446889999999999999999998877 7788


Q ss_pred             EEEEEeccCCChhhhhhcccC-CccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC----CCeEEee
Q 001561          843 LLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK----FEAHLAD  917 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~----~~~kl~D  917 (1052)
                      ++++||++. +|.+.++.++. ....++...+..|+.||+.|+.|||+.   -|+|||+||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 67777765443 345789999999999999999999996   89999999999999877    9999999


Q ss_pred             cccccccCCCCCe--eeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccC----CC--CchhHHH
Q 001561          918 FGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCK----GK--NCRDLVS  988 (1052)
Q Consensus       918 fG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~----~~--~~~~~~~  988 (1052)
                      ||+|+.+...-..  ....++-|..|+|||.+.+ ..||++.||||.|||+.||+|-++-|.+..    ..  -..+.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999987644222  2345678999999997665 568999999999999999999888885432    11  1123444


Q ss_pred             HHHHhhhcccccccccccccchh-------h-----H----H-------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          989 WVFQMKSEKREVEIIDASIWHKD-------R-----E----K-------QLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~-------~-----~----~-------~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .++...+.....+..+-.-..++       +     .    .       ......+++.+++..||.+|.|+.++++
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            45544433332222221111111       0     0    0       0123679999999999999999999987

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=338.60  Aligned_cols=251  Identities=29%  Similarity=0.399  Sum_probs=202.4

Q ss_pred             hcCCcccCeEcccCceEEEEEE-ECCCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      +-+++....||.|.||.||.|. ..+|+-.|+|.+....  ....+.+.+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3467778899999999999998 4579999999876543  233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      |||++|+|.+.++.    ++..++.....+..|++.|++|||++   |||||||||+||+++.+|.+|.+|||.|..+..
T Consensus      1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999874    55567778888999999999999998   999999999999999999999999999998765


Q ss_pred             CCCe---eeecccccccccCccccCC---cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          927 YDTH---VTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       927 ~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ....   ......||+.|||||++.+   .....++||||+|||+.||+||+.||...     +.-++-++... .+.. 
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~-----dne~aIMy~V~-~gh~- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL-----DNEWAIMYHVA-AGHK- 1459 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc-----cchhHHHhHHh-ccCC-
Confidence            4211   1134689999999998765   34567899999999999999999999632     12222222211 1111 


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                              .+.++..+.+-.+++.+|++.||++|.++.|+++
T Consensus      1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                    1223335557789999999999999999988876

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.5e-32  Score=311.14  Aligned_cols=269  Identities=25%  Similarity=0.373  Sum_probs=201.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEee----CCeE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH----GNDR  842 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  842 (1052)
                      .++|++.+.||+|+||.||+|... +|..||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367999999999999999999865 68999999987543  2334567789999999999999999998763    3467


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+. |+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999996 588888763    34589999999999999999999986   99999999999999999999999999997


Q ss_pred             ccCCCCCe---eeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          923 LLRPYDTH---VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       923 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ........   ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||.....   ......+........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~---~~~~~~~~~~~g~~~  232 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY---VHQLKLILSVLGSPS  232 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh---HHHHHHHHHHhCCCh
Confidence            65432211   1223578999999998755 5688999999999999999999999964321   111111111110000


Q ss_pred             -----------cccc---cc---ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcCc
Q 001561          999 -----------EVEI---ID---ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus       999 -----------~~~~---~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                                 ....   ..   ...+.........++.+++.+|++.+|++||+++++++  ++++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                       0000   00   00001111223567899999999999999999999987  6655443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5e-32  Score=304.44  Aligned_cols=245  Identities=27%  Similarity=0.401  Sum_probs=193.9

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      |+..+.||+|+||.||+|+.. ++..||+|++....   .....++..|++++++++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667888999999999999865 68899999986432   23345688899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++ ++.+.+..   ....+++..+..++.+++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++...... 
T Consensus       107 ~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         107 CLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            975 77776653   244589999999999999999999986   9999999999999999999999999998754322 


Q ss_pred             CeeeecccccccccCccccC---CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                          ....|++.|+|||++.   ...++.++|||||||++|||++|+.||....   .....   ........ .     
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~---~~~~~~~~-~-----  242 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSAL---YHIAQNES-P-----  242 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHH---HHHHhccC-C-----
Confidence                2346888999999863   4568899999999999999999999986321   11111   11111110 0     


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1044 (1052)
                         ..........+.+++.+|++.+|.+||++.++++..
T Consensus       243 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 ---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence               001112334688999999999999999999999843

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1e-31  Score=294.05  Aligned_cols=251  Identities=22%  Similarity=0.253  Sum_probs=192.9

Q ss_pred             cHHHHHHhhcCCcccCeE--cccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEe
Q 001561          762 TVSDLLKSTNNFNQANII--GCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCR  837 (1052)
Q Consensus       762 ~~~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  837 (1052)
                      +..+.....++|++.+.+  |+|+||.||++... ++..+|+|.+.......     .|+.....+ +||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe
Confidence            344555556677777776  99999999999864 68889999986432111     122222222 7999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-CeEEe
Q 001561          838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLA  916 (1052)
Q Consensus       838 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~  916 (1052)
                      .++..++||||+++++|.+++...    ..+++.++..++.|+++|++|||+.   +++||||||+||+++.++ .++++
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence            999999999999999999998742    3789999999999999999999986   999999999999999998 99999


Q ss_pred             ecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc
Q 001561          917 DFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE  996 (1052)
Q Consensus       917 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      |||.++.....     ....|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ..+...+.... . 
T Consensus       153 dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~-  224 (267)
T PHA03390        153 DYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-Q-  224 (267)
T ss_pred             cCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-c-
Confidence            99998765432     1246889999999999888999999999999999999999999733221 11111111111 1 


Q ss_pred             ccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 001561          997 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF-IEEVVT 1042 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1042 (1052)
                      .. ..         ........+.+++.+|++.+|.+||+ ++|+++
T Consensus       225 ~~-~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 KK-LP---------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cc-CC---------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            00 00         01123447899999999999999996 688875

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.5e-32  Score=300.39  Aligned_cols=267  Identities=23%  Similarity=0.308  Sum_probs=197.8

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ++|++.+.||+|++|+||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999875 78899999886442  2233567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCCeEEeecccccccCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~~  926 (1052)
                      |++ +++.+++...  ....+++..+..++.|++.||+|||+.   +++||||+|+||++++ ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 4777776542  233467888899999999999999986   9999999999999985 56799999999976543


Q ss_pred             CCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccc----
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE---- 1001 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---- 1001 (1052)
                      .. .......+++.|+|||++.+ ..++.++||||+|+++|+|+||++||....   ..+................    
T Consensus       156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS---EIDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChhhcccc
Confidence            21 11233467889999998765 457889999999999999999999996422   1111111111111100000    


Q ss_pred             --ccc---------ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1002 --IID---------ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1002 --~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                        ..+         .............++.+++.+|++.+|++||++.++++  ++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence              000         00000001123446889999999999999999999987  55544

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-32  Score=300.13  Aligned_cols=259  Identities=24%  Similarity=0.311  Sum_probs=199.9

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      |++.+.||+|++|.||+|... +++.+|+|++.....  .....+.+|++++++++|+||+++++++.+++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999865 788999999875432  24567888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      ++ ++.+++...   ...+++..+..++.|++.|++|||+.   +|+|+||||+||++++++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 787777652   35689999999999999999999986   99999999999999999999999999998765433 


Q ss_pred             eeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcc---cc------
Q 001561          930 HVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK---RE------  999 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---~~------  999 (1052)
                      .......++..|+|||...+. .++.++||||+|+++|+|++|+.||....   ..+............   ..      
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS---EIDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCchHhcccchhh
Confidence            122334678899999987766 78999999999999999999999996422   111111111110000   00      


Q ss_pred             -----cccccc--cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1000 -----VEIIDA--SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1000 -----~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                           ......  ............++.+++.+|+++||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                 000000  0001112234568899999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.8e-32  Score=298.01  Aligned_cols=241  Identities=27%  Similarity=0.330  Sum_probs=186.2

Q ss_pred             eEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHh---cCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          778 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSR---AQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       778 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      +||+|+||.||+|... +++.||+|.+.....   .....+.+|..+++.   .+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999865 688999998865321   222334445444443   479999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +|+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++.......  
T Consensus        81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            9999988864    34589999999999999999999986   99999999999999999999999999997654321  


Q ss_pred             eeecccccccccCccccC-CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       .....|++.|+|||... +..++.++||||+||++|||++|+.||.......... .....   . ..     ..    
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~---~-~~-----~~----  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMT---L-TV-----NV----  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHh---h-cC-----Cc----
Confidence             12346899999999876 4568899999999999999999999996433222111 11110   0 00     00    


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                      ..+.....++.+++.+|++.||++||     +++|+++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            11122345788999999999999999     5999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.4e-33  Score=326.61  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=186.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--------
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--------  839 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  839 (1052)
                      ..+|+..++||+||||.|||++.+ ||..||||++.... ......+.+|+..+++++|||||+++..+.+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            356888899999999999999977 89999999997553 33345688999999999999999998431000        


Q ss_pred             --------------------------------------------------------------------------------
Q 001561          840 --------------------------------------------------------------------------------  839 (1052)
Q Consensus       840 --------------------------------------------------------------------------------  839 (1052)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHH
Q 001561          840 -------------------------------NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH  888 (1052)
Q Consensus       840 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  888 (1052)
                                                     ...||-||||+...+.+++++.....   .....++++.+|++||+|+|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence                                           11367788888887777776532111   45788999999999999999


Q ss_pred             hcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC-----------------CCCeeeecccccccccCccccCCc-
Q 001561          889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP-----------------YDTHVTTDLVGTLGYIPPEYSQTL-  950 (1052)
Q Consensus       889 ~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~~-  950 (1052)
                      ++   +||||||||.||++|+++.|||+|||+|+....                 ......+..+||.-|+|||++.+. 
T Consensus       715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            97   999999999999999999999999999987210                 001122456899999999987665 


Q ss_pred             --CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHccc
Q 001561          951 --TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCID 1028 (1052)
Q Consensus       951 --~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 1028 (1052)
                        .|+.|+|+||+|||++||+.   ||..     ..+.+..+.... .......  +.++    ......-..+|.+|++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa~iL~~LR-~g~iP~~--~~f~----~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERASILTNLR-KGSIPEP--ADFF----DPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCc-----hHHHHHHHHhcc-cCCCCCC--cccc----cccchHHHHHHHHHhc
Confidence              49999999999999999995   5642     222222222211 1111111  1111    1122234689999999


Q ss_pred             CCCCCCCCHHHHHH
Q 001561         1029 QDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1029 ~dP~~RPs~~evl~ 1042 (1052)
                      .||.+|||+.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999986

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-32  Score=310.29  Aligned_cols=265  Identities=23%  Similarity=0.325  Sum_probs=199.2

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeeeceEeeC-----Ce
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-----ND  841 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  841 (1052)
                      .++|.+.+.||+|+||+||+|+.. ++..||+|.+...  .......+.+|+.++++++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357899999999999999999865 7899999998753  223345677899999999999999999988654     34


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a  921 (1052)
                      .++|+||+. ++|.+++..    ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 678777753    34689999999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc--
Q 001561          922 RLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR--  998 (1052)
Q Consensus       922 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~--  998 (1052)
                      ....... .......++..|+|||.+.. ..++.++||||||+++|+|++|++||.....   ...............  
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY---VHQLKLITELLGSPSEE  231 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCChH
Confidence            8764322 22334568889999997654 5688999999999999999999999964221   111111111100000  


Q ss_pred             -c--------ccc-------ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561          999 -E--------VEI-------IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus       999 -~--------~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                       .        ...       ..... .........++.+++.+|++.+|++||+++|+++  +++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence             0        000       00000 0011223457889999999999999999999987  46554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-31  Score=291.10  Aligned_cols=250  Identities=30%  Similarity=0.431  Sum_probs=203.9

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDRLLIY  846 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  846 (1052)
                      +|+..+.||+|++|.||+|... ++..|++|++.....  ...+.+.+|++++++++||||+++++.+.+.  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999876 789999999875542  4456789999999999999999999999988  8899999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++++|.+++...    ..+++..+..++.|+++|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999998753    2789999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCe-eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          927 YDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       927 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .... ......++..|+|||.......+.++||||||+++|+|++|+.||....     +..............      
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~------  222 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP------  222 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC------
Confidence            3321 1234578899999999988889999999999999999999999996432     111111111110111      


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         ...+......+.+++.+|++.+|.+||++.|+++
T Consensus       223 ---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 ---PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               1111222457899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.4e-32  Score=299.54  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=198.5

Q ss_pred             cCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          776 ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      ..+||+|+||.||+|... +++.||+|++........+.+.+|+.++++++|+|++++++++..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            356999999999999864 7899999998755555566789999999999999999999999999999999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeec
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  934 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  934 (1052)
                      .+++..     ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||.+....... .....
T Consensus       105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~  175 (292)
T cd06657         105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS  175 (292)
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence            987743     3478899999999999999999986   99999999999999999999999999987654322 12233


Q ss_pred             ccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHH
Q 001561          935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014 (1052)
Q Consensus       935 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1052)
                      ..|++.|+|||...+..++.++||||+|+++|||++|+.||....   .............    ..     ..  ....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~---~~~~~~~~~~~~~----~~-----~~--~~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLP----PK-----LK--NLHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhCC----cc-----cC--Cccc
Confidence            568899999999888888999999999999999999999986321   1111111111110    00     00  0011


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561         1015 QLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1015 ~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                      ....+.+++.+|++.+|.+||++.++++  ++..
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~  275 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  275 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhc
Confidence            2336789999999999999999999987  4443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-32  Score=308.89  Aligned_cols=268  Identities=25%  Similarity=0.345  Sum_probs=206.1

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----eEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----DRL  843 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  843 (1052)
                      +|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788999999999999999875 58999999987643  344567899999999999999999999988765     789


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      +||||+++ +|.+++..    ...+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+..
T Consensus        81 lv~e~~~~-~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999984 78887764    33789999999999999999999986   999999999999999999999999999987


Q ss_pred             cCCCCC--eeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          924 LRPYDT--HVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       924 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ......  .......+++.|+|||++.+. .++.++||||+|+++|+|++|++||....   ..+....+..........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD---YIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC---HHHHHHHHHHhcCCCChh
Confidence            654321  123345688899999998877 78999999999999999999999996432   111122111111100000


Q ss_pred             -----------cccc------ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcCcc
Q 001561         1001 -----------EIID------ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1050 (1052)
Q Consensus      1001 -----------~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~ 1050 (1052)
                                 ....      ...+..........+.+++.+|++.+|.+||++.++++  +++++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                       0000      00000011123457889999999999999999999998  67776543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-31  Score=293.53  Aligned_cols=247  Identities=23%  Similarity=0.319  Sum_probs=197.8

Q ss_pred             EcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      ||+|++|.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999876 58899999987543   23456789999999999999999999999999999999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeec
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  934 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  934 (1052)
                      .+++...    ..+++..+..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||.+.......  ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            9998752    3488999999999999999999986   99999999999999999999999999998764332  2233


Q ss_pred             ccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHH
Q 001561          935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014 (1052)
Q Consensus       935 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1052)
                      ..|++.|+|||......++.++|+||+|+++|+|++|+.||...... ..+..   .........         ...+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~---~~~~~~~~~---------~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIY---NDILKGNGK---------LEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHH---HHHhccCCC---------CCCCcc
Confidence            57889999999988888999999999999999999999999643221 11111   111110000         011111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHH--HHhhc
Q 001561         1015 QLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDGI 1047 (1052)
Q Consensus      1015 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~--~L~~i 1047 (1052)
                      ....+.+++.+|++.+|++||+     +.|+++  ++.+.
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence            2447899999999999999999     788876  55443

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.98  E-value=4.1e-32  Score=304.52  Aligned_cols=266  Identities=24%  Similarity=0.294  Sum_probs=193.1

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC------
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  840 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  840 (1052)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999865 68999999886432  222334678999999999999999999987654      


Q ss_pred             --eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          841 --DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       841 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                        ..++||||+++ ++.+++..   ....+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence              34999999965 77777654   234689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCe---eeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001561          919 GLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       919 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      |.+.........   ......++..|+|||...+. .++.++||||||+++|||++|++||..............+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999876432211   12234678899999977554 47889999999999999999999996432211111111111000


Q ss_pred             hccccccc-----cc-----ccccchhh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          995 SEKREVEI-----ID-----ASIWHKDR-----EKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       995 ~~~~~~~~-----~~-----~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ........     .+     ........     ......+.+++.+|++.||++||+++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000000     00     00000000     001235679999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=3.5e-32  Score=308.65  Aligned_cols=268  Identities=25%  Similarity=0.343  Sum_probs=199.3

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeC--CeE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHG--NDR  842 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  842 (1052)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888999999999999999865 68899999885432  23334577899999999 999999999998654  367


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||++ ++|..++..    . .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||.+.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----N-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999997 588887754    2 678899999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCC----eeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcc
Q 001561          923 LLRPYDT----HVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       923 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      .......    .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.....   .+....+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~---~~~~~~~~~~~~~~  232 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST---LNQLEKIIEVIGPP  232 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC
Confidence            7643322    12234578999999997654 5678899999999999999999999964221   11111111110000


Q ss_pred             c-----------cccccc----ccc--cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561          998 R-----------EVEIID----ASI--WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus       998 ~-----------~~~~~~----~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                      .           .....+    ...  ..........++.+++.+|++.+|++||++.++++  +++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence            0           000000    000  00001113457899999999999999999999997  565553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.9e-32  Score=294.65  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=196.2

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--CeE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-----CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--NDR  842 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  842 (1052)
                      .+|++.+.||+|+||.||+|... ++..||+|.+...     .....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999865 6899999987532     123345788999999999999999999998764  457


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++|+||+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.++
T Consensus        82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            899999999999998864    23478899999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCC--CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          923 LLRPYD--THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       923 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ......  ........|+..|+|||...+..++.++||||||+++|||++|+.||...   +.....   ......... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~---~~~~~~~~~-  227 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY---EAMAAI---FKIATQPTK-  227 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc---CHHHHH---HHHHcCCCC-
Confidence            654211  11122356899999999998888999999999999999999999999632   111111   111111100 


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                              ...+.....++.+++.+|++ +|..||++.+++.
T Consensus       228 --------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 --------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                    01122334578999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=8.4e-32  Score=296.65  Aligned_cols=244  Identities=26%  Similarity=0.347  Sum_probs=192.3

Q ss_pred             EcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      ||+|+||+||+|... +|+.||+|.+....   ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999754 68999999986432   22234567899999999999999999999999999999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeec
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  934 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  934 (1052)
                      .+++....  ...+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||.+......  .....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG  153 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence            99987542  24689999999999999999999986   9999999999999999999999999999765432  22233


Q ss_pred             ccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHH
Q 001561          935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014 (1052)
Q Consensus       935 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1052)
                      ..++..|+|||+..+..++.++||||+|+++|+|++|+.||.............   ......      .    ...+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~------~----~~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTLEM------A----VEYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hccccc------c----ccCCcc
Confidence            467889999999888889999999999999999999999996432211111110   000000      0    001112


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1015 QLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1015 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                      ....+.+++.+|++.+|++||     ++.++++
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            244788999999999999999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.2e-31  Score=289.16  Aligned_cols=247  Identities=28%  Similarity=0.453  Sum_probs=201.8

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|++.+.||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++|||++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999865 678999999876543  3456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +++++|.+++...    ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999988743    5689999999999999999999986   99999999999999999999999999998765433


Q ss_pred             CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .. .....++..|+|||...+..++.++||||+|+++|+|++|+.||....   .....   ..... ..... +     
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---~~~~~---~~~~~-~~~~~-~-----  219 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN---PMAAL---FRIVQ-DDHPP-L-----  219 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc---HHHHH---HHHhc-cCCCC-C-----
Confidence            21 233568889999999888788999999999999999999999986321   11111   11111 10000 1     


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         +......+.+++.+|+..+|++||++.|++.
T Consensus       220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               1122347889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=1.7e-31  Score=301.58  Aligned_cols=264  Identities=22%  Similarity=0.286  Sum_probs=194.7

Q ss_pred             eEccc--CceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCC
Q 001561          778 IIGCG--GFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  852 (1052)
Q Consensus       778 ~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  852 (1052)
                      .||+|  +||+||+|... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999864 79999999987432  333467889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe--
Q 001561          853 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--  930 (1052)
Q Consensus       853 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--  930 (1052)
                      ++.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+.........  
T Consensus        85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999887643  23588999999999999999999986   9999999999999999999999999865433211110  


Q ss_pred             ee----ecccccccccCccccCC--cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh----------
Q 001561          931 VT----TDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK----------  994 (1052)
Q Consensus       931 ~~----~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~----------  994 (1052)
                      ..    ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......  ...........          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence            00    01234567999998865  34788999999999999999999999643211  11111000000          


Q ss_pred             ----------------------hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561          995 ----------------------SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus       995 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                                            .........+..............+.+++.+|++.||++|||++|+++  ++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                  000000011111111223345668899999999999999999999986  666554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=1.7e-31  Score=296.67  Aligned_cols=256  Identities=18%  Similarity=0.244  Sum_probs=181.9

Q ss_pred             hcCCcccCeEcccCceEEEEEEECC----CcEEEEEEecCCchhh--H---------HHHHHHHHHHHhcCCCceeeeec
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDCGQM--E---------REFQAEVEALSRAQHKNLVSLQG  834 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l~~  834 (1052)
                      .++|++.+.||+|+||+||+|...+    +..+|+|.........  +         .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3579999999999999999998764    3456666543222111  1         11223344555678999999999


Q ss_pred             eEeeCC----eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC
Q 001561          835 YCRHGN----DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK  910 (1052)
Q Consensus       835 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~  910 (1052)
                      ++....    ..++++|++.. ++.+.+..    ....++..+..++.|+++|++|||+.   +|+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            765543    33677776643 45554432    22356788899999999999999986   99999999999999999


Q ss_pred             CCeEEeecccccccCCCCCe------eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCch
Q 001561          911 FEAHLADFGLSRLLRPYDTH------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR  984 (1052)
Q Consensus       911 ~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~  984 (1052)
                      +.++|+|||+|+.+......      ......||+.|+|||+..+..++.++|||||||++|||++|+.||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999876432211      112346999999999999999999999999999999999999999754221110


Q ss_pred             -hH--HHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561          985 -DL--VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus       985 -~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                       ..  .++........         ..   .......+.+++..|+..+|++||+++++.+.|+
T Consensus       243 ~~~~~~~~~~~~~~~~---------~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLHEGK---------IK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhhhhh---------hc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence             00  01111111100         00   0112347889999999999999999999998763

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=9.7e-32  Score=293.92  Aligned_cols=244  Identities=26%  Similarity=0.326  Sum_probs=194.1

Q ss_pred             EcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      ||+|+||.||+|... +|+.||+|++.....   ...+.+.+|++++++++||||+++++.+.++...++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 589999999875533   3456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC-----
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT-----  929 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----  929 (1052)
                      .+++...    ..+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9998752    3689999999999999999999986   999999999999999999999999999876433211     


Q ss_pred             --eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          930 --HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       930 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                        .......++..|+|||.......+.++||||||+++||+++|+.||....   ..........    ... ..  +  
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~----~~~-~~--~--  221 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILN----GKI-EW--P--  221 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhc----CCc-CC--C--
Confidence              12234568889999999888889999999999999999999999996322   1122211111    000 00  0  


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1044 (1052)
                         ........+.+++.+|++.+|++||++.++.+.|
T Consensus       222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         222 ---EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ---ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence               0001235788999999999999999995554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=1.3e-31  Score=297.09  Aligned_cols=255  Identities=24%  Similarity=0.301  Sum_probs=198.2

Q ss_pred             CCcccCeEcccCceEEEEEEEC----CCcEEEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC----GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  842 (1052)
                      +|++.+.||+|++|.||+|...    +++.||||.++...    ....+.+..|++++.++ +||+|+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999743    56889999987432    22335678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+++|+|.+++..    ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++++|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            999999999999988864    34588999999999999999999986   99999999999999999999999999988


Q ss_pred             ccCCCCCeeeecccccccccCccccCCcC--CCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLT--ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ..............|++.|+|||...+..  .+.++||||||+++|||++|+.||.......  .............   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~---  228 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK---  228 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC---
Confidence            75443322233456899999999876654  7889999999999999999999985321111  1111111111100   


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                          .    ..+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       229 ----~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 ----P----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----C----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                0    0111123467899999999999999999888776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=2.1e-31  Score=299.25  Aligned_cols=265  Identities=19%  Similarity=0.204  Sum_probs=194.1

Q ss_pred             cCeEcccCceEEEEEEECCCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCC
Q 001561          776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS  853 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  853 (1052)
                      .+.+|.|+++.||++.. +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            33445555555555544 6899999998754  34455679999999999999999999999999999999999999999


Q ss_pred             hhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC----
Q 001561          854 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT----  929 (1052)
Q Consensus       854 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----  929 (1052)
                      +.+++....  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+|++|||.+........    
T Consensus        86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999987642  33578899999999999999999986   999999999999999999999999999876532211    


Q ss_pred             --eeeecccccccccCccccCC--cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc----cc---
Q 001561          930 --HVTTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----KR---  998 (1052)
Q Consensus       930 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----~~---  998 (1052)
                        .......++..|+|||++..  ..++.++|||||||++|||++|+.||....  ......+........    ..   
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP--ATQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCccccccCchhh
Confidence              11123457789999998765  357889999999999999999999996422  111111111100000    00   


Q ss_pred             ---ccc-----ccccc----ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561          999 ---EVE-----IIDAS----IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus       999 ---~~~-----~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                         ...     ..+..    ...........++.+++.+|++.+|++||+++|+++  ++..+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence               000     00000    001112233457889999999999999999999998  666554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=1.9e-31  Score=296.10  Aligned_cols=251  Identities=25%  Similarity=0.329  Sum_probs=195.9

Q ss_pred             CCcccCeEcccCceEEEEEEE----CCCcEEEEEEecCCch----hhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeE
Q 001561          772 NFNQANIIGCGGFGLVYKATL----TNGTKAAVKRLSGDCG----QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  842 (1052)
                      +|++.+.||+|+||.||+|..    .+|..||+|++.....    ...+.+.+|+++++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    3688999999875322    2345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+++++|.+++..    ...+++..+..++.|+++|++|||+.   +++||||||+||++++++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            999999999999999874    34578899999999999999999986   99999999999999999999999999998


Q ss_pred             ccCCCCCeeeecccccccccCccccCCc--CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          923 LLRPYDTHVTTDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ..............|+..|+|||.....  .++.++||||||+++|+|++|+.||........  .............  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~--  229 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEP--  229 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccCC--
Confidence            7644332333345789999999987653  467899999999999999999999963221111  1111111111100  


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                      .         .+......+.+++.+|++.+|++||     ++.+++.
T Consensus       230 ~---------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 P---------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             C---------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            0         1111234678999999999999997     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=3.2e-31  Score=293.65  Aligned_cols=259  Identities=24%  Similarity=0.325  Sum_probs=195.6

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeeeeceEeeCCe-----
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRA---QHKNLVSLQGYCRHGND-----  841 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  841 (1052)
                      |++.+.||+|+||.||+|... ++..||+|++.....  .....+.+|+.+++++   +|||++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999976 589999999874322  2234566788777666   59999999999988776     


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a  921 (1052)
                      .+++|||+++ ++.+++....  ...+++..++.++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||.+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999974 7888876532  23589999999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc-
Q 001561          922 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV- 1000 (1052)
Q Consensus       922 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 1000 (1052)
                      ........  .....++..|+|||++.+..++.++||||||+++|||++|++||....   ..+....+.......... 
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS---EADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC---hHHHHHHHHHHcCCCChHh
Confidence            87643221  123457889999999988889999999999999999999999986422   222222222111100000 


Q ss_pred             ---------ccccccc---cchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 ---------EIIDASI---WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ---------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                               .......   ...........+.+++.+|++.||.+||++.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                     0000000   01111233467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=8.9e-32  Score=305.61  Aligned_cols=263  Identities=24%  Similarity=0.337  Sum_probs=195.5

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC------C
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------N  840 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  840 (1052)
                      ..+|...+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999864 78999999987532  22335678999999999999999999998654      3


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..++|+||+.. ++..+.      +..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            46899999964 665543      23578999999999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc-
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR-  998 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-  998 (1052)
                      ++.....    .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....   .......+....+... 
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~  236 (342)
T cd07879         164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPGP  236 (342)
T ss_pred             CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCH
Confidence            9764321    223467889999998765 468899999999999999999999996421   1111111111000000 


Q ss_pred             ----------cccccc--cccc----chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcCc
Q 001561          999 ----------EVEIID--ASIW----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus       999 ----------~~~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                                ......  +...    ..........+.+++.+|++.||++||+++|+++  +++..+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                      000000  0000    0000112346789999999999999999999995  6777654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=1.9e-31  Score=294.86  Aligned_cols=259  Identities=24%  Similarity=0.334  Sum_probs=195.7

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEEEEec
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      |++.+.||+|++|+||+|... +++.||+|++..... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999876 578899999875432 22334567999999999 999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                       +|++.+++....  ...+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++|+|||.+....... 
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence             889988886532  34689999999999999999999986   99999999999999999999999999998764322 


Q ss_pred             eeeecccccccccCccccC-CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhc------------
Q 001561          930 HVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE------------  996 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~------------  996 (1052)
                       ......++..|+|||+.. ...++.++|+||||+++|||++|++||.....   .+...........            
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE---IDQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh---HHHHHHHHHhcCCCChhhhhhHhhh
Confidence             123356888999999764 45678999999999999999999999854321   1111111110000            


Q ss_pred             -ccccccccc---cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          997 -KREVEIIDA---SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       997 -~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                       .........   .............+.+++.+|++.+|++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             000000000   0000111112357899999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=2e-31  Score=296.62  Aligned_cols=251  Identities=27%  Similarity=0.433  Sum_probs=193.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ++|++.+.||+|+||.||+|.+. +++.||||++.... .....++.+|++++.+.. ||||+++++++.++...++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            46888999999999999999976 48999999987543 233455677787777775 9999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |++ +++.+++...   ...+++..+..++.|++.|++|||+.  ++|+||||+|+||++++++.+||+|||.+..+...
T Consensus        95 ~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            985 4676666542   34689999999999999999999973  48999999999999999999999999999765432


Q ss_pred             CCeeeecccccccccCccccCCcC----CCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLT----ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ..  .....+++.|+|||.+.+..    ++.++||||||+++|||++|+.||....  ...+....+.   ... .....
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~---~~~-~~~~~  240 (296)
T cd06618         169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK--TEFEVLTKIL---QEE-PPSLP  240 (296)
T ss_pred             Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch--hHHHHHHHHh---cCC-CCCCC
Confidence            21  22335788999999876543    7889999999999999999999996321  1111111111   111 00000


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .       ......++.+++.+|++.||++||++.++++
T Consensus       241 ~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         241 P-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             C-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0       0012347899999999999999999999987

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1.5e-31  Score=300.02  Aligned_cols=263  Identities=25%  Similarity=0.318  Sum_probs=193.2

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeeeeceEeeCC------
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  840 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  840 (1052)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999865 688999998864322  12345678999999999999999999875433      


Q ss_pred             --eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeec
Q 001561          841 --DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       841 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~Df  918 (1052)
                        ..++|+||+++ ++...+..   ....+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              46999999975 56665543   244689999999999999999999986   9999999999999999999999999


Q ss_pred             ccccccCCCCCe----------eeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHH
Q 001561          919 GLSRLLRPYDTH----------VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV  987 (1052)
Q Consensus       919 G~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~  987 (1052)
                      |+++........          ......+++.|+|||...+ ..++.++||||||+++|||++|++||.....   ....
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~---~~~~  236 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD---IDQL  236 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence            999865432211          1123467889999997654 4578999999999999999999999964222   1211


Q ss_pred             HHHHHhhhcccc---------cccc----cccccc---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          988 SWVFQMKSEKRE---------VEII----DASIWH---KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       988 ~~~~~~~~~~~~---------~~~~----~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +.+.........         ....    ......   .........+.+++.+|++.+|++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            111111110000         0000    000000   000112256889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-31  Score=304.08  Aligned_cols=270  Identities=23%  Similarity=0.297  Sum_probs=200.5

Q ss_pred             ccHHHHHHhhcCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEe
Q 001561          761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCR  837 (1052)
Q Consensus       761 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  837 (1052)
                      ....++...+++|++.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|++++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            34456667789999999999999999999975 478999999987542  223456788999999999999999999886


Q ss_pred             eC------CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC
Q 001561          838 HG------NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF  911 (1052)
Q Consensus       838 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~  911 (1052)
                      ..      ...+++++++ +++|.+++..     ..+++..+..++.|+++|++|||+.   +|+||||||+||++++++
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence            43      3467888876 7888887753     3488999999999999999999986   999999999999999999


Q ss_pred             CeEEeecccccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001561          912 EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  990 (1052)
Q Consensus       912 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~  990 (1052)
                      .+||+|||+++.....    .....+++.|+|||...+ ..++.++||||||+++|||++|+.||.....   ......+
T Consensus       158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~---~~~~~~~  230 (345)
T cd07877         158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLI  230 (345)
T ss_pred             CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH
Confidence            9999999999764321    233568889999998765 5678899999999999999999999953221   1111111


Q ss_pred             HHhhhccc---cccccc--------------ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 001561          991 FQMKSEKR---EVEIID--------------ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus       991 ~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                      ........   ...+.+              .............++.+++.+|++.||.+||++.++++  ++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence            11100000   000000              00000000012346889999999999999999999987  4443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-31  Score=288.27  Aligned_cols=241  Identities=24%  Similarity=0.290  Sum_probs=185.7

Q ss_pred             CeEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHH-HhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          777 NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEAL-SRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||.||+|... +|+.||+|++.....   .....+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999865 688999999875432   1222344454444 445899999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      ++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++++|||+++....     
T Consensus        82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            999999864    34588999999999999999999986   999999999999999999999999999876432     


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                      .....|++.|+|||...+..++.++||||+|+++|||++|..||....   .........   .....   ...    ..
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~---~~~~~---~~~----~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET---PDAVFDNIL---SRRIN---WPE----EV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH---hcccC---CCC----cc
Confidence            223468889999999888888999999999999999999999996322   112111111   10000   000    01


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1012 REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1012 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .......+.+++.+|++.+|++||++.++.+
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            1123457899999999999999997654433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.8e-31  Score=298.67  Aligned_cols=244  Identities=27%  Similarity=0.399  Sum_probs=192.3

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD---CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .|+..+.||+|+||.||+|+.. ++..||+|.+...   ......++.+|+++++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999865 6788999988642   22334567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      |+. |++.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++......
T Consensus        96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            996 5777766532   34578999999999999999999986   9999999999999999999999999998765432


Q ss_pred             CCeeeecccccccccCccccC---CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                           ....|++.|+|||.+.   ...++.++|||||||++|||++|+.||....   ..+   ......... ....  
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~---~~~~~~~~~-~~~~--  234 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMS---ALYHIAQNE-SPAL--  234 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc---HHH---HHHHHhhcC-CCCc--
Confidence                 2346888999999864   3567889999999999999999999985321   111   111111110 0000  


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            ........+.+++.+|++.+|++||++.++++
T Consensus       235 ------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~  266 (308)
T cd06634         235 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (308)
T ss_pred             ------CcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence                  01123346889999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=8.2e-31  Score=293.89  Aligned_cols=243  Identities=28%  Similarity=0.390  Sum_probs=191.4

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      |...+.||+|+||+||+|+.. +++.||+|++....   ......+.+|++++++++|||++++++++.+++..|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555677999999999999865 68899999986432   23335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +. |++.+++..   ....+++.++..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||.+.....  
T Consensus       103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 567776654   234689999999999999999999986   999999999999999999999999999865322  


Q ss_pred             CeeeecccccccccCccccC---CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYSQ---TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                         .....|+..|+|||++.   ...++.++||||||+++|||++|+.||....   ........   ..... ....  
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~---~~~~~~~~---~~~~~-~~~~--  241 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHI---AQNDS-PTLQ--  241 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHH---HhcCC-CCCC--
Confidence               12356889999999874   4568889999999999999999999985321   11111111   11110 0100  


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            .......+.+++.+|++.+|.+||++.++++
T Consensus       242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  1112236889999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=3.4e-31  Score=291.86  Aligned_cols=241  Identities=27%  Similarity=0.340  Sum_probs=185.6

Q ss_pred             eEcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHH---HHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          778 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVE---ALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       778 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      +||+|+||.||+|... +++.||+|.+.....   .....+..|..   .++...||+|+++++++.+++..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 688999998865421   11222334433   4444579999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +|+|.+++..    ...+++..+..++.|+++|++|||+.   +|+||||||+||++++++.++|+|||++.......  
T Consensus        81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            9999988863    34689999999999999999999986   99999999999999999999999999997654322  


Q ss_pred             eeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          931 VTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       .....|+..|+|||++.+. .++.++||||+|+++|||++|+.||........... ....  ..       .....  
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~--~~-------~~~~~--  218 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMT--LT-------MAVEL--  218 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHh--hc-------cCCCC--
Confidence             2234789999999988644 688999999999999999999999964322111111 1000  00       00111  


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1042 (1052)
                        +...+.++.+++.+|+..+|.+||     ++.|+++
T Consensus       219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              111234788999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=2.3e-31  Score=293.68  Aligned_cols=248  Identities=24%  Similarity=0.364  Sum_probs=200.7

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  845 (1052)
                      ++|++.+.||+|+||.||+|... ++..||+|++....   ....+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888999999999999999865 78999999987532   234467889999999998 99999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++++|.+++..    ...+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999999875    33689999999999999999999986   99999999999999999999999999998764


Q ss_pred             CCCC-------------------eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhH
Q 001561          926 PYDT-------------------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDL  986 (1052)
Q Consensus       926 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~  986 (1052)
                      ....                   .......++..|+|||......++.++||||+|++++++++|+.||....   ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~  230 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLT  230 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHH
Confidence            3321                   11223467899999999888889999999999999999999999996322   1111


Q ss_pred             HHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 001561          987 VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFI----EEVVT 1042 (1052)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 1042 (1052)
                      .+...   ....           ..+......+.+++.+|++.+|.+||++    .|+++
T Consensus       231 ~~~~~---~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 FQKIL---KLEY-----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHH---hcCC-----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11111   0000           0111123468899999999999999999    77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=3.1e-31  Score=300.71  Aligned_cols=261  Identities=22%  Similarity=0.226  Sum_probs=195.0

Q ss_pred             cCCc-ccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhh--------------HHHHHHHHHHHHhcCCCceeeeec
Q 001561          771 NNFN-QANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--------------EREFQAEVEALSRAQHKNLVSLQG  834 (1052)
Q Consensus       771 ~~~~-~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  834 (1052)
                      ++|. +.+.||+|+||+||+|... +++.||+|++.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 4577999999999999865 78999999886432211              124778999999999999999999


Q ss_pred             eEeeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeE
Q 001561          835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH  914 (1052)
Q Consensus       835 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~k  914 (1052)
                      ++..++..++||||++ |+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999997 588888753    34588999999999999999999986   999999999999999999999


Q ss_pred             EeecccccccCCC-------------CCeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCC
Q 001561          915 LADFGLSRLLRPY-------------DTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKG  980 (1052)
Q Consensus       915 l~DfG~a~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~  980 (1052)
                      ++|||.+......             .........+++.|+|||.+.+. .++.++||||+|+++|||++|++||.... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~-  238 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN-  238 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence            9999999865411             01111233568899999987654 46889999999999999999999996422 


Q ss_pred             CCchhHHHHHHHhhhcccccccc-----------cc---cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          981 KNCRDLVSWVFQMKSEKREVEII-----------DA---SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        ..+....+.............           ..   ............++.+++.+|++.+|++||+++|++.
T Consensus       239 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        239 --EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             --HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence              222222222211111100000           00   0000001122457889999999999999999999986

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.4e-31  Score=291.89  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=196.1

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-----CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      +|.+.+.||+|+||.||+|... .+..+++|..+..     ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999865 3444555554421     122334577899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+++++|.+++.........+++..++.++.|+++|++|||+.   +++|+||||+||++++ +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999999876554566799999999999999999999986   9999999999999985 579999999997764


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ... .......|++.|+|||......++.++|+||||+++|+|++|..||...   .   ........... ..     +
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~---~---~~~~~~~~~~~-~~-----~  223 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---N---FLSVVLRIVEG-PT-----P  223 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc---c---HHHHHHHHHcC-CC-----C
Confidence            322 2223356888999999988888899999999999999999999998521   1   11111111111 00     0


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                          ..+.....++.+++.+|++.+|++||++.|+++
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                112233457889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.6e-31  Score=301.28  Aligned_cols=265  Identities=23%  Similarity=0.351  Sum_probs=196.8

Q ss_pred             HHHHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEee-CC
Q 001561          765 DLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH-GN  840 (1052)
Q Consensus       765 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  840 (1052)
                      ++...+++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            33456788999999999999999999855 78999999886432  2234567889999999999999999998865 56


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..++|+||+ +++|.+++..     ..+++..+..++.|+++|++|||+.   +|+||||+|+||++++++.++++|||.
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence            789999998 5688877753     3478888899999999999999986   999999999999999999999999999


Q ss_pred             ccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHH--------
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF--------  991 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~--------  991 (1052)
                      +......    .....+++.|+|||.+.+ ..++.++||||||+++|+|++|++||................        
T Consensus       155 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         155 ARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             ccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9764321    123467889999998765 568999999999999999999999996432111100000000        


Q ss_pred             Hhhhccccccccc-ccccc-----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          992 QMKSEKREVEIID-ASIWH-----KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       992 ~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .........+... .....     ........++.+++.+|++.+|++||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000000 00000     001112357899999999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=2.6e-31  Score=301.72  Aligned_cols=266  Identities=22%  Similarity=0.327  Sum_probs=195.5

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeC---------
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG---------  839 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  839 (1052)
                      ..+|++.+.||.|+||.||+|... +|..||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367999999999999999999865 6889999998765555566788999999999999999999876543         


Q ss_pred             -----CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-CCCCe
Q 001561          840 -----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA  913 (1052)
Q Consensus       840 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~-~~~~~  913 (1052)
                           ...++||||++ ++|.+++..     ..+++..++.++.|+++|++|||+.   +|+||||||+||+++ +++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999997 588777743     3588999999999999999999986   999999999999998 45678


Q ss_pred             EEeecccccccCCCCCe--eeecccccccccCccccC-CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001561          914 HLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  990 (1052)
Q Consensus       914 kl~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~  990 (1052)
                      |++|||.++........  ......++..|+|||.+. +..++.++|||||||++|||++|+.||......   +.....
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~~  231 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL---EQMQLI  231 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence            99999999865432111  112236788999999754 456788999999999999999999999643211   111110


Q ss_pred             HHhhhcccc-----------cccc----cc-cccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561          991 FQMKSEKRE-----------VEII----DA-SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus       991 ~~~~~~~~~-----------~~~~----~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .........           ....    .. ............++.+++.+|++.||++||++.|+++  +++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            000000000           0000    00 0000001123346889999999999999999999985  66543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=293.69  Aligned_cols=244  Identities=23%  Similarity=0.372  Sum_probs=199.8

Q ss_pred             cCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCC
Q 001561          776 ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENG  852 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  852 (1052)
                      .++||.|.||+||-|+++ +|+.||||++.+..  .+.+.+++.|+.+++.++||.||.+--.|+..++.++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            578999999999999865 89999999998653  445678899999999999999999999999999999999999766


Q ss_pred             ChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC---CCCeEEeecccccccCCCCC
Q 001561          853 SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE---KFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       853 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      -|+-.+..   ..+.+++.....+..||+.||.|||..   +|+|+|+||+|||+..   -.++|+||||+|+.++.  .
T Consensus       649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--k  720 (888)
T KOG4236|consen  649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--K  720 (888)
T ss_pred             HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--h
Confidence            56655543   456688888899999999999999975   9999999999999964   46799999999999864  3


Q ss_pred             eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .....++|||.|+|||++..+.|...-|+||.|||+|--+.|..||..  +++..+.++....+...         ..| 
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp---------~PW-  788 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPP---------NPW-  788 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCC---------Cch-
Confidence            344567999999999999999999999999999999999999999952  22222333322222222         222 


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         .+...+++++|...++..-++|-+.++.+.
T Consensus       789 ---~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  789 ---SEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ---hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence               233447889999999999999999988765

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=320.93  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=208.0

Q ss_pred             cCCcccCeEcccCceEEEEEEEC----C----CcEEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeeeeceEeeCC
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT----N----GTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGN  840 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  840 (1052)
                      ++..+.+.+|+|.||.|++|...    .    ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|.+.+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            34455669999999999999743    1    34799999885543 4456789999999999 5999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhccc---CC-------c--cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001561          841 DRLLIYSYMENGSLDYWLHESV---DK-------D--SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  908 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~  908 (1052)
                      ..++|+||++.|+|.++++..+   ..       .  ..++..+.+.++.|||.|++||++.   +++|||+.++|||++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence            9999999999999999998765   10       1  2489999999999999999999986   999999999999999


Q ss_pred             CCCCeEEeecccccccCCCCCeeeecccc--cccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchh
Q 001561          909 EKFEAHLADFGLSRLLRPYDTHVTTDLVG--TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD  985 (1052)
Q Consensus       909 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~  985 (1052)
                      ++..+||+|||+|+...+..........|  ...|||||.+....++.++|||||||++||+++ |..||....  ...+
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--~~~~  530 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--PTEE  530 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--cHHH
Confidence            99999999999999765544443332233  336999999999999999999999999999999 999996421  1223


Q ss_pred             HHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          986 LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      +.+++....+             ...+..+..+++++|+.||+.+|++||++.|+++.++..
T Consensus       531 l~~~l~~G~r-------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  531 LLEFLKEGNR-------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHhcCCC-------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            3332222111             122334456899999999999999999999999998874

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4.1e-31  Score=292.06  Aligned_cols=259  Identities=26%  Similarity=0.336  Sum_probs=198.5

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      |+..+.||+|++|.||+|... +++.||+|++....  ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999876 58999999987653  333456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      + ++|.+++...   ...+++..+..++.+++.|++|||+.   +|+||||+|+||++++++.++|+|||.++.......
T Consensus        81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            8 5899988753   24689999999999999999999996   999999999999999999999999999987643322


Q ss_pred             eeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccc---------
Q 001561          930 HVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE---------  999 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------  999 (1052)
                       ......++..|+|||.+.+. .++.++||||||+++||+++|++||....   ..+....+.........         
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS---EIDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHHHhCCCcHHHHHhhccc
Confidence             22234567789999987666 78899999999999999999999996422   12222222111110000         


Q ss_pred             ---ccccc---ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1000 ---VEIID---ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1000 ---~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         .....   ........+.....+.+++.+|++.+|++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence               00000   00000001112457899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-32  Score=280.27  Aligned_cols=268  Identities=23%  Similarity=0.308  Sum_probs=211.7

Q ss_pred             cHHHHHHhhcCCcccCeEcccCceEEEEEEECCC------cEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeec
Q 001561          762 TVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQG  834 (1052)
Q Consensus       762 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~  834 (1052)
                      ...++.....+++...++.+|.||+||+|.|.+.      +.|-+|.++....+ ....+..|.-.+..+.|||+.++.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            3456666777899999999999999999987643      34667776654433 3356778888888999999999999


Q ss_pred             eEee-CCeEEEEEEeccCCChhhhhhccc----CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC
Q 001561          835 YCRH-GNDRLLIYSYMENGSLDYWLHESV----DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE  909 (1052)
Q Consensus       835 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~  909 (1052)
                      ++.+ .+..+++|.++.-|+|..|+...+    ...+.++..+...++.|++.|++|||++   +|||.||.++|.+||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            8865 467789999999999999998332    2344577788899999999999999997   9999999999999999


Q ss_pred             CCCeEEeecccccccCCCCCeeeeccc-ccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHH
Q 001561          910 KFEAHLADFGLSRLLRPYDTHVTTDLV-GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV  987 (1052)
Q Consensus       910 ~~~~kl~DfG~a~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~  987 (1052)
                      ..++|++|=.+++.+-+.+.+.-.+.- ....||+||.+....|+.++|||||||++|||+| |+.|+..-.+.   +..
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf---Em~  508 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF---EME  508 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---HHH
Confidence            999999999999988776655444332 3448999999999999999999999999999999 99998632211   111


Q ss_pred             HHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561          988 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      .   ..++..+          ...+..++.+++.+|..||..+|++||+++|++.-|.++.
T Consensus       509 ~---ylkdGyR----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  509 H---YLKDGYR----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             H---HHhccce----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            1   1111111          1223345668999999999999999999999999998764

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.2e-31  Score=301.11  Aligned_cols=263  Identities=25%  Similarity=0.340  Sum_probs=198.8

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCe----
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND----  841 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  841 (1052)
                      ..++|++.+.||+|++|.||+|+.. ++..||+|++....  ....+.+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567999999999999999999876 67899999886432  2334567789999999999999999998876554    


Q ss_pred             --EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          842 --RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       842 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                        .++|+||+ +++|.+++..     ..+++..+..++.|+++|++|||+.   +|+||||||+||++++++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 6688888753     4589999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ++......    .....+++.|+|||...+ ..++.++||||+|+++|||++|+.||....   ..+....+........
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~---~~~~~~~i~~~~~~~~  236 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD---HIDQLKRIMNLVGTPD  236 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCC
Confidence            99875432    233467889999998754 467889999999999999999999996322   1111211111111000


Q ss_pred             c-----------ccccc------ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561          999 E-----------VEIID------ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus       999 ~-----------~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .           .....      .............++.+++.+|++.+|++|||+.|+++  ++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence            0           00000      00000001112457899999999999999999999987  55443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-32  Score=282.73  Aligned_cols=240  Identities=26%  Similarity=0.345  Sum_probs=193.2

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHH---HHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMER---EFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~---~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  845 (1052)
                      .+|....+||+|+||+|-.|..+ +.+-+|||+++++.....+   --..|-+++... +-|.+++++..|+.-++.|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            36888999999999999999765 5678999999876532222   124456666655 578999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |||+.||+|-.+++.    -+.+.+..+..+|.+||-||-+||+.   +|+.||+|.+|||+|.+|++||+|||+++.--
T Consensus       429 MEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence            999999999998885    34567788999999999999999985   99999999999999999999999999998632


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      - ....+.+++|||.|+|||++...+|..++|+|||||++|||+.|++||++   +..+++.+.+....           
T Consensus       502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG---eDE~elF~aI~ehn-----------  566 (683)
T KOG0696|consen  502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQAIMEHN-----------  566 (683)
T ss_pred             c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHcc-----------
Confidence            2 33345678999999999999999999999999999999999999999974   33334443332211           


Q ss_pred             cccchhhHHHHHHHHHHHHHcccCCCCCCC
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1035 (1052)
                         -.++...+.++..+....+.+.|.+|-
T Consensus       567 ---vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 ---VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ---CcCcccccHHHHHHHHHHhhcCCcccc
Confidence               122333445778888899999999985

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.1e-31  Score=300.16  Aligned_cols=263  Identities=22%  Similarity=0.315  Sum_probs=197.2

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCC-----
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN-----  840 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  840 (1052)
                      ..++|++.+.||+|+||.||+|... ++..||+|++....  ....+.+.+|++++++++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4568999999999999999999754 78999999986432  223456789999999999999999999887543     


Q ss_pred             -eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          841 -DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       841 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                       ..++||||+ +++|.+++..     ..+++..++.++.|+++|++|||+.   +|+||||||+||+++.++.++++|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             458999999 7788887753     3588999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ++......    .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||.....   ...............
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~  236 (343)
T cd07880         164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH---LDQLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCC
Confidence            99865432    223467889999998765 4588899999999999999999999964221   111111100000000


Q ss_pred             -----------ccccc------cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561          999 -----------EVEII------DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus       999 -----------~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                                 .....      ...............+.+++.+|++.||++||++.++++  +++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                       00000      000000001122346889999999999999999999995  66654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1e-30  Score=295.88  Aligned_cols=265  Identities=23%  Similarity=0.286  Sum_probs=194.4

Q ss_pred             CCcccCeEcccCceEEEEEEEC-C--CcEEEEEEecCCc--hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeC----Ce
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-N--GTKAAVKRLSGDC--GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHG----ND  841 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  841 (1052)
                      +|++.+.||+|+||.||+|... +  +..||+|++....  ....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999865 4  7789999986432  22345678899999999 599999999875432    45


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a  921 (1052)
                      .++++||++ ++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788899886 588887753    45689999999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCCe---eeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcc
Q 001561          922 RLLRPYDTH---VTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       922 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      +........   ......|++.|+|||+..+ ..++.++||||+|+++|+|++|++||....   .......+.......
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~  229 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD---YVDQLNQILQVLGTP  229 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC---HHHHHHHHHHHhCCC
Confidence            875432211   1233578999999997655 568899999999999999999999996422   111221111111000


Q ss_pred             c-----------ccc---cc---cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 001561          998 R-----------EVE---II---DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus       998 ~-----------~~~---~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .           ...   ..   ...............+.+++.+|++.+|++||++.|+++  ++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            0           000   00   000000000112347889999999999999999999987  55543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-31  Score=246.51  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=200.2

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +|...++||+|.||+||+|+.. +++.||+|+++.+.  ........+|+-+++.++|+|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556778999999999999854 78999999987443  33345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +.. +|..+...   -.+.++.+.++.++.|+++|+.|+|++   ++.|||+||+|.+++.+|+.|++|||+|+.++-..
T Consensus        83 cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            964 67766654   355689999999999999999999998   99999999999999999999999999999876432


Q ss_pred             CeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhhhccccc------
Q 001561          929 THVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREV------ 1000 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 1000 (1052)
                       ......+-|..|++|.++.+. -|++..|+||-|||+.|+.. |++-|.   +....+....++.........      
T Consensus       156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp---g~dvddqlkrif~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP---GNDVDDQLKRIFRLLGTPTEDQWPSMT  231 (292)
T ss_pred             -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC---CCcHHHHHHHHHHHhCCCccccCCccc
Confidence             334456779999999987765 57889999999999999998 555554   334445555555544332211      


Q ss_pred             ccccccccchhhH-----HHH----HHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1001 EIIDASIWHKDRE-----KQL----LEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~-----~~~----~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ...|-.....++.     ...    ..=.+++.+.+.-+|.+|.+++++++
T Consensus       232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1222222222211     111    13368888999999999999999876

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=299.50  Aligned_cols=239  Identities=24%  Similarity=0.284  Sum_probs=192.3

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      ...|+....+|.|+|+.|-.+... ++...+||++.+..    .+-.+|+.++.+. +||||+++.+.+.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            456777777999999999888754 78899999997652    2345677666666 69999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEE-CCCCCeEEeecccccccCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL-DEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill-~~~~~~kl~DfG~a~~~~~  926 (1052)
                      .+.|+.+.+.+...    .... .++..|+.+++.|+.|||++   ||+|||+||+|||+ ++.++++|+|||.++...+
T Consensus       397 ~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            99999887766532    2223 67788999999999999996   99999999999999 5999999999999998765


Q ss_pred             CCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccc
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .    ....+-|..|.|||+.....+++++|+||||++||+|++|+.||....+.  .++..    ....          
T Consensus       469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~~----------  528 (612)
T KOG0603|consen  469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQM----------  528 (612)
T ss_pred             h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhcC----------
Confidence            4    22235688999999999999999999999999999999999999753322  11111    1111          


Q ss_pred             ccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        .++....+.++.+|+.+|++.||.+||+|+++..
T Consensus       529 --~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 --PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              1122445668999999999999999999999865

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=270.88  Aligned_cols=252  Identities=26%  Similarity=0.359  Sum_probs=193.7

Q ss_pred             cCeEcccCceEEEEEEEC-CCcEEEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccCC
Q 001561          776 ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMENG  852 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  852 (1052)
                      ...||.|+||+|+|-.++ .|+..|||+++.... ..++++..|.++..+- +.||||+++|.+..++..|+.||.|+- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            457999999999999765 799999999986554 5567888898876665 699999999999999999999999954 


Q ss_pred             Chhhhhhc-ccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          853 SLDYWLHE-SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       853 ~L~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      +++.+-.. +......+++...-+|+...+.||.||-..  -.|+|||+||+|||+|..|.+|+||||.+..+...  --
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iA  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IA  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--HH
Confidence            55443321 112455688888889999999999999874  68999999999999999999999999999776432  11


Q ss_pred             eecccccccccCccccCC--cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccc
Q 001561          932 TTDLVGTLGYIPPEYSQT--LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .+..+|-..|||||.+..  ..|+.++||||+|+++||+.||+.||..+.     +..+.+.+.....+..-..+     
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp~l~~~-----  293 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPPILLFD-----  293 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCCeecCc-----
Confidence            233478889999997653  358999999999999999999999997432     23333333222221111111     


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .........+.+++..|+.+|-..||.+.++.+
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            112234557899999999999999999999876

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-31  Score=299.25  Aligned_cols=255  Identities=27%  Similarity=0.414  Sum_probs=208.1

Q ss_pred             HHhhcCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEee-----C
Q 001561          767 LKSTNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH-----G  839 (1052)
Q Consensus       767 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~  839 (1052)
                      ...+..|++.++||+|.+|.||+++. ++++.+|+|+...+.. ..++++.|.++++.. .|||++.++|++..     +
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            33456788899999999999999974 4788999998875543 345678899999888 69999999998853     5


Q ss_pred             CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          840 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       840 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                      ++.|+|||||.+|+..+.+....  +..+.|+.+..|.+.++.|+.|||..   .++|||||-.|||+++++.||++|||
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeee
Confidence            78999999999999999998765  77899999999999999999999986   99999999999999999999999999


Q ss_pred             cccccCCCCCeeeecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      .+..+... .......+|||.|||||++.     ...|+.++|+||+|++..||.-|.+|+..+-+      ...++...
T Consensus       169 vSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mraLF~Ip  241 (953)
T KOG0587|consen  169 VSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIP  241 (953)
T ss_pred             eeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hhhhccCC
Confidence            99887542 23345579999999999864     34567789999999999999999999864321      11111111


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +        .+......+..+..++.++|..|+.+|-++||++.++++
T Consensus       242 R--------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 R--------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             C--------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1        122223345677789999999999999999999999876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.1e-30  Score=316.72  Aligned_cols=145  Identities=30%  Similarity=0.422  Sum_probs=130.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|+++...   ......+..|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999876 78999999987542   233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ||+++++|.+++..    ...+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999864    23578899999999999999999986   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.1e-30  Score=277.87  Aligned_cols=236  Identities=26%  Similarity=0.313  Sum_probs=191.3

Q ss_pred             EcccCceEEEEEEEC-CCcEEEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCCh
Q 001561          779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      ||+|+||.||++... +++.||+|++.....   .....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999876 589999999875432   2345788999999999999999999999999999999999999999


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeec
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD  934 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  934 (1052)
                      .+++...    ..+++..+..++.|+++|+.|+|+.   +++|+||+|+||+++.++.++++|||.+....... .....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            9998743    3589999999999999999999986   99999999999999999999999999998764322 12334


Q ss_pred             ccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHH
Q 001561          935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014 (1052)
Q Consensus       935 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1052)
                      ..++..|+|||...+...+.++|+||||+++|++++|+.||....   .......+..   ...           ..+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~---~~~-----------~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED---RKEIYEKILK---DPL-----------RFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHhc---CCC-----------CCCCC
Confidence            578889999999988888999999999999999999999996321   1122211111   000           00111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHH
Q 001561         1015 QLLEMLEIACKCIDQDPRRRPFIEE 1039 (1052)
Q Consensus      1015 ~~~~l~~li~~cl~~dP~~RPs~~e 1039 (1052)
                      ....+.+++.+|+..||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1346889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=278.83  Aligned_cols=259  Identities=20%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcC--CC----ceeeeeceEeeCCeE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ--HK----NLVSLQGYCRHGNDR  842 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~l~~~~~~~~~~  842 (1052)
                      +++|.+...+|+|.||.|-++... .+..||+|+++.- ....+...-|++++.++.  .|    -+|++.+||.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            578999999999999999999754 5789999988633 344455678999999993  22    388999999999999


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-------------
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-------------  909 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-------------  909 (1052)
                      ++|+|.+ |-++.+++...  ...+++...++.|+.|++++++|||+.   +++|-|+||+||++.+             
T Consensus       167 Civfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999988 66899999764  456789999999999999999999997   9999999999999832             


Q ss_pred             -------CCCeEEeecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCC
Q 001561          910 -------KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN  982 (1052)
Q Consensus       910 -------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~  982 (1052)
                             ...+||+|||.|+......    ...+.|..|+|||++.+-.++.++||||+||||+|++||..-|+...+.+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                   2458999999998754332    45688999999999999999999999999999999999999997543222


Q ss_pred             chhHHHHHHHhhhccccccc-------------cc-------c---------cc---cchhhHHHHHHHHHHHHHcccCC
Q 001561          983 CRDLVSWVFQMKSEKREVEI-------------ID-------A---------SI---WHKDREKQLLEMLEIACKCIDQD 1030 (1052)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~-------------~~-------~---------~~---~~~~~~~~~~~l~~li~~cl~~d 1030 (1052)
                         ....+....+..+...+             +|       .         ..   .......+..++.+|+.+|+..|
T Consensus       317 ---HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  317 ---HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             ---HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence               22222222211110000             00       0         00   00011233457999999999999


Q ss_pred             CCCCCCHHHHHH
Q 001561         1031 PRRRPFIEEVVT 1042 (1052)
Q Consensus      1031 P~~RPs~~evl~ 1042 (1052)
                      |.+|+|++|++.
T Consensus       394 P~~RiTl~EAL~  405 (415)
T KOG0671|consen  394 PARRITLREALS  405 (415)
T ss_pred             ccccccHHHHhc
Confidence            999999999986

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-32  Score=288.18  Aligned_cols=241  Identities=21%  Similarity=0.274  Sum_probs=196.8

Q ss_pred             CCcccCeEcccCceEEEEEEECCCc-EEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLTNGT-KAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~~g~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      +++.+..||.|+||.|-.+...... .+|+|.+++..   ...++.+..|-.+|...+.|.||+++..|.+....|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3455678999999999999876433 48888877543   3344557889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      -|-||.+...+++    .+.++...+..++..+++|++|||+.   +||+||+||+|.++|.+|.+|+.|||+|+.+...
T Consensus       501 aClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  501 ACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999985    56688889999999999999999996   9999999999999999999999999999998754


Q ss_pred             CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccc
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                        ..+-+++|||.|.|||++..+.++.++|.||+|+++|||++|.+||.+..+-....++   ....         |.  
T Consensus       574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I---LkGi---------d~--  637 (732)
T KOG0614|consen  574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI---LKGI---------DK--  637 (732)
T ss_pred             --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---Hhhh---------hh--
Confidence              3455689999999999999999999999999999999999999999753221111111   1111         10  


Q ss_pred             cchhhHHHHHHHHHHHHHcccCCCCCCCC
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPF 1036 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1036 (1052)
                       ..++........++|++.+...|.+|-.
T Consensus       638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  638 -IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence             1122334456789999999999999975

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.7e-32  Score=265.72  Aligned_cols=265  Identities=25%  Similarity=0.348  Sum_probs=191.5

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecC--CchhhHHHHHHHHHHHHhcCCCceeeeeceEeeC--------
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG--------  839 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  839 (1052)
                      ..|+....||+|.||.||+|+.+ +|++||+|++--  +.........+|++++..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666788999999999999855 678889886532  1122223457899999999999999999988532        


Q ss_pred             CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecc
Q 001561          840 NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFG  919 (1052)
Q Consensus       840 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG  919 (1052)
                      ...|+||++++. +|.-.+..   ....++..++.+++.++..||.|+|+.   .|+|||+||+|+||+.+|.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            347999999976 56665543   345688999999999999999999997   99999999999999999999999999


Q ss_pred             cccccCCCCCe---eeecccccccccCcccc-CCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhh
Q 001561          920 LSRLLRPYDTH---VTTDLVGTLGYIPPEYS-QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS  995 (1052)
Q Consensus       920 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  995 (1052)
                      +|+.+......   ..+..+-|..|++||.+ ....++++.|||+-|||+.||+||.+-|++......-.++........
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99876433221   23445779999999965 556799999999999999999999998864322111122221111111


Q ss_pred             cccccccccccc----------cchhh--HHH------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          996 EKREVEIIDASI----------WHKDR--EKQ------LLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       996 ~~~~~~~~~~~~----------~~~~~--~~~------~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .+....+..-.+          ...++  +..      ..+..+++.+++..||.+|+++++++.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            111111110000          00110  011      126789999999999999999999976

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4.9e-30  Score=275.46  Aligned_cols=221  Identities=22%  Similarity=0.207  Sum_probs=176.2

Q ss_pred             cCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCChhhhhhc
Q 001561          782 GGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE  860 (1052)
Q Consensus       782 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  860 (1052)
                      |.+|.||++... +++.||+|++....     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999865 78999999987542     234455555566799999999999999999999999999999998864


Q ss_pred             ccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeeccccccc
Q 001561          861 SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG  940 (1052)
Q Consensus       861 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~  940 (1052)
                      .    ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++++|||.+......    .....++..
T Consensus        79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~  147 (237)
T cd05576          79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM  147 (237)
T ss_pred             h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence            3    3489999999999999999999986   9999999999999999999999999988665432    122356778


Q ss_pred             ccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHH
Q 001561          941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML 1020 (1052)
Q Consensus       941 y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1020 (1052)
                      |+|||......++.++||||+|+++|||++|+.|+......     .       ...  ...       ..+......+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-------~~~--~~~-------~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-------NTH--TTL-------NIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-------ccc--ccc-------CCcccCCHHHH
Confidence            99999998888999999999999999999999987521100     0       000  000       01111234688


Q ss_pred             HHHHHcccCCCCCCCCHHH
Q 001561         1021 EIACKCIDQDPRRRPFIEE 1039 (1052)
Q Consensus      1021 ~li~~cl~~dP~~RPs~~e 1039 (1052)
                      +++.+|++.||++||++.+
T Consensus       207 ~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         207 SLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHHccCCHHHhcCCCc
Confidence            9999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-30  Score=244.49  Aligned_cols=201  Identities=28%  Similarity=0.402  Sum_probs=169.7

Q ss_pred             CcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEec
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      ......||+|++|.|-+.++. +|...|+|++.... .+..++..+|+++..+. ..|.+|.++|.+......|+.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            344567999999999888754 89999999997543 34456677888876655 7999999999999899999999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                      +- +|+.+-.+....+..+++...-+||..+++|+.|||+.  -.++|||+||+|||++.+|++|+||||.+..+...-.
T Consensus       128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence            54 88888888778889999999999999999999999996  6899999999999999999999999999977643211


Q ss_pred             eeeecccccccccCccccC----CcCCCcccchHHHHHHHHHHHcCCCCCccc
Q 001561          930 HVTTDLVGTLGYIPPEYSQ----TLTATCRGDVYSFGVVLLELLTGRRPVEVC  978 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslGvil~elltG~~pf~~~  978 (1052)
                        .+...|...|||||.+.    ...|+.++||||+|+++.||.+++.||+.+
T Consensus       205 --kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  205 --KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             --HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence              12246888999999764    347899999999999999999999999753

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.6e-29  Score=290.82  Aligned_cols=261  Identities=21%  Similarity=0.324  Sum_probs=182.4

Q ss_pred             hhcCCcccCeEcccCceEEEEEEE-----------------CCCcEEEEEEecCCchhhHHH--------------HHHH
Q 001561          769 STNNFNQANIIGCGGFGLVYKATL-----------------TNGTKAAVKRLSGDCGQMERE--------------FQAE  817 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E  817 (1052)
                      ..++|++.++||+|+||+||+|..                 .+++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999964                 235679999987543322222              3346


Q ss_pred             HHHHHhcCCCce-----eeeeceEee--------CCeEEEEEEeccCCChhhhhhcccC--------------------C
Q 001561          818 VEALSRAQHKNL-----VSLQGYCRH--------GNDRLLIYSYMENGSLDYWLHESVD--------------------K  864 (1052)
Q Consensus       818 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~  864 (1052)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777876654     677777753        3567999999999999999875321                    1


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeecccccccccCc
Q 001561          865 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP  944 (1052)
Q Consensus       865 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aP  944 (1052)
                      ...+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||+++..............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12356788999999999999999986   999999999999999999999999999976543222212223458899999


Q ss_pred             cccCCcCC----------------------CcccchHHHHHHHHHHHcCCC-CCcccCCCC------chhHHHHHHHhhh
Q 001561          945 EYSQTLTA----------------------TCRGDVYSFGVVLLELLTGRR-PVEVCKGKN------CRDLVSWVFQMKS  995 (1052)
Q Consensus       945 E~~~~~~~----------------------~~~~DvwslGvil~elltG~~-pf~~~~~~~------~~~~~~~~~~~~~  995 (1052)
                      |.+.....                      ..+.||||+||++|||++|.. ||......+      ..+...|... ..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~~  458 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-KG  458 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-cc
Confidence            97653221                      124799999999999999885 764321100      1111112111 00


Q ss_pred             cccccccccccccchhhHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 001561          996 EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDP---RRRPFIEEVVT 1042 (1052)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 1042 (1052)
                      ..     .+-..    .........+++.+|+..+|   .+|+|++|+++
T Consensus       459 ~~-----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QK-----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cC-----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            00     01111    11234478899999999766   68999999986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.6e-29  Score=300.91  Aligned_cols=261  Identities=20%  Similarity=0.236  Sum_probs=170.6

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-C----CcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeece------Ee
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-N----GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY------CR  837 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  837 (1052)
                      ..++|+..+.||+|+||.||+|.+. +    +..||+|++......  +.+..|  .++...+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3567999999999999999999875 4    689999987643211  111111  1222223333322222      24


Q ss_pred             eCCeEEEEEEeccCCChhhhhhcccCC----------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 001561          838 HGNDRLLIYSYMENGSLDYWLHESVDK----------------DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVK  901 (1052)
Q Consensus       838 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlk  901 (1052)
                      ++...++||||+++++|.++++.....                ........+..++.|++.||+|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            566789999999999999988753210                01112344668999999999999986   99999999


Q ss_pred             CCceEECC-CCCeEEeecccccccCCCCCeeeecccccccccCccccCCc----------------------CCCcccch
Q 001561          902 SSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL----------------------TATCRGDV  958 (1052)
Q Consensus       902 p~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv  958 (1052)
                      |+|||+++ ++.+||+|||+|+.+............+|+.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999996 58999999999987654444444557899999999954321                      23446799


Q ss_pred             HHHHHHHHHHHcCCCCCcccC-------CCCchhHHHHHHHhhhcccccccccccccc--hhhHHHHHHHHHHHHHcccC
Q 001561          959 YSFGVVLLELLTGRRPVEVCK-------GKNCRDLVSWVFQMKSEKREVEIIDASIWH--KDREKQLLEMLEIACKCIDQ 1029 (1052)
Q Consensus       959 wslGvil~elltG~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~ 1029 (1052)
                      |||||++|||+++..|++...       .....+...|.......      .......  ...........+++.+|++.
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence            999999999999777653210       00000111111111000      0000000  00001122456899999999


Q ss_pred             CCCCCCCHHHHHH
Q 001561         1030 DPRRRPFIEEVVT 1042 (1052)
Q Consensus      1030 dP~~RPs~~evl~ 1042 (1052)
                      ||++|||++|+++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999987

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.9e-30  Score=259.97  Aligned_cols=248  Identities=22%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ..+|+..++||+|+|++|..+++. +.+.+|+|+++++.   .+..+-++.|-.+..+. +||.+|-+..+|..+.+.+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357899999999999999999865 67889999987643   23334467777777777 69999999999999999999


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      |.||++||+|--++++    .+.++++.++.+..+|.-||.|||+.   ||+.||+|.+|||+|.+|++|++|||+++.-
T Consensus       329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999777764    55699999999999999999999986   9999999999999999999999999999863


Q ss_pred             CCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCC-chhHHHHHHHhhhcccccccc
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN-CRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      -. ....+.+++|||.|.|||++.+..|...+|+|++||+++||+.|+.||+.....+ ..+.-.+.++..-++.+ .+ 
T Consensus       402 l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-ri-  478 (593)
T KOG0695|consen  402 LG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-RI-  478 (593)
T ss_pred             CC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-cc-
Confidence            32 2334567899999999999999999999999999999999999999997532111 11222223332221111 00 


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCC
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1035 (1052)
                              +...+.++..+++.-+++||++|.
T Consensus       479 --------prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  479 --------PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --------cceeehhhHHHHHHhhcCCcHHhc
Confidence                    011122456778888999999985

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=272.37  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=196.0

Q ss_pred             hcCCcccCeEcccCceEEEEEE-ECCCcEEEEEEec--CCchhh-----HHHHHHHHHHHHhcCCCceeeeeceEee-CC
Q 001561          770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS--GDCGQM-----EREFQAEVEALSRAQHKNLVSLQGYCRH-GN  840 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~--~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  840 (1052)
                      -++|-...+||+|||+.||+|. +...+.||||+-.  +.+...     .+...+|.++-+.+.||.||++++|+.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            3567788999999999999996 4456778998754  222221     1345789999999999999999999964 46


Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC---CCCCeEEee
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLAD  917 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~---~~~~~kl~D  917 (1052)
                      .++-|.||++|.+|+-|+..    ...+++.+++.|+.||+.||.||... .++|||-|+||.|||+.   .-|.+||+|
T Consensus       542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            77899999999999999875    44589999999999999999999986 78999999999999995   458899999


Q ss_pred             cccccccCCCCCe------eeecccccccccCccccC----CcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHH
Q 001561          918 FGLSRLLRPYDTH------VTTDLVGTLGYIPPEYSQ----TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV  987 (1052)
Q Consensus       918 fG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~  987 (1052)
                      ||+++.++.+...      .+....||.+|++||.+.    ....+.|+||||+|||+|+.+.|+.||+..  ....+++
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn--qsQQdIL  694 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN--QSQQDIL  694 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc--hhHHHHH
Confidence            9999988654321      234568999999999542    345788999999999999999999999632  2222333


Q ss_pred             HHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          988 SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +.-.... . ....       .+..+....++.++|++|+++.-++|....++..
T Consensus       695 qeNTIlk-A-tEVq-------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  695 QENTILK-A-TEVQ-------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhhchhc-c-eecc-------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            2211111 0 1111       1112233447889999999999999988877654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.4e-29  Score=277.02  Aligned_cols=203  Identities=27%  Similarity=0.355  Sum_probs=172.9

Q ss_pred             cCCcccCeEcccCceEEEEEEE-CCCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      .-|..++.||-|+||.|.+++. ++...||.|.+++.+--   ....++.|-++|.....+-||+++..|.+.+.+|.||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            4688899999999999999974 45667899998765422   2234678999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||++||++-.+|.+    .+.+.++.++.++.+++.|+++.|..   |+|||||||+|||||.+|++||+|||+++-+.-
T Consensus       709 dYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             eccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence            99999999888874    45688999999999999999999997   999999999999999999999999999864321


Q ss_pred             C--------CCe---------------------------------eeecccccccccCccccCCcCCCcccchHHHHHHH
Q 001561          927 Y--------DTH---------------------------------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVL  965 (1052)
Q Consensus       927 ~--------~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil  965 (1052)
                      -        ..+                                 .....+||+.|+|||++....++..+|+||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence            0        000                                 00123899999999999999999999999999999


Q ss_pred             HHHHcCCCCCcccCC
Q 001561          966 LELLTGRRPVEVCKG  980 (1052)
Q Consensus       966 ~elltG~~pf~~~~~  980 (1052)
                      |||+.|++||-....
T Consensus       862 ~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTP  876 (1034)
T ss_pred             HHHhhCCCCccCCCC
Confidence            999999999975443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.6e-28  Score=264.38  Aligned_cols=238  Identities=32%  Similarity=0.390  Sum_probs=192.7

Q ss_pred             CceEEEEEEEC-CCcEEEEEEecCCchhh-HHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCChhhhhhc
Q 001561          783 GFGLVYKATLT-NGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE  860 (1052)
Q Consensus       783 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  860 (1052)
                      +||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 58999999997654433 67899999999999999999999999999999999999999999998875


Q ss_pred             ccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeeccccccc
Q 001561          861 SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG  940 (1052)
Q Consensus       861 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~  940 (1052)
                      ..    .+++..++.++.+++++++|||+.   +++|+||+|+||++++++.++++|||.+.......  ......++..
T Consensus        81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            32    288999999999999999999996   99999999999999999999999999998765432  2334578889


Q ss_pred             ccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHH
Q 001561          941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML 1020 (1052)
Q Consensus       941 y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1020 (1052)
                      |++||......++.++||||+|+++|++++|..||...  .......++.....   ....        ........++.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKKIGKPK---PPFP--------PPEWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHhccC---CCCc--------cccccCCHHHH
Confidence            99999988888899999999999999999999998632  11122222111100   0000        00000234788


Q ss_pred             HHHHHcccCCCCCCCCHHHHHH
Q 001561         1021 EIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1021 ~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-30  Score=259.36  Aligned_cols=260  Identities=23%  Similarity=0.322  Sum_probs=193.7

Q ss_pred             ccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC-----CeEEEEE
Q 001561          775 QANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-----NDRLLIY  846 (1052)
Q Consensus       775 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~  846 (1052)
                      -.+.||-|+||.||.+... +|+.||.|++..-.  -...+.+.+|.+++..++|.|++..++...-.     ++.|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            3578999999999999754 89999999886433  33457799999999999999999998876533     3467888


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      |.|.. +|.+.+-    ..+.++.+.+.-+.+||++||+|||+.   +|.||||||.|.+++.+..+||||||+|+..+.
T Consensus       137 ELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  137 ELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence            88843 5555443    567889999999999999999999997   999999999999999999999999999998776


Q ss_pred             CCCeeeecccccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHH------------Hh
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF------------QM  993 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~------------~~  993 (1052)
                      .+...++..+-|..|+|||++++. .|+.+.||||.|||+.|++..+.-|+...+-+..+++....            +.
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            666666677889999999987764 68899999999999999999888886543322222221111            00


Q ss_pred             hhc---ccccccccccccc--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          994 KSE---KREVEIIDASIWH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       994 ~~~---~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .+.   +......+-....  ......-.+...+..+++.+||++|.+..+.+.
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence            000   0000001100000  011122235678888999999999999998876

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=285.78  Aligned_cols=245  Identities=25%  Similarity=0.345  Sum_probs=186.8

Q ss_pred             cccCeEcccCceE-EEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          774 NQANIIGCGGFGL-VYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       774 ~~~~~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      .-.+++|.|+.|+ ||+|... |+.||||++-.+.   ..-.++|+..++.- .|||||++++.-.+....|+..|.|. 
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-  586 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-  586 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence            3346789998884 6999886 8899999986432   34568899999988 59999999999888999999999994 


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-----CCCeEEeecccccccCC
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-----KFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-----~~~~kl~DfG~a~~~~~  926 (1052)
                      .+|+++++..............+.+..|+++||+|||+.   +|||||+||+||||+.     ..+++|+|||+++.+..
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            589999986411111112245578889999999999997   9999999999999975     25799999999999876


Q ss_pred             CCCee--eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcC-CCCCcccCCCCchhHHHHHHHhhhcccccccc
Q 001561          927 YDTHV--TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG-RRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       927 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      .....  .....||-+|+|||++....-+.++||||+||++|+.++| ..||+.....+        ...........-+
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~L  735 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVHL  735 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceeee
Confidence            54433  2356899999999999998889999999999999999985 99997421110        1111111111000


Q ss_pred             cccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .+      ..++  ++.+||.+|++++|..||++.+|+.
T Consensus       736 ~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 EP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00      1111  6889999999999999999999975

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=1.2e-28  Score=239.25  Aligned_cols=257  Identities=20%  Similarity=0.309  Sum_probs=193.2

Q ss_pred             hcCCcccCeEcccCceEEEEEE-ECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeeeeceEeeCC--eEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGN--DRLLI  845 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv  845 (1052)
                      .++|++.+.+|+|.|+.||.|. ..+.++++||+++   +...+.+.+|+.++..++ ||||+++++...++.  ...+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678899999999999999997 4578899999987   344567899999999996 999999999998764  45799


Q ss_pred             EEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCCeEEeeccccccc
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLL  924 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~  924 (1052)
                      +||+++.+....-.       .++..++..++.+++.||.|+|+.   ||+|||+||.|+|+|. ...++++|+|+|.++
T Consensus       114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999887655433       367788899999999999999997   9999999999999995 467999999999998


Q ss_pred             CCCCCeeeecccccccccCccccCC-cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhh--------
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS--------  995 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~--------  995 (1052)
                      .+....  .-.+.+..|--||.+-. ..|+..-|+|||||++..|+..+.||-... ++.+.++.-..-...        
T Consensus       184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHHHHHH
Confidence            764332  22356778899997654 568889999999999999999999985322 222233221111000        


Q ss_pred             ------ccccccccc---ccccchh-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          996 ------EKREVEIID---ASIWHKD-----REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       996 ------~~~~~~~~~---~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                            ......++.   ...|..+     ..-...++.+++.+.+..|..+|||++|++.
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                  000001000   0111111     0112357899999999999999999999986

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-26  Score=247.37  Aligned_cols=283  Identities=22%  Similarity=0.354  Sum_probs=203.4

Q ss_pred             cCCCCccccHHHHHHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcC-----C-
Q 001561          754 QNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-----H-  826 (1052)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h-  826 (1052)
                      ..+.+....+.|... .++|.+.++||.|.|++||+|... +.+.||+|+.+.. ..-.+....|++++++++     | 
T Consensus        62 ~kGGYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~  139 (590)
T KOG1290|consen   62 RKGGYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDP  139 (590)
T ss_pred             hcCCCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            344455555666543 367999999999999999999754 5678999988754 444556788999999984     3 


Q ss_pred             --CceeeeeceEee----CCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 001561          827 --KNLVSLQGYCRH----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV  900 (1052)
Q Consensus       827 --~niv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDl  900 (1052)
                        ..||+++++|..    +.+.+||+|++ |-+|-.++....  -+.++...+.+|++||+.||.|||+.|  +|||-||
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDl  214 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDL  214 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCC
Confidence              369999999975    46889999999 668888887653  345788899999999999999999975  9999999


Q ss_pred             CCCceEECCC-----------C----------------------------------------------------------
Q 001561          901 KSSNILLDEK-----------F----------------------------------------------------------  911 (1052)
Q Consensus       901 kp~Nill~~~-----------~----------------------------------------------------------  911 (1052)
                      ||+|||+..+           +                                                          
T Consensus       215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~  294 (590)
T KOG1290|consen  215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI  294 (590)
T ss_pred             CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence            9999998211           0                                                          


Q ss_pred             --------------------------------------------------------------------------------
Q 001561          912 --------------------------------------------------------------------------------  911 (1052)
Q Consensus       912 --------------------------------------------------------------------------------  911 (1052)
                                                                                                      
T Consensus       295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~  374 (590)
T KOG1290|consen  295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI  374 (590)
T ss_pred             cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence                                                                                            


Q ss_pred             -----------------CeEEeecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCC
Q 001561          912 -----------------EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP  974 (1052)
Q Consensus       912 -----------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~p  974 (1052)
                                       ++||+|||-|..+..    ..+.-+.|..|+|||++.+..|++.+||||++|++|||+||..-
T Consensus       375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyL  450 (590)
T KOG1290|consen  375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYL  450 (590)
T ss_pred             ccccccCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCcee
Confidence                             011222222221100    01112578899999999999999999999999999999999999


Q ss_pred             CcccCCCC---chhHHHHHHHhhhc---------ccccccccc----------ccc---------chhhHHHHHHHHHHH
Q 001561          975 VEVCKGKN---CRDLVSWVFQMKSE---------KREVEIIDA----------SIW---------HKDREKQLLEMLEIA 1023 (1052)
Q Consensus       975 f~~~~~~~---~~~~~~~~~~~~~~---------~~~~~~~~~----------~~~---------~~~~~~~~~~l~~li 1023 (1052)
                      |+...+.+   +++.+..+......         ....++++.          ..|         ..++.+...++.+++
T Consensus       451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL  530 (590)
T KOG1290|consen  451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL  530 (590)
T ss_pred             ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence            98654332   23334333332221         111122211          111         123566778999999


Q ss_pred             HHcccCCCCCCCCHHHHHH--HHhhc
Q 001561         1024 CKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1024 ~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .-|++.+|++|||+.+.++  ||..+
T Consensus       531 ~PmLef~PeKR~tA~~cl~hPwLn~~  556 (590)
T KOG1290|consen  531 SPMLEFDPEKRPTAAQCLKHPWLNPV  556 (590)
T ss_pred             HHHHhcCccccccHHHHhcCccccCC
Confidence            9999999999999999996  66644

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=259.77  Aligned_cols=197  Identities=20%  Similarity=0.273  Sum_probs=167.5

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchh--------hHHHHHHHHHHHHhcC---CCceeeeeceEe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ--------MEREFQAEVEALSRAQ---HKNLVSLQGYCR  837 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~l~~~~~  837 (1052)
                      ..+|...+.+|.|+||.|+.|.++ +...|+||.+.++..-        .--.+-.|+.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            346888999999999999999876 4567899988765311        0112456999999997   999999999999


Q ss_pred             eCCeEEEEEEecc-CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEe
Q 001561          838 HGNDRLLIYSYME-NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLA  916 (1052)
Q Consensus       838 ~~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~  916 (1052)
                      +++.+|++||... +-+|.+++..    ...+++.++..|+.||+.|+++||++   +|||||||-+||.++.+|-+|++
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence            9999999999764 5588888874    45589999999999999999999997   99999999999999999999999


Q ss_pred             ecccccccCCCCCeeeecccccccccCccccCCcCCC-cccchHHHHHHHHHHHcCCCCCc
Q 001561          917 DFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT-CRGDVYSFGVVLLELLTGRRPVE  976 (1052)
Q Consensus       917 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltG~~pf~  976 (1052)
                      |||.|......   ....++||.+|.|||++.+..|- ..-|||++|+++|.++....||.
T Consensus       713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999765432   23446899999999999998875 55799999999999999998874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=8.5e-28  Score=266.16  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=204.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ..+|+....+|.|.||.||||+.. +++.+|+|+++-+......-++.|+-+++..+|||||.+++.+...+..|++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            457888999999999999999854 7899999999987777777788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  928 (1052)
                      +.+|+|++.-+    ...++++.+...+.++..+|++|||+.   +=+|||||-.||++++.|.+|++|||.+..+...-
T Consensus        94 cgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             cCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999988665    466799999999999999999999997   88999999999999999999999999998775432


Q ss_pred             CeeeecccccccccCcccc---CCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHH-hhhccccccccc
Q 001561          929 THVTTDLVGTLGYIPPEYS---QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ-MKSEKREVEIID 1004 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 1004 (1052)
                       .....+.||+.|||||+.   ..+.|...+|||+.|+...|+-.-++|.-..      .-.+..+- .++.......-|
T Consensus       167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl------hpmr~l~LmTkS~~qpp~lkD  239 (829)
T KOG0576|consen  167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL------HPMRALFLMTKSGFQPPTLKD  239 (829)
T ss_pred             -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc------chHHHHHHhhccCCCCCcccC
Confidence             223457999999999953   4667899999999999999998888874210      01111111 111122222223


Q ss_pred             ccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +..       +...+-++++.|+-++|++||+++.+++
T Consensus       240 k~k-------ws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 KTK-------WSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             Ccc-------chHHHHHHHHHHhcCCCccCCChhhhee
Confidence            332       3446789999999999999999987764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=8.3e-26  Score=237.21  Aligned_cols=210  Identities=37%  Similarity=0.579  Sum_probs=183.3

Q ss_pred             EcccCceEEEEEEEC-CCcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCChhh
Q 001561          779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY  856 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  856 (1052)
                      ||+|.+|.||++... +++.+++|++...... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999876 4899999998865432 34678999999999999999999999999899999999999999999


Q ss_pred             hhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-CCCeEEeecccccccCCCCCeeeecc
Q 001561          857 WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADFGLSRLLRPYDTHVTTDL  935 (1052)
Q Consensus       857 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~  935 (1052)
                      ++....   ..+++..+..++.+++++++|||+.   +++|+||+|.||+++. ++.++++|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            987531   4588999999999999999999986   9999999999999999 89999999999987654321 12334


Q ss_pred             cccccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHH
Q 001561          936 VGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014 (1052)
Q Consensus       936 ~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1052)
                      .+...|++||..... .++.++|+|++|++++++                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            678899999988777 788999999999999999                                              


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001561         1015 QLLEMLEIACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus      1015 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                        ..+.+++.+|++.+|.+||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              368899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.9e-27  Score=241.73  Aligned_cols=259  Identities=22%  Similarity=0.260  Sum_probs=192.2

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeeeeceEeeC------Ce
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------ND  841 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  841 (1052)
                      .+|...+.+|.|.- .|..|... .+++||+|+.....  ....+...+|...+..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777888999988 66666543 68899999876442  33446678999999999999999999998532      46


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a  921 (1052)
                      .|+|||+|. ++|...++-      .++.++...+..|++.|++|||+.   +|+||||||+||++..++.+||.|||+|
T Consensus        96 ~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence            799999995 477777662      367788899999999999999997   9999999999999999999999999999


Q ss_pred             cccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccC------------CCCchhHHHH
Q 001561          922 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK------------GKNCRDLVSW  989 (1052)
Q Consensus       922 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~------------~~~~~~~~~~  989 (1052)
                      +.-+..  ...++++.|..|.|||++-+..+.+.+||||.||++.||++|+.-|.+..            +..+......
T Consensus       166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            865432  46678899999999999988889999999999999999999999885311            0011111111


Q ss_pred             HHHhh----hc------ccccccccccccchh---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          990 VFQMK----SE------KREVEIIDASIWHKD---REKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       990 ~~~~~----~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +....    ..      ....+.+....+...   .......+.+++.+|+..+|++|.+++++++
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            00000    00      000011111111110   1122346789999999999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=2.7e-25  Score=236.42  Aligned_cols=198  Identities=32%  Similarity=0.443  Sum_probs=172.5

Q ss_pred             CcccCeEcccCceEEEEEEECC-CcEEEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEecc
Q 001561          773 FNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      |+..+.||.|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5567899999999999998774 889999999866544 56788999999999999999999999999899999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +++|.+++....   ..+++..+..++.+++.++.|||+.   +++|+|++|+||+++.++.++++|||.+.........
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            999999987532   1178999999999999999999986   9999999999999999999999999999876543211


Q ss_pred             eeecccccccccCcccc-CCcCCCcccchHHHHHHHHHHHcCCCCCc
Q 001561          931 VTTDLVGTLGYIPPEYS-QTLTATCRGDVYSFGVVLLELLTGRRPVE  976 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltG~~pf~  976 (1052)
                      ......++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22345678899999988 66778889999999999999999999995

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=3.1e-26  Score=246.34  Aligned_cols=270  Identities=21%  Similarity=0.273  Sum_probs=204.7

Q ss_pred             ccccHHHHHHhhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcC------CCceee
Q 001561          759 KDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ------HKNLVS  831 (1052)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~  831 (1052)
                      ..+.+.++.  ..+|.+....|+|-|++|..|... .|..||||++... ....+.=..|+++|+++.      --++++
T Consensus       422 Yrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  422 YRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             EEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            334455544  457999999999999999999755 5789999999854 333444578999999995      237999


Q ss_pred             eeceEeeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-
Q 001561          832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-  910 (1052)
Q Consensus       832 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-  910 (1052)
                      ++-.|.+.++++||||-+ .-+|.+.+..+. ....+....+..++.|+.-||..|-..   +|+|.||||.|||+++. 
T Consensus       499 l~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            999999999999999977 458888887654 445578889999999999999999987   99999999999999965 


Q ss_pred             CCeEEeecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001561          911 FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  990 (1052)
Q Consensus       911 ~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~  990 (1052)
                      ..+||||||.|.+....   ..+++.-+..|.|||++.+.+|+...|+||.||+|||+.||+.-|.+....   +.+...
T Consensus       574 ~iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN---~MLrl~  647 (752)
T KOG0670|consen  574 NILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN---QMLRLF  647 (752)
T ss_pred             ceeeeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH---HHHHHH
Confidence            56899999999876532   234556677899999999999999999999999999999999998643211   111111


Q ss_pred             HHhhhc--------------------------------cc---ccccccc-----------cccchhhHHHHHHHHHHHH
Q 001561          991 FQMKSE--------------------------------KR---EVEIIDA-----------SIWHKDREKQLLEMLEIAC 1024 (1052)
Q Consensus       991 ~~~~~~--------------------------------~~---~~~~~~~-----------~~~~~~~~~~~~~l~~li~ 1024 (1052)
                      ...++.                                ..   ....+.+           .-..........++.+|+.
T Consensus       648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd  727 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD  727 (752)
T ss_pred             HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence            111100                                00   0000111           0011223445668899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 001561         1025 KCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1025 ~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +|+..||++|.|..|+++
T Consensus       728 kml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  728 KMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHhccChhhcCCHHHHhc
Confidence            999999999999999875

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-27  Score=248.10  Aligned_cols=417  Identities=23%  Similarity=0.253  Sum_probs=299.1

Q ss_pred             eeeccCcccccccccCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccC-Cc
Q 001561          210 ILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFG-NQ  288 (1052)
Q Consensus       210 ~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~  288 (1052)
                      ..+-++-.++.+|..+  .+.-.+++|+.|+|+.+.|.+|+.+++|+.||||+|+|+.+.|.+|.++.+|..|-+.+ |+
T Consensus        50 ~VdCr~~GL~eVP~~L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk  127 (498)
T KOG4237|consen   50 IVDCRGKGLTEVPANL--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK  127 (498)
T ss_pred             eEEccCCCcccCcccC--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence            4556666677777666  46788999999999999899999999999999999999999999999999998887777 99


Q ss_pred             CCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeeccccccc------
Q 001561          289 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFS------  362 (1052)
Q Consensus       289 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~------  362 (1052)
                      |+...-..|++|..|+.|.+.-|++.-.....|..+++|..|.+..|.+..+....|..+.+++.+.+..|.+-      
T Consensus       128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~  207 (498)
T KOG4237|consen  128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP  207 (498)
T ss_pred             hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence            99777788999999999999999999888899999999999999999999777778999999999999998832      


Q ss_pred             ------CCCCccccCCCccceeecccccccccCchhhccCCcCcEE--eccCCcCCCCcccchhhccCcccceEeccccc
Q 001561          363 ------GPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFL--SLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF  434 (1052)
Q Consensus       363 ------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L--~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~  434 (1052)
                            ...|..++...-..-..+.++++..+.+..|...  ++.+  .++.+-+-..+.....|..+++|+.|+|++|.
T Consensus       208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~--~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~  285 (498)
T KOG4237|consen  208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS--LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK  285 (498)
T ss_pred             hhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh--HHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence                  2234445555555556666677765555544332  2222  22333222223334568888999999999999


Q ss_pred             cCccCCccccCCCcccEEEccCCccccCcchhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeEeccCCcccccCCcc
Q 001561          435 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKS  514 (1052)
Q Consensus       435 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  514 (1052)
                      ++.+-+.+|.++..++.|.|..|+|...-...|.++..|+.|+|++|+|+..-|..|..+..|..|+|-.|.+--.  -.
T Consensus       286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn--C~  363 (498)
T KOG4237|consen  286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN--CR  363 (498)
T ss_pred             cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc--cc
Confidence            9888888999999999999999998866677888899999999999999888888888899999999988886521  01


Q ss_pred             hhhh-hhhcccCCCCC----CCCCCCCcccee-eccccCCC----cCCCCCCC-------CCCeeeeecCcccccCCccc
Q 001561          515 LTEL-KSLISSNCTSS----NPTASAGIPLYV-KHNRSTNG----LPYNQASS-------FPPSVFLSNNRINGTIPPEI  577 (1052)
Q Consensus       515 ~~~l-~~L~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~----l~~~~~~~-------~~~~l~Ls~N~l~g~ip~~~  577 (1052)
                      +..| ..|........    .+....++++.- .+....-+    ..-.....       ..+.+..|++.+. .+|.-+
T Consensus       364 l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~i  442 (498)
T KOG4237|consen  364 LAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGI  442 (498)
T ss_pred             hHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCC
Confidence            1111 11211111110    111122222210 01110000    00000000       1112233444443 666654


Q ss_pred             ccccccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeeccc
Q 001561          578 GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN  639 (1052)
Q Consensus       578 ~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~N  639 (1052)
                      -  ..-..|+|.+|+++ .+|.+  .+.+| .+|||+|+++..--..|.+++.|.+|-+|+|
T Consensus       443 P--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  443 P--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             C--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            3  35678999999999 88888  78888 9999999999777778999999999999987

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=4.7e-27  Score=245.81  Aligned_cols=288  Identities=20%  Similarity=0.223  Sum_probs=190.3

Q ss_pred             eeeCCCCC----CCCCCcEEEEEecCCCCcccCCccccCCcCCCeEecCCCCCCCCCcccccCCCCccEEeccC-CcccC
Q 001561           74 VVCGHGST----GSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSH-NMLSG  148 (1052)
Q Consensus        74 v~C~~~~~----~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~-N~l~~  148 (1052)
                      |.|+..+.    ...+...+.|+|..|+|+.+.+.+|+.+++|++||||+|+|+.+-|.+|..+.+|..|-+-+ |+|+.
T Consensus        51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~  130 (498)
T KOG4237|consen   51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD  130 (498)
T ss_pred             EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence            67765443    24667889999999999999999999999999999999999999999999999987776655 99999


Q ss_pred             cccccccccCCccEEEccCcccCCcc-cccccCCcccEEEecCCccCCccchhhhhcccccceeeccCcccc--------
Q 001561          149 PVSGMLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM--------  219 (1052)
Q Consensus       149 ~~~~~l~~l~~L~~L~Ls~N~l~~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~--------  219 (1052)
                      +..+.|++|..|+.|.+.-|++.... ..+..+++|..|.+..|.+. .++...|..+..++.+.+..|.+.        
T Consensus       131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl  209 (498)
T KOG4237|consen  131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWL  209 (498)
T ss_pred             hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchh
Confidence            99999999999999999999887655 34566677777777777666 556666666666666666666531        


Q ss_pred             -----cccccCCCCCCCCEEEcccccCCCCCCccccCC-CCCcEEEcccCcCCchhh-hhhcCCCCCcEEEccCCcCCCC
Q 001561          220 -----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSM-SSLQHVSLSVNNFSGQLS-EKISNLTSLRHLIIFGNQFSGK  292 (1052)
Q Consensus       220 -----~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~  292 (1052)
                           ..+..+++..-..-..+.++++..+.+..|... ..+..=..+.+...+..| ..|..|++|+.|+|++|+|+++
T Consensus       210 a~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i  289 (498)
T KOG4237|consen  210 ADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRI  289 (498)
T ss_pred             hhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchh
Confidence                 111223333333344444444443333333221 111111111222222322 4566666666666666666666


Q ss_pred             CcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeeccccccc
Q 001561          293 LPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFS  362 (1052)
Q Consensus       293 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  362 (1052)
                      -+.+|..+..+++|+|..|++...-...|.++..|+.|+|++|+|+...|.+|..+.+|.+|+|-.|.+.
T Consensus       290 ~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  290 EDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             hhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            6666666666666666666666555555666666666666666666666666666666666666665543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.5e-25  Score=221.72  Aligned_cols=251  Identities=19%  Similarity=0.278  Sum_probs=185.8

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeece-EeeCCeEEEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGY-CRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e  847 (1052)
                      +.|.+.+.+|+|.||.+-.+.++ +.+.+|+|.+.... ...++|.+|...--.+ .|.||+.-++. |+..+.++.++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            35888899999999999999876 56789999887553 3456788888764445 59999998885 556677789999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC--CCCCeEEeecccccccC
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD--EKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~--~~~~~kl~DfG~a~~~~  925 (1052)
                      |++.|+|.+-+..     ..+.+....+++.|+++|+.|||+.   .+||||||.+|||+-  +..++|+||||..+..+
T Consensus       103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999887753     4477888899999999999999985   999999999999994  34579999999998654


Q ss_pred             CCCCeeeecccccccccCccccCC-----cCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQT-----LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      .-..    ..--+..|.|||....     ....+.+|||.||+++|.++||+.||+.. ...+..+++|.....+...  
T Consensus       175 ~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~~--  247 (378)
T KOG1345|consen  175 TTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKNP--  247 (378)
T ss_pred             ceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccCc--
Confidence            3211    1223557999996432     24567899999999999999999999832 2334455666544333322  


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                      ...+  ....    ....++++.++-+.++|++|-...++.++
T Consensus       248 ~~P~--~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  248 ALPK--KFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             cCch--hhcc----cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            1111  1111    22367888999999999999655555543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=2.3e-25  Score=236.97  Aligned_cols=203  Identities=31%  Similarity=0.416  Sum_probs=167.5

Q ss_pred             HHHHHhhcCCcccCeEcccCceEEEEEEEC----CCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 001561          764 SDLLKSTNNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH  838 (1052)
Q Consensus       764 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  838 (1052)
                      .++....+.|...++||+|.|++||+|...    ..+.||+|.+.....  ...+..|++++..+ .+.||+++.+++..
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            344555678999999999999999999743    467899998865432  34588999999999 59999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-CCCCeEEee
Q 001561          839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLAD  917 (1052)
Q Consensus       839 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~-~~~~~kl~D  917 (1052)
                      .+...+|+||++.....++...       ++..++..+++.+..||+++|..   |||||||||+|++.+ ..+.-.|.|
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence            9999999999999988887764       56788999999999999999986   999999999999998 457789999


Q ss_pred             cccccccCCCC-------------C------------------------------eeeecccccccccCccccCC-cCCC
Q 001561          918 FGLSRLLRPYD-------------T------------------------------HVTTDLVGTLGYIPPEYSQT-LTAT  953 (1052)
Q Consensus       918 fG~a~~~~~~~-------------~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~  953 (1052)
                      ||+|..++.+.             .                              ......+||+||+|||++.. ..-+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            99998321100             0                              00112379999999997665 4578


Q ss_pred             cccchHHHHHHHHHHHcCCCCCccc
Q 001561          954 CRGDVYSFGVVLLELLTGRRPVEVC  978 (1052)
Q Consensus       954 ~~~DvwslGvil~elltG~~pf~~~  978 (1052)
                      +++||||.|||+.-+++++.||-..
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             CccceeeccceeehhhccccccccC
Confidence            8999999999999999999999643

>PLN03210 Resistant to P

Probab=99.91  E-value=1.6e-23  Score=270.55  Aligned_cols=272  Identities=21%  Similarity=0.264  Sum_probs=130.2

Q ss_pred             hhhhhcccccceeeccCcccc-------cccccCCCC-CCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhh
Q 001561          199 SRIWSASKEIQILDLSMNHFM-------GSLQGLDHS-PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS  270 (1052)
Q Consensus       199 ~~~~~~~~~L~~L~Ls~n~l~-------~~~~~l~~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  270 (1052)
                      ...|..+.+|+.|.+..+...       ..+.++..+ ++|+.|++.+|.+. .+|..| ...+|++|+|++|++. .++
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence            334455555555555443211       122333332 23555555555544 334443 2345555555555544 334


Q ss_pred             hhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCc
Q 001561          271 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSS  350 (1052)
Q Consensus       271 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  350 (1052)
                      ..+..+++|+.|+|++|.....+|. ++                        .+++|+.|+|++|.....+|..+.++++
T Consensus       628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls------------------------~l~~Le~L~L~~c~~L~~lp~si~~L~~  682 (1153)
T PLN03210        628 DGVHSLTGLRNIDLRGSKNLKEIPD-LS------------------------MATNLETLKLSDCSSLVELPSSIQYLNK  682 (1153)
T ss_pred             cccccCCCCCEEECCCCCCcCcCCc-cc------------------------cCCcccEEEecCCCCccccchhhhccCC
Confidence            4444455555555554432223332 44                        4444555555444433344444444555


Q ss_pred             cceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcEEeccCCcCCCCcccchhhccCcccceEec
Q 001561          351 LCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL  430 (1052)
Q Consensus       351 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L  430 (1052)
                      |+.|++++|..-..+|..+ ++++|+.|++++|...+.+|..   .++|+.|+|++|.+..+|..+    .+++|++|.+
T Consensus       683 L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~----~l~~L~~L~l  754 (1153)
T PLN03210        683 LEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNL----RLENLDELIL  754 (1153)
T ss_pred             CCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccccc----cccccccccc
Confidence            5555555443222344333 4455555555555433333322   234555555555555544322    2344555544


Q ss_pred             cccccC-------ccCCccccCCCcccEEEccCCccccCcchhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeEecc
Q 001561          431 TKNFVG-------EEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFS  503 (1052)
Q Consensus       431 ~~N~l~-------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  503 (1052)
                      .++...       ...+......++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|+
T Consensus       755 ~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls  833 (1153)
T PLN03210        755 CEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLS  833 (1153)
T ss_pred             cccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECC
Confidence            442211       1111122234566666676666665666666667777777776665444566544 56666777766


Q ss_pred             CCcc
Q 001561          504 NNTL  507 (1052)
Q Consensus       504 ~N~l  507 (1052)
                      +|..
T Consensus       834 ~c~~  837 (1153)
T PLN03210        834 GCSR  837 (1153)
T ss_pred             CCCc
Confidence            6643

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=5.5e-23  Score=265.68  Aligned_cols=337  Identities=18%  Similarity=0.205  Sum_probs=227.3

Q ss_pred             ccccccCCccEEEccCcccCC-------cccccccC-CcccEEEecCCccCCccchhhhhcccccceeeccCcccccccc
Q 001561          152 GMLAGLNLIQSLNVSSNSFNG-------SLFELGEF-SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQ  223 (1052)
Q Consensus       152 ~~l~~l~~L~~L~Ls~N~l~~-------~~~~l~~l-~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~  223 (1052)
                      ..|.++.+|+.|.+.++....       .+..+..+ .+|+.|++.++.+. .+|..+  ...+|+.|++++|++..++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLEKLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccccccc
Confidence            345555666666655443211       11223333 34666666666665 444433  34667777777777777777


Q ss_pred             cCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCcccc
Q 001561          224 GLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL  303 (1052)
Q Consensus       224 ~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  303 (1052)
                      ++..+++|+.|+|++|.....+| .+..+++|++|+|++|.....+|..+.++++|+.|++++|..-+.+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            77777778888887765444555 36677778888887776555777777777888888887765444666554 67777


Q ss_pred             ccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccc-------cCCCCccccCCCccc
Q 001561          304 EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF-------SGPLPNSLSDCHDLK  376 (1052)
Q Consensus       304 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-------~~~~p~~~~~l~~L~  376 (1052)
                      +.|++++|.....+|..   ..+|++|++++|.+.. +|..+ .+++|+.|++.++..       ....|..+...++|+
T Consensus       707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~  781 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT  781 (1153)
T ss_pred             CEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence            77777777655455532   3567788888887764 33333 467777777766432       111222233456788


Q ss_pred             eeecccccccccCchhhccCCcCcEEeccCC-cCCCCcccchhhccCcccceEeccccccCccCCccccCCCcccEEEcc
Q 001561          377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNN-SFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALG  455 (1052)
Q Consensus       377 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  455 (1052)
                      .|+|++|...+.+|..++++++|+.|+|++| .+..+|...    .+++|++|++++|.....+|..   ..+|+.|+|+
T Consensus       782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~----~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls  854 (1153)
T PLN03210        782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI----NLESLESLDLSGCSRLRTFPDI---STNISDLNLS  854 (1153)
T ss_pred             heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC----CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence            8888888777778888888888888888876 466666542    5778888888887665555543   3578888999


Q ss_pred             CCccccCcchhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeEeccCCc
Q 001561          456 NCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNT  506 (1052)
Q Consensus       456 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  506 (1052)
                      +|.++ .+|.++..+++|+.|+|++|+--..+|..+..+++|+.+++++|.
T Consensus       855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence            98887 678888889999999998854333677788888899999988885

syringae 6; Provisional

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=1.5e-24  Score=272.44  Aligned_cols=194  Identities=19%  Similarity=0.234  Sum_probs=138.6

Q ss_pred             cCC-CceeeeeceE-------eeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 001561          824 AQH-KNLVSLQGYC-------RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI  895 (1052)
Q Consensus       824 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  895 (1052)
                      ++| +||++++++|       .+++..+.++||+ +++|.+++..   ....+++.++..++.||++||+|||+.   +|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            445 5788888877       2334567888987 5699999974   245689999999999999999999986   99


Q ss_pred             EEcCCCCCceEECC-------------------CCCeEEeecccccccCCCCC---------------eeeecccccccc
Q 001561          896 VHRDVKSSNILLDE-------------------KFEAHLADFGLSRLLRPYDT---------------HVTTDLVGTLGY  941 (1052)
Q Consensus       896 ~HrDlkp~Nill~~-------------------~~~~kl~DfG~a~~~~~~~~---------------~~~~~~~gt~~y  941 (1052)
                      +||||||+|||++.                   ++.+|++|||+++.......               ......+||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44566666666654211000               001124689999


Q ss_pred             cCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHH
Q 001561          942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLE 1021 (1052)
Q Consensus       942 ~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1021 (1052)
                      ||||++.+..++.++|||||||++|||++|.+|+...     .....   .....     ...+..     .....+..+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~---~~~~~-----~~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMS---SLRHR-----VLPPQI-----LLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHH---HHHHh-----hcChhh-----hhcCHHHHH
Confidence            9999999999999999999999999999999986421     01111   00000     011100     111224567


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 001561         1022 IACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1022 li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      ++.+|++++|.+||+|.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            888999999999999999986

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=1.8e-23  Score=249.81  Aligned_cols=61  Identities=25%  Similarity=0.299  Sum_probs=32.3

Q ss_pred             ccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeecccccccCCCC
Q 001561          582 HLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPT  647 (1052)
Q Consensus       582 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~  647 (1052)
                      +|+.|++++|+|+ .+|...   .+|+.|+|++|+|+ .+|..+.++++|..|+|++|+|+|.+|.
T Consensus       403 ~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        403 ELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             CCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            4555555555555 244322   24455555555555 4555555555555555555555555543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-24  Score=215.57  Aligned_cols=250  Identities=23%  Similarity=0.360  Sum_probs=191.3

Q ss_pred             cccCeEcccCceEEEEEEECCCcEEEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccC
Q 001561          774 NQANIIGCGGFGLVYKATLTNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       774 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  851 (1052)
                      ....+|.+...|..|+|+|+ |..+++|++...  .....++|..|.-.++-+.||||.++++.|..+....++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34556889999999999998 555555766432  244557799999999999999999999999999999999999999


Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|...+++.  .....+..++.++|.++|+|++|||+. ++-|..--+.+..|++|++.+++|+ .+-+++.-     .
T Consensus       272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsf-----q  342 (448)
T KOG0195|consen  272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF-----Q  342 (448)
T ss_pred             hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeee-----e
Confidence            9999999975  455678889999999999999999997 5555556789999999999998875 12122110     0


Q ss_pred             eecccccccccCccccCCcCCC---cccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccccccccc
Q 001561          932 TTDLVGTLGYIPPEYSQTLTAT---CRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .....-.|.||+||.++.++.+   .++|+|||++++||+.|.+.||....+-++.-.+               .-..+.
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------------aleglr  407 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------------ALEGLR  407 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------------hhcccc
Confidence            1112346789999988776544   4799999999999999999999754433321110               011111


Q ss_pred             chhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      -..++..+..+.+++.-|+..||.+||.++.++-.||.+.
T Consensus       408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            2223344557899999999999999999999999999864

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=4.5e-23  Score=246.49  Aligned_cols=268  Identities=24%  Similarity=0.312  Sum_probs=159.6

Q ss_pred             ceeeccCcccccccccCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCc
Q 001561          209 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ  288 (1052)
Q Consensus       209 ~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  288 (1052)
                      ..|+|+.|.++.+|..+.  ++|+.|++.+|+|+. +|.   .+++|++|+|++|+|+. +|..   .++|+.|+|++|.
T Consensus       204 ~~LdLs~~~LtsLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~  273 (788)
T PRK15387        204 AVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNP  273 (788)
T ss_pred             cEEEcCCCCCCcCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCc
Confidence            344444444444444332  245555555555542 232   13455555555555552 2321   2345555555555


Q ss_pred             CCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCcc
Q 001561          289 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS  368 (1052)
Q Consensus       289 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  368 (1052)
                      ++ .+|..+   ++|+.|++++|+++. +|.   ..++|+.|++++|++++... .   ..+|+.|++++|+|++ +|..
T Consensus       274 L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~L~~-LP~l  340 (788)
T PRK15387        274 LT-HLPALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQLTS-LPTL  340 (788)
T ss_pred             hh-hhhhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCccccCCC-C---cccccccccccCcccc-cccc
Confidence            54 233322   334455555555552 232   12456666666666664322 1   2345666666666663 4431


Q ss_pred             ccCCCccceeecccccccccCchhhccCCcCcEEeccCCcCCCCcccchhhccCcccceEeccccccCccCCccccCCCc
Q 001561          369 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFES  448 (1052)
Q Consensus       369 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  448 (1052)
                         ..+|+.|+|++|+|++ +|..   .++|+.|++++|+|+.+|..      ..+|+.|++++|.+.. +|..   .++
T Consensus       341 ---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~l------~~~L~~LdLs~N~Lt~-LP~l---~s~  403 (788)
T PRK15387        341 ---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL------PSGLKELIVSGNRLTS-LPVL---PSE  403 (788)
T ss_pred             ---ccccceEecCCCccCC-CCCC---CcccceehhhccccccCccc------ccccceEEecCCcccC-CCCc---ccC
Confidence               1356677777777763 4432   23566667777777766542      2457777777777753 4433   257


Q ss_pred             ccEEEccCCccccCcchhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeEeccCCcccccCCcchhhhhhh
Q 001561          449 LMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL  521 (1052)
Q Consensus       449 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  521 (1052)
                      |+.|++++|++++ +|...   .+|+.|+|++|+++ .+|..++++++|+.|+|++|+|++.+|..+..+.+.
T Consensus       404 L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~s~  471 (788)
T PRK15387        404 LKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA  471 (788)
T ss_pred             CCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHhcC
Confidence            8889999999884 66543   46889999999998 799999999999999999999999888887666544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=4.9e-23  Score=210.11  Aligned_cols=168  Identities=21%  Similarity=0.188  Sum_probs=126.2

Q ss_pred             CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCee
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  931 (1052)
                      |+|.++++..   +..+++.+++.|+.|+++||+|||+.   +      ||+||+++.++.+|+  ||.++......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6888888752   45699999999999999999999986   4      999999999999999  99998754322   


Q ss_pred             eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchh
Q 001561          932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011 (1052)
Q Consensus       932 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1052)
                         ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ................   ..+    ...
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~---~~~----~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPADD---PRD----RSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccCC---ccc----ccc
Confidence               2689999999999999999999999999999999999999963221  1111111111111100   000    011


Q ss_pred             hHHHH--HHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561         1012 REKQL--LEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1012 ~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      .....  .++.+++.+|++.+|++||++.|+++.+..+.
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            11222  26899999999999999999999999776553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=2.7e-22  Score=241.81  Aligned_cols=319  Identities=21%  Similarity=0.282  Sum_probs=171.5

Q ss_pred             CCCCCCHHHHHHHHHHHhcCCCCCCCCC----cCCCCCCceeee----------------eeeCCCCCCCCCCcEEEEEe
Q 001561           34 PFQSCDPSDLLALKEFAGNLTNGSIITS----WSNESMCCQWDG----------------VVCGHGSTGSNAGRVTMLIL   93 (1052)
Q Consensus        34 ~~~~~~~~~~~aLl~~k~~~~~~~~l~s----w~~~~~~c~w~g----------------v~C~~~~~~~~~~~v~~l~L   93 (1052)
                      +.....++|.+.+++....+.-++++.+    |++.++.|.=..                |.|.       .+.||.+..
T Consensus        56 ~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~-------~~~vt~l~~  128 (754)
T PRK15370         56 PPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG-------GKSVTYTRV  128 (754)
T ss_pred             CCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecC-------CCccccccc
Confidence            3455678999999999999987877777    999999996443                6774       244555544


Q ss_pred             cCCCCcccCCccccCCcCCCeEec----CCCCCCCCC---cccc-----cCCCCccEEeccCCcccCcccccccccCCcc
Q 001561           94 PRKGLKGIIPRSLGHLNQLKLLDL----SCNHLEGVV---PVEL-----SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ  161 (1052)
Q Consensus        94 ~~~~l~g~~~~~l~~l~~L~~L~L----s~n~i~~~~---p~~l-----~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~  161 (1052)
                      -+.........+-   ..-.+...    ..+.-.+..   ..++     +-..+...|+++++.++..+ ..+.  .+|+
T Consensus       129 ~g~~~~~~~~~~~---~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP-~~Ip--~~L~  202 (754)
T PRK15370        129 TESEQASSASGSK---DAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIP-ACIP--EQIT  202 (754)
T ss_pred             ccccccccCCCCC---ChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCC-cccc--cCCc
Confidence            3321111110000   00000000    000000000   0001     11245677888888777643 3232  4677


Q ss_pred             EEEccCcccCCcccccccCCcccEEEecCCccCCccchhhhhcccccceeeccCcccccccccCCCCCCCCEEEcccccC
Q 001561          162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLL  241 (1052)
Q Consensus       162 ~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l  241 (1052)
                      .|+|++|.++..+..+.  ++|+.|++++|+|+ .+|..+.   .+|+.|+|++|++..+|                   
T Consensus       203 ~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~~LP-------------------  257 (754)
T PRK15370        203 TLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMELSINRITELP-------------------  257 (754)
T ss_pred             EEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEECcCCccCcCC-------------------
Confidence            88888888876655443  46777777777666 3343222   23444555555444433                   


Q ss_pred             CCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCccc
Q 001561          242 GGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL  321 (1052)
Q Consensus       242 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l  321 (1052)
                           ..+.  ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|++ +|..+.  ++|+.|++++|+++. +|..+
T Consensus       258 -----~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l  323 (754)
T PRK15370        258 -----ERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETL  323 (754)
T ss_pred             -----hhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCccc
Confidence                 3332  24555555555554 2343332  355555555555552 333222  345666666666653 33322


Q ss_pred             ccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcE
Q 001561          322 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLF  401 (1052)
Q Consensus       322 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  401 (1052)
                        .++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ..|+.
T Consensus       324 --~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~  392 (754)
T PRK15370        324 --PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQI  392 (754)
T ss_pred             --cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHH
Confidence              2466677777776664 333332  56777777777776 4555443  46777777777776 3454443  25667


Q ss_pred             EeccCCcCCCCccc
Q 001561          402 LSLSNNSFNHLSGT  415 (1052)
Q Consensus       402 L~L~~N~l~~l~~~  415 (1052)
                      |++++|+|+.+|..
T Consensus       393 LdLs~N~L~~LP~s  406 (754)
T PRK15370        393 MQASRNNLVRLPES  406 (754)
T ss_pred             HhhccCCcccCchh
Confidence            77777777666543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=4.6e-22  Score=220.96  Aligned_cols=165  Identities=21%  Similarity=0.213  Sum_probs=128.5

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC--CCcEEEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCe
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT--NGTKAAVKRLSGD-----CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  841 (1052)
                      ...+|++.+.||+|+||+||+|.+.  +++.||||++...     .....+.+.+|++++++++|+|+++.+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            3467999999999999999999764  5778899987533     12235568999999999999999853322   245


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCceEECCCCCeEEeeccc
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV-KSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDl-kp~Nill~~~~~~kl~DfG~  920 (1052)
                      .++||||++|++|... .    ...      ...++.++++||+|||+.   +|+|||| ||+|||++.++.+||+|||+
T Consensus        93 ~~LVmE~~~G~~L~~~-~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-R----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             cEEEEEccCCCCHHHh-C----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            7999999999998632 1    111      146788999999999986   9999999 99999999999999999999


Q ss_pred             ccccCCCCCee-------eecccccccccCccccCCc
Q 001561          921 SRLLRPYDTHV-------TTDLVGTLGYIPPEYSQTL  950 (1052)
Q Consensus       921 a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~  950 (1052)
                      |+.+.......       .....+++.|+|||++...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99765432111       1345788899999987643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.8e-21  Score=218.05  Aligned_cols=258  Identities=21%  Similarity=0.244  Sum_probs=192.5

Q ss_pred             CCcccCeEcccCceEEEEEEECCC--cEEEEEEecCCchhhHHHHHHHHHHHHhcCC----CceeeeeceE-eeCCeEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLTNG--TKAAVKRLSGDCGQMEREFQAEVEALSRAQH----KNLVSLQGYC-RHGNDRLL  844 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  844 (1052)
                      +|.+.+.||+|+||.||+|.....  ..+|+|............+..|+.++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999986643  4788888765433322267888899888863    5888888888 47778899


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-----CCeEEeecc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-----FEAHLADFG  919 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-----~~~kl~DfG  919 (1052)
                      ||+.+ |.+|.++.....  .+.++..++.+|+.|++.+|+++|+.   |++||||||+|+++...     ..+++.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99977 889999775543  56799999999999999999999986   99999999999999865     469999999


Q ss_pred             cccccC--CCCCe------e-eecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHH
Q 001561          920 LSRLLR--PYDTH------V-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV  990 (1052)
Q Consensus       920 ~a~~~~--~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~  990 (1052)
                      +|+.+.  .....      . .....||..|++++...+...+.+.|+||++.++.|+..|..||..........   ..
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~---~~  249 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS---KF  249 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH---HH
Confidence            999322  21111      1 123569999999999999999999999999999999999999996433222111   11


Q ss_pred             HHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          991 FQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      ...........         .......++.++...+-..+..++|....+...+++.
T Consensus       250 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  250 EKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            11111111000         0111122455666666668999999999999887655

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.3e-21  Score=200.76  Aligned_cols=258  Identities=18%  Similarity=0.229  Sum_probs=201.9

Q ss_pred             cCCcccCeEcccCceEEEEEE-ECCCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeeceEeeCCeEEEEEEe
Q 001561          771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      -+|++.++||+|.||.++.|. +-+++.||||.-....  ...++..|.+..+.+ ..++|..++.+..++..-.+|+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            479999999999999999997 4579999999764332  235678899999888 478999999888888888999998


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-----CCCeEEeecccccc
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-----KFEAHLADFGLSRL  923 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-----~~~~kl~DfG~a~~  923 (1052)
                      + |.+|++...-   .++.++..++..+|.|++.-++|+|+.   ..|.|||||+|+||..     ...+.++|||+|+.
T Consensus       106 L-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  106 L-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             h-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            8 8899987653   467899999999999999999999986   9999999999999974     34589999999999


Q ss_pred             cCCCCCeee------ecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcc
Q 001561          924 LRPYDTHVT------TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       924 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      +.+..+...      ....||.+||+-....+..-+.+.|+-|+|-++++.+-|..||++...++-.+-.+.+-..+...
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            876655433      34589999999999999999999999999999999999999999766555433333332222222


Q ss_pred             cccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 001561          998 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046 (1052)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1046 (1052)
                      ...         ...+..+.++..-+...-+.+-.+-|..+.+...+.+
T Consensus       259 ~i~---------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d  298 (449)
T KOG1165|consen  259 PIE---------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD  298 (449)
T ss_pred             CHH---------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            111         1122334466666766677788888988777665443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=5.6e-22  Score=194.64  Aligned_cols=258  Identities=20%  Similarity=0.247  Sum_probs=199.4

Q ss_pred             hcCCcccCeEcccCceEEEEEE-ECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCC-CceeeeeceEeeCCeEEEEEE
Q 001561          770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH-KNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      .++|++++.||.|+||.+|.|. ..+|+.||||.-+.....  .++..|.++.+.++| ..|..+..|..+...-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4689999999999999999997 668999999987655433  457788999999964 678888888888888899999


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC---CCCeEEeeccccccc
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE---KFEAHLADFGLSRLL  924 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~  924 (1052)
                      .+ |.+|++...-   ....++..+++-.|-|++.-++|+|..   +++||||||+|+|+.-   ...+.++|||+|+.+
T Consensus        92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            88 8899998764   355689999999999999999999986   9999999999999973   456899999999987


Q ss_pred             CCCCCeee------ecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          925 RPYDTHVT------TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       925 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      .+..+...      ....||.+|.+-....+...+.+.|+-|+|.++.++--|..||++....+-..-.+.+.+.+-...
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            65443322      345899999998887777888899999999999999999999987654443333333333222111


Q ss_pred             ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                      . +        ......+.++.-.+..|-..--++-|....+-+.+.
T Consensus       245 i-e--------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  245 I-E--------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             H-H--------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            1 1        111222335667777888888888888777766554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=5.8e-22  Score=234.88  Aligned_cols=259  Identities=21%  Similarity=0.245  Sum_probs=191.6

Q ss_pred             cccCeEcccCceEEEEEEEC-CCcEEEEEEec----C-Cchh-hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          774 NQANIIGCGGFGLVYKATLT-NGTKAAVKRLS----G-DCGQ-MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       774 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ....++|.|++|.|+.+... ..+.++.|.++    . +... ....+..|+.+-..++|||++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999988877643 44445555443    1 1111 1122667888888899999999988888777777779


Q ss_pred             EeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+++ +|..++..    ...++..++..++.|+..|++|+|++   ||.|||+|++|++++.+|.+||+|||.+....-
T Consensus       401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 99988864    24678899999999999999999997   999999999999999999999999999987643


Q ss_pred             CCC---eeeecccccccccCccccCCcCCCc-ccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccccc
Q 001561          927 YDT---HVTTDLVGTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       927 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ...   ......+|+.+|+|||+..+..|++ ..||||.|+++..|.+|+.||-........-     .....   ....
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~---~~~~  544 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNY---SDQR  544 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcc---cccc
Confidence            322   3456679999999999999999987 4799999999999999999996433221110     00000   0000


Q ss_pred             ccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcC
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                      -...-........+.+-..++.+|++++|.+|.|+.+|++  |++.|.
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            0000011111223446788999999999999999999988  777664

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=7e-21  Score=229.66  Aligned_cols=245  Identities=22%  Similarity=0.351  Sum_probs=117.3

Q ss_pred             cceeeccCcccccccccCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCC
Q 001561          208 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN  287 (1052)
Q Consensus       208 L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  287 (1052)
                      .+.|++++++++.+|..+  .++|+.|+|++|+|+ .+|..+.  .+|++|++++|+|+ .+|..+.  .+|+.|+|++|
T Consensus       180 ~~~L~L~~~~LtsLP~~I--p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N  251 (754)
T PRK15370        180 KTELRLKILGLTTIPACI--PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSIN  251 (754)
T ss_pred             ceEEEeCCCCcCcCCccc--ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCC
Confidence            445555555555555443  245666666666666 3344333  35666666666665 3343332  24566666666


Q ss_pred             cCCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCc
Q 001561          288 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN  367 (1052)
Q Consensus       288 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  367 (1052)
                      ++. .+|..+.                          ++|+.|++++|+++. +|..+.  ++|+.|+|++|+|++ +|.
T Consensus       252 ~L~-~LP~~l~--------------------------s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~  300 (754)
T PRK15370        252 RIT-ELPERLP--------------------------SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPA  300 (754)
T ss_pred             ccC-cCChhHh--------------------------CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccc
Confidence            555 3443332                          234444444444442 222221  245555555555552 333


Q ss_pred             cccCCCccceeecccccccccCchhhccCCcCcEEeccCCcCCCCcccchhhccCcccceEeccccccCccCCccccCCC
Q 001561          368 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFE  447 (1052)
Q Consensus       368 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  447 (1052)
                      .+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|.++.+|..+     .++|+.|++++|.+. .+|..+.  +
T Consensus       301 ~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l-----~~sL~~L~Ls~N~L~-~LP~~lp--~  367 (754)
T PRK15370        301 HLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSLPASL-----PPELQVLDVSKNQIT-VLPETLP--P  367 (754)
T ss_pred             cch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccCChhh-----cCcccEEECCCCCCC-cCChhhc--C
Confidence            322  345556666666653 333322  45666666666665554322     134444444444442 2232221  3


Q ss_pred             cccEEEccCCccccCcchhhhcCCCCcEEeCcCccCCCCCChhh----ccCCCCCeEeccCCccc
Q 001561          448 SLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI----GQMENLFYLDFSNNTLT  508 (1052)
Q Consensus       448 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~  508 (1052)
                      +|+.|+|++|+|+ .+|..+.  ..|+.|++++|+++ .+|..+    +.++++..|++.+|.++
T Consensus       368 ~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        368 TITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            4555555555555 3333332  24555555655555 334322    22345555566655554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1.7e-19  Score=203.98  Aligned_cols=259  Identities=28%  Similarity=0.411  Sum_probs=197.2

Q ss_pred             CcccCeEcccCceEEEEEEECCCcEEEEEEecCCchh---hHHHHHHHHHHHHhcCCC-ceeeeeceEeeCCeEEEEEEe
Q 001561          773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHK-NLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      |+..+.||.|+||.||++...  ..+|+|.+......   ....+.+|+..++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999876  78899988755432   467789999999999988 799999999777778999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCC-CeEEeecccccccCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPY  927 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~  927 (1052)
                      +.++++.+++...... ..++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++.....
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999666543211 3688899999999999999999996   899999999999999988 7999999999865443


Q ss_pred             CCe-----eeecccccccccCccccCC---cCCCcccchHHHHHHHHHHHcCCCCCcccCCC-CchhHHHHHHHhhhccc
Q 001561          928 DTH-----VTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGK-NCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       928 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~~  998 (1052)
                      ...     ......||..|+|||...+   ..+....|+||+|++++++++|..||...... ........+......  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            322     2356789999999998887   57888999999999999999999997643221 011222221111111  


Q ss_pred             ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                         .................+.+++.+|+..+|..|.++.+...
T Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence               00000000000222346789999999999999999988765

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=3e-20  Score=191.45  Aligned_cols=170  Identities=14%  Similarity=0.157  Sum_probs=133.4

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHH---------HHHHHHHHHHhcCCCceeeeeceEeeC-
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER---------EFQAEVEALSRAQHKNLVSLQGYCRHG-  839 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~-  839 (1052)
                      .++|+..+++|.|+||.||.+.. ++..+|+|.+.......+.         .+.+|+..+.++.||+|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            67899999999999999999766 5778999999755433332         268899999999999999999886543 


Q ss_pred             -------CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCC
Q 001561          840 -------NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE  912 (1052)
Q Consensus       840 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~  912 (1052)
                             ...++||||++|.+|.++..        ++.    ....+++.+++.+|+.   +++|||+||+||+++.+| 
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence                   35789999999999977632        222    2355899999999986   999999999999999998 


Q ss_pred             eEEeecccccccCCCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHH
Q 001561          913 AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL  969 (1052)
Q Consensus       913 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  969 (1052)
                      ++++|||..+........             ..+.....+..++|+|+||+++....
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999998765321110             11344445667899999999887664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=2e-19  Score=184.06  Aligned_cols=140  Identities=18%  Similarity=0.147  Sum_probs=108.8

Q ss_pred             cCeEcccCceEEEEEEECCCcEEEEEEecCCchh--h------------------------HHHHHHHHHHHHhcCCCce
Q 001561          776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ--M------------------------EREFQAEVEALSRAQHKNL  829 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  829 (1052)
                      ...||+|+||.||+|...+|+.||||+++.....  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999998754211  0                        1122459999999988877


Q ss_pred             eeeeceEeeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCCceEEC
Q 001561          830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLD  908 (1052)
Q Consensus       830 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~HrDlkp~Nill~  908 (1052)
                      .....+..  ...++||||++++++.....    ....++...+..++.|++.+++|+ |+.   +|+||||||+||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            44333222  23489999999987654432    234688999999999999999999 675   999999999999998


Q ss_pred             CCCCeEEeecccccccC
Q 001561          909 EKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       909 ~~~~~kl~DfG~a~~~~  925 (1052)
                       ++.++++|||+|....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=3.3e-19  Score=189.25  Aligned_cols=234  Identities=23%  Similarity=0.325  Sum_probs=149.2

Q ss_pred             CCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcC----------CCceeeeeceEe
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQ----------HKNLVSLQGYCR  837 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~  837 (1052)
                      .+...+.||.|+++.||.+.+. +++++|+|++....   ....+++.+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4556788999999999999876 68999999875332   223455666655444432          222333333221


Q ss_pred             ---------eC---C-----eEEEEEEeccCCChhhhhhc---ccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 001561          838 ---------HG---N-----DRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH  897 (1052)
Q Consensus       838 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  897 (1052)
                               ..   .     ..+++|+-+ -++|.+++..   .......+....++.+..|+++.+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                     11   1     125677777 4577776542   222233455667788889999999999997   9999


Q ss_pred             cCCCCCceEECCCCCeEEeecccccccCCCCCeeeecccccccccCccccCC--------cCCCcccchHHHHHHHHHHH
Q 001561          898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT--------LTATCRGDVYSFGVVLLELL  969 (1052)
Q Consensus       898 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~ell  969 (1052)
                      +||+|+|++++++|.++++||+.....+.    .......+..|.+||....        ..++.+.|.|++|+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999998876543    1221345578999996533        35788999999999999999


Q ss_pred             cCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCC
Q 001561          970 TGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRR 1034 (1052)
Q Consensus       970 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1034 (1052)
                      +|+.||+........+.                    ...... ..++.+.++|..+++++|++|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999974322111110                    111222 556689999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.78  E-value=9.6e-20  Score=213.06  Aligned_cols=250  Identities=22%  Similarity=0.231  Sum_probs=178.6

Q ss_pred             CCcccCeEcccCceEEEEEEECCCcEEEEEEecCCc-hhhHHHHH---HHHHHHHhcCCCceeeeeceEeeCCeEEEEEE
Q 001561          772 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC-GQMEREFQ---AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       772 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  847 (1052)
                      +|...+.+|.+.|=+|.+|+.+.|. |+||++.+.. ...-+.|.   +|++ ...++|||.+++.-+-......|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5666888999999999999998887 8889886554 22233333   3444 455689999999888777777788888


Q ss_pred             eccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc--C
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--R  925 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~--~  925 (1052)
                      |... +|.|.+.    .+..+...+...||.|++.|+..+|..   +|+|||||.+|||++.=.-+.++||..-+..  .
T Consensus       102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            8854 6777664    455678888999999999999999986   9999999999999999889999999765542  2


Q ss_pred             CCCCeeeecccc----cccccCccccCC----------cC-CCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHH
Q 001561          926 PYDTHVTTDLVG----TLGYIPPEYSQT----------LT-ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSW  989 (1052)
Q Consensus       926 ~~~~~~~~~~~g----t~~y~aPE~~~~----------~~-~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~  989 (1052)
                      .++.....-+..    --.|.|||.+..          .. .+++-||||.||++.|+++ |++||+-.          .
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----------Q  243 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----------Q  243 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----------H
Confidence            222222211222    237999995432          12 5678899999999999998 79998621          1


Q ss_pred             HHHhhhcc-cccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcC
Q 001561          990 VFQMKSEK-REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       990 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      .+.....+ ...+..-..       -+...+++++..|++.||++|-++++.++.-+++.
T Consensus       244 L~aYr~~~~~~~e~~Le~-------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  244 LLAYRSGNADDPEQLLEK-------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             HHhHhccCccCHHHHHHh-------CcCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            11111110 000000000       01125789999999999999999999999866654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2e-18  Score=173.55  Aligned_cols=184  Identities=19%  Similarity=0.128  Sum_probs=138.5

Q ss_pred             cccCeEcccCceEEEEEEECCCcEEEEEEecCCch----hhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEEEEe
Q 001561          774 NQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG----QMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       774 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      .+...|++|+||+||.+.. .+.+++.+.+.....    .....+.+|++++++++ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997765 578888887764432    11225789999999995 5889999886    346899999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCceEECCCCCeEEeecccccccCCC
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV-KSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDl-kp~Nill~~~~~~kl~DfG~a~~~~~~  927 (1052)
                      ++|.+|......           ....++.|++++++++|+.   ||+|||| ||+||++++++.++|+|||+|....+.
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999988654311           1134678999999999997   9999999 799999999999999999999865432


Q ss_pred             CCe----e--------eecccccccccCccccC--CcCCCcccchHHHHHHHHHHHcCCCCCc
Q 001561          928 DTH----V--------TTDLVGTLGYIPPEYSQ--TLTATCRGDVYSFGVVLLELLTGRRPVE  976 (1052)
Q Consensus       928 ~~~----~--------~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltG~~pf~  976 (1052)
                      ...    .        ..-...++.|++|+...  ...--.+.+.++-|.-+|.++|+..|.-
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            210    0        00113577888888422  2222357899999999999999999864

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=2.1e-18  Score=177.51  Aligned_cols=140  Identities=18%  Similarity=0.156  Sum_probs=111.3

Q ss_pred             cCeEcccCceEEEEEEECCCcEEEEEEecCCchh--------------------------hHHHHHHHHHHHHhcCCCce
Q 001561          776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ--------------------------MEREFQAEVEALSRAQHKNL  829 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  829 (1052)
                      ...||+|++|.||+|...+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999998778999999998754211                          01223678999999999987


Q ss_pred             eeeeceEeeCCeEEEEEEeccCCChhhh-hhcccCCccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCceEE
Q 001561          830 VSLQGYCRHGNDRLLIYSYMENGSLDYW-LHESVDKDSVLKWDVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILL  907 (1052)
Q Consensus       830 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill  907 (1052)
                      .....+...  ..++||||++++++... +.     ...++..++..++.+++.++.++|+ .   +|+||||||+||++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            554444332  24899999998855332 32     2346788899999999999999998 5   99999999999999


Q ss_pred             CCCCCeEEeecccccccCC
Q 001561          908 DEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       908 ~~~~~~kl~DfG~a~~~~~  926 (1052)
                      + ++.++++|||+|+....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 88999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=5.6e-20  Score=207.01  Aligned_cols=276  Identities=24%  Similarity=0.299  Sum_probs=128.5

Q ss_pred             EecCCccCCccchhhhhcccccceeeccCcccc-----cccccCCCCCCCCEEEcccccCCC------CCCccccCCCCC
Q 001561          187 NISNNSFTGKLNSRIWSASKEIQILDLSMNHFM-----GSLQGLDHSPSLKQLHVDNNLLGG------DLPDSLYSMSSL  255 (1052)
Q Consensus       187 ~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~-----~~~~~l~~~~~L~~L~L~~N~l~~------~~p~~l~~l~~L  255 (1052)
                      +|..+.+++.--...+..+..|+.|+++++.++     .++..+...+++++|+++++.+.+      .++..+..+++|
T Consensus         4 ~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L   83 (319)
T cd00116           4 SLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGL   83 (319)
T ss_pred             ccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCce
Confidence            334444443333344444444555555555542     122334455556666666665552      123345556666


Q ss_pred             cEEEcccCcCCchhhhhhcCCCC---CcEEEccCCcCCCC----CcccccCc-cccccccccCCcccCC----CCccccc
Q 001561          256 QHVSLSVNNFSGQLSEKISNLTS---LRHLIIFGNQFSGK----LPNVLGNL-TQLEFFVAHSNSFSGP----LPLSLSL  323 (1052)
Q Consensus       256 ~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~l~~N~l~~~----~~~~l~~  323 (1052)
                      ++|++++|.+.+..+..+..+.+   |++|++++|++++.    +...+..+ ++|+.|++++|.+++.    ++..+..
T Consensus        84 ~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~  163 (319)
T cd00116          84 QELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRA  163 (319)
T ss_pred             eEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHh
Confidence            66666666666555555544444   66666666666521    11222333 4444444444444421    1222333


Q ss_pred             CCCCcEEEecCccccCc----CCcccccCCccceeecccccccCC----CCccccCCCccceeecccccccccCchhhcc
Q 001561          324 CSKLHVLDLRNNSLTGP----IDLNFSGLSSLCTLDLATNHFSGP----LPNSLSDCHDLKILSLAKNELSGQVPESFGK  395 (1052)
Q Consensus       324 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  395 (1052)
                      +++|++|++++|.+++.    ++..+..+++|+.|+|++|.+++.    ++..+..+++|++|++++|.+++.....+..
T Consensus       164 ~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~  243 (319)
T cd00116         164 NRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALAS  243 (319)
T ss_pred             CCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHH
Confidence            44455555555544421    111122233444444444444322    1122333344444444444444321111111


Q ss_pred             CCcCcEEeccCCcCCCCcccchhhccCcccceEeccccccCc----cCCccccCCCcccEEEccCCccccC----cchhh
Q 001561          396 LTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE----EIPENVGGFESLMVLALGNCGLKGH----IPVWL  467 (1052)
Q Consensus       396 l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l  467 (1052)
                      .                     .....+.|++|++++|.++.    .+...+..+++|+.+++++|.++..    ....+
T Consensus       244 ~---------------------~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~  302 (319)
T cd00116         244 A---------------------LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL  302 (319)
T ss_pred             H---------------------HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence            0                     00012455555555555431    2233444556777777777777744    33344


Q ss_pred             hcC-CCCcEEeCcCccC
Q 001561          468 LRC-KKLQVLDLSWNHF  483 (1052)
Q Consensus       468 ~~l-~~L~~L~Ls~N~l  483 (1052)
                      ... +.|+.|++.+|.+
T Consensus       303 ~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         303 LEPGNELESLWVKDDSF  319 (319)
T ss_pred             hhcCCchhhcccCCCCC
Confidence            444 6788888888764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=9.4e-20  Score=205.19  Aligned_cols=273  Identities=23%  Similarity=0.237  Sum_probs=129.2

Q ss_pred             EEcccccCC-CCCCccccCCCCCcEEEcccCcCCch----hhhhhcCCCCCcEEEccCCcCCC------CCcccccCccc
Q 001561          234 LHVDNNLLG-GDLPDSLYSMSSLQHVSLSVNNFSGQ----LSEKISNLTSLRHLIIFGNQFSG------KLPNVLGNLTQ  302 (1052)
Q Consensus       234 L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~~  302 (1052)
                      |+|.++.++ ......+..+.+|++|+++++.+++.    ++..+...++|++|+++++.+.+      .++..+.++++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            444444444 22333344455566666666555322    33444455556666666655541      12223444445


Q ss_pred             cccccccCCcccCCCCcccccCCC---CcEEEecCccccC----cCCcccccC-CccceeecccccccCC----CCcccc
Q 001561          303 LEFFVAHSNSFSGPLPLSLSLCSK---LHVLDLRNNSLTG----PIDLNFSGL-SSLCTLDLATNHFSGP----LPNSLS  370 (1052)
Q Consensus       303 L~~L~l~~N~l~~~~~~~l~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~  370 (1052)
                      |+.|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++.    ++..+.
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~  162 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR  162 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence            555555555554433333333333   6666666666552    111223334 5566666666666532    223344


Q ss_pred             CCCccceeeccccccccc----CchhhccCCcCcEEeccCCcCCCCcc--cchhhccCcccceEeccccccCccCCcccc
Q 001561          371 DCHDLKILSLAKNELSGQ----VPESFGKLTSLLFLSLSNNSFNHLSG--TLSVLQQCKNLTTLILTKNFVGEEIPENVG  444 (1052)
Q Consensus       371 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~l~~--~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~  444 (1052)
                      .+++|+.|++++|.+++.    ++..+..+++|+.|++++|.++....  ....+..+++|++|++++|.+++.....+.
T Consensus       163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~  242 (319)
T cd00116         163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA  242 (319)
T ss_pred             hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence            555666666666666532    22233444566666666666543211  112233445555555555554432221111


Q ss_pred             -----CCCcccEEEccCCcccc----CcchhhhcCCCCcEEeCcCccCCCC----CChhhccC-CCCCeEeccCCc
Q 001561          445 -----GFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDLSWNHFDGN----IPPWIGQM-ENLFYLDFSNNT  506 (1052)
Q Consensus       445 -----~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~  506 (1052)
                           ..+.|+.|++++|.++.    .+...+..+++|+++++++|.++..    +...+-.. +.|++||+.+|.
T Consensus       243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence                 12455566666555541    2233344445555555555555533    22222222 455555555554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2.9e-19  Score=200.38  Aligned_cols=225  Identities=25%  Similarity=0.262  Sum_probs=176.2

Q ss_pred             eEcccCceEEEEEEE----CCCcEEEEEEecCCchh--hHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEEEEecc
Q 001561          778 IIGCGGFGLVYKATL----TNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYME  850 (1052)
Q Consensus       778 ~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  850 (1052)
                      ++|+|.||.|+.++.    +.|.-+|.|+.++....  .......|..++...+ ||.+|++...++.+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998742    24667888877654311  1113456777888886 9999999999999999999999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH  930 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  930 (1052)
                      +|.+...+..    ...++......+...++-|++++|+.   +|+|||+|++||+++.+|++++.|||.++..-.....
T Consensus        81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            9998877763    45577778888888999999999997   9999999999999999999999999999875433221


Q ss_pred             eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccch
Q 001561          931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010 (1052)
Q Consensus       931 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                           +||..|||||++.  .+..++|.||||++++||+||..||..       +..   ......+           ..
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~---~~Il~~~-----------~~  205 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTM---KRILKAE-----------LE  205 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHH---HHHhhhc-----------cC
Confidence                 8999999999988  678899999999999999999999963       111   1111111           12


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCH
Q 001561         1011 DREKQLLEMLEIACKCIDQDPRRRPFI 1037 (1052)
Q Consensus      1011 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 1037 (1052)
                      .+......+.+++.++...+|..|--.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            233444567888889999999998754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=1e-17  Score=201.56  Aligned_cols=251  Identities=19%  Similarity=0.194  Sum_probs=184.6

Q ss_pred             HHHHhhcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcC---CCceeeeeceEeeCCe
Q 001561          765 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ---HKNLVSLQGYCRHGND  841 (1052)
Q Consensus       765 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  841 (1052)
                      +.....+.|.+.+.||+|+||+||+|...+|+.||+|+-+....   -+|.--.+++.|++   -+.|..+...+.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            34445678999999999999999999988899999998764431   12333334555555   2345556666666778


Q ss_pred             EEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC-------CCCCeE
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-------EKFEAH  914 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~-------~~~~~k  914 (1052)
                      -++|+||.+.|+|.+++.    ....++|..++.++.|+++.+++||.+   +|||+||||+|+|+.       ....++
T Consensus       769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            899999999999999987    466789999999999999999999998   999999999999995       235589


Q ss_pred             EeecccccccCCCCC-eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHh
Q 001561          915 LADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM  993 (1052)
Q Consensus       915 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  993 (1052)
                      |+|||.+..+..... ......++|-.+-.+|+..++.+++++|.|.++-+++-|+.|+.-=                ..
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------------~~  905 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------------VK  905 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------hc
Confidence            999999987654333 2445678899999999999999999999999999999999887631                00


Q ss_pred             hhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 001561          994 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      .+.   ...++..+..-...   .-..+++..++++|-..=|...++...++++
T Consensus       906 ~g~---~~~~~~~~~Ry~~~---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~  953 (974)
T KOG1166|consen  906 NGS---SWMVKTNFPRYWKR---DMWNKFFDLLLNPDCDTLPNLQELRTELEEV  953 (974)
T ss_pred             CCc---ceeccccchhhhhH---HHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence            011   11111111001111   1234566677776666667777777777654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.73  E-value=1.2e-17  Score=188.51  Aligned_cols=216  Identities=28%  Similarity=0.439  Sum_probs=163.3

Q ss_pred             HhcCCCceeeeeceEeeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 001561          822 SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVK  901 (1052)
Q Consensus       822 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlk  901 (1052)
                      +.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..   ....+++.-...+..+++.|++|+|..  +-..|+.++
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~   76 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK   76 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence            567899999999999999999999999999999999976   456689999999999999999999986  333999999


Q ss_pred             CCceEECCCCCeEEeecccccccCCC-CCeeeecccccccccCccccCCc-------CCCcccchHHHHHHHHHHHcCCC
Q 001561          902 SSNILLDEKFEAHLADFGLSRLLRPY-DTHVTTDLVGTLGYIPPEYSQTL-------TATCRGDVYSFGVVLLELLTGRR  973 (1052)
Q Consensus       902 p~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvil~elltG~~  973 (1052)
                      ++|.++|....+|++|||+....... .........-..-|.|||.+...       ..+.++||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998876421 11111112234579999987653       14678999999999999999999


Q ss_pred             CCcccCCCCc-hhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcCc
Q 001561          974 PVEVCKGKNC-RDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       974 pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                      ||+....... .+++.++..     .....+-+.++...  +...++..++..||..+|++||++++|-..++.+-.
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9975432222 334433332     01111122222111  233368899999999999999999999988876643

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.72  E-value=1.4e-19  Score=168.72  Aligned_cols=162  Identities=28%  Similarity=0.463  Sum_probs=107.2

Q ss_pred             cCcccceEeccccccCccCCccccCCCcccEEEccCCccccCcchhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeE
Q 001561          421 QCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL  500 (1052)
Q Consensus       421 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  500 (1052)
                      .+.+.+.|.|++|.++ .+|..+..+.+|+.|++.+|++. .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            4455666666666663 45666777888888888888887 78888888888888888888887 788888888889999


Q ss_pred             eccCCcccc-cCCcchhhhhhhcccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCcccccCCccccc
Q 001561          501 DFSNNTLTG-EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQ  579 (1052)
Q Consensus       501 ~Ls~N~l~~-~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~ip~~~~~  579 (1052)
                      ||++|++.. .+|..                                                              |-.
T Consensus       108 dltynnl~e~~lpgn--------------------------------------------------------------ff~  125 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGN--------------------------------------------------------------FFY  125 (264)
T ss_pred             hccccccccccCCcc--------------------------------------------------------------hhH
Confidence            988888763 33444                                                              444


Q ss_pred             ccccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeecccccccCCCCCC
Q 001561          580 LKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGG  649 (1052)
Q Consensus       580 l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~  649 (1052)
                      ++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|++++.|+.|+.|++.+|+|+-.+|.-+
T Consensus       126 m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~  193 (264)
T KOG0617|consen  126 MTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELA  193 (264)
T ss_pred             HHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhh
Confidence            444555555555555 45555555555555555555554 455555555555555555555555555433

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.72  E-value=7.7e-20  Score=170.44  Aligned_cols=179  Identities=30%  Similarity=0.449  Sum_probs=116.3

Q ss_pred             cCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCcccccCCCCcE
Q 001561          250 YSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV  329 (1052)
Q Consensus       250 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~  329 (1052)
                      ..+++.+.|.||+|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|++
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            34455555556666655 44555566666666666666665 55556666666666666666665 55666666666777


Q ss_pred             EEecCccccC-cCCcccccCCccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcEEeccCCc
Q 001561          330 LDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNS  408 (1052)
Q Consensus       330 L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  408 (1052)
                      |||++|++.. ..|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|++.+|+
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            7776666653 45666767777777777777777 67777788888888888887776 677788888888888888888


Q ss_pred             CCCCcccchhhccCcccceEecccc
Q 001561          409 FNHLSGTLSVLQQCKNLTTLILTKN  433 (1052)
Q Consensus       409 l~~l~~~~~~l~~l~~L~~L~L~~N  433 (1052)
                      ++-+|..+..+.-..+-+.+.+.+|
T Consensus       185 l~vlppel~~l~l~~~k~v~r~E~N  209 (264)
T KOG0617|consen  185 LTVLPPELANLDLVGNKQVMRMEEN  209 (264)
T ss_pred             eeecChhhhhhhhhhhHHHHhhhhC
Confidence            8777765544333333333334444

>PRK10345 hypothetical protein; Provisional

Probab=99.71  E-value=1e-16  Score=165.35  Aligned_cols=137  Identities=15%  Similarity=0.169  Sum_probs=106.1

Q ss_pred             CcccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhc-----CCCceeeeeceEeeCC---e-EE
Q 001561          773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA-----QHKNLVSLQGYCRHGN---D-RL  843 (1052)
Q Consensus       773 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~  843 (1052)
                      +...++||+|+||.||. .-.++.. +||++........+++.+|+++++.+     .||||++++|++.++.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34467899999999996 3234444 68988765444567799999999999     5799999999998763   3 33


Q ss_pred             EEEEe--ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEcCCCCCceEECC----CCCeEEe
Q 001561          844 LIYSY--MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL-AYLHKVCEPHIVHRDVKSSNILLDE----KFEAHLA  916 (1052)
Q Consensus       844 lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~HrDlkp~Nill~~----~~~~kl~  916 (1052)
                      +|+||  +++|+|.+++.+.     .+++.  ..++.+++.++ +|||++   +|+||||||+||+++.    ++.++|+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            78999  5579999999642     24444  35577888777 999997   9999999999999974    3479999


Q ss_pred             ecccc
Q 001561          917 DFGLS  921 (1052)
Q Consensus       917 DfG~a  921 (1052)
                      ||+-+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95444

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.9e-16  Score=167.77  Aligned_cols=148  Identities=19%  Similarity=0.151  Sum_probs=114.1

Q ss_pred             HHHhhcCCcccCeEcccCceEEEEEE--ECCCcEEEEEEecCCchh------------------------hHHHHHHHHH
Q 001561          766 LLKSTNNFNQANIIGCGGFGLVYKAT--LTNGTKAAVKRLSGDCGQ------------------------MEREFQAEVE  819 (1052)
Q Consensus       766 ~~~~~~~~~~~~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~  819 (1052)
                      +.+....|++.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+.+|++
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            33444468899999999999999998  458999999998743210                        1133578999


Q ss_pred             HHHhcCCCc--eeeeeceEeeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCC-eE
Q 001561          820 ALSRAQHKN--LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-IV  896 (1052)
Q Consensus       820 ~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~  896 (1052)
                      .+.++.+..  +.+++++    ...++||||++++++..+...    .......++..++.|++.++++||+.   + |+
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~ii  171 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELV  171 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEE
Confidence            999997533  3444432    235899999999888665422    23355666789999999999999986   8 99


Q ss_pred             EcCCCCCceEECCCCCeEEeecccccccC
Q 001561          897 HRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       897 HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      ||||||+||+++ ++.++++|||.|...+
T Consensus       172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      172 HGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             eCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999999 8899999999987643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=6.5e-16  Score=162.56  Aligned_cols=134  Identities=22%  Similarity=0.324  Sum_probs=113.5

Q ss_pred             CeEcccCceEEEEEEECCCcEEEEEEecCCch--------hhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG--------QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      +.||+|++|.||+|.+ .|..|++|+......        .....+.+|++++..++|++++....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 578899997654321        1124578899999999999998888887777888999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      ++|++|.+++...       .+ .+..++.+++.+++++|+.   +++|||++|+||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988642       12 7889999999999999986   999999999999999 78999999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=7.1e-16  Score=160.18  Aligned_cols=145  Identities=19%  Similarity=0.113  Sum_probs=112.5

Q ss_pred             HHHHhhcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCch----------------------hhHHHHHHHHHHHH
Q 001561          765 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG----------------------QMEREFQAEVEALS  822 (1052)
Q Consensus       765 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~  822 (1052)
                      ++......|.+.+.||+|+||.||+|...+|+.||||++.....                      .....+..|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34444445888899999999999999988899999998764321                      01123577899999


Q ss_pred             hcCCCc--eeeeeceEeeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 001561          823 RAQHKN--LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV  900 (1052)
Q Consensus       823 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDl  900 (1052)
                      ++.|++  +++.++    ....++||||+++++|.+....          .....++.+++.++.++|+.   +|+||||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            998774  444443    2345899999999998765321          23467889999999999986   9999999


Q ss_pred             CCCceEECCCCCeEEeecccccccCC
Q 001561          901 KSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       901 kp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      ||+||++++++.++|+|||.+.....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=6.9e-17  Score=189.63  Aligned_cols=208  Identities=26%  Similarity=0.334  Sum_probs=144.6

Q ss_pred             cCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .+|+.++.|..|+||.||.++++ +.+++|.|+ .++..     +.+-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee-------------------
Confidence            57889999999999999999876 467788843 32211     1111  23333444444                   


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCC
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  929 (1052)
                        |+-...+.    ..++++.+.        +.+++|+|+-   +|+|||+||+|.+|+.-|++|++|||+.+.......
T Consensus       136 --gDc~tllk----~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 --GDCATLLK----NIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             --chhhhhcc----cCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence              33222232    222333322        7789999985   999999999999999999999999999876322110


Q ss_pred             ------------e--eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhh
Q 001561          930 ------------H--VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS  995 (1052)
Q Consensus       930 ------------~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  995 (1052)
                                  +  ....++|||.|.|||++....|...+|+|++|+|+||.+.|+.||.+   ++.++++..+....-
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG---dtpeelfg~visd~i  275 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG---DTPEELFGQVISDDI  275 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC---CCHHHHHhhhhhhhc
Confidence                        0  11235899999999999999999999999999999999999999964   444455443332211


Q ss_pred             cccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCC
Q 001561          996 EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1036 (1052)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1036 (1052)
                                 .|.+..+....++++++.+.++.+|.+|--
T Consensus       276 -----------~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  276 -----------EWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -----------cccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence                       111122233347889999999999999963

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=6e-16  Score=162.79  Aligned_cols=195  Identities=19%  Similarity=0.222  Sum_probs=133.3

Q ss_pred             CCCceeeeeceEee---------------------------CCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHH
Q 001561          825 QHKNLVSLQGYCRH---------------------------GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA  877 (1052)
Q Consensus       825 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~  877 (1052)
                      +|||||+++++|.+                           +...|+||...+. +|..++..     ...+...+.-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence            69999999987643                           2245788776643 67777653     235566778889


Q ss_pred             HHHHHHHHHHHhcCCCCeEEcCCCCCceEEC--CC--CCeEEeecccccccCCCC-----CeeeecccccccccCccccC
Q 001561          878 QGAARGLAYLHKVCEPHIVHRDVKSSNILLD--EK--FEAHLADFGLSRLLRPYD-----THVTTDLVGTLGYIPPEYSQ  948 (1052)
Q Consensus       878 ~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~--~~--~~~kl~DfG~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~  948 (1052)
                      .|+++|+.|||.+   +|+|||+|++|||+.  +|  -.+.|+|||++---+...     .....+.-|...-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999998   999999999999994  33  346889999985422110     01112335677899999865


Q ss_pred             CcC------CCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHH
Q 001561          949 TLT------ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEI 1022 (1052)
Q Consensus       949 ~~~------~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 1022 (1052)
                      ..+      ...|+|.|+.|-+.||+++...||.... +-.-+...     +.+.         .....++.+...+.++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~-----Yqe~---------qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRT-----YQES---------QLPALPSRVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhh-----hhhh---------hCCCCcccCChHHHHH
Confidence            432      2358999999999999999999997521 11111111     0000         1112233344578899


Q ss_pred             HHHcccCCCCCCCCHHHHHHH
Q 001561         1023 ACKCIDQDPRRRPFIEEVVTW 1043 (1052)
Q Consensus      1023 i~~cl~~dP~~RPs~~evl~~ 1043 (1052)
                      +...+++||.+|++..-....
T Consensus       490 V~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHHHhcCCccccCCccHHHhH
Confidence            999999999999987655443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=6.4e-17  Score=178.29  Aligned_cols=174  Identities=25%  Similarity=0.373  Sum_probs=131.4

Q ss_pred             eEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccc
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~  920 (1052)
                      ..|+.|++++..+|.+|+.... .....++.....++.|++.|+.|  .    +.+|||+||.||....+.++||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y--k----~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY--K----GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh--c----cchhhhccccccccccchhhhhhhhhh
Confidence            4689999999999999997544 34556888999999999999999  2    899999999999999999999999999


Q ss_pred             ccccCCCC-----CeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHc-CCCCCcccCCCCchhHHHHHHHhh
Q 001561          921 SRLLRPYD-----THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       921 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      ........     ...++..+||..||+||.+.+..|+.++||||+|++++|++. =..+|+.         ... ....
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------~~t-~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------IAT-LTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---------HHh-hhhh
Confidence            98876544     234456789999999999999999999999999999999996 2222221         000 0001


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1040 (1052)
                      +.    ..+++..+.+++     +-..++.+++.+.|.+||++.++
T Consensus       473 r~----g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  473 RD----GIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hc----CCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence            11    111222222222     23578899999999999954443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=8.7e-16  Score=159.97  Aligned_cols=131  Identities=25%  Similarity=0.364  Sum_probs=107.0

Q ss_pred             eEcccCceEEEEEEECCCcEEEEEEecCCc--------hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEec
Q 001561          778 IIGCGGFGLVYKATLTNGTKAAVKRLSGDC--------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       778 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  849 (1052)
                      .||+|+||.||+|.+ +|..|++|+.....        .....++.+|+++++.++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 47889999865321        111255778999999999887766666666677789999999


Q ss_pred             cCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      +|++|.+++...    ..       .++.+++++++++|+.   +++|||++|+||+++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998877531    10       7889999999999986   999999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1.5e-15  Score=181.93  Aligned_cols=139  Identities=21%  Similarity=0.252  Sum_probs=112.0

Q ss_pred             hcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCc-------hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeE
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC-------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       770 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  842 (1052)
                      ...|...+.||+|+||+||+|.+.+...++.++..+..       ....+.+.+|++++++++|++++....++.+....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34456688999999999999987644433333232211       11235678999999999999999888888877788


Q ss_pred             EEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      ++||||+++++|.+++.            .+..++.+++++++|||+.   +++|||+||+||++ +++.++|+|||+++
T Consensus       412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999988774            3467899999999999986   99999999999999 67899999999997


Q ss_pred             cc
Q 001561          923 LL  924 (1052)
Q Consensus       923 ~~  924 (1052)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>PLN03150 hypothetical protein; Provisional

Probab=99.61  E-value=9.8e-16  Score=185.10  Aligned_cols=116  Identities=39%  Similarity=0.634  Sum_probs=103.6

Q ss_pred             CCeeeeecCcccccCCcccccccccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeecc
Q 001561          559 PPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN  638 (1052)
Q Consensus       559 ~~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~  638 (1052)
                      ...|+|++|.+.|.+|.+++.|++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|..++++++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            46789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCc--cCCCCCCcccCCCCCcCCC-CCCCC
Q 001561          639 NHLQGTIPTGGQ--FYSFPNSSFEGNPGLCGEI-DSPCD  674 (1052)
Q Consensus       639 N~l~g~~p~~~~--~~~~~~~~~~gn~~lcg~~-~~~~~  674 (1052)
                      |+|+|.+|..-.  +.......+.||+++||.+ ...|.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~  538 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG  538 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence            999999997522  2334456789999999963 35564

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=3.2e-14  Score=140.84  Aligned_cols=134  Identities=19%  Similarity=0.165  Sum_probs=114.3

Q ss_pred             cCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCC--CceeeeeceEeeCCeEEEEEEeccCCC
Q 001561          776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH--KNLVSLQGYCRHGNDRLLIYSYMENGS  853 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  853 (1052)
                      .+.||+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  ..+++++++...++..+++|||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            5679999999999999764 7899999865533  4568899999999976  589999988888788999999999887


Q ss_pred             hhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          854 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       854 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      +..+           +......++.+++++++++|....++++|+|++|+||++++.+.++++|||.++.
T Consensus        80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            6543           4566778899999999999986456799999999999999999999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PLN03150 hypothetical protein; Provisional

Probab=99.55  E-value=2.1e-14  Score=173.62  Aligned_cols=134  Identities=31%  Similarity=0.524  Sum_probs=109.9

Q ss_pred             CCCCHHHHHHHHHHHhcCCCCCCCCCcCCCCCCc----eeeeeeeCCCCCCCCCCcEEEEEecCCCCcccCCccccCCcC
Q 001561           36 QSCDPSDLLALKEFAGNLTNGSIITSWSNESMCC----QWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQ  111 (1052)
Q Consensus        36 ~~~~~~~~~aLl~~k~~~~~~~~l~sw~~~~~~c----~w~gv~C~~~~~~~~~~~v~~l~L~~~~l~g~~~~~l~~l~~  111 (1052)
                      .++.++|..||+++|..+.... ..+|.+ .+||    .|.||.|+.... .....|+.|+|+++++.|.+|.+++.+++
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~-~~~W~g-~~C~p~~~~w~Gv~C~~~~~-~~~~~v~~L~L~~n~L~g~ip~~i~~L~~  443 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPL-RFGWNG-DPCVPQQHPWSGADCQFDST-KGKWFIDGLGLDNQGLRGFIPNDISKLRH  443 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCcc-cCCCCC-CCCCCcccccccceeeccCC-CCceEEEEEECCCCCccccCCHHHhCCCC
Confidence            3567889999999999986543 258975 4553    799999953211 11236999999999999999999999999


Q ss_pred             CCeEecCCCCCCCCCcccccCCCCccEEeccCCcccCcccccccccCCccEEEccCcccCC
Q 001561          112 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNG  172 (1052)
Q Consensus       112 L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  172 (1052)
                      |+.|+|++|++.|.+|..++.+++|++|||++|++++.+|..++.+++|++|+|++|.+++
T Consensus       444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g  504 (623)
T PLN03150        444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG  504 (623)
T ss_pred             CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc
Confidence            9999999999999999999999999999999999999998888877777766666666554

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.53  E-value=3.7e-14  Score=146.08  Aligned_cols=137  Identities=20%  Similarity=0.201  Sum_probs=98.6

Q ss_pred             cCeEcccCceEEEEEEECCCcEEEEEEecCCchhh---HHH---------------------HHHHHHHHHhcCCCc--e
Q 001561          776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM---ERE---------------------FQAEVEALSRAQHKN--L  829 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~---------------------~~~E~~~l~~l~h~n--i  829 (1052)
                      .+.||+|+||+||+|...+++.||||++.......   ...                     ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998789999999887532111   111                     135666666664433  3


Q ss_pred             eeeeceEeeCCeEEEEEEeccCCChhh-hhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEEC
Q 001561          830 VSLQGYCRHGNDRLLIYSYMENGSLDY-WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD  908 (1052)
Q Consensus       830 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~  908 (1052)
                      .+.+++    ...++||||++++.+.. .+....     .. .++..++.+++.++.++|..  .+|+||||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE
Confidence            444432    24589999999965422 121110     11 56788999999999999982  3999999999999999


Q ss_pred             CCCCeEEeecccccccC
Q 001561          909 EKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       909 ~~~~~kl~DfG~a~~~~  925 (1052)
                       ++.++++|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=2.4e-15  Score=178.81  Aligned_cols=254  Identities=26%  Similarity=0.329  Sum_probs=188.1

Q ss_pred             cCCcccCeEcccCceEEEEEEECC--CcEEEEEEecCCc--hhhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEEEE
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN--GTKAAVKRLSGDC--GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  845 (1052)
                      ..|...+.||+|+|+.|-.+....  ...+|+|.+....  ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            346777889999999998886543  3456666655432  222334455777777776 99999999999999999999


Q ss_pred             EEeccCCChhhhhhcccCCcc-ccCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEcCCCCCceEECCCC-CeEEeeccccc
Q 001561          846 YSYMENGSLDYWLHESVDKDS-VLKWDVRLKIAQGAARGLAYLH-KVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSR  922 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~  922 (1052)
                      .||.+++++.+.+..   .+. ..+...+-.++.|+..++.|+| .   .++.|||+||+|.+++..+ ..+++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhc
Confidence            999999999887731   222 4566777889999999999999 6   4999999999999999999 99999999999


Q ss_pred             ccCC-C-CCeeeecccc-cccccCccccCCc-CCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccc
Q 001561          923 LLRP-Y-DTHVTTDLVG-TLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       923 ~~~~-~-~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      .+.. . ........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... ..+..|....     
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~-----  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK-----  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc-----
Confidence            8766 2 2333445688 9999999988774 55678999999999999999999987433221 1222222111     


Q ss_pred             ccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                        .......+..    ......++..+++..+|..|.+.+++..
T Consensus       248 --~~~~~~~~~~----~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 --GRFTQLPWNS----ISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --cccccCcccc----CChhhhhcccccccCCchhccccccccc
Confidence              0001111111    2235678888999999999999888754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.49  E-value=2e-13  Score=145.03  Aligned_cols=136  Identities=21%  Similarity=0.223  Sum_probs=105.2

Q ss_pred             cCeEc-ccCceEEEEEEECCCcEEEEEEecCCc-------------hhhHHHHHHHHHHHHhcCCCce--eeeeceEeeC
Q 001561          776 ANIIG-CGGFGLVYKATLTNGTKAAVKRLSGDC-------------GQMEREFQAEVEALSRAQHKNL--VSLQGYCRHG  839 (1052)
Q Consensus       776 ~~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  839 (1052)
                      ..+|| .|+.|+||.+... +..+|+|++....             ......+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45788 8999999999875 7789999875321             1223457889999999998875  6677765432


Q ss_pred             C----eEEEEEEeccC-CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeE
Q 001561          840 N----DRLLIYSYMEN-GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH  914 (1052)
Q Consensus       840 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~k  914 (1052)
                      .    ..++||||++| .+|.+++..     ..++..    .+.+++.++++||+.   ||+||||||+|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2    23599999997 688888753     234443    356899999999986   999999999999999999999


Q ss_pred             Eeeccccccc
Q 001561          915 LADFGLSRLL  924 (1052)
Q Consensus       915 l~DfG~a~~~  924 (1052)
                      ++|||.++..
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999998753

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.44  E-value=5.6e-15  Score=162.58  Aligned_cols=160  Identities=31%  Similarity=0.495  Sum_probs=89.1

Q ss_pred             CCccccCCCcccEEEccCCccccCcchhhhcCCCCcEEeCcCccCCCCCChhhccCCCCCeEeccCCcccccCCcchhhh
Q 001561          439 IPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTEL  518 (1052)
Q Consensus       439 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  518 (1052)
                      +|..+..+..|+.+.|.+|.+. .+|..++++..|.+|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+
T Consensus        90 lp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~  165 (722)
T KOG0532|consen   90 LPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLL  165 (722)
T ss_pred             CchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccc
Confidence            3444444444555555555554 45555555555555555555555 4555555554 555555555554 344444433


Q ss_pred             hhhcccCCCCCCCCCCCCccceeeccccCCCcCCCCCCCCCCeeeeecCcccccCCcccccccccceecccCceeeecCC
Q 001561          519 KSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIP  598 (1052)
Q Consensus       519 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip  598 (1052)
                      ..|                                      ..+|.+.|.+. .+|..+++|.+|+.|++..|++. .+|
T Consensus       166 ~tl--------------------------------------~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp  205 (722)
T KOG0532|consen  166 PTL--------------------------------------AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLP  205 (722)
T ss_pred             hhH--------------------------------------HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence            333                                      12444555555 45666666666666666666666 556


Q ss_pred             CCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeecccccccC
Q 001561          599 SSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGT  644 (1052)
Q Consensus       599 ~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  644 (1052)
                      .+++.| .|..||+|.|+++ .||-.|.+|..|++|-|.+|.|+.+
T Consensus       206 ~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP  249 (722)
T KOG0532|consen  206 EELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP  249 (722)
T ss_pred             HHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC
Confidence            666633 4666666666666 5666666666666666666666643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.36  E-value=3.2e-12  Score=147.82  Aligned_cols=142  Identities=20%  Similarity=0.219  Sum_probs=101.2

Q ss_pred             cCeEcccCceEEEEEEECCCcEEEEEEecCCchhh----------------------------------------HHHHH
Q 001561          776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM----------------------------------------EREFQ  815 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~  815 (1052)
                      .+.||.|++|.||+|++.+|+.||||+.+......                                        +-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986532110                                        01244


Q ss_pred             HHHHHHHhcC----CCceeeeeceEe-eCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHH-HHHHHHh
Q 001561          816 AEVEALSRAQ----HKNLVSLQGYCR-HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR-GLAYLHK  889 (1052)
Q Consensus       816 ~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~  889 (1052)
                      +|.+.+.+++    |.+-+.+-..+. ..+..++||||++|+++.++.....   ...   .+..++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence            5666666552    333333333332 2456799999999999988764321   111   23456666665 4677887


Q ss_pred             cCCCCeEEcCCCCCceEECCCCCeEEeecccccccCC
Q 001561          890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       890 ~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      .   |++|+|+||.||+++++++++++|||++..+.+
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            5   999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.32  E-value=5.9e-14  Score=154.61  Aligned_cols=192  Identities=27%  Similarity=0.399  Sum_probs=94.3

Q ss_pred             EEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCc
Q 001561          233 QLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNS  312 (1052)
Q Consensus       233 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  312 (1052)
                      ..||+.|++. .+|..+..+..|+.|.|..|.+. .+|..+.++..|++|||+.|+++ ..|..+..|+ |+.|.+++|+
T Consensus        79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk  154 (722)
T KOG0532|consen   79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK  154 (722)
T ss_pred             hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence            3444444444 34444444444444444444444 44444444555555555555444 3444444332 4444444444


Q ss_pred             ccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCccccCCCccceeecccccccccCchh
Q 001561          313 FSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPES  392 (1052)
Q Consensus       313 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  392 (1052)
                      ++ .+|..++.+.+|..||.+.|.+. ..|..++++.+|+.|.+..|++. .+|..++.+ .|..||+++|+++ .+|-.
T Consensus       155 l~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~  229 (722)
T KOG0532|consen  155 LT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVD  229 (722)
T ss_pred             cc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchh
Confidence            44 33444444455555555555554 23334455555555555555555 344445433 4555666666665 55556


Q ss_pred             hccCCcCcEEeccCCcCCCCcccchhhccCcccceEecccc
Q 001561          393 FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN  433 (1052)
Q Consensus       393 ~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N  433 (1052)
                      |.+|+.|++|-|.+|.++.-|..+-.-+...-.++|+..-+
T Consensus       230 fr~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  230 FRKMRHLQVLQLENNPLQSPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             hhhhhhheeeeeccCCCCCChHHHHhccceeeeeeecchhc
Confidence            66666666666666666555444332233333344444444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.32  E-value=2e-12  Score=149.93  Aligned_cols=193  Identities=35%  Similarity=0.484  Sum_probs=83.9

Q ss_pred             eeccCcccccccccCCCCCCCCEEEcccccCCCCCCccccCCC-CCcEEEcccCcCCchhhhhhcCCCCCcEEEccCCcC
Q 001561          211 LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMS-SLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF  289 (1052)
Q Consensus       211 L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  289 (1052)
                      ++++.|.+......+...+.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|++
T Consensus        98 l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l  175 (394)
T COG4886          98 LDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL  175 (394)
T ss_pred             eeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchh
Confidence            44455544333333333344555555555554 3344444442 4555555555554 3333444445555555555554


Q ss_pred             CCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCccc
Q 001561          290 SGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL  369 (1052)
Q Consensus       290 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  369 (1052)
                      + .+|...+.+++|+.|++++|+++ .+|........                        |++|.+++|++. ..+..+
T Consensus       176 ~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~------------------------L~~l~~~~N~~~-~~~~~~  228 (394)
T COG4886         176 S-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA------------------------LEELDLSNNSII-ELLSSL  228 (394)
T ss_pred             h-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhh------------------------hhhhhhcCCcce-ecchhh
Confidence            4 33333334444444444444444 22222222233                        444444444322 233344


Q ss_pred             cCCCccceeecccccccccCchhhccCCcCcEEeccCCcCCCCcccchhhccCcccceEeccccccCc
Q 001561          370 SDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE  437 (1052)
Q Consensus       370 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~  437 (1052)
                      .++.++..+.+.+|++. ..+..++.+++++.|++++|.++.++.    +....+++.|++++|.+..
T Consensus       229 ~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~----~~~~~~l~~L~~s~n~~~~  291 (394)
T COG4886         229 SNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS----LGSLTNLRELDLSGNSLSN  291 (394)
T ss_pred             hhcccccccccCCceee-eccchhccccccceecccccccccccc----ccccCccCEEeccCccccc
Confidence            44444444444444444 223444444444555555554444432    3333444444444444433

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=2.2e-12  Score=133.37  Aligned_cols=204  Identities=20%  Similarity=0.294  Sum_probs=143.0

Q ss_pred             HHHHHhcCCCceeeeeceEeeC-----CeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 001561          818 VEALSRAQHKNLVSLQGYCRHG-----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE  892 (1052)
Q Consensus       818 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  892 (1052)
                      ++-+-.+.|-|+|+++.|+.+.     .+...+.|||..|++..+|++.......+....-.+|.-||..||.|||+. +
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            3445556799999999998654     346789999999999999998777777788888889999999999999994 9


Q ss_pred             CCeEEcCCCCCceEECCCCCeEEeecccccccCCC---CCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHH
Q 001561          893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY---DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL  969 (1052)
Q Consensus       893 ~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  969 (1052)
                      ++|+|+++..+-|++..+|-+|+.---........   .........+-++|.|||.-..-..+.++|||+||+...||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            99999999999999999999988421111100000   001111224678999999887778888999999999999998


Q ss_pred             cCCCC-CcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          970 TGRRP-VEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       970 tG~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      .|..- -........++..+.+..        ..-+     .       .=.+++.+|++..|..||+|++++.
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~--------~len-----~-------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVII--------GLEN-----G-------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcceeehhhhhhhhee--------eccC-----c-------cccCcCcccccCCCCCCcchhhhhc
Confidence            87653 111000000000000000        0000     0       1136788999999999999998764

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.31  E-value=2.2e-12  Score=149.51  Aligned_cols=200  Identities=30%  Similarity=0.395  Sum_probs=154.4

Q ss_pred             cEEEecCCccCCccchhhhhcccccceeeccCcccccccccCCCCC-CCCEEEcccccCCCCCCccccCCCCCcEEEccc
Q 001561          184 AVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV  262 (1052)
Q Consensus       184 ~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  262 (1052)
                      ..++++.|.+...+..  ....+.++.|++.+|.++.++......+ +|+.|++++|.+. .+|..+..+++|+.|++++
T Consensus        96 ~~l~~~~~~~~~~~~~--~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          96 PSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             ceeeccccccccCchh--hhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence            4688888887433222  2344789999999999999999888885 9999999999999 5667899999999999999


Q ss_pred             CcCCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCC
Q 001561          263 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID  342 (1052)
Q Consensus       263 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  342 (1052)
                      |+++ .+|...+.+++|+.|++++|+++ .+|...+....|+++.+++|.+. ..+..+.+++++..+.+.+|++... +
T Consensus       173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~  248 (394)
T COG4886         173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-P  248 (394)
T ss_pred             chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-c
Confidence            9999 66666668999999999999999 77877777888999999999644 3556677788888888888877643 4


Q ss_pred             cccccCCccceeecccccccCCCCccccCCCccceeecccccccccCchh
Q 001561          343 LNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPES  392 (1052)
Q Consensus       343 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  392 (1052)
                      ..++.++++++|++++|.++.. +. ++.+.+++.|++++|.++...|..
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             chhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhh
Confidence            4556666677777777777633 32 666667777777777666554443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=5.5e-12  Score=142.75  Aligned_cols=247  Identities=23%  Similarity=0.244  Sum_probs=179.6

Q ss_pred             CCcccCeEcc--cCceEEEEEEE---CCCcEEEEEEecCCc--hhhHHHHHHHHHHHHhcC-CCceeeeeceEeeCCeEE
Q 001561          772 NFNQANIIGC--GGFGLVYKATL---TNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRL  843 (1052)
Q Consensus       772 ~~~~~~~lG~--G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  843 (1052)
                      .|...+.+|.  |.+|.||.+..   .++..+|+|+-+...  +.....-.+|+...++++ |++.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3566788999  99999999976   368899999844322  233334466777777774 999999888999999999


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEcCCCCCceEECCC-CCeEEeec
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR----GLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADF  918 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~Df  918 (1052)
                      +-+|++. .++.++.+..   ...++....+.+..+..+    |+.++|+.   +++|-|+||.||+...+ ...+++||
T Consensus       195 iqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999885 6777766642   233566777777788888    99999996   99999999999999999 88999999


Q ss_pred             ccccccCCCCCe----eeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhh
Q 001561          919 GLSRLLRPYDTH----VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       919 G~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      |+...+....-.    ......|...|++||..++ .++.+.|+|++|.+..+..+|..+........      |..  .
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~--~  338 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQ--L  338 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccc--c
Confidence            999988754411    1222367789999998766 67889999999999999998877654221111      100  0


Q ss_pred             hcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 001561          995 SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                      +.        ..+..++......++...+..|++.+|..|++.+.+..
T Consensus       339 r~--------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  339 RQ--------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc--------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            00        00111222222334556889999999999999888764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=3.8e-11  Score=121.51  Aligned_cols=131  Identities=18%  Similarity=0.144  Sum_probs=96.7

Q ss_pred             cCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCcee-eeeceEeeCCeEEEEEEeccCCCh
Q 001561          776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV-SLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      .+.++.|.++.||++... +..|++|....... ....+..|+++++.+.+.+++ +++.+.  .+..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            457899999999999875 78899998765432 223467899999988665544 344332  3345899999999876


Q ss_pred             hhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC--EPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      .+.  .          .....++.+++++++.||+..  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            543  0          011345678999999999862  12369999999999999 67899999999853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.22  E-value=2e-11  Score=142.33  Aligned_cols=145  Identities=15%  Similarity=0.171  Sum_probs=95.8

Q ss_pred             cCCcccCeEcccCceEEEEEEECC-CcEEEEEEecCCchh----------------------------------hHH---
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQ----------------------------------MER---  812 (1052)
Q Consensus       771 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~---  812 (1052)
                      .+|+. +.||.|++|.||+|++++ |+.||||+.++...+                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34666 789999999999999887 999999999754210                                  011   


Q ss_pred             ---HHHHHHHHHHhcC----CCceeeeeceEee-CCeEEEEEEeccCCChhhhh--hcccCCccccCHHHHHHHHHHHHH
Q 001561          813 ---EFQAEVEALSRAQ----HKNLVSLQGYCRH-GNDRLLIYSYMENGSLDYWL--HESVDKDSVLKWDVRLKIAQGAAR  882 (1052)
Q Consensus       813 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~~i~~  882 (1052)
                         ++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.++-  .........+....+..++.|+. 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence               2344554444442    4444444444433 45678999999999987642  21100111233333333333333 


Q ss_pred             HHHHHHhcCCCCeEEcCCCCCceEECCCC----CeEEeecccccccCC
Q 001561          883 GLAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRP  926 (1052)
Q Consensus       883 ~l~~LH~~~~~~i~HrDlkp~Nill~~~~----~~kl~DfG~a~~~~~  926 (1052)
                            .   .|++|+|+||.||+++.++    +++++|||++..+.+
T Consensus       278 ------~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 ------R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  3   3999999999999999988    999999999987754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.18  E-value=7e-10  Score=126.65  Aligned_cols=168  Identities=18%  Similarity=0.207  Sum_probs=128.2

Q ss_pred             EECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEeccCCChhhhhhcccCCccccCH
Q 001561          791 TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW  870 (1052)
Q Consensus       791 ~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~  870 (1052)
                      +..++.+|.|...+...........+-++.++.++||+|+++++.++..+..|+|+|-+.  .|..++.+       ++.
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~  103 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK  103 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence            344788888888776655445556778889999999999999999999999999999875  35555553       335


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCeeeecccccccccCccccCCc
Q 001561          871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL  950 (1052)
Q Consensus       871 ~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  950 (1052)
                      ......+.||+.||.|||..  .+++|++|.-+.|++++.|+.||++|.++........ ......--..|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence            66777889999999999974  6999999999999999999999999998865433221 11111222356777754433


Q ss_pred             CCCcccchHHHHHHHHHHHcCC
Q 001561          951 TATCRGDVYSFGVVLLELLTGR  972 (1052)
Q Consensus       951 ~~~~~~DvwslGvil~elltG~  972 (1052)
                      .  -..|.|.||++++|++.|.
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcc
Confidence            2  3579999999999999993

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.16  E-value=3.5e-12  Score=133.58  Aligned_cols=138  Identities=22%  Similarity=0.345  Sum_probs=106.2

Q ss_pred             CCCccceeecccccccccC----chhhccCCcCcEEeccCCcCCCCc--ccchhhccCcccceEeccccccCcc----CC
Q 001561          371 DCHDLKILSLAKNELSGQV----PESFGKLTSLLFLSLSNNSFNHLS--GTLSVLQQCKNLTTLILTKNFVGEE----IP  440 (1052)
Q Consensus       371 ~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~l~--~~~~~l~~l~~L~~L~L~~N~l~~~----~p  440 (1052)
                      .-++|+++..++|++....    ...|...+.|+.+.++.|.|..--  .....+..|++|+.|||++|.++..    +.
T Consensus       155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La  234 (382)
T KOG1909|consen  155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA  234 (382)
T ss_pred             CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence            3467899999999886432    245667789999999999886421  1235678899999999999998654    44


Q ss_pred             ccccCCCcccEEEccCCccccCcchhhh-----cCCCCcEEeCcCccCCCC----CChhhccCCCCCeEeccCCccc
Q 001561          441 ENVGGFESLMVLALGNCGLKGHIPVWLL-----RCKKLQVLDLSWNHFDGN----IPPWIGQMENLFYLDFSNNTLT  508 (1052)
Q Consensus       441 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  508 (1052)
                      +.+..++.|+.|++++|.++......+.     ..++|++|.|.+|.++..    +-.++...+.|..|+|++|++.
T Consensus       235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            5677889999999999999865544332     368999999999999732    3345667899999999999994

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.15  E-value=6.2e-10  Score=112.71  Aligned_cols=138  Identities=17%  Similarity=0.156  Sum_probs=100.0

Q ss_pred             cCeEcccCceEEEEEEECC-------CcEEEEEEecCCc----------------------hhhHHHH----HHHHHHHH
Q 001561          776 ANIIGCGGFGLVYKATLTN-------GTKAAVKRLSGDC----------------------GQMEREF----QAEVEALS  822 (1052)
Q Consensus       776 ~~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~  822 (1052)
                      ...||.|--+.||.|...+       +..+|||+.+...                      ....+.+    ++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997543       4789999875210                      0112233    38999999


Q ss_pred             hcCC--CceeeeeceEeeCCeEEEEEEeccCCChhh-hhhcccCCccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEc
Q 001561          823 RAQH--KNLVSLQGYCRHGNDRLLIYSYMENGSLDY-WLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHR  898 (1052)
Q Consensus       823 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~Hr  898 (1052)
                      ++..  -++.+++++    ...++||||+.+..+.. .+.     ...++.++...+..+++.++.+| |..   +++|+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            9953  456666654    45689999998754321 222     22344556677889999999999 775   99999


Q ss_pred             CCCCCceEECCCCCeEEeecccccccCC
Q 001561          899 DVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       899 Dlkp~Nill~~~~~~kl~DfG~a~~~~~  926 (1052)
                      |+++.||+++ ++.++++|||.|....+
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999999997 46899999999976643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.14  E-value=3.1e-12  Score=134.01  Aligned_cols=85  Identities=22%  Similarity=0.245  Sum_probs=48.2

Q ss_pred             CcEEEEEecCCCCccc----CCccccCCcCCCeEecCCC---CCCCCCccc-------ccCCCCccEEeccCCcccCccc
Q 001561           86 GRVTMLILPRKGLKGI----IPRSLGHLNQLKLLDLSCN---HLEGVVPVE-------LSNLKQLEVLDLSHNMLSGPVS  151 (1052)
Q Consensus        86 ~~v~~l~L~~~~l~g~----~~~~l~~l~~L~~L~Ls~n---~i~~~~p~~-------l~~l~~L~~L~Ls~N~l~~~~~  151 (1052)
                      ..++.|+|++|.+...    +.+.+.+.++|+..++|+-   +....+|..       +...++|++||||+|.|....+
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~  109 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI  109 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence            4577788888777544    4456677777777777752   223334433       3344577777777777765433


Q ss_pred             ccc----cccCCccEEEccCccc
Q 001561          152 GML----AGLNLIQSLNVSSNSF  170 (1052)
Q Consensus       152 ~~l----~~l~~L~~L~Ls~N~l  170 (1052)
                      ..|    ..+..|++|.|.+|.+
T Consensus       110 ~~l~~ll~s~~~L~eL~L~N~Gl  132 (382)
T KOG1909|consen  110 RGLEELLSSCTDLEELYLNNCGL  132 (382)
T ss_pred             HHHHHHHHhccCHHHHhhhcCCC
Confidence            322    2334444455544444

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.11  E-value=1.7e-11  Score=124.91  Aligned_cols=128  Identities=25%  Similarity=0.283  Sum_probs=56.2

Q ss_pred             ccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcEEeccCCcCCCCcccchhhccCcccceEe
Q 001561          350 SLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLI  429 (1052)
Q Consensus       350 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~  429 (1052)
                      .|++||||+|.|+ .+..+..-.+.++.|++++|.|...  +.+..+++|+.||||+|.++.+.+.   -.++-+.++|.
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gw---h~KLGNIKtL~  358 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGW---HLKLGNIKTLK  358 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhh---HhhhcCEeeee
Confidence            3444444444443 2333333334444444444444311  1234444444444444444433321   12233444444


Q ss_pred             ccccccCccCCccccCCCcccEEEccCCccccCc-chhhhcCCCCcEEeCcCccCCC
Q 001561          430 LTKNFVGEEIPENVGGFESLMVLALGNCGLKGHI-PVWLLRCKKLQVLDLSWNHFDG  485 (1052)
Q Consensus       430 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~  485 (1052)
                      |+.|.+  +.-+.++.+-+|..||+++|+|...- -..++++|.|+.|.|.+|.+.+
T Consensus       359 La~N~i--E~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  359 LAQNKI--ETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hhhhhH--hhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            444443  11223344445555555555554211 1346666777777777777763

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.10  E-value=1.6e-11  Score=131.93  Aligned_cols=207  Identities=22%  Similarity=0.253  Sum_probs=106.0

Q ss_pred             CCCCCCEEEcccccCCCCCC-ccccCCCCCcEEEcccCcCCchh--hhhhcCCCCCcEEEccCCcCCCCCccc-ccCccc
Q 001561          227 HSPSLKQLHVDNNLLGGDLP-DSLYSMSSLQHVSLSVNNFSGQL--SEKISNLTSLRHLIIFGNQFSGKLPNV-LGNLTQ  302 (1052)
Q Consensus       227 ~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~  302 (1052)
                      ++.+|++..|+++.+..... .....|++++.|||++|-+....  -.....+++|+.|+|+.|++.-..... -..+++
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            44567777777776652211 35566777777777777766332  234456777777777777765222111 123455


Q ss_pred             cccccccCCcccCC-CCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCC--ccccCCCccceee
Q 001561          303 LEFFVAHSNSFSGP-LPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLP--NSLSDCHDLKILS  379 (1052)
Q Consensus       303 L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~  379 (1052)
                      |+.|.++.|.++.. +...+..+++|+.|+|..|............+..|+.|||++|++-. .+  ...+.++.|+.|+
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhh
Confidence            55555555555421 11223345556666666654222222233344556666666665542 22  3345556666666


Q ss_pred             ccccccccc-Cchh-----hccCCcCcEEeccCCcCCCCcccchhhccCcccceEecccccc
Q 001561          380 LAKNELSGQ-VPES-----FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFV  435 (1052)
Q Consensus       380 L~~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l  435 (1052)
                      ++.+.++.. .|+.     ...+++|++|++..|+|..++. +..+..+++|+.|.+..|.+
T Consensus       278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~s-l~~l~~l~nlk~l~~~~n~l  338 (505)
T KOG3207|consen  278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRS-LNHLRTLENLKHLRITLNYL  338 (505)
T ss_pred             ccccCcchhcCCCccchhhhcccccceeeecccCccccccc-cchhhccchhhhhhcccccc
Confidence            666655432 1221     2344566666666666655432 22333334444444444444

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.09  E-value=2.6e-11  Score=130.36  Aligned_cols=208  Identities=21%  Similarity=0.163  Sum_probs=102.8

Q ss_pred             CCCccEEeccCCcccCccc-ccccccCCccEEEccCcccCCcc---cccccCCcccEEEecCCccCCccchhhhhccccc
Q 001561          133 LKQLEVLDLSHNMLSGPVS-GMLAGLNLIQSLNVSSNSFNGSL---FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI  208 (1052)
Q Consensus       133 l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~---~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L  208 (1052)
                      +++|+...|.+..+..... +....+++++.||||.|-|....   .-...+++|+.|+|+.|++.--.....-..+++|
T Consensus       120 ~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~l  199 (505)
T KOG3207|consen  120 LKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHL  199 (505)
T ss_pred             HHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhh
Confidence            3444444444443332111 23334444444444444433322   1123444444444444444422222222234455


Q ss_pred             ceeeccCccccc--ccccCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchh-hhhhcCCCCCcEEEcc
Q 001561          209 QILDLSMNHFMG--SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL-SEKISNLTSLRHLIIF  285 (1052)
Q Consensus       209 ~~L~Ls~n~l~~--~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls  285 (1052)
                      +.|.|+.|.++.  +...+..+|+|+.|+|..|....+-.....-+..|++|||++|++-... ....+.++.|+.|+++
T Consensus       200 K~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls  279 (505)
T KOG3207|consen  200 KQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLS  279 (505)
T ss_pred             heEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcc
Confidence            555555555531  1122344566666666666433233333444566667777766654221 1345566667777777


Q ss_pred             CCcCCCC-Cccc-----ccCccccccccccCCcccCC-CCcccccCCCCcEEEecCccccCc
Q 001561          286 GNQFSGK-LPNV-----LGNLTQLEFFVAHSNSFSGP-LPLSLSLCSKLHVLDLRNNSLTGP  340 (1052)
Q Consensus       286 ~N~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~  340 (1052)
                      .+.++.. .|+.     ...+++|++|++..|++... .-..+..+.+|+.|.+..|.++..
T Consensus       280 ~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  280 STGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             ccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence            7666543 2222     24566777777777777422 113445566777777777877743

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.1e-09  Score=106.17  Aligned_cols=131  Identities=26%  Similarity=0.371  Sum_probs=102.6

Q ss_pred             CeEcccCceEEEEEEECCCcEEEEEEe-cCCc--hh-----hHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEEEe
Q 001561          777 NIIGCGGFGLVYKATLTNGTKAAVKRL-SGDC--GQ-----MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~g~~vavK~~-~~~~--~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  848 (1052)
                      ..+++|+-+.+|.+.+. |.++++|.- ++.-  +.     ....-.+|++++++++--.|...+-+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35889999999999876 444666643 3221  11     123457799999999877777777777788888999999


Q ss_pred             ccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      ++|..|.+.+...           ...++..+-+-+.-||..   +|+|+|+.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999988888653           255677788889999987   999999999999998875 99999999974

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=1.2e-10  Score=131.89  Aligned_cols=245  Identities=21%  Similarity=0.209  Sum_probs=175.3

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC--CCcEEEEEEecCCchhhHHH--HHHHHHHHHhc-CCCceeeeeceEeeCCeEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT--NGTKAAVKRLSGDCGQMERE--FQAEVEALSRA-QHKNLVSLQGYCRHGNDRL  843 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  843 (1052)
                      ...+|..+..||.|.|+.|++...+  ++..|++|...........+  -..|+-+...+ .|.++++....+...+..|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3567889999999999999998754  67889999876544332222  24566666666 5889999888888888888


Q ss_pred             EEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCC-CCeEEeeccccc
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FEAHLADFGLSR  922 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~  922 (1052)
                      +--||+++++......    ....+++..++++..|++.++.++|+   +.++|+|+||+||++..+ +.-++.|||+++
T Consensus       343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccc
Confidence            9999999998776652    34557788889999999999999997   499999999999999886 788999999997


Q ss_pred             ccCCCCCeeeeccccccccc--CccccCCcCCCcccchHHHHHHHHHHHcCCCCCcccCCCCchhHHHHHHHhhhccccc
Q 001561          923 LLRPYDTHVTTDLVGTLGYI--PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      .+.-..    ....+.-+++  +|+......+..++|+||||.-+.|.++|..--+.        ..+|....  .+...
T Consensus       416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~~i~--~~~~p  481 (524)
T KOG0601|consen  416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSLTIR--SGDTP  481 (524)
T ss_pred             ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcc--------cccceeee--ccccc
Confidence            532111    1112223444  55566677788899999999999999998764221        01111100  00000


Q ss_pred             ccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 001561         1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044 (1052)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1044 (1052)
                      .        .  ......+..+...+..+++..||.+.+.....
T Consensus       482 ~--------~--~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  482 N--------L--PGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             C--------C--CchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            0        0  11114677888899999999999998876643

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.04  E-value=4.2e-11  Score=122.12  Aligned_cols=128  Identities=23%  Similarity=0.197  Sum_probs=84.2

Q ss_pred             cccceeeccCcccccccccCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEEcc
Q 001561          206 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIF  285 (1052)
Q Consensus       206 ~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  285 (1052)
                      +.|+.+|||+|.|+.+..+..-.|.++.|++++|.|...  ..+..+++|++||||+|.++ .+..+-.++.+++.|.|+
T Consensus       284 q~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  284 QELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            457778888888887777777778888888888888743  34788888888888888887 455566677888888888


Q ss_pred             CCcCCCCCcccccCccccccccccCCcccCCC-CcccccCCCCcEEEecCcccc
Q 001561          286 GNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL-PLSLSLCSKLHVLDLRNNSLT  338 (1052)
Q Consensus       286 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~  338 (1052)
                      +|.|...  ..++.+-+|+.|++.+|+|.... -..+++++-|+.+.|.+|.+.
T Consensus       361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            8877632  22444555555555555554211 123444444444444444444

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.04  E-value=3.3e-11  Score=139.88  Aligned_cols=127  Identities=30%  Similarity=0.332  Sum_probs=54.7

Q ss_pred             CCCCcEEEccCCcCCCCCc-ccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCC--ccc
Q 001561          276 LTSLRHLIIFGNQFSGKLP-NVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLS--SLC  352 (1052)
Q Consensus       276 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~  352 (1052)
                      +++|+.+++++|++...-+ . ...+.+++.+++..|.+...  ..+..+..+..+++..|.++...+.  ..+.  .|+
T Consensus       161 l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~l--~~~~~~~L~  235 (414)
T KOG0531|consen  161 LKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEGL--NELVMLHLR  235 (414)
T ss_pred             chhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccCc--ccchhHHHH
Confidence            4444444444444442222 1 24444445555555544421  1223333344445555555432211  1112  255


Q ss_pred             eeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcEEeccCCcCC
Q 001561          353 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFN  410 (1052)
Q Consensus       353 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  410 (1052)
                      .+++++|.+. ..+..+..+..+..|++.+|++...  ..+...+.+..+.+..|.+.
T Consensus       236 ~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  236 ELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             HHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence            5555555555 2223444455555555555555422  12333344444444444443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.04  E-value=1.7e-09  Score=114.73  Aligned_cols=142  Identities=20%  Similarity=0.265  Sum_probs=110.2

Q ss_pred             CeEcccCceEEEEEEECCCcEEEEEEecCCch-hhHHHHHHHHHHHHhcCCC--ceeeeeceEeeC---CeEEEEEEecc
Q 001561          777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHK--NLVSLQGYCRHG---NDRLLIYSYME  850 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~  850 (1052)
                      +.|+.|.++.||++...+|..+++|....... ....++..|+++++.+++.  .+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999887778999998764432 1345688999999999763  456677776653   25689999999


Q ss_pred             CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 001561          851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC---------------------------------------  891 (1052)
Q Consensus       851 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  891 (1052)
                      |.++.+.+..     ..++..++..++.++++++++||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9887765431     24677778888888999998888531                                       


Q ss_pred             --------------CCCeEEcCCCCCceEECC--CCCeEEeecccccc
Q 001561          892 --------------EPHIVHRDVKSSNILLDE--KFEAHLADFGLSRL  923 (1052)
Q Consensus       892 --------------~~~i~HrDlkp~Nill~~--~~~~kl~DfG~a~~  923 (1052)
                                    ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245799999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.03  E-value=1.3e-10  Score=115.23  Aligned_cols=83  Identities=31%  Similarity=0.439  Sum_probs=15.7

Q ss_pred             CCcCCCeEecCCCCCCCCCccccc-CCCCccEEeccCCcccCcccccccccCCccEEEccCcccCCccccc-ccCCcccE
Q 001561          108 HLNQLKLLDLSCNHLEGVVPVELS-NLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFEL-GEFSNLAV  185 (1052)
Q Consensus       108 ~l~~L~~L~Ls~n~i~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l-~~l~~L~~  185 (1052)
                      +...+++|+|++|.|+.+  +.++ .+.+|+.||||+|.|+...  .+..++.|++|++++|+|+.....+ ..+++|+.
T Consensus        17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE   92 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred             cccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence            334455666666666532  1233 3555666666666655432  2444555555555555554432222 23444444


Q ss_pred             EEecCCccC
Q 001561          186 FNISNNSFT  194 (1052)
Q Consensus       186 L~Ls~n~l~  194 (1052)
                      |++++|+|.
T Consensus        93 L~L~~N~I~  101 (175)
T PF14580_consen   93 LYLSNNKIS  101 (175)
T ss_dssp             EE-TTS---
T ss_pred             EECcCCcCC
Confidence            444444443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.99  E-value=6.9e-11  Score=137.18  Aligned_cols=198  Identities=29%  Similarity=0.297  Sum_probs=120.7

Q ss_pred             cccccceeeccCcccccccccCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcccCcCCchhhhhhcCCCCCcEEE
Q 001561          204 ASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLI  283 (1052)
Q Consensus       204 ~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  283 (1052)
                      .+..++.+++..|.+......+..+.+|+.|++.+|+|..+ ...+..+++|++|+|++|.|+...  .+..++.|+.|+
T Consensus        70 ~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~  146 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN  146 (414)
T ss_pred             HhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence            34455555666666666555677778888888888888743 333677888888888888887543  455666788888


Q ss_pred             ccCCcCCCCCcccccCccccccccccCCcccCCCC-cccccCCCCcEEEecCccccCcCCcccccCCccceeeccccccc
Q 001561          284 IFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLP-LSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFS  362 (1052)
Q Consensus       284 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  362 (1052)
                      +++|.|+..  ..+..++.|+.+++++|.+...-+ . ...+.+++.+++.+|.+....  .+..+..+..+++..|.++
T Consensus       147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIE--GLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhccc--chHHHHHHHHhhcccccce
Confidence            888888732  234556777777777777764433 2 455666667777777665322  2223344444466666665


Q ss_pred             CCCCccccCCC--ccceeecccccccccCchhhccCCcCcEEeccCCcCCCC
Q 001561          363 GPLPNSLSDCH--DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL  412 (1052)
Q Consensus       363 ~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~l  412 (1052)
                      ..-+  +..+.  .|+.+++++|++. ..+..+..+..+..|++.+|++..+
T Consensus       222 ~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~  270 (414)
T KOG0531|consen  222 KLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL  270 (414)
T ss_pred             eccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc
Confidence            3221  11222  2666666666665 3334455556666666666665543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.99  E-value=4.8e-09  Score=101.04  Aligned_cols=143  Identities=18%  Similarity=0.270  Sum_probs=106.4

Q ss_pred             ccCeEcccCceEEEEEEECCCcEEEEEE-ecCCc-------hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEEEE
Q 001561          775 QANIIGCGGFGLVYKATLTNGTKAAVKR-LSGDC-------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       775 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  846 (1052)
                      ...+|-||+-+.|+++.+. |+...||. +.+.-       .-..++...|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678999999999999986 77766664 33221       112345678999999987666665555666777778999


Q ss_pred             EeccC-CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCC---eEEeeccccc
Q 001561          847 SYMEN-GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSR  922 (1052)
Q Consensus       847 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~---~kl~DfG~a~  922 (1052)
                      ||++| .++.+++......  ....+....++..|-+.+.-||..   +|+|+|+..+||++..++.   +.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 4778887765422  222333367889999999999986   9999999999999975543   5899999985


Q ss_pred             c
Q 001561          923 L  923 (1052)
Q Consensus       923 ~  923 (1052)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            3

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.99  E-value=4.1e-10  Score=111.69  Aligned_cols=124  Identities=27%  Similarity=0.360  Sum_probs=51.3

Q ss_pred             CcEEEEEecCCCCcccCCcccc-CCcCCCeEecCCCCCCCCCcccccCCCCccEEeccCCcccCcccccccccCCccEEE
Q 001561           86 GRVTMLILPRKGLKGIIPRSLG-HLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLN  164 (1052)
Q Consensus        86 ~~v~~l~L~~~~l~g~~~~~l~-~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~  164 (1052)
                      -+.+.|+|++++|+.+  +.++ .+.+|+.||||+|.|+.+.  .+..+++|++|++++|.|+...+.....+++|++|+
T Consensus        19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY   94 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred             cccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence            3678999999999875  3466 6899999999999999653  488899999999999999986554445789999999


Q ss_pred             ccCcccCCcc--cccccCCcccEEEecCCccCCc--cchhhhhcccccceeec
Q 001561          165 VSSNSFNGSL--FELGEFSNLAVFNISNNSFTGK--LNSRIWSASKEIQILDL  213 (1052)
Q Consensus       165 Ls~N~l~~~~--~~l~~l~~L~~L~Ls~n~l~~~--~~~~~~~~~~~L~~L~L  213 (1052)
                      |++|+|....  ..+..+++|++|++.+|.++..  ....++..+++|+.||-
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            9999998654  4577888999999999988733  12234455555555553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.95  E-value=2.4e-10  Score=135.49  Aligned_cols=249  Identities=20%  Similarity=0.241  Sum_probs=171.4

Q ss_pred             hhcCCcccCeEcccCceEEEEEEEC-CCcEEEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeeeeceEeeCCeEEE
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       769 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  844 (1052)
                      ..+.+.+.+.+-.|.++.++-+.-. .|...+.|......   ....+....+-.+.-..++|.++.....+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456777888999999999988643 45555555443221   1111122223233333456777777666666778899


Q ss_pred             EEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeeccccccc
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~  924 (1052)
                      |++|..+++|...++..    ...+.+.++.....+..+.+|||..   .+.|||++|.|.+...+++.+++|||.....
T Consensus       882 ~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            99999999998888753    2455566677777889999999985   6899999999999999999999999844322


Q ss_pred             CCC---------------------C---C------eeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCC
Q 001561          925 RPY---------------------D---T------HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP  974 (1052)
Q Consensus       925 ~~~---------------------~---~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~p  974 (1052)
                      .-.                     .   .      ......+||+.|.+||...+.....++|+|+.|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110                     0   0      012235799999999999999999999999999999999999999


Q ss_pred             CcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 001561          975 VEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIE 1038 (1052)
Q Consensus       975 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1038 (1052)
                      |.....   ..    +++.......       .|.........++.+++...+..+|.+|-.+.
T Consensus      1035 ~na~tp---q~----~f~ni~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETP---QQ----IFENILNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcch---hh----hhhccccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            964221   11    1211111111       11222333444678888889899999997765

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.90  E-value=3.5e-08  Score=109.12  Aligned_cols=171  Identities=22%  Similarity=0.275  Sum_probs=128.9

Q ss_pred             CceEEEEEEE-CCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCceeeeeceEe----eCCeEEEEEEeccCC-Chhh
Q 001561          783 GFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR----HGNDRLLIYSYMENG-SLDY  856 (1052)
Q Consensus       783 ~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~g-~L~~  856 (1052)
                      -..+.||+.. .||..|++|+++++.......-..-+++++++.|+|+|++.+++.    .+...++||+|.++. +|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3457899964 489999999996654433323355688999999999999999886    345688999999864 5655


Q ss_pred             hhhccc-----------CCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccC
Q 001561          857 WLHESV-----------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       857 ~l~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      .-....           ..+...+++..|.++.|++.||.++|+.   |.+.+-+.+++|+++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            433211           1234578899999999999999999997   99999999999999999999998888776554


Q ss_pred             CCCCeeeecccccccccCccccCCcCCCcccchHHHHHHHHHHHcCCCC
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP  974 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~p  974 (1052)
                      .+..               |-+.   --.+-|.=.||.+++.|.||..-
T Consensus       445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            3321               1111   12356999999999999998653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.86  E-value=7.5e-08  Score=103.70  Aligned_cols=262  Identities=18%  Similarity=0.194  Sum_probs=157.2

Q ss_pred             ccCeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeeeece----E--ee-CCeEEEEE
Q 001561          775 QANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGY----C--RH-GNDRLLIY  846 (1052)
Q Consensus       775 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~--~~-~~~~~lv~  846 (1052)
                      ..+.||+|+.+.+|-.--- +..|| |++.........+.   ++.|... .||-+-.=+.|    .  .. +....+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hchhh-eeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4677999999999965211 23344 77765544333322   2333333 46543321111    1  11 22356777


Q ss_pred             EeccCCC-hhhhhhc--ccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccc
Q 001561          847 SYMENGS-LDYWLHE--SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       847 e~~~~g~-L~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~  923 (1052)
                      +.+.+-. ...+...  .+..-....|.-.++++..++.+.+.||.+   |.+-+|+.++|+|+.+++.|.+.|=..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence            7776642 1222211  112334578999999999999999999997   999999999999999999999987543322


Q ss_pred             cCCCCCeeeecccccccccCccccC-----CcCCCcccchHHHHHHHHHHHcC-CCCCcccC-----CCCch-hHHHHHH
Q 001561          924 LRPYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLTG-RRPVEVCK-----GKNCR-DLVSWVF  991 (1052)
Q Consensus       924 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG-~~pf~~~~-----~~~~~-~~~~~~~  991 (1052)
                      .  .........+|...|.+||...     +...+...|-|.+||++++++.| +.||.+..     +...+ ++....+
T Consensus       167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            2  2333445568999999999643     44567789999999999999886 99997532     11111 2222212


Q ss_pred             HhhhcccccccccccccchhhHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHhhcC
Q 001561          992 QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQ--DPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      ...+.........+..+ + ..--...+..+..+|+..  .|.-||+++..+..|..+.
T Consensus       245 ~ya~~~~~g~~p~P~~~-P-~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         245 AYASDQRRGLKPPPRSI-P-LSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             eechhccCCCCCCCCCC-C-hhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            11111111111111111 0 011122456667778754  3678999998888776543

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.82  E-value=3.4e-09  Score=130.98  Aligned_cols=178  Identities=24%  Similarity=0.292  Sum_probs=86.2

Q ss_pred             CCcEEEecCcc--ccCcCCcccccCCccceeecccccccCCCCccccCCCccceeecccccccccCchhhccCCcCcEEe
Q 001561          326 KLHVLDLRNNS--LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLS  403 (1052)
Q Consensus       326 ~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  403 (1052)
                      +|++|-+..|.  +.......|..++.|+.|||++|.=-+.+|..++++-+|++|+|++..++ .+|..+++++.|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            45555555554  33333333455555555555555444455555555555555555555555 4555555555555555


Q ss_pred             ccCCcCCCCcccchhhccCcccceEeccccc--cCccCCccccCCCcccEEEccCCccccCcchhhhcCCCCc----EEe
Q 001561          404 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNF--VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQ----VLD  477 (1052)
Q Consensus       404 L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~  477 (1052)
                      +..+.-....  ......+.+|++|.+....  .+...-..+..+..|+.+.......  .+-..+..+.+|.    .+.
T Consensus       625 l~~~~~l~~~--~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~  700 (889)
T KOG4658|consen  625 LEVTGRLESI--PGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS  700 (889)
T ss_pred             cccccccccc--cchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence            5554422211  1223335555555554432  1112222334444444444433322  1111122222222    333


Q ss_pred             CcCccCCCCCChhhccCCCCCeEeccCCcccc
Q 001561          478 LSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG  509 (1052)
Q Consensus       478 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  509 (1052)
                      +.++... ..+..++.+.+|+.|.+.++.++.
T Consensus       701 ~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e  731 (889)
T KOG4658|consen  701 IEGCSKR-TLISSLGSLGNLEELSILDCGISE  731 (889)
T ss_pred             hcccccc-eeecccccccCcceEEEEcCCCch
Confidence            3333333 445567778888888888888764

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.77  E-value=5.4e-09  Score=129.27  Aligned_cols=250  Identities=26%  Similarity=0.264  Sum_probs=106.3

Q ss_pred             CCcEEEcccCc--CCchhhhhhcCCCCCcEEEccCCcCCCCCcccccCccccccccccCCcccCCCCcccccCCCCcEEE
Q 001561          254 SLQHVSLSVNN--FSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLD  331 (1052)
Q Consensus       254 ~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~  331 (1052)
                      +|++|-+..|.  +....++.|..++.|+.|||++|.=-+.+|..++++-+|++|++++..++ .+|..+.++.+|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            45555555543  33222333444555555555554443445555555555555555555554 4455555555555555


Q ss_pred             ecCccccCcCCcccccCCccceeeccccccc--CCCCccccCCCccceeecccccccccCchhhccCCcCc----EEecc
Q 001561          332 LRNNSLTGPIDLNFSGLSSLCTLDLATNHFS--GPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLL----FLSLS  405 (1052)
Q Consensus       332 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~  405 (1052)
                      +..+.-...++.....+.+|++|.+..-...  ...-..+.++.+|+.+.......  .+-..+..+..|.    .+.+.
T Consensus       625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~  702 (889)
T KOG4658|consen  625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIE  702 (889)
T ss_pred             cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhc
Confidence            5544433333444444555555554433211  11112223333333333322221  0011111222211    22222


Q ss_pred             CCcCCCCcccchhhccCcccceEeccccccCccCCccccC------CCcccEEEccCCccccCcchhhhcCCCCcEEeCc
Q 001561          406 NNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG------FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLS  479 (1052)
Q Consensus       406 ~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  479 (1052)
                      ++..   ......+..+.+|+.|.+.++.+.+........      ++++..+...++..- ..+.+.--.++|+.|++.
T Consensus       703 ~~~~---~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~  778 (889)
T KOG4658|consen  703 GCSK---RTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLV  778 (889)
T ss_pred             cccc---ceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEe
Confidence            2111   122233445555555555555553322221111      122222222222211 233444445677777777


Q ss_pred             CccCCCCCChhhccCCCCCeEeccCCccccc
Q 001561          480 WNHFDGNIPPWIGQMENLFYLDFSNNTLTGE  510 (1052)
Q Consensus       480 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  510 (1052)
                      ++.....+.+....+..+..+-+..+.+.+.
T Consensus       779 ~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l  809 (889)
T KOG4658|consen  779 SCRLLEDIIPKLKALLELKELILPFNKLEGL  809 (889)
T ss_pred             cccccccCCCHHHHhhhcccEEecccccccc
Confidence            6666555555555555566555666665554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.76  E-value=1.1e-07  Score=102.23  Aligned_cols=141  Identities=13%  Similarity=0.097  Sum_probs=101.7

Q ss_pred             CeEcccCceEEEEEEECCCcEEEEEEecCCch-----------hhHHHHHHHHHHHHhcCCCc--eeeeeceEee-----
Q 001561          777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----------QMEREFQAEVEALSRAQHKN--LVSLQGYCRH-----  838 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----  838 (1052)
                      +++-......|+++.+ +|+.|.||+......           .....+.+|++.+.++...+  .++++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455444455777766 478899997754321           11124788999998885433  3444555543     


Q ss_pred             CCeEEEEEEeccCC-ChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECC-------C
Q 001561          839 GNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-------K  910 (1052)
Q Consensus       839 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-------~  910 (1052)
                      ....++|+|++++. +|.+++....  ....+...+..++.+++..++-||..   ||+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23568999999986 7888875432  23345677789999999999999997   9999999999999985       4


Q ss_pred             CCeEEeecccccc
Q 001561          911 FEAHLADFGLSRL  923 (1052)
Q Consensus       911 ~~~kl~DfG~a~~  923 (1052)
                      +.+.++||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6899999998864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=6.7e-08  Score=97.72  Aligned_cols=126  Identities=21%  Similarity=0.243  Sum_probs=82.9

Q ss_pred             EEEEEEECCCcEEEEEEecCCc--------------------------hhhHHHHHHHHHHHHhcCCC--ceeeeeceEe
Q 001561          786 LVYKATLTNGTKAAVKRLSGDC--------------------------GQMEREFQAEVEALSRAQHK--NLVSLQGYCR  837 (1052)
Q Consensus       786 ~Vy~~~~~~g~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  837 (1052)
                      .||.|...+|..+|+|..+...                          ........+|++.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998889999999875210                          01123467899999999766  456665442 


Q ss_pred             eCCeEEEEEEecc--CCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCCceEECCCCCeE
Q 001561          838 HGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAH  914 (1052)
Q Consensus       838 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~HrDlkp~Nill~~~~~~k  914 (1052)
                         ...+||||++  |..+..+....      ++.+....++.+++..+..+ |..   +|+|+|+.+.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999998  54444432211      11334466777888866664 665   99999999999999988 999


Q ss_pred             EeecccccccC
Q 001561          915 LADFGLSRLLR  925 (1052)
Q Consensus       915 l~DfG~a~~~~  925 (1052)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.75  E-value=5.2e-09  Score=85.34  Aligned_cols=61  Identities=43%  Similarity=0.612  Sum_probs=46.6

Q ss_pred             cccceecccCceeeecCCCCcccccCcCeeeCCCCcCCCCCCccccCccccCeeeeccccc
Q 001561          581 KHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL  641 (1052)
Q Consensus       581 ~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~l~l~~N~l  641 (1052)
                      ++|++|+|++|+|+...+..|..+++|++||+++|+++...|..|..+++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3677788888888865556778888888888888888766667778888888888888765

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.71  E-value=9.2e-09  Score=83.89  Aligned_cols=61  Identities=38%  Similarity=0.505  Sum_probs=49.7

Q ss_pred             cCCCeEecCCCCCCCCCcccccCCCCccEEeccCCcccCcccccccccCCccEEEccCccc
Q 001561          110 NQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSF  170 (1052)
Q Consensus       110 ~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  170 (1052)
                      ++|++|+|++|+|+.+.+..|..+++|++|++++|.|+...++.|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4678888888888877777888888888888888888888888888888888888887764

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.69  E-value=1.5e-07  Score=97.17  Aligned_cols=149  Identities=23%  Similarity=0.172  Sum_probs=105.1

Q ss_pred             ccHHHHHHhhcCCcccCeEcccCceEEEEEEECCCcEEEEEEecCCc----------------------hhhHHHHHHHH
Q 001561          761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC----------------------GQMEREFQAEV  818 (1052)
Q Consensus       761 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------------~~~~~~~~~E~  818 (1052)
                      +.+..+.+...-..+...||.|.-+.||.|....|.++|||.=+...                      .......++|+
T Consensus        81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf  160 (304)
T COG0478          81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF  160 (304)
T ss_pred             HHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence            33445554444566788999999999999999999999999543110                      01223457899


Q ss_pred             HHHHhcCCC--ceeeeeceEeeCCeEEEEEEeccCCChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 001561          819 EALSRAQHK--NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV  896 (1052)
Q Consensus       819 ~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~  896 (1052)
                      ++|.++.-.  .|.+.+++    +...+||||++|-.|...-         ++.+....++..|++-+...-..   |||
T Consensus       161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiV  224 (304)
T COG0478         161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIV  224 (304)
T ss_pred             HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---Ccc
Confidence            999999755  67777766    4567999999997654321         12233334444444444444343   999


Q ss_pred             EcCCCCCceEECCCCCeEEeecccccccC
Q 001561          897 HRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       897 HrDlkp~Nill~~~~~~kl~DfG~a~~~~  925 (1052)
                      |+|+.+-||++++||.+.++||-.+....
T Consensus       225 HGDlSefNIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         225 HGDLSEFNILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             ccCCchheEEEecCCCEEEEeCcccccCC
Confidence            99999999999999999999999886543

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.67  E-value=1.9e-08  Score=74.98  Aligned_cols=38  Identities=37%  Similarity=0.773  Sum_probs=29.7

Q ss_pred             HHHHHHHHHHHhcCCC--CCCCCCcCCC--CCCceeeeeeeC
Q 001561           40 PSDLLALKEFAGNLTN--GSIITSWSNE--SMCCQWDGVVCG   77 (1052)
Q Consensus        40 ~~~~~aLl~~k~~~~~--~~~l~sw~~~--~~~c~w~gv~C~   77 (1052)
                      ++|++||++||+++..  .+.+.+|+..  .+||.|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            5799999999999974  3789999987  799999999994

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.52  E-value=5.6e-09  Score=118.68  Aligned_cols=127  Identities=27%  Similarity=0.238  Sum_probs=86.4

Q ss_pred             cccEEEecCCccCCccchhhhhcccccceeeccCcccccccccCCCCCCCCEEEcccccCCCCCCccccCCCCCcEEEcc
Q 001561          182 NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS  261 (1052)
Q Consensus       182 ~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  261 (1052)
                      .|...+.++|++.  ........++.|+.||||+|+++... .+..++.|++|||++|.+....--....+. |+.|.|+
T Consensus       165 ~L~~a~fsyN~L~--~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV--LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH--hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            4667777777776  33445666777888888888887665 677778888888888888733222223333 8888888


Q ss_pred             cCcCCchhhhhhcCCCCCcEEEccCCcCCCCCc-ccccCccccccccccCCccc
Q 001561          262 VNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLP-NVLGNLTQLEFFVAHSNSFS  314 (1052)
Q Consensus       262 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~  314 (1052)
                      +|.++..  ..+.+|.+|+.||+++|-|.+.-. ..++.+..|+.|+|.+|.+-
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            8887633  356778888888888887764322 22456777777888887765

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.50  E-value=2.8e-08  Score=101.97  Aligned_cols=116  Identities=22%  Similarity=0.304  Sum_probs=71.9

Q ss_pred             CCccccCCcCCCeEecCCCCCCCCCcc-cc-cCCCCccEEeccCCcccC--cccccccccCCccEEEccCcccCCccccc
Q 001561          102 IPRSLGHLNQLKLLDLSCNHLEGVVPV-EL-SNLKQLEVLDLSHNMLSG--PVSGMLAGLNLIQSLNVSSNSFNGSLFEL  177 (1052)
Q Consensus       102 ~~~~l~~l~~L~~L~Ls~n~i~~~~p~-~l-~~l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~Ls~N~l~~~~~~l  177 (1052)
                      .+-.++.+..+..|.|.++.|...... .| ...+.++.|||.+|.|+.  .+...+..++.|+.|+|+.|++......+
T Consensus        37 s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~l  116 (418)
T KOG2982|consen   37 SYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSL  116 (418)
T ss_pred             ceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccC
Confidence            333444445556666666666433221 12 235667778888887774  45556677778888888888777655555


Q ss_pred             -ccCCcccEEEecCCccCCccchhhhhcccccceeeccCcc
Q 001561          178 -GEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH  217 (1052)
Q Consensus       178 -~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~  217 (1052)
                       -..++|+.|-|.+..+.-.-.......+++++.|.+|.|.
T Consensus       117 p~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~  157 (418)
T KOG2982|consen  117 PLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNS  157 (418)
T ss_pred             cccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccch
Confidence             3566788888877777644444555555666666666553

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=3.2e-08  Score=113.83  Aligned_cols=150  Identities=21%  Similarity=0.302  Sum_probs=104.6

Q ss_pred             HHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCCeEEeecccccccCCCCCe--------eeecccccccccCccccCC
Q 001561          878 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--------VTTDLVGTLGYIPPEYSQT  949 (1052)
Q Consensus       878 ~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~  949 (1052)
                      .+++.|+.|+|..  .++||++|.|++|.+++.+..|++.|+++.........        ...-..-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455899999985  89999999999999999999999999998765432111        1111244568999999999


Q ss_pred             cCCCcccchHHHHHHHHHHH-cCCCCCcccCCCCchhHHHHHHHhhhcccccccccccccchhhHHHHHHHHHHHHHccc
Q 001561          950 LTATCRGDVYSFGVVLLELL-TGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCID 1028 (1052)
Q Consensus       950 ~~~~~~~DvwslGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 1028 (1052)
                      ...+.++|+||+|+.+|.+. .|+.-+............     ..        .+......+....+.++.+=+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-----~~--------~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-----RN--------LLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-----hc--------ccccccccccccCcHHHHHHHHHHhc
Confidence            88899999999999999999 566555432211111100     00        00001111223344578888999999


Q ss_pred             CCCCCCCCHHHHHH
Q 001561         1029 QDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1029 ~dP~~RPs~~evl~ 1042 (1052)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998877654

>PRK09902 hypothetical protein; Provisional

Probab=98.45  E-value=2.2e-06  Score=87.00  Aligned_cols=138  Identities=19%  Similarity=0.156  Sum_probs=102.6

Q ss_pred             EcccCceEEEEEEECCCcEEEEEEecCCc------hhhHHHHHHHHHHHHhcCCC--ceeeeeceEeeC-----CeEEEE
Q 001561          779 IGCGGFGLVYKATLTNGTKAAVKRLSGDC------GQMEREFQAEVEALSRAQHK--NLVSLQGYCRHG-----NDRLLI  845 (1052)
Q Consensus       779 lG~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~-----~~~~lv  845 (1052)
                      -|+||-+.|+..... |..+-+|+-....      +-.+..|.+|+..+.++..-  .+.++. ++...     -.-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467888889998765 5578888764111      33557799999999998532  244554 33211     235799


Q ss_pred             EEeccC-CChhhhhhcccCCccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCceEECCCCC--eEEeeccccc
Q 001561          846 YSYMEN-GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE--AHLADFGLSR  922 (1052)
Q Consensus       846 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~--~kl~DfG~a~  922 (1052)
                      +|-+++ -+|.+++.+.  .-.+.+...+..+..+++++++-||+.   ++.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997764 4888887643  223457778889999999999999997   9999999999999986667  9999998876


Q ss_pred             c
Q 001561          923 L  923 (1052)
Q Consensus       923 ~  923 (1052)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            5

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.45  E-value=4.4e-08  Score=100.62  Aligned_cols=181  Identities=24%  Similarity=0.248  Sum_probs=99.8

Q ss_pred             CCcCcEEeccCCcCCCCcccchhhccCcccceEeccccccCccCCccccCCCcccEEEccCCccc-cCcchhhhcCCCCc
Q 001561          396 LTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLK-GHIPVWLLRCKKLQ  474 (1052)
Q Consensus       396 l~~L~~L~L~~N~l~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~  474 (1052)
                      .+.++.|||.+|.|+........+.+++.|++|+|+.|.+...+-..-..+.+|+.|-|.+..+. ......+..+|.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            45666777777777766665566667777777777777665444333245566777777666554 12344556677777


Q ss_pred             EEeCcCccCCCC-C-Chhhcc-CCCCCeEec---------cCCcccccCCcchhhhhhhcccCCCCCCCCCCCCccceee
Q 001561          475 VLDLSWNHFDGN-I-PPWIGQ-MENLFYLDF---------SNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK  542 (1052)
Q Consensus       475 ~L~Ls~N~l~~~-~-p~~~~~-l~~L~~L~L---------s~N~l~~~~p~~~~~l~~L~~~~~~~~~~~~~~~~~~~~~  542 (1052)
                      .|++|.|.+... + ..++.. -+.++.|.+         +-|++....|                              
T Consensus       150 elHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fp------------------------------  199 (418)
T KOG2982|consen  150 ELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFP------------------------------  199 (418)
T ss_pred             hhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcc------------------------------
Confidence            777777743210 0 000000 011222222         2222221111                              


Q ss_pred             ccccCCCcCCCCCCCCCCeeeeecCcccccC-CcccccccccceecccCceeeecC-CCCcccccCcCeeeCCCCcCCCC
Q 001561          543 HNRSTNGLPYNQASSFPPSVFLSNNRINGTI-PPEIGQLKHLHVLDLSRNNITGTI-PSSISEIRNLEVLDLSSNDLHGS  620 (1052)
Q Consensus       543 ~~~~~~~l~~~~~~~~~~~l~Ls~N~l~g~i-p~~~~~l~~L~~L~Ls~N~l~g~i-p~~~~~l~~L~~LdLs~N~l~g~  620 (1052)
                                     -...+++..|.+...- -.....++.+-.|+|+.|+|...- -+.+..+++|..|.+++|.|...
T Consensus       200 ---------------nv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~  264 (418)
T KOG2982|consen  200 ---------------NVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDP  264 (418)
T ss_pred             ---------------cchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccc
Confidence                           1123555566554332 123445666778888888887422 24577788888888888888654


Q ss_pred             C
Q 001561          621 I  621 (1052)
Q Consensus       621 ~  621 (1052)
                      +
T Consensus       265 l  265 (418)
T KOG2982|consen  265 L  265 (418)
T ss_pred             c
Confidence            3

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.40  E-value=7.8e-09  Score=117.54  Aligned_cols=179  Identities=23%  Similarity=0.229  Sum_probs=102.2

Q ss_pred             cCCCCCCCCEEEcccccCCCCCCccccCC-CCCcEEEcccCcCC---chhhhhhcCC------CCCcEEEccCCcCCCCC
Q 001561          224 GLDHSPSLKQLHVDNNLLGGDLPDSLYSM-SSLQHVSLSVNNFS---GQLSEKISNL------TSLRHLIIFGNQFSGKL  293 (1052)
Q Consensus       224 ~l~~~~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~---~~~~~~~~~l------~~L~~L~Ls~N~l~~~~  293 (1052)
                      .+..+.+|+.|.|.++.|..  ...+..+ .+|++|.-. |.+.   ..+....+..      ..|...+.++|.+. ..
T Consensus       104 ~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~m  179 (1096)
T KOG1859|consen  104 SIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LM  179 (1096)
T ss_pred             eeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hH
Confidence            34555677777777777763  1122221 244444333 2221   1111111111      24666667777766 55


Q ss_pred             cccccCccccccccccCCcccCCCCcccccCCCCcEEEecCccccCcCCcccccCCccceeecccccccCCCCccccCCC
Q 001561          294 PNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH  373 (1052)
Q Consensus       294 p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  373 (1052)
                      ..++.-++.|+.|+|++|++....  .+..+++|+.|||+.|.++..+.....++. |+.|.|++|.++..  ..+.+++
T Consensus       180 D~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~Lk  254 (1096)
T KOG1859|consen  180 DESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLK  254 (1096)
T ss_pred             HHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHhhh
Confidence            556666677777777777776432  566677777777777777654444444444 77777777776632  3456677


Q ss_pred             ccceeecccccccccCc-hhhccCCcCcEEeccCCcCCC
Q 001561          374 DLKILSLAKNELSGQVP-ESFGKLTSLLFLSLSNNSFNH  411 (1052)
Q Consensus       374 ~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~  411 (1052)
                      +|+.||++.|-|.+.-. ..++.|..|+.|+|.+|.+-.
T Consensus       255 sL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  255 SLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             hhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            77777777776664321 234556677777777776643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=3.4e-06  Score=88.93  Aligned_cols=132  Identities=18%  Similarity=0.149  Sum_probs=86.1

Q ss_pred             CeEcccCceEEEEEEECCCcEEEEEEecCCchhhHHHHHHHHHHHHhcCCCc--eeeeeceEeeCCeEEEEEEeccCCC-
Q 001561          777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN--LVSLQGYCRHGNDRLLIYSYMENGS-  853 (1052)
Q Consensus       777 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  853 (1052)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.  +.+++++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   25577888876533  2345688999999986433  5677778777778889999999863 


Q ss_pred             hhhhhhcccCCccccCHHHHHHHHHHHHHH---------------------------------------HHHHHhcC-CC
Q 001561          854 LDYWLHESVDKDSVLKWDVRLKIAQGAARG---------------------------------------LAYLHKVC-EP  893 (1052)
Q Consensus       854 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~---------------------------------------l~~LH~~~-~~  893 (1052)
                      +...+..        +......++..+++.                                       .++|.... .+
T Consensus        82 ~~~~~~~--------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        82 FSRIISD--------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             hhhhhcC--------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            2111110        001111111111111                                       22222211 34


Q ss_pred             CeEEcCCCCCceEECCCCCeEEeeccccc
Q 001561          894 HIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       894 ~i~HrDlkp~Nill~~~~~~kl~DfG~a~  922 (1052)
                      .++|+|+.|.||++++++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            578999999999999988 9999999885

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1052
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-65
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-63
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-60
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-60
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-48
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-37
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-21
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		5e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		1e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		3e-04
2z7x_B	520	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		3e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		4e-04
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		4e-04
3soa_A	444	Full-Length Human Camkii Length = 444		4e-04
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		4e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  246 bits (628), Expect = 5e-65,   Method: Composition-based stats.
 Identities = 125/294 (42%), Positives = 189/294 (64%), Gaps = 3/294 (1%)
Query: 759  KDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAE 817
            K  ++ +L  +++NF+  NI+G GGFG VYK  L +GT  AVKRL  +  Q  E +FQ E
Sbjct: 26   KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 818  VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA 877
            VE +S A H+NL+ L+G+C    +RLL+Y YM NGS+   L E  +    L W  R +IA
Sbjct: 86   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 878  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 937
             G+ARGLAYLH  C+P I+HRDVK++NILLDE+FEA + DFGL++L+   D HV   + G
Sbjct: 146  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 205
Query: 938  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKS 995
            T+G+I PEY  T  ++ + DV+ +GV+LLEL+TG+R  ++ +  N  D  L+ WV  +  
Sbjct: 206  TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 996  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049
            EK+   ++D  +    +++++ +++++A  C    P  RP + EVV  L+G G+
Sbjct: 266  EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 319

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  241 bits (614), Expect = 2e-63,   Method: Composition-based stats.
 Identities = 123/294 (41%), Positives = 186/294 (63%), Gaps = 3/294 (1%)
Query: 759  KDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAE 817
            K  ++ +L  +++NF   NI+G GGFG VYK  L +G   AVKRL  +  Q  E +FQ E
Sbjct: 18   KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 818  VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA 877
            VE +S A H+NL+ L+G+C    +RLL+Y YM NGS+   L E  +    L W  R +IA
Sbjct: 78   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 878  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 937
             G+ARGLAYLH  C+P I+HRDVK++NILLDE+FEA + DFGL++L+   D HV   + G
Sbjct: 138  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 197
Query: 938  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKS 995
             +G+I PEY  T  ++ + DV+ +GV+LLEL+TG+R  ++ +  N  D  L+ WV  +  
Sbjct: 198  XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 996  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049
            EK+   ++D  +    +++++ +++++A  C    P  RP + EVV  L+G G+
Sbjct: 258  EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  231 bits (590), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 194/603 (32%), Positives = 284/603 (47%), Gaps = 85/603 (14%)
Query: 111 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSF 170
            L+ LD+S N+    +P  L +   L+ LD+S N LSG  S  ++    ++ LN+SSN F
Sbjct: 198 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 256
Query: 171 NGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSP 229
            G +  L    +L   +++ N FTG++   +  A   +  LDLS NHF G++        
Sbjct: 257 VGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 315
Query: 230 SLKQLHVDNNLLGGDLP-DSLYSMSSLQHVSLSVNNFSGQLSEKISNLT-SLRHLIIFGN 287
            L+ L + +N   G+LP D+L  M  L+ + LS N FSG+L E ++NL+ SL  L +  N
Sbjct: 316 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 375
Query: 288 QFSGKLPNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSG 347
            FSG    +L NL Q                           L L+NN  TG I    S 
Sbjct: 376 NFSGP---ILPNLCQ-------------------NPKNTLQELYLQNNGFTGKIPPTLSN 413
Query: 348 LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXX 407
            S L +L L+ N+ SG +P+SL     L+ L L  N L G++P+                
Sbjct: 414 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE--------------- 458
Query: 408 XXXXXXGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWL 467
                      L   K L TLIL  N +  EIP  +    +L  ++L N  L G IP W+
Sbjct: 459 -----------LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 507
Query: 468 LRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCT 527
            R + L +L LS N F GNIP  +G   +L +LD + N   G IP ++ +    I++N  
Sbjct: 508 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 567
Query: 528 SSNPTA------------SAGIPLYVKHNRST--NGLPYNQASSFPPSVF---------- 563
           +                  AG  L  +  RS   N L      +    V+          
Sbjct: 568 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 627
Query: 564 --------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 615
                   +S N ++G IP EIG + +L +L+L  N+I+G+IP  + ++R L +LDLSSN
Sbjct: 628 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 687
Query: 616 DLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDS 675
            L G IP +   LT L++  ++NN+L G IP  GQF +FP + F  NPGLCG     CD 
Sbjct: 688 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 747
Query: 676 MHA 678
            +A
Sbjct: 748 SNA 750

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  231 bits (589), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 194/603 (32%), Positives = 284/603 (47%), Gaps = 85/603 (14%)
Query: 111 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSF 170
            L+ LD+S N+    +P  L +   L+ LD+S N LSG  S  ++    ++ LN+SSN F
Sbjct: 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 171 NGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSP 229
            G +  L    +L   +++ N FTG++   +  A   +  LDLS NHF G++        
Sbjct: 260 VGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318
Query: 230 SLKQLHVDNNLLGGDLP-DSLYSMSSLQHVSLSVNNFSGQLSEKISNLT-SLRHLIIFGN 287
            L+ L + +N   G+LP D+L  M  L+ + LS N FSG+L E ++NL+ SL  L +  N
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 288 QFSGKLPNVLGNLTQLEFFVAHXXXXXXXXXXXXXXXXXXHVLDLRNNSLTGPIDLNFSG 347
            FSG    +L NL Q                           L L+NN  TG I    S 
Sbjct: 379 NFSGP---ILPNLCQ-------------------NPKNTLQELYLQNNGFTGKIPPTLSN 416
Query: 348 LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPEXXXXXXXXXXXXXXXX 407
            S L +L L+ N+ SG +P+SL     L+ L L  N L G++P+                
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE--------------- 461
Query: 408 XXXXXXGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWL 467
                      L   K L TLIL  N +  EIP  +    +L  ++L N  L G IP W+
Sbjct: 462 -----------LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 468 LRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCT 527
            R + L +L LS N F GNIP  +G   +L +LD + N   G IP ++ +    I++N  
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570
Query: 528 SSNPTA------------SAGIPLYVKHNRST--NGLPYNQASSFPPSVF---------- 563
           +                  AG  L  +  RS   N L      +    V+          
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 564 --------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 615
                   +S N ++G IP EIG + +L +L+L  N+I+G+IP  + ++R L +LDLSSN
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 616 DLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDS 675
            L G IP +   LT L++  ++NN+L G IP  GQF +FP + F  NPGLCG     CD 
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750
Query: 676 MHA 678
            +A
Sbjct: 751 SNA 753

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  191 bits (484), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 123/306 (40%), Positives = 177/306 (57%), Gaps = 7/306 (2%)
Query: 741  LSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAV 800
            +++AL+SS LV F++     + + DL ++TNNF+   +IG G FG VYK  L +G K A+
Sbjct: 12   INDALSSSYLVPFESYR---VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVAL 68
Query: 801  KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE 860
            KR + +  Q   EF+ E+E LS  +H +LVSL G+C   N+ +LIY YMENG+L   L+ 
Sbjct: 69   KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
Query: 861  SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL 920
            S      + W+ RL+I  GAARGL YLH      I+HRDVKS NILLDE F   + DFG+
Sbjct: 129  SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185
Query: 921  SRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK 979
            S+     D TH+   + GTLGYI PEY      T + DVYSFGVVL E+L  R  +    
Sbjct: 186  SKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 980  GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
             +   +L  W  +  +  +  +I+D ++  K R + L +  + A KC+      RP + +
Sbjct: 246  PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 1040 VVTWLD 1045
            V+  L+
Sbjct: 306  VLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  188 bits (478), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 122/306 (39%), Positives = 176/306 (57%), Gaps = 7/306 (2%)
Query: 741  LSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAV 800
            +++AL+SS LV F++     + + DL ++TNNF+   +IG G FG VYK  L +G K A+
Sbjct: 12   INDALSSSYLVPFESYR---VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVAL 68
Query: 801  KRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE 860
            KR + +  Q   EF+ E+E LS  +H +LVSL G+C   N+ +LIY YMENG+L   L+ 
Sbjct: 69   KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
Query: 861  SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL 920
            S      + W+ RL+I  GAARGL YLH      I+HRDVKS NILLDE F   + DFG+
Sbjct: 129  SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185
Query: 921  SRLLRPY-DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK 979
            S+       TH+   + GTLGYI PEY      T + DVYSFGVVL E+L  R  +    
Sbjct: 186  SKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 980  GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
             +   +L  W  +  +  +  +I+D ++  K R + L +  + A KC+      RP + +
Sbjct: 246  PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 1040 VVTWLD 1045
            V+  L+
Sbjct: 306  VLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (418), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 163/291 (56%), Gaps = 19/291 (6%)
Query: 765  DLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSG----DCGQMEREF 814
            +L   TNNF++       N +G GGFG+VYK  + N T  AVK+L+        +++++F
Sbjct: 19   ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 77
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E++ +++ QH+NLV L G+   G+D  L+Y YM NGSL   L   +D    L W +R 
Sbjct: 78   DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRC 136
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY-DTHVTT 933
            KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R    +  T + +
Sbjct: 137  KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS 193
Query: 934  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
             +VGT  Y+ PE  +    T + D+YSFGVVLLE++TG   V+  +      L       
Sbjct: 194  RIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIE 251
Query: 994  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
              EK   + ID  +   D    +  M  +A +C+ +   +RP I++V   L
Sbjct: 252  DEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (416), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 162/291 (55%), Gaps = 19/291 (6%)
Query: 765  DLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSG----DCGQMEREF 814
            +L   TNNF++       N +G GGFG+VYK  + N T  AVK+L+        +++++F
Sbjct: 19   ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 77
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E++ +++ QH+NLV L G+   G+D  L+Y YM NGSL   L   +D    L W +R 
Sbjct: 78   DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRC 136
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY-DTHVTT 933
            KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R    +  T +  
Sbjct: 137  KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXX 193
Query: 934  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
             +VGT  Y+ PE  +    T + D+YSFGVVLLE++TG   V+  +      L       
Sbjct: 194  RIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIE 251
Query: 994  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
              EK   + ID  +   D    +  M  +A +C+ +   +RP I++V   L
Sbjct: 252  DEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  164 bits (414), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 161/291 (55%), Gaps = 19/291 (6%)
Query: 765  DLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSG----DCGQMEREF 814
            +L   TNNF++       N +G GGFG+VYK  + N T  AVK+L+        +++++F
Sbjct: 13   ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 71
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E++ +++ QH+NLV L G+   G+D  L+Y YM NGSL   L   +D    L W +R 
Sbjct: 72   DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRC 130
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TT 933
            KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R    +   V   
Sbjct: 131  KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXX 187
Query: 934  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
             +VGT  Y+ PE  +    T + D+YSFGVVLLE++TG   V+  +      L       
Sbjct: 188  RIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIE 245
Query: 994  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
              EK   + ID  +   D    +  M  +A +C+ +   +RP I++V   L
Sbjct: 246  DEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  154 bits (388), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 107/291 (36%), Positives = 155/291 (53%), Gaps = 19/291 (6%)
Query: 765  DLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSG----DCGQMEREF 814
            +L   TNNF++       N  G GGFG+VYK  + N T  AVK+L+        +++++F
Sbjct: 10   ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQF 68
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E++  ++ QH+NLV L G+   G+D  L+Y Y  NGSL   L   +D    L W  R 
Sbjct: 69   DQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPLSWHXRC 127
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TT 933
            KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R    +   V  +
Sbjct: 128  KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXS 184
Query: 934  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
             +VGT  Y  PE  +    T + D+YSFGVVLLE++TG   V+  +      L       
Sbjct: 185  RIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIE 242
Query: 994  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
              EK   + ID      D    +     +A +C+ +   +RP I++V   L
Sbjct: 243  DEEKTIEDYIDKKXNDAD-STSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 6/205 (2%)
Query: 772 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNL 829
           + N    IG G FG V++A   +G+  AVK L       ER  EF  EV  + R +H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           V   G      +  ++  Y+  GSL   LH+S  ++  L    RL +A   A+G+ YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN 155
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
              P IVHRD+KS N+L+D+K+   + DFGLSR L+      +    GT  ++ PE  + 
Sbjct: 156 R-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 950 LTATCRGDVYSFGVVLLELLTGRRP 974
             +  + DVYSFGV+L EL T ++P
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 109/205 (53%), Gaps = 6/205 (2%)
Query: 772 NFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNL 829
           + N    IG G FG V++A   +G+  AVK L       ER  EF  EV  + R +H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           V   G      +  ++  Y+  GSL   LH+S  ++  L    RL +A   A+G+ YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN 155
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
              P IVHR++KS N+L+D+K+   + DFGLSR L+      +    GT  ++ PE  + 
Sbjct: 156 R-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 950 LTATCRGDVYSFGVVLLELLTGRRP 974
             +  + DVYSFGV+L EL T ++P
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP 238

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 137/292 (46%), Gaps = 40/292 (13%)
Query: 769  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRL-----SGDCGQMER--EFQAEVEA 820
            + N       IG GGFGLV+K  L  + +  A+K L      G+   +E+  EFQ EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 821  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
            +S   H N+V L G     N   ++  ++  G L    H  +DK   +KW V+L++    
Sbjct: 77   MSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDI 131
Query: 881  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRPYDTHVTTDL 935
            A G+ Y+     P IVHRD++S NI L    E     A +ADFGLS+       H  + L
Sbjct: 132  ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGL 186
Query: 936  VGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRPV-EVCKGKNCRDLVSWVFQ 992
            +G   ++ PE   ++  + T + D YSF ++L  +LTG  P  E   GK     + ++  
Sbjct: 187  LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINM 241
Query: 993  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            ++ E     I +      D   +L  ++E+   C   DP++RP    +V  L
Sbjct: 242  IREEGLRPTIPE------DCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (255), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 136/283 (48%), Gaps = 31/283 (10%)
Query: 774  NQANIIGCGGFGLVYKATL--TNGTK---AAVKRLSGDCGQMER-EFQAEVEALSRAQHK 827
             +  +IG G FG VYK  L  ++G K    A+K L     + +R +F  E   + +  H 
Sbjct: 47   TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 828  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
            N++ L+G        ++I  YMENG+LD +L E   + SVL+    + + +G A G+ YL
Sbjct: 107  NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL---VGMLRGIAAGMKYL 163
Query: 888  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPE 945
              +   + VHRD+ + NIL++      ++DFGLSR+L   P  T+ T+     + +  PE
Sbjct: 164  ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 946  YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
                   T   DV+SFG+V+ E++T G RP            ++  F++ +       +D
Sbjct: 221  AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP------MD 274
Query: 1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                          + ++  +C  Q+  RRP   ++V+ LD +
Sbjct: 275  CP----------SAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 777 NIIGCGGFGLVYKATLTN---GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
            IIG GGFG VY+A         KAA      D  Q     + E +  +  +H N+++L+
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           G C    +  L+  +   G L+  L  + +  D ++ W V++      ARG+ YLH    
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDEAI 126
Query: 893 PHIVHRDVKSSNILLDEKFE--------AHLADFGLSRLLRPYDTHVTTDL--VGTLGYI 942
             I+HRD+KSSNIL+ +K E          + DFGL+R     + H TT +   G   ++
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWM 181
Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKG 980
            PE  +    +   DV+S+GV+L ELLTG  P     G
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 136/292 (46%), Gaps = 40/292 (13%)
Query: 769  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRL-----SGDCGQMER--EFQAEVEA 820
            + N       IG GGFGLV+K  L  + +  A+K L      G+   +E+  EFQ EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 821  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
            +S   H N+V L G     N   ++  ++  G L    H  +DK   +KW V+L++    
Sbjct: 77   MSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDI 131
Query: 881  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRPYDTHVTTDL 935
            A G+ Y+     P IVHRD++S NI L    E     A +ADFG S+       H  + L
Sbjct: 132  ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGL 186
Query: 936  VGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRPV-EVCKGKNCRDLVSWVFQ 992
            +G   ++ PE   ++  + T + D YSF ++L  +LTG  P  E   GK     + ++  
Sbjct: 187  LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINM 241
Query: 993  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            ++ E     I +      D   +L  ++E+   C   DP++RP    +V  L
Sbjct: 242  IREEGLRPTIPE------DCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 136/292 (46%), Gaps = 40/292 (13%)
Query: 769  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRL-----SGDCGQMER--EFQAEVEA 820
            + N       IG GGFGLV+K  L  + +  A+K L      G+   +E+  EFQ EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 821  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
            +S   H N+V L G     N   ++  ++  G L    H  +DK   +KW V+L++    
Sbjct: 77   MSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDI 131
Query: 881  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRPYDTHVTTDL 935
            A G+ Y+     P IVHRD++S NI L    E     A +ADF LS+       H  + L
Sbjct: 132  ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGL 186
Query: 936  VGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRPV-EVCKGKNCRDLVSWVFQ 992
            +G   ++ PE   ++  + T + D YSF ++L  +LTG  P  E   GK     + ++  
Sbjct: 187  LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINM 241
Query: 993  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            ++ E     I +      D   +L  ++E+   C   DP++RP    +V  L
Sbjct: 242  IREEGLRPTIPE------DCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 109/241 (45%), Gaps = 16/241 (6%)
Query: 433 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 492
           N VG  IP  +     L  L + +  + G IP +L + K L  LD S+N   G +PP I 
Sbjct: 88  NLVGP-IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 493 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 552
            + NL  + F  N ++G IP S      L +S              + +  NR T  +P 
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTS--------------MTISRNRLTGKIPP 192
Query: 553 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 612
             A+     V LS N + G      G  K+   + L++N++   +   +   +NL  LDL
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDL 251
Query: 613 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSP 672
            +N ++G++P    +L FL   +V+ N+L G IP GG    F  S++  N  LCG     
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
Query: 673 C 673
           C
Sbjct: 312 C 312

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH S  K  + K    + IA+  ARG+ YLH      I+HR
Sbjct: 80  PQ-LAIVTQWCEGSSLYHHLHASETKFEMKKL---IDIARQTARGMDYLHAKS---IIHR 132
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +   +   + 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 193 QSDVYAFGIVLYELMTGQLP 212

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 79/294 (26%), Positives = 135/294 (45%), Gaps = 47/294 (15%)
Query: 779  IGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G G FG V+ A   N +        AVK L        ++FQ E E L+  QH+++V  
Sbjct: 23   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR-------------LKIAQG 879
             G C  G+  ++++ YM++G L+ +L      D+++  D +             L IA  
Sbjct: 83   YGVCGDGDPLIMVFEYMKHGDLNKFLRAH-GPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 880  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGT 938
             A G+ YL      H VHRD+ + N L+       + DFG+SR +   D + V    +  
Sbjct: 142  IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 997
            + ++PPE       T   DV+SFGV+L E+ T G++P              W FQ+ +  
Sbjct: 199  IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------W-FQLSN-- 241
Query: 998  REVEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048
               E+I+     +  E+  +   E+ ++   C  ++P++R  I+E+   L  +G
Sbjct: 242  --TEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH S  K  + K    + IA+  ARG+ YLH      I+HR
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKL---IDIARQTARGMDYLHAKS---IIHR 144
Query: 899 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +   +   + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH S  K  + K    + IA+  ARG+ YLH      I+HR
Sbjct: 92  PQ-LAIVTQWCEGSSLYHHLHASETKFEMKKL---IDIARQTARGMDYLHAKS---IIHR 144
Query: 899 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +   +   + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 777 NIIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVS 831
            +IG G FG V    L    K     A+K L SG   +  R+F +E   + +  H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L+G        ++I  +MENGSLD +L ++  + +V++    + + +G A G+ YL    
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL---A 152
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEY 946
           + + VHRD+ + NIL++      ++DFGLSR L   DT   T      G IP     PE 
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED-DTSDPTYTSALGGKIPIRWTAPEA 211
Query: 947 SQTLTATCRGDVYSFGVVLLELLT-GRRP 974
            Q    T   DV+S+G+V+ E+++ G RP
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 128
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +G G FG V+ A   N          AVK L        ++F  E E L+  QH+++V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD----------VRLKIAQGAAR 882
            G C  G+  ++++ YM++G L+ +L  +   D+VL  +            L IAQ  A 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFL-RAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGY 941
           G+ YL      H VHRD+ + N L+ E     + DFG+SR +   D + V    +  + +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
           +PPE       T   DV+S GVVL E+ T G++P
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 78  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 130
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 191 QSDVYAFGIVLYELMTGQLP 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 81  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 133
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 76  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 128
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 81  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 133
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 104 PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 156
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 103 PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 155
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  +       + 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 216 QSDVYAFGIVLYELMTGQLP 235

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 76  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 128
Query: 899 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +       + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 73/252 (28%), Positives = 121/252 (48%), Gaps = 23/252 (9%)
Query: 778  IIGCGGFGLVYKATL----TNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            IIG G  G V    L          A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 56   IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            +G    G   +++  YMENGSLD +L     + ++++    + + +G   G+ YL  +  
Sbjct: 116  EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYLSDL-- 170
Query: 893  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 950
               VHRD+ + N+L+D      ++DFGLSR+L   P   + TT     + +  PE     
Sbjct: 171  -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 951  TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV---FQMKSE---KREVEII 1003
            T +   DV+SFGVV+ E+L  G RP         RD++S V   +++ +       +  +
Sbjct: 230  TFSSASDVWSFGVVMWEVLAYGERPYW---NMTNRDVISSVEEGYRLPAPMGCPHALHQL 286
Query: 1004 DASIWHKDREKQ 1015
                WHKDR ++
Sbjct: 287  MLDCWHKDRAQR 298

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 96  PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 148
Query: 899 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +       + 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 209 QSDVYAFGIVLYELMTGQLP 228

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 32/294 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 22   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 81
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 82   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LV 138
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 139  GMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 195
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 196  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 239
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD
Sbjct: 240  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 293

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 ++I  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   EEPIYIVI-EYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                ++  + E  SL + LH    K  ++K    + IA+  A+G+ YLH      I+HR
Sbjct: 104 PQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHR 156
Query: 899 DVKSSNILLDEKFEAHLADFGL-SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA---TC 954
           D+KS+NI L E     + DFGL +   R   +H    L G++ ++ PE  +       + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 955 RGDVYSFGVVLLELLTGRRP 974
           + DVY+FG+VL EL+TG+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 5    TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 65   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LV 121
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 122  GMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 179  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 222
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 223  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 ++I  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   EEPIYIVI-EYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 37/271 (13%)
Query: 778  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            ++G G FG+V KA        A+K++  +  +  + F  E+  LSR  H N+V L G C 
Sbjct: 16   VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 838  HGNDRLLIYSYMENGSLDYWLHES-----VDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
              N   L+  Y E GSL   LH +           + W ++       ++G+AYLH +  
Sbjct: 73   --NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ------CSQGVAYLHSMQP 124
Query: 893  PHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 951
              ++HRD+K  N+LL        + DFG +  ++   TH+T +  G+  ++ PE  +   
Sbjct: 125  KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGSN 180
Query: 952  ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011
             + + DV+S+G++L E++T R+P +   G   R  + W     +    +           
Sbjct: 181  YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHNGTRPPLI----------- 227
Query: 1012 REKQLLEMLE-IACKCIDQDPRRRPFIEEVV 1041
              K L + +E +  +C  +DP +RP +EE+V
Sbjct: 228  --KNLPKPIESLMTRCWSKDPSQRPSMEEIV 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 37/271 (13%)
Query: 778  IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            ++G G FG+V KA        A+K++  +  +  + F  E+  LSR  H N+V L G C 
Sbjct: 15   VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 838  HGNDRLLIYSYMENGSLDYWLHES-----VDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
              N   L+  Y E GSL   LH +           + W ++       ++G+AYLH +  
Sbjct: 72   --NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ------CSQGVAYLHSMQP 123
Query: 893  PHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 951
              ++HRD+K  N+LL        + DFG +  ++   TH+T +  G+  ++ PE  +   
Sbjct: 124  KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGSN 179
Query: 952  ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011
             + + DV+S+G++L E++T R+P +   G   R  + W     +    +           
Sbjct: 180  YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHNGTRPPLI----------- 226
Query: 1012 REKQLLEMLE-IACKCIDQDPRRRPFIEEVV 1041
              K L + +E +  +C  +DP +RP +EE+V
Sbjct: 227  --KNLPKPIESLMTRCWSKDPSQRPSMEEIV 255

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 51   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 107
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 108  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 164
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 941
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 165  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 222  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 279
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 280  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 15   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 73   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 126
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 127  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 187  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 231
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 232  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 17   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 75   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 128
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 129  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 189  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 233
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 234  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 52   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 108
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 109  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 165
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 941
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 166  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 223  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 280
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 281  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 32   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 91
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 92   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 148
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 149  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 205
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 206  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 249
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 250  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 73/252 (28%), Positives = 120/252 (47%), Gaps = 23/252 (9%)
Query: 778  IIGCGGFGLVYKATL----TNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            IIG G  G V    L          A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 56   IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            +G    G   +++  YMENGSLD +L     + ++++    + + +G   G+ YL  +  
Sbjct: 116  EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYLSDL-- 170
Query: 893  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 950
               VHRD+ + N+L+D      ++DFGLSR+L   P     TT     + +  PE     
Sbjct: 171  -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 951  TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWV---FQMKSE---KREVEII 1003
            T +   DV+SFGVV+ E+L  G RP         RD++S V   +++ +       +  +
Sbjct: 230  TFSSASDVWSFGVVMWEVLAYGERPYW---NMTNRDVISSVEEGYRLPAPMGCPHALHQL 286
Query: 1004 DASIWHKDREKQ 1015
                WHKDR ++
Sbjct: 287  MLDCWHKDRAQR 298

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 778 IIGCGGFGLVYKATLT----NGTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +IG G FG V    L          A+K L  G   +  R+F  E   + +  H N+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           +G    G   +++  +MENG+LD +L +   + +V++    + + +G A G+ YL    +
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL---VGMLRGIAAGMRYL---AD 163
Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 950
              VHRD+ + NIL++      ++DFGLSR++   P   + TT     + +  PE  Q  
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             T   DV+S+G+V+ E+++ G RP
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 779  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V  
Sbjct: 26   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW--DVR---------LKIAQGAA 881
             G C  G   L+++ YM +G L+ +L        +L    DV          L +A   A
Sbjct: 86   FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLG 940
             G+ YL  +   H VHRD+ + N L+ +     + DFG+SR +   D + V    +  + 
Sbjct: 146  AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 941  YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
            ++PPE       T   DV+SFGVVL E+ T G++P              W +Q+ +    
Sbjct: 203  WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------W-YQLSN---- 243
Query: 1000 VEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEV 1040
             E ID     ++ E+      E+  I   C  ++P++R  I++V
Sbjct: 244  TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 779  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V  
Sbjct: 20   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW--DVR---------LKIAQGAA 881
             G C  G   L+++ YM +G L+ +L        +L    DV          L +A   A
Sbjct: 80   FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLG 940
             G+ YL  +   H VHRD+ + N L+ +     + DFG+SR +   D + V    +  + 
Sbjct: 140  AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 941  YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
            ++PPE       T   DV+SFGVVL E+ T G++P              W +Q+ +    
Sbjct: 197  WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------W-YQLSN---- 237
Query: 1000 VEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEV 1040
             E ID     ++ E+      E+  I   C  ++P++R  I++V
Sbjct: 238  TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 779  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V  
Sbjct: 49   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW--DVR---------LKIAQGAA 881
             G C  G   L+++ YM +G L+ +L        +L    DV          L +A   A
Sbjct: 109  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLG 940
             G+ YL  +   H VHRD+ + N L+ +     + DFG+SR +   D + V    +  + 
Sbjct: 169  AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 941  YIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
            ++PPE       T   DV+SFGVVL E+ T G++P              W +Q+ +    
Sbjct: 226  WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------W-YQLSN---- 266
Query: 1000 VEIIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPFIEEV 1040
             E ID     ++ E+      E+  I   C  ++P++R  I++V
Sbjct: 267  TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVCEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 132/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGL+R+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT 207
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 25   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 81
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 82   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 138
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 941
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 139  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 196  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 253
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 254  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 777 NIIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVS 831
            +IG G FG V    L    K     A+K L SG   +  R+F +E   + +  H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L+G        ++I  +MENGSLD +L ++  + +V++    + + +G A G+ YL    
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL---A 126
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEY 946
           + + VHR + + NIL++      ++DFGLSR L   DT   T      G IP     PE 
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLED-DTSDPTYTSALGGKIPIRWTAPEA 185
Query: 947 SQTLTATCRGDVYSFGVVLLELLT-GRRP 974
            Q    T   DV+S+G+V+ E+++ G RP
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 33   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 89
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 90   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 146
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 941
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 147  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 204  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 261
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 262  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 31   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 87
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 88   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 144
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 941
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 145  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 202  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 259
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 260  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 30   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 86
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 87   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 143
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 941
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 144  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 201  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 259  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++  YMENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGL R+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 33   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 89
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 90   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 146
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 941
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 147  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 204  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 261
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 262  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 32   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 88
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 89   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 145
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 941
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 146  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 203  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 260
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 261  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 28   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 84
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 85   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 141
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---RPYDTHVTTDLVGTLGY 941
             YL        VHRD+ + N +LDEKF   +ADFGL+R +     Y  H  T     + +
Sbjct: 142  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 199  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 256
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 257  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 131
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 87  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 139
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 200 DVWSFGILLTEIVTHGRIP 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 85  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 137
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 198 DVWSFGILLTEIVTHGRIP 216

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 80  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 132
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 193 DVWSFGILLTEIVTHGRIP 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 81  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 133
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 194 DVWSFGILLTEIVTHGRIP 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 131
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 88  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 140
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 201 DVWSFGILLTEIVTHGRIP 219

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD+ ++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    TK A+K L    G M  E F  E + + + +H  LV L     
Sbjct: 17   LGNGQFGEVWMGTWNGNTKVAIKTLKP--GTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L +   +   LK    + +A   A G+AY+ ++   + +H
Sbjct: 75   E-EPIYIVTEYMNKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIH 128
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++S+NIL+       +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 129  RDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL+T GR P     G N R+++    Q++   R     D  I         
Sbjct: 189  VWSFGILLTELVTKGRVPY---PGMNNREVLE---QVERGYRMPCPQDCPI--------- 233
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + E+   C  +DP  RP  E + ++L+
Sbjct: 234  -SLHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 777 NIIGCGGFGLVYKATLTNGTK----AAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            +IG G FG V +  L    K     A+K L G   + +R EF +E   + + +H N++ 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L+G   +    +++  +MENG+LD +L  +  + +V++    + + +G A G+ YL    
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL---VGMLRGIASGMRYL---A 133
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGT--LGYIPPEYS 947
           E   VHRD+ + NIL++      ++DFGLSR L     D   T+ L G   + +  PE  
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 948 QTLTATCRGDVYSFGVVLLELLT-GRRP 974
                T   D +S+G+V+ E+++ G RP
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 193  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 251  E-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 304
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL RL+   +          + +  PE +     T + D
Sbjct: 305  RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E +             
Sbjct: 365  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------------ 412
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                ++ C+C  +DP  RP  E +  +L+
Sbjct: 413  ----DLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 85  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 137
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 198 DVWSFGILLTEIVTHGRIP 216

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 89  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 141
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 202 DVWSFGILLTEIVTHGRIP 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 131
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 74  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 126
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 187 DVWSFGILLTEIVTHGRIP 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 84  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 136
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 197 DVWSFGILLTEIVTHGRIP 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 16   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 74   E-EPIXIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 127
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 128  RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 188  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 232
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  ++P  RP  E +  +L+
Sbjct: 233  -SLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 777 NIIGCGGFGLVYKATLTNGTK----AAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            +IG G FG V +  L    K     A+K L G   + +R EF +E   + + +H N++ 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L+G   +    +++  +MENG+LD +L  +  + +V++    + + +G A G+ YL    
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL---VGMLRGIASGMRYL---A 135
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGT--LGYIPPEYS 947
           E   VHRD+ + NIL++      ++DFGLSR L     D   T+ L G   + +  PE  
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 948 QTLTATCRGDVYSFGVVLLELLT-GRRP 974
                T   D +S+G+V+ E+++ G RP
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  G L  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVMEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  G L  +L   + K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 84   E-EPIYIVTEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 198  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 242
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  +DP  RP  E +  +L+
Sbjct: 243  -SLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 275  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 333  E-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 387  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E +             
Sbjct: 447  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------------ 494
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                ++ C+C  ++P  RP  E +  +L+
Sbjct: 495  ----DLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 19   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 77   E-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 130
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 131  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 191  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 235
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  ++P  RP  E +  +L+
Sbjct: 236  -SLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++   MENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 129/288 (44%), Gaps = 38/288 (13%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 32   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 88
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 89   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 145
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-----THVTTDLVGTL 939
             YL        VHRD+ + N +LDEKF   +ADFGL+R +  YD      H  T     +
Sbjct: 146  KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEXXSVHNKTGAKLPV 200
Query: 940  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
             ++  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   + 
Sbjct: 201  KWMALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQP 258
Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                D              + E+  KC       RP   E+V+ +  I
Sbjct: 259  EYCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 34   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 90
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 91   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 147
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR--LLRPYDT-HVTTDLVGTLGY 941
             +L        VHRD+ + N +LDEKF   +ADFGL+R  L + +D+ H  T     + +
Sbjct: 148  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKW 204
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 205  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 262
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 263  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 92   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 148
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 149  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 205
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 941
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 206  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 263  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 320
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 321  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 5    TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++   MENGSLD +L +   + +V++    +
Sbjct: 65   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LV 121
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 122  GMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 179  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 222
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 223  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 778 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +IG G FG V    L    K     A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           +G        ++I  YMENGSLD +L ++  + +V++    + + +G   G+ YL  +  
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYLSDMSA 152
Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 950
              VHRD+ + NIL++      ++DFG+SR+L   P   + T      + +  PE     
Sbjct: 153 ---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 209
Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             T   DV+S+G+V+ E+++ G RP
Sbjct: 210 KFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 38   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 94
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 95   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 151
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 941
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 152  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 208
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 209  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 266
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 267  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 778 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +IG G FG V    L    K     A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           +G        ++I  YMENGSLD +L ++  + +V++    + + +G   G+ YL  +  
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYLSDM-- 129
Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 950
              VHRD+ + NIL++      ++DFG+SR+L   P   + T      + +  PE     
Sbjct: 130 -SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             T   DV+S+G+V+ E+++ G RP
Sbjct: 189 KFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 778 IIGCGGFGLVYKATLTNGTK----AAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +IG G FG V    L    K     A+K L +G   +  R+F +E   + +  H N++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           +G        ++I  YMENGSLD +L ++  + +V++    + + +G   G+ YL  +  
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYLSDM-- 135
Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 950
              VHRD+ + NIL++      ++DFG+SR+L   P   + T      + +  PE     
Sbjct: 136 -SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             T   DV+S+G+V+ E+++ G RP
Sbjct: 195 KFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 22/268 (8%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            IG G FG VYK          + ++     +  + F+ EV  L + +H N++   GY   
Sbjct: 44   IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 839  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
             N   ++  + E  SL   LH    K  + +    + IA+  A+G+ YLH     +I+HR
Sbjct: 104  DN-LAIVTQWCEGSSLYKHLHVQETKFQMFQL---IDIARQTAQGMDYLH---AKNIIHR 156
Query: 899  DVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTA---TC 954
            D+KS+NI L E     + DFGL+ +   +  +       G++ ++ PE  +       + 
Sbjct: 157  DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 955  RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014
            + DVYS+G+VL EL+TG  P       N RD +  +F +    R     D S  +K+  K
Sbjct: 217  QSDVYSYGIVLYELMTGELPYSHI---NNRDQI--IFMV---GRGYASPDLSKLYKNCPK 268
Query: 1015 QLLEMLEIACKCIDQDPRRRPFIEEVVT 1042
                M  +   C+ +    RP   ++++
Sbjct: 269  ---AMKRLVADCVKKVKEERPLFPQILS 293

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 32/296 (10%)
Query: 762  TVSDLLKS--TNNFNQANIIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREF 814
            TV +  K     N +   ++G G FG V    L   +K     A+K L  G   +  R+F
Sbjct: 34   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
              E   + +  H N++ L+G        +++   MENGSLD +L +   + +V++    +
Sbjct: 94   LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL---V 150
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVT 932
             + +G A G+ YL  +     VHRD+ + NIL++      ++DFGLSR+L   P   + T
Sbjct: 151  GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVF 991
                  + +  PE       T   DV+S+G+VL E+++ G RP                +
Sbjct: 208  RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------Y 251
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               S +  ++ +D              + ++   C  +D   RP  E++V+ LD +
Sbjct: 252  WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 34   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 90
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 91   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 147
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 941
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 148  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 204
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 205  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 262
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 263  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 33   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 89
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 90   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 146
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 941
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 147  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 204  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 261
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 262  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L     K   L+    + ++   A G+AY+ ++   + VH
Sbjct: 81   E-EPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERM---NYVH 134
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 135  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 195  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 239
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  ++P  RP  E +  +L+
Sbjct: 240  -SLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 250  E-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 304  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E +             
Sbjct: 364  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------------ 411
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                ++ C+C  ++P  RP  E +  +L+
Sbjct: 412  ----DLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 250  E-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 304  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E +             
Sbjct: 364  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------------ 411
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                ++ C+C  ++P  RP  E +  +L+
Sbjct: 412  ----DLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 33   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 89
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 90   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 146
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 941
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 147  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 204  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 261
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 262  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 75  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 127
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HR+++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 188 DVWSFGILLTEIVTHGRIP 206

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 772  NFNQANIIGCGGFGLVYKATL--TNGTK--AAVKRLS--GDCGQMEREFQAEVEALSRAQ 825
            +FN+  +IG G FG VY  TL   +G K   AVK L+   D G++  +F  E   +    
Sbjct: 31   HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFS 87
Query: 826  HKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++SL G C R     L++  YM++G L  ++       +V      +      A+G+
Sbjct: 88   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGM 144
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDT-HVTTDLVGTLGY 941
             +L        VHRD+ + N +LDEKF   +ADFGL+R +  + +D+ H  T     + +
Sbjct: 145  KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 201
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +  E  QT   T + DV+SFGV+L EL+T  R        N  D+  ++ Q +   +   
Sbjct: 202  MALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQGRRLLQPEY 259
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              D              + E+  KC       RP   E+V+ +  I
Sbjct: 260  CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L     K   L+    + ++   A G+AY+ ++   + VH
Sbjct: 81   E-EPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERM---NYVH 134
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 135  RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E               
Sbjct: 195  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE--------------- 239
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + ++ C+C  ++P  RP  E +  +L+
Sbjct: 240  -SLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L     
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  ++  YM  GSL  +L     K   L+    + +A   A G+AY+ ++   + VH
Sbjct: 250  E-EPIYIVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+ E     +ADFGL+RL+   +          + +  PE +     T + D
Sbjct: 304  RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L EL T GR P      +   D V   ++M       E +             
Sbjct: 364  VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------------ 411
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                ++ C+C  ++P  RP  E +  +L+
Sbjct: 412  ----DLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                L++ +ME+G L  +L     +  +   +  L +      G+AYL + C   ++HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 958
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 959 YSFGVVLLELLT-GRRPVE 976
           +SFGV++ E+ + G+ P E
Sbjct: 188 WSFGVLMWEVFSEGKIPYE 206

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
           +G G  G V+       TK AVK L    G M  + F AE   + + QH+ LV L     
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                 +I  YMENGSL D+    S  K ++ K    L +A   A G+A++    E + +
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQIAEGMAFIE---ERNYI 131
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     T T + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 957 DVYSFGVVLLELLT-GRRP 974
           DV+SFG++L E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 778 IIGCGGFGLVYKATLTNGTK----AAVKRLS-GDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +IG G FG V    L    K     A+K L  G   +  R+F  E   + +  H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           +G        +++  YMENGSLD +L ++  + +V++    + + +G + G+ YL  +  
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQL---VGMLRGISAGMKYLSDM-- 143
Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTL 950
              VHRD+ + NIL++      ++DFGLSR+L   P   + T      + +  PE     
Sbjct: 144 -GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             T   DV+S+G+V+ E+++ G RP
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                L++ +ME+G L  +L     +  +   +  L +      G+AYL + C   ++HR
Sbjct: 77  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 958
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 959 YSFGVVLLELLT-GRRPVE 976
           +SFGV++ E+ + G+ P E
Sbjct: 191 WSFGVLMWEVFSEGKIPYE 209

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                L++ +ME+G L  +L     +  +   +  L +      G+AYL + C   ++HR
Sbjct: 72  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 958
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 959 YSFGVVLLELLT-GRRPVE 976
           +SFGV++ E+ + G+ P E
Sbjct: 186 WSFGVLMWEVFSEGKIPYE 204

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 760 DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           DL   +L   +       +   G FG V+KA L N   A       D    + E+  EV 
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY--EVY 70
Query: 820 ALSRAQHKNLVSLQGYCRHGN----DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
           +L   +H+N++   G  + G     D  LI ++ E GSL  +L     K +V+ W+    
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCH 125
Query: 876 IAQGAARGLAYLHKVC-------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--- 925
           IA+  ARGLAYLH+         +P I HRD+KS N+LL     A +ADFGL+       
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 926 -PYDTHVTTDLVGTLGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLT 970
              DTH     VGT  Y+ PE  +        A  R D+Y+ G+VL EL +
Sbjct: 186 SAGDTHGQ---VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 10/200 (5%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G FGLV+     N  K A+K +    G M E +F  E E + +  H  LV L G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKE--GSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 L++ +ME+G L  +L     +  +   +  L +      G+AYL + C   ++H
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N L+ E     ++DFG++R +       +T     + +  PE       + + D
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 958 VYSFGVVLLELLT-GRRPVE 976
           V+SFGV++ E+ + G+ P E
Sbjct: 207 VWSFGVLMWEVFSEGKIPYE 226

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 13/216 (6%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 827
           +F   N++G G F  VY+A ++  G + A+K +         M +  Q EV+   + +H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           +++ L  Y    N   L+     NG ++ +L   V   S  + + R  + Q    G+ YL
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS--ENEARHFMHQ-IITGMLYL 128
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDLVGTLGYIPPEY 946
           H      I+HRD+  SN+LL       +ADFGL+  L+ P++ H T  L GT  YI PE 
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 947 SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
           +         DV+S G +   LL GR P +    KN
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 8/199 (4%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                L+  +ME+G L  +L     +  +   +  L +      G+AYL + C   ++HR
Sbjct: 75  QAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 958
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 959 YSFGVVLLELLT-GRRPVE 976
           +SFGV++ E+ + G+ P E
Sbjct: 189 WSFGVLMWEVFSEGKIPYE 207

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 8/199 (4%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FGLV+     N  K A+K +  +    E +F  E E + +  H  LV L G C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                L++ +ME+G L  +L     +  +   +  L +      G+AYL    E  ++HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHR 127
Query: 899 DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 958
           D+ + N L+ E     ++DFG++R +       +T     + +  PE       + + DV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 959 YSFGVVLLELLT-GRRPVE 976
           +SFGV++ E+ + G+ P E
Sbjct: 188 WSFGVLMWEVFSEGKIPYE 206

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 122/290 (42%), Gaps = 45/290 (15%)
Query: 771  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKN 828
            +++    +IG G   +V  A       K A+KR++ + C     E   E++A+S+  H N
Sbjct: 15   DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 829  LVSLQGYCRHGNDRLLIYSYMENGS-LDYWLH---ESVDKDSVLKWDVRLKIAQGAARGL 884
            +VS        ++  L+   +  GS LD   H   +   K  VL       I +    GL
Sbjct: 75   IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP----YDTHVTTDLVGTLG 940
             YLHK  +   +HRDVK+ NILL E     +ADFG+S  L          V    VGT  
Sbjct: 135  EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 941  YIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPV------------------------ 975
            ++ PE   Q      + D++SFG+  +EL TG  P                         
Sbjct: 192  WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251
Query: 976  ---EVCK--GKNCRDLVSWVFQMKSEKR--EVEIIDASIWHKDREKQLLE 1018
               E+ K  GK+ R ++S   Q   EKR    E++    + K + K+ L+
Sbjct: 252  QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQ 301

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 122/282 (43%), Gaps = 21/282 (7%)
Query: 771  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKN 828
            +++    +IG G   +V  A       K A+KR++ + C     E   E++A+S+  H N
Sbjct: 10   DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 829  LVSLQGYCRHGNDRLLIYSYMENGS-LDYWLH---ESVDKDSVLKWDVRLKIAQGAARGL 884
            +VS        ++  L+   +  GS LD   H   +   K  VL       I +    GL
Sbjct: 70   IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP----YDTHVTTDLVGTLG 940
             YLHK  +   +HRDVK+ NILL E     +ADFG+S  L          V    VGT  
Sbjct: 130  EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 941  YIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
            ++ PE   Q      + D++SFG+  +EL TG  P           ++    Q      E
Sbjct: 187  WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQNDPPSLE 243
Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
              + D  +  K   K   +M+ +   C+ +DP +RP   E++
Sbjct: 244  TGVQDKEML-KKYGKSFRKMISL---CLQKDPEKRPTAAELL 281

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 49/298 (16%)
Query: 771  NNFNQANIIGCGGFGLVYKATLTNG---TKAAVKRLSGDCGQME-REFQAEVEALSR-AQ 825
            N+    ++IG G FG V KA +        AA+KR+     + + R+F  E+E L +   
Sbjct: 15   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVR 873
            H N+++L G C H     L   Y  +G+L  +L +S  ++ D          S L     
Sbjct: 75   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 874  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
            L  A   ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 135  LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------ 185
Query: 934  DLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 987
             +  T+G +P  +    +      T   DV+S+GV+L E+++ G  P   C G  C +L 
Sbjct: 186  -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC-GMTCAELY 241
Query: 988  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + Q    ++ +   D             E+ ++  +C  + P  RP   +++  L+
Sbjct: 242  EKLPQGYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLN 286

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNLVSLQG 834
            I   G FG V+KA L N    AVK       Q ++ +Q+E E  S    +H+NL+    
Sbjct: 21  EIKARGRFGCVWKAQLMNDF-VAVKIFPL---QDKQSWQSEREIFSTPGMKHENLLQFIA 76
Query: 835 YCRHGN----DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
             + G+    +  LI ++ + GSL  +L     K +++ W+    +A+  +RGL+YLH+ 
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHED 131
Query: 891 C--------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR----PYDTHVTTDLVGT 938
                    +P I HRD KS N+LL     A LADFGL+        P DTH     VGT
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH---GQVGT 188
Query: 939 LGYIPPEYSQ-----TLTATCRGDVYSFGVVLLELLT 970
             Y+ PE  +        A  R D+Y+ G+VL EL++
Sbjct: 189 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 49/298 (16%)
Query: 771  NNFNQANIIGCGGFGLVYKATLTNG---TKAAVKRLSGDCGQME-REFQAEVEALSR-AQ 825
            N+    ++IG G FG V KA +        AA+KR+     + + R+F  E+E L +   
Sbjct: 25   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVR 873
            H N+++L G C H     L   Y  +G+L  +L +S  ++ D          S L     
Sbjct: 85   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 874  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
            L  A   ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 145  LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------ 195
Query: 934  DLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 987
             +  T+G +P  +    +      T   DV+S+GV+L E+++ G  P   C G  C +L 
Sbjct: 196  -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC-GMTCAELY 251
Query: 988  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + Q    ++ +   D             E+ ++  +C  + P  RP   +++  L+
Sbjct: 252  EKLPQGYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLN 296

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 30/271 (11%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+ AT    TK AVK +    G M  E F AE   +   QH  LV L     
Sbjct: 23   LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 838  HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKW-DVRLKIAQGAARGLAYLHKVCEPHI 895
                  +I  +M  GSL D+   +   K  + K  D   +IA+G    +A++    + + 
Sbjct: 81   K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG----MAFIE---QRNY 132
Query: 896  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
            +HRD++++NIL+       +ADFGL+R++   +          + +  PE     + T +
Sbjct: 133  IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 956  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014
             DV+SFG++L+E++T GR P                +   S    +  ++        E 
Sbjct: 193  SDVWSFGILLMEIVTYGRIP----------------YPGMSNPEVIRALERGYRMPRPEN 236
Query: 1015 QLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
               E+  I  +C    P  RP  E + + LD
Sbjct: 237  CPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 779 IGCGGFGLVYKA--TLTNGTKAAVKRLSGDCGQME---REFQAEVEALSRAQHKNLVSLQ 833
           +G GG   VY A  T+ N  K A+K +     + E   + F+ EV   S+  H+N+VS+ 
Sbjct: 19  LGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
                 +   L+  Y+E  +L     E ++    L  D  +        G+ + H +   
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLS----EYIESHGPLSVDTAINFTNQILDGIKHAHDM--- 130
Query: 894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            IVHRD+K  NIL+D      + DFG+++ L       T  ++GT+ Y  PE ++     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 954 CRGDVYSFGVVLLELLTGRRP 974
              D+YS G+VL E+L G  P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 48/299 (16%)
Query: 775  QANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
               ++G G FG   K T    G    +K L     + +R F  EV+ +   +H N++   
Sbjct: 14   HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 834  GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
            G          I  Y++ G+L   +      DS   W  R+  A+  A G+AYLH +   
Sbjct: 74   GVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM--- 127
Query: 894  HIVHRDVKSSNILLDEKFEAHLADFGLSRL-------------LRPYDTHVTTDLVGTLG 940
            +I+HRD+ S N L+ E     +ADFGL+RL             L+  D      +VG   
Sbjct: 128  NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 941  YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRR-------PVEVCKGKNCRDLVSWVFQM 993
            ++ PE     +   + DV+SFG+VL E++ GR        P  +  G N R  +      
Sbjct: 188  WMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 994  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDAA 1052
                                        I  +C D DP +RP   ++  WL+ + +  A
Sbjct: 247  NCPP--------------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 149
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 134/298 (44%), Gaps = 49/298 (16%)
Query: 771  NNFNQANIIGCGGFGLVYKATLTNG---TKAAVKRLSGDCGQME-REFQAEVEALSR-AQ 825
            N+    ++IG G FG V KA +        AA+KR+     + + R+F  E+E L +   
Sbjct: 22   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--VDKD----------SVLKWDVR 873
            H N+++L G C H     L   Y  +G+L  +L +S  ++ D          S L     
Sbjct: 82   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 874  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
            L  A   ARG+ YL    +   +HR++ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 142  LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVY------ 192
Query: 934  DLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 987
             +  T+G +P  +    +      T   DV+S+GV+L E+++ G  P   C G  C +L 
Sbjct: 193  -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC-GMTCAELY 248
Query: 988  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
              + Q    ++ +   D             E+ ++  +C  + P  RP   +++  L+
Sbjct: 249  EKLPQGYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLN 293

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 131
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 129
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 135
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 134
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 136
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 149
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 138
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 131
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 71/235 (30%), Positives = 105/235 (44%), Gaps = 36/235 (15%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSR 823
           NN      IG G FG V++A           T  AVK L  +    M+ +FQ E   ++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV---------------- 867
             + N+V L G C  G    L++ YM  G L+ +L  S+   +V                
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-RSMSPHTVCSLSHSDLSTRARVSS 165
Query: 868 -----LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 922
                L    +L IA+  A G+AYL    E   VHRD+ + N L+ E     +ADFGLSR
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 923 LLRPYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
            +   D +     D +  + ++PPE       T   DV+++GVVL E+ + G +P
Sbjct: 223 NIYSADYYKADGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 131
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 137
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 130
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 162
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L    ++   +K    L+      +G+ YL    
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL---LQYTSQICKGMEYL---G 134
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 9/198 (4%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V+     N TK AVK L    G M  + F  E   +   QH  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  YM  GSL  +L    D+   +     +  +   A G+AY+ +    + +H
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 133
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD++++N+L+ E     +ADFGL+R++   +          + +  PE       T + D
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 958 VYSFGVVLLELLT-GRRP 974
           V+SFG++L E++T G+ P
Sbjct: 194 VWSFGILLYEIVTYGKIP 211

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 26/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            +G G FG V+ AT    TK AVK +      +E  F AE   +   QH  LV L      
Sbjct: 196  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 839  GNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  GSL D+   +   K  + K    +  +   A G+A++    + + +H
Sbjct: 255  -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIE---QRNYIH 307
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+       +ADFGL+R++   +          + +  PE     + T + D
Sbjct: 308  RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L+E++T GR P            +   ++M   +   E               
Sbjct: 368  VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE--------------- 412
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
             E+  I  +C    P  RP  E + + LD
Sbjct: 413  -ELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  ++  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 134
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HRD+ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 828
           ++F + + +G G  G+V K     +G   A K +  +     R +   E++ L       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V   G      +  +   +M+ GSLD  L E+      +  ++  K++    RGLAYL 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLR 131
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
           +  +  I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  Q
Sbjct: 132 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMAPERLQ 186
Query: 949 TLTATCRGDVYSFGVVLLELLTGRRPV 975
               + + D++S G+ L+EL  GR P+
Sbjct: 187 GTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 824 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVR--LKI 876
             QH+N+V+L G C HG   L+I  Y   G L  +L       +DK+     ++R  L  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDL 935
           +   A+G+A+L      + +HRDV + N+LL     A + DFGL+R ++   +  V  + 
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+S+G++L E+ +
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 128/304 (42%), Gaps = 58/304 (19%)
Query: 771  NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQME-REFQAEVEALSR 823
             N      +G G FG V KAT          T  AVK L  +    E R+  +E   L +
Sbjct: 23   KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV--------------------- 862
              H +++ L G C      LLI  Y + GSL  +L ES                      
Sbjct: 83   VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 863  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 922
            D+ ++   D+ +  A   ++G+ YL    E  +VHRD+ + NIL+ E  +  ++DFGLSR
Sbjct: 143  DERALTMGDL-ISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 923  LLRPYDTHVTTDLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVE 976
             +   D++V      + G IP ++    +      T + DV+SFGV+L E++T G  P  
Sbjct: 199  DVYEEDSYVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 977  VCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1036
                +   +L+    +M+      E                EM  +  +C  Q+P +RP 
Sbjct: 255  GIPPERLFNLLKTGHRMERPDNCSE----------------EMYRLMLQCWKQEPDKRPV 298
Query: 1037 IEEV 1040
              ++
Sbjct: 299  FADI 302

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L     +  R+F+ E+E L   QH N+V  +
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 834 GYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           G C     R   LI  Y+  GSL  +L +  ++   +K    L+      +G+ YL    
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---G 132
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQ 948
               +HR++ + NIL++ +    + DFGL+++L P D     V       + +  PE   
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
               +   DV+SFGVVL EL T
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 122
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   TDL GTL Y+PPE
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTDLCGTLDYLPPE 176
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 71
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 127
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   TDL GTL Y+PPE
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTDLCGTLDYLPPE 181
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 67
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   TDL GTL Y+PPE
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTDLCGTLDYLPPE 177
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 827
           N+     +G G FG V  A   T G K A+K ++        M+   + E+  L   +H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           +++ L    +  ++ +++  Y  N   DY     V +D + + + R +  Q     + Y 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYI----VQRDKMSEQEAR-RFFQQIISAVEYC 129
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY- 946
           H+     IVHRD+K  N+LLDE     +ADFGLS ++   D +      G+  Y  PE  
Sbjct: 130 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVI 184
Query: 947 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           S  L A    DV+S GV+L  +L  R P +
Sbjct: 185 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 827
           N+     +G G FG V  A   T G K A+K ++        M+   + E+  L   +H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           +++ L    +  ++ +++  Y  N   DY     V +D + + + R +  Q     + Y 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYI----VQRDKMSEQEAR-RFFQQIISAVEYC 128
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY- 946
           H+     IVHRD+K  N+LLDE     +ADFGLS ++   D +      G+  Y  PE  
Sbjct: 129 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVI 183
Query: 947 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           S  L A    DV+S GV+L  +L  R P +
Sbjct: 184 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 827
           N+     +G G FG V  A   T G K A+K ++        M+   + E+  L   +H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           +++ L    +  ++ +++  Y  N   DY     V +D + + + R +  Q     + Y 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYI----VQRDKMSEQEAR-RFFQQIISAVEYC 123
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY- 946
           H+     IVHRD+K  N+LLDE     +ADFGLS ++   D +      G+  Y  PE  
Sbjct: 124 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVI 178
Query: 947 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           S  L A    DV+S GV+L  +L  R P +
Sbjct: 179 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHK 827
           N+     +G G FG V  A   T G K A+K ++        M+   + E+  L   +H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           +++ L    +  ++ +++  Y  N   DY     V +D + + + R +  Q     + Y 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYI----VQRDKMSEQEAR-RFFQQIISAVEYC 119
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY- 946
           H+     IVHRD+K  N+LLDE     +ADFGLS ++   D +      G+  Y  PE  
Sbjct: 120 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVI 174
Query: 947 SQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           S  L A    DV+S GV+L  +L  R P +
Sbjct: 175 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 97/227 (42%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 120
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   TDL GTL Y+P
Sbjct: 121 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTDLCGTLDYLP 174
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 771 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 824 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR-------LK 875
             QH+N+V+L G C HG   L+I  Y   G L  +L    + D + K D R       L 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAD-LDKEDGRPLELRDLLH 164
Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 934
            +   A+G+A+L      + +HRDV + N+LL     A + DFGL+R ++   +  V  +
Sbjct: 165 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+S+G++L E+ +
Sbjct: 222 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 779 IGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G +G VY     K +LT     AVK L  D  ++E EF  E   +   +H NLV L 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLT----VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 94
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
           G C       ++  YM  G+L  +L E  +++ V    V L +A   +  + YL K    
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAV-VLLYMATQISSAMEYLEK---K 149
Query: 894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLT 951
           + +HRD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE     T
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNT 207
Query: 952 ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMK 994
            + + DV++FGV+L E+ T G  P          DL+   ++M+
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRME 251

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 58/304 (19%)
Query: 771  NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQME-REFQAEVEALSR 823
             N      +G G FG V KAT          T  AVK L  +    E R+  +E   L +
Sbjct: 23   KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV--------------------- 862
              H +++ L G C      LLI  Y + GSL  +L ES                      
Sbjct: 83   VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 863  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 922
            D+ ++   D+ +  A   ++G+ YL    E  +VHRD+ + NIL+ E  +  ++DFGLSR
Sbjct: 143  DERALTMGDL-ISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 923  LLRPYDTHVTTDLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVE 976
             +   D+ V      + G IP ++    +      T + DV+SFGV+L E++T G  P  
Sbjct: 199  DVYEEDSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 977  VCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1036
                +   +L+    +M+      E                EM  +  +C  Q+P +RP 
Sbjct: 255  GIPPERLFNLLKTGHRMERPDNCSE----------------EMYRLMLQCWKQEPDKRPV 298
Query: 1037 IEEV 1040
              ++
Sbjct: 299  FADI 302

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 55/293 (18%)
Query: 772  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
            +F +  +IG GGFG V+KA    +G    +KR+  +  + ERE    V+AL++  H N+V
Sbjct: 12   DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 831  SLQGYCRHGNDR-----------------LLIYSYMENGSLDYWLHESVDK--DSVLKWD 871
               G C  G D                   +   + + G+L+ W+ +   +  D VL   
Sbjct: 68   HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA-- 124
Query: 872  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 931
              L++ +   +G+ Y+H      +++RD+K SNI L +  +  + DFGL   L+      
Sbjct: 125  --LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX 179
Query: 932  TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 991
             +   GTL Y+ PE   +       D+Y+ G++L ELL       VC      D      
Sbjct: 180  RSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELL------HVC------DTAFETS 225
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            +  ++ R+  I D  I+ K +EK LL+      K + + P  RP   E++  L
Sbjct: 226  KFFTDLRDGIISD--IFDK-KEKTLLQ------KLLSKKPEDRPNTSEILRTL 269

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 58/304 (19%)
Query: 771  NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQME-REFQAEVEALSR 823
             N      +G G FG V KAT          T  AVK L  +    E R+  +E   L +
Sbjct: 23   KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV--------------------- 862
              H +++ L G C      LLI  Y + GSL  +L ES                      
Sbjct: 83   VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 863  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 922
            D+ ++   D+ +  A   ++G+ YL    E  +VHRD+ + NIL+ E  +  ++DFGLSR
Sbjct: 143  DERALTMGDL-ISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 923  LLRPYDTHVTTDLVGTLGYIPPEYSQTLT-----ATCRGDVYSFGVVLLELLT-GRRPVE 976
             +   D+ V      + G IP ++    +      T + DV+SFGV+L E++T G  P  
Sbjct: 199  DVYEEDSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 977  VCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1036
                +   +L+    +M+      E                EM  +  +C  Q+P +RP 
Sbjct: 255  GIPPERLFNLLKTGHRMERPDNCSE----------------EMYRLMLQCWKQEPDKRPV 298
Query: 1037 IEEV 1040
              ++
Sbjct: 299  FADI 302

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 779 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
           +G G FG V  Y    TN   G   AVK L  DCG   R  ++ E++ L    H++++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 833 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           +G C    ++   L+  Y+  GSL DY    S+    +L +      AQ    G+AYLH 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLH- 134
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 947
               H +HR++ + N+LLD      + DFGL++ +     +  V  D    + +  PE  
Sbjct: 135 --SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 948 QTLTATCRGDVYSFGVVLLELLT 970
           +        DV+SFGV L ELLT
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 69/269 (25%), Positives = 116/269 (43%), Gaps = 25/269 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG V+     N TK AVK L    G M  + F  E   +   QH  LV L     
Sbjct: 20   LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  +I  +M  GSL  +L    D+   +     +  +   A G+AY+ +    + +H
Sbjct: 78   KEEPIYIITEFMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 132
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++N+L+ E     +ADFGL+R++   +          + +  PE       T + +
Sbjct: 133  RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L E++T G+ P     G+   D++S + Q     R     D            
Sbjct: 193  VWSFGILLYEIVTYGKIPY---PGRTNADVMSALSQGYRMPRMENCPD------------ 237
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
             E+ +I   C  +    RP  + + + LD
Sbjct: 238  -ELYDIMKMCWKEKAEERPTFDYLQSVLD 265

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 95/231 (41%), Gaps = 28/231 (12%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 92
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 146
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGTL 939
           L+Y H      ++HRD+K  N+LL    E  +ADFG S        H  +    DL GTL
Sbjct: 147 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTL 196
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
            Y+PPE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 779 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
           +G G FG V  Y    TN   G   AVK L  DCG   R  ++ E++ L    H++++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 833 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           +G C    ++   L+  Y+  GSL DY    S+    +L +      AQ    G+AYLH 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLHA 135
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 947
               H +HR++ + N+LLD      + DFGL++ +     +  V  D    + +  PE  
Sbjct: 136 ---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 948 QTLTATCRGDVYSFGVVLLELLT 970
           +        DV+SFGV L ELLT
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 97/227 (42%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 120
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   T+L GTL Y+P
Sbjct: 121 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTELCGTLDYLP 174
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 771 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 824 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG--- 879
             QH+N+V+L G C HG   L+I  Y   G L  +L     K  VL+ D    IA     
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR---KSRVLETDPAFAIANSTLS 162
Query: 880 ----------AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYD 928
                      A+G+A+L      + +HRDV + N+LL     A + DFGL+R ++   +
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
             V  +    + ++ PE       T + DV+S+G++L E+ +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 771 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 824 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG--- 879
             QH+N+V+L G C HG   L+I  Y   G L  +L     K  VL+ D    IA     
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR---KSRVLETDPAFAIANSTAS 162
Query: 880 ----------AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYD 928
                      A+G+A+L      + +HRDV + N+LL     A + DFGL+R ++   +
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
             V  +    + ++ PE       T + DV+S+G++L E+ +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 71
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G +    ++ + K S              A  L+
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANALS 127
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPPE 181
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 828
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 889 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRPV 975
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 93/229 (40%), Gaps = 24/229 (10%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 69
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 125
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGTLGY 941
           Y H      ++HRD+K  N+LL    E  +ADFG S        H  +    DL GTL Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDY 175
Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           +PPE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 92
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 146
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+P
Sbjct: 147 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLP 200
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 828
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 889 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRPV 975
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 772 NFNQANI---IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRA 824
           NF+   I   IG G FG V      +  K    +       +ER        E++ +   
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           +H  LV+L    +   D  ++   +  G L Y L ++V      +  V+L I +     L
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICE-LVMAL 128
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            YL       I+HRD+K  NILLDE    H+ DF ++ +L P +T +TT + GT  Y+ P
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT-MAGTKPYMAP 183
Query: 945 EYSQTLTATCRGDVYSF-------GVVLLELLTGRRPVEVCKGKNCRDLV 987
           E    + ++ +G  YSF       GV   ELL GRRP  +    + +++V
Sbjct: 184 E----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 828
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 889 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 184 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 237
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRPV 975
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 828
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 889 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRPV 975
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 828
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 889 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRPV 975
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 771 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 824 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-----------------ESVDKD 865
             QH+N+V+L G C HG   L+I  Y   G L  +L                  E +DK+
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 866 SVLKWDVR--LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR- 922
                ++R  L  +   A+G+A+L      + +HRDV + N+LL     A + DFGL+R 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           ++   +  V  +    + ++ PE       T + DV+S+G++L E+ +
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 828
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 889 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 122 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 175
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRPV 975
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 20/232 (8%)
Query: 760 DLTVSDL-LKSTNNFNQANIIGCGGFG--LVYKATLTNGTKAAVKRL--SGDCGQMEREF 814
           DL   +L  +S   + +   IG G FG  ++ K+T  +G +  +K +  S    +   E 
Sbjct: 12  DLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSSKEREES 70
Query: 815 QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKW 870
           + EV  L+  +H N+V  +          ++  Y E G L   ++        +D +L W
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 930
            V++ +A         L  V +  I+HRD+KS NI L +     L DFG++R+L      
Sbjct: 131 FVQICLA---------LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVE 180
Query: 931 VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
           +    +GT  Y+ PE  +      + D+++ G VL EL T +   E    KN
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 27/254 (10%)
Query: 725 GCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGF 784
           G  +++L+ D  + +RL   L   + V     + KD          ++F + + +G G  
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKV----GELKD----------DDFEKISELGAGNG 46
Query: 785 GLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCRHGNDR 842
           G+V+K +   +G   A K +  +     R +   E++ L       +V   G      + 
Sbjct: 47  GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106
Query: 843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-IVHRDVK 901
            +   +M+ GSLD  L     K   +   +  K++    +GL YL    E H I+HRDVK
Sbjct: 107 SICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVK 159
Query: 902 SSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSF 961
            SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  Q    + + D++S 
Sbjct: 160 PSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 962 GVVLLELLTGRRPV 975
           G+ L+E+  GR P+
Sbjct: 217 GLSLVEMAVGRYPI 230

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 828
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V   G      +  +   +M+ GSLD    + + K   +   +  K++    +GL YL 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 889 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              E H I+HRDVK SNIL++ + E  L DFG+S  L      +  + VGT  Y+ PE  
Sbjct: 125 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DEMANEFVGTRSYMSPERL 178
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           Q    + + D++S G+ L+E+  GR P
Sbjct: 179 QGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 36/269 (13%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            +G G FG V+ AT    TK AVK +      +E  F AE   +   QH  LV L      
Sbjct: 190  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 839  GNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  GSL D+   +   K  + K    +  +   A G+A++    + + +H
Sbjct: 249  -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIE---QRNYIH 301
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD++++NIL+       +ADFGL+R+   +           + +  PE     + T + D
Sbjct: 302  RDLRAANILVSASLVCKIADFGLARVGAKF----------PIKWTAPEAINFGSFTIKSD 351
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            V+SFG++L+E++T GR P            +   ++M   +   E               
Sbjct: 352  VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE--------------- 396
Query: 1017 LEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
             E+  I  +C    P  RP  E + + LD
Sbjct: 397  -ELYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 25  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 83
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 84  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 137
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+P
Sbjct: 138 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLP 191
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 238

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 772 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 72
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 884
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 126
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PP
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPP 180
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           E  +      + D++S GV+  E L G+ P E
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 772 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 8   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 66
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 884
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 120
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PP
Sbjct: 121 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPP 174
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           E  +      + D++S GV+  E L G+ P E
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 772 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 70
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 884
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 124
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PP
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPP 178
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           E  +      + D++S GV+  E L G+ P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 120
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+P
Sbjct: 121 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLP 174
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 147
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 205
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 206 SDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 138
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 196
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 197 SDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 136
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 194
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 136
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 194
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 69
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 123
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+P
Sbjct: 124 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLP 177
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 22/233 (9%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDCG-QMEREFQAEVE 819
           +LK T    +  ++G G FG VYK        T     A+K L+   G +   EF  E  
Sbjct: 34  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 92
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   H +LV L G C     +L +   M +G L  ++HE  D      +L W V++  
Sbjct: 93  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI-- 149
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
               A+G+ YL    E  +VHRD+ + N+L+       + DFGL+RLL   +     D  
Sbjct: 150 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 202
Query: 937 GT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 987
              + ++  E       T + DV+S+GV + EL+T G +P +    +   DL+
Sbjct: 203 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 22/233 (9%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDCG-QMEREFQAEVE 819
           +LK T    +  ++G G FG VYK        T     A+K L+   G +   EF  E  
Sbjct: 11  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   H +LV L G C     +L +   M +G L  ++HE  D      +L W V++  
Sbjct: 70  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI-- 126
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
               A+G+ YL    E  +VHRD+ + N+L+       + DFGL+RLL   +     D  
Sbjct: 127 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179
Query: 937 GT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 987
              + ++  E       T + DV+S+GV + EL+T G +P +    +   DL+
Sbjct: 180 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 71
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 125
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+P
Sbjct: 126 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLP 179
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A   N       K   K      G +E + + EVE  S  +
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 66
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 122
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P        L GTL Y+PPE
Sbjct: 123 YCHS---KKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA--LCGTLDYLPPE 176
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G+ P E    ++    +S V
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 13/208 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKN 828
           ++F + + +G G  G+V+K +   +G   A K +  +     R +   E++ L       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           +V   G      +  +   +M+ GSLD    + + K   +   +  K++    +GL YL 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 889 KVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              E H I+HRDVK SNIL++ + E  L DFG+S  L   D+ +    VGT  Y+ PE  
Sbjct: 141 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS-MANSFVGTRSYMSPERL 194
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRPV 975
           Q    + + D++S G+ L+E+  GR P+
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 772 NFNQANIIGCGGFGLVYKA-----TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           +F     +G G FG VY A           K   K      G +E + + EVE  S  +H
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 64
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 884
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 118
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PP
Sbjct: 119 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPP 172
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           E  +      + D++S GV+  E L G+ P E
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 772 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 67
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 884
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 121
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P  +   T L GTL Y+PP
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTXLCGTLDYLPP 175
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           E  +      + D++S GV+  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 80/306 (26%), Positives = 133/306 (43%), Gaps = 68/306 (22%)
Query: 772  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
            +F +  +IG GGFG V+KA    +G    ++R+  +  + ERE    V+AL++  H N+V
Sbjct: 13   DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 831  SLQGYCRHGNDR------------------------------LLIYSYMENGSLDYWLHE 860
               G C  G D                                +   + + G+L+ W+ +
Sbjct: 69   HYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 861  SVDK--DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 918
               +  D VL     L++ +   +G+ Y+H      ++HRD+K SNI L +  +  + DF
Sbjct: 128  RRGEKLDKVLA----LELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 919  GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC 978
            GL   L+  +    T   GTL Y+ PE   +       D+Y+ G++L ELL       VC
Sbjct: 181  GLVTSLK--NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL------HVC 232
Query: 979  KGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIE 1038
                  D      +  ++ R+  I D  I+ K +EK LL+      K + + P  RP   
Sbjct: 233  ------DTAFETSKFFTDLRDGIISD--IFDK-KEKTLLQ------KLLSKKPEDRPNTS 277
Query: 1039 EVVTWL 1044
            E++  L
Sbjct: 278  EILRTL 283

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 12  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 70
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 126
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPPE 180
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 225

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 132
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 958 VYSFGVVLLELLT 970
           V++FGV+L E+ T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSGDCGQMEREFQAEVE--ALSRA 824
           + F    ++G G FG V+     +G+ A    A+K L     ++    + ++E   L   
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H  +V L    +      LI  ++  G L   L + V      + DV+  +A+  A  L
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALAL 140
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            +LH +    I++RD+K  NILLDE+    L DFGLS+    ++    +   GT+ Y+ P
Sbjct: 141 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 196
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           E       T   D +SFGV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAK 243

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSGDCGQMEREFQAEVE--ALSRA 824
           + F    ++G G FG V+     +G+ A    A+K L     ++    + ++E   L   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H  +V L    +      LI  ++  G L   L + V      + DV+  +A+  A  L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALAL 139
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            +LH +    I++RD+K  NILLDE+    L DFGLS+    ++    +   GT+ Y+ P
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 195
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           E       T   D +SFGV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAK 242

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSGDCGQMEREFQAEVE--ALSRA 824
           + F    ++G G FG V+     +G+ A    A+K L     ++    + ++E   L   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H  +V L    +      LI  ++  G L   L + V      + DV+  +A+  A  L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALAL 139
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            +LH +    I++RD+K  NILLDE+    L DFGLS+    ++    +   GT+ Y+ P
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 195
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           E       T   D +SFGV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAK 242

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 92/229 (40%), Gaps = 24/229 (10%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 71
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G +    ++ + K S              A  L+
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANALS 127
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTLGY 941
           Y H      ++HRD+K  N+LL    E  +ADFG S        H  +     L GTL Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDY 177
Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           +PPE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 771 NNFNQANIIGCGGFGLVYKATL------TNGTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
           NN      +G G FG V +AT           K AVK L       E+E   +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 824 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKW 870
             QH+N+V+L G C HG   L+I  Y   G L            +Y  + S + +  L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDT 929
              L  +   A+G+A+L      + +HRDV + N+LL     A + DFGL+R ++   + 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
            V  +    + ++ PE       T + DV+S+G++L E+ +
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 22/227 (9%)
Query: 759 KDLTVSDLLKSTNN---FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREF 814
           KD  V++L    +    F+    IG G FG VY A  + N    A+K++S    Q   ++
Sbjct: 39  KDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 98
Query: 815 Q---AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD 871
           Q    EV  L + +H N +  +G     +   L+  Y    + D      V K  + + +
Sbjct: 99  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVE 155
Query: 872 VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV 931
           +   +  GA +GLAYLH     +++HRDVK+ NILL E     L DFG + ++ P     
Sbjct: 156 I-AAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206
Query: 932 TTDLVGTLGYIPPEYSQTLTA---TCRGDVYSFGVVLLELLTGRRPV 975
               VGT  ++ PE    +       + DV+S G+  +EL   + P+
Sbjct: 207 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 823
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 23   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 824  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 874
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 83   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 875  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 143  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 929  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 986
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 200  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 249
Query: 987  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 250  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 94/227 (41%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 67
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 121
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +ADFG S    P     T  L GTL Y+P
Sbjct: 122 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTT--LSGTLDYLP 175
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 132
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           RD+ + N L+ E     +ADFGLSRL+    +  H        + +  PE       + +
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPESLAYNKFSIK 190
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 67
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDT--LCGTLDYLPPE 177
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 779 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSL 832
           +G G FG V  Y    TN   G   AVK L   CG Q+   +Q E+E L    H+++V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 833 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           +G C    ++   L+  Y+  GSL DY     V    +L +      AQ    G+AYLH 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLF------AQQICEGMAYLHA 129
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 947
               H +HR + + N+LLD      + DFGL++ +     +  V  D    + +  PE  
Sbjct: 130 ---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 948 QTLTATCRGDVYSFGVVLLELLT 970
           +        DV+SFGV L ELLT
Sbjct: 187 KECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 779 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSL 832
           +G G FG V  Y    TN   G   AVK L   CG Q+   +Q E+E L    H+++V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 833 QGYCRHGNDR--LLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           +G C    ++   L+  Y+  GSL DY     V    +L +      AQ    G+AYLH 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLF------AQQICEGMAYLHA 130
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYS 947
               H +HR + + N+LLD      + DFGL++ +     +  V  D    + +  PE  
Sbjct: 131 ---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 948 QTLTATCRGDVYSFGVVLLELLT 970
           +        DV+SFGV L ELLT
Sbjct: 188 KECKFYYASDVWSFGVTLYELLT 210

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F+    +G G FG VY     ++      K   K      G +E + + EVE  S  +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG-VEHQLRREVEIQSHLR 70
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALS 126
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTT--LCGTLDYLPPE 180
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G  P E    +     +S V
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV 225

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 135
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 958 VYSFGVVLLELLT 970
           V++FGV+L E+ T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 823
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 46   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 824  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 874
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 106  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 875  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 166  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 929  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 986
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 223  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 272
Query: 987  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 273  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 132
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 958 VYSFGVVLLELLT 970
           V++FGV+L E+ T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 958 VYSFGVVLLELLT 970
           V++FGV+L E+ T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 772 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 67
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 884
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 121
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           +Y H      ++HRD+K  N+LL    E  +ADFG S +  P        L GTL Y+PP
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA--LCGTLDYLPP 175
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           E  +      + D++S GV+  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 823
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 39   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 824  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 874
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 99   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 875  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 159  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 929  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 986
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 216  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 265
Query: 987  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 266  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 94/227 (41%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 69
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 123
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +ADFG S +  P        L GTL Y+P
Sbjct: 124 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA--LCGTLDYLP 177
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 773 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQHKN 828
           F+    IG G FG VY A  + N    A+K++S    Q   ++Q    EV  L + +H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
            +  +G     +   L+  Y    + D      V K  + + ++   +  GA +GLAYLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEI-AAVTHGALQGLAYLH 132
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
                +++HRDVK+ NILL E     L DFG + ++ P         VGT  ++ PE   
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVIL 184
Query: 949 TLTA---TCRGDVYSFGVVLLELLTGRRPV 975
            +       + DV+S G+  +EL   + P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 135
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 958 VYSFGVVLLELLT 970
           V++FGV+L E+ T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+          AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 136
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N L+ E     +ADFGLSRL+              + +  PE       + + D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 958 VYSFGVVLLELLT 970
           V++FGV+L E+ T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 68
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 122
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L+Y H      ++HRD+K  N+LL    E  +A+FG S +  P     T  L GTL Y+P
Sbjct: 123 LSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTT--LCGTLDYLP 176
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           PE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 223

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 772 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 67
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 884
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 121
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTLG 940
           +Y H      ++HRD+K  N+LL    E  +ADFG S        H  +     L GTL 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLD 171
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           Y+PPE  +      + D++S GV+  E L G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 772 NFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           +F     +G G FG VY     ++      K   K      G +E + + EVE  S  +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRH 70
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARGL 884
            N++ L GY        LI  Y   G++   L +    D+     +   L      A  L
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANAL 124
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTLG 940
           +Y H      ++HRD+K  N+LL    E  +ADFG S        H  +     L GTL 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLD 174
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           Y+PPE  +      + D++S GV+  E L G+ P E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 823
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 46   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 824  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 874
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 106  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 875  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 166  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 929  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 986
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 223  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 272
Query: 987  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 273  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 94/231 (40%), Gaps = 28/231 (12%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 68
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVRLKIAQGAARG 883
           H N++ L GY        LI  Y   G++   L +    D+     +   L      A  
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANA 122
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD----LVGTL 939
           L+Y H      ++HRD+K  N+LL    E  +ADFG S        H  +     L GTL
Sbjct: 123 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTL 172
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
            Y+PPE  +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 29/236 (12%)
Query: 771 NNFNQANIIGCGGFG---LVYKATLTNG---------TKAAVKRLSGDCGQMEREFQAEV 818
           ++F    ++G G FG   LV K T  +           KA +K       +MER+  A+V
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
                  H  +V L    +      LI  ++  G L   L + V      + DV+  +A+
Sbjct: 88  ------NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE 138
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
             A GL +LH +    I++RD+K  NILLDE+    L DFGLS+    ++    +   GT
Sbjct: 139 -LALGLDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGT 193
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           + Y+ PE       +   D +S+GV++ E+LTG  P +   GK+ ++ ++ + + K
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQ---GKDRKETMTLILKAK 246

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 93/225 (41%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F     +G G FG VY A           K   K      G +E + + EVE  S  +
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLR 69
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 125
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +A+FG S +  P     T  L GTL Y+PPE
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTT--LCGTLDYLPPE 179
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G+ P E    +     +S V
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 42/299 (14%)
Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR 823
            N  +    +G G FG V +AT     K+      AVK L       ERE   +E++ LS 
Sbjct: 41   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 824  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL-------- 874
               H N+V+L G C  G   L+I  Y   G L  +L    D     K    +        
Sbjct: 101  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 875  ------KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                    +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 161  DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 929  THVTT-DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDL 986
             +V   +    + ++ PE       T   DV+S+G+ L EL + G  P            
Sbjct: 218  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 267
Query: 987  VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                  M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++
Sbjct: 268  -----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 769 STNNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 827
           + N+F+   IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIML 243
Query: 828 NLVSL--------QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
           +LVS           Y  H  D+L  I   M  G L Y L +        + D+R   A+
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAE 300
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               GL ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT
Sbjct: 301 -IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGT 353
Query: 939 LGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 996
            GY+ PE  Q   A     D +S G +L +LL G  P    K K+  ++      M  E
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 769 STNNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 827
           + N+F+   IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIML 243
Query: 828 NLVSL--------QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
           +LVS           Y  H  D+L  I   M  G L Y L +        + D+R   A+
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAE 300
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               GL ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT
Sbjct: 301 -IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGT 353
Query: 939 LGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 996
            GY+ PE  Q   A     D +S G +L +LL G  P    K K+  ++      M  E
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 769 STNNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 827
           + N+F+   IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIML 243
Query: 828 NLVSL--------QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
           +LVS           Y  H  D+L  I   M  G L Y L +        + D+R   A+
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAE 300
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               GL ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT
Sbjct: 301 -IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGT 353
Query: 939 LGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 996
            GY+ PE  Q   A     D +S G +L +LL G  P    K K+  ++      M  E
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTNGT-KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+      +   AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK---KNFIH 341
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           R++ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 399
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 400 SDVWAFGVLLWEIAT 414

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 769 STNNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 827
           + N+F+   IIG GGFG VY     + G   A+K L     +M+   Q E  AL+     
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIML 242
Query: 828 NLVSL--------QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
           +LVS           Y  H  D+L  I   M  G L Y L +        + D+R   A+
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAE 299
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               GL ++H      +V+RD+K +NILLDE     ++D GL+        H +   VGT
Sbjct: 300 -IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGT 352
Query: 939 LGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 996
            GY+ PE  Q   A     D +S G +L +LL G  P    K K+  ++      M  E
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 411

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 779 IGCGGFGLVYKATLTNGT-KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G +G VY+      +   AVK L  D  ++E EF  E   +   +H NLV L G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                 +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K    + +H
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNFIH 380
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
           R++ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       + +
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 438
Query: 956 GDVYSFGVVLLELLT 970
            DV++FGV+L E+ T
Sbjct: 439 SDVWAFGVLLWEIAT 453

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 773 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 831
           F+    +G G +G VYKA     G   A+K++  +     +E   E+  + +    ++V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVK 88
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
             G      D  ++  Y   GS+   +     ++  L  D    I Q   +GL YLH + 
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTL 950
           +   +HRD+K+ NILL+ +  A LADFG++  L   D     + ++GT  ++ PE  Q +
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 951 TATCRGDVYSFGVVLLELLTGRRP 974
              C  D++S G+  +E+  G+ P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 779 IGCGGFGLV--YKATLTN---GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
           +G G FG V  Y    TN   G   AVK L  D G   R  ++ E++ L    H++++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 833 QGYCRH-GNDRL-LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           +G C   G   L L+  Y+  GSL DY    S+    +L +      AQ    G+AYLH 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLHA 152
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTH-VTTDLVGTLGYIPPEYS 947
               H +HRD+ + N+LLD      + DFGL++ +   ++ + V  D    + +  PE  
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 948 QTLTATCRGDVYSFGVVLLELLT 970
           +        DV+SFGV L ELLT
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 16/225 (7%)
Query: 771 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            +F+    +G G FG VY     ++      K   K      G +E + + EVE  S  +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG-VEHQLRREVEIQSHLR 70
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L GY        LI  Y   G++    +  + K S              A  L+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALS 126
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S +  P     T  L GTL Y+PPE
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDT--LCGTLDYLPPE 180
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
             +      + D++S GV+  E L G  P E    +     +S V
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV 225

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKN 828
             + +   +G G +G+VYKA  + G   A+KR+  D     +      E+  L    H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA-QGAARGLAYL 887
           +VSL           L++ +ME       L + +D++     D ++KI      RG+A+ 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKD-----LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 943
           H   +  I+HRD+K  N+L++      LADFGL+R     +R Y     T  V TL Y  
Sbjct: 136 H---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-----THEVVTLWYRA 187
Query: 944 PEY---SQTLTATCRGDVYSFGVVLLELLTGR 972
           P+    S+  + +   D++S G +  E++TG+
Sbjct: 188 PDVLMGSKKYSTSV--DIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQA--EVEALSRAQHKN 828
             + +   +G G +G+VYKA  + G   A+KR+  D         A  E+  L    H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA-QGAARGLAYL 887
           +VSL           L++ +ME       L + +D++     D ++KI      RG+A+ 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKD-----LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 943
           H   +  I+HRD+K  N+L++      LADFGL+R     +R Y     T  V TL Y  
Sbjct: 136 H---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-----THEVVTLWYRA 187
Query: 944 PEY---SQTLTATCRGDVYSFGVVLLELLTGR 972
           P+    S+  + +   D++S G +  E++TG+
Sbjct: 188 PDVLMGSKKYSTSV--DIWSIGCIFAEMITGK 217

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSL 832
           +G G FG V    Y     N G + AVK L  + G     + + E+E L    H+N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 833 QGYCRH--GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           +G C    GN   LI  ++ +GSL  +L ++ +K   +    +LK A    +G+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT--DLVGTLGYIPPEYSQ 948
                VHRD+ + N+L++ + +  + DFGL++ +       T   D    + +  PE   
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
                   DV+SFGV L ELLT
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 23   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 839  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 82   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 135
Query: 899  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATCR 955
            D+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + +
Sbjct: 136  DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSSK 192
Query: 956  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWH 1009
             D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH
Sbjct: 193  SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWH 250
Query: 1010 KDREKQ 1015
            +  +++
Sbjct: 251  EKADER 256

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 16   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 839  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 75   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 128
Query: 899  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATCR 955
            D+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + +
Sbjct: 129  DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSSK 185
Query: 956  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWH 1009
             D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH
Sbjct: 186  SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWH 243
Query: 1010 KDREKQ 1015
            +  +++
Sbjct: 244  EKADER 249

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 17   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 839  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 76   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 899  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATCR 955
            D+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + +
Sbjct: 130  DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSSK 186
Query: 956  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWH 1009
             D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH
Sbjct: 187  SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWH 244
Query: 1010 KDREKQ 1015
            +  +++
Sbjct: 245  EKADER 250

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 127/269 (47%), Gaps = 27/269 (10%)
Query: 779  IGCGGFGLVY-KATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 836
            +G G FG V+     ++G +  +K ++ D  Q+  E  +AE+E L    H N++ +    
Sbjct: 30   LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 837  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
               ++  ++    E G L   +  +  +   L      ++ +     LAY H     H+V
Sbjct: 90   EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVV 146
Query: 897  HRDVKSSNILLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQTLTA 952
            H+D+K  NIL  +        + DFGL+ L +  D H +T+  GT  Y+ PE + + +T 
Sbjct: 147  HKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEH-STNAAGTALYMAPEVFKRDVTF 204
Query: 953  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012
             C  D++S GVV+  LLTG  P     G +  ++     Q K+  +E    + ++  +  
Sbjct: 205  KC--DIWSAGVVMYFLLTGCLPF---TGTSLEEV-----QQKATYKEP---NYAVECRPL 251
Query: 1013 EKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
              Q +++L+   + + +DP RRP   +V+
Sbjct: 252  TPQAVDLLK---QMLTKDPERRPSAAQVL 277

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 839  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 71   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 899  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATCR 955
            D+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + +
Sbjct: 125  DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSSK 181
Query: 956  GDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWH 1009
             D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH
Sbjct: 182  SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWH 239
Query: 1010 KDREKQ 1015
            +  +++
Sbjct: 240  EKADER 245

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSL 832
           +G G FG V    Y     N G + AVK L  + G     + + E+E L    H+N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 833 QGYCRH--GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           +G C    GN   LI  ++ +GSL  +L ++ +K ++ +   +LK A    +G+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGMDYLGSR 133
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT--DLVGTLGYIPPEYSQ 948
                VHRD+ + N+L++ + +  + DFGL++ +       T   D    + +  PE   
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 949 TLTATCRGDVYSFGVVLLELLT 970
                   DV+SFGV L ELLT
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 770 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 824
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 942
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 174
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 144 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 196
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 197 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 140 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 192
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 175 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 227
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 198
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 198
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 205
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 199
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 112/234 (47%), Gaps = 17/234 (7%)
Query: 767 LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRA 824
           + S++ F Q   +G G +  VYK    T G   A+K +  D  +        E+  +   
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV-DKDSVLKWDVRLKIAQGAARG 883
           +H+N+V L       N   L++ +M+N    Y    +V +    L+ ++         +G
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDLVGTLGYI 942
           LA+ H   E  I+HRD+K  N+L++++ +  L DFGL+R    P +T  +   V TL Y 
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VVTLWYR 175
Query: 943 PPEY---SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
            P+    S+T + +   D++S G +L E++TG+    +  G N  + +  +F +
Sbjct: 176 APDVLMGSRTYSTSI--DIWSCGCILAEMITGK---PLFPGTNDEEQLKLIFDI 224

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 42/283 (14%)
Query: 779  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 18   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
            L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 78   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 886  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
            YL+       VHRD+ + N ++ E F   + DFG++R +   D        G  G +P  
Sbjct: 138  YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 190
Query: 944  ---PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
               PE  +    T   DV+SFGVVL E+ T   +P +   G +   ++ +V        E
Sbjct: 191  WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GLSNEQVLRFVM-------E 240
Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042
              ++D      +    LLE++ +   C   +P+ RP   E+++
Sbjct: 241  GGLLDKP---DNCPDMLLELMRM---CWQYNPKMRPSFLEIIS 277

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 829
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 830 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
               G    G+   +I  Y+  GS LD       D+  +        + +   +GL YLH
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLH 137
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 947
              +   +HRD+K++N+LL E+ +  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 138 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 192
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           Q      + D++S G+  +EL  G  P
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 770 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 824
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 942
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 173
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 23/247 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG+V           A+K +    G M E EF  E + +    H+ LV L G C 
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  +I  YM NG L  +L E   +    +    L++ +     + YL        +H
Sbjct: 90   KQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 954
            RD+ + N L++++    ++DFGLSR +   D   T+  VG+   + + PPE       + 
Sbjct: 144  RDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSKFPVRWSPPEVLMYSKFSS 200
Query: 955  RGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIW 1008
            + D+++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S W
Sbjct: 201  KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCW 258
Query: 1009 HKDREKQ 1015
            H+  +++
Sbjct: 259  HEKADER 265

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 829
           ++++    +G G FG+V++ T    G   A K +       +   + E++ +S  +H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           V+L       N+ ++IY +M  G L     +  D+ + +  D  ++  +   +GL ++H 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 272
Query: 890 VCEPHIVHRDVKSSNILLDEKF--EAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEY 946
             E + VH D+K  NI+   K   E  L DFGL+  L P  +  VTT   GT  +  PE 
Sbjct: 273 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 327
Query: 947 SQTLTATCRGDVYSFGVVLLELLTGRRP 974
           ++        D++S GV+   LL+G  P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 108/244 (44%), Gaps = 17/244 (6%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG+V           A+K +    G M E EF  E + +    H+ LV L G C 
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
                  +I  YM NG L  +L E   +    +    L++ +     + YL        +H
Sbjct: 90   KQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD+ + N L++++    ++DFGLSR +   +   +      + + PPE       + + D
Sbjct: 144  RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 958  VYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWHKD 1011
            +++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH+ 
Sbjct: 204  IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWHEK 261
Query: 1012 REKQ 1015
             +++
Sbjct: 262  ADER 265

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQ--- 833
           +G GGFG V +    + G + A+K+   +     RE +  E++ + +  H N+VS +   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 834 -GYCRHG-ND-RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            G  +   ND  LL   Y E G L  +L++  +   + +  +R  ++  ++  L YLH  
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-ALRYLH-- 138
Query: 891 CEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
            E  I+HRD+K  NI+L    ++    + D G ++ L      + T+ VGTL Y+ PE  
Sbjct: 139 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLAPELL 195
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           +    T   D +SFG +  E +TG RP
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 760 DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           ++ +S L      F    ++G G +G VYK       + A  ++    G  E E + E+ 
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN 72
Query: 820 ALSR-AQHKNLVSLQGYCRHGN-----DRL-LIYSYMENGSLDYWLHESVDKDSVLKWDV 872
            L + + H+N+ +  G     N     D+L L+  +   GS+   +  +  K + LK + 
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEW 130
Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 932
              I +   RGL++LH   +  ++HRD+K  N+LL E  E  L DFG+S  L        
Sbjct: 131 IAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 933 TDLVGTLGYIPPEY-----SQTLTATCRGDVYSFGVVLLELLTGRRPV 975
           T  +GT  ++ PE      +   T   + D++S G+  +E+  G  P+
Sbjct: 188 T-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQ--- 833
           +G GGFG V +    + G + A+K+   +     RE +  E++ + +  H N+VS +   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 834 -GYCRHG-ND-RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            G  +   ND  LL   Y E G L  +L++  +   + +  +R  ++  ++  L YLH  
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-ALRYLH-- 139
Query: 891 CEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
            E  I+HRD+K  NI+L    ++    + D G ++ L      + T+ VGTL Y+ PE  
Sbjct: 140 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLAPELL 196
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           +    T   D +SFG +  E +TG RP
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D        G  G +P  
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 199
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 770 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 824
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 942
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 174
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 770 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 824
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 942
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 174
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 770 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVK----RLSGDCGQMEREFQAEVEALSRA 824
             +++    +G G +G V  A      +A AVK    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYI 942
            YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYV 174
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
            PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 15/187 (8%)
Query: 806 DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD 865
           DC +     + E+       H+N+V   G+ R GN + L   Y   G L     + ++ D
Sbjct: 46  DCPE---NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPD 98
Query: 866 SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 925
             +      +       G+ YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R
Sbjct: 99  IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 926 PYDT--HVTTDLVGTLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 982
            Y+    +   + GTL Y+ PE  +         DV+S G+VL  +L G  P +     +
Sbjct: 156 -YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDS 213
Query: 983 CRDLVSW 989
           C++   W
Sbjct: 214 CQEYSDW 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 15/187 (8%)
Query: 806 DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD 865
           DC +     + E+       H+N+V   G+ R GN + L   Y   G L     + ++ D
Sbjct: 46  DCPE---NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPD 98
Query: 866 SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 925
             +      +       G+ YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R
Sbjct: 99  IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 155
Query: 926 PYDT--HVTTDLVGTLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 982
            Y+    +   + GTL Y+ PE  +         DV+S G+VL  +L G  P +     +
Sbjct: 156 -YNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDS 213
Query: 983 CRDLVSW 989
           C++   W
Sbjct: 214 CQEYSDW 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 15/187 (8%)
Query: 806 DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD 865
           DC +     + E+       H+N+V   G+ R GN + L   Y   G L     + ++ D
Sbjct: 47  DCPE---NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPD 99
Query: 866 SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 925
             +      +       G+ YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 926 PYDT--HVTTDLVGTLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 982
            Y+    +   + GTL Y+ PE  +         DV+S G+VL  +L G  P +     +
Sbjct: 157 -YNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDS 214
Query: 983 CRDLVSW 989
           C++   W
Sbjct: 215 CQEYSDW 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 829
           ++++    +G G FG+V++ T    G   A K +       +   + E++ +S  +H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           V+L       N+ ++IY +M  G L     +  D+ + +  D  ++  +   +GL ++H 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 166
Query: 890 VCEPHIVHRDVKSSNILLDEKF--EAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEY 946
             E + VH D+K  NI+   K   E  L DFGL+  L P  +  VTT   GT  +  PE 
Sbjct: 167 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 221
Query: 947 SQTLTATCRGDVYSFGVVLLELLTGRRP 974
           ++        D++S GV+   LL+G  P
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 117
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 118 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 173
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 219

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 175
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 174
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 175
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVA 175
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 221

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L     ++  + VL      K+ Q A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 205
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
           L G    G   L+I   M  G L  +L     ++  + VL      K+ Q A   A G+A
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++ E F   + DFG++R +   D +      G  G +P  
Sbjct: 143 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 195
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   DV+SFGVVL E+ T
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G    
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 839 GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
               L I + YM  GSL  +L       SVL  D  LK +      + YL      + VH
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 131
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + D
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREAAFSTKSD 187
Query: 958 VYSFGVVLLELLT-GRRP 974
           V+SFG++L E+ + GR P
Sbjct: 188 VWSFGILLWEIYSFGRVP 205

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 42/283 (14%)
Query: 779  IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++V 
Sbjct: 20   LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGA---ARGLA 885
            L G    G   L+I   M  G L  +L      ++ + VL      K+ Q A   A G+A
Sbjct: 80   LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 886  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
            YL+       VHRD+ + N  + E F   + DFG++R +   D +      G  G +P  
Sbjct: 140  YLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 192
Query: 944  ---PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
               PE  +    T   DV+SFGVVL E+ T   +P +   G +   ++ +V        E
Sbjct: 193  WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GLSNEQVLRFVM-------E 242
Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042
              ++D      +    LLE++ +   C   +P+ RP   E+++
Sbjct: 243  GGLLDKP---DNCPDMLLELMRM---CWQYNPKMRPSFLEIIS 279

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMXGTLPYVA 174
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMXGTLPYVA 174
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
           PE  +         DV+S G+VL  +L G  P +     +C++   W
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDW 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKN 828
            + Q   IG G +G+V  A      T+ A+K++S    Q   +R  + E++ L R +H+N
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHEN 102
Query: 829 LVSLQGYCRHG-----NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
           ++ ++   R        D  ++   ME         + +  D +  +  ++       RG
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQI------LRG 156
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGY 941
           L Y+H     +++HRD+K SN+L++   +  + DFGL+R+  P   H    T+ V T  Y
Sbjct: 157 LKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 942 IPPEY---SQTLTATCRGDVYSFGVVLLELLTGR 972
             PE    S+  T +   D++S G +L E+L+ R
Sbjct: 214 RAPEIMLNSKGYTKSI--DIWSVGCILAEMLSNR 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 779 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 877 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 934
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 197 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 23/250 (9%)
Query: 740 RLSEALASSKLVLFQNSDC---KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT-- 793
           +LS+   S+ +  +  + C   K  ++SDL +    N      +G G FG VY+  ++  
Sbjct: 12  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 71
Query: 794 ----NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 848
               +  + AVK L   C  Q E +F  E   +S+  H+N+V   G       R ++   
Sbjct: 72  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 131
Query: 849 MENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
           M  G L  +L E+  +     S+   D+ L +A+  A G  YL    E H +HRD+ + N
Sbjct: 132 MAGGDLKSFLRETRPRPSQPSSLAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARN 187
Query: 905 ILLD---EKFEAHLADFGLSR-LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
            LL        A + DFG++R + R          +  + ++PPE       T + D +S
Sbjct: 188 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 247
Query: 961 FGVVLLELLT 970
           FGV+L E+ +
Sbjct: 248 FGVLLWEIFS 257

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 15/243 (6%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            +G G FG+V           A+K +  +    E EF  E + +    H+ LV L G C  
Sbjct: 17   LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 839  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
                 +I  YM NG L  +L E   +    +    L++ +     + YL        +HR
Sbjct: 76   QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 899  DVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDV 958
            D+ + N L++++    ++DFGLSR +   +   +      + + PPE       + + D+
Sbjct: 130  DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 959  YSFGVVLLELLT-GRRPVEVCKGKNCRDLVS-----WVFQMKSEKREVEIIDASIWHKDR 1012
            ++FGV++ E+ + G+ P E        + ++     +   + SEK  V  I  S WH+  
Sbjct: 190  WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--VYTIMYSCWHEKA 247
Query: 1013 EKQ 1015
            +++
Sbjct: 248  DER 250

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 113/272 (41%), Gaps = 28/272 (10%)
Query: 779  IGCGGFGLVYKATLTNGTKAAV-KRLSGDCGQM-EREFQ---AEVEALSRAQHKNLVSLQ 833
            IG G +G   K    +  K  V K L  D G M E E Q   +EV  L   +H N+V   
Sbjct: 14   IGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 834  GYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
                 R      ++  Y E G L   + +   +   L  +  L++       L   H+  
Sbjct: 72   DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 892  EP--HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
            +    ++HRD+K +N+ LD K    L DFGL+R+L  +DT      VGT  Y+ PE    
Sbjct: 132  DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTFVGTPYYMSPEQMNR 190
Query: 950  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009
            ++   + D++S G +L EL     P      K          ++  + RE +       +
Sbjct: 191  MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----------ELAGKIREGKFRRIPYRY 240
Query: 1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             D      E+ EI  + ++     RP +EE++
Sbjct: 241  SD------ELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 779 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 877 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 934
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 141 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 23/250 (9%)
Query: 740 RLSEALASSKLVLFQNSDC---KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT-- 793
           +LS+   S+ +  +  + C   K  ++SDL +    N      +G G FG VY+  ++  
Sbjct: 36  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 95
Query: 794 ----NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 848
               +  + AVK L   C  Q E +F  E   +S+  H+N+V   G       R ++   
Sbjct: 96  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155
Query: 849 MENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
           M  G L  +L E+  +     S+   D+ L +A+  A G  YL    E H +HRD+ + N
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARN 211
Query: 905 ILLD---EKFEAHLADFGLSR-LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
            LL        A + DFG++R + R          +  + ++PPE       T + D +S
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271
Query: 961 FGVVLLELLT 970
           FGV+L E+ +
Sbjct: 272 FGVLLWEIFS 281

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 779 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 877 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 934
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 156 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 779 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 877 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 934
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 156 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 9   KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 68
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 129 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 184
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 185 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 113/272 (41%), Gaps = 28/272 (10%)
Query: 779  IGCGGFGLVYKATLTNGTKAAV-KRLSGDCGQM-EREFQ---AEVEALSRAQHKNLVSLQ 833
            IG G +G   K    +  K  V K L  D G M E E Q   +EV  L   +H N+V   
Sbjct: 14   IGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 834  GYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
                 R      ++  Y E G L   + +   +   L  +  L++       L   H+  
Sbjct: 72   DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 892  EP--HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
            +    ++HRD+K +N+ LD K    L DFGL+R+L  +DT      VGT  Y+ PE    
Sbjct: 132  DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMSPEQMNR 190
Query: 950  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009
            ++   + D++S G +L EL     P      K          ++  + RE +       +
Sbjct: 191  MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----------ELAGKIREGKFRRIPYRY 240
Query: 1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             D      E+ EI  + ++     RP +EE++
Sbjct: 241  SD------ELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 137 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 779 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE------------SVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L  +L              S + +  L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 877 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTD 934
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D    TT+
Sbjct: 156 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 779 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 877 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 934
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 149 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 23/250 (9%)
Query: 740 RLSEALASSKLVLFQNSDC---KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT-- 793
           +LS+   S+ +  +  + C   K  ++SDL +    N      +G G FG VY+  ++  
Sbjct: 13  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 72
Query: 794 ----NGTKAAVKRLSGDCG-QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 848
               +  + AVK L   C  Q E +F  E   +S+  H+N+V   G       R ++   
Sbjct: 73  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 132
Query: 849 MENGSLDYWLHESVDK----DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
           M  G L  +L E+  +     S+   D+ L +A+  A G  YL    E H +HRD+ + N
Sbjct: 133 MAGGDLKSFLRETRPRPSQPSSLAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARN 188
Query: 905 ILLD---EKFEAHLADFGLSR-LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
            LL        A + DFG++R + R          +  + ++PPE       T + D +S
Sbjct: 189 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 248
Query: 961 FGVVLLELLT 970
           FGV+L E+ +
Sbjct: 249 FGVLLWEIFS 258

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 779 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 877 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 934
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 148 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 779 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 877 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 934
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 145 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 779 IGCGGFGLVY--------KATLTNGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V         K      TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 877 AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTD 934
           A   ARG+ YL  K C    +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+
Sbjct: 156 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
               + ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 152 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G    
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 839 GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
               L I + YM  GSL  +L       SVL  D  LK +      + YL      + VH
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 125
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 958 VYSFGVVLLELLT-GRRP 974
           V+SFG++L E+ + GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 76/274 (27%), Positives = 117/274 (42%), Gaps = 33/274 (12%)
Query: 773  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 829
            F + + IG G FG VYK  + N TK  V     D  + E E    Q E+  LS+     +
Sbjct: 21   FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 830  VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                G         +I  Y+  GS LD        K   L+      I +   +GL YLH
Sbjct: 80   TRYFGSYLKSTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLH 133
Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 947
                   +HRD+K++N+LL E+ +  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 134  ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 188
Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
            +      + D++S G+  +EL  G  P          DL          K     ++   
Sbjct: 189  KQSAYDFKADIWSLGITAIELAKGEPPNS--------DLHPMRVLFLIPKNSPPTLEGQ- 239
Query: 1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             H    K+ +E       C+++DPR RP  +E++
Sbjct: 240  -HSKPFKEFVE------ACLNKDPRFRPTAKELL 266

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G    
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 839 GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
               L I + YM  GSL  +L       SVL  D  LK +      + YL      + VH
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 196
Query: 958 VYSFGVVLLELLT-GRRP 974
           V+SFG++L E+ + GR P
Sbjct: 197 VWSFGILLWEIYSFGRVP 214

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 137 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 152 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H+N+V   G+ R GN + L   Y   G L     + ++ D  +      +       G+ 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT--HVTTDLVGTLGYIP 943
           YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R Y+    +   + GTL Y+ 
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMXGTLPYVA 174
Query: 944 PEYSQTLTATCRG-DVYSFGVVLLELLTGRRP 974
           PE  +         DV+S G+VL  +L G  P
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 138 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 193
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 138 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 193
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQHKNLVS 831
           +G G +G+V+K+     G   AVK++      S D  +  RE     E    + H+N+V+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL---SGHENIVN 73
Query: 832 LQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           L    R  NDR   L++ YME       LH +V + ++L+   +  +     + + YLH 
Sbjct: 74  LLNVLRADNDRDVYLVFDYMETD-----LH-AVIRANILEPVHKQYVVYQLIKVIKYLH- 126
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY--------------------DT 929
                ++HRD+K SNILL+ +    +ADFGLSR                         D 
Sbjct: 127 --SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 930 HVTTDLVGTLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            + TD V T  Y  PE     T   +G D++S G +L E+L G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 78/283 (27%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 777  NIIGCGGFGLVYKATLTNGTK------AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
            +++G G F  V  A      K       A K L G  G ME E    +  L + +H N+V
Sbjct: 24   DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE----IAVLHKIKHPNIV 79
Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            +L      G    LI   +  G L       V+K    + D    I Q     + YLH +
Sbjct: 80   ALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDASRLIFQ-VLDAVKYLHDL 135
Query: 891  CEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
                IVHRD+K  N+L   LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 136  ---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 190
Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
                 +   D +S GV+   LL G  P      +N   L   + + + E       D+  
Sbjct: 191  AQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDAKLFEQILKAEYE------FDSPY 241
Query: 1008 WH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046
            W    D  K  +  L      +++DP +R   E+ +   W+ G
Sbjct: 242  WDDISDSAKDFIRHL------MEKDPEKRFTCEQALQHPWIAG 278

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 24  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 83
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 144 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 199
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 200 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 70/209 (33%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 778 IIGCGGFGLVYKATL----TNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
           +IG G FG+VY         N  + A+K LS      + E F  E   +    H N+++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 833 QGYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            G      G   +L+  YM +G L  ++  S  ++  +K D+ +      ARG+ YL   
Sbjct: 88  IGIMLPPEGLPHVLL-PYMCHGDLLQFI-RSPQRNPTVK-DL-ISFGLQVARGMEYL--- 140
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSR--LLRPY---DTHVTTDLVGTLGYIPPE 945
            E   VHRD+ + N +LDE F   +ADFGL+R  L R Y     H    L   + +   E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVKWTALE 198
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             QT   T + DV+SFGV+L ELLT   P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 828 NLVSLQGYCRHGNDRLLI-YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
             V L  +C   +++L    SY +NG L  ++ +    D       R   A+     L Y
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALEY 152
Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE 945
           LH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ PE
Sbjct: 153 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                +A    D+++ G ++ +L+ G  P
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 751 VLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM 810
           + FQ+ D ++L           F +   IG G FG V+K  + N T+  V     D  + 
Sbjct: 18  LYFQSMDPEEL-----------FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEA 65
Query: 811 EREF---QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDS 866
           E E    Q E+  LS+     +    G         +I  Y+  GS LD      +D+  
Sbjct: 66  EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ 125
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP 926
           +        I +   +GL YLH   +   +HRD+K++N+LL E  E  LADFG++  L  
Sbjct: 126 IAT------ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT- 175
Query: 927 YDTHVTTD-LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            DT +  +  VGT  ++ PE  +      + D++S G+  +EL  G  P
Sbjct: 176 -DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 56/299 (18%)
Query: 779  IGCGGFGLVYKATL------TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 831
            +G   FG VYK  L            A+K L     G +  EF+ E    +R QH N+V 
Sbjct: 34   LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWL-----HESV---DKDSVLKW-----DVRLKIAQ 878
            L G         +I+SY  +G L  +L     H  V   D D  +K      D    +AQ
Sbjct: 94   LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 879  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
             AA G+ YL      H+VH+D+ + N+L+ +K    ++D GL R +   D +    L+G 
Sbjct: 154  IAA-GMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY---KLLGN 206
Query: 939  ----LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM 993
                + ++ PE       +   D++S+GVVL E+ + G +P   C G + +D+V  +   
Sbjct: 207  SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YC-GYSNQDVVEMI--- 260
Query: 994  KSEKREVEII----DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048
                R  +++    D   W          +  +  +C ++ P RRP  +++ + L   G
Sbjct: 261  ----RNRQVLPCPDDCPAW----------VYALMIECWNEFPSRRPRFKDIHSRLRAWG 305

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 28/272 (10%)
Query: 779  IGCGGFGLVYKATLTNGTKAAV-KRLSGDCGQM-EREFQ---AEVEALSRAQHKNLVSLQ 833
            IG G +G   K    +  K  V K L  D G M E E Q   +EV  L   +H N+V   
Sbjct: 14   IGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 834  GYC--RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
                 R      ++  Y E G L   + +   +   L  +  L++       L   H+  
Sbjct: 72   DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 892  EP--HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
            +    ++HRD+K +N+ LD K    L DFGL+R+L  +D     + VGT  Y+ PE    
Sbjct: 132  DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDEDFAKEFVGTPYYMSPEQMNR 190
Query: 950  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009
            ++   + D++S G +L EL     P      K          ++  + RE +       +
Sbjct: 191  MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----------ELAGKIREGKFRRIPYRY 240
Query: 1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             D      E+ EI  + ++     RP +EE++
Sbjct: 241  SD------ELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 770 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 825
           ++ +    I+G GG   V+ A  L +    AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 826 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTL 939
           + L + H   +  I+HRDVK +NIL+       + DFG++R +      V  T  ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 44  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 103
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 164 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 219
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 220 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +    +IG G FG+V++A L    + A+K++  D     RE Q     +   +H N+V L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNVVDL 97
Query: 833 QGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
           + +     D+       L+  Y+         H +  K ++    ++L + Q   R LAY
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAY 156
Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           +H +    I HRD+K  N+LLD       L DFG +++L   + +V+   + +  Y  PE
Sbjct: 157 IHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX--ICSRYYRAPE 211
Query: 946 YSQTLT-ATCRGDVYSFGVVLLELLTGR 972
                T  T   D++S G V+ EL+ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 114/255 (44%), Gaps = 20/255 (7%)
Query: 734 DMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANI-IGCGGFGLVYKATL 792
           D  RP  +  ++  S       SD ++L    L    +N   A+I +GCG FG V +   
Sbjct: 303 DKPRPMPMDTSVFESPF-----SDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVY 357
Query: 793 TNGTK---AAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 848
               K    A+K L     + +  E   E + + +  +  +V L G C+     +L+   
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEM 416
Query: 849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD 908
              G L  +L   V K   +      ++    + G+ YL    E + VHR++ + N+LL 
Sbjct: 417 AGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLV 470
Query: 909 EKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLL 966
            +  A ++DFGLS+ L   D++ T    G   L +  PE       + R DV+S+GV + 
Sbjct: 471 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 967 ELLT-GRRPVEVCKG 980
           E L+ G++P +  KG
Sbjct: 531 EALSYGQKPYKKMKG 545

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 769 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDC----GQMEREFQAEVEALSR 823
           S  +F     +G G FG V+   +  NG   A+K L  +      Q+E     E   LS 
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSI 62
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAAR 882
             H  ++ + G  +      +I  Y+E G L   L +S    + V K+      A     
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-----YAAEVCL 117
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
            L YLH      I++RD+K  NILLD+     + DFG ++    Y   VT  L GT  YI
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYXLCGTPDYI 170
Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            PE   T       D +SFG+++ E+L G  P
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  AT  + G + AVK++     Q       EV  +    H N+V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
            G++  ++  ++E G+L D   H  ++++ +        +     R L+YLH      ++
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHNQG---VI 163
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L      
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 957 DVYSFGVVLLELLTGRRP 974
           D++S G++++E++ G  P
Sbjct: 223 DIWSLGIMVIEMIDGEPP 240

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 777 NIIGCGGFGLVY--KATLTNGTKAAVKRLSGD-------CGQMEREFQAEVEALSRAQHK 827
           + +G G FG V   K  LT G K AVK L+          G++ RE Q     L   +H 
Sbjct: 22  DTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQN----LKLFRHP 76
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
           +++ L       +D  ++  Y+  G L DY     + K+  L      ++ Q    G+ Y
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDY-----ICKNGRLDEKESRRLFQQILSGVDY 131
Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
            H+     +VHRD+K  N+LLD    A +ADFGLS ++   D        G+  Y  PE 
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRXSCGSPNYAAPEV 186
Query: 947 -SQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
            S  L A    D++S GV+L  LL G  P +
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 829
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 830 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
               G         +I  Y+  GS LD      +D+  +        I +   +GL YLH
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLH 136
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 947
              +   +HRD+K++N+LL E  E  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 137 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 191
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           +      + D++S G+  +EL  G  P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G    
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 839 GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
               L I + YM  GSL  +L       SVL  D  LK +      + YL      + VH
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312
Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+ + N+L+ E   A ++DFGL++      T  T  L   + +  PE  +    + + D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 368
Query: 958 VYSFGVVLLELLT-GRRP 974
           V+SFG++L E+ + GR P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 27/274 (9%)
Query: 712 LAVTLLKMSRRDSGCPIDDLDEDMGRPQR----LSEALASSKLVLFQNSDCKDLTVS--D 765
           ++VT     RRDS  P     ++ G P++     S      ++   Q      L V   D
Sbjct: 89  MSVTRSNSLRRDSPPPPARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGD 148
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRA 824
                +NF +   IG G  G+V  AT+ ++G   AVK++     Q       EV  +   
Sbjct: 149 PRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARG 883
           QH+N+V +      G++  ++  ++E G+L D   H  ++++ +            AA  
Sbjct: 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVC 253
Query: 884 LAYLHKVCEPH---IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
           LA L  +   H   ++HRD+KS +ILL       L+DFG    +   +      LVGT  
Sbjct: 254 LAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPY 312
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           ++ PE    L      D++S G++++E++ G  P
Sbjct: 313 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 56/299 (18%)
Query: 779  IGCGGFGLVYKATL------TNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVS 831
            +G   FG VYK  L            A+K L     G +  EF+ E    +R QH N+V 
Sbjct: 17   LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWL-----HESV---DKDSVLKW-----DVRLKIAQ 878
            L G         +I+SY  +G L  +L     H  V   D D  +K      D    +AQ
Sbjct: 77   LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 879  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
             AA G+ YL      H+VH+D+ + N+L+ +K    ++D GL R +   D +    L+G 
Sbjct: 137  IAA-GMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY---KLLGN 189
Query: 939  ----LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQM 993
                + ++ PE       +   D++S+GVVL E+ + G +P   C G + +D+V  +   
Sbjct: 190  SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YC-GYSNQDVVEMI--- 243
Query: 994  KSEKREVEII----DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048
                R  +++    D   W          +  +  +C ++ P RRP  +++ + L   G
Sbjct: 244  ----RNRQVLPCPDDCPAW----------VYALMIECWNEFPSRRPRFKDIHSRLRAWG 288

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSR 823
           K   +F    I+G G F  V  A  L    + A+K L       E +      E + +SR
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 824 AQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
             H   V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+   
Sbjct: 64  LDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IV 117
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLG 940
             L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  
Sbjct: 118 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSR 823
           K   +F    I+G G F  V  A  L    + A+K L       E +      E + +SR
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 824 AQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
             H   V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+   
Sbjct: 66  LDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IV 119
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLG 940
             L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  
Sbjct: 120 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSR 823
           K   +F    I+G G F  V  A  L    + A+K L       E +      E + +SR
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 824 AQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
             H   V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+   
Sbjct: 67  LDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IV 120
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLG 940
             L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  
Sbjct: 121 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSR 823
           K   +F    I+G G F  V  A  L    + A+K L       E +      E + +SR
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 824 AQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
             H   V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+   
Sbjct: 65  LDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IV 118
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLG 940
             L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 109/242 (45%), Gaps = 28/242 (11%)
Query: 738 PQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATL-TNGT 796
           PQR+S     + L L  +         D     +NF +   IG G  G+V  AT+ ++G 
Sbjct: 8   PQRVSHEQFRAALQLVVDP-------GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGK 57
Query: 797 KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-D 855
             AVK++     Q       EV  +   QH+N+V +      G++  ++  ++E G+L D
Sbjct: 58  LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 117
Query: 856 YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH---IVHRDVKSSNILLDEKFE 912
              H  ++++ +            AA  LA L  +   H   ++HRD+KS +ILL     
Sbjct: 118 IVTHTRMNEEQI------------AAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR 165
Query: 913 AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR 972
             L+DFG    +   +      LVGT  ++ PE    L      D++S G++++E++ G 
Sbjct: 166 VKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224
Query: 973 RP 974
            P
Sbjct: 225 PP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 779 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-- 894
            G++  ++  ++E G+L D   H  ++++ +            AA  LA L  +   H  
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVCLAVLQALSVLHAQ 135
Query: 895 -IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L   
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 954 CRGDVYSFGVVLLELLTGRRP 974
              D++S G++++E++ G  P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 779 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-- 894
            G++  ++  ++E G+L D   H  ++++ +            AA  LA L  +   H  
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVCLAVLQALSVLHAQ 139
Query: 895 -IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L   
Sbjct: 140 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 954 CRGDVYSFGVVLLELLTGRRP 974
              D++S G++++E++ G  P
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPP 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 770 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 825
           ++ +    I+G GG   V+ A  L +    AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 826 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 939
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 770 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 825
           ++ +    I+G GG   V+ A  L +    AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 826 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 939
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 777  NIIGCGGFGLVYKATLTNGTK------AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
            +++G G F  V  A      K       A + L G  G ME E    +  L + +H N+V
Sbjct: 24   DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE----IAVLHKIKHPNIV 79
Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            +L      G    LI   +  G L       V+K    + D    I Q     + YLH +
Sbjct: 80   ALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDASRLIFQ-VLDAVKYLHDL 135
Query: 891  CEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
                IVHRD+K  N+L   LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 136  ---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 190
Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
                 +   D +S GV+   LL G  P      +N   L   + + + E       D+  
Sbjct: 191  AQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDAKLFEQILKAEYE------FDSPY 241
Query: 1008 WH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046
            W    D  K  +  L      +++DP +R   E+ +   W+ G
Sbjct: 242  WDDISDSAKDFIRHL------MEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 777  NIIGCGGFGLVYKATLTNGTK------AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
            +++G G F  V  A      K       A + L G  G ME E    +  L + +H N+V
Sbjct: 24   DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE----IAVLHKIKHPNIV 79
Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            +L      G    LI   +  G L       V+K    + D    I Q     + YLH +
Sbjct: 80   ALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDASRLIFQ-VLDAVKYLHDL 135
Query: 891  CEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
                IVHRD+K  N+L   LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 136  ---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 190
Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
                 +   D +S GV+   LL G  P      +N   L   + + + E       D+  
Sbjct: 191  AQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDAKLFEQILKAEYE------FDSPY 241
Query: 1008 WH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046
            W    D  K  +  L      +++DP +R   E+ +   W+ G
Sbjct: 242  WDDISDSAKDFIRHL------MEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 777  NIIGCGGFGLVYKATLTNGTK------AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
            +++G G F  V  A      K       A + L G  G ME E    +  L + +H N+V
Sbjct: 24   DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE----IAVLHKIKHPNIV 79
Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            +L      G    LI   +  G L       V+K    + D    I Q     + YLH +
Sbjct: 80   ALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDASRLIFQ-VLDAVKYLHDL 135
Query: 891  CEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
                IVHRD+K  N+L   LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 136  ---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 190
Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
                 +   D +S GV+   LL G  P      +N   L   + + + E       D+  
Sbjct: 191  AQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDAKLFEQILKAEYE------FDSPY 241
Query: 1008 WH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046
            W    D  K  +  L      +++DP +R   E+ +   W+ G
Sbjct: 242  WDDISDSAKDFIRHL------MEKDPEKRFTCEQALQHPWIAG 278

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A+   D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 74/278 (26%), Positives = 119/278 (42%), Gaps = 38/278 (13%)
Query: 772  NFNQANIIGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMERE-FQAEVEALSR- 823
            N     ++G G FG V  AT    +K       AVK L       ERE   +E++ +++ 
Sbjct: 46   NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS----------------- 866
              H+N+V+L G C       LI+ Y   G L  +L    +K S                 
Sbjct: 106  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 867  --VLKWDVRLKIAQGAARGLAYLH-KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR- 922
              VL ++  L  A   A+G+ +L  K C    VHRD+ + N+L+       + DFGL+R 
Sbjct: 166  LNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 923  LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE-VCKG 980
            ++   +  V  +    + ++ PE       T + DV+S+G++L E+ + G  P   +   
Sbjct: 222  IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 981  KNCRDLVSWVFQMKS---EKREVEIIDASIWHKDREKQ 1015
             N   L+   F+M        E+ II  S W  D  K+
Sbjct: 282  ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 319

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC-GQMEREFQAEVE-ALSRAQHKNLVSLQGY 835
            +G G +G+V K   + +G   AVKR+      Q ++    +++ ++        V+  G 
Sbjct: 59   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                 D  +    M+  SLD +  + +DK   +  D+  KIA    + L +LH      +
Sbjct: 119  LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 896  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS----QTLT 951
            +HRDVK SN+L++   +  + DFG+S  L   D+   T   G   Y+ PE          
Sbjct: 176  IHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 952  ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKD 1011
             + + D++S G+ ++EL   R P +           SW    +  K+ VE     +    
Sbjct: 234  YSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQL---P 279
Query: 1012 REKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             +K   E ++   +C+ ++ + RP   E++
Sbjct: 280  ADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L   C  Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG+++ 
Sbjct: 138 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQD 193
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 779 IGCGGFGLVYKATLTNGTK---AAVKRLSGDCGQME-REFQAEVEALSRAQHKNLVSLQG 834
           +GCG FG V +       K    A+K L     + +  E   E + + +  +  +V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
            C+     +L+      G L  +L   V K   +      ++    + G+ YL    E +
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLE---EKN 130
Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTLTA 952
            VHRD+ + N+LL  +  A ++DFGLS+ L   D++ T    G   L +  PE       
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 953 TCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
           + R DV+S+GV + E L+ G++P +  KG
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 13  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 878
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 123
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
              + L +LH      ++HRD+KS NILL       L DFG    + P  +  +T +VGT
Sbjct: 124 ECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGT 179
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 85
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 139
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 140 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 769 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-----FQAEVEALS 822
           + ++F+    +G G FG VY A    N    A+K L     Q+E+E      + E+E  S
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVEHQLRREIEIQS 70
Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
             +H N++ +  Y    +DR  IY  +E       L++ + K             +  A 
Sbjct: 71  HLRHPNILRMYNYF---HDRKRIYLMLEFAPRGE-LYKELQKHGRFDEQRSATFMEELAD 126
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGT 938
            L Y H   E  ++HRD+K  N+L+  K E  +ADFG S        H  +     + GT
Sbjct: 127 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGT 176
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           L Y+PPE  +  T   + D++  GV+  E L G  P +
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ--MEREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENI 87
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 24/256 (9%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            +G G FG+V           AVK +  +    E EF  E + + +  H  LV   G C  
Sbjct: 16   LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 839  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-IVH 897
                 ++  Y+ NG L  +L         L+    L++      G+A+L    E H  +H
Sbjct: 75   EYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFL----ESHQFIH 127
Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT---LGYIPPEYSQTLTATC 954
            RD+ + N L+D      ++DFG++R +   D +V++  VGT   + +  PE       + 
Sbjct: 128  RDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSS--VGTKFPVKWSAPEVFHYFKYSS 184
Query: 955  RGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSW---VFQMKSEKREVEIIDASIWHK 1010
            + DV++FG+++ E+ + G+ P ++         VS    +++       +  I  S WH+
Sbjct: 185  KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHE 244
Query: 1011 DREK-----QLLEMLE 1021
              EK     QLL  +E
Sbjct: 245  LPEKRPTFQQLLSSIE 260

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 103
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 157
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 158 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 144
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 144
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 75  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 128
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 129 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 96  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 149
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 150 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 90  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 143
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 144 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 90  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 143
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 144 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 144
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 94  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 147
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 148 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 146
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHK 827
           +F    I+G G F  V  A  L    + A+K L       E +      E + +SR  H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 828 NLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             V L  Y    +D  L +  SY +NG L  ++ +    D       R   A+     L 
Sbjct: 94  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAE-IVSALE 147
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPP 944
           YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT  Y+ P
Sbjct: 148 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E     +A    D+++ G ++ +L+ G  P
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 91
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 145
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 146 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 202
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 83
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 137
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 138 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 779 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-- 894
            G++  ++  ++E G+L D   H  ++++ +            AA  LA L  +   H  
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVCLAVLQALSVLHAQ 189
Query: 895 -IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L   
Sbjct: 190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYG 248
Query: 954 CRGDVYSFGVVLLELLTGRRP 974
              D++S G++++E++ G  P
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPP 269

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 779 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  AT+ ++G   AVK++     Q       EV  +   QH+N+V +     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH-- 894
            G++  ++  ++E G+L D   H  ++++ +            AA  LA L  +   H  
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------AAVCLAVLQALSVLHAQ 144
Query: 895 -IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+KS +ILL       L+DFG    +   +      LVGT  ++ PE    L   
Sbjct: 145 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYG 203
Query: 954 CRGDVYSFGVVLLELLTGRRP 974
              D++S G++++E++ G  P
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPP 224

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 769 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-----FQAEVEALS 822
           + ++F+    +G G FG VY A    N    A+K L     Q+E+E      + E+E  S
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVEHQLRREIEIQS 69
Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
             +H N++ +  Y    +DR  IY  +E       L++ + K             +  A 
Sbjct: 70  HLRHPNILRMYNYF---HDRKRIYLMLEFAPRGE-LYKELQKHGRFDEQRSATFMEELAD 125
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGT 938
            L Y H   E  ++HRD+K  N+L+  K E  +ADFG S        H  +     + GT
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGT 175
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           L Y+PPE  +  T   + D++  GV+  E L G  P +
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 77/315 (24%), Positives = 138/315 (43%), Gaps = 50/315 (15%)
Query: 754  QNSDCKDLTVSDLLKSTNNFNQA-----------NIIGCGGFGLVYKATLTNGTKAAVK- 801
            Q+ D  DL   D  K++++ N+              IG GG   V++         A+K 
Sbjct: 28   QHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 87
Query: 802  -RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY--WL 858
              L     Q    ++ E+  L++ Q  +   ++ Y     D+  IY  ME G++D   WL
Sbjct: 88   VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWL 146
Query: 859  HESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 918
             +   K S+  W+ +          L  +H + +  IVH D+K +N L+ +     L DF
Sbjct: 147  KK---KKSIDPWERK----SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDF 198
Query: 919  GLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTATCRG-----------DVYSFGVVLL 966
            G++  ++P  T V  D  VGT+ Y+PPE  + ++++              DV+S G +L 
Sbjct: 199  GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 967  ELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKC 1026
             +  G+ P +        + +S +  +     E+E  D        EK L ++L+    C
Sbjct: 259  YMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIP------EKDLQDVLKC---C 304
Query: 1027 IDQDPRRRPFIEEVV 1041
            + +DP++R  I E++
Sbjct: 305  LKRDPKQRISIPELL 319

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 139/316 (43%), Gaps = 50/316 (15%)
Query: 754  QNSDCKDLTVSDLLKSTNNFNQA-----------NIIGCGGFGLVYKATLTNGTKAAVK- 801
            Q+ D  DL   D  K++++ N+              IG GG   V++         A+K 
Sbjct: 28   QHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 87
Query: 802  -RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY--WL 858
              L     Q    ++ E+  L++ Q  +   ++ Y     D+  IY  ME G++D   WL
Sbjct: 88   VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWL 146
Query: 859  HESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 918
             +   K S+  W+ +          L  +H + +  IVH D+K +N L+ +     L DF
Sbjct: 147  KK---KKSIDPWERK----SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDF 198
Query: 919  GLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTATCRG-----------DVYSFGVVLL 966
            G++  ++P  T V  D  VGT+ Y+PPE  + ++++              DV+S G +L 
Sbjct: 199  GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 967  ELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKC 1026
             +  G+ P +        + +S +  +     E+E  D        EK L ++L+  C C
Sbjct: 259  YMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIP------EKDLQDVLK--C-C 304
Query: 1027 IDQDPRRRPFIEEVVT 1042
            + +DP++R  I E++ 
Sbjct: 305  LKRDPKQRISIPELLA 320

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 81
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 135
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 136 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 88
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 142
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 143 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 199
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 89
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 143
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 144 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 200
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 80
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 134
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 135 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 191
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 81
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 135
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 136 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 13  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 878
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 123
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
              + L +LH      ++HRD+KS NILL       L DFG    + P  +   +++VGT
Sbjct: 124 ECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSEMVGT 179
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 112/262 (42%), Gaps = 40/262 (15%)
Query: 779  IGCGGFGLVYKATLTNG-TKAAVK----------RLSGDCGQMER---EFQAEVEALSRA 824
            +G G +G V      NG ++ A+K          R S D   +E+   E   E+  L   
Sbjct: 44   LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 825  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
             H N++ L           L+  + E G L     + +++    + D    I +    G+
Sbjct: 104  DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---FEQIINRHKFDECDA-ANIMKQILSGI 159
Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEK---FEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
             YLHK    +IVHRD+K  NILL+ K       + DFGLS        +   D +GT  Y
Sbjct: 160  CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAYY 214
Query: 942  IPPEY-SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
            I PE   +     C  DV+S GV++  LL G  P     G+N +D++  V + K      
Sbjct: 215  IAPEVLKKKYNEKC--DVWSCGVIMYILLCGYPPF---GGQNDQDIIKKVEKGKY----- 264
Query: 1001 EIIDASIWHK--DREKQLLEML 1020
               D + W    D  K+L++++
Sbjct: 265  -YFDFNDWKNISDEAKELIKLM 285

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 42/294 (14%)
Query: 767  LKSTN---NFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQAEVEAL 821
            +++TN    F    ++G G F  V+  K  LT G   A+K +       +   + E+  L
Sbjct: 2    MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 822  SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESV--DKDSVLKWDVRLKIAQ 878
             + +H+N+V+L+          L+   +  G L D  L   V  +KD+ L       + Q
Sbjct: 61   KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQ 113
Query: 879  GAARGLAYLHKVCEPHIVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHVTTDL 935
                 + YLH   E  IVHRD+K  N+L    +E  +  + DFGLS++ +     + +  
Sbjct: 114  QVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTA 167
Query: 936  VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVSWVFQMK 994
             GT GY+ PE       +   D +S GV+   LL G  P  E  + K    +    ++ +
Sbjct: 168  CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE 227
Query: 995  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046
            S            W    E       +  C  +++DP  R   E+ ++  W+DG
Sbjct: 228  S----------PFWDDISES----AKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNL---VSLQ 833
           +G G +G V++ +   G   AVK  S    + E+ +  E E  +    +H+N+   ++  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 834 GYCRHGNDRL-LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH--- 888
              RH + +L LI  Y E GSL DY    ++D  S L+      I    A GLA+LH   
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR------IVLSIASGLAHLHIEI 154
Query: 889 --KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD---LVGTLGYIP 943
                +P I HRD+KS NIL+ +  +  +AD GL+ +       +       VGT  Y+ 
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 944 PEY-SQTLTATC-----RGDVYSFGVVLLELLTGRRPV 975
           PE   +T+   C     R D+++FG+VL E+   RR V
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 250

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 73/313 (23%), Positives = 135/313 (43%), Gaps = 51/313 (16%)
Query: 760  DLTVSDL-LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQ 815
            DL   +L  +S   +    ++G G +G+V K      G   A+K+   S D   +++   
Sbjct: 13   DLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM 72
Query: 816  AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD--YWLHESVDKDSVLKWDVR 873
             E++ L + +H+NLV+L   C+      L++ ++++  LD        +D   V K+  +
Sbjct: 73   REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 874  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
            +        G+ + H     +I+HRD+K  NIL+ +     L DFG +R L      V  
Sbjct: 133  I------INGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYD 182
Query: 934  DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR------------RP 974
            D V T  Y  PE       Y + +      DV++ G ++ E+  G               
Sbjct: 183  DEVATRWYRAPELLVGDVKYGKAV------DVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236
Query: 975  VEVCKGKNCRDLVSWVFQMKSEK------REVEIIDASIWHKDREKQLLEMLEIACKCID 1028
            + +C G    +L+    ++ ++       R  EI +     +   K    ++++A KC+ 
Sbjct: 237  IMMCLG----NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLH 292
Query: 1029 QDPRRRPFIEEVV 1041
             DP +RPF  E++
Sbjct: 293  IDPDKRPFCAELL 305

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 829
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 830 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
               G         +I  Y+  GS LD      +D+  +        I +   +GL YLH
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLH 121
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 947
                  +HRD+K++N+LL E  E  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 122 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 176
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           +      + D++S G+  +EL  G  P
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQHKNL 829
           F +   IG G FG V+K  + N T+  V     D  + E E    Q E+  LS+     +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 830 VSLQGYCRHGNDRLLIYSYMENGS-LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
               G         +I  Y+  GS LD      +D+  +        I +   +GL YLH
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLH 121
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYS 947
                  +HRD+K++N+LL E  E  LADFG++  L   DT +  +  VGT  ++ PE  
Sbjct: 122 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 176
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           +      + D++S G+  +EL  G  P
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR------ 823
             ++  ++IG G   +V +      G + AVK +     ++  E   EV   +R      
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 824 ---AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
              A H ++++L       +   L++  M  G L  +L E V     L       I +  
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSL 209
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              +++LH     +IVHRD+K  NILLD+  +  L+DFG S  L P +     +L GT G
Sbjct: 210 LEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPG 264
Query: 941 YIPPEYSQ-TLTATCRG-----DVYSFGVVLLELLTGRRP 974
           Y+ PE  + ++  T  G     D+++ GV+L  LL G  P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQH 826
           +NF    ++G G FG V  A +   G   AVK L  D    + + +    E   LS A++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 827 KNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
              ++    C    DRL  +  ++  G L + + +S   D       R   A+     L 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAE-IISALM 138
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGTLGYIPP 944
           +LH   +  I++RD+K  N+LLD +    LADFG+ +        VTT    GT  YI P
Sbjct: 139 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV 977
           E  Q +      D ++ GV+L E+L G  P E 
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQI------LRGL 141
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 12/161 (7%)
Query: 817 EVEALSRAQHKNLVSLQGYCRHGNDRLLIY--SYMENGSLDYWLHESVDKDSVLKWDVRL 874
           E + +SR  H   V L  Y    +D  L +  SY +NG L  ++ +    D       R 
Sbjct: 80  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRF 134
Query: 875 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 934
             A+     L YLH      I+HRD+K  NILL+E     + DFG +++L P       +
Sbjct: 135 YTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 935 -LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             VGT  Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 41/222 (18%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNL---VSLQ 833
           +G G +G V++ +   G   AVK  S    + E+ +  E E  +    +H+N+   ++  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 834 GYCRHGNDRL-LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH--- 888
              RH + +L LI  Y E GSL DY    ++D  S L+      I    A GLA+LH   
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR------IVLSIASGLAHLHIEI 125
Query: 889 --KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-------VGTL 939
                +P I HRD+KS NIL+ +  +  +AD GL+ +     +  T  L       VGT 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGNNPRVGTK 181
Query: 940 GYIPPEY-SQTLTATC-----RGDVYSFGVVLLELLTGRRPV 975
            Y+ PE   +T+   C     R D+++FG+VL E+   RR V
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 41/222 (18%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNL---VSLQ 833
           +G G +G V++ +   G   AVK  S    + E+ +  E E  +    +H+N+   ++  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 834 GYCRHGNDRL-LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH--- 888
              RH + +L LI  Y E GSL DY    ++D  S L+      I    A GLA+LH   
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR------IVLSIASGLAHLHIEI 125
Query: 889 --KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-------VGTL 939
                +P I HRD+KS NIL+ +  +  +AD GL+ +     +  T  L       VGT 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGNNPRVGTK 181
Query: 940 GYIPPEY-SQTLTATC-----RGDVYSFGVVLLELLTGRRPV 975
            Y+ PE   +T+   C     R D+++FG+VL E+   RR V
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 769 STNNFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQ---AEVEALSRA 824
              +F    ++G G FG V+ A      +  A+K L  D   M+ + +    E   LS A
Sbjct: 16  KIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 825 -QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA-- 881
            +H  L  +    +   +   +  Y+  G L Y +       S  K+D+       A   
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ------SCHKFDLSRATFYAAEII 129
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            GL +LH      IV+RD+K  NILLD+     +ADFG+ +     D   T +  GT  Y
Sbjct: 130 LGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGTPDY 185
Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           I PE           D +SFGV+L E+L G+ P
Sbjct: 186 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQG 834
           +G G FG V  AT      K A+K +S        M    + E+  L   +H +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                 D +++  Y      DY     V+K  + + + R +  Q     + Y H+     
Sbjct: 77  VITTPTDIVMVIEYAGGELFDY----IVEKKRMTEDEGR-RFFQQIICAIEYCHR---HK 128
Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY-SQTLTAT 953
           IVHRD+K  N+LLD+     +ADFGLS ++   D +      G+  Y  PE  +  L A 
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 954 CRGDVYSFGVVLLELLTGRRPVE 976
              DV+S G+VL  +L GR P +
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 827
           ++   + +   +G GGF   Y+ T  +  +    ++      + +  Q E  +   A HK
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK-SMLLKPHQKEKMSTEIAIHK 97
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR---- 882
           +L +      HG        + E+    Y + E   + S+L+   R K + +  AR    
Sbjct: 98  SLDNPHVVGFHG--------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 883 ----GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               G+ YLH      ++HRD+K  N+ L++  +  + DFGL+  +  +D     DL GT
Sbjct: 150 QTIQGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKDLCGT 205
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             YI PE       +   D++S G +L  LL G+ P E
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 827
           ++   + +   +G GGF   Y+ T  +  +    ++      + +  Q E  +   A HK
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK-SMLLKPHQKEKMSTEIAIHK 81
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR---- 882
           +L +      HG        + E+    Y + E   + S+L+   R K + +  AR    
Sbjct: 82  SLDNPHVVGFHG--------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 133
Query: 883 ----GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               G+ YLH      ++HRD+K  N+ L++  +  + DFGL+  +  +D     DL GT
Sbjct: 134 QTIQGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKDLCGT 189
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             YI PE       +   D++S G +L  LL G+ P E
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 19/215 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEVEALSRAQH 826
            +F    +IG G FG V    L N  K    ++      ++R     F+ E + L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
           K + +L    +  N+  L+  Y   G L   L  S  +D + +   R  +A+     +  
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVI-AIDS 190
Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
           +H++   H VHRD+K  NIL+D      LADFG    L    T  ++  VGT  YI PE 
Sbjct: 191 VHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 947 SQTLTA-------TCRGDVYSFGVVLLELLTGRRP 974
            Q +          C  D +S GV + E+L G  P
Sbjct: 248 LQAMEGGKGRYGPEC--DWWSLGVCMYEMLYGETP 280

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A++++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 38/239 (15%)
Query: 754 QNSDCKDLTVSDLLKSTNNFNQAN---IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ 809
           +  DC+    SDLL+    +++     ++G G +G+VY    L+N  + A+K +     +
Sbjct: 6   EEGDCE----SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR 61
Query: 810 MEREFQAEVEALSRAQHKNLVSLQG-YCRHGNDRLLIYSYMEN---GSLDYWLHES---- 861
             +    E+      +HKN+V   G +  +G     I  +ME    GSL   L       
Sbjct: 62  YSQPLHEEIALHKHLKHKNIVQYLGSFSENG----FIKIFMEQVPGGSLSALLRSKWGPL 117
Query: 862 VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGL 920
            D +  + +  +  +      GL YLH   +  IVHRD+K  N+L++       ++DFG 
Sbjct: 118 KDNEQTIGFYTKQIL-----EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGT 169
Query: 921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 974
           S+ L   +   T    GTL Y+ PE    +    RG     D++S G  ++E+ TG+ P
Sbjct: 170 SKRLAGINP-CTETFTGTLQYMAPE---IIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 770 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 825
           ++ +    I+G GG   V+ A  L      AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 826 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 939
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 770 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 825
           ++ +    I+G GG   V+ A  L      AVK L  D  +       F+ E +  +   
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 826 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 143
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 939
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 144 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 770 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 825
           ++ +    I+G GG   V+ A  L      AVK L  D  +       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 826 HKNLVSL----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           H  +V++    +     G    ++  Y++  +L     + V  +  +     +++   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHTEGPMTPKRAIEVIADAC 126
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTL 939
           + L + H   +  I+HRDVK +NI++       + DFG++R +      VT    ++GT 
Sbjct: 127 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            Y+ PE ++  +   R DVYS G VL E+LTG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 776 ANIIGCGGFGLVY--KATLTNGTKAAVKRLSGD-------CGQMEREFQAEVEALSRAQH 826
            + +G G FG V   +  LT G K AVK L+          G+++RE Q     L   +H
Sbjct: 16  GDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQN----LKLFRH 70
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            +++ L        D  ++  Y+  G L DY          V + + R ++ Q     + 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG----RVEEMEAR-RLFQQILSAVD 125
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H+     +VHRD+K  N+LLD    A +ADFGLS ++   D     D  G+  Y  PE
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRDSCGSPNYAAPE 180
Query: 946 Y-SQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             S  L A    D++S GV+L  LL G  P +
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/111 (38%), Positives = 56/111 (50%), Gaps = 11/111 (9%)
Query: 875 KIAQGAARGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
           K+     + L YL    E H ++HRDVK SNILLDE+ +  L DFG+S  L   D     
Sbjct: 128 KMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKD 182
Query: 934 DLVGTLGYIPPEYSQTLTAT-----CRGDVYSFGVVLLELLTGRRPVEVCK 979
              G   Y+ PE       T      R DV+S G+ L+EL TG+ P + CK
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 14  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 70
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 878
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 124
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
              + L +LH      ++HRD+KS NILL       L DFG    + P  +   + +VGT
Sbjct: 125 ECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSXMVGT 180
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 13  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 878
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 123
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
              + L +LH      ++HRD+KS NILL       L DFG    + P  +   + +VGT
Sbjct: 124 ECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSXMVGT 179
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKN 828
           +N     +IG G +G VYK +L +    AVK  S    Q    F  +  +  +   +H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDN 68
Query: 829 LVS-LQGYCRHGND----RLLIYSYMENGSLDYWL--HESVDKDSVLKWDVRLKIAQGAA 881
           +   + G  R   D     LL+  Y  NGSL  +L  H S        W    ++A    
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-------DWVSSCRLAHSVT 121
Query: 882 RGLAYLHKVC------EPHIVHRDVKSSNILLDEKFEAHLADFGLS------RLLRP-YD 928
           RGLAYLH         +P I HRD+ S N+L+       ++DFGLS      RL+RP  +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 929 THVTTDLVGTLGYIPPEYSQTL-------TATCRGDVYSFGVVLLELL 969
            +     VGT+ Y+ PE  +         +A  + D+Y+ G++  E+ 
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 16   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 837  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 76   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 127
Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 953
            IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+PPE  + ++++
Sbjct: 128  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 186
Query: 954  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 187  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 241
Query: 1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 242  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 271

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 761 LTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVE 819
           ++V D  K    F +   IG G  G VY A  +  G + A+++++      +     E+ 
Sbjct: 14  VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 70
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQ 878
            +   ++ N+V+       G++  ++  Y+  GSL   + E+ +D+  +        + +
Sbjct: 71  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCR 124
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
              + L +LH      ++HR++KS NILL       L DFG    + P  +  +T +VGT
Sbjct: 125 ECLQALEFLHS---NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGT 180
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             ++ PE         + D++S G++ +E++ G  P
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I +Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 27/234 (11%)
Query: 773 FNQANIIGCGGFGLVYKATLTNGT------------KAAVKRLSGDCGQMEREFQAEVEA 820
           F    ++G GG+G V++     G             KA + R + D        +AE   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT----KAERNI 74
Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
           L   +H  +V L    + G    LI  Y+  G L   L    +++ +   D         
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEI 130
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
           +  L +LH   +  I++RD+K  NI+L+ +    L DFGL +    +D  VT    GT+ 
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIE 186
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           Y+ PE           D +S G ++ ++LTG  P     G+N +  +  + + K
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILKCK 237

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 771 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA- 824
            +F+   +IG G +  V      K       K   K L  D   ++   Q E     +A 
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 63
Query: 825 QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
            H  LV L   C     RL  +  Y+  G L + +     +  + +   R   A+  +  
Sbjct: 64  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAE-ISLA 118
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 942
           L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT  T+   GT  YI
Sbjct: 119 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 173
Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKSEKR 998
            PE  +        D ++ GV++ E++ GR P ++    +  D     ++FQ+  EK+
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 231

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 27/234 (11%)
Query: 773 FNQANIIGCGGFGLVYKATLTNGT------------KAAVKRLSGDCGQMEREFQAEVEA 820
           F    ++G GG+G V++     G             KA + R + D        +AE   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT----KAERNI 74
Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
           L   +H  +V L    + G    LI  Y+  G L   L    +++ +   D         
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEI 130
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
           +  L +LH   +  I++RD+K  NI+L+ +    L DFGL +    +D  VT    GT+ 
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIE 186
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           Y+ PE           D +S G ++ ++LTG  P     G+N +  +  + + K
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILKCK 237

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 36   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 837  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 96   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 147
Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 953
            IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+PPE  + ++++
Sbjct: 148  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 954  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 207  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 261
Query: 1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 262  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 291

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 778  IIGCGGFGLVYKATLTN--GTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
            I+G G FG VY+   TN  G K   AVK    DC    +E F +E   +    H ++V L
Sbjct: 31   ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 833  QGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAYLHK 889
             G        ++  +Y Y   G L ++L  + +   VL   +  L+I     + +AYL  
Sbjct: 91   IGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES 143
Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
            +   + VHRD+   NIL+       L DFGLSR +   D +  +     + ++ PE    
Sbjct: 144  I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 950  LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008
               T   DV+ F V + E+L+ G++P    + K+    V  V +      + ++    ++
Sbjct: 201  RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEKGDRLPKPDLCPPVLY 256
Query: 1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                         +  +C D DP  RP   E+V  L  +
Sbjct: 257  ------------TLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 778  IIGCGGFGLVYKATLTN--GTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
            I+G G FG VY+   TN  G K   AVK    DC    +E F +E   +    H ++V L
Sbjct: 15   ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 833  QGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAYLHK 889
             G        ++  +Y Y   G L ++L  + +   VL   +  L+I     + +AYL  
Sbjct: 75   IGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES 127
Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
            +   + VHRD+   NIL+       L DFGLSR +   D +  +     + ++ PE    
Sbjct: 128  I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 950  LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008
               T   DV+ F V + E+L+ G++P    + K+    V  V +      + ++    ++
Sbjct: 185  RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEKGDRLPKPDLCPPVLY 240
Query: 1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                         +  +C D DP  RP   E+V  L  +
Sbjct: 241  ------------TLMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 778  IIGCGGFGLVYKATLTN--GTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
            I+G G FG VY+   TN  G K   AVK    DC    +E F +E   +    H ++V L
Sbjct: 19   ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 833  QGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAYLHK 889
             G        ++  +Y Y   G L ++L  + +   VL   +  L+I     + +AYL  
Sbjct: 79   IGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES 131
Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
            +   + VHRD+   NIL+       L DFGLSR +   D +  +     + ++ PE    
Sbjct: 132  I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 950  LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008
               T   DV+ F V + E+L+ G++P    + K+    V  V +      + ++    ++
Sbjct: 189  RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLEKGDRLPKPDLCPPVLY 244
Query: 1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                         +  +C D DP  RP   E+V  L  +
Sbjct: 245  ------------TLMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 771 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA- 824
            +F+   +IG G +  V      K       K   K L  D   ++   Q E     +A 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 67
Query: 825 QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
            H  LV L   C     RL  +  Y+  G L + +     +  + +   R   A+  +  
Sbjct: 68  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAE-ISLA 122
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 942
           L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT  T+   GT  YI
Sbjct: 123 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 177
Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKSEKR 998
            PE  +        D ++ GV++ E++ GR P ++    +  D     ++FQ+  EK+
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 103
Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           + +    R      +   Y+    +   L++ + K   L  D          RGL Y+H 
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYIPPEYS 947
               +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y  PE  
Sbjct: 163 A---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 948 QTLTATCRG-DVYSFGVVLLELLTGR 972
                  +  D++S G +L E+L+ R
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 138/316 (43%), Gaps = 50/316 (15%)
Query: 754  QNSDCKDLTVSDLLKSTNNFNQA-----------NIIGCGGFGLVYKATLTNGTKAAVK- 801
            Q+ D  DL   D  K++++ N+              IG GG   V++         A+K 
Sbjct: 28   QHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 87
Query: 802  -RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDY--WL 858
              L     Q    ++ E+  L++ Q  +   ++ Y     D+  IY  ME G++D   WL
Sbjct: 88   VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWL 146
Query: 859  HESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 918
             +   K S+  W+ +          L  +H + +  IVH D+K +N L+ +     L DF
Sbjct: 147  KK---KKSIDPWERK----SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDF 198
Query: 919  GLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTATCRG-----------DVYSFGVVLL 966
            G++  ++P  T V  D  VG + Y+PPE  + ++++              DV+S G +L 
Sbjct: 199  GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 967  ELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKC 1026
             +  G+ P +        + +S +  +     E+E  D        EK L ++L+  C C
Sbjct: 259  YMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIP------EKDLQDVLK--C-C 304
Query: 1027 IDQDPRRRPFIEEVVT 1042
            + +DP++R  I E++ 
Sbjct: 305  LKRDPKQRISIPELLA 320

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 20   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 837  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 80   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 131
Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 953
            IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+PPE  + ++++
Sbjct: 132  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 190
Query: 954  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 191  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 245
Query: 1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 246  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 275

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG VYKA        AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
           + N+  ++  +   G++D  + E   +  + +  +++ + +     L YLH   +  I+H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQV-VCKQTLDALNYLH---DNKIIH 158
Query: 898 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
           RD+K+ NIL     +  LADFG+S    R ++  D+      +GT  ++ PE     T+ 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS-----FIGTPYWMAPEVVMCETSK 213
Query: 954 CR-----GDVYSFGVVLLELLTGRRP 974
            R      DV+S G+ L+E+     P
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 759 KDLTVSDLLK-STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCG-QM 810
           K  ++SDL +    N      +G G FG VY+  ++      +  + AVK L      Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQD 91
Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK----DS 866
           E +F  E   +S+  H+N+V   G       R ++   M  G L  +L E+  +     S
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSR- 922
           +   D+ L +A+  A G  YL    E H +HRD+ + N LL        A + DFG++R 
Sbjct: 152 LAMLDL-LHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           + R          +  + ++PPE       T + D +SFGV+L E+ +
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLT--------NGTKAAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A                AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGA------- 880
           +++L G C       +I  Y   G+L  +L           +D+ R+   Q         
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 881 ----ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 17   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 837  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 77   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 128
Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 953
            IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+PPE  + ++++
Sbjct: 129  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 954  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 188  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 242
Query: 1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 243  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 272

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG VYKA        AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
           + N+  ++  +   G++D  + E   +  + +  +++ + +     L YLH   +  I+H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQV-VCKQTLDALNYLH---DNKIIH 158
Query: 898 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
           RD+K+ NIL     +  LADFG+S    R ++  D+      +GT  ++ PE     T+ 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYWMAPEVVMCETSK 213
Query: 954 CR-----GDVYSFGVVLLELLTGRRP 974
            R      DV+S G+ L+E+     P
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 11/203 (5%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME-REFQAEVEALSRAQH-KNLVSLQGY 835
           IG G +G V K     +G   AVKR+     + E ++   +++ + R+     +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                D  +    M      ++ +     D V+  ++  KI     + L +L +  +  I
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--I 147
Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT-- 953
           +HRD+K SNILLD      L DFG+S  L   D+   T   G   Y+ PE      +   
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 954 --CRGDVYSFGVVLLELLTGRRP 974
              R DV+S G+ L EL TGR P
Sbjct: 206 YDVRSDVWSLGITLYELATGRFP 228

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV-TTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 141
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H     + V T  Y 
Sbjct: 142 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 198
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L R +H+N+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 88
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 142
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H     + V T  Y 
Sbjct: 143 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 199
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 771 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA- 824
            +F+   +IG G +  V      K       K   K L  D   ++   Q E     +A 
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 78
Query: 825 QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
            H  LV L   C     RL  +  Y+  G L + +     +  + +   R   A+  +  
Sbjct: 79  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAE-ISLA 133
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 942
           L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT  T+   GT  YI
Sbjct: 134 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 188
Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKSEKR 998
            PE  +        D ++ GV++ E++ GR P ++    +  D     ++FQ+  EK+
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 246

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWL--------HESVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D    TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L   +H+N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENI 85
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 139
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 140 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG VYKA        AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
           + N+  ++  +   G++D  + E   +  + +  +++ + +     L YLH   +  I+H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQV-VCKQTLDALNYLH---DNKIIH 158
Query: 898 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
           RD+K+ NIL     +  LADFG+S    R ++  D       +GT  ++ PE     T+ 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDX-----FIGTPYWMAPEVVMCETSK 213
Query: 954 CR-----GDVYSFGVVLLELLTGRRP 974
            R      DV+S G+ L+E+     P
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 44/223 (19%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVKRLSGDCGQMEREFQA-------EVE 819
           S + + +   +G G +G VYKA  T+TN T  A+KR+     ++E E +        EV 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNET-VAIKRI-----RLEHEEEGVPGTAIREVS 85
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
            L   QH+N++ L+    H +   LI+ Y EN      L + +DK+  +   V       
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-----LKKYMDKNPDVSMRVIKSFLYQ 140
Query: 880 AARGLAYLH-KVCEPHIVHRDVKSSNILL-----DEKFEAHLADFGLSRLLRPYDTHVTT 933
              G+ + H + C    +HRD+K  N+LL      E     + DFGL+R         T 
Sbjct: 141 LINGVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 934 DLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELL 969
           +++ TL Y PPE       YS ++      D++S   +  E+L
Sbjct: 197 EII-TLWYRPPEILLGSRHYSTSV------DIWSIACIWAEML 232

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 111/229 (48%), Gaps = 20/229 (8%)
Query: 771 NNFNQANIIGCGGFGLVYK--ATLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
             + + + +G G +  VYK  + LT+   A  + RL  + G      + EV  L   +H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 60
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLA 885
           N+V+L           L++ Y     LD  L + +D   + +   +V+L + Q   RGLA
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQ-LLRGLA 114
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H+     ++HRD+K  N+L++E+ E  LADFGL+R  +   T    + V TL Y PP+
Sbjct: 115 YCHR---QKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPD 170
Query: 946 YSQTLT-ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
                T  + + D++  G +  E+ TGR    +  G    + + ++F++
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR---PLFPGSTVEEQLHFIFRI 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 21/200 (10%)
Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG VYKA     G  AA K +     +   ++  E+E L+   H  +V L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
           H     ++  +   G++D  + E +D+  + +  +++ + +     L +LH      I+H
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLE-LDR-GLTEPQIQV-VCRQMLEALNFLH---SKRIIH 132
Query: 898 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPE--YSQTLT 951
           RD+K+ N+L+  + +  LADFG+S    + L+  D+      +GT  ++ PE    +T+ 
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-----FIGTPYWMAPEVVMCETMK 187
Query: 952 AT---CRGDVYSFGVVLLEL 968
            T    + D++S G+ L+E+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 21/200 (10%)
Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG VYKA     G  AA K +     +   ++  E+E L+   H  +V L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
           H     ++  +   G++D  + E +D+  + +  +++ + +     L +LH      I+H
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLE-LDR-GLTEPQIQV-VCRQMLEALNFLH---SKRIIH 140
Query: 898 RDVKSSNILLDEKFEAHLADFGLS----RLLRPYDTHVTTDLVGTLGYIPPE--YSQTLT 951
           RD+K+ N+L+  + +  LADFG+S    + L+  D+      +GT  ++ PE    +T+ 
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-----FIGTPYWMAPEVVMCETMK 195
Query: 952 AT---CRGDVYSFGVVLLEL 968
            T    + D++S G+ L+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D    TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 84
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 143
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 144 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 198
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 88
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 147
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 148 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 202
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 69/237 (29%), Positives = 106/237 (44%), Gaps = 40/237 (16%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L       +R+FQ E++ L +A H + +   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKY 76
Query: 834 GYCRHGNDRL---LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
               +G  R    L+  Y+ +G L         +D + +   RL     A+R L Y  ++
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCL---------RDFLQRHRARLD----ASRLLLYSSQI 123
Query: 891 CE-------PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLG 940
           C+          VHRD+ + NIL++ +    +ADFGL++LL P D     V       + 
Sbjct: 124 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIF 182
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 997
           +  PE       + + DV+SFGVVL EL T       C  K+C     ++  M SE+
Sbjct: 183 WYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCD-KSCSPSAEFLRMMGSER 232

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           ++ L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 771 NNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA- 824
            +F+   +IG G +  V      K       +   K L  D   ++   Q E     +A 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDW-VQTEKHVFEQAS 110
Query: 825 QHKNLVSLQGYCRHGNDRLL-IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
            H  LV L   C     RL  +  Y+  G L + +     +  + +   R   A+  +  
Sbjct: 111 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAE-ISLA 165
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTTDLVGTLGYI 942
           L YLH   E  I++RD+K  N+LLD +    L D+G+ +  LRP DT  T+   GT  YI
Sbjct: 166 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYI 220
Query: 943 PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKSEKR 998
            PE  +        D ++ GV++ E++ GR P ++    +  D     ++FQ+  EK+
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 80
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 139
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 140 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 194
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 95
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 154
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 155 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 209
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 773 FNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQM--EREFQAEVEALSRAQHKNL 829
           +   + IG G +G+V  A    N  + A+K++S    Q   +R  + E++ L   +H+N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENI 85
Query: 830 VSLQGYCR-----HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +    R        D  ++   ME         + +  D +  +  ++       RGL
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------LRGL 139
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTLGYI 942
            Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y 
Sbjct: 140 KYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 943 PPEYSQTLTATCRG-DVYSFGVVLLELLTGR 972
            PE         +  D++S G +L E+L+ R
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 155
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 214
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 215 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 269
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 270 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 76
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 190
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 107/257 (41%), Gaps = 43/257 (16%)
Query: 761 LTVSDLLKSTN-----------NFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSG 805
           LTV   L++ N           NF    ++G G +G V+     +G       A+K L  
Sbjct: 33  LTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK 92
Query: 806 DC----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHE 860
                  +     + E + L   +    +    Y      +L LI  Y+  G L  + H 
Sbjct: 93  ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHL 150
Query: 861 SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL 920
           S  ++   + +V++ + +     L +LHK+    I++RD+K  NILLD      L DFGL
Sbjct: 151 S-QRERFTEHEVQIYVGE-IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG---------DVYSFGVVLLELLTG 971
           S+     +T    D  GT+ Y+ P+         RG         D +S GV++ ELLTG
Sbjct: 206 SKEFVADETERAYDFCGTIEYMAPD-------IVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 972 RRPVEVCKGKNCRDLVS 988
             P  V   KN +  +S
Sbjct: 259 ASPFTVDGEKNSQAEIS 275

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 779 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQ-----MEREFQAEVEALSRAQHKNLVSL 832
           IG G FG V+   L  + T  AVK     C +     ++ +F  E   L +  H N+V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            G C       ++   ++ G    +L     + + L+    L++   AA G+ YL   C 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 947
              +HRD+ + N L+ EK    ++DFG+SR     +        G L  +P     PE  
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 948 QTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 988
                +   DV+SFG++L E  + G  P      +  R+ V 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC-GQMEREFQAEVE-ALSRAQHKNLVSLQGY 835
            +G G +G+V K   + +G   AVKR+      Q ++    +++ ++        V+  G 
Sbjct: 15   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                 D  +    M+  SLD +  + +DK   +  D+  KIA    + L +LH   +  +
Sbjct: 75   LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSV 131
Query: 896  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-VGTLGYIPPEYS----QTL 950
            +HRDVK SN+L++   +  + DFG+S  L      V  D+  G   Y+ PE         
Sbjct: 132  IHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 951  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
              + + D++S G+ ++EL   R P +           SW    +  K+ VE     +   
Sbjct: 189  GYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQL--- 234
Query: 1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
              +K   E ++   +C+ ++ + RP   E++
Sbjct: 235  PADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 89
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 148
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 149 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 203
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 204 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 24/217 (11%)
Query: 769 STNNFNQANIIGCGGFGLVY-----KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR 823
           + ++F     +G G FG VY     K+      K   K      G +E + + E+E  + 
Sbjct: 21  TIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG-VEHQLRREIEIQAH 79
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
             H N++ L  Y        LI  Y   G L    ++ + K           I +  A  
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFDEQRTATIMEELADA 135
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT----DLVGTL 939
           L Y H      ++HRD+K  N+LL  K E  +ADFG S        H  +     + GTL
Sbjct: 136 LMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWS-------VHAPSLRRKTMCGTL 185
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
            Y+PPE  +      + D++  GV+  ELL G  P E
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 769 STNNFNQANIIGCGGFGLVYKATL--TNGTKAAVKRLSGDCGQMEREFQA--EVEALSRA 824
           + N F Q  ++G GGFG V    +  T    A  K       + + E  A  E + L + 
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 825 QHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA--- 880
             + +VSL  Y     D L L+ + M  G L + ++                + Q     
Sbjct: 242 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH---------------MGQAGFPE 285
Query: 881 ARGLAYLHKVC-------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
           AR + Y  ++C          IV+RD+K  NILLD+     ++D GL+  +   +     
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK 343
Query: 934 DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
             VGT+GY+ PE  +    T   D ++ G +L E++ G+ P +  K K  R+ V 
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 110
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 169
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 224
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 81
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 140
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 141 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 195
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 196 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 88
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 147
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 148 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 202
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 104
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 163
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 164 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 218
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 219 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 114
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 173
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 174 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 228
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 229 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 112
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 171
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 172 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 226
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 227 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D     RE Q     + +  H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 110
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 169
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 224
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 31/243 (12%)
Query: 811  EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW 870
            E   + E+  L + +H+N+V+L+      N   L+   +  G L       V+K    + 
Sbjct: 64   ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL---FDRIVEKGFYTEK 120
Query: 871  DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPY 927
            D    I Q     + YLH++    IVHRD+K  N+L    DE+ +  ++DFGLS++    
Sbjct: 121  DASTLIRQ-VLDAVYYLHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG 176
Query: 928  DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 987
            D  V +   GT GY+ PE       +   D +S GV+   LL G  P      +N   L 
Sbjct: 177  D--VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDSKLF 231
Query: 988  SWVFQMKSEKREVEIIDASIWH--KDREKQLLEMLEIACKCIDQDPRRRPFIEEVV--TW 1043
              + + + E       D+  W    D  K  +  L      +++DP +R   E+     W
Sbjct: 232  EQILKAEYE------FDSPYWDDISDSAKDFIRNL------MEKDPNKRYTCEQAARHPW 279
Query: 1044 LDG 1046
            + G
Sbjct: 280  IAG 282

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L       +R+FQ E++ L +A H + +   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKY 73
Query: 834 GYCRHGNDR---LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
               +G  R    L+  Y+ +G L         +D + +   RL     A+R L Y  ++
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCL---------RDFLQRHRARLD----ASRLLLYSSQI 120
Query: 891 CE-------PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           C+          VHRD+ + NIL++ +    +ADFGL++LL P D      +V   G  P
Sbjct: 121 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDXX--VVREPGQSP 177
Query: 944 -----PEYSQTLTATCRGDVYSFGVVLLELLT 970
                PE       + + DV+SFGVVL EL T
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 779 IGCGGFGLVYKATLTNGTK--------AAVKRLSGDCGQME-REFQAEVEALSR-AQHKN 828
           +G G FG V  A      K         AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------SVDKDSVLKWDVRLK----I 876
           +++L G C       +I  Y   G+L  +L          S D + V +  +  K     
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDL 935
               ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +  TT+ 
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
              + ++ PE       T + DV+SFGV++ E+ T
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L       +R+FQ E++ L +A H + +   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKY 89
Query: 834 GYCRHGNDRL---LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
               +G  R    L+  Y+ +G L         +D + +   RL     A+R L Y  ++
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCL---------RDFLQRHRARLD----ASRLLLYSSQI 136
Query: 891 CE-------PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLG 940
           C+          VHRD+ + NIL++ +    +ADFGL++LL P D     V       + 
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIF 195
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           +  PE       + + DV+SFGVVL EL T
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G +G V+      G K AVK   + +     RE +     L R  H+N++       
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMR--HENILGFIAADI 101
Query: 838 HGN----DRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC- 891
            G        LI  Y ENGSL DY    ++D  S+LK      +A  +  GL +LH    
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLK------LAYSSVSGLCHLHTEIF 155
Query: 892 ----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT---TDLVGTLGYIPP 944
               +P I HRD+KS NIL+ +     +AD GL+         V       VGT  Y+PP
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 945 EY------SQTLTATCRGDVYSFGVVLLELLTGRRPV 975
           E            +    D+YSFG++L E+   RR V
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCV 250

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 114/246 (46%), Gaps = 26/246 (10%)
Query: 756 SDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA-----AVKRLSGDCGQM 810
           S+  +  ++ + K T    +  ++G G FG V+K       ++      +K +    G+ 
Sbjct: 17  SEKANKVLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR- 74
Query: 811 EREFQAEVE---ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDK 864
            + FQA  +   A+    H ++V L G C  G+   L+  Y+  GSL   + +   ++  
Sbjct: 75  -QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGP 132
Query: 865 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL 924
             +L W V++      A+G+ YL    E  +VHR++ + N+LL    +  +ADFG++ LL
Sbjct: 133 QLLLNWGVQI------AKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 183
Query: 925 RPYDTHVTTDLVGT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
            P D  +      T + ++  E       T + DV+S+GV + EL+T G  P    +   
Sbjct: 184 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 243
Query: 983 CRDLVS 988
             DL+ 
Sbjct: 244 VPDLLE 249

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 779 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQ-----MEREFQAEVEALSRAQHKNLVSL 832
           IG G FG V+   L  + T  AVK     C +     ++ +F  E   L +  H N+V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            G C       ++   ++ G    +L     + + L+    L++   AA G+ YL   C 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 947
              +HRD+ + N L+ EK    ++DFG+SR     +        G L  +P     PE  
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 948 QTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 988
                +   DV+SFG++L E  + G  P      +  R+ V 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKXQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 779 IGCGGFGLV----YKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V    Y     N G   AVK+L       +R+FQ E++ L +A H + +   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKY 77
Query: 834 GYCRHGNDRL---LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
               +G  R    L+  Y+ +G L         +D + +   RL     A+R L Y  ++
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCL---------RDFLQRHRARLD----ASRLLLYSSQI 124
Query: 891 CE-------PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH---VTTDLVGTLG 940
           C+          VHRD+ + NIL++ +    +ADFGL++LL P D     V       + 
Sbjct: 125 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIF 183
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
           +  PE       + + DV+SFGVVL EL T
Sbjct: 184 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 769 STNNFNQANIIGCGGFGLVYKATL--TNGTKAAVKRLSGDCGQMEREFQA--EVEALSRA 824
           + N F Q  ++G GGFG V    +  T    A  K       + + E  A  E + L + 
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 825 QHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA--- 880
             + +VSL  Y     D L L+ + M  G L + ++                + Q     
Sbjct: 242 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH---------------MGQAGFPE 285
Query: 881 ARGLAYLHKVC-------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
           AR + Y  ++C          IV+RD+K  NILLD+     ++D GL+  +   +     
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK 343
Query: 934 DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
             VGT+GY+ PE  +    T   D ++ G +L E++ G+ P +  K K  R+ V 
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++   F   + DFG++R +   D +      G  G +P  
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 197
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLEL 968
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++   F   + DFG++R +   D        G  G +P  
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 197
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLEL 968
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++   F   + DFG++R +   D        G  G +P  
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 197
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLEL 968
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 836
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 837 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 159
Query: 892 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 941
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 217
Query: 942 IPPEY------SQTLTATCRGDVYSFGVVLLEL 968
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 770 TNNFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 824
           ++ +    ++G G FG V   K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++ L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDA-ARIIRQVLSGI 139
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            Y+HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYY 194
Query: 942 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 989
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 195 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 32/287 (11%)
Query: 763  VSDLLKSTNNFNQANIIGCGGFGLVYKATLT--NGT--KAAVKRLSGD-CGQME-REFQA 816
            + D++   N      I+G G FG V +  L   +GT  K AVK +  D   Q E  EF +
Sbjct: 26   LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 817  EVEALSRAQHKNLVSLQGYCRHGNDR-----LLIYSYMENGSL-DYWLHESVDKDSV-LK 869
            E   +    H N++ L G C   + +     ++I  +M+ G L  Y L+  ++     + 
Sbjct: 86   EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 870  WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 929
                LK     A G+ YL      + +HRD+ + N +L +     +ADFGLS+ +   D 
Sbjct: 146  LQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 930  HVTTDLVGT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
            +    +    + +I  E       T + DV++FGV + E+ T  R +    G    ++  
Sbjct: 203  YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYD 260
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035
            ++      K+  + +D             E+ EI   C   DP  RP
Sbjct: 261  YLLHGHRLKQPEDCLD-------------ELYEIMYSCWRTDPLDRP 294

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 61/242 (25%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 828
           +G G +G V  A    +G K A+K+LS       R FQ+E+ A         L   QH+N
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYW-LHESVDKDSVLKWDVRLKIAQGAA 881
           ++ L          R+  D  L+  +M+        L  S +K   L + +         
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM--------L 136
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---T 938
           +GL Y+H      +VHRD+K  N+ ++E  E  + DFGL+R       H   ++ G   T
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVT 186
Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 991
             Y  PE       Y+QT+      D++S G ++ E+LTG+    + KGK+  D ++ + 
Sbjct: 187 RWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK---TLFKGKDYLDQLTQIL 237
Query: 992 QM 993
           ++
Sbjct: 238 KV 239

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 61/242 (25%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 828
           +G G +G V  A    +G K A+K+LS       R FQ+E+ A         L   QH+N
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHE-SVDKDSVLKWDVRLKIAQGAA 881
           ++ L          R+  D  L+  +M+         E S +K   L + +         
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQM--------L 154
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---T 938
           +GL Y+H      +VHRD+K  N+ ++E  E  + DFGL+R       H   ++ G   T
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVT 204
Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 991
             Y  PE       Y+QT+      D++S G ++ E+LTG+    + KGK+  D ++ + 
Sbjct: 205 RWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK---TLFKGKDYLDQLTQIL 255
Query: 992 QM 993
           ++
Sbjct: 256 KV 257

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++   F   + DFG++R +   D +      G  G +P  
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 196
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLEL 968
              PE  +    T   D++SFGVVL E+
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++   F   + DFG++R +   D        G  G +P  
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK----GGKGLLPVR 194
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLEL 968
              PE  +    T   D++SFGVVL E+
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 39/279 (13%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   ++ Y 
Sbjct: 36   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 837  RHGNDRLLIYSYMENGSLDY--WLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                D+  IY  ME G++D   WL +   K S+  W+ +          L  +H + +  
Sbjct: 96   YEITDQY-IYMVMECGNIDLNSWLKK---KKSIDPWERK----SYWKNMLEAVHTIHQHG 147
Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPEYSQTLTAT 953
            IVH D+K +N L+ +     L DFG++  ++P    V  D  VGT+ Y+PPE  + ++++
Sbjct: 148  IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 954  CRG-----------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
                          DV+S G +L  +  G+ P +        + +S +  +     E+E 
Sbjct: 207  RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEF 261
Query: 1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             D        EK L ++L+    C+ +DP++R  I E++
Sbjct: 262  PDIP------EKDLQDVLKC---CLKRDPKQRISIPELL 291

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 778 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 888
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 87  HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 138
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 139 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTPNYIAPEVLS 194
Query: 949 TLTATCRGDVYSFGVVLLELLTGRRPVE 976
               +   DV+S G ++  LL G+ P E
Sbjct: 195 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 771 NNFNQANIIGCGGFGLVYK-ATLTNGTKAAVKRLSGDCGQME--REFQAEVEALSRAQHK 827
             +N   ++G G FG V K        + AVK ++    + +       EVE L +  H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           N++ L       +   ++      G L     E + +    + D   +I +    G+ Y+
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDA-ARIIKQVFSGITYM 137
Query: 888 HKVCEPHIVHRDVKSSNILLDEKF---EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           HK    +IVHRD+K  NILL+ K    +  + DFGLS   +        D +GT  YI P
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAP 192
Query: 945 EYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
           E  + T    C  DV+S GV+L  LL+G  P     GKN  D++  V
Sbjct: 193 EVLRGTYDEKC--DVWSAGVILYILLSGTPPF---YGKNEYDILKRV 234

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 868
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 107
Query: 869 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 108 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 159
Query: 929 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 160 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 214

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 868
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 119
Query: 869 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 120 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
Query: 929 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 868
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 869 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 130 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181
Query: 929 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 236

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 868
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 869 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 130 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181
Query: 929 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 236

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 868
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 109
Query: 869 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 110 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161
Query: 929 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 868
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 869 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 114 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165
Query: 929 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 166 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 868
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 69  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 127
Query: 869 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 128 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 179
Query: 929 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
            +      G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 180 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 234

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 778 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 888
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 83  HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 134
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 135 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTPNYIAPEVLS 190
Query: 949 TLTATCRGDVYSFGVVLLELLTGRRPVE 976
               +   DV+S G ++  LL G+ P E
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 26/240 (10%)
Query: 762 TVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA-----AVKRLSGDCGQMEREFQA 816
            ++ + K T    +  ++G G FG V+K       ++      +K +    G+  + FQA
Sbjct: 5   VLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQA 61
Query: 817 EVE---ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKW 870
             +   A+    H ++V L G C  G+   L+  Y+  GSL   + +   ++    +L W
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 930
            V++      A+G+ YL    E  +VHR++ + N+LL    +  +ADFG++ LL P D  
Sbjct: 121 GVQI------AKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 931 VTTDLVGT-LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 988
           +      T + ++  E       T + DV+S+GV + EL+T G  P    +     DL+ 
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 827
           ++   + +   +G GGF   Y+ T  +  +    ++      + +  Q E  +   A HK
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK-SMLLKPHQKEKMSTEIAIHK 97
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR---- 882
           +L +      HG        + E+    Y + E   + S+L+   R K + +  AR    
Sbjct: 98  SLDNPHVVGFHG--------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 883 ----GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               G+ YLH      ++HRD+K  N+ L++  +  + DFGL+  +  +D      L GT
Sbjct: 150 QTIQGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKTLCGT 205
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             YI PE       +   D++S G +L  LL G+ P E
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 122/276 (44%), Gaps = 46/276 (16%)
Query: 779  IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL----- 832
            +GCGG GLV+ A   +   + A+K++     Q  +    E++ + R  H N+V +     
Sbjct: 19   LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 833  ---------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
                      G     N   ++  YME       L   +++  +L+   RL + Q   RG
Sbjct: 79   PSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQ-LLRG 132
Query: 884  LAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDT---HVTTDLVGTL 939
            L Y+H     +++HRD+K +N+ ++ E     + DFGL+R++ P+ +   H++  LV   
Sbjct: 133  LKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 940  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
               P         T   D+++ G +  E+LTG+                 +F    E  +
Sbjct: 190  YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT----------------LFAGAHELEQ 233
Query: 1000 VEIIDASI--WHKDREKQLLEMLEIACKCIDQDPRR 1033
            +++I  SI   H++  ++LL ++ +  +    +P +
Sbjct: 234  MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHK 269

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHRD+ + N ++   F   + DFG++R +  Y+T       G  G +P  
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETAYYRK--GGKGLLPVR 197
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLEL 968
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V 
Sbjct: 113 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV 166
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 776 ANIIGCGGFGLVY--KATLTNGTKAAVKRLSGD-------CGQMEREFQAEVEALSRAQH 826
            + +G G FG V   +  LT G K AVK L+          G+++RE Q     L   +H
Sbjct: 16  GDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQN----LKLFRH 70
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            +++ L        D  ++  Y+  G L DY          V + + R ++ Q     + 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG----RVEEMEAR-RLFQQILSAVD 125
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H+     +VHRD+K  N+LLD    A +ADFGLS ++   D        G+  Y  PE
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPNYAAPE 180
Query: 946 Y-SQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             S  L A    D++S GV+L  LL G  P +
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 836
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 837 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 146
Query: 892 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 941
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 204
Query: 942 IPPEY------SQTLTATCRGDVYSFGVVLLEL 968
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK 827
           ++   + +   +G GGF   Y+ T  +  +    ++      + +  Q E  +   A HK
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK-SMLLKPHQKEKMSTEIAIHK 97
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR---- 882
           +L +      HG        + E+    Y + E   + S+L+   R K + +  AR    
Sbjct: 98  SLDNPHVVGFHG--------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 883 ----GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               G+ YLH      ++HRD+K  N+ L++  +  + DFGL+  +  +D      L GT
Sbjct: 150 QTIQGVQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKXLCGT 205
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             YI PE       +   D++S G +L  LL G+ P E
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           IG G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 147
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 200
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 NWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 778 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 888
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 83  HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 134
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 135 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTPNYIAPEVLS 190
Query: 949 TLTATCRGDVYSFGVVLLELLTGRRPVE 976
               +   DV+S G ++  LL G+ P E
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKXQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 770 TNNFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 824
           ++ +    ++G G FG V   K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++ L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDA-ARIIRQVLSGI 162
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            Y+HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 163 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYY 217
Query: 942 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 989
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 218 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 274

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 779 IGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V K               + +   +   ++ E  AE   + +  +  +V + 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           G C      +L+    E G L+ +L ++   KD  +     +++    + G+ YL    E
Sbjct: 437 GICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE---E 487
Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTL 950
            + VHRD+ + N+LL  +  A ++DFGLS+ LR  + +      G   + +  PE     
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
             + + DV+SFGV++ E  + G++P    KG
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 770 TNNFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 824
           ++ +    ++G G FG V   K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++ L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDA-ARIIRQVLSGI 163
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            Y+HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 164 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYY 218
Query: 942 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 989
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 219 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 275

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 18/181 (9%)
Query: 791 TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYME 850
           T +N  K ++K    D       F+ E++ ++  +++  ++ +G   + ++  +IY YME
Sbjct: 74  TKSNNDKISIKSKYDD-------FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYME 126
Query: 851 NGSL----DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNIL 906
           N S+    +Y+     +    +   V   I +      +Y+H   E +I HRDVK SNIL
Sbjct: 127 NDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184
Query: 907 LDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY--SQTLTATCRGDVYSFGVV 964
           +D+     L+DFG S  +   D  +     GT  ++PPE+  +++     + D++S G+ 
Sbjct: 185 MDKNGRVKLSDFGESEYM--VDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 965 L 965
           L
Sbjct: 242 L 242

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQHK 827
           + +     IG G +G+V  A     G + A+K++    D     +    E++ L   +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 828 NLVSLQGYCR----HGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGA 880
           N+++++   R    +G  +   ++   ME+      LH+ +     L  + VR  + Q  
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESD-----LHQIIHSSQPLTLEHVRYFLYQ-L 168
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYD-THVTTDLVG 937
            RGL Y+H      ++HRD+K SN+L++E  E  + DFG++R L   P +  +  T+ V 
Sbjct: 169 LRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 938 TLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 982
           T  Y  PE   +L    +  D++S G +  E+L  R   ++  GKN
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR---QLFPGKN 268

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 779 IGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G G FG V K               + +   +   ++ E  AE   + +  +  +V + 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
           G C      +L+    E G L+ +L ++   KD  +     +++    + G+ YL    E
Sbjct: 438 GICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE---E 488
Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT--LGYIPPEYSQTL 950
            + VHRD+ + N+LL  +  A ++DFGLS+ LR  + +      G   + +  PE     
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
             + + DV+SFGV++ E  + G++P    KG
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 579

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 836
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 837 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 121
Query: 892 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 941
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 179
Query: 942 IPPEY------SQTLTATCRGDVYSFGVVLLEL 968
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 836
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 837 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 120
Query: 892 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 941
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 178
Query: 942 IPPEY------SQTLTATCRGDVYSFGVVLLEL 968
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 836
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 837 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 126
Query: 892 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 941
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 184
Query: 942 IPPEY------SQTLTATCRGDVYSFGVVLLEL 968
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF--QAEVEALSRAQHKNLVSLQGYC 836
           IG G FG V++     G + AVK  S    + ER +  +AE+      +H+N++      
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 837 RHGNDRL----LIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
              N       L+  Y E+GSL DY    +V  + ++K      +A   A GLA+LH   
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK------LALSTASGLAHLHMEI 123
Query: 892 -----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----VGTLGY 941
                +P I HRD+KS NIL+ +     +AD GL+  +R      T D+     VGT  Y
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 181
Query: 942 IPPEY------SQTLTATCRGDVYSFGVVLLEL 968
           + PE        +   +  R D+Y+ G+V  E+
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 143
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYR 196
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 197 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 147
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 148 GLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYR 200
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 231

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 147
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 200
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 NWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 149
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIML 202
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 203 NWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 167
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 166
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 107/268 (39%), Gaps = 37/268 (13%)
Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            ++G G +G+VY    L+N  + A+K +     +  +    E+      +HKN+V   G  
Sbjct: 15   VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 837  RHGNDRLLIYSYMENGSLDYWLHES----VDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
                   +    +  GSL   L        D +  + +  +  +      GL YLH   +
Sbjct: 75   SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLH---D 126
Query: 893  PHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLT 951
              IVHRD+K  N+L++       ++DFG S+ L   +   T    GTL Y+ PE    + 
Sbjct: 127  NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPE---IID 182
Query: 952  ATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006
               RG     D++S G  ++E+ TG+ P               +F++  E  E    +A 
Sbjct: 183  KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 242
Query: 1007 IWHKDREKQLLEMLEIACKCIDQDPRRR 1034
             +                KC + DP +R
Sbjct: 243  AF--------------ILKCFEPDPDKR 256

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 778 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 888
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 107 HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEVLS 214
Query: 949 TLTATCRGDVYSFGVVLLELLTGRRPVE 976
               +   DV+S G ++  LL G+ P E
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 149
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIML 202
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 203 NWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 17/210 (8%)
Query: 772 NFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQ---AEVEALSRA-QH 826
           +F    ++G G FG V+ A      +  A+K L  D   M+ + +    E   LS A +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA--RGL 884
             L  +    +   +   +  Y+  G L Y +       S  K+D+       A    GL
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ------SCHKFDLSRATFYAAEIILGL 131
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            +LH      IV+RD+K  NILLD+     +ADFG+ +     D   T    GT  YI P
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYIAP 187
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E           D +SFGV+L E+L G+ P
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 767 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 823
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAA 881
             H N+V L       N   L++ ++   S+D  L + +D  ++    + L  +      
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMD--LKDFMDASALTGIPLPLIKSYLFQLL 116
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 117 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 170
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 171 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 832
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 833 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 154
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 155 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 207
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 208 NWMHYNQTV------DIWSVGCIMAELLTGR 232

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 767 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 823
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA 881
             H N+V L       N   L++ +         LH+ + K  D+     + L + +   
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 882 ----RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDL 935
               +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     
Sbjct: 114 FQLLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-- 167
Query: 936 VGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           V TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 205

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 767 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 823
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA 881
             H N+V L       N   L++ +         LH+ + K  D+     + L + +   
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 882 ----RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDL 935
               +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     
Sbjct: 113 FQLLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-- 166
Query: 936 VGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           V TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 778 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 888
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 105 HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 156
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 157 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEVLS 212
Query: 949 TLTATCRGDVYSFGVVLLELLTGRRPVE 976
               +   DV+S G ++  LL G+ P E
Sbjct: 213 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D    +R    E++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 190
Query: 944 PEYSQTLTA-TCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D    +R    E++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 190
Query: 944 PEYSQTLTA-TCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D    +R    E++ + +  H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 77
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 136
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 137 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 191
Query: 944 PEYSQTLTA-TCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 767 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 823
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAA 881
             H N+V L       N   L++ ++   S+D  L + +D  ++    + L  +      
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL---SMD--LKDFMDASALTGIPLPLIKSYLFQLL 115
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 116 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 169
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 170 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 203

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 148
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 149 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 201
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 202 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 148
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 149 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 201
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 202 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 232

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 138
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 139 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 191
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 832
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 833 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKSQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 832
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 833 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 144
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 145 SA---DIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 197
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 198 NWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 13/175 (7%)
Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVL 868
           ++ E  AE   + +  +  +V + G C      +L+    E G L+ +L ++   KD  +
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 869 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                +++    + G+ YL    E + VHRD+ + N+LL  +  A ++DFGLS+ LR  +
Sbjct: 114 -----IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165
Query: 929 THVTTDLVGT--LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG 980
                   G   + +  PE       + + DV+SFGV++ E  + G++P    KG
Sbjct: 166 NXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSG--DCGQMEREFQAEVEALSRAQHK 827
           + +     IG G +G+V  A     G + A+K++    D     +    E++ L   +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 828 NLVSLQGYCR----HGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGA 880
           N+++++   R    +G  +   ++   ME+      LH+ +     L  + VR  + Q  
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESD-----LHQIIHSSQPLTLEHVRYFLYQ-L 167
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYD-THVTTDLVG 937
            RGL Y+H      ++HRD+K SN+L++E  E  + DFG++R L   P +  +  T+ V 
Sbjct: 168 LRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 938 TLGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKN 982
           T  Y  PE   +L    +  D++S G +  E+L  R   ++  GKN
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR---QLFPGKN 267

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 159
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 160 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 212
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 213 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 138
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 139 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 191
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 767 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 823
           L S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAA 881
             H N+V L       N   L++ ++   S+D  L + +D  ++    + L  +      
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMD--LKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 117 QGLAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 170
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 171 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 138
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 191
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 NWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++        RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIV 76
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 190
Query: 944 PEYSQTLT-ATCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 139
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 140 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 192
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 193 NWMHYNQTV------DIWSVGCIMAELLTGR 217

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 832
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 833 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 156
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 157 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 209
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 210 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 140
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 141 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 193
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 194 NWMHYNQTV------DIWSVGCIMAELLTGR 218

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 70  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 121 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 174
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 175 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 208

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 139
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 140 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 192
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 193 NWMHYNQTV------DIWSVGCIMAELLTGR 217

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++  D    +R    E++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 190
Query: 944 PEYSQTLTA-TCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 155
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 156 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 208
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 209 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 239

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA---- 881
           H N+V L       N   L++ ++     D+        D+     + L + +       
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDF-------MDASALTGIPLPLIKSYLFQLL 113
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 167
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 142
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 143 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 195
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 773 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME--REFQAEVEALSRAQHKNL 829
           +N   ++G G FG V K        + AVK ++    + +       EVE L +  H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           + L       +   ++      G L     E + +    + D   +I +    G+ Y+HK
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK 139
Query: 890 VCEPHIVHRDVKSSNILLDEK---FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
               +IVHRD+K  NILL+ K    +  + DFGLS   +        D +GT  YI PE 
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEV 194
Query: 947 SQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
            + T    C  DV+S GV+L  LL+G  P     GKN  D++  V
Sbjct: 195 LRGTYDEKC--DVWSAGVILYILLSGTPPF---YGKNEYDILKRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 773 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME--REFQAEVEALSRAQHKNL 829
           +N   ++G G FG V K        + AVK ++    + +       EVE L +  H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           + L       +   ++      G L     E + +    + D   +I +    G+ Y+HK
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK 139
Query: 890 VCEPHIVHRDVKSSNILLDEK---FEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
               +IVHRD+K  NILL+ K    +  + DFGLS   +        D +GT  YI PE 
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEV 194
Query: 947 SQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
            + T    C  DV+S GV+L  LL+G  P     GKN  D++  V
Sbjct: 195 LRGTYDEKC--DVWSAGVILYILLSGTPPF---YGKNEYDILKRV 234

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 147
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 200
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 NWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHR++ + N ++   F   + DFG++R +   D +      G  G +P  
Sbjct: 146 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 198
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLELLT 970
              PE  +    T   D++SFGVVL E+ +
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 832
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 833 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 144
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 145 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 197
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 198 NWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 167
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 149
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 202
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 203 NWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 832
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 833 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 147
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 200
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 NWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 156
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 157 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 209
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 210 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 240

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 832
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 833 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 141
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 142 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 194
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 195 NWMHYNQTV------DIWSVGCIMAELLTGR 219

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 167
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 147
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 148 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 200
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 201 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 231

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 166
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 70  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 121 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 174
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 175 WYRAPEILLGXKYYSTAV------DIWSLGCIFAEMVTRR 208

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 142
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 143 GLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYR 195
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 767 LKSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSR 823
           L    NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L  
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA 881
             H N+V L       N   L++ +         LH+ + K  D+     + L + +   
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 882 ----RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDL 935
               +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  
Sbjct: 114 FQLLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THE 167
Query: 936 VGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           V TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 205

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNAMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 155
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 156 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 208
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 209 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 239

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 779 IGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +G G FG+VY+    +       T+ AVK ++      ER EF  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L G    G   L++   M +G L  +L       E+            +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-- 943
           YL+       VHR++ + N ++   F   + DFG++R +   D +      G  G +P  
Sbjct: 145 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 197
Query: 944 ---PEYSQTLTATCRGDVYSFGVVLLEL 968
              PE  +    T   D++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 114 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 167
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 203

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 166
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 138
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 191
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 192 NWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 114 LLQGLAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 167
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 203

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL
Sbjct: 114 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 167
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 WYRAPEILLGXKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 115 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 168
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 169 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 31/239 (12%)
Query: 770 TNNFNQANIIGCGGFG--LVYKATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 824
           ++ +    ++G G FG  ++ K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N++ L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAA-RIIRQVLSGI 145
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            Y+HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 146 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYY 200
Query: 942 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 989
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 201 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 257

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 778 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G GGF   ++ +  +  +    ++      + +  Q E  ++  + H++L        
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-IAQGAAR--------GLAYLH 888
           HG        + E+    + + E   + S+L+   R K + +  AR        G  YLH
Sbjct: 81  HG--------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
           +     ++HRD+K  N+ L+E  E  + DFGL+  +  YD      L GT  YI PE   
Sbjct: 133 R---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEVLS 188
Query: 949 TLTATCRGDVYSFGVVLLELLTGRRPVE 976
               +   DV+S G ++  LL G+ P E
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 114 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 167
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 168 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 203

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 16/216 (7%)
Query: 769 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA--EVEALSRAQ 825
           +T+ +     IG G +G VYKA    +G   A+K +    G+         EV  L R +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 826 ---HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIAQGA 880
              H N+V L   C        I   +    +D  L   +DK     L  +    + +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTL 939
            RGL +LH  C   IVHRD+K  NIL+       LADFGL+R+   Y   +  D +V TL
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVTL 175
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
            Y  PE     T     D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 131 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 184 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSR-AQ 825
           ++F+   +IG G FG V  A         AVK L        + E+   +E   L +  +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H  LV L    +  +    +  Y+  G L Y L     +   L+   R   A+ A+  L 
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIAS-ALG 153
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           YLH +   +IV+RD+K  NILLD +    L DFGL +    +++  T+   GT  Y+ PE
Sbjct: 154 YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPE 209
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                      D +  G VL E+L G  P
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 112 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 165
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 112 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 165
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 113 LLQGLAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 166
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 112 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 165
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 152
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 153 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 205
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 206 NWMHYNQTV------DIWSVGCIMAELLTGR 230

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 113 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 166
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 113/245 (46%), Gaps = 25/245 (10%)
Query: 745 LASSKLVLFQNS-DCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA---- 798
           + +++ + FQ S +  +  +  +LK T  F +  ++G G FG VYK   +  G K     
Sbjct: 14  IPTTENLYFQGSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV 72
Query: 799 AVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYW 857
           A+K L      +  +E   E   ++   + ++  L G C     +L I   M  G L  +
Sbjct: 73  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDY 131
Query: 858 LHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH 914
           + E  D      +L W V++      A+G+ YL    +  +VHRD+ + N+L+       
Sbjct: 132 VREHKDNIGSQYLLNWCVQI------AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVK 182
Query: 915 LADFGLSRLL--RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-G 971
           + DFGL++LL     + H     V  + ++  E       T + DV+S+GV + EL+T G
Sbjct: 183 ITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 241
Query: 972 RRPVE 976
            +P +
Sbjct: 242 SKPYD 246

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAARGLA 885
           N+V L       N   L++ +         LH+ + K  D+     + L + +     L 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 886 YLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGYIP 943
                C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL Y  
Sbjct: 114 QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRA 171
Query: 944 PE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           PE       YS  +      D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAARG 883
           H N+V L       N   L++ ++   S+D  L + +D  ++    + L  +      +G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMD--LKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 884 LAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGY 941
           LA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL Y
Sbjct: 117 LAF----CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 170
Query: 942 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
             PE       YS  +      D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 32/272 (11%)
Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNL-VSLQGY 835
            +G G +G+V K   + +G   AVKR+      Q ++    +++   R       V+  G 
Sbjct: 42   LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 836  C-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
              R G+  + I   + + SLD +  + +DK   +  D+  KIA    + L +LH   +  
Sbjct: 102  LFREGD--VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 157
Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-VGTLGY-----IPPEYSQ 948
            ++HRDVK SN+L++   +    DFG+S  L      V  D+  G   Y     I PE +Q
Sbjct: 158  VIHRDVKPSNVLINALGQVKXCDFGISGYLV---DDVAKDIDAGCKPYXAPERINPELNQ 214
Query: 949  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008
                + + D++S G+  +EL   R P +           SW    +  K+ VE     + 
Sbjct: 215  K-GYSVKSDIWSLGITXIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQL- 261
Query: 1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                +K   E ++   +C+ ++ + RP   E+
Sbjct: 262  --PADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  A    +G + AVK +     Q       EV  +   QH N+V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 838 HGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
            G +  ++  +++ G+L D      ++++ +        + +   + LAYLH      ++
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT------VCEAVLQALAYLHA---QGVI 163
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY-SQTLTATCR 955
           HRD+KS +ILL       L+DFG    +   D      LVGT  ++ PE  S++L AT  
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKXLVGTPYWMAPEVISRSLYAT-E 221
Query: 956 GDVYSFGVVLLELLTGRRP 974
            D++S G++++E++ G  P
Sbjct: 222 VDIWSLGIMVIEMVDGEPP 240

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 16/218 (7%)
Query: 765 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMEREFQ---AEVE 819
           D +K T+ FN   ++G G FG V  A    GT+   A+K L  D    + + +    E  
Sbjct: 14  DRVKLTD-FNFLMVLGKGSFGKVMLAD-RKGTEELYAIKILKKDVVIQDDDVECTMVEKR 71
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
            L+       ++    C    DRL  +  Y+  G L Y + +        K    +  A 
Sbjct: 72  VLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAA 127
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
             + GL +LHK     I++RD+K  N++LD +    +ADFG+ +     D   T +  GT
Sbjct: 128 EISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMMDGVTTREFCGT 183
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             YI PE           D +++GV+L E+L G+ P +
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 24/232 (10%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTK-AAVKR--LSGDCGQMEREFQAEVEALSRAQHK 827
             + +   IG G +G V+KA      +  A+KR  L  D   +      E+  L   +HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           N+V L           L++ + +     Y+   + D D  +      ++     +GL + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL----KGLGFC 117
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 943
           H     +++HRD+K  N+L++   E  LADFGL+R     +R Y   V      TL Y P
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRP 169
Query: 944 PE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
           P+  +   L +T   D++S G +  EL    RP  +  G +  D +  +F++
Sbjct: 170 PDVLFGAKLYSTS-IDMWSAGCIFAELANAARP--LFPGNDVDDQLKRIFRL 218

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA-- 881
           H N+V L       N   L++ +         LH+ + K  D+     + L + +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 882 --RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVG 937
             +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V 
Sbjct: 112 LLQGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VV 165
Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y  PE       YS  +      D++S G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 201

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 128 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 181 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 148
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 149 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 201
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 202 NWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 130 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 183 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLAYL 887
                      ND  L+ +++    L+     ++ K + L  D V+  I Q   RGL Y+
Sbjct: 85  VFTPARSLEEFNDVYLV-THLMGADLN-----NIVKCAKLTDDHVQFLIYQ-ILRGLKYI 137
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 945
           H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE  
Sbjct: 138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 946 -----YSQTLTATCRGDVYSFGVVLLELLTGR 972
                Y+QT+      D++S G ++ ELLTGR
Sbjct: 191 LNWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 130 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 183 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 128 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 181 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 41/295 (13%)
Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRL-------SGDCGQMEREFQAEVEALSR 823
            +  N    +G G FG V +A      K A  R         G      R   +E++ L  
Sbjct: 27   DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 824  -AQHKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLH----ESVDKDSVLKWDVRLK-- 875
               H N+V+L G C + G   ++I  + + G+L  +L     E V    + K  + L+  
Sbjct: 87   IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 876  --IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVT 932
               +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D    
Sbjct: 147  ICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSW 989
             D    L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L   
Sbjct: 204  GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--- 260
Query: 990  VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                  E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 261  -----KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSL-- 832
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 833 ----QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 148
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y  PE   
Sbjct: 149 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 201
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 202 NWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 132
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 133 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 186 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 136
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 137 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 190 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 134 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 187 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 120
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 121 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 174 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 130 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 183 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 130 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 183 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/280 (22%), Positives = 107/280 (38%), Gaps = 35/280 (12%)
Query: 772  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----------GDCGQMEREFQAEVEA 820
            NF     IG G F  VY+A  L +G   A+K++            DC +       E++ 
Sbjct: 33   NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-------EIDL 85
Query: 821  LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
            L +  H N++         N+  ++    + G L   +     +  ++      K     
Sbjct: 86   LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 881  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
               L ++H      ++HRD+K +N+ +       L D GL R      T     LVGT  
Sbjct: 146  CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPY 201
Query: 941  YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
            Y+ PE         + D++S G +L E+   + P    K             + S  +++
Sbjct: 202  YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLYSLCKKI 250
Query: 1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            E  D      D   +  E+ ++   CI+ DP +RP +  V
Sbjct: 251  EQCDYPPLPSDHYSE--ELRQLVNMCINPDPEKRPDVTYV 288

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 765 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTK-AAVKRL-----SGDCGQMEREFQAEV 818
           D+      + + + +G G F  VYKA   N  +  A+K++     S     + R    E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
           + L    H N++ L     H ++  L++ +ME       L   +  +S++     +K   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-----LEVIIKDNSLVLTPSHIKAYM 118
Query: 879 -GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL----RPYDTHVTT 933
               +GL YLH+     I+HRD+K +N+LLDE     LADFGL++      R Y   V T
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVT 175
Query: 934 DLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELL 969
                  Y  PE      A   G   D+++ G +L ELL
Sbjct: 176 RW-----YRAPEL--LFGARMYGVGVDMWAVGCILAELL 207

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 770 TNNFNQANIIGCGGFGLVY--KATLTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRA 824
           ++ +    ++G G FG V   K  +T G + AVK +S    + + + ++   EV+ L + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 825 QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H N+  L  +        L+      G L     E + +    + D   +I +    G+
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDA-ARIIRQVLSGI 139
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            Y HK     IVHRD+K  N+LL+ K +     + DFGLS       +    D +GT  Y
Sbjct: 140 TYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKXKDKIGTAYY 194
Query: 942 IPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSW 989
           I PE    T    C  DV+S GV+L  LL+G  P           +V KGK   +L  W
Sbjct: 195 IAPEVLHGTYDEKC--DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRL-------SGDCGQMEREFQAEVEALSR 823
           +  N    +G G FG V +A      K A  R         G      R   +E++ L  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 824 -AQHKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWL---------HESVDKDSVLKWDV 872
              H N+V+L G C + G   ++I  + + G+L  +L         ++ + KD  L  + 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD-FLTLEH 145
Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHV 931
            +  +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D   
Sbjct: 146 LIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR 202
Query: 932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
             D    L ++ PE       T + DV+SFGV+L E+ +
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 777 NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSL 832
            ++G GGFG V+   +   G   A K+L+    +  + +Q    E + L++   + +VSL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKV 890
                   D  L+ + M  G + Y ++ +VD+D+    + R     AQ    GL +LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQ-IVSGLEHLH-- 306
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
            + +I++RD+K  N+LLD+     ++D GL+  L+   T  T    GT G++ PE     
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 951 TATCRGDVYSFGVVLLELLTGRRPVEV 977
                 D ++ GV L E++  R P   
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 777 NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSL 832
            ++G GGFG V+   +   G   A K+L+    +  + +Q    E + L++   + +VSL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKV 890
                   D  L+ + M  G + Y ++ +VD+D+    + R     AQ    GL +LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQ-IVSGLEHLH-- 306
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
            + +I++RD+K  N+LLD+     ++D GL+  L+   T  T    GT G++ PE     
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 951 TATCRGDVYSFGVVLLELLTGRRPVEV 977
                 D ++ GV L E++  R P   
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + D+GL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRWYR 189
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 777 NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSL 832
            ++G GGFG V+   +   G   A K+L+    +  + +Q    E + L++   + +VSL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKV 890
                   D  L+ + M  G + Y ++ +VD+D+    + R     AQ    GL +LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQ-IVSGLEHLH-- 306
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
            + +I++RD+K  N+LLD+     ++D GL+  L+   T  T    GT G++ PE     
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 951 TATCRGDVYSFGVVLLELLTGRRPVEV 977
                 D ++ GV L E++  R P   
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 15/221 (6%)
Query: 763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 818
           V ++     +F    +IG G FG V    + N  +    ++      ++R     F+ E 
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 125
Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
           + L     + + +L    +  N   L+  Y   G L   L +  DK   L  D+      
Sbjct: 126 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK---LPEDMARFYIG 182
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
                +  +H++   H VHRD+K  N+LLD      LADFG    +    T  ++  VGT
Sbjct: 183 EMVLAIDSIHQL---HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGT 239
Query: 939 LGYIPPEYSQTLTATC-----RGDVYSFGVVLLELLTGRRP 974
             YI PE  Q +           D +S GV + E+L G  P
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 777 NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQHKNLVSL 832
            ++G GGFG V+   +   G   A K+L+    +  + +Q    E + L++   + +VSL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKV 890
                   D  L+ + M  G + Y ++ +VD+D+    + R     AQ    GL +LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQ-IVSGLEHLH-- 306
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
            + +I++RD+K  N+LLD+     ++D GL+  L+   T  T    GT G++ PE     
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 951 TATCRGDVYSFGVVLLELLTGRRPVEV 977
                 D ++ GV L E++  R P   
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---TL 939
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R       H   ++ G   T 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATR 186
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 187 WYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 118/290 (40%), Gaps = 45/290 (15%)
Query: 779  IGCGGFGLVYKATLTNGTKAAVKRL-------SGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A      K A  R         G      R   +E++ L     H N+V
Sbjct: 37   LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-----------ESVDKDSVLKWDVRLKIAQ 878
            +L G C + G   ++I  + + G+L  +L            E + KD  L  +  +  + 
Sbjct: 97   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD-FLTLEHLIXYSF 155
Query: 879  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVG 937
              A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D     D   
Sbjct: 156  QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 938  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMK 994
             L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L        
Sbjct: 213  PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------- 264
Query: 995  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
             E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 265  KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTK-AAVKRLSGDCGQ------MEREFQAE 817
           L ++   +     IG G +G V+KA  L NG +  A+KR+    G+        RE  A 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AV 64
Query: 818 VEALSRAQHKNLVSLQGYCR-HGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDV 872
           +  L   +H N+V L   C     DR     L++ +++     Y   + V +  V    +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETI 122
Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 932
           +  + Q   RGL +LH      +VHRD+K  NIL+    +  LADFGL+R+   Y   + 
Sbjct: 123 KDMMFQ-LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMA 175
Query: 933 -TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
            T +V TL Y  PE     +     D++S G +  E+   R+P+
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 43/214 (20%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 138
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---TLGYIPPE 945
                 I+HRD+K SN+ ++E  E  + DFGL+R       H   ++ G   T  Y  PE
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPE 188
Query: 946 -------YSQTLTATCRGDVYSFGVVLLELLTGR 972
                  Y+QT+      D++S G ++ ELLTGR
Sbjct: 189 IMLNWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG---TL 939
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R       H   ++ G   T 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATR 186
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 187 WYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 108/256 (42%), Gaps = 41/256 (16%)
Query: 773 FNQANIIGCGGFG--LVYKATLTNGTKA-AVKRLSGDCGQMEREFQAEVEALSRAQHKNL 829
           + +   +G G +G  L+ +  +T+  +A  + R +        +   EV  L    H N+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           + L  +     +  L+    + G L     E + +    + D  + I Q    G+ YLHK
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGEL---FDEIIHRMKFNEVDAAVIIKQ-VLSGVTYLHK 154
Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
               +IVHRD+K  N+LL+ K +  L    DFGLS +    +     + +GT  YI PE 
Sbjct: 155 ---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEV 209
Query: 947 -SQTLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGK-------------N 982
             +     C  DV+S GV+L  LL G  P           +V KGK              
Sbjct: 210 LRKKYDEKC--DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267
Query: 983 CRDLVSWVFQMKSEKR 998
            +DL+  + Q  S++R
Sbjct: 268 AKDLIKQMLQFDSQRR 283

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 17/222 (7%)
Query: 763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 818
           V ++     +F    +IG G FG V    + N  +    ++      ++R     F+ E 
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 141
Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIA 877
           + L     + + +L    +  N   L+  Y   G L   L +  DK   L  D+ R  I 
Sbjct: 142 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK---LPEDMARFYIG 198
Query: 878 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 937
           +     +  +H++   H VHRD+K  N+LLD      LADFG    +    T  ++  VG
Sbjct: 199 E-MVLAIDSIHQL---HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVG 254
Query: 938 TLGYIPPEYSQTLTATC-----RGDVYSFGVVLLELLTGRRP 974
           T  YI PE  Q +           D +S GV + E+L G  P
Sbjct: 255 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 159
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL---VGTL 939
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R       H   ++   V T 
Sbjct: 160 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATR 209
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 210 WYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 243

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 37/209 (17%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLVS 831
           IG G +G+VYKA    G   A+K++     ++E+E +        E+  L   +H N+V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L          +L++ +++   L   L       ESV   S L     L++  G    +A
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-----LQLLNG----IA 114
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H   +  ++HRD+K  N+L++ + E  +ADFGL+R         T ++V TL Y  P+
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
Query: 946 Y---SQTLTATCRGDVYSFGVVLLELLTG 971
               S+  + T   D++S G +  E++ G
Sbjct: 171 VLMGSKKYSTTI--DIWSVGCIFAEMVNG 197

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 156
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG-- 940
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R       H   ++ G +   
Sbjct: 157 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATR 206
Query: 941 -YIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 207 WYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 240

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 166
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 32/207 (15%)
Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           IG G +G+V+K      G   A+K+   S D   +++    E+  L + +H NLV+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
            R      L++ Y ++  L    HE       +   +   I     + + + HK    + 
Sbjct: 71  FRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNC 123
Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRP----YDTHVTTD-------LVGTLGYIPP 944
           +HRDVK  NIL+ +     L DFG +RLL      YD  V T        LVG   Y PP
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTG 971
                       DV++ G V  ELL+G
Sbjct: 184 V-----------DVWAIGCVFAELLSG 199

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAA-----VKRLSG-DCGQMEREFQAEVEA 820
           K ++N++    +G G F +V +    T G + A      K+LS  D  ++ERE       
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 58
Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q  
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-I 114
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVG 937
              +AY H      IVHR++K  N+LL  K +     LADFGL+  +   D+       G
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 169
Query: 938 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T GY+ PE  +    +   D+++ GV+L  LL G  P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAA-----VKRLSG-DCGQMEREFQAEVEA 820
           K ++N++    +G G F +V +    T G + A      K+LS  D  ++ERE       
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 57
Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q  
Sbjct: 58  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-I 113
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVG 937
              +AY H      IVHR++K  N+LL  K +     LADFGL+  +   D+       G
Sbjct: 114 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 168
Query: 938 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T GY+ PE  +    +   D+++ GV+L  LL G  P
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAA-----VKRLSG-DCGQMEREFQAEVEA 820
           K ++N++    +G G F +V +    T G + A      K+LS  D  ++ERE       
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 58
Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q  
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-I 114
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVG 937
              +AY H      IVHR++K  N+LL  K +     LADFGL+  +   D+       G
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 169
Query: 938 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T GY+ PE  +    +   D+++ GV+L  LL G  P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 113 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 166
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 102/239 (42%), Gaps = 20/239 (8%)
Query: 762 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAE 817
           T +D      N+     IG G F  V  A  +  G + AVK +     +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-E 63
Query: 818 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 876
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   + T   
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FC 173
Query: 937 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 45/213 (21%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLVS 831
           IG G +G+VYKA    G   A+K++     ++E+E +        E+  L   +H N+V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L          +L++ +++   L   L       ESV   S L     L++  G    +A
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-----LQLLNG----IA 114
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGY 941
           Y H   +  ++HRD+K  N+L++ + E  +ADFGL+R     +R Y     T  V TL Y
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-----THEVVTLWY 166
Query: 942 IPPEY---SQTLTATCRGDVYSFGVVLLELLTG 971
             P+    S+  + T   D++S G +  E++ G
Sbjct: 167 RAPDVLMGSKKYSTTI--DIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 45/213 (21%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQA-------EVEALSRAQHKNLVS 831
           IG G +G+VYKA    G   A+K++     ++E+E +        E+  L   +H N+V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIAQGAARGLA 885
           L          +L++ +++   L   L       ESV   S L     L++  G    +A
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-----LQLLNG----IA 114
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGY 941
           Y H   +  ++HRD+K  N+L++ + E  +ADFGL+R     +R Y     T  V TL Y
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-----THEVVTLWY 166
Query: 942 IPPEY---SQTLTATCRGDVYSFGVVLLELLTG 971
             P+    S+  + T   D++S G +  E++ G
Sbjct: 167 RAPDVLMGSKKYSTTI--DIWSVGCIFAEMVNG 197

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAARG 883
           H N+V L       N   L++ +++       L + +D  ++    + L  +      +G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-----LKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 884 LAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGY 941
           LA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL Y
Sbjct: 119 LAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 172
Query: 942 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
             PE       YS  +      D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 128/302 (42%), Gaps = 60/302 (19%)
Query: 767  LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            L+  ++F +  ++G G FG V KA    +    A+K++     ++     +EV  L+   
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLN 60
Query: 826  H-------------KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWD 871
            H             +N V      +  +   +   Y ENG+L   +H E++++     W 
Sbjct: 61   HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 872  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-------LL 924
            +  +I +     L+Y+H      I+HRD+K  NI +DE     + DFGL++       +L
Sbjct: 121  LFRQILEA----LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 925  R------PYDTHVTTDLVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELL----TGRR 973
            +      P  +   T  +GT  Y+  E    T     + D+YS G++  E++    TG  
Sbjct: 174  KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 974  PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1033
             V + K       VS  F    +  ++++          EK+++ +L      ID DP +
Sbjct: 234  RVNILKKLRS---VSIEFPPDFDDNKMKV----------EKKIIRLL------IDHDPNK 274
Query: 1034 RP 1035
            RP
Sbjct: 275  RP 276

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK--DSVLKWDVRLKIAQGAA---- 881
           N+V L       N   L++ +         LH+ + K  D+     + L + +       
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 882 RGLAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTL 939
           +GLA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL
Sbjct: 115 QGLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTL 168
Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       YS  +      D++S G +  E++T R
Sbjct: 169 WYRAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 202

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 102/239 (42%), Gaps = 20/239 (8%)
Query: 762 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAE 817
           T +D      N+     IG G F  V  A  +  G + AVK   +   +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-E 63
Query: 818 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 876
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   + T   
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FC 173
Query: 937 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 123
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 124 ----AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 177 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK-----RLSG-DCGQMEREFQAEVEA 820
           K ++N++    +G G F +V +    T G + A K     +LS  D  ++ERE       
Sbjct: 26  KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 81
Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q  
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-I 137
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVG 937
              +AY H      IVHR++K  N+LL  K +     LADFGL+  +   D+       G
Sbjct: 138 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 192
Query: 938 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T GY+ PE  +    +   D+++ GV+L  LL G  P
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++        RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIV 76
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 190
Query: 944 PEYSQTLTA-TCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 113/254 (44%), Gaps = 26/254 (10%)
Query: 737 RPQRLSEALASSKLV--LFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LT 793
           R + L   L   +LV  L  + +  +  +  +LK T  F +  ++G G FG VYK   + 
Sbjct: 14  RKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIP 72
Query: 794 NGTK-----AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY 848
            G K     A ++       +  +E   E   ++   + ++  L G C     +L I   
Sbjct: 73  EGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQL 131
Query: 849 MENGSLDYWLHESVD---KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNI 905
           M  G L  ++ E  D      +L W V++      A+G+ YL    +  +VHRD+ + N+
Sbjct: 132 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE---DRRLVHRDLAARNV 182
Query: 906 LLDEKFEAHLADFGLSRLL--RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGV 963
           L+       + DFGL++LL     + H     V  + ++  E       T + DV+S+GV
Sbjct: 183 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGV 241
Query: 964 VLLELLT-GRRPVE 976
            + EL+T G +P +
Sbjct: 242 TVWELMTFGSKPYD 255

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 769 STNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQ 825
           S  NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAARG 883
           H N+V L       N   L++ ++        L   +D  ++    + L  +      +G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKTFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 884 LAYLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGY 941
           LA+    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+     V TL Y
Sbjct: 119 LAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWY 172
Query: 942 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
             PE       YS  +      D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 123/293 (41%), Gaps = 43/293 (14%)
Query: 763  VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNG----TKAAVKRLSGD--CGQMEREFQA 816
            + D+L     F    ++G G FG V +A L        K AVK L  D        EF  
Sbjct: 15   LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 817  EVEALSRAQHKNLVSLQGYCRHGNDR------LLIYSYMENGSLDYWLHESVDKDSVLKW 870
            E   +    H ++  L G       +      ++I  +M++G L  +L  S   ++    
Sbjct: 75   EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 871  DVR--LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
             ++  ++     A G+ YL      + +HRD+ + N +L E     +ADFGLSR +   D
Sbjct: 135  PLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 929  THVTTDLVGTLGYIPPEY--SQTLT---ATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             +      G    +P ++   ++L     T   DV++FGV + E++T G+ P     G  
Sbjct: 192  YYRQ----GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY---AGIE 244
Query: 983  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035
              ++ +++      K+  E ++             E+ ++  +C   DP++RP
Sbjct: 245  NAEIYNYLIGGNRLKQPPECME-------------EVYDLMYQCWSADPKQRP 284

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 772 NFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           ++    +IG G FG+VY+A L + G   A+K++        RE Q     + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIV 76
Query: 831 SLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            L+ +     ++       L+  Y+         H S  K ++    V+L + Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+   + +  Y  
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRA 190
Query: 944 PEYSQTLTA-TCRGDVYSFGVVLLELLTGR 972
           PE     T  T   DV+S G VL ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 817 EVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
           EV+ L +   H N++ L+          L++  M+ G L  +L E V     L      K
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRK 115
Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
           I +     +  LHK+   +IVHRD+K  NILLD+     L DFG S  L P +     ++
Sbjct: 116 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 170
Query: 936 VGTLGYIPPEYSQ-TLTATCRG-----DVYSFGVVLLELLTGRRP 974
            GT  Y+ PE  + ++     G     D++S GV++  LL G  P
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 776 ANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQ 833
           + ++G G +  V  A +L NG + AVK +    G        EVE L + Q +KN++ L 
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
            +        L++  ++ GS+       + K          ++ +  A  L +LH     
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSI----LAHIQKQKHFNEREASRVVRDVAAALDFLHT---K 130
Query: 894 HIVHRDVKSSNILLD--EKFE-AHLADFGLSRLLR------PYDTHVTTDLVGTLGYIPP 944
            I HRD+K  NIL +  EK     + DF L   ++      P  T   T   G+  Y+ P
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 945 EYSQTLTATC-----RGDVYSFGVVLLELLTGRRPVEVCKGKNC 983
           E  +  T        R D++S GVVL  +L+G  P     G +C
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADC 234

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA--QHKNL---VSLQ 833
           +G G +G V++  L +G   AVK  S    + E+ +  E E  +    +H N+   ++  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSS---RDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 834 GYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC- 891
              R+ + +L LI  Y E+GSL  +L         L+  + L++A  AA GLA+LH    
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT-----LEPHLALRLAVSAACGLAHLHVEIF 126
Query: 892 ----EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGTLGYIPP 944
               +P I HRD KS N+L+    +  +AD GL+ +      ++       VGT  Y+ P
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 945 EY-SQTLTATC-----RGDVYSFGVVLLELLTGRRPV 975
           E   + +   C       D+++FG+VL E+   RR +
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 779 IGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYC 836
           +G G F +  K       +A AVK +S    +ME   Q E+ AL   + H N+V L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 837 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                  L+   +  G L     E + K           I +     ++++H V    +V
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VV 128
Query: 897 HRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
           HRD+K  N+L    ++  E  + DFG +RL +P D         TL Y  PE        
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPCFTLHYAAPELLNQNGYD 187
Query: 954 CRGDVYSFGVVLLELLTGRRPVE 976
              D++S GV+L  +L+G+ P +
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 123/300 (41%), Gaps = 48/300 (16%)
Query: 771  NNFNQANIIGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR 823
            +  N    +G G FG V +A       T T  T A      G      R   +E++ L  
Sbjct: 28   DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 824  -AQHKNLVSLQGYC-RHGNDRLLIYSYMENGSLDYWLH------------ESVDKDSVLK 869
               H N+V+L G C + G   ++I  + + G+L  +L             E + KD  L 
Sbjct: 88   IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKD-FLT 146
Query: 870  WDVRLKIAQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPY 927
             +  +  +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  
Sbjct: 147  LEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 928  DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCR 984
            D     D    L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR
Sbjct: 203  DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 985  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
             L         E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 263  RL--------KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 30/234 (12%)
Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAEVEALSRAQHK 827
           N+     IG G F  V  A  +  G + AVK +     +   +++ F+ EV  +    H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSL-DY-----WLHESVDKDSVLKWDVRLKIAQGAA 881
           N+V L           L+  Y   G + DY     W+ E          + R K  Q  +
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK---------EARAKFRQIVS 117
Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
             + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   + T   G+  Y
Sbjct: 118 -AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FCGSPPY 171
Query: 942 IPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
             PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 172 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 817 EVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
           EV+ L +   H N++ L+          L++  M+ G L  +L E V     L      K
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRK 128
Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
           I +     +  LHK+   +IVHRD+K  NILLD+     L DFG S  L P +     ++
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 183
Query: 936 VGTLGYIPPEYSQ-TLTATCRG-----DVYSFGVVLLELLTGRRP 974
            GT  Y+ PE  + ++     G     D++S GV++  LL G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 102/239 (42%), Gaps = 20/239 (8%)
Query: 762 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAE 817
           T +D      N+     IG G F  V  A  +  G + AV+   +   +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-E 63
Query: 818 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 876
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   + T   
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FC 173
Query: 937 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 771 NNFNQANIIGCGGFGLVYKA--TLTNGTKAAVK-RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF +   IG G +G+VYKA   LT    A  K RL  +   +      E+  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ--GAARGLA 885
           N+V L       N   L++ ++        L   +D  ++    + L  +      +GLA
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD-----LKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 886 YLHKVCEPH-IVHRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGYIP 943
           +    C  H ++HRD+K  N+L++ +    LADFGL+R    P  T+  T  V TL Y  
Sbjct: 117 F----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRA 170
Query: 944 PE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           PE       YS  +      D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAV------DIWSLGCIFAEMVTRR 200

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 769 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA--EVEALSRAQ 825
           +T+ +     IG G +G VYKA    +G   A+K +    G+         EV  L R +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 826 ---HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIAQGA 880
              H N+V L   C        I   +    +D  L   +DK     L  +    + +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTL 939
            RGL +LH  C   IVHRD+K  NIL+       LADFGL+R+   Y   +    +V TL
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVTL 175
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
            Y  PE     T     D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 779 IGCGGFGLVYKA-TLTNGTK-AAVKRLSGDCGQ------MEREFQAEVEALSRAQHKNLV 830
           IG G +G V+KA  L NG +  A+KR+    G+        RE  A +  L   +H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 77
Query: 831 SLQGYCR-HGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            L   C     DR     L++ +++     Y   + V +  V    ++  + Q   RGL 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQ-LLRGLD 134
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPP 944
           +LH      +VHRD+K  NIL+    +  LADFGL+R+   Y   +  T +V TL Y  P
Sbjct: 135 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAP 188
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
           E     +     D++S G +  E+   R+P+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 779 IGCGGFGLVYKA-TLTNGTK-AAVKRLSGDCGQ------MEREFQAEVEALSRAQHKNLV 830
           IG G +G V+KA  L NG +  A+KR+    G+        RE  A +  L   +H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 77
Query: 831 SLQGYCR-HGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            L   C     DR     L++ +++     Y   + V +  V    ++  + Q   RGL 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQ-LLRGLD 134
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLVGTLGYIPP 944
           +LH      +VHRD+K  NIL+    +  LADFGL+R+   Y   +  T +V TL Y  P
Sbjct: 135 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAP 188
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
           E     +     D++S G +  E+   R+P+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  +  + +G K AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 111
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 165
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R    +     T  V T  Y 
Sbjct: 166 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 218
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+ T+      D++S G ++ ELLTGR
Sbjct: 219 APEIMLNWMHYNMTV------DIWSVGCIMAELLTGR 249

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 115/266 (43%), Gaps = 34/266 (12%)
Query: 771  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQAEVEAL---- 821
            + +    ++G GGFG VY    +++    A+K +      D G++    +  +E +    
Sbjct: 8    SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 822  SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
              +    ++ L  +    +  +LI   ME       L + + +   L+ ++         
Sbjct: 68   VSSGFSGVIRLLDWFERPDSFVLILERMEPVQD---LFDFITERGALQEELARSFFWQVL 124
Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              + + H      ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  
Sbjct: 125  EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRV 178
Query: 941  YIPPEYSQTLTATCR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDL 986
            Y PPE+ +      R   V+S G++L +++ G  P     E+ +G+          C+ L
Sbjct: 179  YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHL 238
Query: 987  VSWVFQMK-SEKREVEIIDASIWHKD 1011
            + W   ++ S++   E I    W +D
Sbjct: 239  IRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 24/232 (10%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTK-AAVKR--LSGDCGQMEREFQAEVEALSRAQHK 827
             + +   IG G +G V+KA      +  A+KR  L  D   +      E+  L   +HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           N+V L           L++ + +     Y+   + D D  +      ++     +GL + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL----KGLGFC 117
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTLGYIP 943
           H     +++HRD+K  N+L++   E  LA+FGL+R     +R Y   V      TL Y P
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRP 169
Query: 944 PE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
           P+  +   L +T   D++S G +  EL    RP  +  G +  D +  +F++
Sbjct: 170 PDVLFGAKLYSTS-IDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRL 218

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  +  FGL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 16/218 (7%)
Query: 765 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMEREFQ---AEVE 819
           D +K T+ FN   ++G G FG V  +    GT    AVK L  D    + + +    E  
Sbjct: 15  DRMKLTD-FNFLMVLGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
            L+       ++    C    DRL  +  Y+  G L Y + +        K    +  A 
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAA 128
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
             A GL +L       I++RD+K  N++LD +    +ADFG+ +    +D   T    GT
Sbjct: 129 EIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGT 184
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             YI PE           D ++FGV+L E+L G+ P E
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 29   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 88
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 89   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 145
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 146  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 202
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 203  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 259
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 260  IPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 312

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++  G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 134 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 187 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++  G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++  G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD---KDSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL     + H    
Sbjct: 134 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 187 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 131 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 184 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 24   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 83
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 84   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 140
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 141  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 197
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 198  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 255  IPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNG----TKAAVKRLSGDCG-QMEREFQAEVE 819
           +LK T    +  ++G G FG VYK   + +G       A+K L  +   +  +E   E  
Sbjct: 13  ILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++      +  L G C     +L +   M  G L   + E+  +     +L W +++  
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI-- 128
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
               A+G++YL  V    +VHRD+ + N+L+       + DFGL+RLL   +T    D  
Sbjct: 129 ----AKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-- 179
Query: 937 GTLGYIPPEYSQTLTA-----TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 988
              G +P ++    +      T + DV+S+GV + EL+T G +P +    +   DL+ 
Sbjct: 180 --GGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 235

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + DF L+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 24   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 83
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 84   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 140
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 141  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 197
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 198  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 255  IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 769 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQA--EVEALSRAQ 825
           +T+ +     IG G +G VYKA    +G   A+K +    G+         EV  L R +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 826 ---HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIAQGA 880
              H N+V L   C        I   +    +D  L   +DK     L  +    + +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGTL 939
            RGL +LH  C   IVHRD+K  NIL+       LADFGL+R+   Y   +    +V TL
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVTL 175
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
            Y  PE     T     D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 124/286 (43%), Gaps = 39/286 (13%)
Query: 751  VLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----G 805
            VLFQ    K+    + L+S   +    ++G GGFG VY    +++    A+K +      
Sbjct: 16   VLFQGPHMKE---KEPLES--QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 70
Query: 806  DCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES 861
            D G++    +  +E +      +    ++ L  +    +  +LI   +E       L + 
Sbjct: 71   DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDF 127
Query: 862  VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGL 920
            + +   L+ ++           + + H      ++HRD+K  NIL+D  + E  L DFG 
Sbjct: 128  ITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 184
Query: 921  SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGRRPV---- 975
              LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G  P     
Sbjct: 185  GALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 241
Query: 976  EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
            E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 242  EIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 287

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 65/239 (27%), Positives = 101/239 (42%), Gaps = 20/239 (8%)
Query: 762 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAE 817
           + +D      N+     IG G F  V  A  +  G + AVK   +   +   +++ F+ E
Sbjct: 6   SATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-E 64
Query: 818 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 876
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 120
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            Q     + Y H   + +IVHRD+K+ N+LLD      +ADFG S      +   T    
Sbjct: 121 RQ-IVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FC 174
Query: 937 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 230

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSLQGY------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + D GL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRWYR 189
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 9    LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 68
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 69   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 125
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 126  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 182
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 183  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+ +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 240  IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 129 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 182 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 134 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 187 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKA----AVKRL-SGDCGQMEREFQAEVE 819
           +LK T  F +  ++G G FG VYK   +  G K     A+K L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK---DSVLKWDVRLKI 876
            ++   + ++  L G C     +L I   M  G L  ++ E  D      +L W V++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTTD 934
               A+G+ YL    +  +VHRD+ + N+L+       + DFG ++LL     + H    
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVE 976
            V  + ++  E       T + DV+S+GV + EL+T G +P +
Sbjct: 180 KV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 16/218 (7%)
Query: 765 DLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLSGDCGQMEREFQ---AEVE 819
           D +K T+ FN   ++G G FG V   +   GT    AVK L  D    + + +    E  
Sbjct: 336 DRMKLTD-FNFLMVLGKGSFGKVM-LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
            L+       ++    C    DRL  +  Y+  G L Y + +        K    +  A 
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAA 449
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
             A GL +L       I++RD+K  N++LD +    +ADFG+ +    +D   T    GT
Sbjct: 450 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGT 505
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
             YI PE           D ++FGV+L E+L G+ P E
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 131  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 187
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 188  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRP 247
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 248  TFEEIQNHPWMQD 260

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 101/239 (42%), Gaps = 20/239 (8%)
Query: 762 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAE 817
           T +D      N+     IG G F  V  A  +  G + AV+ +     +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-E 63
Query: 818 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 876
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S        +   +  
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF--GNKLDEFC 173
Query: 937 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 817 EVEALSRAQ-HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
           EV+ L +   H N++ L+          L++  M+ G L  +L E V     L      K
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRK 128
Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
           I +     +  LHK+   +IVHRD+K  NILLD+     L DFG S  L P +      +
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRSV 183
Query: 936 VGTLGYIPPEYSQ-TLTATCRG-----DVYSFGVVLLELLTGRRP 974
            GT  Y+ PE  + ++     G     D++S GV++  LL G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQM---EREFQAEVEALSRAQHKNLVSLQG 834
           +G G +G V  A  T  G + AVK+LS     +   +R ++ E+  L   +H+N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 835 Y------CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                      ND  L+   M        L+  V    +    V+  I Q   RGL Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 142
Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
                 I+HRD+K SN+ ++E  E  + D GL+R    +     T  V T  Y  PE   
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRWYRAPEIML 195
Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGR 972
               Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 NWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 28/219 (12%)
Query: 776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
             +IG G FG VY           +  +  D     + F+ EV A  + +H+N+V   G 
Sbjct: 38  GELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARGLAYLHKVCEP 893
           C       +I S  +  +L      SV +D+ +  DV    +IAQ   +G+ YLH     
Sbjct: 98  CMSPPHLAIITSLCKGRTL-----YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 894 HIVHRDVKSSNILLDEKFEAHLADFGLS---------------RLLRPYDTHVTTDLVGT 938
            I+H+D+KS N+  D   +  + DFGL                R+   +  H+  +++  
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEV 977
           L   P      L  +   DV++ G +  EL     P + 
Sbjct: 209 LS--PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 779 IGCGGFGLVYKATLTNGTK--AAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLV----S 831
           IG G F  VYK   T  T   A  +       + ER+ F+ E E L   QH N+V    S
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHE-SVDKDSVLK-WDVRLKIAQGAARGLAYLHK 889
            +   +     +L+     +G+L  +L    V K  VL+ W       +   +GL +LH 
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQFLHT 147
Query: 890 VCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YS 947
              P I+HRD+K  NI +        + D GL+ L R         ++GT  +  PE Y 
Sbjct: 148 RTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFXAPEXYE 203
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRPVEVCK 979
           +    +   DVY+FG   LE  T   P   C+
Sbjct: 204 EKYDESV--DVYAFGXCXLEXATSEYPYSECQ 233

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 16/207 (7%)
Query: 773 FNQANIIGCGGFGLVYKATLTNGTK--AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           +   N IG G +G V K  +  GT+   A K++     +    F+ E+E +    H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            L        D  L+      G     L E V    V +     +I +     +AY HK+
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 891 CEPHIVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              ++ HRD+K  N L           L DFGL+   +P     T   VGT  Y+ P+  
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVL 180
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           + L      D +S GV++  LL G  P
Sbjct: 181 EGLYGP-ECDEWSAGVMMYVLLCGYPP 206

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 120/285 (42%), Gaps = 40/285 (14%)
Query: 758  CKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----GD 806
            C DL  + L          + +    ++G GGFG VY    +++    A+K +      D
Sbjct: 24   CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 83
Query: 807  CGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV 862
             G++    +  +E +      +    ++ L  +    +  +LI   +E       L + +
Sbjct: 84   WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFI 140
Query: 863  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLS 921
             +   L+ ++           + + H      ++HRD+K  NIL+D  + E  L DFG  
Sbjct: 141  TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 197
Query: 922  RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGRRPV----E 976
             LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G  P     E
Sbjct: 198  ALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254
Query: 977  VCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
            + +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 255  IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 773 FNQANIIGCGGFGLVYKATLTNGTK--AAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
           +   N IG G +G V K  +  GT+   A K++     +    F+ E+E +    H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            L        D  L+      G     L E V    V +     +I +     +AY HK+
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 142
Query: 891 CEPHIVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              ++ HRD+K  N L           L DFGL+   +P     T   VGT  Y+ P+  
Sbjct: 143 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVL 197
Query: 948 QTLTA-TCRGDVYSFGVVLLELLTGRRP 974
           + L    C  D +S GV++  LL G  P
Sbjct: 198 EGLYGPEC--DEWSAGVMMYVLLCGYPP 223

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 129/302 (42%), Gaps = 67/302 (22%)
Query: 773  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER-----------------EFQ 815
            FN++  +G G F  ++K          V+R  GD GQ+                    F 
Sbjct: 12   FNES--LGQGTFTKIFKG---------VRREVGDYGQLHETEVLLKVLDKAHRNYSESFF 60
Query: 816  AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
                 +S+  HK+LV   G C  G++ +L+  +++ GSLD +L ++ +  ++L W  +L+
Sbjct: 61   EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLE 117
Query: 876  IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA--------HLADFGLSRLLRPY 927
            +A+  A  + +L    E  ++H +V + NILL  + +          L+D G+S  + P 
Sbjct: 118  VAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 928  DTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD 985
            D      L   + ++PPE            D +SFG  L E+ + G +P+     +  R 
Sbjct: 175  DI-----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RK 227
Query: 986  LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
            L     Q   ++ ++    A+           E+  +   C+D +P  RP    ++  L+
Sbjct: 228  L-----QFYEDRHQLPAPKAA-----------ELANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 1046 GI 1047
             +
Sbjct: 272  SL 273

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 71/290 (24%), Positives = 125/290 (43%), Gaps = 35/290 (12%)
Query: 771  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVK-----RLSGDCGQMERE-FQAEVEALSR 823
            +++     +G G F +V K      G + A K     RLS     + RE  + EV  L  
Sbjct: 5    DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
             +H N+++L     +  D +LI   +  G L  +L E   K+S+ + D   +  +    G
Sbjct: 65   IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTE-DEATQFLKQILDG 120
Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTL 939
            + YLH      I H D+K  NI+L +K        L DFG++  +   +     ++ GT 
Sbjct: 121  VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTP 175
Query: 940  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
             ++ PE           D++S GV+   LL+G  P     G+  ++ ++ +  +  +  E
Sbjct: 176  EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGETKQETLTNISAVNYDFDE 232
Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV--TWLDGI 1047
                + S   KD  ++LL           +DP+RR  I + +  +W+  I
Sbjct: 233  EYFSNTSELAKDFIRRLLV----------KDPKRRMTIAQSLEHSWIKAI 272

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+         E+  L   +H+N
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L             ND  L+   M        L+  V    +    V+  I Q   R
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-ILR 136
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + D GL+R    +     T  V T  Y 
Sbjct: 137 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRWYR 189
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 178  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 234
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 235  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 294
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 295  TFEEIQNHPWMQD 307

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 120/285 (42%), Gaps = 40/285 (14%)
Query: 758  CKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS----GD 806
            C DL  + L          + +    ++G GGFG VY    +++    A+K +      D
Sbjct: 5    CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 64
Query: 807  CGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV 862
             G++    +  +E +      +    ++ L  +    +  +LI   +E       L + +
Sbjct: 65   WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFI 121
Query: 863  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLS 921
             +   L+ ++           + + H      ++HRD+K  NIL+D  + E  L DFG  
Sbjct: 122  TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 922  RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGRRPV----E 976
             LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G  P     E
Sbjct: 179  ALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 235
Query: 977  VCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
            + +G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 236  IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 136  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 192
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 193  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 252
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 253  TFEEIQNHPWMQD 265

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 57/221 (25%)
Query: 779 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQA---------EVEALSRAQH 826
           +G G +G V   Y A L    K AVK+LS       R FQ+         E+  L   +H
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLS-------RPFQSLIHARRTYRELRLLKHLKH 78
Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--SVDKDSVLKWD------VRLKIAQ 878
           +N++ L        D     + +E+ S  Y +      D ++++K        V+  + Q
Sbjct: 79  ENVIGLL-------DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQ 131
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
              RGL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R          T  V T
Sbjct: 132 -LLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVAT 183
Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
             Y  PE       Y+QT+      D++S G ++ ELL G+
Sbjct: 184 RWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLQGK 218

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 20/239 (8%)
Query: 762 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAE 817
           T +D      N+     IG G F  V  A  +  G + AVK +     +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-E 63
Query: 818 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 876
           V  +    H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKF 119
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            Q  +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   +     
Sbjct: 120 RQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDA-FC 173
Query: 937 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           G   Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 150  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 206
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 207  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 266
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 267  TFEEIQNHPWMQD 279

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 151  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 207
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 208  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRP 267
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 268  TFEEIQNHPWMQD 280

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 150  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 206
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 207  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRP 266
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 267  TFEEIQNHPWMQD 279

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 779  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 72   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 876
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 132  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 190
Query: 877  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 934
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 191  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 935  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 991
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 247  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 301
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 302  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 26/240 (10%)
Query: 764 SDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVE 819
           SD      N+     IG G F  V  A  +  G + A+K   +   +   +++ F+ EV 
Sbjct: 5   SDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVR 63
Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQ 878
            +    H N+V L           LI  Y   G + DY +     K+     + R K  Q
Sbjct: 64  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQ 119
Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR---PYDTHVTTDL 935
             +  + Y H   +  IVHRD+K+ N+LLD      +ADFG S         DT      
Sbjct: 120 IVS-AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-----F 170
Query: 936 VGTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
            G+  Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 171 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 227

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 779  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 876
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 153
Query: 877  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 934
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 154  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 935  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 991
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 210  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 264
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 265  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG-DCGQMEREFQAEVEALSRAQHK 827
           +++F   +++G G +G+V  AT    G   A+K++   D          E++ L   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           N++++    R  +       Y+    +   LH  +    +    ++  I Q   R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-TLRAVKVL 128
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--------RPYDTHV-TTDLVGT 938
           H     +++HRD+K SN+L++   +  + DFGL+R++         P       T+ V T
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 939 LGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 991
             Y  PE   T     R  DV+S G +L EL   RRP  +  G++ R  +  +F
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP--IFPGRDYRHQLLLIF 236

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 129/302 (42%), Gaps = 67/302 (22%)
Query: 773  FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER-----------------EFQ 815
            FN++  +G G F  ++K          V+R  GD GQ+                    F 
Sbjct: 12   FNES--LGQGTFTKIFKG---------VRREVGDYGQLHETEVLLKVLDKAHRNYSESFF 60
Query: 816  AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
                 +S+  HK+LV   G C  G++ +L+  +++ GSLD +L ++ +  ++L W  +L+
Sbjct: 61   EAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLE 117
Query: 876  IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA--------HLADFGLSRLLRPY 927
            +A+  A  + +L    E  ++H +V + NILL  + +          L+D G+S  + P 
Sbjct: 118  VAKQLAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 928  DTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD 985
            D      L   + ++PPE            D +SFG  L E+ + G +P+     +  R 
Sbjct: 175  DI-----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RK 227
Query: 986  LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
            L     Q   ++ ++    A+           E+  +   C+D +P  RP    ++  L+
Sbjct: 228  L-----QFYEDRHQLPAPKAA-----------ELANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 1046 GI 1047
             +
Sbjct: 272  SL 273

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG-DCGQMEREFQAEVEALSRAQHK 827
           +++F   +++G G +G+V  AT    G   A+K++   D          E++ L   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           N++++    R  +       Y+    +   LH  +    +    ++  I Q   R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-TLRAVKVL 128
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--------RPYDTHV-TTDLVGT 938
           H     +++HRD+K SN+L++   +  + DFGL+R++         P       T+ V T
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 939 LGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 991
             Y  PE   T     R  DV+S G +L EL   RRP  +  G++ R  +  +F
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP--IFPGRDYRHQLLLIF 236

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 136  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 192
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 193  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 252
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 253  TFEEIQNHPWMQD 265

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 35/290 (12%)
Query: 771  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVK-----RL-SGDCGQMEREFQAEVEALSR 823
            +++     +G G F +V K      G + A K     RL S   G    E + EV  L  
Sbjct: 26   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
             +H N+++L     +  D +LI   +  G L  +L E   K+S+ + D   +  +    G
Sbjct: 86   IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTE-DEATQFLKQILDG 141
Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTL 939
            + YLH      I H D+K  NI+L +K        L DFG++  +   +     ++ GT 
Sbjct: 142  VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTP 196
Query: 940  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
             ++ PE           D++S GV+   LL+G  P     G+  ++ ++ +  +  +  E
Sbjct: 197  EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGETKQETLTNISAVNYDFDE 253
Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV--TWLDGI 1047
                + S   KD  ++LL           +DP+RR  I + +  +W+  I
Sbjct: 254  EYFSNTSELAKDFIRRLLV----------KDPKRRMXIAQSLEHSWIKAI 293

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 779  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 876
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 153
Query: 877  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 934
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 154  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 935  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 991
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 210  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 264
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 265  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 119/292 (40%), Gaps = 47/292 (16%)
Query: 779  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 876
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 86   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 144
Query: 877  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDL 935
            +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D     D 
Sbjct: 145  SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 936  VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQ 992
               L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L      
Sbjct: 202  RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 255
Query: 993  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
               E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 256  --KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 55/243 (22%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLS-----------------------GD 806
           N +   + IG G +G+V  A   N  T  A+K LS                       G 
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 807 C----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV 862
           C    G +E+ +Q E+  L +  H N+V L       N+  L           Y + E V
Sbjct: 73  CIQPRGPIEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHL-----------YMVFELV 120
Query: 863 DKDSVLKWDVRLKIAQGAAR--------GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH 914
           ++  V++      +++  AR        G+ YLH      I+HRD+K SN+L+ E     
Sbjct: 121 NQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIK 177
Query: 915 LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTG 971
           +ADFG+S   +  D  + ++ VGT  ++ PE          G   DV++ GV L   + G
Sbjct: 178 IADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 972 RRP 974
           + P
Sbjct: 237 QCP 239

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 779  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 37   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 876
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 97   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD-FLTLEHLICY 155
Query: 877  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 934
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 156  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 935  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 991
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 212  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 266
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 267  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N F    ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             ++H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   D         
Sbjct: 65  QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEI 119
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH   E ++V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 120 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPE 176
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N F    ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 62
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             ++H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   D         
Sbjct: 63  QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEI 117
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH   E ++V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 118 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPE 174
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 175 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N F    ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 63
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             ++H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   D         
Sbjct: 64  QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEI 118
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH   E ++V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 119 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPE 175
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 136  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 192
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 193  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 252
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 253  TFEEIQNHPWMQD 265

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 779  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 876
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 153
Query: 877  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 934
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 154  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 935  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 991
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 210  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 264
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 265  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 10   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 69
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 70   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 126
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 127  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 183
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 184  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 241  IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 135  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 191
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 192  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 251
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 252  TFEEIQNHPWMQD 264

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 131  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 187
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 188  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 247
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 248  TFEEIQNHPWMQD 260

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 151  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 207
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMKSEKRE 999
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++   R 
Sbjct: 208  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPXDRP 267
Query: 1000 V-EIIDASIWHKD 1011
              E I    W +D
Sbjct: 268  TFEEIQNHPWMQD 280

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 134  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 190
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+ +G+          C+ L+ W   ++ S++ 
Sbjct: 191  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 250
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 251  TFEEIQNHPWMQD 263

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 10   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 69
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 70   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 126
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 127  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 183
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 184  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 241  IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 10   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 69
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 70   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 126
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 127  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 183
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 184  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 241  IPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 9    LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 68
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 69   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 125
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 126  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 182
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 183  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 240  IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 9    LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 68
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 69   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 125
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 126  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 182
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 183  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 240  IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 10   LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 69
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 70   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 126
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 127  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 183
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 184  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 241  IPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 119/292 (40%), Gaps = 47/292 (16%)
Query: 779  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 876
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 86   NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 144
Query: 877  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDL 935
            +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D     D 
Sbjct: 145  SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 936  VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQ 992
               L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L      
Sbjct: 202  RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 255
Query: 993  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
               E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 256  --KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 65/239 (27%), Positives = 98/239 (41%), Gaps = 20/239 (8%)
Query: 762 TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAE 817
           T +D      N+     IG G F  V  A  +  G + AVK   +   +   +++ F+ E
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-E 63
Query: 818 VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKI 876
           V       H N+V L           L+  Y   G + DY +     K+     + R K 
Sbjct: 64  VRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK----EARAKF 119
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
            Q     + Y H   +  IVHRD+K+ N+LLD      +ADFG S     +   +     
Sbjct: 120 RQ-IVSAVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDA-FC 173
Query: 937 GTLGYIPPEYSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           G   Y  PE  Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 229

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 127/302 (42%), Gaps = 60/302 (19%)
Query: 767  LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            L+  ++F +  ++G G FG V KA    +    A+K++     ++     +EV  L+   
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLN 60
Query: 826  H-------------KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWD 871
            H             +N V      +  +   +   Y EN +L   +H E++++     W 
Sbjct: 61   HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 872  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-------LL 924
            +  +I +     L+Y+H      I+HRD+K  NI +DE     + DFGL++       +L
Sbjct: 121  LFRQILEA----LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 925  R------PYDTHVTTDLVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELL----TGRR 973
            +      P  +   T  +GT  Y+  E    T     + D+YS G++  E++    TG  
Sbjct: 174  KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 974  PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1033
             V + K       VS  F    +  ++++          EK+++ +L      ID DP +
Sbjct: 234  RVNILKKLRS---VSIEFPPDFDDNKMKV----------EKKIIRLL------IDHDPNK 274
Query: 1034 RP 1035
            RP
Sbjct: 275  RP 276

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 25/233 (10%)
Query: 755 NSDCKDLTVSDLLK-----STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSG 805
           NS  +++ VS L K     + N F    ++G G FG V     KAT   G   A+K L  
Sbjct: 131 NSGAEEMEVS-LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKK 186
Query: 806 DCGQMEREFQ---AEVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHES 861
           +    + E      E   L  ++H  L +L+ Y    +DRL  +  Y   G L + L   
Sbjct: 187 EVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL--- 242
Query: 862 VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS 921
             ++ V   D            L YLH   E ++V+RD+K  N++LD+     + DFGL 
Sbjct: 243 -SRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 299
Query: 922 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           +     D        GT  Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 300 K-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 32/80 (40%), Positives = 40/80 (50%)
Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRDVK  NIL+     A+L DFG++            + VGTL Y  PE      AT R 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 957 DVYSFGVVLLELLTGRRPVE 976
           D+Y+   VL E LTG  P +
Sbjct: 217 DIYALTCVLYECLTGSPPYQ 236

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 750  LVLFQNSDCKDLTVSDLLKST------NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKR 802
            L   + + C DL  + L          + +    ++G GGFG VY    +++    A+K 
Sbjct: 9    LAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 68
Query: 803  LS----GDCGQMEREFQAEVEAL----SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL 854
            +      D G++    +  +E +      +    ++ L  +    +  +LI   +E    
Sbjct: 69   VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEP 125
Query: 855  DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEA 913
               L + + +   L+ ++           + + H      ++HRD+K  NIL+D  + E 
Sbjct: 126  VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 182
Query: 914  HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGR 972
             L DFG   LL+  DT V TD  GT  Y PPE+ +      R   V+S G++L +++ G 
Sbjct: 183  KLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 973  RPV----EVCKGK---------NCRDLVSWVFQMK-SEKREVEIIDASIWHKD 1011
             P     E+  G+          C+ L+ W   ++ S++   E I    W +D
Sbjct: 240  IPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 25/233 (10%)
Query: 755 NSDCKDLTVSDLLK-----STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSG 805
           NS  +++ VS L K     + N F    ++G G FG V     KAT   G   A+K L  
Sbjct: 128 NSGAEEMEVS-LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKK 183
Query: 806 DCGQMEREFQ---AEVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHES 861
           +    + E      E   L  ++H  L +L+ Y    +DRL  +  Y   G L + L   
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL--- 239
Query: 862 VDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS 921
             ++ V   D            L YLH   E ++V+RD+K  N++LD+     + DFGL 
Sbjct: 240 -SRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
Query: 922 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           +     D        GT  Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 297 K-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 70/287 (24%), Positives = 124/287 (43%), Gaps = 35/287 (12%)
Query: 771  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVK-----RLSGDCGQMERE-FQAEVEALSR 823
            +++     +G G F +V K      G + A K     RLS     + RE  + EV  L  
Sbjct: 12   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
             +H N+++L     +  D +LI   +  G L  +L E   K+S+ + D   +  +    G
Sbjct: 72   IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTE-DEATQFLKQILDG 127
Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTL 939
            + YLH      I H D+K  NI+L +K        L DFG++  +   +     ++ GT 
Sbjct: 128  VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTP 182
Query: 940  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
             ++ PE           D++S GV+   LL+G  P     G+  ++ ++ +  +  +  E
Sbjct: 183  EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGETKQETLTNISAVNYDFDE 239
Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV--TWL 1044
                + S   KD  ++LL           +DP+RR  I + +  +W+
Sbjct: 240  EYFSNTSELAKDFIRRLLV----------KDPKRRMXIAQSLEHSWI 276

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 19/219 (8%)
Query: 769 STNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL-----SGDCGQMEREFQAEVEALS 822
           +T+ +     IG G +G VYKA    +G   A+K +      G  G +      EV  L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 823 RAQ---HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV--LKWDVRLKIA 877
           R +   H N+V L   C        I   +    +D  L   +DK     L  +    + 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 878 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-TDLV 936
           +   RGL +LH  C   IVHRD+K  NIL+       LADFGL+R+   Y   +  T +V
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVV 180
Query: 937 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV 975
            TL Y  PE     T     D++S G +  E+   R+P+
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG-DCGQMEREFQAEVEALSRAQHK 827
           +++F   +++G G +G+V  AT    G   A+K++   D          E++ L   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           N++++    R  +       Y+    +   LH  +    +    ++  I Q   R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-TLRAVKVL 128
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL--RPYDTHVTT-------DLVGT 938
           H     +++HRD+K SN+L++   +  + DFGL+R++     D    T       + V T
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 939 LGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 991
             Y  PE   T     R  DV+S G +L EL   RRP  +  G++ R  +  +F
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP--IFPGRDYRHQLLLIF 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 779  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 876
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 86   NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 144
Query: 877  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 934
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 145  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 935  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 991
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 201  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 255
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 256  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 779  IGCGGFGLVYKA-------TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLV 830
            +G G FG V +A       T T  T A      G      R   +E++ L     H N+V
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 831  SLQGYC-RHGNDRLLIYSYMENGSLDYWLH-------------ESVDKDSVLKWDVRLKI 876
            +L G C + G   ++I  + + G+L  +L              E + KD  L  +  +  
Sbjct: 86   NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD-FLTLEHLICY 144
Query: 877  AQGAARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTD 934
            +   A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D
Sbjct: 145  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 935  LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVF 991
                L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L     
Sbjct: 201  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 255
Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 256  ---KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 102/249 (40%), Gaps = 30/249 (12%)
Query: 770  TNNFNQANIIGCGGFG--LVYKATLTNGTKAA--VKRLSGDCGQMEREFQAEVEALSRAQ 825
            ++ + +   +G G +G  L+ K  LT   +A   +K+ S            EV  L +  
Sbjct: 20   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N++ L  +     +  L+      G L     E + +    + D  + I +    G  
Sbjct: 80   HPNIMKLYEFFEDKRNYYLVMEVYRGGEL---FDEIILRQKFSEVDAAV-IMKQVLSGTT 135
Query: 886  YLHKVCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYI 942
            YLHK    +IVHRD+K  N+LL+ K    L    DFGLS            + +GT  YI
Sbjct: 136  YLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV--GGKMKERLGTAYYI 190
Query: 943  PPEY-SQTLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSWVF 991
             PE   +     C  DV+S GV+L  LL G  P            V KGK   D   W  
Sbjct: 191  APEVLRKKYDEKC--DVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWT- 247
Query: 992  QMKSEKREV 1000
            Q+  E +++
Sbjct: 248  QVSDEAKQL 256

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 22/230 (9%)
Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSG---DCGQMEREFQAEVEALSRAQHK 827
           N+     IG G F  V  A  +  G + A+K +     +   +++ F+ EV  +    H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
           N+V L           LI  Y   G + DY +     K+     + R K  Q  +  + Y
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQIVS-AVQY 129
Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE 945
            H   +  IVHRD+K+ N+LLD      +ADFG S     +      D   G   Y  PE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPYAAPE 183
Query: 946 YSQTLTATC-RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
             Q         DV+S GV+L  L++G  P +   G+N ++L   V + K
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGK 230

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           +G G +G V   Y A L    K AVK+LS       R FQ+ + A  R  ++ L  L+ +
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLS-------RPFQSLIHA--RRTYRELRLLK-H 83
Query: 836 CRHGN-----DRLLIYSYMENGSLDYW--------LHESVDKDSVLKWDVRLKIAQGAAR 882
            +H N     D     + +E+ S  Y         L+  V   ++    V+  + Q   R
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQ-LLR 142
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R          T  V T  Y 
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQA----DEEMTGYVATRWYR 195
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELL G+
Sbjct: 196 APEIMLNWMHYNQTV------DIWSVGCIMAELLQGK 226

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 66/133 (49%), Gaps = 19/133 (14%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            ++HRD+K  NIL+D  + E  L DFG   LL+  DT V TD  GT  Y PPE+ +     
Sbjct: 131  VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT-VYTDFDGTRVYSPPEWIRYHRYH 187
Query: 954  CR-GDVYSFGVVLLELLTGRRPV----EVCKGK---------NCRDLVSWVFQMK-SEKR 998
             R   V+S G++L +++ G  P     E+  G+          C+ L+ W   ++ S++ 
Sbjct: 188  GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRP 247
Query: 999  EVEIIDASIWHKD 1011
              E I    W +D
Sbjct: 248  TFEEIQNHPWMQD 260

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 772 NFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNL 829
           +F     +G GGFG+V++A    +    A+KR+     ++ RE    EV+AL++ +H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 830 VS-LQGYCRHGNDRLL------IYSYME-----NGSLDYWLHESVDKDSVLKWDVRLKIA 877
           V     +        L      +Y Y++       +L  W++     +   +  V L I 
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER-SVCLHIF 124
Query: 878 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL----------SRLLRPY 927
              A  + +LH      ++HRD+K SNI         + DFGL            +L P 
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 928 DTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELL 969
             +   T  VGT  Y+ PE     + + + D++S G++L ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 770 TNNFNQANIIGCGGFG--LVYKATLTNGTKAA--VKRLSGDCGQMEREFQAEVEALSRAQ 825
           ++ + +   +G G +G  L+ K  LT   +A   +K+ S            EV  L +  
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N++ L  +     +  L+      G L     E + +    + D  + I +    G  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL---FDEIILRQKFSEVDAAV-IMKQVLSGTT 118
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           YLHK    +IVHRD+K  N+LL+ K    L    DFGLS            + +GT  YI
Sbjct: 119 YLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV--GGKMKERLGTAYYI 173
Query: 943 PPEY-SQTLTATCRGDVYSFGVVLLELLTGRRP 974
            PE   +     C  DV+S GV+L  LL G  P
Sbjct: 174 APEVLRKKYDEKC--DVWSCGVILYILLCGYPP 204

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           +G G +G V   Y A L    K AVK+LS       R FQ+ + A  R  ++ L  L+ +
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLS-------RPFQSLIHA--RRTYRELRLLK-H 83
Query: 836 CRHGN-----DRLLIYSYMENGSLDYWLHE--SVDKDSVLKWD------VRLKIAQGAAR 882
            +H N     D     + +E+ S  Y +      D ++++K        V+  + Q   R
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQ-LLR 142
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R          T  V T  Y 
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQA----DEEMTGYVATRWYR 195
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ ELL G+
Sbjct: 196 APEIMLNWMHYNQTV------DIWSVGCIMAELLQGK 226

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 41/289 (14%)
Query: 779  IGCGGFGLV-YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G GGF  V     L +G   A+KR+     Q   E Q E +      H N++ L  YC 
Sbjct: 37   LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 838  H----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
                  ++  L+  + + G+L   +    DK + L  D  L +  G  RGL  +H     
Sbjct: 97   RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---K 153
Query: 894  HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG-----------TLGYI 942
               HRD+K +NILL ++ +  L D G    +     HV                 T+ Y 
Sbjct: 154  GYAHRDLKPTNILLGDEGQPVLMDLG---SMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 943  PPEYSQTLTATC----RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 998
             PE   ++ + C    R DV+S G VL  ++ G  P ++   K   D V+   Q +    
Sbjct: 211  APELF-SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--DSVALAVQNQLSIP 267
Query: 999  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            +     +++W      QLL  +      +  DP +RP I  +++ L+ +
Sbjct: 268  QSPRHSSALW------QLLNSM------MTVDPHQRPHIPLLLSQLEAL 304

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 90/224 (40%), Gaps = 24/224 (10%)
Query: 763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 818
           + DL     ++    +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           + ++ A    +V L  +    +DR L  +  YM  G L   ++   + D   KW  R   
Sbjct: 126 DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYT 179
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
           A+     L  +H +     +HRDVK  N+LLD+     LADFG    +           V
Sbjct: 180 AE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 937 GTLGYIPPEYSQT------LTATCRGDVYSFGVVLLELLTGRRP 974
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 277

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 90/224 (40%), Gaps = 24/224 (10%)
Query: 763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 818
           + DL     ++    +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           + ++ A    +V L  +    +DR L  +  YM  G L   ++   + D   KW  R   
Sbjct: 126 DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYT 179
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
           A+     L  +H +     +HRDVK  N+LLD+     LADFG    +           V
Sbjct: 180 AE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 937 GTLGYIPPEYSQT------LTATCRGDVYSFGVVLLELLTGRRP 974
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 90/224 (40%), Gaps = 24/224 (10%)
Query: 763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 818
           + DL     ++    +IG G FG V      +  K    +L      ++R     F  E 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           + ++ A    +V L  +    +DR L  +  YM  G L   ++   + D   KW  R   
Sbjct: 121 DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKW-ARFYT 174
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
           A+     L  +H +     +HRDVK  N+LLD+     LADFG    +           V
Sbjct: 175 AE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 937 GTLGYIPPEYSQT------LTATCRGDVYSFGVVLLELLTGRRP 974
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP 272

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 60/302 (19%)
Query: 767  LKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            L+  ++F +  ++G G FG V KA    +    A+K++     ++     +EV  L+   
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVXLLASLN 60
Query: 826  H-------------KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWD 871
            H             +N V      +  +   +   Y EN +L   +H E++++     W 
Sbjct: 61   HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 872  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-------LL 924
            +  +I +     L+Y+H      I+HR++K  NI +DE     + DFGL++       +L
Sbjct: 121  LFRQILEA----LSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 925  R------PYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELL----TGRR 973
            +      P  +   T  +GT  Y+  E    T     + D YS G++  E +    TG  
Sbjct: 174  KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXE 233
Query: 974  PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1033
             V + K       VS  F    +  + ++          EK+++ +L      ID DP +
Sbjct: 234  RVNILKKLRS---VSIEFPPDFDDNKXKV----------EKKIIRLL------IDHDPNK 274
Query: 1034 RP 1035
            RP
Sbjct: 275  RP 276

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 49/217 (22%)
Query: 779 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 828
           +G G +G V  A     G K A+K+L        R FQ+E+ A         L   +H+N
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           ++ L              D  L+  +M         HE + +D +     +  + Q   +
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI-----QFLVYQ-MLK 139
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL Y+H      I+HRD+K  N+ ++E  E  + DFGL+R     D+ +   +V T  Y 
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMXGXVV-TRWYR 192
Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+QT+      D++S G ++ E++TG+
Sbjct: 193 APEVILNWMRYTQTV------DIWSVGCIMAEMITGK 223

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 24/224 (10%)
Query: 763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE----FQAEV 818
           +  L     +++   +IG G FG V         K    +L      ++R     F  E 
Sbjct: 67  IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
           + ++ A    +V L  +C   +D+ L  +  YM  G L   ++   + D   KW  +   
Sbjct: 127 DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL---VNLMSNYDVPEKW-AKFYT 180
Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
           A+     L  +H +    ++HRDVK  N+LLD+     LADFG    +           V
Sbjct: 181 AE-VVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV 236
Query: 937 GTLGYIPPEYSQT------LTATCRGDVYSFGVVLLELLTGRRP 974
           GT  YI PE  ++          C  D +S GV L E+L G  P
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLFEMLVGDTP 278

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 23/225 (10%)
Query: 775 QANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSL 832
           Q +++G G    V     L    + AVK +    G +      EVE L + Q H+N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
             +    +   L++  M  GS+   +H+    +  L+  V   + Q  A  L +LH    
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASV---VVQDVASALDFLHN--- 129
Query: 893 PHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLR------PYDTHVTTDLVGTLGYIP 943
             I HRD+K  NIL +   +     + DFGL   ++      P  T       G+  Y+ 
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 944 PEYSQTLTATC-----RGDVYSFGVVLLELLTGRRPVEVCKGKNC 983
           PE  +  +        R D++S GV+L  LL+G  P     G +C
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 12   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 72   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 127
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 128  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 182
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 183  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 239
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 240  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 267

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 12   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 72   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 127
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 128  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 182
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 183  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 239
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 240  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 267

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 776 ANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           A  +G G FG+V++   T+  K  + +     G  +   + E+  L+ A+H+N++ L   
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP-- 893
                + ++I+ ++    LD  + E ++  S  + + R  ++        Y+H+VCE   
Sbjct: 70  FESMEELVMIFEFIS--GLD--IFERINT-SAFELNEREIVS--------YVHQVCEALQ 116
Query: 894 -----HIVHRDVKSSNILLDEKFEA--HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
                +I H D++  NI+   +  +   + +FG +R L+P D      L     Y  PE 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEV 174
Query: 947 SQTLTATCRGDVYSFGVVLLELLTGRRP 974
            Q    +   D++S G ++  LL+G  P
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V++      G + AVK++     ++E     E+ A +      +V L G  R
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-----RLEVFRAEELMACAGLTSPRIVPLYGAVR 155
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G    +    +E GSL     + V +   L  D  L     A  GL YLH      I+H
Sbjct: 156 EGPWVNIFMELLEGGSLG----QLVKEQGCLPEDRALYYLGQALEGLEYLHSR---RILH 208
Query: 898 RDVKSSNILL-DEKFEAHLADFGLSRLLRP---YDTHVTTDLV-GTLGYIPPEYSQTLTA 952
            DVK+ N+LL  +   A L DFG +  L+P     + +T D + GT  ++ PE     + 
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 953 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 988
             + DV+S   ++L +L G  P  +  +G  C  + S
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIAS 305

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 785 GLVYKATLTNGTKAAVKRLSGDCGQME----------REFQAEVEALSR-AQHKNLVSLQ 833
           G V K T+  G+ +  KR       ME          R+   E+E L R  QH N+++L+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 834 GYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
                G    L+   M  G L D  L +    +    +     +     + + YLH    
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLHS--- 139
Query: 893 PHIVHRDVKSSNIL-LDEKFEA---HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
             +VHRD+K SNIL +DE        + DFG ++ LR  +  + T    T  ++ PE  +
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLK 198
Query: 949 TLTATCRGDVYSFGVVLLELLTGRRP 974
                   D++S G++L  +L G  P
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 35/228 (15%)
Query: 769 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEA 820
             + + +   IG G FG V+KA     G K A+K++      ME E +        E++ 
Sbjct: 16  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKI 70
Query: 821 LSRAQHKNLVSLQGYCRHGN---DRLLIYSYMENGSLDYWLHE--SVDKDSVLKWDVR-- 873
           L   +H+N+V+L   CR      +R     Y+     D+  H+   +  + ++K+ +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYL---VFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 874 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---LLRPYDTH 930
            ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R   L +    +
Sbjct: 128 KRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 931 VTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPV 975
              + V TL Y PPE    L     G   D++  G ++ E+ T R P+
Sbjct: 185 RYXNRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 773 FNQANIIGCGGFGLVYK-ATLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
           ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886 YLHKVCEPHIVHRDVKSSNI-LLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
           YLH +    I H D+K  NI LLD    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPAF 183
Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           + PE           D++S GV+   LL+G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 76/175 (43%), Gaps = 28/175 (16%)
Query: 812 REFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLLIYSYMENGSLDYWLHESVDKDSVLK 869
           R+F  E   L    H N++ + G C+        LI  +M  GSL   LHE  +   V+ 
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVD 109
Query: 870 WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLS-----R 922
               +K A   ARG+A+LH + EP I    + S ++++DE   A   +AD   S     R
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR 168
Query: 923 LLRPYDTHVTTDLVGTLGYIPPEYSQTL---TATCRGDVYSFGVVLLELLTGRRP 974
           +  P              ++ PE  Q     T     D++SF V+L EL+T   P
Sbjct: 169 MYAP-------------AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 38/224 (16%)
Query: 767 LKSTNNFNQANIIGCGGFGL----VYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALS 822
           ++ T+ +     IG G + +    ++KAT     + AVK +     + +R+   E+E L 
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIID----KSKRDPTEEIEILL 70
Query: 823 R-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
           R  QH N+++L+     G    ++   M+ G L          D +L+     +    A 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---------LDKILRQKFFSEREASAV 121
Query: 882 -----RGLAYLHKVCEPHIVHRDVKSSNIL-LDEK---FEAHLADFGLSRLLRPYDTHVT 932
                + + YLH      +VHRD+K SNIL +DE        + DFG ++ LR  +  + 
Sbjct: 122 LFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 933 TDLVGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T    T  ++ PE    Q   A C  D++S GV+L  +LTG  P
Sbjct: 179 TPCY-TANFVAPEVLERQGYDAAC--DIWSLGVLLYTMLTGYTP 219

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 785 GLVYKATLTNGTKAAVKRLSGDCGQME----------REFQAEVEALSR-AQHKNLVSLQ 833
           G V K T+  G+ +  KR       ME          R+   E+E L R  QH N+++L+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 834 GYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
                G    L+   M  G L D  L +    +    +     +     + + YLH    
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLH---S 139
Query: 893 PHIVHRDVKSSNIL-LDEKFEA---HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
             +VHRD+K SNIL +DE        + DFG ++ LR  +  + T    T  ++ PE  +
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLK 198
Query: 949 TLTATCRGDVYSFGVVLLELLTGRRP 974
                   D++S G++L  +L G  P
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V++      G + AVK++  +  ++E     E+ A +      +V L G  R
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G    +    +E GSL     + + +   L  D  L     A  GL YLH      I+H
Sbjct: 121 EGPWVNIFMELLEGGSLG----QLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILH 173
Query: 898 RDVKSSNILL-DEKFEAHLADFGLSRLLRP---YDTHVTTDLV-GTLGYIPPEYSQTLTA 952
            DVK+ N+LL  +   A L DFG +  L+P     + +T D + GT  ++ PE       
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 953 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 988
             + D++S   ++L +L G  P  +  +G  C  + S
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 63  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 117
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 118 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 173
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 773  FNQANIIGCGGFGLVYKA-TLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
            ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73   HPNVITLHEVYENKTDVILIGELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886  YLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            YLH +    I H D+K  NI+L +    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129  YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE           D++S GV+   LL+G  P     G   ++ ++ V  +  E  +  
Sbjct: 184  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF---LGDTKQETLANVSAVNYEFEDEY 240
Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
              + S   KD  ++LL           +DP++R  I++
Sbjct: 241  FSNTSALAKDFIRRLLV----------KDPKKRMTIQD 268

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 65  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 119
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 120 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 175
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
           + N+F+   ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
              +H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   +         
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
              L YLH      +V+RD+K  N++LD+     + DFGL +     D        GT  
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           Y+ PE  +        D +  GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 773 FNQANIIGCGGFGLVYK-ATLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
           ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886 YLHKVCEPHIVHRDVKSSNI-LLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
           YLH +    I H D+K  NI LLD    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           + PE           D++S GV+   LL+G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 37/229 (16%)
Query: 769 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEA 820
             + + +   IG G FG V+KA     G K A+K++      ME E +        E++ 
Sbjct: 16  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKI 70
Query: 821 LSRAQHKNLVSLQGYCRHGNDRL--------LIYSYMENGSLDYWLHESVDKDSVLKWDV 872
           L   +H+N+V+L   CR              L++ + E+  L   L   + K ++ +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK- 128
Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---LLRPYDT 929
             ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R   L +    
Sbjct: 129 --RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 930 HVTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPV 975
           +   + V TL Y PPE    L     G   D++  G ++ E+ T R P+
Sbjct: 184 NRYXNRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 785 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 844
           GL Y A      ++   R     G    E + EV  L +  H N+++L     +  D +L
Sbjct: 37  GLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
           I   +  G L  +L +   K+S+ + +    I Q    G+ YLH      I H D+K  N
Sbjct: 93  ILELVSGGELFDFLAQ---KESLSEEEATSFIKQ-ILDGVNYLHT---KKIAHFDLKPEN 145
Query: 905 ILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
           I+L +K        L DFGL+  +   D     ++ GT  ++ PE           D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 961 FGVVLLELLTGRRP 974
            GV+   LL+G  P
Sbjct: 204 IGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 785 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 844
           GL Y A      ++   R     G    E + EV  L +  H N+++L     +  D +L
Sbjct: 37  GLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
           I   +  G L  +L +   K+S+ + +    I Q    G+ YLH      I H D+K  N
Sbjct: 93  ILELVSGGELFDFLAQ---KESLSEEEATSFIKQ-ILDGVNYLHT---KKIAHFDLKPEN 145
Query: 905 ILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
           I+L +K        L DFGL+  +   D     ++ GT  ++ PE           D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 961 FGVVLLELLTGRRP 974
            GV+   LL+G  P
Sbjct: 204 IGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 785 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 844
           GL Y A      ++   R     G    E + EV  L +  H N+++L     +  D +L
Sbjct: 37  GLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
           I   +  G L  +L +   K+S+ + +    I Q    G+ YLH      I H D+K  N
Sbjct: 93  ILELVSGGELFDFLAQ---KESLSEEEATSFIKQ-ILDGVNYLHT---KKIAHFDLKPEN 145
Query: 905 ILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
           I+L +K        L DFGL+  +   D     ++ GT  ++ PE           D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 961 FGVVLLELLTGRRP 974
            GV+   LL+G  P
Sbjct: 204 IGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 17/194 (8%)
Query: 785 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 844
           GL Y A      ++   R     G    E + EV  L +  H N+++L     +  D +L
Sbjct: 37  GLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
           I   +  G L  +L +   K+S+ + +    I Q    G+ YLH      I H D+K  N
Sbjct: 93  ILELVSGGELFDFLAQ---KESLSEEEATSFIKQ-ILDGVNYLHT---KKIAHFDLKPEN 145
Query: 905 ILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYS 960
           I+L +K        L DFGL+  +   D     ++ GT  ++ PE           D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 961 FGVVLLELLTGRRP 974
            GV+   LL+G  P
Sbjct: 204 IGVITYILLSGASP 217

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 52/307 (16%)
Query: 755  NSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-ERE 813
              D  D   S ++    +F   +++G G  G +    + +    AVKR+  +C    +RE
Sbjct: 8    EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE 67
Query: 814  FQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR 873
             Q   E+    +H N++    +C    DR   Y  +E  +    L E V++       + 
Sbjct: 68   VQLLRES---DEHPNVIRY--FCTE-KDRQFQYIAIELCAAT--LQEYVEQKDFAHLGLE 119
Query: 874  -LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-----KFEAHLADFGLSRLLR-- 925
             + + Q    GLA+LH +   +IVHRD+K  NIL+       K +A ++DFGL + L   
Sbjct: 120  PITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 926  PYDTHVTTDLVGTLGYIPPEYSQTLTATCRG------DVYSFGVVLLELLT-GRRPVEVC 978
             +     + + GT G+I PE    L+  C+       D++S G V   +++ G  P    
Sbjct: 177  RHSFSRRSGVPGTEGWIAPE---MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF--- 230
Query: 979  KGKNCRDLVSWVFQMKSEKREVEII----DASIWHKDREKQLLEMLEIACKCIDQDPRRR 1034
                           KS +R+  I+         H ++ + ++   E+  K I  DP++R
Sbjct: 231  --------------GKSLQRQANILLGACSLDCLHPEKHEDVIAR-ELIEKMIAMDPQKR 275
Query: 1035 PFIEEVV 1041
            P  + V+
Sbjct: 276  PSAKHVL 282

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 773 FNQANIIGCGGFGLVYK-ATLTNGTKAAVKRL------SGDCGQMEREFQAEVEALSRAQ 825
           ++    +G G F +V K    + G + A K +      S   G    + + EV  L   Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N+++L     +  D +LI   +  G L  +L E   K+S+ + +    + Q    G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQ-ILNGVY 128
Query: 886 YLHKVCEPHIVHRDVKSSNI-LLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
           YLH +    I H D+K  NI LLD    K    + DFGL+  +   +     ++ GT  +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 942 IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           + PE           D++S GV+   LL+G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 37/229 (16%)
Query: 769 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEA 820
             + + +   IG G FG V+KA     G K A+K++      ME E +        E++ 
Sbjct: 16  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKI 70
Query: 821 LSRAQHKNLVSLQGYCRHGNDRL--------LIYSYMENGSLDYWLHESVDKDSVLKWDV 872
           L   +H+N+V+L   CR              L++ + E+  L   L   + K ++ +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK- 128
Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---LLRPYDT 929
             ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R   L +    
Sbjct: 129 --RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 930 HVTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPV 975
           +   + V TL Y PPE    L     G   D++  G ++ E+ T R P+
Sbjct: 184 NRYXNRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 19/217 (8%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V++      G + AVK++  +  + E     E+ A +      +V L G  R
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGAVR 136
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G    +    +E GSL     + V +   L  D  L     A  GL YLH      I+H
Sbjct: 137 EGPWVNIFMELLEGGSLG----QLVKEQGCLPEDRALYYLGQALEGLEYLHSR---RILH 189
Query: 898 RDVKSSNILL-DEKFEAHLADFGLSRLLRP----YDTHVTTDLVGTLGYIPPEYSQTLTA 952
            DVK+ N+LL  +   A L DFG +  L+P     D      + GT  ++ PE     + 
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 953 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 988
             + DV+S   ++L +L G  P  +  +G  C  + S
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIAS 286

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V++      G + AVK++  +  ++E     E+ A +      +V L G  R
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 134
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G    +    +E GSL     + + +   L  D  L     A  GL YLH      I+H
Sbjct: 135 EGPWVNIFMELLEGGSLG----QLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILH 187
Query: 898 RDVKSSNILL-DEKFEAHLADFGLSRLLRP---YDTHVTTDLV-GTLGYIPPEYSQTLTA 952
            DVK+ N+LL  +   A L DFG +  L+P     + +T D + GT  ++ PE       
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 953 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 988
             + D++S   ++L +L G  P  +  +G  C  + S
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 284

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 37/229 (16%)
Query: 769 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEA 820
             + + +   IG G FG V+KA     G K A+K++      ME E +        E++ 
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKI 69
Query: 821 LSRAQHKNLVSLQGYCRHGNDRL--------LIYSYMENGSLDYWLHESVDKDSVLKWDV 872
           L   +H+N+V+L   CR              L++ + E+  L   L   + K ++ +   
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK- 127
Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR---LLRPYDT 929
             ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R   L +    
Sbjct: 128 --RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 930 HVTTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPV 975
           +   + V TL Y PPE    L     G   D++  G ++ E+ T R P+
Sbjct: 183 NRYXNRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 779 IGCGGFGLVYK-ATLTNGTKAAVKRLSGDCGQMER------EFQAEVEALSRAQHKNLVS 831
           +G G F +V K    + G + A K +     +  R      E + EV  L +  H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L     +  D +LI   +  G L  +L     K+S+ + +    I Q    G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHT-- 133
Query: 892 EPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              I H D+K  NI+L +K        L DFGL+  +   D     ++ GT  ++ PE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIV 190
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
                    D++S GV+   LL+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 46/239 (19%)
Query: 770 TNNFNQANIIGCGGFGLVYKAT--LTNG--TKAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
           +N F   + IG G F  VY AT  L  G   K A+K L      +     AE++ L+ A 
Sbjct: 20  SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR--IAAELQCLTVAG 77
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES-VDKDSVLKWDVRLKIAQGAARGL 884
            ++ V    YC   ND ++I       ++ Y  HES +D  + L +    +      + L
Sbjct: 78  GQDNVMGVKYCFRKNDHVVI-------AMPYLEHESFLDILNSLSFQEVREYMLNLFKAL 130
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAH-LADFGLSR--------LLRPYDTHVTTD- 934
             +H+     IVHRDVK SN L + + + + L DFGL++        LL+   +    + 
Sbjct: 131 KRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQER 187
Query: 935 ------------------LVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELLTGRRP 974
                               GT G+  PE  ++    T   D++S GV+ L LL+GR P
Sbjct: 188 CSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 32/151 (21%)
Query: 895  IVHRDVKSSNILLD-EKFEAHLADFGLSRLL--RPYDTHVTTDLVGTLGYIPPEY-SQTL 950
            +VHRD+K  NIL+D  +  A L DFG   LL   PY     TD  GT  Y PPE+ S+  
Sbjct: 160  VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-----TDFDGTRVYSPPEWISRHQ 214
Query: 951  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
                   V+S G++L +++ G  P E                     R+ EI++A +   
Sbjct: 215  YHALPATVWSLGILLYDMVCGDIPFE---------------------RDQEILEAELHFP 253
Query: 1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
                   +   +  +C+   P  RP +EE++
Sbjct: 254  AHVSP--DCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG V++      G + AVK++  +  ++E     E+ A +      +V L G  R
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 136
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G    +    +E GSL     + + +   L  D  L     A  GL YLH      I+H
Sbjct: 137 EGPWVNIFMELLEGGSLG----QLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILH 189
Query: 898 RDVKSSNILL-DEKFEAHLADFGLSRLLRP---YDTHVTTDLV-GTLGYIPPEYSQTLTA 952
            DVK+ N+LL  +   A L DFG +  L+P     + +T D + GT  ++ PE       
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 953 TCRGDVYSFGVVLLELLTGRRP-VEVCKGKNCRDLVS 988
             + D++S   ++L +L G  P  +  +G  C  + S
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 286

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 57/206 (27%), Positives = 82/206 (39%), Gaps = 17/206 (8%)
Query: 779 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC-GQMER--EFQAEVEALSRAQHKNLVS 831
           +G G FG+V    + A        AVK L  D   Q E   +F  EV A+    H+NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 76  LYGVVLTPPMKMV----TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--- 128
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQT 949
               +HRD+ + N+LL  +    + DFGL R L   D H  +         +  PE  +T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
            T +   D + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 129/297 (43%), Gaps = 55/297 (18%)
Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 835
             I+G G  G V       G   AVKR+  D   +      E++ L+ +  H N++  + Y
Sbjct: 21   KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVI--RYY 75
Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-------IAQGAARGLAYLH 888
            C    DR L Y  +E  +L+  L + V+  +V   +++L+       + +  A G+A+LH
Sbjct: 76   CSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 889  KVCEPHIVHRDVKSSNILLD-------------EKFEAHLADFGLSRLLRPYDTHVTTDL 935
             +    I+HRD+K  NIL+              E     ++DFGL + L    +   T+L
Sbjct: 133  SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 936  ---VGTLGYIPPEY------SQTLTATCRG-DVYSFGVVLLELLT-GRRPVEVCKGKNCR 984
                GT G+  PE        QT     R  D++S G V   +L+ G+ P      +   
Sbjct: 190  NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248
Query: 985  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
            +++  +F +   K    + D S+        + E  ++  + ID DP +RP   +V+
Sbjct: 249  NIIRGIFSLDEMK---CLHDRSL--------IAEATDLISQMIDHDPLKRPTAMKVL 294

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 777 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQG 834
            ++  GGF  VY+A  + +G + A+KRL  +  +  R    EV  + + + H N+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 835 YCRHGNDR-------LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
               G +         L+ + +  G L  +L + ++    L  D  LKI     R + ++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY 927
           H+  +P I+HRD+K  N+LL  +    L DFG +  +  Y
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 779 IGCGGFGLVYK-ATLTNGTKAAVKRLSGDCGQMER------EFQAEVEALSRAQHKNLVS 831
           +G G F +V K    + G + A K +     +  R      E + EV  L +  H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L     +  D +LI   +  G L  +L     K+S+ + +    I Q    G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHT-- 133
Query: 892 EPHIVHRDVKSSNILLDEKF----EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              I H D+K  NI+L +K        L DFGL+  +   D     ++ GT  ++ PE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIV 190
Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
                    D++S GV+   LL+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 23/225 (10%)
Query: 775 QANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSL 832
           Q +++G G    V     L    + AVK +    G +      EVE L + Q H+N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
             +    +   L++  M  GS+   +H+    +  L+  V   + Q  A  L +LH    
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASV---VVQDVASALDFLHN--- 129
Query: 893 PHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLR------PYDTHVTTDLVGTLGYIP 943
             I HRD+K  NIL +   +     + DF L   ++      P  T       G+  Y+ 
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 944 PEYSQTLTATC-----RGDVYSFGVVLLELLTGRRPVEVCKGKNC 983
           PE  +  +        R D++S GV+L  LL+G  P     G +C
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 17/206 (8%)
Query: 779 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVS 831
           +G G FG+V    + A        AVK L  D     +   +F  EV A+    H+NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQT 949
               +HRD+ + N+LL  +    + DFGL R L   D H  +         +  PE  +T
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
            T +   D + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 81/206 (39%), Gaps = 17/206 (8%)
Query: 779 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC-GQMER--EFQAEVEALSRAQHKNLVS 831
           +G G FG+V    + A        AVK L  D   Q E   +F  EV A+    H+NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 80  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 133
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQT 949
               +HRD+ + N+LL  +    + DFGL R L   D H            +  PE  +T
Sbjct: 134 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
            T +   D + FGV L E+ T G+ P
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 69   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 124
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 931
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 125  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 178
Query: 932  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 179  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 233
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1044
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 234  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAV------KRLSGDCGQMEREF---QAEVEA 820
           +  ++  + +G G FG V+ A      K  V      +++  DC   + +      E+  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 821 LSRAQHKNLVS-LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
           LSR +H N++  L  +   G  +L++  +     LD  L   +D+   L   +   I + 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH--GSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
               + YL       I+HRD+K  NI++ E F   L DFG +  L       T    GT+
Sbjct: 139 LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTI 193
Query: 940 GYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRP 974
            Y  PE    +    RG   +++S GV L  L+    P
Sbjct: 194 EYCAPEV--LMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 82/206 (39%), Gaps = 17/206 (8%)
Query: 779 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC-GQMER--EFQAEVEALSRAQHKNLVS 831
           +G G FG+V    + A        AVK L  D   Q E   +F  EV A+    H+NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 86  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGYIPPEYSQT 949
               +HRD+ + N+LL  +    + DFGL R L   D H  +         +  PE  +T
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
            T +   D + FGV L E+ T G+ P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 17/206 (8%)
Query: 779 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVS 831
           +G G FG+V    + A        AVK L  D     +   +F  EV A+    H+NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 80  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 133
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL--GYIPPEYSQT 949
               +HRD+ + N+LL  +    + DFGL R L   D H        +   +  PE  +T
Sbjct: 134 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
            T +   D + FGV L E+ T G+ P
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 202  ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 257
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 931
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 258  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 311
Query: 932  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 312  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 366
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1044
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 367  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 38/224 (16%)
Query: 767 LKSTNNFNQANIIGCGGFGL----VYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALS 822
           ++ T+ +     IG G + +    ++KAT     + AVK +     + +R+   E+E L 
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKAT---NXEFAVKIID----KSKRDPTEEIEILL 70
Query: 823 R-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA- 880
           R  QH N+++L+     G    ++    + G L          D +L+     +    A 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELXKGGEL---------LDKILRQKFFSEREASAV 121
Query: 881 ----ARGLAYLHKVCEPHIVHRDVKSSNIL-LDEKFEAH---LADFGLSRLLRPYDTHVT 932
                + + YLH      +VHRD+K SNIL +DE        + DFG ++ LR  +  + 
Sbjct: 122 LFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLX 178
Query: 933 TDLVGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T    T  ++ PE    Q   A C  D++S GV+L   LTG  P
Sbjct: 179 TPCY-TANFVAPEVLERQGYDAAC--DIWSLGVLLYTXLTGYTP 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 81/206 (39%), Gaps = 17/206 (8%)
Query: 779 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC-GQMER--EFQAEVEALSRAQHKNLVS 831
           +G G FG+V    + A        AVK L  D   Q E   +F  EV A+    H+NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 86  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQT 949
               +HRD+ + N+LL  +    + DFGL R L   D H            +  PE  +T
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
            T +   D + FGV L E+ T G+ P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 80/206 (38%), Gaps = 17/206 (8%)
Query: 779 IGCGGFGLV----YKATLTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVS 831
           +G G FG+V    + A        AVK L  D     +   +F  EV A+    H+NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L G       +++     E   L   L                + A   A G+ YL    
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQT 949
               +HRD+ + N+LL  +    + DFGL R L   D H            +  PE  +T
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
            T +   D + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 63   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 118
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 931
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 119  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 932  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 173  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 227
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1044
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 228  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 188  ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 243
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 931
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 244  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 297
Query: 932  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 298  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 352
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1044
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 353  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 157
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 158 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 215
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 216 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 248

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 44/240 (18%)
Query: 760 DLTVSDL-LKSTNNFNQANII-----GCGGFGLVYKA-TLTNGTKAAVK-----RLSGDC 807
           DL   +L  +S  NFN   I+     G G F +V +  + + G + A K     R   DC
Sbjct: 12  DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC 71
Query: 808 GQMEREFQAEVEALSRAQH-KNLVSLQGYCRHGNDRLLIYSYMENGSLDYW----LHESV 862
                E   E+  L  A+    +++L     + ++ +LI  Y   G +       L E V
Sbjct: 72  ---RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128
Query: 863 DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF---EAHLADFG 919
            ++ V++      + +    G+ YLH   + +IVH D+K  NILL   +   +  + DFG
Sbjct: 129 SENDVIR------LIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 920 LSRLLRPYDTHVTT--DLVGTLGYIPPE---YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           +SR +     H     +++GT  Y+ PE   Y    TAT   D+++ G++   LLT   P
Sbjct: 180 MSRKI----GHACELREIMGTPEYLAPEILNYDPITTAT---DMWNIGIIAYMLLTHTSP 232

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 51/225 (22%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEA--------- 820
             + Q   IG G  G+V  A  T  G   AVK+LS       R FQ +  A         
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYRELVL 76
Query: 821 LSRAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDV 872
           L    HKN++SL      Q       D  L+   M + +L   +H  +D +  S L + +
Sbjct: 77  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQM 135
Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR------LLRP 926
                     G+ +LH      I+HRD+K SNI++       + DFGL+R      ++ P
Sbjct: 136 LC--------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 184
Query: 927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 971
           Y        V T  Y  PE    +      D++S G ++ EL+ G
Sbjct: 185 Y--------VVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 63   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 118
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 931
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 119  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 932  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 173  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 227
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1044
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 228  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 129
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 62   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 117
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 931
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 118  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 171
Query: 932  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 172  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 226
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1044
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 227  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 31/198 (15%)
Query: 751 VLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTK-AAVKRLSG---- 805
           + FQ +  K++ V D      N+   ++IG G +G VY A   N  K  A+K+++     
Sbjct: 14  LYFQGAIIKNVKVPD------NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFED 67
Query: 806 --DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD 863
             DC ++ RE    +  L+R +   ++ L        D ++    ++   L Y + E  D
Sbjct: 68  LIDCKRILRE----ITILNRLKSDYIIRLH-------DLIIPEDLLKFDEL-YIVLEIAD 115
Query: 864 KDSVLKWDVRLKIAQGAARGLAY-----LHKVCEPHIVHRDVKSSNILLDEKFEAHLADF 918
            D    +   + + +   + + Y        + E  I+HRD+K +N LL++     + DF
Sbjct: 116 SDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDF 175
Query: 919 GLSRLLRP-YDTHVTTDL 935
           GL+R +    D H+  DL
Sbjct: 176 GLARTINSDKDIHIVNDL 193

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 15/209 (7%)
Query: 770 TNNFNQANIIGCGGFGLVYKATLTNGTKA-AVKRLSGDCGQMEREFQAEVEALSRAQHKN 828
           ++ F   + +G G   +VY+       K  A+K L     +  +  + E+  L R  H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
           ++ L+       +  L+   +  G L       V+K    + D    + Q     +AYLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL---FDRIVEKGYYSERDAADAVKQ-ILEAVAYLH 165
Query: 889 KVCEPHIVHRDVKSSNILLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
              E  IVHRD+K  N+L           +ADFGLS+++      +   + GT GY  PE
Sbjct: 166 ---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPE 220
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             +        D++S G++   LL G  P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
            + E+E L +  H  ++ ++ +     D  ++   ME G L     + V    + +   +L
Sbjct: 63   ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKL 118
Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHV 931
               Q     + YLH   E  I+HRD+K  N+LL  + E     + DFG S++L   +T +
Sbjct: 119  YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 932  TTDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
               L GT  Y+ PE   ++         D +S GV+L   L+G  P         R  VS
Sbjct: 173  MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----SEHRTQVS 227
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1044
               Q+ S K         +W +  EK     L++  K +  DP+ R   EE +   WL
Sbjct: 228  LKDQITSGKYN---FIPEVWAEVSEK----ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 134
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 135 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAA-----VKRLSG-DCGQMEREFQAEVEALS 822
           T+ +     IG G F +V +   L  G + A      K+LS  D  ++ERE  A +  L 
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLERE--ARICRL- 59
Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
             +H N+V L           L++  +  G L     + V ++   + D    I Q    
Sbjct: 60  -LKHSNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQ-ILE 114
Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVGTL 939
            + + H++    +VHRD+K  N+LL  K +     LADFGL+  ++  D        GT 
Sbjct: 115 AVLHCHQM---GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG-DQQAWFGFAGTP 170
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 16/244 (6%)
Query: 760 DLTVSDLLKSTNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK-----RLSGDCGQMERE 813
           D+   D+L   + +    +IG G F +V +      G + AVK     + +   G    +
Sbjct: 14  DMADDDVL-FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 814 FQAEVEALSRAQHKNLVSL-QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV 872
            + E       +H ++V L + Y   G    +++ +M+   L + + +  D   V    V
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA---HLADFGLSRLLRPYDT 929
                +     L Y H   + +I+HRDVK  N+LL  K  +    L DFG++  L     
Sbjct: 132 ASHYMRQILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL 188
Query: 930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
            V    VGT  ++ PE  +        DV+  GV+L  LL+G  P    K +    ++  
Sbjct: 189 -VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKG 247
Query: 990 VFQM 993
            ++M
Sbjct: 248 KYKM 251

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA------LAYLES- 129
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 130 --KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 132
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 133 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 190
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 191 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 223

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 129
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 126
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCG-----QMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++    +    A+      C       +  +F  E   + +  H ++V L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLH---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA------LAYLES- 131
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 132 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 189
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 190 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 222

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA------LAYLES- 129
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +        +     + ++ PE     
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFR 187
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 27/179 (15%)
Query: 811 EREFQAEVEALSRAQHKNLVSLQG--YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVL 868
           E   + E++ L R +HKN++ L    Y        ++  Y   G     + E +D     
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-----MQEMLDSVP-- 102
Query: 869 KWDVRLKIAQGAAR------GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 922
             + R  + Q          GL YLH      IVH+D+K  N+LL       ++  G++ 
Sbjct: 103 --EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157
Query: 923 LLRPY---DTHVTTDLVGTLGYIPPEYSQTLT--ATCRGDVYSFGVVLLELLTGRRPVE 976
            L P+   DT  T+   G+  + PPE +  L   +  + D++S GV L  + TG  P E
Sbjct: 158 ALHPFAADDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 51/293 (17%)
Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 835
             I+G G  G V       G   AVKR+  D   +      E++ L+ +  H N++  + Y
Sbjct: 39   KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVI--RYY 93
Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-------IAQGAARGLAYLH 888
            C    DR L Y  +E  +L+  L + V+  +V   +++L+       + +  A G+A+LH
Sbjct: 94   CSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 889  KVCEPHIVHRDVKSSNILLD-------------EKFEAHLADFGLSRLLRPYDTHVTTDL 935
             +    I+HRD+K  NIL+              E     ++DFGL + L         +L
Sbjct: 151  SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 936  ---VGTLGYIPPEYSQTLTA---TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 988
                GT G+  PE  +  T    T   D++S G V   +L+ G+ P      +   +++ 
Sbjct: 208  NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-NIIR 266
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             +F +   K    + D S+        + E  ++  + ID DP +RP   +V+
Sbjct: 267  GIFSLDEMK---CLHDRSL--------IAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 51/293 (17%)
Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 835
             I+G G  G V       G   AVKR+  D   +      E++ L+ +  H N++  + Y
Sbjct: 39   KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVI--RYY 93
Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-------IAQGAARGLAYLH 888
            C    DR L Y  +E  +L+  L + V+  +V   +++L+       + +  A G+A+LH
Sbjct: 94   CSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 889  KVCEPHIVHRDVKSSNILLD-------------EKFEAHLADFGLSRLLRPYDTHVTTDL 935
             +    I+HRD+K  NIL+              E     ++DFGL + L         +L
Sbjct: 151  SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 936  ---VGTLGYIPPEYSQTLTA---TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVS 988
                GT G+  PE  +  T    T   D++S G V   +L+ G+ P      +   +++ 
Sbjct: 208  NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-NIIR 266
Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
             +F +   K    + D S+        + E  ++  + ID DP +RP   +V+
Sbjct: 267  GIFSLDEMK---CLHDRSL--------IAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATL---TNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA------LAYLES- 509
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 31/233 (13%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
           IG GGFGL+Y A  TN  +   + +     Q      +E++   R   K+ +  +   R 
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK-KWIERK 103
Query: 839 GNDRLLI---------------YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
             D L I               Y +M    L   L +   ++   K    L++       
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKF--EAHLADFGLSRLLRP------YDTHVTTDL 935
           L Y+H   E   VH D+K++N+LL  K   + +LAD+GLS    P      Y  +     
Sbjct: 164 LEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
            GT+ +   +  + +  + R DV   G  +L  L G+ P E    +N +D V+
Sbjct: 221 NGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE----QNLKDPVA 269

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 881  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGT 938
            A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D    
Sbjct: 210  AKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMKS 995
            L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L         
Sbjct: 266  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--------K 317
Query: 996  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 318  EGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEA--------- 820
             + Q   IG G  G+V  A  T  G   AVK+LS       R FQ +  A         
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHAKRAYRELVL 74
Query: 821 LSRAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD--SVLKWDV 872
           L    HKN++SL      Q       D  L+   M + +L   +H  +D +  S L + +
Sbjct: 75  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQM 133
Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 932
                     G+ +LH      I+HRD+K SNI++       + DFGL+R        + 
Sbjct: 134 LC--------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAS--TNFMM 180
Query: 933 TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 971
           T  V T  Y  PE    +      D++S G ++ EL+ G
Sbjct: 181 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 881  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGT 938
            A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D    
Sbjct: 208  AKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMKS 995
            L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L         
Sbjct: 264  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--------K 315
Query: 996  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 316  EGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 92/246 (37%), Gaps = 25/246 (10%)
Query: 745 LASSKLV--LFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKR 802
           LA  K V    Q ++   + + ++    ++F    +IG G F  V    +    +    +
Sbjct: 33  LAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMK 92
Query: 803 LSGDCGQMERE----FQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWL 858
           +      ++R     F+ E + L     + +  L    +  N   L+  Y   G L   L
Sbjct: 93  IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL 152
Query: 859 H---ESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL 915
               E +  +    +   + +A  +   L Y         VHRD+K  NILLD      L
Sbjct: 153 SKFGERIPAEMARFYLAEIVMAIDSVHRLGY---------VHRDIKPDNILLDRCGHIRL 203
Query: 916 ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG-------DVYSFGVVLLEL 968
           ADFG    LR   T  +   VGT  Y+ PE  Q +             D ++ GV   E+
Sbjct: 204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 969 LTGRRP 974
             G+ P
Sbjct: 264 FYGQTP 269

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 881  ARGLAYL-HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGT 938
            A+G+ +L  + C    +HRD+ + NILL EK    + DFGL+R + +  D     D    
Sbjct: 203  AKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCK--GKNCRDLVSWVFQMKS 995
            L ++ PE       T + DV+SFGV+L E+ + G  P    K   + CR L         
Sbjct: 259  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--------K 310
Query: 996  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            E   +   D +           EM +    C   +P +RP   E+V  L
Sbjct: 311  EGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR-LLRPYDTHVTTDLVGTL 939
           A+G+ +L        +HRD+ + NILL EK    + DFGL+R + +  D     D    L
Sbjct: 201 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 940 GYIPPEYSQTLTATCRGDVYSFGVVLLELLT 970
            ++ PE       T + DV+SFGV+L E+ +
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 779 IGCGGFGLVYKATL---TNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQ 833
           IG G FG V++       N   A   +   +C    +  +F  E   + +  H ++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 834 GYCRHGNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           G     N   +I      G L  +L     S+D  S++ +  +L  A      LAYL   
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA------LAYLES- 509
Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE     
Sbjct: 510 --KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 951 TATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             T   DV+ FGV + E+L  G +P +  K  +
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 55/297 (18%)
Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 835
             I+G G  G V       G   AVKR+  D   +      E++ L+ +  H N++  + Y
Sbjct: 21   KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVI--RYY 75
Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK-------IAQGAARGLAYLH 888
            C    DR L Y  +E  +L+  L + V+  +V   +++L+       + +  A G+A+LH
Sbjct: 76   CSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 889  KVCEPHIVHRDVKSSNILLD-------------EKFEAHLADFGLSRLLRPYDTHVTTDL 935
             +    I+HRD+K  NIL+              E     ++DFGL + L         +L
Sbjct: 133  SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 936  ---VGTLGYIPPEY------SQTLTATCRG-DVYSFGVVLLELLT-GRRPVEVCKGKNCR 984
                GT G+  PE        QT     R  D++S G V   +L+ G+ P      +   
Sbjct: 190  NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248
Query: 985  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
            +++  +F +   K    + D S+        + E  ++  + ID DP +RP   +V+
Sbjct: 249  NIIRGIFSLDEMK---CLHDRSL--------IAEATDLISQMIDHDPLKRPTAMKVL 294

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLV---YKATLTNGTKAAV---KRLSG-DCGQMEREFQAEVEA 820
           + T+++     +G G F +V    K T T    A +   K+LS  D  ++ERE  A +  
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLERE--ARICR 85
Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
           L +  H N+V L           L++  +  G L     + V ++   + D    I Q  
Sbjct: 86  LLK--HPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIHQI- 139
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVG 937
              L  ++ + +  IVHRD+K  N+LL  K +     LADFGL+  ++  +        G
Sbjct: 140 ---LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG-EQQAWFGFAG 195
Query: 938 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 18/217 (8%)
Query: 766 LLKSTNNFNQANIIGCGGFGL--VYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR 823
           ++  ++ ++    IG G FG+  + +  LT     AVK +      ++   Q E+     
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIERGAA-IDENVQREIINHRS 72
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
            +H N+V  +          +I  Y   G L    +E +        D      Q    G
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSG 128
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLA--DFGLSRLLRPYDTHVTTDLVGTLGY 941
           ++Y H +    I HRD+K  N LLD      L   DFG S+    +    +T  VGT  Y
Sbjct: 129 VSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAY 183
Query: 942 IPPEY--SQTLTATCRGDVYSFGVVLLELLTGRRPVE 976
           I PE    Q        DV+S GV L  +L G  P E
Sbjct: 184 IAPEVLLRQEYDGKI-ADVWSCGVTLYVMLVGAYPFE 219

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 881  ARGLAYLH-KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT-DLVGT 938
            ARG+ +L  + C    +HRD+ + NILL E     + DFGL+R +     +V   D    
Sbjct: 209  ARGMEFLSSRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK 997
            L ++ PE       + + DV+S+GV+L E+ + G  P    +     D  S +       
Sbjct: 265  LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE--DFCSRL------- 315
Query: 998  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            RE   + A       E    E+ +I   C  +DP+ RP   E+V  L
Sbjct: 316  REGMRMRAP------EYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 13/200 (6%)
Query: 779 IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG+V++       +  V +       +++   + E+  +++  H  L++L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
              + +LI  ++  G L         +D  +     +   + A  GL ++H   E  IVH
Sbjct: 119 DKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVH 172
Query: 898 RDVKSSNILLDEKFEA--HLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQTLTATC 954
            D+K  NI+ + K  +   + DFGL+  L P +   VTT    T  +  PE         
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGF 229
Query: 955 RGDVYSFGVVLLELLTGRRP 974
             D+++ GV+   LL+G  P
Sbjct: 230 YTDMWAIGVLGYVLLSGLSP 249

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 779 IGCGGFGLVYKATLTNGTKA---AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG- 834
           +G G +G VYKA   +G      A+K++ G    M      E+  L   +H N++SLQ  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 86
Query: 835 YCRHGNDRL-LIYSYMENGSLDYW----LHESVDKDSVLKWDVRLKIAQGAARGLAY--- 886
           +  H + ++ L++ Y E+   D W     H +   +        +++ +G  + L Y   
Sbjct: 87  FLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKK-----PVQLPRGMVKSLLYQIL 138
Query: 887 --LHKVCEPHIVHRDVKSSNILL----DEKFEAHLADFGLSRLLR-PYDTHVTTD-LVGT 938
             +H +    ++HRD+K +NIL+     E+    +AD G +RL   P       D +V T
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 939 LGYIPPEYSQTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCR 984
             Y  PE         +  D+++ G +  ELLT   P+  C+ ++ +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIK 244

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 53/193 (27%), Positives = 84/193 (43%), Gaps = 19/193 (9%)
Query: 785 GLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL 844
           G  Y A + N  K + +    D  ++ERE  A +  L   +H N+V L           L
Sbjct: 47  GQEYAAKIINTKKLSAR----DHQKLERE--ARICRL--LKHPNIVRLHDSISEEGHHYL 98
Query: 845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
           I+  +  G L     + V ++   + D    I Q     + + H++    +VHRD+K  N
Sbjct: 99  IFDLVTGGEL---FEDIVAREYYSEADASHCIQQ-ILEAVLHCHQM---GVVHRDLKPEN 151
Query: 905 ILLDEKFEA---HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSF 961
           +LL  K +     LADFGL+  +   +        GT GY+ PE  +        D+++ 
Sbjct: 152 LLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 210
Query: 962 GVVLLELLTGRRP 974
           GV+L  LL G  P
Sbjct: 211 GVILYILLVGYPP 223

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 770 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK-----RLSG-DCGQMEREFQAEVEALS 822
           T+ +     +G G F +V +   +  G + A K     +LS  D  ++ERE  A +  L 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLERE--ARICRLL 60
Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           +  H N+V L           L++  +  G L     + V ++   + D    I Q    
Sbjct: 61  K--HPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQ---- 111
Query: 883 GLAYLHKVCEPH---IVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLV 936
               L  V   H   IVHRD+K  N+LL  K +     LADFGL+  ++  D        
Sbjct: 112 ---ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG-DQQAWFGFA 167
Query: 937 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           GT GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 770 TNNFNQANIIGCGGFGLVYKA-TLTNGTKAAVK-----RLSG-DCGQMEREFQAEVEALS 822
           T+ +     +G G F +V +   +  G + A K     +LS  D  ++ERE  A +  L 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLERE--ARICRL- 59
Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
             +H N+V L           L++  +  G L     + V ++   + D    I Q    
Sbjct: 60  -LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQ---- 111
Query: 883 GLAYLHKVCEPH---IVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLV 936
               L  V   H   IVHRD+K  N+LL  K +     LADFGL+  ++  D        
Sbjct: 112 ---ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG-DQQAWFGFA 167
Query: 937 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           GT GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 768 KSTNNFNQANIIGCGGFGLVY-KATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           K  + F    + G G FG V      + G   A+K++  D     RE Q  ++ L+   H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHH 78
Query: 827 KNLVSLQGYCRH--GNDRLLIYSYMENGSLDYWLHE---SVDKDSVLKWDVRLKIAQ-GA 880
            N+V LQ Y       DR  IY  +    +   LH    +  +  V    + +K+     
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA-HLADFGLSRLLRPYDTHVTTDLVGTL 939
            R +  LH +   ++ HRD+K  N+L++E      L DFG ++ L P + +V    + + 
Sbjct: 139 IRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA--YICSR 195
Query: 940 GYIPPEY---SQTLTATCRGDVYSFGVVLLELLTG 971
            Y  PE    +Q  T     D++S G +  E++ G
Sbjct: 196 YYRAPELIFGNQHYTTAV--DIWSVGCIFAEMMLG 228

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 25/178 (14%)
Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTK-AAVKRLSG------DCGQMEREFQAEVEALSR 823
           +N+   ++IG G +G VY A   N  K  A+K+++       DC ++ RE    +  L+R
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILNR 81
Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
            +   ++ L  Y     D LL +  +      Y + E  D D    +   + + +   + 
Sbjct: 82  LKSDYIIRL--YDLIIPDDLLKFDEL------YIVLEIADSDLKKLFKTPIFLTEEHIKT 133
Query: 884 LAY-----LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR-PYDTHVTTDL 935
           + Y      + + E  I+HRD+K +N LL++     + DFGL+R +    DT++  DL
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 68/151 (45%), Gaps = 16/151 (10%)
Query: 851 NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL--D 908
           NGS+ +   ES+D   V +  +   I +     L YLH      I HRD+K  N L   +
Sbjct: 151 NGSI-HGFRESLD--FVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTN 204
Query: 909 EKFEAHLADFGLSR---LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC--RGDVYSFGV 963
           + FE  L DFGLS+    L   + +  T   GT  ++ PE   T   +   + D +S GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 964 VLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
           +L  LL G  P     G N  D +S V   K
Sbjct: 265 LLHLLLMGAVPF---PGVNDADTISQVLNKK 292

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD----CGQMEREFQAEVEALSRAQ 825
           + F +   IG G FG V     +  G   A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWDVRLKIAQGAARGL 884
              LV L+   +  ++  ++  YM  G  D + H   + + S  +   R   AQ      
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFS--EPHARFYAAQ-IVLTF 154
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            YLH +    +++RD+K  N+L+D++    +ADFG ++ ++      T  L GT  Y+ P
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAP 207
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E   +       D ++ GV++ E+  G  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD----CGQMEREFQAEVEALSRAQ 825
           + F +   IG G FG V     +  G   A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH-ESVDKDSVLKWDVRLKIAQGAARGL 884
              LV L+   +  ++  ++  YM  G  D + H   + + S  +   R   AQ      
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFS--EPHARFYAAQ-IVLTF 154
Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            YLH +    +++RD+K  N+L+D++    +ADFG ++ ++      T  L GT  Y+ P
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAP 207
Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           E   +       D ++ GV++ E+  G  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 753 FQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQ 809
           F + +  D T + +LK   N      IG G  G+V   Y A L      A+K+LS     
Sbjct: 10  FYSVEIGDSTFT-VLKRYQNLKP---IGSGAQGIVVAAYDAILERNV--AIKKLS----- 58
Query: 810 MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLD-----YWLHESVDK 864
             R FQ +  A  +  ++ LV L     H N   L+  +    SL+     Y + E +D 
Sbjct: 59  --RPFQNQTHA--KRAYRELV-LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA 113
Query: 865 DSVLKWDVRLKIAQGAARGLAYLHKVCEPH-----IVHRDVKSSNILLDEKFEAHLADFG 919
           +  L   +++++       L Y   V   H     I+HRD+K SNI++       + DFG
Sbjct: 114 N--LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG 171
Query: 920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG 971
           L+R      + + T  V T  Y  PE    +      D++S GV++ E++ G
Sbjct: 172 LARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 779 IGCGGFGLV---YKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           IG G  G+V   Y A L      A+K+LS       R FQ +  A  +  ++ LV L   
Sbjct: 32  IGSGAQGIVCAAYDAILERNV--AIKKLS-------RPFQNQTHA--KRAYRELV-LMKV 79
Query: 836 CRHGNDRLLIYSYMENGSLD-----YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
             H N   L+  +    SL+     Y + E +D +  L   +++++       L Y   V
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV 137
Query: 891 CEPH-----IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
              H     I+HRD+K SNI++       + DFGL+R      + + T  V T  Y  PE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 195
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTG 971
               +      D++S GV++ E++ G
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 33/157 (21%)
Query: 112 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 171
           +K  DLS + +  ++    S+   LE L L+ N ++        GL  +  LN+S N   
Sbjct: 277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN--- 333
Query: 172 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG----SLQGLDH 227
                                F G ++SR++    ++++LDLS NH       S  GL  
Sbjct: 334 ---------------------FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL-- 370
Query: 228 SPSLKQLHVDNNLLGGDLPDSLYS-MSSLQHVSLSVN 263
            P+LK+L +D N L   +PD ++  ++SLQ + L  N
Sbjct: 371 -PNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405

>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 24/167 (14%)
Query: 497 LFYLDFSNNTLTGEIPKS---LTELKSLISSNCTSSNPTASAGIPLYVKH----NRSTNG 549
             +LDFSNN LT  + ++   LTEL++LI         +  A +   +K     + S N 
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385
Query: 550 LPYNQAS---SFPPSVF---LSNNRINGTI----PPEIGQLKHLHVLDLSRNNITGTIPS 599
           + Y++     S+  S+    +S+N +  TI    PP I       VLDL  N I  +IP 
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK------VLDLHSNKI-KSIPK 438
Query: 600 SISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 646
            + ++  L+ L+++SN L     G F++LT L K  +  N    + P
Sbjct: 439 QVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 23/229 (10%)
Query: 423 KNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL--KGHIPVWLLRCKKLQVLDLSW 480
           K+L  L  T N  G    E      SL  L L   GL  KG           L+ LDLS+
Sbjct: 325 KSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 481 NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLY 540
           N        ++G +E L +LDF ++ L     K ++E    +S             I L 
Sbjct: 383 NGVITMSSNFLG-LEQLEHLDFQHSNL-----KQMSEFSVFLS---------LRNLIYLD 427
Query: 541 VKHNRST---NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTI 597
           + H  +    NG+ +N  SS        N+     +P    +L++L  LDLS+  +    
Sbjct: 428 ISHTHTRVAFNGI-FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 598 PSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 646
           P++ + + +L+VL+++SN L     G F++LT L K  +  N    + P
Sbjct: 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 114 LLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGS 173
           LLDL  N +  +   +  NLK L  L L +N +S    G  A L  ++ L +S N     
Sbjct: 56  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ---- 111
Query: 174 LFELGEF--SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM------GSLQGL 225
           L EL E     L    +  N  T K+   +++   ++ +++L  N         G+ QG+
Sbjct: 112 LKELPEKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 226 DH------------------SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 267
                                PSL +LH+D N +      SL  +++L  + LS N+ S 
Sbjct: 171 KKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230
Query: 268 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 309
             +  ++N   LR L +  N+   K+P  L +   ++    H
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 768 KSTNNFNQANIIGCGGFGLVYK--ATLTNGTKAAV----KRLSG-DCGQMEREFQAEVEA 820
           + T  +     +G G F +V +    L     AA+    K+LS  D  ++ERE  A +  
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE--ARICR 65
Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
           L   +H N+V L           LI+  +  G L     + V ++   + D    I Q  
Sbjct: 66  L--LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQ-I 119
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVG 937
              + + H++    +VHR++K  N+LL  K +     LADFGL+  +   +        G
Sbjct: 120 LEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAG 175
Query: 938 TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 114 LLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGS 173
           LLDL  N +  +   +  NLK L  L L +N +S    G  A L  ++ L +S N     
Sbjct: 56  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ---- 111
Query: 174 LFELGEF--SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM------GSLQGL 225
           L EL E     L    +  N  T K+   +++   ++ +++L  N         G+ QG+
Sbjct: 112 LKELPEKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 226 DH------------------SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 267
                                PSL +LH+D N +      SL  +++L  + LS N+ S 
Sbjct: 171 KKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230
Query: 268 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 309
             +  ++N   LR L +  N+   K+P  L +   ++    H
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/91 (28%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
             YLH +    +++RD+K  N+L+D++    +ADFG ++ ++      T  L GT  Y+ 
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEYLA 207
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           PE   +       D ++ GV++ E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
             YLH +    +++RD+K  N+L+D++    + DFG ++ ++      T  L GT  Y+ 
Sbjct: 175 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTLCGTPEYLA 227
Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           PE   +       D ++ GV++ E+  G  P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 17/209 (8%)
Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD----CGQMEREFQAEVEALSRAQ 825
           + F +   IG G FG V     +  G   A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
              LV L+   +  ++  ++  Y+  G +   L   + + S  +   R   AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR-IGRFS--EPHARFYAAQ-IVLTFE 155
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           YLH +    +++RD+K  N+L+D++    +ADFG ++ ++      T  L GT  Y+ PE
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
              +       D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           YLH +    +++RD+K  N+L+DE+    + DFG ++ ++      T  L GT  Y+ PE
Sbjct: 143 YLHSL---DLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 195
Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
              +       D ++ GV++ E+  G  P
Sbjct: 196 IILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 22/219 (10%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLS-GDCGQMEREFQAEVEA 820
           ++  ++ +     IG G FG+   A L    +A    AVK +  G+  +++   + E+  
Sbjct: 14  IMHDSDRYELVKDIGAGNFGV---ARLMRDKQANELVAVKYIERGE--KIDENVKREIIN 68
Query: 821 LSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
               +H N+V  +          ++  Y   G L     E +        D      Q  
Sbjct: 69  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQL 124
Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGT 938
             G++Y H +    + HRD+K  N LLD      L  ADFG S+    +    +   VGT
Sbjct: 125 ISGVSYAHAM---QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA--VGT 179
Query: 939 LGYIPPEYSQTLTATCR-GDVYSFGVVLLELLTGRRPVE 976
             YI PE         +  DV+S GV L  +L G  P E
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 13/233 (5%)
Query: 766 LLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
           ++  ++ +     IG G FG+          +    +      +++   + E+      +
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 72
Query: 826 HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
           H N+V  +          ++  Y   G L     E +        D      Q    G++
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVS 128
Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLA--DFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           Y H +    + HRD+K  N LLD      L   DFG S+    +    +T  VGT  YI 
Sbjct: 129 YCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 183
Query: 944 PEYSQTLTATCR-GDVYSFGVVLLELLTGRRPVEVCKG-KNCRDLVSWVFQMK 994
           PE         +  DV+S GV L  +L G  P E  +  KN R  +  +  ++
Sbjct: 184 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 236

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1052
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-154
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-143
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-141
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-63
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-24
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-124
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-114
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-92
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-81
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-71
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-48
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-89
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-62
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-45
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-33
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-83
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-72
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-58
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-35
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-78
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-58
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-76
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-73
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-66
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-55
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-52
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-42
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-11
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-73
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-54
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-68
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-61
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-57
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-41
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-39
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-52
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-51
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-29
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-51
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-33
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-30
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-49
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-42
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-26
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-21
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-32
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-32
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-34
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-26
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-31
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-34
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-34
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-07
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-33
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-29
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-32
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-32
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-31
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-27
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-04
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-30
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-30
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-28
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-10
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-11
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-11
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-11
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-22
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-19
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-06
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-07
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-10
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-06
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-12
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-12
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	9e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	7e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  460 bits (1185), Expect = e-154
 Identities = 128/294 (43%), Positives = 192/294 (65%), Gaps = 3/294 (1%)

Query: 759  KDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQM-EREFQAE 817
            K  ++ +L  +++NF+  NI+G GGFG VYK  L +GT  AVKRL  +  Q  E +FQ E
Sbjct: 18   KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 818  VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA 877
            VE +S A H+NL+ L+G+C    +RLL+Y YM NGS+   L E  +    L W  R +IA
Sbjct: 78   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 878  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 937
             G+ARGLAYLH  C+P I+HRDVK++NILLDE+FEA + DFGL++L+   DTHVTT + G
Sbjct: 138  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197

Query: 938  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRD--LVSWVFQMKS 995
            T+G+I PEY  T  ++ + DV+ +GV+LLEL+TG+R  ++ +  N  D  L+ WV  +  
Sbjct: 198  TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 996  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049
            EK+   ++D  +    +++++ +++++A  C    P  RP + EVV  L+G G+
Sbjct: 258  EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  447 bits (1153), Expect = e-143
 Identities = 162/595 (27%), Positives = 262/595 (44%), Gaps = 78/595 (13%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
             L +    L G   R++    +LKLL++S N   G +P     LK L+ L L+ N  +G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTG 283

Query: 149 PVSGMLAG-LNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASK 206
            +   L+G  + +  L++S N F G++    G  S L    +S+N+F+G+L        +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343

Query: 207 EIQILDLSMNHFMGSLQG--LDHSPSLKQLHVDNNLLGGDLPDSL--YSMSSLQHVSLSV 262
            +++LDLS N F G L     + S SL  L + +N   G +  +L     ++LQ + L  
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403

Query: 263 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 322
           N F+G++   +SN + L  L +  N  SG +P+ LG+L++L       N   G +P  L 
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463

Query: 323 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
               L  L L  N LTG I    S  ++L  + L+ N  +G +P  +    +L IL L+ 
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 442
           N  SG +P   G   SL++L L+ N F   +GT                       IP  
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLF---NGT-----------------------IPAA 557

Query: 443 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWN--HFDGNIPPWIGQMENLFYL 500
           +      +        + G   V++      +    + N   F G     + ++      
Sbjct: 558 MFKQSGKIAANF----IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613

Query: 501 DFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP 560
           + ++    G    +     S++  +                                   
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLD----------------------------------- 638

Query: 561 SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 620
              +S N ++G IP EIG + +L +L+L  N+I+G+IP  + ++R L +LDLSSN L G 
Sbjct: 639 ---MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR 695

Query: 621 IPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDS 675
           IP +   LT L++  ++NN+L G IP  GQF +FP + F  NPGLCG     CD 
Sbjct: 696 IPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  441 bits (1136), Expect = e-141
 Identities = 181/625 (28%), Positives = 259/625 (41%), Gaps = 88/625 (14%)

Query: 37  SCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRK 96
                ++  L  F   L + +++  WS+    C +DGV C          +VT + L  K
Sbjct: 8   QSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTC-------RDDKVTSIDLSSK 60

Query: 97  GLKGI---IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGM 153
            L      +  SL  L  L+ L LS +H+ G V         L  LDLS N LSGPV+  
Sbjct: 61  PLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVT-- 117

Query: 154 LAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDL 213
                              +L  LG  S L   N+S+N+               +++LDL
Sbjct: 118 -------------------TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158

Query: 214 SMNHFMG----SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL 269
           S N   G         D    LK L +  N + GD+   +    +L+ + +S NNFS  +
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216

Query: 270 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 329
              + + ++L+HL I GN+ SG     +   T+L+     SN F GP+P        L  
Sbjct: 217 PF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQY 273

Query: 330 LDLRNNSLTGPIDLNFSG-LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ 388
           L L  N  TG I    SG   +L  LDL+ NHF G +P     C  L+ L+L+ N  SG+
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333

Query: 389 VP-ESFGKLTSLLFLSLSNNSFNHLSGTL--SVLQQCKNLTTLILTKNFVGEEIPENVGG 445
           +P ++  K+  L  L LS    N  SG L  S+     +L TL L+ N     I  N+  
Sbjct: 334 LPMDTLLKMRGLKVLDLSF---NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 390

Query: 446 F--ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFS 503
               +L  L L N G  G IP  L  C +L  L LS+N+  G IP  +G +  L  L   
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450

Query: 504 NNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF 563
            N L GEIP+ L  +K+L                                       ++ 
Sbjct: 451 LNMLEGEIPQELMYVKTLE--------------------------------------TLI 472

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
           L  N + G IP  +    +L+ + LS N +TG IP  I  + NL +L LS+N   G+IP 
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532

Query: 624 SFEKLTFLSKFSVANNHLQGTIPTG 648
                  L    +  N   GTIP  
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  230 bits (588), Expect = 1e-63
 Identities = 92/331 (27%), Positives = 150/331 (45%), Gaps = 12/331 (3%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 142
           SN   +  L L    L G IP SLG L++L+ L L  N LEG +P EL  +K LE L L 
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474

Query: 143 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRI 201
            N L+G +   L+    +  +++S+N   G +   +G   NLA+  +SNNSF+G + + +
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534

Query: 202 WSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVD--NNLLGGDLPDSLYSMSSLQHVS 259
                 +  LDL+ N F G++       ++ +       N + G     + +    +   
Sbjct: 535 GDCRS-LIWLDLNTNLFNGTI-----PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588

Query: 260 LSVN--NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 317
            + N   F G  SE+++ L++     I    + G       N   + F     N  SG +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648

Query: 318 PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 377
           P  +     L +L+L +N ++G I      L  L  LDL++N   G +P ++S    L  
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708

Query: 378 LSLAKNELSGQVPESFGKLTSLLFLSLSNNS 408
           + L+ N LSG +PE  G+  +       NN 
Sbjct: 709 IDLSNNNLSGPIPEM-GQFETFPPAKFLNNP 738

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  106 bits (268), Expect = 9e-24
 Identities = 35/166 (21%), Positives = 67/166 (40%), Gaps = 8/166 (4%)

Query: 40  PSDLLAL-KEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGS------NAGRVTMLI 92
           P+ +     + A N   G       N+ M  +  G        G                
Sbjct: 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 614

Query: 93  LPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSG 152
           +  +   G    +  +   +  LD+S N L G +P E+ ++  L +L+L HN +SG +  
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674

Query: 153 MLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKL 197
            +  L  +  L++SSN  +G +   +   + L   ++SNN+ +G +
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 59.9 bits (146), Expect = 3e-09
 Identities = 19/78 (24%), Positives = 35/78 (44%), Gaps = 4/78 (5%)

Query: 582 HLHVLDLSRNNIT---GTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN 638
            +  +DLS   +      + SS+  +  LE L LS++ ++GS+   F+    L+   ++ 
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSR 109

Query: 639 NHLQGTIPTGGQFYSFPN 656
           N L G + T     S   
Sbjct: 110 NSLSGPVTTLTSLGSCSG 127

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  380 bits (977), Expect = e-124
 Identities = 116/294 (39%), Positives = 166/294 (56%), Gaps = 4/294 (1%)

Query: 755  NSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF 814
              +   + + DL ++TNNF+   +IG G FG VYK  L +G K A+KR + +  Q   EF
Sbjct: 23   PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82

Query: 815  QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL 874
            + E+E LS  +H +LVSL G+C   N+ +LIY YMENG+L   L+ S      + W+ RL
Sbjct: 83   ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL-LRPYDTHVTT 933
            +I  GAARGL YLH      I+HRDVKS NILLDE F   + DFG+S+       TH++T
Sbjct: 143  EICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199

Query: 934  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
             + GTLGYI PEY      T + DVYSFGVVL E+L  R  +     +   +L  W  + 
Sbjct: 200  VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259

Query: 994  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
             +  +  +I+D ++  K R + L +  + A KC+      RP + +V+  L+  
Sbjct: 260  HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  354 bits (910), Expect = e-114
 Identities = 110/308 (35%), Positives = 175/308 (56%), Gaps = 23/308 (7%)

Query: 753  FQNSDCKDLTVSDLLKSTNNFNQ------ANIIGCGGFGLVYKATLTNGTKAAVKRLSGD 806
              ++     +  +L   TNNF++       N +G GGFG+VYK  + N T  AVK+L+  
Sbjct: 7    VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65

Query: 807  C----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESV 862
                  +++++F  E++ +++ QH+NLV L G+   G+D  L+Y YM NGSL   L    
Sbjct: 66   VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL- 124

Query: 863  DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 922
            D    L W +R KIAQGAA G+ +LH   E H +HRD+KS+NILLDE F A ++DFGL+R
Sbjct: 125  DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 923  LLRPYD-THVTTDLVGTLGYIPPEY-SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKG 980
                +  T +T+ +VGT  Y+ PE     +T   + D+YSFGVVLLE++TG   V+  + 
Sbjct: 182  ASEKFAQTVMTSRIVGTTAYMAPEALRGEITP--KSDIYSFGVVLLEIITGLPAVD--EH 237

Query: 981  KNCRDLVSWVFQMKSEKREVE-IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
            +  + L+    +++ E++ +E  ID  +   D    +  M  +A +C+ +   +RP I++
Sbjct: 238  REPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 1040 VVTWLDGI 1047
            V   L  +
Sbjct: 297  VQQLLQEM 304

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  309 bits (794), Expect = 1e-92
 Identities = 128/607 (21%), Positives = 213/607 (35%), Gaps = 53/607 (8%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           +  + P     L  LK+L+L  N L  +     +    L  L L  N +    +      
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 158 NLIQSLNVSSNSFNG-SLFELGEFSNLAVFNISNNSFTG-KLNSRIWSASKEIQILDLSM 215
             + +L++S N  +   L    +  NL    +SNN     K       A+  ++ L+LS 
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 216 NHFMGSLQG-LDHSPSLKQLHVDNNLLGGDLPDSL---YSMSSLQHVSLSVNNFSGQLSE 271
           N       G       L  L ++N  LG  L + L    + +S++++SLS +  S   + 
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 272 KISNL--TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 329
               L  T+L  L +  N  +    +    L QLE+F    N+       SL     +  
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 330 LDLRNN---------SLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 380
           L+L+ +         SL    D +F  L  L  L++  N   G   N  +   +LK LSL
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360

Query: 381 AKNELSGQV--PESFGKL--TSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVG 436
           + +  S +    E+F  L  + L  L+L+ N  + +           +L  L L  N +G
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES--DAFSWLGHLEVLDLGLNEIG 418

Query: 437 EEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG--NIPPWIGQ 493
           +E+      G E++  + L                  LQ L L         + P     
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478

Query: 494 MENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYN 553
           + NL  LD SNN +       L  L+ L                 L ++HN     L  +
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEI---------------LDLQHNNLAR-LWKH 522

Query: 554 QASSFPPSVF----------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 603
                P              L +N  +         L  L ++DL  NN+     S  + 
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582

Query: 604 IRNLEVLDLSSNDLHGSIPGSFEK-LTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGN 662
             +L+ L+L  N +       F      L++  +  N    T  +   F ++ N +    
Sbjct: 583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNI 642

Query: 663 PGLCGEI 669
           P L    
Sbjct: 643 PELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  279 bits (715), Expect = 1e-81
 Identities = 111/588 (18%), Positives = 194/588 (32%), Gaps = 96/588 (16%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           +P  L     + +L+L+ N L  +     +   QL  LD+  N +S     +   L +++
Sbjct: 19  VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
            LN+  N  +                +S+ +F              +  L L  N     
Sbjct: 77  VLNLQHNELSQ---------------LSDKTFAF---------CTNLTELHLMSNSIQKI 112

Query: 222 LQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS--NLTS 278
                    +L  L + +N L      +   + +LQ + LS N      SE++     +S
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172

Query: 279 LRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL---CSKLHVLDLRNN 335
           L+ L +  NQ     P     + +L     ++      L   L L    + +  L L N+
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232

Query: 336 SLTGPIDLNFSGL--SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESF 393
            L+   +  F GL  ++L  LDL+ N+ +    +S +    L+   L  N +      S 
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292

Query: 394 GKLTSLLFLSLSNN------SFNHLSG-TLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 446
             L ++ +L+L  +      S   L        Q  K L  L +  N +         G 
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352

Query: 447 ESLMVLALGNCGLKGHIPV----WLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 502
            +L  L+L N               L    L +L+L+ N            + +L  LD 
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412

Query: 503 SNNTLTGEIPKS----LTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF 558
             N +  E+       L  +  +                            L YN+    
Sbjct: 413 GLNEIGQELTGQEWRGLENIFEIY---------------------------LSYNKYLQL 445

Query: 559 PPSVF----------LSNNRING--TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 606
             + F          L    +    + P     L++L +LDLS NNI       +  +  
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505

Query: 607 LEVLDLSSNDLH--------GSIPGSFEKLTFLSKFSVANNHLQGTIP 646
           LE+LDL  N+L         G      + L+ L   ++ +N       
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  249 bits (637), Expect = 7e-71
 Identities = 98/496 (19%), Positives = 162/496 (32%), Gaps = 40/496 (8%)

Query: 182 NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNNL 240
           +  V + S+     KL          I +L+L+ N               L  L V  N 
Sbjct: 5   SHEVADCSHL----KLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 241 LGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNL 300
           +    P+    +  L+ ++L  N  S    +  +  T+L  L +  N       N     
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 301 TQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG--PIDLNFSGLSSLCTLDLAT 358
             L       N  S     +      L  L L NN +      +L+    SSL  L+L++
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 359 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFG---KLTSLLFLSLSNNSFNHLSGT 415
           N      P        L  L L   +L   + E        TS+  LSLSN+  +  S T
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 416 LSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 475
             +  +  NLT L L+ N +     ++      L    L    ++      L     ++ 
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 476 LDLSWNHFDGNI---------PPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNC 526
           L+L  +    +I               ++ L +L+  +N + G      T L +L     
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY--- 357

Query: 527 TSSNPTASAGIPLYVKHNR-STNGLPYNQASSFPPS----VFLSNNRINGTIPPEIGQLK 581
                       L + ++  S   L      S   S    + L+ N+I+         L 
Sbjct: 358 ------------LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405

Query: 582 HLHVLDLSRNNITGTIP-SSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNH 640
           HL VLDL  N I   +       + N+  + LS N        SF  +  L +  +    
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465

Query: 641 LQGTIPTGGQFYSFPN 656
           L+    +   F    N
Sbjct: 466 LKNVDSSPSPFQPLRN 481

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  181 bits (461), Expect = 8e-48
 Identities = 69/334 (20%), Positives = 122/334 (36%), Gaps = 33/334 (9%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
           T   +    L  I   S   L  L+ L++  N + G+     + L  L+ L LS++  S 
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367

Query: 149 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI 208
                               +     F     S L + N++ N  +  + S  +S    +
Sbjct: 368 -------------------RTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSWLGHL 407

Query: 209 QILDLSMNHFMGSLQG--LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 266
           ++LDL +N     L G       ++ ++++  N       +S   + SLQ + L      
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467

Query: 267 G--QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS--------GP 316
                      L +L  L +  N  +    ++L  L +LE      N+ +        G 
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527

Query: 317 LPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 376
               L   S LH+L+L +N         F  L  L  +DL  N+ +    +  ++   LK
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587

Query: 377 ILSLAKNELSGQVPESFGK-LTSLLFLSLSNNSF 409
            L+L KN ++    + FG    +L  L +  N F
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.5 bits (194), Expect = 6e-15
 Identities = 27/113 (23%), Positives = 47/113 (41%), Gaps = 4/113 (3%)

Query: 93  LPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSG 152
           L +    G     L  L+ L +L+L  N  + +      +L +L+++DL  N L+   + 
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578

Query: 153 MLAGLNLIQSLNVSSN---SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 202
           +      ++SLN+  N   S    +F    F NL   ++  N F     S  W
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPA-FRNLTELDMRFNPFDCTCESIAW 630

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 68.5 bits (168), Expect = 8e-12
 Identities = 21/101 (20%), Positives = 41/101 (40%), Gaps = 1/101 (0%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 142
                + +L L   G   I       L +LK++DL  N+L  +     +N   L+ L+L 
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592

Query: 143 HNMLSGPVSGMLA-GLNLIQSLNVSSNSFNGSLFELGEFSN 182
            N+++     +       +  L++  N F+ +   +  F N
Sbjct: 593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 48.5 bits (116), Expect = 1e-05
 Identities = 13/79 (16%), Positives = 24/79 (30%), Gaps = 1/79 (1%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELS-NLKQLEVLDLSHNMLSGPVSGMLAG 156
           L  +      +   LK L+L  N +  V         + L  LD+  N        +   
Sbjct: 572 LNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 631

Query: 157 LNLIQSLNVSSNSFNGSLF 175
           +N I   + +    +    
Sbjct: 632 VNWINETHTNIPELSSHYL 650

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  300 bits (769), Expect = 1e-89
 Identities = 92/630 (14%), Positives = 190/630 (30%), Gaps = 78/630 (12%)

Query: 44  LALKEFAGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIP 103
           L  K ++          +W+       W       G + ++ GRVT L L   G  G +P
Sbjct: 42  LNGKNWSQQGFGTQPGANWNFNKELDMWGAQP---GVSLNSNGRVTGLSLEGFGASGRVP 98

Query: 104 RSLGHLNQLKLLDLSCNHLEG----VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNL 159
            ++G L +L++L L  +  +       P  +S     E                    + 
Sbjct: 99  DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDF 158

Query: 160 --IQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 216
             +    ++S+    S+                +N+ T  ++  +   +K ++   +  +
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTK-LRQFYMGNS 216

Query: 217 HFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNL 276
            F+          + +  + +             ++  L  V +       +L   +  L
Sbjct: 217 PFVAEN----ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272

Query: 277 TSLRHLIIFGNQF--------SGKLPNVLGNLTQLEFFVAHSNSF-SGPLPLSLSLCSKL 327
             ++ + +  N+           +         +++      N+  + P+  SL    KL
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332

Query: 328 HVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 387
            +L+   N L G +   F     L +L+LA N  +    N       ++ LS A N+L  
Sbjct: 333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391

Query: 388 QVPESF--GKLTSLLFLSLSNNSF-----NHLSGTLSVLQQCKNLTTLILTKNFVGEEIP 440
            +P  F    ++ +  +  S N        +         +  N++++ L+ N + +   
Sbjct: 392 -IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450

Query: 441 ENVGGFESLMVLALGNCGLKG-------HIPVWLLRCKKLQVLDLSWNHFDGNIPPW-IG 492
           E       L  + L    L                    L  +DL +N        +   
Sbjct: 451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRAT 510

Query: 493 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 552
            +  L  +D S N+ +   P       +L                   +++ R       
Sbjct: 511 TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG---------------FGIRNQRD------ 548

Query: 553 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 612
                         NR     P  I     L  L +  N+I   +   I+   N+ VLD+
Sbjct: 549 -----------AQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP--NISVLDI 594

Query: 613 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 642
             N                  + +  +  Q
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  222 bits (569), Expect = 3e-62
 Identities = 65/464 (14%), Positives = 144/464 (31%), Gaps = 58/464 (12%)

Query: 225 LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ----LSEKISNLTSLR 280
           L+ +  +  L ++     G +PD++  ++ L+ ++L  +           + IS   S  
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 281 HLIIFGNQFSGKLPNVLG--NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLT 338
                   +     +     + + L     +S+     +  S  +  K   +   +N++T
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 339 GPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTS 398
             +      L+ L    +  + F              +  +    +        +  L  
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEA-----WENENSEYAQQYKTEDLKWDNLKD 250

Query: 399 LLFLSLSNNSFNHLSGTL-SVLQQCKNLTTLILTKN--------FVGEEIPENVGGFESL 449
           L  + + N         L + L+    +  + +  N            +   +    E +
Sbjct: 251 LTDVEVYNCP---NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307

Query: 450 MVLALGNCGLK-GHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLT 508
            ++ +G   LK   +   L + KKL +L+  +N  +G   P  G    L  L+ + N +T
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQIT 366

Query: 509 GEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP--SVFLSN 566
                     + + +               L   HN+         A S     ++  S 
Sbjct: 367 EIPANFCGFTEQVEN---------------LSFAHNKLKYIPNIFDAKSVSVMSAIDFSY 411

Query: 567 NRING-------TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG 619
           N I          + P   +  ++  ++LS N I+       S    L  ++L  N L  
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

Query: 620 -------SIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 656
                      +F+    L+   +  N L   +    +  + P 
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPY 514

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  172 bits (438), Expect = 4e-45
 Identities = 51/336 (15%), Positives = 109/336 (32%), Gaps = 40/336 (11%)

Query: 100 GIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNL 159
             +  SL  + +L +L+   N LEG +P    +  +L  L+L++N ++   +        
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378

Query: 160 IQSLNVSSNSFNG--SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 217
           +++L+ + N      ++F+    S ++  + S N                     +   +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS-----------------VDGKN 421

Query: 218 FMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG-------QLS 270
           F           ++  +++ NN +     +   + S L  ++L  N  +          +
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481

Query: 271 EKISNLTSLRHLIIFGNQFSGKLPN--VLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLH 328
           E   N   L  + +  N+ +  L +      L  L       NSFS   P      S L 
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK 539

Query: 329 VLDLRN------NSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
              +RN      N          +   SL  L + +N     +   +    ++ +L +  
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKD 596

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSV 418
           N                    L  +    + G  ++
Sbjct: 597 NPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDAL 632

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  136 bits (344), Expect = 3e-33
 Identities = 38/332 (11%), Positives = 89/332 (26%), Gaps = 81/332 (24%)

Query: 353 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF--N 410
             +   + +      SL+    +  LSL     SG+VP++ G+LT L  L+L ++    N
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 411 HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG--FESLMVLALGNCGLKGHIPVWLL 468
                   +    +       +    +   +      F  L+   + +   +  I     
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 469 RCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTS 528
              K   +    N+    +   + ++  L      N+    E      E ++        
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS------- 232

Query: 529 SNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDL 588
                                                  +   T   +   LK L  +++
Sbjct: 233 ------------------------------------EYAQQYKTEDLKWDNLKDLTDVEV 256

Query: 589 SRNNITGTIPSSISEIRNLEVLDLSSNDL------------------------------- 617
                   +P+ +  +  +++++++ N                                 
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316

Query: 618 --HGSIPGSFEKLTFLSKFSVANNHLQGTIPT 647
                +  S +K+  L       N L+G +P 
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  282 bits (723), Expect = 2e-83
 Identities = 111/568 (19%), Positives = 184/568 (32%), Gaps = 66/568 (11%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           L+ +   S     +L++LDLS   ++ +      +L  L  L L+ N +     G  +GL
Sbjct: 40  LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99

Query: 158 NLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 216
           + +Q L     +      F +G    L   N+++N          +S    ++ LDLS N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 217 HFMG----SLQGLDHSPSLK-QLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE 271
                    L+ L   P L   L +  N +   +    +    L  ++L  N  S  + +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218

Query: 272 K-ISNLTSLRHLIIFGNQFSGKL------PNVLGNLTQLEFFV---AHSNSFSGPLPLSL 321
             I  L  L    +   +F  +        + L  L  L       A+ + +   +    
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278

Query: 322 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 381
           +  + +    L + ++    D  FS       L+L    F       L     L   S  
Sbjct: 279 NCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336

Query: 382 KNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPE 441
                     S   L SL FL LS N  +             +L  L L+ N V   +  
Sbjct: 337 GGNAF-----SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSS 390

Query: 442 NVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 500
           N  G E L  L   +  LK      +    + L  LD+S  H           + +L  L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450

Query: 501 DFSNNTLTGEI-PKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFP 559
             + N+      P   TEL++L                 L                    
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTF---------------LD------------------- 476

Query: 560 PSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG 619
               LS  ++    P     L  L VL++S NN           + +L+VLD S N +  
Sbjct: 477 ----LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532

Query: 620 SIPGSFEKL-TFLSKFSVANNHLQGTIP 646
           S     +   + L+  ++  N    T  
Sbjct: 533 SKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  249 bits (639), Expect = 7e-72
 Identities = 109/546 (19%), Positives = 183/546 (33%), Gaps = 71/546 (13%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGV-VPVELSNLKQLEVLDLSHNMLS 147
             L+     L  +    +GHL  LK L+++ N ++   +P   SNL  LE LDLS N + 
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 148 GPVSGMLAGL----NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWS 203
                 L  L     L  SL++S N  N       +   L    + NN  +  +      
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222

Query: 204 ASKEIQILDLSMNHFMGSLQGLDHSPS----LKQLHVDNN------LLGGDLPDSLYSMS 253
               +++  L +  F           S    L  L ++            D+ D    ++
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282

Query: 254 SLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 313
           ++   SL          +  S     +HL +   +F       L +L +L F      S 
Sbjct: 283 NVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSN 335

Query: 314 SGPLPLSLSLCSKLHVLDLRNNSLT--GPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 371
            G    S      L  LDL  N L+  G    +  G +SL  LDL+ N     + ++   
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG 394

Query: 372 CHDLKILSLAKNELSGQVPES-FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 430
              L+ L    + L      S F  L +L++L +S+           +     +L  L +
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN--GIFNGLSSLEVLKM 452

Query: 431 TKN-FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP 489
             N F    +P+      +L  L L  C L+   P        LQVL++S N+F      
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512

Query: 490 WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNG 549
               + +L  LD+S N +     + L    S ++                          
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF------------------------- 547

Query: 550 LPYNQASSFPPSVFLSNNRINGTIPPE--IGQLKHLHVLDLSRNNITGTIPSSISEIRNL 607
                       + L+ N    T   +  +  +K    L +    +    PS     + +
Sbjct: 548 ------------LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD---KQGM 592

Query: 608 EVLDLS 613
            VL L+
Sbjct: 593 PVLSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  210 bits (536), Expect = 4e-58
 Identities = 83/442 (18%), Positives = 145/442 (32%), Gaps = 35/442 (7%)

Query: 229 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 288
           P++    ++ N     +PD+L    S +++ LS N      S    +   L+ L +   +
Sbjct: 8   PNITYQCMELNFY--KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63

Query: 289 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGL 348
                     +L+ L   +   N        + S  S L  L     +L    +     L
Sbjct: 64  IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

Query: 349 SSLCTLDLATNHF-SGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNN 407
            +L  L++A N   S  LP   S+  +L+ L L+ N++          L  +  L+LS +
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 408 -SFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPV 465
            S N ++       +   L  L L  NF    + +    G   L V  L     +    +
Sbjct: 184 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 466 W------LLRCKKLQVLDLSWNHFD---GNIPPWIGQMENLFYLDFSNNTLTGEIPKS-L 515
                  L     L + +    + D    +I      + N+      + T+      S  
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303

Query: 516 TELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF--------LSNN 567
              + L   NC           P     +        N+  +    V         LS N
Sbjct: 304 FGWQHLELVNCKFG------QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357

Query: 568 RIN--GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGS- 624
            ++  G           L  LDLS N +  T+ S+   +  LE LD   ++L      S 
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

Query: 625 FEKLTFLSKFSVANNHLQGTIP 646
           F  L  L    +++ H +    
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFN 438

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  155 bits (394), Expect = 1e-39
 Identities = 57/375 (15%), Positives = 100/375 (26%), Gaps = 36/375 (9%)

Query: 294 PNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCT 353
            N+  +   L+      N        S     +L VLDL    +    D  +  LS L T
Sbjct: 24  DNLPFSTKNLDL---SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80

Query: 354 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLS 413
           L L  N        + S    L+ L   +  L+       G L +L  L++++N      
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 414 GTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESL----MVLALGNCGLKGHIPVWLLR 469
                     NL  L L+ N +      ++     +    + L L    +   I     +
Sbjct: 141 -LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFK 198

Query: 470 CKKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTS 528
             +L  L L  N    N+    I  +  L            E    L +          +
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN--LEKFDKSALEGLCN 256

Query: 529 SNPTASAGIPLYVKHNR-STNGLPYNQASSFPP------SVFLSNNRINGTIPPEIGQLK 581
                     L ++  R +      +             S  L +  I      +     
Sbjct: 257 ----------LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNF 304

Query: 582 HLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 641
               L+L               ++   +  L+     G    S   L  L    ++ N L
Sbjct: 305 GWQHLELVNCKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL 359

Query: 642 QGTIPTGGQFYSFPN 656
                     +   +
Sbjct: 360 SFKGCCSQSDFGTTS 374

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  143 bits (362), Expect = 1e-35
 Identities = 58/306 (18%), Positives = 96/306 (31%), Gaps = 15/306 (4%)

Query: 82  GSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDL 141
            S       L L            L  L +L        +          +L  LE LDL
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS-----EVDLPSLEFLDL 354

Query: 142 SHNMLS--GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNS 199
           S N LS  G  S    G   ++ L++S N              L   +  +++       
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEF 414

Query: 200 RIWSASKEIQILDLSMNHFMGSLQG-LDHSPSLKQLHV-DNNLLGGDLPDSLYSMSSLQH 257
            ++ + + +  LD+S  H   +  G  +   SL+ L +  N+     LPD    + +L  
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474

Query: 258 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 317
           + LS            ++L+SL+ L +  N F          L  L+      N      
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534

Query: 318 PLSL-SLCSKLHVLDLRNNSLTGPIDLN--FSGLSSLCTLDLATNHFSGPLPNSLSDCHD 374
              L    S L  L+L  N      +       +     L +         P+       
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK---QG 591

Query: 375 LKILSL 380
           + +LSL
Sbjct: 592 MPVLSL 597

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  273 bits (700), Expect = 5e-78
 Identities = 101/660 (15%), Positives = 203/660 (30%), Gaps = 93/660 (14%)

Query: 41  SDLLALKEF------------AGNLTNGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRV 88
            D  ALK              +G + N     +W+       W       G    N GRV
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQ---PGVDLDNNGRV 325

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
           T L L   G KG +P ++G L +LK+L    +       +        ++ +   + +  
Sbjct: 326 TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385

Query: 149 PVSGM-LAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 207
               M L     +   ++  ++ N +  E+      +  ++ +      L +RI   SK 
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINRNP-EMKPIKKDSRISLKDTQIGN-LTNRITFISKA 443

Query: 208 I------QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS 261
           I      QI+  + +         + +   +  + D      +   S  ++  L  V L 
Sbjct: 444 IQRLTKLQIIYFANSP----FTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499

Query: 262 VNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL 321
                 QL + + +L  L+ L I  N+       +  + T+L                  
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTRL--------------ADDE 544

Query: 322 SLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 380
               K+ +  +  N+L   P   +   +  L  LD   N        +      L  L L
Sbjct: 545 DTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKL 602

Query: 381 AKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIP 440
             N++     +       +  L  S+N   ++    +  +    + ++  + N +     
Sbjct: 603 DYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFN-AKSVYVMGSVDFSYNKI-GSEG 660

Query: 441 ENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 500
            N+                         +      + LS+N               +  +
Sbjct: 661 RNISCSMDD------------------YKGINASTVTLSYNEIQKFPTELFATGSPISTI 702

Query: 501 DFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP 560
             SNN +T  IP++  + K     N             + ++ N+ T  L  +  ++  P
Sbjct: 703 ILSNNLMT-SIPENSLKPKDGNYKNTYLLTT-------IDLRFNKLT-SLSDDFRATTLP 753

Query: 561 S---VFLSNNRINGTIPPEIGQLKHLHVLDLSR------NNITGTIPSSISEIRNLEVLD 611
               + +S N  + + P +      L    +        N I    P+ I+   +L  L 
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812

Query: 612 LSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNS----SFEGNPGLCG 667
           + SND+   +         L    +A+N    +I                 ++    + G
Sbjct: 813 IGSNDI-RKVDEKL--TPQLYILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQDIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  214 bits (547), Expect = 6e-58
 Identities = 73/546 (13%), Positives = 159/546 (29%), Gaps = 100/546 (18%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           +K I   S   L   ++ +L+ N +  +    +  L +L+++  +++  +   +  +   
Sbjct: 414 MKPIKKDSRISLKDTQIGNLT-NRITFI-SKAIQRLTKLQIIYFANSPFTY-DNIAVDWE 470

Query: 158 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 217
           +          +   S   L    +L    + N     +L   ++   + +Q L+++ N 
Sbjct: 471 DANSDYAKQYENEELSWSNL---KDLTDVELYNCPNMTQLPDFLYDLPE-LQSLNIACNR 526

Query: 218 FMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG-QLSEKISNL 276
            + + Q       L               D   +   +Q   +  NN      S  +  +
Sbjct: 527 GISAAQLKADWTRL--------------ADDEDTGPKIQIFYMGYNNLEEFPASASLQKM 572

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL-SLCSKLHVLDLRNN 335
             L  L    N+         G   +L       N     +P    +   ++  L   +N
Sbjct: 573 VKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHN 629

Query: 336 SLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD-----CHDLKILSLAKNELSGQV 389
            L   P   N   +  + ++D + N       N           +   ++L+ NE+    
Sbjct: 630 KLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFP 689

Query: 390 PESFGKLTSLLFLSLSNNSF-----NHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN-- 442
            E F   + +  + LSNN       N L       +    LTT+ L  N +   + ++  
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFR 748

Query: 443 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 502
                 L  + +         P   L   +L+   +                      D 
Sbjct: 749 ATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ------------------RDA 789

Query: 503 SNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSV 562
             N +  + P  +T   SLI                                       +
Sbjct: 790 EGNRILRQWPTGITTCPSLIQ--------------------------------------L 811

Query: 563 FLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 622
            + +N I   +  ++     L++LD++ N       +S+       +  L  +       
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRG 868

Query: 623 GSFEKL 628
                +
Sbjct: 869 CDALGI 874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  124 bits (313), Expect = 4e-29
 Identities = 54/454 (11%), Positives = 122/454 (26%), Gaps = 78/454 (17%)

Query: 230 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 289
            LK + V       +  +   +      + ++  + +  L      + +      +    
Sbjct: 172 ELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYT---TYSQSG 228

Query: 290 SGKLPNVLGNLTQLEFFVA------------HSNSFSGPLPLSLSLCSKLHVLDLRNNSL 337
             +      ++    F V                  +  +    +L +    LD +N   
Sbjct: 229 IKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRY 288

Query: 338 TGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLT 397
                +N +  S     +   + +       L +   +  LSLA     G+VP++ G+LT
Sbjct: 289 YSGT-INNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLT 347

Query: 398 SLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNC 457
            L  LS   +S   +SG L   ++     +               +   + L +  L   
Sbjct: 348 ELKVLSFGTHSE-TVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406

Query: 458 GLKGHIPVWLLRCKKLQVLDLSWNHFDGN------IPPWIGQMENLFYLDFSNNTLTGEI 511
            +  +  +  +  KK   + L              I   I ++  L  + F+N+  T + 
Sbjct: 407 AINRNPEMKPI--KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDN 464

Query: 512 PKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRING 571
                E  +                                               +   
Sbjct: 465 IAVDWEDANS-------------------------------------------DYAKQYE 481

Query: 572 TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG---------SIP 622
                   LK L  ++L        +P  + ++  L+ L+++ N              + 
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 623 GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 656
              +    +  F +  N+L+   P          
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVK 574

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  253 bits (649), Expect = 1e-76
 Identities = 83/307 (27%), Positives = 123/307 (40%), Gaps = 34/307 (11%)

Query: 760  DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE 819
            DL   +L   +       +   G FG V+KA L      AVK       Q   + + EV 
Sbjct: 13   DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVY 70

Query: 820  ALSRAQHKNLVSLQGYCRHGND----RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
            +L   +H+N++   G  + G        LI ++ E GSL  +L  +V     + W+    
Sbjct: 71   SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCH 125

Query: 876  IAQGAARGLAYLH-------KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
            IA+  ARGLAYLH          +P I HRD+KS N+LL     A +ADFGL+       
Sbjct: 126  IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 929  THV-TTDLVGTLGYIPPEY-----SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
            +   T   VGT  Y+ PE      +    A  R D+Y+ G+VL EL +     +    + 
Sbjct: 186  SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 983  CRDLVSWVFQMKSEKREVEIIDA--------SIWHKDREKQLLEMLEIACKCIDQDPRRR 1034
                   + Q  S +   E++            W K     +  + E   +C D D   R
Sbjct: 246  MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH--AGMAMLCETIEECWDHDAEAR 303

Query: 1035 PFIEEVV 1041
                 V 
Sbjct: 304  LSAGCVG 310

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  254 bits (652), Expect = 1e-73
 Identities = 113/566 (19%), Positives = 201/566 (35%), Gaps = 53/566 (9%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           IP +L   N  + L+ S N L  +     S L  L  LDL+   +           + + 
Sbjct: 27  IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 162 SLNVSSNSFNG-SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 220
           +L +++N     +   L     L          +  ++       K ++ L L  NH   
Sbjct: 85  TLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISS 143

Query: 221 -SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN-NFSGQLSEKISNLTS 278
             L     +  LK L   NN +     + + S+    ++SL++N N    +     +   
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203

Query: 279 LRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLT 338
            + L   G Q    +   L N T                         L +    +    
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNST----------------------IQSLWLGTFEDMDDE 241

Query: 339 GPIDLNFSGLS--SLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL 396
                 F GL   S+ +++L  ++F     N+      L+ L L    LS ++P     L
Sbjct: 242 DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300

Query: 397 TSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALG 455
           ++L  L LS N F +L           +LT L +  N    E+        E+L  L L 
Sbjct: 301 STLKKLVLSANKFENLCQ--ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358

Query: 456 NCGLK--GHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPK 513
           +  ++      + L     LQ L+LS+N           +   L  LD +   L  +  +
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418

Query: 514 S----LTELKSL-ISSNC-TSSNPTASAGIP----LYVKHNRSTNGLPYNQASSFPP--- 560
           S    L  LK L +S +    S+     G+P    L ++ N         + +S      
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP-KGNIQKTNSLQTLGR 477

Query: 561 --SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 618
              + LS   ++         LK ++ +DLS N +T +   ++S ++ +  L+L+SN + 
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536

Query: 619 GSIPGSFEKLTFLSKFSVANNHLQGT 644
             +P     L+     ++  N L  T
Sbjct: 537 IILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  232 bits (595), Expect = 6e-66
 Identities = 99/534 (18%), Positives = 170/534 (31%), Gaps = 75/534 (14%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           L  +   +L     LK L      +  +  + L N K LE L L  N +S          
Sbjct: 93  LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152

Query: 158 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 217
             ++ L+  +N+ +                +S    +    +   S       L+L+ N 
Sbjct: 153 EKLKVLDFQNNAIH---------------YLSKEDMSSLQQATNLS-------LNLNGND 190

Query: 218 FMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSL--YSMSSLQHVSLSVNNFSGQLSEKISN 275
             G   G   S   + L+         +   L   ++ SL   +    +           
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 276 L--TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLR 333
           L   S+  + +  + F     N     + L+     +   S  LP  L   S L  L L 
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLS 309

Query: 334 NNSLTGPIDLNFSGLSSLCTLDLATNHFSGPL-PNSLSDCHDLKILSLAKNEL--SGQVP 390
            N       ++ S   SL  L +  N     L    L +  +L+ L L+ +++  S    
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369

Query: 391 ESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESL 449
                L+ L  L+LS N    L       ++C  L  L L    +  +  ++       L
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKT--EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427

Query: 450 MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNI---PPWIGQMENLFYLDFSNNT 506
            VL L +  L             LQ L+L  NHF          +  +  L  L  S   
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

Query: 507 LTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSN 566
           L+     + T LK +                                        V LS+
Sbjct: 488 LSSIDQHAFTSLKMMN--------------------------------------HVDLSH 509

Query: 567 NRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 620
           NR+  +    +  LK +  L+L+ N+I+  +PS +  +     ++L  N L  +
Sbjct: 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  203 bits (519), Expect = 1e-55
 Identities = 89/453 (19%), Positives = 152/453 (33%), Gaps = 35/453 (7%)

Query: 208 IQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 263
            + L+ S N        +   L    +L  L +    +     D+  S   L  + L+ N
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRL---INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 264 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL 323
                    +S   +L+HL       S      L N   LE     SN  S         
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 324 CSKLHVLDLRNNSLTGPIDLNFSGLSSL--CTLDLATNHFSGPLPNSLSDCHDLKILSLA 381
             KL VLD +NN++      + S L      +L+L  N  +G +     D    + L+  
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210

Query: 382 KNELSGQVPE--SFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 439
             +    + +      + SL   +  +     +S  +       ++ ++ L K++     
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270

Query: 440 PENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFY 499
                 F  L  L L    L   +P  L+    L+ L LS N F+           +L +
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329

Query: 500 LDFSNNTLTGEIP----KSLTELKSL-ISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 554
           L    NT   E+     ++L  L+ L +S +   ++             N     L + Q
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC----------CNLQLRNLSHLQ 379

Query: 555 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIP-SSISEIRNLEVLDLS 613
                 S+ LS N           +   L +LDL+   +      S    +  L+VL+LS
Sbjct: 380 ------SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433

Query: 614 SNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 646
            + L  S    F+ L  L   ++  NH      
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  194 bits (495), Expect = 1e-52
 Identities = 75/455 (16%), Positives = 126/455 (27%), Gaps = 52/455 (11%)

Query: 228 SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 287
             S + L    N+L      +   + +L  + L+         +   +   L  L++  N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 288 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG 347
                    L     L+         S    + L     L  L L +N ++         
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 348 LSSLCTLDLATNHFSGPLPNSLSDCHDLKI--LSLAKNELSGQVPESFGKLTSLLFLSLS 405
              L  LD   N         +S         L+L  N+++G +            L+  
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210

Query: 406 NNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFE--SLMVLALGNCGLKGHI 463
                 +          ++L           +  P    G    S+  + L         
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270

Query: 464 PVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLIS 523
                    LQ LDL+  H    +P  +  +  L  L  S N        S +   SL  
Sbjct: 271 SNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329

Query: 524 SNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRIN--G 571
                          L +K N         +                   LS++ I    
Sbjct: 330 ---------------LSIKGN--------TKRLELGTGCLENLENLRELDLSHDDIETSD 366

Query: 572 TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGS-FEKLTF 630
               ++  L HL  L+LS N        +  E   LE+LDL+   L      S F+ L  
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426

Query: 631 LSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 665
           L   +++++ L                 F+G P L
Sbjct: 427 LKVLNLSHSLLD----------ISSEQLFDGLPAL 451

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  189 bits (483), Expect = 5e-51
 Identities = 71/439 (16%), Positives = 137/439 (31%), Gaps = 52/439 (11%)

Query: 237 DNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV 296
           +  L   ++P +L   +S + +  S N      +   S L +L  L +   Q      + 
Sbjct: 21  NLGL--NEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 297 LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDL 356
             +  +L+  V  +N        +LS    L  L      ++    +      +L +L L
Sbjct: 77  FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136

Query: 357 ATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL--LFLSLSNNSFNHLSG 414
            +NH S            LK+L    N +     E    L     L L+L+ N    +  
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP 196

Query: 415 TLSVLQQCKNLTTLILTKNFVGEEIPENVGG--FESLMVLALGNCGLKGHIPVWLLRCKK 472
                       +L          I + +     +SL +    +   +   P       +
Sbjct: 197 GAF---DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253

Query: 473 --LQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSN 530
             ++ ++L  ++F             L  LD +   L+ E+P  L  L +L         
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKK------- 305

Query: 531 PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPE-IGQ 579
                   L          L  N+  +                +  N     +    +  
Sbjct: 306 --------LV---------LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348

Query: 580 LKHLHVLDLSRNNIT--GTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVA 637
           L++L  LDLS ++I         +  + +L+ L+LS N+       +F++   L    +A
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408

Query: 638 NNHLQGTIPTGGQFYSFPN 656
              L+        F +   
Sbjct: 409 FTRLKV-KDAQSPFQNLHL 426

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  164 bits (418), Expect = 1e-42
 Identities = 64/334 (19%), Positives = 115/334 (34%), Gaps = 38/334 (11%)

Query: 87  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 146
            V  + L +     I   +    + L+ LDL+  HL   +P  L  L  L+ L LS N  
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKF 313

Query: 147 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 206
                   +    +  L++  N+    L   G   NL                      +
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGT-GCLENL----------------------E 350

Query: 207 EIQILDLSMNHFM------GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 260
            ++ LDLS +           L+ L     L+ L++  N       ++      L+ + L
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNL---SHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407

Query: 261 SVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPL 319
           +      + ++    NL  L+ L +  +        +   L  L+      N F      
Sbjct: 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467

Query: 320 ---SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 376
              SL    +L +L L    L+      F+ L  +  +DL+ N  +     +LS    + 
Sbjct: 468 KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI- 526

Query: 377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFN 410
            L+LA N +S  +P     L+    ++L  N  +
Sbjct: 527 YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  128 bits (324), Expect = 6e-31
 Identities = 55/256 (21%), Positives = 103/256 (40%), Gaps = 13/256 (5%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEG-VVPVELSNLKQLEVLDLSHNML--SGPVSGML 154
            + +   S  +   L  L +  N     +    L NL+ L  LDLSH+ +  S   +  L
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372

Query: 155 AGLNLIQSLNVSSNSFNGSLFELGEFSNLA---VFNISNNSFTGKLNSRIWSASKEIQIL 211
             L+ +QSLN+S N       +   F       + +++      K     +     +++L
Sbjct: 373 RNLSHLQSLNLSYNEPLS--LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430

Query: 212 DLSMNHFMGSLQG-LDHSPSLKQLHVDNNLLGG---DLPDSLYSMSSLQHVSLSVNNFSG 267
           +LS +    S +   D  P+L+ L++  N          +SL ++  L+ + LS  + S 
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

Query: 268 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKL 327
                 ++L  + H+ +  N+ +      L +L  +   +A  N  S  LP  L + S+ 
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLAS-NHISIILPSLLPILSQQ 549

Query: 328 HVLDLRNNSLTGPIDL 343
             ++LR N L      
Sbjct: 550 RTINLRQNPLDCTCSN 565

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 65.8 bits (161), Expect = 4e-11
 Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 2/101 (1%)

Query: 96  KGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLA 155
                    SL  L +L++L LS   L  +     ++LK +  +DLSHN L+      L+
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521

Query: 156 GLNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTG 195
            L  I  LN++SN  +  L   L   S     N+  N    
Sbjct: 522 HLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  243 bits (622), Expect = 8e-73
 Identities = 89/333 (26%), Positives = 138/333 (41%), Gaps = 43/333 (12%)

Query: 344 NFSGLSS-LCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ--VPESFGKLTSLL 400
           N + LSS L T D     + G L ++ +  + +  L L+   L     +P S   L  L 
Sbjct: 20  NPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79

Query: 401 FLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLK 460
           FL +     N+L G                        IP  +     L  L + +  + 
Sbjct: 80  FLYIGGI--NNLVGP-----------------------IPPAIAKLTQLHYLYITHTNVS 114

Query: 461 GHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKS 520
           G IP +L + K L  LD S+N   G +PP I  + NL  + F  N ++G IP S      
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 521 LISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQL 580
           L +S              + +  NR T  +P   A+     V LS N + G      G  
Sbjct: 175 LFTS--------------MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220

Query: 581 KHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNH 640
           K+   + L++N++   +   +   +NL  LDL +N ++G++P    +L FL   +V+ N+
Sbjct: 221 KNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279

Query: 641 LQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPC 673
           L G IP GG    F  S++  N  LCG     C
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  215 bits (550), Expect = 6e-63
 Identities = 81/368 (22%), Positives = 142/368 (38%), Gaps = 95/368 (25%)

Query: 259 SLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSG--KLPNVLGNLTQLEF-FVAHSNSFSG 315
                 + G L +  +    + +L + G        +P+ L NL  L F ++   N+  G
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91

Query: 316 PLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDL 375
           P+P +++  ++LH L + + +++G I    S + +L TLD + N  SG LP S+S   +L
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151

Query: 376 KILSLAKNELSGQVPESFGKLTSLL-FLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 434
             ++   N +SG +P+S+G  + L   +++S    N L+G                    
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISR---NRLTG-------------------- 188

Query: 435 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM 494
              +IP               N                L  +DLS N  +G+     G  
Sbjct: 189 ---KIPP-----------TFANL--------------NLAFVDLSRNMLEGDASVLFGSD 220

Query: 495 ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 554
           +N   +  + N+L  ++   +   K+L                                 
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLN-------------------------------- 247

Query: 555 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSS 614
                  + L NNRI GT+P  + QLK LH L++S NN+ G IP     ++  +V   ++
Sbjct: 248 ------GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYAN 300

Query: 615 NDLHGSIP 622
           N      P
Sbjct: 301 NKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  189 bits (482), Expect = 9e-54
 Identities = 82/332 (24%), Positives = 128/332 (38%), Gaps = 61/332 (18%)

Query: 36  QSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQ--WDGVVCGHGSTGSNAGRVTMLIL 93
           + C+P D  AL +   +L N + ++SW   + CC   W GV+C    T +   RV  L L
Sbjct: 1   ELCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLC---DTDTQTYRVNNLDL 57

Query: 94  PRKGLK---------------------------GIIPRSLGHLNQLKLLDLSCNHLEGVV 126
               L                            G IP ++  L QL  L ++  ++ G +
Sbjct: 58  SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117

Query: 127 PVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAV 185
           P  LS +K L  LD S+N LSG +   ++ L  +  +    N  +G++    G FS L  
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177

Query: 186 F-NISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGD 244
              IS N  TGK+     + +  +  +DLS N                        L GD
Sbjct: 178 SMTISRNRLTGKIPPTFANLN--LAFVDLSRNM-----------------------LEGD 212

Query: 245 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 304
                 S  + Q + L+ N+ +  L + +    +L  L +  N+  G LP  L  L  L 
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 305 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 336
                 N+  G +P   +L  +  V    NN 
Sbjct: 272 SLNVSFNNLCGEIPQGGNL-QRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  186 bits (476), Expect = 7e-53
 Identities = 76/331 (22%), Positives = 126/331 (38%), Gaps = 59/331 (17%)

Query: 187 NISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQ---GLDHSPSLKQLHV-DNNLLG 242
           +  N ++ G L     + +  +  LDLS  +          L + P L  L++   N L 
Sbjct: 32  DCCNRTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 243 GDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQ 302
           G +P ++  ++ L ++ ++  N SG + + +S + +L  L    N  SG LP  + +L  
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 303 LEFFVAHSNSFSGPLPLSLSLCSKLH-VLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF 361
           L       N  SG +P S    SKL   + +  N LTG I   F+ L +L  +DL+ N  
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209

Query: 362 SGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQ 421
            G          + + + LAKN L+  +    G   +L  L L N   N + GT      
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRN---NRIYGT------ 259

Query: 422 CKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWN 481
                                                    +P  L + K L  L++S+N
Sbjct: 260 -----------------------------------------LPQGLTQLKFLHSLNVSFN 278

Query: 482 HFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 512
           +  G IP   G ++      ++NN      P
Sbjct: 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  240 bits (615), Expect = 1e-68
 Identities = 108/565 (19%), Positives = 191/565 (33%), Gaps = 72/565 (12%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           LK +   S  + ++L+ LDLS   +E +       L  L  L L+ N +     G  +GL
Sbjct: 44  LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103

Query: 158 NLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 216
             +++L              +G+   L   N+++N          +S    +  +DLS N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163

Query: 217 HFMG----SLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE 271
           +        LQ L  +P     L +  N +   + D  +    L  ++L  N  S  + +
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMK 222

Query: 272 K-ISNLTSLRHLIIFGNQFSG---------KLPNVLGNLTQLEFFVAHSNSFSGPLPLSL 321
             + NL  L    +   +F            +   L ++T  EF + ++N FS    +  
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD-IVKF 281

Query: 322 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 381
              + +  + L   S+    D+         +L +            L     LK L+L 
Sbjct: 282 HCLANVSAMSLAGVSIKYLEDVPK--HFKWQSLSIIRCQLKQFPTLDLP---FLKSLTLT 336

Query: 382 KNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPE 441
            N+ S  +      L SL +L LS N+ +             +L  L L+ N     +  
Sbjct: 337 MNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA-IIMSA 393

Query: 442 NVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 500
           N  G E L  L   +  LK           +KL  LD+S+ +   +       + +L  L
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453

Query: 501 DFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQAS 556
             + N+           + T L  L                                   
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFL----------------------------------- 478

Query: 557 SFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSND 616
                  LS  ++          L  L +L++S NN+     S  +++ +L  LD S N 
Sbjct: 479 ------DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532

Query: 617 LHGSIPGSFEKLTFLSKFSVANNHL 641
           +  S          L+ F++ NN +
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  218 bits (558), Expect = 6e-61
 Identities = 98/579 (16%), Positives = 176/579 (30%), Gaps = 72/579 (12%)

Query: 100 GIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNL 159
           G +   +  +  +         L  V P ++ +    + +DLS N L    S   +  + 
Sbjct: 2   GSLNPCIEVVPNITY-QCMDQKLSKV-PDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 160 IQSLNVSSNSFNGSLFELGEFSNLA---VFNISNNSFTGKLNSRIWSASKEIQILDLSMN 216
           +Q L++S         E   +  L       ++ N      +   +S    ++ L     
Sbjct: 58  LQWLDLSRCEIET--IEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVET 114

Query: 217 HFMGSLQG-LDHSPSLKQLHVDNNLLGG-DLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS 274
                    +    +LK+L+V +N +    LP    ++++L HV LS N         + 
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 275 NLTSLR----HLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL 330
            L         L +  N            +   E  +  + + S  +   L   + LHV 
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234

Query: 331 DLRNNSLTGPIDLN------FSGLSSLCT--LDLATNHFSGPLPNSLSDCHDLKILSLAK 382
            L         +L         GL  +      L   +             ++  +SLA 
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 442
             +     E   K      LS+                    L +L LT N     I   
Sbjct: 295 VSIKY--LEDVPKHFKWQSLSIIRCQLKQFPT-----LDLPFLKSLTLTMNKG--SISFK 345

Query: 443 VGGFESLMVLALGNCGLK--GHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 500
                SL  L L    L   G      L    L+ LDLS+N     +      +E L +L
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHL 404

Query: 501 DFSNNTLTGEIPKS-LTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFP 559
           DF ++TL      S    L+ L+  +                        + Y       
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLD------------------------ISYTNTKIDF 440

Query: 560 PSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNLE 608
             +F          ++ N         +     +L  LDLS+  +          +  L+
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500

Query: 609 VLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPT 647
           +L++S N+L       + +L  LS    + N ++ +   
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  206 bits (527), Expect = 7e-57
 Identities = 92/531 (17%), Positives = 154/531 (29%), Gaps = 96/531 (18%)

Query: 97  GLKGIIPRSLGHLNQLKLLDLSCNHLEGV-VPVELSNLKQLEVLDLSHNMLSGPVSGMLA 155
            L  +    +G L  LK L+++ N +    +P   SNL  L  +DLS+N +       L 
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 156 GL----NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQIL 211
            L     +  SL++S N  +    +  +   L    +  N  +  +          + + 
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234

Query: 212 DLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE 271
            L +  F             + L +    +   L D      ++    L+  N       
Sbjct: 235 RLILGEF----------KDERNLEIFEPSIMEGLCD-----VTIDEFRLTYTNDFSDDIV 279

Query: 272 KISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLD 331
           K   L ++  + + G            ++  LE                +    K   L 
Sbjct: 280 KFHCLANVSAMSLAGV-----------SIKYLE---------------DVPKHFKWQSLS 313

Query: 332 LRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPE 391
           +    L          L  L +L L  N  S  +         L  L L++N LS     
Sbjct: 314 IIRCQLK---QFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCC 368

Query: 392 SF--GKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFES 448
           S+      SL  L LS N    +S         + L  L    + +      +     E 
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAIIMSANFM---GLEELQHLDFQHSTLKRVTEFSAFLSLEK 425

Query: 449 LMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSNNTL 507
           L+ L +     K       L    L  L ++ N F  N          NL +LD S   L
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485

Query: 508 TGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNN 567
                     L  L                                        + +S+N
Sbjct: 486 EQISWGVFDTLHRLQ--------------------------------------LLNMSHN 507

Query: 568 RINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 618
            +         QL  L  LD S N I  +        ++L   +L++N + 
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  160 bits (407), Expect = 3e-41
 Identities = 81/467 (17%), Positives = 138/467 (29%), Gaps = 76/467 (16%)

Query: 228 SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 287
             S K + +  N L      S  + S LQ + LS         +    L  L +LI+ GN
Sbjct: 31  PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90

Query: 288 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNFS 346
                 P     LT LE  VA     +      +     L  L++ +N +    +   FS
Sbjct: 91  PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 347 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKI----LSLAKNELSGQVPESFGKLTSLLFL 402
            L++L  +DL+ N+      N L    +       L ++ N +   + +   +   L  L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHEL 209

Query: 403 SLSNNSFN-----HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMV--LALG 455
           +L  N  +          L+ L   + +      +  +    P  + G   + +    L 
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 456 NCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSL 515
                    V       +  + L+           + +      L      L       L
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327

Query: 516 TELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPP 575
             LKSL                                          L+ N+   +I  
Sbjct: 328 PFLKSLT-----------------------------------------LTMNKG--SISF 344

Query: 576 EIGQLKHLHVLDLSRNNITGTIPSSISEI--RNLEVLDLSSNDLHGSIPGSFEKLTFLSK 633
           +   L  L  LDLSRN ++ +   S S++   +L  LDLS N     +  +F  L  L  
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH 403

Query: 634 FSVANNHLQGTIPTGG---------------QFYSFPNSSFEGNPGL 665
               ++ L+                            +  F G   L
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  154 bits (392), Expect = 2e-39
 Identities = 76/420 (18%), Positives = 137/420 (32%), Gaps = 49/420 (11%)

Query: 91  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG-VVPVELSNLKQLEVLDLSHNMLSGP 149
           L +    +  I  ++   +  L  L L  N     ++   L NL  L V  L        
Sbjct: 186 LDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD- 243

Query: 150 VSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQ 209
                      ++L +   S    L ++     +  F ++  +     +   +     + 
Sbjct: 244 ----------ERNLEIFEPSIMEGLCDV----TIDEFRLTYTNDFS-DDIVKFHCLANVS 288

Query: 210 ILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL 269
            + L+       L+ +      + L +    L       L     L+ ++L++N  S  +
Sbjct: 289 AMSLAGVSI-KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGS--I 342

Query: 270 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 329
           S K   L SL +L +  N  S        +L                        + L  
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLG----------------------TNSLRH 380

Query: 330 LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS-LSDCHDLKILSLAKNELSGQ 388
           LDL  N     +  NF GL  L  LD   +        S       L  L ++       
Sbjct: 381 LDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439

Query: 389 VPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFES 448
               F  LTSL  L ++ NSF   + + +V     NLT L L+K  + +           
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLS-NVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498

Query: 449 LMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLT 508
           L +L + +  L         +   L  LD S+N  + +        ++L + + +NN++ 
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  144 bits (366), Expect = 4e-36
 Identities = 63/382 (16%), Positives = 108/382 (28%), Gaps = 51/382 (13%)

Query: 294 PNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCT 353
            ++  +   ++      N        S S  S+L  LDL    +    D  + GL  L  
Sbjct: 28  DDIPSSTKNIDL---SFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84

Query: 354 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLS 413
           L L  N      P S S    L+ L   + +L+       G+L +L  L++++N  +   
Sbjct: 85  LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144

Query: 414 GTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKL 473
              +      NL  + L+ N++      ++        +                     
Sbjct: 145 -LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV--------------------N 183

Query: 474 QVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKS----LTELKSLISSNCTSS 529
             LD+S N     I     Q   L  L    N  +  I K+    L  L           
Sbjct: 184 LSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242

Query: 530 NPTASAGIPLYV-----KHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIP 574
           +          +             L Y    S     F          L+   I     
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYL 300

Query: 575 PEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKF 634
            ++ +      L + R  +       +     L+ L L+ N   GSI      L  LS  
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQFPTLDLP---FLKSLTLTMN--KGSISFKKVALPSLSYL 355

Query: 635 SVANNHLQGTIPTGGQFYSFPN 656
            ++ N L  +           +
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNS 377

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  203 bits (519), Expect = 8e-59
 Identities = 83/273 (30%), Positives = 133/273 (48%), Gaps = 21/273 (7%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQG 834
              IG G FG V++A   +G+  AVK L       +   EF  EV  + R +H N+V   G
Sbjct: 43   EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 835  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                  +  ++  Y+  GSL   LH+S  ++  L    RL +A   A+G+ YLH    P 
Sbjct: 102  AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC 954
            IVHR++KS N+L+D+K+   + DFGLSR L+      +    GT  ++ PE  +   +  
Sbjct: 160  IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 955  RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014
            + DVYSFGV+L EL T ++P       N   +V+ V     + + +EI       ++   
Sbjct: 219  KSDVYSFGVILWELATLQQPWG---NLNPAQVVAAVGF---KCKRLEIP------RNLNP 266

Query: 1015 QLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            Q+  ++E    C   +P +RP    ++  L  +
Sbjct: 267  QVAAIIE---GCWTNEPWKRPSFATIMDLLRPL 296

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  203 bits (518), Expect = 2e-58
 Identities = 70/326 (21%), Positives = 120/326 (36%), Gaps = 49/326 (15%)

Query: 760  DLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE 819
            +   S+     +N     +IG G +G VYK +L +    AVK  S       + F  E  
Sbjct: 2    EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKN 57

Query: 820  --ALSRAQHKNLVSLQGYCRHGNDR-----LLIYSYMENGSLDYWLHESVDKDSVLKWDV 872
               +   +H N+                  LL+  Y  NGSL  +L           W  
Sbjct: 58   IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112

Query: 873  RLKIAQGAARGLAYLH------KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP 926
              ++A    RGLAYLH         +P I HRD+ S N+L+       ++DFGLS  L  
Sbjct: 113  SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 927  -------YDTHVTTDLVGTLGYIPPEY-------SQTLTATCRGDVYSFGVVLLELLTGR 972
                    + +     VGT+ Y+ PE            +A  + D+Y+ G++  E+    
Sbjct: 173  NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-- 230

Query: 973  RPVEVCKGKNCRDL-VSWVFQMKSEKREVEIIDASIWHKDR----------EKQLLEMLE 1021
            R  ++  G++  +  +++  ++ +     ++       K R             +  + E
Sbjct: 231  RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 1022 IACKCIDQDPRRRPFIEEVVTWLDGI 1047
                C DQD   R   +     +  +
Sbjct: 291  TIEDCWDQDAEARLTAQXAEERMAEL 316

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  199 bits (507), Expect = 2e-57
 Identities = 81/286 (28%), Positives = 131/286 (45%), Gaps = 38/286 (13%)

Query: 777  NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ-------MEREFQAEVEALSRAQHKN 828
              IG GGFGLV+K   + + +  A+K L     +         +EFQ EV  +S   H N
Sbjct: 25   KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 829  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
            +V L G     N   ++  ++  G L + L    DK   +KW V+L++    A G+ Y+ 
Sbjct: 85   IVKLYGLMH--NPPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 889  KVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
                P IVHRD++S NI L    E     A +ADFGLS+       H  + L+G   ++ 
Sbjct: 140  N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMA 194

Query: 944  PE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            PE   ++  + T + D YSF ++L  +LTG  P +     +    + ++  ++ E     
Sbjct: 195  PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGK-IKFINMIREEGLRPT 250

Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            I       +D   +L  ++E    C   DP++RP    +V  L  +
Sbjct: 251  IP------EDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  198 bits (505), Expect = 5e-57
 Identities = 68/276 (24%), Positives = 124/276 (44%), Gaps = 33/276 (11%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
             ++G G FG+V KA        A+K++  +     + F  E+  LSR  H N+V L G C
Sbjct: 14   EVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 837  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
               N   L+  Y E GSL   LH + +          +      ++G+AYLH +    ++
Sbjct: 71   L--NPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 897  HRDVKSSNILLDEKFE-AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
            HRD+K  N+LL        + DFG +  +        T+  G+  ++ PE  +    + +
Sbjct: 128  HRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYSEK 183

Query: 956  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR--- 1012
             DV+S+G++L E++T R+P +        ++    F+          I  ++ +  R   
Sbjct: 184  CDVFSWGIILWEVITRRKPFD--------EIGGPAFR----------IMWAVHNGTRPPL 225

Query: 1013 -EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
             +     +  +  +C  +DP +RP +EE+V  +  +
Sbjct: 226  IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  194 bits (495), Expect = 5e-56
 Identities = 63/283 (22%), Positives = 109/283 (38%), Gaps = 42/283 (14%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQG 834
              +     G ++K     G    VK L       +  R+F  E   L    H N++ + G
Sbjct: 16   TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 835  YCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
             C+         I  +M  GSL   LHE    + V+     +K A   ARG+A+LH   E
Sbjct: 75   ACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LE 131

Query: 893  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE---YSQT 949
            P I    + S ++++DE   A ++   +           +   +    ++ PE       
Sbjct: 132  PLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKPE 185

Query: 950  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDL--VSWVFQMKSEKREVEI---ID 1004
             T     D++SF V+L EL+T   P          DL  +    ++  E     I   I 
Sbjct: 186  DTNRRSADMWSFAVLLWELVTREVPFA--------DLSNMEIGMKVALEGLRPTIPPGIS 237

Query: 1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              +       +L++       C+++DP +RP  + +V  L+ +
Sbjct: 238  PHV------SKLMK------ICMNEDPAKRPKFDMIVPILEKM 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  193 bits (493), Expect = 1e-55
 Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 26/275 (9%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            IG G FG VYK    +G   AVK L+      Q  + F+ EV  L + +H N++   GY 
Sbjct: 32   IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 837  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                   ++  + E  SL + LH     ++  +    + IA+  ARG+ YLH      I+
Sbjct: 90   TAPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSII 142

Query: 897  HRDVKSSNILLDEKFEAHLADFGLSRLL-RPYDTHVTTDLVGTLGYIPPE---YSQTLTA 952
            HRD+KS+NI L E     + DFGL+    R   +H    L G++ ++ PE      +   
Sbjct: 143  HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 953  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012
            + + DVY+FG+VL EL+TG+ P       N RD +  +    S   ++  + ++      
Sbjct: 203  SFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMVGRGSLSPDLSKVRSNC----- 254

Query: 1013 EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
             K++  ++    +C+ +    RP    ++  ++ +
Sbjct: 255  PKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 286

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  192 bits (489), Expect = 3e-55
 Identities = 78/283 (27%), Positives = 119/283 (42%), Gaps = 36/283 (12%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRL----SGDCGQMEREFQAEVEALSRAQHKNLVSL 832
             IIG GGFG VY+A    G + AVK        D  Q     + E +  +  +H N+++L
Sbjct: 13   EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            +G C    +  L+  +   G L+  L         +  D+ +  A   ARG+ YLH    
Sbjct: 72   RGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 893  PHIVHRDVKSSNILLDEKFEAH--------LADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
              I+HRD+KSSNIL+ +K E          + DFGL+R    + T   +   G   ++ P
Sbjct: 127  VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSA-AGAYAWMAP 183

Query: 945  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
            E  +    +   DV+S+GV+L ELLTG  P     G +   +   V      K  + I  
Sbjct: 184  EVIRASMFSKGSDVWSYGVLLWELLTGEVPFR---GIDGLAVAYGVAM---NKLALPIPS 237

Query: 1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                            ++   C + DP  RP    ++  L  I
Sbjct: 238  TC---------PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  187 bits (477), Expect = 3e-53
 Identities = 71/300 (23%), Positives = 117/300 (39%), Gaps = 42/300 (14%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE--ALSRAQHKNLVSLQG 834
              +G G +G V++ +   G   AVK  S    + E+ +  E E       +H+N++    
Sbjct: 14   ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 835  YCRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-- 888
                         LI  Y E GSL  +L       + L     L+I    A GLA+LH  
Sbjct: 70   SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 889  ---KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGTLGYI 942
                  +P I HRD+KS NIL+ +  +  +AD GL+ +       +       VGT  Y+
Sbjct: 125  IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 943  PPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC--RDLVSW---VF 991
             PE            +  R D+++FG+VL E+        + +       D+V       
Sbjct: 185  APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 992  QMKS----EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
             M+     +++   I +   W  D    L  + ++  +C  Q+P  R     +   L  I
Sbjct: 245  DMRKVVCVDQQRPNIPNR--WFSD--PTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  187 bits (476), Expect = 1e-52
 Identities = 72/300 (24%), Positives = 113/300 (37%), Gaps = 42/300 (14%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE--ALSRAQHKNLVSLQG 834
              IG G +G V+      G K AVK         E  +  E E       +H+N++    
Sbjct: 43   KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98

Query: 835  YCRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-- 888
                G        LI  Y ENGSL  +L       + L     LK+A  +  GL +LH  
Sbjct: 99   ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 889  ---KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGTLGYI 942
                  +P I HRD+KS NIL+ +     +AD GL+         V       VGT  Y+
Sbjct: 154  IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 943  PPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 996
            PPE            +    D+YSFG++L E+        + +       + +   + S+
Sbjct: 214  PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ----LPYHDLVPSD 269

Query: 997  KREVEIIDASIWHKDR---------EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                ++ +     K R         ++ L +M ++  +C   +P  R     V   L  +
Sbjct: 270  PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  185 bits (471), Expect = 5e-52
 Identities = 78/361 (21%), Positives = 133/361 (36%), Gaps = 57/361 (15%)

Query: 715  TLLKMSRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFN 774
              L       G  + DL  DM      +    S   +L Q +  + + +           
Sbjct: 3    PSLDRPFISEGTTLKDLIYDMT-----TSGSGSGLPLLVQRTIARTIVLQ---------- 47

Query: 775  QANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVE--ALSRAQHKNLVSL 832
                IG G FG V++     G + AVK  S    + ER +  E E       +H+N++  
Sbjct: 48   --ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101

Query: 833  QGYCRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                   N       L+  Y E+GSL  +L+        +  +  +K+A   A GLA+LH
Sbjct: 102  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLH 156

Query: 889  -----KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL---VGTLG 940
                    +P I HRD+KS NIL+ +     +AD GL+         +       VGT  
Sbjct: 157  MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 941  YIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC--RDLVSW--- 989
            Y+ PE        +   +  R D+Y+ G+V  E+        + +       DLV     
Sbjct: 217  YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 990  VFQMKS---EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDG 1046
            V +M+    E++    I       +  + + +++    +C   +   R     +   L  
Sbjct: 277  VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLSQ 333

Query: 1047 I 1047
            +
Sbjct: 334  L 334

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  195 bits (497), Expect = 1e-51
 Identities = 130/653 (19%), Positives = 224/653 (34%), Gaps = 72/653 (11%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV-SGMLAGLNLI 160
           +P+    LN  + L LS N++  V       L+QL++L+L        +       L  +
Sbjct: 19  VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75

Query: 161 QSLNVSSNSFNGSLFELGEF---SNLAVFNISNNSFTGK-LNSRIWSASKEIQILDLSMN 216
           + L++ S+           F    +L    +     +   L    +   K +  LDLS N
Sbjct: 76  RILDLGSSKI--YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133

Query: 217 HF--MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYS--MSSLQHVSLSVNNFSGQLSEK 272
               +          SLK +   +N +       L      +L   SL+ N+   ++S  
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193

Query: 273 ISNL------TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 326
                       L  L + GN ++  +                SN+ S     SL L   
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNF------------SNAISKSQAFSLILAHH 241

Query: 327 LHVLDLRNNSLTGPIDLNFSGL--SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNE 384
           +       +++  P    F+GL  SS+  LDL+                DLK+L+LA N+
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301

Query: 385 LSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG 444
           ++    E+F  L +L  L+LS N    L    S       +  + L KN +     +   
Sbjct: 302 INKIADEAFYGLDNLQVLNLSYNLLGELYS--SNFYGLPKVAYIDLQKNHIAIIQDQTFK 359

Query: 445 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 504
             E L  L L +  L       +     +  + LS N     +P           +  S 
Sbjct: 360 FLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKL-VTLPK---INLTANLIHLSE 410

Query: 505 NTLT----GEIPKSLTELKSL-ISSNC-TSSNPTASAGIPLYVKH-NRSTNGLPYNQASS 557
           N L           +  L+ L ++ N  +S +   +      ++      N L     + 
Sbjct: 411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470

Query: 558 FPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRN 606
               VF          L++N +N ++PP +   L  L  L L+ N +T    + +    N
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527

Query: 607 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 666
           LE+LD+S N L    P  F     LS   + +N           F ++ N +     G  
Sbjct: 528 LEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECEL-STFINWLNHTNVTIAGPP 583

Query: 667 GEI--DSPCDSMHAKLKPVIPSGSNSKFGPGSIIAITFSIGVGIALLLAVTLL 717
            +I    P       L  +   G + +    S+    F +      L  +T+L
Sbjct: 584 ADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTIL 636

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  123 bits (311), Expect = 6e-29
 Identities = 74/330 (22%), Positives = 128/330 (38%), Gaps = 44/330 (13%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
           V  L L    +  +  R    L  LK+L+L+ N +  +       L  L+VL+LS+N+L 
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 207
                            + S++F G          +A  ++  N     +  + +   ++
Sbjct: 328 ----------------ELYSSNFYG-------LPKVAYIDLQKNHIA-IIQDQTFKFLEK 363

Query: 208 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 267
           +Q LDL  N    +L  +   PS+  + +  N L      +L    +   + LS N    
Sbjct: 364 LQTLDLRDN----ALTTIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLEN 415

Query: 268 -QLSEKISNLTSLRHLIIFGNQFSGKLPNVL-GNLTQLEFFVAHSNSFSGPLPLSLSL-- 323
             +   +  +  L+ LI+  N+FS    +        LE      N         L    
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475

Query: 324 ---CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 380
               S L VL L +N L       FS L++L  L L +N  +    N L    +L+IL +
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDI 533

Query: 381 AKNELSGQVPESFGKLTSLLFLSLSNNSFN 410
           ++N+L    P+ F  L+ L    +++N F 
Sbjct: 534 SRNQLLAPNPDVFVSLSVLD---ITHNKFI 560

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  118 bits (297), Expect = 3e-27
 Identities = 68/361 (18%), Positives = 126/361 (34%), Gaps = 30/361 (8%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 142
                + +L L    +  I   +   L+ L++L+LS N L  +       L ++  +DL 
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346

Query: 143 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 202
            N ++         L  +Q+L++  N+       +    ++    +S N         + 
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLV-----TLP 397

Query: 203 SASKEIQILDLSMNHF--MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYS-MSSLQHVS 259
             +    ++ LS N    +  L  L   P L+ L ++ N       D   S   SL+ + 
Sbjct: 398 KINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457

Query: 260 LSVNNFSGQLSEKI-----SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS 314
           L  N        ++       L+ L+ L +  N  +   P V  +LT L     +SN  +
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

Query: 315 GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN----SLS 370
             L  +  L + L +LD+  N L      N     SL  LD+  N F          +  
Sbjct: 518 V-LSHN-DLPANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKFICECELSTFINWL 572

Query: 371 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 430
           +  ++ I     +             + +   SLS    +      S+      + T+ L
Sbjct: 573 NHTNVTIAGPPAD----IYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTL 628

Query: 431 T 431
           T
Sbjct: 629 T 629

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  183 bits (467), Expect = 1e-51
 Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 39/286 (13%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
             +IG G FG VY     +G   A++ +    D     + F+ EV A  + +H+N+V   G
Sbjct: 39   ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 835  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
             C       +I S  +  +L   +    D   VL  +   +IAQ   +G+ YLH      
Sbjct: 97   ACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150

Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLR----PYDTHVTTDLVGTLGYIPPEYSQTL 950
            I+H+D+KS N+  D   +  + DFGL  +                 G L ++ PE  + L
Sbjct: 151  ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 951  TATCRG---------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            +              DV++ G +  EL     P +    +    ++  +      K  + 
Sbjct: 210  SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK---TQPAEAIIWQM--GTGMKPNLS 264

Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
             I          K++ ++L     C   +   RP   +++  L+ +
Sbjct: 265  QIGMG-------KEISDILL---FCWAFEQEERPTFTKLMDMLEKL 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  182 bits (463), Expect = 3e-51
 Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 36/286 (12%)

Query: 777  NIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
             ++G G FG   K T    G    +K L     + +R F  EV+ +   +H N++   G 
Sbjct: 16   EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                     I  Y++ G+L   +      DS   W  R+  A+  A G+AYLH     +I
Sbjct: 76   LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 896  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-------------TDLVGTLGYI 942
            +HRD+ S N L+ E     +ADFGL+RL+    T                  +VG   ++
Sbjct: 130  IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 943  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
             PE     +   + DV+SFG+VL E++                             +  +
Sbjct: 190  APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP---------------DYLPRTMDFGL 234

Query: 1003 IDASIWHKDREKQLLEML-EIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                   +            I  +C D DP +RP   ++  WL+ +
Sbjct: 235  NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  185 bits (472), Expect = 1e-50
 Identities = 102/482 (21%), Positives = 171/482 (35%), Gaps = 51/482 (10%)

Query: 105 SLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLN 164
           +   L +     L   ++   V    ++L Q+  L      +       +  LN +  +N
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQIN 74

Query: 165 VSSNSFNGSLFELGEFSNLAVFNISNNSFT-----GKLNSRIWSASKEIQILDLSMNHFM 219
            S+N     +  L   + L    ++NN          L +        +  L L  N   
Sbjct: 75  FSNNQLT-DITPLKNLTKLVDILMNNNQIADITPLANLTN--------LTGLTLFNNQIT 125

Query: 220 GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 279
             +  L +  +L +L + +N +      +L  ++SLQ +S   N  +    + ++NLT+L
Sbjct: 126 -DIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTD--LKPLANLTTL 179

Query: 280 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 339
             L I  N+ S    +VL  LT LE  +A +N  S   P  L + + L  L L  N L  
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235

Query: 340 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 399
                 + L++L  LDLA N  S   P  LS    L  L L  N++S         LT+L
Sbjct: 236 IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTAL 289

Query: 400 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 459
             L L+ N    +S     +   KNLT L L  N + +  P  V     L  L   N  +
Sbjct: 290 TNLELNENQLEDISP----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343

Query: 460 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELK 519
                  L     +  L    N      P  +  +  +  L  ++   T         + 
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399

Query: 520 SLISS---NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF----PPSVFLSNNRINGT 572
              +          P   +    Y + + + N   Y    S+    P ++       +GT
Sbjct: 400 IPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGT 459

Query: 573 IP 574
           + 
Sbjct: 460 VT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  183 bits (466), Expect = 6e-50
 Identities = 102/510 (20%), Positives = 173/510 (33%), Gaps = 53/510 (10%)

Query: 113 KLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNG 172
                    +  +     + L +     L    ++  VS     L+ + +L         
Sbjct: 5   SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 59

Query: 173 SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLK 232
           S+  +   +NL   N SNN  T            ++  + ++ N     +  L +  +L 
Sbjct: 60  SIDGVEYLNNLTQINFSNNQLTDITPL---KNLTKLVDILMNNNQIA-DITPLANLTNLT 115

Query: 233 QLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGK 292
            L + NN +     D L ++++L  + LS N  S      +S LTSL+ L   GNQ +  
Sbjct: 116 GLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDL 170

Query: 293 LPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLC 352
            P  L NLT LE     SN  S      L+  + L  L   NN ++         L++L 
Sbjct: 171 KP--LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDIT--PLGILTNLD 224

Query: 353 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL 412
            L L  N        +L+   +L  L LA N++S         LT L  L L  N  +++
Sbjct: 225 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNI 280

Query: 413 SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKK 472
           S     L     LT L L +N + +     +   ++L  L L    +    P  +    K
Sbjct: 281 SP----LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTK 332

Query: 473 LQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPT 532
           LQ L    N         +  + N+ +L   +N ++   P  L  L  +           
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQ--------- 379

Query: 533 ASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNN 592
                 L +     TN  P N  ++      + N       P  I         D++ N 
Sbjct: 380 ------LGLNDQAWTN-APVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNL 432

Query: 593 ITGTIPSSISEIRNLEVLDLSSNDLHGSIP 622
            +               +   +    G++ 
Sbjct: 433 PSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  135 bits (341), Expect = 1e-33
 Identities = 68/354 (19%), Positives = 120/354 (33%), Gaps = 67/354 (18%)

Query: 297 LGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDL 356
              L +    V    + +  +  +     ++  L      +          L++L  ++ 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVSQTD--LDQVTTLQADRLGIKSID--GVEYLNNLTQINF 75

Query: 357 ATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL 416
           + N  +   P  L +   L  + +  N+++         LT+L  L+L NN    +    
Sbjct: 76  SNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP-- 129

Query: 417 SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVL 476
             L+   NL  L L+ N + +     + G  SL  L+ GN  +    P  L     L+ L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ-VTDLKP--LANLTTLERL 182

Query: 477 DLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSNCTSSNPTASA 535
           D+S N         + ++ NL  L  +NN ++   P   LT L  L              
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDEL-------------- 226

Query: 536 GIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITG 595
                                       L+ N++       +  L +L  LDL+ N I+ 
Sbjct: 227 ---------------------------SLNGNQL--KDIGTLASLTNLTDLDLANNQISN 257

Query: 596 TIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGG 649
             P  +S +  L  L L +N +    P     LT L+   +  N L+   P   
Sbjct: 258 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISN 307

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  114 bits (288), Expect = 6e-27
 Identities = 54/315 (17%), Positives = 106/315 (33%), Gaps = 63/315 (20%)

Query: 332 LRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPE 391
            ++  +        + L+      L   + +  +    +D   +  L   +  +     +
Sbjct: 9   TQDTPINQIF--TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--ID 62

Query: 392 SFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMV 451
               L +L  ++ SNN    ++     L+    L  +++  N +       +    +L  
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP----LKNLTKLVDILMNNNQI--ADITPLANLTNLTG 116

Query: 452 LALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEI 511
           L L N  +    P  L     L  L+LS N    +I   +  + +L  L F N     + 
Sbjct: 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTI-SDISA-LSGLTSLQQLSFGNQVTDLKP 172

Query: 512 PKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRING 571
             +LT L+ L                                          +S+N++  
Sbjct: 173 LANLTTLERL-----------------------------------------DISSNKV-- 189

Query: 572 TIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFL 631
           +    + +L +L  L  + N I+   P  +  + NL+ L L+ N L     G+   LT L
Sbjct: 190 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIGTLASLTNL 245

Query: 632 SKFSVANNHLQGTIP 646
           +   +ANN +    P
Sbjct: 246 TDLDLANNQISNLAP 260

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  186 bits (475), Expect = 2e-50
 Identities = 88/538 (16%), Positives = 175/538 (32%), Gaps = 82/538 (15%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           +  I    L     L++L L  + +  +      +L  LE LDLS N LS   S     L
Sbjct: 38  ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL 97

Query: 158 NLIQSLNVSSNSFNGSLFELGEFSNLA---VFNISNNSFTGKLNSRIWSASKEIQILDLS 214
           + ++ LN+  N +  +L     F NL       I N     ++    ++    +  L++ 
Sbjct: 98  SSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156

Query: 215 MNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS 270
                     SL+ +     +  L +  +     L      +SS++++ L   N +    
Sbjct: 157 ALSLRNYQSQSLKSI---RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213

Query: 271 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL 330
             +        +     + S         L +L  ++   +       +    C+   + 
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE------VEFDDCTLNGLG 267

Query: 331 DLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVP 390
           D   +      +L      ++  L +   +    L    S    +K +++  +++     
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327

Query: 391 ESFGKLTSLLFLSLSNNSFNHLS-GTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESL 449
                L SL FL LS N          +      +L TL+L++N +   + +      +L
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL-RSMQKTGEILLTL 386

Query: 450 MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLT- 508
                                K L  LD+S N F   +P      E + +L+ S+  +  
Sbjct: 387 ---------------------KNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRV 424

Query: 509 --GEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPS----- 561
               IP++L  L                               +  N   SF        
Sbjct: 425 VKTCIPQTLEVLD------------------------------VSNNNLDSFSLFLPRLQ 454

Query: 562 -VFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 618
            +++S N++     P+      L V+ +SRN +          + +L+ + L +N   
Sbjct: 455 ELYISRNKL--KTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  154 bits (391), Expect = 1e-39
 Identities = 101/585 (17%), Positives = 192/585 (32%), Gaps = 126/585 (21%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           IP  L     +K LDLS N +  +   +L     L+VL L  + ++         L  ++
Sbjct: 20  IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
            L++S N  +               ++S++ F                            
Sbjct: 78  HLDLSDNHLS---------------SLSSSWF---------------------------- 94

Query: 222 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYS-MSSLQHVSLSVNNFSGQLSEK-ISNLTSL 279
                   SLK L++  N        SL+  +++LQ + +       ++     + LTSL
Sbjct: 95  ----GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150

Query: 280 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 339
             L I            L ++                          +H L L  +    
Sbjct: 151 NELEIKALSLRNYQSQSLKSIR------------------------DIHHLTLHLSESAF 186

Query: 340 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 399
            +++    LSS+  L+L   + +    + L        +       S    ESF +L  L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246

Query: 400 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 459
           L   L  +       TL+ L       + ++++    E +        ++  L +    L
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV--------TIRRLHIPQFYL 298

Query: 460 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ-MENLFYLDFSNNTLTGEIPKSLTEL 518
              +       +K++ + +  +     +P    Q +++L +LD S N +  E  K+    
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357

Query: 519 KSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP-----SVFLSNNRINGTI 573
            +  S               L +  N   + +               S+ +S N  +  +
Sbjct: 358 GAWPSLQ------------TLVLSQNHLRS-MQ-KTGEILLTLKNLTSLDISRNTFH-PM 402

Query: 574 PPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSK 633
           P      + +  L+LS   I   + + I   + LEVLD+S+N+L  S      +L  L  
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL-DSFSLFLPRLQEL-- 456

Query: 634 FSVANNHLQGTIPTGG-------------QFYSFPNSSFEGNPGL 665
             ++ N L+ T+P                Q  S P+  F+    L
Sbjct: 457 -YISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  124 bits (313), Expect = 9e-30
 Identities = 63/353 (17%), Positives = 113/353 (32%), Gaps = 31/353 (8%)

Query: 324 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
           C    V D R+ S T  P  L     +++ +LDL+ N  +      L  C +L++L L  
Sbjct: 4   CDASGVCDGRSRSFTSIPSGL----TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE-EIPE 441
           + ++    ++F  L SL  L LS+N  + LS   S      +L  L L  N      +  
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS--SWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 442 NVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 500
                 +L  L +GN      I          L  L++            +  + ++ +L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 501 DFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP 560
               +     +      L S+       +N       PL V    S       + S    
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 561 SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIR--------NLEVLDL 612
             F    +    +   I +L  +   D + N +    PS    +          +  L +
Sbjct: 238 ESFNELLK----LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293

Query: 613 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 665
               L   +   +  L  + + +V N+ +             P S  +    L
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVF----------LVPCSFSQHLKSL 336

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  119 bits (300), Expect = 4e-28
 Identities = 59/354 (16%), Positives = 117/354 (33%), Gaps = 30/354 (8%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
             L L       ++      L+ ++ L+L   +L       L   +    +       S 
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234

Query: 149 PVSGMLAGLNLIQSLNVSSNSF---NGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSAS 205
                   L  +    +  +     + +L  LG+F+      +S       +        
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT------- 287

Query: 206 KEIQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNN 264
             I+ L +   +    L         +K++ V+N+ +          + SL+ + LS N 
Sbjct: 288 --IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENL 345

Query: 265 FS---GQLSEKISNLTSLRHLIIFGNQFS--GKLPNVLGNLTQLEFFVAHSNSFSGPLPL 319
                 + S       SL+ L++  N      K   +L  L  L       N+F  P+P 
Sbjct: 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404

Query: 320 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 379
           S     K+  L+L +  +     +      +L  LD++ N+        L     L+ L 
Sbjct: 405 SCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLDS-FSLFL---PRLQELY 457

Query: 380 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
           +++N+L      S      LL + +S N    +     +  +  +L  + L  N
Sbjct: 458 ISRNKLKTLPDASL--FPVLLVMKISRNQLKSVP--DGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  101 bits (254), Expect = 2e-22
 Identities = 64/307 (20%), Positives = 106/307 (34%), Gaps = 35/307 (11%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLK--------QLEVLDLSHNMLSGPVSGM 153
           + R +  L++++  D + N L    P E   +          +  L +    L   +S +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305

Query: 154 LAGLNLIQSLNVSSNSFNGSLFELGEFS---NLAVFNISNNSFT--GKLNSRIWSASKEI 208
            + L  ++ + V ++     L          +L   ++S N        NS    A   +
Sbjct: 306 YSLLEKVKRITVENSKV--FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 209 QILDLSMNHF--MGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 265
           Q L LS NH   M     +     +L  L +  N     +PDS      ++ ++LS    
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGI 422

Query: 266 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCS 325
              +   I    +L  L +  N         L  L +L       N     LP   SL  
Sbjct: 423 R-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELYI---SRNKLKT-LP-DASLFP 473

Query: 326 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 385
            L V+ +  N L    D  F  L+SL  + L TN +          C  +  LS   N+ 
Sbjct: 474 VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC-------SCPRIDYLSRWLNKN 526

Query: 386 SGQVPES 392
           S +   S
Sbjct: 527 SQKEQGS 533

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 84.4 bits (209), Expect = 6e-17
 Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 14/212 (6%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVV---PVELSNLKQLEVL 139
           S   +V  + +    +  +      HL  L+ LDLS N +                L+ L
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

Query: 140 DLSHNMLS--GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKL 197
            LS N L        +L  L  + SL++S N+F+           +   N+S+      +
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST----GI 422

Query: 198 NSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 257
                   + +++LD+S N+       L   P L++L++  N L   LPD+      L  
Sbjct: 423 RVVKTCIPQTLEVLDVSNNNLDSFSLFL---PRLQELYISRNKL-KTLPDAS-LFPVLLV 477

Query: 258 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 289
           + +S N            LTSL+ + +  N +
Sbjct: 478 MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  184 bits (468), Expect = 2e-49
 Identities = 106/557 (19%), Positives = 178/557 (31%), Gaps = 73/557 (13%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
              L L    L+ +   S     +L++LDLS   ++ +      +L  L  L L+ N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNG-SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 206
               G  +GL+ +Q L     +      F +G    L   N+++N          +S   
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 207 EIQILDLSMNHFM----GSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS 261
            ++ LDLS N         L+ L   P     L +  N +   +    +    L  ++L 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208

Query: 262 VNNFSGQLSEK-ISNLTSLRHLIIFGNQFSG---------KLPNVLGNLTQLEFFVAHSN 311
            N  S  + +  I  L  L    +   +F                L NLT  EF +A+ +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 312 SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 371
            +   +    +  + +    L + ++      +FS       L+L    F       L  
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKL-- 324

Query: 372 CHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 431
              LK L+   N+       S   L SL FL LS N  +             +L  L L+
Sbjct: 325 -KSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 432 KNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPW 490
            N V   +  N  G E L  L   +  LK      +    + L  LD+S  H        
Sbjct: 382 FNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440

Query: 491 IGQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 546
              + +L  L  + N+            L  L  L                         
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD------------------------ 476

Query: 547 TNGLPYNQASSFPPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIR 605
                            LS  ++   + P     L  L VL+++ N +          + 
Sbjct: 477 -----------------LSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518

Query: 606 NLEVLDLSSNDLHGSIP 622
           +L+ + L +N    S P
Sbjct: 519 SLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  175 bits (445), Expect = 2e-46
 Identities = 110/569 (19%), Positives = 194/569 (34%), Gaps = 99/569 (17%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
            +L L R  ++ I   +   L+ L  L L+ N ++ +     S L  L+ L      L+ 
Sbjct: 55  QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114

Query: 149 PVSGMLAGLNLIQSLNVSSNSFN----GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSA 204
             +  +  L  ++ LNV+ N          F     +NL   ++S+N       + +   
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYF--SNLTNLEHLDLSSNKIQSIYCTDLRVL 172

Query: 205 SK---EIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPD-SLYSMSSLQHVSL 260
            +       LDLS+N       G      L +L + NN    ++    +  ++ L+   L
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232

Query: 261 SVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLS 320
            +  F  +      NL          +   G     L NLT  EF +A+ + +   +   
Sbjct: 233 VLGEFRNE-----GNLEKFDK-----SALEG-----LCNLTIEEFRLAYLDYYLDDIIDL 277

Query: 321 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 380
            +  + +    L + ++      +FS       L+L    F       L     LK L+ 
Sbjct: 278 FNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTF 332

Query: 381 AKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIP 440
             N+       S   L SL FL LS N  +             +L  L L+ N V     
Sbjct: 333 TSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI---- 386

Query: 441 ENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI--GQMENLF 498
                                 +    L  ++L+ LD   ++    +  +     + NL 
Sbjct: 387 ---------------------TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 424

Query: 499 YLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF 558
           YLD S+             L SL                 L                   
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEV---------------LK------------------ 451

Query: 559 PPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 617
                ++ N       P+I  +L++L  LDLS+  +    P++ + + +L+VL+++SN L
Sbjct: 452 -----MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506

Query: 618 HGSIPGSFEKLTFLSKFSVANNHLQGTIP 646
                G F++LT L K  +  N    + P
Sbjct: 507 KSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  162 bits (412), Expect = 3e-42
 Identities = 93/462 (20%), Positives = 160/462 (34%), Gaps = 48/462 (10%)

Query: 208 IQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 263
            + LDLS N        S       P L+ L +    +      +  S+S L  + L+ N
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSF---PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 264 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF-SGPLPLSLS 322
                     S L+SL+ L+      +      +G+L  L+      N   S  LP   S
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 323 LCSKLHVLDLRNNSLTGPIDLNFSGLSSL----CTLDLATNHFSGPLPNSLSDCHDLKIL 378
             + L  LDL +N +      +   L  +     +LDL+ N  +   P +  +   L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKL 205

Query: 379 SLAKNELSGQVPE-SFGKLTSLLFLSLSNNSFNHL----SGTLSVLQQCKNLTTLILTKN 433
           +L  N  S  V +     L  L    L    F +         S L+   NLT       
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 434 ---FVGEEIPENVGGFESLMVLALGNCGLKGHIP-VWLLRCKKLQVLDLSWNHFDGNIPP 489
              +  ++I +      ++   +L +  ++      +    + L++++  +  F      
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL--- 322

Query: 490 WIGQMENLFYLDFSNNTLTGEIP-KSLTELKSL-ISSNCTSSNPTASAGIPLYVKHNRST 547
              ++++L  L F++N          L  L+ L +S N  S     S           S 
Sbjct: 323 ---KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ----------SD 369

Query: 548 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRN 606
            G    +       + LS N +  T+      L+ L  LD   +N+      S+   +RN
Sbjct: 370 FGTTSLK------YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422

Query: 607 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTG 648
           L  LD+S      +  G F  L+ L    +A N  Q      
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  156 bits (396), Expect = 4e-40
 Identities = 85/431 (19%), Positives = 144/431 (33%), Gaps = 49/431 (11%)

Query: 245 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 304
           +PD+L    S +++ LS N      S    +   L+ L +   +          +L+ L 
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 305 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF-SG 363
             +   N        + S  S L  L     +L    +     L +L  L++A N   S 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 364 PLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL----LFLSLSNNSFNHLS-GTLSV 418
            LP   S+  +L+ L L+ N++          L  +    L L LS N  N +  G    
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199

Query: 419 LQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPV------WLLRCK 471
           +     L  L L  NF    + +    G   L V  L     +    +       L    
Sbjct: 200 I----RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255

Query: 472 KLQVLDLSWNHFDGNIPPWIG---QMENLFYLDFSNNTLTGEIPKS-LTELKSLISSNCT 527
            L + +    + D  +   I     + N+      + T+      S     + L   NC 
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC- 314

Query: 528 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLD 587
                                  P  +  S    +  ++N+       E+  L  L  LD
Sbjct: 315 ------------------KFGQFPTLKLKSL-KRLTFTSNKGG-NAFSEVD-LPSLEFLD 353

Query: 588 LSRNNIT--GTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTI 645
           LSRN ++  G    S     +L+ LDLS N +  ++  +F  L  L      +++L+  +
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QM 411

Query: 646 PTGGQFYSFPN 656
                F S  N
Sbjct: 412 SEFSVFLSLRN 422

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.0 bits (182), Expect = 1e-13
 Identities = 34/156 (21%), Positives = 68/156 (43%), Gaps = 11/156 (7%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVE-LSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 160
           +  +   L QL+ LD   ++L+ +       +L+ L  LD+SH       +G+  GL+ +
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 161 QSLNVSSNSFNGSLFE--LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF 218
           + L ++ NSF  +       E  NL   ++S      +L+   +++   +Q+L+++ N  
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQL 506

Query: 219 ----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLY 250
                G    L    SL+++ +  N      P   Y
Sbjct: 507 KSVPDGIFDRL---TSLQKIWLHTNPWDCSCPRIDY 539

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 57.8 bits (140), Expect = 1e-08
 Identities = 22/82 (26%), Positives = 38/82 (46%)

Query: 101 IIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 160
            +P     L  L  LDLS   LE + P   ++L  L+VL+++ N L     G+   L  +
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520

Query: 161 QSLNVSSNSFNGSLFELGEFSN 182
           Q + + +N ++ S   +   S 
Sbjct: 521 QKIWLHTNPWDCSCPRIDYLSR 542

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  164 bits (417), Expect = 1e-44
 Identities = 68/412 (16%), Positives = 138/412 (33%), Gaps = 67/412 (16%)

Query: 231 LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFS 290
              L      +    PD+   ++      L   + +         L S+  L++ G + +
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 291 GKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSS 350
             +   +  LT LE+   + N  +   PLS     KL  L +  N +T         L++
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISPLSN--LVKLTNLYIGTNKITDIS--ALQNLTN 111

Query: 351 LCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFN 410
           L  L L  ++ S   P  L++   +  L+L  N            +T L +L+++ +   
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168

Query: 411 HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRC 470
            ++     +    +L +L L  N + +     +    SL         +    P  +   
Sbjct: 169 DVTP----IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANM 220

Query: 471 KKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSN 530
            +L  L +  N    ++ P +  +  L +L+   N ++     ++ +L  L         
Sbjct: 221 TRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISD--INAVKDLTKLKM------- 269

Query: 531 PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR 590
                                          + + +N+I  +    +  L  L+ L L+ 
Sbjct: 270 -------------------------------LNVGSNQI--SDISVLNNLSQLNSLFLNN 296

Query: 591 NNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 642
           N +       I  + NL  L LS N +    P     L+ +     AN  ++
Sbjct: 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  160 bits (406), Expect = 3e-43
 Identities = 74/394 (18%), Positives = 144/394 (36%), Gaps = 52/394 (13%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
             L      +  I P     L +     L    +  VV      L+ +  L ++   ++ 
Sbjct: 3   ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58

Query: 149 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI 208
            + G +  L  ++ LN++ N     +  L     L    I  N  T              
Sbjct: 59  -IQG-IEYLTNLEYLNLNGNQIT-DISPLSNLVKLTNLYIGTNKIT-------------- 101

Query: 209 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ 268
                        +  L +  +L++L+++ + +       L +++ +  ++L  N+    
Sbjct: 102 ------------DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD 147

Query: 269 LSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLH 328
           LS  +SN+T L +L +  ++    +   + NLT L     + N      P  L+  + LH
Sbjct: 148 LSP-LSNMTGLNYLTVTESKVK-DVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLH 202

Query: 329 VLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ 388
                 N +T       + ++ L +L +  N  +    + L++   L  L +  N++S  
Sbjct: 203 YFTAYVNQITDIT--PVANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD- 257

Query: 389 VPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFES 448
              +   LT L  L++ +N  + +S     L     L +L L  N +G E  E +GG  +
Sbjct: 258 -INAVKDLTKLKMLNVGSNQISDISV----LNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312

Query: 449 LMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH 482
           L  L L    +    P  L    K+   D +   
Sbjct: 313 LTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  152 bits (386), Expect = 1e-40
 Identities = 69/377 (18%), Positives = 124/377 (32%), Gaps = 65/377 (17%)

Query: 271 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL 330
              ++L      ++     +  +      L  +   V      +    +     + L  L
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQGIEY--LTNLEYL 71

Query: 331 DLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVP 390
           +L  N +T       S L  L  L + TN  +    ++L +  +L+ L L ++ +S    
Sbjct: 72  NLNGNQITDIS--PLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISD--I 125

Query: 391 ESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLM 450
                LT +  L+L     NH    LS L     L  L +T++ V +     +     L 
Sbjct: 126 SPLANLTKMYSLNLG---ANHNLSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLY 180

Query: 451 VLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGE 510
            L+L    ++   P+  L    L       N      P  +  M  L  L   NN +T  
Sbjct: 181 SLSLNYNQIEDISPLASL--TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236

Query: 511 IP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRI 569
            P  +L++L  L                                          +  N+I
Sbjct: 237 SPLANLSQLTWL-----------------------------------------EIGTNQI 255

Query: 570 NGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLT 629
             +    +  L  L +L++  N I+    S ++ +  L  L L++N L          LT
Sbjct: 256 --SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311

Query: 630 FLSKFSVANNHLQGTIP 646
            L+   ++ NH+    P
Sbjct: 312 NLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  111 bits (280), Expect = 1e-26
 Identities = 49/305 (16%), Positives = 97/305 (31%), Gaps = 66/305 (21%)

Query: 347 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN 406
           G ++L TL    N          +D  +     L K  ++     +  +L S+  L ++ 
Sbjct: 1   GAATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAG 53

Query: 407 NSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVW 466
                + G    ++   NL  L L  N + +  P  +     L  L +G   +   I   
Sbjct: 54  EKVASIQG----IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISA- 105

Query: 467 LLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP--KSLTELKSLISS 524
           L     L+ L L+ ++    I P +  +  ++ L+   N    ++    ++T L  L   
Sbjct: 106 LQNLTNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYL--- 160

Query: 525 NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLH 584
                                                  ++ +++       I  L  L+
Sbjct: 161 --------------------------------------TVTESKVKD--VTPIANLTDLY 180

Query: 585 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGT 644
            L L+ N I    P  ++ + +L       N +    P     +T L+   + NN +   
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236

Query: 645 IPTGG 649
            P   
Sbjct: 237 SPLAN 241

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 96.8 bits (242), Expect = 1e-21
 Identities = 38/193 (19%), Positives = 82/193 (42%), Gaps = 13/193 (6%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           +K + P  + +L  L  L L+ N +E + P  L++L  L       N ++      +A +
Sbjct: 167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220

Query: 158 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 217
             + SL + +N     L  L   S L    I  N  +  +N+       ++++L++  N 
Sbjct: 221 TRLNSLKIGNNKIT-DLSPLANLSQLTWLEIGTNQIS-DINA--VKDLTKLKMLNVGSNQ 276

Query: 218 FMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLT 277
               +  L++   L  L ++NN LG +  + +  +++L  + LS N+ +      +++L+
Sbjct: 277 I-SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLS 333

Query: 278 SLRHLIIFGNQFS 290
            +           
Sbjct: 334 KMDSADFANQVIK 346

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  166 bits (422), Expect = 2e-44
 Identities = 103/547 (18%), Positives = 178/547 (32%), Gaps = 103/547 (18%)

Query: 101 IIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 160
           I PR++     L+      ++L   +PVE  N+K       + +               +
Sbjct: 3   INPRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60

Query: 161 QSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 220
               +                      ++N   +      +      ++ L  S N    
Sbjct: 61  AVSRLRDCLDR----------QAHELELNNLGLS-----SLPELPPHLESLVASCNS--- 102

Query: 221 SLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 279
            L  L   P SLK L VDNN L   L D       L+++ +S N    +L E + N + L
Sbjct: 103 -LTELPELPQSLKSLLVDNNNLK-ALSDLP---PLLEYLGVSNNQLE-KLPE-LQNSSFL 155

Query: 280 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 339
           + + +  N    KLP++  +L  +    A +N     LP  L     L  +   NNSL  
Sbjct: 156 KIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK 209

Query: 340 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 399
             DL      SL ++    N         L +   L  +    N L   +P+    L +L
Sbjct: 210 LPDL----PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL 262

Query: 400 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 459
              ++ +N    L           +LT L +++N     + E      +L  L   +  +
Sbjct: 263 ---NVRDNYLTDLPELPQ------SLTFLDVSENIF-SGLSEL---PPNLYYLNASSNEI 309

Query: 460 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELK 519
           +  +         L+ L++S N     +P    ++E L     S N L  E+P+    LK
Sbjct: 310 R-SLCDLP---PSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQNLK 360

Query: 520 SLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF-----LSNNRINGTIP 574
            L                            + YN    FP           N+ +   +P
Sbjct: 361 QLH---------------------------VEYNPLREFPDIPESVEDLRMNSHLA-EVP 392

Query: 575 PEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKF 634
                LK L    +  N +    P       ++E L ++S  +      + E    L   
Sbjct: 393 ELPQNLKQL---HVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDD 445

Query: 635 SVANNHL 641
              ++H 
Sbjct: 446 VFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  164 bits (418), Expect = 8e-44
 Identities = 102/517 (19%), Positives = 169/517 (32%), Gaps = 89/517 (17%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           +P    ++        + +  E   P      +++ V  L   +                
Sbjct: 26  MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-----------AH 74

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
            L +++   + SL E     +L     S NS T +L     S  K + + + ++      
Sbjct: 75  ELELNNLGLS-SLPE--LPPHLESLVASCNSLT-ELPELPQSL-KSLLVDNNNLKALSDL 129

Query: 222 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRH 281
                  P L+ L V NN L   LP+ L + S L+ + +  N     L +      SL  
Sbjct: 130 P------PLLEYLGVSNNQL-EKLPE-LQNSSFLKIIDVDNN----SLKKLPDLPPSLEF 177

Query: 282 LIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPI 341
           +    NQ   +LP  L NL  L    A +NS    LP        L  +   NN L    
Sbjct: 178 IAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILEELP 231

Query: 342 DLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLF 401
           +L    L  L T+    N     LP+       L+ L++  N L+  +PE    LT    
Sbjct: 232 EL--QNLPFLTTIYADNNLLKT-LPDLPP---SLEALNVRDNYLT-DLPELPQSLTF--- 281

Query: 402 LSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKG 461
           L +S N F+ LS          NL  L  + N +   + +      SL  L + N  L  
Sbjct: 282 LDVSENIFSGLSELP------PNLYYLNASSNEI-RSLCDL---PPSLEELNVSNNKLI- 330

Query: 462 HIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL 521
            +P       +L+ L  S+NH    +P       NL  L    N L  E P     ++ L
Sbjct: 331 ELPALP---PRLERLIASFNHL-AEVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDL 382

Query: 522 ISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLK 581
             ++  +  P     +                        + +  N +    P     ++
Sbjct: 383 RMNSHLAEVPELPQNL----------------------KQLHVETNPLR-EFPDIPESVE 419

Query: 582 HLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 618
               L ++   +      +      LE      +  H
Sbjct: 420 D---LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  156 bits (396), Expect = 5e-41
 Identities = 92/444 (20%), Positives = 156/444 (35%), Gaps = 61/444 (13%)

Query: 87  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 146
           +   L L   GL   +P    HL  L     SCN L   +P    +LK L V + +   L
Sbjct: 72  QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126

Query: 147 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 206
           S           L++ L VS+N     L EL   S L + ++ NNS       ++     
Sbjct: 127 SDL-------PPLLEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLK-----KLPDLPP 173

Query: 207 EIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 266
            ++ +    N     L  L + P L  ++ DNN L   LPD      SL+ +    N   
Sbjct: 174 SLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLK-KLPDLP---LSLESIVAGNNILE 228

Query: 267 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 326
            +L E + NL  L  +    N     LP++  +L  L       N  +  LP      + 
Sbjct: 229 -ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEALNV---RDNYLTD-LPELPQSLTF 281

Query: 327 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 386
           L V +   + L+           +L  L+ ++N     L +       L+ L+++ N+L 
Sbjct: 282 LDVSENIFSGLS-------ELPPNLYYLNASSNEIRS-LCDLPPS---LEELNVSNNKLI 330

Query: 387 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 446
            ++P    +L  L     S N    +           NL  L +  N +  E P+     
Sbjct: 331 -ELPALPPRLERL---IASFNHLAEVPELPQ------NLKQLHVEYNPL-REFPDIPESV 379

Query: 447 ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNT 506
           E L +           +P      + L+ L +  N      P     +E+L         
Sbjct: 380 EDLRM-----NSHLAEVPEL---PQNLKQLHVETNPLR-EFPDIPESVEDLRMNSERVVD 430

Query: 507 LTGEIPKSLTELKSLISSNCTSSN 530
                 ++  +L+  +  +    +
Sbjct: 431 PYEFAHETTDKLEDDVFEHHHHHH 454

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  130 bits (329), Expect = 3e-32
 Identities = 70/396 (17%), Positives = 128/396 (32%), Gaps = 107/396 (27%)

Query: 251 SMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHS 310
           S + LQ      +N + ++  +  N+ S        +++    P   G   ++       
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV----- 62

Query: 311 NSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLS 370
                   L   L  + H L+L N  L+                          LP    
Sbjct: 63  ------SRLRDCLDRQAHELELNNLGLS-------------------------SLPELPP 91

Query: 371 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 430
               L+ L  + N L+ ++PE    L SLL  + +  + + L            L  L +
Sbjct: 92  ---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL---------PPLLEYLGV 138

Query: 431 TKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPW 490
           + N + E++PE +     L ++ + N  LK  +P        L+ +    N  +  +P  
Sbjct: 139 SNNQL-EKLPE-LQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLE-ELPE- 190

Query: 491 IGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGL 550
           +  +  L  +   NN+L  ++P     L+S++                            
Sbjct: 191 LQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---------------------------- 221

Query: 551 PYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVL 610
                          NN +     PE+  L  L  +    N +  T+P       +LE L
Sbjct: 222 -------------AGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEAL 262

Query: 611 DLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 646
           ++  N L   +P   + LTFL       + L    P
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.7 bits (127), Expect = 4e-07
 Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 18/105 (17%)

Query: 551 PYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE------- 603
           P N +++F       ++ +   +P E   +K       + +      P    E       
Sbjct: 5   PRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63

Query: 604 ------IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 642
                  R    L+L++  L  S+P     L  L     + N L 
Sbjct: 64  RLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT 104

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  159 bits (404), Expect = 9e-42
 Identities = 69/426 (16%), Positives = 144/426 (33%), Gaps = 47/426 (11%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           I     + N+ K+  ++ + L+  +     +   ++ LDLS N LS   +  LA    ++
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
            LN+SSN     L+E  +  +L                        ++ LDL+ N+    
Sbjct: 62  LLNLSSN----VLYETLDLESL----------------------STLRTLDLNNNY---- 91

Query: 222 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRH 281
           +Q L   PS++ LH  NN +   +  S       +++ L+ N  +          + +++
Sbjct: 92  VQELLVGPSIETLHAANNNI-SRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148

Query: 282 LIIFGNQFSG-KLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 340
           L +  N+        +  +   LE      N     +   +   +KL  LDL +N L   
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVF-AKLKTLDLSSNKLAF- 205

Query: 341 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS-GQVPESFGKLTSL 399
           +   F   + +  + L  N     +  +L    +L+   L  N    G + + F K   +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 400 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 459
              +++  +   L+G     ++C   T          +          +L          
Sbjct: 265 --QTVAKQTVKKLTG--QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG 320

Query: 460 KG----HIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSL 515
           +G     +        + + +D     +   I     + +    L+     L  ++    
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380

Query: 516 TELKSL 521
                L
Sbjct: 381 RAHAEL 386

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  146 bits (370), Expect = 2e-37
 Identities = 69/411 (16%), Positives = 126/411 (30%), Gaps = 52/411 (12%)

Query: 245 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 304
           + +   + +  +   ++ ++    L+    +  +++ L + GN  S      L   T+LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 305 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 364
                SN     L L  SL S L  LDL NN +            S+ TL  A N+ S  
Sbjct: 62  LLNLSSNVLYETLDLE-SL-STLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114

Query: 365 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 424
             +        K + LA N+++       G  + + +L L  N  + ++    +      
Sbjct: 115 SCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN-FAELAASSDT 170

Query: 425 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD 484
           L  L L  NF+  ++   V                            KL+ LDLS N   
Sbjct: 171 LEHLNLQYNFI-YDVKGQVV-------------------------FAKLKTLDLSSNKLA 204

Query: 485 GNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL----ISSN---CTSSNPTASAGI 537
             + P       + ++   NN L   I K+L   ++L    +  N   C +     S   
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

Query: 538 PLYVKHNRSTNGLPYN--QASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLS----RN 591
            +     ++   L     +  + P               P   +L  L   + +    + 
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322

Query: 592 NITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 642
           + T  +            +D         I     +             L 
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  130 bits (328), Expect = 6e-32
 Identities = 76/436 (17%), Positives = 143/436 (32%), Gaps = 25/436 (5%)

Query: 80  STGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVL 139
           S   +A  V  L L    L  I    L    +L+LL+LS N L   +   L +L  L  L
Sbjct: 28  SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTL 85

Query: 140 DLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNS 199
           DL++N +       L     I++L+ ++N+   S              ++NN  T  L  
Sbjct: 86  DLNNNYVQ-----ELLVGPSIETLHAANNNI--SRVSCSRGQGKKNIYLANNKIT-MLRD 137

Query: 200 RIWSASKEIQILDLSMNHFMG--SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 257
                   +Q LDL +N        +    S +L+ L++  N +  D+   +   + L+ 
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQV-VFAKLKT 195

Query: 258 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS-GP 316
           + LS N  +  +  +  +   +  + +  N+    +   L     LE F    N F  G 
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253

Query: 317 LPLSLSLCSKLHVLDLR-NNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLS--DCH 373
           L    S   ++  +  +    LTG  +   +  +              P  + L      
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRK 313

Query: 374 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
           +  +LS   +E    +            +      +  +     V  + +   TL   K 
Sbjct: 314 EHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQ--VTLRKQAKITLEQKKK 370

Query: 434 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD-GNIPPWIG 492
            + E++         L        G +  +         LQ+L      ++   +     
Sbjct: 371 ALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSV 429

Query: 493 QMENLFYLDFSNNTLT 508
           Q   +   D   +  T
Sbjct: 430 QNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 73.0 bits (179), Expect = 2e-13
 Identities = 25/193 (12%), Positives = 54/193 (27%), Gaps = 41/193 (21%)

Query: 472 KLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNP 531
           + ++  ++ +     +        N+  LD S N L+      L     L          
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL-------- 62

Query: 532 TASAGIPLYVKHNRSTNGLPYNQASSFPP--------SVFLSNNRINGTIPPEIGQLKHL 583
                  L          L  N               ++ L+NN +      E+     +
Sbjct: 63  -------LN---------LSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSI 101

Query: 584 HVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQG 643
             L  + NNI+  +  S    +  + + L++N +           + +    +  N +  
Sbjct: 102 ETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID- 157

Query: 644 TIPTGGQFYSFPN 656
           T+       S   
Sbjct: 158 TVNFAELAASSDT 170

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 13/70 (18%), Positives = 27/70 (38%)

Query: 577 IGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSV 636
                   +  ++ +++   + S      N++ LDLS N L           T L   ++
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 637 ANNHLQGTIP 646
           ++N L  T+ 
Sbjct: 66  SSNVLYETLD 75

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  147 bits (372), Expect = 6e-39
 Identities = 57/376 (15%), Positives = 104/376 (27%), Gaps = 65/376 (17%)

Query: 267 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 326
           G       + +   +L   G+       +VL    +      +    +     S    + 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NN 57

Query: 327 LHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 385
             +      +L      L  +       L+L +       P+       L+ +++    L
Sbjct: 58  PQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGL 116

Query: 386 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG 445
             ++P++  +   L  L+L+ N    L  +++       L  L +       E+PE +  
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLRALPASIA---SLNRLRELSIRACPELTELPEPLA- 171

Query: 446 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 505
                                      LQ L L W     ++P  I  ++NL  L   N+
Sbjct: 172 --------------STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216

Query: 506 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLS 565
            L+  +  ++  L  L                 L                        L 
Sbjct: 217 PLS-ALGPAIHHLPKLEE---------------LD-----------------------LR 237

Query: 566 NNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSF 625
                   PP  G    L  L L   +   T+P  I  +  LE LDL        +P   
Sbjct: 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297

Query: 626 EKLTFLSKFSVANNHL 641
            +L       V  +  
Sbjct: 298 AQLPANCIILVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  141 bits (357), Expect = 6e-37
 Identities = 59/377 (15%), Positives = 111/377 (29%), Gaps = 67/377 (17%)

Query: 243 GDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQ 302
           G      +  S  +++    +       + +S      +        + +      N   
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 303 LEFFVAHSNSFSGPLPLSLSLCS--KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNH 360
            +       +        L   +      L+LR+  L          LS L  + +    
Sbjct: 58  PQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAG 115

Query: 361 FSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQ 420
               LP+++     L+ L+LA+N L   +P S   L  L  LS+                
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA-------------- 159

Query: 421 QCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSW 480
            C  LT   L +     +      G  +L  L L   G++  +P  +   + L+ L +  
Sbjct: 160 -CPELTE--LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215

Query: 481 NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLY 540
           +     + P I  +  L  LD    T     P        L                 L 
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR---------------LI 259

Query: 541 VKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSS 600
           +K                        + +  T+P +I +L  L  LDL        +PS 
Sbjct: 260 LKD----------------------CSNL-LTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296

Query: 601 ISEIRNLEVLDLSSNDL 617
           I+++    ++ +  +  
Sbjct: 297 IAQLPANCIILVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  132 bits (334), Expect = 8e-34
 Identities = 53/340 (15%), Positives = 99/340 (29%), Gaps = 29/340 (8%)

Query: 181 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNL 240
           S         ++     +  +     + Q    +  +   S     +S + +        
Sbjct: 12  SGRENLYFQGSTALRPYHDVL----SQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRA 67

Query: 241 LGGDLPDSLY--SMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLG 298
           L     D L   +      + L       Q  ++   L+ L+H+ I       +LP+ + 
Sbjct: 68  LK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124

Query: 299 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLAT 358
               LE      N     LP S++  ++L  L +R       +    +            
Sbjct: 125 QFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTD--------- 174

Query: 359 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSV 418
                          +L+ L L    +   +P S   L +L  L + N+  + L   +  
Sbjct: 175 ------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIH- 226

Query: 419 LQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDL 478
                 L  L L         P   GG   L  L L +C     +P+ + R  +L+ LDL
Sbjct: 227 --HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284

Query: 479 SWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTEL 518
                   +P  I Q+     +    +             
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  129 bits (327), Expect = 6e-33
 Identities = 48/308 (15%), Positives = 86/308 (27%), Gaps = 33/308 (10%)

Query: 348 LSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNN 407
            S    L    +    P  + LS           +               +    + +  
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 408 SFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWL 467
           +    +  L    Q      L L    +  + P+       L  + +   GL   +P  +
Sbjct: 67  ALKATADLLEDATQ-PGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123

Query: 468 LRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCT 527
            +   L+ L L+ N     +P  I  +  L  L         E+P+ L    +       
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182

Query: 528 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF---------LSNNRINGTIPPEIG 578
            +  +      L          L +    S P S+          + N+ ++  + P I 
Sbjct: 183 VNLQS------LR---------LEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226

Query: 579 QLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN 638
            L  L  LDL         P        L+ L L       ++P    +LT L K  +  
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286

Query: 639 NHLQGTIP 646
                 +P
Sbjct: 287 CVNLSRLP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  126 bits (320), Expect = 5e-32
 Identities = 54/332 (16%), Positives = 102/332 (30%), Gaps = 34/332 (10%)

Query: 103 PRSLGHLNQLKLLDLS-CNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
                H +  + L       L       LS  ++    D +    +       A  N  Q
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPY-HDVLSQWQRHYNADRNRWHSAW----RQANSNNPQ 59

Query: 162 SLNVSSNSFNGSLFELGEFS--NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF- 218
               +  +   +   L + +        + +     +   + +  S  +Q + +      
Sbjct: 60  IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGLM 117

Query: 219 -----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNN--------- 264
                M           L+ L +  N L   LP S+ S++ L+ +S+             
Sbjct: 118 ELPDTMQQFA------GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170

Query: 265 FSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLC 324
            S   S +   L +L+ L +        LP  + NL  L+     ++  S  L  ++   
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHL 228

Query: 325 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNE 384
            KL  LDLR  +        F G + L  L L        LP  +     L+ L L    
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288

Query: 385 LSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL 416
              ++P    +L +   + +  +    L    
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  113 bits (285), Expect = 2e-27
 Identities = 43/268 (16%), Positives = 87/268 (32%), Gaps = 46/268 (17%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
            P     L+ L+ + +    L   +P  +     LE L L+ N L               
Sbjct: 96  FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-------------- 140

Query: 162 SLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 220
                      +L   +   + L   +I       +L   + S     +   L       
Sbjct: 141 -----------ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV------ 183

Query: 221 SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLR 280
                    +L+ L ++   +   LP S+ ++ +L+ + +  +  S  L   I +L  L 
Sbjct: 184 ---------NLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232

Query: 281 HLIIFGNQFSGKLPNVLGNLTQL-EFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 339
            L + G       P + G    L    +   ++    LPL +   ++L  LDLR      
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLS 291

Query: 340 PIDLNFSGLSSLCTLDLATNHFSGPLPN 367
            +    + L + C + +  +  +    +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 66.5 bits (163), Expect = 1e-11
 Identities = 26/211 (12%), Positives = 63/211 (29%), Gaps = 53/211 (25%)

Query: 93  LPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG-PVS 151
           LP              L  L+ L L    +   +P  ++NL+ L+ L + ++ LS    +
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPA 224

Query: 152 GMLAGLNLIQSLNVSSNSFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQI 210
             +  L  ++ L++   +   +     G  + L    + +                    
Sbjct: 225 --IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC------------------- 263

Query: 211 LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS 270
                                      +NL    LP  ++ ++ L+ + L       +L 
Sbjct: 264 ---------------------------SNL--LTLPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 271 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLT 301
             I+ L +   +++  +  +    +      
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  139 bits (352), Expect = 2e-36
 Identities = 64/345 (18%), Positives = 128/345 (37%), Gaps = 44/345 (12%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           I     + N+ K+  ++ + L+  +     +   ++ LDLS N LS   +  LA    ++
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
            LN+SSN     L+E  +  +L                        ++ LDL+ N+    
Sbjct: 62  LLNLSSN----VLYETLDLESL----------------------STLRTLDLNNNY---- 91

Query: 222 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRH 281
           +Q L   PS++ LH  NN +   +  S       +++ L+ N  +          + +++
Sbjct: 92  VQELLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQY 148

Query: 282 LIIFGNQFSG-KLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 340
           L +  N+        +  +   LE      N     +   +   +KL  LDL +N L   
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVF-AKLKTLDLSSNKLAF- 205

Query: 341 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS-GQVPESFGKLTSL 399
           +   F   + +  + L  N     +  +L    +L+   L  N    G + + F K   +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 400 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG 444
              +++  +   L+G          + TL     +  E++P    
Sbjct: 265 --QTVAKQTVKKLTGQNEEE---CTVPTLGHYGAYCCEDLPAPFA 304

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  137 bits (346), Expect = 1e-35
 Identities = 62/352 (17%), Positives = 121/352 (34%), Gaps = 63/352 (17%)

Query: 325 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNE 384
           ++  +  + ++SL   +        ++  LDL+ N  S      L+    L++L+L+ N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 385 LSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVG 444
           L          L++L  L L+NN        +  L    ++ TL    N +   +  +  
Sbjct: 70  LYE--TLDLESLSTLRTLDLNNNY-------VQELLVGPSIETLHAANNNI-SRVSCSR- 118

Query: 445 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG-NIPPWIGQMENLFYLDFS 503
             +    + L N  +     +      ++Q LDL  N  D  N        + L +L+  
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 504 NNTLTGEIPKS--LTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPS 561
            N +  ++       +LK+L                                        
Sbjct: 178 YNFIY-DVKGQVVFAKLKTL---------------------------------------- 196

Query: 562 VFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH-GS 620
             LS+N++   + PE      +  + L  N +   I  ++   +NLE  DL  N  H G+
Sbjct: 197 -DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253

Query: 621 IPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSP 672
           +   F K   +   +VA   ++       +  + P     G    C ++ +P
Sbjct: 254 LRDFFSKNQRVQ--TVAKQTVKKLTGQNEEECTVPTLGHYGA-YCCEDLPAP 302

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  110 bits (276), Expect = 2e-26
 Identities = 61/291 (20%), Positives = 108/291 (37%), Gaps = 23/291 (7%)

Query: 80  STGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVL 139
           S   +A  V  L L    L  I    L    +L+LL+LS N L   +   L +L  L  L
Sbjct: 28  SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTL 85

Query: 140 DLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNS 199
           DL++N +       L     I++L+ ++N+   S              ++NN  T  L  
Sbjct: 86  DLNNNYVQ-----ELLVGPSIETLHAANNNI--SRVSCSRGQGKKNIYLANNKIT-MLRD 137

Query: 200 RIWSASKEIQILDLSMNHF--MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 257
                   +Q LDL +N    +   +    S +L+ L++  N +  D+   +   + L+ 
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQV-VFAKLKT 195

Query: 258 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS-GP 316
           + LS N  +  +  +  +   +  + +  N+    +   L     LE F    N F  G 
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253

Query: 317 LPLSLSLCSKLHVLDLRNNS-LTGPIDLNFSG-----LSSLCTLDLATNHF 361
           L    S   ++  +  +    LTG  +   +        + C  DL     
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 44/261 (16%), Positives = 76/261 (29%), Gaps = 67/261 (25%)

Query: 390 PESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESL 449
            E            ++++S        S+ Q   N+  L L+ N +  +I          
Sbjct: 3   HEIKQNGNRYKIEKVTDSSLKQALA--SLRQSAWNVKELDLSGNPL-SQISAAD--LAPF 57

Query: 450 MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG 509
                                 KL++L+LS N         +  +  L  LD +NN +  
Sbjct: 58  ---------------------TKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ- 93

Query: 510 EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF------ 563
           E+      +++L                               N  S    S        
Sbjct: 94  ELL-VGPSIETLH---------------------------AANNNISRVSCSRGQGKKNI 125

Query: 564 -LSNNRINGTIPPEIGQLKHLHVLDLSRNNITG-TIPSSISEIRNLEVLDLSSNDLHGSI 621
            L+NN+I      + G    +  LDL  N I         +    LE L+L  N ++  +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DV 184

Query: 622 PGSFEKLTFLSKFSVANNHLQ 642
            G       L    +++N L 
Sbjct: 185 KGQV-VFAKLKTLDLSSNKLA 204

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 13/70 (18%), Positives = 26/70 (37%)

Query: 573 IPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLS 632
           I           +  ++ +++   + S      N++ LDLS N L           T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 633 KFSVANNHLQ 642
             ++++N L 
Sbjct: 62  LLNLSSNVLY 71

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  141 bits (356), Expect = 1e-35
 Identities = 60/328 (18%), Positives = 115/328 (35%), Gaps = 31/328 (9%)

Query: 87  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 146
              +L L +  +K +          L+ L+L+ N +  V P   +NL  L  L L  N L
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92

Query: 147 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 206
                G+  GL+ +  L++S N                   + +  F   L +       
Sbjct: 93  KLIPLGVFTGLSNLTKLDISENKIV---------------ILLDYMFQD-LYN------- 129

Query: 207 EIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 262
            ++ L++  N  +     +  GL    SL+QL ++   L     ++L  +  L  + L  
Sbjct: 130 -LKSLEVGDNDLVYISHRAFSGL---NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185

Query: 263 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 322
            N +         L  L+ L I    +   +         L        + +    L++ 
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245

Query: 323 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
               L  L+L  N ++         L  L  + L     +   P +    + L++L+++ 
Sbjct: 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFN 410
           N+L+      F  + +L  L L +N   
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  127 bits (322), Expect = 3e-31
 Identities = 64/386 (16%), Positives = 131/386 (33%), Gaps = 66/386 (17%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           +P  +    + +LLDL  N ++ +   E ++   LE L+L+ N++S              
Sbjct: 26  VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-------------- 69

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
              V   +FN          NL    + +N                 ++  + +  F   
Sbjct: 70  --AVEPGAFNN-------LFNLRTLGLRSN-----------------RLKLIPLGVF--- 100

Query: 222 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNLTSLR 280
             GL    +L +L +  N +   L      + +L+ + +  N+    +S +  S L SL 
Sbjct: 101 -TGL---SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLE 155

Query: 281 HLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 340
            L +     +      L +L  L        + +     S     +L VL++ +      
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215

Query: 341 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLL 400
           +  N     +L +L +   + +     ++     L+ L+L+ N +S        +L  L 
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275

Query: 401 FLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALG---- 455
            + L       +       +    L  L ++ N +   + E+V     +L  L L     
Sbjct: 276 EIQLVGGQLAVVEP--YAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETLILDSNPL 332

Query: 456 --NCGLKGHIPVWLLRCKKLQVLDLS 479
             +C L      W+ R +     +  
Sbjct: 333 ACDCRLL-----WVFRRRWRLNFNRQ 353

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  124 bits (313), Expect = 4e-30
 Identities = 72/347 (20%), Positives = 120/347 (34%), Gaps = 58/347 (16%)

Query: 323 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
           + ++  +LDL  N +       F+    L  L+L  N  S   P + ++  +L+ L L  
Sbjct: 30  IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 442
           N L       F  L++L  L +S N    L   +   Q   NL +L +  N +   I   
Sbjct: 90  NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYM--FQDLYNLKSLEVGDNDL-VYISHR 146

Query: 443 V-GGFESLMVLALGNCGLKGHIPV-WLLRCKKLQVLDLSWNHFDGNIPPWI-GQMENLFY 499
              G  SL  L L  C L   IP   L     L VL L   + +  I  +   ++  L  
Sbjct: 147 AFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKV 204

Query: 500 LDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFP 559
           L+ S+      +  +     +L S                                    
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTS------------------------------------ 228

Query: 560 PSVFLSNNRINGTIPPE-IGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLH 618
             + +++  +   +P   +  L +L  L+LS N I+    S + E+  L+ + L    L 
Sbjct: 229 --LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285

Query: 619 GSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 665
              P +F  L +L   +V+ N L           +   S F     L
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLT----------TLEESVFHSVGNL 322

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  138 bits (350), Expect = 2e-35
 Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 18/204 (8%)

Query: 779 IGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGYC 836
           IG G FG V+   L  + T  AVK          + +F  E   L +  H N+V L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 837 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                  ++   ++ G    +L     + + L+    L++   AA G+ YL        +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235

Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTLT 951
           HRD+ + N L+ EK    ++DFG+SR     D        G L  +P     PE      
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE--ADGVYAAS--GGLRQVPVKWTAPEALNYGR 291

Query: 952 ATCRGDVYSFGVVLLELLT-GRRP 974
            +   DV+SFG++L E  + G  P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (347), Expect = 5e-35
 Identities = 69/380 (18%), Positives = 125/380 (32%), Gaps = 46/380 (12%)

Query: 245 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 304
           +  +L        V + +         +   L + + +    +        +L +  Q+E
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 305 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 364
               +          + +    +  L +  N++       F  +  L  L L  N  S  
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132

Query: 365 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 424
                 +   L  LS++ N L     ++F   TSL  L LS+N   H+      L    +
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-----LSLIPS 187

Query: 425 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD 484
           L    ++ N +   +   +    ++  L   +  +   +   +    +L +L L  N+  
Sbjct: 188 LFHANVSYNLL-STLAIPI----AVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT 239

Query: 485 GNIPPWIGQMENLFYLDFSNNTLTGEIPK----SLTELKSL-ISSNCTSSNPTASAGIP- 538
                W+     L  +D S N L  +I       +  L+ L IS+N   +       IP 
Sbjct: 240 D--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPT 296

Query: 539 LYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIP 598
           L V                    + LS+N +   +     Q   L  L L  N+I  T+ 
Sbjct: 297 LKV--------------------LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK 334

Query: 599 SSISEIRNLEVLDLSSNDLH 618
            S      L+ L LS ND  
Sbjct: 335 LST--HHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (346), Expect = 5e-35
 Identities = 72/389 (18%), Positives = 135/389 (34%), Gaps = 51/389 (13%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           I  +L +      + +     +     E   L   +++   ++ +    + +L     ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM-- 219
            LN++                     I   +F           +  IQ L +  N     
Sbjct: 73  LLNLNDLQIE---------------EIDTYAFAY---------AHTIQKLYMGFNAIRYL 108

Query: 220 --GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLT 277
                Q +   P L  L ++ N L        ++   L  +S+S NN      +     T
Sbjct: 109 PPHVFQNV---PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165

Query: 278 SLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSL 337
           SL++L +  N+ +    +++ +L          N  S     +L++   +  LD  +NS+
Sbjct: 166 SLQNLQLSSNRLTHVDLSLIPSLFHANV---SYNLLS-----TLAIPIAVEELDASHNSI 217

Query: 338 TGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLT 397
                +       L  L L  N+ +      L +   L  + L+ NEL   +   F K+ 
Sbjct: 218 N---VVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272

Query: 398 SLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNC 457
            L  L +SNN    L+      Q    L  L L+ N +   +  N   F+ L  L L + 
Sbjct: 273 RLERLYISNNRLVALNLYG---QPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHN 328

Query: 458 GLKGHIPVWLLRCKKLQVLDLSWNHFDGN 486
            +   + +       L+ L LS N +D N
Sbjct: 329 SIV-TLKLSTH--HTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  134 bits (340), Expect = 4e-34
 Identities = 66/360 (18%), Positives = 121/360 (33%), Gaps = 51/360 (14%)

Query: 78  HGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLE 137
            G          ++      ++ +    L    Q++LL+L+   +E +     +    ++
Sbjct: 37  FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQ 96

Query: 138 VLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKL 197
            L +  N +      +   + L+  L +  N  +               ++    F    
Sbjct: 97  KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS---------------SLPRGIFHN-- 139

Query: 198 NSRIWSASKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMS 253
                  + ++  L +S N+       + Q      SL+ L + +N L   +  SL  + 
Sbjct: 140 -------TPKLTTLSMSNNNLERIEDDTFQAT---TSLQNLQLSSNRL-THVDLSL--IP 186

Query: 254 SLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 313
           SL H ++S N  S      ++   ++  L    N  +     V   LT L+      N+ 
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKL---QHNNL 238

Query: 314 SGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH 373
           +      L     L  +DL  N L   +   F  +  L  L ++ N     L        
Sbjct: 239 T-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 295

Query: 374 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
            LK+L L+ N L   V  +  +   L  L L +NS   L      L     L  L L+ N
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK-----LSTHHTLKNLTLSHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  125 bits (316), Expect = 5e-31
 Identities = 63/369 (17%), Positives = 127/369 (34%), Gaps = 33/369 (8%)

Query: 307 VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLP 366
           V         +  +L      + + +   +           L++   +    +       
Sbjct: 3   VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 62

Query: 367 NSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLT 426
             L     +++L+L   ++      +F    ++  L +  N+  +L     V Q    LT
Sbjct: 63  ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP--HVFQNVPLLT 120

Query: 427 TLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFD 484
            L+L +N +   +P  +      L  L++ N  L+  I     +    LQ L LS N   
Sbjct: 121 VLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178

Query: 485 GNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL-ISSNCTSSNPTASAGIPLYVKH 543
            ++      + +LF+ + S N L+  +      ++ L  S N  +        +   V  
Sbjct: 179 -HVDL--SLIPSLFHANVSYNLLS-TLAI-PIAVEELDASHNSINV-------VRGPVNV 226

Query: 544 NRSTNGLPYNQASSFPP--------SVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNIT 594
             +   L +N  +             V LS N +   I      +++ L  L +S N + 
Sbjct: 227 ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 285

Query: 595 GTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSF 654
             +      I  L+VLDLS N L   +  +  +   L    + +N +  T+      ++ 
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST-HHTL 341

Query: 655 PNSSFEGNP 663
            N +   N 
Sbjct: 342 KNLTLSHND 350

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (338), Expect = 9e-35
 Identities = 62/267 (23%), Positives = 104/267 (38%), Gaps = 33/267 (12%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
             IG G F  VYK        + A    +         + F+ E E L   QH N+V    
Sbjct: 33   EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 835  YCRH---GNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
                   G   +++ +  M +G+L       + +  V+K  V     +   +GL +LH  
Sbjct: 93   SWESTVKGKKCIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 891  CEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
              P I+HRD+K  NI +        + D GL+ L R         ++GT  ++ PE  + 
Sbjct: 148  RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYEE 204

Query: 950  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009
                   DVY+FG+ +LE+ T   P   C+        + +++  +   +    D     
Sbjct: 205  -KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFDK---V 254

Query: 1010 KDRE-KQLLEMLEIACKCIDQDPRRRP 1035
               E K+++E       CI Q+   R 
Sbjct: 255  AIPEVKEIIE------GCIRQNKDERY 275

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  134 bits (338), Expect = 3e-34
 Identities = 36/315 (11%), Positives = 72/315 (22%), Gaps = 51/315 (16%)

Query: 762  TVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD---CGQMEREFQAE 817
              S L +          +  G   +V+    +      A+K  +                
Sbjct: 53   VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112

Query: 818  VEALSRAQHKNLVSLQGYCR-----------------------HGNDRLLIYSYME---- 850
              A +R   ++    +   R                                  M     
Sbjct: 113  TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV 172

Query: 851  -NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE 909
                L   L                 +     R  A L       +VH      N+ +  
Sbjct: 173  DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMP 229

Query: 910  KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY--SQTLTATCRGDVYSFGVVLLE 967
                 L D                     + Y P E+  + T T T   + +  G+ +  
Sbjct: 230  DGRLMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285

Query: 968  LLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEML-EIACKC 1026
            +     P           LV+   +   ++  + +             L + +  +  + 
Sbjct: 286  VWCLFLPF---------GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336

Query: 1027 IDQDPRRRPFIEEVV 1041
            ++ D RRR    E +
Sbjct: 337  LNFDRRRRLLPLEAM 351

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  137 bits (346), Expect = 5e-34
 Identities = 96/462 (20%), Positives = 178/462 (38%), Gaps = 39/462 (8%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
            T+L + +  +  +    +  L++L++L +S N ++ +        ++LE LDLSHN L 
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA---VFNISNNSFTGKLNSRIWSA 204
                    L   + L++S N+F+ +L    EF N++      +S           I   
Sbjct: 83  KISCHPTVNL---KHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138

Query: 205 SKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 260
           +    +L L   +        LQ  +   SL  +   N      L  S+ ++++L+  ++
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTE-SLHIVFPTNKEFHFILDVSVKTVANLELSNI 197

Query: 261 SVNNFSGQLSEKISNLT-----------SLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 309
                  + S  +S L            +L ++    N F   L  V    T + +F   
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV--WHTTVWYFSIS 255

Query: 310 SNSFSGPLPLSLSLCS-----KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 364
           +    G L       S      L +  + ++    P    +   S++   +   +     
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 365 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 424
                S       L  + N L+  V E+ G LT L  L L  N    LS    +  Q K+
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375

Query: 425 LTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 483
           L  L +++N V  +  +      +SL+ L + +  L   I   L    +++VLDL  N  
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKI 433

Query: 484 DGNIPPWIGQMENLFYLDFSNNTLTGEIPK----SLTELKSL 521
             +IP  + ++E L  L+ ++N L   +P      LT L+ +
Sbjct: 434 K-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKI 473

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  101 bits (253), Expect = 2e-22
 Identities = 82/412 (19%), Positives = 128/412 (31%), Gaps = 42/412 (10%)

Query: 253 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNS 312
                +++S N  S   +  I +L+ LR LII  N+      +V     +LE+     N 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 313 FSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 371
                 +S      L  LDL  N+    PI   F  +S L  L L+T H        ++ 
Sbjct: 81  LVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137

Query: 372 CHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 431
            +  K+L +          E    L      SL      +       +      T   L 
Sbjct: 138 LNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTN--KEFHFILDVSVKTVANLE 193

Query: 432 KNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI 491
            +                 VL    C     I   L    KL  L L+      N    I
Sbjct: 194 LS-------------NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240

Query: 492 GQM---ENLFYLDFSNNTLTG-----EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 543
            Q+     ++Y   SN  L G     +   S T LK+L      S            +  
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300

Query: 544 NRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPEIGQLKHLHVLDLSRNNI 593
           N +      +                     SNN +  T+    G L  L  L L  N +
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

Query: 594 T--GTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQ 642
                I    +++++L+ LD+S N +      G       L   ++++N L 
Sbjct: 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 99.6 bits (248), Expect = 1e-21
 Identities = 55/360 (15%), Positives = 108/360 (30%), Gaps = 25/360 (6%)

Query: 309 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS 368
             N  S      +   SKL +L + +N +       F     L  LDL+ N       + 
Sbjct: 29  SQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHP 88

Query: 369 LSDCHDLKILSLAKNEL-SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 427
             +   LK L L+ N   +  + + FG ++ L FL LS         ++  +        
Sbjct: 89  TVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE--KSSVLPIAHLNISKV 143

Query: 428 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGN- 486
           L++     GE+      G +     +L           ++L      V +L  ++     
Sbjct: 144 LLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVL 201

Query: 487 ----------IPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAG 536
                     I   +     L  L  +N   T      + +L    +    S +     G
Sbjct: 202 EDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQG 261

Query: 537 IPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGT 596
              +   + S   L             + ++              ++++ + + +     
Sbjct: 262 QLDFRDFDYSGTSLKALSIHQ------VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 597 IPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 656
                S+I     LD S+N L  ++  +   LT L    +  N L+             +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 4/93 (4%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
           +S N I+     +I  L  L +L +S N I     S     + LE LDLS N L   I  
Sbjct: 28  ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS- 85

Query: 624 SFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 656
                  L    ++ N     +P   +F +   
Sbjct: 86  -CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQ 116

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 18/82 (21%), Positives = 36/82 (43%), Gaps = 3/82 (3%)

Query: 561 SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 620
            V  S N +   +P ++   +   +L++S+N I+    S I  +  L +L +S N +   
Sbjct: 4   LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60

Query: 621 IPGSFEKLTFLSKFSVANNHLQ 642
               F+    L    +++N L 
Sbjct: 61  DISVFKFNQELEYLDLSHNKLV 82

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  130 bits (328), Expect = 2e-33
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK----RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G GG   VY A       K A+K            ++R F+ EV   S+  H+N+VS+ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77

Query: 834 GYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
                  +    Y  ME   G     L E ++    L  D  +        G+ + H + 
Sbjct: 78  DV---DEEDDCYYLVMEYIEGPT---LSEYIESHGPLSVDTAINFTNQILDGIKHAHDM- 130

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQT 949
              IVHRD+K  NIL+D      + DFG+++ L   +T +T    ++GT+ Y  PE ++ 
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 950 LTATCRGDVYSFGVVLLELLTGRRP 974
                  D+YS G+VL E+L G  P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (329), Expect = 2e-33
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL- 832
           +G GG   V+ A  L +    AVK     L+ D     R F+ E +  +   H  +V++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78

Query: 833 -QGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
             G         L Y  ME  +G     L + V  +  +     +++   A + L + H+
Sbjct: 79  DTG-EAETPAGPLPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 134

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYS 947
                I+HRDVK +NI++       + DFG++R +      VT    ++GT  Y+ PE +
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
           +  +   R DVYS G VL E+LTG  P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (329), Expect = 2e-33
 Identities = 61/278 (21%), Positives = 103/278 (37%), Gaps = 23/278 (8%)

Query: 768  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREF-QAEVEALSR 823
             +  NF     IG G F  VY+A  L +G   A+K  ++        R     E++ L +
Sbjct: 29   NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88

Query: 824  AQHKNLVSLQGYCRHGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
              H N++         ++ L I     + G L   +     +  ++      K       
Sbjct: 89   LNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147

Query: 883  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
             L ++H      ++HRD+K +N+ +       L D GL R      T   + LVGT  Y+
Sbjct: 148  ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYM 203

Query: 943  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
             PE         + D++S G +L E+   + P       N   L   + Q        + 
Sbjct: 204  SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY-GDKMNLYSLCKKIEQCDYPPLPSDH 262

Query: 1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                +      +QL+        CI+ DP +RP +  V
Sbjct: 263  YSEEL------RQLVN------MCINPDPEKRPDVTYV 288

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  129 bits (327), Expect = 3e-33
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 39/292 (13%)

Query: 777  NIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 830
              +G G FG V            G + AVK L  + G     + + E+E L    H+N+V
Sbjct: 27   RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 831  SLQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
              +G C         LI  ++ +GSL  +L ++ +K   +    +LK A    +G+ YL 
Sbjct: 87   KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLG 143

Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP----- 943
                   VHRD+ + N+L++ + +  + DFGL++ +   D    T  V      P     
Sbjct: 144  ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYT--VKDDRDSPVFWYA 197

Query: 944  PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003
            PE           DV+SFGV L ELLT             + +     QM        ++
Sbjct: 198  PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT----RLV 253

Query: 1004 DASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            +       +E + L        E+ ++  KC +  P  R   + ++   + +
Sbjct: 254  N-----TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  128 bits (323), Expect = 4e-33
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 20/205 (9%)

Query: 777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 835
             IG G FGLV+     N  K A+K +      M  E F  E E + +  H  LV L G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
           C       L+  +ME+G L  +L        +   +  L +      G+AYL    E  +
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYL---EEACV 125

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 950
           +HRD+ + N L+ E     ++DFG++R +   D   T+   GT    P     PE     
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSS-TGTK--FPVKWASPEVFSFS 180

Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             + + DV+SFGV++ E+ + G+ P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  128 bits (324), Expect = 5e-33
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)

Query: 777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
             IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 837 RHGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                 L I + YM  GSL  +L       SVL  D  LK +      + YL      + 
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 950
           VHRD+ + N+L+ E   A ++DFGL++     +   T       G +P     PE  +  
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQ----DTGKLPVKWTAPEALREK 189

Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             + + DV+SFG++L E+ + GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  135 bits (340), Expect = 5e-33
 Identities = 84/520 (16%), Positives = 160/520 (30%), Gaps = 79/520 (15%)

Query: 78  HGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLE 137
            G          ++      ++ +    L    Q++LL+L+   +E +     +    ++
Sbjct: 43  FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQ 102

Query: 138 VLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKL 197
            L +  N +      +   + L+  L +  N  +               ++    F    
Sbjct: 103 KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS---------------SLPRGIFHN-- 145

Query: 198 NSRIWSASKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMS 253
                  + ++  L +S N+       + Q      SL+ L + +N L   +  SL  + 
Sbjct: 146 -------TPKLTTLSMSNNNLERIEDDTFQAT---TSLQNLQLSSNRL-THVDLSL--IP 192

Query: 254 SLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 313
           SL H ++S N  S      ++   ++  L    N  +     V   LT L+      N+ 
Sbjct: 193 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKL---QHNNL 244

Query: 314 SGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH 373
           +      L     L  +DL  N L   +   F  +  L  L ++ N     L        
Sbjct: 245 T-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 301

Query: 374 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
            LK+L L+ N L   V  +  +   L  L L +NS   L      L     L  L L+ N
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK-----LSTHHTLKNLTLSHN 355

Query: 434 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWN-HFDGNIPPWIG 492
                                 +C     +   + R     V D   +   D  +   + 
Sbjct: 356 DW--------------------DCNSLRALFRNVAR---PAVDDADQHCKIDYQLEHGLC 392

Query: 493 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 552
             E+     + +  L      S+ E        C++++   S  +     +     G+P 
Sbjct: 393 CKESD--KPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINS--VQSLSHYITQQGGVPL 448

Query: 553 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNN 592
                    V      +      +I Q + L  L    + 
Sbjct: 449 QGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDT 488

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  132 bits (334), Expect = 3e-32
 Identities = 67/425 (15%), Positives = 126/425 (29%), Gaps = 87/425 (20%)

Query: 245 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE 304
           +  +L        V + +         +   L + + +    +        +L +  Q+E
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 305 FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 364
                                   +L+L +  +       F+   ++  L +  N     
Sbjct: 79  ------------------------LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL 114

Query: 365 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 424
            P+   +   L +L L +N+LS      F     L  LS+SNN+   +       Q   +
Sbjct: 115 PPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED--DTFQATTS 172

Query: 425 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD 484
           L  L L+ N +   +        SL    +    L       L     ++ LD S N  +
Sbjct: 173 LQNLQLSSNRL-THVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224

Query: 485 GNIPPWIGQMENLFYLDFSNNTLTGEIP--KSLTELKSLISSNCTSSNPTASAGIPLYVK 542
             +         L  L   +N LT +     +   L  +                     
Sbjct: 225 -VVRG--PVNVELTILKLQHNNLT-DTAWLLNYPGLVEV--------------------- 259

Query: 543 HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI 601
                                LS N +   I      +++ L  L +S N +   +    
Sbjct: 260 --------------------DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297

Query: 602 SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEG 661
             I  L+VLDLS N L   +  +  +   L    + +N +  T+      ++  N +   
Sbjct: 298 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKNLTLSH 354

Query: 662 NPGLC 666
           N   C
Sbjct: 355 NDWDC 359

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  128 bits (325), Expect = 6e-33
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 777 NIIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            +IG G FG VY  TL +        AVK L+      E  +F  E   +    H N++S
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 832 LQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           L G C R     L++  YM++G L  ++       +V      +      A+G+ YL   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLA-- 145

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 945
                VHRD+ + N +LDEKF   +ADFGL+R +  YD    +    T   +P      E
Sbjct: 146 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALE 202

Query: 946 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
             QT   T + DV+SFGV+L EL+T G  P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  128 bits (323), Expect = 6e-33
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 20/205 (9%)

Query: 777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 835
             +G G FG+V           A+K +      M  + F  E + +    H+ LV L G 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
           C       +I  YM NG L  +L E        +    L++ +     + YL        
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QF 141

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 950
           +HRD+ + N L++++    ++DFGLSR +   D   T+  VG+    P     PE     
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSS-VGSK--FPVRWSPPEVLMYS 196

Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             + + D+++FGV++ E+ + G+ P
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMP 221

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (323), Expect = 1e-32
 Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 20/210 (9%)

Query: 777 NIIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            +IG G FG+VY     +      + A+K LS      +   F  E   +    H N+++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 832 LQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           L G          ++  YM +G L  ++               +      ARG+ YL   
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLA-- 141

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 945
            E   VHRD+ + N +LDE F   +ADFGL+R +   D    +        +P      E
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKWTALE 198

Query: 946 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
             QT   T + DV+SFGV+L ELLT G  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  132 bits (334), Expect = 1e-32
 Identities = 65/258 (25%), Positives = 109/258 (42%), Gaps = 22/258 (8%)

Query: 777  NIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQG 834
            + +G G +G VY+          AVK L  D   ME E F  E   +   +H NLV L G
Sbjct: 226  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 835  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
             C       +I  +M  G+L  +L E       +   V L +A   +  + YL    + +
Sbjct: 284  VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKN 338

Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIPPEYSQTLTA 952
             +HR++ + N L+ E     +ADFGLSRL+    Y  H        + +  PE       
Sbjct: 339  FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 396

Query: 953  TCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK---REVEIIDASIW 1008
            + + DV++FGV+L E+ T G  P          +L+   ++M+  +    +V  +  + W
Sbjct: 397  SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 456

Query: 1009 HKDREK-----QLLEMLE 1021
              +        ++ +  E
Sbjct: 457  QWNPSDRPSFAEIHQAFE 474

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  126 bits (320), Expect = 1e-32
 Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 20/204 (9%)

Query: 778 IIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 836
            +G G FG+V           AVK +      M  + F  E + + +  H  LV   G C
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 837 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                  ++  Y+ NG L  +L         L+    L++      G+A+L        +
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126

Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTLT 951
           HRD+ + N L+D      ++DFG++R +   D    +  VGT    P     PE      
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSS-VGTK--FPVKWSAPEVFHYFK 181

Query: 952 ATCRGDVYSFGVVLLELLT-GRRP 974
            + + DV++FG+++ E+ + G+ P
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP 205

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  126 bits (320), Expect = 1e-32
 Identities = 69/279 (24%), Positives = 111/279 (39%), Gaps = 28/279 (10%)

Query: 771  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQM---EREF-QAEVEALSRAQ 825
             ++     IG G +G   K    ++G     K L  D G M   E++   +EV  L   +
Sbjct: 6    EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELK 63

Query: 826  HKNLVSLQG-YCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
            H N+V          N  L I   Y E G L   + +   +   L  +  L++       
Sbjct: 64   HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 884  LAYLH--KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            L   H        ++HRD+K +N+ LD K    L DFGL+R+L   DT      VGT  Y
Sbjct: 124  LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVGTPYY 182

Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
            + PE    ++   + D++S G +L EL     P       + ++L       K  + +  
Sbjct: 183  MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELA-----GKIREGKFR 234

Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
             I    +         E+ EI  + ++     RP +EE+
Sbjct: 235  RIP-YRYSD-------ELNEIITRMLNLKDYHRPSVEEI 265

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  127 bits (320), Expect = 2e-32
 Identities = 66/268 (24%), Positives = 110/268 (41%), Gaps = 53/268 (19%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQ 825
           +   +F +  +IG GGFG V+KA    +G    +KR+     +   E  + EV+AL++  
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLD 62

Query: 826 HKNLVSLQGY---------------CRHGNDRLLIY-SYMENGSLDYWLH----ESVDKD 865
           H N+V   G                 R     L I   + + G+L+ W+     E +DK 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 866 SVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 925
             L+        Q   +G+ Y+H      +++RD+K SNI L +  +  + DFGL   L+
Sbjct: 123 LALEL-----FEQ-ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173

Query: 926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP--------VEV 977
                  +   GTL Y+ PE   +       D+Y+ G++L ELL              ++
Sbjct: 174 NDGKRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231

Query: 978 CKGK-------NCRDLVSWVFQMKSEKR 998
             G          + L+  +   K E R
Sbjct: 232 RDGIISDIFDKKEKTLLQKLLSKKPEDR 259

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  127 bits (322), Expect = 2e-32
 Identities = 62/205 (30%), Positives = 83/205 (40%), Gaps = 21/205 (10%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK----RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
           +G GG G VY+A         A+K     LS D     R  Q E     R Q  ++V + 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVVPIH 100

Query: 834 GYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
            +   G     +Y  M   NG     L   + +   L     + I +     L   H   
Sbjct: 101 DF---GEIDGQLYVDMRLINGVD---LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT--DLVGTLGYIPPEYSQT 949
                HRDVK  NIL+     A+L DFG++      D  +T   + VGTL Y+ PE    
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSE 209

Query: 950 LTATCRGDVYSFGVVLLELLTGRRP 974
             AT R D+Y+   VL E LTG  P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  127 bits (322), Expect = 2e-32
 Identities = 65/283 (22%), Positives = 104/283 (36%), Gaps = 43/283 (15%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQME--REFQAEVEALSRAQHKNLVSLQGY 835
            +G GGF  V     L +G   A+KR+   C + +   E Q E +      H N++ L  Y
Sbjct: 37   LGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 836  CRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
            C           L+  + + G+L   +    DK + L  D  L +  G  RGL  +H   
Sbjct: 95   CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152

Query: 892  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL--------VGTLGYIP 943
                 HRD+K +NILL ++ +  L D G       +       L          T+ Y  
Sbjct: 153  -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 944  PE----YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
            PE     S       R DV+S G VL  ++ G  P                + M  +K +
Sbjct: 212  PELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGP----------------YDMVFQKGD 254

Query: 1000 VE--IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                 +   +      +    + ++    +  DP +RP I  +
Sbjct: 255  SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  130 bits (330), Expect = 2e-32
 Identities = 85/473 (17%), Positives = 165/473 (34%), Gaps = 58/473 (12%)

Query: 109 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 168
                         +    +    L  L  LD  ++ ++  ++G +  L  +  L  +SN
Sbjct: 20  FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTSN 74

Query: 169 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 228
           +      +L + +NL      +N    KL +   +   ++  L+   N     L  LD S
Sbjct: 75  NITT--LDLSQNTNLTYLACDSN----KLTNLDVTPLTKLTYLNCDTNK----LTKLDVS 124

Query: 229 --PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFG 286
             P L  L+   N L  ++  S    + L  +   +N    +L   ++  T L  L    
Sbjct: 125 QNPLLTYLNCARNTL-TEIDVS--HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179

Query: 287 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFS 346
           N+ + +L   +     L      +N+ +    L L+   +L  LD  +N LT   +++ +
Sbjct: 180 NKIT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT---EIDVT 230

Query: 347 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN 406
            L+ L   D + N  +  L   +S    L  L   + +L           T L++     
Sbjct: 231 PLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEG 284

Query: 407 NSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVW 466
                       +     L  L      +  E+   +     L+ L L N  L   +   
Sbjct: 285 CRKI----KELDVTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT-ELD-- 334

Query: 467 LLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNC 526
           +    KL+ L     H   +    +G++  L     +       +PK      SL  +  
Sbjct: 335 VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSL--TIA 389

Query: 527 TSSNPTASAGIPLYVK------HNRSTNGLPYNQASSFPPSVFLSNNRINGTI 573
            S +     G P+ ++      ++++TN + +   S+  P+V  +    NG I
Sbjct: 390 VSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAI 442

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  129 bits (326), Expect = 7e-32
 Identities = 78/408 (19%), Positives = 134/408 (32%), Gaps = 56/408 (13%)

Query: 255 LQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFS 314
                 +        +     L +L  L    +  +  +   +  LT L   +  SN+ +
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77

Query: 315 GPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHD 374
               L LS  + L  L   +N LT   +L+ + L+ L  L+  TN  +      +S    
Sbjct: 78  T---LDLSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLT---KLDVSQNPL 128

Query: 375 LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 434
           L  L+ A+N L+          T L  L    N       T   +     LTTL  + N 
Sbjct: 129 LTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKI----TKLDVTPQTQLTTLDCSFNK 181

Query: 435 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM 494
           +  E+   V   + L  L      +   +   L +  +L  LD S N     I   +  +
Sbjct: 182 I-TELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPL 232

Query: 495 ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 554
             L Y D S N LT     +L++L +L                            L    
Sbjct: 233 TQLTYFDCSVNPLTELDVSTLSKLTTLHCIQ----------------------TDLLEID 270

Query: 555 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSS 614
            +     ++            ++     L++LD     IT  +   +S+   L  L L++
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNN 327

Query: 615 NDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGN 662
            +L   +       T L   S  N H+Q    + G+  +  N+     
Sbjct: 328 TELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEG 371

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  128 bits (324), Expect = 1e-31
 Identities = 76/452 (16%), Positives = 149/452 (32%), Gaps = 47/452 (10%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 142
                +T L      +  +    +  L  L  L  + N++     ++LS    L  L   
Sbjct: 39  EQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACD 93

Query: 143 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 202
            N L+   +  +  L  +  LN  +N       ++ +   L   N + N     L     
Sbjct: 94  SNKLT---NLDVTPLTKLTYLNCDTNKLTK--LDVSQNPLLTYLNCARN----TLTEIDV 144

Query: 203 SASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 262
           S + ++  LD  +N  +  L  +     L  L    N +  +L   +     L  ++   
Sbjct: 145 SHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFNKI-TELD--VSQNKLLNRLNCDT 200

Query: 263 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 322
           NN +      ++    L  L    N+ + ++   +  LTQL +F    N  +    L +S
Sbjct: 201 NNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVS 251

Query: 323 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
             SKL  L      L    +++ +  + L             L   ++    L +L    
Sbjct: 252 TLSKLTTLHCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQA 306

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 442
             ++        +   L++L L+N     L      +     L +L      + ++    
Sbjct: 307 AGIT---ELDLSQNPKLVYLYLNNTELTELD-----VSHNTKLKSLSCVNAHI-QDFSS- 356

Query: 443 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 502
           VG   +L             +P   L    L  + +S +  D    P   +  +    D 
Sbjct: 357 VGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQ 414

Query: 503 SNNTLTGEIPKSLTELKSLISSNCTSSNPTAS 534
           + NT+T    ++L+     ++   TS N    
Sbjct: 415 ATNTIT---WENLSTDNPAVTYTFTSENGAIV 443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  126 bits (319), Expect = 6e-31
 Identities = 72/479 (15%), Positives = 147/479 (30%), Gaps = 77/479 (16%)

Query: 206 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 265
             +  LD   +     + G++    L +L   +N +   L  S    ++L +++   N  
Sbjct: 42  ATLTSLDCHNSSI-TDMTGIEKLTGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKL 97

Query: 266 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCS 325
           +   +  ++ LT L +L    N+ + KL   +     L +     N+ +    + +S  +
Sbjct: 98  T---NLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNT 148

Query: 326 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 385
           +L  LD   N     +D   +  + L TLD + N  +      +S    L  L+   N +
Sbjct: 149 QLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI 203

Query: 386 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG 445
           +        +   L FL  S+N    +      +     LT    + N +  E+   V  
Sbjct: 204 TKL---DLNQNIQLTFLDCSSNKLTEID-----VTPLTQLTYFDCSVNPL-TELD--VST 252

Query: 446 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 505
              L  L      L   I   L    +L             +   +     L+ LD    
Sbjct: 253 LSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAA 307

Query: 506 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPS---- 561
            +T        +L  L  +N                            + +    S    
Sbjct: 308 GITELDLSQNPKLVYLYLNN---------------------------TELTELDVSHNTK 340

Query: 562 ---VFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIR-----NLEVLDLS 613
              +   N  I       +G++  L+    +          +++        + ++LD  
Sbjct: 341 LKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398

Query: 614 SNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSP 672
            N +  +I      +   +  ++   +L    P     ++  N +  G      E   P
Sbjct: 399 GNPM--NIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEAPQP 455

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  133 bits (335), Expect = 3e-32
 Identities = 62/365 (16%), Positives = 114/365 (31%), Gaps = 87/365 (23%)

Query: 253 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNS 312
           +    +++  +  +  L + +     +  L+I  N  +  LP +   L  LE      N 
Sbjct: 40  NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLEV---SGNQ 92

Query: 313 FSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC 372
            +  LP+      +L +       L        +  S LC L +  N  +  LP      
Sbjct: 93  LTS-LPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTS-LPVLPPG- 142

Query: 373 HDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK 432
             L+ LS++ N+L+  +P    +L  L      NN    L    S       L  L ++ 
Sbjct: 143 --LQELSVSDNQLA-SLPALPSELCKL---WAYNNQLTSLPMLPS------GLQELSVSD 190

Query: 433 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 492
           N +   +P        L      N  L   +P        L+ L +S N    ++P    
Sbjct: 191 NQL-ASLPTLPSELYKLWAY---NNRLT-SLPALP---SGLKELIVSGNRL-TSLPVLPS 241

Query: 493 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 552
           +++ L     S N LT  +P   + L SL                               
Sbjct: 242 ELKEL---MVSGNRLT-SLPMLPSGLLSL------------------------------- 266

Query: 553 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 612
                      +  N++   +P  +  L     ++L  N ++         +R +     
Sbjct: 267 ----------SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQA--LREITSAPG 312

Query: 613 SSNDL 617
            S  +
Sbjct: 313 YSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (331), Expect = 9e-32
 Identities = 71/351 (20%), Positives = 124/351 (35%), Gaps = 74/351 (21%)

Query: 319 LSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKIL 378
           +   L +   VL++  + LT    L     + + TL +  N+ +  LP       +L+ L
Sbjct: 34  MRACLNNGNAVLNVGESGLT---TLPDCLPAHITTLVIPDNNLTS-LPALPP---ELRTL 86

Query: 379 SLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEE 438
            ++ N+L+  +P     L     LS+ +N   HL    S       L  L +  N +   
Sbjct: 87  EVSGNQLT-SLPVLPPGLLE---LSIFSNPLTHLPALPS------GLCKLWIFGNQL-TS 135

Query: 439 IPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLF 498
           +P        L  L++ +  L   +P       +L  L    N    ++P        L 
Sbjct: 136 LPVL---PPGLQELSVSDNQLA-SLPALP---SELCKLWAYNNQLT-SLPMLPS---GLQ 184

Query: 499 YLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF 558
            L  S+N L   +P   +EL  L + N                           N+ +S 
Sbjct: 185 ELSVSDNQLA-SLPTLPSELYKLWAYN---------------------------NRLTSL 216

Query: 559 PPSV------FLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 612
           P          +S NR+  ++P    +LK    L +S N +T ++P   S    L  L +
Sbjct: 217 PALPSGLKELIVSGNRLT-SLPVLPSELKE---LMVSGNRLT-SLPMLPS---GLLSLSV 268

Query: 613 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNP 663
             N L   +P S   L+  +  ++  N L  +  T        ++     P
Sbjct: 269 YRNQLT-RLPESLIHLSSETTVNLEGNPL--SERTLQALREITSAPGYSGP 316

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  125 bits (314), Expect = 1e-29
 Identities = 75/327 (22%), Positives = 124/327 (37%), Gaps = 52/327 (15%)

Query: 109 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 168
            N   +L++  + L   +P  L     +  L +  N L+  +  +   L   ++L VS N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALPPEL---RTLEVSGN 91

Query: 169 SFNGSL-FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH 227
               SL         L++F+          +         +  L +  N     L  L  
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPSG--------LCKLWIFGNQ----LTSLPV 138

Query: 228 S-PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFG 286
             P L++L V +N L   LP      S L  +    N  +  L    S L  L    +  
Sbjct: 139 LPPGLQELSVSDNQL-ASLPALP---SELCKLWAYNNQLT-SLPMLPSGLQELS---VSD 190

Query: 287 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFS 346
           NQ +  LP +   L +L    A++N  +  LP   +L S L  L +  N LT    L   
Sbjct: 191 NQLA-SLPTLPSELYKLW---AYNNRLT-SLP---ALPSGLKELIVSGNRLTSLPVL--- 239

Query: 347 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN 406
             S L  L ++ N  +  LP   S    L  LS+ +N+L+ ++PES   L+S   ++L  
Sbjct: 240 -PSELKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293

Query: 407 NSFNHLSGTLSVLQQCKNLTTLILTKN 433
           N  +  +      Q  + +T+      
Sbjct: 294 NPLSERTL-----QALREITSAPGYSG 315

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  120 bits (303), Expect = 3e-28
 Identities = 82/356 (23%), Positives = 124/356 (34%), Gaps = 50/356 (14%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
            +L +   GL   +P  L     +  L +  N+L   +P     L+    L++S N L+ 
Sbjct: 43  AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TLEVSGNQLTS 95

Query: 149 -PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 207
            PV     GL  +   +                S L    I  N  T      +      
Sbjct: 96  LPVL--PPGLLELSIFSNPLTHLPALP------SGLCKLWIFGNQLT-----SLPVLPPG 142

Query: 208 IQILDLSMNHFMGSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 266
           +Q L +S N     L  L   P  L +L   NN L   LP      S LQ +S+S N  +
Sbjct: 143 LQELSVSDNQ----LASLPALPSELCKLWAYNNQLT-SLPMLP---SGLQELSVSDNQLA 194

Query: 267 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 326
             L    S L  L     + N+ +  LP +   L +L       N  +  LP+  S   +
Sbjct: 195 -SLPTLPSELYKLW---AYNNRLT-SLPALPSGLKELI---VSGNRLTS-LPVLPS---E 242

Query: 327 LHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 385
           L  L +  N LT  P        S L +L +  N  +  LP SL        ++L  N L
Sbjct: 243 LKELMVSGNRLTSLP-----MLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPL 296

Query: 386 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQC-KNLTTLILTKNFVGEEIP 440
           S +  ++  ++TS    S     F+    +     +         L     GE  P
Sbjct: 297 SERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  113 bits (285), Expect = 4e-26
 Identities = 73/347 (21%), Positives = 117/347 (33%), Gaps = 50/347 (14%)

Query: 181 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPS-LKQLHVDNN 239
           +  AV N+  +  T  L   +      I  L +  N    +L  L   P  L+ L V  N
Sbjct: 40  NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDN----NLTSLPALPPELRTLEVSGN 91

Query: 240 LLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGN 299
            L   LP     +  L   S  + +         +  + L  L IFGNQ +  LP +   
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVLPPG 142

Query: 300 LTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLAT 358
           L +L       N  +  LP   S   +L  L   NN LT  P        S L  L ++ 
Sbjct: 143 LQELSV---SDNQLAS-LPALPS---ELCKLWAYNNQLTSLP-----MLPSGLQELSVSD 190

Query: 359 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSV 418
           N  +  LP   S+   L  L    N L+  +P     L  L    +S N    L    S 
Sbjct: 191 NQLAS-LPTLPSE---LYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRLTSLPVLPS- 241

Query: 419 LQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDL 478
                 L  L+++ N +   +P        L+ L++    L   +P  L+       ++L
Sbjct: 242 -----ELKELMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291

Query: 479 SWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSN 525
             N         + ++ +                 +  E ++L  + 
Sbjct: 292 EGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA 338

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  127 bits (321), Expect = 3e-32
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 23/210 (10%)

Query: 777 NIIGCGGFGLVYKATLTNGTKA-----AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 830
            ++G G FG VYK       +      A+K L          E   E   ++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            L G C   +   LI   M  G L  ++ E  D    +     L      A+G+ YL   
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE-- 134

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 945
            +  +VHRD+ + N+L+       + DFGL++LL   +           G +P      E
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALE 189

Query: 946 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                  T + DV+S+GV + EL+T G +P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (318), Expect = 3e-32
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 20/206 (9%)

Query: 779 IGCGGFGLVYKATLTNGTKA---AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 834
           +GCG FG V +       K    A+K L     + +  E   E + + +  +  +V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
            C+     +L+      G L  +L     K   +      ++    + G+ YL    E +
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQT 949
            VHRD+ + N+LL  +  A ++DFGLS+ L   D++ T     + G  P     PE    
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA---RSAGKWPLKWYAPECINF 187

Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
              + R DV+S+GV + E L+ G++P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  127 bits (320), Expect = 5e-32
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 26/217 (11%)

Query: 777 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 829
             +G G FG VY+  ++         + AVK L   C + +  +F  E   +S+  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGLAY 886
           V   G       R ++   M  G L  +L E+     + S L     L +A+  A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L    E H +HRD+ + N LL       +    DFG++R +  Y         G    +P
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYR--KGGCAMLP 208

Query: 944 -----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                PE       T + D +SFGV+L E+ + G  P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  127 bits (322), Expect = 6e-32
 Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 777 NIIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            +IG G FG VY  TL +        AVK L+      E  +F  E   +    H N++S
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 832 LQGYC-RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           L G C R     L++  YM++G L  ++       +V      +      A+G+ +L   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLA-- 209

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 945
                VHRD+ + N +LDEKF   +ADFGL+R +  YD    +    T   +P      E
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTGAKLPVKWMALE 266

Query: 946 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
             QT   T + DV+SFGV+L EL+T G  P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  129 bits (325), Expect = 9e-32
 Identities = 72/257 (28%), Positives = 112/257 (43%), Gaps = 22/257 (8%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 835
              +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L   
Sbjct: 190  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                    ++  YM  GSL  +L         L+    + +A   A G+AY+ ++   + 
Sbjct: 248  V-SEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 301

Query: 896  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY--IPPEYSQTLTAT 953
            VHRD++++NIL+ E     +ADFGL+RL+   D   T             PE +     T
Sbjct: 302  VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 954  CRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK---REVEIIDASIWH 1009
             + DV+SFG++L EL T GR P      +   D V   ++M         +  +    W 
Sbjct: 360  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 419

Query: 1010 KDREK-----QLLEMLE 1021
            K+ E+      L   LE
Sbjct: 420  KEPEERPTFEYLQAFLE 436

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  127 bits (320), Expect = 1e-31
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 24/211 (11%)

Query: 777 NIIGCGGFGLVYKATLTNGTKA----AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            ++G G FG V    L   +K     A+K L     + +R +F  E   + +  H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L+G        +++  YMENGSLD +L +    D+       + + +G A G+ YL    
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLS--- 164

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIP-----P 944
           +   VHRD+ + NIL++      ++DFGL R+L   P   + T       G IP     P
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG-----GKIPIRWTSP 219

Query: 945 EYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
           E       T   DV+S+G+VL E+++ G RP
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  125 bits (317), Expect = 1e-31
 Identities = 69/292 (23%), Positives = 108/292 (36%), Gaps = 40/292 (13%)

Query: 777  NIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 831
            + +G G FG V            G   AVK+L       +R+FQ E++ L       +V 
Sbjct: 29   SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 832  LQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
             +G       +   L+  Y+ +G L  +L     +   L     L  +    +G+ YL  
Sbjct: 89   YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLG- 144

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----P 944
                  VHRD+ + NIL++ +    +ADFGL++LL     +     V   G  P     P
Sbjct: 145  --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV---VREPGQSPIFWYAP 199

Query: 945  EYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003
            E       + + DV+SFGVVL EL T   +    C        +    +       +   
Sbjct: 200  ESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---CSPSAEFLRMMGCERDVPALSRL--- 253

Query: 1004 DASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                     E Q L        E+ E+   C    P+ RP    +   LD +
Sbjct: 254  ----LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (324), Expect = 1e-31
 Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 24/205 (11%)

Query: 777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
             IG G FG V       G K AVK +  D     + F AE   +++ +H NLV L G  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 837 RHGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                 L I + YM  GSL  +L       SVL  D  LK +      + YL      + 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 950
           VHRD+ + N+L+ E   A ++DFGL++         ++        +P     PE  +  
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGK--LPVKWTAPEALREK 361

Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
             + + DV+SFG++L E+ + GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  126 bits (318), Expect = 2e-31
 Identities = 46/308 (14%), Positives = 85/308 (27%), Gaps = 73/308 (23%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLS-------GDCGQMERE---------------- 813
            ++G        +AT    G    V               QM+ E                
Sbjct: 80   VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 814  -----FQAEVEALSRAQHKNLVSLQGYCRHGN--DRLLIYSYMENGSLDY--WLHESVDK 864
                 F    + +   Q K ++ ++   R      R  +Y  M++    +   L      
Sbjct: 140  KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 865  DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL 924
               L    RL++     R LA LH      +VH  ++  +I+LD++    L  F      
Sbjct: 200  HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 925  RPYDTHVTTDLVGTLGYIPPEY-----------SQTLTATCRGDVYSFGVVLLELLTGRR 973
                         + G+ PPE             +    T   D ++ G+V+  +     
Sbjct: 257  -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 974  PVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRR 1033
            P+             W+F+          I   +      + LL         +      
Sbjct: 312  PIT---KDAALGGSEWIFRSCKN------IPQPV------RALL------EGFLRYPKED 350

Query: 1034 RPFIEEVV 1041
            R    + +
Sbjct: 351  RLLPLQAM 358

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  124 bits (313), Expect = 2e-31
 Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 43/226 (19%)

Query: 779 IGCGGFGLVYKATLTNGTKA------AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           +G G FG V+ A   N +        AVK L        ++FQ E E L+  QH+++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWL------------HESVDKDSVLKWDVRLKIAQGA 880
            G C  G+  ++++ YM++G L+ +L             +       L     L IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
           A G+ YL      H VHRD+ + N L+       + DFG+SR +  Y T      VG   
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYR--VGGHT 195

Query: 941 YIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
            +P     PE      +      T   DV+SFGV+L E+ T G++P
Sbjct: 196 MLPIRWMPPESIMYRKF------TTESDVWSFGVILWEIFTYGKQP 235

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  126 bits (317), Expect = 2e-31
 Identities = 77/346 (22%), Positives = 131/346 (37%), Gaps = 64/346 (18%)

Query: 725  GCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGF 784
            G  +++L+ D  + +RL          L Q     +L   D  K        + +G G  
Sbjct: 1    GKKLEELELDEQQRKRLEA-------FLTQKQKVGELKDDDFEK-------ISELGAGNG 46

Query: 785  GLVYKATLT-NGTKAAVKRLSGDCGQMEREF-QAEVEALSRAQHKNLVSLQGYCRHGNDR 842
            G+V+K +   +G   A K +  +     R     E++ L       +V   G      + 
Sbjct: 47   GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106

Query: 843  LLIYSYMENGSLDYWLHESVDKDSVLKWDVRL------KIAQGAARGLAYLHKVCEPHIV 896
             +   +M+ GSLD           VLK   R+      K++    +GL YL +  +  I+
Sbjct: 107  SICMEHMDGGSLD----------QVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 154

Query: 897  HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
            HRDVK SNIL++ + E  L DFG+S  L   D+   +  VGT  Y+ PE  Q    + + 
Sbjct: 155  HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGTHYSVQS 211

Query: 957  DVYSFGVVLLELLTGRRPVEVCKGKN------CRDLVSWVFQMKSEKREVEIIDASIWHK 1010
            D++S G+ L+E+  GR P+     K       C+            +     ++      
Sbjct: 212  DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271

Query: 1011 DREKQLLEMLEIACK---------------------CIDQDPRRRP 1035
                 + E+L+                         C+ ++P  R 
Sbjct: 272  RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  125 bits (315), Expect = 2e-31
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 23/210 (10%)

Query: 777 NIIGCGGFGLVYKATL-----TNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 830
            ++G G FG V+K        +      +K +    G+         + A+    H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            L G C  G+   L+  Y+  GSL   + +       L   + L      A+G+ YL   
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLE-- 132

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 945
            E  +VHR++ + N+LL    +  +ADFG++ LL P D  +      +    P      E
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY----SEAKTPIKWMALE 187

Query: 946 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                  T + DV+S+GV + EL+T G  P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  123 bits (312), Expect = 2e-31
 Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 37/291 (12%)

Query: 777  NIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 831
              +G G FG V            G   AVK+L     +  R+F+ E+E L   QH N+V 
Sbjct: 16   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 832  LQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
             +G C     R   LI  Y+  GSL  +L +  ++   +     L+      +G+ YL  
Sbjct: 76   YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 131

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----P 944
                  +HRD+ + NIL++ +    + DFGL+++L P D       V   G  P     P
Sbjct: 132  --TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFK--VKEPGESPIFWYAP 186

Query: 945  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
            E       +   DV+SFGVVL EL T     +    +  R + +           +E++ 
Sbjct: 187  ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL- 245

Query: 1005 ASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                   +    L        E+  I  +C + +  +RP   ++   +D I
Sbjct: 246  -------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (311), Expect = 3e-31
 Identities = 68/205 (33%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 835
             +G G FG V+       TK AVK L    G M  + F AE   + + QH+ LV L   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                   +I  YMENGSL  +L         L  +  L +A   A G+A++    E + 
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 950
           +HRD++++NIL+ +     +ADFGL+RL+   D   T          P     PE     
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAK---FPIKWTAPEAINYG 185

Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
           T T + DV+SFG++L E++T GR P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  124 bits (314), Expect = 3e-31
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 777 NIIGCGGFGLVYKATLT----NGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
            IIG G  G V    L          A+K L     + +R +F +E   + +  H N++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L+G    G   +++  YMENGSLD +L     +         + + +G   G+ YL    
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLS--- 168

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIP-----P 944
           +   VHRD+ + N+L+D      ++DFGLSR+L   P   + TT      G IP     P
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG-----GKIPIRWTAP 223

Query: 945 EYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
           E     T +   DV+SFGVV+ E+L  G RP
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (315), Expect = 3e-31
 Identities = 64/282 (22%), Positives = 113/282 (40%), Gaps = 37/282 (13%)

Query: 768  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQM---EREF-QAEVEALS 822
            +S   + +   IG G FG         +G +  +K +  +  +M   ERE  + EV  L+
Sbjct: 21   QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLA 78

Query: 823  RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWL----HESVDKDSVLKWDVRLKIAQ 878
              +H N+V  +          ++  Y E G L   +         +D +L W       Q
Sbjct: 79   NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-----FVQ 133

Query: 879  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
                 L ++H   +  I+HRD+KS NI L +     L DFG++R+L      +    +GT
Sbjct: 134  -ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGT 188

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 998
              Y+ PE  +      + D+++ G VL EL T +   E     + ++LV     +K    
Sbjct: 189  PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLV-----LKIISG 240

Query: 999  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                +            L  ++    +   ++PR RP +  +
Sbjct: 241  SFPPVSLHY-----SYDLRSLVS---QLFKRNPRDRPSVNSI 274

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  124 bits (313), Expect = 4e-31
 Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 42/227 (18%)

Query: 777 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
             +G G FG V+ A   N          AVK L        ++FQ E E L+  QH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWL-----------HESVDKDSVLKWDVRLKIAQG 879
              G C  G   L+++ YM +G L+ +L                    L     L +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
            A G+ YL      H VHRD+ + N L+ +     + DFG+SR +  Y T      VG  
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYR--VGGR 219

Query: 940 GYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
             +P     PE      ++   T +   DV+SFGVVL E+ T G++P
Sbjct: 220 TMLPIRWMPPESILYRKFT---TES---DVWSFGVVLWEIFTYGKQP 260

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  124 bits (312), Expect = 5e-31
 Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 37/291 (12%)

Query: 777  NIIGCGGFGLVYKATLT-----NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 831
              +G G FG V            G   AVK+L     +  R+F+ E+E L   QH N+V 
Sbjct: 47   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 832  LQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
             +G C     R   LI  Y+  GSL  +L +  ++   +     L+      +G+ YL  
Sbjct: 107  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG- 162

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----P 944
                  +HRD+ + NIL++ +    + DFGL+++L P D       V   G  P     P
Sbjct: 163  --TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYK--VKEPGESPIFWYAP 217

Query: 945  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
            E       +   DV+SFGVVL EL T     +    +  R + +           +E++ 
Sbjct: 218  ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL- 276

Query: 1005 ASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                   +    L        E+  I  +C + +  +RP   ++   +D I
Sbjct: 277  -------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  124 bits (314), Expect = 5e-31
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 38/223 (17%)

Query: 777 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 829
             +G G FG VY+  ++         + AVK L   C + +  +F  E   +S+  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHES---VDKDSVLKWDVRLKIAQGAARGLAY 886
           V   G       R ++   M  G L  +L E+     + S L     L +A+  A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHL---ADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           L    E H +HRD+ + N LL       +    DFG++R +  Y         G    +P
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYR--KGGCAMLP 249

Query: 944 -----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                PE      ++   + T   D +SFGV+L E+ + G  P
Sbjct: 250 VKWMPPEAFMEGIFT---SKT---DTWSFGVLLWEIFSLGYMP 286

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  123 bits (310), Expect = 5e-31
 Identities = 61/304 (20%), Positives = 105/304 (34%), Gaps = 65/304 (21%)

Query: 771  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA---EVEALSRAQH 826
             +F     +G GGFG+V++A    +    A+KR+       E   +    EV+AL++ +H
Sbjct: 5    TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEH 62

Query: 827  KNLVSL-------QGYCRHGNDRLLIYSY--ME---NGSLDYWLHESVDKDSVLKWDVRL 874
              +V             +       +Y Y  M+     +L  W++         +  V L
Sbjct: 63   PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCL 121

Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL---------- 924
             I    A  + +LH      ++HRD+K SNI         + DFGL   +          
Sbjct: 122  HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 925  -RPYDTHVTTDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEV 977
                     T  VGT  Y+ PE      YS       + D++S G++L ELL        
Sbjct: 179  TPMPAYARHTGQVGTKLYMSPEQIHGNSYSH------KVDIFSLGLILFELL-------- 224

Query: 978  CKGKNCRDLVSWVFQMKSEKREV-EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF 1036
                       + F  + E+      +    +     ++      +    +   P  RP 
Sbjct: 225  -----------YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE 273

Query: 1037 IEEV 1040
               +
Sbjct: 274  AINI 277

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  122 bits (309), Expect = 6e-31
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 32/223 (14%)

Query: 777 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 829
             +G   FG VYK  L            A+K L        R EF+ E    +R QH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWL------------HESVDKDSVLKWDVRLKIA 877
           V L G         +I+SY  +G L  +L             +     S L+    + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 878 QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVG 937
              A G+ YL      H+VH+D+ + N+L+ +K    ++D GL R +  Y        + 
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYK--LL 187

Query: 938 TLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
               +P     PE       +   D++S+GVVL E+ + G +P
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (311), Expect = 7e-31
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 25/211 (11%)

Query: 778 IIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVS 831
           +IG G FG VYK  L   +       A+K L     + +R +F  E   + +  H N++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L+G        ++I  YMENG+LD +L E   +         + + +G A G+ YL    
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLA--- 164

Query: 892 EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLGYIP-----P 944
             + VHRD+ + NIL++      ++DFGLSR+L   P  T+ T+      G IP     P
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG-----GKIPIRWTAP 219

Query: 945 EYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
           E       T   DV+SFG+V+ E++T G RP
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  125 bits (315), Expect = 7e-31
 Identities = 36/302 (11%), Positives = 67/302 (22%), Gaps = 62/302 (20%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLS-------GDCGQMERE------FQAEVEALSR 823
            ++G        +AT    G    V               QM+ E       +        
Sbjct: 85   VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 824  AQHKNLVSLQGYCRHGNDRLLI-------------------YSYMENGSLDYWLHESVDK 864
              H   +      +    + +I                          +    L      
Sbjct: 145  KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 865  DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL 924
               L    RL++     R LA LH      +VH  ++  +I+LD++    L  F      
Sbjct: 205  HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 925  RPYDTHVTTDLVGTLGYIPPE-----YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCK 979
                                             T   D ++ G+ +  +     P     
Sbjct: 262  GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT--- 318

Query: 980  GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039
                     W+F+           +     +     LLE        +      R    +
Sbjct: 319  DDAALGGSEWIFR--------SCKNIPQPVRA----LLE------GFLRYPKEDRLLPLQ 360

Query: 1040 VV 1041
             +
Sbjct: 361  AM 362

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  123 bits (310), Expect = 7e-31
 Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 26/217 (11%)

Query: 777 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 829
             +G G FG+VY+            T+ A+K ++      ER EF  E   +      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRL------KIAQGAARG 883
           V L G    G   L+I   M  G L  +L       +              ++A   A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           +AYL+       VHRD+ + N ++ E F   + DFG++R +  Y+T       G  G +P
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYR--KGGKGLLP 203

Query: 944 -----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                PE  +    T   DV+SFGVVL E+ T   +P
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  122 bits (308), Expect = 8e-31
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 20/206 (9%)

Query: 777 NIIGCGGFGLVYKATLTNG-TKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQG 834
           + +G G +G VY+          AVK L      ME E F  E   +   +H NLV L G
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
            C       +I  +M  G+L  +L E       +   V L +A   +  + YL K    +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---N 131

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQT 949
            +HRD+ + N L+ E     +ADFGLSRL         T   G     P     PE    
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAK--FPIKWTAPESLAY 186

Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
              + + DV++FGV+L E+ T G  P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (324), Expect = 9e-31
 Identities = 53/209 (25%), Positives = 73/209 (34%), Gaps = 34/209 (16%)

Query: 779 IGCGGFGLVYKA--TLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
           I  GG G +Y A     NG    +K    SGD         AE + L+   H ++V +  
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVVHPSIVQIFN 146

Query: 835 YCRHGNDRLLIYSY--ME--NG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           +  H +       Y  ME   G SL     +       L     +         L+YLH 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLH- 199

Query: 890 VCEPHIVHRDVKSSNILLDE---KFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
                +V+ D+K  NI+L E   K    L D G    +          L GT G+  PE 
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQLK----LIDLGAVSRI----NS-FGYLYGTPGFQAPE- 247

Query: 947 SQTLT-ATCRGDVYSFGVVLLELLTGRRP 974
               T  T   D+Y+ G  L  L      
Sbjct: 248 -IVRTGPTVATDIYTVGRTLAALTLDLPT 275

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  122 bits (308), Expect = 1e-30
 Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 60/304 (19%)

Query: 770  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN 828
             ++F +  ++G G FG V KA    +    A+K++     +      +EV  L+   H+ 
Sbjct: 5    ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQY 63

Query: 829  LVSLQG-YCRHGNDRLLIYS------------YMENGSLDYWLHE---SVDKDSVLKWDV 872
            +V     +    N    + +            Y ENG+L   +H    +  +D   +   
Sbjct: 64   VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-- 121

Query: 873  RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL-------- 924
                 Q     L+Y+H      I+HRD+K  NI +DE     + DFGL++ +        
Sbjct: 122  ---FRQ-ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 925  -----RPYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC 978
                  P  +   T  +GT  Y+  E    T     + D+YS G++  E++         
Sbjct: 175  LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST---- 230

Query: 979  KGKNCRDLVSWVFQMKSEKREVEIIDASIWHK--DREKQLLEMLEIACKCIDQDPRRRPF 1036
             G    ++      +K  +                 EK+++         ID DP +RP 
Sbjct: 231  -GMERVNI------LKKLRSVSIEFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPG 277

Query: 1037 IEEV 1040
               +
Sbjct: 278  ARTL 281

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  122 bits (309), Expect = 1e-30
 Identities = 78/308 (25%), Positives = 127/308 (41%), Gaps = 77/308 (25%)

Query: 777  NIIGCGGFGLVYKATLTNG---TKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKNLVS 831
            ++IG G FG V KA +        AA+KR+     + +  +F  E+E L +   H N+++
Sbjct: 31   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHES------------VDKDSVLKWDVRLKIAQG 879
            L G C H     L   Y  +G+L  +L +S                S L     L  A  
Sbjct: 91   LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 880  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
             ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y       +  T+
Sbjct: 151  VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------VKKTM 200

Query: 940  GYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLV 987
            G +P      E      Y+   T +   DV+S+GV+L E+++ G  P     G  C +L 
Sbjct: 201  GRLPVRWMAIESLNYSVYT---TNS---DVWSYGVLLWEIVSLGGTPYC---GMTCAELY 251

Query: 988  SWVFQMKSEKREVEIIDASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEE 1039
              +                      +   L        E+ ++  +C  + P  RP   +
Sbjct: 252  EKL---------------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 290

Query: 1040 VVTWLDGI 1047
            ++  L+ +
Sbjct: 291  ILVSLNRM 298

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  126 bits (319), Expect = 1e-30
 Identities = 72/257 (28%), Positives = 112/257 (43%), Gaps = 22/257 (8%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGY 835
              +G G FG V+  T    T+ A+K L    G M  E F  E + + + +H+ LV L   
Sbjct: 273  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                    ++  YM  GSL  +L         L+    + +A   A G+AY+ ++   + 
Sbjct: 331  V-SEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 384

Query: 896  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY--IPPEYSQTLTAT 953
            VHRD++++NIL+ E     +ADFGL+RL+   D   T             PE +     T
Sbjct: 385  VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 954  CRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEK---REVEIIDASIWH 1009
             + DV+SFG++L EL T GR P      +   D V   ++M         +  +    W 
Sbjct: 443  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 502

Query: 1010 KDREK-----QLLEMLE 1021
            K+ E+      L   LE
Sbjct: 503  KEPEERPTFEYLQAFLE 519

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  122 bits (308), Expect = 1e-30
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 777 NIIGCGGFGLVYKATLTNG----TKAAVKRL-SGDCGQMER-EFQAEVEALSRAQHKNLV 830
            I+G G FG V +  L        K AVK +   +  Q E  EF +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 831 SLQGYC-----RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--LKIAQGAARG 883
            L G C     +     ++I  +M+ G L  +L  S  +       ++  LK     A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
           + YL      + +HRD+ + N +L +     +ADFGLS+ +   D +      G +  +P
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAKMP 212

Query: 944 -----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                 E       T + DV++FGV + E+ T G  P
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  125 bits (315), Expect = 2e-30
 Identities = 79/391 (20%), Positives = 130/391 (33%), Gaps = 50/391 (12%)

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPL-SLSLCSKLHVLDLRNN 335
             + ++ +  N  +         L  L+F      +    +   +    S L +L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 336 SLTG-PIDLNFSGLSSLCTLDLATNHF-SGPLP-NSLSDCHDLKILSLAKNELSGQVPES 392
                     F+GL++L  L L   +     L  N       L++L L  N +    P S
Sbjct: 90  QFLQLETGA-FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 393 -FGKLTSLLFLSLSNNSFNHL-SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLM 450
            F  +     L L+ N    +    L   Q  K+ T L L+                   
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQG-KHFTLLRLSSI----------------T 191

Query: 451 VLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGE 510
           +  +    L         +   +  LDLS N F  ++            +     + +  
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251

Query: 511 IPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF------- 563
           +  S          N T     AS               L  ++  +   SVF       
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCD---------LSKSKIFALLKSVFSHFTDLE 302

Query: 564 ---LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLH 618
              L+ N IN  I       L HL  L+LS+N +  +I S +   +  LEVLDLS N + 
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360

Query: 619 GSIP-GSFEKLTFLSKFSVANNHLQGTIPTG 648
            ++   SF  L  L + ++  N L+ ++P G
Sbjct: 361 -ALGDQSFLGLPNLKELALDTNQLK-SVPDG 389

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  121 bits (304), Expect = 4e-29
 Identities = 82/418 (19%), Positives = 145/418 (34%), Gaps = 62/418 (14%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL-SNLKQLEVLDLSHNML 146
           V  + L    +  +   S   L  L+ L +       V+       L  L +L L +N  
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 147 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 206
               +G   GL  ++ L ++  + +G++     F  L                       
Sbjct: 92  LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL----------------------T 129

Query: 207 EIQILDLSMNHFMGSLQGL------DHSPSLKQLHVDNNLLGGDLPDSLYSMSSL----- 255
            +++L L  N+    ++ +       +      L +  N +     + L +         
Sbjct: 130 SLEMLVLRDNN----IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185

Query: 256 -----QHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHS 310
                    ++      +        TS+  L + GN F   +           FF A +
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR--------FFDAIA 237

Query: 311 NSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGL--SSLCTLDLATNHFSGPLPNS 368
            +    L LS    S        + +   P +  F GL  S + T DL+ +     L + 
Sbjct: 238 GTKIQSLILS---NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSV 294

Query: 369 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 428
            S   DL+ L+LA+NE++     +F  LT LL L+LS N    +     + +    L  L
Sbjct: 295 FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS--RMFENLDKLEVL 352

Query: 429 ILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLL-RCKKLQVLDLSWNHFD 484
            L+ N +   + +    G  +L  LAL    LK  +P  +  R   LQ + L  N +D
Sbjct: 353 DLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  114 bits (287), Expect = 7e-27
 Identities = 82/383 (21%), Positives = 136/383 (35%), Gaps = 44/383 (11%)

Query: 293 LPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLN-FSGLSSL 351
           +P +  ++  ++      NS +     S S    L  L +   +    I  N F GLSSL
Sbjct: 25  VPELPAHVNYVDL---SLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 352 CTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQV--PESFGKLTSLLFLSLSNNSF 409
             L L  N F      + +   +L++L+L +  L G V     F  LTSL  L L +N+ 
Sbjct: 82  IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 410 NHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLR 469
             +    S     +    L LT N V + I E      +                  LLR
Sbjct: 142 KKIQPA-SFFLNMRRFHVLDLTFNKV-KSICEED--LLNFQGKHFT-----------LLR 186

Query: 470 CKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSL--ISSNCT 527
              + + D++             +  ++  LD S N     + K   +  +   I S   
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246

Query: 528 SSNPTASAGIP---LYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEI-GQLKHL 583
           S++    +           N +  GL  +   +      LS ++I   +   +      L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKT----CDLSKSKIF-ALLKSVFSHFTDL 301

Query: 584 HVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 642
             L L++N I   I  +    + +L  L+LS N L       FE L  L    ++ NH++
Sbjct: 302 EQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360

Query: 643 GTIPTGGQFYSFPNSSFEGNPGL 665
                     +  + SF G P L
Sbjct: 361 ----------ALGDQSFLGLPNL 373

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.7 bits (124), Expect = 9e-07
 Identities = 40/233 (17%), Positives = 77/233 (33%), Gaps = 38/233 (16%)

Query: 10  FVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALK-EFAGNLTNGSIITSWSNESMC 68
               T +  L L+         +  F +   + + +L    + N+ +    T++ +    
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267

Query: 69  CQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPV 128
                        G  A  V    L +  +  ++     H   L+ L L+ N +  +   
Sbjct: 268 TFK----------GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN 317

Query: 129 ELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNI 188
               L  L  L+LS N L    S M   L+ ++ L++S N                   +
Sbjct: 318 AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR---------------AL 362

Query: 189 SNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG--LDHSPSLKQLHVDNN 239
            + SF   L +        ++ L L  N    S+     D   SL+++ +  N
Sbjct: 363 GDQSFL-GLPN--------LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.1 bits (107), Expect = 1e-04
 Identities = 23/88 (26%), Positives = 40/88 (45%)

Query: 84  NAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSH 143
               +  L L +  L  I  R   +L++L++LDLS NH+  +       L  L+ L L  
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380

Query: 144 NMLSGPVSGMLAGLNLIQSLNVSSNSFN 171
           N L     G+   L  +Q + + +N ++
Sbjct: 381 NQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  124 bits (314), Expect = 2e-30
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 20/205 (9%)

Query: 777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQGY 835
             +G G FG V+ AT    TK AVK +    G M    F AE   +   QH  LV L   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                   +I  +M  GSL  +L    D+ S       +  +   A G+A++    + + 
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQTL 950
           +HRD++++NIL+       +ADFGL+R++   D   T          P     PE     
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAR---EGAKFPIKWTAPEAINFG 360

Query: 951 TATCRGDVYSFGVVLLELLT-GRRP 974
           + T + DV+SFG++L+E++T GR P
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP 385

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  120 bits (304), Expect = 3e-30
 Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 23/208 (11%)

Query: 778 IIGCGGFGLVYKATLTNG----TKAAVKRL-SGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           I+G G FG VY+   TN        AVK          + +F +E   +    H ++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            G         +I      G L ++L       + LK    +  +    + +AYL     
Sbjct: 79  IGIIE-EEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLE---S 131

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 947
            + VHRD+   NIL+       L DFGLSR +   D         ++  +P     PE  
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYK---ASVTRLPIKWMSPESI 186

Query: 948 QTLTATCRGDVYSFGVVLLELLT-GRRP 974
                T   DV+ F V + E+L+ G++P
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP 214

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  121 bits (306), Expect = 3e-30
 Identities = 69/293 (23%), Positives = 107/293 (36%), Gaps = 43/293 (14%)

Query: 777  NIIGCGGFGLVYKATLTN-----GTKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 830
              +G G FG V            G   AVK L  D G   R  ++ E++ L    H++++
Sbjct: 37   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 831  SLQGYCRHGNDR--LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
              +G C         L+  Y+  GSL  +L         +     L  AQ    G+AYLH
Sbjct: 97   KYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP----- 943
                 H +HRD+ + N+LLD      + DFGL++ +     +     V   G  P     
Sbjct: 152  ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR---VREDGDSPVFWYA 205

Query: 944  PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
            PE  +        DV+SFGV L ELLT                 ++   QM        +
Sbjct: 206  PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTVL----RL 260

Query: 1003 IDASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
             +          + L        E+  +   C + +   RP  E ++  L  +
Sbjct: 261  TE-----LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  121 bits (306), Expect = 3e-30
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 23/210 (10%)

Query: 777 NIIGCGGFGLVYKATLTNGTKA-----AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLV 830
            ++G G FG VYK       +      A+K L          E   E   ++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            L G C   +   LI   M  G L  ++ E  D    +     L      A+G+ YL   
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE-- 134

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 945
            +  +VHRD+ + N+L+       + DFGL++LL   +           G +P      E
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALE 189

Query: 946 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                  T + DV+S+GV + EL+T G +P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  121 bits (306), Expect = 3e-30
 Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 22/246 (8%)

Query: 736 GRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTN 794
            + QRL      ++ VL            +  +  +       +G G FG V++      
Sbjct: 25  AKLQRLGPETEDNEGVLLTEKL--KPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82

Query: 795 GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY-SYMENGS 853
           G + AVK++     ++E     E+ A +      +V L G  R G   + I+   +E GS
Sbjct: 83  GFQCAVKKV-----RLEVFRVEELVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEGGS 136

Query: 854 LDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK-FE 912
           L     + + +   L  D  L     A  GL YLH      I+H DVK+ N+LL      
Sbjct: 137 L----GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSR 189

Query: 913 AHLADFGLSRLLRPYDTHVTT----DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLEL 968
           A L DFG +  L+P     +      + GT  ++ PE         + D++S   ++L +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 969 LTGRRP 974
           L G  P
Sbjct: 250 LNGCHP 255

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  120 bits (303), Expect = 3e-30
 Identities = 54/208 (25%), Positives = 80/208 (38%), Gaps = 23/208 (11%)

Query: 778 IIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSL 832
            IG G FG V++    +        A+K          R +F  E   + +  H ++V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            G     N   +I      G L  +L     +   L     +  A   +  LAYL     
Sbjct: 82  IGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE---S 134

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 947
              VHRD+ + N+L+       L DFGLSR +   D+        + G +P     PE  
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYK---ASKGKLPIKWMAPESI 189

Query: 948 QTLTATCRGDVYSFGVVLLELLT-GRRP 974
                T   DV+ FGV + E+L  G +P
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKP 217

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  126 bits (318), Expect = 3e-30
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 20/206 (9%)

Query: 779 IGCGGFGLVYKATLTNGTKA---AVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSLQG 834
           +GCG FG V +       K    A+K L     + +  E   E + + +  +  +V L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
            C+     +L+      G L  +L     K   +      ++    + G+ YL    E +
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYSQT 949
            VHR++ + N+LL  +  A ++DFGLS+ L   D++ T     + G  P     PE    
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPLKWYAPECINF 513

Query: 950 LTATCRGDVYSFGVVLLELLT-GRRP 974
              + R DV+S+GV + E L+ G++P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 4e-30
 Identities = 62/286 (21%), Positives = 108/286 (37%), Gaps = 44/286 (15%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQGYC 836
            +  GGF  VY+A  + +G + A+KRL  +  +  R    EV  + + + H N+V      
Sbjct: 36   LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 837  -------RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
                     G    L+ + +  G L  +L +   +   L  D  LKI     R + ++H+
Sbjct: 96   SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHR 154

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL-----------VGT 938
              +P I+HRD+K  N+LL  +    L DFG +  +  Y  +  +               T
Sbjct: 155  -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 939  LGYIPPE---YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS 995
              Y  PE            + D+++ G +L  L   + P                F+  +
Sbjct: 214  PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----------------FEDGA 257

Query: 996  EKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
            + R   I++        + Q      +    +  +P  R  I EVV
Sbjct: 258  KLR---IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (303), Expect = 4e-30
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 11/210 (5%)

Query: 770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN 828
            +      ++G G +G+VY    L+N  + A+K +     +  +    E+      +HKN
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 829 LVSLQGYCRHGNDRLLIY-SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           +V   G        + I+   +  GSL   L          +  +     Q    GL YL
Sbjct: 81  IVQYLGSFSEN-GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-ILEGLKYL 138

Query: 888 HKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE- 945
           H   +  IVHRD+K  N+L++       ++DFG S+ L   +    T   GTL Y+ PE 
Sbjct: 139 H---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEI 194

Query: 946 -YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                       D++S G  ++E+ TG+ P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (302), Expect = 5e-30
 Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 43/222 (19%)

Query: 778 IIGCGGFGLVYKATL--------TNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 829
            +G G F  ++K            + T+  +K L          F      +S+  HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 830 VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
           V   G C  G++ +L+  +++ GSLD +L +     + +    +L++A+  A  + +L  
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLE- 130

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAH--------LADFGLSRLLRPYDTHVTTDLVGTLGY 941
             E  ++H +V + NILL  + +          L+D G+S  + P D             
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI----------LQ 178

Query: 942 IP-----PE---YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                  PE     + L      D +SFG  L E+ + G +P
Sbjct: 179 ERIPWVPPECIENPKNLNLAT--DKWSFGTTLWEICSGGDKP 218

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  120 bits (302), Expect = 9e-30
 Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 59/299 (19%)

Query: 777  NIIGCGGFGLVYKATLTNG----TKAAVKRL-SGDCGQMERE-FQAEVEALSRAQHKNLV 830
             ++G G FG V +A L        K AVK L +      + E F  E   +    H ++ 
Sbjct: 29   RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 831  SLQGYC------RHGNDRLLIYSYMENGSLDYWL--HESVDKDSVLKWDVRLKIAQGAAR 882
             L G              ++I  +M++G L  +L      +    L     ++     A 
Sbjct: 89   KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 883  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
            G+ YL      + +HRD+ + N +L E     +ADFGLSR +   D +      G    +
Sbjct: 149  GMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASKL 201

Query: 943  P-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE 996
            P      E       T   DV++FGV + E++T G+ P     G    ++ +++      
Sbjct: 202  PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA---GIENAEIYNYL------ 252

Query: 997  KREVEIIDASIWHKDREKQLL--------EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                                L        E+ ++  +C   DP++RP    +   L+ I
Sbjct: 253  ---------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  118 bits (299), Expect = 1e-29
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 778 IIGCGGFGLVYKATLTNG---TKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSL 832
            +G G FG V K            AVK L  +     ++ E  AE   + +  +  +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            G C      +L+    E G L+ +L     ++  +K    +++    + G+ YL    E
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE---E 135

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 947
            + VHRD+ + N+LL  +  A ++DFGLS+ LR  + +       T G  P     PE  
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ---THGKWPVKWYAPECI 192

Query: 948 QTLTATCRGDVYSFGVVLLELLT-GRRP 974
                + + DV+SFGV++ E  + G++P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  119 bits (300), Expect = 1e-29
 Identities = 73/308 (23%), Positives = 126/308 (40%), Gaps = 54/308 (17%)

Query: 754  QNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKR--LSGDCGQME 811
            +N   + ++V         ++    IG GG   V++         A+K   L     Q  
Sbjct: 16   ENLYFQSMSVKG-----RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 70

Query: 812  REFQAEVEALSRAQHKNL--VSLQGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSV 867
              ++ E+  L++ Q  +   + L  Y         IY  ME  N  L+ WL +   K S+
Sbjct: 71   DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKK---KKSI 124

Query: 868  LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE---KFEAHLADFGLSRLL 924
              W+ +          +  +H   +  IVH D+K +N L+ +   K    L DFG++  +
Sbjct: 125  DPWERKSYWKN-MLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK----LIDFGIANQM 176

Query: 925  RPYDTHVTTD-LVGTLGYIPPE------YSQTLTATCRG-----DVYSFGVVLLELLTGR 972
            +P  T V  D  VGT+ Y+PPE       S+    +        DV+S G +L  +  G+
Sbjct: 177  QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

Query: 973  RPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPR 1032
             P +        + +S +  +     E+E  D        EK L ++L     C+ +DP+
Sbjct: 237  TPFQ-----QIINQISKLHAIIDPNHEIEFPD------IPEKDLQDVL---KCCLKRDPK 282

Query: 1033 RRPFIEEV 1040
            +R  I E+
Sbjct: 283  QRISIPEL 290

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  118 bits (298), Expect = 1e-29
 Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 23/210 (10%)

Query: 778 IIGCGGFGLVYKATLT----NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLV 830
            +G G FG+V +             AVK L  D     +   +F  EV A+    H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
            L G         ++      GSL   L +              + A   A G+ YL   
Sbjct: 85  RLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE-- 138

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PE 945
                +HRD+ + N+LL  +    + DFGL R L   D H           +P     PE
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM---QEHRKVPFAWCAPE 194

Query: 946 YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
             +T T +   D + FGV L E+ T G+ P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  124 bits (313), Expect = 2e-29
 Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 38/298 (12%)

Query: 768  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQ 825
            ++   +     +G GGFG V +      G + A+K+   +     RE +  E++ + +  
Sbjct: 11   QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 826  HKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
            H N+VS              +  LL   Y E G L  +L++  +    LK      +   
Sbjct: 71   HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSD 129

Query: 880  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLV 936
             +  L YLH   E  I+HRD+K  NI+L    +     + D G ++ L       T   V
Sbjct: 130  ISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTE-FV 184

Query: 937  GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVC----------KGKNCRDL 986
            GTL Y+ PE  +    T   D +SFG +  E +TG RP              + K+   +
Sbjct: 185  GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244

Query: 987  VSWVFQMKSEKREVEIID----ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            V +     + K    +      + I     E+ L  ML           R+R    + 
Sbjct: 245  VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW-------HQRQRGTDPQN 295

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (305), Expect = 2e-29
 Identities = 69/309 (22%), Positives = 117/309 (37%), Gaps = 58/309 (18%)

Query: 755  NSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREF 814
              D  D   S ++    +F   +++G G  G +    + +    AVKR+  +C       
Sbjct: 8    EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFA 64

Query: 815  QAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWD 871
              EV+ L    +H N++      +   DR   Y  +E    +L  ++     KD      
Sbjct: 65   DREVQLLRESDEHPNVIRYFCTEK---DRQFQYIAIELCAATLQEYV---EQKDFAHLGL 118

Query: 872  VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-----AHLADFGLSRLLRP 926
              + + Q    GLA+LH +   +IVHRD+K  NIL+          A ++DFGL + L  
Sbjct: 119  EPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175

Query: 927  --YDTHVTTDLVGTLGYIPPEY---SQTLTATCRGDVYSFGVVLLELLTGRRP------- 974
              +     + + GT G+I PE          T   D++S G V   +++           
Sbjct: 176  GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235

Query: 975  --VEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE-KQLLEMLEIACKCIDQDP 1031
                +  G    D +                     H+D   ++L+E      K I  DP
Sbjct: 236  RQANILLGACSLDCLHPE-----------------KHEDVIARELIE------KMIAMDP 272

Query: 1032 RRRPFIEEV 1040
            ++RP  + V
Sbjct: 273  QKRPSAKHV 281

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  123 bits (310), Expect = 4e-29
 Identities = 54/208 (25%), Positives = 80/208 (38%), Gaps = 23/208 (11%)

Query: 778 IIGCGGFGLVYKATLTNG----TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNLVSL 832
            IG G FG V++    +        A+K          R +F  E   + +  H ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
            G     N   +I      G L  +L     +   L     +  A   +  LAYL     
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLE---S 509

Query: 893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP-----PEYS 947
              VHRD+ + N+L+       L DFGLSR +   D+        + G +P     PE  
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYK---ASKGKLPIKWMAPESI 564

Query: 948 QTLTATCRGDVYSFGVVLLELLT-GRRP 974
                T   DV+ FGV + E+L  G +P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  117 bits (295), Expect = 5e-29
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 12/203 (5%)

Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMERE-FQAEVEALSRA-QHKNLVSLQGY 835
           +G G +G+V K     +G   AVKR+       E++    +++   R       V+  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                D  +    M + SLD +  + +DK   +  D+  KIA    + L +LH   +  +
Sbjct: 75  LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE----YSQTLT 951
           +HRDVK SN+L++   +  + DFG+S  L   D        G   Y+ PE          
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQKG 189

Query: 952 ATCRGDVYSFGVVLLELLTGRRP 974
            + + D++S G+ ++EL   R P
Sbjct: 190 YSVKSDIWSLGITMIELAILRFP 212

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  118 bits (297), Expect = 6e-29
 Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 45/289 (15%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKR--LSGDCGQMEREFQAEVEALSRAQHKN 828
              ++    IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +
Sbjct: 9    RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 829  L--VSLQGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
               + L  Y         IY  ME  N  L+ WL +   K S+  W+ +          +
Sbjct: 69   DKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKK---KKSIDPWERKSYWKN-MLEAV 121

Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIP 943
              +H   +  IVH D+K +N L+ +     L DFG++  ++P  T V  D  VGT+ Y+P
Sbjct: 122  HTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 944  PE------YSQTLTATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 992
            PE       S+    +        DV+S G +L  +  G+ P +        + +S +  
Sbjct: 178  PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHA 232

Query: 993  MKSEKREVEIID-ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            +     E+E  D      +D    +L        C+ +DP++R  I E+
Sbjct: 233  IIDPNHEIEFPDIPEKDLQD----VL------KCCLKRDPKQRISIPEL 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  119 bits (299), Expect = 7e-29
 Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 43/282 (15%)

Query: 777  NIIGCGGFGLVYKATLTNGTKAAVKR--LSGDCGQMEREFQAEVEALSRAQHKNL--VSL 832
              IG GG   V++         A+K   L     Q    ++ E+  L++ Q  +   + L
Sbjct: 62   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 833  QGYCRHGNDRLLIYSYME--NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
              Y         IY  ME  N  L+ WL +   K S+  W+ +          +  +H  
Sbjct: 122  YDYEITDQY---IYMVMECGNIDLNSWLKK---KKSIDPWERKSYWKN-MLEAVHTIH-- 172

Query: 891  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGTLGYIPPE---- 945
             +  IVH D+K +N L+ +     L DFG++  ++P  T V  D  VG + Y+PPE    
Sbjct: 173  -QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 946  -------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 998
                          + + DV+S G +L  +  G+ P +        + +S +  +     
Sbjct: 231  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNH 285

Query: 999  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            E+E  D        EK L ++L+    C+ +DP++R  I E+
Sbjct: 286  EIEFPD------IPEKDLQDVLK---CCLKRDPKQRISIPEL 318

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (295), Expect = 1e-28
 Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 47/232 (20%)

Query: 777 NIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQH 826
             +G G FG V  A                AVK L  D  + +  +  +E+E +    +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRL 874
           KN+++L G C       +I  Y   G+L            +Y    +   +  + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 875 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 934
                 ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +    
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK--- 214

Query: 935 LVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
              T G +P     PE      Y      T + DV+SFGV++ E+ T G  P
Sbjct: 215 -KTTNGRLPVKWMAPEALFDRVY------THQSDVWSFGVLMWEIFTLGGSP 259

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  117 bits (294), Expect = 3e-28
 Identities = 71/313 (22%), Positives = 116/313 (37%), Gaps = 79/313 (25%)

Query: 777  NIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQH 826
              +G G FG V  A                AVK L  D  + +  +  +E+E +    +H
Sbjct: 87   KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 827  KNLVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRL 874
            KN+++L G C       +I  Y   G+L            +Y    +   +  + +   +
Sbjct: 147  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 875  KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 934
                  ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +    
Sbjct: 207  SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK--- 260

Query: 935  LVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
               T G +P     PE      Y      T + DV+SFGV++ E+ T G  P     G  
Sbjct: 261  -KTTNGRLPVKWMAPEALFDRVY------THQSDVWSFGVLMWEIFTLGGSPYP---GIP 310

Query: 983  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLL--------EMLEIACKCIDQDPRRR 1034
              +L   +                     +E   +        E+  +   C    P +R
Sbjct: 311  VEELFKLL---------------------KEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349

Query: 1035 PFIEEVVTWLDGI 1047
            P  +++V  LD I
Sbjct: 350  PTFKQLVEDLDRI 362

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  114 bits (287), Expect = 8e-28
 Identities = 63/232 (27%), Positives = 91/232 (39%), Gaps = 47/232 (20%)

Query: 777 NIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 828
             +G G FG V +AT             AVK L       ER    +E++ LS    H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--------------VDKDSVLKWDVRL 874
           +V+L G C  G   L+I  Y   G L  +L                  D +  L  +  L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 875 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD 934
             +   A+G+A+L      + +HRD+ + NILL       + DFGL+R +   +      
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDSNYV- 202

Query: 935 LVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
            V     +P     PE      Y      T   DV+S+G+ L EL + G  P
Sbjct: 203 -VKGNARLPVKWMAPESIFNCVY------TFESDVWSYGIFLWELFSLGSSP 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  114 bits (288), Expect = 1e-27
 Identities = 75/318 (23%), Positives = 113/318 (35%), Gaps = 84/318 (26%)

Query: 777  NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 829
              IG G FG V++A           T  AVK L  +     + +FQ E   ++   + N+
Sbjct: 53   RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 830  VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR---------------- 873
            V L G C  G    L++ YM  G L+ +L                               
Sbjct: 113  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 874  ----LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 929
                L IA+  A G+AYL    E   VHRD+ + N L+ E     +ADFGLSR +   D 
Sbjct: 173  CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 930  HVTTDLVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRPVEV 977
            +           IP     PE      Y      T   DV+++GVVL E+ + G +P   
Sbjct: 230  YK----ADGNDAIPIRWMPPESIFYNRY------TTESDVWAYGVVLWEIFSYGLQPYY- 278

Query: 978  CKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLE--------MLEIACKCIDQ 1029
              G    +++ +V                     R+  +L         +  +   C  +
Sbjct: 279  --GMAHEEVIYYV---------------------RDGNILACPENCPLELYNLMRLCWSK 315

Query: 1030 DPRRRPFIEEVVTWLDGI 1047
             P  RP    +   L  +
Sbjct: 316  LPADRPSFCSIHRILQRM 333

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  114 bits (287), Expect = 1e-27
 Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 43/228 (18%)

Query: 777 NIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 828
             +G G FG V +AT           K AVK L       E+    +E++ +S   QH+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWL----------HESVDKDSVLKWDVRLKIAQ 878
           +V+L G C HG   L+I  Y   G L  +L                +S       L  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
             A+G+A+L      + +HRDV + N+LL     A + DFGL+R +     ++    V  
Sbjct: 172 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI----VKG 224

Query: 939 LGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
              +P     PE      Y      T + DV+S+G++L E+ + G  P
Sbjct: 225 NARLPVKWMAPESIFDCVY------TVQSDVWSYGILLWEIFSLGLNP 266

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  118 bits (296), Expect = 1e-27
 Identities = 93/470 (19%), Positives = 170/470 (36%), Gaps = 46/470 (9%)

Query: 208 IQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLY-SMSSLQHVSLSV 262
            + L LS N      M  +  L     L+ L + +N +   L   ++     L+++ +S 
Sbjct: 54  TKALSLSQNSISELRMPDISFL---SELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSH 109

Query: 263 NNFSGQLSE-KISNLTSLRHLIIFGNQF-SGKLPNVLGNLTQLEFFVAHSNSF-SGPLPL 319
           N    +L       + SLRHL +  N F    +    GNLT+L F    +  F    L  
Sbjct: 110 N----RLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLP 165

Query: 320 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 379
              L     +LDL +  + G    +    ++   L L  +  S          + L  L 
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTT-VLHLVFHPNSLFSVQVNMSVNALGHLQ 224

Query: 380 LAKNELSGQVPESFGKLTSLLF--LSLSNNSFNHLSGTLSVLQQCK-----------NLT 426
           L+  +L+ +  +      S L    +L N +  H+  T     +             N+ 
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284

Query: 427 TLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGN 486
            L +T+    EE   +    +SLM+  + N               ++ +  LS +     
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344

Query: 487 IPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 546
                    +  +L+F+ N  T  + +  + LK L +      N   +      +  N S
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL-QRNGLKNFFKVALMTKNMS 403

Query: 547 TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 606
           +        +S     +                 + + VL+LS N +TG++   +     
Sbjct: 404 SLETLDVSLNSLNSHAYDRT----------CAWAESILVLNLSSNMLTGSVFRCLPP--K 451

Query: 607 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 656
           ++VLDL +N +  SIP     L  L + +VA+N L+ ++P  G F    +
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDRLTS 498

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  113 bits (285), Expect = 3e-26
 Identities = 82/441 (18%), Positives = 154/441 (34%), Gaps = 25/441 (5%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML-S 147
            +L L    ++ +          L+ LD+S N L+    +    +  L  LDLS N    
Sbjct: 79  RVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDV 135

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 207
            PV      L  +  L +S+  F           +L+   +   S+  K           
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195

Query: 208 IQILDLSMN-HFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 266
             +L L  + + + S+Q      +L  L + N  L  +    L +  S      ++ N +
Sbjct: 196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255

Query: 267 GQLSEKISNLTSLRHLIIFGNQFSGKLPNV-LGNLTQLEFFVAHSNSFSGPLPLSLSLCS 325
            Q        T    + +F   +   +  + + NLT  E               S +   
Sbjct: 256 LQ----HIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE------RIDREEFTYSETALK 305

Query: 326 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 385
            L +  ++N       +  +S  + +    L+ +                  L+  +N  
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365

Query: 386 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN-VG 444
           +  V +    L  L  L L  N   +      + +   +L TL ++ N +     +    
Sbjct: 366 TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA 425

Query: 445 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 504
             ES++VL L +  L G +   L    K++VLDL  N    +IP  +  ++ L  L+ ++
Sbjct: 426 WAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS 482

Query: 505 NTLTGEIPK----SLTELKSL 521
           N L   +P      LT L+ +
Sbjct: 483 NQLK-SVPDGVFDRLTSLQYI 502

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 92.6 bits (230), Expect = 2e-19
 Identities = 71/337 (21%), Positives = 131/337 (38%), Gaps = 25/337 (7%)

Query: 93  LPRKGLKGIIPRSLGHLN--QLKLLDLSCNHLEGVVPVELSNLKQLEVLDL-----SHNM 145
           L    +KG    SL   N   L L+    +     V + ++ L  L++ ++     +   
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237

Query: 146 LSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEF---SNLAVFNISNNSFTGKLNSRIW 202
           L   +S +  G  L+        +      +L +F     +   NI N + T +++   +
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297

Query: 203 SAS----KEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 257
           + S    K + I  +    F+ S + L      +    +  +           S SS   
Sbjct: 298 TYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTF 357

Query: 258 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNV---LGNLTQLEFFVAHSNSF- 313
           ++ + N F+  + +  S L  L+ LI+  N        V     N++ LE      NS  
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLN 416

Query: 314 SGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGL-SSLCTLDLATNHFSGPLPNSLSDC 372
           S     + +    + VL+L +N LTG +   F  L   +  LDL  N     +P  ++  
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIMS-IPKDVTHL 472

Query: 373 HDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSF 409
             L+ L++A N+L       F +LTSL ++ L +N +
Sbjct: 473 QALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 88.4 bits (219), Expect = 4e-18
 Identities = 57/378 (15%), Positives = 103/378 (27%), Gaps = 51/378 (13%)

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 336
              + L +  N  S      +  L++L       N               L  LD+ +N 
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111

Query: 337 LTGPIDLNFSGLSSLCTLDLATNHF-SGPLPNSLSDCHDLKILSLAKNELSGQVPESFGK 395
           L     ++   ++SL  LDL+ N F   P+     +   L  L L+  +           
Sbjct: 112 LQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLP 165

Query: 396 LTSL-LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLAL 454
           +  L L   L +    H+ G  +   Q  N T L L  +       +      +L  L L
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225

Query: 455 GN-------CGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ---MENLFYLDFSN 504
            N       C         L R   L  + L            + Q      + YL+  N
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285

Query: 505 NTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFL 564
            T+T  I +           +    +                   +          +++ 
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEH-------------------VKNQVFLFSKEALYS 326

Query: 565 SNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGS 624
                             +++  LS ++             +   L+ + N    S+   
Sbjct: 327 V--------------FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372

Query: 625 FEKLTFLSKFSVANNHLQ 642
              L  L    +  N L+
Sbjct: 373 CSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 64.1 bits (156), Expect = 2e-10
 Identities = 38/227 (16%), Positives = 79/227 (34%), Gaps = 7/227 (3%)

Query: 91  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 150
           L +  +  +     S   L  L +  +             S   ++ +  LS +      
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345

Query: 151 SGMLAGLNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTG-KLNSRIWSASKEI 208
                  +    LN + N F  S+F+       L    +  N        + +      +
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL 405

Query: 209 QILDLSMNHFM-GSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 266
           + LD+S+N     +         S+  L++ +N+L G +   L     ++ + L  N   
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM 463

Query: 267 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 313
             + + +++L +L+ L +  NQ       V   LT L++   H N +
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  115 bits (289), Expect = 1e-27
 Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 47/230 (20%)

Query: 779 IGCGGFGLVYKATLTN--------GTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 828
           +G G FG V  A             TK AVK L  D  + +  +  +E+E +    +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLKI 876
           +++L G C       +I  Y   G+L            +Y  + S + +  L     +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
           A   ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D +      
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK----K 249

Query: 937 GTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
            T G +P     PE      Y      T + DV+SFGV+L E+ T G  P
Sbjct: 250 TTNGRLPVKWMAPEALFDRIY------THQSDVWSFGVLLWEIFTLGGSP 293

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  112 bits (282), Expect = 2e-27
 Identities = 69/252 (27%), Positives = 104/252 (41%), Gaps = 35/252 (13%)

Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQH 826
            +F     +G G FG VY A    +    A+K L         +E + + EVE  S  +H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 827 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            N++ L GY  H   R+ LI  Y   G++    +  + K S              A  L+
Sbjct: 69  PNILRLYGYF-HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H      ++HRD+K  N+LL    E  +ADFG S    P        L GTL Y+PPE
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTD--LCGTLDYLPPE 177

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDL 986
             +      + D++S GV+  E L G+ P E          + + +           RDL
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237

Query: 987 VSWVFQMKSEKR 998
           +S + +    +R
Sbjct: 238 ISRLLKHNPSQR 249

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (285), Expect = 2e-27
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 13/204 (6%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRA-QHKNLVSLQGY 835
           IG G +G V K     +G   AVKR+     + E++    +++ + R+     +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVD-KDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                D  +    M + S D +        D V+  ++  KI     + L +L +     
Sbjct: 90  LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146

Query: 895 IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE----YSQTL 950
           I+HRD+K SNILLD      L DFG+S  L   D+   T   G   Y+ PE     +   
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSASRQ 204

Query: 951 TATCRGDVYSFGVVLLELLTGRRP 974
               R DV+S G+ L EL TGR P
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFP 228

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  113 bits (284), Expect = 2e-27
 Identities = 59/303 (19%), Positives = 102/303 (33%), Gaps = 36/303 (11%)

Query: 768  KSTNN--FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQAEVEALSR 823
            +ST+N  +  ++I+G G    V++      G   A+K  +     +       E E L +
Sbjct: 4    QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 824  AQHKNLVSLQGYCRHGNDRL--LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
              HKN+V L         R   LI  +   GSL   L E       L     L + +   
Sbjct: 64   LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVV 122

Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVG 937
             G+ +L +     IVHR++K  NI+     +      L DFG +R L   D    + L G
Sbjct: 123  GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS-LYG 177

Query: 938  TLGYIPPEYSQTLTATCRG--------DVYSFGVVLLELLTGRRP-VEVCKGKNCRDL-- 986
            T  Y+ P+  +                D++S GV      TG  P       +  +++  
Sbjct: 178  TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 987  ---------VSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFI 1037
                          Q           D  +         + +  +    ++ D  +    
Sbjct: 238  KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 1038 EEV 1040
            ++ 
Sbjct: 298  DQF 300

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  113 bits (284), Expect = 2e-27
 Identities = 65/237 (27%), Positives = 96/237 (40%), Gaps = 52/237 (21%)

Query: 777 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSRAQHKNL 829
             +G G FG V KAT  +       T  AVK L  +    E  +  +E   L +  H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 830 VSLQGYCRHGNDRLLIYSYMENGSL-DY-------------------WLHESVDKDSVLK 869
           + L G C      LLI  Y + GSL  +                           +  L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 870 WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 929
               +  A   ++G+ YL    E  +VHRD+ + NIL+ E  +  ++DFGLSR +  Y+ 
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV--YEE 203

Query: 930 HVTTDLVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                   + G IP      E      Y      T + DV+SFGV+L E++T G  P
Sbjct: 204 DSYV--KRSQGRIPVKWMAIESLFDHIY------TTQSDVWSFGVLLWEIVTLGGNP 252

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (284), Expect = 2e-27
 Identities = 58/287 (20%), Positives = 106/287 (36%), Gaps = 26/287 (9%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
             +L L    +  I      +L  L  L L  N +  + P   + L +LE L LS N L 
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFN----GSLFELGEFSNLAVFNISNNSFT-GKLNSRIW 202
                M   L   Q L V  N            L   + + V  +  N      + +  +
Sbjct: 114 ELPEKMPKTL---QELRVHENEITKVRKSVFNGL---NQMIVVELGTNPLKSSGIENGAF 167

Query: 203 SASKEIQILDLSMNHFMGSLQGLDHS--PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 260
              K++  + ++  +    +  +     PSL +LH+D N +      SL  +++L  + L
Sbjct: 168 QGMKKLSYIRIADTN----ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 223

Query: 261 SVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSG----- 315
           S N+ S   +  ++N   LR L +  N+   K+P  L +   ++    H+N+ S      
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282

Query: 316 -PLPLSLSLCSKLHVLDLRNNSLT-GPIDLN-FSGLSSLCTLDLATN 359
              P   +  +    + L +N +    I  + F  +     + L   
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  106 bits (267), Expect = 4e-25
 Identities = 74/343 (21%), Positives = 124/343 (36%), Gaps = 71/343 (20%)

Query: 324 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
           C  L V+   +  L   P DL          LDL  N  +        +  +L  L L  
Sbjct: 31  CH-LRVVQCSDLGLEKVPKDL----PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 442
           N++S   P +F  L  L  L LS N    L   +      K L  L + +N +  ++ ++
Sbjct: 86  NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP-----KTLQELRVHENEI-TKVRKS 139

Query: 443 V-GGFESLMVLALGNCGLK-GHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFY 499
           V  G   ++V+ LG   LK   I     +  KKL  + ++  +    IP   G   +L  
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTE 196

Query: 500 LDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQA 555
           L    N +T ++     K L  L  L                           GL +N  
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKL---------------------------GLSFNSI 228

Query: 556 SSFPPSVF----------LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSS----- 600
           S+                L+NN++   +P  +   K++ V+ L  NNI+  I S+     
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPP 286

Query: 601 --ISEIRNLEVLDLSSNDL-HGSI-PGSFEKLTFLSKFSVANN 639
              ++  +   + L SN + +  I P +F  +   +   + N 
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  100 bits (252), Expect = 4e-23
 Identities = 60/310 (19%), Positives = 102/310 (32%), Gaps = 40/310 (12%)

Query: 205 SKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 260
             +  +LDL  N       G  + L    +L  L + NN +    P +   +  L+ + L
Sbjct: 51  PPDTALLDLQNNKITEIKDGDFKNL---KNLHTLILINNKISKISPGAFAPLVKLERLYL 107

Query: 261 SVNNFSGQLSEKISNL-TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL-- 317
           S N    QL E    +  +L+ L +  N+ +    +V   L Q+      +N        
Sbjct: 108 SKN----QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 163

Query: 318 PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 377
             +     KL  + + + ++T    +      SL  L L  N  +     SL   ++L  
Sbjct: 164 NGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAK 220

Query: 378 LSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE 437
           L L+ N +S     S      L  L L+NN    + G L+     K +  + L  N +  
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH---KYIQVVYLHNNNI-S 276

Query: 438 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF-DGNIPPWI-GQME 495
            I  N   F                 P +  +      + L  N      I P     + 
Sbjct: 277 AIGSND--FCP---------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319

Query: 496 NLFYLDFSNN 505
               +   N 
Sbjct: 320 VRAAVQLGNY 329

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  112 bits (283), Expect = 3e-27
 Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 46/231 (19%)

Query: 777 NIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 828
             +G G FG V +A              AVK L       E     +E++ L     H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 829 LVSLQGYC-RHGNDRLLIYSYMENGSL------------DYWLHESVDKDSVLKWDVRLK 875
           +V+L G C + G   ++I  + + G+L             Y +         L  +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDL 935
            +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R +  Y        
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYV-- 205

Query: 936 VGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                 +P     PE      Y      T + DV+SFGV+L E+ + G  P
Sbjct: 206 RKGDARLPLKWMAPETIFDRVY------TIQSDVWSFGVLLWEIFSLGASP 250

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  112 bits (281), Expect = 5e-27
 Identities = 67/316 (21%), Positives = 111/316 (35%), Gaps = 52/316 (16%)

Query: 737  RPQRLSEALASSKLVL---FQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-L 792
            +P+R+S    +S+ +    +  S  +             F + + +G G +G V+K    
Sbjct: 27   QPRRVSFRGEASETLQSPGYDPSRPESFFQQS-------FQRLSRLGHGSYGEVFKVRSK 79

Query: 793  TNGTKAAVKRL-SGDCGQMERE-FQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYM 849
             +G   AVKR  S   G  +R    AEV +  +  QH   V L+         L +    
Sbjct: 80   EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQ--T 136

Query: 850  E--NGSLDYWLHE---SVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSN 904
            E    SL         S+ +  V  +     +       LA+LH      +VH DVK +N
Sbjct: 137  ELCGPSLQQHCEAWGASLPEAQVWGY-----LRD-TLLALAHLH---SQGLVHLDVKPAN 187

Query: 905  ILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVV 964
            I L  +    L DFGL   L            G   Y+ PE  Q  +     DV+S G+ 
Sbjct: 188  IFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQG-SYGTAADVFSLGLT 244

Query: 965  LLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIAC 1024
            +LE+                         +  ++  +      +      +L  +L    
Sbjct: 245  ILEVACNMEL---------------PHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV--- 286

Query: 1025 KCIDQDPRRRPFIEEV 1040
              ++ DP+ R   E +
Sbjct: 287  MMLEPDPKLRATAEAL 302

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  114 bits (287), Expect = 5e-27
 Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 55/302 (18%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNL 829
            N      I+G G  G V       G   AVKR+  D          E++ L+    H N+
Sbjct: 15   NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 830  VSLQGYCRHGNDRLLIYSYME--NGSLDYWL---HESVDKDSVLKWDVRLKIAQGAARGL 884
            +    YC        +Y  +E  N +L   +   + S +   + K    + + +  A G+
Sbjct: 72   IRY--YCSE-TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAH-------------LADFGLSRLLRPYDTHV 931
            A+LH +    I+HRD+K  NIL+                    ++DFGL + L    +  
Sbjct: 129  AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 932  TTDL---VGTLGYIPPEYSQTLTATCRG-------DVYSFGVVLLELLT-GRRPVEVCKG 980
             T+L    GT G+  PE  +               D++S G V   +L+ G+ P      
Sbjct: 186  RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG---D 242

Query: 981  KNCRDLVSWVFQMKSEKREVEIIDASIWHKDRE--KQLLEMLEIACKCIDQDPRRRPFIE 1038
            K  R+       +      ++ +              L+       + ID DP +RP   
Sbjct: 243  KYSRE-----SNIIRGIFSLDEMKCLHDRSLIAEATDLIS------QMIDHDPLKRPTAM 291

Query: 1039 EV 1040
            +V
Sbjct: 292  KV 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (283), Expect = 1e-26
 Identities = 59/304 (19%), Positives = 99/304 (32%), Gaps = 46/304 (15%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVS 831
            I+G G    V++      G   A+K               RE     E L +  HKN+V 
Sbjct: 16   ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE----FEVLKKLNHKNIVK 71

Query: 832  LQGYCRHGNDRL--LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
            L         R   LI  +   GSL   L E  +   + + +  + +      G+ +L +
Sbjct: 72   LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG-GMNHLRE 130

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
                 IVHR++K  NI+     +      L DFG +R L   D    + L GT  Y+ P+
Sbjct: 131  N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS-LYGTEEYLHPD 185

Query: 946  YSQTLTATCRG--------DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 997
              +                D++S GV      TG  P    +G   R     ++++ + K
Sbjct: 186  MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKIITGK 243

Query: 998  REVEIIDASIWHKDREKQLLEML--------------EIACKCIDQDPRRRPFIEEVVTW 1043
                I               +M                +    ++ D  +    ++    
Sbjct: 244  PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

Query: 1044 LDGI 1047
               I
Sbjct: 304  TSDI 307

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (278), Expect = 2e-26
 Identities = 55/263 (20%), Positives = 97/263 (36%), Gaps = 49/263 (18%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVEALSR 823
           +S   + +   +G GGF   ++ +        A K   +          +   E+     
Sbjct: 38  RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97

Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             H+++V   G+     D   ++  +E     SL   L     + ++ + + R  + Q  
Sbjct: 98  LAHQHVVGFHGFFE---DNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQ-I 150

Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
             G  YLH+     ++HRD+K  N+ L+E  E  + DFGL+  +          L GT  
Sbjct: 151 VLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPN 206

Query: 941 YIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK--- 981
           YI PE      +S  +      DV+S G ++  LL G+ P E          + K +   
Sbjct: 207 YIAPEVLSKKGHSFEV------DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 260

Query: 982 ------NCRDLVSWVFQMKSEKR 998
                     L+  + Q     R
Sbjct: 261 PKHINPVAASLIQKMLQTDPTAR 283

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (275), Expect = 2e-26
 Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 20/204 (9%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
           +G GGF   ++ +        A K   +          +   E+       H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 835 YCRHGNDRLLIYSYME---NGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           +     D   ++  +E     SL +        + ++ + + R  + Q    G  YLH+ 
Sbjct: 83  FFE---DNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQ-IVLGCQYLHRN 134

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
               ++HRD+K  N+ L+E  E  + DFGL+  +          L GT  YI PE     
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKK 190

Query: 951 TATCRGDVYSFGVVLLELLTGRRP 974
             +   DV+S G ++  LL G+ P
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPP 214

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  108 bits (273), Expect = 3e-26
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 27/219 (12%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD---CGQMEREFQAEVEALSR 823
           +   +F   N++G G F  VY+A  +  G + A+K +         M +  Q EV+   +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67

Query: 824 AQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQGAA 881
            +H +++ L  Y    ++ + L+     NG +        ++       + R  + Q   
Sbjct: 68  LKHPSILELYNYF-EDSNYVYLVLEMCHNGEM---NRYLKNRVKPFSENEARHFMHQ-II 122

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
            G+ YLH      I+HRD+  SN+LL       +ADFGL+  L+       T L GT  Y
Sbjct: 123 TGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNY 178

Query: 942 IPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           I PE      +          DV+S G +   LL GR P
Sbjct: 179 ISPEIATRSAHGLES------DVWSLGCMFYTLLIGRPP 211

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (275), Expect = 4e-26
 Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 31/231 (13%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLS-----------------GDCGQM 810
           K  N++     +  G F  +      +    A+K+                         
Sbjct: 28  KYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86

Query: 811 EREFQAEVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLK 869
             +F+ E++ ++  +++  ++ +G      D + +IY YMEN S+  +       D    
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 870 W----DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR 925
                 V   I +      +Y+H   E +I HRDVK SNIL+D+     L+DFG S  + 
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 926 PYDTHVTTDLVGTLGYIPPE--YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             D  +     GT  ++PPE   +++     + D++S G+ L  +     P
Sbjct: 204 --DKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  109 bits (275), Expect = 5e-26
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 52/237 (21%)

Query: 777 NIIGCGGFGLVYKATLTNG------TKAAVKRLSGDCGQMER-EFQAEVEALSR-AQHKN 828
            ++G G FG V  AT           + AVK L       ER    +E++ +++   H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVR--------------- 873
           +V+L G C       LI+ Y   G L  +L    +K S  + +                 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 874 ----LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 929
               L  A   A+G+ +L        VHRD+ + N+L+       + DFGL+R +     
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI--MSD 225

Query: 930 HVTTDLVGTLGYIP-----PE------YSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                 V     +P     PE      Y      T + DV+S+G++L E+ + G  P
Sbjct: 226 SNYV--VRGNARLPVKWMAPESLFEGIY------TIKSDVWSYGILLWEIFSLGVNP 274

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (268), Expect = 1e-25
 Identities = 61/304 (20%), Positives = 100/304 (32%), Gaps = 69/304 (22%)

Query: 770  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQ-AEVEALSR-AQ 825
            T  F++   IG G FG V+K     +G   A+KR      G ++ +    EV A +   Q
Sbjct: 10   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 826  HKNLVSLQGYCRHGNDRLLIYS-YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            H ++V         +D +LI + Y   GSL   + E+    S  K      +     RGL
Sbjct: 70   HSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 885  AYLHKVCEPHIVHRDVKSSNILLDE-------------------KFEAHLADFGLSRLLR 925
             Y+H      +VH D+K SNI +                     K    + D G    + 
Sbjct: 129  RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 926  PYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCR 984
                       G   ++  E   +  T   + D+++  + ++                  
Sbjct: 186  SPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR-------- 232

Query: 985  DLVSWVFQMKSEKREVEIIDASIWHKDREKQL--------LEMLEIACKCIDQDPRRRPF 1036
                               +   WH+ R+ +L         E  E+    I  DP RRP 
Sbjct: 233  -------------------NGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPS 273

Query: 1037 IEEV 1040
               +
Sbjct: 274  AMAL 277

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  107 bits (268), Expect = 2e-25
 Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 10/197 (5%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G VY A  +  G + A+++++      +     E+  +   ++ N+V+      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G++  ++  Y+  GSL       V  ++ +       + +   + L +LH      ++H
Sbjct: 88  VGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+KS NILL       L DFG    + P  +  +T +VGT  ++ PE         + D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 198

Query: 958 VYSFGVVLLELLTGRRP 974
           ++S G++ +E++ G  P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (266), Expect = 3e-25
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 27/215 (12%)

Query: 773 FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS 831
           +     +G G FG VYKA     G  AA K +     +   ++  E+E L+   H  +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK------IAQGAARGLA 885
           L G   H     ++  +   G++D           +L+ D  L       + +     L 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVD---------AIMLELDRGLTEPQIQVVCRQMLEALN 131

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY---- 941
           +LH      I+HRD+K+ N+L+  + +  LADFG+S           +  +GT  Y    
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTP-YWMAP 186

Query: 942 --IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             +  E  +      + D++S G+ L+E+     P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (266), Expect = 3e-25
 Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 11/198 (5%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 836
           IG G FG V+K          A+K +  +  + E E  Q E+  LS+     +    G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 837 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                  +I  Y+  GS        + +   L       I +   +GL YLH       +
Sbjct: 90  LKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE---KKI 141

Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           HRD+K++N+LL E  E  LADFG++  L        T  VGT  ++ PE  +      + 
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKA 200

Query: 957 DVYSFGVVLLELLTGRRP 974
           D++S G+  +EL  G  P
Sbjct: 201 DIWSLGITAIELARGEPP 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (267), Expect = 4e-25
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 10/197 (5%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           IG G  G+V  A    +G + AVK +     Q       EV  +   QH N+V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            G +  ++  +++ G+L       +     L  +    + +   + LAYLH      ++H
Sbjct: 113 VGEELWVLMEFLQGGALT-----DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIH 164

Query: 898 RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
           RD+KS +ILL       L+DFG    +        + LVGT  ++ PE           D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLYATEVD 223

Query: 958 VYSFGVVLLELLTGRRP 974
           ++S G++++E++ G  P
Sbjct: 224 IWSLGIMVIEMVDGEPP 240

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (263), Expect = 6e-25
 Identities = 61/252 (24%), Positives = 103/252 (40%), Gaps = 35/252 (13%)

Query: 771 NNFNQANIIGCGGFGLVYKA-TLTNGTKAAVKRLSGD---CGQMEREFQAEVEALSRAQH 826
           ++F+    +G G FG VY A    N    A+K L         +E + + E+E  S  +H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 827 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            N++ +  Y  H   R+ L+  +   G L    ++ + K             +  A  L 
Sbjct: 74  PNILRMYNYF-HDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALH 128

Query: 886 YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
           Y H+     ++HRD+K  N+L+  K E  +ADFG S       +     + GTL Y+PPE
Sbjct: 129 YCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLDYLPPE 182

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDL 986
             +  T   + D++  GV+  E L G  P +          +               +DL
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242

Query: 987 VSWVFQMKSEKR 998
           +S + +    +R
Sbjct: 243 ISKLLRYHPPQR 254

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  105 bits (265), Expect = 6e-25
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 16/204 (7%)

Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMERE-FQAEVEALSRA-QHKNLVSLQGY 835
           +G G  G V+K      G   AVK++     + E +    +++ + ++     +V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 836 CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                D  +    M   +              +   +  K+     + L YL +  +  +
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE--KHGV 146

Query: 896 VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA--- 952
           +HRDVK SNILLDE+ +  L DFG+S  L   D        G   Y+ PE          
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKP 204

Query: 953 --TCRGDVYSFGVVLLELLTGRRP 974
               R DV+S G+ L+EL TG+ P
Sbjct: 205 DYDIRADVWSLGISLVELATGQFP 228

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  105 bits (264), Expect = 7e-25
 Identities = 62/239 (25%), Positives = 102/239 (42%), Gaps = 26/239 (10%)

Query: 747 SSKLVLFQNSDCKDLTVSDLLKSTNN----FNQANIIGCGGFGLVYKAT-LTNGTKAAVK 801
           S + V  +N   + L   D    T      F+    +G G +G VYKA     G   A+K
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 802 RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES 861
           ++        +E   E+  + +    ++V   G      D  ++  Y   GS+       
Sbjct: 61  QV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS------ 112

Query: 862 VDKDSVLKWDVRLK------IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL 915
              D +   +  L       I Q   +GL YLH +     +HRD+K+ NILL+ +  A L
Sbjct: 113 ---DIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKL 166

Query: 916 ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           ADFG++  L        T ++GT  ++ PE  Q +   C  D++S G+  +E+  G+ P
Sbjct: 167 ADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (263), Expect = 9e-25
 Identities = 67/315 (21%), Positives = 120/315 (38%), Gaps = 63/315 (20%)

Query: 768  KSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS---------GDCGQMERE 813
             ST+ F +      I+G G   +V +        + AVK +           +  ++   
Sbjct: 10   HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 814  FQAEVEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV 872
               EV+ L + + H N++ L+          L++  M+ G L        +K ++ + + 
Sbjct: 70   TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL---FDYLTEKVTLSEKET 126

Query: 873  RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT 932
            R  +       +  LHK+   +IVHRD+K  NILLD+     L DFG S  L P      
Sbjct: 127  RKIMRA-LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKL 180

Query: 933  TDLVGTLGYIPPE-YSQTLTATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRDL 986
             ++ GT  Y+ PE    ++     G     D++S GV++  LL G  P            
Sbjct: 181  REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------------ 228

Query: 987  VSWVFQMKSEKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFI 1037
                F  + +   + +I        +  W    D  K L+       + +   P++R   
Sbjct: 229  ----FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV------SRFLVVQPQKRYTA 278

Query: 1038 EEVVT--WLDGIGID 1050
            EE +   +     ++
Sbjct: 279  EEALAHPFFQQYVVE 293

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (264), Expect = 1e-24
 Identities = 60/334 (17%), Positives = 99/334 (29%), Gaps = 73/334 (21%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
            T+L L    +  +       L  L  L L  N +  +     S L++L+ L +S N L 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 207
                + + L     L +  N                   +    F+G  N         
Sbjct: 116 EIPPNLPSSL---VELRIHDNRIR---------------KVPKGVFSGLRN--------- 148

Query: 208 IQILDLSMNHFM------GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS 261
           +  +++  N         G+  GL     L  L +    L   +P  L    +L  + L 
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGL----KLNYLRISEAKL-TGIPKDL--PETLNELHLD 201

Query: 262 VNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL 321
            N       E +   + L  L +  NQ           +  +      + S S       
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQ-----------IRMI-----ENGSLSF------ 239

Query: 322 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHD------L 375
                L  L L NN L+  +      L  L  + L TN+ +    N              
Sbjct: 240 --LPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYY 296

Query: 376 KILSLAKNELSGQV--PESFGKLTSLLFLSLSNN 407
             +SL  N +      P +F  +T  L +   N 
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  101 bits (254), Expect = 2e-23
 Identities = 57/308 (18%), Positives = 97/308 (31%), Gaps = 37/308 (12%)

Query: 205 SKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 260
           S +  +LDL  N          +GL     L  L + NN +      +   +  LQ + +
Sbjct: 53  SPDTTLLDLQNNDISELRKDDFKGL---QHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109

Query: 261 SVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF-SGPLPL 319
           S N+   ++   +   +SL  L I  N+       V   L  +       N   +     
Sbjct: 110 SKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166

Query: 320 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 379
                 KL+ L +    LT    +      +L  L L  N         L     L  L 
Sbjct: 167 GAFDGLKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLG 223

Query: 380 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 439
           L  N++      S   L +L  L L NN  + +   L  L   K L  + L  N +  ++
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDL---KLLQVVYLHTNNI-TKV 279

Query: 440 PENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD-GNIPPWIGQ-MENL 497
             N   F  +                + ++      + L  N      + P   + + + 
Sbjct: 280 GVND--FCPV---------------GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR 322

Query: 498 FYLDFSNN 505
             + F N 
Sbjct: 323 LAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 64/365 (17%), Positives = 119/365 (32%), Gaps = 98/365 (26%)

Query: 324 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
           C  L V+   +  L   P +++         LDL  N  S    +       L  L L  
Sbjct: 33  CH-LRVVQCSDLGLKAVPKEIS----PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 442
           N++S    ++F  L  L  L +S N    +   L       +L  L +  N +  ++P+ 
Sbjct: 88  NKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP-----SSLVELRIHDNRI-RKVPKG 141

Query: 443 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF-DGNIPPWIGQMENLFYLD 501
           V  F  L                     + +  +++  N   +    P       L YL 
Sbjct: 142 V--FSGL---------------------RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLR 178

Query: 502 FSNNTLTG---EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSF 558
            S   LTG   ++P++L EL                               L +N+  + 
Sbjct: 179 ISEAKLTGIPKDLPETLNELH------------------------------LDHNKIQAI 208

Query: 559 PPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNL 607
                          L +N+I   I       L  L  L L  N ++  +P+ + +++ L
Sbjct: 209 ELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL 266

Query: 608 EVLDLSSNDLHGSIP-------GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFE 660
           +V+ L +N++   +        G   K  + +  S+ NN +         ++    ++F 
Sbjct: 267 QVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPV--------PYWEVQPATFR 317

Query: 661 GNPGL 665
                
Sbjct: 318 CVTDR 322

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 54/302 (17%), Positives = 94/302 (31%), Gaps = 40/302 (13%)

Query: 327 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 386
             +LDL+NN ++     +F GL  L  L L  N  S     + S    L+ L ++KN L 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

Query: 387 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEE-IPENVGG 445
              P     L  L    + +N    +     V    +N+  + +  N +           
Sbjct: 116 EIPPNLPSSLVEL---RIHDNRIRKVPK--GVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 446 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSN 504
              L  L +    L   IP  L     L  L L  N     I      +   L+ L   +
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226

Query: 505 NTLTGEIP----KSLTELKSL-ISSNCTSSNPTASAGIP----LYVKHNRSTNGLPYNQA 555
           N +   I       L  L+ L + +N  S  P     +     +Y         L  N  
Sbjct: 227 NQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVY---------LHTNNI 276

Query: 556 SSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTI--PSSISEIRNLEVLDLS 613
           +    + F               +  + + + L  N +      P++   + +   +   
Sbjct: 277 TKVGVNDFCPVGFGV--------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328

Query: 614 SN 615
           + 
Sbjct: 329 NY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 68/323 (21%), Positives = 108/323 (33%), Gaps = 78/323 (24%)

Query: 345 FSGLSSLCTLDLATNHFSGPLPNSLSDCH-DLKILSLAKNELSGQVPESFGKLTSLLFLS 403
            SG+  L +L      +S   P     CH  L+++  +   L   VP+          L 
Sbjct: 10  TSGIPDLDSLPPT---YSAMCP---FGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLD 60

Query: 404 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHI 463
           L NN  + L       +  ++L  L+L  N +  +I E    F  L              
Sbjct: 61  LQNNDISELRK--DDFKGLQHLYALVLVNNKI-SKIHEKA--FSPL-------------- 101

Query: 464 PVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPK-SLTELKSLI 522
                  +KLQ L +S NH    IPP      +L  L   +N +  ++PK   + L+++ 
Sbjct: 102 -------RKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMN 150

Query: 523 SSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF---------LSNNRINGTI 573
                           + +  N   N       S F P  F         +S  ++   I
Sbjct: 151 C---------------IEMGGNPLEN-------SGFEPGAFDGLKLNYLRISEAKLT-GI 187

Query: 574 PPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSK 633
           P ++   + L+ L L  N I       +     L  L L  N +     GS   L  L +
Sbjct: 188 PKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245

Query: 634 FSVANNHLQGTIPTGGQFYSFPN 656
             + NN L   +P G        
Sbjct: 246 LHLDNNKLS-RVPAG--LPDLKL 265

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 2e-24
 Identities = 46/206 (22%), Positives = 76/206 (36%), Gaps = 16/206 (7%)

Query: 780 GCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMER--EFQAEVEALSRAQHKNLVSLQGYC 836
           G      V  A     G    V+R++ +    E     Q E+       H N+V  +   
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 837 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
              N+  ++ S+M  GS    +         +       I QG  + L Y+H +     V
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHM---GYV 150

Query: 897 HRDVKSSNILLDEKFEAHLADFGLSRLL------RPYDTHVTTDLVGTLGYIPPE-YSQT 949
           HR VK+S+IL+    + +L+    +  +      +          V  L ++ PE   Q 
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210

Query: 950 LTA-TCRGDVYSFGVVLLELLTGRRP 974
           L     + D+YS G+   EL  G  P
Sbjct: 211 LQGYDAKSDIYSVGITACELANGHVP 236

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (257), Expect = 5e-24
 Identities = 69/271 (25%), Positives = 111/271 (40%), Gaps = 27/271 (9%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 836
            IG G   +V  A       K A+KR++ +  Q   +    E++A+S+  H N+VS     
Sbjct: 23   IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 837  RHGNDRLLIYSYMENGSL----DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
               ++  L+   +  GS+     + + +   K  VL       I +    GL YLHK   
Sbjct: 83   VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140

Query: 893  PHIVHRDVKSSNILLDEKFEAHLADFG----LSRLLRPYDTHVTTDLVGTLGYIPPE-YS 947
               +HRDVK+ NILL E     +ADFG    L+         V    VGT  ++ PE   
Sbjct: 141  -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199

Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
            Q      + D++SFG+  +EL TG  P         +     V  +  +     +     
Sbjct: 200  QVRGYDFKADIWSFGITAIELATGAAP-------YHKYPPMKVLMLTLQNDPPSLETGVQ 252

Query: 1008 WHKDREK---QLLEMLEIACKCIDQDPRRRP 1035
              +  +K      +M+     C+ +DP +RP
Sbjct: 253  DKEMLKKYGKSFRKMIS---LCLQKDPEKRP 280

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  105 bits (263), Expect = 1e-23
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 35/286 (12%)

Query: 766  LLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRL--SGDCGQMEREFQAEV 818
            +     + ++       +G G +G V          + A+K +  +        +   EV
Sbjct: 28   ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 819  EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
              L    H N++ L  +     +  L+    + G L     E + +    + D    I +
Sbjct: 88   AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---FDEIIHRMKFNEVDAA-VIIK 143

Query: 879  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDL 935
                G+ YLHK    +IVHRD+K  N+LL+ K +     + DFGLS +          + 
Sbjct: 144  QVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKER 198

Query: 936  VGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
            +GT  YI PE   +     C  DV+S GV+L  LL G  P     G+  ++++  V + K
Sbjct: 199  LGTAYYIAPEVLRKKYDEKC--DVWSIGVILFILLAGYPP---FGGQTDQEILRKVEKGK 253

Query: 995  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                  E  + S   KD  KQ+L+           D +RR   ++ 
Sbjct: 254  YTFDSPEWKNVSEGAKDLIKQMLQF----------DSQRRISAQQA 289

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (257), Expect = 1e-23
 Identities = 62/338 (18%), Positives = 114/338 (33%), Gaps = 48/338 (14%)

Query: 312 SFSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLS 370
           S       +   C +  +    + SL   P  L      ++ +LDL+ N  +    + L 
Sbjct: 18  SKEESSNQASLSCDRNGICKGSSGSLNSIPSGLT----EAVKSLDLSNNRITYISNSDLQ 73

Query: 371 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 430
            C +L+ L L  N ++    +SF  L SL  L LS N  ++LS   S  +   +LT L L
Sbjct: 74  RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSS--SWFKPLSSLTFLNL 131

Query: 431 TKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPV-WLLRCKKLQVLDLSWNHFDGNIP 488
             N        ++      L +L +GN      I          L+ L++  +      P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191

Query: 489 PWIGQMENLFYLDFSNNTLT---GEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNR 545
             +  ++N+ +L                  + ++ L   +                    
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD-------------------- 231

Query: 546 STNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIR 605
               L     S        S           + +      + ++  ++   +   +++I 
Sbjct: 232 --TDLDTFHFSELSTGETNS-----------LIKKFTFRNVKITDESLF-QVMKLLNQIS 277

Query: 606 NLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQ 642
            L  L+ S N L  S+P G F++LT L K  +  N   
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (255), Expect = 2e-23
 Identities = 71/313 (22%), Positives = 108/313 (34%), Gaps = 37/313 (11%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
           V  L L    +  I    L     L+ L L+ N +  +     S+L  LE LDLS+N LS
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 207
              S     L+ +  LN+  N +  +L E   FS+L            KL          
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHL-----------TKLQILRVGNMDT 161

Query: 208 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 267
              +            GL     L++L +D + L    P SL S+ ++ H+ L +     
Sbjct: 162 FTKIQR------KDFAGL---TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212

Query: 268 QLSEKISNLTSLRHLIIFGNQFSG----KLP----NVLGNLTQLEFFVAHSNSFSGPLPL 319
            L   +   +S+  L +           +L     N L              S    + L
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL 272

Query: 320 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 379
              + S L  L+   N L    D  F  L+SL  + L TN +          C  +  LS
Sbjct: 273 LNQI-SGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYLS 324

Query: 380 LAKNELSGQVPES 392
              N+ S +   S
Sbjct: 325 RWLNKNSQKEQGS 337

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 57/267 (21%), Positives = 103/267 (38%), Gaps = 13/267 (4%)

Query: 228 SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFG 286
           + ++K L + NN +       L    +LQ + L+ N  +  + E   S+L SL HL +  
Sbjct: 51  TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSY 109

Query: 287 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL-SLCSKLHVLDLRNNSLTGPIDLN- 344
           N  S    +    L+ L F     N +      SL S  +KL +L + N      I    
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 345 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSL 404
           F+GL+ L  L++  +      P SL    ++  L L   +    +       +S+  L L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229

Query: 405 SNNSFNHL------SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCG 458
            +   +        +G  + L +      + +T   +  ++ + +     L+ L      
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQ 288

Query: 459 LKGHIPVWLL-RCKKLQVLDLSWNHFD 484
           LK  +P  +  R   LQ + L  N +D
Sbjct: 289 LKS-VPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 53/321 (16%), Positives = 94/321 (29%), Gaps = 82/321 (25%)

Query: 351 LCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFN 410
                + +         +   C    I   +   L+  +P       ++  L LSNN   
Sbjct: 9   WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT 65

Query: 411 HLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRC 470
           ++S   S LQ+C NL  L+LT N +   I E+   F SL                     
Sbjct: 66  YISN--SDLQRCVNLQALVLTSNGI-NTIEEDS--FSSL--------------------- 99

Query: 471 KKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSNNTLT----GEIPKSLTELKSLISSN 525
             L+ LDLS+N+   N+   W   + +L +L+   N         +   LT+L+ L   N
Sbjct: 100 GSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158

Query: 526 CTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHV 585
                                      +  +      F                L  L  
Sbjct: 159 M--------------------------DTFTKIQRKDFAG--------------LTFLEE 178

Query: 586 LDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGT 644
           L++  +++    P S+  I+N+  L L        +     +  + +    + +  L   
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237

Query: 645 IPTGGQFYSFPNSSFEGNPGL 665
                 F              
Sbjct: 238 -----HFSELSTGETNSLIKK 253

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  105 bits (264), Expect = 1e-23
 Identities = 55/330 (16%), Positives = 99/330 (30%), Gaps = 69/330 (20%)

Query: 333 RNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPES 392
            NN+ +   +  ++ +S                 ++        +    +NE    + E 
Sbjct: 7   INNNFSLSQNSFYNTISGTYAD----------YFSAWDKWEKQALPGENRNEAVSLLKEC 56

Query: 393 FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVL 452
              +     L L+  + + L   L        +T L +T+N +   +PE      SL  L
Sbjct: 57  L--INQFSELQLNRLNLSSLPDNL-----PPQITVLEITQNAL-ISLPELPA---SLEYL 105

Query: 453 ALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 512
              +  L   +P      K L   D+  N     +P        L Y++  NN LT  +P
Sbjct: 106 DACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPA---LLEYINADNNQLT-MLP 156

Query: 513 KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSV------FLSN 566
           +  T L+ L                            +  NQ +  P          +S 
Sbjct: 157 ELPTSLEVLS---------------------------VRNNQLTFLPELPESLEALDVST 189

Query: 567 NRINGTIPPEIGQLKHL----HVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 622
           N +  ++P    +  H            N IT  IP +I  +     + L  N L   I 
Sbjct: 190 NLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247

Query: 623 GSFEKLTFLSKFSVANNHLQGTIPTGGQFY 652
            S  + T    +     +   +       +
Sbjct: 248 ESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  103 bits (258), Expect = 6e-23
 Identities = 55/298 (18%), Positives = 108/298 (36%), Gaps = 32/298 (10%)

Query: 126 VPVELSNLKQLEV-LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGE--FSN 182
           + + L       +  +  +N +SG  +   +  +  +   +   + N ++  L E   + 
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60

Query: 183 LAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSP-SLKQLHVDNNLL 241
            +   ++  + +  L   +     +I +L+++ N     L  L   P SL+ L   +N L
Sbjct: 61  FSELQLNRLNLS-SLPDNL---PPQITVLEITQNA----LISLPELPASLEYLDACDNRL 112

Query: 242 GGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLT 301
              LP+     +SL+H+ +  N  +  L E  + L  +       NQ +  LP +  +L 
Sbjct: 113 S-TLPELP---ASLKHLDVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPTSLE 163

Query: 302 QLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG-P--IDLNFSGLSSLCTLDLAT 358
            L      +N  +  LP        L  LD+  N L   P     N     +        
Sbjct: 164 VLS---VRNNQLTF-LPELPE---SLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRE 216

Query: 359 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL 416
           N  +  +P ++        + L  N LS ++ ES  + T+          F+   G  
Sbjct: 217 NRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  101 bits (253), Expect = 3e-22
 Identities = 63/338 (18%), Positives = 112/338 (33%), Gaps = 35/338 (10%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPV-ELSNLKQLEVLDLSHNMLSG-PVSGMLA 155
           + G         ++ +   L   +    V + +   + Q   L L+   LS  P +    
Sbjct: 22  ISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSLPDN---- 77

Query: 156 GLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSM 215
               I  L ++ N+   SL E    ++L   +  +N  +  L     S    ++ LD+  
Sbjct: 78  LPPQITVLEITQNAL-ISLPE--LPASLEYLDACDNRLS-TLPELPAS----LKHLDVDN 129

Query: 216 NHFMGSLQGLDHSP-SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS 274
           N     L  L   P  L+ ++ DNN L   LP+     +SL+ +S+  N    QL+    
Sbjct: 130 NQ----LTMLPELPALLEYINADNNQL-TMLPELP---TSLEVLSVRNN----QLTFLPE 177

Query: 275 NLTSLRHLIIFGNQFSGKLPNVLGNLTQLE----FFVAHSNSFSGPLPLSLSLCSKLHVL 330
              SL  L +  N     LP V       E    FF    N  +  +P ++        +
Sbjct: 178 LPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTI 235

Query: 331 DLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVP 390
            L +N L+  I  + S  ++         +FS       +    L               
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT--AWFPENKQ 293

Query: 391 ESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 428
               ++          N+F+     LS     +N +  
Sbjct: 294 SDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGF 331

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 90.4 bits (224), Expect = 8e-19
 Identities = 60/364 (16%), Positives = 107/364 (29%), Gaps = 96/364 (26%)

Query: 252 MSSLQHVSLSVNNFSGQLS----EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFV 307
           +    + SLS N+F   +S    +  S         + G                L    
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGEN--------RNEAVSL---- 52

Query: 308 AHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN 367
                      L   L ++   L L   +L+    L  +    +  L++  N     LP 
Sbjct: 53  -----------LKECLINQFSELQLNRLNLS---SLPDNLPPQITVLEITQNALI-SLPE 97

Query: 368 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 427
             +    L+ L    N LS  +PE    L  L    + NN    L    +       L  
Sbjct: 98  LPAS---LEYLDACDNRLS-TLPELPASLKHL---DVDNNQLTMLPELPA------LLEY 144

Query: 428 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNI 487
           +    N +   +PE      SL VL++ N  L   +P      + L+ LD+S N  + ++
Sbjct: 145 INADNNQL-TMLPELPT---SLEVLSVRNNQLT-FLPELP---ESLEALDVSTNLLE-SL 195

Query: 488 PPWIGQMENL----FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 543
           P    +  +      +     N +T  IP+++  L    +                    
Sbjct: 196 PAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT-------------------- 234

Query: 544 NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 603
                             + L +N ++  I   + Q          R   + +     + 
Sbjct: 235 ------------------IILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276

Query: 604 IRNL 607
            R L
Sbjct: 277 HRPL 280

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 29/213 (13%), Positives = 58/213 (27%), Gaps = 20/213 (9%)

Query: 102 IPRSLGHLNQLK----LLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           +P      +  +          N +   +P  + +L     + L  N LS  +   L+  
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253

Query: 158 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNN--SFTGKLNSRIWSASKEIQILDLSM 215
                 +     F+ S  +           ++           S+IW A +     +   
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEH----EEHA 309

Query: 216 NHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISN 275
           N F   L  L  + S +            +   L  +S+   +       +   +E   +
Sbjct: 310 NTFSAFLDRLSDTVSARNTS----GFREQVAAWLEKLSASAELRQQSFAVAADATESCED 365

Query: 276 LTSLRHLIIFGNQF-----SGKLPNVLGNLTQL 303
             +L    +           G   N  G L  L
Sbjct: 366 RVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (260), Expect = 1e-23
 Identities = 46/232 (19%), Positives = 86/232 (37%), Gaps = 12/232 (5%)

Query: 207 EIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 262
             ++L+L  N        S + L     L+ L +  N +      +   +++L  + L  
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHL---RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121

Query: 263 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEF-FVAHSNSFSGPLPLSL 321
           N  +   +     L+ L+ L +  N            +  L    +      S     + 
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181

Query: 322 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 381
              S L  L+L   +L   I  N + L  L  LDL+ NH S   P S      L+ L + 
Sbjct: 182 EGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239

Query: 382 KNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
           ++++      +F  L SL+ ++L++N+   L     +     +L  + L  N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH--DLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  100 bits (252), Expect = 2e-22
 Identities = 66/329 (20%), Positives = 114/329 (34%), Gaps = 83/329 (25%)

Query: 86  GRVTMLILPRKGLKGI---IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 142
            + + +I  RK L+ +   I  +       +LL+L  N ++ +      +L+ LE+L LS
Sbjct: 43  NQFSKVICVRKNLREVPDGISTNT------RLLNLHENQIQIIKVNSFKHLRHLEILQLS 96

Query: 143 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 202
            N +     G   GL  + +L +  N              L    I N +F         
Sbjct: 97  RNHIRTIEIGAFNGLANLNTLELFDN-------------RLT--TIPNGAFVY------- 134

Query: 203 SASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 262
                                       LK+L + NN +      +   + SL+ + L  
Sbjct: 135 -------------------------LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGE 169

Query: 263 NNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL 321
                 +SE     L++LR+L +       ++PN L  L +L+                 
Sbjct: 170 LKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDE---------------- 211

Query: 322 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 381
                   LDL  N L+     +F GL  L  L +  +       N+  +   L  ++LA
Sbjct: 212 --------LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263

Query: 382 KNELSGQVPESFGKLTSLLFLSLSNNSFN 410
            N L+    + F  L  L  + L +N +N
Sbjct: 264 HNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 97.9 bits (244), Expect = 1e-21
 Identities = 63/294 (21%), Positives = 98/294 (33%), Gaps = 69/294 (23%)

Query: 327 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 386
             +L+L  N +      +F  L  L  L L+ NH       + +   +L  L L  N L+
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125

Query: 387 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GG 445
                +F  L+ L  L L NN    +        +  +L  L L +      I E    G
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIESIPS--YAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 446 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 505
             +L  L L  C L+  IP  L    KL  LDLS NH    I P        F       
Sbjct: 184 LSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRP------GSF------- 227

Query: 506 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLS 565
                  + L  L+ L                            +  +Q      + F +
Sbjct: 228 -------QGLMHLQKL---------------------------WMIQSQIQVIERNAFDN 253

Query: 566 NNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLH 618
                         L+ L  ++L+ NN+T  +P  + + + +LE + L  N  +
Sbjct: 254 --------------LQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 83.6 bits (207), Expect = 6e-17
 Identities = 63/327 (19%), Positives = 109/327 (33%), Gaps = 85/327 (25%)

Query: 349 SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNS 408
           +    +     +    +P+ +S   + ++L+L +N++      SF  L  L  L LS N 
Sbjct: 43  NQFSKVICVRKNLRE-VPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 409 FNHL-SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWL 467
              +  G  + L    NL TL L  N +   IP     F  L                  
Sbjct: 100 IRTIEIGAFNGL---ANLNTLELFDNRL-TTIPNGA--FVYL------------------ 135

Query: 468 LRCKKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSNNTLTGEIP----KSLTELKSLI 522
               KL+ L L  N  + +IP     ++ +L  LD         I     + L+ L+ L 
Sbjct: 136 ---SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191

Query: 523 SSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKH 582
                                                    L+   +     P +  L  
Sbjct: 192 -----------------------------------------LAMCNL--REIPNLTPLIK 208

Query: 583 LHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 642
           L  LDLS N+++   P S   + +L+ L +  + +      +F+ L  L + ++A+N+L 
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268

Query: 643 GTIPTGGQFYSFPNS---SFEGNPGLC 666
             +P    F    +        NP  C
Sbjct: 269 -LLP-HDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 19/89 (21%), Positives = 41/89 (46%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 142
           +   ++  L L    L  I P S   L  L+ L +  + ++ +      NL+ L  ++L+
Sbjct: 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263

Query: 143 HNMLSGPVSGMLAGLNLIQSLNVSSNSFN 171
           HN L+     +   L+ ++ +++  N +N
Sbjct: 264 HNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (252), Expect = 2e-23
 Identities = 45/211 (21%), Positives = 75/211 (35%), Gaps = 8/211 (3%)

Query: 205 SKEIQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 260
               Q + L  N        S +      +L  L + +N+L      +   ++ L+ + L
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRAC---RNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87

Query: 261 SVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPL 319
           S N     +       L  L  L +         P +   L  L++     N+       
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 320 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 379
           +      L  L L  N ++   +  F GL SL  L L  N  +   P++  D   L  L 
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 380 LAKNELSGQVPESFGKLTSLLFLSLSNNSFN 410
           L  N LS    E+   L +L +L L++N + 
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 48/264 (18%), Positives = 93/264 (35%), Gaps = 60/264 (22%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           +P  +      + + L  N +  V        + L +L L  N+L+              
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-------------- 69

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM-- 219
              + + +F G        + L   ++S+N+    ++   +     +  L L        
Sbjct: 70  --RIDAAAFTG-------LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120

Query: 220 --GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNL 276
             G  +GL    +L+ L++ +N L     D+   + +L H+ L  N  S  + E+    L
Sbjct: 121 GPGLFRGL---AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGL 176

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 336
            SL  L++  N+ +   P+   +L +L                          L L  N+
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLM------------------------TLYLFANN 212

Query: 337 LTG-PIDLNFSGLSSLCTLDLATN 359
           L+  P +   + L +L  L L  N
Sbjct: 213 LSALPTEA-LAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 47/207 (22%), Positives = 71/207 (34%), Gaps = 7/207 (3%)

Query: 253 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNS 312
           ++ Q + L  N  S   +       +L  L +  N  +         L  LE      N+
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 313 FSGPLPLS-LSLCSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLS 370
               +  +      +LH L L    L      L F GL++L  L L  N       ++  
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL-FRGLAALQYLYLQDNALQALPDDTFR 150

Query: 371 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 430
           D  +L  L L  N +S     +F  L SL  L L  N   H+       +    L TL L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP--HAFRDLGRLMTLYL 208

Query: 431 TKNFVGEEIPENV-GGFESLMVLALGN 456
             N +   +P        +L  L L +
Sbjct: 209 FANNL-SALPTEALAPLRALQYLRLND 234

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 42/248 (16%), Positives = 71/248 (28%), Gaps = 52/248 (20%)

Query: 438 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP-WIGQMEN 496
            +P  +    +   + L    +          C+ L +L L  N     I       +  
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLAL 81

Query: 497 LFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 552
           L  LD S+N     +       L  L +L                            L  
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLH---------------------------LDR 114

Query: 553 NQASSFPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI 601
                  P +F          L +N +   +P +    L +L  L L  N I+     + 
Sbjct: 115 CGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173

Query: 602 SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSF-- 659
             + +L+ L L  N +    P +F  L  L    +  N+L   +P            +  
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALP-TEALAPLRALQYLR 231

Query: 660 -EGNPGLC 666
              NP +C
Sbjct: 232 LNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 54/289 (18%), Positives = 87/289 (30%), Gaps = 84/289 (29%)

Query: 371 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 430
            C    + +         VP       +   + L  N  +H+    +  + C+NLT L L
Sbjct: 17  SCPQQGLQA---------VPVGI--PAASQRIFLHGNRISHVPA--ASFRACRNLTILWL 63

Query: 431 TKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP- 489
             N +   I      F  L                       L+ LDLS N    ++ P 
Sbjct: 64  HSNVL-ARIDA--AAFTGL---------------------ALLEQLDLSDNAQLRSVDPA 99

Query: 490 WIGQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYVKHNR 545
               +  L  L      L  E+     + L  L+ L                        
Sbjct: 100 TFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY----------------------- 135

Query: 546 STNGLPYNQASSFPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNIT 594
               L  N   + P   F          L  NRI+ ++P      L  L  L L +N + 
Sbjct: 136 ----LQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA 190

Query: 595 GTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQ 642
              P +  ++  L  L L +N+L  ++P  +   L  L    + +N   
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 48/212 (22%), Positives = 78/212 (36%), Gaps = 32/212 (15%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCN-HLEGVVPVELSNLKQLEVLDL 141
                +T+L L    L  I   +   L  L+ LDLS N  L  V P     L +L  L L
Sbjct: 53  RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112

Query: 142 SHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRI 201
               L     G+  GL  +Q L +  N+                  + +++F    N   
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQ---------------ALPDDTFRDLGN--- 154

Query: 202 WSASKEIQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 257
                 +  L L  N        + +GL    SL +L +  N +    P +   +  L  
Sbjct: 155 ------LTHLFLHGNRISSVPERAFRGL---HSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 258 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 289
           + L  NN S   +E ++ L +L++L +  N +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 21/74 (28%), Positives = 33/74 (44%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           +  +  R+   L+ L  L L  N +  V P    +L +L  L L  N LS   +  LA L
Sbjct: 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224

Query: 158 NLIQSLNVSSNSFN 171
             +Q L ++ N + 
Sbjct: 225 RALQYLRLNDNPWV 238

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 2e-23
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 20/229 (8%)

Query: 759 KDLTVSDLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAE 817
            ++ +S L      F    ++G G +G VYK   +  G  AA+K +    G  E E + E
Sbjct: 12  DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQE 70

Query: 818 VEALSRA-QHKNLVS-----LQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKW 870
           +  L +   H+N+ +     ++      +D+L L+  +   GS+   +  +      LK 
Sbjct: 71  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--TLKE 128

Query: 871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 930
           +    I +   RGL++LH+     ++HRD+K  N+LL E  E  L DFG+S  L      
Sbjct: 129 EWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185

Query: 931 VTTDLVGTLGYIPPEYSQTLTAT-----CRGDVYSFGVVLLELLTGRRP 974
             T  +GT  ++ PE              + D++S G+  +E+  G  P
Sbjct: 186 RNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (255), Expect = 3e-23
 Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 32/278 (11%)

Query: 720 SRRDSGCPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLL---KSTNNFNQA 776
            RR     + D           ++ L  ++    +N   + +   D L    +   F Q 
Sbjct: 36  QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK 95

Query: 777 ----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS--------GDCGQMEREFQAEVEALSR 823
               ++IG G   +V +      G + AVK +             ++    + E   L +
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 824 -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
            A H ++++L       +   L++  M  G L        +K ++ + + R  +      
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGEL---FDYLTEKVALSEKETRSIMRS-LLE 211

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
            +++LH     +IVHRD+K  NILLD+  +  L+DFG S  L P       +L GT GY+
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELCGTPGYL 266

Query: 943 PPE-YSQTLTATCRG-----DVYSFGVVLLELLTGRRP 974
            PE    ++  T  G     D+++ GV+L  LL G  P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  100 bits (251), Expect = 3e-23
 Identities = 59/311 (18%), Positives = 102/311 (32%), Gaps = 73/311 (23%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           +P  +   +    L+L  N L+ +       L QL  L LS N LS              
Sbjct: 22  VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-------------- 65

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
                S S  G        ++L   ++S N                  ++ +S       
Sbjct: 66  FKGCCSQSDFG-------TTSLKYLDLSFN-----------------GVITMS------- 94

Query: 222 LQGLDHSPSLKQLHVDNNLLGGDLPDSL-YSMSSLQHVSLSVNNFSGQLSEKISNLTSLR 280
                    L+ L   ++ L      S+  S+ +L ++ +S  +     +   + L+SL 
Sbjct: 95  -SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 153

Query: 281 HLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 340
            L + GN F                     + F+            L  LDL    L   
Sbjct: 154 VLKMAGNSFQENFL---------------PDIFTE--------LRNLTFLDLSQCQLEQL 190

Query: 341 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL-TSL 399
               F+ LSSL  L+++ N+F           + L++L  + N +     +      +SL
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 250

Query: 400 LFLSLSNNSFN 410
            FL+L+ N F 
Sbjct: 251 AFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 51/238 (21%), Positives = 82/238 (34%), Gaps = 15/238 (6%)

Query: 205 SKEIQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLL--GGDLPDSLYSMSSLQHV 258
                 L+L  N       G    L     L +L + +N L   G    S +  +SL+++
Sbjct: 27  PSSATRLELESNKLQSLPHGVFDKL---TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83

Query: 259 SLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLP-NVLGNLTQLEFFVAHSNSFSGPL 317
            LS N     +S     L  L HL    +        +V  +L  L +            
Sbjct: 84  DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 142

Query: 318 PLSLSLCSKLHVLDL-RNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 376
               +  S L VL +  N+     +   F+ L +L  LDL+        P + +    L+
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202

Query: 377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLS-GTLSVLQQCKNLTTLILTKN 433
           +L+++ N         +  L SL  L  S N         L       +L  L LT+N
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP--SSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 93.9 bits (234), Expect = 6e-21
 Identities = 55/279 (19%), Positives = 87/279 (31%), Gaps = 51/279 (18%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLE--GVVPVELSNLKQLEVLDLSHNM 145
            T L L    L+ +       L QL  L LS N L   G           L+ LDLS N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 146 LSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSAS 205
           +   +S    GL  ++ L+   ++    + E   F +L                      
Sbjct: 90  VIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL---------------------- 125

Query: 206 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 265
                                   +L  L + +             +SSL+ + ++ N+F
Sbjct: 126 -----------------------RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162

Query: 266 SGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLC 324
                  I + L +L  L +   Q     P    +L+ L+      N+F           
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222

Query: 325 SKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFS 362
           + L VLD   N +            SSL  L+L  N F+
Sbjct: 223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 61/299 (20%), Positives = 97/299 (32%), Gaps = 71/299 (23%)

Query: 374 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
               L L  N+L       F KLT L  LSLS+N  +             +L  L L+ N
Sbjct: 29  SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 434 FVGEEIPENVGGFESLMVLALGNCGLKGHIPV-WLLRCKKLQVLDLSWNHFDGNIPPWIG 492
            V   +  N  G E L  L   +  LK        L  + L  LD+S  H          
Sbjct: 89  GV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFN--- 143

Query: 493 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 552
               +F                L+ L+ L                               
Sbjct: 144 ---GIF--------------NGLSSLEVL------------------------------- 155

Query: 553 NQASSFPPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLD 611
                      ++ N       P+I  +L++L  LDLS+  +    P++ + + +L+VL+
Sbjct: 156 ----------KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205

Query: 612 LSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNS----SFEGNPGLC 666
           +S N+        ++ L  L     + NH+  T     +   FP+S    +   N   C
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSK-KQELQHFPSSLAFLNLTQNDFAC 262

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  101 bits (252), Expect = 4e-23
 Identities = 51/248 (20%), Positives = 76/248 (30%), Gaps = 58/248 (23%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           IG G +G+V  A         A+K     ++     +     + EV  + +  H N+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 833 QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG------------- 879
                      L+      G L   L+  +D  +       +K                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 880 ----------------AAR-------GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL- 915
                            +         L YLH      I HRD+K  N L        + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 916 -ADFGLSRLL---RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLL 966
             DFGLS+        + +  T   GT  ++ PE    L  T        D +S GV+L 
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE---VLNTTNESYGPKCDAWSAGVLLH 267

Query: 967 ELLTGRRP 974
            LL G  P
Sbjct: 268 LLLMGAVP 275

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  103 bits (258), Expect = 5e-23
 Identities = 73/296 (24%), Positives = 113/296 (38%), Gaps = 54/296 (18%)

Query: 766  LLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS---GDCGQMEREFQAE 817
            +  ST  F+       ++G G FG V        G + AVK +S         +     E
Sbjct: 17   VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 818  VEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIA 877
            V+ L +  H N++ L  +        L+      G L     E + +    + D   +I 
Sbjct: 77   VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAA-RII 132

Query: 878  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-AHL--ADFGLSRLLRPYDTHVTTD 934
            +    G+ Y+HK     IVHRD+K  N+LL+ K + A++   DFGLS       +    D
Sbjct: 133  RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKD 187

Query: 935  LVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
             +GT  YI PE    T    C  DV+S GV+L  LL+G  P                F  
Sbjct: 188  KIGTAYYIAPEVLHGTYDEKC--DVWSTGVILYILLSGCPP----------------FNG 229

Query: 994  KSEKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
             +E   ++ +       +   W K  +  K L+       K +   P  R    + 
Sbjct: 230  ANEYDILKKVEKGKYTFELPQWKKVSESAKDLI------RKMLTYVPSMRISARDA 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  102 bits (255), Expect = 7e-23
 Identities = 60/326 (18%), Positives = 107/326 (32%), Gaps = 77/326 (23%)

Query: 86  GRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNM 145
            + + ++  R+GL  + P+ +   +  + L+L  N+++ +      +L  LEVL L  N 
Sbjct: 54  NQFSKVVCTRRGLSEV-PQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 146 LSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSAS 205
           +     G   GL  + +L +  N              L    I + +F            
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDN-------------WLT--VIPSGAFEY---------- 145

Query: 206 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 265
                                    L++L + NN +      +   + SL  + L     
Sbjct: 146 ----------------------LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183

Query: 266 SGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLC 324
              +SE     L +L++L +                           + +          
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK------------------DMPNLTP--------L 217

Query: 325 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNE 384
             L  L++  N        +F GLSSL  L +  +  S    N+      L  L+LA N 
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277

Query: 385 LSGQVPESFGKLTSLLFLSLSNNSFN 410
           LS    + F  L  L+ L L +N +N
Sbjct: 278 LSSLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 96.7 bits (241), Expect = 4e-21
 Identities = 64/294 (21%), Positives = 96/294 (32%), Gaps = 69/294 (23%)

Query: 327 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 386
              L+L  N++       F  L  L  L L  N        + +    L  L L  N L+
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136

Query: 387 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GG 445
                +F  L+ L  L L NN    +        +  +L  L L +    E I E    G
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIESIPS--YAFNRVPSLMRLDLGELKKLEYISEGAFEG 194

Query: 446 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 505
             +L  L LG C +K  +P  L     L+ L++S NHF   I P        F       
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRP------GSF------- 238

Query: 506 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLS 565
                    L+ LK L                            +  +Q S    + F  
Sbjct: 239 -------HGLSSLKKL---------------------------WVMNSQVSLIERNAFDG 264

Query: 566 NNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLH 618
                         L  L  L+L+ NN++ ++P  + + +R L  L L  N  +
Sbjct: 265 --------------LASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 88.7 bits (220), Expect = 2e-18
 Identities = 49/231 (21%), Positives = 83/231 (35%), Gaps = 24/231 (10%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 142
            +   + +L L R  ++ I   +   L  L  L+L  N L  +       L +L  L L 
Sbjct: 96  RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155

Query: 143 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 202
           +N +    S     +  +  L            +LGE   L    IS  +F G L +   
Sbjct: 156 NNPIESIPSYAFNRVPSLMRL------------DLGELKKLE--YISEGAFEG-LFN--- 197

Query: 203 SASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 262
                ++ L+L M +    +  L     L++L +  N      P S + +SSL+ + +  
Sbjct: 198 -----LKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 263 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 313
           +  S         L SL  L +  N  S    ++   L  L     H N +
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 84.0 bits (208), Expect = 5e-17
 Identities = 59/323 (18%), Positives = 101/323 (31%), Gaps = 77/323 (23%)

Query: 349 SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNS 408
           +    +       S  +P  +    + + L+L +N +     ++F  L  L  L L  NS
Sbjct: 54  NQFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 409 FNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLL 468
              +           +L TL L  N++   IP     FE L                   
Sbjct: 111 IRQIEV--GAFNGLASLNTLELFDNWL-TVIPSGA--FEYL------------------- 146

Query: 469 RCKKLQVLDLSWNHFDGNIPP-WIGQMENLFYLDFSN-NTLTGEIPKSLTELKSLISSNC 526
              KL+ L L  N    +IP     ++ +L  LD      L      +   L +L     
Sbjct: 147 --SKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY--- 200

Query: 527 TSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVL 586
                       L                        L    I     P +  L  L  L
Sbjct: 201 ------------LN-----------------------LGMCNI--KDMPNLTPLVGLEEL 223

Query: 587 DLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 646
           ++S N+     P S   + +L+ L + ++ +      +F+ L  L + ++A+N+L  ++P
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLP 282

Query: 647 TGGQFYSFPNS---SFEGNPGLC 666
               F             NP  C
Sbjct: 283 -HDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 20/89 (22%), Positives = 35/89 (39%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 142
           +    +  L +       I P S   L+ LK L +  + +  +       L  L  L+L+
Sbjct: 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274

Query: 143 HNMLSGPVSGMLAGLNLIQSLNVSSNSFN 171
           HN LS     +   L  +  L++  N +N
Sbjct: 275 HNNLSSLPHDLFTPLRYLVELHLHHNPWN 303

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  102 bits (255), Expect = 1e-22
 Identities = 67/306 (21%), Positives = 113/306 (36%), Gaps = 64/306 (20%)

Query: 766  LLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS-------------GDC 807
            + K      ++      +G G +G V         ++ A+K +               + 
Sbjct: 27   VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 808  GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV 867
             +   E   E+  L    H N++ L           L+  + E G L     + +++   
Sbjct: 87   EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---FEQIINRHKF 143

Query: 868  LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-AHL--ADFGLSRLL 924
             + D    I +    G+ YLHK    +IVHRD+K  NILL+ K    ++   DFGLS   
Sbjct: 144  DECDAA-NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 925  RPYDTHVTTDLVGTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC 983
                 +   D +GT  YI PE   +     C  DV+S GV++  LL G  P         
Sbjct: 200  SK--DYKLRDRLGTAYYIAPEVLKKKYNEKC--DVWSCGVIMYILLCGYPP--------- 246

Query: 984  RDLVSWVFQMKSEKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRR 1034
                   F  ++++  ++ +       D + W    D  K+L+         +  D  +R
Sbjct: 247  -------FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELI------KLMLTYDYNKR 293

Query: 1035 PFIEEV 1040
               EE 
Sbjct: 294  CTAEEA 299

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  100 bits (249), Expect = 1e-22
 Identities = 40/256 (15%), Positives = 76/256 (29%), Gaps = 23/256 (8%)

Query: 739 QRLSEALASSKLVLFQNSDCKDLTV-SDLLKSTNNFNQANIIGCGGFGLVYKAT------ 791
             LS+ ++S             +   ++    +      +++G G F  VY+AT      
Sbjct: 32  SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91

Query: 792 LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN 851
             N  K  +K                +E L  +     +         N  +L+      
Sbjct: 92  AKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151

Query: 852 GSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEK 910
           G+L +         + V+   + +  A      +  +H      I+H D+K  N +L   
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNG 208

Query: 911 FEAH-----------LADFGLSRLLRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDV 958
           F              L D G S  ++ +      T    T G+   E         + D 
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268

Query: 959 YSFGVVLLELLTGRRP 974
           +     +  +L G   
Sbjct: 269 FGVAATVYCMLFGTYM 284

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 53/281 (18%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G G FG V+     ++G +  +K     R      Q+E E    +E L    H N++ +
Sbjct: 30   LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE----IEVLKSLDHPNIIKI 85

Query: 833  QGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
                   ++  ++    E G L +  +       ++ +  V   + Q     LAY H   
Sbjct: 86   FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ-MMNALAYFHSQ- 143

Query: 892  EPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YS 947
              H+VH+D+K  NIL  +        + DFGL+ L +      +T+  GT  Y+ PE + 
Sbjct: 144  --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYMAPEVFK 199

Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
            + +T  C  D++S GVV+  LLTG  P                F   S +   +      
Sbjct: 200  RDVTFKC--DIWSAGVVMYFLLTGCLP----------------FTGTSLEEVQQKATYKE 241

Query: 1008 WHKDRE--------KQLLEMLEIACKCIDQDPRRRPFIEEV 1040
             +   E          LL       + + +DP RRP   +V
Sbjct: 242  PNYAVECRPLTPQAVDLL------KQMLTKDPERRPSAAQV 276

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 22/231 (9%)

Query: 754 QNSDCKDLTVSDLLKSTN---NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ 809
           +    KD  V++L    +    F+    IG G FG VY A  + N    A+K++S    Q
Sbjct: 34  RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93

Query: 810 MEREF---QAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS 866
              ++     EV  L + +H N +  +G     +   L+  Y    + D  L E   K  
Sbjct: 94  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK-- 149

Query: 867 VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP 926
            L+      +  GA +GLAYLH     +++HRDVK+ NILL E     L DFG + ++ P
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206

Query: 927 YDTHVTTDLVGTLGYIPPE---YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            ++      VGT  ++ PE            + DV+S G+  +EL   + P
Sbjct: 207 ANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.9 bits (247), Expect = 3e-22
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 24/228 (10%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKA--AVKRLS-GDCGQME--REFQAEVEALSRAQ 825
           ++F     IG G FG V      N TK   A+K ++   C +    R    E++ +   +
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQK-NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 826 HKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQGAAR 882
           H  LV+L  Y     + + ++   +  G L Y L ++V   ++      V+L I +    
Sbjct: 74  HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-----TVKLFICE-LVM 126

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
            L YL       I+HRD+K  NILLDE    H+ DF ++ +L       T  + GT  Y+
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181

Query: 943 PPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 987
            PE   +          D +S GV   ELL GRRP  +    + +++V
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.4 bits (248), Expect = 7e-22
 Identities = 73/294 (24%), Positives = 110/294 (37%), Gaps = 53/294 (18%)

Query: 767  LKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGD--CGQMEREFQAEVE 819
            L     F +      ++G G FG V K        + AVK ++      +       EVE
Sbjct: 14   LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73

Query: 820  ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
             L +  H N++ L       +   ++      G L     E + +    + D   +I + 
Sbjct: 74   LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAA-RIIKQ 129

Query: 880  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE-AHL--ADFGLSRLLRPYDTHVTTDLV 936
               G+ Y+HK    +IVHRD+K  NILL+ K +   +   DFGLS   +        D +
Sbjct: 130  VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI 184

Query: 937  GTLGYIPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS 995
            GT  YI PE    T    C  DV+S GV+L  LL+G  P                F  K+
Sbjct: 185  GTAYYIAPEVLRGTYDEKC--DVWSAGVILYILLSGTPP----------------FYGKN 226

Query: 996  EKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            E   ++ +       D   W    D  K L+       K +   P  R    + 
Sbjct: 227  EYDILKRVETGKYAFDLPQWRTISDDAKDLI------RKMLTFHPSLRITATQC 274

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 8e-22
 Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 61/290 (21%)

Query: 769  STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
              + F    ++G GGFG V+    KAT   G   A K+L+    +  + +Q    E + L
Sbjct: 183  GEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239

Query: 822  SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQG 879
            ++   + +VSL  Y       L L+ + M  G + Y ++   + +   +        AQ 
Sbjct: 240  AKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ- 297

Query: 880  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
               GL +LH+    +I++RD+K  N+LLD+     ++D GL+  L+   T       GT 
Sbjct: 298  IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTP 353

Query: 940  GYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
            G++ PE      Y  ++      D ++ GV L E++  R P                F+ 
Sbjct: 354  GFMAPELLLGEEYDFSV------DYFALGVTLYEMIAARGP----------------FRA 391

Query: 994  KSEKREVEIIDASIWHKDRE---------KQLLEMLEIACKCIDQDPRRR 1034
            + EK E + +   +  +            K   E L      + +DP +R
Sbjct: 392  RGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL------LQKDPEKR 435

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 96.5 bits (241), Expect = 9e-22
 Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 48/230 (20%)

Query: 767 LKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE----FQA--EVE 819
           + S++ F Q   +G G +  VYK    T G   A+K +     +++ E      A  E+ 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIREIS 55

Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
            +   +H+N+V L       N   L++ +M+    D  L + +D  +V      L++   
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFMD---ND--LKKYMDSRTVGNTPRGLELNLV 110

Query: 880 AA------RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDT 929
                   +GLA+ H+     I+HRD+K  N+L++++ +  L DFGL+R     +  + +
Sbjct: 111 KYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-S 166

Query: 930 HVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
                 V TL Y  P+       YS   T+    D++S G +L E++TG+
Sbjct: 167 S----EVVTLWYRAPDVLMGSRTYS---TSI---DIWSCGCILAEMITGK 206

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.6 bits (241), Expect = 1e-21
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 32/214 (14%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMERE-FQAEVEALSRAQHKNLV 830
            +G G F +V K    + G + A K     +       + RE  + EV  L +  H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
           +L     +  D +LI   +  G L         K+S+ + +    I Q    G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL---FDFLAQKESLSEEEATSFIKQ-ILDGVNYLHTK 134

Query: 891 CEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE- 945
               I H D+K  NI+L +K        L DFGL+  +         ++ GT  ++ PE 
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAPEI 189

Query: 946 -----YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                           D++S GV+   LL+G  P
Sbjct: 190 VNYEPLG---LEA---DMWSIGVITYILLSGASP 217

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-----FQA--EVEALS 822
             + +   IG G +G V+KA         A+KR+     +++ +       A  E+  L 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLK 56

Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
             +HKN+V L           L++ + +   L  +         +    V+  + Q   +
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQ-LLK 112

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGT 938
           GL + H     +++HRD+K  N+L++   E  LA+FGL+R     +R Y +      V T
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SA----EVVT 164

Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           L Y PP+       YS ++      D++S G +  EL    RP
Sbjct: 165 LWYRPPDVLFGAKLYSTSI------DMWSAGCIFAELANAGRP 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.2 bits (245), Expect = 1e-21
 Identities = 59/239 (24%), Positives = 93/239 (38%), Gaps = 37/239 (15%)

Query: 759 KDLTVSDLLKSTNNFNQ----ANIIGCGGFGLVYKAT-LTNGTKAAVKRLS--------G 805
            DLTV D              +  +G G  G V  A       K A++ +S         
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178

Query: 806 DCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDK 864
                    + E+E L +  H  ++ ++ +     D  ++   ME G L D      V  
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDK----VVGN 233

Query: 865 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLS 921
             + +   +L   Q     + YLH+     I+HRD+K  N+LL  + E     + DFG S
Sbjct: 234 KRLKEATCKLYFYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289

Query: 922 RLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG------DVYSFGVVLLELLTGRRP 974
           ++L   +T +   L GT  Y+ PE    L +          D +S GV+L   L+G  P
Sbjct: 290 KILG--ETSLMRTLCGTPTYLAPE---VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.5 bits (240), Expect = 1e-21
 Identities = 45/290 (15%), Positives = 87/290 (30%), Gaps = 38/290 (13%)

Query: 766  LLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
             L    +                K              +           A    + R  
Sbjct: 57   ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116

Query: 826  HKNLVSLQGYCRHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
              +  +  G  +  + ++ +Y  M+     +L  W++     +   +  V L I    A 
Sbjct: 117  PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED-REHGVCLHIFIQIAE 175

Query: 883  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL-----------RPYDTHV 931
             + +LH      ++HRD+K SNI         + DFGL   +                  
Sbjct: 176  AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232

Query: 932  TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 991
             T  VGT  Y+ PE       + + D++S G++L ELL                     F
Sbjct: 233  HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-------------------F 273

Query: 992  QMKSEKREV-EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
              + E+  +   +    +     ++  +   +    +   P  RP   ++
Sbjct: 274  STQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 32/213 (15%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMERE-FQAEVEALSRAQHKNLVS 831
           +G G F +V K      G + A K     RLS     + RE  + EV  L   +H N+++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L     +  D +LI   +  G L        +K+S+ + +    + Q    G+ YLH   
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL---FDFLAEKESLTEDEATQFLKQ-ILDGVHYLHSK- 127

Query: 892 EPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 945
              I H D+K  NI+L +K   +    L DFG++  +     +   ++ GT  ++ PE  
Sbjct: 128 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTPEFVAPEIV 183

Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                          D++S GV+   LL+G  P
Sbjct: 184 NYEPLG---LEA---DMWSIGVITYILLSGASP 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 96.2 bits (240), Expect = 2e-21
 Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 27/213 (12%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVS 831
           +IG G F +V +      G + AVK     + +   G    + + E       +H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW----DVRLKIAQGAARGLAYL 887
           L           +++ +M+   L     E V +               + Q     L Y 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQ-ILEALRYC 146

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           H   + +I+HRDVK   +LL  K  +    L  FG++  L      V    VGT  ++ P
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTPHFMAP 202

Query: 945 EYSQTLTATCRG---DVYSFGVVLLELLTGRRP 974
           E    +     G   DV+  GV+L  LL+G  P
Sbjct: 203 E---VVKREPYGKPVDVWGCGVILFILLSGCLP 232

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 95.3 bits (238), Expect = 2e-21
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 41/220 (18%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-----FQA--EVEALSR 823
             + +   +G G +G+VYKA  + G   A+KR+     +++ E       A  E+  L  
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-----RLDAEDEGIPSTAIREISLLKE 75

Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
             H N+VSL           L++ +ME   L   L E+  K  +    +++ + Q   RG
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQ-LLRG 131

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTL 939
           +A+ H+     I+HRD+K  N+L++      LADFGL+R     +R Y TH     V TL
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-TH----EVVTL 183

Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  P+       YS ++      D++S G +  E++TG+
Sbjct: 184 WYRAPDVLMGSKKYSTSV------DIWSIGCIFAEMITGK 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 60/295 (20%), Positives = 100/295 (33%), Gaps = 59/295 (20%)

Query: 768  KSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALS 822
             +  + NQ     N IG G +G V  A       + A K++     +    F+ E+E + 
Sbjct: 2    STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 823  RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
               H N++ L        D  L+      G L       V K    + D    +      
Sbjct: 62   SLDHPNIIRLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESDAARIMKD-VLS 117

Query: 883  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTL 939
             +AY HK+   ++ HRD+K  N L           L DFGL+   +P    +    VGT 
Sbjct: 118  AVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTP 172

Query: 940  GYIPPE-----YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
             Y+ P+     Y          D +S GV++  LL G  P                F   
Sbjct: 173  YYVSPQVLEGLYGP------ECDEWSAGVMMYVLLCGYPP----------------FSAP 210

Query: 995  SEKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            ++   +  I           W     + + L+       + + + P++R    + 
Sbjct: 211  TDSEVMLKIREGTFTFPEKDWLNVSPQAESLI------RRLLTKSPKQRITSLQA 259

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 96.3 bits (240), Expect = 3e-21
 Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 31/209 (14%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG+V++      G     K ++      +   + E+  +++  H  L++L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 838 HGNDRLLIYSYMENGSL-------DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
              + +LI  ++  G L       DY + E+         +V   + Q A  GL ++H+ 
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEA---------EVINYMRQ-ACEGLKHMHEH 168

Query: 891 CEPHIVHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE--- 945
               IVH D+K  NI+ + K  + +   DFGL+  L P    +      T  +  PE   
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVD 223

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                  T   D+++ GV+   LL+G  P
Sbjct: 224 REPVGFYT---DMWAIGVLGYVLLSGLSP 249

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 43/207 (20%), Positives = 85/207 (41%), Gaps = 28/207 (13%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSLQGYC 836
           +G G FG+V++    ++      K +       ++   + E+  L+ A+H+N++ L    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 837 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQGAARGLAYLHKVCEPHI 895
               + ++I+ ++    +             L   ++   + Q     L +LH     +I
Sbjct: 71  ESMEELVMIFEFISGLDI---FERINTSAFELNEREIVSYVHQ-VCEALQFLHSH---NI 123

Query: 896 VHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE------YS 947
            H D++  NI+   +  + +   +FG +R L+P        L     Y  PE       S
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 948 QTLTATCRGDVYSFGVVLLELLTGRRP 974
              TAT   D++S G ++  LL+G  P
Sbjct: 182 ---TAT---DMWSLGTLVYVLLSGINP 202

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 54/253 (21%), Positives = 87/253 (34%), Gaps = 49/253 (19%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLS----------GDCGQMEREFQAEVEALSRAQHK 827
           +G GGFG V+    LT+  + A+K +            D      E     +  +   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 828 NLVSLQGYCRHGNDRLLIYSYMENGS--LDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            ++ L  +       +L+           DY     + +   L               + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDY-----ITEKGPLGEGPSRCFFGQVVAAIQ 153

Query: 886 YLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           + H      +VHRD+K  NIL+D  +  A L DFG   LL   D   T    GT  Y PP
Sbjct: 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTD-FDGTRVYSPP 207

Query: 945 EYSQTLTATCRG------DVYSFGVVLLELLTGRRPVE----VCKGK---------NCRD 985
           E+                 V+S G++L +++ G  P E    + + +         +C  
Sbjct: 208 EWISR-----HQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA 262

Query: 986 LVSWVFQMKSEKR 998
           L+      K   R
Sbjct: 263 LIRRCLAPKPSSR 275

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.5 bits (238), Expect = 5e-21
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 772 NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
             ++  I+G G FG V+K      G K A K +     + + E + E+  +++  H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 831 SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQGAARGLAYLHK 889
            L       ND +L+  Y++ G L       +D+   L   D  L + Q    G+ ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL---FDRIIDESYNLTELDTILFMKQ-ICEGIRHMHQ 205

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 945
           +   +I+H D+K  NIL   +    +   DFGL+R  +P          GT  ++ PE  
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVNFGTPEFLAPEVV 260

Query: 946 -YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            Y      T   D++S GV+   LL+G  P
Sbjct: 261 NYDFVSFPT---DMWSVGVIAYMLLSGLSP 287

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 93.6 bits (233), Expect = 7e-21
 Identities = 58/290 (20%), Positives = 106/290 (36%), Gaps = 46/290 (15%)

Query: 249 LYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 308
             ++++   ++   +N +   +   ++L  +  L  FG   +  +   +  L  L     
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70

Query: 309 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATNHFSGPLPN 367
             N  +   PL     +K+  L+L  N L    ++   +GL S+ TLDL +   +     
Sbjct: 71  KDNQITDLAPLKN--LTKITELELSGNPLK---NVSAIAGLQSIKTLDLTSTQITDV--T 123

Query: 368 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 427
            L+   +L++L L  N+++         LT+L +LS+ N   + L+     L     LTT
Sbjct: 124 PLAGLSNLQVLYLDLNQIT--NISPLAGLTNLQYLSIGNAQVSDLTP----LANLSKLTT 177

Query: 428 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNI 487
           L    N +      ++    SL                       L  + L  N    ++
Sbjct: 178 LKADDNKI-----SDISPLASL---------------------PNLIEVHLKNNQIS-DV 210

Query: 488 PPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGI 537
            P +    NLF +  +N T+T +       L         S  P A A I
Sbjct: 211 SP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATI 259

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 54/286 (18%), Positives = 109/286 (38%), Gaps = 33/286 (11%)

Query: 92  ILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVS 151
           I     +  I P     L     +    +++   V    ++L  +  L      ++  + 
Sbjct: 3   ITQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE 57

Query: 152 GMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFT-----GKLNSRIWSASK 206
           G +  LN +  L +  N     L  L   + +    +S N          L        +
Sbjct: 58  G-VQYLNNLIGLELKDNQIT-DLAPLKNLTKITELELSGNPLKNVSAIAGL--------Q 107

Query: 207 EIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFS 266
            I+ LDL+    +  +  L    +L+ L++D N +  ++   L  +++LQ++S+     S
Sbjct: 108 SIKTLDLTSTQ-ITDVTPLAGLSNLQVLYLDLNQI-TNIS-PLAGLTNLQYLSIGNAQVS 164

Query: 267 GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSK 326
                 ++NL+ L  L    N+ S  +   L +L  L      +N  S   P  L+  S 
Sbjct: 165 D--LTPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSN 218

Query: 327 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPL-PNSLSD 371
           L ++ L N ++T   +      ++L   ++       P+ P ++SD
Sbjct: 219 LFIVTLTNQTIT---NQPVFYNNNLVVPNVVKGPSGAPIAPATISD 261

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 43/275 (15%), Positives = 87/275 (31%), Gaps = 60/275 (21%)

Query: 369 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 428
                +   ++  K+ ++     +   L  +  LS        + G    +Q   NL  L
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG----VQYLNNLIGL 68

Query: 429 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 488
            L  N +  ++   +     +  L L    LK      +   + ++ LDL+      ++ 
Sbjct: 69  ELKDNQI-TDL-APLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQI-TDVT 123

Query: 489 PWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRST 547
           P +  + NL  L    N +T   P   LT L+ L                          
Sbjct: 124 P-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYL-------------------------- 156

Query: 548 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNL 607
                           + N +++  + P +  L  L  L    N I+    S ++ + NL
Sbjct: 157 ---------------SIGNAQVS-DLTP-LANLSKLTTLKADDNKISDI--SPLASLPNL 197

Query: 608 EVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 642
             + L +N +   +       + L   ++ N  + 
Sbjct: 198 IEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTIT 230

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 48/296 (16%), Positives = 97/296 (32%), Gaps = 63/296 (21%)

Query: 321 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 380
               +    +    +++T  +    + L  + TL       +  +   +   ++L  L L
Sbjct: 15  DPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLEL 70

Query: 381 AKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIP 440
             N+++         LT +  L LS N   ++S     +   +++ TL LT   + +   
Sbjct: 71  KDNQIT--DLAPLKNLTKITELELSGNPLKNVSA----IAGLQSIKTLDLTSTQITD--V 122

Query: 441 ENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 500
             + G  +L VL L    +  +I   L     LQ L +       ++ P +  +  L  L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178

Query: 501 DFSNNTLTG-EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFP 559
              +N ++      SL  L  +                                      
Sbjct: 179 KADDNKISDISPLASLPNLIEV-------------------------------------- 200

Query: 560 PSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 615
               L NN+I+  + P +    +L ++ L+   IT      +    NL V ++   
Sbjct: 201 ---HLKNNQIS-DVSP-LANTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKG 248

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 37/239 (15%), Positives = 74/239 (30%), Gaps = 58/239 (24%)

Query: 404 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHI 463
               + N +           N   +   K+ V +         + +  L+    G+   I
Sbjct: 4   TQPTAINVIFP----DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI 56

Query: 464 PVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG-EIPKSLTELKSLI 522
              +     L  L+L  N    ++ P +  +  +  L+ S N L        L  +K+L 
Sbjct: 57  EG-VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTL- 112

Query: 523 SSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKH 582
                                                    L++ +I   + P +  L +
Sbjct: 113 ----------------------------------------DLTSTQIT-DVTP-LAGLSN 130

Query: 583 LHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 641
           L VL L  N IT    S ++ + NL+ L + +  +   +      L+ L+     +N +
Sbjct: 131 LQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKI 185

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 93.9 bits (234), Expect = 7e-21
 Identities = 58/251 (23%), Positives = 102/251 (40%), Gaps = 47/251 (18%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQA--EVEALSRAQHK--NL 829
           +G GGFG VY    +++    A+K +      D G++    +   EV  L +       +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 830 VSLQGYCRHGNDRLLIYSYMEN-GSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           + L  +    +  +LI    E    L D+     + +   L+ ++           + + 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDF-----ITERGALQEELARSFFWQVLEAVRHC 165

Query: 888 HKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
           H      ++HRD+K  NIL+D  + E  L DFG   LL+  DT  T    GT  Y PPE+
Sbjct: 166 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTD-FDGTRVYSPPEW 219

Query: 947 SQTLTATCRG------DVYSFGVVLLELLTGRRP----VEVCKGK---------NCRDLV 987
            +               V+S G++L +++ G  P     E+ +G+          C+ L+
Sbjct: 220 IR-----YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274

Query: 988 SWVFQMKSEKR 998
            W   ++   R
Sbjct: 275 RWCLALRPSDR 285

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 94.7 bits (236), Expect = 7e-21
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 45/230 (19%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
           K  + F    + G G FG V        G   A+K++  D     RE Q  ++ L+   H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH 78

Query: 827 KNLVSLQGYCRHGNDR-------LLIYSYMENGSLDYWLHESVDKDSVLKWD-----VRL 874
            N+V LQ Y     +R        ++  Y+        LH         +       +++
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DT--LHRCCRNYYRRQVAPPPILIKV 133

Query: 875 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-----KFEAHLADFGLSRLLRPYDT 929
            + Q   R +  LH     ++ HRD+K  N+L++E     K    L DFG ++ L P + 
Sbjct: 134 FLFQ-LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK----LCDFGSAKKLSPSEP 187

Query: 930 HVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           +     + +  Y  PE       Y+  +      D++S G +  E++ G 
Sbjct: 188 N--VAYICSRYYRAPELIFGNQHYTTAV------DIWSVGCIFAEMMLGE 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.2 bits (235), Expect = 7e-21
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 46/223 (20%)

Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-----FQA--EVEALS 822
             +    ++G G +G+V K      G   A+K+          +       A  E++ L 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMREIKLLK 79

Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVD--KDSVLKWDVRLKIAQGA 880
           + +H+NLV+L   C+      L++ ++++      + + ++   + +    V+  + Q  
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDH---T--ILDDLELFPNGLDYQVVQKYLFQ-I 133

Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL----RPYDTHVTTDLV 936
             G+ + H     +I+HRD+K  NIL+ +     L DFG +R L      Y      D V
Sbjct: 134 INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-----DDEV 185

Query: 937 GTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            T  Y  PE       Y     A    DV++ G ++ E+  G 
Sbjct: 186 ATRWYRAPELLVGDVKYG---KAV---DVWAIGCLVTEMFMGE 222

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.4 bits (232), Expect = 8e-21
 Identities = 60/304 (19%), Positives = 101/304 (33%), Gaps = 45/304 (14%)

Query: 124 GVVPVEL-SNLKQLEVLDLSHNMLSGPV--SGMLAGLNLIQSLNVSSNSFNGSLF----E 176
           G   VEL    + LE L    +  +     + ++  L+L + L V +      +      
Sbjct: 32  GAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSL-KRLTVRAARIPSRILFGALR 90

Query: 177 LGEFSNLAVFNISNNSFTGKLNSRIWSAS-KEIQILDLSMNHFMGSLQGLDH-----SPS 230
           +   S L    + N   TG     +  A+  ++ IL+L    +      L        P 
Sbjct: 91  VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150

Query: 231 LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKIS----NLTSLRHLIIFG 286
           LK L +          + +    +L  + LS N   G+     +       +L+ L +  
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210

Query: 287 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG-PIDLNF 345
                                    + SG      +   +L  LDL +NSL       + 
Sbjct: 211 AGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249

Query: 346 SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLS 405
              S L +L+L+       +P  L     L +L L+ N L    P S  +L  +  LSL 
Sbjct: 250 DWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLK 304

Query: 406 NNSF 409
            N F
Sbjct: 305 GNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 92.3 bits (229), Expect = 3e-20
 Identities = 64/340 (18%), Positives = 100/340 (29%), Gaps = 64/340 (18%)

Query: 299 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLAT 358
           +  + ++  A +   +  + L     S  ++L   +         +     SL  L +  
Sbjct: 18  SDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRA 77

Query: 359 NHFSGPLPNSLSDCHD---LKILSLAKNELSGQVPESFGKLT--SLLFLSLSNNSFNHLS 413
                 +            L+ L+L   E++G  P    + T   L  L+L N S+    
Sbjct: 78  ARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRD 137

Query: 414 GTLSVLQQC--KNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRC- 470
             L+ LQQ     L  L + +        E V  F +L  L L +    G   +    C 
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197

Query: 471 ---KKLQVLDLSWNHF---DGNIPPWIGQMENLFYLDFSNNTLTGEIPKS----LTELKS 520
                LQVL L         G           L  LD S+N+L            ++L S
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257

Query: 521 LISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQL 580
           L                                          LS   +   +P  +   
Sbjct: 258 LN-----------------------------------------LSFTGLK-QVPKGLPA- 274

Query: 581 KHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 620
             L VLDLS N +      S  E+  +  L L  N    S
Sbjct: 275 -KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 87.6 bits (217), Expect = 8e-19
 Identities = 60/304 (19%), Positives = 100/304 (32%), Gaps = 47/304 (15%)

Query: 222 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE---KISNLTS 278
           L G   S       VD     G   D + S+S L+ +++       ++     ++  ++ 
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLS-LKRLTVRAARIPSRILFGALRVLGISG 96

Query: 279 LRHLIIFGNQFSGKLPNVLGNLT--QLEFFVAHSNSFSGPLPLSLSLCSKLH----VLDL 332
           L+ L +   + +G  P  L   T   L      + S++        L   L     VL +
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156

Query: 333 RNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC----HDLKILSLAKNE---L 385
                            +L TLDL+ N   G      + C      L++L+L        
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216

Query: 386 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG 445
           SG           L  L LS+NS    +G  S       L +L L+   + +++P+ +  
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPS-CDWPSQLNSLNLSFTGL-KQVPKGLP- 273

Query: 446 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 505
                                     KL VLDLS+N  D N  P   ++  +  L    N
Sbjct: 274 -------------------------AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGN 306

Query: 506 TLTG 509
               
Sbjct: 307 PFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.1 bits (213), Expect = 3e-18
 Identities = 44/249 (17%), Positives = 78/249 (31%), Gaps = 24/249 (9%)

Query: 109 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG--PVSGMLAGLNLIQSLNVS 166
           L +L +             + +  +  L+ L L +  ++G  P   + A    +  LN+ 
Sbjct: 70  LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129

Query: 167 SNSFNGSLFELGEFSN-----LAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
           + S+      L E        L V +I+        +         +  LDLS N  +G 
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN-FSCEQVRVFPALSTLDLSDNPELGE 188

Query: 222 LQGLDHS------PSLKQLHVDNNL---LGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEK 272
             GL  +      P+L+ L + N       G       +   LQ + LS N+        
Sbjct: 189 R-GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247

Query: 273 I-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLD 331
                + L  L +           +   L+ L+      N      P    L  ++  L 
Sbjct: 248 SCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDL---SYNRLDR-NPSPDEL-PQVGNLS 302

Query: 332 LRNNSLTGP 340
           L+ N     
Sbjct: 303 LKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 46/217 (21%), Positives = 71/217 (32%), Gaps = 28/217 (12%)

Query: 447 ESLMVLALGNCGLKGHIPVWLLR---CKKLQVLDLSWNHFDGNIPPWIGQ--MENLFYLD 501
            SL  L +    +   I    LR      LQ L L      G  PP + +    +L  L+
Sbjct: 68  LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127

Query: 502 FSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPS 561
             N +        L EL+  +                L +    S N     Q   FP  
Sbjct: 128 LRNVSWAT-RDAWLAELQQWLKPGLKV----------LSIAQAHSLN-FSCEQVRVFPAL 175

Query: 562 VFL--SNNRINGTIPPEI----GQLKHLHVLDLSRNNIT---GTIPSSISEIRNLEVLDL 612
             L  S+N   G           +   L VL L    +    G   +  +    L+ LDL
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235

Query: 613 SSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIPTG 648
           S N L  +    S +  + L+  +++   L+  +P G
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 34/164 (20%), Positives = 56/164 (34%), Gaps = 14/164 (8%)

Query: 87  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG-------VVPVELSNLKQLEVL 139
            + +L + +          +     L  LDLS N   G       + P++   L+ L + 
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209

Query: 140 DLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELG--EFSNLAVFNISNNSFTGKL 197
           +      SG  S + A    +Q L++S NS   +         S L   N+S       L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT----GL 265

Query: 198 NSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLL 241
                    ++ +LDLS N         D  P +  L +  N  
Sbjct: 266 KQVPKGLPAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 24/99 (24%), Positives = 34/99 (34%), Gaps = 5/99 (5%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVEL-SNLKQLEVLDLSHNMLSGPVSGMLAG 156
             G+         QL+ LDLS N L             QL  L+LS   L     G+ A 
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK 275

Query: 157 LNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTG 195
           L     L++S N  +       E   +   ++  N F  
Sbjct: 276 L---SVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLD 310

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.3 bits (235), Expect = 8e-21
 Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 60/302 (19%)

Query: 763  VSDLLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAE 817
            V  L +++  F         IG G + +  +        + AVK +     + +R+   E
Sbjct: 10   VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEE 65

Query: 818  VEALSR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
            +E L R  QH N+++L+     G    ++   M+ G L   L + + +    + +    +
Sbjct: 66   IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---LDKILRQKFFSEREAS-AV 121

Query: 877  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVT 932
                 + + YLH      +VHRD+K SNIL  ++        + DFG ++ LR  +  + 
Sbjct: 122  LFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLL 177

Query: 933  TDLVGTLGYIPPE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWV 990
                 T  ++ PE    Q   A C  D++S GV+L  +LTG  P                
Sbjct: 178  MTPCYTANFVAPEVLERQGYDAAC--DIWSLGVLLYTMLTGYTP---------------- 219

Query: 991  FQMKSEKREVEIIDA----------SIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIE 1038
            F    +    EI+              W+   D  K L+       K +  DP +R    
Sbjct: 220  FANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLV------SKMLHVDPHQRLTAA 273

Query: 1039 EV 1040
             V
Sbjct: 274  LV 275

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 25/218 (11%)

Query: 770 TNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRL--SGDCGQMEREFQAEVEALS 822
           +  F+        +G G F +V +    T G + A K +       +  ++ + E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           + QH N+V L    +  +   L++  +  G L     + V ++   + D    I Q    
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQ-ILE 116

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTL 939
            +AY H      IVHR++K  N+LL  K +     LADFGL+  +    +       GT 
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTP 171

Query: 940 GYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRP 974
           GY+ PE    L         D+++ GV+L  LL G  P
Sbjct: 172 GYLSPE---VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 60/245 (24%), Positives = 93/245 (37%), Gaps = 36/245 (14%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
           IG G F  V  A  +  G + A+K   +   +   +++ F+ EV  +    H N+V L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81

Query: 835 YCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
                    LI  Y   G + DY +         +K        +     + Y H+    
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLV-----AHGRMKEKEARSKFRQIVSAVQYCHQK--- 133

Query: 894 HIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQTLTA 952
            IVHRD+K+ N+LLD      +ADFG S         +     G   Y  PE +      
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDA-FCGAPPYAAPELFQGKKYD 191

Query: 953 TCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDLVSWVFQM 993
               DV+S GV+L  L++G  P +          V +GK         +C +L+     +
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251

Query: 994 KSEKR 998
              KR
Sbjct: 252 NPIKR 256

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 50/230 (21%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-----FQA--EVE 819
            S + + +   +G G +G VYKA         A+KR+     ++E E       A  EV 
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIREVS 85

Query: 820 ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQ 878
            L   QH+N++ L+    H +   LI+ Y E    D  L + +DK+  +    ++  + Q
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAE---ND--LKKYMDKNPDVSMRVIKSFLYQ 140

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH-----LADFGLSRL----LRPYDT 929
               G+ + H       +HRD+K  N+LL     +      + DFGL+R     +R +  
Sbjct: 141 -LINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-- 194

Query: 930 HVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
              T  + TL Y PPE       YS ++      D++S   +  E+L   
Sbjct: 195 ---THEIITLWYRPPEILLGSRHYSTSV------DIWSIACIWAEMLMKT 235

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 62/299 (20%), Positives = 107/299 (35%), Gaps = 47/299 (15%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 835
            ++G G    V     L    + AVK +    G +      EVE L + Q H+N++ L  +
Sbjct: 20   VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                +   L++  M  GS+   L     +    + +    + Q  A  L +LH      I
Sbjct: 80   FEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEAS-VVVQDVASALDFLH---NKGI 132

Query: 896  VHRDVKSSNILLDEKFEAH---LADFGLSRLLRP------YDTHVTTDLVGTLGYIPPEY 946
             HRD+K  NIL +   +     + DF L   ++         T       G+  Y+ PE 
Sbjct: 133  AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192

Query: 947  SQTLTATCRG-----DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
             +  +          D++S GV+L  LL+G  P        C     W         +  
Sbjct: 193  VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV----GRCGSDCGWDRGEACPACQNM 248

Query: 1002 IIDA----------SIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046
            + ++            W       K L+       K + +D ++R    +V+   W+ G
Sbjct: 249  LFESIQEGKYEFPDKDWAHISCAAKDLI------SKLLVRDAKQRLSAAQVLQHPWVQG 301

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.4 bits (240), Expect = 1e-20
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 25/206 (12%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
           +G G FG+V++ T    G   A K +       +   + E++ +S  +H  LV+L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 838 HGNDRLLIYSYMENGSLDYWLHESVDKDSVLK-WDVRLKIAQGAARGLAYLHKVCEPHIV 896
             N+ ++IY +M  G L     +  D+ + +   +    + Q   +GL ++H+    + V
Sbjct: 225 DDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQ-VCKGLCHMHEN---NYV 277

Query: 897 HRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE------YSQ 948
           H D+K  NI+   K    L   DFGL+  L P          GT  +  PE         
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEGKPVG- 334

Query: 949 TLTATCRGDVYSFGVVLLELLTGRRP 974
               T   D++S GV+   LL+G  P
Sbjct: 335 --YYT---DMWSVGVLSYILLSGLSP 355

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 66/287 (22%), Positives = 114/287 (39%), Gaps = 53/287 (18%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            ++G G F  V+       G   A+K +       +   + E+  L + +H+N+V+L+   
Sbjct: 16   VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 837  RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
                   L+   +  G L       +++    + D  L I Q     + YLH+     IV
Sbjct: 76   ESTTHYYLVMQLVSGGEL---FDRILERGVYTEKDASLVIQQ-VLSAVKYLHEN---GIV 128

Query: 897  HRDVKSSNILLDEKFE-AHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTAT 953
            HRD+K  N+L     E + +   DFGLS++ +     + +   GT GY+ PE    L   
Sbjct: 129  HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEV---LAQK 182

Query: 954  CRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII------- 1003
                  D +S GV+   LL G  P                F  ++E +  E I       
Sbjct: 183  PYSKAVDCWSIGVITYILLCGYPP----------------FYEETESKLFEKIKEGYYEF 226

Query: 1004 DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046
            ++  W    +  K  +      C  +++DP  R   E+ ++  W+DG
Sbjct: 227  ESPFWDDISESAKDFI------CHLLEKDPNERYTCEKALSHPWIDG 267

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 32/213 (15%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMERE-FQAEVEALSRAQHKNLVS 831
           +G G F +V K    + G + A K     +       + RE  + EV  L +  H N+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 832 LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
           L     +  D +LI   +  G L         K+S+ + +    I Q    G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL---FDFLAQKESLSEEEATSFIKQ-ILDGVNYLHTK- 134

Query: 892 EPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 945
              I H D+K  NI+L +K        L DFGL+  +         ++ GT  ++ PE  
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAPEIV 190

Query: 946 ----YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                          D++S GV+   LL+G  P
Sbjct: 191 NYEPLG---LEA---DMWSIGVITYILLSGASP 217

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 93.4 bits (233), Expect = 1e-20
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 41/228 (17%)

Query: 765 DLLKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE---FQA--EV 818
           D+      + + + +G G F  VYKA         A+K++        ++     A  E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 819 EALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKW---DVRLK 875
           + L    H N++ L     H ++  L++ +ME    D  L E + KD+ L      ++  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFME---TD--L-EVIIKDNSLVLTPSHIKAY 117

Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHV 931
           +     +GL YLH+     I+HRD+K +N+LLDE     LADFGL++      R Y TH 
Sbjct: 118 MLM-TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-TH- 171

Query: 932 TTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
               V T  Y  PE       Y          D+++ G +L ELL   
Sbjct: 172 ---QVVTRWYRAPELLFGARMYG---VGV---DMWAVGCILAELLLRV 210

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 71/283 (25%), Positives = 107/283 (37%), Gaps = 57/283 (20%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQG 834
            ++G G FG V K        + AVK ++      +       EVE L +  H N++ L  
Sbjct: 29   MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 835  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                 +   ++      G L     E + +    + D    I Q    G+ Y+HK    +
Sbjct: 89   ILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIKQ-VFSGITYMHKH---N 141

Query: 895  IVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-----Y 946
            IVHRD+K  NILL+ K +     + DFGLS   +        D +GT  YI PE     Y
Sbjct: 142  IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPEVLRGTY 199

Query: 947  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII--- 1003
             +      + DV+S GV+L  LL+G  P                F  K+E   ++ +   
Sbjct: 200  DE------KCDVWSAGVILYILLSGTPP----------------FYGKNEYDILKRVETG 237

Query: 1004 ----DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                D   W    D  K L+       K +   P  R    + 
Sbjct: 238  KYAFDLPQWRTISDDAKDLI------RKMLTFHPSLRITATQC 274

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.6 bits (238), Expect = 2e-20
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 66/291 (22%)

Query: 769  STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREFQ---AEVEAL 821
            + N F Q  ++G GGFG V     +AT   G   A K+L     +  +       E + L
Sbjct: 182  TKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQIL 238

Query: 822  SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             +   + +VSL  Y     D L L+ + M  G L + ++  + +    +       A+  
Sbjct: 239  EKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARAVFYAAE-I 295

Query: 881  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGT 938
              GL  LH+     IV+RD+K  NILLD+    H  ++D GL+  +    T      VGT
Sbjct: 296  CCGLEDLHRE---RIVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQT--IKGRVGT 348

Query: 939  LGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 992
            +GY+ PE      Y+ +       D ++ G +L E++ G+ P                FQ
Sbjct: 349  VGYMAPEVVKNERYTFSP------DWWALGCLLYEMIAGQSP----------------FQ 386

Query: 993  MKSEKREVEIIDASIWHKDRE---------KQLLEMLEIACKCIDQDPRRR 1034
             + +K + E ++  +     E         + L   L      + +DP  R
Sbjct: 387  QRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL------LCKDPAER 431

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.8 bits (229), Expect = 2e-20
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMERE-----FQA--EVEALSR 823
             ++    IG G +G+VYKA    G   A+K++     ++E+E          E+  L  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKE 56

Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
            +H N+V L          +L++ +++   L   L     +  +     +  + Q    G
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQ-LLNG 112

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVGTL 939
           +AY H      ++HRD+K  N+L++ + E  +ADFGL+R     +R Y TH     + TL
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-TH----EIVTL 164

Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  P+       YS T+      D++S G +  E++ G 
Sbjct: 165 WYRAPDVLMGSKKYSTTI------DIWSVGCIFAEMVNGT 198

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.3 bits (230), Expect = 3e-20
 Identities = 63/302 (20%), Positives = 116/302 (38%), Gaps = 65/302 (21%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMERE-FQAEVEALSRAQHKNLVS 831
            +G G F +V K    + G + A K     R       + RE  + EV  L   QH N+++
Sbjct: 19   LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
            L     +  D +LI   +  G L        +K+S+ + +    + Q    G+ YLH + 
Sbjct: 79   LHEVYENKTDVILILELVAGGEL---FDFLAEKESLTEEEATEFLKQ-ILNGVYYLHSL- 133

Query: 892  EPHIVHRDVKSSNILLDEKFEAH----LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-- 945
               I H D+K  NI+L ++        + DFGL+  +     +   ++ GT  ++ PE  
Sbjct: 134  --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPEIV 189

Query: 946  ----YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
                           D++S GV+   LL+G  P                F   +++  + 
Sbjct: 190  NYEPLG---LEA---DMWSIGVITYILLSGASP----------------FLGDTKQETLA 227

Query: 1002 IIDASIWHKDRE---------KQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1050
             + A  +  + E         K  +       + + +DP++R  I++ +   W+      
Sbjct: 228  NVSAVNYEFEDEYFSNTSALAKDFI------RRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

Query: 1051 AA 1052
             A
Sbjct: 282  QA 283

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 93.9 bits (234), Expect = 3e-20
 Identities = 90/470 (19%), Positives = 132/470 (28%), Gaps = 96/470 (20%)

Query: 106 LGHLNQLKLLDLSCNHL--EGVVPV--ELSNLKQLEVLDLSHNMLSGP----VSGMLAGL 157
           L  L Q +++ L    L       +   L     L  L+L  N L       V   L   
Sbjct: 24  LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83

Query: 158 NL-IQSLNVSSNSFN----GSLFE-LGEFSNLAVFNISNNSFTGK----LNSRIWSASKE 207
           +  IQ L++ +        G L   L     L   ++S+N         L   +      
Sbjct: 84  SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143

Query: 208 IQILDLSMNHF----MGSL-QGLDHSPSLKQLHVDNNLLGGD----LPDSL-YSMSSLQH 257
           ++ L L            L   L   P  K+L V NN +       L   L  S   L+ 
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203

Query: 258 VSLSVNNFSGQ----LSEKISNLTSLRHLIIFGNQFSGK-----LPNVLGNLTQLEFFVA 308
           + L     +      L   +++  SLR L +  N+          P +L   ++L     
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 309 HSNSFSGP----LPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGP 364
                +      L   L     L  L L  N L         G   LC   L        
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGD------EGARLLCET-LLEPGCQ-- 314

Query: 365 LPNSLSDCHDLKILSLAKNELSGQVPESFGKL----TSLLFLSLSNNSF-----NHLSGT 415
                     L+ L +     +      F  +      LL L +SNN         L   
Sbjct: 315 ----------LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364

Query: 416 LSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 475
           L   Q    L  L L    V +          S   LA             LL    L+ 
Sbjct: 365 LG--QPGSVLRVLWLADCDVSDS---------SCSSLAAT-----------LLANHSLRE 402

Query: 476 LDLSWNHFDGNIPPWIGQM-----ENLFYLDFSNNTLTGEIPKSLTELKS 520
           LDLS N         + +        L  L   +   + E+   L  L+ 
Sbjct: 403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 452

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 89.6 bits (223), Expect = 1e-18
 Identities = 83/479 (17%), Positives = 159/479 (33%), Gaps = 113/479 (23%)

Query: 181 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF----MGSL-QGLDHSPSLKQLH 235
            ++   +I     +    + +    ++ Q++ L            +   L  +P+L +L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 236 VDNNLLGGD----LPDSLYSMS-SLQHVSLSVNNFSGQ----LSEKISNLTSLRHLIIFG 286
           + +N LG      +   L + S  +Q +SL     +G     LS  +  L +L+ L +  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 287 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFS 346
           N        +L                       L    +L  L L   SL+       +
Sbjct: 123 NLLGDAGLQLLCEGL-------------------LDPQCRLEKLQLEYCSLSA------A 157

Query: 347 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL-----TSLLF 401
               L ++              L    D K L+++ N+++        +        L  
Sbjct: 158 SCEPLASV--------------LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203

Query: 402 LSLSNNSFNHLSGTL--SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 459
           L L +      +      ++    +L  L L  N                    LG+ G+
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSN-------------------KLGDVGM 244

Query: 460 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM----ENLFYLDFSNNTLTGEIPKSL 515
               P  L    +L+ L +            + ++    E+L  L  + N L  E  + L
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304

Query: 516 TELKSLISSNCTSSNPTASAGIPLYVKHNRST--------NGLPYNQASSFPPSVFLSNN 567
            E  +L+   C   +        L+VK    T        + L  N+       + +SNN
Sbjct: 305 CE--TLLEPGCQLES--------LWVKSCSFTAACCSHFSSVLAQNRFLL---ELQISNN 351

Query: 568 RINGTIPPEIGQ-LKH----LHVLDLSRNNIT----GTIPSSISEIRNLEVLDLSSNDL 617
           R+      E+ Q L      L VL L+  +++     ++ +++    +L  LDLS+N L
Sbjct: 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 72.7 bits (179), Expect = 3e-13
 Identities = 75/379 (19%), Positives = 120/379 (31%), Gaps = 83/379 (21%)

Query: 102 IPRSLGHLNQLKLLDLSCNHL--EGVVPV---ELSNLKQLEVLDLSHNMLS----GPVSG 152
           +  +L  L  L+ L LS N L   G+  +    L    +LE L L +  LS     P++ 
Sbjct: 105 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 164

Query: 153 MLAGLNLIQSLNVSSNSFNGS-LFELGEF-----SNLAVFNISNNSFTGKLNSRIWSA-- 204
           +L      + L VS+N  N + +  L +        L    + +   T      +     
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224

Query: 205 -SKEIQILDLSMNHFMG------SLQGLDHSPSLKQLHVDNNLLGGD----LPDSLYSMS 253
               ++ L L  N              L  S  L+ L +    +       L   L +  
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284

Query: 254 SLQHVSLSVNNFSG----QLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 308
           SL+ +SL+ N         L E +      L  L +    F+    +   ++        
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV-------- 336

Query: 309 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNS 368
                       L+    L  L + NN L        +G+  LC   L            
Sbjct: 337 ------------LAQNRFLLELQISNNRLED------AGVRELCQG-LGQPGSV------ 371

Query: 369 LSDCHDLKILSLAKNELSGQVPESFGKL----TSLLFLSLSNNSF-----NHLSGTLSVL 419
                 L++L LA  ++S     S         SL  L LSNN         L  ++   
Sbjct: 372 ------LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR-- 423

Query: 420 QQCKNLTTLILTKNFVGEE 438
           Q    L  L+L   +  EE
Sbjct: 424 QPGCLLEQLVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.1 bits (123), Expect = 1e-06
 Identities = 53/272 (19%), Positives = 80/272 (29%), Gaps = 58/272 (21%)

Query: 374 DLKILSLAKNELSGQVPESFGK-LTSLLFLSLSNNSFN--HLSGTLSVLQQCKNLTTLIL 430
           D++ L +   ELS          L     + L +            S L+    L  L L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 431 TKNFVGEEIPENVGGFESL-MVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD----G 485
             N +G+       G   +   L   +C              K+Q L L          G
Sbjct: 64  RSNELGDV------GVHCVLQGLQTPSC--------------KIQKLSLQNCCLTGAGCG 103

Query: 486 NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTE--------LKSLISSNCTSSNPTASAGI 537
            +   +  +  L  L  S+N L     + L E        L+ L    C+ S  +    +
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP-L 162

Query: 538 PLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQ-LKH----LHVLDLSRNN 592
              ++       L             +SNN IN      + Q LK     L  L L    
Sbjct: 163 ASVLRAKPDFKEL------------TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG 210

Query: 593 ITGTIPSSISEI----RNLEVLDLSSNDLHGS 620
           +T      +  I     +L  L L SN L   
Sbjct: 211 VTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 49.2 bits (118), Expect = 5e-06
 Identities = 47/219 (21%), Positives = 81/219 (36%), Gaps = 32/219 (14%)

Query: 96  KGLKGIIPRSLGHLNQLKLLDLSCNHL--EGVVPV--ELSNLKQLEVLDLSHNMLSGP-- 149
            G+  + P  L   ++L+ L +    +  +G   +   L   + L+ L L+ N L     
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301

Query: 150 ---VSGMLAGLNLIQSLNVSSNSFNGSLFE-----LGEFSNLAVFNISNNSFTGK----L 197
                 +L     ++SL V S SF  +        L +   L    ISNN         L
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361

Query: 198 NSRIWSASKEIQILDLSMNHF----MGSL-QGLDHSPSLKQLHVDNNLLGGD----LPDS 248
              +      +++L L+          SL   L  + SL++L + NN LG      L +S
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421

Query: 249 LYSM-SSLQHVSLSVNNFSGQ----LSEKISNLTSLRHL 282
           +      L+ + L    +S +    L     +  SLR +
Sbjct: 422 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 33/216 (15%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVKRLS--------GDCGQMEREFQAEVEALSRAQHKN 828
            +G G  G V  A       K A+K +S                  + E+E L +  H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 829 LVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
           ++ ++ +     D  ++   ME G L D      V    + +   +L   Q     + YL
Sbjct: 77  IIKIKNFF-DAEDYYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQ-MLLAVQYL 130

Query: 888 HKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
           H+     I+HRD+K  N+LL  + E     + DFG S++L   +T +   L GT  Y+ P
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 185

Query: 945 EYSQTLTATCRG------DVYSFGVVLLELLTGRRP 974
           E    L +          D +S GV+L   L+G  P
Sbjct: 186 E---VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 34/261 (13%), Positives = 71/261 (27%), Gaps = 51/261 (19%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG---QMEREFQAEVEALSRAQHKNLVSLQG 834
             G       ++A       + A+  +         + +E  +    LSR     +  +  
Sbjct: 39   HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98

Query: 835  YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
                    L++  ++  GSL      S      ++        Q  A      H+     
Sbjct: 99   VVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAHRA---G 149

Query: 895  IVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATC 954
            +       S + +    +  LA                         +P        A  
Sbjct: 150  VALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPD-------ANP 181

Query: 955  RGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREK 1014
            + D+   G  L  LL  R P+        R  ++   +  +     + I+ +   +D   
Sbjct: 182  QDDIRGIGASLYALLVNRWPLP---EAGVRSGLAPAERDTAG----QPIEPADIDRDIPF 234

Query: 1015 QLLEMLEIACKCIDQDPRRRP 1035
            Q+     +A + +  D   R 
Sbjct: 235  QI---SAVAARSVQGDGGIRS 252

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 92.8 bits (231), Expect = 4e-20
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 30/217 (13%)

Query: 770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 829
              +    +IG G FG+V++A L    + A+K++  D      + + E++ +   +H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD---KRFKNR-ELQIMRIVKHPNV 94

Query: 830 VSLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
           V L+ +     D+       L+  Y+         H +  K ++    ++L + Q   R 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRS 153

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           LAY+H +    I HRD+K  N+LLD       L DFG +++L   + +     + +  Y 
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VSYICSRYYR 208

Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       Y+  +      D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNI------DIWSTGCVMAELMQGQ 239

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.5 bits (228), Expect = 4e-20
 Identities = 56/221 (25%), Positives = 84/221 (38%), Gaps = 42/221 (19%)

Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQA-------EVEALS 822
             + +   IG G +G+V+K      G   A+K+          +          E+  L 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLK 57

Query: 823 RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
           + +H NLV+L    R      L++ Y ++  L             L   V+    Q   +
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL---VKSITWQ-TLQ 113

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL----RPYDTHVTTDLVGT 938
            + + HK    + +HRDVK  NIL+ +     L DFG +RLL      Y      D V T
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-----DDEVAT 165

Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
             Y  PE       Y          DV++ G V  ELL+G 
Sbjct: 166 RWYRSPELLVGDTQYG---PPV---DVWAIGCVFAELLSGV 200

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.5 bits (228), Expect = 4e-20
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 45/222 (20%)

Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE----FQA--EVEALSR 823
             + + + +G G +  VYK          A+K +     ++E E      A  EV  L  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKD 56

Query: 824 AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVL--KWDVRLKIAQGAA 881
            +H N+V+L           L++ Y++    D  L + +D    +    +V+L + Q   
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLD---KD--LKQYLDDCGNIINMHNVKLFLFQ-LL 110

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL----LRPYDTHVTTDLVG 937
           RGLAY H      ++HRD+K  N+L++E+ E  LADFGL+R      + Y  +     V 
Sbjct: 111 RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DN----EVV 162

Query: 938 TLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           TL Y PP+       YS  +      D++  G +  E+ TGR
Sbjct: 163 TLWYRPPDILLGSTDYSTQI------DMWGVGCIFYEMATGR 198

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.3 bits (225), Expect = 5e-20
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 53/280 (18%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G G +G V  A         AVK     R       +++E    +       H+N+V  
Sbjct: 15   LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70

Query: 833  QGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAAR--------G 883
             G+ R GN + L   Y   G L D            ++ D+ +      A+        G
Sbjct: 71   YGHRREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPD--AQRFFHQLMAG 117

Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGTLGY 941
            + YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R    +  +   + GTL Y
Sbjct: 118  VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPY 173

Query: 942  IPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
            + PE   +        DV+S G+VL  +L G  P +     +C++   W       +++ 
Sbjct: 174  VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWK------EKKT 226

Query: 1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
             +             L ++L         +P  R  I ++
Sbjct: 227  YLNPWKKIDSAPLALLHKILVE-------NPSARITIPDI 259

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 62/289 (21%), Positives = 101/289 (34%), Gaps = 46/289 (15%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 835
             +G G F +  K     +    AVK +S    +ME   Q E+ AL   + H N+V L   
Sbjct: 18   PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                    L+   +  G L         K    + +    I +     ++++H V    +
Sbjct: 75   FHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEAS-YIMRKLVSAVSHMHDV---GV 127

Query: 896  VHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA 952
            VHRD+K  N+L  ++ +     + DFG +RL  P D         TL Y  PE    L  
Sbjct: 128  VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLHYAAPE---LLNQ 183

Query: 953  TCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI-- 1007
                   D++S GV+L  +L+G+ P +             + +         I       
Sbjct: 184  NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK--------IKKGDFSF 235

Query: 1008 ----WHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048
                W       K L+         +  DP +R  +  +    WL    
Sbjct: 236  EGEAWKNVSQEAKDLI------QGLLTVDPNKRLKMSGLRYNEWLQDGS 278

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 94.0 bits (233), Expect = 7e-20
 Identities = 47/288 (16%), Positives = 88/288 (30%), Gaps = 52/288 (18%)

Query: 231 LKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFS 290
           + +    +  +    PD   + +     +L   + +   +   + L S+  +I   +   
Sbjct: 1   MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK 56

Query: 291 GKLPNVLGNLTQLEFFVAHSN---SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFS 346
             +   +  L  +     + N            L+    L  L L  N +    DL +  
Sbjct: 57  -SVQG-IQYLPNVTKLFLNGNKLTDIKP-----LTNLKNLGWLFLDENKIK---DLSSLK 106

Query: 347 GLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSN 406
            L  L +L L  N  S  +   L     L+ L L  N+++        +LT L  LSL +
Sbjct: 107 DLKKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLED 162

Query: 407 NSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVW 466
           N  + +      L     L  L L+KN +      ++     L                 
Sbjct: 163 NQISDIVP----LAGLTKLQNLYLSKNHI-----SDLRALAGL----------------- 196

Query: 467 LLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKS 514
               K L VL+L               +     +  ++ +L      S
Sbjct: 197 ----KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 90.2 bits (223), Expect = 1e-18
 Identities = 55/276 (19%), Positives = 101/276 (36%), Gaps = 60/276 (21%)

Query: 369 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 428
                +    +L K  ++     +  +L S+  +  +N+    + G    +Q   N+T L
Sbjct: 17  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG----IQYLPNVTKL 70

Query: 429 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 488
            L  N +  +I + +   ++L  L L    +K  +   L   KKL+ L L  N    +I 
Sbjct: 71  FLNGNKL-TDI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN 125

Query: 489 PWIGQMENLFYLDFSNNTLTGEIP--KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 546
             +  +  L  L   NN +T +I     LT+L +L                         
Sbjct: 126 G-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTL------------------------- 158

Query: 547 TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 606
                            L +N+I+  I P +  L  L  L LS+N+I+     +++ ++N
Sbjct: 159 ----------------SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKN 198

Query: 607 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ 642
           L+VL+L S +           L   +     +  L 
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.4 bits (221), Expect = 2e-18
 Identities = 52/285 (18%), Positives = 95/285 (33%), Gaps = 29/285 (10%)

Query: 91  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 150
            I     +K I P       +    +L    +   V    + L  ++ +  +++ +   V
Sbjct: 4   TITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-V 58

Query: 151 SGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFT-----GKLNSRIWSAS 205
            G +  L  +  L ++ N     +  L    NL    +  N          L        
Sbjct: 59  QG-IQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIKDLSSLKDLKK------ 110

Query: 206 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 265
             ++ L L  N     + GL H P L+ L++ NN +  D+   L  ++ L  +SL  N  
Sbjct: 111 --LKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKI-TDI-TVLSRLTKLDTLSLEDNQI 165

Query: 266 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCS 325
           S  +   ++ LT L++L +  N  S  L   L  L  L+     S           S   
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 326 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLS 370
             + +   + SL  P  +  S        ++  +        S  
Sbjct: 222 VPNTVKNTDGSLVTPEII--SDDGDYEKPNVKWHLPEFTNEVSFI 264

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 87.1 bits (215), Expect = 1e-17
 Identities = 48/272 (17%), Positives = 98/272 (36%), Gaps = 22/272 (8%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
                L +K +   +      LN +  +  + + ++ V    +  L  +  L L+ N L+
Sbjct: 23  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 78

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 207
             +   L  L  +  L +  N     L  L +   L   ++ +N  +  +N        +
Sbjct: 79  D-IKP-LTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGIS-DING--LVHLPQ 132

Query: 208 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 267
           ++ L L  N  +  +  L     L  L +++N +  D+   L  ++ LQ++ LS N+ S 
Sbjct: 133 LESLYLGNNK-ITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS- 188

Query: 268 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKL 327
            L   ++ L +L  L +F  +   K  N   NL           S   P  +S       
Sbjct: 189 DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS------- 240

Query: 328 HVLDLRNNSLTGPIDLNFSGLSSLCTLDLATN 359
              D    ++   +    + +S +    +   
Sbjct: 241 DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 272

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 92.5 bits (230), Expect = 7e-20
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 31/220 (14%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
               ++    +IG G FG+VY+A L  +G   A+K++  D      + + E++ + +  H
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNR-ELQIMRKLDH 106

Query: 827 KNLVSLQGYCRHGNDRL------LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
            N+V L+ +     ++       L+  Y+         H S  K ++    V+L + Q  
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-L 165

Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
            R LAY+H      I HRD+K  N+LLD +     L DFG ++ L           + + 
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSR 220

Query: 940 GYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            Y  PE       Y+ ++      DV+S G VL ELL G+
Sbjct: 221 YYRAPELIFGATDYTSSI------DVWSAGCVLAELLLGQ 254

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 90.4 bits (225), Expect = 8e-20
 Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 20/216 (9%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQ-----AEVEAL 821
           K   +F    I+G G F  V  A       + A+K L      + +E +      E + +
Sbjct: 27  KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVM 84

Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQG 879
           SR  H   V L  +    +++L    SY +NG L  ++     K         R   A+ 
Sbjct: 85  SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE- 138

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD-LVGT 938
               L YLH      I+HRD+K  NILL+E     + DFG +++L P       +  VGT
Sbjct: 139 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 939 LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             Y+ PE     +A    D+++ G ++ +L+ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 90.6 bits (225), Expect = 1e-19
 Identities = 60/256 (23%), Positives = 93/256 (36%), Gaps = 57/256 (22%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQA---EVEALSRAQHKNL 829
           +G G FG V+ A       +  VK     ++  DC   + +      E+  LSR +H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 830 VSLQGYCRHGNDRLLIYSYMEN----GSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
           + +        ++      ME       L  +     +D+   L   +   I +     +
Sbjct: 92  IKVLDIFE---NQGFFQLVMEKHGSGLDLFAF-----IDRHPRLDEPLASYIFRQLVSAV 143

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            YL       I+HRD+K  NI++ E F   L DFG +  L        T   GT+ Y  P
Sbjct: 144 GYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYT-FCGTIEYCAP 198

Query: 945 E------YSQTLTATCRG---DVYSFGVVLLELLTGRRP----VEVCKGK---------N 982
           E      Y        RG   +++S GV L  L+    P     E  +            
Sbjct: 199 EVLMGNPY--------RGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250

Query: 983 CRDLVSWVFQMKSEKR 998
              LVS + Q   E+R
Sbjct: 251 LMSLVSGLLQPVPERR 266

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 90.8 bits (226), Expect = 2e-19
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 31/225 (13%)

Query: 766 LLKSTNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQ 815
           ++ ++  F+        +G G F +V +    T G + A K     +LS    Q     +
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LE 76

Query: 816 AEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK 875
            E     + QH N+V L    +  +   L++  +  G L     + V ++   + D    
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHC 133

Query: 876 IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVT 932
           I Q     +AY H      IVHR++K  N+LL  K +     LADFGL+  +    +   
Sbjct: 134 IQQ-ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAW 187

Query: 933 TDLVGTLGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRP 974
               GT GY+ PE    L         D+++ GV+L  LL G  P
Sbjct: 188 HGFAGTPGYLSPE---VLKKDPYSKPVDIWACGVILYILLVGYPP 229

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 49/232 (21%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLS--------------------------GDCGQME 811
           IG G +G+V  A    + T  A+K LS                                 
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 812 REFQAEVEALSRAQHKNLVSL-QGYCRHGNDRL-LIYSYMENGSL-DYWLHESVDKDSVL 868
            +   E+  L +  H N+V L +       D L +++  +  G + +            L
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV------PTLKPL 134

Query: 869 KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
             D      Q   +G+ YLH      I+HRD+K SN+L+ E     +ADFG+S   +  D
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 929 THVTTDLVGTLGYIPPEYSQTLTATCRG------DVYSFGVVLLELLTGRRP 974
             ++   VGT  ++ PE   +L+ T +       DV++ GV L   + G+ P
Sbjct: 192 ALLSN-TVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 91.0 bits (226), Expect = 2e-19
 Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 27/219 (12%)

Query: 771 NNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMERE---FQAEVEALSR 823
            +F    +IG G FG V     K         A+K L+        E   F+ E + L  
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVN 130

Query: 824 AQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
              K + +L  Y    ++ L L+  Y   G L   L  S  +D + +   R  +A+    
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAE-MVI 186

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLG 940
            +  +H++   H VHRD+K  NIL+D     H  LADFG    L    T  ++  VGT  
Sbjct: 187 AIDSVHQL---HYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 941 YIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 974
           YI PE  Q +           D +S GV + E+L G  P
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 53/280 (18%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +G G +G V  A         AVK     R       +++E    +       H+N+V  
Sbjct: 15   LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70

Query: 833  QGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAAR--------G 883
             G+ R GN + L   Y   G L D            ++ D+ +      A+        G
Sbjct: 71   YGHRREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPD--AQRFFHQLMAG 117

Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP--YDTHVTTDLVGTLGY 941
            + YLH +    I HRD+K  N+LLDE+    ++DFGL+ + R    +  +   + GTL Y
Sbjct: 118  VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPY 173

Query: 942  IPPE-YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
            + PE   +        DV+S G+VL  +L G  P +     +C++   W       +++ 
Sbjct: 174  VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWK------EKKT 226

Query: 1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
             +             L ++L         +P  R  I ++
Sbjct: 227  YLNPWKKIDSAPLALLHKILVE-------NPSARITIPDI 259

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 89.2 bits (222), Expect = 3e-19
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 39/231 (16%)

Query: 766 LLKSTNNFNQ-----ANIIGCGGFGLVYKAT-LTNGTKAAVK-----RLSGDCGQMEREF 814
             +S  NFN      +  +G G F +V +    + G + A K     R   DC     E 
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC---RAEI 75

Query: 815 QAEVEALSRAQH-KNLVSLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDV 872
             E+  L  A+    +++L     + ++ +LI  Y   G +    L E  +  S  + DV
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS--ENDV 133

Query: 873 RLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDT 929
              I Q    G+ YLH+    +IVH D+K  NILL   +      + DFG+SR +     
Sbjct: 134 IRLIKQ-ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--A 187

Query: 930 HVTTDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
               +++GT  Y+ PE       +   TAT   D+++ G++   LLT   P
Sbjct: 188 CELREIMGTPEYLAPEILNYDPIT---TAT---DMWNIGIIAYMLLTHTSP 232

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.6 bits (223), Expect = 3e-19
 Identities = 61/243 (25%), Positives = 95/243 (39%), Gaps = 70/243 (28%)

Query: 769 STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-----FQA--EVEA 820
             + + +   IG G FG V+KA     G K A+K++      ME E       A  E++ 
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKI 69

Query: 821 LSRAQHKNLVSLQGYC-----RHGNDRLLIY-----------SYMENGSLDYWLHESVDK 864
           L   +H+N+V+L   C      +   +  IY             + N  +      S  K
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIK 127

Query: 865 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL- 923
                     ++ Q    GL Y+H+     I+HRD+K++N+L+       LADFGL+R  
Sbjct: 128 ----------RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174

Query: 924 -------LRPYDTHVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELL 969
                     Y     T+ V TL Y PPE       Y          D++  G ++ E+ 
Sbjct: 175 SLAKNSQPNRY-----TNRVVTLWYRPPELLLGERDYG---PPI---DLWGAGCIMAEMW 223

Query: 970 TGR 972
           T  
Sbjct: 224 TRS 226

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.5 bits (225), Expect = 3e-19
 Identities = 61/265 (23%), Positives = 104/265 (39%), Gaps = 40/265 (15%)

Query: 729 DDLDED-MGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLV 787
            +L    + + + +++ L  ++ ++ +  + + L   D       F    +IG G F  V
Sbjct: 26  QELGASELAQDKYVADFLQWAEPIVVRLKEVR-LQRDD-------FEILKVIGRGAFSEV 77

Query: 788 Y----KATLTNGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG 839
                K T   G   A+K ++       G++   F+ E + L     + +  L  +    
Sbjct: 78  AVVKMKQT---GQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLH-FAFQD 132

Query: 840 NDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHR 898
            + L L+  Y   G L   L +  ++        R  +A+     +  +H++     VHR
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAE--MARFYLAE-IVMAIDSVHRL---GYVHR 186

Query: 899 DVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRG 956
           D+K  NILLD     H  LADFG    LR   T  +   VGT  Y+ PE  Q +      
Sbjct: 187 DIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244

Query: 957 DVY-------SFGVVLLELLTGRRP 974
             Y       + GV   E+  G+ P
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTP 269

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 57/234 (24%), Positives = 87/234 (37%), Gaps = 51/234 (21%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQAEVEALSRAQHKNLVSL- 832
           +G G +G V +        + AVK L           E   + E++ L R +HKN++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 833 QGYCRHGNDRL-LIYSYMENGS---LDYWLHESVDKDSVLKWDVRLKIAQGAAR------ 882
                    ++ ++  Y   G    LD    +            R  + Q  A       
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK------------RFPVCQ--AHGYFCQL 118

Query: 883 --GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY--DTHVTTDLVGT 938
             GL YLH      IVH+D+K  N+LL       ++  G++  L P+  D    T   G+
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGS 174

Query: 939 LGYIPPEYSQTLTATCRG------DVYSFGVVLLELLTGRRPVEVCKGKNCRDL 986
             + PPE    +            D++S GV L  + TG  P E   G N   L
Sbjct: 175 PAFQPPE----IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE---GDNIYKL 221

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 43/249 (17%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLS-------GDCGQMEREFQAEVEALSRAQHKNLV 830
           +G G FG V        G K AVK L+          G+++RE    ++ L   +H +++
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHPHII 74

Query: 831 SLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
            L        D  ++  Y+  G L DY     + K   ++     ++ Q     + Y H+
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDY-----ICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQ 948
                +VHRD+K  N+LLD    A +ADFGLS ++   +   T+   G+  Y  PE  S 
Sbjct: 130 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISG 184

Query: 949 TLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDLVSW 989
            L A    D++S GV+L  LL G  P +          +  G          +   L+  
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMH 244

Query: 990 VFQMKSEKR 998
           + Q+   KR
Sbjct: 245 MLQVDPLKR 253

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 89.7 bits (223), Expect = 7e-19
 Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 55/294 (18%)

Query: 769  STNNFNQA----NIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMERE-FQAEVEAL 821
            +   F +       +G G F +V +   +  G + A   ++       + +  + E    
Sbjct: 5    TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64

Query: 822  SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
               +H N+V L           LI+  +  G L     + V ++   + D    I Q   
Sbjct: 65   RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQ-IL 120

Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGT 938
              + + H   +  +VHR++K  N+LL  K +     LADFGL+  +   +        GT
Sbjct: 121  EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGT 176

Query: 939  LGYIPPEYSQTLTATCRG---DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS 995
             GY+ PE    L     G   D+++ GV+L  LL G  P                F  + 
Sbjct: 177  PGYLSPE---VLRKDPYGKPVDLWACGVILYILLVGYPP----------------FWDED 217

Query: 996  EKREVEII-------DASIWHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
            + R  + I        +  W       K L+       K +  +P +R    E 
Sbjct: 218  QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI------NKMLTINPSKRITAAEA 265

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 89.1 bits (221), Expect = 8e-19
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 43/221 (19%)

Query: 779 IGCGGFGLVYKA---TLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGY 835
           +G G +G VYKA      +    A+K++ G    +      E+  L   +H N++SLQ  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKV 86

Query: 836 CR-HGNDRL-LIYSYMENGSLDYW-LHESVDKDSVLKWDVRLKIAQGAA------RGLAY 886
              H + ++ L++ Y E    D W + +        K  V+L      +       G+ Y
Sbjct: 87  FLSHADRKVWLLFDYAE---HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAH----LADFGLSRL----LRPYDTHVTTDLVGT 938
           LH      ++HRD+K +NIL+  +        +AD G +RL    L+P    +   +V T
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVV-T 198

Query: 939 LGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
             Y  PE       Y+    A    D+++ G +  ELLT  
Sbjct: 199 FWYRAPELLLGARHYT---KAI---DIWAIGCIFAELLTSE 233

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 86.9 bits (216), Expect = 2e-18
 Identities = 70/285 (24%), Positives = 109/285 (38%), Gaps = 50/285 (17%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRL-------SGDCGQMEREFQAEVEALSRAQHKNLV 830
            +G G FG V  AT      K A+K +       S    ++ERE    +  L   +H +++
Sbjct: 17   LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHII 72

Query: 831  SLQGYCRHGNDRLLIYSYME--NGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
             L        D   I   +E   G L DY     + +   +  D   +  Q     + Y 
Sbjct: 73   KLYDVITTPTD---IVMVIEYAGGELFDY-----IVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 888  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-Y 946
            H+     IVHRD+K  N+LLD+     +ADFGLS ++      + T   G+  Y  PE  
Sbjct: 125  HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKT-SCGSPNYAAPEVI 179

Query: 947  SQTLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDLV 987
            +  L A    DV+S G+VL  +L GR P +          V               + L+
Sbjct: 180  NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239

Query: 988  SWVFQMKSEKR-EVEIIDASIW-HKDREKQLLEMLEIACKCIDQD 1030
              +      +R  ++ I    W + +    L  M E+     D  
Sbjct: 240  RRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSR 284

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 52/230 (22%), Positives = 86/230 (37%), Gaps = 57/230 (24%)

Query: 770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA-------- 820
              +     IG G  G+V  A         A+K+LS       R FQ +  A        
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76

Query: 821 -LSRAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLK---W 870
            +    HKN++ L      Q       D  ++   M+            +   V++    
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----------ANLCQVIQMELD 125

Query: 871 DVRLK--IAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
             R+   + Q    G+ +LH      I+HRD+K SNI++       + DFGL+R      
Sbjct: 126 HERMSYLLYQ-MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 179

Query: 929 THVTTDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           + + T  V T  Y  PE      Y + +      D++S G ++ E++ G 
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENV------DIWSVGCIMGEMIKGG 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 61/299 (20%), Positives = 106/299 (35%), Gaps = 67/299 (22%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQGY 835
            ++G G  G V +      G K A+K L  D  +  +E    V+   + +   ++V +   
Sbjct: 36   VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQE----VDHHWQASGGPHIVCILDV 90

Query: 836  C---RHGNDRL-LIYSYMENGSLDYWLHESVDKDSVL--KWDVRLKIAQGAARGLAYLHK 889
                 HG   L +I   ME G L        ++      + +   +I +     + +LH 
Sbjct: 91   YENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHS 146

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE- 945
                +I HRDVK  N+L   K +     L DFG +   +    +       T  Y+ PE 
Sbjct: 147  H---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA---KETTQNALQTPCYTPYYVAPEV 200

Query: 946  -YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
               +    +C  D++S GV++  LL G  P                F   + +     + 
Sbjct: 201  LGPEKYDKSC--DMWSLGVIMYILLCGFPP----------------FYSNTGQAISPGMK 242

Query: 1005 ASI-----------WHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048
              I           W +  +  KQL+         +  DP  R  I + +   W++   
Sbjct: 243  RRIRLGQYGFPNPEWSEVSEDAKQLI------RLLLKTDPTERLTITQFMNHPWINQSM 295

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 85.3 bits (212), Expect = 4e-18
 Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 42/229 (18%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEV-------- 818
            +T+ +     IG G +G VYKA    +G   A+K +              +        
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREV 62

Query: 819 ---EALSRAQHKNLVSL----QGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKW 870
                L   +H N+V L             ++ L++ +++   L  +L +      +   
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAE 120

Query: 871 DVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH 930
            ++  + Q   RGL +LH      IVHRD+K  NIL+       LADFGL+   R Y   
Sbjct: 121 TIKDLMRQ-FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA---RIYSYQ 173

Query: 931 VT-TDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           +  T +V TL Y  PE      Y+   T     D++S G +  E+   +
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYA---TPV---DMWSVGCIFAEMFRRK 216

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 86.2 bits (214), Expect = 4e-18
 Identities = 43/217 (19%), Positives = 79/217 (36%), Gaps = 36/217 (16%)

Query: 778 IIGCGGFGLVYKATLTNGTKAAVKRLS--GDCGQMEREFQAEVEA---------LSRAQH 826
            I  G +G V     + G   A+KR+      G+                    L+   H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 827 KNLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLK--IAQGAAR 882
            N++ L+    H  +  +  +Y   E   +   L + +    ++     ++  +      
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTE--LMRTDLAQVIHDQRIVISPQHIQYFMYH-ILL 145

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYI 942
           GL  LH+     +VHRD+   NILL +  +  + DF L+R          T  V    Y 
Sbjct: 146 GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA--DANKTHYVTHRWYR 200

Query: 943 PPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            PE       +++ +      D++S G V+ E+   +
Sbjct: 201 APELVMQFKGFTKLV------DMWSAGCVMAEMFNRK 231

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 85.3 bits (212), Expect = 6e-18
 Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 50/232 (21%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKA--TLTNGTKAAVKRLSGDCGQMERE-----FQA--EV 818
           ++   +     IG G +G V+KA      G   A+KR+     +++            EV
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-----RVQTGEEGMPLSTIREV 62

Query: 819 EAL---SRAQHKNLVSL----QGYCRHGNDRL-LIYSYMEN---GSLDYWLHESVDKDSV 867
             L      +H N+V L             +L L++ +++      LD      V  +++
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 868 LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY 927
                +L       RGL +LH      +VHRD+K  NIL+    +  LADFGL+   R Y
Sbjct: 123 KDMMFQL------LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA---RIY 170

Query: 928 DTHVT-TDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 972
              +  T +V TL Y  PE      Y+   T     D++S G +  E+   +
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYA---TPV---DLWSVGCIFAEMFRRK 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.0 bits (218), Expect = 6e-18
 Identities = 69/237 (29%), Positives = 98/237 (41%), Gaps = 40/237 (16%)

Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLS-GDCGQMEREFQAEVE---- 819
           + N+F+   IIG GGFG VY      T   G   A+K L        + E  A  E    
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIML 243

Query: 820 -ALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKI 876
             +S      +V +  Y  H  D+L  I   M  G L Y L     +  V     +R   
Sbjct: 244 SLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYA 298

Query: 877 AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
           A+    GL ++H      +V+RD+K +NILLDE     ++D GL+        H     V
Sbjct: 299 AE-IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SV 351

Query: 937 GTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDL 986
           GT GY+ PE       Y  +       D +S G +L +LL G  P    K K+  ++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSA------DWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 86.8 bits (215), Expect = 7e-18
 Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 35/212 (16%)

Query: 777 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQH 826
             IG G  G+V  A         A+K+LS       R FQ +  A         +    H
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 120

Query: 827 KNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
           KN++SL      Q       D  L+   M+    +  L + V +  +    +   + Q  
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA---N--LCQ-VIQMELDHERMSYLLYQ-M 173

Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
             G+ +LH      I+HRD+K SNI++       + DFGL+R      + + T  V T  
Sbjct: 174 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 228

Query: 941 YIPPEYSQTLTATCRGDVYSFGVVLLELLTGR 972
           Y  PE    +      D++S G ++ E++  +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 65/275 (23%), Positives = 91/275 (33%), Gaps = 59/275 (21%)

Query: 726 CPIDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFG 785
             + DLD    R  +  +   S             +   D       +    +IG G FG
Sbjct: 31  ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAED-------YEVVKVIGRGAFG 83

Query: 786 LVY----KATLTNGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            V     K+T       A+K LS             F  E + ++ A    +V L  Y  
Sbjct: 84  EVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQLF-YAF 138

Query: 838 HGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR--------GLAYLH 888
             +  L ++  YM  G L   +                 + +  AR         L  +H
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMS-------------NYDVPEKWARFYTAEVVLALDAIH 185

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
            +     +HRDVK  N+LLD+    H  LADFG    +           VGT  YI PE 
Sbjct: 186 SM---GFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE- 239

Query: 947 SQTLTATCRGDVY-------SFGVVLLELLTGRRP 974
              L +      Y       S GV L E+L G  P
Sbjct: 240 --VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.4 bits (214), Expect = 1e-17
 Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 44/283 (15%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLS-------GDCGQMEREFQAEVEALSRAQHKNLV 830
            +G G FG V        G K AVK L+          G++ RE    ++ L   +H +++
Sbjct: 24   LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRHPHII 79

Query: 831  SLQGYCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
             L       +D  ++  Y+  G L DY     + K+  L      ++ Q    G+ Y H+
Sbjct: 80   KLYQVISTPSDIFMVMEYVSGGELFDY-----ICKNGRLDEKESRRLFQQILSGVDYCHR 134

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQ 948
                 +VHRD+K  N+LLD    A +ADFGLS ++   +   T+   G+  Y  PE  S 
Sbjct: 135  H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISG 189

Query: 949  TLTATCRGDVYSFGVVLLELLTGRRPVE----------VCKGK---------NCRDLVSW 989
             L A    D++S GV+L  LL G  P +          +C G          +   L+  
Sbjct: 190  RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKH 249

Query: 990  VFQMKSEKR-EVEIIDASIWHKDREKQLLEMLEIACKCIDQDP 1031
            + Q+   KR  ++ I    W K    + L   + +      D 
Sbjct: 250  MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDD 292

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 45/206 (21%), Positives = 87/206 (42%), Gaps = 29/206 (14%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQGYC 836
           +G G +  V++A  +TN  K  VK L       +++ + E++ L       N+++L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIV 100

Query: 837 RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIV 896
           +    R     +    + D    +     +   +D+R  + +   + L Y H +    I+
Sbjct: 101 KDPVSRTPALVFEHVNNTD--FKQLYQTLT--DYDIRFYMYE-ILKALDYCHSM---GIM 152

Query: 897 HRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-------YSQ 948
           HRDVK  N+++D E  +  L D+GL+    P   +     V +  +  PE       Y  
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDY 210

Query: 949 TLTATCRGDVYSFGVVLLELLTGRRP 974
           +L      D++S G +L  ++  + P
Sbjct: 211 SL------DMWSLGCMLASMIFRKEP 230

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 63/306 (20%), Positives = 105/306 (34%), Gaps = 80/306 (26%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGY 835
            ++G G  G V +        K A+K L  DC +  RE    VE   RA    ++V +   
Sbjct: 69   VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIVDV 123

Query: 836  CRHGNDR----LLIYSYMENGSLDYWLHESVDKDS----------VLKWDVRLKIAQGAA 881
              +        L++   ++ G L        D+            ++K      I +   
Sbjct: 124  YENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMK-----SIGEA-- 173

Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHVTTDLVGT 938
              + YLH +   +I HRDVK  N+L   K       L DFG ++       +  T    T
Sbjct: 174  --IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYT 226

Query: 939  LGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 992
              Y+ PE      Y +    +C  D++S GV++  LL G  P       +   +   +  
Sbjct: 227  PYYVAPEVLGPEKYDK----SC--DMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKT 277

Query: 993  MKSEKREVEIIDASI------WHK--DREKQLLEMLEIACKCIDQDPRRRPFIEEVVT-- 1042
                     I           W +  +  K L+         +  +P +R  I E +   
Sbjct: 278  --------RIRMGQYEFPNPEWSEVSEEVKMLI------RNLLKTEPTQRMTITEFMNHP 323

Query: 1043 WLDGIG 1048
            W+    
Sbjct: 324  WIMQST 329

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.8 bits (205), Expect = 5e-17
 Identities = 57/207 (27%), Positives = 84/207 (40%), Gaps = 27/207 (13%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            +G G   +VY+          A+K L       ++  + E+  L R  H N++ L+   
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 837 RHGNDRLLIYSYME---NGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
                   I   +E    G L       V+K    + D    + Q     +AYLH   E 
Sbjct: 118 ---ETPTEISLVLELVTGGEL---FDRIVEKGYYSERDAADAVKQ-ILEAVAYLH---EN 167

Query: 894 HIVHRDVKSSNILLDEKFE-AHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
            IVHRD+K  N+L       A L  ADFGLS+++      +   + GT GY  PE    L
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPE---IL 222

Query: 951 TATCRG---DVYSFGVVLLELLTGRRP 974
                G   D++S G++   LL G  P
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEP 249

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 7e-17
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 60/231 (25%)

Query: 770 TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA-------- 820
              +     +G G +G V  A    +G K A+K+LS       R FQ+E+ A        
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75

Query: 821 -LSRAQHKNLVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-- 871
            L   QH+N++ L          R+  D  L+  +M+            D   ++     
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----------TDLQKIMGLKFS 124

Query: 872 ---VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
              ++  + Q   +GL Y+H      +VHRD+K  N+ ++E  E  + DFGL+R      
Sbjct: 125 EEKIQYLVYQ-MLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179

Query: 929 THVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
               T  V T  Y  PE       Y+QT+      D++S G ++ E+LTG+
Sbjct: 180 ---MTGYVVTRWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK 221

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.4 bits (204), Expect = 8e-17
 Identities = 54/204 (26%), Positives = 75/204 (36%), Gaps = 22/204 (10%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVK---RLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
           IG G FG+             AVK   R +     ++RE    +      +H N+V  + 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83

Query: 835 YCRHGNDRLLIYSYMENGSL-DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
                    +I  Y   G L +      +        D      Q    G++Y H +   
Sbjct: 84  VILTPTHLAIIMEYASGGELYER-----ICNAGRFSEDEARFFFQQLLSGVSYCHSM--- 135

Query: 894 HIVHRDVKSSNILLDEKFEAHL--ADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-YSQTL 950
            I HRD+K  N LLD      L   DFG S+    +    +T  VGT  YI PE   +  
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQE 193

Query: 951 TATCRGDVYSFGVVLLELLTGRRP 974
                 DV+S GV L  +L G  P
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYP 217

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 51/218 (23%)

Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 828
           +G G +G V  A     G K A+K+L        R FQ+E+ A         L   +H+N
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELRLLKHMRHEN 85

Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAA 881
           ++ L              D  L+  +M     D  L + + K   L  D ++  + Q   
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGT---D--LGK-LMKHEKLGEDRIQFLVYQ-ML 138

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
           +GL Y+H      I+HRD+K  N+ ++E  E  + DFGL+R          T  V T  Y
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWY 191

Query: 942 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
             PE       Y+QT+      D++S G ++ E++TG+
Sbjct: 192 RAPEVILNWMRYTQTV------DIWSVGCIMAEMITGK 223

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 33/238 (13%), Positives = 69/238 (28%), Gaps = 17/238 (7%)

Query: 205 SKEIQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNLLGGDLP-DSLYSMSSLQHVS 259
            +    L   +        G+  G      L+++ +  N +   +  D   ++  L  + 
Sbjct: 29  PRNAIELRFVLTKLRVIQKGAFSGF---GDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85

Query: 260 LSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLP 318
           +   N    ++ +   NL +L++L+I              +  Q        N     + 
Sbjct: 86  IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145

Query: 319 LSL--SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 376
            +    L  +  +L L  N +    +  F+G           N+      +         
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205

Query: 377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 434
           IL +++  +          L  L   S  N         L  L++   L    LT   
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARSTYNLK------KLPTLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 47/283 (16%), Positives = 97/283 (34%), Gaps = 25/283 (8%)

Query: 112 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHN-MLSGPVSGMLAGLNLIQSLNVSSN-- 168
              L      L  +     S    LE +++S N +L    + + + L  +  + +     
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91

Query: 169 --SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG-- 224
               N   F+     NL    ISN      L       S +  +LD+  N  + +++   
Sbjct: 92  LLYINPEAFQ--NLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148

Query: 225 -LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNLTSLRHL 282
            +  S     L ++ N +  ++ +S ++ + L  ++LS NN   +L   +    +    L
Sbjct: 149 FVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207

Query: 283 IIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS------ 336
            I   +        L NL +L     ++      LP +L     L    L   S      
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRARSTYNLKK---LP-TLEKLVALMEASLTYPSHCCAFA 263

Query: 337 --LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI 377
                  +L+     S+   ++     +    +SL++ ++   
Sbjct: 264 NWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSY 306

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 41/291 (14%), Positives = 76/291 (26%), Gaps = 63/291 (21%)

Query: 371 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL-SGTLSVLQQCKNLTTLI 429
            C + K+           +P       + + L         +  G  S      +L  + 
Sbjct: 15  LCQESKVTE---------IPSDL--PRNAIELRFVLTKLRVIQKGAFSGF---GDLEKIE 60

Query: 430 LTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNI 487
           +++N V E I  +V      L  + +       +I     +    LQ L +S      ++
Sbjct: 61  ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHL 119

Query: 488 PPWIGQ-MENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 546
           P            LD  +N        ++  ++       +                   
Sbjct: 120 PDVHKIHSLQKVLLDIQDNI-------NIHTIERNSFVGLSF---------------ESV 157

Query: 547 TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRN 606
              L  N       S F                 +   +     NN+             
Sbjct: 158 ILWLNKNGIQEIHNSAF--------------NGTQLDELNLSDNNNLEELPNDVFHGASG 203

Query: 607 LEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 656
             +LD+S   +H S+P    E L  L   S    +L+  +PT         
Sbjct: 204 PVILDISRTRIH-SLPSYGLENLKKLRARS--TYNLK-KLPT---LEKLVA 247

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 37/173 (21%), Positives = 67/173 (38%), Gaps = 15/173 (8%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNM-LSGPVSGMLAG 156
           L  I P +  +L  L+ L +S   ++ +  V   +  Q  +LD+  N+ +         G
Sbjct: 92  LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151

Query: 157 L-NLIQSLNVSSN---SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILD 212
           L      L ++ N     + S F         +    NN+   +L + ++  +    ILD
Sbjct: 152 LSFESVILWLNKNGIQEIHNSAFNG--TQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 208

Query: 213 LSMNHFMGSLQ--GLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 263
           +S      SL   GL++   L+     N      LP +L  + +L   SL+  
Sbjct: 209 ISRTRIH-SLPSYGLENLKKLRARSTYNL---KKLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 3/102 (2%)

Query: 91  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 150
           L L + G++ I   +       +L     N+LE +            +LD+S   +    
Sbjct: 159 LWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 218

Query: 151 SGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNS 192
           S  L  L  +++ +  +      L  L +   L   +++  S
Sbjct: 219 SYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYPS 257

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 57/311 (18%), Positives = 107/311 (34%), Gaps = 45/311 (14%)

Query: 91  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 150
            I     +K I         +    +L    +   V    + L  ++ +  +++ +   V
Sbjct: 7   TITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-V 61

Query: 151 SGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQI 210
            G +  L  +  L ++ N     +  L    NL    +  N                 ++
Sbjct: 62  QG-IQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDEN-----------------KV 102

Query: 211 LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS 270
            DLS          L     LK L +++N +  D+ + L  +  L+ + L  N  +    
Sbjct: 103 KDLS---------SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--I 149

Query: 271 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL 330
             +S LT L  L +  NQ S  +   L  LT+L+      N  S    L+      L VL
Sbjct: 150 TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRALAG--LKNLDVL 205

Query: 331 DLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKN--ELSGQ 388
           +L +         + S L    T+           P  +SD  D +  ++  +  E + +
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNE 263

Query: 389 VPESFGKLTSL 399
           V   F +  ++
Sbjct: 264 VSFIFYQPVTI 274

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 54/274 (19%), Positives = 100/274 (36%), Gaps = 58/274 (21%)

Query: 369 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 428
                +    +L K  ++     +  +L S+  +  +N+    + G    +Q   N+T L
Sbjct: 20  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG----IQYLPNVTKL 73

Query: 429 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 488
            L  N +  +I + +   ++L  L L    +K  +   L   KKL+ L L  N    +I 
Sbjct: 74  FLNGNKL-TDI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN 128

Query: 489 PWIGQMENLFYLDFSNNTLTG-EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRST 547
             +  +  L  L   NN +T   +   LT+L +L                          
Sbjct: 129 G-LVHLPQLESLYLGNNKITDITVLSRLTKLDTL-------------------------- 161

Query: 548 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNL 607
                           L +N+I+  I P +  L  L  L LS+N+I+     +++ ++NL
Sbjct: 162 ---------------SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNL 202

Query: 608 EVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 641
           +VL+L S +           L   +     +  L
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.9 bits (187), Expect = 6e-15
 Identities = 52/266 (19%), Positives = 86/266 (32%), Gaps = 28/266 (10%)

Query: 271 EKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSN---SFSGPLPLSLSLCSKL 327
                        +     +  +      L  ++  +A+++   S  G     +     +
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG-----IQYLPNV 70

Query: 328 HVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 386
             L L  N LT   D+   + L +L  L L  N       +SL D   LK LSL  N +S
Sbjct: 71  TKLFLNGNKLT---DIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS 125

Query: 387 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 446
                    L  L  L L NN    ++     L +   L TL L  N +  +I   + G 
Sbjct: 126 --DINGLVHLPQLESLYLGNNKITDITV----LSRLTKLDTLSLEDNQI-SDI-VPLAGL 177

Query: 447 ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNT 506
             L  L L    +   +   L   K L VL+L               +     +  ++ +
Sbjct: 178 TKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 507 LTGEIPKSLTELKSLISSNCTSSNPT 532
           L    P+ +++       N     P 
Sbjct: 236 LVT--PEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 37/233 (15%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
           +  +I     +K +    + +L  +  L L+ N L  + P  L+NLK L  L L  N + 
Sbjct: 48  IDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK 103

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 207
             +S  L  L  ++SL++  N  +  +  L     L    + NN                
Sbjct: 104 D-LSS-LKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNN---------------- 144

Query: 208 IQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG 267
            +I D++          L     L  L +++N +  D+   L  ++ LQ++ LS N+ S 
Sbjct: 145 -KITDIT---------VLSRLTKLDTLSLEDNQI-SDIV-PLAGLTKLQNLYLSKNHIS- 191

Query: 268 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLS 320
            L   ++ L +L  L +F  +   K  N   NL           S   P  +S
Sbjct: 192 DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.9 bits (130), Expect = 9e-08
 Identities = 34/163 (20%), Positives = 65/163 (39%), Gaps = 8/163 (4%)

Query: 106 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 165
           L HL QL+ L L  N +  +    LS L +L+ L L  N +S  +   LAGL  +Q+L +
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYL 185

Query: 166 SSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL 225
           S N  +  L  L    NL V  + +     K  +   +      + +   +  + + + +
Sbjct: 186 SKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS--LVTPEII 242

Query: 226 DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ 268
                 ++ +V  +L      +  +       +  +   F G+
Sbjct: 243 SDDGDYEKPNVKWHLP-EFTNEVSFIFYQPVTIGKAKARFHGR 284

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.2 bits (198), Expect = 6e-16
 Identities = 45/252 (17%), Positives = 85/252 (33%), Gaps = 63/252 (25%)

Query: 768 KSTNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH 826
            S+  ++    +G G FG+V +     +G + A+K++  D     RE       +    H
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDI----MKVLDH 59

Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD--------------- 871
            N++ L  Y     D         +         +   +                     
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 872 -----------------------VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD 908
                                  + + I Q   R + ++H +    I HRD+K  N+L++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHSL---GICHRDIKPQNLLVN 175

Query: 909 -EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-------YSQTLTATCRGDVYS 960
            +     L DFG ++ L P +       + +  Y  PE       Y+ ++      D++S
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSI------DLWS 227

Query: 961 FGVVLLELLTGR 972
            G V  EL+ G+
Sbjct: 228 IGCVFGELILGK 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.0 bits (198), Expect = 6e-16
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 49/228 (21%)

Query: 770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA-------- 820
              +   + IG G +G+V  A    N  + A+K++S         F+ +           
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--------PFEHQTYCQRTLREIK 77

Query: 821 -LSRAQHKNLVSLQ-----GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VR 873
            L R +H+N++ +             D  ++   ME    D  L++ + K   L  D + 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET---D--LYK-LLKTQHLSNDHIC 131

Query: 874 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT- 932
             + Q   RGL Y+H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H   
Sbjct: 132 YFLYQ-ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 933 -TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            T+ V T  Y  PE       Y++++      D++S G +L E+L+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSI------DIWSVGCILAEMLSNR 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 79.7 bits (197), Expect = 7e-16
 Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 51/218 (23%)

Query: 779 IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHKN 828
           +G G +G V  A  T  G + AVK+LS       R FQ+ + A         L   +H+N
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 89

Query: 829 LVSL------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAA 881
           ++ L             ND  L+   M     D  L+  + K   L  D V+  I Q   
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNN-IVKCQKLTDDHVQFLIYQ-IL 142

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
           RGL Y+H      I+HRD+K SN+ ++E  E  + DFGL+R          T  V T  Y
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWY 195

Query: 942 IPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
             PE       Y+QT+      D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 48/224 (21%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVKRLS----GDCGQMEREFQAEVEALSRAQHKNLVSL 832
            +GCGG GLV+ A       + A+K++            RE    ++ + R  H N+V +
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHDNIVKV 73

Query: 833 --------------QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
                          G     N   ++  YME    D  L   +++  +L+   RL + Q
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---D--LANVLEQGPLLEEHARLFMYQ 128

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVT--TDL 935
              RGL Y+H     +++HRD+K +N+ ++ E     + DFGL+R++ P+ +H    ++ 
Sbjct: 129 -LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 936 VGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           + T  Y  P        Y++ +      D+++ G +  E+LTG+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAI------DMWAAGCIFAEMLTGK 222

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.7 bits (187), Expect = 8e-15
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 36/223 (16%)

Query: 769 STNNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLSGDC--GQMEREFQAEVEALS 822
             + F    ++G G FG V+     +G+ A    A+K L       +     + E + L 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81

Query: 823 RAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESV--DKDSVLKWDVRLKIAQG 879
              H  +V L  Y      +L LI  ++  G L   L + V   ++     DV+  +A+ 
Sbjct: 82  EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLAE- 134

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVG 937
            A  L +LH +    I++RD+K  NILLDE  E H  L DFGLS+    ++    +   G
Sbjct: 135 LALALDHLHSL---GIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKAYS-FCG 188

Query: 938 TLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T+ Y+ PE      ++Q+       D +SFGV++ E+LTG  P
Sbjct: 189 TVEYMAPEVVNRRGHTQSA------DWWSFGVLMFEMLTGTLP 225

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 31/241 (12%), Positives = 66/241 (27%), Gaps = 74/241 (30%)

Query: 375 LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 434
                L ++  +     +  ++ SL +++L+N +   L+G    ++   N+  L +    
Sbjct: 25  YLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG----IEYAHNIKDLTINNIH 77

Query: 435 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM 494
                  N      L                       L+ L +       +  P +  +
Sbjct: 78  A-----TNYNPISGL---------------------SNLERLRIMGKDVTSDKIPNLSGL 111

Query: 495 ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 554
            +L  LD S++     I   +  L  + S               + + +N          
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNS---------------IDLSYN---------- 146

Query: 555 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSS 614
                         I  T    +  L  L  L++  + +       I +   L  L   S
Sbjct: 147 ------------GAI--TDIMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFS 190

Query: 615 N 615
            
Sbjct: 191 Q 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 27/160 (16%), Positives = 60/160 (37%), Gaps = 9/160 (5%)

Query: 368 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 427
           + +  + L  ++LA   ++           ++  L+++N    + +     +    NL  
Sbjct: 39  TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNP----ISGLSNLER 92

Query: 428 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNI 487
           L +    V  +   N+ G  SL +L + +      I   +    K+  +DLS+N    +I
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

Query: 488 PPWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSL-ISSN 525
            P +  +  L  L+   + +      +   +L  L   S 
Sbjct: 153 MP-LKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 31/211 (14%), Positives = 79/211 (37%), Gaps = 35/211 (16%)

Query: 301 TQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATN 359
           +  + ++      S    ++ +  + L  + L N ++T   DL       ++  L +   
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT---DLTGIEYAHNIKDLTINNI 76

Query: 360 HFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVL 419
           H +   P  +S   +L+ L +   +++     +   LTSL  L +S+++ +     L+ +
Sbjct: 77  HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI--LTKI 132

Query: 420 QQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLS 479
                + ++ L+ N     I  ++   ++L                      +L+ L++ 
Sbjct: 133 NTLPKVNSIDLSYN---GAI-TDIMPLKTL---------------------PELKSLNIQ 167

Query: 480 WNHFDGNIPPWIGQMENLFYLDFSNNTLTGE 510
           ++    +    I     L  L   + T+ G+
Sbjct: 168 FDGVH-DYRG-IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 28/184 (15%), Positives = 62/184 (33%), Gaps = 14/184 (7%)

Query: 274 SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLR 333
           S   +  + ++  +  +      + +LT +     +    +G     +     +  L + 
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTIN 74

Query: 334 NNSLTGPIDL-NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPES 392
           N   T   +    SGLS+L  L +     +     +LS    L +L ++ +     +   
Sbjct: 75  NIHAT---NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 393 FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVL 452
              L  +  + LS N        +  L+    L +L +  + V +     +  F  L  L
Sbjct: 132 INTLPKVNSIDLSYNG---AITDIMPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQL 186

Query: 453 ALGN 456
              +
Sbjct: 187 YAFS 190

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 29/196 (14%), Positives = 72/196 (36%), Gaps = 32/196 (16%)

Query: 97  GLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAG 156
           G       +   +N L  + L+  ++  +    +     ++ L +++   +      ++G
Sbjct: 31  GQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISG 86

Query: 157 LNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSM 215
           L+ ++ L +            L   ++L + +IS+++    + ++I +   ++  +DLS 
Sbjct: 87  LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI-NTLPKVNSIDLSY 145

Query: 216 NHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISN 275
           N  +  +  L   P LK L++  +                      V+++ G     I +
Sbjct: 146 NGAITDIMPLKTLPELKSLNIQFD---------------------GVHDYRG-----IED 179

Query: 276 LTSLRHLIIFGNQFSG 291
              L  L  F     G
Sbjct: 180 FPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 27/209 (12%), Positives = 69/209 (33%), Gaps = 33/209 (15%)

Query: 131 SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISN 190
           S  K      L  +  +  ++   A +N +  + +++ +    L  +    N+    I+N
Sbjct: 20  STFKAYLNGLLGQSSTA-NIT--EAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINN 75

Query: 191 NSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLY 250
                                + +          +    +L++L +    +  D   +L 
Sbjct: 76  I-----------------HATNYN---------PISGLSNLERLRIMGKDVTSDKIPNLS 109

Query: 251 SMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHS 310
            ++SL  + +S +     +  KI+ L  +  + +  N     +   L  L +L+      
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQF 168

Query: 311 NSFSGPLPLSLSLCSKLHVLDLRNNSLTG 339
           +       +      KL+ L   + ++ G
Sbjct: 169 DGVHDYRGIE-DF-PKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 26/172 (15%), Positives = 52/172 (30%), Gaps = 45/172 (26%)

Query: 471 KKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSNCTSS 529
             L  + L+  +   ++   I    N+  L  +N   T   P   L+ L+ L        
Sbjct: 44  NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNPISGLSNLERL-------- 93

Query: 530 NPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLS 589
                                             +    +     P +  L  L +LD+S
Sbjct: 94  ---------------------------------RIMGKDVTSDKIPNLSGLTSLTLLDIS 120

Query: 590 RNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 641
            +    +I + I+ +  +  +DLS N     I    + L  L   ++  + +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 29/179 (16%), Positives = 62/179 (34%), Gaps = 31/179 (17%)

Query: 229 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 288
            SL  + + N  +  DL   +    +++ ++++  + +      IS L++L  L I G  
Sbjct: 44  NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKD 99

Query: 289 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGL 348
            +      L  LT L                         +LD+ +++    I    + L
Sbjct: 100 VTSDKIPNLSGLTSLT------------------------LLDISHSAHDDSILTKINTL 135

Query: 349 SSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNN 407
             + ++DL+ N     +   L    +LK L++  + +             L  L   + 
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 17/82 (20%), Positives = 34/82 (41%), Gaps = 2/82 (2%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
           ++N       P  I  L +L  L +   ++T     ++S + +L +LD+S +    SI  
Sbjct: 73  INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 624 SFEKLTFLSKFSVANNHLQGTI 645
               L  ++   ++ N     I
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI 152

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 17/85 (20%), Positives = 35/85 (41%), Gaps = 4/85 (4%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
           L+N  +       I    ++  L ++  + T    + IS + NLE L +   D+      
Sbjct: 51  LANINVTDLTG--IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIP 106

Query: 624 SFEKLTFLSKFSVANNHLQGTIPTG 648
           +   LT L+   ++++    +I T 
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTK 131

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 52/211 (24%), Positives = 81/211 (38%), Gaps = 17/211 (8%)

Query: 208 IQILDLSMNHFM----GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYS-MSSLQHVSLSV 262
            + LDLS N        S       P L+ L +    +   + D  Y  +S L  + L+ 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSF---PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85

Query: 263 NNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF-SGPLPLS 320
           N     L+    S L+SL+ L+      +      +G+L  L+      N   S  LP  
Sbjct: 86  NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 321 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL----CTLDLATNHFSGPLPNSLSDCHDLK 376
            S  + L  LDL +N +      +   L  +     +LDL+ N  +  +         LK
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLK 203

Query: 377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNN 407
            L+L  N+L       F +LTSL  + L  N
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 47/245 (19%), Positives = 70/245 (28%), Gaps = 46/245 (18%)

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 336
            S ++L +  N           +  +L+                         LDL    
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQV------------------------LDLSRCE 63

Query: 337 LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL 396
           +    D  +  LS L TL L  N        + S    L+ L   +  L+       G L
Sbjct: 64  IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

Query: 397 TSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGN 456
            +L  L++++N                NL  L L+ N + + I         L  + L N
Sbjct: 124 KTLKELNVAHNLIQSFK-LPEYFSNLTNLEHLDLSSNKI-QSIYCTD--LRVLHQMPLLN 179

Query: 457 CGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLT 516
                              LDLS N  +  I P   +   L  L    N L         
Sbjct: 180 -----------------LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFD 221

Query: 517 ELKSL 521
            L SL
Sbjct: 222 RLTSL 226

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.5 bits (163), Expect = 6e-12
 Identities = 57/254 (22%), Positives = 92/254 (36%), Gaps = 55/254 (21%)

Query: 112 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 171
            K LDLS N L  +      +  +L+VLDLS   +     G    L+ + +L ++ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN--- 86

Query: 172 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG--LDHSP 229
                      +   +++  +F+G            +Q L     +   SL+   + H  
Sbjct: 87  ----------PIQ--SLALGAFSG---------LSSLQKLVAVETNLA-SLENFPIGHLK 124

Query: 230 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 289
           +LK+L+V +NL+            S +        F        SNLT+L HL +  N+ 
Sbjct: 125 TLKELNVAHNLI-----------QSFK----LPEYF--------SNLTNLEHLDLSSNKI 161

Query: 290 SGKLPNVLGNLTQLEFFVA----HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNF 345
                  L  L Q+           N  +  +        +L  L L  N L    D  F
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIF 220

Query: 346 SGLSSLCTLDLATN 359
             L+SL  + L TN
Sbjct: 221 DRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 55/273 (20%), Positives = 87/273 (31%), Gaps = 74/273 (27%)

Query: 374 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
             K L L+ N L      SF     L  L LS      +       Q   +L+TLILT N
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED--GAYQSLSHLSTLILTGN 86

Query: 434 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI-G 492
            + + +      F  L                       LQ L     +   ++  +  G
Sbjct: 87  PI-QSLALGA--FSGL---------------------SSLQKLVAVETNLA-SLENFPIG 121

Query: 493 QMENLFYLDFSNNTLTGEIPK-----SLTELKSLISSNCTSSNPTASAGIPLYVKHNRST 547
            ++ L  L+ ++N +           +LT L+ L                          
Sbjct: 122 HLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHL-------------------------- 154

Query: 548 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHV-LDLSRNNITGTIPSSISEIRN 606
             L  N+  S   +               + Q+  L++ LDLS N +   I     +   
Sbjct: 155 -DLSSNKIQSIYCTDLRV-----------LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR 201

Query: 607 LEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 639
           L+ L L +N L     G F++LT L K  +  N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 9/182 (4%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
            +L L R  ++ I   +   L+ L  L L+ N ++ +     S L  L+ L      L+ 
Sbjct: 55  QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114

Query: 149 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFS---NLAVFNISNNSFTGKLNSRIWSAS 205
             +  +  L  ++ LNV+ N    S      FS   NL   ++S+N     +        
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172

Query: 206 KEIQI----LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLS 261
            ++ +    LDLS+N       G      LK+L +D N L          ++SLQ + L 
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 232

Query: 262 VN 263
            N
Sbjct: 233 TN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 19/113 (16%), Positives = 40/113 (35%), Gaps = 18/113 (15%)

Query: 550 LPYNQASSFPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIP 598
           L   +  +     +          L+ N I  ++       L  L  L     N+  ++ 
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLE 116

Query: 599 SSISEI-RNLEVLDLSSNDLHGSIP--GSFEKLTFLSKFSVANNHLQGTIPTG 648
           +      + L+ L+++ N +  S      F  LT L    +++N +Q +I   
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCT 167

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 20/65 (30%), Positives = 33/65 (50%), Gaps = 3/65 (4%)

Query: 585 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQG 643
            LDLS N +      S      L+VLDLS  ++  +I  G+++ L+ LS   +  N +Q 
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ- 89

Query: 644 TIPTG 648
           ++  G
Sbjct: 90  SLALG 94

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 56/227 (24%)

Query: 778 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHK 827
           ++G G +G+V  AT    G   A+K++          F   + A         L   +H+
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIKILKHFKHE 69

Query: 828 NLVSLQ-----GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAA 881
           N++++          + N+  +I   M+    D  LH  V    +L  D ++  I Q   
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQT---D--LHR-VISTQMLSDDHIQYFIYQ-TL 122

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--------- 932
           R +  LH     +++HRD+K SN+L++   +  + DFGL+R++       +         
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 933 TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
            + V T  Y  PE       YS+ +      DV+S G +L EL   R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAM------DVWSCGCILAELFLRR 220

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.2 bits (185), Expect = 4e-14
 Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 37/223 (16%)

Query: 769 STNNFNQANIIGCGGFGLVY----KATLTNGTKAAVKRLSGDCGQMEREF---QAEVEAL 821
           + N F    ++G G FG V     KAT   G   A+K L  +    + E      E   L
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 202

Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQG 879
             ++H  L +L+ Y    +DRL  +  Y   G L + L     ++ V   D  R   A+ 
Sbjct: 203 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEI 257

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVG 937
            +  L YLH   E ++V+RD+K  N++LD+  + H  + DFGL +        + T   G
Sbjct: 258 VS-ALDYLHS--EKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGATMKT-FCG 311

Query: 938 TLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T  Y+ PE      Y + +      D +  GVV+ E++ GR P
Sbjct: 312 TPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 348

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.7 bits (182), Expect = 5e-14
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 38/223 (17%)

Query: 771 NNFNQANIIGCGGFGLVY--KATLTNGTKA--AVKRLS-----GDCGQMEREFQAEVEAL 821
             F    ++G GG+G V+  +      T    A+K L       +        +AE   L
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNIL 75

Query: 822 SRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQG 879
              +H  +V L  Y      +L LI  Y+  G L   L     ++ +   D     +A+ 
Sbjct: 76  EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE----REGIFMEDTACFYLAE- 129

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVG 937
            +  L +LH+     I++RD+K  NI+L+   + H  L DFGL +    +D  VT    G
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNH--QGHVKLTDFGLCK-ESIHDGTVTHTFCG 183

Query: 938 TLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           T+ Y+ PE      +++ +      D +S G ++ ++LTG  P
Sbjct: 184 TIEYMAPEILMRSGHNRAV------DWWSLGALMYDMLTGAPP 220

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 74.4 bits (183), Expect = 5e-14
 Identities = 66/347 (19%), Positives = 113/347 (32%), Gaps = 78/347 (22%)

Query: 136 LEVLDLSHNMLSG----PVSGMLAGLNLIQSLNVSSNSFNG----SLFE-LGEFSNLAVF 186
           +E   L  + ++      V  +L   + ++ + +S N+        L E +    +L + 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 187 NISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGD-- 244
             S+  FTG++   I  A + +             LQ L   P L  + + +N  G    
Sbjct: 66  EFSDI-FTGRVKDEIPEALRLL-------------LQALLKCPKLHTVRLSDNAFGPTAQ 111

Query: 245 --LPDSLYSMSSLQHVSLSVNNFS-------------GQLSEKISNLTSLRHLIIFGNQF 289
             L D L   + L+H+ L  N                  +++K  N   LR +I   N+ 
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

Query: 290 SGK----LPNVLGNLTQLEFFVAHSNSF-----SGPLPLSLSLCSKLHVLDLRNNSLTGP 340
                        +   L       N          L   L+ C +L VLDL++N+ T  
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH- 230

Query: 341 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL---- 396
                 G S+L                +L    +L+ L L    LS +   +        
Sbjct: 231 -----LGSSALA--------------IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271

Query: 397 --TSLLFLSLSNNSFNHLSGTL---SVLQQCKNLTTLILTKNFVGEE 438
               L  L L  N     +       + ++  +L  L L  N   EE
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 51/315 (16%), Positives = 91/315 (28%), Gaps = 63/315 (20%)

Query: 230 SLKQLHVDNNLLGGD----LPDSLYSMSSLQHVSLSVNNFSGQ----LSEKISNLTSLRH 281
           S++   +  + +  +    +   L    S++ + LS N    +    LSE I++   L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 282 LIIFGNQFSGK----------LPNVLGNLTQLEFFVAHSNSFS--GPLPLS--LSLCSKL 327
                                L   L    +L       N+F      PL   LS  + L
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 328 HVLDLRNNSLT-------------GPIDLNFSGLSSLCTLDLATNHFSGP----LPNSLS 370
             L L NN L                ++        L ++    N            +  
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184

Query: 371 DCHDLKILSLAKNELSGQ-----VPESFGKLTSLLFLSLSNNSF-----NHLSGTLSVLQ 420
               L  + + +N +  +     + E       L  L L +N+F     + L+     L+
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA---IALK 241

Query: 421 QCKNLTTLILTKNFVGEE----IPE--NVGGFESLMVLALGNCGLKGHIPVWLLR----- 469
              NL  L L    +       + +  +      L  L L    ++      L       
Sbjct: 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 301

Query: 470 CKKLQVLDLSWNHFD 484
              L  L+L+ N F 
Sbjct: 302 MPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 59/407 (14%), Positives = 110/407 (27%), Gaps = 109/407 (26%)

Query: 254 SLQHVSLSVNNFSGQ----LSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 309
           S++  SL ++  + +    +   +    S++ +++ GN    +    L            
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN--------- 55

Query: 310 SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL 369
                      ++    L + +  +       D     L  L                +L
Sbjct: 56  -----------IASKKDLEIAEFSDIFTGRVKDEIPEALRLLL--------------QAL 90

Query: 370 SDCHDLKILSLAKNELSGQVPESFGKL----TSLLFLSLSNNSF-----NHLSGTL---- 416
             C  L  + L+ N       E         T L  L L NN         ++  L    
Sbjct: 91  LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELA 150

Query: 417 --SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQ 474
                +    L ++I  +N +            S+   A                 + L 
Sbjct: 151 VNKKAKNAPPLRSIICGRNRLENG---------SMKEWAKT-----------FQSHRLLH 190

Query: 475 VLDLSWNHF-DGNIPPWIGQ----MENLFYLDFSNNTLT-------GEIPKSLTELKSLI 522
            + +  N      I   + +     + L  LD  +NT T           KS   L+ L 
Sbjct: 191 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250

Query: 523 SSNCTSSNPTASA-GIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQ-- 579
            ++C  S   A+A         N     L             L  N I       +    
Sbjct: 251 LNDCLLSARGAAAVVDAFSKLENIGLQTL------------RLQYNEIELDAVRTLKTVI 298

Query: 580 ---LKHLHVLDLSRNNIT--GTIPSSISEI----RNLEVLDLSSNDL 617
              +  L  L+L+ N  +    +   I E+       E+ +L   + 
Sbjct: 299 DEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEE 345

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 26/131 (19%), Positives = 48/131 (36%), Gaps = 25/131 (19%)

Query: 96  KGLKGIIPRSLGHLNQLKLLDLSCNHL--EGVVPV--ELSNLKQLEVLDLSHNMLSGPVS 151
           +G++ ++   L +  +LK+LDL  N     G   +   L +   L  L L+  +LS    
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA--R 259

Query: 152 GMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGK----LNSRIWSASKE 207
           G  A   ++ + +   N              L    +  N         L + I     +
Sbjct: 260 GAAA---VVDAFSKLEN------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304

Query: 208 IQILDLSMNHF 218
           +  L+L+ N F
Sbjct: 305 LLFLELNGNRF 315

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 74.0 bits (182), Expect = 5e-14
 Identities = 53/244 (21%), Positives = 89/244 (36%), Gaps = 32/244 (13%)

Query: 779 IGCGGFGLVYKATLTNGT------KAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSL 832
           IG GGFG +Y A + +           VK    D G +  E +    A    Q +  +  
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 833 QGYCRHGNDRLLIYSYMENGSLDY-------------WLHESVDKDSVLKWDVRLKIAQG 879
           +     G  +       +     Y              ++E+  K    K  V L+++  
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRK-TV-LQLSLR 160

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE--AHLADFGLSRLLRPYDTHV------ 931
               L Y+H   E   VH D+K+SN+LL+ K     +L D+GL+    P   H       
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217

Query: 932 TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVF 991
                GT+ +   +    +  + RGD+   G  +++ LTG  P E           S + 
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR 277

Query: 992 QMKS 995
             ++
Sbjct: 278 YREN 281

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.1 bits (180), Expect = 9e-14
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 44/228 (19%)

Query: 771 NNFNQANIIGCGGFGLVYKATLTNGTKA----AVKRLS----------GDCGQMEREFQA 816
            NF    ++G G +G V+     +G       A+K L            +  + ER+   
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 817 EVEALSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESV--DKDSVLKWDVR 873
            +      Q   LV+L  Y      +L LI  Y+  G L   L +     +      +V+
Sbjct: 114 HIR-----QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQ 162

Query: 874 LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHV 931
           + + +     L +LHK+    I++RD+K  NILLD     H  L DFGLS+     +T  
Sbjct: 163 IYVGE-IVLALEHLHKL---GIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETER 216

Query: 932 TTDLVGTLGYIPPEYSQTLTATCRG-----DVYSFGVVLLELLTGRRP 974
             D  GT+ Y+ P+    +     G     D +S GV++ ELLTG  P
Sbjct: 217 AYDFCGTIEYMAPD---IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 49/238 (20%), Positives = 91/238 (38%), Gaps = 34/238 (14%)

Query: 321 LSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 379
               +     +L   S+T   DL +   LS +   +   ++        +    +LK L 
Sbjct: 15  DPGLANAVKQNLGKQSVT---DLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELH 69

Query: 380 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 439
           L+ N++S         LT L  LS++ N   +L+G          L+ L L  N +    
Sbjct: 70  LSHNQIS--DLSPLKDLTKLEELSVNRNRLKNLNGI-----PSACLSRLFLDNNEL--RD 120

Query: 440 PENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFY 499
            +++   ++L +L++ N  LK  I + L    KL+VLDL  N    N    + +++ + +
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNW 176

Query: 500 LDFSNNTLTGEIPKSLTELKSL---------------ISSNCTSSNPTASAGIPLYVK 542
           +D +      E  K   EL                  IS+  +  +      +P+Y  
Sbjct: 177 IDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTD 234

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 33/198 (16%), Positives = 71/198 (35%), Gaps = 14/198 (7%)

Query: 106 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 165
              L      +L    +  +V      L  ++  +  ++ +   ++G +     ++ L++
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS-LAG-MQFFTNLKELHL 70

Query: 166 SSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL 225
           S N  +  L  L + + L   +++ N     LN      S  +  L L  N        L
Sbjct: 71  SHNQIS-DLSPLKDLTKLEELSVNRNRLK-NLNG---IPSACLSRLFLDNNELR-DTDSL 124

Query: 226 DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIF 285
            H  +L+ L + NN L   +   L  +S L+ + L  N  +      ++ L  +  + + 
Sbjct: 125 IHLKNLEILSIRNNKL-KSI-VMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLT 180

Query: 286 GNQFSGKLPNVLGNLTQL 303
           G +   +       L   
Sbjct: 181 GQKCVNEPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 44/264 (16%), Positives = 79/264 (29%), Gaps = 81/264 (30%)

Query: 369 LSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL 428
                +    +L K  ++     S  +L+ +   +  N++   L+G    +Q   NL  L
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAG----MQFFTNLKEL 68

Query: 429 ILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIP 488
            L+ N    +I  ++   + L                      KL+ L ++ N    N+ 
Sbjct: 69  HLSHN----QI-SDLSPLKDL---------------------TKLEELSVNRNRLK-NLN 101

Query: 489 PWIGQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRST 547
                   L  L   NN L        L  L+ L                          
Sbjct: 102 G--IPSACLSRLFLDNNELRDTDSLIHLKNLEIL-------------------------- 133

Query: 548 NGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNL 607
                           + NN++  +I   +G L  L VLDL  N IT      ++ ++ +
Sbjct: 134 ---------------SIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN--TGGLTRLKKV 174

Query: 608 EVLDLSSNDLHGSIPGSFEKLTFL 631
             +DL+             +L   
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 33/176 (18%), Positives = 64/176 (36%), Gaps = 38/176 (21%)

Query: 106 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 165
           L  L +L+ L ++ N L+ +  +  + L +   L L +N L    S  L  L  ++ L++
Sbjct: 81  LKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNELRDTDS--LIHLKNLEILSI 135

Query: 166 SSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL 225
            +N    S+  LG  S L V ++  N                 +I +           GL
Sbjct: 136 RNNKLK-SIVMLGFLSKLEVLDLHGN-----------------EITNTG---------GL 168

Query: 226 DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE--KISNLTSL 279
                +  + +        + + +     L  ++ +V +  G+      ISN  S 
Sbjct: 169 TRLKKVNWIDLTGQKC---VNEPVKYQPELY-ITNTVKDPDGRWISPYYISNGGSY 220

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 28/194 (14%), Positives = 56/194 (28%), Gaps = 69/194 (35%)

Query: 470 CKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP--KSLTELKSLISSNCT 527
                  +L       ++     ++  +   +  N+ +   +   +  T LK L      
Sbjct: 18  LANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKEL------ 68

Query: 528 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLD 587
                                               LS+N+I+  + P +  L  L  L 
Sbjct: 69  -----------------------------------HLSHNQIS-DLSP-LKDLTKLEELS 91

Query: 588 LSRNNITG-------------------TIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKL 628
           ++RN +                         S+  ++NLE+L + +N L  SI      L
Sbjct: 92  VNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFL 149

Query: 629 TFLSKFSVANNHLQ 642
           + L    +  N + 
Sbjct: 150 SKLEVLDLHGNEIT 163

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 34/219 (15%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREF---QAEVEALSRAQH 826
           N+F+   ++G G FG V        G   A+K L  +    + E      E   L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 827 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGL 884
             L +L+ Y    +DRL  +  Y   G L + L     ++ V   +  R   A+     L
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAE-IVSAL 118

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDLVGTLGY 941
            YLH      +V+RD+K  N++LD+  + H  + DFGL +  +    T       GT  Y
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171

Query: 942 IPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           + PE      Y + +      D +  GVV+ E++ GR P
Sbjct: 172 LAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.1 bits (179), Expect = 3e-13
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 45/225 (20%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD---------CGQMEREFQAEVEA 820
            +FN   ++G G FG V  +         AVK L  D         C  +E+   A    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-- 398

Query: 821 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 878
               +   L  L   C    DRL  +  Y+  G L Y +     +    K        A+
Sbjct: 399 ---GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAE 450

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 935
             A GL +L       I++RD+K  N++LD   E H  +ADFG+ +  +    T  T   
Sbjct: 451 -IAIGLFFLQ---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVT--TKTF 502

Query: 936 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            GT  YI PE      Y +++      D ++FGV+L E+L G+ P
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAP 541

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 50/220 (22%), Positives = 78/220 (35%), Gaps = 29/220 (13%)

Query: 779 IGCGGFGLVYKAT--LTNGTKA--AVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG 834
           IG GGFGL+Y A         A   VK    + G +  E +       +   K  +  + 
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 835 YCRHGNDRLLIYSYMENGSLDYW------LHESVDKDSVLKWDVR------LKIAQGAAR 882
               G          E     Y       L   + K  +   +        L++      
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK--ISGQNGTFKKSTVLQLGIRMLD 162

Query: 883 GLAYLHKVCEPHIVHRDVKSSNILLDEKFE--AHLADFGLSRLLRPYDTHV------TTD 934
            L Y+H+      VH D+K++N+LL  K     +LAD+GLS    P   H          
Sbjct: 163 VLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219

Query: 935 LVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
             GT+ +   +  + +  + R DV   G  +L  L G+ P
Sbjct: 220 HNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.2 bits (177), Expect = 3e-13
 Identities = 49/265 (18%), Positives = 91/265 (34%), Gaps = 83/265 (31%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHK 827
           +IG G +G V +A         A+K++        R F+  ++          L+R  H 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHD 112

Query: 828 NLVSLQ-----GYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAA 881
           ++V +            ++  ++    +    D    +       L    ++  +     
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD---SD--FKKLFRTPVYLTELHIKTLLYN-LL 166

Query: 882 RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--------- 932
            G+ Y+H      I+HRD+K +N L+++     + DFGL+R +   +   +         
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 933 -----------------TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLEL 968
                            T  V T  Y  PE       Y++ +      DV+S G +  EL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI------DVWSIGCIFAEL 277

Query: 969 LT----------GRRPVEVCKGKNC 983
           L            R P  +  G +C
Sbjct: 278 LNMIKENVAYHADRGP--LFPGSSC 300

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.7 bits (176), Expect = 5e-13
 Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 60/238 (25%)

Query: 778 IIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEA---------LSRAQHK 827
           +IG G +G VY A         A+K+++       R F+  ++          L+R +  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREITILNRLKSD 85

Query: 828 NLVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGL 884
            ++ L       +      +Y  +E    D  L +       L  + ++  +      G 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLE--IADSDLKKLFKTPIFLTEEHIKTILYN-LLLGE 142

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT------------ 932
            ++H+     I+HRD+K +N LL++     + DFGL+R +                    
Sbjct: 143 NFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199

Query: 933 ---------TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                    T  V T  Y  PE       Y++++      D++S G +  ELL   + 
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI------DIWSTGCIFAELLNMLQS 251

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.7 bits (174), Expect = 6e-13
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 45/225 (20%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD---------CGQMEREFQAEVEA 820
            +FN   ++G G FG V  +         AVK L  D         C  +E+   A    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-- 77

Query: 821 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 878
               +   L  L   C    DRL  +  Y+  G L Y +     +    K        A+
Sbjct: 78  ---GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAE 129

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 935
             A GL +L       I++RD+K  N++LD   E H  +ADFG+ +  +    T  T   
Sbjct: 130 -IAIGLFFLQ---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVT--TKTF 181

Query: 936 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            GT  YI PE      Y +++      D ++FGV+L E+L G+ P
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAP 220

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 47/184 (25%), Positives = 68/184 (36%), Gaps = 14/184 (7%)

Query: 229 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS--EKISNLTSLRHLIIFG 286
                LH+  NLL      +L   + L  ++L       +L+  +    L  L  L +  
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA----ELTKLQVDGTLPVLGTLDLSH 86

Query: 287 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL--SLCSKLHVLDLRNNSLTG-PIDL 343
           NQ    LP +   L  L       N  +  LPL     L  +L  L L+ N L   P  L
Sbjct: 87  NQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGL-GELQELYLKGNELKTLPPGL 143

Query: 344 NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLS 403
             +    L  L LA N+ +      L+   +L  L L +N L   +P+ F     L F  
Sbjct: 144 -LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAF 201

Query: 404 LSNN 407
           L  N
Sbjct: 202 LHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 48/205 (23%), Positives = 71/205 (34%), Gaps = 39/205 (19%)

Query: 473 LQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLTGEIP--KSLTELKSL-ISSNCTS 528
             +L LS N                L  L+     LT ++    +L  L +L +S N   
Sbjct: 33  TTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQ 90

Query: 529 SNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDL 588
           S P     +P       +   + +N+ +S P                    L  L  L L
Sbjct: 91  SLPLLGQTLP-----ALTVLDVSFNRLTSLPLGAL--------------RGLGELQELYL 131

Query: 589 SRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIP 646
             N +  T+P  + +    LE L L++N+L   +P G    L  L    +  N L  TIP
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 647 TGGQFYSFPNSSFE-----GNPGLC 666
            G     F +         GNP LC
Sbjct: 189 KG----FFGSHLLPFAFLHGNPWLC 209

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 43/204 (21%), Positives = 65/204 (31%), Gaps = 48/204 (23%)

Query: 327 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSG-PLPNSLSDCHDLKILSLAKNEL 385
             +L L  N L           + L  L+L     +   +  +L     L  L L+ N+L
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP---VLGTLDLSHNQL 89

Query: 386 SGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGG 445
              +P     L +L  L +S N    L   L  L+    L  L L  N + + +P  +  
Sbjct: 90  Q-SLPLLGQTLPALTVLDVSFNRLTSLP--LGALRGLGELQELYLKGNEL-KTLPPGL-- 143

Query: 446 FESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH--------FDGNIPPWIGQMENL 497
                                     KL+ L L+ N+         +G        +ENL
Sbjct: 144 LTPT---------------------PKLEKLSLANNNLTELPAGLLNG--------LENL 174

Query: 498 FYLDFSNNTLTGEIPKSLTELKSL 521
             L    N+L   IPK       L
Sbjct: 175 DTLLLQENSLYT-IPKGFFGSHLL 197

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 52/276 (18%), Positives = 82/276 (29%), Gaps = 81/276 (29%)

Query: 345 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSL 404
            S ++S   ++    + +  LP  L    D  IL L++N L      +    T L  L+L
Sbjct: 6   VSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 405 SNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 464
                      L V      L TL L+ N + + +P      ++L               
Sbjct: 63  DRAELT----KLQVDGTLPVLGTLDLSHNQL-QSLP---LLGQTL--------------- 99

Query: 465 VWLLRCKKLQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLTGEIP----KSLTELK 519
                   L VLD+S+N    ++P      +  L  L    N L   +P        +L+
Sbjct: 100 ------PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLE 151

Query: 520 SLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQ 579
            L                            L  N  +  P  +                 
Sbjct: 152 KL---------------------------SLANNNLTELPAGLL--------------NG 170

Query: 580 LKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 615
           L++L  L L  N++  TIP        L    L  N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 43/202 (21%), Positives = 61/202 (30%), Gaps = 31/202 (15%)

Query: 136 LEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTG 195
             +L LS N+L       L     +  LN+        L +L     L            
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE----LTKLQVDGTL------------ 76

Query: 196 KLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSS 254
                       +  LDLS N    SL  L    P+L  L V  N L      +L  +  
Sbjct: 77  ----------PVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125

Query: 255 LQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 313
           LQ + L  N     L   + +    L  L +  N  +     +L  L  L+  +   NS 
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 314 SGPLPLSLSLCSKLHVLDLRNN 335
              +P        L    L  N
Sbjct: 185 YT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 31/175 (17%), Positives = 52/175 (29%), Gaps = 49/175 (28%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
             L L    L+ + P     L  L +LD+S N L  +    L  L +L+ L L  N L  
Sbjct: 80  GTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 149 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI 208
              G+L     ++ L++++N                                        
Sbjct: 139 LPPGLLTPTPKLEKLSLANN---------------------------------------- 158

Query: 209 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 263
            + +L            +   +L  L +  N L   +P   +    L    L  N
Sbjct: 159 NLTELPAGLL-------NGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.3 bits (174), Expect = 8e-13
 Identities = 42/241 (17%), Positives = 90/241 (37%), Gaps = 31/241 (12%)

Query: 103 PRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQS 162
            R      QL   +LS      V+  EL + K+L+ L+  +      +  ++  L+ +  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 163 LNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSL 222
              +   F+    +  +    A  +   + F  + +        ++++L L+       L
Sbjct: 401 EKETLQYFST--LKAVDPMRAAYLDDLRSKFLLENSVLKME-YADVRVLHLAHKDLT-VL 456

Query: 223 QGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHL 282
             L+    +  L + +N L   LP +L ++  L+ +  S N     +   ++NL  L+ L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQEL 513

Query: 283 IIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID 342
           ++  N+        L     ++                L  C +L +L+L+ NSL     
Sbjct: 514 LLCNNR--------LQQSAAIQ---------------PLVSCPRLVLLNLQGNSLCQEEG 550

Query: 343 L 343
           +
Sbjct: 551 I 551

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.5 bits (164), Expect = 1e-11
 Identities = 46/318 (14%), Positives = 95/318 (29%), Gaps = 20/318 (6%)

Query: 173 SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLK 232
              E  +       +      +   +  +   S+   +L +     +          +  
Sbjct: 237 GRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRP 296

Query: 233 QLHVDNNLLGGDLPDSLYSMSSLQHV--------SLSVNNFSGQLSEKISNLTSLRHLII 284
                 +L    L D L   +              + + +         +    L    +
Sbjct: 297 SHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCEL 356

Query: 285 FGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLN 344
              + S  L + L +  +L+     +      + L +     L          +    ++
Sbjct: 357 SVEK-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVD 415

Query: 345 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSL 404
               + L  L    + F         +  D+++L LA  +L+  V     +L  +  L L
Sbjct: 416 PMRAAYLDDLR---SKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDL 470

Query: 405 SNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 464
           S+N    L   L+     + L  L  + N + E +   V     L  L L N  L+    
Sbjct: 471 SHNRLRALPPALA---ALRCLEVLQASDNAL-ENVD-GVANLPRLQELLLCNNRLQQSAA 525

Query: 465 VWLLR-CKKLQVLDLSWN 481
           +  L  C +L +L+L  N
Sbjct: 526 IQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.5 bits (159), Expect = 5e-11
 Identities = 56/394 (14%), Positives = 110/394 (27%), Gaps = 26/394 (6%)

Query: 18  WLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQWDGVVCG 77
           W + +  +                + + LKE    L   +  T  +++S       ++  
Sbjct: 181 WHYRSCLLPQLHPQPDSGPQGRLPENVLLKEL--ELVQNAFFTDPNDQSAWFYHRWLLGR 238

Query: 78  HGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSN----- 132
                 +      +      L     R L   +++  L L  +     V     +     
Sbjct: 239 AEPH--DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRP 296

Query: 133 ----LKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNI 188
               L  L    L+  +       +  G +  +   +  +       +      L    +
Sbjct: 297 SHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCEL 356

Query: 189 SNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDS 248
           S      K            ++ +L   +    L  +    +L  L  +   L       
Sbjct: 357 SVE----KSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK 412

Query: 249 LYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA 308
                   ++    + F  + S        +R L +     +  L + L  L  +     
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDL 470

Query: 309 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATNHFSG-PLP 366
             N     LP +L+    L VL   +N+L    ++   + L  L  L L  N        
Sbjct: 471 SHNRLRA-LPPALAALRCLEVLQASDNALE---NVDGVANLPRLQELLLCNNRLQQSAAI 526

Query: 367 NSLSDCHDLKILSLAKNELSGQVPESFGKLTSLL 400
             L  C  L +L+L  N L  Q      +L  +L
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEML 559

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.4 bits (156), Expect = 1e-10
 Identities = 55/335 (16%), Positives = 101/335 (30%), Gaps = 54/335 (16%)

Query: 313 FSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC 372
           FS PL +   + + L ++D    S+        +  S +   DL     +  LP      
Sbjct: 261 FSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRV 320

Query: 373 HDLKILSLAKNELSGQVPESFGK-LTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 431
                 S  +  L    PE + +   +   L     S    +   S L+ CK L  L   
Sbjct: 321 IWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPE 380

Query: 432 KNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWI 491
             +    +   +    +L  L      L+    +  +   +   LD   + F        
Sbjct: 381 NKW---CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLK 437

Query: 492 GQMENLFYLDFSNNTLTGEIP--KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNG 549
            +  ++  L  ++  LT  +   + L  +  L                            
Sbjct: 438 MEYADVRVLHLAHKDLT-VLCHLEQLLLVTHL---------------------------- 468

Query: 550 LPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEV 609
                         LS+NR+   +PP +  L+ L VL  S N +   +   ++ +  L+ 
Sbjct: 469 -------------DLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQE 512

Query: 610 LDLSSNDLHGSIPG--SFEKLTFLSKFSVANNHLQ 642
           L L +N L               L   ++  N L 
Sbjct: 513 LLLCNNRL-QQSAAIQPLVSCPRLVLLNLQGNSLC 546

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.1 bits (172), Expect = 1e-12
 Identities = 64/239 (26%), Positives = 101/239 (42%), Gaps = 68/239 (28%)

Query: 777 NIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA----------- 824
             +G G +G+V+K+     G   AVK++          FQ   +A  R            
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQ-RTFREIMILTELS 66

Query: 825 QHKNLVSLQGYCR--HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLK--IAQGA 880
            H+N+V+L    R  +  D  L++ YME    D  LH +V + ++L+  V  +  + Q  
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMET---D--LH-AVIRANILE-PVHKQYVVYQ-L 118

Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT-------- 932
            + + YLH      ++HRD+K SNILL+ +    +ADFGLSR                  
Sbjct: 119 IKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 933 ------------TDLVGTLGYIPPE-------YSQTLTATCRGDVYSFGVVLLELLTGR 972
                       TD V T  Y  PE       Y++ +      D++S G +L E+L G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI------DMWSLGCILGEILCGK 228

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 34/161 (21%), Positives = 59/161 (36%), Gaps = 20/161 (12%)

Query: 317 LPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 376
           +  +LS       L L  N++   I  + SG+ +L  L L  N     + N  +    L+
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLE 96

Query: 377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVG 436
            L ++ N+++        KL +L  L +SNN   +    +  L     L  L+L  N + 
Sbjct: 97  ELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGE-IDKLAALDKLEDLLLAGNPLY 153

Query: 437 EEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLD 477
            +  E              N     +    + R   L+ LD
Sbjct: 154 NDYKE--------------NNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 31/138 (22%), Positives = 55/138 (39%), Gaps = 27/138 (19%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           +  +L  L   K L LS N++E +    LS ++ L +L L  N++   +  + A  + ++
Sbjct: 40  MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIKK-IENLDAVADTLE 96

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
            L +S N    SL  + +  NL V  +SNN                 +I +         
Sbjct: 97  ELWISYNQIA-SLSGIEKLVNLRVLYMSNN-----------------KITNWG------E 132

Query: 222 LQGLDHSPSLKQLHVDNN 239
           +  L     L+ L +  N
Sbjct: 133 IDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 21/79 (26%), Positives = 31/79 (39%), Gaps = 4/79 (5%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
                I   +   +  LK    L LS NNI   I SS+S + NL +L L  N +   I  
Sbjct: 32  GMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIEN 87

Query: 624 SFEKLTFLSKFSVANNHLQ 642
                  L +  ++ N + 
Sbjct: 88  LDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 30/155 (19%), Positives = 53/155 (34%), Gaps = 40/155 (25%)

Query: 365 LPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKN 424
           +  +LS     K L+L+ N +      S   + +L  LSL  N    +    +V      
Sbjct: 40  MDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRNLIKKIENLDAV---ADT 94

Query: 425 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFD 484
           L  L ++ N +      ++ G E L                       L+VL +S N   
Sbjct: 95  LEELWISYNQI-----ASLSGIEKL---------------------VNLRVLYMSNN--- 125

Query: 485 GNIPPW-----IGQMENLFYLDFSNNTLTGEIPKS 514
             I  W     +  ++ L  L  + N L  +  ++
Sbjct: 126 -KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.6 bits (171), Expect = 1e-12
 Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 21/211 (9%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQ 825
           + F++   +G G FG V       +G   A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVN 99

Query: 826 HKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARG 883
              LV L+ +    N  L ++  Y+  G +   L     +         R   AQ     
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQ-IVLT 153

Query: 884 LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
             YLH +    +++RD+K  N+L+D++    + DFG ++         T  L GT   + 
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALA 206

Query: 944 PEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           PE   +       D ++ GV++ E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 45/225 (20%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLS---------GDCGQMEREFQAEVEA 820
            +F+   +IG G +  V    L       A+K +           D  Q E+    +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-- 66

Query: 821 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 878
              + H  LV L   C     RL  +  Y+  G L + +     +   L  +  R   A+
Sbjct: 67  ---SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAE 118

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 935
             +  L YLH   E  I++RD+K  N+LLD   E H  L D+G+ +  LRP DT  T+  
Sbjct: 119 -ISLALNYLH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDT--TSTF 170

Query: 936 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            GT  YI PE      Y  ++      D ++ GV++ E++ GR P
Sbjct: 171 CGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 209

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 69.2 bits (170), Expect = 2e-12
 Identities = 73/263 (27%), Positives = 103/263 (39%), Gaps = 42/263 (15%)

Query: 728 IDDLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANIIGCGGFGLV 787
           I    E        +   A S+ +    S       SD       F+   +IG G FG V
Sbjct: 2   ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGKV 54

Query: 788 YKATL-TNGTKAAVKRLSGDCGQMEREF---QAEVEALSRA-QHKNLVSLQGYCRHGNDR 842
             A         AVK L       ++E     +E   L +  +H  LV L  +     D+
Sbjct: 55  LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADK 113

Query: 843 L-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQGAARGLAYLHKVCEPHIVHRDV 900
           L  +  Y+  G L Y L     ++        R   A+  A  L YLH +   +IV+RD+
Sbjct: 114 LYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAE-IASALGYLHSL---NIVYRDL 165

Query: 901 KSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDLVGTLGYIPPE------YSQTLT 951
           K  NILLD   + H  L DFGL +  +    T  T+   GT  Y+ PE      Y +T+ 
Sbjct: 166 KPENILLDS--QGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTV- 220

Query: 952 ATCRGDVYSFGVVLLELLTGRRP 974
                D +  G VL E+L G  P
Sbjct: 221 -----DWWCLGAVLYEMLYGLPP 238

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 51/283 (18%), Positives = 93/283 (32%), Gaps = 57/283 (20%)

Query: 779  IGCGGFGLVYKAT---------LTNGTKAAVK------RLSGDCGQMEREFQA-EVEALS 822
                  G++Y+A               K ++K      RL  +    +R  +  +V    
Sbjct: 50   QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 823  RAQHKNLV---SLQGYCRHGND-RLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIA 877
            +     L+   +  G+  H +  R L+   +  G SL   L  S       +  V L++A
Sbjct: 110  KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER-SV-LQVA 165

Query: 878  QGAARGLAYLHKVCEPHIVHRDVKSSNILL--DEKFEAHLADFGLSRLLRPYDTHV---- 931
                  L +LH   E   VH +V + NI +  +++ +  LA +G +    P   HV    
Sbjct: 166  CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 932  --TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSW 989
               +   G L +I  +  +    + R D+ S G  +L+ L G  P   C           
Sbjct: 223  GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT------- 275

Query: 990  VFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPR 1032
                +   ++          K +           C    +   
Sbjct: 276  ----EDIMKQ----------KQKFVDKPGPFVGPCGHWIRPSE 304

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 68.4 bits (168), Expect = 3e-12
 Identities = 57/218 (26%), Positives = 85/218 (38%), Gaps = 31/218 (14%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD---------CGQMEREFQAEVEA 820
            +F    ++G G FG V+ A         A+K L  D         C  +E+   +    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-- 74

Query: 821 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
               +H  L  +        + L  +  Y+  G L Y +                  A+ 
Sbjct: 75  ---WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAE- 126

Query: 880 AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDLV 936
              GL +LH      IV+RD+K  NILLD+  + H  +ADFG+ +  +       T    
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAK--TNTFC 179

Query: 937 GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
           GT  YI PE           D +SFGV+L E+L G+ P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.9 bits (169), Expect = 3e-12
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 45/225 (20%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLS---------GDCGQMEREFQAEVEA 820
            +F+   +IG G +  V    L       A++ +           D  Q E+    +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-- 109

Query: 821 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 878
              + H  LV L   C     RL  +  Y+  G L + +     +   L  +  R   A+
Sbjct: 110 ---SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAE 161

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 935
             +  L YLH   E  I++RD+K  N+LLD   E H  L D+G+ +  LRP DT  T+  
Sbjct: 162 -ISLALNYLH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDT--TSTF 213

Query: 936 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            GT  YI PE      Y  ++      D ++ GV++ E++ GR P
Sbjct: 214 CGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 252

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 70.3 bits (171), Expect = 3e-12
 Identities = 81/482 (16%), Positives = 160/482 (33%), Gaps = 126/482 (26%)

Query: 209 QILDLSMNHFMGSLQGLDHSPSLK-QLHVD--NNLLGGDLPDSLYSMSSLQHVSLSVNNF 265
           ++L ++    M  ++     PS+  +++++  + L   +   + Y++S LQ         
Sbjct: 85  EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL------ 138

Query: 266 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCS 325
             +L + +  L   ++++I G   SGK    +     L + V     F     L+L  C+
Sbjct: 139 --KLRQALLELRPAKNVLIDGVLGSGK--TWVALDVCLSYKVQCKMDF-KIFWLNLKNCN 193

Query: 326 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNEL 385
               +      L   ID N++  S         +  +  L       H +      + EL
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSD--------HSSNIKLR-----IHSI------QAEL 234

Query: 386 SGQVPESFGKLTSLLFLS-LSN----NSFNHLSGTLSVLQQCKNLTTLILTKN-----FV 435
              +     +   LL L  + N    N+FN           CK    L+ T+      F+
Sbjct: 235 RRLLKSKPYE-NCLLVLLNVQNAKAWNAFNL---------SCK---ILLTTRFKQVTDFL 281

Query: 436 GEEIPENV------GGF---ESLMVLALGNCGLKGHIPVWL-LRCKKL--QVLD---LSW 480
                 ++            E   +L             +L  R + L  +VL       
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLK-----------YLDCRPQDLPREVLTTNPRRL 330

Query: 481 NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLY 540
           +    +I   +   +N  +   + + LT  I  SL  L+                  P  
Sbjct: 331 SIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVLE------------------PAE 370

Query: 541 VKHNRSTNGLPYNQASSFPPSVFLSNNRI----NGTIPPEIGQ-LKHLH---VLDLSRNN 592
            +         +++ S FPPS  +    +       I  ++   +  LH   +++     
Sbjct: 371 YRKM-------FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423

Query: 593 ITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFY 652
            T +IPS   E++ +++ +  +  LH SI    +       F   ++ L         FY
Sbjct: 424 STISIPSIYLELK-VKLENEYA--LHRSI---VDHYNIPKTFD--SDDL-IPPYLDQYFY 474

Query: 653 SF 654
           S 
Sbjct: 475 SH 476

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.2 bits (150), Expect = 8e-10
 Identities = 61/397 (15%), Positives = 119/397 (29%), Gaps = 119/397 (29%)

Query: 730  DLDEDMGRPQRLSEALASSKLVLFQNSDCKDLTVSDLLKSTNNFNQANI----IGCGGFG 785
            ++D  +     +S  L     +L +  +     V ++L+    F  + I           
Sbjct: 50   EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109

Query: 786  LVYKAT---LTNG----TKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQG---- 834
             +Y      L N      K  V RL     Q   + +   +AL   +    V + G    
Sbjct: 110  RMYIEQRDRLYNDNQVFAKYNVSRL-----QPYLKLR---QALLELRPAKNVLIDGVLGS 161

Query: 835  --------YCRHGNDRLLIYSYMENGSLDYWLH--ESVDKDSVLK--------------- 869
                     C   + ++     M+     +WL+       ++VL+               
Sbjct: 162  GKTWVALDVCL--SYKVQ--CKMDFKI--FWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215

Query: 870  -----WDVRLKI--AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 922
                  +++L+I   Q   R L          +V  +V+++       F     +    +
Sbjct: 216  RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF-----NLS-CK 267

Query: 923  LL---RPYDTHVTTDLVGTLGYIPP--EYSQTLTATCRGDVYSFGVVL--LELLTGRRPV 975
            +L   R     VT  L            +S TLT           ++L  L+      P 
Sbjct: 268  ILLTTR--FKQVTDFLSAATTTHISLDHHSMTLTPD-----EVKSLLLKYLDCRPQDLPR 320

Query: 976  EVCK---------GKNCRDLVS-WVF--QMKSEKREVEIIDASIWHKDRE--KQLLEMLE 1021
            EV            ++ RD ++ W     +  +K    II++S+   +    +++ + L 
Sbjct: 321  EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT-TIIESSLNVLEPAEYRKMFDRLS 379

Query: 1022 IACKCIDQDPRRRPFIEEV--------VTWLDGIGID 1050
            +             F            + W D I  D
Sbjct: 380  V-------------FPPSAHIPTILLSLIWFDVIKSD 403

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 6e-09
 Identities = 106/712 (14%), Positives = 183/712 (25%), Gaps = 269/712 (37%)

Query: 404  LSNNSFNHLSGTLSVLQQCKNLTTLILTKN------FVGEEIPENVGGFESLM------- 450
            LS    +H+  +   +     L   +L+K       FV E +  N   ++ LM       
Sbjct: 46   LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN---YKFLMSPIKTEQ 102

Query: 451  -------------VLALGNCG---LKGHI----PVWLLRCKKLQVLDL------------ 478
                            L N      K ++    P   LR + L  L              
Sbjct: 103  RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR-QALLELRPAKNVLIDGVLGS 161

Query: 479  --SW------------NHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISS 524
              +W               D  I          F+L+  N      + + L +L   I  
Sbjct: 162  GKTWVALDVCLSYKVQCKMDFKI----------FWLNLKNCNSPETVLEMLQKLLYQIDP 211

Query: 525  NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRING-TIPPEIGQLKHL 583
            N T S    S+ I            L  +   +    +  S    N   +   +   K  
Sbjct: 212  NWT-SRSDHSSNIK-----------LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259

Query: 584  HVLDLS-RNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP-----GSF---EKLTFLSKF 634
            +  +LS +  +T T        R  +V D  S      I       +    E  + L K+
Sbjct: 260  NAFNLSCKILLT-T--------RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310

Query: 635  SVANNHLQGTIPTGGQFYSFPNSSFEGNP---GLCGE--IDSPC------DSMHAKLKPV 683
                           +    P      NP    +  E   D              KL  +
Sbjct: 311  ------------LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358

Query: 684  IPSGSNSKFGPGSI------IAITFSIGVGI-ALLLAVTLLKMSRRDSGCPIDDLDEDMG 736
            I   S +   P         +++ F     I  +LL++    + + D    +  +++   
Sbjct: 359  I-ESSLNVLEPAEYRKMFDRLSV-FPPSAHIPTILLSLIWFDVIKSD---VMVVVNK--- 410

Query: 737  RPQRLSEALASSKLVLFQNSDCKDLTVS--DLLKSTNNFNQANIIGCGGFGLVYKATLTN 794
                    L    LV       K+ T+S   +                   L  K  L N
Sbjct: 411  --------LHKYSLV---EKQPKESTISIPSIY------------------LELKVKLEN 441

Query: 795  GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS----LQGYCRHGNDRLLIYSYME 850
                                         A H+++V      + +    +D +  Y    
Sbjct: 442  ---------------------------EYALHRSIVDHYNIPKTFD--SDDLIPPY---- 468

Query: 851  NGSLD-YWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH-KVCEPHIVHRDVKSSNILLD 908
               LD Y+                          + + H K  E     R      + LD
Sbjct: 469  ---LDQYFYSH-----------------------IGH-HLKNIEHP--ERMTLFRMVFLD 499

Query: 909  EKF-EAHLADFGLSRLLRPYDTHVTTDLVGTLGYI---PPEYSQTLTATCRGDVYSFGVV 964
             +F E  +     +        +    L     YI    P+Y + + A            
Sbjct: 500  FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA------------ 547

Query: 965  LLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL 1016
            +L+ L   +  E        DL+      + E     I +      +  KQ+
Sbjct: 548  ILDFL--PKIEENLICSKYTDLLRIALMAEDE----AIFE------EAHKQV 587

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 8e-05
 Identities = 59/364 (16%), Positives = 114/364 (31%), Gaps = 98/364 (26%)

Query: 731  LDEDMGRPQRLSEALASSKLVLF-QNSDCKD--------LT---VSDLLKSTNNFNQANI 778
            +D + G  Q   + + S     F  N DCKD        L+   +  ++ S +  +    
Sbjct: 7    MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            +    F  +    L+   +  V++   +  ++  +F                 ++   R 
Sbjct: 67   L----FWTL----LSKQEEM-VQKFVEEVLRINYKFLMS-------------PIKTEQRQ 104

Query: 839  GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGLAYLHKVCEPH--- 894
             +    +Y    +      L+   D     K++V RL+      + L  L     P    
Sbjct: 105  PSMMTRMYIEQRDR-----LYN--DNQVFAKYNVSRLQPYLKLRQALLEL----RPAKNV 153

Query: 895  IVHRDV---KSS---NILLDEKFEAHLADFG-----LSRLLRPYDTHVTTDLVGTLGYIP 943
            ++   +   K+    ++ L  K +  + DF      L     P    V   L   L  I 
Sbjct: 154  LIDGVLGSGKTWVALDVCLSYKVQCKM-DFKIFWLNLKNCNSPET--VLEMLQKLLYQID 210

Query: 944  PEYSQTLTATCRG--DVYSFGVVLLELLTGRRPVE-------VCKGK-------NCRDLV 987
            P ++     +      ++S    L  LL  +           V   K       +C+ L+
Sbjct: 211  PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL 270

Query: 988  SWVFQMKSEKREVEIIDA-------SIWHKDREKQLL--EMLEIACKCIDQDPRRRPFIE 1038
            +         R  ++ D         I        L   E+  +  K +D  P+  P   
Sbjct: 271  T--------TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP--R 320

Query: 1039 EVVT 1042
            EV+T
Sbjct: 321  EVLT 324

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.4 bits (168), Expect = 3e-12
 Identities = 63/225 (28%), Positives = 89/225 (39%), Gaps = 45/225 (20%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGD---------CGQMEREFQAEVEA 820
           +NF    ++G G FG V  A +   G   AVK L  D         C   E+   +    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-- 80

Query: 821 LSRAQHKNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWD-VRLKIAQ 878
                H  L  L   C    DRL  +  ++  G L + +     K         R   A+
Sbjct: 81  ---RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAE 132

Query: 879 GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRL-LRPYDTHVTTDL 935
                L +LH   +  I++RD+K  N+LLD   E H  LADFG+ +  +    T  T   
Sbjct: 133 -IISALMFLH---DKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGVT--TATF 184

Query: 936 VGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            GT  YI PE      Y   +      D ++ GV+L E+L G  P
Sbjct: 185 CGTPDYIAPEILQEMLYGPAV------DWWAMGVLLYEMLCGHAP 223

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 35/218 (16%)

Query: 771 NNFNQANIIGCGGFGLVYKATL-TNGTKAAVKRLSGDCGQMEREFQ---AEVEALSRAQH 826
            +F     +G G FG V+      NG   A+K L  +     ++ +    E   LS   H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 827 KNLVSLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDV-RLKIAQGAARGL 884
             ++ +         ++ +I  Y+E G L   L     K       V +   A+     L
Sbjct: 66  PFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAE-VCLAL 119

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYI 942
            YLH      I++RD+K  NILLD+    H  + DFG ++    Y   VT  L GT  YI
Sbjct: 120 EYLHSK---DIIYRDLKPENILLDK--NGHIKITDFGFAK----YVPDVTYTLCGTPDYI 170

Query: 943 PPE------YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
            PE      Y++++      D +SFG+++ E+L G  P
Sbjct: 171 APEVVSTKPYNKSI------DWWSFGILIYEMLAGYTP 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 24/229 (10%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGY 835
           IG G FG +Y  T +  G + A+K         Q+  E +   + +       + +++  
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG--IPTIRWC 73

Query: 836 CRHGNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH 894
              G+  +++   +  G SL+  L     +   LK    L +A      + Y+H     +
Sbjct: 74  GAEGDYNVMVMELL--GPSLED-LFNFCSRKFSLK--TVLLLADQMISRIEYIHSK---N 125

Query: 895 IVHRDVKSSNILL---DEKFEAHLADFGLSRLLRPYDTHV------TTDLVGTLGYIPPE 945
            +HRDVK  N L+    +    ++ DFGL++  R   TH         +L GT  Y    
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
               +  + R D+ S G VL+    G  P +  K    R     + + K
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 63.9 bits (156), Expect = 7e-12
 Identities = 28/114 (24%), Positives = 41/114 (35%), Gaps = 4/114 (3%)

Query: 320 SLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS 379
             +   +   LDLR   +    +L  + L     +D + N     L         LK L 
Sbjct: 14  QYTNAVRDRELDLRGYKIPVIENLG-ATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLL 70

Query: 380 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
           +  N +          L  L  L L+NNS   L   L  L   K+LT L + +N
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELG-DLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 31/162 (19%), Positives = 52/162 (32%), Gaps = 31/162 (19%)

Query: 270 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 329
           + + +N    R L + G +    + N+   L Q +                         
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFD------------------------A 46

Query: 330 LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS--G 387
           +D  +N +   +D  F  L  L TL +  N              DL  L L  N L   G
Sbjct: 47  IDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104

Query: 388 QVPESFGKLTSLLFLSLSNNSFNHLSG-TLSVLQQCKNLTTL 428
            + +    L SL +L +  N   +     L V+ +   +  L
Sbjct: 105 DL-DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 23/106 (21%), Positives = 44/106 (41%), Gaps = 9/106 (8%)

Query: 206 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 265
            +   +D S N  +  L G      LK L V+NN +         ++  L  + L+ N+ 
Sbjct: 42  DQFDAIDFSDNE-IRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100

Query: 266 SGQLSE--KISNLTSLRHLIIFGNQFSGKLPN----VLGNLTQLEF 305
             +L +   +++L SL +L I  N  +    +    V+  + Q+  
Sbjct: 101 V-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV 144

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 26/144 (18%), Positives = 53/144 (36%), Gaps = 33/144 (22%)

Query: 101 IIPRSLGHLNQLKL--LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLN 158
           +I ++  + N ++   LDL    +  +  +  + L Q + +D S N +   + G    L 
Sbjct: 8   LIEQAAQYTNAVRDRELDLRGYKIPVIENLG-ATLDQFDAIDFSDNEIR-KLDG-FPLLR 64

Query: 159 LIQSLNVSSN---SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSM 215
            +++L V++N        L +     +L    ++NN                  +++L  
Sbjct: 65  RLKTLLVNNNRICRIGEGLDQ--ALPDLTELILTNN-----------------SLVELG- 104

Query: 216 NHFMGSLQGLDHSPSLKQLHVDNN 239
                 L  L    SL  L +  N
Sbjct: 105 -----DLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 18/80 (22%), Positives = 31/80 (38%), Gaps = 3/80 (3%)

Query: 563 FLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 622
            L   +I   I      L     +D S N I   +      +R L+ L +++N +     
Sbjct: 25  DLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGE 81

Query: 623 GSFEKLTFLSKFSVANNHLQ 642
           G  + L  L++  + NN L 
Sbjct: 82  GLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 15/71 (21%), Positives = 25/71 (35%), Gaps = 7/71 (9%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
            S+N I   +      L+ L  L ++ N I          + +L  L L++N L      
Sbjct: 49  FSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----- 101

Query: 624 SFEKLTFLSKF 634
               L  L+  
Sbjct: 102 ELGDLDPLASL 112

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.4 bits (95), Expect = 9e-04
 Identities = 17/79 (21%), Positives = 28/79 (35%), Gaps = 5/79 (6%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
           L+   I      +         LDL    I   I +  + +   + +D S N++   + G
Sbjct: 4   LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG 59

Query: 624 SFEKLTFLSKFSVANNHLQ 642
            F  L  L    V NN + 
Sbjct: 60  -FPLLRRLKTLLVNNNRIC 77

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 40/176 (22%), Positives = 71/176 (40%), Gaps = 18/176 (10%)

Query: 805 GDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDK 864
           G   +  +++   +    + +  ++ S Q     G       S +E       L++    
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF-- 189

Query: 865 DSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL 924
              L  +  +  +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R +
Sbjct: 190 ---LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 925 RPYDTHVTTDLVGTLGYIP-----PEYSQTLTATCRGDVYSFGVVLLELLT-GRRP 974
                +V          +P     PE       T + DV+SFGV+L E+ + G  P
Sbjct: 244 YKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 9/94 (9%)

Query: 777 NIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSRA-QHKN 828
             +G G FG V +A              AVK L       E     +E++ L     H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 829 LVSLQGYC-RHGNDRLLIYSYMENGSLDYWLHES 861
           +V+L G C + G   ++I  + + G+L  +L   
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 42/253 (16%), Positives = 77/253 (30%), Gaps = 52/253 (20%)

Query: 112 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 171
            + L L   HL  +     SNL  +  + +S +               +Q L   S+SF 
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSID-------------VTLQQL--ESHSFY 77

Query: 172 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF--MGSLQGLDHSP 229
                    S +    I N      ++         ++ L +          L  +  + 
Sbjct: 78  N-------LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTD 130

Query: 230 SLKQLHV-DNNLLGGDLPDSLYSMSS-LQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 287
               L + DN  +     ++   + +    + L  N F+  +     N T L  + +  N
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189

Query: 288 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG 347
           +           LT +       ++F G       + S   +LD+   S+T    L   G
Sbjct: 190 K----------YLTVI-----DKDAFGG-------VYSGPSLLDVSQTSVT---ALPSKG 224

Query: 348 LSSLCTLDLATNH 360
           L  L  L      
Sbjct: 225 LEHLKELIARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 45/233 (19%), Positives = 75/233 (32%), Gaps = 38/233 (16%)

Query: 324 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
           C +     +    +   P     S   S  TL L   H      ++ S+  ++  + ++ 
Sbjct: 10  CHQEEDFRVTCKDIQRIP-----SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64

Query: 383 N-ELSGQVPESFGKLTSLLFLSLSNN---------SFNHLSG---------------TLS 417
           +  L      SF  L+ +  + + N          +   L                  L+
Sbjct: 65  DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLT 124

Query: 418 VLQQCKNLTTLILTKNFVGEEIPENV--GGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 475
            +        L +T N     IP N   G     + L L N G    +  +     KL  
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183

Query: 476 LDLSWNHFDGNIPPWI--GQMENLFYLDFSNNTLTGEIP-KSLTELKSLISSN 525
           + L+ N +   I      G       LD S  ++T  +P K L  LK LI+ N
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 34/268 (12%), Positives = 77/268 (28%), Gaps = 52/268 (19%)

Query: 371 DCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLIL 430
           +CH  +   +   ++  ++P       S   L L       +           N++ + +
Sbjct: 9   ECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPS--HAFSNLPNISRIYV 62

Query: 431 TKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIP 488
           + +   +++  +       +  + + N     +I    L+    L+ L +         P
Sbjct: 63  SIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFP 121

Query: 489 P--WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRS 546
               +   +  F L+ ++N     IP                                 +
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIP-------------------------------VNA 150

Query: 547 TNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI--SEI 604
             GL     +     + L NN    ++         L  + L++N     I         
Sbjct: 151 FQGLCNETLT-----LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204

Query: 605 RNLEVLDLSSNDLHGSIP-GSFEKLTFL 631
               +LD+S   +  ++P    E L  L
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKGLEHLKEL 231

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 19/106 (17%), Positives = 38/106 (35%), Gaps = 8/106 (7%)

Query: 557 SFPPSV---FLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLD 611
           S PPS     L    +  TIP      L ++  + +S +     + S     +  +  ++
Sbjct: 28  SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86

Query: 612 LSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPN 656
           + +      I   + ++L  L    + N  L+   P   + YS   
Sbjct: 87  IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDI 131

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.2 bits (161), Expect = 3e-11
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 26/230 (11%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLV-SLQG 834
           IG G FG +Y  T +    + A+K  +      Q+  E +         Q    + +++ 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI----YRILQGGTGIPNVRW 70

Query: 835 YCRHGNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEP 893
           +   G+  +L+   +  G SL+  L     +   LK    L +A      + ++H     
Sbjct: 71  FGVEGDYNVLVMDLL--GPSLED-LFNFCSRKLSLK--TVLMLADQMINRVEFVHSK--- 122

Query: 894 HIVHRDVKSSNILLDEKFEAH---LADFGLSRLLRPYDTHV------TTDLVGTLGYIPP 944
             +HRD+K  N L+     A+   + DFGL++  R   TH         +L GT  Y   
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182

Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
                +  + R D+ S G VL+  L G  P +  K    +     + + K
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 47/210 (22%), Positives = 75/210 (35%), Gaps = 50/210 (23%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQHKNLVSLQGY 835
           ++G G  G V +        K A+K L  DC +  RE    VE   R +Q  ++V +   
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIVDV 79

Query: 836 CRHGNDR----LLIYSYMENGSLDYWLHESVDKDSVL--KWDVRLKIAQGAARGLAYLHK 889
             +        L++   ++ G L        D+      + +    +       + YLH 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKS-IGEAIQYLHS 135

Query: 890 VCEPHIVHRDVKSSNILLDEKFEAH---LADFGLSR--LLRPYDTHVTTDLVGTLGYIPP 944
           +   +I HRDVK  N+L   K       L DFG ++      YD                
Sbjct: 136 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSC------------- 179

Query: 945 EYSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                       D++S GV++  LL G  P
Sbjct: 180 ------------DMWSLGVIMYILLCGYPP 197

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 66.5 bits (162), Expect = 3e-11
 Identities = 68/446 (15%), Positives = 149/446 (33%), Gaps = 41/446 (9%)

Query: 104 RSLGHLNQLKLLDLSC-NHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLA-GLNLIQ 161
           +   H     L+      ++   +    S+   LE + L   +++     ++A      +
Sbjct: 74  KGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFK 133

Query: 162 SLNVSSNSF--NGSLFELGE-FSNLAVFNISNNSF---TGKLNSRIWSASKEIQILDLSM 215
            L +SS        L  +     NL   ++  +     +G   S        +  L++S 
Sbjct: 134 VLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC 193

Query: 216 NHFMGSLQGL----DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV------NNF 265
                S   L       P+LK L ++  +    L   L     L+ +           + 
Sbjct: 194 LASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDV 253

Query: 266 SGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGP-LPLSLSLC 324
              LS  +S    LR L  F +     LP V    ++L        +     L   L  C
Sbjct: 254 YSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQC 313

Query: 325 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLA-TNHFSGPLPNSLSD---------CHD 374
            KL  L + +      +++  S    L  L +  +  F      +L++         C  
Sbjct: 314 PKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPK 373

Query: 375 LKILSLAKNELSGQ----VPESFGKLTSLLFLSLSNNSFNHLS------GTLSVLQQCKN 424
           L+ +     +++      +  +   +T      +   + ++L+      G  ++++ CK+
Sbjct: 374 LESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKD 433

Query: 425 LTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSW-NH 482
           L  L L+     +         + + +L++   G        +L  C  L+ L++     
Sbjct: 434 LRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493

Query: 483 FDGNIPPWIGQMENLFYLDFSNNTLT 508
            D  +     ++E +  L  S+ +++
Sbjct: 494 GDKALLANASKLETMRSLWMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 64/455 (14%), Positives = 120/455 (26%), Gaps = 74/455 (16%)

Query: 197 LNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDS-----LYS 251
           L  +   A   +         +            L+++     L    + D        S
Sbjct: 73  LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEI----RLKRMVVTDDCLELIAKS 128

Query: 252 MSSLQHVSLS-VNNFSGQ-LSEKISNLTSLRHLIIFGNQFSGK-------LPNVLGNLTQ 302
             + + + LS    FS   L+   +   +L+ L +  +             P+   +L  
Sbjct: 129 FKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188

Query: 303 LEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNN-SLTGPIDLNFSGLSSLCTLDLA---- 357
           L      S      L   ++ C  L  L L     L     L       L  L       
Sbjct: 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATL-LQRAPQLEELGTGGYTA 247

Query: 358 --TNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGT 415
                    L  +LS C +L+ LS   + +   +P  +   + L  L+LS  +       
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDL- 306

Query: 416 LSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 475
           + +L QC  L  L +                  L VLA                CK L+ 
Sbjct: 307 VKLLCQCPKLQRLWVLDYI----------EDAGLEVLAST--------------CKDLRE 342

Query: 476 LDLS-WNHFDGNIPPWIGQ---------MENLFYLDFSNNTLTGE----IPKSLTELKSL 521
           L +     F       + +            L  + +    +T      I ++   +   
Sbjct: 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRF 402

Query: 522 ISSNCTSSNPTASAGIPLYVKHNRSTNGLPY-NQASSFPPSVFLSNNRINGTIPPEIGQL 580
                    P        Y+       G     +       + LS    +          
Sbjct: 403 RLCIIEPKAPD-------YLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYA 455

Query: 581 KHLHVLDLSRNNITGTIPSSISE-IRNLEVLDLSS 614
           K + +L ++    +      +     +L  L++  
Sbjct: 456 KKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD 490

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 53.7 bits (129), Expect = 3e-07
 Identities = 52/314 (16%), Positives = 93/314 (29%), Gaps = 38/314 (12%)

Query: 248 SLYSMSSLQHVSLSVNNFSGQLSEKI----SNLTSLRHLIIFGNQFS----GKLPNVLGN 299
            L         +L  + + G +   I    S+ T L  + +     +      +     N
Sbjct: 72  ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKN 131

Query: 300 LTQLEFFVAHSNSFSGP-LPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCT----L 354
              L   ++    FS   L    + C  L  LDLR + +        S      T    L
Sbjct: 132 FKVLV--LSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189

Query: 355 DLATNHFS---GPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNH 411
           +++          L   ++ C +LK L L +     ++     +   L  L     +   
Sbjct: 190 NISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEV 249

Query: 412 ----LSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL--KGHIPV 465
                SG    L  CK L  L    + V   +P        L  L L    +     + +
Sbjct: 250 RPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKL 309

Query: 466 WLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGE-------------IP 512
            L +C KLQ L +     D  +       ++L  L    +                  + 
Sbjct: 310 -LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS 368

Query: 513 KSLTELKSLISSNC 526
               +L+S++    
Sbjct: 369 MGCPKLESVLYFCR 382

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 46/326 (14%), Positives = 97/326 (29%), Gaps = 52/326 (15%)

Query: 299 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLAT 358
              + + F+ +  + S      +    K+  ++L+        +L   G        +  
Sbjct: 42  RWCRRKVFIGNCYAVS--PATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA 99

Query: 359 NHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGK-LTSLLFLSLSNNSFNHLSGTLS 417
                      S    L+ + L +  ++    E   K   +   L LS+       G  +
Sbjct: 100 ---------MSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA 150

Query: 418 VLQQCKNLTTLILTKNFVGEEIPENVGGFE----SLMVLALGNCGLK---GHIPVWLLRC 470
           +   C+NL  L L ++ V +     +  F     SL+ L +     +     +   + RC
Sbjct: 151 IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRC 210

Query: 471 KKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSN 530
             L+ L L+       +   + +   L   +      T E+   +    S+  S C    
Sbjct: 211 PNLKSLKLNRAVPLEKLATLLQRAPQL--EELGTGGYTAEVRPDVYSGLSVALSGC---- 264

Query: 531 PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR 590
                      K  R  +G                 + +   +P        L  L+LS 
Sbjct: 265 -----------KELRCLSGF---------------WDAVPAYLPAVYSVCSRLTTLNLSY 298

Query: 591 NNITGT-IPSSISEIRNLEVLDLSSN 615
             +    +   + +   L+ L +   
Sbjct: 299 ATVQSYDLVKLLCQCPKLQRLWVLDY 324

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 39/273 (14%), Positives = 84/273 (30%), Gaps = 43/273 (15%)

Query: 368 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLF----------LSLSNNSFNHLSGTLS 417
            + +C+ +   ++ +          F K+ S+            L              +
Sbjct: 49  FIGNCYAVSPATVIRR---------FPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA 99

Query: 418 VLQQCKNLTTLILTKNFVGEEIPENVG-GFESLMVLALGNCGLKGHIPVWLL--RCKKLQ 474
           +      L  + L +  V ++  E +   F++  VL L +C       +  +   C+ L+
Sbjct: 100 MSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLK 159

Query: 475 VLDLSWNHFDGNIPPWIGQME----NLFYLDFSN--NTLTGE----IPKSLTELKSLISS 524
            LDL  +  D     W+        +L  L+ S   + ++      +      LKSL  +
Sbjct: 160 ELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLN 219

Query: 525 NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLH 584
                       +   ++       L     ++       S       +   +   K L 
Sbjct: 220 RAVPLE-----KLATLLQRAPQLEELGTGGYTAEVRPDVYSG------LSVALSGCKELR 268

Query: 585 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 617
            L    + +   +P+  S    L  L+LS   +
Sbjct: 269 CLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATV 301

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 49/239 (20%), Positives = 90/239 (37%), Gaps = 42/239 (17%)

Query: 779 IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQG- 834
           IG G FG++++ T L N  + A+K         Q+  E++          +K L    G 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---------YKLLAGCTGI 68

Query: 835 -----YCRHGNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
                + + G   +L+   +  G SL+  L +   +   +K       A+     +  +H
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL--GPSLED-LLDLCGRKFSVK--TVAMAAKQMLARVQSIH 123

Query: 889 KVCEPHIVHRDVKSSNILLDEKFEA-----HLADFGLSRLLR--------PYDTHVTTDL 935
           +     +V+RD+K  N L+           ++ DFG+ +  R        PY      +L
Sbjct: 124 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK--KNL 178

Query: 936 VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
            GT  Y+          + R D+ + G V +  L G  P +  K    +     + + K
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 47/182 (25%), Positives = 68/182 (37%), Gaps = 8/182 (4%)

Query: 230 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFGNQ 288
             K+L + +N L      + + ++ L+ + L+ N     L   I   L +L  L +  N+
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96

Query: 289 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSL--SLCSKLHVLDLRNNSLTG-PIDLNF 345
                  V   L  L       N     LP  +  SL +KL  L L  N L   P  + F
Sbjct: 97  LQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSL-TKLTYLSLGYNELQSLPKGV-F 153

Query: 346 SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLS 405
             L+SL  L L  N        +     +LK L L  N+L      +F  L  L  L L 
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213

Query: 406 NN 407
            N
Sbjct: 214 EN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 49/193 (25%)

Query: 473 LQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLT---GEIPKSLTELKSLISSNCTS 528
            + LDL  N    ++P     ++  L  L  ++N L      I K L  L++L       
Sbjct: 39  TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETL------- 90

Query: 529 SNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPEI- 577
                                +  N+  + P  VF          L  N++  ++PP + 
Sbjct: 91  --------------------WVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF 129

Query: 578 GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFS 635
             L  L  L L  N +  ++P  +  ++ +L+ L L +N L   +P G+F+KLT L    
Sbjct: 130 DSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLK 187

Query: 636 VANNHLQGTIPTG 648
           + NN L+  +P G
Sbjct: 188 LDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 53.8 bits (130), Expect = 9e-08
 Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 14/187 (7%)

Query: 180 FSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-----DHSPSLKQL 234
            ++    ++ +N  +  L S+ +    ++++L L+ N     LQ L         +L+ L
Sbjct: 36  PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNK----LQTLPAGIFKELKNLETL 90

Query: 235 HVDNNLLGGDLPDSLY-SMSSLQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGK 292
            V +N L   LP  ++  + +L  + L  N     L  ++  +LT L +L +  N+    
Sbjct: 91  WVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSL 148

Query: 293 LPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLC 352
              V   LT L+    ++N        +    ++L  L L NN L    +  F  L  L 
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLK 208

Query: 353 TLDLATN 359
            L L  N
Sbjct: 209 MLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 52/204 (25%), Positives = 80/204 (39%), Gaps = 24/204 (11%)

Query: 95  RKGLKGI---IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVS 151
            K L  I   IP         K LDL  N L  +       L +L +L L+ N L    +
Sbjct: 25  SKKLTAIPSNIPADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78

Query: 152 GMLAGLNLIQSLNVSSNSFNGSLFELGEF---SNLAVFNISNNSFTGKLNSRIWSASKEI 208
           G+   L  +++L V+ N    +L  +G F    NLA   +  N     L  R++ +  ++
Sbjct: 79  GIFKELKNLETLWVTDNKLQ-AL-PIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKL 135

Query: 209 QILDLSMNHFMGSLQGL-----DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 263
             L L  N     LQ L     D   SLK+L + NN L      +   ++ L+ + L  N
Sbjct: 136 TYLSLGYNE----LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191

Query: 264 NFSGQLSEKISNLTSLRHLIIFGN 287
                      +L  L+ L +  N
Sbjct: 192 QLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 42/184 (22%), Positives = 66/184 (35%), Gaps = 46/184 (25%)

Query: 472 KLQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLT---GEIPKSLTELKSLISSNCT 527
           KL++L L+ N     +P  I  +++NL  L  ++N L      +   L  L  L      
Sbjct: 62  KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAEL------ 114

Query: 528 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPEI 577
                                 L  NQ  S PP VF          L  N +  ++P  +
Sbjct: 115 ---------------------RLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152

Query: 578 -GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFS 635
             +L  L  L L  N +   +P     ++  L+ L L +N L     G+F+ L  L    
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211

Query: 636 VANN 639
           +  N
Sbjct: 212 LQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 45/174 (25%), Positives = 71/174 (40%), Gaps = 14/174 (8%)

Query: 354 LDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL- 412
           LDL +N  S     +      L++L L  N+L       F +L +L  L +++N    L 
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALP 101

Query: 413 SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLM---VLALGNCGLKGHIPVWLL- 468
            G    L    NL  L L +N + + +P  V  F+SL     L+LG   L+  +P  +  
Sbjct: 102 IGVFDQL---VNLAELRLDRNQL-KSLPPRV--FDSLTKLTYLSLGYNELQ-SLPKGVFD 154

Query: 469 RCKKLQVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLTGEIPKSLTELKSL 521
           +   L+ L L  N     +P     ++  L  L   NN L      +   L+ L
Sbjct: 155 KLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL 207

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 36/176 (20%), Positives = 58/176 (32%), Gaps = 25/176 (14%)

Query: 89  TMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG 148
            +L L    L+ +       L  L+ L ++ N L+ +       L  L  L L  N L  
Sbjct: 64  RLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS 123

Query: 149 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEI 208
               +   L  +  L++  N                  ++    F  KL          +
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQ---------------SLPKGVFD-KL--------TSL 159

Query: 209 QILDLSMNHFMGSLQGL-DHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 263
           + L L  N      +G  D    LK L +DNN L      +  S+  L+ + L  N
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 55/247 (22%), Positives = 90/247 (36%), Gaps = 42/247 (17%)

Query: 771 NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHK 827
            NF     IGCG FG +     L      A+K   +     Q+  E++          +K
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF---------YK 59

Query: 828 NLVSLQG------YCRHGNDRLLIYSYMENG-SLDYWLHESVDKDSVLKWDVRLKIAQGA 880
            L S  G      +   G    ++   +  G SL+  L +  D+   LK    L IA   
Sbjct: 60  QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLED-LFDLCDRTFSLK--TVLMIAIQL 114

Query: 881 ARGLAYLHKVCEPHIVHRDVKSSNILL-----DEKFEAHLADFGLSRLLR--------PY 927
              + Y+H     ++++RDVK  N L+       +   H+ DF L++           PY
Sbjct: 115 ISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPY 171

Query: 928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 987
             H    L GT  Y+          + R D+ + G + +  L G  P +  K    ++  
Sbjct: 172 REH--KSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229

Query: 988 SWVFQMK 994
             +   K
Sbjct: 230 QKIGDTK 236

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 49/186 (26%), Positives = 69/186 (37%), Gaps = 30/186 (16%)

Query: 253 SSLQHVSLSVNNFSGQLSEKI-SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSN 311
           S    + LS NN S   +E   + LT+L  L++  N            L  +      S 
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-----------LNFI-----SSE 82

Query: 312 SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 371
           +F             L  LDL +N L    +  FS L +L  L L  NH      N+  D
Sbjct: 83  AFVP--------VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134

Query: 372 CHDLKILSLAKNELSGQVPE----SFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 427
              L+ L L++N++S + P        KL  L+ L LS+N    L  T            
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193

Query: 428 LILTKN 433
           L L  N
Sbjct: 194 LYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 33/164 (20%), Positives = 57/164 (34%), Gaps = 28/164 (17%)

Query: 105 SLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLN 164
           +   L  L  L LS NHL  +       +  L  LDLS N L      + + L  ++ L 
Sbjct: 59  TPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118

Query: 165 VSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM----G 220
           + +N     + +   F ++A                      ++Q L LS N        
Sbjct: 119 LYNNHI--VVVDRNAFEDMA----------------------QLQKLYLSQNQISRFPVE 154

Query: 221 SLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNN 264
            ++  +  P L  L + +N L       L  + +     L ++N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 41/167 (24%)

Query: 523 SSNCTSSNPTAS----------AGIPLYVKHNRSTNGLPYNQASSFPPSVF--------- 563
            +NC  ++   S            +P Y         L +N  S                
Sbjct: 13  PANCLCASNILSCSKQQLPNVPQSLPSYTALLD----LSHNNLSRLRAEWTPTRLTNLHS 68

Query: 564 --LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHG 619
             LS+N +N  I  E    + +L  LDLS N++  T+   + S+++ LEVL L +N +  
Sbjct: 69  LLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV- 125

Query: 620 SIP-GSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 665
            +   +FE +  L K  ++ N +            FP    +    L
Sbjct: 126 VVDRNAFEDMAQLQKLYLSQNQIS----------RFPVELIKDGNKL 162

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 42/193 (21%), Positives = 63/193 (32%), Gaps = 54/193 (27%)

Query: 473 LQVLDLSWNHFDGNIPPWI--GQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNC 526
             +LDLS N+    +       ++ NL  L  S+N L   I       +  L+ L     
Sbjct: 41  TALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL----- 93

Query: 527 TSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTIPPE 576
                                  L  N   +    +F          L NN I   +   
Sbjct: 94  ----------------------DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRN 130

Query: 577 I-GQLKHLHVLDLSRNNITGTIP----SSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFL 631
               +  L  L LS+N I+   P       +++  L +LDLSSN L        +KL   
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189

Query: 632 SKFSVA--NNHLQ 642
            K  +   NN L+
Sbjct: 190 VKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 42/187 (22%), Positives = 63/187 (33%), Gaps = 37/187 (19%)

Query: 126 VPVELSNLKQLEVLDLSHNMLSG-PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 184
           VP  L +     +LDLSHN LS          L  + SL +S N    +      F  + 
Sbjct: 33  VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL--NFISSEAFVPV- 87

Query: 185 VFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF----MGSLQGLDHSPSLKQLHVDNNL 240
                                  ++ LDLS NH           L    +L+ L + NN 
Sbjct: 88  ---------------------PNLRYLDLSSNHLHTLDEFLFSDL---QALEVLLLYNNH 123

Query: 241 LGGDLPDSLYSMSSLQHVSLSVNN---FSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVL 297
           +     ++   M+ LQ + LS N    F  +L +  + L  L  L +  N+        L
Sbjct: 124 IVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183

Query: 298 GNLTQLE 304
             L    
Sbjct: 184 QKLPAWV 190

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 48.3 bits (115), Expect = 9e-06
 Identities = 41/211 (19%), Positives = 63/211 (29%), Gaps = 64/211 (30%)

Query: 424 NLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLR-CKKLQVLDLSWN 481
               L L+ N +     E       +L  L L +  L   I          L+ LDLS N
Sbjct: 40  YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98

Query: 482 H--------FDGNIPPWIGQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSS 529
           H        F          ++ L  L   NN +   +     + + +L+ L        
Sbjct: 99  HLHTLDEFLFSD--------LQALEVLLLYNNHIV-VVDRNAFEDMAQLQKL-------- 141

Query: 530 NPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLS 589
                               L  NQ S FP  +    N+           L  L +LDLS
Sbjct: 142 -------------------YLSQNQISRFPVELIKDGNK-----------LPKLMLLDLS 171

Query: 590 RNNITGTIPSSISEIRNL--EVLDLSSNDLH 618
            N +     + + ++       L L +N L 
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 57.0 bits (138), Expect = 1e-09
 Identities = 36/133 (27%), Positives = 55/133 (41%), Gaps = 8/133 (6%)

Query: 299 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLA 357
           ++ +L    + SN   G L        +L  L   N  LT    + N   L+ L  L+L+
Sbjct: 18  DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT---SIANLPKLNKLKKLELS 72

Query: 358 TNHFSGPLPNSLSDCHDLKILSLAKNELSG-QVPESFGKLTSLLFLSLSNNSFNHLSG-T 415
            N  SG L      C +L  L+L+ N++      E   KL +L  L L N    +L+   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132

Query: 416 LSVLQQCKNLTTL 428
            +V +    LT L
Sbjct: 133 ENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 25/113 (22%), Positives = 41/113 (36%), Gaps = 6/113 (5%)

Query: 371 DCHDLKILSLAKNELS-GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLI 429
              D+K L L  +  + G++     +   L FLS  N     ++     L +   L  L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN----LPKLNKLKKLE 70

Query: 430 LTKNFVGEEIPENVGGFESLMVLALGNCGLKG-HIPVWLLRCKKLQVLDLSWN 481
           L+ N V   +        +L  L L    +K       L + + L+ LDL   
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 19/80 (23%), Positives = 40/80 (50%), Gaps = 3/80 (3%)

Query: 564 LSNNRIN-GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 622
           L N+R N G +     + + L  L      +T +I +++ ++  L+ L+LS N + G + 
Sbjct: 24  LDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLE 81

Query: 623 GSFEKLTFLSKFSVANNHLQ 642
              EK   L+  +++ N ++
Sbjct: 82  VLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 25/105 (23%), Positives = 46/105 (43%), Gaps = 7/105 (6%)

Query: 206 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 265
           +E++ L       + S+  L     LK+L + +N + G L        +L H++LS N  
Sbjct: 42  EELEFLSTINVG-LTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100

Query: 266 SGQLS-EKISNLTSLRHLIIFGNQFSGKLPN----VLGNLTQLEF 305
               + E +  L +L+ L +F  + +  L +    V   L QL +
Sbjct: 101 KDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTY 144

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 4/111 (3%)

Query: 251 SMSSLQHVSLSVNNFS-GQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 309
           + S ++ + L  +  + G+L         L  L       +  + N L  L +L+     
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 310 SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATN 359
            N  SG L +    C  L  L+L  N +     +     L +L +LDL   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 8e-05
 Identities = 20/64 (31%), Positives = 32/64 (50%), Gaps = 1/64 (1%)

Query: 106 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVS-GMLAGLNLIQSLN 164
           L  LN+LK L+LS N + G + V       L  L+LS N +    +   L  L  ++SL+
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 165 VSSN 168
           + + 
Sbjct: 120 LFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 9e-05
 Identities = 26/104 (25%), Positives = 46/104 (44%), Gaps = 4/104 (3%)

Query: 420 QQCKNLTTLILTKN-FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDL 478
           +   ++  L+L  +     ++      FE L  L+  N GL   I   L +  KL+ L+L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLEL 71

Query: 479 SWNHFDGNIPPWIGQMENLFYLDFSNNTLTG-EIPKSLTELKSL 521
           S N   G +     +  NL +L+ S N +      + L +L++L
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENL 115

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 22/141 (15%), Positives = 48/141 (34%), Gaps = 30/141 (21%)

Query: 101 IIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLI 160
           +  R+   + +L L +   N  +  +       ++LE L   +  L+             
Sbjct: 11  LRNRTPSDVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLT------------- 55

Query: 161 QSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF-- 218
                       S+  L + + L    +S+N  +      +      +  L+LS N    
Sbjct: 56  ------------SIANLPKLNKLKKLELSDNRVS-GGLEVLAEKCPNLTHLNLSGNKIKD 102

Query: 219 MGSLQGLDHSPSLKQLHVDNN 239
           + +++ L    +LK L + N 
Sbjct: 103 LSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 16/53 (30%), Positives = 29/53 (54%), Gaps = 1/53 (1%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITG-TIPSSISEIRNLEVLDLSSN 615
           LS+NR++G +     +  +L  L+LS N I   +    + ++ NL+ LDL + 
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 17/71 (23%), Positives = 29/71 (40%), Gaps = 7/71 (9%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
             N  +  +I   + +L  L  L+LS N ++G +     +  NL  L+LS N +      
Sbjct: 49  TINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK----- 101

Query: 624 SFEKLTFLSKF 634
               +  L K 
Sbjct: 102 DLSTIEPLKKL 112

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 30/129 (23%), Positives = 47/129 (36%), Gaps = 25/129 (19%)

Query: 210 ILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL 269
           +LD S ++        D    L+ L   N  L   + + L  ++ L+ + LS N  SG L
Sbjct: 23  VLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELSDNRVSGGL 80

Query: 270 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 329
                   +L HL + GN+          +L+ +E                L     L  
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIK--------DLSTIE---------------PLKKLENLKS 117

Query: 330 LDLRNNSLT 338
           LDL N  +T
Sbjct: 118 LDLFNCEVT 126

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 62/377 (16%), Positives = 108/377 (28%), Gaps = 81/377 (21%)

Query: 106 LGHLNQLKLLDLSCNHL-----EGVVPVELSNLKQLEVLDLSHNMLSGP----VSGMLAG 156
               + +  LDLS N+L       ++    +    +  L+LS N L       +  +LA 
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 157 LNL-IQSLNVSSNSF-NGSLFELGEF-----SNLAVFNISNNSFTGK----LNSRIWSAS 205
           +   + SLN+S N     S  EL +        + V ++  N F+ K          +  
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 206 KEIQILDLSMNHF----MGSL-QGLDHSP-SLKQLHVDNNLLG----GDLPDSLYSM-SS 254
             I  L+L  N         L Q L   P ++  L++  N L      +L   L S+ +S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 255 LQHVSLSVNNFSGQLSEKI-----SNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH 309
           +  + LS N    +   ++     S    +  L +  N   G     L  L         
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL--------- 248

Query: 310 SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL 369
                            L  + L  + +          L +                 + 
Sbjct: 249 -----------KDSLKHLQTVYLDYDIVKNMSKEQCKALGA-----------------AF 280

Query: 370 SDCHDLKILSLAKNELSGQVPESFGKL-----TSLLFLSLSNNSFNHLSG---TLSVLQQ 421
            +   + ++     E+          L           SL N            +  L  
Sbjct: 281 PNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNI 340

Query: 422 CKNLTTLILTKNFVGEE 438
              L   I T   + E 
Sbjct: 341 PDELRESIQTCKPLLEH 357

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 49/331 (14%), Positives = 95/331 (28%), Gaps = 84/331 (25%)

Query: 321 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 380
            S+   +  LDL  N+L             L     A    S            +  L+L
Sbjct: 18  TSIPHGVTSLDLSLNNLYS------ISTVELIQA-FANTPAS------------VTSLNL 58

Query: 381 AKNELSGQVPESFGKL-----TSLLFLSLSNNSFNHLSGTL--SVLQQCK-NLTTLILTK 432
           + N L  +  +   ++      ++  L+LS N  ++ S       L      +T L L  
Sbjct: 59  SGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118

Query: 433 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 492
           N    +        E     +     +                L+L  N         + 
Sbjct: 119 NDFSSK-----SSSEFKQAFSNLPASIT--------------SLNLRGNDLGIKSSDELI 159

Query: 493 QM-----ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCT------SSNPTASAGIPL-- 539
           Q+      N+  L+   N L  +    L +   L S   +      S+N           
Sbjct: 160 QILAAIPANVNSLNLRGNNLASKNCAELAK--FLASIPASVTSLDLSANLLGLKSYAELA 217

Query: 540 -YVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQL----KHLHVLDLSRNNIT 594
                  +              S+ L  N ++G     +  L    KHL  + L  + + 
Sbjct: 218 YIFSSIPNHVV-----------SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266

Query: 595 GT-------IPSSISEIRNLEVLDLSSNDLH 618
                    + ++   I+ + ++D +  ++H
Sbjct: 267 NMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 46/312 (14%), Positives = 98/312 (31%), Gaps = 56/312 (17%)

Query: 269 LSEKISNLTSLRHLIIFGNQFSGK-----LPNVLGNLTQLEFFVAHSNSFS--GPLPLSL 321
           + E  S    +  L +  N          +         +       NS        L  
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 322 SL---CSKLHVLDLRNNSLTGP-IDLNFSGL----SSLCTLDLATNHFSG----PLPNSL 369
            L    + +  L+L  N L+    D     L     ++  LDL  N FS         + 
Sbjct: 74  ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133

Query: 370 SDCH-DLKILSLAKNELSGQVPESFGKL-----TSLLFLSLSNNSFN-----HLSGTLSV 418
           S+    +  L+L  N+L  +  +   ++      ++  L+L  N+        L+  L+ 
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA- 192

Query: 419 LQQCKNLTTLILTKNFVGEE--------IPENVGGFESLMVLALGNCGLKG----HIPVW 466
                ++T+L L+ N +G +                  ++ L L    L G    ++ + 
Sbjct: 193 -SIPASVTSLDLSANLLGLKSYAELAYIFSSIPN---HVVSLNLCLNCLHGPSLENLKLL 248

Query: 467 LLRCKKLQVLDLSWNHFDG-------NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELK 519
               K LQ + L ++            +      ++ +  +D +   +       ++ L 
Sbjct: 249 KDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNL- 307

Query: 520 SLISSNCTSSNP 531
            +   +  +  P
Sbjct: 308 -IRELSGKADVP 318

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 53/301 (17%), Positives = 92/301 (30%), Gaps = 81/301 (26%)

Query: 369 LSDCHDLKILSLAKNELSGQVPESFGKL-----TSLLFLSLSNNSFNHLSGTL--SVLQQ 421
            S  H +  L L+ N L         +       S+  L+LS NS    +      +L  
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 422 CK-NLTTLILTKNFVGEEIPENVGGFESLM-VLALGNCGLKGHIPVWLLRCKKLQVLDLS 479
              N+T+L L+ NF+  +        + L+  LA                   + VLDL 
Sbjct: 78  IPANVTSLNLSGNFLSYK------SSDELVKTLAAIPF--------------TITVLDLG 117

Query: 480 WNHFDGNIPPWIGQM-----ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTAS 534
           WN F         Q       ++  L+   N L  +    L +   L +     +     
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ--ILAAIPANVN----- 170

Query: 535 AGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQL-----KHLHVLDLS 589
                                     S+ L  N +      E+ +        +  LDLS
Sbjct: 171 --------------------------SLNLRGNNLASKNCAELAKFLASIPASVTSLDLS 204

Query: 590 RNNITGTIPSSISEI-----RNLEVLDLSSNDLHGS----IPGSFEKLTFLSKFSVANNH 640
            N +     + ++ I      ++  L+L  N LHG     +    + L  L    +  + 
Sbjct: 205 ANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDI 264

Query: 641 L 641
           +
Sbjct: 265 V 265

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 4e-09
 Identities = 32/216 (14%), Positives = 56/216 (25%), Gaps = 53/216 (24%)

Query: 767 LKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRL--------SGDCGQMEREFQAEV 818
              T    +   IG G FG V++    + T  A+K +        +G   +   E   E+
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 819 EAL---------SRAQHKNLVSLQGYC-----------------------------RHGN 840
                          + +  + L                                    +
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDV 900
           D+L I    E G +D  L +   K  +        I       LA           HRD+
Sbjct: 135 DQLFIVLEFEFGGID--LEQMRTK--LSSLATAKSILHQLTASLAVAEA--SLRFEHRDL 188

Query: 901 KSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLV 936
              N+LL +     L      +        +   ++
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 31/111 (27%), Positives = 43/111 (38%), Gaps = 6/111 (5%)

Query: 321 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 380
            +    L  L L N  L   +  N   L  L  L+L+ N   G L        +L  L+L
Sbjct: 45  TAEFVNLEFLSLINVGLIS-VS-NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102

Query: 381 AKNELS--GQVPESFGKLTSLLFLSLSNNSFNHLSG-TLSVLQQCKNLTTL 428
           + N+L     + E   KL  L  L L N    +L+    SV +    LT L
Sbjct: 103 SGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 34/152 (22%), Positives = 57/152 (37%), Gaps = 10/152 (6%)

Query: 330 LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQV 389
           +D++        +   + +  L  LD   ++  G +    ++  +L+ LSL    L    
Sbjct: 8   MDMKRRIHLELRNRTPAAVREL-VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI--S 63

Query: 390 PESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGE-EIPENVGGFES 448
             +  KL  L  L LS N        L+  ++  NLT L L+ N + +    E +   E 
Sbjct: 64  VSNLPKLPKLKKLELSENRIFGGLDMLA--EKLPNLTHLNLSGNKLKDISTLEPLKKLEC 121

Query: 449 LMVLALGN---CGLKGHIPVWLLRCKKLQVLD 477
           L  L L N     L  +         +L  LD
Sbjct: 122 LKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 26/105 (24%), Positives = 45/105 (42%), Gaps = 7/105 (6%)

Query: 206 KEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNF 265
             ++ L L     + S+  L   P LK+L +  N + G L      + +L H++LS N  
Sbjct: 49  VNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107

Query: 266 SGQLS-EKISNLTSLRHLIIFGNQFSGKLPN----VLGNLTQLEF 305
               + E +  L  L+ L +F  + +  L +    V   L QL +
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTY 151

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 29/139 (20%), Positives = 52/139 (37%), Gaps = 11/139 (7%)

Query: 374 DLKILSLAKNELS-GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK 432
            ++ L L   + + G++     +  +L FLSL N     +S     L +   L  L L++
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN----LPKLPKLKKLELSE 80

Query: 433 NFVGEEIPENVGGFESLMVLALGNCGLK--GHIPVWLLRCKKLQVLDLSWN---HFDGNI 487
           N +   +        +L  L L    LK    +   L + + L+ LDL      + +   
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDYR 139

Query: 488 PPWIGQMENLFYLDFSNNT 506
                 +  L YLD  +  
Sbjct: 140 ESVFKLLPQLTYLDGYDRE 158

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 21/81 (25%), Positives = 40/81 (49%), Gaps = 3/81 (3%)

Query: 563 FLSNNRIN-GTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSI 621
            L N + N G I     +  +L  L L    +  ++ S++ ++  L+ L+LS N + G +
Sbjct: 30  VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGL 87

Query: 622 PGSFEKLTFLSKFSVANNHLQ 642
               EKL  L+  +++ N L+
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 21/98 (21%), Positives = 33/98 (33%), Gaps = 3/98 (3%)

Query: 263 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 322
            +  G++    +   +L  L +        + N L  L +L+      N   G L +   
Sbjct: 35  KSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAE 92

Query: 323 LCSKLHVLDLRNNSLTGPIDL-NFSGLSSLCTLDLATN 359
               L  L+L  N L     L     L  L +LDL   
Sbjct: 93  KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 20/64 (31%), Positives = 32/64 (50%), Gaps = 1/64 (1%)

Query: 106 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVS-GMLAGLNLIQSLN 164
           L  L +LK L+LS N + G + +    L  L  L+LS N L    +   L  L  ++SL+
Sbjct: 67  LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126

Query: 165 VSSN 168
           + + 
Sbjct: 127 LFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 27/110 (24%), Positives = 38/110 (34%), Gaps = 4/110 (3%)

Query: 109 LNQLKLLDLSCNHLEGVVPVEL-SNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSS 167
              ++ L L            L +    LE L L +  L   VS  L  L  ++ L +S 
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSE 80

Query: 168 NSFNGSLFELGE-FSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMN 216
           N   G L  L E   NL   N+S N              + ++ LDL   
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.1 bits (94), Expect = 9e-04
 Identities = 20/71 (28%), Positives = 30/71 (42%), Gaps = 7/71 (9%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
           L N  +  ++   + +L  L  L+LS N I G +     ++ NL  L+LS N L      
Sbjct: 56  LINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL-----K 108

Query: 624 SFEKLTFLSKF 634
               L  L K 
Sbjct: 109 DISTLEPLKKL 119

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 26/128 (20%), Positives = 49/128 (38%), Gaps = 22/128 (17%)

Query: 535 AGIPLYVKHNRSTNGLPYNQASSFPPS-VF----------LSNNRINGTIPPEI-GQLKH 582
             IP Y    R    L  N+ +    + +F           SNN+I   I          
Sbjct: 28  EHIPQYTAELR----LNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 583 LHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNH 640
           ++ + L+ N +   +   +   + +L+ L L SN +   +   SF  L+ +   S+ +N 
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140

Query: 641 LQGTIPTG 648
           +  T+  G
Sbjct: 141 IT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 26/123 (21%), Positives = 44/123 (35%), Gaps = 8/123 (6%)

Query: 329 VLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 387
            L L NN  T       F  L  L  ++ + N  +     +      +  + L  N L  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95

Query: 388 QVPESFGKLTSLLFLSLSNNSFNHL-SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 446
              + F  L SL  L L +N    + + +   L    ++  L L  N +   +    G F
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLS---SVRLLSLYDNQI-TTVAP--GAF 149

Query: 447 ESL 449
           ++L
Sbjct: 150 DTL 152

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 31/173 (17%), Positives = 58/173 (33%), Gaps = 51/173 (29%)

Query: 474 QVLDLSWNHFDGNIPPWIG--QMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCT 527
             L L+ N F   +       ++  L  ++FSNN +T +I     +  + +  +      
Sbjct: 35  AELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEI------ 86

Query: 528 SSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLD 587
                                 L  N+  +    +F                L+ L  L 
Sbjct: 87  ---------------------LLTSNRLENVQHKMFKG--------------LESLKTLM 111

Query: 588 LSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANN 639
           L  N IT     S   + ++ +L L  N +  ++  G+F+ L  LS  ++  N
Sbjct: 112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 21/85 (24%), Positives = 36/85 (42%)

Query: 87  RVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 146
            V  ++L    L+ +  +    L  LK L L  N +  V       L  + +L L  N +
Sbjct: 82  GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141

Query: 147 SGPVSGMLAGLNLIQSLNVSSNSFN 171
           +    G    L+ + +LN+ +N FN
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 32/158 (20%), Positives = 56/158 (35%), Gaps = 32/158 (20%)

Query: 209 QILDLSMNHF-----MGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 263
             L L+ N F      G  + L   P L++++  NN +      +    S +  + L+ N
Sbjct: 35  AELRLNNNEFTVLEATGIFKKL---PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 264 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL 323
                  +    L SL+ L++  N+ +    +    L+ +                    
Sbjct: 92  RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR------------------- 132

Query: 324 CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHF 361
                +L L +N +T      F  L SL TL+L  N F
Sbjct: 133 -----LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 16/82 (19%), Positives = 30/82 (36%), Gaps = 1/82 (1%)

Query: 88  VTMLILPRKGLKGIIPRSL-GHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 146
              L L       +    +   L QL+ ++ S N +  +          +  + L+ N L
Sbjct: 34  TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93

Query: 147 SGPVSGMLAGLNLIQSLNVSSN 168
                 M  GL  +++L + SN
Sbjct: 94  ENVQHKMFKGLESLKTLMLRSN 115

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 58.4 bits (141), Expect = 9e-09
 Identities = 60/444 (13%), Positives = 134/444 (30%), Gaps = 50/444 (11%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSL----GHLNQLKLLDLSCNHL--EGVVPVELSNLKQL 136
               R  M  L  +   G +   +     +L QLK +      +    +  +  +    L
Sbjct: 81  KGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDL 140

Query: 137 EVLDLSH--NMLSGPVSGMLAGLNLIQSLNVSSNSF----NGSLFELGE-FSNLAVFNIS 189
           E L L       +  +  ++     I++L +  +SF       L EL +  ++L V N  
Sbjct: 141 ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY 200

Query: 190 NNSFTGKLNS---RIWSASKEIQILDLSMNHFM---GSLQGLDHSPSLKQLHVDNNLLGG 243
              F          I    + +  + +     +   G  +   +        ++ ++   
Sbjct: 201 MTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMP 260

Query: 244 DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLII-FGNQFSGKLPNVLGNLTQ 302
           +   +L     L  + LS    +  +         +R L + +    +     ++     
Sbjct: 261 EKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319

Query: 303 LEFF-VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLS------------ 349
           LE     +     G L +    C +L  L +   +    ++     +S            
Sbjct: 320 LEVLETRNVIGDRG-LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQ 378

Query: 350 SLCTLDLATNHFS----GPLPNSLSDCHDLKILSLAKNELSGQVPESFG------KLTSL 399
            L  + +  +  +      +   L +  D +++ L + E    +P   G          L
Sbjct: 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL 438

Query: 400 LFLSLSNNSFNHLS--GTLSVLQQCKNLTTLILTKNFVGEE-IPENVGGFESLMVLALGN 456
              +        L+  G   + Q   N+  ++L      +E + E   G  +L  L +  
Sbjct: 439 RRFAFYLRQ-GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG 497

Query: 457 CGLKGHIPVWLLR-CKKLQVLDLS 479
           C          +     L+ L + 
Sbjct: 498 CCFSERAIAAAVTKLPSLRYLWVQ 521

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 58.0 bits (140), Expect = 1e-08
 Identities = 57/424 (13%), Positives = 127/424 (29%), Gaps = 74/424 (17%)

Query: 227 HSPSLKQLHVDNNLLG--GDLPDSLYSMSSLQHVSLS-VNNFSGQ-LSEKISNLTSLRHL 282
           +   LK +H    ++        +      L+ + L   + F+   L   +++   ++ L
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTL 169

Query: 283 IIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID 342
           ++  + FS K    L  L                        + L VL+     +T    
Sbjct: 170 LMEESSFSEKDGKWLHEL--------------------AQHNTSLEVLNF---YMTEFAK 206

Query: 343 LNFSGL-------SSLCTLDLATNHFSGP--LPNSLSDCHDLKILSLAKNELSGQVPESF 393
           ++   L        SL ++ +             + ++  +    SL ++    +   + 
Sbjct: 207 ISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL 266

Query: 394 GKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK-NFVGEEIPENVGGFESLMVL 452
                L  L LS    N +     +      +  L L       E+    +    +L VL
Sbjct: 267 VFPRKLCRLGLSYMGPNEMP---ILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVL 323

Query: 453 ALGNC-GLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQME------------NLFY 499
              N  G +G   +    CK+L+ L +     +  +    G +              L Y
Sbjct: 324 ETRNVIGDRGLEVL-AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY 382

Query: 500 LDFSNNTLT-------GEIPKSLTELKSLISSNCTS-SNPTASAGIPLYVKHNRSTNGLP 551
           +    + +T       G   K+L + + ++       ++     G+   +   +      
Sbjct: 383 MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRF- 441

Query: 552 YNQASSFPPSVFLSNNRINGTIPPEIGQL-KHLHVLDLSRNNITGTIPSSISEI-RNLEV 609
                    + +L    +       IGQ   ++  + L     +       S    NL+ 
Sbjct: 442 ---------AFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQK 492

Query: 610 LDLS 613
           L++ 
Sbjct: 493 LEMR 496

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 45/399 (11%), Positives = 122/399 (30%), Gaps = 41/399 (10%)

Query: 66  SMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHL----NQLKLLDLS-CN 120
                 +           +   + +L         I P+ L  +      L  + +    
Sbjct: 172 EESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE 231

Query: 121 HLEGV-VPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGE 179
            LE V      +NL++     L+ ++        L     +  L +S    N        
Sbjct: 232 ILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPF 291

Query: 180 FSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGL-DHSPSLKQLHVDN 238
            + +   ++       + +  +      +++L+         L+ L  +   LK+L ++ 
Sbjct: 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351

Query: 239 NLLGGDLPDSLYSMS------------SLQHVSLSVNNFSGQ----LSEKISNLTSLRHL 282
                 + D    +S             L+++++ V++ + +    +   + NL   R +
Sbjct: 352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411

Query: 283 IIFGNQFSGKLPN------VLGNLTQLEFFVAHSNSF----SGPLPLSLSLCSKLHVLDL 332
           ++   +    LP       +L    +L  F  +         G   +       +  + L
Sbjct: 412 LLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIG-QYSPNVRWMLL 470

Query: 333 RNNSLT--GPIDLNFSGLSSLCTLDLATNHFSGP-LPNSLSDCHDLKILSLAKNELSGQV 389
                +  G ++    G  +L  L++    FS   +  +++    L+ L +     S   
Sbjct: 471 GYVGESDEGLMEF-SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTG 529

Query: 390 PESFGK---LTSLLFLSLSNNSFNHLSGTLSVLQQCKNL 425
            +         ++  +        +  G +  ++   ++
Sbjct: 530 QDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHI 568

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 47.6 bits (113), Expect = 2e-05
 Identities = 42/343 (12%), Positives = 92/343 (26%), Gaps = 37/343 (10%)

Query: 310 SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSL 369
           +  ++            L  L L+        +L         T  +     +       
Sbjct: 58  ALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNN------- 110

Query: 370 SDCHDLKILSLAKNELS--GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 427
                LK +   +  +S       +  +   L  L L   S     G LS++  C+ + T
Sbjct: 111 --LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKT 168

Query: 428 LILTKNFVGEEIPENVG----GFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDLS 479
           L++ ++   E+  + +        SL VL              +      C+ L  + + 
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG 228

Query: 480 WNHF--DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGI 537
                           +E       + +    E   +L   + L     +   P     +
Sbjct: 229 DFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPIL 288

Query: 538 PLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTI 597
             +    R  +               L            I +  +L VL+  RN I    
Sbjct: 289 FPFAAQIRKLD--------------LLYALLETEDHCTLIQKCPNLEVLET-RNVIGDRG 333

Query: 598 PSSISEI-RNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 639
              +++  + L+ L +        +      ++     ++A  
Sbjct: 334 LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG 376

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 33/138 (23%), Positives = 58/138 (42%), Gaps = 22/138 (15%)

Query: 525 NCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTI 573
           +C   +  +  +GIP     +     L     ++   + F          L  N++  T+
Sbjct: 20  DCQGKSLDSVPSGIPA----DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTL 74

Query: 574 PPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTF 630
              +   L  L  L L+ N +  ++P  +   +  L+ L L  N L  S+P G F++LT 
Sbjct: 75  SAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK 132

Query: 631 LSKFSVANNHLQGTIPTG 648
           L +  +  N LQ +IP G
Sbjct: 133 LKELRLNTNQLQ-SIPAG 149

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 23/151 (15%)

Query: 511 IPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF------- 563
           IP    +L  L S+   + +     G+        +   L YNQ  +    VF       
Sbjct: 33  IPADTEKLD-LQSTGLATLSDATFRGLT-----KLTWLNLDYNQLQTLSAGVFDDLTELG 86

Query: 564 ---LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLH 618
              L+NN++  ++P  +   L  L  L L  N +  ++PS +   +  L+ L L++N L 
Sbjct: 87  TLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144

Query: 619 GSIP-GSFEKLTFLSKFSVANNHLQGTIPTG 648
            SIP G+F+KLT L   S++ N LQ ++P G
Sbjct: 145 -SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 41/151 (27%), Positives = 60/151 (39%), Gaps = 6/151 (3%)

Query: 260 LSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPL 319
           L     +         LT L  L +  NQ       V  +LT+L      +N  +  LPL
Sbjct: 42  LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-LPL 100

Query: 320 SL--SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLK 376
            +   L ++L  L L  N L       F  L+ L  L L TN     +P    D   +L+
Sbjct: 101 GVFDHL-TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQ 158

Query: 377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNN 407
            LSL+ N+L      +F +L  L  ++L  N
Sbjct: 159 TLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 43/167 (25%), Positives = 58/167 (34%), Gaps = 22/167 (13%)

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 336
                L +     +         LT+L +     N             ++L  L L NN 
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94

Query: 337 LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLKILSLAKNELSGQVPES-FG 394
           L       F  L+ L  L L  N     LP+ + D    LK L L  N+L   +P   F 
Sbjct: 95  LASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152

Query: 395 KLTSLLFLSLSNN--------SFNHLSGTLSVLQQCKNLTTLILTKN 433
           KLT+L  LSLS N        +F+ L            L T+ L  N
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRL----------GKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 18/154 (11%)

Query: 500 LDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSF 558
           LD  +  L      +   L  L   N   +     SAG+   +     T GL  NQ +S 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT-ELGTLGLANNQLASL 98

Query: 559 PPSVF----------LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRN 606
           P  VF          L  N++  ++P  +  +L  L  L L+ N +  +IP+    ++ N
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156

Query: 607 LEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANN 639
           L+ L LS+N L  S+P G+F++L  L   ++  N
Sbjct: 157 LQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 22/138 (15%)

Query: 525 NCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTI 573
            C S   T+   GIP       +   L  N   S P  VF          L  N++  ++
Sbjct: 13  ECYSQGRTSVPTGIPA----QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SL 67

Query: 574 PPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTF 630
           P  +  +L  L  L+LS N +  ++P+ +  ++  L+ L L++N L  S+P G F+KLT 
Sbjct: 68  PNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ 125

Query: 631 LSKFSVANNHLQGTIPTG 648
           L    +  N L+ ++P G
Sbjct: 126 LKDLRLYQNQLK-SVPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 39/130 (30%), Positives = 56/130 (43%), Gaps = 23/130 (17%)

Query: 329 VLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLKILSLAKNELSG 387
            LDL  NSL    +  F  L+SL  L L  N     LPN + +    L  L+L+ N+L  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 388 QVPESFGKLTSLLFLSLSNN--------SFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 439
                F KLT L  L+L+ N         F+ L+           L  L L +N + + +
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT----------QLKDLRLYQNQL-KSV 139

Query: 440 PENVGGFESL 449
           P+  G F+ L
Sbjct: 140 PD--GVFDRL 147

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 17/103 (16%), Positives = 34/103 (33%), Gaps = 3/103 (2%)

Query: 566 NNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPS-SISEIRNLEVLDLSSNDLHGSIPGS 624
                      +   ++L  L +        +    +  +  L  L +  + L    P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 625 FEKLTFLSKFSVANNHLQGTIPTGG-QFYSFPNSSFEGNPGLC 666
           F     LS+ +++ N L+ ++     Q  S       GNP  C
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 22/94 (23%), Positives = 34/94 (36%), Gaps = 2/94 (2%)

Query: 318 PLSLSLCSKLHVLDLRNNSLTGPIDLN-FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLK 376
              L     L  L + N      ++L    GL  L  L +  +      P++      L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFN 410
            L+L+ N L     ++   L SL  L LS N  +
Sbjct: 84  RLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.3 bits (122), Expect = 1e-06
 Identities = 28/112 (25%), Positives = 45/112 (40%), Gaps = 9/112 (8%)

Query: 68  CCQWD-GVVCGHGSTGSN------AGRVTMLILPR-KGLKGIIPRSLGHLNQLKLLDLSC 119
           C     G+ C       +      A  +T L +   + L+ +  R L  L +L+ L +  
Sbjct: 6   CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 120 NHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFN 171
           + L  V P       +L  L+LS N L       + GL+L Q L +S N  +
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL-QELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 7/112 (6%)

Query: 324 CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN-SLSDCHDLKILSLAK 382
                 L    +     +  +  G  +L  L +        L    L    +L+ L++ K
Sbjct: 7   PHGSSGLRCTRDGALDSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLS-GTLSVLQQCKNLTTLILTKN 433
           + L    P++F     L  L+LS N+   LS  T+  L    +L  L+L+ N
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL----SLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 6e-06
 Identities = 15/80 (18%), Positives = 31/80 (38%), Gaps = 2/80 (2%)

Query: 564 LSNNRINGTIPPE-IGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 622
           + N +    +    +  L  L  L + ++ +    P +      L  L+LS N L     
Sbjct: 38  IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSW 97

Query: 623 GSFEKLTFLSKFSVANNHLQ 642
            + + L+ L +  ++ N L 
Sbjct: 98  KTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 6e-06
 Identities = 18/96 (18%), Positives = 27/96 (28%), Gaps = 2/96 (2%)

Query: 244 DLPDSLYSMSSLQHVSLSVNNFSGQL-SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQ 302
           D    L    +L  + +        L    +  L  LR+L I  +      P+      +
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 303 LEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLT 338
           L       N+    L         L  L L  N L 
Sbjct: 82  LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 21/90 (23%), Positives = 30/90 (33%), Gaps = 2/90 (2%)

Query: 273 ISNLTSLRHLIIFGNQFSGKLPN-VLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLD 331
           +    +L  L I   Q    L    L  L +L       +      P +     +L  L+
Sbjct: 27  LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86

Query: 332 LRNNSLTGPIDLNFSGLSSLCTLDLATNHF 361
           L  N+L         GL SL  L L+ N  
Sbjct: 87  LSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 22/138 (15%), Positives = 40/138 (28%), Gaps = 48/138 (34%)

Query: 486 NIPPWIGQMENLFYLDFSNNTLTGEIP----KSLTELKSLISSNCTSSNPTASAGIPLYV 541
           +    +   ENL  L   N      +     + L EL++L                    
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL-------------------- 61

Query: 542 KHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQ-LKHLHVLDLSRNNITGTIPSS 600
                                 +  + +   + P+       L  L+LS N +  ++   
Sbjct: 62  ---------------------TIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWK 98

Query: 601 ISEIRNLEVLDLSSNDLH 618
             +  +L+ L LS N LH
Sbjct: 99  TVQGLSLQELVLSGNPLH 116

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 40/137 (29%), Positives = 63/137 (45%), Gaps = 21/137 (15%)

Query: 525 NCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSFPPSVF----------LSNNRINGTI 573
           +C S    +  AGIP     N     L  NQ +   P VF          L +N++   +
Sbjct: 25  DCRSKRHASVPAGIPT----NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-AL 79

Query: 574 PPEI-GQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIPGSFEKLTFL 631
           P  +   L  L VLDL  N +T  +PS++   + +L+ L +  N L   +P   E+LT L
Sbjct: 80  PVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHL 137

Query: 632 SKFSVANNHLQGTIPTG 648
           +  ++  N L+ +IP G
Sbjct: 138 THLALDQNQLK-SIPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 39/169 (23%), Positives = 58/169 (34%), Gaps = 45/169 (26%)

Query: 474 QVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN---TLTGEIPKSLTELKSLISSNCTSSN 530
           Q+L L  N      P     + NL  L   +N    L   +  SLT+L  L         
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL--------- 93

Query: 531 PTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR 590
                              L  NQ +  P +VF               +L HL  L +  
Sbjct: 94  ------------------DLGTNQLTVLPSAVF--------------DRLVHLKELFMCC 121

Query: 591 NNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 639
           N +T  +P  I  + +L  L L  N L     G+F++L+ L+   +  N
Sbjct: 122 NKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 35/122 (28%), Positives = 52/122 (42%), Gaps = 8/122 (6%)

Query: 329 VLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLKILSLAKNELSG 387
           +L L +N +T      F  L +L  L L +N     LP  + D    L +L L  N+L+ 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 388 QVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFE 447
                F +L  L  L +  N    L   +  L    +LT L L +N + + IP   G F+
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTELPRGIERL---THLTHLALDQNQL-KSIPH--GAFD 156

Query: 448 SL 449
            L
Sbjct: 157 RL 158

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 34/135 (25%), Positives = 54/135 (40%), Gaps = 2/135 (1%)

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 336
            ++  + +  N      P       +L      +N  S   P +      L+ L L  N 
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91

Query: 337 LTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGK 395
           +T  P  L F GL SL  L L  N  +    ++  D H+L +LSL  N+L      +F  
Sbjct: 92  ITELPKSL-FEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150

Query: 396 LTSLLFLSLSNNSFN 410
           L ++  + L+ N F 
Sbjct: 151 LRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 23/101 (22%), Positives = 33/101 (32%), Gaps = 19/101 (18%)

Query: 550 LPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLE 608
           L  N     PP  F                 K L  +DLS N I+  +       +R+L 
Sbjct: 39  LEQNTIKVIPPGAFSP--------------YKKLRRIDLSNNQIS-ELAPDAFQGLRSLN 83

Query: 609 VLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTIPTG 648
            L L  N +   +P   FE L  L    +  N +   +   
Sbjct: 84  SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVD 122

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 37/172 (21%), Positives = 55/172 (31%), Gaps = 50/172 (29%)

Query: 474 QVLDLSWNHFDGNIPPWI-GQMENLFYLDFSNNTLTGEIPK----SLTELKSLISSNCTS 528
             + L  N     IPP      + L  +D SNN ++ E+       L  L SL       
Sbjct: 35  TEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSL------- 85

Query: 529 SNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDL 588
                                L  N+ +  P S+F                L  L +L L
Sbjct: 86  --------------------VLYGNKITELPKSLF--------------EGLFSLQLLLL 111

Query: 589 SRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 639
           + N I   +      ++ NL +L L  N L     G+F  L  +    +A N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 31/153 (20%), Positives = 59/153 (38%), Gaps = 25/153 (16%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
           +T + L +  +K I P +     +L+ +DLS N +  + P     L+ L  L L  N ++
Sbjct: 34  ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKE 207
                +  GL  +Q L +++N  N  L  +  F +L                        
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN-CL-RVDAFQDL----------------------HN 129

Query: 208 IQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNN 239
           + +L L  N      +G      +++ +H+  N
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 18/74 (24%), Positives = 32/74 (43%)

Query: 98  LKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           +  +       L  L+LL L+ N +  +      +L  L +L L  N L     G  + L
Sbjct: 92  ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151

Query: 158 NLIQSLNVSSNSFN 171
             IQ+++++ N F 
Sbjct: 152 RAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 30/133 (22%), Positives = 55/133 (41%), Gaps = 4/133 (3%)

Query: 353 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL 412
            + L  N      P + S    L+ + L+ N++S   P++F  L SL  L L  N    L
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITEL 95

Query: 413 SGTLSVLQQCKNLTTLILTKNFVGEEIPENV-GGFESLMVLALGNCGLKGHIPVWLLRCK 471
               S+ +   +L  L+L  N +   +  +      +L +L+L +  L+          +
Sbjct: 96  PK--SLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 472 KLQVLDLSWNHFD 484
            +Q + L+ N F 
Sbjct: 153 AIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 32/149 (21%), Positives = 59/149 (39%), Gaps = 28/149 (18%)

Query: 374 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
            +  + L +N +    P +F     L  + LSNN  + L+      Q  ++L +L+L  N
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAP--DAFQGLRSLNSLVLYGN 90

Query: 434 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ 493
            +  E+P+++  FE L                       LQ+L L+ N     +     Q
Sbjct: 91  KI-TELPKSL--FEGL---------------------FSLQLLLLNANKI-NCLRVDAFQ 125

Query: 494 -MENLFYLDFSNNTLTGEIPKSLTELKSL 521
            + NL  L   +N L      + + L+++
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 32/175 (18%), Positives = 59/175 (33%), Gaps = 47/175 (26%)

Query: 115 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL 174
           + L  N ++ + P   S  K+L  +DLS+N +S        GL  + SL +  N      
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN------ 90

Query: 175 FELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQL 234
                                             +I +L  + F       +   SL+ L
Sbjct: 91  ----------------------------------KITELPKSLF-------EGLFSLQLL 109

Query: 235 HVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQF 289
            ++ N +     D+   + +L  +SL  N          S L +++ + +  N F
Sbjct: 110 LLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 54.7 bits (132), Expect = 8e-08
 Identities = 46/220 (20%), Positives = 84/220 (38%), Gaps = 38/220 (17%)

Query: 778 IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYC 836
            +G G F  V+ A  + N T  A+K + GD        + E++ L R    +        
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 837 RHGNDRLLIYSYMENGSLDY------WLHESVD------KDSVLKWDVRLKIAQGAARGL 884
            +   +LL +   +  +  +       L E++       +   +      +I++    GL
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144

Query: 885 AYLHKVCEPHIVHRDVKSSNILLDEKFEAH------LADFGLSRLLRPYDTHVTTDLVGT 938
            Y+H+ C   I+H D+K  N+L++            +AD G +      D H T  +  T
Sbjct: 145 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYTNSIQ-T 198

Query: 939 LGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 972
             Y  PE      +          D++S   ++ EL+TG 
Sbjct: 199 REYRSPEVLLGAPWGCGA------DIWSTACLIFELITGD 232

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 4/86 (4%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP- 622
           L  N+    +P E+   KHL ++DLS N I+     S S +  L  L LS N L   IP 
Sbjct: 38  LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPP 95

Query: 623 GSFEKLTFLSKFSVANNHLQGTIPTG 648
            +F+ L  L   S+  N +   +P G
Sbjct: 96  RTFDGLKSLRLLSLHGNDIS-VVPEG 120

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 30/131 (22%), Positives = 51/131 (38%), Gaps = 25/131 (19%)

Query: 511 IPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRIN 570
           IP+ +TEL   +  N  +  P   +        + +   L  N+ S+     F       
Sbjct: 29  IPRDVTELY--LDGNQFTLVPKELSNY-----KHLTLIDLSNNRISTLSNQSF------- 74

Query: 571 GTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKL 628
                    +  L  L LS N +   IP      +++L +L L  ND+   +P G+F  L
Sbjct: 75  -------SNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL 125

Query: 629 TFLSKFSVANN 639
           + LS  ++  N
Sbjct: 126 SALSHLAIGAN 136

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 45/277 (16%), Positives = 82/277 (29%), Gaps = 50/277 (18%)

Query: 112 LKLLDLSCNHL-----EGVVPVELSNLKQLEVLDLSHNMLSGP-VSGMLAGLNLIQSLNV 165
           L+ L+L+   +       V  V  S    L+ ++L+   L    +  +L      + L +
Sbjct: 74  LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGL 133

Query: 166 SSNSF-NGSLFELGEF-----SNLAVFNISNNSFT---GKLNSRIWSASKEIQILDLSMN 216
             NS    +  +L +        +    +SNN  T     +     + +  +  L L   
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHT 193

Query: 217 HF----MGSL-QGLDHSPSLKQLHVDNNLLGG----DLPDSLYSMSSLQHVSLSVNNFS- 266
                 +  L   LD +  L++L+V  N  G      L  +     SL+ + L  N  S 
Sbjct: 194 GLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253

Query: 267 ------GQLSEKISNLTSLRHLIIFGNQFS----GKLPNVLGNLTQLEFFVAHSNSFSGP 316
                   L         +   +  G   S      L  V  NL   +      +     
Sbjct: 254 EGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLL 313

Query: 317 LPLS---------------LSLCSKLHVLDLRNNSLT 338
             L                L +  ++  L  +  S  
Sbjct: 314 RDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 51.6 bits (124), Expect = 7e-07
 Identities = 56/362 (15%), Positives = 98/362 (27%), Gaps = 67/362 (18%)

Query: 99  KGIIPRSLGHLNQLKLLDLSCNHLE-GVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGL 157
           K +       L   +LLD    H E          L  L  L+L+   ++          
Sbjct: 36  KKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMT--PVKCTV-- 91

Query: 158 NLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNH 217
            +   L                   L   N+++          +       + L L +N 
Sbjct: 92  -VAAVLGSGR-------------HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNS 137

Query: 218 F----MGSL-QGLDHSPS-LKQLHVDNNLLGGD----LPDSLYSMSSLQHVSLSVNNFSG 267
                   L   L H    +  L + NN L       L + L   +S+ H+SL       
Sbjct: 138 LGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197

Query: 268 Q----LSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL 323
           +    L+ ++     L+ L +  N         L                      +   
Sbjct: 198 EGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR--------------------AARE 237

Query: 324 CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDL-----KIL 378
              L +L L  N L+        G   L  L          +  SL++   +      IL
Sbjct: 238 HPSLELLHLYFNELSS------EGRQVLRDL-GGAAEGGARVVVSLTEGTAVSEYWSVIL 290

Query: 379 SLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTL--SVLQQCKNLTTLILTKNFVG 436
           S  +  L+        +   LL   L ++    L+      +L+    +  L+      G
Sbjct: 291 SEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350

Query: 437 EE 438
             
Sbjct: 351 SP 352

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 39/183 (21%)

Query: 499 YLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIP-------LYVKHNRSTN--- 548
             +    ++T +   +  EL S+      +S+  +  GI        L +  N+  +   
Sbjct: 23  KANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISA 80

Query: 549 ----------GLPYNQASSFPPSVF----------LSNNRINGTIPPEI-GQLKHLHVLD 587
                      L  NQ  S P  VF          L  N++  ++P  +  +L +L  L+
Sbjct: 81  LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLN 139

Query: 588 LSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNHLQGTI 645
           L+ N +  ++P  +  ++ NL  LDLS N L  S+P G F+KLT L    +  N L+ ++
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SV 196

Query: 646 PTG 648
           P G
Sbjct: 197 PDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 209 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ 268
              +L            +   S+ Q+  +N+ +   +   +  + ++++++L  N    +
Sbjct: 22  IKANLKKKSV-TDAVTQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVRYLALGGN----K 74

Query: 269 LSEKIS---NLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF-SGPLPLSLSLC 324
           L   IS    LT+L +LI+ GNQ       V   LT L+  V   N   S P  +   L 
Sbjct: 75  LH-DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL- 132

Query: 325 SKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD-CHDLKILSLAKN 383
           + L  L+L +N L       F  L++L  LDL+ N     LP  + D    LK L L +N
Sbjct: 133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQN 191

Query: 384 ELSGQVPE-SFGKLTSLLFLSLSNN 407
           +L   VP+  F +LTSL ++ L +N
Sbjct: 192 QLKS-VPDGVFDRLTSLQYIWLHDN 215

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 27/128 (21%), Positives = 44/128 (34%), Gaps = 25/128 (19%)

Query: 525 NCTSSNPTA-SAGIPLYVKHNRSTNGLPYNQASSFPPS-VFLSNNRINGTIPPEIGQLKH 582
           +CT          IPL+         L  N+        +F              G+L H
Sbjct: 14  DCTGRGLKEIPRDIPLHTTELL----LNDNELGRISSDGLF--------------GRLPH 55

Query: 583 LHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTFLSKFSVANNH 640
           L  L+L RN +T  I  +      +++ L L  N +   I    F  L  L   ++ +N 
Sbjct: 56  LVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQ 113

Query: 641 LQGTIPTG 648
           +   +  G
Sbjct: 114 IS-CVMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 30/115 (26%), Positives = 46/115 (40%), Gaps = 21/115 (18%)

Query: 329 VLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDC-HDLKILSLAKNELS 386
            L L +N L     D  F  L  L  L+L  N  +G +  +  +    ++ L L +N++ 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK 91

Query: 387 GQVPESFGKLTSLLFLSLSNN--------SFNHLSGTLSVLQQCKNLTTLILTKN 433
               + F  L  L  L+L +N        SF HL           +LT+L L  N
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL----------NSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 32/87 (36%), Positives = 43/87 (49%), Gaps = 4/87 (4%)

Query: 326 KLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD-CHDLKILSLAKNE 384
            L  L+L+ N LTG     F G S +  L L  N     + N +    H LK L+L  N+
Sbjct: 55  HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQ 113

Query: 385 LSGQVPE-SFGKLTSLLFLSLSNNSFN 410
           +S  V   SF  L SL  L+L++N FN
Sbjct: 114 ISC-VMPGSFEHLNSLTSLNLASNPFN 139

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 49.2 bits (118), Expect = 9e-07
 Identities = 38/138 (27%), Positives = 58/138 (42%), Gaps = 33/138 (23%)

Query: 523 SSNCTSSNPT--------AS--AGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGT 572
            S C+ S            S   GIP     + +   L  N+  S P  VF         
Sbjct: 2   PSRCSCSGTEIRCNSKGLTSVPTGIPS----SATRLELESNKLQSLPHGVF--------- 48

Query: 573 IPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDLHGSIP-GSFEKLTF 630
                 +L  L  L LS+N I  ++P  +  ++  L +L L  N L  S+P G F+KLT 
Sbjct: 49  -----DKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQ 101

Query: 631 LSKFSVANNHLQGTIPTG 648
           L + ++  N L+ ++P G
Sbjct: 102 LKELALDTNQLK-SVPDG 118

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.2 bits (116), Expect = 4e-06
 Identities = 30/171 (17%), Positives = 56/171 (32%), Gaps = 21/171 (12%)

Query: 243 GDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLG---- 298
            DL   L +M  L ++ +   N    LS       +L+ L I        +   +     
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 299 -NLTQLEFFVAHSNSFSGPLP------LSLSLCSKLHVLDLRNNSLTGPI---DLNFSGL 348
            NL +L  +V   +              S      L  L + +      +    L    L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 349 SSLCTLDLATNHFSG----PLPNSLSDCHDLKILSLAKNELSGQVPESFGK 395
             L T+D++    +      L + +     LK +++  N LS ++ +   K
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.2 bits (116), Expect = 4e-06
 Identities = 25/166 (15%), Positives = 50/166 (30%), Gaps = 26/166 (15%)

Query: 477 DLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASA- 535
           ++SW     ++ P +  M  L  L            K    LKSL   +    +      
Sbjct: 155 EISW-IEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDI 213

Query: 536 ---------------GIPLYVKHNRSTNGLPYNQASSFPP--SVFLSNNRINGTIPPEIG 578
                          G+  Y          P      FP    + + +      +     
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273

Query: 579 Q---LKHLHVLDLSRNNITGT----IPSSISEIRNLEVLDLSSNDL 617
           +   L  L  +D+S   +T      +   + +I++L+ +++  N L
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 9e-06
 Identities = 29/164 (17%), Positives = 52/164 (31%), Gaps = 19/164 (11%)

Query: 291 GKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLT--GPIDLNFSGL 348
             L  VL  +  L          +  L +       L  L++ +  L      D+  S L
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 349 SSLCTLDLATNHFSGPLPNSLSD---------CHDLKILSLAKNELSGQVPESFGK---L 396
            +L  L L            ++            +LK L +   E    V E F +   L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 397 TSLLFLSLSNNSFNHLSGT--LSVLQQCKNLTTLILTKNFVGEE 438
             L  + +S            L  + + K+L  + +  N++ +E
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 1e-05
 Identities = 23/154 (14%), Positives = 48/154 (31%), Gaps = 29/154 (18%)

Query: 108 HLNQLKLLDLSCNH-----LEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQS 162
               LK L++         +E ++  +L NL++L +     +        +         
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR------- 243

Query: 163 LNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSAS--KEIQILDLSMNHFMG 220
                      LF    F NL    I +      +      +    +++ +D+S      
Sbjct: 244 ----------PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293

Query: 221 S-----LQGLDHSPSLKQLHVDNNLLGGDLPDSL 249
                 L  +D    LK +++  N L  ++   L
Sbjct: 294 EGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 41.9 bits (97), Expect = 9e-04
 Identities = 15/86 (17%), Positives = 35/86 (40%), Gaps = 8/86 (9%)

Query: 87  RVTMLILPRKGLKGIIPRSLGH---LNQLKLLDLSCNHL--EGVVPV--ELSNLKQLEVL 139
            +  L +     + ++         L QL+ +D+S   L  EG   +   +  +K L+ +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312

Query: 140 DLSHNMLSGP-VSGMLAGLNLIQSLN 164
           ++ +N LS      +   L +   ++
Sbjct: 313 NMKYNYLSDEMKKELQKSLPMKIDVS 338

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 43/226 (19%), Positives = 70/226 (30%), Gaps = 35/226 (15%)

Query: 392 SFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMV 451
                  +  + LSN+     S    +L QC  L  L L    + + I   +    +L+ 
Sbjct: 88  EHFSPFRVQHMDLSNSVIEV-STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 146

Query: 452 LALGNC-GLKGHIPVWLLR-CKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG 509
           L L  C G        LL  C +L  L+LSW                    DF+   +  
Sbjct: 147 LNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF------------------DFTEKHVQV 188

Query: 510 EIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRI 569
            +      +  L  S    +     + +   V+   +   L               +  +
Sbjct: 189 AVAHVSETITQLNLSGYRKN--LQKSDLSTLVRRCPNLVHL-----------DLSDSVML 235

Query: 570 NGTIPPEIGQLKHLHVLDLSR-NNITGTIPSSISEIRNLEVLDLSS 614
                 E  QL +L  L LSR  +I       + EI  L+ L +  
Sbjct: 236 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 50/232 (21%), Positives = 82/232 (35%), Gaps = 44/232 (18%)

Query: 321 LSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH---DLKI 377
           LS CSKL  L L    L+ PI    +  S+L  L+             LS C    +  +
Sbjct: 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN-------------LSGCSGFSEFAL 160

Query: 378 LSLAKNELSGQVPESFGKLTSLLFLSLSN-NSFNHLSGTLSVLQQCKNLTTLIL---TKN 433
            +L  +             + L  L+LS    F      ++V    + +T L L    KN
Sbjct: 161 QTLLSS------------CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 208

Query: 434 FVGEEIPENVGGFESLMVLALGNC-GLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPP--- 489
               ++   V    +L+ L L +   LK        +   LQ L LS  +   +I P   
Sbjct: 209 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY---DIIPETL 265

Query: 490 -WIGQMENLFYLDFSNNTLTG---EIPKSLTELKSLISSNCTSSNPTASAGI 537
             +G++  L  L        G    + ++L  L+ +  S+ T+         
Sbjct: 266 LELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-INCSHFTTIARPTIGNK 316

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.1 bits (109), Expect = 5e-05
 Identities = 32/149 (21%), Positives = 44/149 (29%), Gaps = 55/149 (36%)

Query: 875 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL--------------------------- 907
           KI Q   +GL YLH  C   I+H D+K  NILL                           
Sbjct: 150 KIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 908 ----------------------DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
                                  EK +  +AD G +  +  + T      + T  Y   E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE----DIQTRQYRSLE 263

Query: 946 YSQTLTATCRGDVYSFGVVLLELLTGRRP 974
                      D++S   +  EL TG   
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYL 292

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 33/106 (31%), Positives = 45/106 (42%), Gaps = 21/106 (19%)

Query: 875 KIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE--KFEAHLADFGLSRLLRPYDTHVT 932
           K A    + L  LHK     I+H D+K  NILL +  +    + DFG S         V 
Sbjct: 204 KFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVY 257

Query: 933 TDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 972
           T +  +  Y  PE      Y   +      D++S G +L ELLTG 
Sbjct: 258 TYIQ-SRFYRAPEVILGARYGMPI------DMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 30/109 (27%), Positives = 44/109 (40%), Gaps = 20/109 (18%)

Query: 872 VRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL--DEKFEAHLADFGLSRLLRPYDT 929
            R K AQ     L +L    E  I+H D+K  NILL   ++    + DFG S        
Sbjct: 159 TR-KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC----QLG 212

Query: 930 HVTTDLVGTLGYIPPE------YSQTLTATCRGDVYSFGVVLLELLTGR 972
                 + +  Y  PE      Y   +      D++S G +L+E+ TG 
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAI------DMWSLGCILVEMHTGE 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1052
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-64
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-58
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-28
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-23
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-05
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.003
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-08
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.004
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 2e-66
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 22/281 (7%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
                    IG G FG VYK          +  ++    Q  + F+ EV  L + +H N++
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
               GY        ++  + E  SL + LH     ++  +    + IA+  A+G+ YLH  
Sbjct: 68   LFMGYS-TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHA- 122

Query: 891  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYSQT 949
                I+HRD+KS+NI L E     + DFGL+ +   +  +H    L G++ ++ PE  + 
Sbjct: 123  --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 950  LTA---TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006
                  + + DVY+FG+VL EL+TG+ P       N RD + ++        ++  + ++
Sbjct: 181  QDKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                        M  +  +C+ +    RP   +++  ++ +
Sbjct: 238  CPK--------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 8e-64
 Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 22/277 (7%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
                    +G G FG V+       TK AVK L          F AE   + + QH+ LV
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
             L           +I  YMENGSL  +L         L  +  L +A   A G+A++   
Sbjct: 72   RLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE-- 126

Query: 891  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
             E + +HRD++++NIL+ +     +ADFGL+RL+   +          + +  PE     
Sbjct: 127  -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 951  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
            T T + DV+SFG++L E++T  R                 +   +    ++ ++      
Sbjct: 186  TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 230

Query: 1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
              +    E+ ++   C  + P  RP  + + + L+  
Sbjct: 231  RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 4e-62
 Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 22/277 (7%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
            +       IG G FGLV+     N  K A+K +       E +F  E E + +  H  LV
Sbjct: 5    SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63

Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
             L G C       L++ +ME+G L  +L       +    +  L +      G+AYL   
Sbjct: 64   QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYL--- 117

Query: 891  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
             E  ++HRD+ + N L+ E     ++DFG++R +       +T     + +  PE     
Sbjct: 118  EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 951  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
              + + DV+SFGV++ E+ +  +     + ++  ++V  +           +    +   
Sbjct: 178  RYSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDI------STGFRLYKPRLAST 229

Query: 1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                    + +I   C  + P  RP    ++  L  I
Sbjct: 230  -------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 3e-61
 Identities = 63/275 (22%), Positives = 116/275 (42%), Gaps = 22/275 (8%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
             +      +G G FG V+  T    T+ A+K L          F  E + + + +H+ LV
Sbjct: 17   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
             L           ++  YM  GSL  +L    +    L+    + +A   A G+AY+ + 
Sbjct: 76   QLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER- 131

Query: 891  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
               + VHRD++++NIL+ E     +ADFGL+RL+   +          + +  PE +   
Sbjct: 132  --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 951  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
              T + DV+SFG++L EL T  R                 +     +  ++ ++      
Sbjct: 190  RFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMP 234

Query: 1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
               +    + ++ C+C  ++P  RP  E +  +L+
Sbjct: 235  CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (520), Expect = 1e-59
 Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 41/305 (13%)

Query: 762  TVSDLLKSTNNFNQA---------NIIGCGGFGLVYKATLTNGTK----AAVKRL-SGDC 807
            T  D  ++   F +           +IG G FG V    L    K     A+K L SG  
Sbjct: 8    TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 808  GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSV 867
             +  R+F +E   + +  H N++ L+G        ++I  +MENGSLD +L ++  + + 
Sbjct: 68   EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT- 126

Query: 868  LKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY 927
                  + + +G A G+ YL      + VHRD+ + NIL++      ++DFGLSR L   
Sbjct: 127  --VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 928  DTHVTT----DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKN 982
             +  T          + +  PE  Q    T   DV+S+G+V+ E+++ G RP        
Sbjct: 182  TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW---DMT 238

Query: 983  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042
             +D+++ + Q       ++                 + ++   C  +D   RP   ++V 
Sbjct: 239  NQDVINAIEQDYRLPPPMDCPS-------------ALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 1043 WLDGI 1047
             LD +
Sbjct: 286  TLDKM 290

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 1e-59
 Identities = 52/274 (18%), Positives = 105/274 (38%), Gaps = 22/274 (8%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
             +      +G G FG+V           A+K +  +    E EF  E + +    H+ LV
Sbjct: 4    KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
             L G C       +I  YM NG L  +L    +     +    L++ +     + YL   
Sbjct: 63   QLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES- 118

Query: 891  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
                 +HRD+ + N L++++    ++DFGLSR +   +   +      + + PPE     
Sbjct: 119  --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 951  TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHK 1010
              + + D+++FGV++ E+ +  +                 ++  +     E I   +   
Sbjct: 177  KFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLY 221

Query: 1011 DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                   ++  I   C  +    RP  + +++ +
Sbjct: 222  RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-59
 Identities = 66/300 (22%), Positives = 118/300 (39%), Gaps = 38/300 (12%)

Query: 770  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHK 827
             ++F + + +G G  G+V+K +   +G   A K +  +    +  +   E++ L      
Sbjct: 5    DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 828  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
             +V   G      +  +   +M+ GSLD  L     K   +   +  K++    +GL YL
Sbjct: 65   YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 888  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
             +     I+HRDVK SNIL++ + E  L DFG+S  L      +    VGT  Y+ PE  
Sbjct: 121  REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERL 175

Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRP--------------------------VEVCKGK 981
            Q    + + D++S G+ L+E+  GR P                               G+
Sbjct: 176  QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 982  NCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQL-LEMLEIACKCIDQDPRRRPFIEEV 1040
                         +    ++ I      K       LE  +   KC+ ++P  R  ++++
Sbjct: 236  PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (514), Expect = 5e-59
 Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 22/278 (7%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTN-GTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 829
             +    + +G G +G VY+          AVK L  D  ++E EF  E   +   +H NL
Sbjct: 17   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75

Query: 830  VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
            V L G C       +I  +M  G+L  +L E   ++  +   V L +A   +  + YL K
Sbjct: 76   VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK 133

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
                + +HRD+ + N L+ E     +ADFGLSRL+              + +  PE    
Sbjct: 134  ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 950  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009
               + + DV++FGV+L E+ T                    +      +  E+++     
Sbjct: 191  NKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLEKDYRM 235

Query: 1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            +  E    ++ E+   C   +P  RP   E+    + +
Sbjct: 236  ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 3e-58
 Identities = 68/278 (24%), Positives = 106/278 (38%), Gaps = 28/278 (10%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
                    IG G FG V       G K AVK +  D     + F AE   +++ +H NLV
Sbjct: 7    KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLV 63

Query: 831  SLQGYCRHGNDRL-LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
             L G        L ++  YM  GSL  +L       SVL  D  LK +      + YL  
Sbjct: 64   QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQT 949
                + VHRD+ + N+L+ E   A ++DFGL++                + +  PE  + 
Sbjct: 122  ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALRE 174

Query: 950  LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009
               + + DV+SFG++L E+ +  R          +D+V  V +                 
Sbjct: 175  KKFSTKSDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPRVEKGYKMDAPDGCPP----- 227

Query: 1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                     + E+   C   D   RP   ++   L+ I
Sbjct: 228  --------AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 5e-58
 Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 30/292 (10%)

Query: 779  IGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH 838
            IG G FG V++     G + AVK  S    +     +AE+      +H+N++        
Sbjct: 11   IGKGRFGEVWRGKWR-GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 839  GNDRL----LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC--- 891
             N       L+  Y E+GSL  +L+        +  +  +K+A   A GLA+LH      
Sbjct: 69   DNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 892  --EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV---TTDLVGTLGYIPPEY 946
              +P I HRD+KS NIL+ +     +AD GL+         +       VGT  Y+ PE 
Sbjct: 124  QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 947  ------SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC----RDLVSWVFQMKSE 996
                   +   +  R D+Y+ G+V  E+        + +                +   +
Sbjct: 184  LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 997  KREVEIIDASIWHKDREKQLL-EMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                + +  +I ++ +  + L  M +I  +C   +   R     +   L  +
Sbjct: 244  VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (507), Expect = 6e-58
 Identities = 75/305 (24%), Positives = 115/305 (37%), Gaps = 46/305 (15%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDC-GQMEREFQAEVEALSR 823
            NN      IG G FG V++A           T  AVK L  +    M+ +FQ E   ++ 
Sbjct: 13   NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHE--------------------SVD 863
              + N+V L G C  G    L++ YM  G L+ +L                      S  
Sbjct: 73   FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 864  KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL 923
                L    +L IA+  A G+AYL    E   VHRD+ + N L+ E     +ADFGLSR 
Sbjct: 133  GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 924  LRPYD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
            +   D      +    + ++PPE       T   DV+++GVVL E+ +            
Sbjct: 190  IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-------- 241

Query: 983  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042
                    +   + +  +  +         E   LE+  +   C  + P  RP    +  
Sbjct: 242  -------PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 1043 WLDGI 1047
             L  +
Sbjct: 295  ILQRM 299

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-57
 Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 40/300 (13%)

Query: 771  NNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
            N  +    +G G FG V +AT             AVK L       ERE   +E++ LS 
Sbjct: 23   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 824  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHES--------------VDKDSVL 868
               H N+V+L G C  G   L+I  Y   G L  +L                  D +  L
Sbjct: 83   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 869  KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
              +  L  +   A+G+A+L      + +HRD+ + NILL       + DFGL+R ++   
Sbjct: 143  DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 929  TH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 987
             + V  +    + ++ PE       T   DV+S+G+ L EL +                 
Sbjct: 200  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 988  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                 M  + +  ++I         E    EM +I   C D DP +RP  +++V  ++  
Sbjct: 247  -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-56
 Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 26/282 (9%)

Query: 772  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKN 828
            ++     IG G +G   K    ++G     K L         ++   +EV  L   +H N
Sbjct: 5    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 829  LVSLQGYCRHGNDRLL--IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
            +V          +  L  +  Y E G L   + +   +   L  +  L++       L  
Sbjct: 65   IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 887  LHK--VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
             H+       ++HRD+K +N+ LD K    L DFGL+R+L   DT      VGT  Y+ P
Sbjct: 125  CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSP 183

Query: 945  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
            E    ++   + D++S G +L EL     P                F   S+K     I 
Sbjct: 184  EQMNRMSYNEKSDIWSLGCLLYELCALMPP----------------FTAFSQKELAGKIR 227

Query: 1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WL 1044
               + +   +   E+ EI  + ++     RP +EE++    +
Sbjct: 228  EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-56
 Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 29/287 (10%)

Query: 769  STNNFNQANIIGCGGFGLVYKATLTNGT-----KAAVKRLSGDCGQMER-EFQAEVEALS 822
              +   +  +IG G FG VYK  L   +       A+K L     + +R +F  E   + 
Sbjct: 5    HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 823  RAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAAR 882
            +  H N++ L+G        ++I  YMENG+LD +L E   KD        + + +G A 
Sbjct: 65   QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAA 121

Query: 883  GLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR--PYDTHVTTDLVGTLG 940
            G+ YL      + VHRD+ + NIL++      ++DFGLSR+L   P  T+ T+     + 
Sbjct: 122  GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 941  YIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
            +  PE       T   DV+SFG+V+ E++T                    +   S    +
Sbjct: 179  WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEVM 223

Query: 1001 EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            + I+              + ++  +C  Q+  RRP   ++V+ LD +
Sbjct: 224  KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-55
 Identities = 64/288 (22%), Positives = 115/288 (39%), Gaps = 31/288 (10%)

Query: 765  DLLKSTNNFNQANI-IGCGGFGLVYKATL---TNGTKAAVKRLSGDCGQMERE-FQAEVE 819
             L    +N   A+I +GCG FG V +            A+K L     + + E    E +
Sbjct: 2    KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 820  ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
             + +  +  +V L G C      +L+      G L  +L     K   +      ++   
Sbjct: 62   IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQ 117

Query: 880  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVG 937
             + G+ YL +    + VHRD+ + N+LL  +  A ++DFGLS+ L   D++ T  +    
Sbjct: 118  VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 938  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSE 996
             L +  PE       + R DV+S+GV + E L+ G++P +        ++++++ Q K  
Sbjct: 175  PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---KMKGPEVMAFIEQGKRM 231

Query: 997  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
            +   E                E+  +   C       RP    V   +
Sbjct: 232  ECPPECPP-------------ELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 5e-55
 Identities = 75/294 (25%), Positives = 124/294 (42%), Gaps = 37/294 (12%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNG---TKAAVKRLSGD-CGQMEREFQAEVEALSR-AQ 825
            N+    ++IG G FG V KA +        AA+KR+         R+F  E+E L +   
Sbjct: 10   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKD------------SVLKWDVR 873
            H N+++L G C H     L   Y  +G+L  +L +S   +            S L     
Sbjct: 70   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 874  LKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTT 933
            L  A   ARG+ YL    +   +HRD+ + NIL+ E + A +ADFGLSR    Y      
Sbjct: 130  LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 934  DLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM 993
                 + ++  E       T   DV+S+GV+L E+++         G  C +L   + Q 
Sbjct: 187  --RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQG 242

Query: 994  KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               ++ +   D             E+ ++  +C  + P  RP   +++  L+ +
Sbjct: 243  YRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (484), Expect = 1e-54
 Identities = 67/276 (24%), Positives = 109/276 (39%), Gaps = 34/276 (12%)

Query: 773  FNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQHKN 828
            F+    IG G FG VY A  + N    A+K++S    Q     ++   EV  L + +H N
Sbjct: 17   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 829  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
             +  +G     +   L+  Y    + D            L+      +  GA +GLAYLH
Sbjct: 77   TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
                 +++HRDVK+ NILL E     L DFG + ++ P         VGT  ++ PE   
Sbjct: 133  ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184

Query: 949  TLT---ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005
             +       + DV+S G+  +EL   + P+      N    +  + Q +S   +      
Sbjct: 185  AMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHWSE 241

Query: 1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
                                C+ + P+ RP  E ++
Sbjct: 242  ------------YFRNFVDSCLQKIPQDRPTSEVLL 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 1e-54
 Identities = 67/304 (22%), Positives = 116/304 (38%), Gaps = 47/304 (15%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMERE-FQAEVEALSR 823
             N     ++G G FG V  AT           + AVK L       ERE   +E++ +++
Sbjct: 37   ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 824  -AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDS---------------- 866
               H+N+V+L G C       LI+ Y   G L  +L    +K S                
Sbjct: 97   LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 867  ---VLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL 923
               VL ++  L  A   A+G+ +L        VHRD+ + N+L+       + DFGL+R 
Sbjct: 157  DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 924  LRPYDTHVT-TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKN 982
            +     +V   +    + ++ PE       T + DV+S+G++L E+ +            
Sbjct: 214  IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-------- 265

Query: 983  CRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLL-EMLEIACKCIDQDPRRRPFIEEVV 1041
                    +           +  + +  D+      E+  I   C   D R+RP    + 
Sbjct: 266  -------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 1042 TWLD 1045
            ++L 
Sbjct: 319  SFLG 322

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-54
 Identities = 76/285 (26%), Positives = 119/285 (41%), Gaps = 32/285 (11%)

Query: 772  NFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDCGQME-REFQAEVEALSRAQH 826
            +FN   +IG G FG VY  TL +        AVK L+      E  +F  E   +    H
Sbjct: 30   HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 827  KNLVSLQGYCRHGNDR-LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
             N++SL G C       L++  YM++G L  ++    ++         +      A+G+ 
Sbjct: 88   PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGM- 143

Query: 886  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP---YDTHVTTDLVGTLGYI 942
                +     VHRD+ + N +LDEKF   +ADFGL+R +        H  T     + ++
Sbjct: 144  --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 943  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
              E  QT   T + DV+SFGV+L EL+T   P       N  D+  ++ Q +   +    
Sbjct: 202  ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYLLQGRRLLQPEYC 259

Query: 1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
             D              + E+  KC       RP   E+V+ +  I
Sbjct: 260  PD-------------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-54
 Identities = 59/276 (21%), Positives = 109/276 (39%), Gaps = 32/276 (11%)

Query: 777  NIIGCGGFGLVYKATLTN---GTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVS 831
              +G G FG V K            AVK L  +     ++ E  AE   + +  +  +V 
Sbjct: 13   KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 832  LQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
            + G C   +  +L+    E G L+ +L     ++  +K    +++    + G+ YL +  
Sbjct: 73   MIGICEAES-WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-- 125

Query: 892  EPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTD--LVGTLGYIPPEYSQT 949
              + VHRD+ + N+LL  +  A ++DFGLS+ LR  + +          + +  PE    
Sbjct: 126  -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 950  LTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008
               + + DV+SFGV++ E  + G++P                ++         +++    
Sbjct: 185  YKFSSKSDVWSFGVLMWEAFSYGQKP----------------YRGMKGSEVTAMLEKGER 228

Query: 1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
                     EM ++   C   D   RP    V   L
Sbjct: 229  MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-54
 Identities = 57/270 (21%), Positives = 104/270 (38%), Gaps = 31/270 (11%)

Query: 779  IGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG VYKA        AA K +     +   ++  E++ L+   H N+V L     
Sbjct: 20   LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
            + N+  ++  +   G++D  +    + +  L       + +     L YLH   +  I+H
Sbjct: 80   YENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKIIH 133

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA----- 952
            RD+K+ NIL     +  LADFG+S           +  +GT  ++ PE     T+     
Sbjct: 134  RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPY 192

Query: 953  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012
              + DV+S G+ L+E+     P                    +  R +  I  S      
Sbjct: 193  DYKADVWSLGITLIEMAEIEPP----------------HHELNPMRVLLKIAKSEPPTLA 236

Query: 1013 EKQLL--EMLEIACKCIDQDPRRRPFIEEV 1040
            +         +   KC++++   R    ++
Sbjct: 237  QPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 66/273 (24%), Positives = 106/273 (38%), Gaps = 31/273 (11%)

Query: 777  NIIGCGGFGLVYKATLT-NGTKAAVKRLS--GDCGQMEREFQAEVEALSRAQHKNLVSLQ 833
              IG G F  VYK   T    + A   L          + F+ E E L   QH N+V   
Sbjct: 15   IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 834  GYC----RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
                   +     +L+   M +G+L  +L     +  V+K  V     +   +GL +LH 
Sbjct: 75   DSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 890  VCEPHIVHRDVKSSNILL-DEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
               P I+HRD+K  NI +        + D GL+ L R         ++GT  ++ PE  +
Sbjct: 131  -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186

Query: 949  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008
                    DVY+FG+ +LE+ T   P    + +N   +   V          ++      
Sbjct: 187  E-KYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAIP--- 240

Query: 1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
                     E+ EI   CI Q+   R  I++++
Sbjct: 241  ---------EVKEIIEGCIRQNKDERYSIKDLL 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-53
 Identities = 69/277 (24%), Positives = 111/277 (40%), Gaps = 31/277 (11%)

Query: 769  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLS---GDCGQMEREFQAEVEALSRA 824
            +  +F     +G G FG VY A    +    A+K L     +   +E + + EVE  S  
Sbjct: 4    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 825  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            +H N++ L GY        LI  Y   G++   L     K S              A  L
Sbjct: 64   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANAL 119

Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            +Y H      ++HRD+K  N+LL    E  +ADFG S       +   T L GTL Y+PP
Sbjct: 120  SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPP 173

Query: 945  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
            E  +      + D++S GV+  E L G+ P E       ++    +   + E    + + 
Sbjct: 174  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRI--SRVEFTFPDFVT 228

Query: 1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVV 1041
                            ++  + +  +P +RP + EV+
Sbjct: 229  E------------GARDLISRLLKHNPSQRPMLREVL 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-52
 Identities = 62/292 (21%), Positives = 107/292 (36%), Gaps = 30/292 (10%)

Query: 766  LLKSTNNFNQANIIGCGGFGLVYKATLTN-----GTKAAVKRLS-GDCGQMEREFQAEVE 819
            +LK T  F +  ++G G FG VYK              A+K L      +  +E   E  
Sbjct: 5    ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 820  ALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
             ++   + ++  L G C     +L I   M  G L  ++ E  D          L     
Sbjct: 64   VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQ 119

Query: 880  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT-HVTTDLVGT 938
             A+G+ YL    +  +VHRD+ + N+L+       + DFGL++LL   +  +        
Sbjct: 120  IAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR 998
            + ++  E       T + DV+S+GV + EL+T                    +       
Sbjct: 177  IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASE 221

Query: 999  EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050
               I++            +++  I  KC   D   RP   E++     +  D
Sbjct: 222  ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 5e-52
 Identities = 55/265 (20%), Positives = 112/265 (42%), Gaps = 28/265 (10%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            IG G  G VY A  +  G + A+++++      +     E+  +   ++ N+V+      
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
             G++  ++  Y+  GSL   + E+              + +   + L +LH      ++H
Sbjct: 88   VGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 898  RDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGD 957
            RD+KS NILL       L DFG    + P  +  +T +VGT  ++ PE         + D
Sbjct: 140  RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 198

Query: 958  VYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLL 1017
            ++S G++ +E++ G  P                +  ++  R + +I  +   + +  + L
Sbjct: 199  IWSLGIMAIEMIEGEPP----------------YLNENPLRALYLIATNGTPELQNPEKL 242

Query: 1018 --EMLEIACKCIDQDPRRRPFIEEV 1040
                 +   +C+D D  +R   +E+
Sbjct: 243  SAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  183 bits (466), Expect = 8e-52
 Identities = 63/273 (23%), Positives = 113/273 (41%), Gaps = 24/273 (8%)

Query: 771  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNL 829
            ++++    +G G FG+V++ T    G   A K +       +   + E++ +S  +H  L
Sbjct: 26   DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 830  VSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHK 889
            V+L       N+ ++IY +M  G L   +    D+ + +  D  ++  +   +GL ++H 
Sbjct: 86   VNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMH- 141

Query: 890  VCEPHIVHRDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
              E + VH D+K  NI+   K      L DFGL+  L P  +   T   GT  +  PE +
Sbjct: 142  --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVA 197

Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
            +        D++S GV+   LL+G  P     G+N  + +  V        +      S 
Sbjct: 198  EGKPVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWNMDDSAFSGIS- 253

Query: 1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                      +  +   K +  DP  R  I + 
Sbjct: 254  ---------EDGKDFIRKLLLADPNTRMTIHQA 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-51
 Identities = 62/275 (22%), Positives = 104/275 (37%), Gaps = 27/275 (9%)

Query: 771  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLS-GDCGQMEREFQAEVEALSRAQHKN 828
             +++    +G G +G V  A         AVK +            + E+       H+N
Sbjct: 5    EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 829  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
            +V   G+ R GN + L   Y   G L   +      D  +      +       G+ YLH
Sbjct: 65   VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLVGTLGYIPPEYS 947
                  I HRD+K  N+LLDE+    ++DFGL+ + R  +   +   + GTL Y+ PE  
Sbjct: 121  ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 948  QTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006
            +         DV+S G+VL  +L G                    Q     +E       
Sbjct: 178  KRREFHAEPVDVWSCGIVLTAMLAGEL---------------PWDQPSDSCQEYSDWKEK 222

Query: 1007 IWHKDREKQL-LEMLEIACKCIDQDPRRRPFIEEV 1040
              + +  K++    L +  K + ++P  R  I ++
Sbjct: 223  KTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 7e-51
 Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 32/291 (10%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTN------GTKAAVKRLSGDCGQMER-EFQAEVEALSR 823
                 +  +G G FG+VY+            T+ A+K ++      ER EF  E   +  
Sbjct: 20   EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH------ESVDKDSVLKWDVRLKIA 877
                ++V L G    G   L+I   M  G L  +L        +    +       +++A
Sbjct: 80   FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 878  QGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD-THVTTDLV 936
               A G+AYL        VHRD+ + N ++ E F   + DFG++R +   D        +
Sbjct: 140  GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 937  GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 996
              + ++ PE  +    T   DV+SFGVVL E+ T                    +Q  S 
Sbjct: 197  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---------------PYQGLSN 241

Query: 997  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
            ++ +  +         +     + E+   C   +P+ RP   E+++ +   
Sbjct: 242  EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 8e-51
 Identities = 62/275 (22%), Positives = 95/275 (34%), Gaps = 27/275 (9%)

Query: 778  IIGCGGFGLVYKATLTN----GTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHKNLVSL 832
             IG G FG V++    +        A+K          RE F  E   + +  H ++V L
Sbjct: 14   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 833  QGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCE 892
             G     N   +I      G L  +L         L     +  A   +  LAYL     
Sbjct: 74   IGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE---S 126

Query: 893  PHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA 952
               VHRD+ + N+L+       L DFGLSR +     +  +     + ++ PE       
Sbjct: 127  KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 953  TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDR 1012
            T   DV+ FGV + E+L         +G    D++  +   +                  
Sbjct: 187  TSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPMPPNCPP-------- 236

Query: 1013 EKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
                  +  +  KC   DP RRP   E+   L  I
Sbjct: 237  -----TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 7e-50
 Identities = 61/284 (21%), Positives = 99/284 (34%), Gaps = 32/284 (11%)

Query: 771  NNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC---GQMEREFQAEVEALSR 823
             +      +G G FG+V +             AVK L  D     +   +F  EV A+  
Sbjct: 8    KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
              H+NL+ L G       ++ +      GSL   L                + A   A G
Sbjct: 68   LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEG 123

Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTH--VTTDLVGTLGY 941
            + YL        +HRD+ + N+LL  +    + DFGL R L   D H  +         +
Sbjct: 124  MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001
              PE  +T T +   D + FGV L E+ T  +                 +   +  + + 
Sbjct: 181  CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILH 225

Query: 1002 IIDASIWHKDREKQL-LEMLEIACKCIDQDPRRRPFIEEVVTWL 1044
             ID       R +    ++  +  +C    P  RP    +  +L
Sbjct: 226  KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (448), Expect = 2e-49
 Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 26/273 (9%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG+V++      G     K ++      +   + E+  +++  H  L++L     
Sbjct: 37   LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
               + +LI  ++  G L   +     +D  +     +   + A  GL ++H   E  IVH
Sbjct: 97   DKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSIVH 150

Query: 898  RDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
             D+K  NI+ + K  +   + DFGL+  L P +    T    T  +  PE          
Sbjct: 151  LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVGFY 208

Query: 956  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1015
             D+++ GV+   LL+G  P     G++  + +  V +   E  E      S         
Sbjct: 209  TDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVKRCDWEFDEDAFSSVS--------- 256

Query: 1016 LLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046
              E  +     + ++PR+R  + + +   WL G
Sbjct: 257  -PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-48
 Identities = 69/300 (23%), Positives = 115/300 (38%), Gaps = 41/300 (13%)

Query: 771  NNFNQANIIGCGGFGLVYKATLT--------NGTKAAVKRLSGDCGQME-REFQAEVEAL 821
            +       +G G FG V  A             TK AVK L  D  + +  +  +E+E +
Sbjct: 13   DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 822  SR-AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLH------------ESVDKDSVL 868
                +HKN+++L G C       +I  Y   G+L  +L              S + +  L
Sbjct: 73   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 869  KWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD 928
                 +  A   ARG+ YL        +HRD+ + N+L+ E     +ADFGL+R +   D
Sbjct: 133  SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 929  THVTTDL-VGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLV 987
             +  T      + ++ PE       T + DV+SFGV+L E+ T                 
Sbjct: 190  YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236

Query: 988  SWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               +     +   +++              E+  +   C    P +RP  +++V  LD I
Sbjct: 237  --PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 5e-48
 Identities = 63/283 (22%), Positives = 103/283 (36%), Gaps = 29/283 (10%)

Query: 768  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG---QMEREFQAEVEALSR 823
            K   +F    I+G G F  V  A  L    + A+K L                E + +SR
Sbjct: 5    KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 824  AQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARG 883
              H   V L    +         SY +NG L  ++     K                   
Sbjct: 65   LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSA 120

Query: 884  LAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYI 942
            L YLH      I+HRD+K  NILL+E     + DFG +++L P          VGT  Y+
Sbjct: 121  LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 943  PPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
             PE     +A    D+++ G ++ +L+ G  P       N   +   + +++ +      
Sbjct: 178  SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEYLIFQKIIKLEYD------ 228

Query: 1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                 +   + + L+E      K +  D  +R   EE+  +  
Sbjct: 229  FPEKFF--PKARDLVE------KLLVLDATKRLGCEEMEGYGP 263

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-46
 Identities = 67/299 (22%), Positives = 110/299 (36%), Gaps = 39/299 (13%)

Query: 771  NNFNQANIIGCGGFGLVYKAT------LTNGTKAAVKRLSGDCGQME-REFQAEVEALSR 823
            +       +G G FG V +A              AVK L       E R   +E++ L  
Sbjct: 13   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 824  -AQHKNLVSLQGYCRHGNDRLLI-YSYMENGSLDYWLH------------ESVDKDSVLK 869
               H N+V+L G C      L++   + + G+L  +L                     L 
Sbjct: 73   IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 870  WDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT 929
             +  +  +   A+G+ +L        +HRD+ + NILL EK    + DFGL+R +     
Sbjct: 133  LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 930  HV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVS 988
            +V   D    L ++ PE       T + DV+SFGV+L E+ +               +  
Sbjct: 190  YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDE 244

Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047
               +   E   +   D +           EM +    C   +P +RP   E+V  L  +
Sbjct: 245  EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (418), Expect = 3e-46
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 30/276 (10%)

Query: 770  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ---MEREFQAEVEALSRAQ 825
            ++ +    I+G GG   V+ A  L      AVK L  D  +       F+ E +  +   
Sbjct: 6    SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 826  HKNLVSLQGYCRH----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
            H  +V++          G    ++  Y++  +L   +H     +  +     +++   A 
Sbjct: 66   HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121

Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV--TTDLVGTL 939
            + L +     +  I+HRDVK +NI++       + DFG++R +      V  T  ++GT 
Sbjct: 122  QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 940  GYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE 999
             Y+ PE ++  +   R DVYS G VL E+LTG  P     G +   +     +       
Sbjct: 179  QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAYQHVRE------ 229

Query: 1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035
             + I  S  H+     L  ++    K + ++P  R 
Sbjct: 230  -DPIPPSARHEGLSADLDAVVL---KALAKNPENRY 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 6e-46
 Identities = 47/265 (17%), Positives = 104/265 (39%), Gaps = 25/265 (9%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G FG+V++    ++      K +    G  +   + E+  L+ A+H+N++ L     
Sbjct: 13   LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 838  HGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVH 897
               + ++I+ ++    +   ++ S  +   L     +         L +LH     +I H
Sbjct: 72   SMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLH---SHNIGH 125

Query: 898  RDVKSSNILLDEKFEAH--LADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
             D++  NI+   +  +   + +FG +R L+P D            Y  PE  Q    +  
Sbjct: 126  FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTA 183

Query: 956  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQ 1015
             D++S G ++  LL+G  P      +  + ++  +   +    E    + SI        
Sbjct: 184  TDMWSLGTLVYVLLSGINPFL---AETNQQIIENIMNAEYTFDEEAFKEISI-------- 232

Query: 1016 LLEMLEIACKCIDQDPRRRPFIEEV 1040
              E ++   + + ++ + R    E 
Sbjct: 233  --EAMDFVDRLLVKERKSRMTASEA 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 9e-46
 Identities = 56/273 (20%), Positives = 100/273 (36%), Gaps = 21/273 (7%)

Query: 770  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQ-MEREFQAEVEALSRAQHK 827
             + ++  +++G G F  V  A         A+K ++    +  E   + E+  L + +H 
Sbjct: 8    RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 828  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
            N+V+L      G    LI   +  G L   +     +          ++       + YL
Sbjct: 68   NIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYL 123

Query: 888  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
            H +   H   +        LDE  +  ++DFGLS++  P    V +   GT GY+ PE  
Sbjct: 124  HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 181

Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
                 +   D +S GV+   LL G  P      +N   L   + + + E       D S 
Sbjct: 182  AQKPYSKAVDCWSIGVIAYILLCGYPPFY---DENDAKLFEQILKAEYEFDSPYWDDIS- 237

Query: 1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                         +     +++DP +R   E+ 
Sbjct: 238  ---------DSAKDFIRHLMEKDPEKRFTCEQA 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  163 bits (414), Expect = 1e-44
 Identities = 67/277 (24%), Positives = 102/277 (36%), Gaps = 36/277 (12%)

Query: 769  STNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQME------REFQAEVEAL 821
            + N+F+   IIG GGFG VY       G   A+K L     +M+         +  +  +
Sbjct: 2    TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 822  SRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
            S      +V +       +    I   M  G L Y L     +  V         A    
Sbjct: 62   STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEII 117

Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
             GL ++H      +V+RD+K +NILLDE     ++D GL+        H +    GT GY
Sbjct: 118  LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGY 171

Query: 942  IPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000
            + PE  Q   A     D +S G +L +LL G  P                F+    K + 
Sbjct: 172  MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----------------FRQHKTKDKH 215

Query: 1001 EIIDASIWHKDREKQLL--EMLEIACKCIDQDPRRRP 1035
            EI   ++            E+  +    + +D  RR 
Sbjct: 216  EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 252

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  160 bits (406), Expect = 1e-44
 Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 39/286 (13%)

Query: 772  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCG---------QMEREFQAEVEAL 821
            N+    I+G G   +V +        + AVK +    G         ++      EV+ L
Sbjct: 4    NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 822  SRAQ-HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGA 880
             +   H N++ L+          L++  M+ G L  +L     +   L      KI +  
Sbjct: 64   RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119

Query: 881  ARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLG 940
               +  LH   + +IVHRD+K  NILLD+     L DFG S  L P       ++ GT  
Sbjct: 120  LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPS 174

Query: 941  YIPPEYSQTLTA------TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK 994
            Y+ PE  +              D++S GV++  LL G  P      +    ++  +    
Sbjct: 175  YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---FWHRKQMLMLRMIMSGN 231

Query: 995  SEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
             +    E  D S            + ++  + +   P++R   EE 
Sbjct: 232  YQFGSPEWDDYS----------DTVKDLVSRFLVVQPQKRYTAEEA 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 5e-44
 Identities = 60/301 (19%), Positives = 106/301 (35%), Gaps = 26/301 (8%)

Query: 768  KSTNNFNQANIIGCGGFGLVYKAT--LTNGTKAAVKRLSGDCGQ--MEREFQAEVE---A 820
            ++   +     IG G +G V+KA      G   A+KR+    G+  M      EV     
Sbjct: 4    RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 821  LSRAQHKNLVSLQGYCRHG--NDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQ 878
            L   +H N+V L   C     +    +    E+   D   +     +  +  +    +  
Sbjct: 64   LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 879  GAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGT 938
               RGL +LH      +VHRD+K  NIL+    +  LADFGL+R+        +   V T
Sbjct: 124  QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VVT 178

Query: 939  LGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRP----------VEVCKGKNCRDLVS 988
            L Y  PE     +     D++S G +  E+   +             ++           
Sbjct: 179  LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 989  WVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046
            W   +   ++      A    K          ++  KC+  +P +R      ++  +   
Sbjct: 239  WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

Query: 1047 I 1047
            +
Sbjct: 299  L 299

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-43
 Identities = 68/285 (23%), Positives = 103/285 (36%), Gaps = 33/285 (11%)

Query: 771  NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMERE---FQAEVEALSRA-Q 825
             +F    ++G G FG V+ A         A+K L  D   M+ +      E   LS A +
Sbjct: 2    EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            H  L  +    +   +   +  Y+  G L Y +                  A     GL 
Sbjct: 62   HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQ 117

Query: 886  YLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPE 945
            +L       IV+RD+K  NILLD+     +ADFG+ +     D    T   GT  YI PE
Sbjct: 118  FL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173

Query: 946  YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005
                       D +SFGV+L E+L G+ P     G++  +L   +               
Sbjct: 174  ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMDNPFYPR------ 224

Query: 1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT---WLDGI 1047
              W +   K LL       K   ++P +R  +   +        I
Sbjct: 225  --WLEKEAKDLLV------KLFVREPEKRLGVRGDIRQHPLFREI 261

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-43
 Identities = 63/290 (21%), Positives = 119/290 (41%), Gaps = 23/290 (7%)

Query: 770  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE-FQAEVEALSRAQHK 827
               +   + IG G +G+V  A    N  + A+K++S    Q   +    E++ L R +H+
Sbjct: 7    GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 828  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
            N++ +    R      +   Y+    +   L++ + K   L  D          RGL Y+
Sbjct: 67   NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 888  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVT--TDLVGTLGYIPPE 945
            H     +++HRD+K SN+LL+   +  + DFGL+R+  P   H    T+ V T  Y  PE
Sbjct: 126  H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 946  YSQTLTATCR-GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
                     +  D++S G +L E+L+ R         +  + +  +    S++    II+
Sbjct: 183  IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 1005 ASIWHKDREKQLL--------------EMLEIACKCIDQDPRRRPFIEEV 1040
                +                      + L++  K +  +P +R  +E+ 
Sbjct: 243  LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 4e-43
 Identities = 57/293 (19%), Positives = 105/293 (35%), Gaps = 23/293 (7%)

Query: 772  NFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKN 828
            NF +   IG G +G+VYKA     G   A+K++  D     +      E+  L    H N
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 829  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
            +V L       N   L++ ++      +    ++     +   +         +GLA+  
Sbjct: 63   IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC- 118

Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
                  ++HRD+K  N+L++ +    LADFGL+R         T ++V      P     
Sbjct: 119  --HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 949  TLTATCRGDVYSFGVVLLELLTGRRP----------VEVCKGKNCRDLVSW--VFQMKSE 996
                +   D++S G +  E++T R              + +     D V W  V  M   
Sbjct: 177  CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 997  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047
            K          + K       +   +  + +  DP +R   +  +   +   +
Sbjct: 237  KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (395), Expect = 7e-43
 Identities = 55/289 (19%), Positives = 92/289 (31%), Gaps = 27/289 (9%)

Query: 767  LKSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ 825
            L+  N +     IG G FG +Y  T +  G + A+K           +   E +     Q
Sbjct: 3    LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQ 60

Query: 826  HKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
                +    +C    D  ++   +   SL+   +    K         L +A      + 
Sbjct: 61   GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIE 117

Query: 886  YLHKVCEPHIVHRDVKSSNIL---LDEKFEAHLADFGLSRLLRPYDTHV------TTDLV 936
            Y+H     + +HRDVK  N L     +    ++ DFGL++  R   TH         +L 
Sbjct: 118  YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 937  GTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE 996
            GT  Y        +  + R D+ S G VL+    G  P +  K    R     + + K  
Sbjct: 175  GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234

Query: 997  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
                 +          +    E       C       +P    +     
Sbjct: 235  TPIEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (395), Expect = 9e-43
 Identities = 67/290 (23%), Positives = 108/290 (37%), Gaps = 39/290 (13%)

Query: 769  STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC---GQMEREFQAEVEALSRA 824
            S  +F     +G G FG V+      NG   A+K L  +     +       E   LS  
Sbjct: 2    SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 825  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
             H  ++ + G  +      +I  Y+E G L   L +S    + +      ++        
Sbjct: 62   THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------- 114

Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
              L  +    I++RD+K  NILLD+     + DFG ++ +      VT  L GT  YI P
Sbjct: 115  LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAP 170

Query: 945  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
            E   T       D +SFG+++ E+L G  P       N       +  + +E R     +
Sbjct: 171  EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY---DSNTMKTYEKI--LNAELRFPPFFN 225

Query: 1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRR-----PFIEEVVT--WLDGI 1047
              +      K LL       + I +D  +R        E+V    W   +
Sbjct: 226  EDV------KDLLS------RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 2e-42
 Identities = 65/285 (22%), Positives = 106/285 (37%), Gaps = 32/285 (11%)

Query: 777  NIIGCGGFGLVYKATLTN-GTKAAVKRL-----SGDCGQMEREFQAEVEALSRAQHKNLV 830
            + +G G F  VYKA   N     A+K++     S     + R    E++ L    H N++
Sbjct: 4    DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 831  SLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV 890
             L     H ++  L++ +ME            D   VL             +GL YLH  
Sbjct: 64   GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117

Query: 891  CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTL 950
             +  I+HRD+K +N+LLDE     LADFGL++          T  V T  Y  PE     
Sbjct: 118  -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGA 175

Query: 951  TA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009
                   D+++ G +L ELL     +    G +  D ++ +F+      E +  D     
Sbjct: 176  RMYGVGVDMWAVGCILAELLLRVPFL---PGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 1010 KDREKQLL--------------EMLEIACKCIDQDPRRRPFIEEV 1040
                 +                ++L++       +P  R    + 
Sbjct: 233  DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  154 bits (389), Expect = 3e-42
 Identities = 53/284 (18%), Positives = 108/284 (38%), Gaps = 21/284 (7%)

Query: 771  NNFNQANIIGCGGFGLVYKATLTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHKN 828
              ++    IG G +G+VYKA    G   A+K  RL  +   +      E+  L   +H N
Sbjct: 2    EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 829  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
            +V L          +L++ +++              +  L+             G+AY H
Sbjct: 62   IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
               +  ++HRD+K  N+L++ + E  +ADFGL+R         T ++V      P     
Sbjct: 118  ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 949  TLTATCRGDVYSFGVVLLELLTGRRP----------VEVCKGKNCRDLVSW--VFQMKSE 996
            +   +   D++S G +  E++ G             + + +     +  +W  V ++   
Sbjct: 175  SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 997  KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
                 + +   W    +      +++  K +  DP +R   ++ 
Sbjct: 235  DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 6e-42
 Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 31/298 (10%)

Query: 772  NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLV 830
            ++    +IG G FG+VY+A L  +G   A+K++  D    +R    E++ + +  H N+V
Sbjct: 21   SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76

Query: 831  SLQGYCRHGNDR------LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
             L+ +     ++       L+  Y+         H S  K + L             R L
Sbjct: 77   RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRSL 135

Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAH-LADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
            AY+H      I HRD+K  N+LLD       L DFG ++ L   + +V+  +       P
Sbjct: 136  AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191

Query: 944  PEYSQTLTATCRGDVYSFGVVLLELLTGRRP------------VEVCKGKNCRDLVSWVF 991
                     T   DV+S G VL ELL G+              +    G   R+ +  + 
Sbjct: 192  ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 992  QMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047
               +E +  +I         R +   E + +  + ++  P  R    E     + D +
Sbjct: 252  PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-41
 Identities = 62/297 (20%), Positives = 116/297 (39%), Gaps = 44/297 (14%)

Query: 773  FNQANI---------IGCGGFGLVYKAT-LTNGTKAAVKRL------SGDCGQMEREFQA 816
            F Q N+         +G G F +V K    + G + A K +      S   G    + + 
Sbjct: 3    FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 817  EVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
            EV  L   QH N+++L     +  D +LI   +  G     L + + +   L  +   + 
Sbjct: 63   EVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEF 118

Query: 877  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE----KFEAHLADFGLSRLLRPYDTHVT 932
             +    G+   + +    I H D+K  NI+L +    K    + DFGL+  +     +  
Sbjct: 119  LKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEF 173

Query: 933  TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ 992
             ++ GT  ++ PE           D++S GV+   LL+G  P     G   ++ ++ V  
Sbjct: 174  KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSA 230

Query: 993  MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047
            +  E  +    + S   KD             + + +DP++R  I++ +   W+   
Sbjct: 231  VNYEFEDEYFSNTSALAKD----------FIRRLLVKDPKKRMTIQDSLQHPWIKPK 277

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (377), Expect = 1e-40
 Identities = 43/288 (14%), Positives = 89/288 (30%), Gaps = 31/288 (10%)

Query: 771  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH-KN 828
             ++     IG G FG++++ T L N  + A+K           + + E            
Sbjct: 5    VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62

Query: 829  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
            + ++  + + G   +L+   +     D                     A+     +  +H
Sbjct: 63   IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 889  KVCEPHIVHRDVKSSNILLDEKFEAH-----LADFGLSRLLRPYDTHV------TTDLVG 937
               E  +V+RD+K  N L+      +     + DFG+ +  R   T          +L G
Sbjct: 119  ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 938  TLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 997
            T  Y+          + R D+ + G V +  L G  P    +G           ++  +K
Sbjct: 176  TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP---WQGLKAATNKQKYERIGEKK 232

Query: 998  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045
            +   +       +       E  +      +      P  + +     
Sbjct: 233  QSTPL------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 7e-40
 Identities = 60/283 (21%), Positives = 103/283 (36%), Gaps = 45/283 (15%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE------FQAEVEALSRAQ--HKN 828
            ++G GGFG VY    +++    A+K +  D      E         EV  L +       
Sbjct: 11   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 829  LVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLH 888
            ++ L  +    +  +LI    E     +     + +   L+ ++           + +  
Sbjct: 71   VIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVLEAVRHC- 126

Query: 889  KVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
                  ++HRD+K  NIL+D  + E  L DFG   LL+     V TD  GT  Y PPE+ 
Sbjct: 127  --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWI 181

Query: 948  QTLTATCRG-DVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006
            +      R   V+S G++L +++ G  P                F+   E    ++    
Sbjct: 182  RYHRYHGRSAAVWSLGILLYDMVCGDIP----------------FEHDEEIIRGQVFFRQ 225

Query: 1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047
                       E   +   C+   P  RP  EE+    W+  +
Sbjct: 226  RVSS-------ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 4e-39
 Identities = 57/272 (20%), Positives = 103/272 (37%), Gaps = 30/272 (11%)

Query: 778  IIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGY 835
            ++G G  G V +        K A+K L     Q   + + EVE   RA Q  ++V +   
Sbjct: 19   VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 836  CRH----GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC 891
              +        L++   ++ G L   + +    D         +I +     + YLH + 
Sbjct: 74   YENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI- 130

Query: 892  EPHIVHRDVKSSNILLDEKFE---AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ 948
              +I HRDVK  N+L   K       L DFG ++    +++  T     T  Y+ PE   
Sbjct: 131  --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLG 186

Query: 949  TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008
                    D++S GV++  LL G  P            ++    MK+  R  +    +  
Sbjct: 187  PEKYDKSCDMWSLGVIMYILLCGYPPFY------SNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
              +  +++  ++      +  +P +R  I E 
Sbjct: 241  WSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 54/288 (18%), Positives = 103/288 (35%), Gaps = 27/288 (9%)

Query: 771  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVK--RLSGDCGQMEREFQAEVEALSRAQHK 827
              + +   IG G +G V+KA         A+K  RL  D   +      E+  L   +HK
Sbjct: 2    QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 828  NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYL 887
            N+V L           L++ + +              +  L  ++         +GL + 
Sbjct: 62   NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 888  HKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYS 947
            H     +++HRD+K  N+L++   E  LA+FGL+R         + ++V      P    
Sbjct: 118  HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 948  QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007
                 +   D++S G +  EL    RP+    G +  D +  +F++     E +    + 
Sbjct: 175  GAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 1008 WHKDREKQLL---------------EMLEIACKCIDQDPRRRPFIEEV 1040
                +   +                   ++    +  +P +R   EE 
Sbjct: 233  LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 37/303 (12%)

Query: 768  KSTNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRL--SGDCGQMEREFQAEVEALSRA 824
               + + +   IG G FG V+KA     G K A+K++    +          E++ L   
Sbjct: 7    DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 825  QHKNLVSLQGYC--------RHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKI 876
            +H+N+V+L   C        R      L++ + E+       +  V            ++
Sbjct: 67   KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRV 122

Query: 877  AQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT---HVTT 933
             Q    GL Y+       I+HRD+K++N+L+       LADFGL+R          +  T
Sbjct: 123  MQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 934  DLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVE--------VCKGKNCR 984
            + V TL Y PPE            D++  G ++ E+ T    ++            + C 
Sbjct: 180  NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 985  DLVSWVFQMKSEKREVEIIDASIWHKDREKQLL-------EMLEIACKCIDQDPRRRPFI 1037
             +   V+         E ++     K + K  L         L++  K +  DP +R   
Sbjct: 240  SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 1038 EEV 1040
            ++ 
Sbjct: 300  DDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 33/273 (12%)

Query: 769  STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE---FQAEVEALSRA 824
            + N+F+   ++G G FG V        G   A+K L  +    + E      E   L   
Sbjct: 3    TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 825  QHKNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
            +H  L +L+   +  +    +  Y   G L + L     ++ V   +         A  +
Sbjct: 63   RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYG---AEIV 115

Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPP 944
            + L  +    +V+RD+K  N++LD+     + DFGL +              GT  Y+ P
Sbjct: 116  SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAP 174

Query: 945  EYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004
            E  +        D +  GVV+ E++ GR P                F  +  +R  E+I 
Sbjct: 175  EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELIL 218

Query: 1005 ASIWHKDRE--KQLLEMLEIACKCIDQDPRRRP 1035
                   R    +   +L      + +DP++R 
Sbjct: 219  MEEIRFPRTLSPEAKSLLA---GLLKKDPKQRL 248

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 5e-37
 Identities = 56/291 (19%), Positives = 108/291 (37%), Gaps = 31/291 (10%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGY 835
            +G G +G V  A     G K A+K+L          +    E+  L   +H+N++ L   
Sbjct: 26   VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85

Query: 836  CRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHI 895
                        +             + K   L  D    +     +GL Y+H      I
Sbjct: 86   FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGI 142

Query: 896  VHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCR 955
            +HRD+K  N+ ++E  E  + DFGL+R     D+ +T  +V      P      +  T  
Sbjct: 143  IHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYTQT 199

Query: 956  GDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ------------MKSEKREVEII 1003
             D++S G ++ E++TG+      KG +  D +  + +            ++S++ +  + 
Sbjct: 200  VDIWSVGCIMAEMITGKTL---FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 1004 DASIWHKDREKQLL-----EMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047
                  K     +L       + +  K +  D  +R    E +   + + +
Sbjct: 257  GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (339), Expect = 6e-35
 Identities = 45/279 (16%), Positives = 96/279 (34%), Gaps = 28/279 (10%)

Query: 771  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMERE---FQAEVEALSRAQH 826
            + F++   +G G FG V       +G   A+K L        ++      E   L     
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 827  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
              LV L+   +  ++  ++  Y+  G +   L     +            A        Y
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEY 156

Query: 887  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
            LH +    +++RD+K  N+L+D++    + DFG ++ ++     +     GT   + PE 
Sbjct: 157  LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEI 209

Query: 947  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK-----REVE 1001
              +       D ++ GV++ E+  G  P           +   +   K         +++
Sbjct: 210  ILSKGYNKAVDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEV 1040
             +  ++   D  K+   +          D +   +    
Sbjct: 267  DLLRNLLQVDLTKRFGNLKNGV-----NDIKNHKWFATT 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  131 bits (330), Expect = 5e-34
 Identities = 53/301 (17%), Positives = 106/301 (35%), Gaps = 46/301 (15%)

Query: 769  STNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSR-AQH 826
            + +++     +G G +  V++A  +TN  K  VK L       +++ + E++ L      
Sbjct: 33   NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGG 89

Query: 827  KNLVSLQGYCRHGNDRL--LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGL 884
             N+++L    +    R   L++ ++ N                L             + L
Sbjct: 90   PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKAL 142

Query: 885  AYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLRPYDTHVTTDLVGTLGYIP 943
             Y H +    I+HRDVK  N+++D +  +  L D+GL+    P   +     V +  +  
Sbjct: 143  DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKG 197

Query: 944  PEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002
            PE            D++S G +L  ++  + P     G +  D +  + ++   +   + 
Sbjct: 198  PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDY 255

Query: 1003 IDASIWHKDREKQLL-----------------------EMLEIACKCIDQDPRRRPFIEE 1039
            ID      D     +                       E L+   K +  D + R    E
Sbjct: 256  IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315

Query: 1040 V 1040
             
Sbjct: 316  A 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 7e-34
 Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 31/278 (11%)

Query: 769  STNNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLS----GDCGQMEREFQAEVEA 820
               NF    ++G G +G V+          G   A+K L         +     + E + 
Sbjct: 22   GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81

Query: 821  LSRAQHK-NLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQG 879
            L   +    LV+L    +      LI  Y+  G L   L +   ++   + +V++ + + 
Sbjct: 82   LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEI 138

Query: 880  AARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTL 939
                +  L  + +  I++RD+K  NILLD      L DFGLS+     +T    D  GT+
Sbjct: 139  ----VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 940  GYIPPE--YSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK 997
             Y+ P+             D +S GV++ ELLTG  P         ++  + + +   + 
Sbjct: 195  EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRRILKS 251

Query: 998  REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP 1035
                  + S              ++  + + +DP++R 
Sbjct: 252  EPPYPQEMS----------ALAKDLIQRLLMKDPKKRL 279

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-32
 Identities = 60/291 (20%), Positives = 103/291 (35%), Gaps = 29/291 (9%)

Query: 770  TNNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQH 826
               +   + +G G +G V  A     G + AVK+LS         +    E+  L   +H
Sbjct: 17   PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 827  KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
            +N++ L                     L      ++ K   L  D    +     RGL Y
Sbjct: 77   ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 887  LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEY 946
            +H      I+HRD+K SN+ ++E  E  + DFGL+   R  D  +T  +       P   
Sbjct: 137  IH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 190

Query: 947  SQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ------------MK 994
               +      D++S G ++ ELLTGR       G +  D +  + +            + 
Sbjct: 191  LNWMHYNQTVDIWSVGCIMAELLTGRTL---FPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 995  SEKREVEIIDASIWHKDREKQLL-----EMLEIACKCIDQDPRRRPFIEEV 1040
            SE     I   +   K     +        +++  K +  D  +R    + 
Sbjct: 248  SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-29
 Identities = 57/304 (18%), Positives = 103/304 (33%), Gaps = 46/304 (15%)

Query: 771  NNFNQANIIGCGGFGLVYKAT-LTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHK 827
              +     IG G  G+V  A         A+K+LS         +    E+  +    HK
Sbjct: 17   KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 828  NLVSLQGYCRH------GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAA 881
            N++SL              D  L+   M+         E          +    +     
Sbjct: 77   NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQML 129

Query: 882  RGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHVTTDLVGTLGY 941
             G+ +LH      I+HRD+K SNI++       + DFGL+R      + + T  V T  Y
Sbjct: 130  CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 184

Query: 942  IPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPV----------EVCKGKNCRDLVSWVF 991
              PE    +      D++S G ++ E++  +             +V +            
Sbjct: 185  RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 992  QMKSEKREVE------------IIDASIWHKDREKQLL---EMLEIACKCIDQDPRRRPF 1036
               + +  VE            +   S++  D E   L   +  ++  K +  DP +R  
Sbjct: 245  LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 1037 IEEV 1040
            +++ 
Sbjct: 305  VDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (285), Expect = 7e-28
 Identities = 55/311 (17%), Positives = 100/311 (32%), Gaps = 55/311 (17%)

Query: 779  IGCGGFGLVYKAT-LTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCR 837
            +G G F  V+ A  + N T  A+K + GD    E   + E++ L R    +         
Sbjct: 21   LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMGA 79

Query: 838  HGNDRLLIYSY------------MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLA 885
            +   +LL +               E    +        +   +      +I++    GL 
Sbjct: 80   NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 886  YLHKVCEPHIVHRDVKSSNILLD-EKFEAHLADFGLSRLLRPYDTHVTTDLV-GTLGYIP 943
            Y+H      I+H D+K  N+L++      +L    ++ L               T  Y  
Sbjct: 140  YMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 944  PEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQM---------- 993
            PE        C  D++S   ++ EL+TG    E  +G +       + Q+          
Sbjct: 198  PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257

Query: 994  ------------------------KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQ 1029
                                    K    E  + +   + KD  K++ + L      +  
Sbjct: 258  LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS---PMLQL 314

Query: 1030 DPRRRPFIEEV 1040
            DPR+R     +
Sbjct: 315  DPRKRADAGGL 325

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  100 bits (248), Expect = 2e-23
 Identities = 75/312 (24%), Positives = 121/312 (38%), Gaps = 12/312 (3%)

Query: 36  QSCDPSDLLALKEFAGNLTNGSIITSWSNESMCCQ--WDGVVCGHGSTGSNAGRVTMLIL 93
           + C+P D  AL +   +L N + ++SW   + CC   W GV+C    T +   RV  L L
Sbjct: 1   ELCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLC---DTDTQTYRVNNLDL 57

Query: 94  PRKGLKGI--IPRSLGHLNQLKLLDLS-CNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 150
               L     IP SL +L  L  L +   N+L G +P  ++ L QL  L ++H  +SG +
Sbjct: 58  SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117

Query: 151 SGMLAGLNLIQSLNVSSNSFNGSLFE-LGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQ 209
              L+ +  + +L+ S N+ +G+L   +    NL       N  +G +     S SK   
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177

Query: 210 ILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQL 269
            + +S N   G +     + +       +  +       L+             N     
Sbjct: 178 SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 270 SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHV 329
             K+    +L  L +  N+  G LP  L  L  L       N+  G +P       +  V
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDV 295

Query: 330 LDLRNNS-LTGP 340
               NN  L G 
Sbjct: 296 SAYANNKCLCGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 88.7 bits (218), Expect = 1e-19
 Identities = 65/281 (23%), Positives = 102/281 (36%), Gaps = 16/281 (5%)

Query: 394 GKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN-FVGEEIPENVGGFESLMVL 452
            +   +  L LS  +        S L     L  L +     +   IP  +     L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 453 ALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 512
            + +  + G IP +L + K L  LD S+N   G +PP I  + NL  + F  N ++G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 513 KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGT 572
            S      L +S   S N                  G      ++   +    +  +   
Sbjct: 167 DSYGSFSKLFTSMTISRN---------------RLTGKIPPTFANLNLAFVDLSRNMLEG 211

Query: 573 IPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLS 632
               +              N        +   +NL  LDL +N ++G++P    +L FL 
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 633 KFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPC 673
             +V+ N+L G IP GG    F  S++  N  LCG     C
Sbjct: 272 SLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 58.2 bits (139), Expect = 2e-09
 Identities = 56/253 (22%), Positives = 91/253 (35%), Gaps = 30/253 (11%)

Query: 208 IQILDLSMNHFMGSLQGLDHSPSLKQLHV----DNNLLGGDLPDSLYSMSSLQHVSLSVN 263
           +  LDLS  +            +L  L+       N L G +P ++  ++ L ++ ++  
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 264 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSL 323
           N SG + + +S + +L  L    N  SG LP  + +L  L       N  SG +P S   
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 324 CSKLHV-LDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKI----- 377
            SKL   + +  N LTG I   F+ L+                    SD +  KI     
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231

Query: 378 -----------------LSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQ 420
                            L L  N + G +P+   +L  L  L++S    N+L G +    
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF---NNLCGEIPQGG 288

Query: 421 QCKNLTTLILTKN 433
             +         N
Sbjct: 289 NLQRFDVSAYANN 301

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.8 bits (130), Expect = 2e-08
 Identities = 55/265 (20%), Positives = 95/265 (35%), Gaps = 7/265 (2%)

Query: 227 HSPSLKQLHVDNNLLGGD--LPDSLYSMSSLQHVSLSVN-NFSGQLSEKISNLTSLRHLI 283
            +  +  L +    L     +P SL ++  L  + +    N  G +   I+ LT L +L 
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107

Query: 284 IFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDL 343
           I     SG +P+ L  +  L       N+ SG LP S+S    L  +    N ++G I  
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 344 NFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLS 403
           ++   S L T   +       L   +        L+      +    ++     S     
Sbjct: 168 SYGSFSKLFT---SMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 404 LSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHI 463
             + + N L+  L  +   KNL  L L  N +   +P+ +   + L  L +    L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 464 PVWLLRCKKLQVLDLSWNHFDGNIP 488
           P      ++  V   + N      P
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.1 bits (235), Expect = 2e-21
 Identities = 70/382 (18%), Positives = 124/382 (32%), Gaps = 33/382 (8%)

Query: 274 SNLTSLRHLIIFGNQFSGKLP-NVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDL 332
           + L      ++     +  +    L  +T L+       S  G     +   + L  ++ 
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73

Query: 333 RNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN----SLSDCHDLKILSLAKNELSGQ 388
            NN LT         L+ L  + +  N  +   P     +L+            + L   
Sbjct: 74  SNNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 389 VPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENV----- 443
              +  +L+S     +S  S       LS   Q  +L  L         +I  N      
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 444 --GGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLD 501
                 +L  L   N  +    P+ +     L  L L+ N         +  + NL  LD
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 502 FSNNTLTGEIP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPP 560
            +NN ++   P   LT+L  L       SN +  AG+        + N L      S   
Sbjct: 248 LANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 561 ---SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 617
               + L  N I+   P  +  L  L  L  + N ++    SS++ + N+  L    N +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363

Query: 618 HGSIPGSFEKLTFLSKFSVANN 639
               P     LT +++  + + 
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.1 bits (222), Expect = 1e-19
 Identities = 74/373 (19%), Positives = 128/373 (34%), Gaps = 48/373 (12%)

Query: 81  TGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLD 140
           + ++  +VT L   R G+K I    + +LN L  ++ S N L  + P  L NL +L  + 
Sbjct: 39  SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94

Query: 141 LSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSR 200
           +++N ++                N++  +   +     +              +  ++  
Sbjct: 95  MNNNQIADITPLA-------NLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI 147

Query: 201 IWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSL 260
              +           N         + +   +     N +    +   L ++ SL   + 
Sbjct: 148 SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATN- 206

Query: 261 SVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLS 320
             N  S      I   T+L  L + GNQ        L +LT L      +N  S   PLS
Sbjct: 207 --NQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 260

Query: 321 LSLCSKLHVLDLRNNSLTGPIDLN--------------------FSGLSSLCTLDLATNH 360
               +KL  L L  N ++    L                      S L +L  L L  N+
Sbjct: 261 G--LTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318

Query: 361 FSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQ 420
            S   P  +S    L+ L  A N++S     S   LT++ +LS  +N  + L+     L 
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP----LA 370

Query: 421 QCKNLTTLILTKN 433
               +T L L   
Sbjct: 371 NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.1 bits (222), Expect = 1e-19
 Identities = 80/423 (18%), Positives = 136/423 (32%), Gaps = 58/423 (13%)

Query: 83  SNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLS 142
           +        +L +  +   + ++   L+Q+  L      ++ +    +  L  L  ++ S
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFS 74

Query: 143 HNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIW 202
           +N L+                             +    NL        +     +    
Sbjct: 75  NNQLTD----------------------------ITPLKNLTKLVDILMNNNQIADITPL 106

Query: 203 SASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSV 262
           +    +  L L  N         + +   +     N +        + ++S L  +    
Sbjct: 107 ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTI------SDISALSGLTSLQQLS 160

Query: 263 NNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 322
                   + ++NLT+L  L I  N+ S         LT LE  +A +N  S   P  L 
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITP--LG 216

Query: 323 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
           + + L  L L  N L        + L++L  LDLA N  S   P  LS    L  L L  
Sbjct: 217 ILTNLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 442
           N++S   P     LT+L  L L+ N    +S         KNLT L L  N + +  P  
Sbjct: 273 NQISNISP--LAGLTALTNLELNENQLEDISPI----SNLKNLTYLTLYFNNISDISP-- 324

Query: 443 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 502
           V     L  L   N  +       L     +  L    N      P  +  +  +  L  
Sbjct: 325 VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380

Query: 503 SNN 505
           ++ 
Sbjct: 381 NDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 85.4 bits (210), Expect = 4e-18
 Identities = 82/457 (17%), Positives = 154/457 (33%), Gaps = 75/457 (16%)

Query: 160 IQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFM 219
           + S  ++ ++    +F     +      +   + T  ++    +   ++  L       +
Sbjct: 1   LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQ---TDLDQVTTLQADRLG-I 56

Query: 220 GSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSL 279
            S+ G+++  +L Q++  NN L    P  L +++ L  + ++ N  +           + 
Sbjct: 57  KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTG 114

Query: 280 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTG 339
             L          L N+    T L      SN+ S      +S  S L  L   +     
Sbjct: 115 LTLFNNQITDIDPLKNL----TNLNRLELSSNTIS-----DISALSGLTSLQQLSFGNQV 165

Query: 340 PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL 399
                 + L++L  LD+++N  S       +   +L+ L    N++S   P      T+L
Sbjct: 166 TDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGIL--TNL 221

Query: 400 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL 459
             LSL+ N    +      L    NLT L L  N +    P  + G   L  L LG   +
Sbjct: 222 DELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 275

Query: 460 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP-KSLTEL 518
               P+  L            N         I  ++NL YL    N ++   P  SLT+L
Sbjct: 276 SNISPLAGLTALTNL----ELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKL 331

Query: 519 KSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIG 578
           + L                                         F +NN++  +    + 
Sbjct: 332 QRL-----------------------------------------FFANNKV--SDVSSLA 348

Query: 579 QLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 615
            L +++ L    N I+   P  ++ +  +  L L+  
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 75.8 bits (185), Expect = 6e-15
 Identities = 43/227 (18%), Positives = 80/227 (35%), Gaps = 15/227 (6%)

Query: 61  SWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCN 120
           +                  S  +    +  LI     +  I P     L  L  L L+ N
Sbjct: 172 ANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGN 229

Query: 121 HLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEF 180
            L+      L++L  L  LDL++N +S      L+GL  +  L + +N  +     +   
Sbjct: 230 QLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN----ISPL 281

Query: 181 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNL 240
           + L        +     +    S  K +  L L  N+    +  +     L++L   NN 
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFFANNK 340

Query: 241 LGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 287
           +      SL +++++  +S   N  S      ++NLT +  L +   
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.2 bits (134), Expect = 1e-08
 Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 6/114 (5%)

Query: 55  NGSIITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKL 114
           +     +        + +       S  SN   +T L L    +  I P  +  L +L+ 
Sbjct: 276 SNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 333

Query: 115 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 168
           L  + N +       L+NL  +  L   HN +S      LA L  I  L ++  
Sbjct: 334 LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 54.6 bits (130), Expect = 3e-08
 Identities = 42/285 (14%), Positives = 90/285 (31%), Gaps = 17/285 (5%)

Query: 340 PIDLNF--SGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLT 397
           PI+  F  + L+      L   + +  +  S +D   +  L   +  +     +    L 
Sbjct: 11  PINQIFTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLN 66

Query: 398 SLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNC 457
           +L  ++ SNN    ++         KNLT L+       +          + +       
Sbjct: 67  NLTQINFSNNQLTDITP-------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119

Query: 458 GLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTE 517
                I          ++   S    D +    +  ++ L + +   +        +L  
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 518 LKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEI 577
           L    +     S       +   +  N   + +      +    + L+ N++       +
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTL 237

Query: 578 GQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIP 622
             L +L  LDL+ N I+   P  +S +  L  L L +N +    P
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.1 bits (108), Expect = 2e-05
 Identities = 46/250 (18%), Positives = 79/250 (31%), Gaps = 53/250 (21%)

Query: 445 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 504
                M   LG   +   +    L   ++  L         +I   +  + NL  ++FSN
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDL--DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75

Query: 505 NTLTGEIP-KSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVF 563
           N LT   P K+LT+L  ++ +N   ++ T  A +          N +          ++ 
Sbjct: 76  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 564 LSNNRIN--------------------------------------------GTIPPEIGQ 579
                 N                                             +    + +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 580 LKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN 639
           L +L  L  + N I+   P  I  + NL+ L L+ N L     G+   LT L+   +ANN
Sbjct: 196 LTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251

Query: 640 HLQGTIPTGG 649
            +    P  G
Sbjct: 252 QISNLAPLSG 261

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 93.2 bits (230), Expect = 4e-21
 Identities = 55/288 (19%), Positives = 93/288 (32%), Gaps = 17/288 (5%)

Query: 327 LHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELS 386
             +LDL+NN +T   D +F  L +L TL L  N  S   P + +    L+ L L+KN+L 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 387 GQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGF 446
               +    L  L       N    +  ++        +  L                G 
Sbjct: 93  ELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 447 ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNT 506
           + L  + + +  +   IP  L     L  L L  N         +  + NL  L  S N+
Sbjct: 150 KKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 507 LTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSN 566
           ++     SL     L   +  ++      G     K+ +    L  N  S+   + F   
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVY-LHNNNISAIGSNDFCP- 264

Query: 567 NRINGTIPPEIGQLKHLHVLDLSRNNITGT--IPSSISEIRNLEVLDL 612
                  P    +      + L  N +      PS+   +     + L
Sbjct: 265 -------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.4 bits (215), Expect = 3e-19
 Identities = 49/268 (18%), Positives = 88/268 (32%), Gaps = 14/268 (5%)

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 336
                L +  N+ +        NL  L   +  +N  S   P + +   KL  L L  N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 337 LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKL 396
           L    +     L  L   +         + N L+    +  L     + SG    +F  +
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGM 149

Query: 397 TSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGN 456
             L ++ +++ +   +   L       +LT L L  N + +    ++ G  +L  L L  
Sbjct: 150 KKLSYIRIADTNITTIPQGL-----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204

Query: 457 CGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTG------E 510
             +       L     L+ L L+ N     +P  +   + +  +   NN ++        
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263

Query: 511 IPKSLTELKSLISSNCTSSNPTASAGIP 538
            P   T+  S  S     SNP     I 
Sbjct: 264 PPGYNTKKASY-SGVSLFSNPVQYWEIQ 290

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.6 bits (213), Expect = 6e-19
 Identities = 58/301 (19%), Positives = 103/301 (34%), Gaps = 18/301 (5%)

Query: 69  CQWDGVVCGHGSTGS----NAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 124
           C    V C                 +L L    +  I      +L  L  L L  N +  
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 125 VVPVELSNLKQLEVLDLSHNMLSG-PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNL 183
           + P   + L +LE L LS N L   P         L    N  +         L +   +
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129

Query: 184 AVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGG 243
            +      S   +  +  +   K++  + ++  +     QGL   PSL +LH+D N +  
Sbjct: 130 ELGTNPLKSSGIENGA--FQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITK 185

Query: 244 DLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQL 303
               SL  +++L  + LS N+ S   +  ++N   LR L +  N+     P  L +   +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYI 244

Query: 304 EFFVAHSNSFSG------PLPLSLSLCSKLHVLDLRNNSLT--GPIDLNFSGLSSLCTLD 355
           +    H+N+ S         P   +  +    + L +N +         F  +     + 
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304

Query: 356 L 356
           L
Sbjct: 305 L 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.1 bits (196), Expect = 8e-17
 Identities = 48/258 (18%), Positives = 91/258 (35%), Gaps = 11/258 (4%)

Query: 181 SNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNN 239
            + A+ ++ NN  T  +    +   K +  L L  N       G       L++L++  N
Sbjct: 31  PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89

Query: 240 LLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGN 299
            L  +LP+ +        V  +      +      N   +  L     + SG        
Sbjct: 90  QLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148

Query: 300 LTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATN 359
           + +L +      + +    +   L   L  L L  N +T     +  GL++L  L L+ N
Sbjct: 149 MKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 360 HFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGT---- 415
             S     SL++   L+ L L  N+L  +VP        +  + L NN+ + +       
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 416 LSVLQQCKNLTTLILTKN 433
                +  + + + L  N
Sbjct: 265 PGYNTKKASYSGVSLFSN 282

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 75.1 bits (183), Expect = 5e-15
 Identities = 60/326 (18%), Positives = 100/326 (30%), Gaps = 57/326 (17%)

Query: 324 CSKLHVLDLRNNSLTG-PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
           C    V    +  L   P DL          LDL  N  +        +  +L  L L  
Sbjct: 10  CHLRVV-QCSDLGLEKVPKDLP----PDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 64

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 442
           N++S   P +F  L  L  L LS N    L   +   +  + L         V + +   
Sbjct: 65  NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNG 122

Query: 443 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 502
           +     +  L        G         KKL  + ++  +    IP  +    +L  L  
Sbjct: 123 LNQMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHL 178

Query: 503 SNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSV 562
             N +T     SL  L +L                                         
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGL------------------------------------ 202

Query: 563 FLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG--- 619
             S N I+      +    HL  L L+ N +   +P  +++ + ++V+ L +N++     
Sbjct: 203 --SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 259

Query: 620 ---SIPGSFEKLTFLSKFSVANNHLQ 642
                PG   K    S  S+ +N +Q
Sbjct: 260 NDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 73.5 bits (179), Expect = 2e-14
 Identities = 39/240 (16%), Positives = 68/240 (28%), Gaps = 20/240 (8%)

Query: 438 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 497
           ++P+++       +L L N  +           K L  L L  N      P     +  L
Sbjct: 24  KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 498 FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASS 557
             L  S N L     K    L+ L                    +  +    +       
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHEN---------------EITKVRKSVFNGLNQM 126

Query: 558 FPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDL 617
               +  +  + +G        +K L  + ++  NIT TIP  +    +L  L L  N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKI 183

Query: 618 HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMH 677
                 S + L  L+K  ++ N +                    N  L        D  +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.4 bits (132), Expect = 1e-08
 Identities = 22/117 (18%), Positives = 42/117 (35%), Gaps = 3/117 (2%)

Query: 561 SVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGS 620
            V  S+  +   +P ++       +LDL  N IT         ++NL  L L +N +   
Sbjct: 14  VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70

Query: 621 IPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMH 677
            PG+F  L  L +  ++ N L+       +              +   + +  + M 
Sbjct: 71  SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.8 bits (107), Expect = 2e-05
 Identities = 44/253 (17%), Positives = 76/253 (30%), Gaps = 24/253 (9%)

Query: 10  FVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALKEFAGNLTNGSIITSWSNESMCC 69
           F P+  L+ L+L+      L    P +       L + E        S+    +   +  
Sbjct: 75  FAPLVKLERLYLSKNQLKEL----PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 70  QWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVE 129
                +   G        +  L   R     I     G    L  L L  N +  V    
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAAS 190

Query: 130 LSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNIS 189
           L  L  L  L LS N +S   +G LA    ++ L++++N        L +   + V  + 
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250

Query: 190 NNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLL--GGDLPD 247
           NN+ +                  +  N F           S   + + +N +      P 
Sbjct: 251 NNNISA-----------------IGSNDFCP-PGYNTKKASYSGVSLFSNPVQYWEIQPS 292

Query: 248 SLYSMSSLQHVSL 260
           +   +     V L
Sbjct: 293 TFRCVYVRAAVQL 305

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.6 bits (211), Expect = 1e-19
 Identities = 25/156 (16%), Positives = 46/156 (29%), Gaps = 21/156 (13%)

Query: 777 NIIGCGGFGLVYKATLTNGTKAAVKRLSGD----------CGQMEREFQAEVEALSRAQH 826
            ++G G    V+        +  VK                   +  F       +R + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 827 KNLVSLQGYCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAY 886
           + L  LQG           Y++  N  L   +         ++     ++       +A 
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVEN--PDEVLDMILEEVAK 118

Query: 887 LHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR 922
            +      IVH D+   N+L+ E     + DF  S 
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.2 bits (188), Expect = 7e-16
 Identities = 48/287 (16%), Positives = 91/287 (31%), Gaps = 30/287 (10%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           +P  +      + + L  N +  V        + L +L L  N                 
Sbjct: 26  VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSN----------------- 66

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
                              + L   ++S+N+    ++   +     +  L L        
Sbjct: 67  ------VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120

Query: 222 LQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLR 280
             G      +L+ L++ +N L     D+   + +L H+ L  N  S         L SL 
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180

Query: 281 HLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGP 340
            L++  N+ +   P+   +L +L      +N+ S     +L+    L  L L +N     
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240

Query: 341 IDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 387
                   + L     +++     LP  L       +  LA N+L G
Sbjct: 241 CRAR-PLWAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.6 bits (158), Expect = 5e-12
 Identities = 51/257 (19%), Positives = 86/257 (33%), Gaps = 7/257 (2%)

Query: 205 SKEIQILDLSMNHFMGSLQG-LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 263
               Q + L  N              +L  L + +N+L      +   ++ L+ + LS N
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 264 NFSGQL-SEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLS 322
                +       L  L  L +         P +   L  L++     N+       +  
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 323 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
               L  L L  N ++   +  F GL SL  L L  N  +   P++  D   L  L L  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPEN 442
           N LS    E+   L +L +L L++N +               L     + + V   +P+ 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWV---CDCRARPLWAWLQKFRGSSSEVPCSLPQR 267

Query: 443 VGG--FESLMVLALGNC 457
           + G   + L    L  C
Sbjct: 268 LAGRDLKRLAANDLQGC 284

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.2 bits (157), Expect = 7e-12
 Identities = 52/292 (17%), Positives = 85/292 (29%), Gaps = 43/292 (14%)

Query: 373 HDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK 432
              + + L  N +S     SF    +L  L L +N    +               L    
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS-DN 90

Query: 433 NFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIG 492
             +    P    G   L  L L  CGL+   P        LQ L L  N           
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 493 QMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPY 552
            + NL +L    N ++    ++   L SL                               
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL--------------------------- 183

Query: 553 NQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDL 612
                      L  NR+    P     L  L  L L  NN++     +++ +R L+ L L
Sbjct: 184 -----------LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232

Query: 613 SSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP---TGGQFYSFPNSSFEG 661
           + N        +     +L KF  +++ +  ++P    G        +  +G
Sbjct: 233 NDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (144), Expect = 3e-10
 Identities = 53/269 (19%), Positives = 80/269 (29%), Gaps = 33/269 (12%)

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 336
            + + + + GN+ S            L     HSN  +     + +  + L  LDL +N+
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 337 LTGPI-DLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGK 395
               +    F GL  L TL L         P        L+ L L  N L     ++F  
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 396 LTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALG 455
           L +L  L L  N  + +                                G  SL  L L 
Sbjct: 152 LGNLTHLFLHGNRISSV--------------------------PERAFRGLHSLDRLLLH 185

Query: 456 NCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP--- 512
              +    P       +L  L L  N+        +  +  L YL  ++N    +     
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP 245

Query: 513 --KSLTELKSLISSNCTSSNPTASAGIPL 539
               L +     SS    S P   AG  L
Sbjct: 246 LWAWLQKF-RGSSSEVPCSLPQRLAGRDL 273

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.8 bits (130), Expect = 2e-08
 Identities = 37/206 (17%), Positives = 68/206 (33%), Gaps = 3/206 (1%)

Query: 62  WSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNH 121
              +        +     +T    GR+  L L R GL+ + P     L  L+ L L  N 
Sbjct: 81  LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140

Query: 122 LEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFS 181
           L+ +      +L  L  L L  N +S        GL+ +  L +  N             
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 182 NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLL 241
              +      +    L +   +  + +Q L L+ N ++   +       L++    ++ +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEV 260

Query: 242 GGDLPDSLYSMSSLQHVSLSVNNFSG 267
              LP  L          L+ N+  G
Sbjct: 261 PCSLPQRLAGRDLK---RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.0 bits (120), Expect = 3e-07
 Identities = 42/223 (18%), Positives = 70/223 (31%), Gaps = 7/223 (3%)

Query: 1   MWESMVVLGFVPMTCLKWLFLAFFVCSCLGLQTPFQSCDPSDLLALK---EFAGNLTNGS 57
                 +             L     + L    P        L  L         L  G 
Sbjct: 65  SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124

Query: 58  IITSWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDL 117
                + + +  Q + +      T  + G +T L L    +  +  R+   L+ L  L L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184

Query: 118 SCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFEL 177
             N +  V P    +L +L  L L  N LS   +  LA L  +Q L ++ N +       
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244

Query: 178 GEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMG 220
             ++ L  F  S++     L  R+        +  L+ N   G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLPQRL----AGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.0 bits (115), Expect = 1e-06
 Identities = 38/231 (16%), Positives = 63/231 (27%), Gaps = 18/231 (7%)

Query: 438 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 497
            +P  +    +   + L    +          C+ L +L L  N            +  L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 498 FYLDFSNNTLTGEI-PKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQAS 556
             LD S+N     + P +   L  L + +                        L  N   
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 557 SFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSND 616
           + P   F                  +L  L L  N I+     +   + +L+ L L  N 
Sbjct: 143 ALPDDTFRDLG--------------NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188

Query: 617 LHGSIPGSFEKLTFLSKFSV-ANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 666
           +    P +F  L  L    + ANN             +        NP +C
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 0.003
 Identities = 11/97 (11%), Positives = 24/97 (24%), Gaps = 3/97 (3%)

Query: 585 VLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGT 644
                +  +   +P  I      + + L  N +      SF     L+   + +N L   
Sbjct: 15  TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 645 IPTGGQFYSFPNSSFEGNPGLCGEIDSPCDSMHAKLK 681
                   +        +      +D        +L 
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.7 bits (148), Expect = 1e-10
 Identities = 45/295 (15%), Positives = 85/295 (28%), Gaps = 36/295 (12%)

Query: 353 TLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHL 412
           TLDL   +    +   L     +      ++ +   + E F     +  + LSN+    +
Sbjct: 4   TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIE-V 60

Query: 413 SGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKK 472
           S    +L QC  L  L L    + + I   +    +L+ L L  C       +  L    
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 473 LQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPT 532
            ++ +L+ +         +           +   L+G                       
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG----------------------- 157

Query: 533 ASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSR-N 591
                       +S       +  +        +  +      E  QL +L  L LSR  
Sbjct: 158 ------YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211

Query: 592 NITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIP 646
           +I       + EI  L+ L +      G++    E L  L    +  +H      
Sbjct: 212 DIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIAR 263

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 3e-08
 Identities = 57/298 (19%), Positives = 91/298 (30%), Gaps = 49/298 (16%)

Query: 293 LPNVLGNLTQLEFFVAH-SNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL 351
            P+V G L            SF            ++  +DL N+ +              
Sbjct: 13  HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV------------ 60

Query: 352 CTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNH 411
                        L   LS C  L+ LSL    LS  +  +  K ++L+ L+LS  S   
Sbjct: 61  -----------STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109

Query: 412 LSGTLSVLQQCKNLTTLIL------TKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPV 465
                ++L  C  L  L L      T+  V   +         L +        K  +  
Sbjct: 110 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 169

Query: 466 WLLRCKKLQVLDLSWNH-FDGNIPPWIGQMENLFYLDFSN-NTLTGEIPKSLTELKSLIS 523
            + RC  L  LDLS +     +      Q+  L +L  S    +  E    L E+ +L +
Sbjct: 170 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229

Query: 524 SNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLK 581
                          L V        L   + +   P + ++ +       P IG  K
Sbjct: 230 ---------------LQVFGIVPDGTLQLLKEAL--PHLQINCSHFTTIARPTIGNKK 270

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 8e-08
 Identities = 46/287 (16%), Positives = 84/287 (29%), Gaps = 23/287 (8%)

Query: 209 QILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG- 267
           Q LDL+  +    + G   S  +       + +   L +   S   +QH+ LS +     
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVS 61

Query: 268 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKL 327
            L   +S  + L++L + G + S  + N L   + L        S      L   L    
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS--- 118

Query: 328 HVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 387
                  + L           +         +        +LS        S        
Sbjct: 119 -----SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS-------- 165

Query: 388 QVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTK-NFVGEEIPENVGGF 446
               +  +    L     ++S    +       Q   L  L L++   +  E    +G  
Sbjct: 166 -DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224

Query: 447 ESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ 493
            +L  L +      G + +       LQ+   + +HF     P IG 
Sbjct: 225 PTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 2e-07
 Identities = 38/278 (13%), Positives = 86/278 (30%), Gaps = 17/278 (6%)

Query: 115 LDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSL 174
           LDL+  +L   V   L +   +       + +  P++   +   + Q +++S++    S 
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRV-QHMDLSNSVIEVST 62

Query: 175 FE--LGEFSNLAVFNISNNSFTGKL--------NSRIWSASKEIQILDLSMNHFMGSLQG 224
               L + S L   ++     +  +        N    + S      + ++   + S   
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 225 LDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLII 284
           LD              +   +     +++ L       N     LS  +    +L HL +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 285 FGN-QFSGKLPNVLGNLTQLEFF-VAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID 342
             +             L  L+   ++          L L     L  L +      G + 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 343 LNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 380
           L    L     L +  +HF+     ++ +  + +I  +
Sbjct: 243 LLKEALPH---LQINCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (119), Expect = 4e-07
 Identities = 39/267 (14%), Positives = 76/267 (28%), Gaps = 15/267 (5%)

Query: 139 LDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLN 198
           LDL+   L   V+G L    +I +     +  +  L E      +   ++SN+       
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63

Query: 199 SRIWSASKEIQILDLSMNHFMGS-LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQH 257
             I S   ++Q L L         +  L  + +L +L++       +        S  + 
Sbjct: 64  HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123

Query: 258 VSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA--------- 308
             L+++       + +    +     I     SG   N+  +                  
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183

Query: 309 HSNSFSGPLPLSLSLCSKLHVLDLRN-NSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPN 367
            S              + L  L L     +     L    + +L TL +      G L  
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243

Query: 368 SLSDCHDLKILSLAKNELSGQVPESFG 394
                  L+I     +  +     + G
Sbjct: 244 LKEALPHLQINC---SHFTTIARPTIG 267

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.7 bits (117), Expect = 8e-07
 Identities = 45/258 (17%), Positives = 94/258 (36%), Gaps = 16/258 (6%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGV-VPVELSNLKQLEVLDLSHNML 146
           V     PR  +   +        +++ +DLS + +E   +   LS   +L+ L L    L
Sbjct: 25  VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83

Query: 147 SGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASK 206
           S P+   LA  + +  LN+S  S           S+ +  +  N S+      +    + 
Sbjct: 84  SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143

Query: 207 EIQILDLSMNHFMGSLQGLDHSPSLKQ----------LHVDNNLLGGDLPDSLYSMSSLQ 256
                 ++  +  G  + L  S                  D+ +L  D     + ++ LQ
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203

Query: 257 HVSLS-VNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSG 315
           H+SLS   +   +   ++  + +L+ L +FG    G L  +   L  L+    + + F+ 
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTT 260

Query: 316 PLPLSLSLCSKLHVLDLR 333
               ++       +  ++
Sbjct: 261 IARPTIGNKKNQEIWGIK 278

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 4e-05
 Identities = 38/279 (13%), Positives = 87/279 (31%), Gaps = 25/279 (8%)

Query: 159 LIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF 218
           L Q+L+++  + +  +        +  F    +     L      +   +Q +DLS +  
Sbjct: 1   LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVI 58

Query: 219 MGS--LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNL 276
             S     L     L+ L ++   L   + ++L   S+L  ++LS  +   + + +    
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNS 336
           +  R   +  +         +              + SG                  N  
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK---------------NLQ 163

Query: 337 LTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK-NELSGQVPESFGK 395
            +    L     + +      +              + L+ LSL++  ++  +     G+
Sbjct: 164 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223

Query: 396 LTSLLFLSLSNN----SFNHLSGTLSVLQ-QCKNLTTLI 429
           + +L  L +       +   L   L  LQ  C + TT+ 
Sbjct: 224 IPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIA 262

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 58.3 bits (139), Expect = 2e-09
 Identities = 52/324 (16%), Positives = 86/324 (26%), Gaps = 24/324 (7%)

Query: 323 LCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAK 382
           L  + H L+L N  L+   +L       L +L  + N  +  LP            SL  
Sbjct: 36  LDRQAHELELNNLGLSSLPEL----PPHLESLVASCNSLT-ELPELPQ--------SLKS 82

Query: 383 NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTL--ILTKNFVGEEIP 440
             +     ++   L  LL     +N+       L      K +      L K        
Sbjct: 83  LLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142

Query: 441 ENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL 500
           E +    + +        L     ++       ++ DL  +         I +       
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202

Query: 501 DFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAG-IPLYVKHNRSTNGLPYNQASSFP 559
                T+  +     T      S    +           L                 S  
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262

Query: 560 PSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG 619
           P      N  +  I         L  L++S N +   +P+       LE L  S N L  
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-A 317

Query: 620 SIPGSFEKLTFLSKFSVANNHLQG 643
            +P   + L  L    V  N L+ 
Sbjct: 318 EVPELPQNLKQL---HVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 8e-06
 Identities = 55/366 (15%), Positives = 92/366 (25%), Gaps = 61/366 (16%)

Query: 253 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNS 312
                + L+       LS        L  L+   N  + +LP +  +L  L     +  +
Sbjct: 38  RQAHELELNNLG----LSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 313 FSGPLP-LSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD 371
            S   P L     S   +  L     +  + +     +SL  L             +   
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 372 CHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 431
               ++ +L           S  KL  L     S  + N++   L  LQ    LTT+   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 432 KNFVGEEIPENVGGFESLMVLAL--------GNCGLKGHIPVWLLRCKKLQVLDLSWNHF 483
            N +              +             +               +L       N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 484 DGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKH 543
              I        +L  L+ SNN L  E+P     L+ LI                     
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI--------------------- 310

Query: 544 NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 603
                                S N +   +P     LK    L +  N +    P     
Sbjct: 311 --------------------ASFNHLA-EVPELPQNLKQ---LHVEYNPLR-EFPDIPES 345

Query: 604 IRNLEV 609
           + +L +
Sbjct: 346 VEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.8 bits (104), Expect = 3e-05
 Identities = 44/322 (13%), Positives = 89/322 (27%), Gaps = 23/322 (7%)

Query: 110 NQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS------GPVSGMLAGLNLIQSL 163
            Q   L+L+   L  +          LE L  S N L+        +  +L   N +++L
Sbjct: 38  RQAHELELNNLGLSSLPE----LPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKAL 93

Query: 164 NVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQ 223
           +              +   L     S+      +++       ++      +      L+
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 224 GLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLI 283
            L    +L  L                 +S    V+ +         + +  LT++    
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 284 IFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVL-----DLRNNSLT 338
                     P++     +  +             L +S      +          N+ +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 339 GPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTS 398
             I        SL  L+++ N     LP        L+ L  + N L+ +VPE    L  
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLA-EVPELPQNLKQ 328

Query: 399 LLFLSLSNNSFNHLSGTLSVLQ 420
              L +  N           ++
Sbjct: 329 ---LHVEYNPLREFPDIPESVE 347

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.3 bits (95), Expect = 4e-04
 Identities = 51/324 (15%), Positives = 99/324 (30%), Gaps = 26/324 (8%)

Query: 88  VTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS 147
              L L   GL  + P    HL   + L  SCN L   +P    +LK L V + +   LS
Sbjct: 40  AHELELNNLGLSSL-PELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94

Query: 148 GPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGK----LNSRIWS 203
                +         L       N S  ++ +  N ++  + +   + +     N+++  
Sbjct: 95  DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154

Query: 204 ASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVN 263
             +   +  L+  +   +         L    +       +    L ++  L  +    N
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214

Query: 264 NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAH--------SNSFSG 315
                     S            +           ++++  F             N+ S 
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274

Query: 316 PLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDL 375
            +     L   L  L++ NN L   +    +    L  L  + NH +  +P       +L
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHLAE-VPELPQ---NL 326

Query: 376 KILSLAKNELSGQVPESFGKLTSL 399
           K L +  N L  + P+    +  L
Sbjct: 327 KQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.0 bits (94), Expect = 6e-04
 Identities = 20/123 (16%), Positives = 37/123 (30%), Gaps = 8/123 (6%)

Query: 61  SWSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCN 120
             ++     Q    +    +  S    +   +         I         L+ L++S N
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 294

Query: 121 HLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEF 180
            L  +     +   +LE L  S N L+  V  +   L   + L+V  N            
Sbjct: 295 KLIEL----PALPPRLERLIASFNHLAE-VPELPQNL---KQLHVEYNPLREFPDIPESV 346

Query: 181 SNL 183
            +L
Sbjct: 347 EDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 54/342 (15%), Positives = 100/342 (29%), Gaps = 28/342 (8%)

Query: 134 KQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSF 193
           +Q   L+L++  LS  +  +   L   +SL  S NS    L EL    +L    + NN+ 
Sbjct: 38  RQAHELELNNLGLSS-LPELPPHL---ESLVASCNSLT-ELPEL--PQSLKSLLVDNNNL 90

Query: 194 TGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMS 253
                  +      ++ L +S N                      ++    L        
Sbjct: 91  KA-----LSDLPPLLEYLGVSNNQLEK-----LPELQNSSFLKIIDVDNNSLKKLPDLPP 140

Query: 254 SLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSF 313
           SL+ ++   N        +     +  +      +    LP  L ++      +      
Sbjct: 141 SLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPEL 200

Query: 314 SGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCH 373
                L+        +  L +   +           +       +  F     N  S   
Sbjct: 201 QNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 260

Query: 374 DLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKN 433
           +L       N  S ++        SL  L++SNN    L            L  LI + N
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPP------RLERLIASFN 314

Query: 434 FVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQV 475
            +  E+PE      +L  L +    L+   P      + L++
Sbjct: 315 HL-AEVPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLRM 351

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 52.8 bits (126), Expect = 6e-09
 Identities = 21/135 (15%), Positives = 45/135 (33%), Gaps = 21/135 (15%)

Query: 474 QVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTA 533
           +VL L+       +   + Q+  + +LD S+N L    P +L  L+ L            
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQA------- 50

Query: 534 SAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPE-IGQLKHLHVLDLSRNN 592
                     + +   +           + L NNR+  +   + +     L +L+L  N+
Sbjct: 51  ---------SDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 101

Query: 593 ITGTIPSSISEIRNL 607
           +          +  +
Sbjct: 102 LCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 2e-06
 Identities = 24/130 (18%), Positives = 43/130 (33%), Gaps = 16/130 (12%)

Query: 402 LSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKG 461
           L L++     L      L+Q   +T L L+ N     +        +L  L +       
Sbjct: 3   LHLAHKDLTVLCH----LEQLLLVTHLDLSHN----RLRALPPALAALRCLEVLQASDNA 54

Query: 462 HIPVW-LLRCKKLQVLDLSWNHF-DGNIPPWIGQMENLFYLDFSNNTLTGE------IPK 513
              V  +    +LQ L L  N          +     L  L+   N+L  E      + +
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

Query: 514 SLTELKSLIS 523
            L  + S+++
Sbjct: 115 MLPSVSSILT 124

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 6e-06
 Identities = 22/123 (17%), Positives = 45/123 (36%), Gaps = 7/123 (5%)

Query: 376 KILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFV 435
           ++L LA  +L+  V     +L  +  L LS+N    L   L+ L+  +    ++   +  
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLE----VLQASDNA 54

Query: 436 GEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQME 495
            E +           +L   N   +      L+ C +L +L+L  N           ++ 
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLA 113

Query: 496 NLF 498
            + 
Sbjct: 114 EML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 7e-06
 Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 8/126 (6%)

Query: 113 KLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNG 172
           ++L L+   L   V   L  L  +  LDLSHN L      + A   L       +   N 
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN- 57

Query: 173 SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS----LQGLDHS 228
            +  +     L    + NN        +   +   + +L+L  N          +  +  
Sbjct: 58  -VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 229 PSLKQL 234
           PS+  +
Sbjct: 117 PSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.9 bits (103), Expect = 8e-06
 Identities = 27/106 (25%), Positives = 39/106 (36%), Gaps = 7/106 (6%)

Query: 138 VLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKL 197
           VL L+H  L+      L  L L+  L++S N        L     L V   S+N+     
Sbjct: 2   VLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 198 NSRIWSASKEIQILDLSMNHF--MGSLQGLDHSPSLKQLHVDNNLL 241
                     +Q L L  N      ++Q L   P L  L++  N L
Sbjct: 60  GVANL---PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 21/123 (17%), Positives = 44/123 (35%), Gaps = 4/123 (3%)

Query: 232 KQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSG 291
           + LH+ +  L   +   L  +  + H+ LS N         ++ L  L  ++   +    
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCL-EVLQASDNALE 56

Query: 292 KLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL 351
            +  V       E  + ++          L  C +L +L+L+ NSL     +       L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 352 CTL 354
            ++
Sbjct: 117 PSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 18/102 (17%), Positives = 34/102 (33%), Gaps = 24/102 (23%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPS---------------------SIS 602
           L++  +  T+   + QL  +  LDLS N +    P+                      ++
Sbjct: 5   LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62

Query: 603 EIRNLEVLDLSSNDL-HGSIPGSFEKLTFLSKFSVANNHLQG 643
            +  L+ L L +N L   +          L   ++  N L  
Sbjct: 63  NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 1e-04
 Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 5/101 (4%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           +   L  L  +  LDLS N L  + P  L+ L+ LEVL  S N L          L  +Q
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVA--NLPRLQ 68

Query: 162 SLNVSSNSFNG--SLFELGEFSNLAVFNISNNSFTGKLNSR 200
            L + +N      ++  L     L + N+  NS   +   +
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 26/142 (18%), Positives = 41/142 (28%), Gaps = 29/142 (20%)

Query: 259 SLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLP 318
            L+  + +      +  L  + HL +  N+     P  L  L  LE   A  N+      
Sbjct: 4   HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60

Query: 319 LSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKIL 378
           ++     +   L L NN L                               L  C  L +L
Sbjct: 61  VANLPRLQ--ELLLCNNRLQ-----------------------QSAAIQPLVSCPRLVLL 95

Query: 379 SLAKNELSGQVPESFGKLTSLL 400
           +L  N L         +L  +L
Sbjct: 96  NLQGNSLCQ-EEGIQERLAEML 116

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 54.7 bits (130), Expect = 1e-08
 Identities = 34/239 (14%), Positives = 61/239 (25%), Gaps = 34/239 (14%)

Query: 375 LKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNF 434
              ++  K+ ++  V ++   L  +  LS        + G    +Q   NL  L L  N 
Sbjct: 21  AIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEG----VQYLNNLIGLELKDNQ 74

Query: 435 VGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQM 494
           + +  P             L            L     +  L         +        
Sbjct: 75  ITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124

Query: 495 ENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQ 554
                          +I               +  N   S   PL      +T     N+
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 555 ASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLS 613
            S   P                +  L +L  + L  N I+   P  ++   NL ++ L+
Sbjct: 185 ISDISP----------------LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 3e-08
 Identities = 34/225 (15%), Positives = 67/225 (29%), Gaps = 17/225 (7%)

Query: 132 NLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNN 191
            L     +    + ++  V+   A L+ I +L+        ++  +   +NL    + +N
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73

Query: 192 SFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYS 251
             T   +        +I  L+LS N                       +        L +
Sbjct: 74  QIT---DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 252 MSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSN 311
           +  L            Q++             +            L NL++L    A  N
Sbjct: 131 LQVLYL-------DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 312 SFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDL 356
             S   PL+      L  + L+NN ++       +  S+L  + L
Sbjct: 184 KISDISPLAS--LPNLIEVHLKNNQISDVS--PLANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.6 bits (117), Expect = 6e-07
 Identities = 31/216 (14%), Positives = 64/216 (29%), Gaps = 8/216 (3%)

Query: 423 KNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH 482
            N   +   K+ V + + +     + +  L+    G+   I   +     L  L+L  N 
Sbjct: 19  ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74

Query: 483 FDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK 542
                P           L  +       I    +     ++S   +     +    L V 
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 543 HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSIS 602
           +         +  +      +LS      +    +  L  L  L    N I+   P  ++
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192

Query: 603 EIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVAN 638
            + NL  + L +N +    P      + L   ++ N
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 6e-07
 Identities = 42/226 (18%), Positives = 77/226 (34%), Gaps = 17/226 (7%)

Query: 109 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 168
           L     +    +++   V    ++L  +  L      ++      + G+  + +L     
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-----IEGVQYLNNLIGLEL 70

Query: 169 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 228
             N  + +L    NL        S     N    +  + I+ LDL+          L   
Sbjct: 71  KDN-QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV-TPLAGL 128

Query: 229 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 288
            +L+ L++D N     + +            LS+ N        ++NL+ L  L    N+
Sbjct: 129 SNLQVLYLDLN----QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 289 FSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRN 334
            S   P  L +L  L      +N  S   P  L+  S L ++ L N
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 16/82 (19%), Positives = 28/82 (34%), Gaps = 4/82 (4%)

Query: 62  WSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNH 121
                             +  +N  ++T L      +  I P  L  L  L  + L  N 
Sbjct: 149 GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206

Query: 122 LEGVVPVELSNLKQLEVLDLSH 143
           +  V P  L+N   L ++ L++
Sbjct: 207 ISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 32/222 (14%), Positives = 71/222 (31%), Gaps = 22/222 (9%)

Query: 173 SLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLK 232
            +F     +N        ++ T  +     +    I  L         +++G+ +  +L 
Sbjct: 11  VIFPDPALANAIKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVT-TIEGVQYLNNLI 66

Query: 233 QLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGK 292
            L + +N +    P    +  +   +S +       ++   S  T         +     
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 293 LPNVLGNLTQLEFFVAHSNSFSGPL--------------PLSLSLCSKLHVLDLRNNSLT 338
             + L  L      + + +  +G                   L+  SKL  L   +N ++
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186

Query: 339 GPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSL 380
                  + L +L  + L  N  S   P  L++  +L I++L
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 14/61 (22%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 106 LGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNV 165
           L +L++L  L    N +  + P  L++L  L  + L +N +S      LA  + +  + +
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 166 S 166
           +
Sbjct: 225 T 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.004
 Identities = 31/219 (14%), Positives = 61/219 (27%), Gaps = 25/219 (11%)

Query: 229 PSLKQLHVDNNLLGGDLPD--SLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFG 286
           P+L    +       ++ D  +   +  +  +S      +    E +  L +L  L +  
Sbjct: 16  PALANA-IKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 287 NQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFS 346
           NQ +   P              +       +    S+ +         +        N  
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 347 GLSSLCTLDLATNHFSGPL--------------PNSLSDCHDLKILSLAKNELSGQVPES 392
            L          +  +G                   L++   L  L    N++S      
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISP 190

Query: 393 FGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILT 431
              L +L+ + L NN  + +S     L    NL  + LT
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP----LANTSNLFIVTLT 225

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 54.9 bits (130), Expect = 2e-08
 Identities = 42/323 (13%), Positives = 88/323 (27%), Gaps = 40/323 (12%)

Query: 345 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ----VPESFGKLTSLL 400
           FS       LD  T      +   L +   +K + L+ N +  +    + E+      L 
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 401 FLSLSNNSFNHLSGTL--------SVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVL 452
               S+     +   +          L +C  L T+ L+ N  G    E +  F S    
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122

Query: 453 ALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIP 512
                     +           + +L+ N    N PP    +     L+  +     +  
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182

Query: 513 KSLTELKSLISSNCTSSNPTASAGIPL----------------YVKHNRSTNGLPYNQAS 556
           +S   L ++               +                     H  S+      ++ 
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242

Query: 557 SFPPSVFLSNNRINGTIPPEIGQ------LKHLHVLDLSRNNITGTIPSSISEI-----R 605
                + L++  ++      +           L  L L  N I      ++  +      
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302

Query: 606 NLEVLDLSSNDLHGSIPGSFEKL 628
           +L  L+L+ N          +++
Sbjct: 303 DLLFLELNGNRF-SEEDDVVDEI 324

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.1 bits (115), Expect = 2e-06
 Identities = 41/340 (12%), Positives = 96/340 (28%), Gaps = 34/340 (10%)

Query: 205 SKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGD----LPDSLYSMSSLQHVSL 260
            K +++  ++          L    S+K++ +  N +G +    L +++ S   L+    
Sbjct: 7   GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 261 SVN---NFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPL 317
           S         ++ E +  L          +              +        ++    L
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 318 PLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFS-GPLPNSLSDCHDLK 376
            L  +         +        ++        L ++    N    G +          +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 377 ILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVG 436
           +L   K   +G  PE                    L G     +            +   
Sbjct: 187 LLHTVKMVQNGIRPE--------------GIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 232

Query: 437 EEIPENVGGFESLMVLALGNCGLKGHIPVWLLRC------KKLQVLDLSWNHFDGNIPPW 490
             +   +  + +L  L L +C L       ++          LQ L L +N  + +    
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292

Query: 491 I-----GQMENLFYLDFSNNTLTGEIPKSLTELKSLISSN 525
           +      +M +L +L+ + N    E    + E++ + S+ 
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTR 331

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 43/329 (13%), Positives = 96/329 (29%), Gaps = 23/329 (6%)

Query: 112 LKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGP----VSGMLAGLNLIQSLNVSS 167
           LKL  ++    + V    L     ++ + LS N +       +S  +A    ++    S 
Sbjct: 10  LKLDAITTEDEKSVFA-VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 168 NSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDH 227
                   E+ E   L +  +       KL++   S +         +  F+     L+H
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCP---KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125

Query: 228 SPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGN 287
                                  +++     +  + +    +    + L +         
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS----IICGRNRLENGSMKEWAKT 181

Query: 288 QFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSG 347
             S +L + +  +          +     L     L       +   +  +  + +    
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 348 LSSLCTLDLATNHFSGPLPNSLSDCHD------LKILSLAKNELSGQVPES-----FGKL 396
             +L  L L     S     ++ D         L+ L L  NE+      +       K+
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 397 TSLLFLSLSNNSFNHLSGTLSVLQQCKNL 425
             LLFL L+ N F+     +  +++  + 
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFST 330

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (126), Expect = 5e-08
 Identities = 35/184 (19%), Positives = 47/184 (25%), Gaps = 6/184 (3%)

Query: 322 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 381
            L     +L L  N L           + L  L+L            L     L +L   
Sbjct: 28  DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL-----DRAELTKLQVDGTLPVLGTL 82

Query: 382 KNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPE 441
               +          T      L  +     S  L  L+    L  L L  N +    P 
Sbjct: 83  DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142

Query: 442 NVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLD 501
            +     L  L+L N  L       L   + L  L L  N     IP        L +  
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201

Query: 502 FSNN 505
              N
Sbjct: 202 LHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 7e-08
 Identities = 37/207 (17%), Positives = 66/207 (31%), Gaps = 11/207 (5%)

Query: 443 VGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDF 502
           V    S + +      L   +P  L   K   +L LS N         +     L  L+ 
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 503 SN-NTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNR------STNGLPYNQA 555
                   ++  +L  L +L  S+    +          +          ++  L   + 
Sbjct: 63  DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 556 SSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN 615
                 ++L  N +    P  +     L  L L+ NN+T      ++ + NL+ L L  N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 616 DLHGSIPGSFEKLTFLSKFSVANNHLQ 642
            L+ +IP  F     L    +  N   
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 8e-08
 Identities = 35/188 (18%), Positives = 63/188 (33%), Gaps = 5/188 (2%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           +P  L       +L LS N L       L    +L  L+L    L+         L ++ 
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLG 80

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
           +L++S N              L V ++S N  T      +    +  ++           
Sbjct: 81  TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140

Query: 222 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRH 281
              L  +P L++L + NN L       L  + +L  + L  N+    + +       L  
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199

Query: 282 LIIFGNQF 289
             + GN +
Sbjct: 200 AFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 1e-05
 Identities = 48/247 (19%), Positives = 69/247 (27%), Gaps = 47/247 (19%)

Query: 345 FSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSL 404
            S ++S   ++    + +  LP  L    D  IL L++N L      +    T L  L+L
Sbjct: 6   VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 405 SNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIP 464
                  L            L TL L+ N +               VL +    L     
Sbjct: 63  DRAELTKLQVD----GTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPL 117

Query: 465 VWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISS 524
             L    +LQ L L  N      P  +     L  L  +NN LT      L  L++L   
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL--- 174

Query: 525 NCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLH 584
                                               ++ L  N +  TIP        L 
Sbjct: 175 -----------------------------------DTLLLQENSLY-TIPKGFFGSHLLP 198

Query: 585 VLDLSRN 591
              L  N
Sbjct: 199 FAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 2e-05
 Identities = 40/205 (19%), Positives = 66/205 (32%), Gaps = 10/205 (4%)

Query: 469 RCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTS 528
           +      ++    +    +PP + +  +   L  S N L      +L     L   N   
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 529 SNPTASAGIP-------LYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLK 581
           +  T             L + HN+  +     Q       + +S NR+       +  L 
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 582 HLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHL 641
            L  L L  N +    P  ++    LE L L++N+L     G    L  L    +  N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 642 QGTIPTGGQFYSFPNSSFEGNPGLC 666
                     +  P +   GNP LC
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 2e-04
 Identities = 11/65 (16%), Positives = 29/65 (44%), Gaps = 3/65 (4%)

Query: 576 EIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFS 635
           E+ ++     ++  + N+T  +P  +   ++  +L LS N L+     +    T L++ +
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 636 VANNH 640
           +    
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 4e-04
 Identities = 44/202 (21%), Positives = 59/202 (29%), Gaps = 27/202 (13%)

Query: 253 SSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLE-------- 304
           +S   V+    N +  L   +        L +  N         L   T+L         
Sbjct: 10  ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

Query: 305 -------------FFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL 351
                          +  S++    LPL       L VLD+  N LT        GL  L
Sbjct: 67  LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126

Query: 352 CTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNH 411
             L L  N      P  L+    L+ LSLA N L+         L +L  L L  NS   
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT 186

Query: 412 LSGTLSVLQQCKNLTTLILTKN 433
           +            L    L  N
Sbjct: 187 IPKGFF---GSHLLPFAFLHGN 205

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 1e-07
 Identities = 28/194 (14%), Positives = 58/194 (29%), Gaps = 30/194 (15%)

Query: 445 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 504
            F   +   L    +   +    L    +  +  + +         I  + N+  L  + 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 505 NTLTGEIPKSLTELKSLISSNCTSS------------------NPTASAGIPLYVKHNRS 546
           N LT   P +  +    +  +                      +   S    L       
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 547 TNGLPYNQASSFPPSVFLSNNRINGTI------PPEIGQLKHLHVLDLSRNNITGTIPSS 600
           +  L  N+ +       L+                 +  L  L  L LS+N+I+     +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRA 195

Query: 601 ISEIRNLEVLDLSS 614
           ++ ++NL+VL+L S
Sbjct: 196 LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 31/196 (15%), Positives = 68/196 (34%), Gaps = 15/196 (7%)

Query: 91  LILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPV 150
             L +K +   + ++   LN +  +  + + ++ V    +  L  +  L L+ N L+   
Sbjct: 29  DNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDI- 83

Query: 151 SGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQI 210
                    + +L      F          S   +  + + S      S I       Q+
Sbjct: 84  -------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136

Query: 211 LDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLS 270
             L + +   +   +    +        +    D+   L  ++ LQ++ LS N+ S  L 
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR 194

Query: 271 EKISNLTSLRHLIIFG 286
             ++ L +L  L +F 
Sbjct: 195 A-LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.8 bits (102), Expect = 3e-05
 Identities = 24/197 (12%), Positives = 59/197 (29%), Gaps = 15/197 (7%)

Query: 109 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 168
             +    +L    +   V    + L  ++ +  +++ +       +  L  +  L ++ N
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 169 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 228
                       +NL              +       K+++ L L  N        +   
Sbjct: 79  KLTDIKP----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134

Query: 229 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 288
                   +N +    +   L  + +L      +++        ++ LT L++L +  N 
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-----LAGLTKLQNLYLSKNH 189

Query: 289 FSGKLPNVLGNLTQLEF 305
            S      L  L  L+ 
Sbjct: 190 ISD--LRALAGLKNLDV 204

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 9e-05
 Identities = 29/209 (13%), Positives = 76/209 (36%), Gaps = 16/209 (7%)

Query: 172 GSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSL 231
             +F    F+     N+   S T  +     +    I  +  + +  + S+QG+ + P++
Sbjct: 15  KQIFSDDAFAETIKDNLKKKSVTDAVTQ---NELNSIDQIIANNSD-IKSVQGIQYLPNV 70

Query: 232 KQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFSG 291
            +L ++ N L          +++L+++     + +                +   +    
Sbjct: 71  TKLFLNGNKLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125

Query: 292 KLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL 351
            +  ++        ++ ++      +   L+    L + D + + +        +GL+ L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-----PLAGLTKL 180

Query: 352 CTLDLATNHFSGPLPNSLSDCHDLKILSL 380
             L L+ NH S     +L+   +L +L L
Sbjct: 181 QNLYLSKNHISD--LRALAGLKNLDVLEL 207

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 29/188 (15%), Positives = 56/188 (29%), Gaps = 6/188 (3%)

Query: 423 KNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNH 482
                 +L K  V + + +     + +  L     G+K    V  L    L  ++ S N 
Sbjct: 18  AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEYL--NNLTQINFSNNQ 73

Query: 483 FDGNIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK 542
                P           ++ +       +          + +N  +          L   
Sbjct: 74  LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 133

Query: 543 HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSIS 602
              S      +  S       L+ +    T    +  L  L  LD+S N ++    S ++
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLA 191

Query: 603 EIRNLEVL 610
           ++ NLE L
Sbjct: 192 KLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 31/188 (16%), Positives = 54/188 (28%), Gaps = 5/188 (2%)

Query: 445 GFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN 504
                M   LG   +   +        ++  L         +I   +  + NL  ++FSN
Sbjct: 16  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71

Query: 505 NTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFL 564
           N LT   P         I  N               +      N    +       +   
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 565 SNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHG-SIPG 623
                + TI           +  L+ ++   T    ++ +  LE LD+SSN +   S+  
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLA 191

Query: 624 SFEKLTFL 631
               L  L
Sbjct: 192 KLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 37/196 (18%), Positives = 64/196 (32%), Gaps = 15/196 (7%)

Query: 109 LNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSN 168
           L +     L   ++   V    ++L Q+  L      +   + G +  LN +  +N S+N
Sbjct: 17  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNN 72

Query: 169 SFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHS 228
                        NL        +     +    +    +  L L  N         + +
Sbjct: 73  QLTDITP----LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128

Query: 229 PSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQ 288
              +     N +        L S+  L   S  V +        ++NLT+L  L I  N+
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP-----LANLTTLERLDISSNK 183

Query: 289 FSGKLPNVLGNLTQLE 304
            S    +VL  LT LE
Sbjct: 184 VSD--ISVLAKLTNLE 197

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 7e-06
 Identities = 23/143 (16%), Positives = 40/143 (27%), Gaps = 9/143 (6%)

Query: 368 SLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTT 427
             ++    + L L   ++   +      L     +  S+N    L G        + L T
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF----PLLRRLKT 67

Query: 428 LILTKNFVGEEIPENVGGFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDLSWNHF 483
           L++  N +             L  L L N  L           L     L +L     + 
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 484 DGNIPPWIGQMENLFYLDFSNNT 506
                  I ++  +  LDF    
Sbjct: 128 KHYRLYVIYKVPQVRVLDFQKVK 150

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (99), Expect = 5e-05
 Identities = 29/163 (17%), Positives = 49/163 (30%), Gaps = 29/163 (17%)

Query: 268 QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKL 327
           + + + +N    R L + G +    + N+   L Q +                       
Sbjct: 9   EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFD----------------------- 44

Query: 328 HVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSG 387
             +D  +N +       F  L  L TL +  N              DL  L L  N L  
Sbjct: 45  -AIDFSDNEIRKLD--GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 101

Query: 388 -QVPESFGKLTSLLFLSLSNNSFNHLSG-TLSVLQQCKNLTTL 428
               +    L SL +L +  N   +     L V+ +   +  L
Sbjct: 102 LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 8e-05
 Identities = 19/102 (18%), Positives = 29/102 (28%), Gaps = 5/102 (4%)

Query: 564 LSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPG 623
           L+   I      +         LDL    I   I +  + +   + +D S N++      
Sbjct: 3   LTAELIEQ--AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLD 57

Query: 624 SFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL 665
            F  L  L    V NN +        Q           N  L
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (94), Expect = 2e-04
 Identities = 11/48 (22%), Positives = 23/48 (47%), Gaps = 3/48 (6%)

Query: 101 IIPRSLGHLNQLKL--LDLSCNHLEGVVPVELSNLKQLEVLDLSHNML 146
           +I ++  + N ++   LDL    +  V+    + L Q + +D S N +
Sbjct: 7   LIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 1e-05
 Identities = 18/84 (21%), Positives = 28/84 (33%), Gaps = 9/84 (10%)

Query: 445 GFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQ-----ME 495
               L VL L +C +       +   LL    L+ LDLS N         + +       
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 496 NLFYLDFSNNTLTGEIPKSLTELK 519
            L  L   +   + E+   L  L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 15/85 (17%), Positives = 28/85 (32%), Gaps = 5/85 (5%)

Query: 564 LSNNRINGTIPPEI-GQLKHLHVLDLSRNNITG----TIPSSISEIRNLEVLDLSSNDLH 618
           +    ++     E+   L+   V+ L    +T      I S++     L  L+L SN+L 
Sbjct: 9   IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68

Query: 619 GSIPGSFEKLTFLSKFSVANNHLQG 643
                   +        +    LQ 
Sbjct: 69  DVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 7e-05
 Identities = 16/95 (16%), Positives = 28/95 (29%), Gaps = 10/95 (10%)

Query: 327 LHVLDLRNNSLT-GPIDLNFSGLSSLCTLDLATNHFSG----PLPNSLSDCHDLKILSLA 381
           +  LD++   L+          L     + L     +      + ++L     L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 382 KNELSGQVPESFGKL-----TSLLFLSLSNNSFNH 411
            NEL         +        +  LSL N     
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 9e-05
 Identities = 17/67 (25%), Positives = 27/67 (40%), Gaps = 5/67 (7%)

Query: 112 LKLLDLSCNHLEGVVPVEL-SNLKQLEVLDLSHNMLSG----PVSGMLAGLNLIQSLNVS 166
           ++ LD+ C  L      EL   L+Q +V+ L    L+      +S  L     +  LN+ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 167 SNSFNGS 173
           SN     
Sbjct: 64  SNELGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 18/126 (14%), Positives = 33/126 (26%), Gaps = 3/126 (2%)

Query: 374 DLKILSLAKNELS-GQVPESFGKLTSLLFLSLSNNSFN--HLSGTLSVLQQCKNLTTLIL 430
           D++ L +   ELS  +  E    L     + L +            S L+    L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 431 TKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPW 490
             N +G+     V          +    L+               L       + ++   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 491 IGQMEN 496
           +     
Sbjct: 123 LLGDAG 128

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 13/74 (17%), Positives = 24/74 (32%), Gaps = 9/74 (12%)

Query: 564 LSNNRINGT----IPPEIGQLKHLHVLDLSRNNITGTIPSSISEI-----RNLEVLDLSS 614
           L++  ++ +    +   +     L  LDLS N +       + E        LE L L  
Sbjct: 376 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 435

Query: 615 NDLHGSIPGSFEKL 628
                 +    + L
Sbjct: 436 IYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 10/92 (10%)

Query: 424 NLTTLILTKNFVGEE-IPENVGGFESLMVLALGNCGLKG----HIPVWLLRCKKLQVLDL 478
           ++ +L +    + +    E +   +   V+ L +CGL       I   L     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 479 SWNHFDGNIPPWIGQM-----ENLFYLDFSNN 505
             N         + Q        +  L   N 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 14/87 (16%), Positives = 32/87 (36%), Gaps = 9/87 (10%)

Query: 225 LDHSPSLKQLHVDNNLLGGD----LPDSLYSMSSLQHVSLSVNNFSGQLSEKIS-----N 275
                 L+ L + +  +       L  +L +  SL+ + LS N        ++       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 276 LTSLRHLIIFGNQFSGKLPNVLGNLTQ 302
              L  L+++   +S ++ + L  L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 4e-04
 Identities = 18/96 (18%), Positives = 30/96 (31%), Gaps = 11/96 (11%)

Query: 344 NFSGLSSLCTLDLATNHFSG----PLPNSLSDCHDLKILSLAKNELSGQVPESFGK---- 395
                S L  L LA    S      L  +L   H L+ L L+ N L         +    
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 396 -LTSLLFLSLSNNSFNHLSGTL--SVLQQCKNLTTL 428
               L  L L +  ++        ++ +   +L  +
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 7e-04
 Identities = 10/92 (10%), Positives = 30/92 (32%), Gaps = 5/92 (5%)

Query: 182 NLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHF----MGSL-QGLDHSPSLKQLHV 236
           ++   +I     +    + +    ++ Q++ L            +   L  +P+L +L++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 237 DNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQ 268
            +N LG      +          +   +    
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 7e-04
 Identities = 21/100 (21%), Positives = 32/100 (32%), Gaps = 9/100 (9%)

Query: 67  MCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGI----IPRSLGHLNQLKLLDLSCNHL 122
              +  GV       G     + +L L    +       +  +L   + L+ LDLS N L
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409

Query: 123 EGVVPVELS-----NLKQLEVLDLSHNMLSGPVSGMLAGL 157
                ++L          LE L L     S  +   L  L
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 0.001
 Identities = 9/66 (13%), Positives = 24/66 (36%), Gaps = 5/66 (7%)

Query: 583 LHVLDLSRNNITGT-IPSSISEIRNLEVLDLSSNDLHG----SIPGSFEKLTFLSKFSVA 637
           +  LD+    ++       +  ++  +V+ L    L       I  +      L++ ++ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 638 NNHLQG 643
           +N L  
Sbjct: 64  SNELGD 69

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 13/96 (13%), Positives = 30/96 (31%), Gaps = 11/96 (11%)

Query: 205 SKEIQILDLSMNHF--MGSLQGLDHSPSLKQLHVDNNLLGGD----LPDSLYSMSSLQHV 258
           S +IQ LD+           + L      + + +D+  L       +  +L    +L  +
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 259 SLSVNNFSGQLSEKI-----SNLTSLRHLIIFGNQF 289
           +L  N         +     +    ++ L +     
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 15/76 (19%), Positives = 27/76 (35%), Gaps = 6/76 (7%)

Query: 456 NCGLKGHIPVWLLRCKKLQVLDLSWNHFDGN----IPPWIGQMENLFYLDFSNNTLTGEI 511
           + G++            L+VL L+      +    +   +    +L  LD SNN L    
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413

Query: 512 PKSLTELKSLISSNCT 527
              L  ++S+    C 
Sbjct: 414 ILQL--VESVRQPGCL 427

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 17/85 (20%), Positives = 27/85 (31%), Gaps = 9/85 (10%)

Query: 321 LSLCSKLHVLDLRNNSLTG----PIDLNFSGLSSLCTLDLATNHFSGPLPNSLSD----- 371
               S L VL L +  ++      +        SL  LDL+ N         L +     
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 372 CHDLKILSLAKNELSGQVPESFGKL 396
              L+ L L     S ++ +    L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (98), Expect = 1e-04
 Identities = 35/209 (16%), Positives = 62/209 (29%), Gaps = 2/209 (0%)

Query: 322 SLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLA 381
            L      L      L       FSG   L  ++++ N     +   +            
Sbjct: 26  DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85

Query: 382 KNELSGQV--PESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEI 439
           +   +     PE+F  L +L +L +SN    HL     +    K L  +    N    E 
Sbjct: 86  EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 145

Query: 440 PENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFY 499
              VG     ++L L   G++          +  ++     N+ +               
Sbjct: 146 NSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 205

Query: 500 LDFSNNTLTGEIPKSLTELKSLISSNCTS 528
           LD S   +       L  LK L + +  +
Sbjct: 206 LDISRTRIHSLPSYGLENLKKLRARSTYN 234

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 5e-04
 Identities = 8/44 (18%), Positives = 16/44 (36%)

Query: 101 IIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHN 144
           +        +   +LD+S   +  +    L NLK+L      + 
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 5e-04
 Identities = 25/251 (9%), Positives = 71/251 (28%), Gaps = 18/251 (7%)

Query: 366 PNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNL 425
            + +  C + ++    +++++ ++P       + + L         +           +L
Sbjct: 2   HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQK--GAFSGFGDL 55

Query: 426 TTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDG 485
             + +++N V E I  +V      +                        +  L  ++   
Sbjct: 56  EKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 115

Query: 486 NIPPWIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNR 545
              P + ++ +L  +                           S    +   + L++  N 
Sbjct: 116 KHLPDVHKIHSLQKVLLDIQDNINIHTI-----------ERNSFVGLSFESVILWLNKNG 164

Query: 546 STNGLPYNQASSFPPSVFLSNNRINGTIPPEI-GQLKHLHVLDLSRNNITGTIPSSISEI 604
                      +    + LS+N     +P ++        +LD+SR  I       +  +
Sbjct: 165 IQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224

Query: 605 RNLEVLDLSSN 615
           + L      + 
Sbjct: 225 KKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 15/108 (13%), Positives = 34/108 (31%)

Query: 62  WSNESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNH 121
                +    +       S    +    +L L + G++ I   +       +L     N+
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188

Query: 122 LEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNS 169
           LE +            +LD+S   +    S  L  L  +++ +  +  
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 29/208 (13%), Positives = 54/208 (25%), Gaps = 7/208 (3%)

Query: 102 IPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQ 161
           IP  L        L      L  +     S    LE +++S N +   +   +       
Sbjct: 23  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 162 SLNVSSNSFNGSLFELGEFSNLAVFNISNNSFTGKLNSRIWSASKEIQILDLSMNHFMGS 221
                  + N        F NL        S TG  +         +Q + L +   +  
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 222 LQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKI-----SNL 276
                +S            L  +    +++ +        +N       E++        
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 277 TSLRHLIIFGNQFSGKLPNVLGNLTQLE 304
           +    L I   +        L NL +L 
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLR 228

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 28/224 (12%), Positives = 55/224 (24%), Gaps = 19/224 (8%)

Query: 438 EIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL 497
           EIP ++    + + L      L+            L+ +++S N     I   +      
Sbjct: 22  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 498 FYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPL--------------YVKH 543
            +                             SN        +                 +
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 544 NRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSISE 603
             +     +   S     ++L+ N I           +   +     NN+          
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 604 IRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPT 647
                +LD+S   +H       E L  L   S    +L+  +PT
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNLK-KLPT 240

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 3e-04
 Identities = 18/127 (14%), Positives = 38/127 (29%), Gaps = 9/127 (7%)

Query: 245 LPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIF--GNQFSGKLPNVLGNLTQ 302
           L   +         +L +            +L +    ++    +  +  L  +  N+ +
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR-----SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPE 66

Query: 303 LEFFVAHSNSFSG--PLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNH 360
           L      +N       +   +     L +L+L  N L    +L+      L  L L  N 
Sbjct: 67  LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126

Query: 361 FSGPLPN 367
            S    +
Sbjct: 127 LSDTFRD 133

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 0.001
 Identities = 20/138 (14%), Positives = 37/138 (26%), Gaps = 7/138 (5%)

Query: 388 QVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFE 447
           Q+     K       +L              L        L    +     +        
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLRSDPD----LVAQNIDVVLNRRSSMA-ATLRIIEENIP 65

Query: 448 SLMVLALGNCGLKGH--IPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNN 505
            L+ L L N  L     +   + +   L++L+LS N           +   L  L    N
Sbjct: 66  ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125

Query: 506 TLTGEIPKSLTELKSLIS 523
           +L+       T + ++  
Sbjct: 126 SLSDTFRDQSTYISAIRE 143

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.003
 Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 4/108 (3%)

Query: 299 NLTQLEFFVA--HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLN--FSGLSSLCTL 354
           +L      V     +S +  L +      +L  L+L NN L    D++       +L  L
Sbjct: 37  DLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96

Query: 355 DLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFL 402
           +L+ N               L+ L L  N LS    +    ++++   
Sbjct: 97  NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 0.001
 Identities = 17/109 (15%), Positives = 34/109 (31%), Gaps = 2/109 (1%)

Query: 559 PPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSI-SEIRNLEVLDLSSNDL 617
              +  + +         +   ++L  L +        +       +  L  L +  + L
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 618 HGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGLC 666
               P +F     LS+ +++ N L+       Q  S       GNP  C
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.5 bits (85), Expect = 0.004
 Identities = 20/130 (15%), Positives = 51/130 (39%), Gaps = 3/130 (2%)

Query: 65  ESMCCQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEG 124
             +  + + +     +    A  +  L L    +K I  +    L+QLK L+L  N +  
Sbjct: 57  VKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC 116

Query: 125 VVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLA 184
           V+P    +L  L  L+L+ N  +     +      ++  +++  +         +  ++ 
Sbjct: 117 VMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS--KVRDVQ 173

Query: 185 VFNISNNSFT 194
           + ++ ++ F 
Sbjct: 174 IKDLPHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.5 bits (85), Expect = 0.004
 Identities = 28/202 (13%), Positives = 51/202 (25%), Gaps = 43/202 (21%)

Query: 424 NLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHF 483
           + T L+L  N +G    + + G    +V           I                  + 
Sbjct: 30  HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89

Query: 484 DGNIPP-WIGQMENLFYLDFSNNTLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVK 542
              I       +  L  L+  +N ++  +P S   L SL S N                 
Sbjct: 90  IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL---------------- 133

Query: 543 HNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHVLDLSRNNITGTIPSSIS 602
                                   +             + L    L+        PS + 
Sbjct: 134 -----------------------ASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV- 169

Query: 603 EIRNLEVLDLSSNDLHGSIPGS 624
             R++++ DL  ++   S   S
Sbjct: 170 --RDVQIKDLPHSEFKCSSENS 189

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1052
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.95
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.91
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.9
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.9
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.87
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.86
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.85
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.82
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.82
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.81
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.81
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.68
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.59
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.57
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.5
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.24
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.79
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.7
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.58
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.29
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.29
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	98.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	98.17
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.88

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.49  Aligned_cols=254  Identities=22%  Similarity=0.362  Sum_probs=209.8

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEEC
Q ss_conf             08755684721285289999987-99589999944884354999999999999549985002403486089079999824
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf             05388789812858299999998999899999984301727999999999998679998805857798899989999703


Q ss_pred             CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47983323000468764559999999999999999998741799849769999866877899769901144322488997
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  929 (1052)
                      +||+|.+++..     ..+++.++..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus       100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1         100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-
T ss_conf             79808988641-----5999999999999999999999987---97226776888688789968642515641321366-


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             03412444456558213487677861034999999999992999975458777014899999963024433112443463
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||...   +..+.........   . .....     
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~~~~~~---~-~~~~~-----  238 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE---NPLRALYLIATNG---T-PELQN-----  238 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHHC---S-CCCSS-----
T ss_pred             CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHCC---C-CCCCC-----
T ss_conf             6444444477736826644799880120313729999980488998997---9999999998579---9-98888-----


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf             101999999999998812379999999899999--99610
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                        +...+..+.+++.+|+++||++|||+.|+++  +++..
T Consensus       239 --~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         239 --PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             --GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             --CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             --55379999999999866996689099999649965778

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=372.11  Aligned_cols=258  Identities=24%  Similarity=0.415  Sum_probs=214.1

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEEC
Q ss_conf             30875568472128528999998799589999944884354999999999999549985002403486089079999824
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  849 (1052)
                      ..+|+..+.||+|+||+||+|++.++..||||++.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf             69958888982088829999998899999999987886-76899999999999668997565352431599337999836


Q ss_pred             CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47983323000468764559999999999999999998741799849769999866877899769901144322488997
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  929 (1052)
                      ++|+|.+++..   ....+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||+|+.......
T Consensus        83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC
T ss_conf             99918997520---134788999999999999987765316---431044315326666887768655321002368873


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             034124444565582134876778610349999999999929-9997545877701489999996302443311244346
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG-RRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .......||+.|+|||++.+..++.++||||||+++|||+|+ ++||..   ....+..+.+.....      ...+   
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~---~~~~~~~~~i~~~~~------~~~p---  224 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDISTGFR------LYKP---  224 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS---CCHHHHHHHHHHTCC------CCCC---
T ss_pred             EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHHCCC------CCCC---
T ss_conf             3504300176667857860799984033210599999998789888778---999999999980688------8995---


Q ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             310199999999999881237999999989999999610855
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                          ...+.++.+++.+||+.||++|||++|+++.|+++++.
T Consensus       225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ----43679999999997657976891999999999999857

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=379.18  Aligned_cols=261  Identities=25%  Similarity=0.352  Sum_probs=215.1

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEE
Q ss_conf             308755684721285289999987-9958999994488435499999999999954998500240348608907999982
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  848 (1052)
                      .++|++.+.||+|+||+||+|.+. ++..||+|+++.+.. ..+++.+|++++++++|||||++++++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf             7993986598208880899999999996999999777610-399999999999867999882677527457854787631


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             44798332300046876455999999999999999999874179984976999986687789976990114432248899
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  928 (1052)
                      +++|++.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+|||+++++.+||+|||+|+......
T Consensus        95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             CCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf             4676067775303--554157999999999999978889878---93057604576899899928983244546537887


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             70341244445655821348767786103499999999999299997545877701489999996302443311244346
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      ........|++.|+|||++.+..++.++||||||+++|||++|..||...  .+.....+.+    .......       
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~--~~~~~~~~~i----~~~~~~~-------  236 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELL----EKDYRME-------  236 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHH----HTTCCCC-------
T ss_pred             CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHH----HCCCCCC-------
T ss_conf             22103556654666927872799981043021789999998679988774--2599999998----5588888-------


Q ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             3101999999999998812379999999899999996108556
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1051 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1051 (1052)
                        .+...+.++.+++.+||+.||++|||++|++++|+.+.++.
T Consensus       237 --~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         237 --RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             --CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf             --87433099999999975779768939999999999998757

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=365.47  Aligned_cols=256  Identities=24%  Similarity=0.363  Sum_probs=211.7

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEE
Q ss_conf             308755684721285289999987-9958999994488435499999999999954998500240348608907999982
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  848 (1052)
                      .++|++.+.||+|+||.||+|+.. +|..||+|++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             65758988984076819999998899989999998452431699999999999867997999299999989999999985


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCC
Q ss_conf             447983323000468764559999999999999999998741799849769999866877--899769901144322488
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD--EKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~  926 (1052)
                      ++||+|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++  .++.+||+|||+|+....
T Consensus       105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf             799889999976---237899999999999999999999756---97600015467364168898699954521044256


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             99703412444456558213487677861034999999999992999975458777014899999963024433112443
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ...  .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.   +..+....+......      ....
T Consensus       179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~------~~~~  247 (350)
T d1koaa2         179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWN------MDDS  247 (350)
T ss_dssp             TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC------SCCG
T ss_pred             CCC--CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHCCCC------CCCC
T ss_conf             543--20006862421889975899872676554659999998598998997---999999999847889------8942


Q ss_pred             CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             463101999999999998812379999999899999--9961
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                          .....+.++.+++.+|++.||++|||++|+++  ++..
T Consensus       248 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~  285 (350)
T d1koaa2         248 ----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  285 (350)
T ss_dssp             ----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             ----23589999999999975689667908999862913288

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=369.37  Aligned_cols=260  Identities=25%  Similarity=0.353  Sum_probs=208.7

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEE
Q ss_conf             308755684721285289999987-99589999944884-3549999999999995499850024034860890799998
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  847 (1052)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf             74608998972174809999999999979999998456641279999999999985799888469654046743679886


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             24479833230004687645599999999999999999987417998497699998668778997699011443224889
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  927 (1052)
                      |+++|+|.+++.    ....+++.++..++.|++.|++|||+.   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             CCCCCCHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf             458980899975----379999999999999999999999975---9835754689978878998798323142240468


Q ss_pred             CC-EEEECCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             97-03412444456558213487677-86103499999999999299997545877701489999996302443311244
Q 001561          928 DT-HVTTDLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       928 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .. ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......  .... ..  ..... ..    
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~-~~--~~~~~-~~----  226 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYS-DW--KEKKT-YL----  226 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHH-HH--HTTCT-TS----
T ss_pred             CCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHH--HHHH-HH--HCCCC-CC----
T ss_conf             865311132557474287286189999971016173799999982997888898599--9999-98--63888-78----


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCCC
Q ss_conf             3463101999999999998812379999999899999--99610855
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGID 1050 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~ 1050 (1052)
                      .    .....+.++.+++.+|++.||++|||++|+++  |+++-.+.
T Consensus       227 ~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~k  269 (271)
T d1nvra_         227 N----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  269 (271)
T ss_dssp             T----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             C----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCC
T ss_conf             8----644699999999999767996689099999619845859889

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=375.02  Aligned_cols=268  Identities=24%  Similarity=0.390  Sum_probs=209.1

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEE
Q ss_conf             308755684721285289999987-99589999944884-3549999999999995499850024034860890799998
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  847 (1052)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++... .....++.+|+.+++.++|||||++++++.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             56888978971277809999999899969999998754097899999999999986799999949999998999999997


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             24479833230004687645599999999999999999987417998497699998668778997699011443224889
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  927 (1052)
                      |++||+|.+++..    ...+++..+..++.|++.|+.|||+.  .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf             6799868998742----49999999999999999999999985--99971445779946878998999548776256788


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC---------
Q ss_conf             97034124444565582134876778610349999999999929999754587770148999999630244---------
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR---------  998 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  998 (1052)
                         .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+....  ..........         
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH--C------------------
T ss_pred             ---CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHHHCCCCCCCCCCCCCC
T ss_conf             ---62111377141194687589989488899899999999988899899887899999--9887517754577421233


Q ss_pred             ----CCCCCCCC----------------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf             ----33112443----------------463101999999999998812379999999899999--996108
Q 001561          999 ----EVEIIDAS----------------IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus       999 ----~~~~~~~~----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                          .....+..                .........+.++.+++.+|++.||++|||++|+++  ++++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf             322111122235413477887665026876676444899999999998689946790899996098647698

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=369.01  Aligned_cols=259  Identities=27%  Similarity=0.445  Sum_probs=210.5

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CC---CEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEE
Q ss_conf             308755684721285289999987-99---589999944884-3549999999999995499850024034860890799
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NG---TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  844 (1052)
                      .++|++.++||+|+||+||+|+++ ++   ..||+|.+.... ....++|.+|++++++++|||||++++++.+++..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             00427856980278829999999579978899999997844598999999999999985799888618999962887799


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             99824479833230004687645599999999999999999987417998497699998668778997699011443224
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~  924 (1052)
                      ||||+++|+|.+++..   ....+++.++..++.|+++|++|||+.   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       105 v~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEECCCCCCEEEECC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf             9972279853002104---567999999999999999988988527---9835761504489889991998884431575


Q ss_pred             CCCCCEE----EECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf             8899703----412444456558213487677861034999999999992-99997545877701489999996302443
Q 001561          925 RPYDTHV----TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE  999 (1052)
Q Consensus       925 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      .......    .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...   ...+....+....   . 
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~---~~~~~~~~i~~~~---~-  251 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDY---R-  251 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTC---C-
T ss_pred             CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC---CHHHHHHHHHCCC---C-
T ss_conf             67777653650256668830038788836997861214453578999986799999999---9999999997378---8-


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             311244346310199999999999881237999999989999999610855
Q 001561         1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      .         ..+...+.++.+++.+||+.+|++||+++|+++.|+.+.++
T Consensus       252 ~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         252 L---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             C---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             C---------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             9---------99742269999999997587976892999999999998418

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.19  Aligned_cols=261  Identities=28%  Similarity=0.477  Sum_probs=207.6

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEE
Q ss_conf             3087556847212852899999879958999994488--43549999999999995499850024034860890799998
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGD--CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  847 (1052)
                      .++|++.+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             451899889830788589999999--989999997346998999999999999984799878645679715-58999996


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             24479833230004687645599999999999999999987417998497699998668778997699011443224889
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  927 (1052)
                      |+++|+|.+++..   ....+++..+..++.|+++|++|||+.   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 y~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          84 WCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             CCCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf             5899888999852---357899999999999999998887509---9951614789979818997887500221333556


Q ss_pred             CC-EEEECCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf             97-03412444456558213487---677861034999999999992999975458777014899999963024433112
Q 001561          928 DT-HVTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       928 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      .. .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.....   .+............+  .. 
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~---~~~~~~~~~~~~~~p--~~-  231 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIFMVGRGYLSP--DL-  231 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHHHHHHTSCCC--CG-
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHCCCCCC--CC-
T ss_conf             776312566557431799999505689999531516359999999978899899896---999999996588898--60-


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             44346310199999999999881237999999989999999610855
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                           .......+.++.+++.+||+.+|++|||++|+++.|+.+.++
T Consensus       232 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         232 -----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             -----003655549999999997588976892999999999999970

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=363.11  Aligned_cols=255  Identities=21%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEEC
Q ss_conf             08755684721285289999987-99589999944884354999999999999549985002403486089079999824
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  849 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++..........+.+|++++++++||||+++++++.+++..|+||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf             03599899931778299999998999799999988726467999999999998679979891999999899999999828


Q ss_pred             CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf             47983323000468764559999999999999999998741799849769999866877--8997699011443224889
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD--EKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~  927 (1052)
                      +||+|.+++..   ....+++.++..++.|++.|++|||+.   +|+||||||+|||++  .++.+||+|||+|+.+...
T Consensus       109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf             99808888986---389989999999999999999999977---926513144553113467884899525630343788


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             97034124444565582134876778610349999999999929999754587770148999999630244331124434
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      .  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||..   .+..+....+....   ..   .....
T Consensus       183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~---~~~~~~~~~i~~~~---~~---~~~~~  251 (352)
T d1koba_         183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCD---WE---FDEDA  251 (352)
T ss_dssp             S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC---SSHHHHHHHHHHCC---CC---CCSST
T ss_pred             C--CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHHCC---CC---CCCCC
T ss_conf             7--20100476453489997479989763338989999999968899899---79999999998478---89---89300


Q ss_pred             CCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             63101999999999998812379999999899999--9961
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                      +    ...+.++.+++.+|++.||.+|||+.|+++  ++++
T Consensus       252 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         252 F----SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             T----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             C----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             2----479999999999975699668918999960973488

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.33  Aligned_cols=257  Identities=26%  Similarity=0.404  Sum_probs=208.7

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEEC
Q ss_conf             30875568472128528999998799589999944884354999999999999549985002403486089079999824
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|++.+.||+|+||+||+|.++++..||||++.... ...+++.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf             89938867981079828999999999999999986476-888999999999986799988578731045-9769999957


Q ss_pred             CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47983323000468764559999999999999999998741799849769999866877899769901144322488997
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  929 (1052)
                      ++|+|.+++...  ....+++..+..++.|+++|+.|||+.   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        90 ~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC
T ss_conf             898288887514--789887889999999999999999748---954675642251562024404234101477358864


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             03412444456558213487677861034999999999992999975458777014899999963024433112443463
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .......|++.|+|||++.+..++.++||||||+++|||+||..|+..  .....+....+..    .....  .     
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~--~~~~~~~~~~i~~----~~~~~--~-----  231 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--GMTNPEVIQNLER----GYRMV--R-----  231 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHT----TCCCC--C-----
T ss_pred             CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCC--CCCHHHHHHHHHH----CCCCC--C-----
T ss_conf             420356774444582898379998245645257999999968988888--8899999999970----68888--9-----


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             101999999999998812379999999899999996108
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                        +...+.++.+++.+||+.+|++|||++++++.|+++-
T Consensus       232 --p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             --6557199999999975889768939999999861132

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.06  Aligned_cols=256  Identities=23%  Similarity=0.359  Sum_probs=208.3

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEEECEEEE--CCEEEE
Q ss_conf             308755684721285289999987-99589999944884--3549999999999995499850024034860--890799
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH--GNDRLL  844 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l  844 (1052)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+  ....|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             33379967983088919999999999979999998746579799999999999999778999824899999178998999


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf             99824479833230004687645599999999999999999987417--9984976999986687789976990114432
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC--EPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~  922 (1052)
                      ||||+++|+|.+++.........+++..++.++.|++.|+.|||+..  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf             99568999389999851545789999999999999999999999716778878858676542574788857980010003


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             24889970341244445655821348767786103499999999999299997545877701489999996302443311
Q 001561          923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ...... ......+||+.|+|||++.+..++.++||||+|+++|||+||+.||...   +..+....+...    ....+
T Consensus       163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~~~i~~~----~~~~~  234 (269)
T d2java1         163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREG----KFRRI  234 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHT----CCCCC
T ss_pred             ECCCCC-CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCC---CHHHHHHHHHCC----CCCCC
T ss_conf             224577-7556677882327999983999993898875278999980188998998---999999999718----99889


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             2443463101999999999998812379999999899999
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                               +...+.++.+++.+|++.||++|||++|+++
T Consensus       235 ---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             ---------7435999999999976799557918999972

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.18  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=206.9

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEEC
Q ss_conf             08755684721285289999987-99589999944884354999999999999549985002403486089079999824
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  849 (1052)
                      +.|++.+.||+|+||+||+|++. ++..||+|++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             37598479930778199999999999399999987289999999999999998679999884988980099589999627


Q ss_pred             CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47983323000468764559999999999999999998741799849769999866877899769901144322488997
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  929 (1052)
                      ++|+|.+++..   ....+++..+..++.|++.|+.|||+.   +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus        92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~  164 (288)
T d2jfla1          92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I  164 (288)
T ss_dssp             TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred             CCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-C
T ss_conf             99818899986---289999999999999999999999988---9887140700314878999899716123035778-6


Q ss_pred             EEEECCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             034124444565582134-----876778610349999999999929999754587770148999999630244331124
Q 001561          930 HVTTDLVGTLGYIPPEYS-----QTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ......+||+.|+|||++     ....++.++||||+||++|||++|+.||...   +..+....+..   ... .... 
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~---~~~~~~~~i~~---~~~-~~~~-  236 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAK---SEP-PTLA-  236 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS---CGGGHHHHHHH---SCC-CCCS-
T ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHC---CCC-CCCC-
T ss_conf             410010256264799998320257888880665787899999982088999998---99999999970---799-8777-


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHH
Q ss_conf             43463101999999999998812379999999899999--996
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1045 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1045 (1052)
                            .+...+.++.+++.+|++.||++|||+.|+++  ++.
T Consensus       237 ------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~  273 (288)
T d2jfla1         237 ------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT  273 (288)
T ss_dssp             ------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred             ------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf             ------6566999999999997669966891999996292318

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.42  Aligned_cols=249  Identities=27%  Similarity=0.422  Sum_probs=207.6

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEE
Q ss_conf             08755684721285289999987-99589999944884---354999999999999549985002403486089079999
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ......+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             82447983323000468764559999999999999999998741799849769999866877899769901144322488
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  926 (1052)
                      ||+++|+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf             50479858988750----48999999999999999999999988---946522023441466899871155563354488


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             99703412444456558213487677861034999999999992999975458777014899999963024433112443
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...   +..+....+.   ....  ..    
T Consensus       159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~---~~~~--~~----  223 (263)
T d2j4za1         159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRIS---RVEF--TF----  223 (263)
T ss_dssp             C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHH---TTCC--CC----
T ss_pred             C---CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC---CHHHHHHHHH---CCCC--CC----
T ss_conf             8---523557887634999975899893144046759999983299998889---9999999997---1899--99----


Q ss_pred             CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             463101999999999998812379999999899999--9961
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                           +...+.++.+++.+|+++||++|||++|+++  ++.+
T Consensus       224 -----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         224 -----PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             -----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             -----8668999999999976479768909999971907078

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.33  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=207.9

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEECC-C-----CEEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEEECEEEECCE
Q ss_conf             3087556847212852899999879-9-----589999944884-35499999999999954-99850024034860890
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN-G-----TKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  841 (1052)
                      .++|++.++||+|+||+||+|++.. +     ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf             89939701983078819999998578855420499999966335878999999999999971589968687788862995


Q ss_pred             EEEEEEECCCCCHHHHHHCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf             7999982447983323000468-------------------764559999999999999999998741799849769999
Q 001561          842 RLLIYSYMENGSLDYWLHESVD-------------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKS  902 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp  902 (1052)
                      .++||||+++|+|.++++....                   ....+++..++.++.|++.|++|||+.   +|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCH
T ss_conf             89999727999599999862577751022100001222001257789999999999999999999739---905052703


Q ss_pred             CCEEECCCCCEEEEECCCCCCCCCCCCE-EEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf             8668778997699011443224889970-3412444456558213487677861034999999999992-9999754587
Q 001561          903 SNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKG  980 (1052)
Q Consensus       903 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~  980 (1052)
                      +||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |++||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf             21443459828985142222045778615623435787657838872799996330300039999998389999999898


Q ss_pred             CCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf             77014899999963024433112443463101999999999998812379999999899999996
Q 001561          981 KNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLD 1045 (1052)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1045 (1052)
                         .+.+..+..   .....         +.+...+.++.+++.+||+.+|++|||++|+++.|.
T Consensus       273 ---~~~~~~~~~---~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 ---DANFYKLIQ---NGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ---SHHHHHHHH---TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---HHHHHHHHH---CCCCC---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ---999999985---69989---------988767899999999975889668939999999974

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.72  Aligned_cols=255  Identities=22%  Similarity=0.378  Sum_probs=214.0

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEEC
Q ss_conf             30875568472128528999998799589999944884354999999999999549985002403486089079999824
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|+..+.||+|+||+||+|+++++..||+|+++.... ..+++.+|+.++++++||||+++++++.++...++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf             699799689820788399999988998999999874757-7899999999999668986015889985078169999704


Q ss_pred             CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47983323000468764559999999999999999998741799849769999866877899769901144322488997
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  929 (1052)
                      ++|++..++..   ....+++..+.+++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf             89938886410---246776899999999999999987546---843466541358876998479886144202357872


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             03412444456558213487677861034999999999992-99997545877701489999996302443311244346
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .......||+.|+|||++.+..++.++||||||+++|||+| |+.||....   ..+....+..    ..  ....+.  
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~~i~~----~~--~~~~p~--  224 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQ----GL--RLYRPH--  224 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHHT----TC--CCCCCT--
T ss_pred             EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCC---HHHHHHHHHH----CC--CCCCCC--
T ss_conf             252465788775780786379988521033643246739755999988999---9999999980----79--789965--


Q ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             310199999999999881237999999989999999610
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                           ..+.++.+++.+||+.+|++|||++++++.|.+|
T Consensus       225 -----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         225 -----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf             -----4659999999997668976893999999874188

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.46  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=206.6

Q ss_pred             HCCCCCCCE-ECCCCCEEEEEEEEC---CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEE
Q ss_conf             308755684-721285289999987---99589999944884-3549999999999995499850024034860890799
Q 001561          770 TNNFNQANI-IGCGGFGLVYKATLT---NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       770 ~~~y~~~~~-LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  844 (1052)
                      .++|.+.+. ||+|+||+||+|.++   ++..||||+++... ....++|.+|++++++++|||||++++++.+ +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf             44718878487306080999999960897689999998820397899999999999986799888068656036-80799


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             99824479833230004687645599999999999999999987417998497699998668778997699011443224
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~  924 (1052)
                      ||||+++|+|.+++..   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf             9980789968997521---256999999999999999987899868---8105767646604546885420331342115


Q ss_pred             CCCCCEEE--ECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf             88997034--12444456558213487677861034999999999992-9999754587770148999999630244331
Q 001561          925 RPYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001 (1052)
Q Consensus       925 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ........  ....||+.|+|||++.+..++.++||||||+++|||+| |+.||.....   .+....+..    .....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~----~~~~~  232 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQ----GKRME  232 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHT----TCCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH---HHHHHHHHC----CCCCC
T ss_conf             54343211356211374335868872799995412322017899999389999999799---999999981----89999


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             12443463101999999999998812379999999899999996108
Q 001561         1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      .         +...+.++.+++.+||+.+|++||++.++++.|+.+-
T Consensus       233 ~---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         233 C---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             C---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             9---------9767899999999975779768909999999999999

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=360.49  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=208.0

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEE
Q ss_conf             308755684721285289999987-99589999944884-3549999999999995499850024034860890799998
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  847 (1052)
                      .+.|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             66669988994065839999999999989999998157731289999999999986799899919899998998889885


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCC
Q ss_conf             2447983323000468764559999999999999999998741799849769999866877---8997699011443224
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLL  924 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~Dfg~a~~~  924 (1052)
                      |++||+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||++.   +++.+||+|||+|+..
T Consensus        88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             CCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf             2689848886530----36788789999999999998752413---0556870463001104688824998315435872


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             88997034124444565582134876778610349999999999929999754587770148999999630244331124
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID 1004 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ...  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...   ...+....+..   ....   ..
T Consensus       161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~---~~~~---~~  229 (307)
T d1a06a_         161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILK---AEYE---FD  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHT---TCCC---CC
T ss_pred             CCC--CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHC---CCCC---CC
T ss_conf             589--7044003284225918873799980787345159999998597999998---99999999861---6877---78


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             43463101999999999998812379999999899999--9961
Q 001561         1005 ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                      ...    ....+.++.+++.+|+++||++|||+.|+++  ++.+
T Consensus       230 ~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         230 SPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             766----6678999999999976089757918999862984479

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=362.37  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=208.0

Q ss_pred             CCCCCCCEECCCCCEEEEEEEECCC-----CEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEE
Q ss_conf             0875568472128528999998799-----589999944884-3549999999999995499850024034860890799
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNG-----TKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  844 (1052)
                      ..|+..++||+|+||+||+|.++..     ..||||++.... .....+|.+|+.++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf             99686159811779099999996899878799999998844596899999999999985689878323677833880389


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             99824479833230004687645599999999999999999987417998497699998668778997699011443224
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~  924 (1052)
                      |+||++++++.+++..   ....+++..+..++.|++.|+.|||+.   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEECCCCCCHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf             9972135740222102---345420899999999999854121212---3425765644278889984998455103003


Q ss_pred             CCCCC--EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             88997--0341244445655821348767786103499999999999299997545877701489999996302443311
Q 001561          925 RPYDT--HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       925 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|..|+...  ....+....+..    ....  
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~----~~~~--  232 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAIND----GFRL--  232 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHT----TCCC--
T ss_pred             CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC--CCHHHHHHHHHC----CCCC--
T ss_conf             57876526742677773434888870499997355634489899999679886556--899999999863----5789--


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             244346310199999999999881237999999989999999610855
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                             ..+...+.++.+++.+||+.+|++||++.|+++.|+.+.+.
T Consensus       233 -------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         233 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             -------98504579999999997767976893999999999998669

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=358.36  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=201.7

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEE
Q ss_conf             08755684721285289999987-99589999944884---354999999999999549985002403486089079999
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  846 (1052)
                      +.|+..+.||+|+||+||+|+.. ++..||+|++....   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             82447983323000468764559999999999999999998741799849769999866877899769901144322488
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  926 (1052)
                      ||+++|++..++.    ....+++..+..++.|++.|+.|||+.   +|+||||||+|||++.++.+||+|||+|.....
T Consensus        95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EECCCCCHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf             8069994578997----379999999999999999999999868---976667884217987999789844365334677


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf             99703412444456558213487---677861034999999999992999975458777014899999963024433112
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQT---LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                           ....+||+.|+|||++.+   ..|+.++||||+||++|||++|+.||...   ...+....+..   ... ....
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~---~~~~~~~~i~~---~~~-~~~~  235 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQ---NES-PALQ  235 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHH---SCC-CCCS
T ss_pred             -----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHH---CCC-CCCC
T ss_conf             -----87313476636889983467888672145455899999998788999997---99999999982---899-9888


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             443463101999999999998812379999999899999--9961
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                      .        ...+.++.+++.+|++.||++|||++|+++  ++.+
T Consensus       236 ~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         236 S--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             C--------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf             7--------888999999999977379657918999971997537

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.50  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=207.9

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEE
Q ss_conf             308755684721285289999987-99589999944884---35499999999999954998500240348608907999
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  845 (1052)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             98244798332300046876455999999999999999999874179984976999986687789976990114432248
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  925 (1052)
                      |||++||+|.+++..    ...+++..+..++.|++.|+.|||+.   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf             003579860555532----56775999999999996521134315---96224647778476589988882056520035


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             89970341244445655821348767786103499999999999299997545877701489999996302443311244
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .. .......+||+.|+|||++.+..|+.++||||+||++|||++|++||...   +..++...+...   .  ...   
T Consensus       157 ~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~---~~~~~~~~i~~~---~--~~~---  224 (337)
T d1o6la_         157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILME---E--IRF---  224 (337)
T ss_dssp             CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC---C--CCC---
T ss_pred             CC-CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCC---CHHHHHHHHHCC---C--CCC---
T ss_conf             67-86205510088996666504898883331022306788998789999996---999999998528---9--989---


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH--HHHH
Q ss_conf             3463101999999999998812379999999-----899999--9961
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDG 1046 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~--~L~~ 1046 (1052)
                            +...+.++.+++.+|+++||.+||+     +.|+++  ++++
T Consensus       225 ------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         225 ------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             ------CCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCC
T ss_conf             ------866899999999866638934422565234999972915036

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=362.36  Aligned_cols=248  Identities=24%  Similarity=0.338  Sum_probs=205.5

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEE
Q ss_conf             08755684721285289999987-99589999944884---354999999999999549985002403486089079999
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             82447983323000468764559999999999999999998741799849769999866877899769901144322488
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  926 (1052)
                      ||++||+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+|+.+..
T Consensus        88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf             70489877776531----59999999999999999999762165---088476774123668885388603210242256


Q ss_pred             CC-CEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             99-70341244445655821348767786103499999999999299997545877701489999996302443311244
Q 001561          927 YD-THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       927 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...   +..+....+.   ....  .+.  
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~---~~~~--~~p--  230 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKII---KLEY--DFP--  230 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH---TTCC--CCC--
T ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCC---CHHHHHHHHH---CCCC--CCC--
T ss_conf             77643335556775525844002689896662304569999980388998995---9999999997---1899--998--


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             3463101999999999998812379999999899999
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                             ...+.++.+++.+|++.||++|||++|++.
T Consensus       231 -------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         231 -------EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -------CCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf             -------547999999999985579768919789737

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.28  Aligned_cols=245  Identities=27%  Similarity=0.399  Sum_probs=195.4

Q ss_pred             CCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEEECEEEE----CCEEEEE
Q ss_conf             755684721285289999987-99589999944884--3549999999999995499850024034860----8907999
Q 001561          773 FNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH----GNDRLLI  845 (1052)
Q Consensus       773 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv  845 (1052)
                      |+..+.||+|+||+||+|.+. ++..||+|++....  ....+.+.+|++++++++|||||++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf             88516970082849999999999959999998512279899999999999998579998506999984033458889999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEEEECCCCC
Q ss_conf             9824479833230004687645599999999999999999987417998--49769999866877-89976990114432
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPH--IVHRDVKSSNILLD-EKFEAHLADFGLSR  922 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlkp~NIll~-~~~~~kl~Dfg~a~  922 (1052)
                      |||+++|+|.+++..    ...+++..+..++.|++.|++|||+.   +  |+||||||+|||++ +++.+||+|||+|+
T Consensus        91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf             957898948999751----35546999999999999999999978---99799687674351166799988980057654


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             24889970341244445655821348767786103499999999999299997545877701489999996302443311
Q 001561          923 LLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      .....   .....+||+.|+|||++.+ .++.++||||+||++|||++|+.||....  +.......+    ........
T Consensus       164 ~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i----~~~~~~~~  233 (270)
T d1t4ha_         164 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRV----TSGVKPAS  233 (270)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHH----TTTCCCGG
T ss_pred             ECCCC---CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHH----HCCCCCCC
T ss_conf             23687---6677553813008988478-99986711007999999987889998765--599999999----73899865


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             2443463101999999999998812379999999899999
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                              .....+.++.+++.+|+++||++|||++|+++
T Consensus       234 --------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 --------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             --------67557899999999976379758929999967

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.78  Aligned_cols=256  Identities=22%  Similarity=0.350  Sum_probs=208.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC------HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEE
Q ss_conf             308755684721285289999987-99589999944884------35499999999999954998500240348608907
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC------GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  842 (1052)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++.+..      ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf             56779827981178959999999999989999998756632134068999999999999867998999388999979989


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEEC
Q ss_conf             999982447983323000468764559999999999999999998741799849769999866877899----7699011
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF----EAHLADF  918 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~----~~kl~Df  918 (1052)
                      |+||||+++|+|.+++..    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++    .+|++||
T Consensus        89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEECCCCCCCCCHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf             999986778643100103----56421557899999999998766625---42211333012798258986664696433


Q ss_pred             CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf             44322488997034124444565582134876778610349999999999929999754587770148999999630244
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       919 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      |+|......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...   +..+....+..   ...
T Consensus       162 G~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~---~~~  233 (293)
T d1jksa_         162 GLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA---VNY  233 (293)
T ss_dssp             TTCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHT---TCC
T ss_pred             HHHHHCCCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHH---CCC
T ss_conf             442105777--6312247777430999981899997665221409999997088998899---99999999981---688


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf             33112443463101999999999998812379999999899999--99610
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                             ..........+..+.+++.+|++.||++|||++|+++  +++..
T Consensus       234 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         234 -------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             -------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             -------CCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf             -------88701047889999999999863896689199999619041888

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.29  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=201.0

Q ss_pred             CEECCCCCEEEEEEEEC---CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEECCC
Q ss_conf             84721285289999987---99589999944884--35499999999999954998500240348608907999982447
Q 001561          777 NIIGCGGFGLVYKATLT---NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYMEN  851 (1052)
Q Consensus       777 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  851 (1052)
                      +.||+|+||+||+|.+.   .++.||+|+++...  ....+++.+|++++++++|||||++++++.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCEE
Q ss_conf             98332300046876455999999999999999999874179984976999986687789976990114432248899703
Q 001561          852 GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDTHV  931 (1052)
Q Consensus       852 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  931 (1052)
                      |+|.++++.    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+|+.........
T Consensus        92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf             968999752----25789999999999999997668747---95567776113102356751234134533134323443


Q ss_pred             E--ECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             4--12444456558213487677861034999999999992-99997545877701489999996302443311244346
Q 001561          932 T--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIW 1008 (1052)
Q Consensus       932 ~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .  ....||+.|+|||++.+..++.++||||||+++|||+| |+.||....   ..+....+..    .....       
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~~i~~----~~~~~-------  230 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEK----GERMG-------  230 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHT----TCCCC-------
T ss_pred             CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC---HHHHHHHHHC----CCCCC-------
T ss_conf             224456778420391665379998434430340313289658999999989---9999999982----89999-------


Q ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             310199999999999881237999999989999999610
Q 001561         1009 HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus      1009 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                        .+...+.++.+++.+||+.||++||+++++++.|+..
T Consensus       231 --~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         231 --CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf             --9865679999999997588976890989999985288

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.33  Aligned_cols=258  Identities=26%  Similarity=0.410  Sum_probs=210.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEEC
Q ss_conf             30875568472128528999998799589999944884354999999999999549985002403486089079999824
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSYM  849 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  849 (1052)
                      .++|++.+.||+|+||.||+|+++++.+||+|++.... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf             79979846993079809999999999999999988044-888999999999986666788689999823-9759999944


Q ss_pred             CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47983323000468764559999999999999999998741799849769999866877899769901144322488997
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  929 (1052)
                      ++|++..++...  ....+++.+++.++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf             799435420000--355305999999999999999987541---143353123079998999299844255542568873


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             03412444456558213487677861034999999999992999975458777014899999963024433112443463
Q 001561          930 HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASIWH 1009 (1052)
Q Consensus       930 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .......||+.|+|||++....++.++||||||+++|||++|..|+..  .....+....+....    ...        
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~--~~~~~~~~~~i~~~~----~~~--------  234 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGY----RMP--------  234 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHTTC----CCC--------
T ss_pred             EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCC--CCCHHHHHHHHHHCC----CCC--------
T ss_conf             352454556654580898379989177413235899999868999998--888999999998268----999--------


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             1019999999999988123799999998999999961085
Q 001561         1010 KDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1010 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                       .+...+.++.+++.+||+.||++||++++|+++|+.+-.
T Consensus       235 -~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         235 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf             -983237999999999756697589199999998766623

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.93  Aligned_cols=256  Identities=23%  Similarity=0.385  Sum_probs=207.3

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCC----EEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEE
Q ss_conf             08755684721285289999987-995----89999944884-3549999999999995499850024034860890799
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGT----KAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  844 (1052)
                      .+|++.++||+|+||+||+|.+. +++    +||+|++.... ....+++.+|++++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf             999783198208992999999958998898999999965134979999999999999867998881589999619-8369


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             99824479833230004687645599999999999999999987417998497699998668778997699011443224
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~  924 (1052)
                      ++|++.+|+|.+++..   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEECCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf             9984268740101113---345799999999999999999999876---9504762120311679987586025522233


Q ss_pred             CCCCCEE-EECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             8899703-412444456558213487677861034999999999992-99997545877701489999996302443311
Q 001561          925 RPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI 1002 (1052)
Q Consensus       925 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ....... .....||+.|+|||++.+..++.++||||||+++|||+| |++||.....   .++...+......      
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~i~~~~~~------  232 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERL------  232 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHHHHHTCCC------
T ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHCCCCC------
T ss_conf             5444532236510586446708874699983565440799999999779999999998---9999999759989------


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             24434631019999999999988123799999998999999961085
Q 001561         1003 IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus      1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                             ..+...+.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       233 -------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         233 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -------9985568999999998478993469199999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=348.04  Aligned_cols=254  Identities=28%  Similarity=0.357  Sum_probs=199.6

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHH---HHHHHHHCCCCCEEEEECEEEECCEE
Q ss_conf             308755684721285289999987-99589999944884---354999999---99999954998500240348608907
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQA---EVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~  842 (1052)
                      .++|++.++||+|+||.||+|+.. +++.||+|++.+..   ......+.+   ++.+++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf             77685101884288909999999999979999998458754266799999999999998508998588999999989988


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf             99998244798332300046876455999999999999999999874179984976999986687789976990114432
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~  922 (1052)
                      |+||||++||+|.+++..    ...+++..+..++.|++.|+.|||+.   +|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEE
T ss_conf             999991489838999873----25532789999999999999999977---96220444221678588967982201023


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf             24889970341244445655821348-76778610349999999999929999754587770148999999630244331
Q 001561          923 LLRPYDTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVE 1001 (1052)
Q Consensus       923 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ......   ....+||+.|+|||++. +..++.++||||+||++|||+||+.||......+...    +........ ..
T Consensus       156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~-~~  227 (364)
T d1omwa3         156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMA-VE  227 (364)
T ss_dssp             ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCC-CC
T ss_pred             ECCCCC---CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHHCCCCC-CC
T ss_conf             337886---4331134554216876038999844104677899999985999888899899999----998604688-87


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH--HHHHC
Q ss_conf             12443463101999999999998812379999999-----899999--99610
Q 001561         1002 IIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPF-----IEEVVT--WLDGI 1047 (1052)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~--~L~~i 1047 (1052)
                           ...    ..+.++.+++.+|++.||++||+     ++|+++  +++++
T Consensus       228 -----~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         228 -----LPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             -----CCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             -----CCC----CCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf             -----887----78999999999985669888088743579999749102378

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=351.49  Aligned_cols=262  Identities=29%  Similarity=0.427  Sum_probs=212.6

Q ss_pred             HHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCE
Q ss_conf             6308755684721285289999987------99589999944884-3549999999999995499850024034860890
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       769 ~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  841 (1052)
                      ..++|++.+.||+|+||+||+|++.      ++..||||++.... ....+++.+|+.++++++||||+++++++.+...
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf             98893886798207883999999888765778829999998821085799999999999996689976552466605980


Q ss_pred             EEEEEEECCCCCHHHHHHCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf             799998244798332300046--------------------876455999999999999999999874179984976999
Q 001561          842 RLLIYSYMENGSLDYWLHESV--------------------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVK  901 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk  901 (1052)
                      .++++||+++|+|.++++...                    .....+++..++.++.|++.|++|||+.   +++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEEC
T ss_conf             389998158992999998527554210000111001210346788989999999999999985541357---86854884


Q ss_pred             CCCEEECCCCCEEEEECCCCCCCCCCCC-EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCC
Q ss_conf             9866877899769901144322488997-0341244445655821348767786103499999999999299-9975458
Q 001561          902 SSNILLDEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR-RPVEVCK  979 (1052)
Q Consensus       902 p~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~-~pf~~~~  979 (1052)
                      |+|||++.++.+||+|||+|+....... .......|++.|+|||.+.+..++.++||||||+++|||++|. +||... 
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-  246 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-  246 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred             CCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCC-
T ss_conf             0116898999289833144211367764111577776767679899726889805630252362999980689999998-


Q ss_pred             CCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             7770148999999630244331124434631019999999999988123799999998999999961085
Q 001561          980 GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGI 1049 (1052)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1049 (1052)
                        ...+....+..    ......         +...+.++.+++.+||+.+|++||||.||+++|++|.+
T Consensus       247 --~~~e~~~~v~~----~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         247 --AHEEVIYYVRD----GNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             --CHHHHHHHHHT----TCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --CHHHHHHHHHC----CCCCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             --99999999973----997888---------73252999999999748896579399999999998429

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=350.40  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=206.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEE
Q ss_conf             308755684721285289999987-99589999944884---35499999999999954998500240348608907999
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  845 (1052)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf             54708888972076808999999899979999998457754889999999999999863696753303568528800567


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             98244798332300046876455999999999999999999874179984976999986687789976990114432248
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  925 (1052)
                      |||++||++..++..    ...+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        83 mE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          83 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EEECCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEEC
T ss_conf             650378632234322----22111007999999998765541247---67705568105038689988983175216712


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             89970341244445655821348767786103499999999999299997545877701489999996302443311244
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ..    ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...   +..+....+..   ...  ..   
T Consensus       156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~---~~~--~~---  220 (316)
T d1fota_         156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILN---AEL--RF---  220 (316)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH---CCC--CC---
T ss_pred             CC----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCC---CHHHHHHHHHC---CCC--CC---
T ss_conf             45----64345763435999983899980430465333689997598999996---99999999970---898--89---


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH--HHHHC
Q ss_conf             346310199999999999881237999999-----9899999--99610
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT--WLDGI 1047 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~--~L~~i 1047 (1052)
                            +...+.++.+++.+|+++||.+|+     +++++++  +++++
T Consensus       221 ------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         221 ------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             ------CCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCC
T ss_conf             ------9778999999999995449976664310219999819351467

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.93  Aligned_cols=255  Identities=18%  Similarity=0.301  Sum_probs=208.0

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEE
Q ss_conf             308755684721285289999987-9958999994488435499999999999954998500240348608907999982
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  848 (1052)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++..... ....+.+|+++++.++||||+++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf             0105887898317783999999989996999999757866-599999999999857997989098999889988999953


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCC
Q ss_conf             4479833230004687645599999999999999999987417998497699998668778--99769901144322488
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE--KFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~  926 (1052)
                      ++||+|.+++..   .+..+++.++..++.|++.|++|||+.   +|+||||||+|||++.  ...+|++|||.++....
T Consensus        83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf             899808899875---389999999999999999999999876---99751355444344378851899764411100346


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             99703412444456558213487677861034999999999992999975458777014899999963024433112443
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .  .......+++.|+|||...+..++.++||||+||++|+|++|+.||...   +..+....+..   ....   .+. 
T Consensus       157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~---~~~~---~~~-  224 (321)
T d1tkia_         157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMN---AEYT---FDE-  224 (321)
T ss_dssp             T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH---TCCC---CCH-
T ss_pred             C--CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCC---CHHHHHHHHHH---CCCC---CCH-
T ss_conf             7--7532122332223402104877784011302799999998289999998---99999999983---8999---880-


Q ss_pred             CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             463101999999999998812379999999899999--9961
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                         ......+.++.+++.+|++.||++|||++|+++  ++++
T Consensus       225 ---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         225 ---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             ---223678999999999986699668909999963996566

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=350.15  Aligned_cols=249  Identities=19%  Similarity=0.277  Sum_probs=206.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEE
Q ss_conf             08755684721285289999987-99589999944884---354999999999999549985002403486089079999
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  846 (1052)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++.+..   ....+.+.+|+++++.++||||+++++++.+....++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             82447983323000468764559999999999999999998741799849769999866877899769901144322488
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRP  926 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  926 (1052)
                      ||+.+|++..++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf             23346622666751----58989999999999999989999859---986176799993607789788610103332256


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             99703412444456558213487677861034999999999992999975458777014899999963024433112443
Q 001561          927 YDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       927 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .    .....||+.|+|||++.+..++.++||||+||++|||++|+.||..   .+.......+..   ...  ..    
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~i~~---~~~--~~----  257 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVS---GKV--RF----  257 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH---CCC--CC----
T ss_pred             C----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC---CCHHHHHHHHHC---CCC--CC----
T ss_conf             6----6433676356788997179988533114500789999758899899---599999999861---798--89----


Q ss_pred             CCCHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH--HHHHC
Q ss_conf             46310199999999999881237999999-----9899999--99610
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT--WLDGI 1047 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~--~L~~i 1047 (1052)
                           +...+.++.+++.+|++.||.+|+     +++++++  +++++
T Consensus       258 -----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         258 -----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             -----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             -----CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCC
T ss_conf             -----7668999999999983409986065534549999719051589

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.25  Aligned_cols=256  Identities=21%  Similarity=0.276  Sum_probs=201.1

Q ss_pred             HCCCCCC-CEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHC-CCCCEEEEECEEEE----CCEE
Q ss_conf             3087556-84721285289999987-9958999994488435499999999999954-99850024034860----8907
Q 001561          770 TNNFNQA-NIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRA-QHKNLVSLQGYCRH----GNDR  842 (1052)
Q Consensus       770 ~~~y~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~  842 (1052)
                      .++|++. ++||+|+||+||+|+.. +++.||+|++...     ..+.+|+.++.++ +||||+++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf             148798107965454869999998899989999998974-----779999999998669999782989995034689789


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECC
Q ss_conf             9999824479833230004687645599999999999999999987417998497699998668778---9976990114
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE---KFEAHLADFG  919 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~kl~Dfg  919 (1052)
                      |+||||++||+|.+++...  ....+++.++..++.|++.|++|||+.   +|+||||||+||+++.   .+.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             9999778998499999862--787757999999999999999999976---98644410022011355556631135455


Q ss_pred             CCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf             43224889970341244445655821348767786103499999999999299997545877701489999996302443
Q 001561          920 LSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  999 (1052)
Q Consensus       920 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      +|+......  .....+||+.|+|||++.+..|+.++||||+||++|+|+||+.||........   ...+......   
T Consensus       160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~---  231 (335)
T d2ozaa1         160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRM---  231 (335)
T ss_dssp             TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS---
T ss_pred             EEEECCCCC--CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH---HHHHHHHHHC---
T ss_conf             123336888--64322677563792777489888888887645167788658899889887788---9999999853---


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             3112443463101999999999998812379999999899999--9961
Q 001561         1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus      1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                         .............+.++.+++.+|++.||++|||+.|+++  ++.+
T Consensus       232 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 ---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             ---CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             ---CCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHC
T ss_conf             ---8888898543469999999999975699657909999970987617

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.80  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=210.8

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEECC----CCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEE
Q ss_conf             3087556847212852899999879----9589999944884-3549999999999995499850024034860890799
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN----GTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  844 (1052)
                      .++|++.+.||+|+||.||+|++..    +..||+|.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf             8996987799307882999999936996449999999365668799999999999998689999856988995-374799


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             99824479833230004687645599999999999999999987417998497699998668778997699011443224
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLL  924 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~  924 (1052)
                      ||||+++|++.+++..   ....+++..++.++.|+++|+.|||+.   +++||||||+||+++.++.+||+|||+|+..
T Consensus        85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf             9984069807765422---478999999999999998775230226---7441410265532067896787650342133


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf             8899703412444456558213487677861034999999999992-999975458777014899999963024433112
Q 001561          925 RPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII 1003 (1052)
Q Consensus       925 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ............||+.|+|||++.+..++.++||||||+++|||++ |.+||....   ..+....+....    ...  
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~---~~~~~~~i~~~~----~~~--  229 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIENGE----RLP--  229 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHTTC----CCC--
T ss_pred             CCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---HHHHHHHHHCCC----CCC--
T ss_conf             67762330540058310326675169988745244424789999826999988899---999999998189----998--


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             44346310199999999999881237999999989999999610855
Q 001561         1004 DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                             .+...+.++.+++.+||..||++|||+.|+++.|+.+.++
T Consensus       230 -------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             -------9877799999999997687976892999999999999778

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.39  Aligned_cols=270  Identities=24%  Similarity=0.353  Sum_probs=208.7

Q ss_pred             HHHHHHHHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEEEC
Q ss_conf             9899996308755684721285289999987------99589999944884-35499999999999954-9985002403
Q 001561          763 VSDLLKSTNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQG  834 (1052)
Q Consensus       763 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~  834 (1052)
                      ...+....++|++.+.||+|+||.||+|.+.      +++.||+|++.... ....+.+..|...+.++ +|++|+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf             82526167997984498416783999999867775557839999998600171789999999999886149984997411


Q ss_pred             EEEEC-CEEEEEEEECCCCCHHHHHHCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf             48608-907999982447983323000468------------76455999999999999999999874179984976999
Q 001561          835 YCRHG-NDRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVK  901 (1052)
Q Consensus       835 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk  901 (1052)
                      ++.+. ...++||||+++|+|.++++....            ....+++..+..++.|+++|+.|||+.   +|+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred             EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCC
T ss_conf             540479757999984589929999985366666532220233214689999999999999999988737---97178677


Q ss_pred             CCCEEECCCCCEEEEECCCCCCCCCCCCE-EEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCC
Q ss_conf             98668778997699011443224889970-34124444565582134876778610349999999999929-99975458
Q 001561          902 SSNILLDEKFEAHLADFGLSRLLRPYDTH-VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTG-RRPVEVCK  979 (1052)
Q Consensus       902 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG-~~pf~~~~  979 (1052)
                      |+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++||||||+++|||++| .+||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCC
T ss_conf             31065779982898457520011356652224751667210203686468899663221367899999868899998999


Q ss_pred             CCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             77701489999996302443311244346310199999999999881237999999989999999610855
Q 001561          980 GKNCRDLVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus       980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      ..  ..+...+..    .......         ...+.++.+++.+||+.||++|||++|+++.|+++.++
T Consensus       242 ~~--~~~~~~~~~----~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         242 ID--EEFCRRLKE----GTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             CS--HHHHHHHHH----TCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH--HHHHHHHHC----CCCCCCC---------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             89--999999963----8988888---------65789999999997677966791999999999799867

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=342.69  Aligned_cols=259  Identities=23%  Similarity=0.339  Sum_probs=208.9

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECC----E
Q ss_conf             308755684721285289999987-99589999944884---354999999999999549985002403486089----0
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN----D  841 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  841 (1052)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++...   ......+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             79999824479833230004687645599999999999999999987417998497699998668778997699011443
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a  921 (1052)
                      .|+||||++|++|.+++..    ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++..+++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEEHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf             9999977889871011203----58999999999999999999999857---9527634675566575432010034443


Q ss_pred             CCCCCCCC--EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf             22488997--0341244445655821348767786103499999999999299997545877701489999996302443
Q 001561          922 RLLRPYDT--HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  999 (1052)
Q Consensus       922 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      ........  ......+||+.|+|||++.+..++.++||||+|+++|||+||++||...   +..+...   ........
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~---~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SPVSVAY---QHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHH---HHHHCCCC
T ss_pred             HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCC---CHHHHHH---HHHHCCCC
T ss_conf             22123544333346425762436999983999996632026528999997697998996---9999999---99846999


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHCC
Q ss_conf             311244346310199999999999881237999999-9899999996108
Q 001561         1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP-FIEEVVTWLDGIG 1048 (1052)
Q Consensus      1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~ 1048 (1052)
                      .   ......    ..+.++.+++.+|+++||.+|| +++++++.|.++.
T Consensus       233 ~---~~~~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 P---PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             C---GGGTSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             C---CCHHCC----CCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf             9---710034----789999999999866797677739999999999975

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.70  Aligned_cols=263  Identities=27%  Similarity=0.406  Sum_probs=210.7

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEEECEEEECCE
Q ss_conf             308755684721285289999987------99589999944884-35499999999999954-99850024034860890
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  841 (1052)
                      .++|++.++||+|+||.||+|++.      ++..||||+++... .....++.+|+.+++++ +|||||++++++.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf             89969854982068829999998066447788699999987424877999999999998762699988789989831997


Q ss_pred             EEEEEEECCCCCHHHHHHCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf             7999982447983323000468--------------76455999999999999999999874179984976999986687
Q 001561          842 RLLIYSYMENGSLDYWLHESVD--------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL  907 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll  907 (1052)
                      .++||||+++|+|.++++....              ....+++..+..++.|++.|++|||+.   +++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCC
T ss_conf             899997379987999998535665444445332223345889999999999999999988757---92666241021000


Q ss_pred             CCCCCEEEEECCCCCCCCCCCC-EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHH
Q ss_conf             7899769901144322488997-03412444456558213487677861034999999999992-999975458777014
Q 001561          908 DEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD  985 (1052)
Q Consensus       908 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~  985 (1052)
                      +.++.+|++|||.++....... .......||+.|+|||++.+..++.++||||||+++|||+| |.+||......  ..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SK  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HH
T ss_pred             CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH--HH
T ss_conf             0257521023401023367886158620135968767788617999974001025899999985899887789989--99


Q ss_pred             HHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             89999996302443311244346310199999999999881237999999989999999610855
Q 001561          986 LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      +...+....    ...         .+...+..+.+++.+||+.||++|||+.|++++|+++..+
T Consensus       257 ~~~~i~~~~----~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         257 FYKMIKEGF----RML---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHTC----CCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCC----CCC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             999986689----889---------8543659999999997577965792999999999876534

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.40  Aligned_cols=259  Identities=29%  Similarity=0.451  Sum_probs=207.3

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCC--EEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEEECEEEECCEEEEE
Q ss_conf             08755684721285289999987-995--89999944884-35499999999999954-998500240348608907999
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGT--KAAVKRLSGDC-GQMEREFQAEVEALSRA-QHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  845 (1052)
                      ++|++.++||+|+||+||+|.++ ++.  .||||++.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EEECCCCCHHHHHHCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf             98244798332300046------------876455999999999999999999874179984976999986687789976
Q 001561          846 YSYMENGSLDYWLHESV------------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEA  913 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~  913 (1052)
                      |||+++|+|.++++...            .....+++..+.+++.|++.|+.|+|+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCE
T ss_conf             980289869999864035555512310123457899999999999999998766308---95455505204898688763


Q ss_pred             EEEECCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHHHHH
Q ss_conf             99011443224889970341244445655821348767786103499999999999299-99754587770148999999
Q 001561          914 HLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR-RPVEVCKGKNCRDLVSWVFQ  992 (1052)
Q Consensus       914 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~-~pf~~~~~~~~~~~~~~~~~  992 (1052)
                      ||+|||+|+.......  .....||..|+|||.+.+..++.++||||||+++|||++|. +||..   .+..+....+. 
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~---~~~~~~~~~i~-  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAELYEKLP-  240 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHGG-
T ss_pred             EECCCCCCCCCCCCCC--CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCC---CCHHHHHHHHH-
T ss_conf             8743443224442234--55301377555538752699996221531388999998368999999---99999999998-


Q ss_pred             HHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             6302443311244346310199999999999881237999999989999999610855
Q 001561          993 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                        . .....         .+...+.++.+++.+||+.||++||||.|+++.|+++.++
T Consensus       241 --~-~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         241 --Q-GYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             --G-TCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --H-CCCCC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             --2-68888---------8766789999999997678966894999999999999861

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.30  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=206.6

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC--CC--CEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEE
Q ss_conf             308755684721285289999987--99--589999944884---35499999999999954998500240348608907
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT--NG--TKAAVKRLSGDC---GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  842 (1052)
                      .++|++.+.||+|+||.||+|++.  ++  ..||+|++....   ....++|.+|++++++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf             4891997898038883999999988999079999999983555798999999999999986899998789877740-100


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf             99998244798332300046876455999999999999999999874179984976999986687789976990114432
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSR  922 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~  922 (1052)
                      ++|+||+++|++.+++..   ....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+|++|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             HEEEEEECCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHH
T ss_conf             114654238612544421---268999999999999999999875217---87520566888156556543325611555


Q ss_pred             CCCCCCCEEE--ECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf             2488997034--12444456558213487677861034999999999992-99997545877701489999996302443
Q 001561          923 LLRPYDTHVT--TDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKRE  999 (1052)
Q Consensus       923 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      ..........  ....|+..|+|||++.+..++.++||||||+++|||+| |+.||..   .+..+...++..   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~---~~~~~~~~~i~~---~~~~  233 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---LNGSQILHKIDK---EGER  233 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHHHT---SCCC
T ss_pred             HCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHH---CCCC
T ss_conf             3035887526547632573107999983799994215661489999999689999999---699999999984---7999


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             3112443463101999999999998812379999999899999996108
Q 001561         1000 VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus      1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      ..         .....+..+.+++.+||+.||++|||+.|+++.|++.+
T Consensus       234 ~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         234 LP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf             99---------85445399999999976889667929999999999649

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.09  Aligned_cols=262  Identities=24%  Similarity=0.284  Sum_probs=203.3

Q ss_pred             CCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHH-----HHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEE
Q ss_conf             5684721285289999987-9958999994488435-----499999999999954998500240348608907999982
Q 001561          775 QANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQ-----MEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       775 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  848 (1052)
                      ..++||+|+||+||+|+.. +++.||+|++......     ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf             56385127282999999999996999999842021245679999999999999867999986898542258740220455


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             44798332300046876455999999999999999999874179984976999986687789976990114432248899
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  928 (1052)
                      ++++.+.....    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.|+......
T Consensus        82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             HCCHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf             34507765541----266778999999999999999886316---35503577625885377841146576100057875


Q ss_pred             CEEEECCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC-
Q ss_conf             703412444456558213487-677861034999999999992999975458777014899999963024433112443-
Q 001561          929 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS- 1006 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1006 (1052)
                      . .....+||+.|+|||++.. ..++.++||||+||++|||++|++||..   .+..+....+.............+.. 
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~---~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             C-CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCC---CCHHHHHHHHHHHCCCCCHHHCCCHHC
T ss_conf             5-433020473336399972677888056436304289999859699999---999999999998518997254521000


Q ss_pred             --------CC-----CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf             --------46-----3101999999999998812379999999899999--99610
Q 001561         1007 --------IW-----HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1007 --------~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                              ..     .........++.+++.+|++.||++|||++|+++  ++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             21344303478988678565689999999999763894569089999679965789

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.36  Aligned_cols=253  Identities=27%  Similarity=0.403  Sum_probs=207.9

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEE-CCEEEEEEEE
Q ss_conf             308755684721285289999987995899999448843549999999999995499850024034860-8907999982
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRH-GNDRLLIYSY  848 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~  848 (1052)
                      .++|++.+.||+|+||.||+|+++ +.+||+|+++.+.  ..+++.+|++++++++||||+++++++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf             899488579820798089999999-9099999988577--7999999999998678989854987887238928999963


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             44798332300046876455999999999999999999874179984976999986687789976990114432248899
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  928 (1052)
                      +++|+|.+++...  ....+++..++.++.|++.|+.|||+.   +|+||||||+||+++.++.+|++|||.++..... 
T Consensus        83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             CCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC-
T ss_conf             6999899998745--788889999999999998523211337---6553666567601468997763245600344787-


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             703412444456558213487677861034999999999992-9999754587770148999999630244331124434
Q 001561          929 THVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDASI 1007 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                         .....+++.|+|||++.+..++.++||||||+++|||+| |++||...   +..+...++...    .....     
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~~----~~~~~-----  221 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKG----YKMDA-----  221 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTTT----CCCCC-----
T ss_pred             ---CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHCC----CCCCC-----
T ss_conf             ---765566646778178727988858877757999999997899999999---999999999808----99999-----


Q ss_pred             CCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             6310199999999999881237999999989999999610855
Q 001561         1008 WHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1008 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                          +...+.++.+++.+||+.||.+|||+.+++++|++++..
T Consensus       222 ----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         222 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ----765799999999997566976893999999999999867

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.06  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=202.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHH-HCCCCCEEEEECEEEECCEEEEE
Q ss_conf             08755684721285289999987-99589999944884---354999999999999-54998500240348608907999
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---GQMEREFQAEVEALS-RAQHKNLVSLQGYCRHGNDRLLI  845 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv  845 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ......+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             98244798332300046876455999999999999999999874179984976999986687789976990114432248
Q 001561          846 YSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLR  925 (1052)
Q Consensus       846 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  925 (1052)
                      |||+++|+|.+++..    ...+++.++..++.|++.|+.|||+.   +|+||||||+|||++.++.+|++|||.|+...
T Consensus        82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEECCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf             750379808998640----47899999999999999999999868---93403476540444489963015553023235


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             89970341244445655821348767786103499999999999299997545877701489999996302443311244
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDA 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .. ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+   .+..+....+..   ...  ..   
T Consensus       155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~---~~~--~~---  222 (320)
T d1xjda_         155 LG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRM---DNP--FY---  222 (320)
T ss_dssp             CT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH---CCC--CC---
T ss_pred             CC-CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHC---CCC--CC---
T ss_conf             66-5334545787776899998279988323201122789898738899999---899999999971---899--89---


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH--HHHH
Q ss_conf             346310199999999999881237999999989-9999--9961
Q 001561         1006 SIWHKDREKQLLEMLEIACKCIDQDPRRRPFIE-EVVT--WLDG 1046 (1052)
Q Consensus      1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~--~L~~ 1046 (1052)
                            +...+.++.+++.+|++.||.+||++. ++++  ++++
T Consensus       223 ------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         223 ------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             ------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             ------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHHCC
T ss_conf             ------75679999999999654489878388999980901315

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.43  Aligned_cols=254  Identities=29%  Similarity=0.424  Sum_probs=203.2

Q ss_pred             CCEECCCCCEEEEEEEECCC----CEEEEEEECCC-CHHHHHHHHHHHHHHHHCCCCCEEEEECEEEEC-CEEEEEEEEC
Q ss_conf             68472128528999998799----58999994488-435499999999999954998500240348608-9079999824
Q 001561          776 ANIIGCGGFGLVYKATLTNG----TKAAVKRLSGD-CGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-NDRLLIYSYM  849 (1052)
Q Consensus       776 ~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~  849 (1052)
                      .++||+|+||+||+|++..+    ..||||++... ......+|.+|++++++++||||+++++++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf             66981368809999999779987999999998843697899999999999986789998678678980699438999874


Q ss_pred             CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             47983323000468764559999999999999999998741799849769999866877899769901144322488997
Q 001561          850 ENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYDT  929 (1052)
Q Consensus       850 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  929 (1052)
                      ++|+|.+++..   .....++..++.++.|++.|+.|+|+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ECCCHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC
T ss_conf             06741442101---345404899999999988765200336---762577668757677999889910652322556655


Q ss_pred             E---EEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             0---3412444456558213487677861034999999999992999975458777014899999963024433112443
Q 001561          930 H---VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIIDAS 1006 (1052)
Q Consensus       930 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .   ......||+.|+|||.+....++.++||||||+++|||+||+.||....  ...+...++....   . .  ..+ 
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i~~g~---~-~--~~p-  256 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGR---R-L--LQP-  256 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTC---C-C--CCC-
T ss_pred             CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHCCC---C-C--CCC-
T ss_conf             53100256555645567688743799974574661999999997899998889--9999999998089---8-8--996-


Q ss_pred             CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             46310199999999999881237999999989999999610855
Q 001561         1007 IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus      1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                            ...+.++.+++.+||+.||++||++.||++.|+.+...
T Consensus       257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             ------44759999999997688976893999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.50  Aligned_cols=263  Identities=28%  Similarity=0.392  Sum_probs=212.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEECC--------CCEEEEEEECCCCH-HHHHHHHHHHHHHHHC-CCCCEEEEECEEEEC
Q ss_conf             3087556847212852899999879--------95899999448843-5499999999999954-998500240348608
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLTN--------GTKAAVKRLSGDCG-QMEREFQAEVEALSRA-QHKNLVSLQGYCRHG  839 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  839 (1052)
                      .++|++.+.||+|+||.||+|+...        +..||+|++..+.. ....++.+|...+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf             89969700985167828999998578755566754999999881128688999999999999813999697346522018


Q ss_pred             CEEEEEEEECCCCCHHHHHHCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf             907999982447983323000468------------76455999999999999999999874179984976999986687
Q 001561          840 NDRLLIYSYMENGSLDYWLHESVD------------KDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILL  907 (1052)
Q Consensus       840 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll  907 (1052)
                      ...++||||+++|+|.+++.....            ....+++.++..++.|++.|++|||+.   +|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEEE
T ss_conf             868999973699909999986067764322233457434679999999999999999876637---97863022102245


Q ss_pred             CCCCCEEEEECCCCCCCCCCCC-EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCHH
Q ss_conf             7899769901144322488997-03412444456558213487677861034999999999992-999975458777014
Q 001561          908 DEKFEAHLADFGLSRLLRPYDT-HVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLT-GRRPVEVCKGKNCRD  985 (1052)
Q Consensus       908 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~  985 (1052)
                      +.++.+||+|||.++....... .......|++.|+|||.+.+..++.++||||||+++|||++ |++||...   +..+
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~---~~~~  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PVEE  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHH
T ss_pred             CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC---CHHH
T ss_conf             4789767622111011355555431466788846632667517988825554775888887401798989999---9999


Q ss_pred             HHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             899999963024433112443463101999999999998812379999999899999996108556
Q 001561          986 LVSWVFQMKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGIDA 1051 (1052)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1051 (1052)
                      ....+.    ........         ...+.++.+++.+||+.+|.+|||+.|+++.|+++..-.
T Consensus       246 ~~~~i~----~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~  298 (299)
T d1fgka_         246 LFKLLK----EGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  298 (299)
T ss_dssp             HHHHHH----TTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHH----CCCCCCCC---------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf             999997----28888987---------435299999999976679767939999999998886047

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=337.94  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=205.5

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---------HHHHHHHHHHHHHHHHCC-CCCEEEEECEEEE
Q ss_conf             308755684721285289999987-99589999944884---------354999999999999549-9850024034860
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC---------GQMEREFQAEVEALSRAQ-HKNLVSLQGYCRH  838 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  838 (1052)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++....         ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762146


Q ss_pred             CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf             89079999824479833230004687645599999999999999999987417998497699998668778997699011
Q 001561          839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       839 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  918 (1052)
                      .+..|+||||+++|+|.++++.    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCCEEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCC
T ss_conf             7605999976898668999986----59999999999999999999999875---9943234625489868998387124


Q ss_pred             CCCCCCCCCCCEEEECCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             443224889970341244445655821348------76778610349999999999929999754587770148999999
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQ------TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQ  992 (1052)
Q Consensus       919 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~  992 (1052)
                      |.++......  .....+||+.|+|||++.      ...++.++||||+|+++|||++|+.||...   +..+....+..
T Consensus       155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~---~~~~~~~~i~~  229 (277)
T d1phka_         155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLMLRMIMS  229 (277)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH
T ss_pred             HHEEECCCCC--CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCC---CHHHHHHHHHH
T ss_conf             0316726887--213452467888988860534456788992331856560231032288898899---99999999981


Q ss_pred             HHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             63024433112443463101999999999998812379999999899999--9961
Q 001561          993 MKSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                         ....   ...    ......+.++.+++.+|++++|++||++.|+++  +|++
T Consensus       230 ---~~~~---~~~----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         230 ---GNYQ---FGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             ---TCCC---CCT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ---CCCC---CCC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf             ---8988---898----543468999999999976589668919999973978797

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.48  Aligned_cols=269  Identities=25%  Similarity=0.314  Sum_probs=202.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEECC----EEEEEE
Q ss_conf             0875568472128528999998799589999944884354999999999999549985002403486089----079999
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN----DRLLIY  846 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~  846 (1052)
                      ++|.+.+.||+|+||.||+|++. |..||+|++...... ....+.|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf             68999889820788199999999-989999998720046-7999999999962799868326889983798604899999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             824479833230004687645599999999999999999987417-----998497699998668778997699011443
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC-----EPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a  921 (1052)
                      ||+++|+|.+++++     ..+++..++.++.|++.|++|+|+..     +++|+||||||+|||++.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ECCCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf             64669898999865-----8999899999999999999998876652046898661531731357868877688763866


Q ss_pred             CCCCCCCCEE---EECCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC--------H
Q ss_conf             2248899703---4124444565582134876------778610349999999999929999754587770--------1
Q 001561          922 RLLRPYDTHV---TTDLVGTLGYIPPEYSQTL------TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC--------R  984 (1052)
Q Consensus       922 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltG~~pf~~~~~~~~--------~  984 (1052)
                      +.........   .....||+.|+|||++.+.      .++.++||||||+++|||+||..||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             CCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
T ss_conf             23467776200135525035476782210565454677767501220159999999628998876631124101225564


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCCCCH-HHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             48999999630244331124434631-0199999999999881237999999989999999610855
Q 001561          985 DLVSWVFQMKSEKREVEIIDASIWHK-DREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                      ..............    ..+..... ........+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       236 ~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         236 PSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHCCC----CCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             30999999875024----6888776557768999999999997606985895999999999988886

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.20  Aligned_cols=269  Identities=22%  Similarity=0.291  Sum_probs=206.7

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEE
Q ss_conf             08755684721285289999987-995899999448843--549999999999995499850024034860890799998
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG--QMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  847 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|+++....  ....++.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322432037886


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             24479833230004687645599999999999999999987417998497699998668778997699011443224889
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  927 (1052)
                      |+.++.+......   ....+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+|++|||.|+.....
T Consensus        82 ~~~~~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ECCCCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf             2377445554420---256888899999999999999986528---8992135711401134676210357861343688


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC--
Q ss_conf             970341244445655821348767-78610349999999999929999754587770148999999630244331124--
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLT-ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEIID-- 1004 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1004 (1052)
                       ........||+.|+|||+..... ++.++|+||+|+++|+|++|+.||...   +..+....+..............  
T Consensus       156 -~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD---SEIDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             -SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             -CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCC---CHHHHHHHHHHHCCCCCHHHCCCCC
T ss_conf             -641001036521541122136657774221033331342796687998988---9999999999832898333144422


Q ss_pred             ----------CCCC---CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             ----------4346---3101999999999998812379999999899999--9961085
Q 001561         1005 ----------ASIW---HKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus      1005 ----------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                                ....   .......+.++.+++.+|++.||++|||++|+++  +++++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             242124345432222044416678999999999976399557918999967870146999

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.49  Aligned_cols=263  Identities=23%  Similarity=0.362  Sum_probs=210.7

Q ss_pred             HHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCE
Q ss_conf             6308755684721285289999987------99589999944884-3549999999999995499850024034860890
Q 001561          769 STNNFNQANIIGCGGFGLVYKATLT------NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGND  841 (1052)
Q Consensus       769 ~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  841 (1052)
                      ..++|++.+.||+|+||+||+|.+.      ++..||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf             68991883598207881899999878644778968999998701286899999999999997699988412547842881


Q ss_pred             EEEEEEECCCCCHHHHHHCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             799998244798332300046------87645599999999999999999987417998497699998668778997699
Q 001561          842 RLLIYSYMENGSLDYWLHESV------DKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHL  915 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl  915 (1052)
                      .++||||+++|+|.+++....      .....+++..+..++.|+++|+.|||+.   +|+||||||+|||++.++.+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEE
T ss_conf             0677760489988999875033211344468879999999999999999987647---9654328677540359964999


Q ss_pred             EECCCCCCCCCCCCEE-EECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHHHHHH
Q ss_conf             0114432248899703-41244445655821348767786103499999999999299-997545877701489999996
Q 001561          916 ADFGLSRLLRPYDTHV-TTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGR-RPVEVCKGKNCRDLVSWVFQM  993 (1052)
Q Consensus       916 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~-~pf~~~~~~~~~~~~~~~~~~  993 (1052)
                      +|||+|+......... .....|++.|+|||.+.+..++.++||||||+++|||+||. +||...   +..+....+.  
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~~i~--  249 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFVM--  249 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHHHHH--
T ss_pred             EECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC---CHHHHHHHHH--
T ss_conf             42454202357763031340231632378888736998833344437899999996899999998---9999999998--


Q ss_pred             HHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             302443311244346310199999999999881237999999989999999610855
Q 001561          994 KSEKREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIGID 1050 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1050 (1052)
                       ... ....         +...+..+.+++.+||+.+|++|||+.++++.|++..+.
T Consensus       250 -~~~-~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         250 -EGG-LLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             -TTC-CCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -HCC-CCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf             -088-8888---------633539999999997577965893999999997876177

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=336.66  Aligned_cols=269  Identities=23%  Similarity=0.295  Sum_probs=201.2

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-C-CCEEEEEEECCCC--HHHHHHHHHHHHHHHHC---CCCCEEEEECEEEE----
Q ss_conf             308755684721285289999987-9-9589999944884--35499999999999954---99850024034860----
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-N-GTKAAVKRLSGDC--GQMEREFQAEVEALSRA---QHKNLVSLQGYCRH----  838 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~----  838 (1052)
                      .++|++.+.||+|+||+||+|++. + ++.||+|++....  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             58979888992155869999999888998999999802324516799999999999987425898802366322146666


Q ss_pred             -CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf             -8907999982447983323000468764559999999999999999998741799849769999866877899769901
Q 001561          839 -GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLAD  917 (1052)
Q Consensus       839 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  917 (1052)
                       ....++++||++++.+......   ....+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+|++|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCEEEEEEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECC
T ss_conf             67469999974058714444430---378999899999999999999999758---898357986278985899754210


Q ss_pred             CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf             14432248899703412444456558213487677861034999999999992999975458777014899999963024
Q 001561          918 FGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       918 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      ||.++....  ........||+.|+|||++.+..++.++||||+||++|||++|++||...   +..+....+.......
T Consensus       160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHCC--CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHHCCC
T ss_conf             001011002--34577765485114831001798881110003289999998787998998---9899999999840799


Q ss_pred             CCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             433112-------------443463101999999999998812379999999899999--9961085
Q 001561          998 REVEII-------------DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus       998 ~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                      ......             ...............+.+++.+|++.||++|||++|+++  +++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCHH
T ss_conf             6110532111103330223456454404458999999999987489667918999966963407521

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=333.27  Aligned_cols=261  Identities=20%  Similarity=0.293  Sum_probs=205.6

Q ss_pred             CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEEE
Q ss_conf             0875568472128528999998799589999944884--35499999999999954998500240348608907999982
Q 001561          771 NNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYSY  848 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  848 (1052)
                      ++|++.++||+|+||+||+|++++++.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             99634318722778189999968999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             44798332300046876455999999999999999999874179984976999986687789976990114432248899
Q 001561          849 MENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPYD  928 (1052)
Q Consensus       849 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  928 (1052)
                      +.++.+..+..    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||.|.......
T Consensus        82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             EHHHHHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf             00456789986----047751445689999999999986057---48826787750568689978732366430114676


Q ss_pred             CEEEECCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC-----
Q ss_conf             703412444456558213487-67786103499999999999299997545877701489999996302443311-----
Q 001561          929 THVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEI----- 1002 (1052)
Q Consensus       929 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1002 (1052)
                       .......|++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...   ...+....+............     
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV---SEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCC---CHHHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             -54101024311013788717888884100211175899997797998988---98999999998638997110421233


Q ss_pred             ----------CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ----------2443463101999999999998812379999999899999
Q 001561         1003 ----------IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT 1042 (1052)
Q Consensus      1003 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1042 (1052)
                                .............+..+.+++.+|++.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             32214333335676466651258999999999986689668909999856

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.36  Aligned_cols=265  Identities=24%  Similarity=0.296  Sum_probs=198.1

Q ss_pred             CCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEEECEEEEC------CEEEE
Q ss_conf             8755684721285289999987-9958999994488435499999999999954998500240348608------90799
Q 001561          772 NFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVSLQGYCRHG------NDRLL  844 (1052)
Q Consensus       772 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~l  844 (1052)
                      +|+..++||+|+||+||+|++. +++.||+|++..+...    ..+|++++++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             767516982176839999999999979999998816068----9999999986689898738789974476577318999


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCC
Q ss_conf             9982447983323000468764559999999999999999998741799849769999866877899-769901144322
Q 001561          845 IYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRL  923 (1052)
Q Consensus       845 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~Dfg~a~~  923 (1052)
                      ||||++++.+.. +.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEECCCCCCHHH-HHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf             984168860788-886310368999999999999999999999866---8764578860378735897116733660544


Q ss_pred             CCCCCCEEEECCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC----
Q ss_conf             4889970341244445655821348-76778610349999999999929999754587770148999999630244----
Q 001561          924 LRPYDTHVTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR----  998 (1052)
Q Consensus       924 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~----  998 (1052)
                      .....  .....+|++.|+|||.+. ...++.++||||+||++|||++|++||....   ..+....+........    
T Consensus       173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~---~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS---GVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCCCCHHHH
T ss_pred             CCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCC---HHHHHHHHHHHHCCCHHHHH
T ss_conf             04776--53200255555682776404688821000246527785502879989879---99999999997489817765


Q ss_pred             --------C---CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             --------3---3112443463101999999999998812379999999899999--9961085
Q 001561          999 --------E---VEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus       999 --------~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                              .   ................+.++.+++.+|++.||++|||+.|+++  +++++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             4306210110355445674444315689999999999976589557929999966984524667

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=328.07  Aligned_cols=266  Identities=23%  Similarity=0.281  Sum_probs=201.6

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEEECEEEE--------
Q ss_conf             308755684721285289999987-99589999944884--3549999999999995499850024034860--------
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH--------  838 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------  838 (1052)
                      .++|++.+.||+|+||+||+|++. +++.||||++....  .....++.+|+.++++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             27988999972274829999999899979999998422246378999999999999835999660676540246544445


Q ss_pred             CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf             89079999824479833230004687645599999999999999999987417998497699998668778997699011
Q 001561          839 GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADF  918 (1052)
Q Consensus       839 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  918 (1052)
                      ....++||||++++.+.....    ....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+|++||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEECCCCCCCCHHHH----CCCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEEC
T ss_conf             763899985357874101222----034433089999999999999885229---9885676722203668996876313


Q ss_pred             CCCCCCCCCCCE---EEECCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             443224889970---34124444565582134876-77861034999999999992999975458777014899999963
Q 001561          919 GLSRLLRPYDTH---VTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMK  994 (1052)
Q Consensus       919 g~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  994 (1052)
                      |+++........   .....+||+.|+|||++.+. .++.++||||+|+++|||++|+.||...   +..+....+....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~---~~~~~~~~i~~~~  238 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLALISQLC  238 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHH
T ss_pred             CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCC---CHHHHHHHHHHHC
T ss_conf             5002235544432113566024978742899707999891787006786466174487998998---9999999999841


Q ss_pred             HCCCCC---CCCCC----------CCCCHH-----HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHH
Q ss_conf             024433---11244----------346310-----1999999999998812379999999899999--996
Q 001561          995 SEKREV---EIIDA----------SIWHKD-----REKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLD 1045 (1052)
Q Consensus       995 ~~~~~~---~~~~~----------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1045 (1052)
                      ......   .....          ......     .......+.+++.+|+++||++|||++|+++  +++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~  309 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  309 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred             CCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             89982553443203444332013344555033404445998999999998738965890999997495015

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=327.74  Aligned_cols=263  Identities=21%  Similarity=0.320  Sum_probs=202.3

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECC------
Q ss_conf             308755684721285289999987-99589999944884--354999999999999549985002403486089------
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN------  840 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  840 (1052)
                      .++|++.+.||+|+||+||+|... +++.||+|++....  ....+.+.+|+++++.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             EEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf             07999982447983323000468764559999999999999999998741799849769999866877899769901144
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~  920 (1052)
                      ..++||||+ +.++..+.+     ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEECC-CCCHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf             599998405-521899987-----40226999999999999999998737---876456685111121001221134310


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf             32248899703412444456558213487-67786103499999999999299997545877701489999996302443
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQT-LTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKRE  999 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      |+.....    ....+||+.|+|||++.+ ..++.++||||+||++|+|++|++||...   +..+..............
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~---~~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS---DHLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCH
T ss_pred             EECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCC---CHHHHHHHHHHCCCCCCH
T ss_conf             2206876----310245533358899817878996501030038999999786998889---768999999850378848


Q ss_pred             C-----------------CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf             3-----------------112443463101999999999998812379999999899999--996108
Q 001561         1000 V-----------------EIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus      1000 ~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                      .                 .......+..........+.+++.+|++.||.+|||+.|+++  +++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             88865300034433115786665566775568999999999997729955792999996396237587

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=329.56  Aligned_cols=267  Identities=23%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECC----EEE
Q ss_conf             308755684721285289999987-99589999944884-354999999999999549985002403486089----079
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC-GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGN----DRL  843 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~  843 (1052)
                      +.+|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||+++++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             89859978994064809999999999949999998031095899999999999997689898858889950564554149


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             99982447983323000468764559999999999999999998741799849769999866877899769901144322
Q 001561          844 LIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       844 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~  923 (1052)
                      ++++++.+|+|.+++..     ..+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf             99996259865664405-----8999999999999999999999978---986777876437887999778754570565


Q ss_pred             CCCCCCE--EEECCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf             4889970--341244445655821348-7677861034999999999992999975458777014899999963024433
Q 001561          924 LRPYDTH--VTTDLVGTLGYIPPEYSQ-TLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       924 ~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      .......  .....+||+.|+|||++. ...++.++||||+|+++|+|++|+.||....   ..+...............
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~---~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---YLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCHH
T ss_pred             CCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCC---HHHHHHHHHHHCCCCCHH
T ss_conf             04777641010110265200038786047888741010046701337766979978888---899999876520699756


Q ss_pred             C---------------C--CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf             1---------------1--2443463101999999999998812379999999899999--99610
Q 001561         1001 E---------------I--IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGI 1047 (1052)
Q Consensus      1001 ~---------------~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1047 (1052)
                      .               .  .....+.........++.+++.+|++.||++|||++|+++  +++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             642343322220244677557787778378999999999999764895679089998619865558

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.04  Aligned_cols=247  Identities=24%  Similarity=0.405  Sum_probs=198.5

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCH------HHHHHHHHHHHHHHHCC--CCCEEEEECEEEECC
Q ss_conf             308755684721285289999987-995899999448843------54999999999999549--985002403486089
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCG------QMEREFQAEVEALSRAQ--HKNLVSLQGYCRHGN  840 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~  840 (1052)
                      .++|++.+.||+|+||+||+|+.. ++..||+|++.....      ....++.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             EEEEEEEECCC-CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEEC
Q ss_conf             07999982447-9833230004687645599999999999999999987417998497699998668778-997699011
Q 001561          841 DRLLIYSYMEN-GSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-KFEAHLADF  918 (1052)
Q Consensus       841 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~Df  918 (1052)
                      ..++||||+.+ +++.+++..    ...+++.++..++.|++.|++|||+.   +|+||||||+||+++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEEEECCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCC
T ss_conf             689999833686228999861----58999999999999999999999877---97556676111477447884897754


Q ss_pred             CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf             4432248899703412444456558213487677-861034999999999992999975458777014899999963024
Q 001561          919 GLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTA-TCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEK  997 (1052)
Q Consensus       919 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      |+|+....   .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...     .+       .....
T Consensus       156 G~a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~-------i~~~~  220 (273)
T d1xwsa_         156 GSGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EE-------IIRGQ  220 (273)
T ss_dssp             TTCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HH-------HHHCC
T ss_pred             CCCEECCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC-----HH-------HHHCC
T ss_conf             65353244---45566565877479999848997886533255403453675688998873-----67-------76154


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             433112443463101999999999998812379999999899999--9961085
Q 001561          998 REVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                      .   ...    .    ..+.++.+++.+|++.||++|||++|+++  +++++..
T Consensus       221 ~---~~~----~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         221 V---FFR----Q----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             C---CCS----S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             C---CCC----C----CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             4---778----7----79999999999976089758939999853986678878

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=0  Score=324.75  Aligned_cols=295  Identities=29%  Similarity=0.488  Sum_probs=177.2

Q ss_pred             CCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC--EEEEEEECCCCCCCCCCCEEEEEECCCCCCCC--CCCCCCCCCCC
Q ss_conf             899888999999995189998877867999983--02113619999999889389998048997434--77222288678
Q 001561           37 SCDPSDLLALKEFAGNLTNGSIITSWSNESMCC--QWDGVVCGHGSTGSNAGRVTMLILPRKGLKGI--IPRSLGHLNQL  112 (1052)
Q Consensus        37 ~~~~~~~~aL~~~~~~~~~~~~~~sw~~~~~~c--~w~gv~C~~~~~~~~~~~v~~l~l~~~~l~~~--~~~~l~~l~~L  112 (1052)
                      -|.++|++||++||+++.++..+++|+.++|||  .|+||+|+..+   ...||++|+|.++++.|.  +|++++++++|
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~---~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L   78 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSS---SCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEEECCC---CCEEEEEEECCCCCCCCCCCCCHHHHCCCCC
T ss_conf             9898999999999997799986778899999988948896974899---9479889989899888888798478467533


Q ss_pred             CEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf             9686679-978998960255888764883467724485443234667711898057656774333345775219981287
Q 001561          113 KLLDLSC-NHLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNN  191 (1052)
Q Consensus       113 ~~L~Ls~-n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n  191 (1052)
                      ++|+|++ |+++|.+|..|+++++|++|+|++|.+.+..+..+..+..|+.++++.|.+.                    
T Consensus        79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~--------------------  138 (313)
T d1ogqa_          79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS--------------------  138 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE--------------------
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC--------------------
T ss_conf             520202654333002431145420011020356434433222220111001111224555--------------------


Q ss_pred             CCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCHHHH
Q ss_conf             35786304554114434244356743333456688999998898316669998981212899985998336767730345
Q 001561          192 SFTGKLNSRIWSASKEIQILDLSMNHFMGSLQGLDHSPSLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSE  271 (1052)
Q Consensus       192 ~l~~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~l~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~  271 (1052)
                                                                         +.+|..+..+++|+++++++|.+.+.+|.
T Consensus       139 ---------------------------------------------------~~~p~~l~~l~~L~~l~l~~n~l~~~ip~  167 (313)
T d1ogqa_         139 ---------------------------------------------------GTLPPSISSLPNLVGITFDGNRISGAIPD  167 (313)
T ss_dssp             ---------------------------------------------------SCCCGGGGGCTTCCEEECCSSCCEEECCG
T ss_pred             ---------------------------------------------------CCCCHHHCCCCCCCEEECCCCCCCCCCCC
T ss_conf             ---------------------------------------------------56851220674000000235533562031


Q ss_pred             HHCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf             21289988-59982698678987300058444451024677545877843335788849990286223757756656876
Q 001561          272 KISNLTSL-RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSS  350 (1052)
Q Consensus       272 ~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  350 (1052)
                      .+..+..+ +.++++.|++++..|..+.++..+ .+++..+...+.+|..+..+++++.+++++|.+.+.++ .+..+++
T Consensus       168 ~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~  245 (313)
T d1ogqa_         168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKN  245 (313)
T ss_dssp             GGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTT
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf             214431123231022464353324332222222-33333343322222222222221112222222222222-2224554


Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf             6564135544669999311388766645324532434583100167767578525886
Q 001561          351 LCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLSLSNNS  408 (1052)
Q Consensus       351 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  408 (1052)
                      |+.|+|++|++++.+|..++++++|+.|+|++|+++|.+|. ++++++|+.+++++|+
T Consensus       246 L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             CCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             CCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCHHHHCCCC
T ss_conf             44444765706660876884799999897958835166898-6667998978868895

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=319.47  Aligned_cols=262  Identities=18%  Similarity=0.261  Sum_probs=200.1

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCEEEEECEEEEC--CEEEEEE
Q ss_conf             08755684721285289999987-99589999944884354999999999999549-98500240348608--9079999
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHG--NDRLLIY  846 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~  846 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++...   .+++.+|+.+++.++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             67189789831748199999988999799999988899---999999999998515799876799999816877126888


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCC
Q ss_conf             82447983323000468764559999999999999999998741799849769999866877899-76990114432248
Q 001561          847 SYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKF-EAHLADFGLSRLLR  925 (1052)
Q Consensus       847 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~  925 (1052)
                      ||+++++|....+       .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+|++|||.|+...
T Consensus       112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EECCCCCHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf             6317985899746-------899999999999999999887643---344345644123774899836641565426646


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHH---------
Q ss_conf             8997034124444565582134876-778610349999999999929999754587770148999999630---------
Q 001561          926 PYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKS---------  995 (1052)
Q Consensus       926 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---------  995 (1052)
                      ...  .....++|+.|+|||...+. .++.++||||+|+++|+|++|+.||.....  ..+....+.....         
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~--~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         182 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHHH
T ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCH--HHHHHHHHHHHHCCCHHHHHHH
T ss_conf             887--444322486424761026888888452323354555876048899988760--1899999999878841555554


Q ss_pred             ---CCCCCCC---CC--------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             ---2443311---24--------43463101999999999998812379999999899999--9961085
Q 001561          996 ---EKREVEI---ID--------ASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus       996 ---~~~~~~~---~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                         .......   ..        .............++.+++.+|++.||++|||++|+++  ++.++..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             HCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf             2254447430000033343311211552112448999999999986699568908999964935588797

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=320.57  Aligned_cols=260  Identities=20%  Similarity=0.243  Sum_probs=199.1

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEE-EECEEEECCEEEEEEE
Q ss_conf             308755684721285289999987-99589999944884354999999999999549985002-4034860890799998
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKNLVS-LQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e  847 (1052)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.....  ..++..|+++++.++|++++. +.++..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf             8889996898507880999999988998999999721005--88899999999970389960179999951987789998


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCC
Q ss_conf             2447983323000468764559999999999999999998741799849769999866877---8997699011443224
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLD---EKFEAHLADFGLSRLL  924 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~Dfg~a~~~  924 (1052)
                      |+ ++++...+..   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++   .+..+|++|||+|+.+
T Consensus        84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EC-CCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf             73-8713332443---068876899999999999999999979---9442667876606433577761565046751342


Q ss_pred             CCCCCE------EEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf             889970------34124444565582134876778610349999999999929999754587770148999999630244
Q 001561          925 RPYDTH------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       925 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ......      ......||+.|+|||+..+..++.++||||||+++|||++|+.||......+................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             CCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCC
T ss_conf             55445541000135776787353299999189989832188617789999849876655305779999998523567898


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             3311244346310199999999999881237999999989999999610
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGI 1047 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1047 (1052)
                      ..         ......+.++.+++.+|+..+|++||+++++.+.|+.+
T Consensus       237 ~~---------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         237 IE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HH---------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             HH---------HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             35---------75347889999999998439955791999999999999

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=319.58  Aligned_cols=262  Identities=20%  Similarity=0.246  Sum_probs=203.1

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEEECEEEE------CC
Q ss_conf             308755684721285289999987-99589999944884--3549999999999995499850024034860------89
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRH------GN  840 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~  840 (1052)
                      .++|++.++||+|+||+||+|++. ++..||+|++....  .....++.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf             37759988962175859999999999989999998823369799999999999998648987648998970256434576


Q ss_pred             EEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf             07999982447983323000468764559999999999999999998741799849769999866877899769901144
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~  920 (1052)
                      ..|+||||+.++.+..+ .      ..+++..+..++.|++.|+.|||+.   ||+||||||+|||++.++.++++|||.
T Consensus        96 ~~~iv~Ey~~~~l~~~~-~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVI-Q------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEEECCSEEHHHHH-T------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEEEECCCHHHHHHH-H------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHH
T ss_conf             26999841446778765-0------3899999999999999999886522---112456776321136544313201023


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHC----
Q ss_conf             3224889970341244445655821348767786103499999999999299997545877701489999996302----
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE----  996 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----  996 (1052)
                      ++.....  ......++|+.|+|||++.+..+++++||||+||++|+|++|+.||.+.   +..+....+......    
T Consensus       166 ~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~---~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR---DYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCHH
T ss_pred             HHCCCCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCC---CHHHHHHHHHHHCCCCCHH
T ss_conf             2114666--5533221465555813314777787743335662578986598998889---7788999999720589879


Q ss_pred             ---------------C-CC-----CCCC---CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             ---------------4-43-----3112---443463101999999999998812379999999899999--9961
Q 001561          997 ---------------K-RE-----VEII---DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDG 1046 (1052)
Q Consensus       997 ---------------~-~~-----~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1046 (1052)
                                     . ..     ....   ............+.++.+++.+|++.||++|||++|+++  +++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             9987656677776417543566642126433354321013337999999999987699457908999966942087

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=318.50  Aligned_cols=261  Identities=17%  Similarity=0.194  Sum_probs=207.5

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCC-CCEEEEECEEEECCEEEEEEE
Q ss_conf             308755684721285289999987-995899999448843549999999999995499-850024034860890799998
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQH-KNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e  847 (1052)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.....  ...+.+|++.+..++| ++++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             9806997998417882999999988997999999750258--29999999999996489998779999601881179999


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCC
Q ss_conf             24479833230004687645599999999999999999987417998497699998668778-----9976990114432
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDE-----KFEAHLADFGLSR  922 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-----~~~~kl~Dfg~a~  922 (1052)
                      |+ +++|.+++..   ....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.     ++.+|++|||+|+
T Consensus        82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EC-CCCHHHHHHH---HCCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf             64-8887999975---203110689999999999999999977---9662667713152347543447956872366057


Q ss_pred             CCCCCCCE------EEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             24889970------341244445655821348767786103499999999999299997545877701489999996302
Q 001561          923 LLRPYDTH------VTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSE  996 (1052)
Q Consensus       923 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      .+......      .....+||+.|+|||++.+..++.++||||+|+++|||++|+.||......+.......+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf             71467665411102467627751026798964888886999898319999998698767885302199999999705679


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             4433112443463101999999999998812379999999899999996108
Q 001561          997 KREVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVTWLDGIG 1048 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1048 (1052)
                      ....+         .....+.++.+++..|+..+|++||+++.+.+.|+++.
T Consensus       235 ~~~~~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         235 TPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             SCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCHHH---------HCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf             99589---------65799899999999984399300859999999999999

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=318.73  Aligned_cols=269  Identities=22%  Similarity=0.307  Sum_probs=209.6

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEEECEEEECCEEEEEEE
Q ss_conf             08755684721285289999987-99589999944884--3549999999999995499850024034860890799998
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHGNDRLLIYS  847 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  847 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++...  .....++.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444431158863


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             24479833230004687645599999999999999999987417998497699998668778997699011443224889
Q 001561          848 YMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRLLRPY  927 (1052)
Q Consensus       848 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  927 (1052)
                      ++.++++..++.    ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.|+.....
T Consensus        82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ECCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf             023322211212----356540367899999999998774339---9860014676121133782665204601104688


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC---
Q ss_conf             970341244445655821348767-7861034999999999992999975458777014899999963024433112---
Q 001561          928 DTHVTTDLVGTLGYIPPEYSQTLT-ATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREVEII--- 1003 (1052)
Q Consensus       928 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1003 (1052)
                      .. ......+++.|+|||++.... ++.++||||+||++|||++|+.||..  +.+..+....+.............   
T Consensus       155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CC-CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC--CCCHHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf             75-100103443101466750698888044402654188998518999988--999999999998611899735513443


Q ss_pred             ------------CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf             ------------443463101999999999998812379999999899999--9961085
Q 001561         1004 ------------DASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIGI 1049 (1052)
Q Consensus      1004 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1049 (1052)
                                  ...............+.+++.+|+++||++|||++|+++  +|+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             HCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             222113344454431043306568999999999986499668909999964953407989

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=324.07  Aligned_cols=259  Identities=25%  Similarity=0.334  Sum_probs=205.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC----CCCEEEEEEECCCC----HHHHHHHHHHHHHHHHCCC-CCEEEEECEEEECC
Q ss_conf             308755684721285289999987----99589999944884----3549999999999995499-85002403486089
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT----NGTKAAVKRLSGDC----GQMEREFQAEVEALSRAQH-KNLVSLQGYCRHGN  840 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~  840 (1052)
                      .++|++.+.||+|+||+||+|+..    +|+.||+|++....    ....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf             10259998983287839999998765887948999998367721016899999999999986467983999620002487


Q ss_pred             EEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf             07999982447983323000468764559999999999999999998741799849769999866877899769901144
Q 001561          841 DRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGL  920 (1052)
Q Consensus       841 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~  920 (1052)
                      ..++++||+.+|+|.+++..    ...+.+..+..++.|++.|+.|+|+.   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             CEEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCC
T ss_conf             30012312341179999873----04543788888899999999885149---989654773201246999888741320


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf             322488997034124444565582134876--778610349999999999929999754587770148999999630244
Q 001561          921 SRLLRPYDTHVTTDLVGTLGYIPPEYSQTL--TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKR  998 (1052)
Q Consensus       921 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      |+.+............|++.|+|||.+.+.  .++.++||||+||++|+|++|+.||......+....+   ........
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~~~~~  252 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKSE  252 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHHCC
T ss_pred             HHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HHHCCCCC
T ss_conf             222034444322122233333106876057768871325177779999997689998888777799999---98335689


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH--HHHHCC
Q ss_conf             3311244346310199999999999881237999999-----9899999--996108
Q 001561          999 EVEIIDASIWHKDREKQLLEMLEIACKCIDQDPRRRP-----FIEEVVT--WLDGIG 1048 (1052)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~--~L~~i~ 1048 (1052)
                       ..         .+...+.++.+++.+|++++|++||     +++|+++  +++++.
T Consensus       253 -~~---------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         253 -PP---------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             -CC---------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             -CC---------CCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCC
T ss_conf             -98---------865479999999999744589881999745099997497234899

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=316.51  Aligned_cols=264  Identities=22%  Similarity=0.292  Sum_probs=201.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEEECEEEEC-----CE
Q ss_conf             308755684721285289999987-99589999944884--35499999999999954998500240348608-----90
Q 001561          770 TNNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDC--GQMEREFQAEVEALSRAQHKNLVSLQGYCRHG-----ND  841 (1052)
Q Consensus       770 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  841 (1052)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++....  ....+++.+|+.+++.++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf             98718888983178839999999999979999998820028689999999999998668987425999996346456686


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             79999824479833230004687645599999999999999999987417998497699998668778997699011443
Q 001561          842 RLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAHLADFGLS  921 (1052)
Q Consensus       842 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a  921 (1052)
                      .+++++++.+|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEEEEEECCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf             4999996258862320022-----4530999999999999999999738---8765166776334554322001321000


Q ss_pred             CCCCCCCCEEEECCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf             22488997034124444565582134876-77861034999999999992999975458777014899999963024433
Q 001561          922 RLLRPYDTHVTTDLVGTLGYIPPEYSQTL-TATCRGDVYSFGVVLLELLTGRRPVEVCKGKNCRDLVSWVFQMKSEKREV 1000 (1052)
Q Consensus       922 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      .....    ......|++.|+|||+..+. .++.++||||+|+++|+|++|++||.+.   +.......+..........
T Consensus       169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~---~~~~~~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT---DHIDQLKLILRLVGTPGAE  241 (348)
T ss_dssp             -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCHH
T ss_pred             CCCCC----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHCCCCCHH
T ss_conf             12575----4444345435558355337756785512432058999997688997889---8899999999730799757


Q ss_pred             CC-----------------CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf             11-----------------2443463101999999999998812379999999899999--996108
Q 001561         1001 EI-----------------IDASIWHKDREKQLLEMLEIACKCIDQDPRRRPFIEEVVT--WLDGIG 1048 (1052)
Q Consensus      1001 ~~-----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1048 (1052)
                      ..                 ................+.+++.+|++.||++|||+.|+++  ++.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             7320010244544430355787555662678999999999997758834593899985599548799

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=286.55  Aligned_cols=269  Identities=22%  Similarity=0.288  Sum_probs=195.3

Q ss_pred             CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEEECEEEE
Q ss_conf             08755684721285289999987-99589999944884354999999999999549-----------9850024034860
Q 001561          771 NNFNQANIIGCGGFGLVYKATLT-NGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-----------HKNLVSLQGYCRH  838 (1052)
Q Consensus       771 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~  838 (1052)
                      ++|++.++||+|+||+||+|+.. +++.||||++..+.. ..+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             857998997507781899999999997999999834313-3689999999999840145555542276764789987631


Q ss_pred             --CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCC----
Q ss_conf             --89079999824479833230004687645599999999999999999987417998497699998668778997----
Q 001561          839 --GNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFE----  912 (1052)
Q Consensus       839 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~----  912 (1052)
                        ....++++++...+......... .....+++..+..++.|++.|+.|||+.  .+|+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEEEECCCCCCCC
T ss_conf             2565202343200035420000012-2346786899999999999998887640--586465677057056305765644


Q ss_pred             --EEEEECCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC---HHHH
Q ss_conf             --69901144322488997034124444565582134876778610349999999999929999754587770---1489
Q 001561          913 --AHLADFGLSRLLRPYDTHVTTDLVGTLGYIPPEYSQTLTATCRGDVYSFGVVLLELLTGRRPVEVCKGKNC---RDLV  987 (1052)
Q Consensus       913 --~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~---~~~~  987 (1052)
                        ++++|||.+......    ....+||+.|+|||+.....++.++|+||+|+++++|++|+.||....+...   .+..
T Consensus       169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CEEEEEECCCCCCCCCC----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf             30567531442123445----42236652105713214667776432012378999998788998987554321026899


Q ss_pred             HHHHHHHHCCC------------------C-CCCCCCC---------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf             99999630244------------------3-3112443---------463101999999999998812379999999899
Q 001561          988 SWVFQMKSEKR------------------E-VEIIDAS---------IWHKDREKQLLEMLEIACKCIDQDPRRRPFIEE 1039 (1052)
Q Consensus       988 ~~~~~~~~~~~------------------~-~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1039 (1052)
                      ...........                  . ..+....         ...........++.+++.+|+..||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             99999837998788624532200013201220243235776444210001567435899999999987799457908999


Q ss_pred             HHH--HHHHC
Q ss_conf             999--99610
Q 001561         1040 VVT--WLDGI 1047 (1052)
Q Consensus      1040 vl~--~L~~i 1047 (1052)
                      +++  ++++.
T Consensus       325 ~L~Hp~f~~~  334 (362)
T d1q8ya_         325 LVNHPWLKDT  334 (362)
T ss_dssp             HHTCGGGTTC
T ss_pred             HHCCCCCCCC
T ss_conf             9669340789

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.8e-44  Score=261.39  Aligned_cols=259  Identities=29%  Similarity=0.498  Sum_probs=195.3

Q ss_pred             CCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCHHHCCCCCCC
Q ss_conf             66564135544669--9993113887666453245-32434583100167767578525886777766400001376652
Q 001561          350 SLCTLDLATNHFSG--PLPNSLSDCHDLKILSLAK-NELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLT  426 (1052)
Q Consensus       350 ~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~L~  426 (1052)
                      .++.|+|++|.+++  .+|..++++++|++|++++ |.++|.+|..++++++|++|+|++|++..+              
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~--------------  116 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA--------------  116 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE--------------
T ss_pred             EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC--------------
T ss_conf             988998989988888879847846753352020265433300243114542001102035643443--------------


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHCCCCCC-CEEECCCC
Q ss_conf             67424565676689554587766489815883545751323227899589475763789999100038998-76950279
Q 001561          427 TLILTKNFVGEEIPENVGGFESLMVLALGNCGLKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENL-FYLDFSNN  505 (1052)
Q Consensus       427 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N  505 (1052)
                                  .+..+..+..|+.+++++|.+.+.+|..+..++.|+.+++++|.+.+.+|..+..+..+ +.+++++|
T Consensus       117 ------------~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n  184 (313)
T d1ogqa_         117 ------------IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN  184 (313)
T ss_dssp             ------------CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSS
T ss_pred             ------------CCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             ------------32222201110011112245555685122067400000023553356203121443112323102246


Q ss_pred             CCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCE
Q ss_conf             56445881046664300268999999877885520201456798677888999983441037501159934325434553
Q 001561          506 TLTGEIPKSLTELKSLISSNCTSSNPTASAGIPLYVKHNRSTNGLPYNQASSFPPSVFLSNNRINGTIPPEIGQLKHLHV  585 (1052)
Q Consensus       506 ~l~~~ip~~l~~l~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ls~N~l~~~~p~~~~~l~~L~~  585 (1052)
                      .+++..|..+..+..                                       ..++++.+.+.+.+|..++.+++++.
T Consensus       185 ~l~~~~~~~~~~l~~---------------------------------------~~l~l~~~~~~~~~~~~~~~~~~l~~  225 (313)
T d1ogqa_         185 RLTGKIPPTFANLNL---------------------------------------AFVDLSRNMLEGDASVLFGSDKNTQK  225 (313)
T ss_dssp             EEEEECCGGGGGCCC---------------------------------------SEEECCSSEEEECCGGGCCTTSCCSE
T ss_pred             CCCCCCCCCCCCCCC---------------------------------------CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             435332433222222---------------------------------------23333334332222222222222111


Q ss_pred             ECCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             50238364201797742556767643778857899971233735667046015524247999985577888764589887
Q 001561          586 LDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQGTIPTGGQFYSFPNSSFEGNPGL  665 (1052)
Q Consensus       586 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~  665 (1052)
                      +++++|.+++.+| .++.+++|+.|+|++|+++|.+|.+++++++|+.|+|++|+|+|.+|..+.+.++..+.+.||+.+
T Consensus       226 l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l  304 (313)
T d1ogqa_         226 IHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL  304 (313)
T ss_dssp             EECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEE
T ss_pred             CCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCC
T ss_conf             2222222222222-222455444444765706660876884799999897958835166898666799897886889500


Q ss_pred             CCCCCCCCC
Q ss_conf             579999998
Q 001561          666 CGEIDSPCD  674 (1052)
Q Consensus       666 c~~~~~~~~  674 (1052)
                      ||.+.++|.
T Consensus       305 ~g~plp~c~  313 (313)
T d1ogqa_         305 CGSPLPACT  313 (313)
T ss_dssp             ESTTSSCCC
T ss_pred             CCCCCCCCC
T ss_conf             198988989

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=3.8e-39  Score=231.68  Aligned_cols=59  Identities=19%  Similarity=0.432  Sum_probs=41.7

Q ss_pred             CCCCCCCCEECCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf             325434553502383642017977425567676437788578999712337356670460155
Q 001561          577 IGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANN  639 (1052)
Q Consensus       577 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N  639 (1052)
                      +..+++|+.|++++|++++ ++ .++.+++|++|++++|++++..|  +..+++|+.|++++|
T Consensus       325 l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         325 VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf             3668988989898998999-74-67089999989897995899800--003999999639789

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=2.8e-39  Score=232.41  Aligned_cols=38  Identities=18%  Similarity=0.441  Sum_probs=23.1

Q ss_pred             CCCCCCCCCEECCCCCEEEECCCCCCCCCCCCCEEECCCC
Q ss_conf             4325434553502383642017977425567676437788
Q 001561          576 EIGQLKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSN  615 (1052)
Q Consensus       576 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  615 (1052)
                      .++++++|++|++++|++++.+|  +.++++|+.|+|++|
T Consensus       346 ~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf             67089999989897995899800--003999999639789

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-34  Score=205.52  Aligned_cols=104  Identities=28%  Similarity=0.381  Sum_probs=66.3

Q ss_pred             CEEEEEEECCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             30211361999999988938999804899743477222288678968667997899896025588876488346772448
Q 001561           69 CQWDGVVCGHGSTGSNAGRVTMLILPRKGLKGIIPRSLGHLNQLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG  148 (1052)
Q Consensus        69 c~w~gv~C~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~  148 (1052)
                      |.|++|.|+..                 +++. +|..+.  +.+++|+|++|+|+.+.+.+|.++++|++|++++|.+..
T Consensus        10 c~~~~~~C~~~-----------------~L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~   69 (305)
T d1xkua_          10 CHLRVVQCSDL-----------------GLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK   69 (305)
T ss_dssp             EETTEEECTTS-----------------CCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             ECCCEEEECCC-----------------CCCC-CCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC
T ss_conf             55999985599-----------------9885-198889--997989784991898696576046565231123443445


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf             5443234667711898057656774333345775219981287357
Q 001561          149 PVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNLAVFNISNNSFT  194 (1052)
Q Consensus       149 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~n~l~  194 (1052)
                      ..+..|..++.|++|++++|+++..+..  ....+..|++++|.+.
T Consensus        70 i~~~~f~~l~~L~~L~l~~n~l~~l~~~--~~~~l~~L~~~~n~l~  113 (305)
T d1xkua_          70 ISPGAFAPLVKLERLYLSKNQLKELPEK--MPKTLQELRVHENEIT  113 (305)
T ss_dssp             BCTTTTTTCTTCCEEECCSSCCSBCCSS--CCTTCCEEECCSSCCC
T ss_pred             CCHHHHHCCCCCCEECCCCCCCCCCCCC--HHHHHHHHHCCCCCHH
T ss_conf             2356652798557831568756767640--0111323210246102

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6e-34  Score=202.67  Aligned_cols=61  Identities=20%  Similarity=0.205  Sum_probs=21.3

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHCCCCCCCEEECCCCCCC
Q ss_conf             9988983166699989812128999859983367677303452128998859982698678
Q 001561          230 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIFGNQFS  290 (1052)
Q Consensus       230 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  290 (1052)
                      ++++|++++|+++...+.+|.++++|++|++++|.+....|..|.++++|++|++++|+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~   92 (305)
T d1xkua_          32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK   92 (305)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC
T ss_conf             9798978499189869657604656523112344344523566527985578315687567

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-32  Score=192.36  Aligned_cols=42  Identities=19%  Similarity=0.188  Sum_probs=14.3

Q ss_pred             HHHCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCC
Q ss_conf             232278995894757637899991000389987695027956
Q 001561          466 WLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSNNTL  507 (1052)
Q Consensus       466 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  507 (1052)
                      .+..+++|+.|++++|.+.+..|..++.+++|++|++++|.+
T Consensus       196 ~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l  237 (284)
T d1ozna_         196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW  237 (284)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred             HHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC
T ss_conf             766532000233333522100000235546568898119988

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-32  Score=194.34  Aligned_cols=86  Identities=30%  Similarity=0.381  Sum_probs=33.3

Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEE
Q ss_conf             78884999028622375775665687665641355446699993113887666453245324345831001677675785
Q 001561          324 CSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSLLFLS  403 (1052)
Q Consensus       324 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  403 (1052)
                      +++|+.|++++|.+....+..|.++++|+.+++++|++++..|..|..+++|+.|++++|++.+..+..|..+++|++|+
T Consensus       152 ~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~  231 (284)
T d1ozna_         152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR  231 (284)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEE
T ss_pred             CCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
T ss_conf             34050223141765662566654656341314211434662816766532000233333522100000235546568898


Q ss_pred             CCCCCC
Q ss_conf             258867
Q 001561          404 LSNNSF  409 (1052)
Q Consensus       404 L~~N~l  409 (1052)
                      +++|++
T Consensus       232 l~~N~l  237 (284)
T d1ozna_         232 LNDNPW  237 (284)
T ss_dssp             CCSSCE
T ss_pred             ECCCCC
T ss_conf             119988

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-29  Score=178.22  Aligned_cols=11  Identities=27%  Similarity=0.108  Sum_probs=3.4

Q ss_pred             CCCCEEECCCC
Q ss_conf             67676437788
Q 001561          605 RNLEVLDLSSN  615 (1052)
Q Consensus       605 ~~L~~L~Ls~N  615 (1052)
                      ++|+.|+|++|
T Consensus       195 ~~L~~L~L~~N  205 (266)
T d1p9ag_         195 HLLPFAFLHGN  205 (266)
T ss_dssp             CCCSEEECCSC
T ss_pred             CCCCEEEECCC
T ss_conf             88999983699

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=2.4e-26  Score=160.24  Aligned_cols=33  Identities=33%  Similarity=0.266  Sum_probs=15.5

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             7896866799789989602558887648834677244
Q 001561          111 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLS  147 (1052)
Q Consensus       111 ~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~  147 (1052)
                      +++.|||++|+++ .+|+.   +++|++|+|++|.|+
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~   71 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT   71 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS
T ss_pred             CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC
T ss_conf             9989993799988-78898---789888989999796

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=3e-25  Score=154.15  Aligned_cols=55  Identities=29%  Similarity=0.331  Sum_probs=27.1

Q ss_pred             CCCCCEECCCCCEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf             434553502383642017977425567676437788578999712337356670460155242
Q 001561          580 LKHLHVLDLSRNNITGTIPSSISEIRNLEVLDLSSNDLHGSIPGSFEKLTFLSKFSVANNHLQ  642 (1052)
Q Consensus       580 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~  642 (1052)
                      +++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|+.|++++|+++
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR  337 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred             CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC
T ss_conf             898898979799168-35665---487998989999687-54532---288898987699189

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-30  Score=184.15  Aligned_cols=12  Identities=50%  Similarity=0.625  Sum_probs=4.0

Q ss_pred             CCCEECCCCCEE
Q ss_conf             455350238364
Q 001561          582 HLHVLDLSRNNI  593 (1052)
Q Consensus       582 ~L~~L~Ls~N~l  593 (1052)
                      +|++|+|++|.|
T Consensus       398 ~L~~L~Ls~N~i  409 (460)
T d1z7xw1         398 SLRELDLSNNCL  409 (460)
T ss_dssp             CCCEEECCSSSC
T ss_pred             CCCEEECCCCCC
T ss_conf             889898999969

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.8e-30  Score=182.22  Aligned_cols=37  Identities=30%  Similarity=0.387  Sum_probs=14.0

Q ss_pred             CCCEECCCCCEEEEC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf             455350238364201----7977425567676437788578
Q 001561          582 HLHVLDLSRNNITGT----IPSSISEIRNLEVLDLSSNDLH  618 (1052)
Q Consensus       582 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  618 (1052)
                      .|+.|+|++|.|+..    ++..+...++|++|+|++|+++
T Consensus       370 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~  410 (460)
T d1z7xw1         370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG  410 (460)
T ss_dssp             CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             CCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf             77889897997975999999999962998898989999698

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.5e-27  Score=165.70  Aligned_cols=165  Identities=15%  Similarity=0.088  Sum_probs=119.6

Q ss_pred             CCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCC------------------HHHHHHHHHHHHHHHHCCCCCEEEEEC
Q ss_conf             75568472128528999998799589999944884------------------354999999999999549985002403
Q 001561          773 FNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDC------------------GQMEREFQAEVEALSRAQHKNLVSLQG  834 (1052)
Q Consensus       773 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~~iv~~~~  834 (1052)
                      +.+.++||+|+||+||+|...+|+.||+|+++...                  .........|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf             02277802485659999997999999999986044346665565630008889999997789999999816999144998


Q ss_pred             EEEECCEEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf             48608907999982447983323000468764559999999999999999998741799849769999866877899769
Q 001561          835 YCRHGNDRLLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVCEPHIVHRDVKSSNILLDEKFEAH  914 (1052)
Q Consensus       835 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~k  914 (1052)
                      +..    .+++|||+++....+           ++......++.|++.+++|||+.   +|+||||||+|||++++ .++
T Consensus        82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred             ECC----CEEEEEEECCCCCCC-----------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEE
T ss_conf             628----889999504565420-----------01578999999999999998268---88983689036114289-899


Q ss_pred             EEECCCCCCCCCCCCEEEECCCCCCCCCCCC-----CCCCCCCCCCCCHHHHHHHH
Q ss_conf             9011443224889970341244445655821-----34876778610349999999
Q 001561          915 LADFGLSRLLRPYDTHVTTDLVGTLGYIPPE-----YSQTLTATCRGDVYSFGVVL  965 (1052)
Q Consensus       915 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwslGvil  965 (1052)
                      ++|||.|.........         .|....     ....+.|+.++|+||..--+
T Consensus       143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             EEECCCCCCCCCCCCH---------HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf             9877884308998709---------9998779999999757899844689999987

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.91  E-value=1.1e-23  Score=145.40  Aligned_cols=17  Identities=24%  Similarity=0.411  Sum_probs=5.6

Q ss_pred             CCCCCCCEEECCCCCCC
Q ss_conf             25567676437788578
Q 001561          602 SEIRNLEVLDLSSNDLH  618 (1052)
Q Consensus       602 ~~l~~L~~L~Ls~N~l~  618 (1052)
                      +.+++|++|++++|+++
T Consensus       192 ~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         192 ASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             GGCTTCCEEECTTSCCC
T ss_pred             CCCCCCCEEECCCCCCC
T ss_conf             47999998979599689

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.9e-23  Score=143.08  Aligned_cols=38  Identities=18%  Similarity=0.190  Sum_probs=17.9

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             78968667997899896025588876488346772448
Q 001561          111 QLKLLDLSCNHLEGVVPVELSNLKQLEVLDLSHNMLSG  148 (1052)
Q Consensus       111 ~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~Ls~N~l~~  148 (1052)
                      .+++|+|++|+|+.+.+..|.++++|++|++++|.+..
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~   67 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE   67 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCC
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCC
T ss_conf             88999876991896496686146432321102211242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5.8e-23  Score=141.38  Aligned_cols=15  Identities=13%  Similarity=-0.115  Sum_probs=5.5

Q ss_pred             CCCEEECCCCCCCCC
Q ss_conf             764883467724485
Q 001561          135 QLEVLDLSHNMLSGP  149 (1052)
Q Consensus       135 ~L~~L~Ls~N~l~~~  149 (1052)
                      ++++|||++|.|+.+
T Consensus        30 ~l~~L~Ls~n~i~~l   44 (242)
T d1xwdc1          30 NAIELRFVLTKLRVI   44 (242)
T ss_dssp             CCSEEEEESCCCCEE
T ss_pred             CCCEEECCCCCCCCC
T ss_conf             889998769918964

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.87  E-value=1e-21  Score=134.37  Aligned_cols=187  Identities=22%  Similarity=0.264  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             44445102467754587784333578884999028622375775665687665641355446699993113887666453
Q 001561          300 LTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILS  379 (1052)
Q Consensus       300 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  379 (1052)
                      +.+.....+..+.+.+.++.  ..+.+|+.|++++|.++....  +..+++|++|++++|++++..+  ++.+++|+.|+
T Consensus        23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~   96 (210)
T d1h6ta2          23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF   96 (210)
T ss_dssp             HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCC
T ss_conf             99999998575765775188--795484589782798887444--7648998987698960258601--13586212014


Q ss_pred             CCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             24532434583100167767578525886777766400001376652674245656766895545877664898158835
Q 001561          380 LAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCGL  459 (1052)
Q Consensus       380 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l  459 (1052)
                      +++|+++ .++ .+..+++|+.|++++|.+..++.    +..+++++.++++.|.+  ..+..+..+++|+.+++++|++
T Consensus        97 l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~~~~----l~~l~~l~~l~~~~n~l--~~~~~~~~l~~L~~l~l~~n~l  168 (210)
T d1h6ta2          97 LDENKVK-DLS-SLKDLKKLKSLSLEHNGISDING----LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI  168 (210)
T ss_dssp             CCSSCCC-CGG-GGTTCTTCCEEECTTSCCCCCGG----GGGCTTCCEEECCSSCC--CCCGGGGGCTTCSEEECCSSCC
T ss_pred             CCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC
T ss_conf             3333321-222-12122211122345653221122----01111122211222333--4543100013321001346430


Q ss_pred             CCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCC
Q ss_conf             457513232278995894757637899991000389987695027
Q 001561          460 KGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYLDFSN  504 (1052)
Q Consensus       460 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  504 (1052)
                      ++..+  +..+++|+.|++++|+++ .+| .+..+++|++|++++
T Consensus       169 ~~i~~--l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         169 SDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             CCCCC--CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf             25645--367898999989799899-872-116999989997118

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.86  E-value=5.8e-21  Score=130.20  Aligned_cols=184  Identities=21%  Similarity=0.283  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             84444510246775458778433357888499902862237577566568766564135544669999311388766645
Q 001561          299 NLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKIL  378 (1052)
Q Consensus       299 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  378 (1052)
                      ++.+.....+..+.+++.+.  ...+.+++.|++++|.++..  ..+..+++|++|++++|++++..+  ++.+++|+.|
T Consensus        16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHHHCCCCCCCCCC--HHHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf             99999999967787788559--87946878998999999775--202137886757545655667640--1677522311


Q ss_pred             ECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             32453243458310016776757852588677776640000137665267424565676689554587766489815883
Q 001561          379 SLAKNELSGQVPESFGKLTSLLFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIPENVGGFESLMVLALGNCG  458 (1052)
Q Consensus       379 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~  458 (1052)
                      ++++|.+....+  +..++.|+.|++++|.+..++.    +..+++|+.|++++|.+  ...+.+..+++|+.|++.+|.
T Consensus        90 ~l~~n~~~~~~~--l~~l~~L~~L~l~~~~~~~~~~----~~~l~~L~~L~l~~n~l--~~~~~l~~~~~L~~L~l~~n~  161 (199)
T d2omxa2          90 LMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP----LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLNFSSNQ  161 (199)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG----GTTCTTCSEEECCSSCC--CCCGGGTTCTTCSEEECCSSC
T ss_pred             CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC----CCHHHHHHHHHHHHHHH--CCCCCCCCCCCCCCCCCCCCC
T ss_conf             112222222211--1112232221112222223210----00122367764311110--023433321111112234555


Q ss_pred             CCCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEE
Q ss_conf             545751323227899589475763789999100038998769
Q 001561          459 LKGHIPVWLLRCKKLQVLDLSWNHFDGNIPPWIGQMENLFYL  500 (1052)
Q Consensus       459 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  500 (1052)
                      +++..+  +..+++|+.|++++|+++ .++ .++++++|+.|
T Consensus       162 l~~l~~--l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L  199 (199)
T d2omxa2         162 VTDLKP--LANLTTLERLDISSNKVS-DIS-VLAKLTNLESL  199 (199)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred             CCCCCC--CCCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCC
T ss_conf             567701--167998999978799799-881-01278998949

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.85  E-value=1.4e-21  Score=133.63  Aligned_cols=174  Identities=19%  Similarity=0.197  Sum_probs=0.0

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-HHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99889831666999898121289998599833676773-03452128998859982698678987300058444451024
Q 001561          230 SLKQLHVDNNLLGGDLPDSLYSMSSLQHVSLSVNNFSG-QLSEKISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVA  308 (1052)
Q Consensus       230 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l  308 (1052)
                      +.+.++++++.++ .+|..+.  +++++|+|++|.|+. ..+..|..+++|++|++++|.+....+..+..+++|+.|++
T Consensus         9 ~~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L   85 (192)
T d1w8aa_           9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEE
T ss_conf             6999997089967-0298989--787889848987755302002578762721301363221212122211222210100


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf             67754587784333578884999028622375775665687665641355446699993113887666453245324345
Q 001561          309 HSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQ  388 (1052)
Q Consensus       309 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  388 (1052)
                      ++|++....+..|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|.+. .......-...++.+.+..+.++..
T Consensus        86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~-~~~~~~~~~~~l~~~~l~~~~~~c~  164 (192)
T d1w8aa_          86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN-CNCHLAWFAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC-CSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred             CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHCCCCCCEEEC
T ss_conf             355344349799807974655245774535359778568753342000364434-3530277764235403568982768


Q ss_pred             CCHHHCCCCCCCEEECCCCCCC
Q ss_conf             8310016776757852588677
Q 001561          389 VPESFGKLTSLLFLSLSNNSFN  410 (1052)
Q Consensus       389 ~~~~~~~l~~L~~L~L~~N~l~  410 (1052)
                      .|   ..+..++.++++.|.+.
T Consensus       165 ~p---~~l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         165 AP---SKVRDVQIKDLPHSEFK  183 (192)
T ss_dssp             SS---TTTTTSBGGGSCTTTCC
T ss_pred             CC---HHHCCCEEEECCHHHCC
T ss_conf             98---43369886144875575

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=4.1e-21  Score=131.06  Aligned_cols=34  Identities=24%  Similarity=0.259  Sum_probs=11.1

Q ss_pred             CCCCCEEECCCCCCCCHHHHHHCCCCCCCEEECC
Q ss_conf             9998599833676773034521289988599826
Q 001561          252 MSSLQHVSLSVNNFSGQLSEKISNLTSLRHLIIF  285 (1052)
Q Consensus       252 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  285 (1052)
                      +++|++|+++++.+++..+..+..+++|++|+++
T Consensus        70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls  103 (284)
T d2astb2          70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  103 (284)
T ss_dssp             BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             CCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCC
T ss_conf             8776514523467986789998518997571510

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=8.6e-21  Score=129.25  Aligned_cols=13  Identities=23%  Similarity=0.335  Sum_probs=4.3

Q ss_pred             CCCCCEEECCCCC
Q ss_conf             9988599826986
Q 001561          276 LTSLRHLIIFGNQ  288 (1052)
Q Consensus       276 l~~L~~L~L~~N~  288 (1052)
                      +++|++|+++++.
T Consensus        70 c~~L~~L~L~~~~   82 (284)
T d2astb2          70 CSKLQNLSLEGLR   82 (284)
T ss_dssp             BCCCSEEECTTCB
T ss_pred             CCCCCCCCCCCCC
T ss_conf             8776514523467

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.81  E-value=3e-21  Score=131.80  Aligned_cols=50  Identities=22%  Similarity=0.460  Sum_probs=22.9

Q ss_pred             CCCCEEECCCCCCCCC----CCHHHC-CCCCCCEEECCCCCCCCCCCCCHHHHHHH
Q ss_conf             8995894757637899----991000-38998769502795644588104666430
Q 001561          471 KKLQVLDLSWNHFDGN----IPPWIG-QMENLFYLDFSNNTLTGEIPKSLTELKSL  521 (1052)
Q Consensus       471 ~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L  521 (1052)
                      +.|+.|++++|.++..    +...+. +.++|++|++++|.+.. ....+..+..+
T Consensus       273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~-~~~~~~~l~~~  327 (344)
T d2ca6a1         273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREV  327 (344)
T ss_dssp             CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT-TSHHHHHHHHH
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCC-CCHHHHHHHHH
T ss_conf             88898989898698089999999997038999989787980898-62599999999

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.81  E-value=1.3e-21  Score=133.84  Aligned_cols=15  Identities=33%  Similarity=0.467  Sum_probs=6.1

Q ss_pred             CCCCCEEECCCCCCC
Q ss_conf             789958947576378
Q 001561          470 CKKLQVLDLSWNHFD  484 (1052)
Q Consensus       470 l~~L~~L~Ls~N~l~  484 (1052)
                      .++|+.|++++|.+.
T Consensus       301 ~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         301 MPDLLFLELNGNRFS  315 (344)
T ss_dssp             CTTCCEEECTTSBSC
T ss_pred             CCCCCEEECCCCCCC
T ss_conf             899998978798089

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=4.4e-17  Score=108.55  Aligned_cols=129  Identities=19%  Similarity=0.166  Sum_probs=0.0

Q ss_pred             HHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             21289988599826986789873000584444510246775458778433357888499902862237577566568766
Q 001561          272 KISNLTSLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSL  351 (1052)
Q Consensus       272 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  351 (1052)
                      .+.+..++++|+|++|+|+ .++..+..+++|+.|++++|.++..  ..+..+++|+.|++++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             HCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf             5168574848978899788-6576200414599898979978764--774457613064310213457776322334534


Q ss_pred             CEEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCC---CHHHCCCCCCCEEE
Q ss_conf             564135544669999-31138876664532453243458---31001677675785
Q 001561          352 CTLDLATNHFSGPLP-NSLSDCHDLKILSLAKNELSGQV---PESFGKLTSLLFLS  403 (1052)
Q Consensus       352 ~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~  403 (1052)
                      +.|++++|+++.... ..+..+++|+.|++++|.++...   +..+..+++|+.||
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf             43420300016654211001365320664079963456106999998789958337

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.59  E-value=5.6e-15  Score=96.83  Aligned_cols=118  Identities=24%  Similarity=0.276  Sum_probs=0.0

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             59982698678987300058444451024677545877843335788849990286223757756656876656413554
Q 001561          280 RHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPIDLNFSGLSSLCTLDLATN  359 (1052)
Q Consensus       280 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  359 (1052)
                      |.|++++|+++ .++. ++.+++|++|++++|.++ .+|..++.+++|+.|++++|.++....  +..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~~--~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred             CEEECCCCCCC-CCCC-CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCC
T ss_conf             98986899898-8710-105898898979787168-652156554313545324321123574--123355576888898


Q ss_pred             CCCCCCC-CCCCCCCCCCEEECCCCCCCCCC---CHHHCCCCCCCEE
Q ss_conf             4669999-31138876664532453243458---3100167767578
Q 001561          360 HFSGPLP-NSLSDCHDLKILSLAKNELSGQV---PESFGKLTSLLFL  402 (1052)
Q Consensus       360 ~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L  402 (1052)
                      +++.... ..+..+++|+.|++++|+++...   ......+++|+.+
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf             65888882565379999999897996886826799999989673138

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.57  E-value=6.8e-17  Score=107.52  Aligned_cols=148  Identities=24%  Similarity=0.284  Sum_probs=0.0

Q ss_pred             CCCCCCCEEEECCC--CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCC
Q ss_conf             35788849990286--2237577566568766564135544669999311388766645324532434583100167767
Q 001561          322 SLCSKLHVLDLRNN--SLTGPIDLNFSGLSSLCTLDLATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPESFGKLTSL  399 (1052)
Q Consensus       322 ~~l~~L~~L~L~~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  399 (1052)
                      .....++.++++++  .+. ..+..+..+++|++|+|++|.|+ .++ .+..+++|+.|++++|.++ .++..+..++.|
T Consensus        20 ~~~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L   95 (198)
T d1m9la_          20 VVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL   95 (198)
T ss_dssp             CCCTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHC
T ss_pred             CCCCCCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCC
T ss_conf             8545331002555568520-02467762604615199446899-864-4247825357341353432-100003322123


Q ss_pred             CEEECCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCHH----------HH
Q ss_conf             57852588677776640000137665267424565676689-55458776648981588354575132----------32
Q 001561          400 LFLSLSNNSFNHLSGTLSVLQQCKNLTTLILTKNFVGEEIP-ENVGGFESLMVLALGNCGLKGHIPVW----------LL  468 (1052)
Q Consensus       400 ~~L~L~~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~p~~----------l~  468 (1052)
                      +.|++++|.++.+    +.+..+++|+.|++++|.+..... ..+..+++|+.|++++|.+....+..          +.
T Consensus        96 ~~L~l~~N~i~~l----~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~  171 (198)
T d1m9la_          96 EELWISYNQIASL----SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK  171 (198)
T ss_dssp             CEEECSEEECCCH----HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHH
T ss_pred             CCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf             3333333222222----222222234111234102125542212367776302342798434676322220558999998


Q ss_pred             CCCCCCEEE
Q ss_conf             278995894
Q 001561          469 RCKKLQVLD  477 (1052)
Q Consensus       469 ~l~~L~~L~  477 (1052)
                      .+|+|+.||
T Consensus       172 ~lp~L~~LD  180 (198)
T d1m9la_         172 RLPNLKKLD  180 (198)
T ss_dssp             HCSSCCEES
T ss_pred             HCCCCCEEC
T ss_conf             788958769

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=1.1e-13  Score=89.65  Aligned_cols=89  Identities=19%  Similarity=0.159  Sum_probs=37.4

Q ss_pred             CCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             2228867896866799-789989602558887648834677244854432346677118980576567743333457752
Q 001561          105 SLGHLNQLKLLDLSCN-HLEGVVPVELSNLKQLEVLDLSHNMLSGPVSGMLAGLNLIQSLNVSSNSFNGSLFELGEFSNL  183 (1052)
Q Consensus       105 ~l~~l~~L~~L~Ls~n-~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L  183 (1052)
                      .+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++|+++..+.......+|
T Consensus        26 ~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l  105 (156)
T d2ifga3          26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL  105 (156)
T ss_dssp             TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCC
T ss_pred             CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCCCC
T ss_conf             02576565743168986644369212256666672162021247742011124554333322678785157456335321


Q ss_pred             CEEEECCCCC
Q ss_conf             1998128735
Q 001561          184 AVFNISNNSF  193 (1052)
Q Consensus       184 ~~L~Ls~n~l  193 (1052)
                      +.|+|++|.+
T Consensus       106 ~~L~L~~Np~  115 (156)
T d2ifga3         106 QELVLSGNPL  115 (156)
T ss_dssp             CEEECCSSCC
T ss_pred             CCCCCCCCCC
T ss_conf             2433579863

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.24  E-value=4.3e-11  Score=75.16  Aligned_cols=150  Identities=16%  Similarity=0.109  Sum_probs=103.3

Q ss_pred             HHHHHHHCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCEEEEECEEEECCEE
Q ss_conf             89999630875568472128528999998799589999944884354999999999999549-98500240348608907
Q 001561          764 SDLLKSTNNFNQANIIGCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDR  842 (1052)
Q Consensus       764 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  842 (1052)
                      .++.+..+.|+..+..+.+..+.||++.. ++..+++|+...........+.+|...+..+. +-.+.+++++..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf             99997513527997678998771899990-89869999848876532556999999999876069987289997508964


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q ss_conf             9999824479833230004687645599999999999999999987417-------------------------------
Q 001561          843 LLIYSYMENGSLDYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKVC-------------------------------  891 (1052)
Q Consensus       843 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------  891 (1052)
                      ++||++++|..+.+.....         .....++.++++.++.||+..                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEECCCCCCCCCCCCC---------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf             9999860433435433440---------2699999989999999855684214357644656555778998776555543


Q ss_pred             -------------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             -------------------------99849769999866877899769901144322
Q 001561          892 -------------------------EPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       892 -------------------------~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~  923 (1052)
                                               ...++|+|+.+.||++++++...++||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             033232005799999999844986781789860047642364996599960231441

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.79  E-value=3.1e-08  Score=59.18  Aligned_cols=131  Identities=16%  Similarity=0.075  Sum_probs=86.6

Q ss_pred             EECCCC-CEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC--CCCEEEEECEEEECCEEEEEEEECCCCCH
Q ss_conf             472128-528999998799589999944884354999999999999549--98500240348608907999982447983
Q 001561          778 IIGCGG-FGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQ--HKNLVSLQGYCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       778 ~LG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      .+..|. .+.||+....++..+++|.......   ..+..|...++.+.  .-.+.+++++..+++..++||++++|..+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             76786547758999938987899995896677---689999999999986599988613222456615999874413554


Q ss_pred             HHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q ss_conf             323000468764559999999999999999998741--------------------------------------------
Q 001561          855 DYWLHESVDKDSVLKWDVRLKIAQGAARGLAYLHKV--------------------------------------------  890 (1052)
Q Consensus       855 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  890 (1052)
                      .+..         ...   ...+.++++.++.||+.                                            
T Consensus        94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             CCCC---------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHH
T ss_conf             3221---------268---9999999999998736885448875541246889999998754110113401121379999


Q ss_pred             -----------CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             -----------799849769999866877899769901144322
Q 001561          891 -----------CEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       891 -----------~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~  923 (1052)
                                 ....++|+|+.+.||+++++..+.++||+.+..
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             99998718765795678678887635773796589998533265

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.70  E-value=5.3e-10  Score=69.06  Aligned_cols=121  Identities=21%  Similarity=0.106  Sum_probs=0.0

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC--CCCCCCCCCCEEE
Q ss_conf             88599826986789873000584444510246775458778433357888499902862237577--5665687665641
Q 001561          278 SLRHLIIFGNQFSGKLPNVLGNLTQLEFFVAHSNSFSGPLPLSLSLCSKLHVLDLRNNSLTGPID--LNFSGLSSLCTLD  355 (1052)
Q Consensus       278 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~  355 (1052)
                      +.+.|++++.    .....+..+..+..+....+... .++.....++.|++|++++|+|+...+  ..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l----~~~~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGL----RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCC----SSCTTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             HHCEEECCCC----CCCCHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCC
T ss_conf             3086534359----89821554664011225556766-607889748787886377766667731588986588561000


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHH-------HCCCCCCCEEE
Q ss_conf             3554466999931138876664532453243458310-------01677675785
Q 001561          356 LATNHFSGPLPNSLSDCHDLKILSLAKNELSGQVPES-------FGKLTSLLFLS  403 (1052)
Q Consensus       356 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~-------~~~l~~L~~L~  403 (1052)
                      |++|.++...+-.+.....|+.+++++|.++......       +..+|+|+.||
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             CCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf             4357213423442220331042664899767676661569999999889978799

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.58  E-value=2.6e-07  Score=54.06  Aligned_cols=76  Identities=13%  Similarity=0.056  Sum_probs=48.4

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEEECCC-------CHHHHHHHHHHHHHHHHCC-C-C-CEEEEECEEEECCEEEE
Q ss_conf             684721285289999987-9958999994488-------4354999999999999549-9-8-50024034860890799
Q 001561          776 ANIIGCGGFGLVYKATLT-NGTKAAVKRLSGD-------CGQMEREFQAEVEALSRAQ-H-K-NLVSLQGYCRHGNDRLL  844 (1052)
Q Consensus       776 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~-~iv~~~~~~~~~~~~~l  844 (1052)
                      .+.||.|....||++... ++..+++|.-...       .+....+...|.+.++.+. + | .+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf             99807985276899995799848999617713034677788877899999999998650579885528998--5988779


Q ss_pred             EEEECCCCC
Q ss_conf             998244798
Q 001561          845 IYSYMENGS  853 (1052)
Q Consensus       845 v~e~~~~g~  853 (1052)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEECCCCCC
T ss_conf             871357765

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.29  E-value=4.2e-07  Score=52.88  Aligned_cols=110  Identities=13%  Similarity=0.155  Sum_probs=0.0

Q ss_pred             CCCCCCCEEECCC-CCCCCCC-----CCCCCCCCCCEEEECCCCCC---CCCCHHHHHCCCCCCEEECCCCCCCC-----
Q ss_conf             4667711898057-6567743-----33345775219981287357---86304554114434244356743333-----
Q 001561          155 AGLNLIQSLNVSS-NSFNGSL-----FELGEFSNLAVFNISNNSFT---GKLNSRIWSASKEIQILDLSMNHFMG-----  220 (1052)
Q Consensus       155 ~~l~~L~~L~L~~-N~l~~~~-----~~l~~l~~L~~L~Ls~n~l~---~~~~~~~~~~l~~L~~L~ls~n~l~~-----  220 (1052)
                      .+.+.|++|+|++ +.+....     ..+...++|+.|++++|.+.   ...-...+...+.|+.|++++|.+..     
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf             28999819782799998989999999997637764540120156215679887531000234330033010214599999


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCC-------CCCCCCCCCCCCEEECCCCC
Q ss_conf             456688999998898316669998-------98121289998599833676
Q 001561          221 SLQGLDHSPSLKQLHVDNNLLGGD-------LPDSLYSMSSLQHVSLSVNN  264 (1052)
Q Consensus       221 ~~~~l~~~~~L~~L~L~~N~l~~~-------~~~~l~~l~~L~~L~L~~n~  264 (1052)
                      +..++...++|++|++++|.+...       +...+...+.|+.|+++.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             999998489389877887768886579999999999729985386486888

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.29  E-value=7.5e-06  Score=45.92  Aligned_cols=139  Identities=11%  Similarity=0.091  Sum_probs=77.5

Q ss_pred             CCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCC--EEEEEC-----EEEECCEEEEEEEECCCCCH
Q ss_conf             28528999998799589999944884354999999999999549985--002403-----48608907999982447983
Q 001561          782 GGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHKN--LVSLQG-----YCRHGNDRLLIYSYMENGSL  854 (1052)
Q Consensus       782 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~-----~~~~~~~~~lv~e~~~~g~L  854 (1052)
                      +..-.||++...+|..|++|+.... .....++..|...+..+....  ++..+.     .+......+.++++++|..+
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             CCCCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf             6120269998389997999984787-788999999999999998559987875206898056653479999865277688


Q ss_pred             HHH--------------HHC----CC-CCCCCCC-------------------HHHHHHHHHHHHHHHHHHHH----CCC
Q ss_conf             323--------------000----46-8764559-------------------99999999999999999874----179
Q 001561          855 DYW--------------LHE----SV-DKDSVLK-------------------WDVRLKIAQGAARGLAYLHK----VCE  892 (1052)
Q Consensus       855 ~~~--------------l~~----~~-~~~~~l~-------------------~~~~~~i~~~i~~~l~~LH~----~~~  892 (1052)
                      ...              ++.    .. ......+                   ...+..+...+...++.+..    ...
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf             99999999998999999886303578655677897887665689998747699889899999999999999984545687


Q ss_pred             CCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             9849769999866877899769901144322
Q 001561          893 PHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       893 ~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~  923 (1052)
                      .+++|+|+.+.|||++++  ..++||+.+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             120247888042878389--35886520146

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=98.21  E-value=7.4e-05  Score=40.35  Aligned_cols=160  Identities=10%  Similarity=-0.018  Sum_probs=84.1

Q ss_pred             CCHHHHHHHHCCCCCCCEE-----CCCCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCC--CEEEEE
Q ss_conf             4498999963087556847-----212852899999879958999994488435499999999999954998--500240
Q 001561          761 LTVSDLLKSTNNFNQANII-----GCGGFGLVYKATLTNGTKAAVKRLSGDCGQMEREFQAEVEALSRAQHK--NLVSLQ  833 (1052)
Q Consensus       761 ~~~~~~~~~~~~y~~~~~L-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~  833 (1052)
                      .+.+++.....+|.++++.     ..|.--+.|++...+ .++++|++.....  ..++..|.+.+..+...  .+...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-DPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECC-CCEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             899999999986799985685237888526738999789-7289998078999--8899999999875430255545564


Q ss_pred             C------EEEECCEEEEEEEECCCCCHHHHHHC------------------CC-CCCC------------------CCCH
Q ss_conf             3------48608907999982447983323000------------------46-8764------------------5599
Q 001561          834 G------YCRHGNDRLLIYSYMENGSLDYWLHE------------------SV-DKDS------------------VLKW  870 (1052)
Q Consensus       834 ~------~~~~~~~~~lv~e~~~~g~L~~~l~~------------------~~-~~~~------------------~l~~  870 (1052)
                      .      +.........++.+..+......-..                  .. ....                  ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf             10489762134125502453114655333204678888899876454443202453101110120024567777653114


Q ss_pred             HHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             9999999999999999874-1799849769999866877899769901144322
Q 001561          871 DVRLKIAQGAARGLAYLHK-VCEPHIVHRDVKSSNILLDEKFEAHLADFGLSRL  923 (1052)
Q Consensus       871 ~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~  923 (1052)
                      ......+......+...+. ....+++|+|+.+.|++++.+...-++||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             127999999987642048554545033378636564020454126742221236

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=98.17  E-value=1e-05  Score=45.12  Aligned_cols=73  Identities=15%  Similarity=0.097  Sum_probs=48.5

Q ss_pred             CCEECCCCCEEEEEEEECCC--------CEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCEEEEECEEEECCEEEEEE
Q ss_conf             68472128528999998799--------589999944884354999999999999549-985002403486089079999
Q 001561          776 ANIIGCGGFGLVYKATLTNG--------TKAAVKRLSGDCGQMEREFQAEVEALSRAQ-HKNLVSLQGYCRHGNDRLLIY  846 (1052)
Q Consensus       776 ~~~LG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  846 (1052)
                      .+.|+.|-.-.+|++...++        ..|.+++......  .....+|..+++.+. +.-..++++++.+    ..|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCCH--HHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf             99917853343489996887754457898179996599611--65899999999999757999808998189----5699


Q ss_pred             EECCCCCH
Q ss_conf             82447983
Q 001561          847 SYMENGSL  854 (1052)
Q Consensus       847 e~~~~g~L  854 (1052)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEECCCCC
T ss_conf             97345548

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.88  E-value=2.3e-06  Score=48.75  Aligned_cols=111  Identities=16%  Similarity=0.181  Sum_probs=0.0

Q ss_pred             CCCCCCCEEEECC-CCCCCCCCHHHHH---CCCCCCEEECCCCCC-----CCCCCCCCCCCCCCEEECCCCCCCC----C
Q ss_conf             4577521998128-7357863045541---144342443567433-----3345668899999889831666999----8
Q 001561          178 GEFSNLAVFNISN-NSFTGKLNSRIWS---ASKEIQILDLSMNHF-----MGSLQGLDHSPSLKQLHVDNNLLGG----D  244 (1052)
Q Consensus       178 ~~l~~L~~L~Ls~-n~l~~~~~~~~~~---~l~~L~~L~ls~n~l-----~~~~~~l~~~~~L~~L~L~~N~l~~----~  244 (1052)
                      .+.++|++|++++ +.++......++.   ..+.|+.|++++|.+     ..+...+...++++.+++++|.++.    .
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf             55999868876899998989999999888419825743015896117789999987752122101210254322014788


Q ss_pred             CCCCCCCCCCCCE--EECCCCCCCC----HHHHHHCCCCCCCEEECCCCC
Q ss_conf             9812128999859--9833676773----034521289988599826986
Q 001561          245 LPDSLYSMSSLQH--VSLSVNNFSG----QLSEKISNLTSLRHLIIFGNQ  288 (1052)
Q Consensus       245 ~~~~l~~l~~L~~--L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~  288 (1052)
                      +...+...++|+.  |+++.|.+..    .+...+...++|++|+++.+.
T Consensus        94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             99999848652477321677867679999999999849984788581898